[Document(page_content="This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability  \nfor its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official \nJournal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links \nembedded in this document  \n►B REGULATION (EC) No 1272/2008 OF THE EUROPEAN PARLIAMENT AND OF THE \nCOUNCIL  \nof 16 December 2008  \non classification, labelling and packaging of substances and mixtures, amending and repealing \nDirectives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006  \n(Text with EEA relevance)  \n(OJ L 353, 31.12.2008, p. 1)  \nAmended by:  \nOfficial Journal  \nNo page  date  \n►M1 Commission Regulation (EC) No 790/2009 of 10 August 2009  L 235  1  5.9.2009  \n►M2 Commission Regulation (EU) No 286/2011 of 10 March 2011  L  8 3  1  30.3.2011  \n►M3 Commission Regulation (EU) No 618/2012 of 10 July 2012  L 179  3  11.7.2012  \n►M4 Commission Regulation (EU) No 487/2013 of 8 May 2013  L 149  1  1.6.2013  \n►M5 Council Regulation (EU) No 517/2013 of 13 May 2013  L 158  1  10.6.2013  \n►M6 Commission Regulation (EU) No 758/2013 of 7 August 2013  L 216  1  10.8.2013  \n►M7 Commission Regulation (EU) No 944/2013 of 2 October 2013  L 261  5  3.10.2013  \n►M8 Commission Regulation (EU) No 605/2014 of 5 June 2014  L 167  3 6  6.6.2014  \n►M9 amended by Commission Regulation (EU) 2015/491 of 23 March \n2015  L 78  1 2  24.3.2015  \n►M10  Commission Regulation (EU) No 1297/2014 of 5 December 2014  L 350  1  6.12.2014  \n►M11  Commission Regulation (EU) 2015/1221 of 24 July 2015  L 197  1 0  25.7.2015  \n►M12  Commission Regulation (EU) 2016/918 of 19 May 2016  L 156  1  14.6.2016  \n►M13  Commission Regulation (EU) 2016/1179 of 19 July 2016  L 195  1 1  20.7.2016  \n►M14  Commission Regulation (EU) 2017/542 of 22 March 2017  L  7 8  1  23.3.2017  \n►M15  Commission Regulation (EU) 2017/776 of 4 May 2017  L 116  1  5.5.2017  \n►M16  Commission Regulation (EU) 2018/669 of 16 April 2018  L 115  1  4.5.2018  \n►M17  Notice concerning the classification of pitch, coal tar, high temperature \nas Aquatic Acute 1 and Aquatic Chronic 1 according to Regulatio n \n(EC) No 1272/2008 of the European Parliament and of the Council  \n2018/C 239/03  C 239  3  9.7.2018  \n►M18  Commission Regulation (EU) 2018/1480 of 4 October 2018  L 251  1  5.10.2018  02008R1272 — EN — 01.03.2022 — 021.001 — 1", metadata={'source': 'data/ycla_en.pdf', 'page': 0}), Document(page_content='►M19  Commission Regulation (EU) 2019/521 of 27 March 2019  L  8 6  1  28.3.2019  \n►M20  Regulation (EU) 2019/1243 of the European Parliament and of th e \nCouncil of 20 June 2019  L 198  241  25.7.2019  \n►M21  Commission Delegated Regulation (EU) 2020/11 of 29 October 201 9 L  6  8  10.1.2020  \n►M22  Commission Delegated Regulation (EU) 2020/217 of 4 October 201 9 L  4 4  1  18.2.2020  \n►M23  Commission Delegated Regulation (EU) 2020/1182 of 19 May 2020  L 261  2  11.8.2020  \n►M24  Commission Delegated Regulation (EU) 2020/1413 of 29 June 2020  L 326  1  8.10.2020  \n►M25  Commission Delegated Regulation (EU) 2020/1676 of 31 August 20 20 L 379  1  13.11.2020  \n►M26  Commission Delegated Regulation (EU) 2020/1677 of 31 August 20 20 L 379  3  13.11.2020  \n►M27  Commission Delegated Regulation (EU) 2021/643 of 3 February 20 21 L 133  5  20.4.2021  \n►M28  Commission Delegated Regulation (EU) 2021/797 of 8 March 2021  L 176  1  19.5.2021  \n►M29  Commission Delegated Regulation (EU) 2021/1962 of 12 August 20 21 L 400  1 6  12.11.2021  \nCorrected by:  \n►C1 Corrigendum, OJ L 16, 20.1.2011, p. 1 (1272/2008)  \n►C2 Corrigendum, OJ L 138, 26.5.2011, p. 66 (286/2011)  \n►C3 Corrigendum, OJ L 349, 21.12.2016, p. 1 (1272/2008)  \n►C4 Corrigendum, OJ L 117, 3.5.2019, p. 8 (1272/2008)  \n►C5 Corrigendum, OJ L 51, 25.2.2020, p. 13 (2020/217)  \n►C6 Corrigendum, OJ L 214, 17.6.2021, p. 72 (2020/217)  02008R1272 — EN — 01.03.2022 — 021.001 — 2', metadata={'source': 'data/ycla_en.pdf', 'page': 1}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 3  \nREGULATION (EC) No 1272/2008 OF THE EUROPEAN \nPARLIAMENT AND OF THE COUNCIL  \nof 16 December 2008  \non classification, labelling and packaging of substances and \nmixtures, amending and repealing Directives 67/548/EEC and \n1999/45/EC, and amending Regulation (EC) No 1907/2006  \n(Text with EEA relevance)  \nTITLE I  \nGENERAL ISSUES  \nArticle 1  \nPurpose and scope  \n1. The purpose of this Regulation is to ensure a high level of \nprotection of human health and the environment as well as the f ree \nmovement of substances, mixtures and articles as referred to in  \nArticle 4(8) by:  \n(a) harmonising the criteria for classification of substances a nd \nmixtures, and the rules on labelling and packaging for hazardou s \nsubstances and mixtures;  \n(b) providing an obligation for:  \n(i) manufacturers, importers and downstream users to classify \nsubstances and mixtures placed on the market;  \n(ii) suppliers to label and package substances and mixtures pla ced \non the market;  \n(iii) manufacturers, producers of articles and importers to cla ssify \nthose substances not placed on the market that are subject to \nregistration or notification under Regulation (EC) No \n1907/2006;  \n(c) providing an obligation for manufacturers and importers of \nsubstances to notify the Agency of such classifications and lab el \nelements if these have not been submitted to the Agency as part  of a \nregistration under Regulation (EC) No 1907/2006;  \n(d) establishing a list of substances with their harmonised cla ssifications \nand labelling elements at Community level in Part 3 of Annex VI ; \n(e) establishing a classification and labelling inventory of su bstances, \nwhich is made up of all notifications, submissions and harmonis ed \nclassifications and labelling elements referred to in points (c ) and \n(d). \n2. This Regulation shall not apply to the following:  \n(a) radioactive substances and mixtures within the scope of Cou ncil \nDirective 96/29/Euratom of 13 May 1996 laying down basic \nsafety standards for the protection of the health of workers an d \nthe general public against the danger arising from ionising rad i\xad\nation (  1 ); \n(b) substances and mixtures which are subject to customs superv ision, \nprovided that they do not undergo any treatment or processing, and \nwhich are in temporary storage, or in a free zone or free wareh ouse \nwith a view to re-exportation, or in transit;  ▼B \n( 1 ) OJ L 159, 29.6.1996, p. 1.', metadata={'source': 'data/ycla_en.pdf', 'page': 2}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 4  \n(c) non-isolated intermediates;  \n(d) substances and mixtures for scientific research and develop ment, \nwhich are not placed on the market, provided they are used unde r \ncontrolled conditions in accordance with Community workplace an d \nenvironmental legislation.  \n3. Waste as defined in Directive 2006/12/EC of the European \nParliament and of the Council of 5 April 2006 on waste (  1 ) is not a \nsubstance, mixture or article within the meaning of Article 2 o f this \nRegulation.  \n4. Member States may allow for exemptions from this Regulation in \nspecific cases for certain substances or mixtures, where necess ary in the \ninterests of defence.  \n5. This Regulation shall not apply to substances and mixtures i n the \nfollowing forms, which are in the finished state, intended for the final \nuser:  \n(a) medicinal products as defined in Directive 2001/83/EC;  \n(b) veterinary medicinal products as defined in Directive 2001/ 82/EC;  \n(c) cosmetic products as defined in Directive 76/768/EEC;  \n(d) medical devices as defined in Directives 90/385/EEC and \n93/42/EEC, which are invasive or used in direct physical contac t \nwith the human body, and in Directive 98/79/EC;  \n(e) food or feeding stuffs as defined in Regulation (EC) No 178 /2002 \nincluding when they are used:  \n(i) as a food additive in foodstuffs within the scope of Direct ive \n89/107/EEC;  \n(ii) as a flavouring in foodstuffs within the scope of Directiv e \n88/388/EEC and Decision 1999/217/EC;  \n(iii) as an additive in feeding stuffs within the scope of Regu lation \n(EC) No 1831/2003;  \n(iv) in animal nutrition within the scope of Directive 82/471/E EC. \n6. Save where Article 33 applies this Regulation shall not appl y to \nthe transport of dangerous goods by air, sea, road, rail or inl and \nwaterways.  \nArticle 2  \nDefinitions  \nFor the purpose of this Regulation, the following definitions s hall apply:  \n1. ‘hazard class’ means the nature of the physical, health or e nviron\xad\nmental hazard;  \n2. ‘hazard category’ means the division of criteria within each  hazard \nclass, specifying hazard severity;  \n3. ‘hazard pictogram’ means a graphical composition that includ es a \nsymbol plus other graphic elements, such as a border, backgroun d \npattern or colour that is intended to convey specific informati on on \nthe hazard concerned;  ▼B \n( 1 ) OJ L 114, 27.4.2006, p. 9.', metadata={'source': 'data/ycla_en.pdf', 'page': 3}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 5  \n4. ‘signal word’ means a word that indicates the relative level  of \nseverity of hazards to alert the reader to a potential hazard; the \nfollowing two levels are distinguished:  \n(a) ‘Danger’ means a signal word indicating the more severe \nhazard categories;  \n(b) ‘Warning’ means a signal word indicating the less severe \nhazard categories;  \n5. ‘hazard statement’ means a phrase assigned to a hazard class  and \ncategory that describes the nature of the hazards of a hazardou s \nsubstance or mixture, including, where appropriate, the degree of \nhazard;  \n6. ‘precautionary statement’ means a phrase that describes reco m\xad\nmended measure(s) to minimise or prevent adverse effects \nresulting from exposure to a hazardous substance or mixture due  \nto its use or disposal;  \n7. ‘substance’ means a chemical element and its compounds in th e \nnatural state or obtained by any manufacturing process, includi ng \nany additive necessary to preserve its stability and any impuri ty \nderiving from the process used, but excluding any solvent which  \nmay be separated without affecting the stability of the substan ce or \nchanging its composition;  \n8. ‘mixture’ means a mixture or solution composed of two or mor e \nsubstances;  \n9. ‘article’ means an object which during production is given a  special \nshape, surface or design which determines its function to a gre ater \ndegree than does its chemical composition;  \n10. ‘producer of an article’ means any natural or legal person who \nmakes or assembles an article within the Community;  \n11. ‘polymer’ means a substance consisting of molecules charact erised \nby the sequence of one or more types of monomer units. Such \nmolecules must be distributed over a range of molecular weights  \nwherein differences in the molecular weight are primarily attri bu\xad\ntable to differences in the number of monomer units. A polymer \ncomprises the following:  \n(a) a simple weight majority of molecules containing at least t hree \nmonomer units which are covalently bound to at least one other \nmonomer unit or other reactant;  \n(b) less than a simple weight majority of molecules of the same  \nmolecular weight.  \nIn the context of this definition a ‘monomer unit’ means the re acted \nform of a monomer substance in a polymer;  \n12. ‘monomer’ means a substance which is capable of forming cov alent \nbonds with a sequence of additional like or unlike molecules un der \nthe conditions of the relevant polymer-forming reaction used fo r the \nparticular process;  \n13. ‘registrant’ means the manufacturer or the importer of a su bstance \nor the producer or importer of an article submitting a registra tion \nfor a substance under Regulation (EC) No 1907/2006;  \n14. ‘manufacturing’ means production or extraction of substance s in the \nnatural state;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 4}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 6  \n15. ‘manufacturer’ means any natural or legal person establishe d within \nthe Community who manufactures a substance within the \nCommunity;  \n16. ‘import’ means the physical introduction into the customs t erritory \nof the Community;  \n17. ‘importer’ means any natural or legal person established wi thin the \nCommunity who is responsible for import;  \n18. ‘placing on the market’ means supplying or making available , \nwhether in return for payment or free of charge, to a third par ty. \nImport shall be deemed to be placing on the market;  \n19. ‘downstream user’ means any natural or legal person establi shed \nwithin the Community, other than the manufacturer or the import er, \nwho uses a substance, either on its own or in a mixture, in the  \ncourse of his industrial or professional activities. A distribu tor or a \nconsumer is not a downstream user. A re-importer exempted \npursuant to Article 2(7)(c) of Regulation (EC) No 1907/2006 \nshall be regarded as a downstream user;  \n20. ‘distributor’ means any natural or legal person established  within \nthe Community, including a retailer, who only stores and places  on \nthe market a substance, on its own or in a mixture, for third p arties;  \n21. ‘intermediate’ means a substance that is manufactured for a nd \nconsumed in or used for chemical processing in order to be tran s\xad\nformed into another substance (hereinafter referred to as ‘syn\xad\nthesis’);  \n22. ‘non-isolated intermediate’ means an intermediate that duri ng \nsynthesis is not intentionally removed (except for sampling) fr om \nthe equipment in which the synthesis takes place. Such equipmen t \nincludes the reaction vessel, its ancillary equipment, and any \nequipment through which the substance(s) pass(es) during a \ncontinuous flow or batch process as well as the pipework for \ntransfer from one vessel to another for the purpose of the next  \nreaction step, but it excludes tanks or other vessels in which the \nsubstance(s) are stored after the manufacture;  \n23. ‘the Agency’ means the European Chemicals Agency establishe d by \nRegulation (EC) No 1907/2006;  \n24. ‘competent authority’ means the authority or authorities or  bodies \nestablished by the Member States to carry out the obligations \narising from this Regulation;  \n25. ‘use’ means any processing, formulation, consumption, stora ge, \nkeeping, treatment, filling into containers, transfer from one \ncontainer to another, mixing, production of an article or any o ther \nutilisation;  \n26. ‘supplier’ means any manufacturer, importer, downstream use r or \ndistributor placing on the market a substance, on its own or in  a  \nmixture, or a mixture;  \n27. ‘alloy’ means a metallic material, homogeneous on a macrosc opic \nscale, consisting of two or more elements so combined that they  \ncannot be readily separated by mechanical means; alloys are \nconsidered to be mixtures for the purposes of this Regulation;  \n28. ‘UN RTDG’ means the United Nations Recommendations on the \nTransport of Dangerous Goods;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 5}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 7  \n29. ‘notifier’ means the manufacturer or the importer, or group  of \nmanufacturers or importers notifying to the Agency;  \n30. ‘scientific research and development’ means any scientific experi\xad\nmentation, analysis or chemical research carried out under \ncontrolled conditions;  \n31. ‘cut-off value’ means a threshold of any classified impurit y, \nadditive or individual constituent in a substance or in a mixtu re, \nabove which threshold these shall be taken into account for det er\xad\nmining if the substance or the mixture, respectively, shall be clas\xad\nsified;  \n32. ‘concentration limit’ means a threshold of any classified i mpurity, \nadditive or individual constituent in a substance or in a mixtu re that \nmay trigger classification of the substance or the mixture, res pect\xad\nively;  \n33. ‘differentiation’ means distinction within hazard classes d epending \non the route of exposure or the nature of the effects;  \n34. ‘M-factor’ means a multiplying factor. It is applied to the  concen\xad\ntration of a substance classified as hazardous to the aquatic e nvi\xad\nronment acute category 1 or chronic category 1, and is used to \nderive by the summation method the classification of a mixture in \nwhich the substance is present;  \n35. ‘package’ means the complete product of the packing operati on, \nconsisting of the packaging and its contents;  \n36. ‘packaging’ means one or more receptacles and any other \ncomponents or materials necessary for the receptacles to perfor m \ntheir containment and other safety functions;  \n37. ‘intermediate packaging’ means packaging placed between inn er \npackaging, or articles, and outer packaging.  \nArticle 3  \nHazardous substances and mixtures and specification of hazard \nclasses  \nA substance or a mixture fulfilling the criteria relating to ph ysical \nhazards, health hazards or environmental hazards, laid down in Parts \n2 to 5 of Annex I is hazardous and shall be classified in relat ion to the \nrespective hazard classes provided for in that Annex.  \nWhere, in Annex I, hazard classes are differentiated on the bas is of the \nroute of exposure or the nature of the effects, the substance o r mixture \nshall be classified in accordance with such differentiation.  \nArticle 4  \nGeneral obligations to classify, label and package  \n1. Manufacturers, importers and downstream users shall classify  \nsubstances or mixtures in accordance with Title II before placi ng \nthem on the market.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 6}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 8  \n2. Without prejudice to the requirements of paragraph 1, manufa c\xad\nturers, producers of articles and importers shall classify thos e substances \nnot placed on the market in accordance with Title II where:  \n(a) Articles 6, 7(1) or (5), 17 or 18 of Regulation (EC) No 190 7/2006 \nprovide for registration of a substance;  \n(b) Articles 7(2) or 9 of Regulation (EC) No 1907/2006 provide for \nnotification.  \n3. If a substance is subject to harmonised classification and l abelling \nin accordance with Title V through an entry in Part 3 of Annex VI, that \nsubstance shall be classified in accordance with that entry, an d a clas\xad\nsification of that substance in accordance with Title II shall not be \nperformed for the hazard classes or differentiations covered by  that \nentry.  \nHowever, where the substance also falls within one or more haza rd \nclasses or differentiations not covered by an entry in Part 3 o f Annex \nVI, classification under Title II shall be carried out for thos e hazard \nclasses or differentiations.  \n4. Where a substance or mixture is classified as hazardous, sup pliers \nshall ensure that the substance or mixture is labelled and pack aged in \naccordance with Titles III and IV, before placing it on the mar ket. \n5. In fulfilling their responsibilities under paragraph 4, dist ributors \nmay use the classification for a substance or mixture derived i n \naccordance with Title II by an actor in the supply chain.  \n6. In fulfilling their responsibilities under paragraphs 1 and 4, down\xad\nstream users may use the classification of a substance or mixtu re \nderived in accordance with Title II by an actor in the supply c hain, \nprovided that they do not change the composition of the substan ce or \nmixture.  \n7. A mixture referred to in Part 2 of Annex II that contains an y \nsubstance classified as hazardous shall not be placed on the ma rket, \nunless it is labelled in accordance with Title III.  \n8. For the purposes of this Regulation, the articles referred t o in \nsection 2.1 of Annex I shall be classified, labelled and packag ed in \naccordance with the rules for substances and mixtures before be ing \nplaced on the market.  \n9. Suppliers in a supply chain shall cooperate to meet the \nrequirements for classification, labelling and packaging in thi s Regu\xad\nlation.  \n10. Substances and mixtures shall not be placed on the market u nless \nthey comply with this Regulation.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 7}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 9  \nTITLE II  \nHAZARD CLASSIFICATION  \nCHAPTER 1  \nIdentification and examination of information  \nArticle 5  \nIdentification and examination of available information on \nsubstances  \n1. Manufacturers, importers and downstream users of a substance  \nshall identify the relevant available information for the purpo ses of \ndetermining whether the substance entails a physical, health or  environ\xad\nmental hazard as set out in Annex I, and, in particular, the fo llowing:  \n(a) data generated in accordance with any of the methods referr ed to in \nArticle 8(3);  \n(b) epidemiological data and experience on the effects on human s, such \nas occupational data and data from accident databases;  \n(c) any other information generated in accordance with section 1 of \nAnnex XI to Regulation (EC) No 1907/2006;  \n(d) any new scientific information;  \n(e) any other information generated under internationally recog nised \nchemical programmes.  \nThe information shall relate to the forms or physical states in  which the \nsubstance is placed on the market and in which it can reasonabl y be \nexpected to be used.  \n2. Manufacturers, importers and downstream users shall examine the \ninformation referred to in paragraph 1 to ascertain whether it is \nadequate, reliable and scientifically valid for the purpose of the \nevaluation pursuant to Chapter 2 of this Title.  \nArticle 6  \nIdentification and examination of available information on mixtures  \n1. Manufacturers, importers and downstream users of a mixture s hall \nidentify the relevant available information on the mixture itse lf or the \nsubstances contained in it for the purposes of determining whet her the \nmixture entails a physical, health or environmental hazard as s et out in \nAnnex I, and, in particular, the following:  \n(a) data generated in accordance with any of the methods referr ed to in \nArticle 8(3) on the mixture itself or the substances contained in it;  \n(b) epidemiological data and experience on the effects on human s for \nthe mixture itself or the substances contained in it, such as o ccupa\xad\ntional data or data from accident databases;  \n(c) any other information generated in accordance with section 1 of \nAnnex XI to Regulation (EC) No 1907/2006 for the mixture itself  \nor the substances contained in it;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 8}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 10  \n(d) any other information generated under internationally recog nised \nchemical programmes for the mixture itself or the substances \ncontained in it.  \nThe information shall relate to the forms or physical states in  which the \nmixture is placed on the market and, when relevant, in which it  can \nreasonably be expected to be used.  \n2. Subject to paragraphs 3 and 4, where the information referre d to in \nparagraph 1 is available for the mixture itself, and the manufa cturer, \nimporter or downstream user has ascertained that information to  be \nadequate and reliable and where applicable, scientifically vali d, that \nmanufacturer, importer or downstream user shall use that inform ation \nfor the purposes of the evaluation pursuant to Chapter 2 of thi s Title.  \n3. For the evaluation of mixtures pursuant to Chapter 2 of this  Title \nin relation to the ‘germ cell mutagenicity’, ‘carcinogenicity’ and ‘repro\xad\nductive toxicity’ hazard classes referred to in sections 3.5.3. 1, 3.6.3.1 \nand 3.7.3.1 of Annex I, the manufacturer, importer or downstrea m user \nshall only use the relevant available information referred to i n paragraph \n1 for the substances in the mixture.  \nFurther, in cases where the available test data on the mixture itself \ndemonstrate germ cell mutagenic, carcinogenic or toxic to repro duction \neffects which have not been identified from the information on the \nindividual substances, those data shall also be taken into acco unt. \n4. For the evaluation of mixtures pursuant to Chapter 2 of this  Title \nin relation to the ‘biodegradation and bioaccumulation’ propert ies within \nthe ‘hazardous to the aquatic environment’ hazard class referre d to in \nsections 4.1.2.8 and 4.1.2.9 of Annex I, the manufacturer, impo rter or \ndownstream user shall only use the relevant available informati on \nreferred to in paragraph 1 for the substances in the mixture.  \n5. Where no or inadequate test data on the mixture itself of th e kind \nreferred to in paragraph 1 are available, the manufacturer, imp orter or \ndownstream user shall use other available information on indivi dual \nsubstances and similar tested mixtures which may also be consid ered \nrelevant for the purposes of determining whether the mixture is  \nhazardous, provided that that manufacturer, importer or downstr eam \nuser has ascertained that information to be adequate and reliab le for \nthe purpose of the evaluation pursuant to Article 9(4).  \nArticle 7  \nAnimal and human testing  \n1. Where new tests are carried out for the purposes of this Reg u\xad\nlation, tests on animals within the meaning of Directive 86/609 /EEC \nshall be undertaken only where no other alternatives, which pro vide \nadequate reliability and quality of data, are possible.  \n2. Tests on non-human primates shall be prohibited for the purp oses \nof this Regulation.  \n3. Tests on humans shall not be performed for the purposes of t his \nRegulation. Data obtained from other sources, such as clinical studies, \ncan however be used for the purposes of this Regulation.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 9}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 11  \nArticle 8  \nGenerating new information for substances and mixtures  \n1. For the purposes of determining whether a substance or a mix ture \nentails a health or environmental hazard as set out in Annex I to this \nRegulation, the manufacturer, importer or downstream user may, \nprovided that he has exhausted all other means of generating \ninformation including by applying the rules provided for in sec tion 1 \nof Annex XI to Regulation (EC) No 1907/2006, perform new tests.  \n2. For the purposes of determining whether a substance or a mix ture \nentails any of the physical hazards referred to in Part 2 of An nex I, the \nmanufacturer, importer or downstream user shall perform the tes ts \nrequired in that Part, unless there is adequate and reliable in formation \nalready available.  \n3. The tests referred to in paragraph 1 shall be conducted in \naccordance with one of the following methods:  \n(a) the test methods referred to in Article 13(3) of Regulation  (EC) No \n1907/2006;  \nor \n(b) sound scientific principles that are internationally recogn ised or \nmethods validated according to international procedures.  \n4. Where the manufacturer, importer or downstream user carries out \nnew ecotoxicological or toxicological tests and analyses, these  shall be \ncarried out in compliance with Article 13(4) of Regulation (EC)  No \n1907/2006.  \n5. Where new tests for physical hazards are carried out for the  \npurposes of this Regulation, they shall be carried out, at the latest \nfrom 1 January 2014, in compliance with a relevant recognised \nquality system or by laboratories complying with a relevant rec ognised \nstandard.  \n6. Tests that are carried out for the purposes of this Regulati on shall \nbe carried out on the substance or on the mixture in the form(s ) or \nphysical state(s) in which the substance or mixture is placed o n the \nmarket and in which it can reasonably be expected to be used.  \nCHAPTER 2  \nEvaluation of hazard information and decision on classification  \nArticle 9  \nEvaluation of hazard information for substances and mixtures  \n1. Manufacturers, importers and downstream users of a substance  or \na mixture shall evaluate the information identified in accordan ce with \nChapter 1 of this Title by applying to it the criteria for clas sification for \neach hazard class or differentiation in Parts 2 to 5 of Annex I , so as to \nascertain the hazards associated with the substance or mixture.  \n2. In evaluating available test data for a substance or a mixtu re which \nhave been obtained from test methods other than those referred to in \nArticle 8(3), manufacturers, importers and downstream users sha ll \ncompare the test methods employed with those indicated in that \nArticle in order to determine whether the use of those test met hods \naffects the evaluation referred to in paragraph 1 of this Artic le. ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 10}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 12  \n3. Where the criteria cannot be applied directly to available i dentified \ninformation, manufacturers, importers and downstream users shal l carry \nout an evaluation by applying a weight of evidence determinatio n using \nexpert judgement in accordance with section 1.1.1 of Annex I to  this \nRegulation, weighing all available information having a bearing  on the \ndetermination of the hazards of the substance or the mixture, a nd in \naccordance with section 1.2 of Annex XI to Regulation (EC) No \n1907/2006.  \n4. Where only the information referred to in Article 6(5) is av ailable, \nmanufacturers, importers and downstream users shall apply the b ridging \nprinciples referred to in section 1.1.3 and in each section of Parts 3 and \n4 of Annex I for the purposes of the evaluation.  \nHowever, where that information permits the application neither  of the \nbridging principles nor the principles for using expert judgeme nt and \nweight of evidence determination as described in Part 1 of Anne x I, \nmanufacturers, importers and downstream users shall evaluate th e \ninformation by applying the other method or methods described i n \neach section of Parts 3 and 4 of Annex I.  \n5. When evaluating the available information for the purposes o f \nclassification, the manufacturers, importers and downstream use rs shall \nconsider the forms or physical states in which the substance or  mixture \nis placed on the market and in which it can reasonably be expec ted to \nbe used.  \nArticle 10  \nConcentration limits and M-factors for classification of substances \nand mixtures  \n1. Specific concentration limits and generic concentration limi ts are \nlimits assigned to a substance indicating a threshold at or abo ve which \nthe presence of that substance in another substance or in a mix ture as an \nidentified impurity, additive or individual constituent leads t o the clas\xad\nsification of the substance or mixture as hazardous.  \nSpecific concentration limits shall be set by the manufacturer,  importer \nor downstream user where adequate and reliable scientific infor mation \nshows that the hazard of a substance is evident when the substa nce is \npresent at a level below the concentrations set for any hazard class in \nPart 2 of Annex I or below the generic concentration limits set  for any \nhazard class in Parts 3, 4 and 5 of Annex I.  \nIn exceptional circumstances specific concentration limits may be set by \nthe manufacturer, importer or downstream user where he has adeq uate, \nreliable and conclusive scientific information that a hazard of  a  \nsubstance classified as hazardous is not evident at a level abo ve the \nconcentrations set for the relevant hazard class in Part 2 of A nnex I or \nabove the generic concentration limits set for the relevant haz ard class \nin Parts 3, 4 and 5 of that Annex.  \n2. M-factors for substances classified as hazardous to the aqua tic \nenvironment, acute category 1 or chronic category 1, shall be e stab\xad\nlished by manufacturers, importers and downstream users.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 11}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 13  \n3. Notwithstanding paragraph 1, specific concentration limits s hall \nnot be set for harmonised hazard classes or differentiations fo r \nsubstances included in Part 3 of Annex VI.  \n4. Notwithstanding paragraph 2, M-factors shall not be set for \nharmonised hazard classes or differentiations for substances in cluded \nin Part 3 of Annex VI for which an M-factor is given in that Pa rt. \nHowever, where an M-factor is not given in Part 3 of Annex VI f or \nsubstances classified as hazardous to the aquatic environment, acute \ncategory 1 or chronic category 1, an M-factor based on availabl e data \nfor the substance shall be set by the manufacturer, importer or  down\xad\nstream user. When a mixture including the substance is classifi ed by the \nmanufacturer, importer or downstream user using the summation \nmethod, this M-factor shall be used.  \n5. In setting the specific concentration limit or M-factor manu fac\xad\nturers, importers and downstream users shall take into account any \nspecific concentration limits or M-factors for that substance w hich \nhave been included in the classification and labelling inventor y. \n6. Specific concentration limits set in accordance with paragra ph 1 \nshall take precedence over the concentrations in the relevant s ections of \nPart 2 of Annex I or the generic concentration limits for class ification in \nthe relevant sections of Parts 3, 4 and 5 of Annex I.  \n7. The Agency shall provide further guidance for the applicatio n of \nparagraphs 1 and 2.  \nArticle 11  \nCut-off values  \n1. Where a substance contains another substance, itself classif ied as \nhazardous, whether in the form of an identified impurity, addit ive or \nindividual constituent, this shall be taken into account for th e purposes \nof classification, if the concentration of the identified impur ity, additive \nor individual constituent is equal to, or greater than, the app licable cut- \noff value in accordance with paragraph 3.  \n2. Where a mixture contains a substance classified as hazardous , \nwhether as a component or in the form of an identified impurity  or \nadditive, this information shall be taken into account for the purposes of \nclassification, if the concentration of that substance is equal  to or greater \nthan its cut-off value in accordance with paragraph 3.  \n3. The cut-off value referred to in paragraphs 1 and 2 shall be  \ndetermined as set out in section 1.1.2.2 of Annex I.  \nArticle 12  \nSpecific cases requiring further evaluation  \nWhere, as a result of the evaluation carried out pursuant to Ar ticle 9, the \nfollowing properties or effects are identified, manufacturers, importers \nand downstream users shall take them into account for the purpo ses of \nclassification:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 12}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 14  \n(a) adequate and reliable information demonstrates that in prac tice the \nphysical hazards of a substance or a mixture differ from those \nshown by tests;  \n(b) conclusive scientific experimental data show that the subst ance or \nmixture is not biologically available and those data have been ascer\xad\ntained to be adequate and reliable;  \n(c) adequate and reliable scientific information demonstrates t he \npotential occurrence of synergistic or antagonistic effects amo ng \nthe substances in a mixture for which the evaluation was decide d \non the basis of the information for the substances in the mixtu re. \nArticle 13  \nDecision to classify substances and mixtures  \nIf the evaluation undertaken pursuant to Article 9 and Article 12 shows \nthat the hazards associated with the substance or mixture meet the \ncriteria for classification in one or more hazard classes or di fferenti\xad\nations in Parts 2 to 5 of Annex I, manufacturers, importers and  down\xad\nstream users shall classify the substance or mixture in relatio n to the \nrelevant hazard class or classes or differentiations by assigni ng the \nfollowing:  \n(a) one or more hazard categories for each relevant hazard clas s or \ndifferentiation;  \n(b) subject to Article 21, one or more hazard statements corres ponding \nto each hazard category assigned in accordance with (a).  \nArticle 14  \nSpecific rules for the classification of mixtures  \n1. The classification of a mixture shall not be affected where the \nevaluation of the information indicates any of the following:  \n(a) that the substances in the mixture react slowly with atmosp heric \ngases, in particular oxygen, carbon dioxide, water vapour, to f orm \ndifferent substances at low concentration;  \n(b) that the substances in the mixture react very slowly with o ther \nsubstances in the mixture to form different substances at low \nconcentration;  \n(c) that the substances in the mixture may self-polymerise to f orm \noligomers or polymers, at low concentration.  \n2. A mixture need not be classified for explosive, oxidising, o r \nflammable properties as referred to in Part 2 of Annex I provid ed \nthat any of the following requirements are met:  \n(a) none of the substances in the mixture possesses any of thos e prop\xad\nerties and, on the basis of the information available to the su pplier, \nthe mixture is unlikely to present hazards of this kind;  \n(b) in the event of a change in the composition of a mixture, s cientific \nevidence indicates that an evaluation of the information on the  \nmixture will not lead to a change in classification.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 13}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 15  \n__________  \n▼B \nArticle 15  \nReview of classification for substances and mixtures  \n1. Manufacturers, importers and downstream users shall take all  \nreasonable steps available to them to make themselves aware of new \nscientific or technical information that may affect the classif ication of \nthe substances or mixtures they place on the market. When a man u\xad\nfacturer, importer or downstream user becomes aware of such \ninformation which he considers to be adequate and reliable, tha t manu\xad\nfacturer, importer or downstream user shall without undue delay  carry \nout a new evaluation in accordance with this Chapter.  \n2. Where the manufacturer, importer or downstream user introduc es a \nchange to a mixture that has been classified as hazardous, that  manu\xad\nfacturer, importer or downstream user shall carry out a new eva luation \nin accordance with this Chapter where the change is either of t he \nfollowing:  \n(a) a change in the composition of the initial concentration of  one or \nmore of the hazardous constituents in concentrations at or abov e the \nlimits in Table 1.2 of Part 1 of Annex I;  \n(b) a change in the composition involving the substitution or a ddition of \none or more constituents in concentrations at or above the cut- off \nvalue referred to in Article 11(3).  \n3. A new evaluation in accordance with paragraphs 1 and 2 shall  not \nbe required if there is valid scientific justification that thi s will not result \nin a change of classification.  \n4. Manufacturers, importers and downstream users shall adapt th e \nclassification of the substance or the mixture in accordance wi th the \nresults of the new evaluation except where there are harmonised  hazard \nclasses or differentiations for substances included in Part 3 o f Annex VI.  \n5. For paragraphs 1 to 4 of this Article, when the substance or  \nmixture concerned is within the scope of Directive 91/414/EEC o r \nDirective 98/8/EC, the requirements of those Directives shall a lso apply.  \nArticle 16  \nClassification of substances included in the classification and \nlabelling inventory  \n1. Manufacturers and importers may classify a substance differe ntly \nfrom the classification already included in the classification and \nlabelling inventory, provided they submit the reasons for the c lassifi\xad\ncation to the Agency together with the notification in accordan ce with \nArticle 40.  \n2. Paragraph 1 shall not apply if the classification included i n the \nclassification and labelling inventory is a harmonised classifi cation \nincluded in Part 3 of Annex VI.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 14}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 16  \nTITLE III  \nHAZARD COMMUNICATION IN THE FORM OF LABELLING  \nCHAPTER 1  \nContent of the label  \nArticle 17  \nGeneral rules  \n1. A substance or mixture classified as hazardous and contained  in \npackaging shall bear a label including the following elements:  \n(a) the name, address and telephone number of the supplier(s);  \n(b) the nominal quantity of the substance or mixture in the pac kage \nmade available to the general public, unless this quantity is \nspecified elsewhere on the package;  \n(c) product identifiers as specified in Article 18;  \n(d) where applicable, hazard pictograms in accordance with Arti cle 19;  \n(e) where applicable, signal words in accordance with Article 2 0; \n(f) where applicable, hazard statements in accordance with Arti cle 21;  \n(g) where applicable, the appropriate precautionary statements in \naccordance with Article 22;  \n(h) where applicable, a section for supplemental information in  \naccordance with Article 25.  \n2. The label shall be written in the official language(s) of th e \nMember State(s) where the substance or mixture is placed on the  \nmarket, unless the Member State(s) concerned provide(s) otherwi se. \nSuppliers may use more languages on their labels than those req uired by \nthe Member States, provided that the same details appear in all  \nlanguages used.  \nArticle 18  \nProduct identifiers  \n1. The label shall include details permitting the identificatio n of the \nsubstance or mixture (hereinafter referred to as ‘product ident ifiers’).  \nThe term used for identification of the substance or mixture sh all be the \nsame as that used in the safety data sheet drawn up in accordan ce with \nArticle 31 of Regulation (EC) No 1907/2006 (hereinafter referre d to as \n‘safety data sheet’), without prejudice to Article 17(2) of thi s Regu\xad\nlation.  \n2. The product identifier for a substance shall consist of at l east the \nfollowing:  \n(a) if the substance is included in Part 3 of Annex VI, a name and an \nidentification number as given therein;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 15}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 17  \n(b) if the substance is not included in Part 3 of Annex VI, but  appears \nin the classification and labelling inventory, a name and an id enti\xad\nfication number as given therein;  \n(c) if the substance is not included in Part 3 of Annex VI nor in the \nclassification and labelling inventory, the number provided by the \nCAS (hereinafter referred to as ‘the CAS number’), together wit h \nthe name set out in the nomenclature provided by the IUPAC (her e\xad\ninafter referred to as ‘the IUPAC Nomenclature’), or the CAS \nnumber together with another international chemical name(s); or  \n(d) if the CAS number is not available, the name set out in the  IUPAC \nNomenclature or another international chemical name(s).  \nWhere the name in the IUPAC nomenclature exceeds 100 characters , \none of the other names (usual name, trade name, abbreviation) r eferred \nto in section 2.1.2 of Annex VI to Regulation (EC) No 1907/2006  may \nbe used provided that the notification in accordance with Artic le 40 \nincludes both the name set out in the IUPAC Nomenclature and th e \nother name used.  \n3. The product identifier for a mixture shall consist of both o f the \nfollowing:  \n(a) the trade name or the designation of the mixture;  \n(b) the identity of all substances in the mixture that contribu te to the \nclassification of the mixture as regards acute toxicity, skin c orrosion \nor serious eye damage, germ cell mutagenicity, carcinogenicity,  \nreproductive toxicity, respiratory or skin sensitisation, speci fic \ntarget organ toxicity (STOT) or aspiration hazard.  \nWhere, in the case referred to in (b), that requirement leads t o the \nprovision of multiple chemical names, a maximum of four chemica l \nnames shall suffice, unless more than four names are needed to \nreflect the nature and the severity of the hazards.  \nThe chemical names selected shall identify the substances prima rily \nresponsible for the major health hazards which have given rise to the \nclassification and the choice of the corresponding hazard state ments.  \nArticle 19  \nHazard pictograms  \n1. The label shall include the relevant hazard pictogram(s), in tended \nto convey specific information on the hazard concerned.  \n2. Subject to Article 33, hazard pictograms shall fulfil the \nrequirements laid down in section 1.2.1 of Annex I and in Annex  V . \n3. The hazard pictogram relevant for each specific classificati on is set \nout in the tables indicating the label elements required for ea ch hazard \nclass in Annex I.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 16}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 18  \nArticle 20  \nSignal words  \n1. The label shall include the relevant signal word in accordan ce with \nthe classification of the hazardous substance or mixture.  \n2. The signal word relevant for each specific classification is  set out \nin the tables indicating the label elements required for each h azard class \nin Parts 2 to 5 of Annex I.  \n3. Where the signal word ‘Danger’ is used on the label, the sig nal \nword ‘Warning’ shall not appear on the label.  \nArticle 21  \nHazard statements  \n1. The label shall include the relevant hazard statements in \naccordance with the classification of the hazardous substance o r \nmixture.  \n2. The hazard statements relevant for each classification are s et out in \nthe tables indicating the label elements required for each haza rd class in \nParts 2 to 5 of Annex I.  \n3. Where a substance is included in Part 3 of Annex VI, the haz ard \nstatement relevant for each specific classification covered by the entry in \nthat Part shall be used on the label, together with the hazard statements \nreferred to in paragraph 2 for any other classification not cov ered by \nthat entry.  \n4. The hazard statements shall be worded in accordance with Ann ex \nIII. \nArticle 22  \nPrecautionary statements  \n1. The label shall include the relevant precautionary statement s. \n2. The precautionary statements shall be selected from those se t out \nin the tables in Parts 2 to 5 of Annex I indicating the label e lements for \neach hazard class.  \n3. The precautionary statements shall be selected in accordance  with \nthe criteria laid down in Part 1 of Annex IV taking into accoun t the \nhazard statements and the intended or identified use or uses of  the \nsubstance or the mixture.  \n4. The precautionary statements shall be worded in accordance w ith \nPart 2 of Annex IV.  \nArticle 23  \nDerogations from labelling requirements for special cases  \nThe specific provisions on labelling laid down in section 1.3 o f Annex I \nshall apply in respect of the following:  \n(a) transportable gas cylinders;  \n(b) gas containers intended for propane, butane or liquefied pe troleum \ngas; ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 17}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 19  \n(c) aerosols and containers fitted with a sealed spray attachme nt and \ncontaining substances or mixtures classified as presenting an \naspiration hazard;  \n(d) metals in massive form, alloys, mixtures containing polymer s, \nmixtures containing elastomers;  \n(e) explosives, as referred to in section 2.1 of Annex I, place d on the \nmarket with a view to obtaining an explosive or pyrotechnic eff ect; \n▼M12  \n(f) substances or mixtures classified as corrosive to metals bu t not \nclassified as skin corrosion or as serious eye damage (Category  1). \n▼B \nArticle 24  \nRequest for use of an alternative chemical name  \n1. The manufacturer, importer or downstream user of a substance  in \na mixture may submit a request to the Agency to use an alternat ive \nchemical name which refers to that substance in a mixture eithe r by \nmeans of a name that identifies the most important functional c hemical \ngroups or by means of an alternative designation, where the sub stance \nmeets the criteria set out in Part 1 of Annex I and where he ca n demon\xad\nstrate that disclosure on the label or in the safety data sheet  of the \nchemical identity of that substance puts the confidential natur e of his \nbusiness, in particular his intellectual property rights, at ri sk. \n2. Any request referred to in paragraph 1 of this Article shall  be \nmade in the format referred to in Article 111 of Regulation (EC ) No \n1907/2006 and shall be accompanied by a fee.  \nThe level of the fees shall be determined by the Commission in \naccordance with the regulatory procedure referred to in Article  54(2) \nof this Regulation.  \nA reduced fee shall be set for SMEs.  \n3. The Agency may require further information from the manufac\xad\nturer, importer or downstream user making the request if such \ninformation is necessary to take a decision. If the Agency rais es no \nobjection within six weeks of the request or the receipt of fur ther \nrequired information, the use of the requested name shall be de emed \nto be allowed.  \n4. If the Agency does not accept the request, the practical \narrangements referred to in Article 118(3) of Regulation (EC) N o \n1907/2006 shall apply.  \n5. The Agency shall inform competent authorities of the outcome  of \nthe request in accordance with paragraph 3 or 4 and provide the m with \nthe information submitted by the manufacturer, importer or down stream \nuser.  \n6. Where new information shows that an alternative chemical nam e \nused does not provide sufficient information for necessary heal th and \nsafety precautions to be taken at the workplace and to ensure t hat risks \nfrom handling the mixture can be controlled, the Agency shall r eview \nits decision on the use of that alternative chemical name. The Agency \nmay withdraw its decision or amend it by a decision specifying which \nalternative chemical name is allowed to be used. If the Agency \nwithdraws or amends its decision, the practical arrangements re ferred \nto in Article 118(3) of Regulation (EC) No 1907/2006 shall appl y. ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 18}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 20  \n7. Where the use of an alternative chemical name has been allow ed, \nbut the classification of the substance in a mixture for which the alter\xad\nnative name is used no longer meets the criteria set out in sec tion 1.4.1 \nof Annex I, the supplier of that substance in a mixture shall u se the \nproduct identifier for the substance in accordance with Article  18 on the \nlabel and in the safety data sheet, and not the alternative che mical name.  \n8. For substances, whether on their own or in a mixture, where a \njustification in accordance with Article 10(a)(xi) of Regulatio n (EC) No \n1907/2006 regarding information referred to in Article 119(2)(f ) or (g) \nof that Regulation has been accepted as valid by the Agency, th e manu\xad\nfacturer, importer or downstream user may use on the label and in the \nsafety data sheet a name that will be made publicly available o ver the \nInternet. For those substances in a mixture for which Article 1 19(2)(f) \nor (g) of that Regulation no longer applies, the manufacturer, importer \nor downstream user may submit a request to the Agency to use an  \nalternative chemical name as provided for in paragraph 1 of thi s Article.  \n9. Where the supplier of a mixture, before 1 June 2015, has dem on\xad\nstrated under Article 15 of Directive 1999/45/EC that the discl osure of \nthe chemical identity of a substance in a mixture puts the conf idential \nnature of his business at risk, he can continue to use the agre ed alter\xad\nnative name for the purposes of this Regulation.  \nArticle 25  \nSupplemental information on the label  \n1. Statements shall be included in the section for supplemental  \ninformation on the label where a substance or mixture classifie d as \nhazardous has the physical properties or health properties refe rred to \nin sections 1.1 and 1.2 of Annex II.  \nThe statements shall be worded in accordance with sections 1.1 and 1.2 \nof Annex II and Part 2 of Annex III.  \nWhere a substance is included in Part 3 of Annex VI, any supple mental \nhazard statements given therein for the substance shall be incl uded in \nthe supplemental information on the label.  \n2. A statement shall be included in the section for supplementa l \ninformation on the label where a substance or mixture classifie d as \nhazardous falls within the scope of Directive 91/414/EEC.  \nThe statement shall be worded in accordance with Part 4 of Anne x II \nand Part 3 of Annex III to this Regulation.  \n3. The supplier may include supplemental information in the sec tion \nfor supplemental information on the label other than that refer red to in \nparagraphs 1 and 2, provided that that information does not mak e it \nmore difficult to identify the label elements referred to in Ar ticle 17(1) \n(a) to (g) and that it provides further details and does not co ntradict or \ncast doubt on the validity of the information specified by thos e \nelements.  \n4. Statements such as ‘non-toxic’, ‘non-harmful’, ‘non-pollutin g’, \n‘ecological’ or any other statements indicating that the substa nce or \nmixture is not hazardous or any other statements that are incon sistent \nwith the classification of that substance or mixture shall not appear on \nthe label or packaging of any substance or mixture.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 19}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 21  \n__________  \n▼B \n6. Where a mixture contains any substance classified as hazardo us, it \nshall be labelled in accordance with Part 2 of Annex II.  \nThe statements shall be worded in accordance with Part 3 of Ann ex III \nand shall be placed in the supplemental information section of the label.  \nThe label shall also include the product identifier referred to  in \nArticle 18 and the name, address and telephone number of the \nsupplier of the mixture.  \n▼M21  \n7. Where under Annex VIII the submitter creates a unique formul a \nidentifier, it shall be included in the supplemental informatio n on the \nlabel in accordance with the provisions of Section 5 of Part A of that \nAnnex.  \n▼M25  \n8. In the case of a bespoke paint for which no submission in \naccordance with Annex VIII has been made and no corresponding \nunique formula identifier has been created, the unique formula \nidentifiers of all the mixtures contained in the bespoke paint in a \nconcentration exceeding 0,1 % which themselves are subject to n otifi\xad\ncation under Article 45 shall be included in the supplemental \ninformation on the label of the bespoke paint, located together  and \nlisted in descending order of the mixtures’ concentration in th e \nbespoke paint, in accordance with the provisions of Section 5 o f Part \nA of Annex VIII.  \nIn a case falling within the first subparagraph, where the conc entration \nof a mixture with a unique formula identifier in the bespoke pa int \nexceeds 5 %, the concentration of that mixture shall also be in cluded \nin the supplemental information on the label of the bespoke pai nt next \nto its unique formula identifier, in accordance with Section 3. 4 of Part B \nof Annex VIII.  \nFor the purposes of this paragraph, ‘bespoke paint’ means a pai nt that is \nformulated in limited amounts on a tailor-made basis for an ind ividual \nconsumer or professional user at the point of sale by tinting o r colour \nmixing.  \n▼B \nArticle 26  \nPrinciples of precedence for hazard pictograms  \n1. Where the classification of a substance or mixture would res ult in \nmore than one hazard pictogram on the label, the following rule s of \nprecedence shall apply to reduce the number of hazard pictogram s \nrequired:  \n(a) if the hazard pictogram ‘GHS01’ applies, the use of the haz ard \npictograms ‘GHS02’ and ‘GHS03’ shall be optional, except in \ncases where more than one of these hazard pictograms are \ncompulsory;  \n(b) if the hazard pictogram ‘GHS06’ applies, the hazard pictogr am \n‘GHS07’ shall not appear;  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 20}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 22  \n(c) if the hazard pictogram ‘GHS05’ applies, the hazard pictogr am \n‘GHS07’ shall not appear for skin or eye irritation;  \n(d) if the hazard pictogram ‘GHS08’ applies for respiratory sen siti\xad\nsation, the hazard pictogram ‘GHS07’ shall not appear for skin \nsensitisation or for skin and eye irritation;  \n▼M2 \n(e) if the hazard pictogram ‘GHS02’ or ‘GHS06’ applies, the use  of the \nhazard pictogram ‘GHS04’ shall be optional.  \n▼B \n2. Where the classification of a substance or mixture would res ult in \nmore than one hazard pictogram for the same hazard class the la bel \nshall include the hazard pictogram corresponding to the most se vere \nhazard category for each hazard class concerned.  \nFor substances that are included in Part 3 of Annex VI and also  subject \nto classification pursuant to Title II, the label shall include  the hazard \npictogram corresponding to the most severe hazard category for each \nrelevant hazard class.  \nArticle 27  \nPrinciples of precedence for hazard statements  \nIf a substance or mixture is classified within several hazard c lasses or \ndifferentiations of a hazard class, all hazard statements resul ting from \nthe classification shall appear on the label, unless there is e vident dupli\xad\ncation or redundancy.  \nArticle 28  \nPrinciples of precedence for precautionary statements  \n1. Where the selection of the precautionary statements results in \ncertain precautionary statements being clearly redundant or unn ecessary \ngiven the specific substance, mixture or packaging, such statem ents \nshall be omitted from the label.  \n2. Where the substance or mixture is supplied to the general pu blic, \none precautionary statement addressing the disposal of that sub stance or \nmixture as well as the disposal of packaging shall appear on th e label, \nunless not required under Article 22.  \nIn all other cases, a precautionary statement addressing dispos al shall \nnot be required, where it is clear that the disposal of the sub stance or \nmixture or the packaging does not present a hazard to human hea lth or \nthe environment.  \n3. Not more than six precautionary statements shall appear on t he \nlabel, unless necessary to reflect the nature and the severity of the \nhazards.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 21}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 23  \nArticle 29  \nExemptions from labelling and packaging requirements  \n1. Where the packaging of a substance or a mixture is either in  such \na shape or form or is so small that it is impossible to meet th e \nrequirements of Article 31 for a label in the languages of the \nMember State in which the substance or mixture is placed on the  \nmarket, the label elements in accordance with the first subpara graph \nof Article 17(2) shall be provided in accordance with section 1 .5.1 of \nAnnex I.  \n2. If the full label information cannot be provided in the way \nspecified in paragraph 1 the label information may be reduced i n \naccordance with section 1.5.2 of Annex I.  \n3. When a hazardous substance or mixture referred to in Part 5 of \nAnnex II is supplied to the general public without packaging it  shall be \naccompanied by a copy of the label elements in accordance with \nArticle 17.  \n4. For certain mixtures classified as hazardous to the environm ent, \nexemptions to certain provisions on environmental labelling or specific \nprovisions in relation to environmental labelling may be determ ined in \naccordance with the procedure referred to in Article 53, where it can be \ndemonstrated that there would be a reduction in the environment al \nimpact. Such exemptions or specific provisions are defined in P art 2 \nof Annex II.  \n▼M21  \n4a. Where under Annex VIII the submitter creates a unique formu la \nidentifier, the submitter may, instead of including it in the s upplemental \ninformation on the label, opt to show it in another way permitt ed by \nSection 5 of Part A of that Annex.  \n▼B \n5. The Commission may request the Agency to prepare and submit to \nit further draft exemptions from labelling and packaging requir ements.  \nArticle 30  \nUpdating information on labels  \n1. The supplier shall ensure that the label is updated, without  undue \ndelay, following any change to the classification and labelling  of that \nsubstance or mixture, where the new hazard is more severe or wh ere \nnew supplemental labelling elements are required under Article 25, \ntaking into account the nature of the change as regards the pro tection \nof human health and the environment. Suppliers shall cooperate in \naccordance with Article 4(9) to complete the changes to the lab elling \nwithout undue delay.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 22}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 24  \n2. Where labelling changes are required other than those referr ed to \nin paragraph 1, the supplier shall ensure that the label is upd ated within \n18 months.  \n3. The supplier of a substance or a mixture within the scope of  \nDirectives 91/414/EEC or 98/8/EC shall update the label in acco rdance \nwith those Directives.  \nCHAPTER 2  \nApplication of labels  \nArticle 31  \nGeneral rules for the application of labels  \n1. Labels shall be firmly affixed to one or more surfaces of th e \npackaging immediately containing the substance or mixture and s hall \nbe readable horizontally when the package is set down normally.  \n2. The colour and presentation of any label shall be such that the \nhazard pictogram stands out clearly.  \n3. The label elements referred to in Article 17(1) shall be cle arly and \nindelibly marked. They shall stand out clearly from the backgro und and \nbe of such size and spacing as to be easily read.  \n4. The shape, colour and the size of a hazard pictogram as well  as the \ndimensions of the label shall be as set out in section 1.2.1 of  Annex I.  \n5. A label shall not be required when the label elements referr ed to in \nArticle 17(1) are shown clearly on the packaging itself. In suc h cases, \nthe requirements of this Chapter applicable to a label shall be  applied to \nthe information shown on the packaging.  \nArticle 32  \nLocation of information on the label  \n1. The hazard pictograms, signal word, hazard statements and \nprecautionary statements shall be located together on the label . \n2. The supplier may decide the order of the hazard statements o n the \nlabel. However, subject to paragraph 4, all hazard statements s hall be \ngrouped on the label by language.  \nThe supplier may decide the order of the precautionary statemen ts on \nthe label. However, subject to paragraph 4, all precautionary s tatements \nshall be grouped on the label by language.  \n3. Groups of hazard statements and groups of precautionary \nstatements referred to in paragraph 2 shall be located together  on the \nlabel by language.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 23}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 25  \n4. The supplemental information shall be placed in the suppleme ntal \ninformation section referred to in Article 25, and shall be loc ated with \nthe other label elements specified in Article 17(1)(a) to (g).  \n5. In addition to its use in hazard pictograms, colour may be u sed on \nother areas of the label to implement special labelling require ments.  \n6. Label elements resulting from the requirements provided for in \nother Community acts shall be placed in the section for supplem ental \ninformation on the label referred to in Article 25.  \nArticle 33  \nSpecific rules for labelling of outer packaging, inner packaging and \nsingle packaging  \n1. Where a package consists of an outer and an inner packaging,  \ntogether with any intermediate packaging, and the outer packagi ng \nmeets labelling provisions in accordance with the rules on the \ntransport of dangerous goods, the inner and any intermediate \npackaging shall be labelled in accordance with this Regulation.  The \nouter packaging may also be labelled in accordance with this Re gu\xad\nlation. Where the hazard pictogram(s) required by this Regulati on \nrelate to the same hazard as in the rules for the transport of \ndangerous goods, the hazard pictogram(s) required by this Regul ation \nneed not appear on the outer packaging.  \n2. Where the outer packaging of a package is not required to me et \nlabelling provisions in accordance with rules on the transport of \ndangerous goods, both the outer and any inner packaging, includ ing \nany intermediate packaging, shall be labelled in accordance wit h this \nRegulation. However, if the outer packaging permits the inner o r inter\xad\nmediate packaging labelling to be clearly seen, the outer packa ging need \nnot be labelled.  \n3. Single packages that meet the labelling provisions in accord ance \nwith the rules on the transport of dangerous goods shall be lab elled both \nin accordance with this Regulation and the rules on the transpo rt of \ndangerous goods. Where the hazard pictogram(s) required by this  Regu\xad\nlation relate to the same hazard as in rules on the transport o f dangerous \ngoods, the hazard pictogram(s) required by this Regulation need  not \nappear.  \nArticle 34  \nReport on communication on safe use of chemicals  \n1. By 20 January 2012, the Agency shall carry out a study on th e \ncommunication of information to the general public on the safe use of \nsubstances and mixtures and the potential need for additional \ninformation on labels. This study shall be carried out in consu ltation \nwith competent authorities and stakeholders and drawing as appr opriate \non relevant best practice.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 24}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 26  \n2. Without prejudice to the labelling rules provided for in thi s Title, \nthe Commission shall, on the basis of the study referred to in paragraph \n1, submit a report to the European Parliament and the Council a nd, if \njustified, present a legislative proposal to amend this Regulat ion. \nTITLE IV  \nPACKAGING  \nArticle 35  \nPackaging  \n1. Packaging containing hazardous substances or mixtures shall \nsatisfy the following requirements:  \n(a) the packaging shall be designed and constructed so that its  contents \ncannot escape, except in cases where other more specific safety  \ndevices are prescribed;  \n(b) the materials constituting the packaging and fastenings sha ll not be \nsusceptible to damage by the contents, or liable to form hazard ous \ncompounds with the contents;  \n(c) the packaging and fastenings shall be strong and solid thro ughout to \nensure that they will not loosen and will safely meet the norma l \nstresses and strains of handling;  \n(d) packaging fitted with replaceable fastening devices shall b e \ndesigned so that it can be refastened repeatedly without the \ncontents escaping.  \n2. Packaging containing a hazardous substance or a mixture supp lied \nto the general public shall not have either a shape or design l ikely to \nattract or arouse the active curiosity of children or to mislea d \nconsumers, or have a similar presentation or a design used for \nfoodstuff or animal feeding stuff or medicinal or cosmetic prod ucts, \nwhich would mislead consumers.  \nWhere the packaging contains a substance or mixture which meets  the \nrequirements in section 3.1.1 of Annex II it shall have a child -resistant \nfastening in accordance with sections 3.1.2, 3.1.3 and 3.1.4.2 of \nAnnex II.  \nWhere the packaging contains a substance or mixture which meets  the \nrequirements in section 3.2.1 of Annex II it shall bear a tacti le warning \nof danger in accordance with section 3.2.2 of Annex II.  \n▼M10  \nWhere a liquid consumer laundry detergent, as defined in Articl e 2(1a) \nof Regulation (EC) No 648/2004 of the European Parliament and o f the \nCouncil (  1 ), is contained in a soluble packaging for single use, the \nadditional requirements of section 3.3 of Annex II shall apply.  \n▼B \n3. The packaging of substances and mixtures shall be deemed to \nsatisfy the requirements of paragraph 1(a), (b) and (c) if it c omplies \nwith the requirements of the rules on the transport of dangerou s goods \nby air, sea, road, rail or inland waterways.  ▼B \n( 1 ) Regulation (EC) No 648/2004 of the European Parliament and of  the Council \nof 31 March 2004 on detergents (OJ L 104, 8.4.2004, p. 1).', metadata={'source': 'data/ycla_en.pdf', 'page': 25}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 27  \nTITLE V  \nHARMONISATION OF CLASSIFICATION AND LABELLING OF \nSUBSTANCES AND THE CLASSIFICATION AND LABELLING \nINVENTORY  \nCHAPTER 1  \nEstablishing harmonised classification and labelling of substances  \nArticle 36  \nHarmonisation of classification and labelling of substances  \n1. A substance that fulfils the criteria set out in Annex I for  the \nfollowing shall normally be subject to harmonised classificatio n and \nlabelling in accordance with Article 37:  \n(a) respiratory sensitisation, category 1 (Annex I, section 3.4 ); \n(b) germ cell mutagenicity, category 1A, 1B or 2 (Annex I, sect ion \n3.5); \n(c) carcinogenicity, category 1A, 1B or 2 (Annex I, section 3.6 ); \n(d) reproductive toxicity, category 1A, 1B or 2 (Annex I, secti on 3.7).  \n2. A substance that is an active substance in the meaning of Di rective \n91/414/EEC or Directive 98/8/EC shall normally be subject to \nharmonised classification and labelling. For such substances, t he \nprocedures set out in Article 37, paragraphs 1, 4, 5 and 6 shal l apply.  \n3. Where a substance fulfils the criteria for other hazard clas ses or \ndifferentiations than those referred to in paragraph 1 and does  not fall \nunder paragraph 2, a harmonised classification and labelling in  \naccordance with Article 37 may also be added to Annex VI on a \ncase-by-case basis, if justification is provided demonstrating the need \nfor such action at Community level.  \nArticle 37  \nProcedure for harmonisation of classification and labelling of \nsubstances  \n1. A competent authority may submit to the Agency a proposal fo r \nharmonised classification and labelling of substances and, wher e appro\xad\npriate, specific concentration limits or M-factors, or a propos al for a \nrevision thereof.  \nThe proposal shall follow the format set out in Part 2 of Annex  VI and \ncontain the relevant information provided for in Part 1 of Anne x VI.  \n2. A manufacturer, importer or downstream user of a substance m ay \nsubmit to the Agency a proposal for harmonised classification a nd \nlabelling of that substance and, where appropriate, specific co ncentration \nlimits or M-factors, provided that there is no entry in Part 3 of Annex \nVI for such a substance in relation to the hazard class or diff erentiation \ncovered by that proposal.  \nThe proposal shall be drawn up in accordance with the relevant Parts of \nsections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 and it \nshall follow the format set out in Part B of the Chemical Safet y Report \nof section 7 of that Annex. It shall contain the relevant infor mation \nprovided for in Part 1 of Annex VI to this Regulation. Article 111 of \nRegulation (EC) No 1907/2006 shall apply.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 26}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 28  \n3. Where the proposal of the manufacturer, importer or downstre am \nuser concerns the harmonised classification and labelling of a substance \nin accordance with Article 36(3), it shall be accompanied by th e fee \ndetermined by the Commission in accordance with the regulatory \nprocedure referred to in Article 54(2).  \n4. The Committee for Risk Assessment of the Agency set up \npursuant to Article 76(1)(c) of Regulation (EC) No 1907/2006 sh all \nadopt an opinion on any proposal submitted pursuant to paragrap hs 1 \nor 2 within 18 months of receipt of the proposal, giving the pa rties \nconcerned the opportunity to comment. The Agency shall forward this \nopinion and any comments to the Commission.  \n▼M20  \n5. The Commission shall without undue delay adopt delegated act s in \naccordance with Article 53a, where it finds that the harmonisat ion of the \nclassification and labelling of the substance concerned is appr opriate, to \namend Annex VI by inclusion of that substance together with the  \nrelevant classification and labelling elements in Table 3.1 of Part 3 of \nAnnex VI and, where appropriate, the specific concentration lim its or \nM-factors.  \nA corresponding entry shall be included in Table 3.2 of Part 3 of Annex \nVI subject to the same conditions, until 31 May 2015.  \nWhere, in the case of harmonisation of classification and label ling of \nsubstances, imperative grounds of urgency so require, the proce dure \nprovided for in Article 53b shall apply to delegated acts adopt ed \npursuant to this paragraph.  \n▼B \n6. Manufacturers, importers and downstream users who have new \ninformation which may lead to a change of the harmonised classi fication \nand labelling elements of a substance in Part 3 of Annex VI sha ll \nsubmit a proposal in accordance with the second subparagraph of  \nparagraph 2 to the competent authority in one of the Member Sta tes \nin which the substance is placed on the market.  \nArticle 38  \nContent of opinions and decisions for harmonised classification and \nlabelling in Part 3 of Annex VI; accessibility of information  \n1. Any opinion referred to in Article 37(4) and any decision \naccording to Article 37(5) shall at least specify for each subs tance:  \n(a) the identity of the substance as specified in sections 2.1 to 2.3.4 of \nAnnex VI to Regulation (EC) No 1907/2006;  \n(b) the classification of the substance referred to in Article 36, including \na statement of reasons;  \n(c) the specific concentration limits or M-factors, where appli cable;  \n(d) the label elements specified in points (d), (e) and (f) of Article 17(1) \nfor the substance, together with any supplemental hazard statem ents \nfor the substance, determined in accordance with Article 25(1);  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 27}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 29  \n(e) any other parameter enabling an assessment to be made of th e \nhealth or environmental hazard of mixtures containing the \nhazardous substance in question or of substances containing suc h \nhazardous substances as identified impurities, additives and co nsti\xad\ntuents, if relevant.  \n2. When making publicly available an opinion or a decision as \nreferred to in Article 37(4) and (5) of this Regulation, Articl e 118(2) \nand Article 119 of Regulation (EC) No 1907/2006 shall apply.  \nCHAPTER 2  \nClassification and labelling inventory  \nArticle 39  \nScope  \nThis Chapter shall apply to:  \n(a) substances subject to registration in accordance with Regul ation \n(EC) No 1907/2006;  \n(b) substances within the scope of Article 1 which meet the cri teria for \nclassification as hazardous and are placed on the market either  on \ntheir own or in a mixture above the concentration limits specif ied in \nthis Regulation or Directive 1999/45/EC, where relevant, which \nresults in the classification of the mixture as hazardous.  \nArticle 40  \nObligation to notify the Agency  \n1. Any manufacturer or importer, or group of manufacturers or \nimporters (hereinafter referred to as ‘the notifier(s)’), who p laces on \nthe market a substance referred to in Article 39, shall notify to the \nAgency the following information in order for it to be included  in the \ninventory referred to in Article 42:  \n(a) the identity of the notifier(s) responsible for placing the  substance or \nsubstances on the market as specified in section 1 of Annex VI to \nRegulation (EC) No 1907/2006;  \n(b) the identity of the substance or substances as specified in  section \n2.1 to 2.3.4 to Annex VI to Regulation (EC) No 1907/2006;  \n(c) the classification of the substance or substances in accord ance with \nArticle 13;  \n(d) where a substance has been classified in some but not all h azard \nclasses or differentiations, an indication of whether this is d ue to \nlack of data, inconclusive data, or data which are conclusive \nalthough insufficient for classification;  \n(e) specific concentration limits or M-factors, where applicabl e, in \naccordance with Article 10 of this Regulation together with a j ustifi\xad\ncation using the relevant Parts of sections 1, 2 and 3 of Annex  I to \nRegulation (EC) No 1907/2006;  \n(f) the label elements specified in points (d), (e) and (f) of Article 17(1) \nfor the substance or substances together with any supplemental \nhazard statements for the substance, determined in accordance \nwith Article 25(1).  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 28}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 30  \nThe information referred to in (a) to (f) shall not be notified , if it has \nbeen submitted to the Agency as part of a registration pursuant  to \nRegulation (EC) No 1907/2006, or if it has already been notifie d by \nthat notifier.  \nThe notifier shall submit this information in the format specif ied \npursuant to Article 111 of Regulation (EC) No 1907/2006.  \n2. The information listed in paragraph 1 shall be updated and n otified \nto the Agency by the notifier(s) concerned when, pursuant to th e review \nin Article 15(1), a decision to change the classification and l abelling of \nthe substance has been taken.  \n3. Substances placed on the market on or after 1 December 2010 \nshall be notified in accordance with paragraph 1 within one mon th after \ntheir placing on the market.  \nHowever, substances placed on the market before 1 December 2010  \nmay be notified in accordance with paragraph 1 before that date . \nArticle 41  \nAgreed entries  \nWhere the notification in Article 40(1) results in different en tries on the \ninventory referred to in Article 42 for the same substance, the  notifiers \nand registrants shall make every effort to come to an agreed en try to be \nincluded in the inventory. The notifiers shall inform the Agenc y accord\xad\ningly.  \nArticle 42  \nThe classification and labelling inventory  \n1. The Agency shall establish and maintain a classification and  \nlabelling inventory in the form of a database.  \nThe information notified pursuant to Article 40(1) shall be inc luded in \nthe inventory, as well as information submitted as part of regi strations \nunder Regulation (EC) No 1907/2006.  \nInformation in the inventory which corresponds to the informati on \nreferred to in Article 119(1) of Regulation (EC) No 1907/2006 s hall \nbe publicly accessible. The Agency shall grant access to the ot her \ninformation on each substance in the inventory to the notifiers  and \nregistrants who have submitted information on that substance in  \naccordance with Article 29(1) of Regulation (EC) No 1907/2006. It \nshall grant access to such information to other parties subject  to \nArticle 118 of that Regulation.  \n2. The Agency shall update the inventory when it receives updat ed \ninformation in accordance with Article 40(2) or Article 41.  \n3. In addition to the information referred to in paragraph 1, t he \nAgency shall, where applicable, include the following informati on in \neach entry:  \n(a) whether, in respect of the entry, there is harmonised class ification \nand labelling at Community level by inclusion in Part 3 of Anne x \nVI; \n(b) whether, in respect of the entry, it is a joint entry betwe en regis\xad\ntrants of the same substance as referred to in Article 11(1) of  \nRegulation (EC) No 1907/2006;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 29}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 31  \n(c) whether it is an agreed entry of two or more notifiers or r egistrants \nin accordance with Article 41;  \n(d) whether the entry differs from another entry on the invento ry for the \nsame substance.  \nThe information referred to in (a) shall be updated where a dec ision is \ntaken in accordance with Article 37(5).  \nTITLE VI  \nCOMPETENT AUTHORITIES AND ENFORCEMENT  \nArticle 43  \nAppointment of competent authorities and enforcement authorities \nand cooperation between authorities  \nMember States shall appoint the competent authority or competen t auth\xad\norities responsible for proposals for harmonised classification  and \nlabelling and the authorities responsible for the enforcement o f the \nobligations set out in this Regulation.  \nThe competent authorities and the authorities responsible for e nforce\xad\nment shall cooperate with each other in the performance of thei r tasks \nunder this Regulation and shall give the corresponding authorit ies of \nother Member States all necessary and useful support to this en d. \nArticle 44  \nHelpdesk  \nMember States shall establish national helpdesks to provide adv ice to \nmanufacturers, importers, distributors, downstream users and an y other \ninterested parties on their respective responsibilities and obl igations \nunder this Regulation.  \nArticle 45  \nAppointment of bodies responsible for receiving information \nrelating to emergency health response  \n1. Member States shall appoint a body or bodies responsible for  \nreceiving information relevant, in particular, for formulating preven\xad\ntative and curative measures, in particular in the event of eme rgency \nhealth response, from importers and downstream users placing mi xtures \non the market. This information shall include the chemical comp osition \nof mixtures placed on the market and classified as hazardous on  the \nbasis of their health or physical effects, including the chemic al identity \nof substances in mixtures for which a request for use of an alt ernative \nchemical name has been accepted by the Agency, in accordance wi th \nArticle 24.  \n2. The appointed bodies shall provide all requisite guarantees for \nmaintaining the confidentiality of the information received. Su ch \ninformation may only be used:  \n(a) to meet medical demand by formulating preventative and cura tive \nmeasures, in particular in the event of an emergency;  \nand ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 30}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 32  \n(b) where requested by the Member State, to undertake statistic al \nanalysis to identify where improved risk management measures \nmay be needed.  \nThe information shall not be used for other purposes.  \n3. The appointed bodies shall have at their disposal all the \ninformation required from the importers and downstream users \nresponsible for marketing to carry out the tasks for which they  are \nresponsible.  \n▼M20  \n4. The Commission is empowered to adopt delegated acts in \naccordance with Article 53a amending Annex VIII to further \nharmonise the information relating to emergency health response  and \npreventative measures, following consultation with relevant sta keholders \nsuch as the European Association of Poison Centres and Clinical  Toxi\xad\ncologists (EAPCCT).  \n▼B \nArticle 46  \nEnforcement and reporting  \n1. Member States shall take all necessary measures, including m ain\xad\ntaining a system of official controls, to ensure that substance s and \nmixtures are not placed on the market, unless they have been cl assified, \nlabelled, notified and packaged in accordance with this Regulat ion. \n2. Member States shall submit a report to the Agency every five  \nyears by 1 July on the results of the official controls, and ot her enforce\xad\nment measures taken. The first report shall be submitted by 20 January \n2012. The Agency shall make those reports available to the \nCommission, which shall take them into account for its report u nder \nArticle 117 of Regulation (EC) No 1907/2006.  \n3. The Forum referred to in Article 76(1)(f) of Regulation (EC)  No \n1907/2006 shall undertake the tasks specified in Article 77(4)( a) to (g) \nof Regulation (EC) No 1907/2006 concerning enforcement of this Regu\xad\nlation.  \nArticle 47  \nPenalties for non-compliance  \nMember States shall introduce penalties for non-compliance with  this \nRegulation and shall take all measures necessary to ensure that  this \nRegulation is applied. The penalties must be effective, proport ionate \nand dissuasive. Member States shall notify the Commission of th e \nprovisions for penalties by 20 June 2010 and shall notify it wi thout \ndelay of any subsequent amendment affecting them.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 31}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 33  \nTITLE VII  \nCOMMON AND FINAL PROVISIONS  \nArticle 48  \nAdvertisement  \n1. Any advertisement for a substance classified as hazardous sh all \nmention the hazard classes or hazard categories concerned.  \n2. Any advertisement for a mixture classified as hazardous or \ncovered by Article 25(6) which allows a member of the general \npublic to conclude a contract for purchase without first having  sight \nof the label shall mention the type or types of hazard indicate d on the \nlabel.  \nThe first subparagraph shall be without prejudice to Directive 97/7/EC \nof the European Parliament and of the Council of 20 May 1997 on  the \nprotection of consumers in respect of distance contracts (  1 ). \nArticle 49  \nObligation to maintain information and requests for information  \n1. The supplier shall assemble and keep available all the infor mation \nused by that supplier for the purposes of classification and la belling \nunder this Regulation for a period of at least 10 years after t he \nsubstance or the mixture was last supplied by that supplier.  \nThe supplier shall keep this information together with the info rmation \nrequired in Article 36 of Regulation (EC) No 1907/2006.  \n2. In the event of a supplier ceasing activity, or transferring  part or \nall of his operations to a third party, the party responsible f or liquidating \nthe supplier's undertaking or assuming responsibility for the p lacing on \nthe market of the substance or mixture concerned shall be bound  by the \nobligation in paragraph 1 in place of the supplier.  \n3. The competent authority or the enforcement authorities of a \nMember State in which a supplier is established or the Agency m ay \nrequire the supplier to submit to it any information referred t o in the \nfirst subparagraph of paragraph 1.  \nHowever, where that information is available to the Agency as p art of a \nregistration pursuant to Regulation (EC) No 1907/2006 or a noti fication \npursuant to Article 40 of this Regulation, the Agency shall use  that \ninformation and the authority shall address itself to the Agenc y. \nArticle 50  \nTasks of the Agency  \n1. The Agency shall provide the Member States and the instituti ons \nof the Community with the best possible scientific and technica l advice \non questions relating to chemicals which fall within its remit and which \nare referred to it in accordance with this Regulation.  ▼B \n( 1 ) OJ L 144, 4.6.1997, p. 19.", metadata={'source': 'data/ycla_en.pdf', 'page': 32}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 34  \n2. The Secretariat of the Agency shall:  \n(a) provide industry with technical and scientific guidance and  tools \nwhere appropriate on how to comply with the obligations laid \ndown by this Regulation;  \n(b) provide competent authorities with technical and scientific  guidance \non the operation of this Regulation and provide support to the \nhelpdesks established by Member States under Article 44.  \nArticle 51  \nFree movement clause  \nOn grounds relating to the classification, labelling or packagi ng of \nsubstances and mixtures within the meaning of this Regulation, \nMember States shall not prohibit, restrict or impede the placin g on \nthe market of substances or mixtures which comply with this Reg ulation \nand, where appropriate, with Community acts adopted in implemen \xad\ntation of this Regulation.  \nArticle 52  \nSafeguard clause  \n1. Where a Member State has justifiable grounds for believing t hat a \nsubstance or a mixture, although satisfying the requirements of  this \nRegulation, constitutes a serious risk to human health or the e nviron\xad\nment due to reasons of classification, labelling or packaging, it may take \nappropriate provisional measures. The Member State shall immedi ately \ninform the Commission, the Agency and the other Member States \nthereof, giving the reasons for its decision.  \n2. Within 60 days of receipt of the information from the Member  \nState, the Commission shall in accordance with the regulatory p rocedure \nreferred to in Article 54(2) either authorise the provisional m easure for a \ntime period defined in the decision or require the Member State  to \nrevoke the provisional measure.  \n3. In the case of an authorisation of a provisional measure rel ated to \nclassification or labelling of a substance as referred to in pa ragraph 2, \nthe competent authority of the Member State concerned shall in \naccordance with the procedure laid down in Article 37 submit a \nproposal to the Agency for harmonised classification and labell ing, \nwithin three months of the date of the Commission decision.  \nArticle 53  \nAdaptations to technical and scientific progress \n▼M20  \n1. The Commission is empowered to adopt delegated acts in \naccordance with Article 53a amending Article 6(5), Article 11(3 ), \nArticles 12 and 14, point (b) of Article 18(3), Article 23, Art icles 25 \nto 29, the second and third subparagraphs of Article 35(2) and Annexes \nI to VIII in order to adapt them to technical and scientific pr ogress, \ntaking due account of the further development of the GHS, in pa rticular \nany UN amendments relating to the use of information on similar  \nmixtures, and considering the developments in internationally \nrecognised chemical programmes and of the data from accident da ta\xad\nbases.  \nWhere imperative grounds of urgency so require, the procedure \nprovided for in Article 53b shall apply to delegated acts adopt ed \npursuant to this paragraph.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 33}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 35  \n2. Member States and the Commission shall, in the manner appro\xad\npriate to their role in the relevant UN fora, promote the harmo nisation \nof the criteria for classification and labelling of persistent,  bioaccumu\xad\nlative and toxic (PBT) and very persistent and very bioaccumula tive \n(vPvB) substances at the level of the UN.  \n▼M20  \nArticle 53a  \nExercise of the delegation  \n1. The power to adopt delegated acts is conferred on the Commis sion \nsubject to the conditions laid down in this Article.  \n2. The power to adopt delegated acts referred to in Article 37( 5), \nArticle 45(4) and Article 53(1) shall be conferred on the Commi ssion \nfor a period of five years from 26 July 2019. The Commission sh all \ndraw up a report in respect of the delegation of power not late r than \nnine months before the end of the five-year period. The delegat ion of \npower shall be tacitly extended for periods of an identical dur ation, \nunless the European Parliament or the Council opposes such \nextension not later than three months before the end of each pe riod. \n3. The delegation of power referred to in Articles 37(5), Artic le 45(4) \nand Article 53(1) may be revoked at any time by the European \nParliament or by the Council. A decision to revoke shall put an  end \nto the delegation of the power specified in that decision. It s hall take \neffect the day following the publication of the decision in the  Official \nJournal of the European Union  or at a later date specified therein. It \nshall not affect the validity of any delegated acts already in force.  \n4. Before adopting a delegated act, the Commission shall consul t \nexperts designated by each Member State in accordance with the prin\xad\nciples laid down in the Interinstitutional Agreement of 13 Apri l 2016 on \nBetter Law-Making (  1 ). \n5. As soon as it adopts a delegated act, the Commission shall n otify \nit simultaneously to the European Parliament and to the Council . \n6. A delegated act adopted pursuant to Article 37(5), Article 4 5(4) \nand Article 53(1) shall enter into force only if no objection h as been \nexpressed either by the European Parliament or by the Council w ithin a \nperiod of two months of notification of that act to the Europea n \nParliament and the Council or if, before the expiry of that per iod, the \nEuropean Parliament and the Council have both informed the \nCommission that they will not object. That period shall be exte nded \nby two months at the initiative of the European Parliament or o f the \nCouncil.  \nArticle 53b  \nUrgency procedure  \n1. Delegated acts adopted under this Article shall enter into f orce \nwithout delay and shall apply as long as no objection is expres sed in \naccordance with paragraph 2. The notification of a delegated ac t to the \nEuropean Parliament and to the Council shall state the reasons for the \nuse of the urgency procedure.  ▼B \n( 1 ) OJ L 123, 12.5.2016, p. 1.', metadata={'source': 'data/ycla_en.pdf', 'page': 34}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 36  \n2. Either the European Parliament or the Council may object to a \ndelegated act in accordance with the procedure referred to in \nArticle 53a(6). In such a case, the Commission shall repeal the  act \nimmediately following the notification of the decision to objec t by the \nEuropean Parliament or by the Council.  \nArticle 53c  \nSeparate delegated acts for different delegated powers  \nThe Commission shall adopt a separate delegated act in respect of each \npower delegated to it pursuant to this Regulation.  \n▼B \nArticle 54  \nCommittee procedure  \n1. The Commission shall be assisted by the Committee instituted  by \nArticle 133 of Regulation (EC) No 1907/2006.  \n2. Where reference is made to this paragraph, Articles 5 and 7 of \nDecision 1999/468/EC shall apply, having regard to the provisio ns of \nArticle 8 thereof.  \nThe period laid down in Article 5 (6) of Decision 1999/468/EC s hall be \nset at three months.  \n▼M20  __________  \n▼B \nArticle 55  \nAmendments to Directive 67/548/EEC  \nDirective 67/548/EEC shall be amended as follows:  \n1. in Article 1(2), the second subparagraph shall be deleted;  \n2. Article 4 shall be amended as follows:  \n(a) paragraph 3 shall be replaced by the following:  \n‘3. Where an entry containing the harmonised classification \nand labelling for a particular substance has been included in \nPart 3 of Annex VI to Regulation (EC) No 1272/2008 of the \nEuropean Parliament and of the Council of 16 December 2008 \non classification, labelling and packaging of substances and \nmixtures (*), the substance shall be classified in accordance \nwith that entry and paragraphs 1 and 2 shall not apply to the \ndanger categories covered by that entry.  \n___________  \n(*) OJ L 353, 31.12.2008, p. 1’;  \n(b) paragraph 4 shall be deleted;  \n3. Article 5 shall be amended as follows:  \n(a) paragraph 1, second subparagraph shall be deleted;  \n(b) paragraph 2 shall be replaced by the following:  \n‘2. The measures in the first subparagraph of paragraph 1 \nshall apply until the substance is listed in Part 3 of Annex VI  to \nRegulation (EC) No 1272/2008 for the danger categories \ncovered by that entry or until a decision not to list it has \nbeen taken in accordance with the procedure laid down in \nArticle 37 of Regulation (EC) No 1272/2008.’;  ▼M20', metadata={'source': 'data/ycla_en.pdf', 'page': 35}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 37  \n4. Article 6 shall be replaced by the following:  \n‘Article 6  \nObligation to carry out investigations  \nManufacturers, distributors and importers of substances which \nappear in the EINECS but for which no entry has been included \nin Part 3 of Annex VI to Regulation (EC) No 1272/2008 shall car ry \nout an investigation to make themselves aware of the relevant a nd \naccessible data which exist concerning the properties of such \nsubstances. On the basis of this information, they shall packag e \nand provisionally label dangerous substances according to the \nrules laid down in Articles 22 to 25 of this Directive and the \ncriteria in Annex VI to this Directive.’;  \n5. Article 22(3) and (4) shall be deleted;  \n6. Article 23(2) shall be amended as follows:  \n(a) in point (a), the words ‘Annex I’ shall be replaced by ‘Par t 3 of \nAnnex VI to Regulation (EC) No 1272/2008’;  \n(b) in point (c), the words ‘Annex I’ shall be replaced by ‘Par t 3 of \nAnnex VI to Regulation (EC) No 1272/2008’;  \n(c) in point (d), the words ‘Annex I’ shall be replaced by ‘Par t 3 of \nAnnex VI to Regulation (EC) No 1272/2008’;  \n(d) in point (e), the words ‘Annex I’ shall be replaced by ‘Par t 3 of \nAnnex VI to Regulation (EC) No 1272/2008’;  \n(e) in point (f), the words ‘Annex I’ shall be replaced by ‘Par t 3 of \nAnnex VI of Regulation (EC) No 1272/2008’;  \n7. Article 24(4) second subparagraph shall be deleted;  \n8. Article 28 shall be deleted;  \n9. Article 31(2) and (3) shall be deleted;  \n10. the following Article shall be inserted after Article 32:  \n‘Article 32a  \nTransitional provision regarding labelling and packaging of \nsubstances  \nArticles 22 to 25 shall not apply to substances from 1 December  \n2010.’;  \n11. Annex I shall be deleted.  \nArticle 56  \nAmendments to Directive 1999/45/EC  \nDirective 1999/45/EC shall be amended as follows:  \n1. in Article 3(2), first indent, the words ‘Annex I to Directi ve \n67/548/EEC’ shall be replaced by ‘Part 3 of Annex VI to Regulat ion \n(EC) No 1272/2008 of the European Parliament and of the Council  \nof 16 December 2008 on classification, labelling and packaging of \nsubstances and mixtures (*).  \n___________  \n(*) OJ L 353, 31.12.2008, p. 1’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 36}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 38  \n2. the words ‘Annex I to Directive 67/548/EEC’ shall be replace d by \n‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’ in:  \n(a) Article 3(3);  \n(b) Article 10(2), points 2.3.1, 2.3.2, 2.3.3 and 2.4 first ind ent; \n(c) Annex II, points (a) and (b) and the last paragraph of the Intro\xad\nduction;  \n(d) Annex II, Part A,  \n— point 1.1.1 (a) and (b),  \n— point 1.2 (a) and (b),  \n— point 2.1.1 (a) and (b),  \n— point 2.2 (a) and (b),  \n— point 2.3 (a) and (b),  \n— point 3.1.1 (a) and (b),  \n— point 3.3 (a) and (b),  \n— point 3.4 (a) and (b),  \n— point 4.1.1 (a) and (b),  \n— point 4.2.1 (a) and (b),  \n— point 5.1.1 (a) and (b),  \n— point 5.2.1 (a) and (b),  \n— point 5.3.1 (a) and (b),  \n— point 5.4.1 (a) and (b),  \n— point 6.1 (a) and (b),  \n— point 6.2 (a) and (b),  \n— point 7.1 (a) and (b),  \n— point 7.2 (a) and (b),  \n— point 8.1 (a) and (b),  \n— point 8.2 (a) and (b),  \n— point 9.1 (a) and (b),  \n— point 9.2 (a) and (b),  \n— point 9.3 (a) and (b),  \n— point 9.4 (a) and (b);  \n(e) Annex II, the introductory paragraph of Part B;  \n(f) Annex III, point (a) and (b) of the Introduction;  \n(g) Annex III, Part A, section (a) Aquatic environment  \n— point 1.1 (a) and (b),  \n— point 2.1 (a) and (b),  \n— point 3.1 (a) and (b),  \n— point 4.1 (a) and (b),  \n— point 5.1 (a) and (b),  \n— point 6.1 (a) and (b),  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 37}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 39  \n(h) Annex III, Part A, section (b) Non-aquatic environment poin t \n1.1 (a) and (b);  \n(i) Annex V, section A points 3 and 4;  \n(j) Annex V, section B point 9;  \n(k) Annex VI, Part A, the third column of the table under point  2 ; \n(l) Annex VI Part B point 1, first paragraph, and the first col umn of \nthe table under point 3;  \n(m) Annex VIII, Appendix 1, second column of the table;  \n(n) Annex VIII, Appendix 2, second column of the table;  \n3. in Annex VI, Part B, point 1, paragraph 3 first indent and p aragraph \n5, the words ‘Annex I’ shall be replaced by ‘Part 3 of Annex VI  to \nRegulation (EC) No 1272/2008’;  \n4. in Annex VI, Part B, point 4.2, final paragraph, the words ‘ Annex I \nto Directive 67/548/EEC (19th adaptation)’ shall be replaced by  ‘Part \n3 of Annex VI to Regulation (EC) No 1272/2008’.  \nArticle 57  \nAmendments to Regulation (EC) No 1907/2006 from the entry into \nforce of this Regulation  \nRegulation (EC) No 1907/2006 shall be amended as from the entry  into \nforce of this Regulation as follows:  \n1. Article 14(2) shall be amended as follows:  \n(a) point (b) shall be replaced by the following:  \n‘(b) the specific concentration limits that have been set in Pa rt \n3 of Annex VI to Regulation (EC) No 1272/2008 of the \nEuropean Parliament and of the Council of 16 December \n2008 on classification, labelling and packaging of \nsubstances and mixtures (*);  \n(ba) for substances classified as hazardous to the aquatic \nenvironment, if a multiplying factor (hereinafter referred \nto as “M-factor”) has been set in Part 3 of Annex VI to \nRegulation (EC) No 1272/2008, the cut-off value in Table \n1.1 of Annex I to that Regulation adjusted using the calcu\xad\nlation set out in section 4.1 of Annex I to that Regulation;  \n___________  \n(*) OJ L 353, 31.12.2008, p. 1’;  \n(b) point (e) shall be replaced by the following:  \n‘(e) the specific concentration limits given in an agreed entry  \nin the classification and labelling inventory referred to in \nArticle 42 of Regulation (EC) No 1272/2008;  \n(ea) for substances classified as hazardous to the aquatic \nenvironment, if an M-factor has been set in an agreed \nentry in the classification and labelling inventory referred \nto in Article 42 of Regulation (EC) No 1272/2008, the cut- \noff value in Table 1.1 of Annex I to that Regulation \nadjusted using the calculation set out in section 4.1 of \nAnnex I to that Regulation;’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 38}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 40  \n2. Article 31 shall be amended as follows:  \n(a) paragraph 8 shall be replaced by the following:  \n‘8. A safety data sheet shall be provided free of charge on \npaper or electronically no later than the date on which the \nsubstance or mixture is first supplied.’;  \n(b) the following paragraph shall be added:  \n‘10. Where substances are classified in accordance with \nRegulation (EC) No 1272/2008 during the period from its \nentry into force until 1 December 2010, that classification \nmay be added in the safety data sheet together with the clas\xad\nsification in accordance with Directive 67/548/EEC.  \nFrom 1 December 2010 until 1 June 2015, the safety data \nsheets for substances shall contain the classification accordin g \nto both Directive 67/548/EEC and Regulation (EC) \nNo 1272/2008.  \nWhere mixtures are classified in accordance with Regulation \n(EC) No 1272/2008 during the period from its entry into \nforce until 1 June 2015, that classification may be added in \nthe safety data sheet, together with the classification in \naccordance with Directive 1999/45/EC. However, until 1 June \n2015, where substances or mixtures are both classified and \nlabelled in accordance with Regulation (EC) No 1272/2008 \nthat classification shall be provided in the safety data sheet,  \ntogether with the classification in accordance with Directives \n67/548/EEC and 1999/45/EC respectively, for the substance, \nthe mixture and its constituents.’;  \n3. Article 56(6)(b) shall be replaced by the following:  \n‘(b) for all other substances, below the lowest of the concentr ation \nlimits specified in Directive 1999/45/EC or in Part 3 of Annex \nVI to Regulation (EC) No 1272/2008 which result in the \nclassification of the mixture as dangerous.’;  \n4. Article 59(2) and 3 shall be amended as follows:  \n(a) in paragraph 2, the second sentence shall be replaced by th e \nfollowing:  \n‘The dossier may be limited, if appropriate, to a reference to an \nentry in Part 3 of Annex VI to Regulation (EC) \nNo 1272/2008.’;  \n(b) in paragraph 3, the second sentence shall be replaced by th e \nfollowing:  \n‘The dossier may be limited, if appropriate, to a reference to an \nentry in Part 3 of Annex VI to Regulation (EC) \nNo 1272/2008.’;  \n5. in Article 76(1)(c), the words ‘Title XI’ shall be replaced by ‘Title \nV of Regulation (EC) No 1272/2008’;  \n6. Article 77 shall be amended as follows:  \n(a) in paragraph 2, the first sentence of point (e) shall be re placed \nby the following:  \n‘(e) establishing and maintaining database(s) with information \non all registered substances, the classification and labelling \ninventory and the harmonised classification and labelling \nlist established in accordance with Regulation (EC) \nNo 1272/2008;’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 39}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 41  \n(b) in paragraph 3, point (a), the words ‘Titles VI to XI’ shal l be \nreplaced by ‘Titles VI to X’;  \n7. Title XI shall be deleted;  \n8. Annex XV, sections I and II shall be amended as follows:  \n(a) section I shall be amended as follows:  \n(i) the first indent shall be deleted;  \n(ii) the second indent shall be replaced by the following:  \n‘— the identification of CMRs, PBTs, vPvBs, or a \nsubstance of equivalent concern in accordance with \nArticle 59,’;  \n(b) in section II, point 1 shall be deleted;  \n9. the table in Annex XVII shall be amended as follows:  \n(a) the column ‘Designation of the substance, of the groups of \nsubstances or of the preparation’, shall be amended as follows:  \n(i) entries 28, 29 and 30 shall be replaced by the following:  \n‘28. Substances which appear in Part 3 of Annex VI to \nRegulation (EC) No 1272/2008 classified as \ncarcinogen category 1A or 1B (Table 3.1) or \ncarcinogen category 1 or 2 (Table 3.2) and listed as \nfollows:  \n— Carcinogen category 1A (Table 3.1)/carcinogen \ncategory 1 (Table 3.2) listed in Appendix 1  \n— Carcinogen category 1B (Table 3.1)/carcinogen \ncategory 2 (Table 3.2) listed in Appendix 2  \n29. Substances which appear in Part 3 of Annex VI to \nRegulation (EC) No 1272/2008 classified as germ \ncell mutagen category 1A or 1B (Table 3.1) or \nmutagen category 1 or 2 (Table 3.2) and listed as \nfollows:  \n— Mutagen category 1A (Table 3.1)/mutagen \ncategory 1 (Table 3.2) listed in Appendix 3  \n— Mutagen category 1B (Table 3.1)/mutagen \ncategory 2 (Table 3.2) listed in Appendix 4  \n30. Substances which appear in Part 3 of Annex VI to \nRegulation (EC) No 1272/2008 classified as toxic to \nreproduction category 1A or 1B (Table 3.1) or toxic to \nreproduction category 1 or 2 (Table 3.2) and listed as \nfollows:  \n— Reproductive toxicant category 1A adverse effects \non sexual function and fertility or on development \n(Table 3.1) or reproductive toxicant category 1 \nwith R60 (May impair fertility) or R61 (May \ncause harm to the unborn child) (Table 3.2) \nlisted in Appendix 5  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 40}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 42  \n— Reproductive toxicant category 1B adverse effects \non sexual function and fertility or on development \n(Table 3.1) or reproductive toxicant category 2 \nwith R60 (May impair fertility) or R61 (May \ncause harm to the unborn child) (Table 3.2) \nlisted in Appendix 6’;  \n(b) in the column ‘Conditions of restriction’, in entry 28, the  first \nindent of point 1 shall be replaced by the following:  \n‘— either the relevant specific concentration limit specified i n \nPart 3 of Annex VI to Regulation (EC) No 1272/2008, or’;  \n10. Appendices 1 to 6 to Annex XVII shall be amended as follows : \n(a) the Foreword shall be amended as follows:  \n(i) in the section entitled ‘Substances’, the words ‘Annex I to  \nDirective 67/548/EEC’ shall be replaced by ‘Part 3 of \nAnnex VI to Regulation (EC) No 1272/2008’;  \n(ii) in the section entitled ‘Index number’, the words ‘Annex \nI to Directive 67/548/EEC’ shall be replaced by ‘Part 3 of \nAnnex VI to Regulation (EC) No 1272/2008’;  \n(iii) in the section entitled ‘Notes’, the words ‘the foreword of \nAnnex I to Directive 67/548/EEC’ shall be replaced by \n‘Part 1 of Annex VI to Regulation (EC) No 1272/2008’;  \n(iv) Note A shall be replaced by the following:  \n‘Note A:  \nWithout prejudice to Article 17(2) of Regulation (EC) No \n1272/2008, the name of the substance must appear on the \nlabel in the form of one of the designations given in Part \n3 of Annex VI to that Regulation.  \nIn that Part, use is sometimes made of a general \ndescription such as “... compounds” or “... salts”. In \nthis case, the supplier who places such a substance on \nthe market is required to state on the label the correct \nname, due account being taken of Section 1.1.1.4 of \nAnnex VI to Regulation (EC) No 1272/2008.  \nIn accordance with Regulation (EC) No 1272/2008, \nwhere a substance is included in Part 3 of Annex VI to \nthat Regulation, the labelling elements relevant for each \nspecific classification covered by the entry in that Part \nshall be included in the label, together with the applicable \nlabel elements for any other classification not covered by \nthat entry, and any other applicable label elements in \naccordance with Article 17 of that Regulation.  \nFor substances belonging to one particular group of \nsubstances included in Part 3 of Annex VI to Regulation \n(EC) No 1272/2008, the labelling elements relevant for \neach specific classification covered by the entry in that \nPart shall be included in the label, together with the \napplicable label elements for any other classification not \ncovered by that entry, and any other applicable label \nelements in accordance with Article 17 of that Regu\xad\nlation.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 41}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 43  \nFor substances belonging to more than one group of \nsubstances included in Part 3 of Annex VI to Regulation \n(EC) No 1272/2008, the labelling elements relevant for \neach specific classification covered by both entries in that \nPart shall be included in the label, together with the \napplicable label elements for any other classification not \ncovered by that entry, and any other applicable label \nelements in accordance with Article 17 of that Regu\xad\nlation. In cases where two different classifications are \ngiven in the two entries for the same hazard class or \ndifferentiation, the classification reflecting the more \nsevere classification shall be used.’;  \n(v) Note D shall be replaced by the following:  \n‘Note D:  \nCertain substances which are susceptible to spontaneous \npolymerisation or decomposition are generally placed on \nthe market in a stabilised form. It is in this form that they \nare listed in Part 3 of Annex VI to Regulation (EC) \nNo 1272/2008.  \nHowever, such substances are sometimes placed on the \nmarket in a non-stabilised form. In this case, the supplier \nwho places such a substance on the market must state on \nthe label the name of the substance followed by the \nwords “non-stabilised”.’;  \n(vi) Note E shall be deleted;  \n(vii) Note H shall be replaced by the following:  \n‘Note H:  \nThe classification and label shown for this substance \napplies to the hazard or hazards indicated by the hazard \nstatement or hazard statements in combination with the \nhazard classification shown. The requirements of \nArticle 4 of Regulation (EC) No 1272/2008 on \nsuppliers of this substance apply to all other hazard \nclasses, differentiations and categories.  \nThe final label shall follow the requirements of section \n1.2 of Annex I to Regulation (EC) No 1272/2008.’;  \n(viii) Note K shall be replaced by the following:  \n‘Note K:  \nThe classification as a carcinogen or mutagen need not \napply if it can be shown that the substance contains less \nthan 0,1 % w/w 1,3-butadiene (Einecs No 203-450-8). If \nthe substance is not classified as a carcinogen or \nmutagen, at least the precautionary statements (P102- \n)P210-P403 should apply. This note applies only to \ncertain complex oil-derived substances in Part 3 of \nAnnex VI to Regulation (EC) No 1272/2008.’;  \n(ix) Note S shall be replaced by the following:  \n‘Note S:  \nThis substance may not require a label according to \nArticle 17 of Regulation (EC) No 1272/2008 (see \nsection 1.3 of Annex I to that Regulation).’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 42}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 44  \n(b) in Appendix 1, the title shall be replaced by the following : \n‘Point 28 — Carcinogens: category 1A (Table 3.1)/category 1 \n(Table 3.2)’;  \n(c) Appendix 2 shall be amended as follows:  \n(i) the title shall be replaced by ‘Point 28 — Carcinogens: \ncategory 1B (Table 3.1)/ category 2 (Table 3.2)’;  \n(ii) in the entries index Nos 024-017-00-8, 611-024-001, 611- \n029-00-9, 611-030-00-4 and 650-017-00-8, the words \n‘Annex I to Directive 67/548/EEC’ shall be replaced by \n‘Annex VI to Regulation (EC) No 1272/2008.’;  \n(d) in Appendix 3, the title shall be replaced by the following : \n‘Point 29 — Mutagens: category 1A (Table 3.1)/category 1 \n(Table 3.2)’;  \n(e) in Appendix 4, the title shall be replaced by the following : \n‘Point 29 — Mutagens: category 1B (Table 3.1)/category 2 \n(Table 3.2)’;  \n(f) in Appendix 5, the title shall be replaced by the following : \n‘Point 30 — Reproductive toxicants: category 1A (Table \n3.1)/category 1 (Table 3.2)’;  \n(g) in Appendix 6, the title shall be replaced by the following : \n‘Point 30 — Reproductive toxicants: category 1B (Table \n3.1)/category 2 (Table 3.2)’;  \n11. the word ‘preparation’ or ‘preparations’ within the meaning  of \nArticle 3 (2) of Regulation (EC) 1907/2006 shall be replaced by  \n‘mixture’ or ‘mixtures’ respectively throughout the text.  \nArticle 58  \nAmendments to Regulation (EC) No 1907/2006 from 1 December \n2010  \nRegulation (EC) No 1907/2006 shall be amended from 1 December \n2010 as follows:  \n1. in Article 14(4), the introductory sentence shall be replace d by the \nfollowing:  \n‘4. If, as a result of carrying out steps (a) to (d) of paragra ph 3, \nthe registrant concludes that the substance fulfils the criteri a for any \nof the following hazard classes or categories set out in Annex I to \nRegulation (EC) No 1272/2008:  \n(a) hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and B, 2.9, \n2.10, 2.12, 2.13 categories 1 and 2, 2.14 categories 1 and 2, \n2.15 types A to F;  \n(b) hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual fu nction \nand fertility or on development, 3.8 effects other than narcoti c \neffects, 3.9 and 3.10;  \n(c) hazard class 4.1;  \n(d) hazard class 5.1,  \nor is assessed to be a PBT or vPvB, the chemical safety assessm ent \nshall include the following additional steps:’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 43}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 45  \n2. Article 31 shall be amended as follows  \n(a) paragraph 1(a) shall be replaced by the following:  \n‘(a) where a substance meets the criteria for classification \nas hazardous in accordance with Regulation (EC) \nNo 1272/2008 or a mixture meets the criteria for classifi\xad\ncation as dangerous in accordance with Directive \n1999/45/EC; or’;  \n(b) paragraph 4 shall be replaced by the following:  \n‘4. The safety data sheet need not be supplied where \nsubstances that are hazardous in accordance with Regulation \n(EC) No 1272/2008 or mixtures that are dangerous in \naccordance with Directive 1999/45/EC, offered or sold to the \ngeneral public, are provided with sufficient information to \nenable users to take the necessary measures as regards the \nprotection of human health, safety and the environment, \nunless requested by a downstream user or distributor.’;  \n3. Article 40(1) shall be replaced by the following:  \n‘1. The Agency shall examine any testing proposal set out in a \nregistration or a downstream user report for provision of the \ninformation specified in Annexes IX and X for a substance. \nPriority shall be given to registrations of substances which ha ve \nor may have PBT, vPvB, sensitising and/or carcinogenic, \nmutagenic or toxic for reproduction (CMR) properties, or \nsubstances above 100 tonnes per year with uses resulting in wid e\xad\nspread and diffuse exposure, provided they fulfil the criteria for any \nof the following hazard classes or categories set out in Annex I of \nRegulation (EC) No 1272/2008:  \n(a) hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and B, 2.9, \n2.10, 2.12, 2.13 categories 1 and 2, 2.14 categories 1 and 2, \n2.15 types A to F;  \n(b) hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual fu nction \nand fertility or on development, 3.8 effects other than narcoti c \neffects, 3.9 and 3.10;  \n(c) hazard class 4.1;  \n(d) hazard class 5.1.’;  \n4. Article 57(a), (b) and (c) shall be replaced by the followin g: \n‘(a) substances meeting the criteria for classification in the hazard \nclass carcinogenicity category 1A or 1B in accordance with \nsection 3.6 of Annex I to Regulation (EC) No 1272/2008;  \n(b) substances meeting the criteria for classification in the h azard \nclass germ cell mutagenicity category 1A or 1B in accordance \nwith section 3.5 of Annex I to Regulation (EC) No 1272/2008;  \n(c) substances meeting the criteria for classification in the h azard \nclass reproductive toxicity category 1A or 1B, adverse effects \non sexual function and fertility or on development in \naccordance with section 3.7 of Annex I to Regulation(EC) \nNo 1272/2008;’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 44}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 46  \n5. in Article 65 the words ‘Directive 67/548/EEC’ shall be repl aced by \n‘Directive 67/548/EEC and Regulation (EC) No 1272/2008’;  \n6. Article 68(2) shall be replaced by the following:  \n‘2. For a substance on its own, in a mixture or in an article \nwhich meets the criteria for classification in the hazard class es \ncarcinogenicity, germ cell mutagenicity or reproductive toxicit y, \ncategory 1A or 1B, and could be used by consumers and for \nwhich restrictions to consumer use are proposed by the \nCommission, Annex XVII shall be amended in accordance with \nthe procedure referred to in Article 133(4). Articles 69 to 73 \nshall not apply.’;  \n7. Article 119 shall be amended as follows:  \n(a) in paragraph 1, point (a) shall be replaced by the followin g: \n‘(a) without prejudice to paragraph 2(f) and (g) of this Articl e, \nthe name in the IUPAC nomenclature for substances \nfulfilling the criteria for any of the following hazard \nclasses or categories set out in Annex I to Regulation \n(EC) No 1272/2008:  \n— hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and \nB, 2.9, 2.10, 2.12, 2.13 categories 1 and 2, 2.14 \ncategories 1 and 2, 2.15 types A to F;  \n— hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual \nfunction and fertility or on development, 3.8 effects \nother than narcotic effects, 3.9 and 3.10;  \n— hazard class 4.1;  \n— hazard class 5.1.’;  \n(b) paragraph 2 shall be amended as follows:  \n(i) point (f) shall be replaced by the following:  \n‘(f) subject to Article 24 of Regulation (EC) No \n1272/2008, the name in the IUPAC nomenclature for \nnon-phase-in substances referred to in paragraph 1(a) \nof this Article for a period of six years;’  \n(ii) in point (g), the introductory phrase shall be replaced by  \nthe following:  \n‘(g) subject to Article 24 of Regulation (EC) No \n1272/2008, the name in the IUPAC nomenclature for \nsubstances referred to in paragraph 1(a) of this Article \nthat are only used as one or more of the following:’;  \n8. in Article 138(1), the second sentence of the introductory p hrase \nshall be replaced by the following:  \n‘However, for substances meeting the criteria for classificatio n in \nthe hazard classes carcinogenicity, germ cell mutagenicity or r epro\xad\nductive toxicity, category 1A or 1B, in accordance with Regulat ion \n(EC) No 1272/2008, the review shall be carried out by 1 June \n2014.’;  \n9. Annex III shall be amended as follows:  \n(a) point (a) shall be replaced by the following:  \n‘(a) substances for which it is predicted (i.e. by the applicat ion \nof (Q)SARs or other evidence) that they are likely to meet \nthe criteria for category 1A or 1B classification in the \nhazard classes carcinogenicity, germ cell mutagenicity or \nreproductive toxicity or the criteria in Annex XIII;’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 45}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 47  \n(b) in point (b), point (ii) shall be replaced by the following : \n‘(ii) for which it is predicted (i.e. by application of (Q)SARs  or \nother evidence) that they are likely to meet the classifi\xad\ncation criteria for any health or environmental hazard \nclasses or differentiations under Regulation (EC) \nNo 1272/2008.’;  \n10. in Annex V, point 8, the words ‘Directive 67/548/EEC’ shall  be \nreplaced by ‘Regulation (EC) No 1272/2008’;  \n11. in Annex VI, sections 4.1, 4.2 and 4.3 shall be replaced by  the \nfollowing:  \n‘4.1 The hazard classification of the substance(s), resulting f rom \nthe application of Title I and II of Regulation (EC) No \n1272/2008 for all hazard classes and categories in that Regu\xad\nlation,  \nIn addition, for each entry, the reasons why no classification is \ngiven for a hazard class or differentiation of a hazard class \nshould be provided (i.e. if data are lacking, inconclusive, or \nconclusive but not sufficient for classification),  \n4.2 The resulting hazard label for the substance(s), resulting from \nthe application of Title III of Regulation (EC) No 1272/2008,  \n4.3 Specific concentration limits, where applicable, resulting from \nthe application of Article 10 of Regulation (EC) No \n1272/2008 and Articles 4 to 7 of Directive 1999/45/EC.’;  \n12. Annex VIII shall be amended as follows:  \n(a) in column 2, the second indent of point 8.4.2 shall be repl aced \nby the following:  \n‘— the substance is known to be carcinogenic category 1A or \n1B or germ cell mutagenic category 1A, 1B or 2.’;  \n(b) in column 2, the second and third paragraphs of point 8.7.1  \nshall be replaced by the following:  \n‘If a substance is known to have an adverse effect on fertility , \nmeeting the criteria for classification as toxic for reproducti on \ncategory 1A or 1B: May damage fertility (H360F), and the \navailable data are adequate to support a robust risk assessment , \nthen no further testing for fertility will be necessary. Howeve r, \ntesting for developmental toxicity must be considered.  \nIf a substance is known to cause developmental toxicity, \nmeeting the criteria for classification as toxic for reproducti on \ncategory 1A or 1B: May damage the unborn child (H360D), \nand the available data are adequate to support a robust risk \nassessment, then no further testing for developmental toxicity \nwill be necessary. However, testing for effects on fertility mu st \nbe considered.’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 46}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 48  \n13. in Annex IX, column 2, point 8.7, the second and third para graphs \nshall be replaced by the following:  \n‘If a substance is known to have an adverse effect on fertility , \nmeeting the criteria for classification as toxic for reproducti on \ncategory 1A or 1B: May damage fertility (H360F), and the \navailable data are adequate to support a robust risk assessment , \nthen no further testing for fertility will be necessary. Howeve r, \ntesting for developmental toxicity must be considered.  \nIf a substance is known to cause developmental toxicity, meetin g \nthe criteria for classification as toxic for reproduction categ ory 1A \nor 1B: May damage the unborn child (H360D), and the available \ndata are adequate to support a robust risk assessment, then no \nfurther testing for developmental toxicity will be necessary. \nHowever, testing for effects on fertility must be considered.’;  \n14. Annex X shall be amended as follows:  \n(a) in column 2, point 8.7, the second and third paragraphs sha ll be \nreplaced by the following:  \n‘If a substance is known to have an adverse effect on fertility , \nmeeting the criteria for classification as toxic for reproducti on \ncategory 1A or 1B: May damage fertility (H360F), and the \navailable data are adequate to support a robust risk assessment , \nthen no further testing for fertility will be necessary. Howeve r, \ntesting for developmental toxicity must be considered.  \nIf a substance is known to cause developmental toxicity, \nmeeting the criteria for classification as toxic for reproducti on \ncategory 1A or 1B: May damage the unborn child (H360D), \nand the available data are adequate to support a robust risk \nassessment, then no further testing for developmental toxicity \nwill be necessary. However, testing for effects on fertility mu st \nbe considered.’  \n(b) in column 2, point 8.9.1, the second indent of the first \nparagraph shall be replaced by the following:  \n‘— the substance is classified as germ cell mutagen category 2 \nor there is evidence from the repeated dose study(ies) that \nthe substance is able to induce hyperplasia and/or pre- \nneoplastic lesions.’  \n(c) in column 2, the second paragraph of point 8.9.1 shall be \nreplaced by the following:  \n‘If the substance is classified as germ cell mutagen category 1 A \nor 1B, the default presumption would be that a genotoxic \nmechanism for carcinogenicity is likely. In these cases, a carc i\xad\nnogenicity test will normally not be required.’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 47}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 49  \n15. in Annex XIII, the second and third indents of point 1.3 sh all be \nreplaced by the following:  \n‘— the substance is classified as carcinogenic (category 1A or 1B), \ngerm cell mutagenic (category 1A or 1B), or toxic for repro\xad\nduction (category 1A, 1B or 2), or  \n— there is other evidence of chronic toxicity, as identified by  the \nclassifications STOT (repeated exposure), category 1 (oral, \ndermal, inhalation of gases/vapours, inhalation of dust/ \nmist/fume) or category 2 (oral, dermal, inhalation of gases/va\xad\npours, inhalation of dust/mist/fume) according to Regulation \n(EC) No 1272/2008’;  \n16. in the table in Annex XVII, the column ‘Designation of the \nsubstance, of the groups of substances or of the mixture’ shall  be \namended as follows:  \n(a) entry 3 shall be replaced by the following:  \n‘3. Liquid substances or mixtures which are regarded as \ndangerous in accordance with Directive 1999/45/EC or \nare fulfilling the criteria for any of the following hazard \nclasses or categories set out in Annex I to Regulation (EC) \nNo 1272/2008:  \n(a) hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and \nB, 2.9, 2.10, 2.12, 2.13 categories 1 and 2, 2.14 \ncategories 1 and 2, 2.15 types A to F;  \n(b) hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual \nfunction and fertility or on development, 3.8 effects \nother than narcotic effects, 3.9 and 3.10;  \n(c) hazard class 4.1;  \n(d) hazard class 5.1.’;  \n(b) entry 40 shall be replaced by the following:  \n‘40. Substances classified as flammable gases category 1 or 2, \nflammable liquids categories 1, 2 or 3, flammable solids \ncategory 1 or 2, substances and mixtures which, in \ncontact with water, emit flammable gases, category 1, 2 \nor 3, pyrophoric liquids category 1 or pyrophoric solids \ncategory 1, regardless of whether they appear in Part 3 of \nAnnex VI to that Regulation or not’.  \nArticle 59  \nAmendments to Regulation (EC) No 1907/2006 from 1 June 2015  \nRegulation (EC) No 1907/2006 shall be amended from 1 June 2015 as \nfollows:  \n1. Article 14(2) shall be replaced by the following:  \n‘2. A chemical safety assessment in accordance with paragraph 1  \nneed not be performed for a substance which is present in a mix ture \nif the concentration of the substance in the mixture is less th an \n(a) the cut-off value referred to in Article 11, paragraph 3 of  Regu\xad\nlation (EC) No 1272/2008;  \n(b) 0,1 % weight by weight (w/w), if the substance meets the cr iteria \nin Annex XIII to this Regulation.’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 48}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 50  \n2. Article 31 shall be amended as follows:  \n(a) in paragraph 1, point (a) shall be replaced by the followin g: \n‘(a) where a substance or mixture meets the criteria for classi fi\xad\ncation as hazardous in accordance with Regulation (EC) No \n1272/2008; or’;  \n(b) paragraph 3 shall be replaced by the following:  \n‘3. The supplier shall provide the recipient at his request wit h \na safety data sheet compiled in accordance with Annex II, where  \na mixture does not meet the criteria for classification as \nhazardous in accordance with Titles I and II of Regulation \n(EC) No 1272/2008, but contains:  \n(a) in an individual concentration of ≥ 1 % by weight for non- \ngaseous mixtures and ≥ 0,2 % by volume for gaseous \nmixtures at least one substance posing human health or en\xad\nvironmental hazards; or  \n(b) in an individual concentration of ≥ 0,1 % by weight for non - \ngaseous mixtures at least one substance that is carcinogenic \ncategory 2 or toxic to reproduction category 1A, 1B and 2, \nskin sensitiser category 1, respiratory sensitiser category 1, \nor has effects on or via lactation or is persistent, bioaccumu\xad\nlative and toxic (PBT) in accordance with the criteria set out \nin Annex XIII or very persistent and very bioaccumulative \n(vPvB) in accordance with the criteria set out in Annex XIII \nor has been included for reasons other than those referred to \nin point (a) in the list established in accordance with \nArticle 59(1); or  \n(c) a substance for which there are Community workplace \nexposure limits’;  \n(c) paragraph 4 shall be replaced by the following:  \n‘4. The safety data sheet need not be supplied where \nhazardous substances or mixtures offered or sold to the general  \npublic are provided with sufficient information to enable users  to \ntake the necessary measures as regards the protection of human \nhealth, safety and the environment, unless requested by a down\xad\nstream user or distributor.’;  \n3. Article 56(6)(b) shall be replaced by the following:  \n‘(b) for all other substances, below the values specified in \nArticle 11(3) of Regulation (EC) No 1272/2008 which result \nin the classification of the mixture as hazardous.’;  \n4. in Article 65 the words ‘and Directive 1999/45/EC’ shall be deleted;  \n5. Annex II shall be amended as follows:  \n(a) point 1.1 shall be replaced by:  \n‘1.1. Identification of the substance or mixture  \nThe term used for identification of a substance shall be \nidentical to that provided on the label in accordance with \nArticle 18(2) of Regulation (EC) No 1272/2008.  \nThe term used for identification of a mixture shall be \nidentical to that provided on the label in accordance with \nArticle 18(3)(a) of Regulation (EC) No 1272/2008.’;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 49}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 51  \n(b) footnote 1 to point 3.3(a), first indent, shall be deleted;  \n(c) point 3.6 shall be replaced by:  \n‘3.6. Where, in accordance with Article 24 of Regulation (EC) \nNo 1272/2008, the Agency has agreed that the chemical \nidentity of a substance may be kept confidential on the \nlabel and in the safety data sheet, their chemical nature \nshall be described under heading 3 in order to ensure \nsafe handling.  \nThe name used on the safety data sheet (including for the \npurposes of paragraphs 1.1, 3.2, 3.3 and 3.5) shall be the \nsame as that used on the label, agreed in accordance with \nthe procedure set out in Article 24 of Regulation (EC) \nNo 1272/2008.’;  \n6. in Annex VI section 4.3 shall be replaced by the following:  \n‘4.3 Specific concentration limits, where applicable, resulting  from \nthe application of Article 10 of Regulation (EC) \nNo 1272/2008.’;  \n7. Annex XVII shall be amended as follows:  \n(a) in the column ‘Designation of the substance, of the groups of \nsubstances or of the mixture’ of the table in entry 3, the word s \n‘which are regarded as dangerous in accordance with Directive \n1999/45/EC or are’ shall be deleted;  \n(b) in the column ‘Conditions of restriction’ of the table, ent ry 28 \nshall be amended as follows:  \n(i) the second indent of point 1 shall be replaced by the \nfollowing:  \n‘— the relevant generic concentration limit specified in \nPart 3 of Annex I of Regulation (EC) No 1272/2008.’;  \n(ii) point 2 (d) shall be replaced by the following:  \n‘(d) artists’ paints covered by Regulation (EC) \nNo 1272/2008’.  \nArticle 60  \nRepeal  \nDirective 67/548/EEC and Directive 1999/45/EC shall be repealed  with \neffect from 1 June 2015.  \nArticle 61  \nTransitional provisions  \n1. Until 1 December 2010, substances shall be classified, label led \nand packaged in accordance with Directive 67/548/EEC.  \nUntil 1 June 2015, mixtures shall be classified, labelled and p ackaged in \naccordance with Directive 1999/45/EC.  \n2. By way of derogation from the second subparagraph of Article  62 \nof this Regulation and in addition to the requirements of parag raph 1 of \nthis Article, substances and mixtures may, before 1 December 20 10 and \n1 June 2015 respectively, be classified, labelled and packaged in \naccordance with this Regulation. In that case, the provisions o n \nlabelling and packaging in Directives 67/548/EEC and 1999/45/EC  \nshall not apply.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 50}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 52  \n3. From 1 December 2010 until 1 June 2015, substances shall be \nclassified in accordance with both Directive 67/548/EEC and thi s Regu\xad\nlation. They shall be labelled and packaged in accordance with this \nRegulation.  \n4. By way of derogation from the second subparagraph of Article  62 \nof this Regulation, substances classified, labelled and package d in \naccordance with Directive 67/548/EEC and already placed on the \nmarket before 1 December 2010, are not required to be relabelle d and \nrepackaged in accordance with this Regulation until 1 December 2012.  \nBy way of derogation from the second subparagraph of Article 62  of \nthis Regulation, mixtures classified, labelled and packaged in \naccordance with Directive 1999/45/EC and already placed on the \nmarket before 1 June 2015 are not required to be relabelled and  \nrepackaged in accordance with this Regulation until 1 June 2017 . \n5. Where a substance or mixture has been classified in accordan ce \nwith Directive 67/548/EEC or 1999/45/EC before 1 December 2010 or \n1 June 2015 respectively, manufacturers, importers and downstre am \nusers may amend the classification of the substance or mixture using \nthe conversion table in Annex VII to this Regulation.  \n6. Until 1 December 2011 a Member State may maintain any \nexisting and more stringent classification and labelling of sub stances \nentered into Part 3 of Annex VI to this Regulation, provided th at \nthese classifications and labelling elements have been notified  to the \nCommission in accordance with the safeguard clause in Directive  \n67/548/EEC before 20 January 2009 and that the Member State \nsubmits a proposal for harmonised classification and labelling \ncontaining these classifications and labelling elements to the Agency \nin accordance with Article 37(1) of this Regulation by 1 June 2 009. \nIt is a precondition that a decision on the proposed classifica tion and \nlabelling by the Commission in accordance with the safeguard cl ause of \nDirective 67/548/EEC has not yet been taken before 20 January 2 009. \nIf the proposed harmonised classification and labelling submitt ed under \nthe first subparagraph is not included or is included in an ame nded form \nin Part 3 of Annex VI in accordance with Article 37(5), the exe mption \nin the first subparagraph of this paragraph is no longer valid.  \nArticle 62  \nEntry into force  \nThis Regulation shall enter into force on the 20th day followin g its \npublication in the  Official Journal of the European Union . \nTitles II, III and IV shall apply in respect of substances from  \n1 December 2010 and in respect of mixtures from 1 June 2015.  \nThis Regulation shall be binding in its entirety and directly a pplicable in \nall Member States.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 51}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 53  \nANNEX I  \nCLASSIFICATION AND LABELLING REQUIREMENTS FOR \nHAZARDOUS SUBSTANCES AND MIXTURES  \nThis annex sets out the criteria for classification in hazard c lasses and in their \ndifferentiations and sets out additional provisions on how the criteria may be met.  \n1. PART 1: GENERAL PRINCIPLES FOR CLASSIFICATION AND \nLABELLING  \n1.0. Definitions  \nGas means a substance which:  \n(i) at 50  o C has a vapour pressure greater than 300 kPa (absolute); \nor \n(ii) is completely gaseous at 20  o C at a standard pressure of 101,3 \nkPa; \nLiquid means a substance or mixture which:  \n(i) at 50  o C has a vapour pressure of not more than 300 kPa (3 bar);  \n(ii) is not completely gaseous at 20  o C and at a standard pressure of \n101,3 kPa; and  \n(iii) which has a melting point or initial melting point of 20  o C or \nless at a standard pressure of 101,3 kPa;  \nSolid means a substance or mixture which does not meet the defi \xad\nnitions of liquid or gas.  \n1.1. Classification of substances and mixtures  \n1.1.0.  Cooperation to meet the requirements in this Regulation  \nSuppliers in a supply chain shall cooperate to meet the require ments \nfor classification, labelling and packaging set out in this Reg ulation.  \nSuppliers in an industry sector may cooperate to manage the tra n\xad\nsitional arrangements in Article 61 for substances and mixtures  \nplaced on the market.  \nSuppliers in an industry sector may cooperate through formation  of a \nnetwork or by other means to share data and expertise when clas \xad\nsifying substances and mixtures in accordance with Title II of this \nRegulation. In these circumstances suppliers in an industry sec tor \nshall document fully the basis on which classification decision s are \nmade and shall make available to the competent authorities and,  on \nrequest, to the relevant enforcement authorities the documentat ion, \ntogether with the data and information on which classifications  are \nbased. However, where suppliers in an industry sector cooperate  in \nthis way, each supplier shall remain fully responsible for the classifi\xad\ncation, labelling and packaging of substances and mixtures he p laces \non the market, and for meeting any other requirements of this R egu\xad\nlation.  \nThe network may also be used to exchange information and best \npractices with a view to simplifying fulfilment of the notifica tion \nobligations.  \n1.1.1.  The role and application of expert judgement and weight of \nevidence determination  \n1.1.1.1. Where the criteria cannot be applied directly to avail able identified \ninformation, or where only the information referred to in Artic le 6(5) \nis available, the weight of evidence determination using expert  \njudgment shall be applied in accordance with Article 9(3) or 9( 4) \nrespectively.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 52}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 54  \n1.1.1.2. The approach to classifying mixtures may include the a pplication of \nexpert judgement in a number of areas in order to ensure existi ng \ninformation can be used for as many mixtures as possible in ord er to \nprovide protection for human health and the environment. Expert  \njudgement may also be required in interpreting data for hazard clas\xad\nsification of substances, especially where weight of evidence d eter\xad\nminations are needed.  \n1.1.1.3. A weight of evidence determination means that all avai lable \ninformation bearing on the determination of hazard is considere d \ntogether, such as the results of suitable in vitro tests, relev ant \nanimal data, information from the application of the category \napproach (grouping, read-across), (Q)SAR results, human experie nce \nsuch as occupational data and data from accident databases, epi demi\xad\nological and clinical studies and well-documented case reports and \nobservations. The quality and consistency of the data shall be given \nappropriate weight. Information on substances or mixtures relat ed to \nthe substance or mixture being classified shall be considered a s \nappropriate, as well as site of action and mechanism or mode of  \naction study results. Both positive and negative results shall be \nassembled together in a single weight of evidence determination . \n1.1.1.4. For the purpose of classification for health hazards ( Part 3) estab\xad\nlished hazardous effects seen in appropriate animal studies or from \nhuman experience that are consistent with the criteria for clas sifi\xad\ncation shall normally justify classification. Where evidence is  \navailable from both humans and animals and there is a conflict \nbetween the findings, the quality and reliability of the eviden ce \nfrom both sources shall be evaluated in order to resolve the \nquestion of classification. Generally, adequate, reliable and r epresen\xad\ntative data on humans (including epidemiological studies, scien \xad\ntifically valid case studies as specified in this Annex or stat istically \nbacked experience) shall have precedence over other data. Howev er, \neven well-designed and conducted epidemiological studies may la ck \na sufficient number of subjects to detect relatively rare but s till \nsignificant effects, to assess potentially confounding factors.  \nTherefore, positive results from well-conducted animal studies are \nnot necessarily negated by the lack of positive human experienc e \nbut require an assessment of the robustness, quality and statis tical \npower of both the human and animal data.  \n1.1.1.5. For the purpose of classification for health hazards ( Part 3) route of \nexposure, mechanistic information and metabolism studies are \npertinent to determining the relevance of an effect in humans. \nWhen such information, as far as there is reassurance about the  \nrobustness and quality of the data, raises doubt about relevanc e in \nhumans, a lower classification may be warranted. When there is \nscientific evidence that the mechanism or mode of action is not  \nrelevant to humans, the substance or mixture should not be clas sified.  \n1.1.2.  Specific concentration limits, M-factors and generic cut-off values  \n1.1.2.1. Specific concentration limits or M-factors shall be ap plied in \naccordance with Article 10.  \n1.1.2.2.  Cut-off values  \n1.1.2.2.1. Cut-off values indicate when the presence of a subst ance needs to be \ntaken into account for the purposes of classification of a subs tance or \na mixture containing that hazardous substance, whether as an \nidentified impurity, additive, or individual constituent (see A rticle 11).  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 53}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 55  \n1.1.2.2.2. The cut-off values referred to in Article 11 shall b e the following:  \n(a) For health and environmental hazards in Parts 3, 4 and 5 of  this \nAnnex:  \n(i) for substances where a specific concentration limit is set for \nthe relevant hazard class or differentiation either in Part 3 o f \nAnnex VI or in the classification and labelling inventory \nreferred to in Article 42, and where the hazard class or \ndifferentiation is mentioned in Table 1.1, the lower of the \nspecific concentration limit and the relevant generic cut-off \nvalue in Table 1.1; or  \n(ii) for substances where a specific concentration limit is set  for \nthe relevant hazard class or differentiation either in Part 3 o f \nAnnex VI or in the classification and labelling inventory \nreferred to in Article 42, and where the hazard class or \ndifferentiation is not mentioned in Table 1.1, the specific \nconcentration limit set either in Part 3 of Annex VI or in \nthe classification and labelling inventory; or  \n(iii) for substances where no specific concentration limit is s et \nfor the relevant hazard class or differentiation either in Part  \n3 of Annex VI or in the classification and labelling \ninventory referred to in Article 42, and where the hazard \nclass or differentiation is mentioned in Table 1.1, the \nrelevant generic cut-off value set out in that table; or  \n(iv) for substances where no specific concentration limit is se t \nfor the relevant hazard class or differentiation either in Part  \n3 of Annex VI or in the classification and labelling \ninventory referred to in Article 42, and where the hazard \nclass or differentiation is not mentioned in Table 1.1, the \ngeneric concentration limit for classification in the relevant \nsections of Parts 3, 4 and 5 of this Annex.  \n(b) For aquatic environmental hazards in section 4.1 of this An nex: \n(i) for substances where an M-factor has been set for the \nrelevant hazard category either in Part 3 of Annex VI, or \nin the classification and labelling inventory referred to in \nArticle 42, the generic cut-off value in Table 1.1 adjusted \nusing the calculation set out in section 4.1 of this Annex; or  \n(ii) for substances where no M-factor is set for the relevant \nhazard category either in Part 3 of Annex VI or in the \nclassification and labelling inventory referred to in Article 4 2, \nthe relevant generic cut-off value set out in Table 1.1.  \n▼M19  \nTable 1.1  \nGeneric cut-off values  \nHazard class  Generic cut-off values to be taken \ninto account  \nAcute Toxicity:  \n— Category 1-3  0,1 %  \n— Category 4  1  %  \nSkin corrosion/Irritation  1  %  (  1 ) \nSerious damage to eyes/eye \nirritation  1 % (  2 ) ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 54}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 56  \nHazard class  Generic cut-off values to be taken \ninto account  \nSpecific target organ toxicity, \nsingle exposure, Category 3  1 % (  3 ) \nAspiration toxicity  1  %  \nHazardous to Aquatic \nEnvironment  \n— Acute Category 1  0,1 % (  4 ) \n— Chronic \nCategory 1  0,1 % (  4 ) \n— Chronic Category \n2-4 1 % \n( 1 ) Or < 1 % where relevant, see 3.2.3.3.1. \n( 2 ) Or < 1 % where relevant, see 3.3.3.3.1. \n( 3 ) Or < 1 % where relevant, see 3.8.3.4.6. \n( 4 ) Or < 0,1 % where relevant, see 4.1.3.1.  \n▼M2 \nNote:  \nGeneric cut-off values are in weight percentages except for \ngaseous mixtures for those hazard classes where the generic \ncut-off values may be best described in volume percentages.  \n▼B \n1.1.3.  Bridging principles for the classification of mixtures where test \ndata are not available for the complete mixture  \nWhere the mixture itself has not been tested to determine its \nhazardous properties, but there are sufficient data on similar tested \nmixtures and individual hazardous ingredient substances to \nadequately characterise the hazards of the mixture, these data \nshall be used in accordance with the following bridging rules \nreferred to in Article 9(4) for each individual hazard class in  Part \n3 and Part 4 of this Annex, subject to any specific provisions for \nmixtures in each hazard class.  \n1.1.3.1.  Dilution  \n►M2 If a tested mixture ◄ is diluted with a substance (diluent) \nwhich has an equivalent or lower hazard category classification  than \nthe least hazardous original ingredient substance and which is not \nexpected to affect the hazard classification of other ingredien t \nsubstances, then one of the following shall be applied:  \n— the new mixture shall be classified as equivalent to the orig inal \nmixture;  \n— the method explained in each section of Part 3 and in Part 4 for \nclassification of mixtures when data are available for all \ncomponents or only some components of the mixture;  \n— in the case of acute toxicity, the method for classification of \nmixtures based on ingredients of the mixture (additivity \nformula).  \n▼M2 \n1.1.3.2.  Batching  \nThe hazard category of a tested production batch of a mixture c an \nbe assumed to be substantially equivalent to that of another un tested \nproduction batch of the same commercial product, when produced \nby or under the control of the same supplier, unless there is r eason \nto believe there is significant variation such that the hazard classifi\xad\ncation of the untested batch has changed. If the latter occurs,  a new \nevaluation is necessary.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 55}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 57  \n1.1.3.3.  Concentration of highly hazardous mixtures  \nIn the case of the classification of mixtures covered by sectio ns 3.1, \n3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a tested mixture is classi fied in the \nhighest hazard category or sub-category, and the concentration of \nthe components of the tested mixture that are in that category or \nsub-category is increased, the resulting untested mixture shall  be \nclassified in that category or sub-category without additional testing.  \n▼M12  \n1.1.3.4.  Interpolation within one hazard category  \n▼M2 \nIn the case of the classification of mixtures covered by sectio ns 3.1, \n3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures (A, B and C) with \nidentical components, where mixtures A and B have been tested a nd \nare in the same hazard category, and where untested mixture C h as \nthe same hazardous components as mixture A and B but has \nconcentrations of those hazardous components intermediate to th e \nconcentrations in mixtures A and B, then mixture C is assumed t o \nbe in the same hazard category as A and B.  \n▼B \n1.1.3.5.  Substantially similar mixtures  \nGiven the following:  \n(a) two mixtures each containing two ingredients:  \n(i) A + B  \n(ii) C + B;  \n(b) the concentration of ingredient B is essentially the same i n both \nmixtures;  \n(c) the concentration of ingredient A in mixture (i) equals tha t of \ningredient C in mixture (ii);  \n(d) hazard data for A and C are available and substantially equ iv\xad\nalent, i.e. they are in the same hazard category and are not \nexpected to affect the hazard classification of B.  \n▼M2 \nIf mixture (i) or (ii) is already classified based on test data , then the \nother mixture shall be assigned the same hazard category.  \n▼B \n1.1.3.6.  Review of classification where the composition of a mixture has \nchanged  \nThe following variations in initial concentration are defined f or the \napplication of Article 15(2)(a):  \nTable 1.2  \nBridging Principle for changes in the composition of a mixture  \nInitial concentration range of the \nconstituent  Permitted variation in initial \nconcentration of the constituent  \n≤ 2,5 %  ± 30 %  \n2,5 < C ≤ 10 %  ± 20 %  \n10 < C ≤ 25 %  ± 10 %  \n25 < C ≤ 100 %  ±  5  %  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 56}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 58  \n1.1.3.7.  Aerosols  \nIn the case of the classification of mixtures covered by sectio ns 3.1, \n3.2, 3.3, 3.4, 3.8 and 3.9, an aerosol form of a mixture shall be \nclassified in the same hazard category as the tested non-aeroso lised \nform of the mixture, provided that the added propellant does no t \naffect the hazardous properties of the mixture upon spraying.  \n▼M2 \n1.2. Labelling  \n1.2.1.  General rules for the application of labels required by Article 31  \n1.2.1.1. Hazard pictograms shall be in the shape of a square se t at a point.  \n1.2.1.2. Hazard pictograms as laid down in Annex V shall have a  black \nsymbol on a white background with a red frame sufficiently wide  to \nbe clearly visible.  \n1.2.1.3. Each hazard pictogram shall cover at least one fifteen th of the \nminimum surface area of the label dedicated to the information \nrequired by Article 17. The minimum area of each hazard \npictogram shall not be less than 1 cm  2 . \n1.2.1.4. The dimensions of the label and of each pictogram shal l be as \nfollows:  \nTable 1.3  \nMinimum dimensions of labels and pictograms  \nCapacity of the \npackage  Dimensions of the \nlabel (in millimetres) \nfor the information \nrequired by Article 17  Dimensions of each \npictogram (in millimetres)  \nNot exceeding 3 \nlitres:  If possible, at least \n52 × 74  Not smaller than \n10 × 10 \nIf possible, at least \n16 × 16  \nGreater than 3 litres \nbut not exceeding \n50 litres:  At least 74 × 105  At least 23 × 23  \nGreater than 50 \nlitres but not \nexceeding 500 \nlitres:  At least 105 × 148  At least 32 × 32  \nGreater than 500 \nlitres:  At least 148 × 210  At least 46 × 46  \n▼B \n1.3. Derogations from labelling requirements for special cases  \nIn accordance with Article 23 the following derogations shall a pply:  \n1.3.1.  Transportable gas cylinders  \nFor transportable gas cylinders, one of the following shall be \npermitted to be used for gas cylinders with a water capacity of  \nless than or equal to 150 litres:  \n(a) A format and dimensions following the prescriptions of the \ncurrent edition of Standard ISO 7225 relating to ‘Gas \ncylinders — Precautionary labels’. In this case, the label can \nbear the generic name or industrial or commercial name of the \nsubstance or mixture provided that the hazardous substances in \na mixture are shown on the body of the gas cylinder in a clear \nand indelible way.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 57}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 59  \n(b) The information specified in Article 17 provided on a durab le \ninformation disc or label held captive on the cylinder.  \n1.3.2.  Gas containers intended for propane, butane or liquefied \npetroleum gas (LPG)  \n▼M19  \n1.3.2.1. If propane, butane and liquefied petroleum gas or a mi xture \ncontaining these substances classified in accordance with the \ncriteria of this Annex, is placed on the market in closed refil lable \ncylinders or in non-refillable cartridges within the scope of E N 417 \nas fuel gases which are only released for combustion (current \nedition of EN 417, relating to ‘Non-refillable metallic gas car tridges \nfor liquefied petroleum gases, with or without a valve, for use  with \nportable appliances; construction, inspection, testing and mark ing’), \nthese cylinders or cartridges need be labelled only with the ap pro\xad\npriate pictogram and the hazard and precautionary statements \nconcerning flammability.  \n▼B \n1.3.2.2. No information concerning the effects on human health and the \nenvironment is required on the label. Instead the supplier shal l \nprovide the information concerning effects on human health and \nthe environment to downstream users or distributors by means of  \nthe safety data sheet (SDS).  \n1.3.2.3. For consumers, sufficient information shall be transmi tted to enable \nthem to take all necessary measures for health and safety.  \n1.3.3.  Aerosols and containers fitted with a sealed spray attachment and \ncontaining substances or mixtures classified as presenting an \naspiration hazard  \nWith regard to the application of section 3.10.4, substances or  \nmixtures classified in accordance with the criteria of sections  \n3.10.2 and 3.10.3 need not be labelled for this hazard when \nplaced on the market in aerosol containers or in containers fit ted \nwith a sealed spray attachment.  \n1.3.4.  Metals in massive form, alloys, mixtures containing polymers, \nmixtures containing elastomers  \n1.3.4.1. Metals in massive form, alloys, mixtures containing po lymers and \nmixtures containing elastomers do not require a label according  to \nthis Annex, if they do not present a hazard to human health by \ninhalation, ingestion or contact with skin or to the aquatic en viron\xad\nment in the form in which they are placed on the market, althou gh \nclassified as hazardous in accordance with the criteria of this  Annex.  \n1.3.4.2. Instead, the supplier shall provide the information to  downstream \nusers or distributors by means of the SDS.  \n1.3.5.  Explosives placed on the market with a view to obtaining an \nexplosive or pyrotechnic effect  \nExplosives, as referred to in section 2.1, placed on the market  with \na view to obtaining an explosive or pyrotechnic effect shall be  \nlabelled and packaged in accordance with the requirements for \nexplosives only.  \n▼M12  \n1.3.6.  Substances or mixtures classified as corrosive to metals but not \nclassified as skin corrosion or as serious eye damage (Category 1)  \nSubstances or mixtures classified as corrosive to metals but no t \nclassified as skin corrosion or as serious eye damage (Category  1) \nwhich are in the finished state and packaged for consumer use d o \nnot require on the label the hazard pictogram GHS05.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 58}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 60  \n1.4. Request for use of an alternative chemical name  \n1.4.1.  Requests for use of an alternative chemical name under Article 24 \nmay be granted only where  \n(I) the substance has not been assigned a Community workplace \nexposure limit; and  \n(II) the manufacturer, importer or downstream user can demon\xad\nstrate that the use of the alternative chemical name meets \nthe need to provide enough information for necessary health \nand safety precautions to be taken in the workplace and the \nneed to ensure that risks from handling the mixture can be \ncontrolled; and  \n(III) the substance is classified exclusively as one or more of  the \nfollowing hazard categories:  \n(a) any of the hazard categories referred to in Part 2 of this \nAnnex;  \n(b) Acute toxicity, Category 4;  \n(c) Skin corrosion/irritation, Category 2;  \n(d) Serious eye damage/eye irritation, Category 2;  \n(e) Specific target organ toxicity — Single exposure, \nCategory 2 or 3;  \n(f) Specific target organ toxicity — Repeated exposure, \nCategory 2;  \n(g) Hazardous to the aquatic environment — Chronic, \nCategory 3 or 4.  \n1.4.2.  The choice of the chemical name(s) for mixtures intended for the \nfragrance or perfume industry  \nIn the case of substances occurring in nature, a chemical name or \nchemical names of the type ‘essential oil of …’ or ‘extract of …’ \nmay be used instead of the chemical names of the components of \nthat essential oil or extract as referred to in Article 18(3)(b ). \n1.5. Exemptions from labelling and packaging requirements  \n1.5.1.  Exemptions from Article 31 [(Article 29(1))]  \n1.5.1.1. Where Article 29(1) applies, the label elements mentio ned in \nArticle 17 may be provided in one of the following ways:  \n(a) in fold-out labels; or  \n(b) on tie-on tags; or  \n(c) on an outer packaging.  \n1.5.1.2. The label on any inner packaging shall contain at leas t hazard \npictograms, the product identifier referred to in Article 18 an d \nname and telephone number of the supplier of the substance or \nmixture.  \n1.5.2.  Exemptions from Article 17 [(Article 29(2)]  \n1.5.2.1.  Labelling of packages where the contents do not exceed 125 ml  \n1.5.2.1.1. The hazard statements and the precautionary statemen ts linked to \nthe hazard categories listed below may be omitted from the labe l \nelements required by Article 17 where:  \n(a) the contents of the package do not exceed 125 ml; and  \n(b) the substance or mixture is classified in one or more of th e \nfollowing hazard categories:  \n1) Oxidising gases of category 1;  \n2) Gases under pressure;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 59}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 61  \n3) Flammable liquids of category 2 or 3;  \n4) Flammable solids of category 1 or 2;  \n5) Self-reactive substances or mixtures Types C to F;  \n6) Self-heating substances or mixtures of category 2;  \n7) Substances and mixtures which, in contact with water, emit \nflammable gases of categories 1, 2 or 3;  \n8) Oxidising liquids of category 2 or 3;  \n9) Oxidising solids of category 2 or 3;  \n10) Organic peroxides Types C to F;  \n11) Acute toxicity of category 4, if the substances or mixtures  \nare not supplied to the general public;  \n12) Skin irritation of category 2;  \n13) Eye irritation of category 2;  \n14) Specific target organ toxicity — single exposure of \ncategory 2 or 3, if the substance or mixture is not \nsupplied to the general public;  \n15) Specific target organ toxicity — repeated exposure of \ncategory 2, if the substance or mixture is not supplied to \nthe general public;  \n16) Hazardous to the aquatic environment — Acute of \ncategory 1;  \n17) Hazardous to the aquatic environment — Chronic of \ncategory 1 or 2.  \nThe exemptions for labelling of small packages of aerosols as \nflammable laid down in Directive 75/324/EEC shall apply to \naerosol dispensers.  \n1.5.2.1.2. The precautionary statements linked to the hazard ca tegories listed \nbelow may be omitted from the label elements required by Articl e 17 \nwhere:  \n(a) the contents of the package do not exceed 125 ml; and  \n(b) the substance or mixture is classified in one or more of th e \nfollowing hazard categories:  \n1) Flammable gases of category 2;  \n2) Reproductive toxicity: effects on or via lactation;  \n3) Hazardous to the aquatic environment — Chronic of \ncategory 3 or 4.  \n1.5.2.1.3.  ►M2 The pictogram, the signal word, the hazard statement, and \nthe precautionary statement linked to the hazard categories lis ted \nbelow may be omitted from the label elements required by Articl e 17 \nwhere: ◄  \n(a) the contents of the package do not exceed 125 ml; and  \n(b) the substance or mixture is classified in one or more of th e \nfollowing hazard categories:  \n1) Corrosive to metals.  \n1.5.2.2.  Labelling of soluble packaging for single use  \nThe label elements required by Article 17 may be omitted from \nsoluble packaging intended for single use where:  \n(a) The content of each soluble packaging does not exceed a \nvolume of 25 ml;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 60}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 62  \n(b) The classification of the contents of the soluble packaging  is \nexclusively one or more of the hazard categories in 1.5.2.1.1 \n(b), 1.5.2.1.2 (b) or 1.5.2.1.3 (b); and  \n▼B \n(c) The soluble packaging is contained within outer packaging t hat \nfully meets the requirements of Article 17.  \n1.5.2.3. Section 1.5.2.2 shall not apply to substances or mixtu res within the \nscope of Directives 91/414/EEC or 98/8/EC.  \n▼M4 \n1.5.2.4.  Labelling of inner packaging where the contents do not exceed \n10 ml  \n1.5.2.4.1. The label elements required by Article 17 may be omi tted from the \ninner packaging where:  \n(a) the contents of the inner packaging do not exceed 10 ml;  \n(b) the substance or mixture is placed on the market for supply  to a \ndistributor or downstream user for scientific research and deve l\xad\nopment or quality control analysis; and  \n(c) the inner packaging is contained within outer packaging tha t \nmeets the requirements of Article 17.  \n1.5.2.4.2. Notwithstanding sections 1.5.1.2 and 1.5.2.4.1, the label on the \ninner packaging shall contain the product identifier and, where  \nappropriate, the hazard pictograms “GHS01”, “GHS05”, “GHS06” \nand/or “GHS08”. Where more than two pictograms are assigned, \n“GHS06” and “GHS08” may take precedence over “GHS01” and \n“GHS05”.  \n1.5.2.5. Section 1.5.2.4 shall not apply to substances or mixtu res within the \nscope of Regulation (EC) No 1107/2009 or (EU) No 528/2012.  \n▼B \n2. PART 2: PHYSICAL HAZARDS  \n2.1. Explosives  \n2.1.1.  Definitions  \n2.1.1.1. The class of explosives comprises  \n(a) explosive substances and mixtures;  \n(b) explosive articles, except devices containing explosive \nsubstances or mixtures in such quantity or of such a character \nthat their inadvertent or accidental ignition or initiation sha ll not \ncause any effect external to the device either by projection, f ire, \nsmoke, heat or loud noise; and  \n▼M19  \n(c) substances, mixtures and articles not mentioned in points ( a) \nand (b) above, which are manufactured with the view to \nproducing a practical explosive or pyrotechnic effect.  \n▼B \n2.1.1.2. For the purposes of this Regulation the following defi nitions shall \napply:  \nAn explosive substance or mixture is a solid or liquid substanc e or \nmixture of substances which is in itself capable by chemical \nreaction of producing gas at such a temperature and pressure an d \nat such a speed as to cause damage to the surroundings. Pyrotec hnic \nsubstances are included even when they do not evolve gases.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 61}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 63  \nA pyrotechnic substance or mixture is a substance or mixture of  \nsubstances designed to produce an effect by heat, light, sound,  gas \nor smoke or a combination of these as the result of non-detonat ive \nself-sustaining exothermic chemical reactions.  \nAn unstable explosive is an explosive substance or mixture whic h is \nthermally unstable and/or too sensitive for normal handling, \ntransport and use.  \nAn explosive article is an article containing one or more explo sive \nsubstances or mixtures.  \nA pyrotechnic article is an article containing one or more pyro \xad\ntechnic substances or mixtures.  \nAn intentional explosive is a substance, mixture or article whi ch is \nmanufactured with a view to producing a practical, explosive or  \npyrotechnic effect.  \n2.1.2.  Classification criteria  \n2.1.2.1. Substances, mixtures and articles of this class are cl assified as an \nunstable explosive on the basis of the flowchart in Figure 2.1. 2. \n►M4 The test methods are described in Part I of the UN RTDG, \nManual of Tests and Criteria. ◄  \n2.1.2.2. Substances, mixtures and articles of this class, which  are not clas\xad\nsified as an unstable explosive, shall be assigned to one of th e \nfollowing six divisions depending on the type of hazard they \npresent:  \n(a) Division 1.1 Substances, mixtures and articles which have a  \nmass explosion hazard (a mass explosion is one which affects \nalmost the entire quantity present virtually instantaneously);  \n(b) Division 1.2 Substances, mixtures and articles which have a  \nprojection hazard but not a mass explosion hazard;  \n(c) Division 1.3 Substances, mixtures and articles which have a  fire \nhazard and either a minor blast hazard or a minor projection \nhazard or both, but not a mass explosion hazard:  \n(i) combustion of which gives rise to considerable radiant heat ; \nor \n(ii) which burn one after another, producing minor blast or \nprojection effects or both;  \n(d) Division 1.4 Substances, mixtures and articles which presen t no \nsignificant hazard:  \n— substances, mixtures and articles which present only a small \nhazard in the event of ignition or initiation. The effects are  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 62}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 64  \nlargely confined to the package and no projection of \nfragments of appreciable size or range is to be expected. \nAn external fire shall not cause virtually instantaneous \nexplosion of almost the entire contents of the package;  \n(e) Division 1.5 Very insensitive substances or mixtures which \nhave a mass explosion hazard:  \n— substances and mixtures which have a mass explosion \nhazard but are so insensitive that there is very little prob\xad\nability of initiation or of transition from burning to \ndetonation under normal conditions;  \n▼M19  \n(f) Division 1.6 Extremely insensitive articles which do not ha ve a \nmass explosion hazard:  \n— articles which predominantly contain extremely insensitive \nsubstances or mixtures;  \n— and which demonstrate a negligible probability of accidental \ninitiation or propagation.  \n▼B \n2.1.2.3. Explosives, which are not classified as an unstable ex plosive, shall \nbe classified in one of the six divisions referred to in paragr aph \n2.1.2.2 of this Annex based on Test Series 2 to 8 in Part I of the \n►M4 UN RTDG ◄, Manual of Tests and Criteria according to the \nresults of the tests laid down in Table 2.1.1:  \nTable 2.1.1  \nCriteria for explosives  \nCategory  Criteria  \nUnstable \nexplosives or \nexplosives of \nDivisions 1.1 to 1.6  For explosives of Divisions 1.1 to 1.6, the \nfollowing are the core set of tests that need \nto be performed:  \nExplosibility: according to UN Test Series 2 \n(section 12 of the  ►M4 UN RTDG ◄, \nManual of Tests and Criteria). Intentional \nexplosives (  1 ) shall not be subject to UN \nTest Series 2.  \nSensitiveness: according to UN Test Series 3 \n(section 13 of the  ►M4 UN RTDG ◄, \nManual of Tests and Criteria).  \nThermal stability: according to UN Test 3(c) \n(sub-section 13.6.1 of the  ►M4 UN \nRTDG ◄, Manual of Tests and Criteria). \nFurther tests are necessary to allocate the \ncorrect Division.  \n( 1 ) This comprises substances, mixtures and articles which are ma nufactured \nwith a view to producing a practical, explosive or pyrotechnic effect.  \n2.1.2.4. If explosives are unpackaged or repacked in packaging other than \nthe original or similar packaging, they shall be retested.  \n▼M12  \n2.1.3.  Hazard Communication  \nLabel elements shall be used for substances, mixtures or articl es \nmeeting the criteria for classification in this hazard class in  \naccordance with Table 2.1.2.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 63}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 65\n Table 2.1.2  \nLabel elements for explosives  \nClassification  Unstable Explosive  Division 1.1  Division 1.2  Division 1.3  Division 1.4  Division 1.5  Division 1.6  \nGHS Pictograms\n  \nSignal Word  Danger  Danger  Danger  Danger  Warning  Danger  No signal word  \nHazard Statement  H200: Unstable \nExplosive  H201: Explosive; \nmass explosion \nhazard  H202: Explosive; \nsevere projection \nhazard  H203: Explosive; \nfire, blast or \nprojection hazard  H204: Fire or \nprojection hazard  H205: May mass \nexplode in fire  No hazard statement  \nPrecautionary \nStatement Prevention  P201 \nP250 \nP280  P210 \nP230 \nP234 \nP240 \nP250 \nP280  P210 \nP230 \nP234 \nP240 \nP250 \nP280  P210 \nP230 \nP234 \nP240 \nP250 \nP280  P210 \nP234 \nP240 \nP250 \nP280  P210 \nP230 \nP234 \nP240 \nP250 \nP280  No precautionary \nstatement  \nPrecautionary \nStatement Response  P370 + P372 + \nP380 + P373  P370 + P372 + \nP380 + P373  P370 + P372 + \nP380 + P373  P370 + P372 + \nP380 + P373  P370 + P372 + \nP380 + P373 \nP370 + P380 + \nP375  P370 + P372 + \nP380 + P373  No precautionary \nstatement  \nPrecautionary \nStatement Storage  P401  P401  P401  P401  P401  P401  No precautionary \nstatement  \nPrecautionary \nStatement Disposal  P501  P501  P501  P501  P501  P501  No precautionary \nstatement  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 64}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 66\n NOTE 1:  Unpackaged explosives or explosives repackaged in packaging ot her than the original or similar packaging shall include all of  the following label elements:  \n(a) the pictogram: exploding bomb;  \n(b) the signal word ‘Danger’; and  \n(c) the hazard statement: ‘Explosive; mass explosion hazard’  \nunless the hazard is shown to correspond to one of the hazard c ategories in Table 2.1.2, in which case the corresponding symbo l, the signal word and/or the hazard statement shall \nbe assigned.  \nNOTE 2:  Substances and mixtures, as supplied, with a positive result i n Test Series 2 in Part I, Section 12, of the UN RTDG, Manual o f Tests and Criteria, which are exempted \nfrom classification as explosives (based on a negative result i n Test Series 6 in Part I, Section 16 of the UN RTDG, Manual of  Tests and Criteria) still have explosive properties. \nThe user shall be informed of these intrinsic explosive propert ies because they have to be considered for handling — especiall y if the substance or mixture is removed from its \npackaging or is repackaged — and for storage. For this reason, the explosive properties of the substance or mixture shall be c ommunicated in Section 2 (Hazards identification) \nand Section 9 (Physical and chemical properties) of the Safety Data Sheet and other sections of the Safety Data Sheet, as appr opriate.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 65}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 67  \n2.1.4.  Additional Classification Considerations  \n2.1.4.1. The classification of substances, mixtures and article s in the \nexplosives hazard class and further allocation to a division is  a  \nvery complex, three step procedure. Reference to Part I of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria is necessary.  \nThe first step is to ascertain whether the substance or mixture  has \nexplosive effects (Test Series 1). The second step is the accep tance \nprocedure (Test Series 2 to 4) and the third step is the assign ment to \na hazard division (Test Series 5 to 7). The assessment whether a \ncandidate for ‘ammonium nitrate emulsion or suspension or gel, \nintermediate for blasting explosives (ANE)’ is insensitive enou gh \nfor inclusion as an oxidising liquid (section 2.13) or an oxidi sing \nsolid (section 2.14) is answered by Test Series 8 tests.  \n▼M19  \nSome explosive substances and mixtures are wetted with water or  \nalcohols, diluted with other substances or dissolved or suspend ed in \nwater or other liquid substances to suppress or reduce their \nexplosives properties. They may be a candidate for classificati on \nas desensitised explosives (see Section 2.17).  \n▼B \nCertain physical hazards (due to explosive properties) are alte red by \ndilution, as is the case for desensitised explosives, by inclus ion in a \nmixture or article, packaging or other factors.  \nThe classification procedure is set out in the following decisi on \nlogic (see Figures 2.1.1 to 2.1.4).  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 66}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 68  \nFigure 2.1.1  \nOverall scheme of the procedure for classifying a substance, mixture or article in the class \nof explosives (Class 1 for transport)\n  \n► (1) M2 \n► (2) M4 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 67}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 69  \nFigure 2.1.2  \nProcedure for provisional acceptance of a substance, mixture or article in the class of \nexplosives (Class 1 for transport)\n  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 68}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 70  \nFigure 2.1.3  \nProcedure for assignment to a division in the class of explosives (Class 1 for transport)\n  \n( 1 ) See Chapter 3.3 of the UN RTDG, Model Regulations for details . ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 69}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 71  \nFigure 2.1.4  \nProcedure for the classification of ammonium nitrate emulsion, suspension or gel (ANE)\n  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 70}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 72  \n2.1.4.2.  Screening procedure  \nExplosive properties are associated with the presence of certai n \nchemical groups in a molecule which can react to produce very \nrapid increases in temperature or pressure. The screening \nprocedure is aimed at identifying the presence of such reactive  \ngroups and the potential for rapid energy release. If the scree ning \nprocedure identifies the substance or mixture to be a potential  \nexplosive, the acceptance procedure (see section 10.3 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria) has to be \nperformed.  \n▼M2 \nNote:  \nNeither a series 1 type (a) propagation of detonation test nor a series \n2 type (a) test of sensitivity to detonative shock is required if the \nexothermic decomposition energy of organic materials is less th an \n800 J/g. For organic substances and mixtures of organic substan ces \nwith a decomposition energy of 800 J/g or more, tests 1 (a) and  2  \n(a) need not be performed if the outcome of the ballistic morta r \nMk.IIId test (F.1), or the ballistic mortar test (F.2) or the B AM \nTrauzl test (F.3) with initiation by a standard No 8 detonator (see \nAppendix 1 to the UN RTDG, Manual of Tests and Criteria) is ‘no ’. \nIn this case, the results of test 1 (a) and 2 (a) are deemed to  be ‘-’.  \n▼M19  \n2.1.4.3. The acceptance procedure for the hazard class ‘explosi ves’ need not \nbe applied if:  \n▼B \n(a) There are no chemical groups associated with explosive prop \xad\nerties present in the molecule. Examples of groups which may \nindicate explosive properties are given in Table A6.1 in \nAppendix 6 of the  ►M4 UN RTDG ◄, Manual of Tests and \nCriteria; or  \n(b) The substance contains chemical groups associated with \nexplosive properties which include oxygen and the calculated \noxygen balance is less than - 200;  \nThe oxygen balance is calculated for the chemical reaction:  \nC x H y O z + [x+ (y/4)-(z/2)] O  2 → x CO  2 + (y/2) H  2 O \nUsing the formula:  \nOxygen balance = -1 600 [2x + (y/2)-z]/molecular weight;  \n▼M19  \n(c) For an organic substance, or a homogenous mixture of organi c \nsubstances, containing a chemical group (or groups) associated \nwith explosive properties:  \n— the exothermic decomposition energy is less than 500 J/g, or  \n— the onset of exothermic decomposition is 500 °C or above  \nas indicated in Table 2.1.3.  \nTable 2.1.3  \nDecision to apply the acceptance procedure for the hazard class ‘Explosives’ \nfor an organic substance or a homogenous mixture of organic substances  \nDecomposition energy \n(J/g) Decomposition onset \ntemperature \n(°C) Apply acceptance procedure? \n(Yes/No)  \n< 500  < 500  N o  \n< 500  ≥ 500  N o  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 71}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 73  \nDecomposition energy \n(J/g) Decomposition onset \ntemperature \n(°C) Apply acceptance procedure? \n(Yes/No)  \n≥ 500  < 500  Yes  \n≥ 500  ≥ 500  N o  \nThe exothermic decomposition energy may be determined using \na suitable calorimetric technique (see section 20.3.3.3 of the  UN \nRTDG, Manual of Tests and Criteria ). \n▼B \n(d) For mixtures of inorganic oxidising substances with organic  \nmaterial(s), the concentration of the inorganic oxidising \nsubstance is:  \n— less than 15 % by mass, if the oxidising substance is \nassigned to Categories 1 or 2;  \n— less than 30 % by mass, if the oxidising substance is \nassigned to Category 3.  \n2.1.4.4. In the case of mixtures containing any known explosive s, the \nacceptance procedure has to be performed.  \n▼M19  \n2.2. Flammable gases  \n2.2.1.  Definitions  \n2.2.1.1. Flammable gas means a gas or gas mixture having a flam mable \nrange with air at 20 °C and a standard pressure of 101,3 kPa.  \n2.2.1.2. A pyrophoric gas means a flammable gas that is liable to ignite \nspontaneously in air at a temperature of 54 °C or below.  \n2.2.1.3. A chemically unstable gas means a flammable gas that i s able to \nreact explosively even in the absence of air or oxygen.  \n▼M4 \n2.2.2.  Classification criteria  \n▼M19  \n2.2.2.1. A flammable gas is classified in Category 1A, 1B or 2 in \naccordance with Table 2.2.1. Flammable gases that are pyrophori c \nand/or chemically unstable are always classified in Category 1A . \nTable 2.2.1  \nCriteria for categorisation of flammable gases  \nCategory  Criteria  \n1A Flammable gas  Gases, which at 20 °C and a standard pressure of \n101,3 kPa are: \n(a) ignitable when in a mixture of 13 % or less by \nvolume in air; or \n(b) have a flammable range with air of at least 12 \npercentage points regardless of the lower \nflammability limit \nunless data show they meet the criteria for \nCategory 1B  \nPyrophoric gas  Flammable gases that ignite spontaneously in air at \na temperature of 54 °C or below  \nChemically unstable gas  A Flammable gases which are chemically unstable at \n20 °C and a standard pressure of 101,3 kPa  \nB Flammable gases which are chemically unstable at \na temperature greater than 20 °C and/or a pressure \ngreater than 101,3 kPa  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 72}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 74  \nCategory  Criteria  \n1B Flammable gas  Gases which meet the flammability criteria for \nCategory 1A, but which are not pyrophoric, nor \nchemically unstable, and which have at least \neither: \n(a) a lower flammability limit of more than 6 % \nby volume in air; or \n(b) a fundamental burning velocity of less than \n10 cm/s;  \n2 Flammable gas  Gases, other than those of Category 1A or 1B, \nwhich, at 20 °C and a standard pressure of 101,3 \nkPa, have a flammable range while mixed in air.  \nNOTE 1: Aerosols shall not be classified as flammable gases. See \nSection 2.3.  \nNOTE 2: In the absence of data allowing classification into \nCategory 1B, a flammable gas that meets the criteria \nfor Category 1A is classified by default in Category 1A.  \nNOTE 3: Spontaneous ignition for pyrophoric gases is not always \nimmediate, and there may be a delay.  \nNOTE 4: In the absence of data on its pyrophoricity, a flammable \ngas mixture shall be classified as a pyrophoric gas if it \ncontains more than 1 % (by volume) of pyrophoric \ncomponent(s) . \n▼M4 \n2.2.3.  Hazard Communication  \nLabel elements shall be used for substances and mixtures meetin g \nthe criteria for classification in this hazard class in accorda nce with \nTable 2.2.3.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 73}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 75\n Table 2.2.2  \nLabel elements for flammable gases  \nCategory 1A  Gases categorised as 1A meeting pyrophoric or unstable gas A/B  criteria  Category 1B  Category 2  \nPyrophoric gas  Chemically unstable gas  \nCategory A  Category B  \nGHS Pictogram\n  No pictogram  \nSignal Word  Danger  Danger  Danger  Danger  Danger  Warning  \nHazard Statement  H220: Extremely \nflammable gas  H220: Extremely \nflammable gas. \nH232: May ignite spon\xad\ntaneously if exposed to \nair H220: Extremely \nflammable gas. \nH230: May react \nexplosively even in the \nabsence of air  H220: Extremely \nflammable gas. \nH231: May react \nexplosively even in the \nabsence of air at elevated \npressure and/or \ntemperature  H221: Flammable gas  H221: Flammable gas  \nPrecautionary Statement \nPrevention  P210  P210 \nP222 \nP280  P202 \nP210  P202 \nP210  P210  P210  \nPrecautionary Statement \nResponse  P377 \nP381  P377 \nP381  P377 \nP381  P377 \nP381  P377 \nP381  P377 \nP381  \nPrecautionary Statement \nStorage  P403  P403  P403  P403  P403  P403  \nPrecautionary Statement \nDisposal  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 74}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 76  \nIf a flammable gas or gas mixture is classified as pyrophoric a nd/or \nchemically unstable, then all relevant classification(s) shall be \ncommunicated on the safety data sheet as specified in Annex II \nof Regulation (EC) No 1907/2006, and the relevant hazard \ncommunication elements included on the label.  \nThe classification procedure is set out in the following decisi on \nlogic (see Figure 2.2.1).  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 75}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 77  \nFigure 2.2.1  \nFlammable gases\n  \n( 1 ) In the absence of data on its pyrophoricity, a flammable gas \nmixture shall be classified as a pyrophoric gas if it contains \nmore than 1 % (by volume) of pyrophoric component(s).  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 76}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 78\n  \n__________  \n▼M4 \n2.2.4.  Additional Classification Considerations  \n▼M19  \n2.2.4.1. Flammability shall be determined by tests or, for mixt ures where \nthere are sufficient data available, by calculation in accordan ce with \nthe methods adopted by ISO (see ISO 10156 as amended, ‘Gases \nand gas mixtures — Determination of fire potential and oxidisin g \nability for the selection of cylinder valve outlets’ and, if us ing \nfundamental burning velocity for Category 1B, see ISO 817 as \namended ‘Refrigerants-Designation and safety classification, \nAnnex C:- Method of test for burning velocity measurement of \nflammable gases’). Instead of the test apparatus according to I SO \n10156 as amended, the test apparatus for the tube method accord ing \nto clause 4.2 of EN 1839 as amended (Determination of explosion  \nlimits of gases and vapours) may be used.  \n2.2.4.2. Pyrophoricity shall be determined at 54 °C in accordan ce with \neither IEC 60079-20-1 ed1.0 (2010-01) ‘Explosive atmospheres – \nPart 20-1: Material characteristics for gas and vapour classifi cation \n– Test methods and data’ or DIN 51794 ‘Determining the ignition  \ntemperature of petroleum products’.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 77}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 79  \n2.2.4.3. The classification procedure for pyrophoric gases need  not be \napplied when experience in production or handling shows that th e \nsubstance does not ignite spontaneously on coming into contact \nwith air at a temperature of 54 °C or below. Flammable gas \nmixtures, which have not been tested for pyrophoricity and \ncontain more than one percent pyrophoric components, shall be \nclassified as a pyrophoric gas. Expert judgement on the propert ies \nand physical hazards of pyrophoric gases and their mixtures sha ll be \nused in assessing the need for classification of flammable gas \nmixtures containing one percent or less pyrophoric components. In \nthis case, testing need only be considered if expert judgement \nindicates a need for additional data to support the classificat ion \nprocess.  \n▼M4 \n►M19  2.2.4.4. ◄ Chemical instability shall be determined in accorda nce with \nthe method described in Part III of the UN RTDG, Manual \nof Tests and Criteria. If the calculations in accordance with \nISO 10156 as amended show that a gas mixture is not \nflammable it is not necessary to carry out the tests for deter\xad\nmining chemical instability for classification purposes.  \n2.3. Aerosols  \n2.3.1.  Definitions  \nAerosols, this means aerosol dispensers, are any non-refillable  \nreceptacles made of metal, glass or plastics and containing a g as \ncompressed, liquefied or dissolved under pressure, with or with out a \nliquid, paste or powder, and fitted with a release device allow ing the \ncontents to be ejected as solid or liquid particles in suspensi on in a \ngas, as a foam, paste or powder or in a liquid state or in a ga seous \nstate.  \n2.3.2.  Classification criteria  \n▼M12  \n2.3.2.1. Aerosols shall be classified in one of the three categ ories of this \nhazard class, depending on their flammable properties and their  heat \nof combustion. They shall be considered for classification in \nCategory 1 or 2 if they contain more than 1 % components (by \nmass) which are classified as flammable according to the \nfollowing criteria set out in this Part:  \n— Flammable gases (see Section 2.2);  \n— Liquids with a flash point ≤ 93 °C, which includes Flammable \nLiquids according to Section 2.6;  \n— Flammable solids (see Section 2.7);  \nor if their heat of combustion is at least 20 kJ/g.  \nNOTE 1:  Flammable components do not cover pyrophoric, self- \nheating or water-reactive substances and mixtures because such \ncomponents are never used as aerosol contents.  \nNOTE 2:  Aerosols do not fall additionally within the scope of \nSections 2.2 (flammable gases), 2.5 (gases under pressure), 2.6  \n(flammable liquids) and 2.7 (flammable solids). Depending on \ntheir contents, aerosols may however fall within the scope of \nother hazard classes, including their labelling elements.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 78}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 80  \n2.3.2.2. An aerosol shall be classified in one of the three cat egories for this \nClass on the basis of its components, of its chemical heat of \ncombustion and, if applicable, of the results of the foam test (for \nfoam aerosols) and of the ignition distance test and enclosed s pace \ntest (for spray aerosols) in accordance with Figures 2.3.1(a) t o \n2.3.1(c) of this Annex and subsections 31.4, 31.5 and 31.6 of \nPart III of the UN RTDG, Manual of Tests and Criteria. Aerosols  \nwhich do not meet the criteria for inclusion in Category 1 or \nCategory 2 shall be classified in Category 3.  \nNote:  \nAerosols containing more than 1 % flammable components or with \na heat of combustion of at least 20 kJ/g, which are not submitt ed to \nthe flammability classification procedures in this section shal l be \nclassified as aerosols, Category 1.  \n▼M12  \nFigure 2.3.1 (a)  \nFor aerosols\n  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 79}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 81  \nFigure 2.3.1 (b)  \nSpray aerosols\n  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 80}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 82  \nFigure 2.3.1 (c)  \nFoam aerosols\n  \n2.3.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.3.1.  \nTable 2.3.1  \n▼M12  \nLabel elements for aerosols  \n▼M4 \nClassification  Category 1  Category 2  Category 3  \nGHS Pictograms\n  No pictogram  \nSignal Word  Danger  Warning  Warning  \nHazard Statement  H222: Extremely \nflammable aerosol \nH229: Pressurised \ncontainer: May burst \nif heated  H223: Flammable \naerosol \nH229: Pressurised \ncontainer: May \nburst if heated  H229: Pressurised \ncontainer: May \nburst if heated  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 81}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 83  \nClassification  Category 1  Category 2  Category 3  \nPrecautionary \nStatement Prevention  P210 \nP211 \nP251  P210 \nP211 \nP251  P210 \nP251  \nPrecautionary \nStatement Response  \nPrecautionary \nStatement Storage  P410 + P412  P410 + P412  P410 + P412  \nPrecautionary \nStatement Disposal  \n2.3.4.  Additional Classification Considerations  \n2.3.4.1. The chemical heat of combustion (ΔΗ  c ), in kilojoules per gram \n(kJ/g), is the product of the theoretical heat of combustion \n(ΔΗ  comb ), and a combustion efficiency, usually less than 1,0 (a \ntypical combustion efficiency is 0,95 or 95 %).  \nFor a composite aerosol formulation, the chemical heat of \ncombustion is the summation of the weighted heats of combustion  \nfor the individual components, as follows:  \nΔH  c ðproductÞ ¼ X  n \ni ½w i % Ü ΔH  cðiÞ â \nwhere:  \nΔΗ  c = chemical heat of combustion (kJ/g);  \nw i % = mass fraction of component i in the product;  \nΔΗ  c(i) = specific heat of combustion (kJ/g)of component i in the \nproduct.  \nThe chemical heats of combustion can be found in the literature , \ncalculated or determined by tests (see ASTM D 240 as amended — \nStandard Test Methods for Heat of Combustion of Liquid Hydro\xad\ncarbon Fuels by Bomb Calorimeter, EN/ISO 13943 as amended, \n86.l to 86.3 — Fire safety — Vocabulary, and NFPA 30B as \namended — Code for the Manufacture and Storage of Aerosol \nProducts).  \n▼B \n2.4. Oxidising gases  \n2.4.1.  Definitions  \nOxidising gas means any gas or gas mixture which may, generally  \nby providing oxygen, cause or contribute to the combustion of o ther \nmaterial more than air does.  \n2.4.2.  Classification criteria  \n2.4.2.1. An oxidising gas shall be classified in a single categ ory for this \nclass in accordance with Table 2.4.1.:  \nTable 2.4.1  \nCriteria for oxidising gases  \nCategory  Criteria  \n1 Any gas which may, generally by providing oxygen, \ncause or contribute to the combustion of other material \nmore than air does.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 82}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 84  \nNote:  \n‘Gases which cause or contribute to the combustion of other \nmaterial more than air does’ means pure gases or gas mixtures \nwith an oxidising power greater than 23,5 % as determined by a \nmethod specified in ISO 10156 as amended.  \n▼B \n2.4.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.4.2.  \nTable 2.4.2  \nLabel elements for oxidising gases  \nClassification  Category 1  \nGHS Pictogram\n  \nSignal Word  Danger  \nHazard Statement  H270: May cause or intensify \nfire; oxidiser  \nPrecautionary Statement \nPrevention  P220 \nP244  \nPrecautionary Statement \nResponse  P370 + P376  \nPrecautionary Statement \nStorage  P403  \nPrecautionary Statement \nDisposal  \n▼M4 \n2.4.4.  Additional Classification Considerations  \nTo classify an oxidising gas, tests or calculation methods as \ndescribed in ISO 10156 as amended, “Gases and gas mixtures — \nDetermination of fire potential and oxidising ability for the s election \nof cylinder valve outlet” shall be performed.  \n▼B \n2.5. Gases under pressure  \n2.5.1.  Definition  \n2.5.1.1.  ►M4 Gases under pressure are gases which are contained in a \nreceptacle at a pressure of 200 kPa (gauge) or more at 20 °C, o r \nwhich are liquefied or liquefied and refrigerated. ◄  \nThey comprise compressed gases, liquefied gases, dissolved gase s \nand refrigerated liquefied gases.  \n2.5.1.2. The critical temperature is the temperature above whic h a pure gas \ncannot be liquefied, regardless of the degree of compression.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 83}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 85  \n2.5.2.  Classification criteria  \n2.5.2.1. Gases under pressure shall be classified, according to  their physical \nstate when packaged, in one of four groups in accordance with \nTable 2.5.1:  \nTable 2.5.1  \nCriteria for gases under pressure  \nGroup  Criteria  \nCompressed \ngas A gas which when packaged under pressure is \nentirely gaseous at – 50 °C; including all gases \nwith a critical temperature ≤ – 50 °C.  \nLiquefied gas  A gas which, when packaged under pressure, is \npartially liquid at temperatures above – 50 °C. A \ndistinction is made between: \n(i) high pressure liquefied gas: a gas with a \ncritical temperature between – 50 °C and + \n65 °C; and \n(ii) low pressure liquefied gas: a gas with a \ncritical temperature above + 65 °C.  \nRefrigerated \nliquefied gas  A gas which when packaged is made partially \nliquid because of its low temperature.  \nDissolved gas  A gas which when packaged under pressure is \ndissolved in a liquid phase solvent.  \nNote:  \nAerosols shall not be classified as gases under pressure. See s ection 2.3.  \n▼B \n2.5.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.5.2.  \n▼M12  \nTable 2.5.2  \nLabel elements for gases under pressure  \nClassification  Compressed gas  Liquefied gas  Refrigerated \nliquefied gas  Dissolved gas  \nGHS Picto\xad\ngrams\n  \nSignal Word  Warning  Warning  Warning  Warning  \nHazard \nStatement  H280: Contains \ngas under \npressure; may \nexplode if \nheated  H280: Contains \ngas under \npressure; may \nexplode if \nheated  H281: Contains \nrefrigerated gas; \nmay cause \ncryogenic burns \nor injury  H280: Contains \ngas under \npressure; may \nexplode if \nheated  \nPrecautionary \nStatement \nPrevention  P282 ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 84}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 86  \nClassification  Compressed gas  Liquefied gas  Refrigerated \nliquefied gas  Dissolved gas  \nPrecautionary \nStatement \nResponse  P336 + P315  \nPrecautionary \nStatement \nStorage  P410 + P403  P410 + P403  P403  P410 + P403  \nPrecautionary \nStatement \nDisposal  \n▼M2 \nNote:  \nPictogram GHS04 is not required for gases under pressure where \npictogram GHS02 or pictogram GHS06 appears.  \n▼B \n2.5.4.  Additional Classification Considerations  \nFor this group of gases, the following information is required to be \nknown:  \n— the vapour pressure at 50  o C; \n— the physical state at 20  o C at standard ambient pressure;  \n— the critical temperature.  \n▼M4 \nData can be found in the literature, calculated or determined b y \ntesting. Most pure gases are already classified in the UN RTDG,  \nModel Regulations.  \n▼B \n2.6. Flammable liquids  \n2.6.1.  Definition  \nFlammable liquid means a liquid having a flash point of not mor e \nthan 60  o C. \n2.6.2.  Classification criteria  \n2.6.2.1. A flammable liquid shall be classified in one of the t hree categories \nfor this class in accordance with Table 2.6.1:  \nTable 2.6.1  \nCriteria for flammable liquids  \nCategory  Criteria  \n1 Flash point < 23  o C and initial boiling point ≤ 35  o C \n2 Flash point < 23  o C and initial boiling point > 35  o C \n3 Flash point ≥ 23  o C and ≤ 60  o C (  1 ) \n( 1 ) For the purpose of this Regulation gas oils, diesel and light  heating oils \nhaving a flash point between ≥ 55  o C and ≤ 75  o C may be regarded as \nCategory 3.  \n▼M2 \nNote:  \nAerosols shall not be classified as flammable liquids; see sect ion \n2.3. ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 85}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 87  \n2.6.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.6.2.  \nTable 2.6.2  \nLabel elements for flammable liquids  \nClassification  Category 1  Category 2  Category 3  \nGHS Pictograms\n  \nSignal Word  Danger  Danger  Warning  \nHazard Statement  H224: Extremely \nflammable liquid \nand vapour  H225: Highly \nflammable liquid \nand vapour  H226: \nFlammable liquid \nand vapour  \nPrecautionary \nStatement \nPrevention  P210 \nP233 \nP240 \nP241 \nP242 \nP243 \nP280  P210 \nP233 \nP240 \nP241 \nP242 \nP243 \nP280  P210 \nP233 \nP240 \nP241 \nP242 \nP243 \nP280  \nPrecautionary \nStatement \nResponse  P303 + P361 + \nP353 \nP370 + P378  P303 + P361 + \nP353 \nP370 + P378  P303 + P361 + \nP353 \nP370 + P378  \nPrecautionary \nStatement \nStorage  P403 + P235  P403 + P235  P403 + P235  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  \n2.6.4.  Additional Classification Considerations  \n2.6.4.1. For the classification of flammable liquids data on fl ash point and \ninitial boiling point are needed. Data can be determined by tes ting, \nfound in literature or calculated. If data are not available, t he flash \npoint and the initial boiling point shall be determined through  \ntesting. For flash point determination a closed-cup method shal l \nbe used.  \n▼M19  \n2.6.4.2. In the case of mixtures (  1 ) containing known flammable liquids in \ndefined concentrations, although they may contain non-volatile \ncomponents e.g. polymers, additives, the flash point need not b e \ndetermined experimentally if the calculated flash point of the \nmixture, using the method given in 2.6.4.3 below, is at least \n5 °C (  2 ) greater than the relevant classification criterion and \nprovided that:  ▼B \n( 1 ) Up to now, the calculation method is validated for mixtures containing up to six volatile \ncomponents. These components may be flammable liquids like hydrocarbons, ethers, \nalcohols, esters (except acrylates), and water. It is however not yet validated for \nmixtures containing halogenated, sulphurous, and/or phosphoric compounds as well \nas reactive acrylates.  \n( 2 ) If the calculated flash point is less than 5 °C greater than the relevant classification \ncriterion, the calculation method may not be used and the flash point shall be \ndetermined experimentally.', metadata={'source': 'data/ycla_en.pdf', 'page': 86}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 88  \n(a) the composition of the mixture is accurately known (if the \nmaterial has a specified range of composition, the composition \nwith the lowest calculated flash point shall be selected for \nassessment);  \n(b) the lower explosion limit of each component is known (an \nappropriate correlation has to be applied when these data are \nextrapolated to other temperatures than test conditions) as wel l \nas a method for calculating the lower explosion limit  ►M2 of \nthe mixture ◄;  \n(c) the temperature dependence of the saturated vapour pressure  \nand of the activity coefficient is known for each component \nas present in the mixture;  \n(d) the liquid phase is homogeneous.  \n2.6.4.3. One suitable method is described in Gmehling and Rasmu ssen (Ind. \nEng. Fundament, 21, 186, (1982)). For a mixture containing non-  \nvolatile components the flash point is calculated from the vola tile \ncomponents. It is considered that a non-volatile component only  \nslightly decreases the partial pressure of the solvents and the  \ncalculated flash point is only slightly below the measured valu e. \n2.6.4.4. Possible test methods for determining the flash point of flammable \nliquids are listed in Table 2.6.3.  \nTable 2.6.3  \nMethods for determining the flash point of flammable liquids  \nEuropean standards:  EN ISO 1516 as amended \nDetermination of flash/no flash — Closed \ncup equilibrium method  \nEN ISO 1523 as amended \nDetermination of flash point — Closed cup \nequilibrium method  \nEN ISO 2719 as amended \nDetermination of flash point — Pensky- \nMartens closed cup method  \nEN ISO 3679 as amended \nDetermination of flash point — Rapid equi\xad\nlibrium closed cup method  \nEN ISO 3680 as amended \nDetermination of flash/no flash — Rapid \nequilibrium closed cup method  \nEN ISO 13736 as amended \nPetroleum products and other liquids — \nDetermination of flash point — Abel \nclosed cup method  \nNational standards:  \nAssociation \nfrançaise de normal\xad\nisation, AFNOR:  NF M07-036 as amended \nDétermination du point d'éclair — Vase clos \nAbel-Pensky \n(identical to DIN 51755)  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 87}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 89  \n__________  \n▼B \nDeutsches Institut \nfür Normung  DIN 51755 (flash points below 65 C) as \namended Prüfung von Mineralölen und \nanderen brennbaren Flüssigkeiten; \nBestimmung des Flammpunktes im gesch\xad\nlossenen Tiegel, nach Abel-Pensky \n(identical to NF M07-036)  \n▼M2 \n2.6.4.5 Liquids with a flash point of more than 35 °C and not m ore than \n60 °C need not be classified in Category 3 if negative results have \nbeen obtained in the sustained combustibility test L.2, Part II I, \nsection 32 of the UN RTDG, Manual of Tests and Criteria.  \n2.6.4.6. Possible test methods for determining the initial boil ing point of \nflammable liquids are listed in Table 2.6.4.  \nTable 2.6.4  \nMethods for determining the initial boiling point of flammable \nliquids  \nEuropean standards:  EN ISO 3405 as amended \nPetroleum products — Determination of \ndistillation characteristics at atmospheric \npressure  \nEN ISO 3924 as amended \nPetroleum products — Determination of \nboiling range distribution — Gas chroma\xad\ntography method  \nEN ISO 4626 as amended \nVolatile organic liquids — Determination of \nboiling range of organic solvents used as raw \nmaterials  \nRegulation (EC) No \n440/2008 (  1 ) Method A.2 as described in Part A of the \nAnnex to Regulation (EC) No 440/2008  \n( 1 ) OJ L 142, 31.5.2008, p. 1.  \n▼B \n2.7. Flammable solids  \n2.7.1.  Definition  \n2.7.1.1. A flammable solid means a solid which is readily combu stible, or \nmay cause or contribute to fire through friction.  \nReadily combustible solids are powdered, granular, or pasty \nsubstances or mixtures which are dangerous if they can be easil y \nignited by brief contact with an ignition source, such as a bur ning \nmatch, and if the flame spreads rapidly.  \n2.7.2.  Classification criteria  \n2.7.2.1. Powdered, granular or pasty substances or mixtures (ex cept powders \nof metals or metal alloys — see 2.7.2.2) shall be classified as  \nreadily combustible solids when the time of burning of one or  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 88}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 90  \nmore of the test runs, performed in accordance with the test me thod \ndescribed in Part III, sub-section 33.2.1, of the  ►M4 UN \nRTDG ◄, Manual of Tests and Criteria, is less than 45 seconds \nor the rate of burning is more than 2,2 mm/s.  \n▼M19  \n2.7.2.2. Powders of metals or metal alloys shall be classified as flammable \nsolids when they can be ignited and the reaction spreads over t he \nwhole length of the sample (100 mm) in 10 min or less.  \n▼B \n2.7.2.3. A flammable solid shall be classified in one of the tw o categories \nfor this class using Method N.1 as described in 33.2.1 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria in accordance \nwith Table 2.7.1:  \nTable 2.7.1  \nCriteria for flammable solids  \nCategory  Criteria  \n1 Burning rate test \nSubstances and mixtures other than metal powders: \n(a) wetted zone does not stop fire and \n(b) burning time < 45 seconds or burning rate > \n2,2 mm/s \nMetal powders \nburning time ≤ 5 minutes  \n2 Burning rate test \nSubstances and mixtures other than metal powders: \n(a) wetted zone stops the fire for at least 4 minutes and \n(b) burning time < 45 seconds or burning rate > \n2,2 mm/s \nMetal powders \nburning time > 5 minutes and ≤ 10 minutes  \n▼M2 \nNote 1:  \nThe test shall be performed on the substance or mixture in its \nphysical form as presented. If, for example, for the purposes o f \nsupply or transport, the same chemical is to be presented in a \nphysical form different from that which was tested and which is  \nconsidered likely to materially alter its performance in a clas sifi\xad\ncation test, the substance shall also be tested in the new form . \nNote 2:  \nAerosols shall not be classified as flammable solids; see secti on 2.3.  \n▼B \n2.7.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.7.2.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 89}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 91  \nTable 2.7.2  \nLabel elements for flammable solids  \nClassification  Category 1  Category 2  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  \nHazard Statement  H228: Flammable \nSolid  H228: Flammable \nSolid  \nPrecautionary \nStatement \nPrevention  P210 \nP240 \nP241 \nP280  P210 \nP240 \nP241 \nP280  \nPrecautionary \nStatement \nResponse  P370 + P378  P370 + P378  \nPrecautionary \nStatement \nStorage  \nPrecautionary \nStatement \nDisposal  \n2.8. Self-reactive substances and mixtures  \n2.8.1.  Definition  \n2.8.1.1. Self-reactive substances or mixtures are thermally uns table liquid or \nsolid substances or mixtures liable to undergo a strongly exoth ermic \ndecomposition even without participation of oxygen (air). This defi\xad\nnition excludes substances and mixtures classified according to  this \nPart as explosives, organic peroxides or as oxidising.  \n2.8.1.2. A self-reactive substance or mixture is regarded as po ssessing \nexplosive properties when in laboratory testing the formulation  is \nliable to detonate, to deflagrate rapidly or to show a violent effect \nwhen heated under confinement.  \n2.8.2.  Classification criteria  \n2.8.2.1. Any self-reactive substance or mixture shall be consid ered for clas\xad\nsification in this class as a self-reactive substance or mixtur e unless:  \n(a) they are explosives, according to the criteria given in 2.1 ; \n(b) they are oxidising liquids or solids, according to the crit eria \ngiven in 2.13 or 2.14, except that mixtures of oxidising \nsubstances, which contain 5 % or more of combustible \norganic substances shall be classified as self-reactive substan ces \naccording to the procedure defined in 2.8.2.2;  \n(c) they are organic peroxides, according to the criteria given  in \n2.15;  \n(d) their heat of decomposition is less than 300 J/g; or  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 90}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 92  \n(e) their self-accelerating decomposition temperature (SADT) is  \ngreater than 75  o C for a 50 kg package (  1 ). \n2.8.2.2. Mixtures of oxidising substances, meeting the criteria  for classifi\xad\ncation as oxidising substances, which contain 5 % or more of \ncombustible organic substances and which do not meet the criter ia \nmentioned in (a), (c), (d) or (e) in 2.8.2.1, shall be subjecte d to the \nself-reactive substances classification procedure;  \nSuch a mixture showing the properties of a self-reactive substa nce \ntype B to F (see 2.8.2.3) shall be classified as a self-reactiv e \nsubstance.  \nWhere the test is conducted in the package form and the packagi ng \nis changed, a further test shall be conducted where it is consi dered \nthat the change in packaging will affect the outcome of the tes t. \n2.8.2.3. Self-reactive substances and mixtures shall be classif ied in one of \nthe seven categories of ‘types A to G’ for this class, accordin g to \nthe following principles:  \n(a) any self-reactive substance or mixture which can detonate o r \ndeflagrate rapidly, as packaged, shall be defined as self- \nreactive substance TYPE A;  \n(b) any self-reactive substance or mixture possessing explosive  \nproperties and which, as packaged, neither detonates nor defla\xad\ngrates rapidly, but is liable to undergo a thermal explosion in  \nthat package shall be defined as self-reactive substance TYPE \nB; \n(c) any self-reactive substance or mixture possessing explosive  \nproperties when the substance or mixture as packaged cannot \ndetonate or deflagrate rapidly or undergo a thermal explosion \nshall be defined as self-reactive substance TYPE C;  \n(d) any self-reactive substance or mixture which in laboratory \ntesting:  \n(i) detonates partially, does not deflagrate rapidly and shows \nno violent effect when heated under confinement; or  \n(ii) does not detonate at all, deflagrates slowly and shows no \nviolent effect when heated under confinement; or  \n(iii) does not detonate or deflagrate at all and shows a medium  \neffect when heated under confinement;  \nshall be defined as self-reactive substance TYPE D;  \n(e) any self-reactive substance or mixture which, in laboratory  \ntesting, neither detonates nor deflagrates at all and shows low  \nor no effect when heated under confinement shall be defined as \nself-reactive substance TYPE E;  \n(f) any self-reactive substance or mixture which, in laboratory  \ntesting, neither detonates in the cavitated state nor deflagrat es \nat all and shows only a low or no effect when heated under \nconfinement as well as low or no explosive power shall be \ndefined as self-reactive substance TYPE F;  ▼B \n( 1 ) ►M4 See UN RTDG, Manual of Tests and Criteria, subsections 28.1, 2 8.2, 28.3 and \nTable 28.3. ◄', metadata={'source': 'data/ycla_en.pdf', 'page': 91}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 93  \n(g) any self-reactive substance or mixture which, in laboratory  \ntesting, neither detonates in the cavitated state nor deflagrat es \nat all and shows no effect when heated under confinement nor \nany explosive power, provided that it is thermally stable (SADT  \nis 60  o C to 75  o C for a 50 kg package), and, for liquid mixtures, \na diluent having a boiling point not less than 150  o C is used for \ndesensitisation shall be defined as self-reactive substance TYP E \nG. If the mixture is not thermally stable or a diluent having a  \nboiling point less than 150  o C is used for desensitisation, the \nmixture shall be defined as self-reactive substance TYPE F.  \nWhere the test is conducted in the package form and the packagi ng \nis changed, a further test shall be conducted where it is consi dered \nthat the change in packaging will affect the outcome of the tes t. \n2.8.2.4.  Criteria for temperature control  \nSelf-reactive substances need to be subjected to temperature co ntrol \nif their SADT is less than or equal to 55  o C. Test methods for \ndetermining the SADT as well as the derivation of control and \nemergency temperatures are given in, Part II, section 28 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria. The test \nselected shall be conducted in a manner which is representative , \nboth in size and material, of the package.  \n2.8.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.8.1.  \n▼M12  \nTable 2.8.1  \nLabel elements for self-reactive substances and mixtures  \nClassification  Type A  Type B  Type C & D  Type E & F  Type G (  1 ) \nGHS Pictograms\n  \nThere are no \nlabel elements \nallocated to this \nhazard category  \nSignal Word  Danger  Danger  Danger  Warning  \nHazard \nStatement  H240: Heating \nmay cause an \nexplosion  H241: Heating \nmay cause a \nfire or \nexplosion  H242: Heating \nmay cause a \nfire H242: Heating \nmay cause a \nfire \nPrecautionary \nStatement \nPrevention  P210 \nP234 \nP235 \nP240 \nP280  P210 \nP234 \nP235 \nP240 \nP280  P210 \nP234 \nP235 \nP240 \nP280  P210 \nP234 \nP235 \nP240 \nP280 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 92}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 94  \nClassification  Type A  Type B  Type C & D  Type E & F  Type G (  1 ) \nPrecautionary \nStatement \nResponse  P370 + P372 + \nP380 + P373  P370 + P380 + \nP375 [+ \nP378] (  2 ) P370 + P378  P370 + P378  \nPrecautionary \nStatement \nStorage  P403 \nP411 \nP420  P403 \nP411 \nP420  P403 \nP411 \nP420  P403 \nP411 \nP420  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  P501  \n( 1 ) Type G has no hazard communication elements assigned but shou ld be considered for properties belonging to other \nhazard classes. \n( 2 ) See the introduction to Annex IV for details on the use of sq uare brackets.  \n▼B \nType G has no hazard communication elements assigned but shall \nbe considered for properties belonging to other hazard classes.  \n2.8.4.  Additional Classification Considerations  \n2.8.4.1. The properties of self-reactive substances or mixtures  which are \ndecisive for their classification shall be determined experimen tally. \nThe classification of a self reactive substance or mixture shal l be \nperformed in accordance with test series A to H as described in  Part \nII of the  ►M4 UN RTDG ◄, Manual of Tests and Criteria. The \nprocedure for classification is described in Figure 2.8.1.  \n2.8.4.2. The classification procedures for self-reactive substa nces and \nmixtures need not be applied if:  \n(a) There are no chemical groups present in the molecule associ ated \nwith explosive or self reactive properties. Examples of such \ngroups are given in Tables A6.1 and A6.2 in Appendix 6 of \nthe ►M4 UN RTDG ◄, Manual of Tests and Criteria; or  \n(b) For a single organic substance or a homogeneous mixture of \norganic substances, the estimated SADT for a 50 kg package is \ngreater than 75  o C or the exothermic decomposition energy is \nless than 300J/g. The onset temperature and decomposition \nenergy can be estimated using a suitable calorimetric \ntechnique (see Part II, sub-section 20.3.3.3 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria).  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 93}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 95  \nFigure 2.8.1  \nSelf-reactive substances and mixtures\n  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 94}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 96  \n2.9. Pyrophoric liquids  \n2.9.1.  Definition  \nPyrophoric liquid means a liquid substance or mixture which, ev en \nin small quantities, is liable to ignite within five minutes af ter \ncoming into contact with air.  \n2.9.2.  Classification criteria  \n2.9.2.1. A pyrophoric liquid shall be classified in a single ca tegory for this \nclass using test N.3 in Part III, sub-section 33.3.1.5 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria according to \nTable 2.9.1:  \nTable 2.9.1  \nCriteria for pyrophoric liquids  \nCategory  Criteria  \n1 The liquid ignites within 5 min when added to an inert \ncarrier and exposed to air, or it ignites or chars a filter \npaper on contact with air within 5 min.  \n2.9.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.9.2.  \n▼M12  \nTable 2.9.2  \nLabel elements for pyrophoric liquids  \nClassification  Category 1  \nGHS Pictogram\n  \nSignal Word  Danger  \nHazard Statement  H250: Catches fire spontaneously \nif exposed to air  \nPrecautionary Statement \nPrevention  P210 \nP222 \nP231 + P232 \nP233 \nP280  \nPrecautionary Statement \nResponse  P302 + P334 \nP370 + P378  \nPrecautionary Statement Storage  \nPrecautionary Statement \nDisposal  \n▼B \n2.9.4.  Additional Classification Considerations  \n2.9.4.1. The classification procedure for pyrophoric liquids ne ed not be \napplied when experience in manufacture or handling shows that \nthe substance or mixture does not ignite spontaneously on comin g \ninto contact with air at normal temperatures (i.e. the substanc e is \nknown to be stable at room temperature for prolonged periods of  \ntime (days)).  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 95}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 97  \n2.10.  Pyrophoric solids  \n2.10.1.  Definition  \nPyrophoric solid means a solid substance or mixture which, even  in \nsmall quantities, is liable to ignite within five minutes after  coming \ninto contact with air.  \n2.10.2.  Classification criteria  \n2.10.2.1. A pyrophoric solid shall be classified in a single ca tegory for this \nclass using test N.2 in Part III, sub-section 33.3.1.4 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria in accordance \nwith Table 2.10.1:  \nTable 2.10.1  \nCriteria for pyrophoric solids  \nCategory  Criteria  \n1 The solid ignites within 5 minutes of coming into \ncontact with air.  \nNote  \nThe test shall be performed on the substance or mixture in its \nphysical form as presented. If, for example, for the purposes o f \nsupply or transport, the same chemical is to be presented in a \nphysical form different from that which was tested and which is  \nconsidered likely to materially alter its performance in a clas sifi\xad\ncation test, the substance shall also be tested in the new form . \n2.10.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.10.2.  \n▼M12  \nTable 2.10.2  \nLabel elements for pyrophoric solids  \nClassification  Category 1  \nGHS Pictogram\n  \nSignal Word  Danger  \nHazard Statement  H250: Catches fire sponta\xad\nneously if exposed to air  \nPrecautionary Statement \nPrevention  P210 \nP222 \nP231 + P232 \nP233 \nP280  \nPrecautionary Statement \nResponse  P302 + P335 + P334 \nP370 +P378  \nPrecautionary Statement Storage  \nPrecautionary Statement \nDisposal  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 96}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 98  \n2.10.4.  Additional Classification Considerations  \n2.10.4.1. The classification procedure for pyrophoric solids ne ed not be \napplied when experience in manufacture or handling shows that \nthe substance or mixture does not ignite spontaneously on comin g \ninto contact with air at normal temperatures (i.e. the substanc e is \nknown to be stable at room temperature for prolonged periods of  \ntime (days)).  \n2.11.  Self-heating substances and mixtures  \n2.11.1.  Definition  \n2.11.1.1. A self-heating substance or mixture is a liquid or so lid substance or \nmixture, other than a pyrophoric liquid or solid, which, by rea ction \nwith air and without energy supply, is liable to self-heat; thi s \nsubstance or mixture differs from a pyrophoric liquid or solid in \nthat it will ignite only when in large amounts (kilograms) and after \nlong periods of time (hours or days).  \n▼M2 \n2.11.1.2. Self-heating of a substance or a mixture is a process  where the \ngradual reaction of that substance or mixture with oxygen (in t he \nair) generates heat. If the rate of heat production exceeds the  rate of \nheat loss, then the temperature of the substance or mixture wil l rise \nwhich, after an induction time, may lead to self-ignition and \ncombustion.  \n▼B \n2.11.2.  Classification criteria  \n2.11.2.1. A substance or mixture shall be classified as a self- heating \nsubstance or mixture of this class, if in the tests performed i n \naccordance with the test method given in the  ►M4 UN \nRTDG ◄, Manual of Tests and Criteria, Part III, sub-section \n33.3.1.6:  \n(a) a positive result is obtained using a 25 mm cube sample at \n140  o C; \n(b) a positive result is obtained in a test using a 100 mm samp le \ncube at 140  o C and a negative result is obtained in a test using a \n100 mm cube sample at 120  o C and the substance or mixture is \nto be packed in packages with a volume of more than 3 m  3 ; \n(c) a positive result is obtained in a test using a 100 mm samp le \ncube at 140  o C and a negative result is obtained in a test using a \n100 mm cube sample at 100  o C and the substance or mixture is \nto be packed in packages with a volume of more than 450 litres;  \n(d) a positive result is obtained in a test using a 100 mm samp le \ncube at 140  o C and a positive result is obtained in a test using a \n100 mm cube sample at 100  o C. \n2.11.2.2. A self-heating substance or mixture shall be classifi ed in one of the \ntwo categories for this class if, in a test performed in accord ance \nwith test method N.4 in Part III, sub-section 33.3.1.6 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria, the result \nmeets the criteria according to Table 2.11.1:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 97}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 99  \nTable 2.11.1  \nCriteria for self-heating substances and mixtures  \nCategory  Criteria  \n1 A positive result is obtained in a test using a 25 mm \nsample cube at 140  o C \n2 (a) a positive result is obtained in a test using a \n100 mm sample cube at 140  o C and a negative \nresult is obtained in a test using a 25 mm cube \nsample at 140  o C and the substance or mixture is \nto be packed in packages with a volume of more \nthan 3 m  3 ; or \n(b) a positive result is obtained in a test using a \n100 mm sample cube at 140  o C and a negative \nresult is obtained in a test using a 25 mm cube \nsample at 140  o C, a positive result is obtained in \na test using a 100 mm cube sample at 120  o C and \nthe substance or mixture is to be packed in \npackages with a volume of more than 450 litres; or \n(c) a positive result is obtained in a test using a \n100 mm sample cube at 140  o C and a negative \nresult is obtained in a test using a 25 mm cube \nsample at 140  o C and a positive result is obtained \nin a test using a 100 mm cube sample at 100  o C. \nNote  \nThe test shall be performed on the substance or mixture in its \nphysical form as presented. If, for example, for the purposes o f \nsupply or transport, the same chemical is to be presented in a \nphysical form different from that which was tested and which is  \nconsidered likely to materially alter its performance in a clas sifi\xad\ncation test, the substance shall also be tested in the new form . \n2.11.2.3. Substances and mixtures with a temperature of spontan eous \ncombustion higher than 50  o C for a volume of 27 m  3 shall not be \nclassified as a self-heating substance or mixture.  \n2.11.2.4. Substances and mixtures with a spontaneous ignition t emperature \nhigher than 50  o C for a volume of 450 litres shall not be assigned to \nCategory 1 of this class.  \n2.11.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.11.2.  \n▼M12  \nTable 2.11.2  \nLabel elements for self-heating substances and mixtures  \nClassification  Category 1  Category 2  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  \nHazard Statement  H251: Self-heating; \nmay catch fire  H252: Self-heating in \nlarge quantities; may \ncatch fire  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 98}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 100  \nClassification  Category 1  Category 2  \nPrecautionary \nStatement \nPrevention  P235 \nP280  P235 \nP280  \nPrecautionary \nStatement Response  \nPrecautionary \nStatement Storage  P407 \nP413 \nP420  P407 \nP413 \nP420  \nPrecautionary \nStatement Disposal  \n▼B \n2.11.4.  Additional Classification Considerations  \n2.11.4.1. For detailed schemes for the decision logic for class ification and the \ntests to be carried out for ascertaining the different categori es, see \nFigure 2.11.1.  \n2.11.4.2. The classification procedure for self-heating substan ces or mixtures \nneed not be applied if the results of a screening test can be \nadequately correlated with the classification test and an appro priate \nsafety margin is applied. Examples of screening tests are:  \n(a) The Grewer Oven test (VDI guideline 2263, Part 1, 1990, Tes t \nmethods for the Determination of the Safety Characteristics of \nDusts) with an onset temperature 80 K above the reference \ntemperature for a volume of 1 l;  \n(b) The Bulk Powder Screening Test (Gibson, N. Harper, D.J. \nRogers, R.Evaluation of the fire and explosion risks in drying \npowders, Plant Operations Progress, 4 (3), 181-189, 1985) with \nan onset temperature 60 K above the reference temperature for a  \nvolume of 1 l.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 99}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 101  \nFigure 2.11.1.  \nSelf-heating substances and mixtures\n  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 100}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 102  \n2.12.  Substances and mixtures which in contact with water emit \nflammable gases  \n2.12.1.  Definition  \nSubstances or mixtures which, in contact with water, emit \nflammable gases means solid or liquid substances or mixtures \nwhich, by interaction with water, are liable to become sponta\xad\nneously flammable or to give off flammable gases in dangerous \nquantities.  \n2.12.2.  Classification criteria  \n2.12.2.1. A substance or mixture which, in contact with water, emits \nflammable gases shall be classified in one of the three categor ies \nfor this class, using test N.5 in Part III, sub-section 33.4.1. 4 of the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria, in accordance \nwith Table 2.12.1:  \n▼M19  \nTable 2.12.1  \nCriteria for substances and mixtures, which in contact with \nwater, emit flammable gases  \nCategory  Criteria  \n1 Any substance or mixture which reacts vigorously with \nwater at ambient temperatures and demonstrates \ngenerally a tendency for the gas produced to ignite \nspontaneously, or which reacts readily with water at \nambient temperatures such that the rate of evolution \nof flammable gas is equal to or greater than 10 litres \nper kilogram of substance over any one minute.  \n2 Any substance or mixture which reacts readily with \nwater at ambient temperatures such that the maximum \nrate of evolution of flammable gas is equal to or greater \nthan 20 litres per kilogram of substance per hour, and \nwhich does not meet the criteria for Category 1.  \n3 Any substance or mixture which reacts slowly with \nwater at ambient temperatures such that the maximum \nrate of evolution of flammable gas is greater than 1 litre \nper kilogram of substance per hour, and which does not \nmeet the criteria for Categories 1 and 2.  \nNote:  \nThe test shall be performed on the substance or mixture in its \nphysical form as presented. If, for example, for the purposes of \nsupply or transport, the same chemical is to be presented in a \nphysical form different from that which was tested and which is \nconsidered likely to materially alter its performance in a classifi \xad\ncation test, the substance must also be tested in the new form . \n▼B \n2.12.2.2. A substance or mixture shall be classified as a subst ance or mixture \nwhich in contact with water emits flammable gases if spontaneou s \nignition takes place in any step of the test procedure.  \n2.12.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.12.2.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 101}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 103  \nTable 2.12.2  \nLabel elements for substances and mixtures which in contact \nwith water emit flammable gases  \nClassification  Category 1  Category 2  Category 3  \nGHS Picto\xad\ngrams\n  \nSignal Word  Danger  Danger  Warning  \nHazard \nStatement  H260: In \ncontact with \nwater releases \nflammable \ngases which \nmay ignite \nspontaneously  H261: In \ncontact with \nwater releases \nflammable \ngases  H261: In \ncontact with \nwater releases \nflammable \ngases  \nPrecautionary \nStatement \nPrevention  P223 \nP231 + P232 \nP280  P223 \nP231 + P232 \nP280  P231 + P232 \nP280  \nPrecautionary \nStatement \nResponse  P302 + P335 + \nP334 \nP370 + P378  P302 + P335 \n+ P334 \nP370 + P378  P370 + P378  \nPrecautionary \nStatement \nStorage  P402 + P404  P402 + P404  P402 + P404  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  \n▼B \n2.12.4.  Additional Classification Considerations  \n2.12.4.1. The classification procedure for this class need not be applied if:  \n(a) the chemical structure of the substance or mixture does not  \ncontain metals or metalloids; or  \n(b) experience in production or handling shows that the substan ce \nor mixture does not react with water, e.g. the substance is \nmanufactured with water or washed with water; or  \n(c) the substance or mixture is known to be soluble in water to  \nform a stable mixture.  \n2.13.  Oxidising liquids  \n2.13.1.  Definition  \nOxidising liquid means a liquid substance or mixture which, whi le \nin itself not necessarily combustible, may, generally by yieldi ng \noxygen, cause, or contribute to, the combustion of other materi al. \n2.13.2.  Classification criteria  \n2.13.2.1. An oxidising liquid shall be classified in one of the  three categories \nfor this class using test O.2 in Part III, sub-section 34.4.2 o f the  \n►M4 UN RTDG ◄, Manual of Tests and Criteria in accordance \nwith Table 2.13.1:  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 102}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 104  \nTable 2.13.1  \nCriteria for oxidising liquids  \nCategory  Criteria  \n1 Any substance or mixture which, in the 1:1 mixture, by \nmass, of substance (or mixture) and cellulose tested, \nspontaneously ignites; or the mean pressure rise time \nof a 1:1 mixture, by mass, of substance (or mixture) \nand cellulose is less than that of a 1:1 mixture, by \nmass, of 50 % perchloric acid and cellulose.  \n2 Any substance or mixture which, in the 1:1 mixture, by \nmass, of substance (or mixture) and cellulose tested, \nexhibits a mean pressure rise time less than or equal \nto the mean pressure rise time of a 1:1 mixture, by \nmass, of 40 % aqueous sodium chlorate solution and \ncellulose; and the criteria for Category 1 are not met.  \n3 Any substance or mixture which, in the 1:1 mixture, by \nmass, of substance (or mixture) and cellulose tested, \nexhibits a mean pressure rise time less than or equal \nto the mean pressure rise time of a 1:1 mixture, by \nmass, of 65 % aqueous nitric acid and cellulose; and \nthe criteria for Category 1 and 2 are not met.  \n2.13.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.13.2.  \n▼M12  \nTable 2.13.2  \nLabel elements for oxidising liquids  \nClassification  Category 1  Category 2  Category 3  \nGHS Pictograms\n  \nSignal Word  Danger  Danger  Warning  \nHazard \nStatement  H271: May \ncause fire or \nexplosion; \nstrong oxidiser  H272: May \nintensify fire; \noxidiser  H272: May \nintensify fire; \noxidiser  \nPrecautionary \nStatement \nPrevention  P210 \nP220 \nP280 \nP283  P210 \nP220 \nP280  P210 \nP220 \nP280  \nPrecautionary \nStatement \nResponse  P306 + P360 \nP371 + P380 \n+ P375 \nP370 + P378  P370 + P378  P370 + P378  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 103}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 105  \nClassification  Category 1  Category 2  Category 3  \nPrecautionary \nStatement \nStorage  P420  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  \n▼B \n2.13.4.  Additional Classification Considerations  \n2.13.4.1. For organic substances or mixtures the classification  procedure for \nthis class shall not apply if:  \n(a) the substance or mixture does not contain oxygen, fluorine or \nchlorine; or  \n(b) the substance or mixture contains oxygen, fluorine or chlor ine \nand these elements are chemically bonded only to carbon or \nhydrogen.  \n2.13.4.2. For inorganic substances or mixtures the classificati on procedure for \nthis class shall not apply if they do not contain oxygen or hal ogen \natoms.  \n2.13.4.3. In the event of divergence between test results and k nown \nexperience in the handling and use of substances or mixtures \nwhich shows them to be oxidising, judgments based on known \nexperience shall take precedence over test results.  \n2.13.4.4. In cases where substances or mixtures generate a pres sure rise (too \nhigh or too low), caused by chemical reactions not characterisi ng \nthe oxidising properties of the substance or mixture, the test \ndescribed in Part III, sub-section 34.4.2 of the  ►M4 UN \nRTDG ◄, Manual of Tests and Criteria shall be repeated with an \ninert substance, e.g. diatomite (kieselguhr), in place of the c ellulose \nin order to clarify the nature of the reaction and to check for  a false \npositive result.  \n2.14.  Oxidising solids  \n2.14.1.  Definition  \nOxidising solid means a solid substance or mixture which, while  in \nitself is not necessarily combustible, may, generally by yieldi ng \noxygen, cause, or contribute to, the combustion of other materi al. \n2.14.2.  Classification criteria  \n2.14.2.1.  ►M12  An oxidising solid shall be classified in one of the three \ncategories for this class using test O.1 in Part III, sub-secti on 34.4.1 \nor test O.3 in Part III, sub-section 34.4 3 of the UN RTDG, Man ual \nof Tests and Criteria in accordance with Table 2.14.1: ◄  \n▼M12  \nTable 2.14.1  \nCriteria for oxidising solids  \nCategory  Criteria using test O.1  Criteria using test O.3  \n1 Any substance or mixture \nwhich, in the 4:1 or 1:1 \nsample-to-cellulose ratio \n(by mass) tested, exhibits \na mean burning time less \nthan the mean burning \ntime of a 3:2 mixture,  Any substance or mixture \nwhich, in the 4:1 or 1:1 \nsample-to-cellulose ratio \n(by mass) tested, exhibits \na mean burning rate \ngreater than the mean \nburning rate of a 3:1  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 104}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 106  \nCategory  Criteria using test O.1  Criteria using test O.3  \n(by mass), of potassium \nbromate and cellulose.  mixture (by mass) of \ncalcium peroxide and cellu\xad\nlose. \n2 Any substance or mixture \nwhich, in the 4:1 or 1:1 \nsample-to-cellulose ratio \n(by mass) tested, exhibits \na mean burning time \nequal to or less than the \nmean burning time of a \n2:3 mixture (by mass) of \npotassium bromate and \ncellulose and the criteria \nfor Category 1 are not \nmet. Any substance or mixture \nwhich, in the 4:1 or 1:1 \nsample-to-cellulose ratio \n(by mass) tested, exhibits \na mean burning rate equal \nto or greater than the \nmean burning rate of a 1:1 \nmixture (by mass) of \ncalcium peroxide and \ncellulose and the criteria \nfor Category 1 are not met.  \n3 Any substance or mixture \nwhich, in the 4:1 or 1:1 \nsample-to-cellulose ratio \n(by mass) tested, exhibits \na mean burning time \nequal to or less than the \nmean burning time of a \n3:7 mixture (by mass) of \npotassium bromate and \ncellulose and the criteria \nfor Categories 1 and 2 \nare not met.  Any substance or mixture \nwhich, in the 4:1 or 1:1 \nsample-to-cellulose ratio \n(by mass) tested, exhibits \na mean burning rate equal \nto or greater than the \nmean burning rate of a 1:2 \nmixture (by mass) of \ncalcium peroxide and \ncellulose and the criteria \nfor Categories 1 and 2 are \nnot met.  \n▼B \nNote 1  \nSome oxidising solids also present explosion hazards under cert ain \nconditions (when stored in large quantities). Some types of \nammonium nitrate may give rise to an explosion hazard under \nextreme conditions and the ‘Resistance to detonation test’  \n►M12  (IMSBC Code (International Maritime Solid Bulk Cargoes \nCode, IMO), Appendix 2, Section 5) ◄ can be used to assess this  \nhazard. Appropriate information shall be made in the SDS.  \nNote 2  \nThe test shall be performed on the substance or mixture in its \nphysical form as presented. If, for example, for the purposes o f \nsupply or transport, the same chemical is to be presented in a \nphysical form different from that which was tested and which is  \nconsidered likely to materially alter its performance in a clas sifi\xad\ncation test, the substance shall also be tested in the new form . \n2.14.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.14.2.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 105}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 107  \nTable 2.14.2  \nLabel elements for oxidising solids  \nCategory 1  Category 2  Category 3  \nGHS Pictograms\n  \nSignal Word  Danger  Danger  Warning  \nHazard \nStatement  H271: May \ncause fire or \nexplosion; \nstrong oxidiser  H272: May \nintensify fire; \noxidiser  H272: May \nintensify fire; \noxidiser  \nPrecautionary \nStatement \nPrevention  P210 \nP220 \nP280 \nP283  P210 \nP220 \nP280  P210 \nP220 \nP280  \nPrecautionary \nStatement \nResponse  P306 + P360 \nP371 + P380 \n+ P375 \nP370 + P378  P370 + P378  P370 + P378  \nPrecautionary \nStatement \nStorage  P420  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  \n▼B \n2.14.4.  Additional Classification Considerations  \n2.14.4.1. For organic substances or mixtures the classification  procedure for \nthis class shall not apply if:  \n(a) the substance or mixture does not contain oxygen, fluorine or \nchlorine; or  \n(b) the substance or mixture contains oxygen, fluorine or chlor ine \nand these elements are chemically bonded only to carbon or \nhydrogen.  \n2.14.4.2. For inorganic substances or mixtures the classificati on procedure for \nthis class shall not apply if they do not contain oxygen or hal ogen \natoms.  \n2.14.4.3. In the event of divergence between test results and k nown \nexperience in the handling and use of substances or mixtures \nwhich shows them to be oxidising, judgments based on known \nexperience shall take precedence over test results.  \n2.15.  Organic peroxides  \n2.15.1.  Definition  \n2.15.1.1. Organic peroxides means liquid or solid organic subst ances which \ncontain the bivalent -O-O- structure and may be considered deri va\xad\ntives of hydrogen peroxide, where one or both of the hydrogen \natoms have been replaced by organic radicals. The term organic  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 106}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 108  \nperoxide includes organic peroxide mixtures (formulations) \ncontaining at least one organic peroxide. Organic peroxides are  \nthermally unstable substances or mixtures, which can undergo \nexothermic self-accelerating decomposition. In addition, they c an \nhave one or more of the following properties:  \n(i) be liable to explosive decomposition;  \n(ii) burn rapidly;  \n(iii) be sensitive to impact or friction;  \n(iv) react dangerously with other substances.  \n2.15.1.2. An organic peroxide is regarded as possessing explosi ve properties \nwhen in laboratory testing the mixture (formulation) is liable to \ndetonate, to deflagrate rapidly or to show a violent effect whe n \nheated under confinement.  \n2.15.2.  Classification criteria  \n2.15.2.1. Any organic peroxide shall be considered for classifi cation in this \nclass, unless it contains:  \n(a) not more than 1,0 % available oxygen from the organic \nperoxides when containing not more than 1,0 % hydrogen \nperoxide; or  \n(b) not more than 0,5 % available oxygen from the organic \nperoxides when containing more than 1,0 % but not more \nthan 7,0 % hydrogen peroxide.  \nNote  \nThe available oxygen content ( %) of an organic peroxide mixtur e is \ngiven by the formula:  \n16 Ü X  n \ni Í n i Ü c i \nm i Î \nwhere:  \nn i = number of peroxygen groups per molecule of organic \nperoxide i;  \nc i = concentration (mass %) of organic peroxide i;  \nm i = molecular mass of organic peroxide i.  \n2.15.2.2. Organic peroxides shall be classified in one of the s even categories \nof ‘Types A to G’ for this class, according to the following pr in\xad\nciples:  \n(a) any organic peroxide which, as packaged, can detonate or \ndeflagrate rapidly shall be defined as organic peroxide TYPE A;  \n(b) any organic peroxide possessing explosive properties and \nwhich, as packaged, neither detonates nor deflagrates rapidly, \nbut is liable to undergo a thermal explosion in that package \nshall be defined as organic peroxide TYPE B;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 107}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 109  \n(c) any organic peroxide possessing explosive properties when t he \nsubstance or mixture as packaged cannot detonate or deflagrate \nrapidly or undergo a thermal explosion shall be defined as \norganic peroxide TYPE C;  \n(d) any organic peroxide which in laboratory testing:  \n(i) detonates partially, does not deflagrate rapidly and shows \nno violent effect when heated under confinement; or  \n(ii) does not detonate at all, deflagrates slowly and shows no \nviolent effect when heated under confinement; or  \n(iii) does not detonate or deflagrate at all and shows a medium  \neffect when heated under confinement;  \nshall be defined as organic peroxide TYPE D;  \n(e) any organic peroxide which, in laboratory testing, neither \ndetonates nor deflagrates at all and shows low or no effect \nwhen heated under confinement shall be defined as organic \nperoxide TYPE E;  \n(f) any organic peroxide which, in laboratory testing, neither \ndetonates in the cavitated state nor deflagrates at all and \nshows only a low or no effect when heated under confinement \nas well as low or no explosive power shall be defined as \norganic peroxide TYPE F;  \n(g) any organic peroxide which, in laboratory testing, neither \ndetonates in the cavitated state nor deflagrates at all and \nshows no effect when heated under confinement nor any \nexplosive power, provided that it is thermally stable, i.e. the  \nSADT is 60  o C or higher for a 50 kg package (  1 ), and, for \nliquid mixtures, a diluent having a boiling point of not less \nthan 150  o C is used for desensitisation, shall be defined as \norganic peroxide TYPE G. If the organic peroxide is not \nthermally stable or a diluent having a boiling point less than \n150  o C is used for desensitisation, the organic peroxide shall be \ndefined as organic peroxide TYPE F.  \nWhere the test is conducted in the package form and the \npackaging is changed, a further test shall be conducted where \nit is considered that the change in packaging will affect the \noutcome of the test.  \n2.15.2.3.  Criteria for temperature control  \nThe following organic peroxides need to be subjected to \ntemperature control:  \n(a) Organic peroxide types B and C with an SADT ≤ 50 C;  \n(b) Organic peroxide type D showing a medium effect when heated  \nunder confinement (  2 ) with an SADT ≤ 50  o C or showing a low \nor no effect when heated under confinement with an SADT ≤ \n45 o C; and  \n(c) Organic peroxide types E and F with an SADT ≤ 45  o C. ▼B \n( 1 ) ►M4 See UN RTDG, Manual of Tests and Criteria, subsections 28.1, 2 8.2, 28.3 and \nTable 28.3. ◄ \n( 2 ) ►M4 As determined by test series E as prescribed in UN RTDG, Manua l of Tests and \nCriteria, Part II. ◄', metadata={'source': 'data/ycla_en.pdf', 'page': 108}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 110  \nTest methods for determining the SADT as well as the derivation  of \ncontrol and emergency temperatures are given in the  ►M4 UN \nRTDG ◄, Manual of Tests and Criteria, Part II, section 28. The \ntest selected shall be conducted in a manner which is represent ative, \nboth in size and material, of the package.  \n2.15.3.  Hazard Communication  \nLabel elements shall be used for substances or mixtures meeting  the \ncriteria for classification in this hazard class in accordance with \nTable 2.15.1.  \n▼M12  \nTable 2.15.1  \nLabel elements for organic peroxides  \nClassification  Type A  Type B  Type C & D  Type E & F  Type G  \nGHS Pictograms\n  \nThere are no \nlabel elements \nallocated to this \nhazard category  \nSignal Word  Danger  Danger  Danger  Warning  \nHazard \nStatement  H240: Heating \nmay cause an \nexplosion  H241: Heating \nmay cause a \nfire or \nexplosion  H242: Heating \nmay cause a \nfire H242: Heating \nmay cause a \nfire \nPrecautionary \nStatement \nPrevention  P210 \nP234 \nP235 \nP240 \nP280  P210 \nP234 \nP235 \nP240 \nP280  P210 \nP234 \nP235 \nP240 \nP280  P210 \nP234 \nP235 \nP240 \nP280  \nPrecautionary \nStatement \nResponse  P370 + P372 + \nP380 + P373  P370 + P380 + \nP375[+ \nP378] (  1 ) P370 + P378  P370 + P378  \nPrecautionary \nStatement \nStorage  P403 \nP410 \nP411 \nP420  P403 \nP410 \nP411 \nP420  P403 \nP410 \nP411 \nP420  P403 \nP410 \nP411 \nP420  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  P501  \n( 1 ) See the introduction to Annex IV for details on the use of sq uare brackets.  \n▼B \nType G has no hazard communication elements assigned but shall \nbe considered for properties belonging to other hazard classes.  \n2.15.4.  Additional Classification Considerations  \n2.15.4.1. Organic peroxides are classified by definition based on their \nchemical structure and on the available oxygen and hydrogen \nperoxide contents of the mixture (see 2.15.2.1). The properties  o f ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 109}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 111  \norganic peroxides which are necessary for their classification shall \nbe determined experimentally. The classification of organic \nperoxides shall be performed in accordance with test series A t o \nH as described in Part II of the  ►M4 UN RTDG ◄, Manual of \nTests and Criteria. The procedure for classification is describ ed in \nFigure 2.15.1.  \n2.15.4.2. Mixtures of already classified organic peroxides may be classified \nas the same type of organic peroxide as that of the most danger ous \ncomponent. However, as two stable components can form a \nthermally less stable mixture, the SADT of the mixture shall be  \ndetermined.  \nNote: The sum of the individual parts can be more hazardous tha n \nthe individual components.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 110}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 112  \nFigure 2.15.1  \nOrganic Peroxides\n  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 111}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 113  \n2.16.  Corrosive to metals  \n2.16.1.  Definition  \nA substance or a mixture that is corrosive to metals means a \nsubstance or a mixture which by chemical action will materially  \ndamage, or even destroy, metals.  \n2.16.2.  Classification criteria  \n2.16.2.1. A substance or a mixture which is corrosive to metals  is classified \nin a single category for this class, using the test in Part III , sub- \nsection 37.4 of the  ►M4 UN RTDG ◄, Manual of Tests and \nCriteria, in accordance with Table 2.16.1:  \nTable 2.16.1  \nCriteria for substances and mixtures corrosive to metals  \nCategory  Criteria  \n1 Corrosion rate on either steel or aluminium surfaces \nexceeding 6,25 mm per year at a test temperature of \n55 o C when tested on both materials.  \nNote  \nWhere an initial test on either steel or aluminium indicates th e \nsubstance or mixture being tested is corrosive the follow up te st \non the other metal is not required.  \n2.16.3.  Hazard Communication  \nLabel elements shall be used for substances and mixtures meetin g \nthe criteria for classification in this hazard class in accorda nce with \nTable 2.16.2.  \nTable 2.16.2  \nLabel elements for substances and mixtures corrosive to metals  \nClassification  Category 1  \nGHS Pictogram\n  \nSignal Word  Warning  \nHazard Statement  H290: May be corrosive to \nmetals  \nPrecautionary Statement \nPrevention  P234  \nPrecautionary Statement \nResponse  P390  \nPrecautionary Statement \nStorage  P406  \nPrecautionary Statement \nDisposal  \n▼M4 \nNote:  \nWhere a substance or mixture is classified as corrosive to meta ls but \nnot corrosive to skin and/or eyes, the labelling provisions set  out in \nsection 1.3.6 shall be used.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 112}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 114  \n2.16.4.  Additional Classification Considerations  \n2.16.4.1. The corrosion rate can be measured according to the t est method of \nPart III sub-section 37.4 of the  ►M4 UN RTDG ◄, Manual of \nTests and Criteria. The specimen to be used for the test shall be \nmade of the following materials:  \n(a) for the purposes of testing steel, steel types  \n— S235JR+CR (1.0037 resp.St 37-2),  \n— S275J2G3+CR (1.0144 resp.St 44-3), ISO 3574 as \namended, Unified Numbering System (UNS) G 10200, or \nSAE 1020;  \n(b) for the purposes of testing aluminium: non-clad types 7075- T6 \nor AZ5GU-T6.  \n▼M19  \n2.17.  Desensitised explosives  \n2.17.1.  Definitions and general considerations  \n2.17.1.1. Desensitised explosives are solid or liquid explosive  substances or \nmixtures which are phlegmatised to suppress their explosive pro p\xad\nerties in such a manner that they do not mass explode and do no t \nburn too rapidly and therefore may be exempted from the hazard \nclass ‘Explosives’ (see also paragraph 3 in section 2.1.4.1) (  1 ) \n2.17.1.2. The hazard class of desensitised explosives comprises : \n(a) Solid desensitised explosives: explosive substances or mixt ures, \nwhich are wetted with water or alcohols or are diluted with \nother substances, to form a homogeneous solid mixture to \nsuppress their explosive properties.  \nNOTE: This includes desensitisation achieved by formation of \nhydrates of the substances.  \n(b) Liquid desensitised explosives: explosive substances or \nmixtures, which are dissolved or suspended in water or other \nliquid substances, to form a homogeneous liquid mixture to \nsuppress their explosive properties.  \n2.17.2.  Classification criteria  \n2.17.2.1. Any explosive while in a desensitised state shall be considered in \nthis class unless, in that state:  \n(a) It is intended to produce a practical explosive or pyrotech nic \neffect;  \n(b) It has a mass explosion hazard according to test series 6 ( a) or 6 \n(b) or the corrected burning rate according to the burning rate  \ntest described in part V, subsection 51.4 of the  UN RTDG, \nManual of Tests and Criteria  is greater than 1 200 kg/min; or  ▼B \n( 1 ) Unstable explosives as defined in Section 2.1 can also be stabilised by desensitisation \nand consequently may be classified as desensitised explosives, provided all criteria of \nSection 2.17 are met. In this case the desensitised explosive shall be tested according to \ntest series 3 (Part I of the UN RTDG, Manual of Tests and Criteria) because information \nabout its sensitiveness to mechanical stimuli is likely to be important for determining \nconditions for safe handling and use. The results shall be communicated in the safety \ndata sheet.', metadata={'source': 'data/ycla_en.pdf', 'page': 113}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 115  \n(c) The exothermic decomposition energy is less than 300 J/g.  \nNOTE 1: Substances or mixtures, which meet the criterion (a) or \n(b) in their desensitised state shall be classified as explosives (see \nSection 2.1). Substances or mixtures which meet the criterion (c) \nmay fall within the scope of other physical hazard classes.  \nNOTE 2: The exothermic decomposition energy may be estimated \nusing a suitable calorimetric technique (see section 20, sub-section \n20.3.3.3 in Part II of the UN RTDG, Manual of Tests and Criteria).  \n2.17.2.2. Desensitised explosives shall be classified and packa ged for supply \nand use in one of the four categories of this class depending o n the \ncorrected burning rate (A  c ) using the test ‘burning rate test (external \nfire)’ described in Part V, sub-section 51.4 of the  UN RTDG, \nManual of Tests and Criteria , according to Table 2.17.1:  \nTable 2.17.1.  \nCriteria for desensitised explosives  \nCategory  Criteria  \n1 Desensitised explosives with a corrected burning rate \n(A C ) equal to or greater than 300 kg/min but not \nmore than 1 200 kg/min  \n2 Desensitised explosives with a corrected burning rate \n(A C ) equal to or greater than 140 kg/min but less than \n300 kg/min  \n3 Desensitised explosives with a corrected burning rate \n(A C ) equal to or greater than 60 kg/min but less than \n140 kg/min  \n4 Desensitised explosives with a corrected burning rate \n(A C ) less than 60 kg/min  \nNote 1: Desensitised explosives shall be prepared so that they \nremain homogeneous and do not separate during normal storage \nand handling, particularly if desensitised by wetting. The manufac \xad\nturer/supplier shall give information in the safety data sheet about \nthe shelf-life and instructions on verifying desensitisation. Under \ncertain conditions the content of desensitising agent (e.g. phlegma \xad\ntiser, wetting agent or treatment) may decrease during supply and \nuse, and thus, the hazard potential of the desensitised explosive may \nincrease. In addition, the safety data sheet shall include advice on \navoiding increased fire, blast or projection hazards when the \nsubstance or mixture is not sufficiently desensitised.  \nNote 2: Explosive properties of desensitised explosives shall be \ndetermined by test series 2 of the UN RTDG, Manual of Tests \nand Criteria, and shall be communicated in the safety data sheet.  \nNote 3: For the purposes of storage, supply and use, desensitised \nexplosives do not fall additionally within the scope of Sections 2.1 \n(explosives), 2.6 (flammable liquids) and 2.7 (flammable solids).  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 114}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 116  \n2.17.3.  Hazard communication  \nLabel elements shall be used for liquid or solid substances or \nmixtures meeting the criteria for classification in this hazard  class \nin accordance with Table 2.17.2.  \nTable 2.17.2.  \nLabel elements for desensitised explosives  \nCategory 1  Category 2  Category 3  Category 4  \nGHS Pictogram\n  \nSignal word  Danger  Danger  Warning  Warning  \nHazard statement  H206 Fire, blast \nor projection \nhazard; increased \nrisk of explosion \nif desensitising \nagent is reduced  H207 Fire or \nprojection \nhazard; increased \nrisk of explosion \nif desensitising \nagent is reduced  H207 Fire or \nprojection \nhazard; increased \nrisk of explosion \nif desensitising \nagent is reduced  H208: Fire \nhazard; increased \nrisk of explosion \nif desensitising \nagent is reduced  \nPrecautionary statement \nPrevention  P210 \nP212 \nP230 \nP233 \nP280  P210 \nP212 \nP230 \nP233 \nP280  P210 \nP212 \nP230 \nP233 \nP280  P210 \nP212 \nP230 \nP233 \nP280  \nPrecautionary Statement \nResponse  P370 + \nP380+ \nP375  P370 + \nP380+ \nP375  P370 + \nP380+ \nP375  P371 + \nP380 + \nP375  \nPrecautionary Statement \nStorage  P401  P401  P401  P401  \nPrecautionary Statement \nDisposal  P501  P501  P501  P501  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 115}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 117  \n2.17.4.  Additional classification considerations  \nFigure 2.17.1.  \nDesensitised explosives\n  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 116}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 118\n  \n2.17.4.1. The classification procedure for desensitised explosi ves does not \napply if:  \n(a) The substances or mixtures contain no explosives according to \nthe criteria in Section 2.1; or  \n(b) The exothermic decomposition energy is less than 300 J/g.  \n2.17.4.2. The exothermic decomposition energy shall be determin ed using the \nexplosive already desensitised (i.e.: the homogenous solid or l iquids \nmixture formed by the explosive and the substance(s) used to \nsuppress its explosive properties). The exothermic decompositio n \nenergy may be estimated using a suitable calorimetric technique  \n(see Section 20, sub-section 20.3.3.3 in Part II of the  UN RTDG, \nManual of Tests and Criteria ). \n▼B \n3. PART 3: HEALTH HAZARDS  \n3.1. Acute toxicity  \n3.1.1.  Definitions  \n▼M19  \n3.1.1.1. Acute toxicity means serious adverse health effects (i .e., lethality) \noccurring after a single or short-term oral, dermal or inhalati on \nexposure to a substance or mixture.  \n▼B \n3.1.1.2. The hazard class Acute Toxicity is differentiated into : \n— Acute oral toxicity;  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 117}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 119  \n— Acute dermal toxicity;  \n— Acute inhalation toxicity.  \n3.1.2.  Criteria for classification of substances as acutely toxic  \n▼M19  \n3.1.2.1. Substances can be allocated to one of four hazard cate gories based \non acute toxicity by the oral, dermal or inhalation route accor ding \nto the numeric cut-off criteria as shown in the table below. Ac ute \ntoxicity values are expressed as (approximate) LD  50 (oral, dermal) \nor LC  50 (inhalation) values or as acute toxicity estimates (ATE). \nWhile some  in vivo  methods determine LD  50 /LC  50 values directly, \nother newer  in vivo  methods (e.g. using fewer animals) consider \nother indicators of acute toxicity, such as significant clinica l signs \nof toxicity, which are used as a reference to assign the hazard  \ncategory. Explanatory notes are shown following Table 3.1.1.  \nTable 3.1.1  \nAcute toxicity estimate (ATE) values and criteria for acute toxicity hazard categories.  \n▼M2 \nExposure route  Category 1  Category 2  Category 3  Category 4  \nOral (mg/kg bodyweight)  \nATE ≤ 5  5 < ATE ≤ \n50 50 < ATE ≤ \n300 300 < ATE \n≤ 2 000  See: Note (a) \nNote (b)  \nDermal (mg/kg bodyweight)  \nATE ≤ 50  50 < ATE ≤ \n200 200 < ATE ≤ \n1 000  1 000 < ATE \n≤ 2 000  See: Note (a) \nNote (b)  \nGases (ppmV (  1 )) \nATE ≤ 100  100 < ATE ≤ \n500 500 < ATE ≤ \n2 500  2 500 < ATE \n≤ 20 000 see: Note (a) \nNote (b) \nNote (c)  \nVapours (mg/l)  \nATE ≤ 0,5  0,5 < ATE ≤ \n2,0 2,0 < ATE ≤ \n10,0 10,0 < ATE \n≤ 20,0  see: Note (a) \nNote (b) \nNote (c) \nNote (d)  \nDusts and mists (mg/l)  \nATE ≤ 0,05  0,05 < ATE \n≤ 0,5  0,5 < ATE ≤ \n1,0 1,0 < ATE \n≤ 5,0 see: Note (a) \nNote (b) \nNote (c)  \n( 1 ) Gas concentrations are expressed in parts per million per vol ume (ppmV).  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 118}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 120  \nNotes to Table 3.1.1:  \n(a) The acute toxicity estimate (ATE) for the classification of  a  \nsubstance is derived using the LD  50 /LC  50 where available.  \n(b) The acute toxicity estimate (ATE) for the classification of  a  \nsubstance in a mixture is derived using:  \n— the LD  50 /LC  50 where available,  \n— the appropriate conversion value from Table 3.1.2 that \nrelates to the results of a range test, or  \n— the appropriate conversion value from Table 3.1.2 that \nrelates to a classification category.  \n▼M4 \n(c) The ranges of the acute toxicity estimates (ATE) for inhala tion \ntoxicity used in the Table are based on 4-hour testing \nexposures. Conversion of existing inhalation toxicity data \nwhich have been generated using a 1-hour exposure can be \ncarried out by dividing by a factor of 2 for gases and \nvapours and 4 for dusts and mists.  \n▼M2 \n(d) For some substances the test atmosphere will not just be a \nvapour but will consist of a mixture of liquid and vapour \nphases. For other substances the test atmosphere may consist \nof a vapour which is near the gaseous phase. In these latter \ncases, classification shall be based on ppmV as follows: \nCategory 1 (100 ppmV), Category 2 (500 ppmV), Category 3 \n(2 500 ppmV), Category 4 (20 000 ppmV).  \nThe terms ‘dust’, ‘mist’ and ‘vapour’ are defined as follows:  \n— dust: solid particles of a substance or mixture suspended in \na gas (usually air),  \n— mist: liquid droplets of a substance or mixture suspended in \na gas (usually air),  \n— vapour: the gaseous form of a substance or mixture released \nfrom its liquid or solid state.  \nDust is generally formed by mechanical processes. Mist is \ngenerally formed by condensation of supersaturated vapours \nor by physical shearing of liquids. Dusts and mists generally \nhave sizes ranging from less than 1 to about 100 μm.  \n▼B \n3.1.2.2.  Specific considerations for classification of substances as acutely \ntoxic  \n3.1.2.2.1. The preferred test species for evaluation of acute t oxicity by the \noral and inhalation routes is the rat, while the rat or rabbit are \npreferred for evaluation of acute dermal toxicity. When experi\xad\nmental data for acute toxicity are available in several animal \nspecies, scientific judgement shall be used in selecting the mo st \nappropriate LD  50 value from among valid, well-performed tests.  \n3.1.2.3.  Specific considerations for classification of substances as acutely \ntoxic by the inhalation route  \n3.1.2.3.1. Units for inhalation toxicity are a function of the form of the \ninhaled material. Values for dusts and mists are expressed in \nmg/l. Values for gases are expressed in ppmV. Acknowledging \nthe difficulties in testing vapours, some of which consist of \nmixtures of liquid and vapour phases, the table provides values  \nin units of mg/l. However, for those vapours which are near the  \ngaseous phase, classification shall be based on ppmV.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 119}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 121  \n3.1.2.3.2.  ►M12  Of particular importance in classifying for inhalation \ntoxicity is the use of well articulated values in the highest h azard \ncategories for dusts and mists. ◄ Inhaled particles between 1 a nd 4 \nmicrons mean mass aerodynamic diameter (MMAD) will deposit in \nall regions of the rat respiratory tract. This particle size ra nge \ncorresponds to a maximum dose of about 2 mg/l. In order to \nachieve applicability of animal experiments to human exposure, \ndusts and mists would ideally be tested in this range in rats.  \n3.1.2.3.3. In addition to classification for inhalation toxicit y, if data are \navailable that indicates that the mechanism of toxicity was \ncorrosivity, the substance or mixture shall also be labelled as  ‘cor\xad\nrosive to the respiratory tract’ (see note 1 in 3.1.4.1). Corro sion of \nthe respiratory tract is defined by destruction of the respirat ory tract \ntissue after a single, limited period of exposure analogous to skin \ncorrosion; this includes destruction of the mucosa. The corrosi vity \nevaluation can be based on expert judgment using such evidence as: \nhuman and animal experience, existing (in vitro) data, pH value s, \ninformation from similar substances or any other pertinent data . \n3.1.3.  Criteria for classification of mixtures as acutely toxic  \n3.1.3.1. The criteria for classification of substances for acut e toxicity as \noutlined in section 3.1.2 are based on lethal dose data (tested  or \nderived). For mixtures, it is necessary to obtain or derive \ninformation that allows the criteria to be applied to the mixtu re \nfor the purpose of classification. The approach to classificati on \nfor acute toxicity is tiered, and is dependent upon the amount of \ninformation available for the mixture itself and for its ingred ients. \nThe flow chart of Figure 3.1.1 outlines the process to be follo wed. \n▼M2 \n3.1.3.2. For acute toxicity each route of exposure shall be con sidered for the \nclassification of mixtures, but only one route of exposure is n eeded \nas long as this route is followed (estimated or tested) for all  \ncomponents and there is no relevant evidence to suggest acute \ntoxicity by multiple routes. When there is relevant evidence of  \ntoxicity by multiple routes of exposure, classification is to b e \nconducted for all appropriate routes of exposure. All available  \ninformation shall be considered. The pictogram and signal word \nused shall reflect the most severe hazard category and all rele vant \nhazard statements shall be used.  \n▼B \n3.1.3.3. In order to make use of all available data for purpose s of clas\xad\nsifying the hazards of the mixtures, certain assumptions have \nbeen made and are applied where appropriate in the tiered \napproach:  \n(a) the ‘relevant ingredients’ of a mixture are those which are  \npresent in concentrations of 1 % (w/w for solids, liquids, \ndusts, mists and vapours and v/v for gases) or greater, unless \nthere is a reason to suspect that an ingredient present at a \nconcentration of less than 1 % is still relevant for classifyin g \nthe mixture for acute toxicity (see Table 1.1).  \n(b) where a classified mixture is used as an ingredient of anot her \nmixture, the actual or derived acute toxicity estimate (ATE) fo r \nthat mixture may be used, when calculating the classification o f \nthe new mixture using the formulas in section 3.1.3.6.1 and \nparagraph 3.1.3.6.2.3.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 120}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 122  \n(c) If the converted acute toxicity point estimates for all \ncomponents of a mixture are within the same category, then \nthe mixture should be classified in that category.  \n(d) When only range data (or acute toxicity hazard category \ninformation) are available for components in a mixture, they \nmay be converted to point estimates in accordance with Table \n3.1.2 when calculating the classification of the new mixture \nusing the formulas in sections 3.1.3.6.1 and 3.1.3.6.2.3.  \n▼B \nFigure 3.1.1  \nTiered approach to classification of mixtures for acute toxicity\n  \n3.1.3.4.  Classification of mixtures where acute toxicity data are available \nfor the complete mixture  \n3.1.3.4.1. Where the mixture itself has been tested to determin e its acute \ntoxicity, it shall be classified according to the same criteria  as \nthose used for substances, presented in Table 3.1.1. If test da ta \nfor the mixture are not available, the procedures presented und er \nsections 3.1.3.5 and 3.1.3.6 shall be followed.  \n3.1.3.5.  Classification of mixtures where acute toxicity data are available \nfor the complete mixture: bridging principles  \n3.1.3.5.1. Where the mixture itself has not been tested to dete rmine its acute \ntoxicity, but there are sufficient data on the individual ingre dients \nand similar tested mixtures to adequately characterise the haza rds of \nthe mixture, these data shall be used in accordance with the \nbridging rules set out in section 1.1.3.  \n▼M2 \n3.1.3.5.2. If a tested mixture is diluted with a diluent that h as an equivalent or \nlower toxicity classification than the least toxic original \ncomponents, and which is not expected to affect the toxicity of  \nother components, then the new diluted mixture may be classifie d \nas equivalent to the original tested mixture. Alternatively, th e \nformula explained in section 3.1.3.6.1 can be applied.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 121}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 123  \n3.1.3.6.  Classification of mixtures based on ingredients of the mixture \n(Additivity formula)  \n3.1.3.6.1. D a t a a v a i l a b l e f o r a l l i n g r e d i e n t s  \nIn order to ensure that classification of the mixture is accura te, and \nthat the calculation need only be performed once for all system s, \nsectors, and categories, the acute toxicity estimate (ATE) of \ningredients shall be considered as follows:  \n(a) ►M12  include ingredients with a known acute toxicity, which \nfall into any of the acute hazard categories shown in Table \n3.1.1; ◄  \n(b) ignore ingredients that are presumed not acutely toxic (e.g ., \nwater, sugar);  \n▼M2 \n(c) ignore components if the data available are from a limit do se \ntest (at the upper threshold for Category 4 for the appropriate  \nroute of exposure as provided in Table 3.1.1) and do not show \nacute toxicity.  \nComponents that fall within the scope of this section are consi dered \nto be components with a known acute toxicity estimate (ATE). Se e \nnote (b) to Table 3.1.1 and section 3.1.3.3 for appropriate app li\xad\ncation of available data to the equation below, and section \n3.1.3.6.2.3.  \n▼B \nThe ATE of the mixture is determined by calculation from the AT E \nvalues for all relevant ingredients according to the following \nformula for Oral, Dermal or Inhalation Toxicity:  \n100 \nATE  mix ¼ X  \nn C i \nATE  i \nwhere:  \nC i = concentration of ingredient i ( % w/w or % v/v)  \ni = the individual ingredient from 1 to n  \nn = the number of ingredients  \nATE  i = Acute Toxicity Estimate of ingredient i.  \n3.1.3.6.2. C l a s s i f i c a t i o n o f m i x t u r e s w h e n d a t a a r e n o t \na v a i l a b l e f o r a l l c o m p o n e n t s  \n3.1.3.6.2.1. Where an ATE is not available for an individual in gredient of the \nmixture, but available information, such as that listed below, can \nprovide a derived conversion value such as those laid out in Ta ble \n3.1.2, the formula in section 3.1.3.6.1 shall be applied.  \nThis includes evaluation of:  \n(a) extrapolation between oral, dermal and inhalation acute tox icity \nestimates (  1 ). Such an evaluation could require appropriate \npharmacodynamic and pharmacokinetic data;  \n(b) evidence from human exposure that indicates toxic effects b ut \ndoes not provide lethal dose data;  \n(c) evidence from any other toxicity tests/assays available on the \nsubstance that indicates toxic acute effects but does not \nnecessarily provide lethal dose data; or  ▼B \n( 1 ) ►M2 When mixtures contain components that do not have acute toxici ty data for each \nroute of exposure, acute toxicity estimates may be extrapolated  from the available data \nand applied to the appropriate routes (see section 3.1.3.2). Ho wever, specific legislation \nmay require testing for a specific route. In those cases, class ification shall be performed \nfor that route based upon the legal requirements. ◄', metadata={'source': 'data/ycla_en.pdf', 'page': 122}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 124  \n(d) data from closely analogous substances using structure/acti vity \nrelationships.  \nThis approach generally requires substantial supplemental techn ical \ninformation, and a highly trained and experienced expert (exper t \njudgement, see section 1.1.1), to reliably estimate acute toxic ity. If \nsuch information is not available, proceed to paragraph 3.1.3.6 .2.3. \n▼M4 \n3.1.3.6.2.2. In the event that a component without any useable information for \nclassification is used in a mixture at a concentration ≥ 1 %, i t is \nconcluded that the mixture cannot be attributed a definitive ac ute \ntoxicity estimate. In this situation the mixture shall be class ified \nbased on the known components only, with the additional \nstatement on the label and in the SDS that ‘x per cent of the \nmixture consists of component(s) of unknown acute toxicity’, \ntaking into account the provisions set out in section 3.1.4.2.  \n3.1.3.6.2.3. If the total concentration of the relevant ingredi ent(s) with unknown \nacute toxicity is ≤ 10 % then the formula presented in section \n3.1.3.6.1 shall be used. If the total concentration of the rele vant \ningredient(s) with unknown toxicity is > 10 %, the formula \npresented in section 3.1.3.6.1 shall be corrected to adjust for  the \npercentage of the unknown ingredient(s) as follows:  \n100 Ä ð P C unknown if > 10 %Þ \nATE  mix ¼ X  \nn C i \nATE  i \n▼B \nTable 3.1.2  \n▼M2 \nConversion from experimentally obtained acute toxicity range \nvalues (or acute toxicity hazard categories) to acute toxicity \npoint estimates for use in the formulas for the classification of \nmixtures  \n▼B \nExposure routes  Classification Category or experi\xad\nmentally obtained acute toxicity \nrange estimate  Converted acute \ntoxicity point \nestimate \n(see Note 1)  \nOral \n(mg/kg body\xad\nweight)  0 < Category 1 ≤ 5 \n5 < Category 2 ≤ 50 \n50 < Category 3 ≤ 300 \n300 < Category 4 ≤ 2 000  0,5 \n5 \n100 \n500 \nDermal \n(mg/kg body\xad\nweight)  0 < Category 1 ≤ 50 \n50 < Category 2 ≤ 200 \n200 < Category 3 ≤ 1 000 \n1 000 < Category 4 ≤ 2 000  5 \n50 \n300 \n1 100  \nGases \n(ppmV)  0 < Category 1 ≤ 100 \n100 < Category 2 ≤ 500 \n500 < Category 3 ≤ 2 500 \n2 500 < Category 4 ≤ 20 000  10 \n100 \n700 \n4 500  \nVapours \n(mg/l)  0 < Category 1 ≤ 0,5 \n0,5 < Category 2 ≤ 2,0 \n2,0 < Category 3 ≤ 10,0 \n10,0 < Category 4 ≤ 20,0  0,05 \n0,5 \n3 \n11 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 123}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 125  \nExposure routes  Classification Category or experi\xad\nmentally obtained acute toxicity \nrange estimate  Converted acute \ntoxicity point \nestimate \n(see Note 1)  \nDust/mist \n(mg/l)  0< Category 1 ≤ 0,05 \n0,05 < Category 2 ≤ 0,5 \n0,5 < Category 3 ≤ 1,0 \n1,0 < Category 4 ≤ 5,0  0,005 \n0,05 \n0,5 \n1,5 \nNote 1  \nThese values are designed to be used in the calculation of the ATE \nfor classification of a mixture based on its components and do not \nrepresent test results.  \n3.1.4.  Hazard Communication  \n3.1.4.1. Label elements shall be used for substances or mixture s meeting the \ncriteria for classification in this hazard class in accordance with \nTable 3.1.3.  ►M2 Without prejudice to Article 27, combined \nhazard statements may be used in accordance with Annex III. ◄  \n▼M4 \nTable 3.1.3  \nAcute toxicity label elements  \nClassification  Category 1  Category 2  Category 3  Category 4  \nGHS Pictograms\n  \nSignal Word  Danger  Danger  Danger  Warning  \nHazard Statement: \n— Oral  H300: Fatal if \nswallowed  H300: Fatal if \nswallowed  H301: Toxic if \nswallowed  H302: Harmful if \nswallowed  \n— Dermal  H310:Fatal in \ncontact with skin  H310:Fatal in \ncontact with skin  H311: Toxic in \ncontact with skin  H312: Harmful in \ncontact with skin  \n— Inhalation \n(see Note 1)  H330:Fatal if \ninhaled  H330: Fatal if \ninhaled  H331: Toxic if \ninhaled  H332: Harmful if \ninhaled  \nPrecautionary \nStatement \nPrevention (oral)  P264 \nP270  P264 \nP270  P264 \nP270  P264 \nP270  \nPrecautionary \nStatement \nResponse (oral)  P301 + P310 \nP321 \nP330  P301 + P310 \nP321 \nP330  P301 + P310 \nP321 \nP330  P301 + P312 \nP330  \nPrecautionary \nStatement Storage \n(oral)  P405  P405  P405  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 124}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 126  \nClassification  Category 1  Category 2  Category 3  Category 4  \nPrecautionary \nStatement Disposal \n(oral)  P501  P501  P501  P501  \nPrecautionary \nStatement \nPrevention \n(dermal)  P262 \nP264 \nP270 \nP280  P262 \nP264 \nP270 \nP280  P280  P280  \nPrecautionary \nStatement \nResponse (dermal)  P302 + P352 \nP310 \nP321 \nP361 + P364  P302 + P352 \nP310 \nP321 \nP361 + P364  P302 + P352 \nP312 \nP321 \nP361 + P364  P302 + P352 \nP312 \nP321 \nP362 + P364  \nPrecautionary \nStatement Storage \n(dermal)  P405  P405  P405  \nPrecautionary \nStatement Disposal \n(dermal)  P501  P501  P501  P501  \nPrecautionary \nStatement \nPrevention (inha\xad\nlation)  P260 \nP271 \nP284  P260 \nP271 \nP284  P261 \nP271  P261 \nP271  \nPrecautionary \nStatement \nResponse (inha\xad\nlation)  P304 + P340 \nP310 \nP320  P304 + P340 \nP310 \nP320  P304 + P340 \nP311 \nP321  P304 + P340 \nP312  \nPrecautionary \nStatement Storage \n(inhalation)  P403 + P233 \nP405  P403 + P233 \nP405  P403 + P233 \nP405  \nPrecautionary \nStatement Disposal \n(inhalation)  P501  P501  P501  \n▼B \nNote 1  \nIn addition to classification for inhalation toxicity, if data are \navailable that indicates that the mechanism of toxicity is corr osivity, \nthe substance or mixture shall also be labelled as EUH071: ‘cor \xad\nrosive to the respiratory tract’ — see advice at 3.1.2.3.3. In addition \nto an appropriate acute toxicity pictogram, a corrosivity picto gram \n(used for skin and eye corrosivity) may be added together with the \nstatement ‘corrosive to the respiratory tract’.  \nNote 2  \nIn the event that an ingredient without any useable information  at \nall is used in a mixture at a concentration of 1 % or greater, the \nmixture shall be labelled with the additional statement that ‘x  \npercent of the mixture consists of ingredient(s) of unknown \ntoxicity’ — see advice at 3.1.3.6.2.2.  \n▼M4 \n3.1.4.2. The acute toxicity hazard statements differentiate the  hazard based \non the route of exposure. Communication of acute toxicity class ifi\xad\ncation should also reflect this differentiation. If a substance  or \nmixture is classified for more than one route of exposure then all \nrelevant classifications should be communicated on the safety d ata \nsheet as specified in Annex II to Regulation (EC) No 1907/2006 \nand the relevant hazard communication elements included on the \nlabel as prescribed in section 3.1.3.2. If the statement ‘x % o f the ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 125}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 127  \nmixture consists of ingredient(s) of unknown acute toxicity’ is  \ncommunicated, as prescribed in section 3.1.3.6.2.2, then, in th e \ninformation provided in the safety data sheet, it can also be d iffer\xad\nentiated based on the route of exposure. For example, ‘x % of t he \nmixture consists of ingredient(s) of unknown acute oral toxicit y’ \nand ‘x % of the mixture consists of ingredient(s) of unknown ac ute \ndermal toxicity’.  \n▼M12  \n3.2. Skin corrosion/irritation  \n3.2.1.  Definitions and general considerations  \n▼M19  \n3.2.1.1. Skin corrosion means the production of irreversible da mage to the \nskin; namely, visible necrosis through the epidermis and into t he \ndermis occurring after exposure to a substance or mixture.  \nSkin irritation means the production of reversible damage to th e \nskin occurring after exposure to a substance or mixture.  \n▼M12  \n3.2.1.2. In a tiered approach, emphasis shall be placed upon ex isting human \ndata, followed by existing animal data, followed by  in vitro  data \nand then other sources of information. Classification results d irectly \nwhen the data satisfy the criteria. In some cases, classificati on of a \nsubstance or a mixture is made on the basis of the weight of \nevidence within a tier. In a total weight of evidence approach all \navailable information bearing on the determination of skin \ncorrosion/irritation is considered together, including the resu lts of \nappropriate validated  in vitro  tests, relevant animal data, and human \ndata such as epidemiological and clinical studies and well-docu \xad\nmented case reports and observations (see Annex I, Part 1, \nSections 1.1.1.3, 1.1.1.4 and 1.1.1.5).  \n3.2.2.  Classification criteria for substances  \nSubstances shall be allocated to one of the following two categ ories \nwithin this hazard class:  \n(a) Category 1 (skin corrosion)  \nThis category is further subdivided in three sub-categories (1A , \n1B, 1C). Corrosive substances shall be classified in Category 1  \nwhere data is not sufficient for sub-categorisation. When data \nare sufficient, substances shall be classified in one of the th ree \nsub-categories 1A, 1B, or 1C (see Table 3.2.1.)  \n(b) Category 2 (skin irritation) (see Table 3.2.2).  \n3.2.2.1.  Classification based on standard animal test data  \n3.2.2.1.1. S k i n c o r r o s i o n  \n3.2.2.1.1.1. A substance is corrosive to skin when it produces destruction of \nskin tissue, namely, visible necrosis through the epidermis and  into \nthe dermis in at least one tested animal after exposure for up to 4 \nhours.  \n3.2.2.1.1.2. Corrosive substances shall be classified in Catego ry 1 where data is \nnot sufficient for sub-categorisation.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 126}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 128  \n3.2.2.1.1.3. When data are sufficient substances shall be class ified in one of the \nthree sub-categories 1A, 1B, or 1C in accordance with the crite ria \nin Table 3.2.1.  \n3.2.2.1.1.4. Three sub-categories are provided within the corro sion category: \nsub-category 1A — where corrosive responses are noted \nfollowing up to 3 minutes exposure and up to 1 hour observation ; \nsub-category 1B — where corrosive responses are described \nfollowing exposure greater than 3 minutes and up to 1 hour and \nobservations up to 14 days; and sub-category 1C — where \ncorrosive responses occur after exposures greater than 1 hour a nd \nup to 4 hours and observations up to 14 days.  \nTable 3.2.1  \nSkin corrosion category and sub-categories  \nCategory  Criteria  \nCategory 1 (  1 ) Destruction of skin tissue, namely, visible \nnecrosis through the epidermis and into \nthe dermis, in at least one tested animal \nafter exposure ≤ 4 h  \nSub-Category 1A  Corrosive responses in at least one \nanimal following exposure ≤ 3 min \nduring an observation period ≤ 1 h  \nSub-Category 1B  Corrosive responses in at least one \nanimal following exposure > 3 min and \n≤ 1 h and observations ≤ 14 days  \nSub-Category 1C  Corrosive responses in at least one \nanimal after exposures > 1 h and ≤ 4 h \nand observations ≤ 14 days  \n( 1 ) See the conditions for the use of Category 1 in paragraph (a)  of Section \n3.2.2.  \n3.2.2.1.1.5. The use of human data is discussed in Sections 3.2 .1.2 and 3.2.2.2 \nand also in Sections 1.1.1.3, 1.1.1.4 and 1.1.1.5.  \n3.2.2.1.2. S k i n i r r i t a t i o n  \n3.2.2.1.2.1. A substance is irritant to skin when it produces r eversible damage \nto the skin following its application for up to 4 hours. The ma jor \ncriterion for the irritation category is that at least 2 of 3 t ested \nanimals have a mean score of ≥ 2,3 and ≤ 4,0.  \n3.2.2.1.2.2. A single irritation category (Category 2) is prese nted in Table 3.2.2, \nusing the results of animal testing.  \n3.2.2.1.2.3. Reversibility of skin lesions is also considered i n evaluating irritant \nresponses. When inflammation persists to the end of the obser\xad\nvation period in 2 or more test animals, taking into considerat ion \nalopecia (limited area), hyperkeratosis, hyperplasia and scalin g, then \na material shall be considered to be an irritant.  \n3.2.2.1.2.4. Animal irritant responses within a test can be var iable, as they are \nwith corrosion. A separate irritant criterion accommodates case s \nwhere there is a significant irritant response but less than th e \nmean score criterion for a positive test. For example, a test \nmaterial might be designated as an irritant if at least 1 of 3 \ntested animals shows a very elevated mean score throughout the \nstudy, including lesions persisting at the end of an observatio n \nperiod of normally 14 days. Other responses could also fulfil t his \ncriterion. However, it should be ascertained that the responses  are \nthe result of chemical exposure.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 127}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 129  \nTable 3.2.2  \nSkin irritation category  ( a ) \nCategory  Criteria  \nIrritation \n(Category 2)  (1) Mean score of ≥ 2,3 and ≤ 4,0 for erythema/ \neschar or for oedema in at least 2 of 3 tested \nanimals from gradings at 24, 48 and 72 hours \nafter patch removal or, if reactions are \ndelayed, from grades on 3 consecutive days \nafter the onset of skin reactions; or \n(2) Inflammation that persists to the end of the \nobservation period normally 14 days in at \nleast 2 animals, particularly taking into \naccount alopecia (limited area), hyperkeratosis, \nhyperplasia, and scaling reactions; or \n(3) In some cases where there is pronounced \nvariability of response among animals, with \nvery definite positive effects related to \nchemical exposure in a single animal but \nless than the criteria above .  \n( a ) Grading criteria are understood as described in Regulation (E C) No 440/ \n2008.  \n3.2.2.1.2.5. The use of human data is discussed in Sections 3.2 .1.2 and 3.2.2.2 \nand also in Sections 1.1.1.3, 1.1.1.4 and 1.1.1.5.  \n3.2.2.2.  Classification in a tiered approach  \n3.2.2.2.1. A tiered approach to the evaluation of initial infor mation shall be \nconsidered, where applicable, recognising that not all elements  may \nbe relevant.  \n3.2.2.2.2. Existing human and animal data including information  from single \nor repeated exposure shall be the first line of evaluation, as they \ngive information directly relevant to effects on the skin.  \n3.2.2.2.3. Acute dermal toxicity data may be used for classific ation. If a \nsubstance is highly toxic by the dermal route, a skin corrosion /ir\xad\nritation study is not practicable since the amount of test subs tance \nto be applied considerably exceeds the toxic dose and, \nconsequently, results in the death of the animals. When obser\xad\nvations are made of skin corrosion/irritation in acute toxicity  \nstudies and are observed up through the limit dose, these data \nmay be used for classification, provided that the dilutions use d \nand species tested are equivalent. Solid substances (powders) m ay \nbecome corrosive or irritant when moistened or in contact with \nmoist skin or mucous membranes.  \n3.2.2.2.4. In vitro alternatives that have been validated and a ccepted shall be \nused to make classification decisions.  \n3.2.2.2.5. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may indica te the \npotential to cause skin effects, especially when associated wit h \nsignificant acid/alkaline reserve (buffering capacity). General ly, \nsuch substances are expected to produce significant effects on the \nskin. In the absence of any other information, a substance is \nconsidered as corrosive to skin (Skin Corrosion Category 1) if it \nhas a pH ≤ 2 or a pH ≥ 11,5. However, if consideration of acid/  \nalkaline reserve suggests the substance may not be corrosive de spite \nthe low or high pH value, this needs to be confirmed by other d ata, \npreferably by data from an appropriate validated in vitro test.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 128}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 130  \n3.2.2.2.6. In some cases, sufficient information may be availab le from struc\xad\nturally related substances to make classification decisions.  \n3.2.2.2.7. The tiered approach provides guidance on how to orga nize existing \ninformation on a substance and to make a weight of evidence \ndecision about hazard assessment and hazard classification.  \nAlthough information might be gained from the evaluation of sin gle \nparameters within a tier (see Section 3.2.2.2.1.), consideratio n shall \nbe given to the totality of existing information and making an \noverall weight of evidence determination. This is especially tr ue \nwhen there is conflict in information available on some paramet ers. \n3.2.3.  Classification criteria for mixtures  \n3.2.3.1.  Classification of mixtures when data are available for the complete \nmixture  \n3.2.3.1.1. The mixture shall be classified using the criteria f or substances, \ntaking into account the tiered approach to evaluate data for th is \nhazard class.  \n3.2.3.1.2. When considering testing of the mixture, classifiers  are encouraged \nto use a tiered weight of evidence approach as included in the \ncriteria for classification of substances for skin corrosion an d irri\xad\ntation (Sections 3.2.1.2 and 3.2.2.2), to help ensure an accura te \nclassification as well as to avoid unnecessary animal testing. In \nthe absence of any other information, a mixture is considered \ncorrosive to skin (Skin Corrosion Category 1) if it has a pH ≤ 2 \nor a pH ≥ 11,5. However, if consideration of acid/alkaline rese rve \nsuggests the mixture may not be corrosive despite the low or hi gh \npH value, this needs to be confirmed by other data, preferably by \ndata from an appropriate validated in vitro test.  \n3.2.3.2.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.2.3.2.1. Where the mixture itself has not been tested to dete rmine its skin \ncorrosion/irritation potential, but there are sufficient data o n the \nindividual ingredients and similar tested mixtures to adequatel y \ncharacterise the hazards of the mixture, these data shall be us ed \nin accordance with the bridging rules set out in Section 1.1.3.  \n3.2.3.3.  Classification of mixtures when data are available for all \ningredients or only for some ingredients of the mixture  \n3.2.3.3.1. In order to make use of all available data for purpo ses of clas\xad\nsifying the skin corrosion/irritation hazards of mixtures, the \nfollowing assumption has been made and is applied where appro\xad\npriate in the tiered approach:  \nThe ‘relevant ingredients’ of a mixture are those which are pre sent \nin concentrations ≥ 1 % (w/w for solids, liquids, dusts, mists and \nvapours and v/v for gases), unless there is a presumption (e.g. , in \nthe case of skin corrosive ingredients) that an ingredient pres ent at a \nconcentration < 1 % can still be relevant for classifying the m ixture \nfor skin corrosion/irritation.  \n3.2.3.3.2. In general, the approach to classification of mixtur es as corrosive or \nirritant to skin when data are available on the ingredients, bu t not \non the mixture as a whole, is based on the theory of additivity , such  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 129}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 131  \nthat each skin corrosive or skin irritant ingredient contribute s to the \noverall skin corrosive or skin irritant properties of the mixtu re in \nproportion to its potency and concentration. A weighting factor  of \n10 is used for skin corrosive ingredients when they are present  at a \nconcentration below the generic concentration limit for classif i\xad\ncation with Category 1, but are at a concentration that will \ncontribute to the classification of the mixture as skin irritan t. The \nmixture is classified as corrosive or irritant to skin when the  sum of \nthe concentrations of such ingredients exceeds a concentration limit.  \n3.2.3.3.3. Table 3.2.3 provides the generic concentration limit s to be used to \ndetermine if the mixture is considered to be corrosive or irrit ant to \nthe skin.  \n3.2.3.3.4.1. Particular care must be taken when classifying cer tain types of \nmixtures containing substances such as acids and bases, inorgan ic \nsalts, aldehydes, phenols, and surfactants. The approach explai ned \nin Sections 3.2.3.3.1 and 3.2.3.3.2 may not be applicable given  that \nmany such substances are corrosive or irritant to the skin at c oncen\xad\ntrations < 1 %.  \n3.2.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used \nas a classification criterion (see Section 3.2.3.1.2) since pH is a \nbetter indicator of skin corrosion than the concentration limit s in \nTable 3.2.3.  \n3.2.3.3.4.3. A mixture containing ingredients that are corrosiv e or irritant to the \nskin and that cannot be classified on the basis of the additivi ty \napproach (Table 3.2.3), due to chemical characteristics that ma ke \nthis approach unworkable, shall be classified as Skin Corrosion  \nCategory 1 if it contains ≥ 1 % of an ingredient classified as \nSkin Corrosion or as Skin Irritation (Category 2) when it \ncontains ≥ 3 % of an skin irritant ingredient. Classification o f \nmixtures with ingredients for which the approach in Table 3.2.3  \ndoes not apply is summarised in Table 3.2.4.  \n3.2.3.3.5. On occasion, reliable data may show that the skin co rrosion/irri\xad\ntation hazard of an ingredient will not be evident when present  at a \nlevel at or above the generic concentration limits mentioned in  \nTables 3.2.3 and 3.2.4 in Section 3.2.3.3.6. In these cases the  \nmixture shall be classified according to that data (see also \nArticles 10 and 11). On other occasions, when it is expected th at \nthe skin corrosion/irritation hazard of an ingredient is not ev ident \nwhen present at a level at or above the generic concentration l imits \nmentioned in Tables 3.2.3 and 3.2.4, testing of the mixture sha ll be \nconsidered. In those cases the tiered weight of evidence approa ch \nshall be applied, as described in Section 3.2.2.2.  \n3.2.3.3.6. If there are data showing that (an) ingredient(s) is /are corrosive or \nirritant to skin at a concentration of < 1 % (skin corrosive) o r < 3 % \n(skin irritant), the mixture shall be classified accordingly.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 130}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 132  \nTable 3.2.3  \nGeneric concentration limits of ingredients classified as skin \ncorrosion (Category 1, 1A, 1B or 1C)/skin irritation (Category 2) \nthat trigger classification of the mixture as skin corrosion/skin \nirritation where the additivity approach applies  \nSum of ingredients clas\xad\nsified as:  Concentration triggering classification of a \nmixture as:  \nSkin corrosion  Skin irritation  \nCategory 1 (see note \nbelow)  Category 2  \nSkin corrosion Sub- \nCategory 1A, 1B, 1C \nor Category 1  ≥ 5 %  ≥ 1 % but < 5 %  \nSkin irritation \nCategory 2  ≥ 10 %  \n(10 × Skin corrosion \nSub-Category 1A, 1B, \n1C or Category 1) + \nSkin irritation \nCategory 2  ≥ 10 %  \nNote:  \nThe sum of all ingredients of a mixture classified as Skin Corr osion \nSub-Category 1A, 1B, or 1C respectively, shall each be ≥ 5 % in  \norder to classify the mixture as either Skin Corrosion Sub- \nCategory 1A, 1B or 1C. If the sum of the ingredients classified  \nas Skin Corrosion Sub-Category 1A is < 5 % but the sum of \ningredients classified as Skin Corrosion Sub-Category 1A + 1B i s \n≥ 5 %, the mixture shall be classified as Skin Corrosion Sub- \nCategory 1B. Similarly, if the sum of ingredients classified as  \nSkin Corrosion Sub-Category 1A + 1B ingredients is < 5 % but \nthe sum of ingredients classified as Sub-Category 1A + 1B + 1C \nis ≥ 5 % the mixture shall be classified as Skin Corrosion Sub-  \nCategory 1C. Where at least one relevant ingredient in a mixtur e is \nclassified as Category 1 without sub-categorisation, the mixtur e \nshall be classified as Category 1 without sub-categorisation if  the \nsum of all ingredients corrosive to skin is ≥ 5 %.  \nTable 3.2.4  \nGeneric concentration limits of ingredients that trigger classifi \xad\ncation of the mixture as skin corrosion/skin irritation, where the \nadditivity approach does not apply  \nIngredient:  Concentration:  Mixture classified as:  \nAcid with pH ≤ 2  ≥  1  %  Skin corrosion \nCategory 1  \nBase with pH ≥ 11,5  ≥  1  %  Skin corrosion \nCategory 1  \nOther skin corrosive \n(Sub-Categories 1A, \n1B, 1C or Category \n1) ingredients  ≥ 1 %  Skin corrosion \nCategory 1  \nOther skin irritant \n(Category 2) \ningredients, \nincluding acids and \nbases  ≥ 3 %  Skin irritation \nCategory 2  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 131}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 133  \n3.2.4.  Hazard Communication  \n3.2.4.1. Label elements shall be used for substances or mixture s meeting the \ncriteria for classification in this hazard class in accordance with \nTable 3.2.5.  \nTable 3.2.5  \nLabel elements for skin corrosion/irritation  \nClassification  Sub-Categories 1A/1B/ \n1C and Category 1  Category 2  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  \nHazard Statement  H314: Causes severe \nskin burns and eye \ndamage  H315: Causes skin \nirritation  \nPrecautionary \nStatement Prevention  P260 \nP264 \nP280  P264 \nP280  \nPrecautionary \nStatement Response  P301 + P330 + P331 \nP303 + P361 + P353 \nP363 \nP304 + P340 \nP310 \nP321 \nP305 + P351 + P338  P302 + P352 \nP321 \nP332 + P313 \nP362 + P364  \nPrecautionary \nStatement Storage  P405  \nPrecautionary \nStatement Disposal  P501  \n3.3. Serious eye damage/eye irritation  \n3.3.1.  Definitions and general considerations  \n▼M19  \n3.3.1.1. Serious eye damage means the production of tissue dama ge in the \neye, or serious physical decay of vision, which is not fully \nreversible, occurring after exposure of the eye to a substance or \nmixture.  \nEye irritation means the production of changes in the eye, whic h \nare fully reversible, occurring after the exposure of the eye t o a \nsubstance or mixture.  \n▼M12  \n3.3.1.2. In a tiered approach, emphasis shall be placed upon ex isting human \ndata, followed by existing animal data, followed by in vitro da ta, \nand then other sources of information. Classification results d irectly \nwhen the data satisfy the criteria. In other cases, classificat ion of a \nsubstance or a mixture is made on the basis of the weight of \nevidence within a tier. In a total weight of evidence approach all \navailable information bearing on the determination of serious e ye \ndamage/eye irritation is considered together, including the res ults of  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 132}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 134  \nappropriate validated in vitro tests, relevant animal data, and  human \ndata such as epidemiological and clinical studies and well-docu \xad\nmented case reports and observations (see Annex I, Part 1, \nSection 1.1.1.3).  \n3.3.2.  Classification criteria for substances  \nSubstances are allocated to one of the categories within this h azard \nclass, Category 1 (serious eye damage) or Category 2 (eye irri\xad\ntation), as follows:  \n(a) Category 1 (serious eye damage):  \nsubstances that have the potential to seriously damage the eyes  \n(see Table 3.3.1).  \n(b) Category 2 (eye irritation):  \nsubstances that have the potential to induce reversible eye irr i\xad\ntation (see Table 3.3.2).  \n3.3.2.1.  Classification based on standard animal test data  \n3.3.2.1.1. S e r i o u s e y e d a m a g e ( C a t e g o r y 1 ) \n3.3.2.1.1.1. A single hazard category (Category 1) is adopted f or substances \nthat have the potential to seriously damage the eyes. This haza rd \ncategory includes as criteria the observations listed in Table 3.3.1. \nThese observations include animals with grade 4 cornea lesions and \nother severe reactions (e.g. destruction of cornea) observed at  any \ntime during the test, as well as persistent corneal opacity, \ndiscoloration of the cornea by a dye substance, adhesion, pannu s, \nand interference with the function of the iris or other effects  that \nimpair sight. In this context, persistent lesions are considere d those \nwhich are not fully reversible within an observation period of \nnormally 21 days. Hazard classification as Category 1 also \ncontains substances fulfilling the criteria of corneal opacity ≥ 3 \nor iritis > 1,5 observed in at least 2 of 3 tested animals, bec ause \nsevere lesions like these usually do not reverse within a 21-da y \nobservation period.  \n3.3.2.1.1.2. The use of human data is discussed in Section 3.3. 2.2 and also in \nSections 1.1.1.3, 1.1.1.4 and 1.1.1.5.  \nTable 3.3.1  \nSerious eye damage  ( a ) \nCategory  Criteria  \nCategory 1  A substance that produces: \n(a) in at least one animal effects on the cornea, \niris or conjunctiva that are not expected to \nreverse or have not fully reversed within an \nobservation period of normally 21 days; and/ \nor \n(b) in at least 2 of 3 tested animals, a positive \nresponse of: \n(i) corneal opacity ≥ 3; and/or \n(ii) iritis > 1,5; \ncalculated as the mean scores following \ngrading at 24, 48 and 72 hours after instil\xad\nlation of the test material.  \n( a ) Grading criteria are understood as described in Regulation (E C) No 440/ \n2008.  \n3.3.2.1.2. E y e i r r i t a t i o n ( C a t e g o r y 2 )  \n3.3.2.1.2.1. Substances that have the potential to induce rever sible eye irritation \nshall be classified in Category 2 (eye irritation).  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 133}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 135  \n3.3.2.1.2.2. For those substances where there is pronounced var iability among \nanimal responses, this information shall be taken into account in \ndetermining the classification.  \n3.3.2.1.2.3. The use of human data is addressed in Sections 3.3 .2.2, and also in \nSections 1.1.1.3, 1.1.1.4 and 1.1.1.5.  \nTable 3.3.2  \nEye irritation  ( a ) \nCategory  Criteria  \nCategory 2  Substances that produce in at least 2 of 3 tested \nanimals a positive response of: \n(a) corneal opacity ≥ 1; and/or \n(b) iritis ≥ 1; and/or \n(c) conjunctival redness ≥ 2; and/or \n(d) conjunctival oedema (chemosis) ≥ 2 \ncalculated as the mean scores following grading \nat 24, 48 and 72 hours after instillation of the test \nmaterial, and which fully reverses within an \nobservation period of normally 21 days.  \n( a ) Grading criteria are understood as described in Regulation (E C) No 440/ \n2008.  \n3.3.2.2.  Classification in a tiered approach  \n3.3.2.2.1. A tiered approach to the evaluation of initial infor mation shall be \nconsidered where applicable, recognizing that not all elements may \nbe relevant.  \n3.3.2.2.2. Existing human and animal data shall be the first li ne of evaluation \nas they give information directly relevant to effects on the ey e. \nPossible skin corrosion has to be evaluated prior to considerat ion \nof any testing for serious eye damage/eye irritation in order t o \navoid testing for local effects on eyes with skin corrosive \nsubstances. Skin corrosive substances shall be considered as \nleading to serious eye damage (Category 1) as well, while skin \nirritant substances may be considered as leading to eye irritat ion \n(Category 2).  \n3.3.2.2.3. In vitro alternatives that have been validated and a ccepted shall be \nused to make classification decisions.  \n3.3.2.2.4. Likewise, pH extremes like ≤ 2 and ≥ 11,5, may indic ate serious \neye damage, especially when associated with significant acid/al \xad\nkaline reserve (buffering capacity). Generally such substances are \nexpected to produce significant effects on the eyes. In the abs ence \nof any other information, a substance is considered to cause se rious \neye damage (Category 1) if it has a pH ≤ 2 or ≥ 11,5. However, if \nconsideration of acid/alkaline reserve suggests the substance m ay \nnot cause serious eye damage despite the low or high pH value, this \nneeds to be confirmed by other data, preferably by data from an  \nappropriate validated in vitro test.  \n3.3.2.2.5. In some cases sufficient information may be availabl e from struc\xad\nturally related substances to make classification decisions.  \n3.3.2.2.6. The tiered approach provides guidance on how to orga nize existing \ninformation and to make a weight-of-evidence decision about \nhazard assessment and hazard classification. Animal testing wit h \ncorrosive substances shall be avoided whenever possible. \nAlthough information might be gained from the evaluation of \nsingle parameters within a tier (see 3.3.2.1.1) consideration s hall ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 134}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 136  \nbe given to the totality of existing information and making an \noverall weight of evidence determination. This is especially tr ue \nwhen there is conflict in information available on some paramet ers. \n3.3.3.  Classification criteria for mixtures  \n3.3.3.1.  Classification of mixtures when data are available for the complete \nmixture  \n3.3.3.1.1. The mixture shall be classified using the criteria f or substances, and \ntaking into account the tiered approach to evaluate data for th is \nhazard class.  \n3.3.3.1.2. When considering testing of the mixture classifiers are encouraged \nto use a tiered weight of evidence approach as included in the \ncriteria for classification of substances for skin corrosion an d \nserious eye damage/eye irritation to help ensure an accurate cl as\xad\nsification, as well as to avoid unnecessary animal testing. In the \nabsence of any other information, a mixture is considered to ca use \nserious eye damage (Category 1) if it has a pH ≤ 2 or ≥ 11,5. \nHowever, if consideration of acid/alkali reserve suggests the \nmixture may not cause serious eye damage despite the low or \nhigh pH value, this needs to be confirmed by other data, prefer ably \ndata from an appropriate validated in vitro test.  \n3.3.3.2.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.3.3.2.1. Where the mixture itself has not been tested to dete rmine its skin \ncorrosivity or potential to cause serious eye damage/eye irrita tion, \nbut there are sufficient data on the individual ingredients and  \nsimilar tested mixtures to adequately characterise the hazards of \nthe mixture, these data shall be used in accordance with the \nbridging rules set out in Section 1.1.3.  \n3.3.3.3.  Classification of mixtures when data are available for all \ningredients or only for some ingredients of the mixture  \n3.3.3.3.1. In order to make use of all available data for purpo ses of clas\xad\nsifying the serious eye damage/eye irritation properties of the  \nmixtures, the following assumption has been made and is applied  \nwhere appropriate in the tiered approach:  \nThe ‘relevant ingredients’ of a mixture are those which are pre sent \nin concentrations ≥ 1 % (w/w for solids, liquids, dusts, mists and \nvapours and v/v for gases), unless there is a presumption (e.g.  in \nthe case of skin corrosive ingredients) that an ingredient pres ent at a \nconcentration < 1 % can still be relevant for classifying the m ixture \nfor serious eye damage/eye irritation.  \n3.3.3.3.2. In general, the approach to classification of mixtur es as seriously \ndamaging to the eye/eye irritant when data are available on the  \ningredients, but not on the mixture as a whole, is based on the  \ntheory of additivity, such that each skin corrosive or serious eye \ndamaging/eye irritant ingredient contributes to the overall ser ious \neye damage/eye irritation properties of the mixture in proporti on to  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 135}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 137  \nits potency and concentration. A weighting factor of 10 is used  for \nskin corrosive and serious eye damaging ingredients when they a re \npresent at a concentration below the generic concentration limi t for \nclassification with Category 1, but are at a concentration that  will \ncontribute to the classification of the mixture as eye irritant . The \nmixture is classified as seriously damaging to the eye or eye i rritant \nwhen the sum of the concentrations of such ingredients exceeds a \nconcentration limit.  \n3.3.3.3.3. Table 3.3.3 provides the generic concentration limit s to be used to \ndetermine if the mixture shall be classified as seriously damag ing to \nthe eye or as eye irritant.  \n3.3.3.3.4.1. Particular care must be taken when classifying cer tain types of \nmixtures containing substances such as acids and bases, inorgan ic \nsalts, aldehydes, phenols, and surfactants. The approach explai ned \nin Sections 3.3.3.3.1 and 3.3.3.3.2 might not work given that m any \nsuch substances are seriously damaging to the eye/eye irritant at \nconcentrations < 1 %.  \n3.3.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used \nas classification criterion (see Section 3.3.3.1.2) since pH wi ll be a \nbetter indicator of serious eye damage (subject to consideratio n of \nacid/alkali reserve) than the generic concentration limits in \nTable 3.3.3.  \n3.3.3.3.4.3. A mixture containing skin corrosive or serious eye  damaging/eye \nirritating ingredients that cannot be classified based on the \nadditivity approach (Table 3.3.3) due to chemical characteristi cs \nthat make this approach unworkable, shall be classified as \nSerious Eye Damage (Category 1) if it contains ≥ 1 % of a skin \ncorrosive or serious eye damaging ingredient and as Eye Irritat ion \n(Category 2) when it contains ≥ 3 % of an eye irritant ingredie nt. \nClassification of mixtures with ingredients for which the appro ach \nin Table 3.3.3 does not apply is summarised in Table 3.3.4.  \n3.3.3.3.5. On occasion, reliable data may show that the effects  of serious eye \ndamage/eye irritation of an ingredient will not be evident when  \npresent at a level at or above the generic concentration limits  \nmentioned in Tables 3.3.3 and 3.3.4 in Section 3.3.3.3.6. In th ese \ncases the mixture shall be classified according to those data ( see \nalso Articles 10 and 11). On other occasions, when it is expect ed \nthat the skin corrosion/irritation hazards or the effects of se rious eye \ndamage/eye irritation of an ingredient will not be evident when  \npresent at a level at or above the generic concentration limits  \nmentioned in Tables 3.3.3 and 3.3.4, testing of the mixture sha ll \nbe considered. In those cases, the tiered weight of evidence \napproach shall be applied.  \n3.3.3.3.6. If there are data showing that (an) ingredient(s) ma y be corrosive to \nthe skin or seriously damaging to the eye/eye irritating at a c oncen\xad\ntration of < 1 % (corrosive to the skin or seriously damaging t o the \neye) or < 3 % (eye irritant), the mixture shall be classified a ccord\xad\ningly.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 136}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 138  \nTable 3.3.3  \nGeneric concentration limits of ingredients classified as skin \ncorrosion (Category 1, 1A, 1B or 1C) and/or serious eye \ndamage (Category 1) or eye irritation (Category 2) that \ntrigger classification of the mixture as serious eye damage/eye \nirritation where the additivity approach applies  \nSum of ingredients clas\xad\nsified as:  Concentration triggering classification of a \nmixture as:  \nSerious eye damage  Eye irritation  \nCategory 1  Category 2  \nSkin corrosion Sub- \nCategory 1A, 1B, 1C \nor Category 1 + \nSerious eye damage \n(Category 1) (  a ) ≥ 3 %  ≥ 1 % but < 3 %  \nEye irritation \n(Category 2)  ≥ 10 %  \n10 × (Skin corrosion \nSub-Category 1A, 1B, \n1C or Skin corrosion \nCategory 1 + Serious \neye damage \n(Category 1)) + Eye \nirritation (Category 2)  ≥ 10 %  \n( a ) If an ingredient is classified as both Skin Corrosion Sub-Cat egory 1A, \n1B, 1C or Category 1 and Serious Eye Damage (Category 1), its c oncen\xad \ntration is considered only once in the calculation.  \nTable 3.3.4  \nGeneric concentration limits of ingredients that trigger classifi \xad\ncation of the mixture as serious eye damage (Category 1) or eye \nirritation (Category 2), where the additivity approach does not \napply  \nIngredient  Concentration  Mixture classified as:  \nAcid with pH ≤ 2  ≥  1  %  Serious eye damage \n(Category 1)  \nBase with pH ≥ 11,5  ≥  1  %  Serious eye damage \n(Category 1)  \nOther ingredient clas\xad\nsified as skin \ncorrosion (Sub- \nCategory 1A, 1B, 1C \nor Category 1) or \nserious eye damage \n(Category 1)  ≥ 1 %  Serious eye damage \n(Category 1)  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 137}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 139  \nIngredient  Concentration  Mixture classified as:  \nOther ingredient clas\xad\nsified as eye irritation \n(Category 2)  ≥ 3 %  Eye irritation (Category 2)  \n3.3.4.  Hazard Communication  \n3.3.4.1. Label elements shall be used for substances or mixture s meeting the \ncriteria for classification in this hazard class in accordance with \nTable 3.3.5.  \nTable 3.3.5  \nLabel elements for serious eye damage/eye irritation  ( a ) \nClassification  Category 1  Category 2  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  \nHazard Statement  H318: Causes \nserious eye damage  H319: Causes \nserious eye irritation  \nPrecautionary \nStatement \nPrevention  P280  P264 \nP280  \nPrecautionary \nStatement Response  P305 + P351 + P338 \nP310  P305 + P351 + P338 \nP337 + P313  \nPrecautionary \nStatement Storage  \nPrecautionary \nStatement Disposal  \n( a ) Where a chemical is classified as skin corrosion Sub-Category  1A, 1B, \n1C or Category 1, labelling for serious eye damage/eye irritati on can be \nomitted as this information is already included in the hazard s tatement for \nskin corrosion Category 1 (H314).  \n▼B \n3.4. Respiratory or skin sensitisation  \n3.4.1.  Definitions and general considerations  \n▼M19  \n3.4.1.1. Respiratory sensitisation means hypersensitivity of th e airways \noccurring after inhalation of a substance or a mixture.  \n3.4.1.2. Skin sensitisation means an allergic response occurrin g after skin \ncontact with a substance or a mixture.  \n▼B \n3.4.1.3. For the purpose of section 3.4, sensitisation includes  two phases: \nthe first phase is induction of specialised immunological memor y in \nan individual by exposure to an allergen. The second phase is \nelicitation, i.e. production of a cell-mediated or antibody-med iated \nallergic response by exposure of a sensitised individual to an \nallergen.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 138}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 140  \n3.4.1.4. For respiratory sensitisation, the pattern of inductio n followed by \nelicitation phases is shared in common with skin sensitisation.  For \nskin sensitisation, an induction phase is required in which the  \nimmune system learns to react; clinical symptoms can then arise  \nwhen subsequent exposure is sufficient to elicit a visible skin  \nreaction (elicitation phase). As a consequence, predictive test s \nusually follow this pattern in which there is an induction phas e, \nthe response to which is measured by a standardised elicitation  \nphase, typically involving a patch test. The local lymph node \nassay is the exception, directly measuring the induction respon se. \nEvidence of skin sensitisation in humans normally is assessed b y a \ndiagnostic patch test.  \n3.4.1.5. Usually, for both skin and respiratory sensitisation, lower levels are \nnecessary for elicitation than are required for induction. Prov isions \nfor alerting sensitised individuals to the presence of a partic ular \nsensitiser in a mixture can be found  ►M2 in Annex II, section \n2.8. ◄.  \n3.4.1.6. The hazard class Respiratory or Skin Sensitisation is differentiated \ninto: \n— Respiratory Sensitisation  ►M2 and ◄;  \n— Skin Sensitisation.  \n▼M2 \n3.4.2.  Classification criteria for substances  \n3.4.2.1.  Respiratory sensitisers  \n3.4.2.1.1. H a z a r d c a t e g o r i e s  \n3.4.2.1.1.1. Respiratory sensitisers shall be classified in Cat egory 1 where data \nare not sufficient for sub-categorisation.  \n3.4.2.1.1.2. Where data are sufficient a refined evaluation acc ording to \n3.4.2.1.1.3 shall allow the allocation of respiratory sensitise rs into \nsub-category 1A, strong sensitisers, or sub-category 1B for oth er \nrespiratory sensitisers.  \n3.4.2.1.1.3. Effects seen in either humans or animals will norm ally justify clas\xad\nsification in a weight of evidence approach for respiratory sen si\xad\ntisers. Substances may be allocated to one of the two sub-categ ories \n1A or 1B using a weight of evidence approach in accordance with  \nthe criteria given in Table 3.4.1 and on the basis of reliable and \ngood quality evidence from human cases or epidemiological studi es \nand/or observations from appropriate studies in experimental \nanimals.  \n3.4.2.1.1.4. Substances shall be classified as respiratory sens itisers in \naccordance with the criteria in Table 3.4.1:  \nTable 3.4.1  \nHazard category and sub-categories for respiratory sensitisers  \nCategory  Criteria  \nCategory 1  Substances shall be classified as respiratory sensi\xad\ntisers (Category 1) where data are not sufficient for \nsub-categorisation in accordance with the following \ncriteria:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 139}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 141  \nCategory  Criteria  \n(a) if there is evidence in humans that the substance \ncan lead to specific respiratory hypersensitivity; \nand/or \n(b) if there are positive results from an appropriate \nanimal test.  \nSub- \ncategory 1A:  Substances showing a high frequency of occurrence \nin humans; or a probability of occurrence of a high \nsensitisation rate in humans based on animal or other \ntests (  1 ). Severity of reaction may also be considered.  \nSub- \ncategory 1B:  Substances showing a low to moderate frequency of \noccurrence in humans; or a probability of occurrence \nof a low to moderate sensitisation rate in humans \nbased on animal or other tests (  1 ). Severity of \nreaction may also be considered.  \n( 1 ) At present, recognised and validated animal models for the te sting of \nrespiratory hypersensitivity are not available. Under certain c ircum\xad \nstances, data from animal studies may provide valuable informat ion in \na weight of evidence assessment.  \n3.4.2.1.2. H u m a n e v i d e n c e  \n3.4.2.1.2.1. Evidence that a substance can lead to specific res piratory hyper\xad\nsensitivity will normally be based on human experience. In this  \ncontext, hypersensitivity is normally seen as asthma, but other  \nhypersensitivity reactions such as rhinitis/conjunctivitis and \nalveolitis are also considered. The condition will have the cli nical \ncharacter of an allergic reaction. However, immunological mech\xad\nanisms do not have to be demonstrated.  \n3.4.2.1.2.2. When considering the human evidence, it is necessa ry for a \ndecision on classification to take into account, in addition to  the \nevidence from the cases:  \n(a) the size of the population exposed;  \n(b) the extent of exposure.  \nThe use of human data is discussed in sections 1.1.1.3, 1.1.1.4  and \n1.1.1.5.  \n3.4.2.1.2.3. The evidence referred to above could be:  \n(a) clinical history and data from appropriate lung function te sts \nrelated to exposure to the substance, confirmed by other \nsupportive evidence which may include:  \n(i) in vivo immunological test (e.g. skin prick test);  \n(ii) in vitro immunological test (e.g. serological analysis);  \n(iii) studies that indicate other specific hypersensitivity \nreactions where immunological mechanisms of action \nhave not been proven, e.g. repeated low-level irritation, \npharmacologically mediated effects;  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 140}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 142  \n(iv) a chemical structure related to substances known to cause \nrespiratory hypersensitivity;  \n(b) data from one or more positive bronchial challenge tests wi th \nthe substance conducted according to accepted guidelines for \nthe determination of a specific hypersensitivity reaction.  \n3.4.2.1.2.4. Clinical history shall include both medical and oc cupational history \nto determine a relationship between exposure to a specific \nsubstance and development of respiratory hypersensitivity. \nRelevant information includes aggravating factors both in the \nhome and workplace, the onset and progress of the disease, \nfamily history and medical history of the patient in question. The \nmedical history shall also include a note of other allergic or airway \ndisorders from childhood, and smoking history.  \n3.4.2.1.2.5. The results of positive bronchial challenge tests are considered to \nprovide sufficient evidence for classification on their own. It  is \nhowever recognised that in practice many of the examinations \nlisted above will already have been carried out.  \n3.4.2.1.3. A n i m a l s t u d i e s  \n▼M19  \n3.4.2.1.3.1. Data from appropriate animal studies (  1 ) which may be indicative of \nthe potential of a substance to cause sensitisation by inhalati on in \nhumans (  2 ) may include:  \n(a) measurements of Immunoglobulin E (IgE) and other specific \nimmunological parameters, for example in mice;  \n(b) specific pulmonary responses in guinea pigs.  \n▼M2 \n3.4.2.2.  Skin sensitisers  \n3.4.2.2.1. H a z a r d c a t e g o r i e s  \n3.4.2.2.1.1. Skin sensitisers shall be classified in Category 1  where data are not \nsufficient for sub-categorisation.  \n3.4.2.2.1.2. Where data are sufficient a refined evaluation acc ording to section \n3.4.2.2.1.3 allows the allocation of skin sensitisers into sub-  \ncategory 1A, strong sensitisers, or sub-category 1B for other s kin \nsensitisers.  \n3.4.2.2.1.3. Effects seen in either humans or animals will norm ally justify clas\xad\nsification in a weight of evidence approach for skin sensitiser s as \ndescribed in section 3.4.2.2.2. Substances may be allocated to one \nof the two sub-categories 1A or 1B using a weight of evidence \napproach in accordance with the criteria given in Table 3.4.2 a nd \non the basis of reliable and good quality evidence from human \ncases or epidemiological studies and/or observations from appro \xad\npriate studies in experimental animals according to the guidanc e \nvalues provided in sections 3.4.2.2.2.1 and 3.4.2.2.3.2 for sub - \ncategory 1A and in sections 3.4.2.2.2.2 and 3.4.2.2.3.3 for sub - \ncategory 1B.  \n3.4.2.2.1.4. Substances shall be classified as skin sensitisers  in accordance with \nthe criteria in Table 3.4.2:  ▼M2 \n( 1 ) At present, recognised and validated animal models for the testing of respiratory hyper \xad\nsensitivity are not available. Under certain circumstances, data from animal studies may \nprovide valuable information in a weight of evidence assessment.  \n( 2 ) The mechanisms by which substances induce symptoms of asthma are not yet fully \nknown. For preventative measures, these substances are considered respiratory sensi \xad\ntisers. However, if on the basis of the evidence, it can be demonstrated that these \nsubstances induce symptoms of asthma by irritation only in people with bronchial \nhyper-reactivity, they shall not be considered as respiratory sensitisers .', metadata={'source': 'data/ycla_en.pdf', 'page': 141}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 143  \nTable 3.4.2  \nHazard category and sub-categories for skin sensitisers  \nCategory  Criteria  \nCategory 1  Substances shall be classified as skin sensitisers \n(Category 1) where data are not sufficient for sub- \ncategorisation in accordance with the following crite\xad\nria: \n(a) if there is evidence in humans that the substance \ncan lead to sensitisation by skin contact in a \nsubstantial number of persons; or \n(b) if there are positive results from an appropriate \nanimal test (see specific criteria in section \n3.4.2.2.4.1).  \nSub- \ncategory 1A:  Substances showing a high frequency of occurrence \nin humans and/or a high potency in animals can be \npresumed to have the potential to produce significant \nsensitisation in humans. Severity of reaction may \nalso be considered.  \nSub- \ncategory 1B:  Substances showing a low to moderate frequency of \noccurrence in humans and/or a low to moderate \npotency in animals can be presumed to have the \npotential to produce sensitisation in humans. \nSeverity of reaction may also be considered.  \n3.4.2.2.2. H u m a n e v i d e n c e  \n3.4.2.2.2.1. Human evidence for sub-category 1A can include:  \n(a) positive responses at ≤ 500 μg/cm  2 (HRIPT, HMT — induction \nthreshold);  \n(b) diagnostic patch test data where there is a relatively high  and \nsubstantial incidence of reactions in a defined population in \nrelation to relatively low exposure;  \n(c) other epidemiological evidence where there is a relatively high \nand substantial incidence of allergic contact dermatitis in \nrelation to relatively low exposure.  \n3.4.2.2.2.2. Human evidence for sub-category 1B can include:  \n(a) positive responses at > 500 μg/cm2 (HRIPT, HMT — induction \nthreshold);  \n(b) diagnostic patch test data where there is a relatively low but \nsubstantial incidence of reactions in a defined population in \nrelation to relatively high exposure;  \n(c) other epidemiological evidence where there is a relatively low \nbut substantial incidence of allergic contact dermatitis in \nrelation to relatively high exposure.  \nThe use of human data is discussed in sections 1.1.1.3, 1.1.1.4  and \n1.1.1.5.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 142}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 144  \n3.4.2.2.3. A n i m a l s t u d i e s  \n3.4.2.2.3.1. For Category 1, when an adjuvant type test method for skin sensiti\xad\nsation is used, a response of at least 30 % of the animals is \nconsidered as positive. For a non-adjuvant Guinea pig test \nmethod a response of at least 15 % of the animals is considered  \npositive. For Category 1, a stimulation index of three or more is \nconsidered a positive response in the local lymph node assay. T est \nmethods for skin sensitisation are described in the OECD Guidel ine \n406 (the Guinea Pig Maximisation test and the Buehler guinea pi g \ntest) and Guideline 429 (Local Lymph Node Assay). Other methods  \nmay be used provided that they are well-validated and scientifi c \njustification is given. For example, the mouse ear swelling tes t \n(MEST) could be a reliable screening test to detect moderate to  \nstrong sensitisers, and could be used as a first stage in the \nassessment of skin sensitisation potential.  \n3.4.2.2.3.2. Animal test results for sub-category 1A can includ e data with \nvalues indicated in Table 3.4.3  \nTable 3.4.3  \nAnimal test results for sub-category 1A  \nAssay  Criteria  \nLocal lymph node assay  EC3 value ≤ 2 %  \nGuinea pig maximisation test  ≥ 30 % responding at ≤ 0,1 % intradermal induction \ndose or \n≥ 60 % responding at > 0,1 % to ≤ 1 % intradermal \ninduction dose  \nBuehler assay  ≥ 15 % responding at ≤ 0,2 % topical induction \ndose or \n≥ 60 % responding at > 0,2 % to ≤ 20 % topical \ninduction dose  \n3.4.2.2.3.3. Animal test results for sub-category 1B can includ e data with \nvalues indicated in Table 3.4.4 below:  \nTable 3.4.4  \nAnimal test results for sub-category 1B  \nAssay  Criteria  \nLocal lymph node assay  EC3 value > 2 %  \nGuinea pig maximisation test  ≥ 30 % to < 60 % responding at > 0,1 % to ≤ 1 % \nintradermal induction dose or \n≥ 30 % responding at > 1 % intradermal induction \ndose \nBuehler assay  ≥ 15 % to < 60 % responding at > 0,2 % to ≤ 20 % \ntopical induction dose or \n≥ 15 % responding at > 20 % topical induction dose  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 143}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 145  \n3.4.2.2.4. S p e c i f i c c o n s i d e r a t i o n s  \n3.4.2.2.4.1. For classification of a substance, evidence should  include any or all \nof the following using a weight of evidence approach:  \n(a) positive data from patch testing, normally obtained in more  \nthan one dermatology clinic;  \n(b) epidemiological studies showing allergic contact dermatitis  \ncaused by the substance. Situations in which a high proportion \nof those exposed exhibit characteristic symptoms are to be \nlooked at with special concern, even if the number of cases \nis small;  \n(c) positive data from appropriate animal studies;  \n(d) positive data from experimental studies in man (see section  \n1.3.2.4.7);  \n(e) well documented episodes of allergic contact dermatitis, \nnormally obtained in more than one dermatology clinic;  \n(f) severity of reaction may also be considered.  \n3.4.2.2.4.2. Evidence from animal studies is usually much more reliable than \nevidence from human exposure. However, in cases where evidence \nis available from both sources, and there is conflict between t he \nresults, the quality and reliability of the evidence from both sources \nmust be assessed in order to resolve the question of classifica tion \non a case-by-case basis. Normally, human data are not generated  in \ncontrolled experiments with volunteers for the purpose of hazar d \nclassification but rather as part of risk assessment to confirm  lack of \neffects seen in animal tests. Consequently, positive human data  on \nskin sensitisation are usually derived from case-control or oth er, \nless defined studies. Evaluation of human data must therefore b e \ncarried out with caution as the frequency of cases reflect, in \naddition to the inherent properties of the substances, factors such \nas the exposure situation, bioavailability, individual predispo sition \nand preventive measures taken. Negative human data should not \nnormally be used to negate positive results from animal studies . For \nboth animal and human data, consideration should be given to th e \nimpact of vehicle.  \n3.4.2.2.4.3. If none of the abovementioned conditions are met, the substance \nneed not be classified as a skin sensitiser. However, a combina tion \nof two or more indicators of skin sensitisation as listed below  may \nalter the decision. This shall be considered on a case-by-case basis.  \n(a) Isolated episodes of allergic contact dermatitis;  \n(b) epidemiological studies of limited power, e.g. where chance , \nbias or confounders have not been ruled out fully with \nreasonable confidence;  \n(c) data from animal tests, performed according to existing gui de\xad\nlines, which do not meet the criteria for a positive result \ndescribed in section 3.4.2.2.3, but which are sufficiently clos e \nto the limit to be considered significant;  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 144}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 146  \n(d) positive data from non-standard methods;  \n(e) positive results from close structural analogues.  \n3.4.2.2.4.4. I m m u n o l o g i c a l c o n t a c t u r t i c a r i a  \nSubstances meeting the criteria for classification as respirato ry \nsensitisers may in addition cause immunological contact urticar ia. \nConsideration should be given to classifying these substances a lso \nas skin sensitisers. Substances which cause immunological conta ct \nurticaria without meeting the criteria for respiratory sensitis ers \nshould also be considered for classification as skin sensitiser s. \nThere is no recognised animal model available to identify \nsubstances which cause immunological contact urticaria. Therefo re, \nclassification will normally be based on human evidence which w ill \nbe similar to that for skin sensitisation.  \n▼B \n3.4.3.  Classification criteria for mixtures  \n3.4.3.1.  Classification of mixtures when data are available for the complete \nmixture  \n3.4.3.1.1. When reliable and good quality evidence from human e xperience or \nappropriate studies in experimental animals, as described in th e \ncriteria for substances, is available for the mixture, then the  \nmixture can be classified by weight of evidence evaluation of \nthese data. Care shall be exercised in evaluating data on \nmixtures, that the dose used does not render the results incon\xad\nclusive.  \n3.4.3.2.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.4.3.2.1. Where the mixture itself has not been tested to dete rmine its sensi\xad\ntising properties, but there are sufficient data on the individ ual \ningredients and similar tested mixtures to adequately character ise \nthe hazards of the mixture, these data shall be used in accorda nce \nwith the bridging rules set out in section 1.1.3.  \n3.4.3.3.  Classification of mixtures when data are available for all \ningredients or only for some ingredients of the mixture  \n3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser \nwhen at least one ingredient has been classified as a respirato ry or \nskin sensitiser and is present at or above the appropriate gene ric \nconcentration limit as shown in  ►M2 Table 3.4.5 ◄ for solid/ \nliquid and gas respectively.  \n3.4.3.3.2. Some substances that are classified as sensitisers m ay elicit a \nresponse, when present in a mixture in quantities below the con cen\xad\ntrations established in  ►M2 Table 3.4.5 ◄, in individuals who are \nalready sensitised to the substance or mixture (see Note 1 to  \n►M2 Table 3.4.6 ◄).  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 145}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 147  \nTable 3.4.5  \nGeneric concentration limits of components of a mixture classified as either \nrespiratory sensitisers or skin sensitisers that trigger classification of the mixture  \nComponent classified \nas: Generic concentration limits triggering classification of a mix ture as:  \nRespiratory sensitiser \nCategory 1  Skin sensitiser \nCategory 1  \nSolid/liquid  Gas  All physical states  \nRespiratory \nsensitiser \nCategory 1  ≥ 1,0 %  ≥ 0,2 %  \nRespiratory \nsensitiser \nSub-category 1A  ≥ 0,1 %  ≥ 0,1 %  \nRespiratory \nsensitiser \nSub-category 1B  ≥ 1,0 %  ≥ 0,2 %  \nSkin sensitiser \nCategory 1  ≥ 1,0 %  \nSkin sensitiser \nSub-category 1A  ≥ 0,1 %  \nSkin sensitiser \nSub-category 1B  ≥ 1,0 %  \nTable 3.4.6  \nConcentration limits for elicitation of components of a mixture  \nComponent classified \nas: Concentration limits for elicitation  \nRespiratory sensitiser \nCategory 1  Skin sensitiser \nCategory 1  \nSolid/liquid  Gas  All physical states  \nRespiratory \nsensitiser \nCategory 1  ≥ 0,1 % (Note 1)  ≥ 0,1 % (Note 1)  \nRespiratory \nsensitiser \nSub-category 1A  ≥ 0,01 % (Note 1)  ≥ 0,01 % (Note 1)  \nRespiratory \nsensitiser \nSub-category 1B  ≥ 0,1 % (Note 1)  ≥ 0,1 % (Note 1)  \nSkin sensitiser \nCategory 1  ≥ 0,1 % (Note 1)  \nSkin sensitiser \nSub-category 1A  ≥ 0,01 % (Note 1)  \nSkin sensitiser \nSub-category 1B  ≥ 0,1 % (Note 1)  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 146}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 148  \nNote 1:  \nThis concentration limit for elicitation is used for the applic ation of \nthe special labelling requirements of section 2.8 of Annex II t o \nprotect already sensitised individuals. A SDS is required for t he \nmixture containing a component at or above this concentration. \nFor sensitising substances with a specific concentration limit,  the \nconcentration limit for elicitation shall be set at a tenth of the \nspecific concentration limit.  \n▼B \n3.4.4.  Hazard communication  \n▼M2 \n3.4.4.1. Label elements shall be used for substances or mixture s meeting the \ncriteria for classification in this hazard class in accordance with \nTable 3.4.7.  \n▼M4 \nTable 3.4.7  \nRespiratory or skin sensitisation label elements  \nClassification  Respiratory sensitisation  Skin sensitisation  \nCategory 1 and subcategories 1A and \n1B Category 1 and subcat\xad\negories 1A and 1B  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  \nHazard Statement  H334: May cause allergy or \nasthma symptoms or breathing \ndifficulties if inhaled  H317: May cause an \nallergic skin reaction  \nPrecautionary \nStatement Prevention  P261 \nP284  P261 \nP272 \nP280  \nPrecautionary \nStatement Response  P304 + P340 \nP342 + P311  P302 + P352 \nP333 + P313 \nP321 \nP362 + P364  \nPrecautionary \nStatement Storage  \nPrecautionary \nStatement Disposal  P501  P501  \n▼B \n3.5. Germ cell mutagenicity  \n3.5.1.  Definitions and general considerations  \n▼M19  \n3.5.1.1. Germ cell mutagenicity means heritable gene mutations,  including \nheritable structural and numerical chromosome aberrations in ge rm \ncells occurring after exposure to a substance or mixture.  \n3.5.1.2. A mutation means a permanent change in the amount or s tructure \nof the genetic material in a cell. The term ‘mutation’ applies both to \nheritable genetic changes that may be manifested at the phenoty pic \nlevel and to the underlying DNA modifications when known \n(including specific base pair changes and chromosomal trans\xad\nlocations). The term ‘mutagenic’ and ‘mutagen’ will be used for  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 147}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 149  \nagents giving rise to an increased occurrence of mutations in p opu\xad\nlations of cells and/or organisms.  \n3.5.1.3. The more general terms ‘genotoxic’ and ‘genotoxicity’ apply to \nagents or processes which alter the structure, information cont ent, \nor segregation of DNA, including those which cause DNA damage \nby interfering with normal replication processes, or which in a  non- \nphysiological manner (temporarily) alter its replication. Genot \xad\noxicity test results are usually taken as indicators for mutage nic \neffects.  \n▼B \n3.5.2.  Classification criteria for substances  \n3.5.2.1. This hazard class is primarily concerned with substanc es that may \ncause mutations in the germ cells of humans that can be transmi tted \nto the progeny. However, the results from mutagenicity or genot \xad\noxicity tests in vitro and in mammalian somatic and germ cells in \nvivo are also considered in classifying substances and mixtures  \nwithin this hazard class.  \n3.5.2.2. For the purpose of classification for germ cell mutage nicity, \nsubstances are allocated to one of two categories as shown in \nTable 3.5.1.  \nTable 3.5.1  \nHazard categories for germ cell mutagens  \nCategories  Criteria  \nCATEGORY 1:  Substances known to induce heritable mutations or to be regard ed as if they induce \nheritable mutations in the germ cells of humans. \nSubstances known to induce heritable mutations in the germ cell s of humans.  \nCategory 1A:  The classification in Category 1A is based on positive evidenc e from human \nepidemiological studies. \nSubstances to be regarded as if they induce heritable mutations  in the germ cells of \nhumans.  \nCategory 1B:  The classification in Category 1B is based on: \n— positive result(s) from in vivo heritable germ cell mutagenic ity tests in \nmammals; or \n— positive result(s) from in vivo somatic cell mutagenicity tes ts in mammals, in \ncombination with some evidence that the substance has potential  to cause \nmutations to germ cells. It is possible to derive this supporti ng evidence from \nmutagenicity/genotoxicity tests in germ cells in vivo, or by de monstrating the \nability of the substance or its metabolite(s) to interact with the genetic material \nof germ cells; or \n— positive results from tests showing mutagenic effects in the germ cells of \nhumans, without demonstration of transmission to progeny; for e xample, an \nincrease in the frequency of aneuploidy in sperm cells of expos ed people.  \nCATEGORY 2:  Substances which cause concern for humans owing to the possibi lity that they may \ninduce heritable mutations in the germ cells of humans \nThe classification in Category 2 is based on: \n— positive evidence obtained from experiments in mammals and/or  in some cases \nfrom in vitro experiments, obtained from: \n— somatic cell mutagenicity tests in vivo, in mammals; or \n— other in vivo somatic cell genotoxicity tests which are suppo rted by positive \nresults from in vitro mutagenicity assays. \nNote: Substances which are positive in in vitro mammalian mutag enicity assays, and \nwhich also show chemical structure activity relationship to kno wn germ cell \nmutagens, shall be considered for classification as Category 2 mutagens.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 148}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 150  \n3.5.2.3.  Specific considerations for classification of substances as germ cell \nmutagens  \n3.5.2.3.1. To arrive at a classification, test results are cons idered from \nexperiments determining mutagenic and/or genotoxic effects in \ngerm and/or somatic cells of exposed animals. Mutagenic and/or \ngenotoxic effects determined in in vitro tests shall also be \nconsidered.  \n3.5.2.3.2. The system is hazard based, classifying substances o n the basis of \ntheir intrinsic ability to induce mutations in germ cells. The scheme \nis, therefore, not meant for the (quantitative) risk assessment  of \nsubstances.  \n3.5.2.3.3. Classification for heritable effects in human germ c ells is made on \nthe basis of well conducted, sufficiently validated tests, pref erably \nas described in Regulation (EC) No 440/2008 adopted in \naccordance with Article 13(3) of Regulation (EC) No 1907/2006 \n(‘Test Method Regulation’) such as those listed in the followin g \nparagraphs. Evaluation of the test results shall be done using expert \njudgement and all the available evidence shall be weighed in \narriving at a classification.  \n3.5.2.3.4. In vivo heritable germ cell mutagenicity tests, such  as: \n— rodent dominant lethal mutation test;  \n— mouse heritable translocation assay.  \n▼M19  \n3.5.2.3.5. In vivo somatic cell mutagenicity tests, such as:  \n— mammalian bone marrow chromosome aberration test;  \n— mammalian erythrocyte micronucleus test  \n▼B \n3.5.2.3.6. Mutagenicity/genotoxicity tests in germ cells, such as: \n(a) mutagenicity tests:  \n— mammalian spermatogonial chromosome aberration test;  \n— spermatid micronucleus assay;  \n(b) Genotoxicity tests:  \n— sister chromatid exchange analysis in spermatogonia;  \n— unscheduled DNA synthesis test (UDS) in testicular cells.  \n3.5.2.3.7. Genotoxicity tests in somatic cells such as:  \n— liver Unscheduled synthesis test (UDS) in vivo;  \n— mammalian bone marrow Sister Chromatid Exchanges (SCE);  \n3.5.2.3.8. In vitro mutagenicity tests such as:  \n— in vitro mammalian chromosome aberration test;  \n— in vitro mammalian cell gene mutation test;  \n— bacterial reverse mutation tests.  \n3.5.2.3.9. The classification of individual substances shall be  based on the \ntotal weight of evidence available, using expert judgement (See  \n1.1.1). In those instances where a single well-conducted test i s \nused for classification, it shall provide clear and unambiguous ly \npositive results. If new, well validated, tests arise these may  also \nbe used in the total weight of evidence to be considered. The \nrelevance of the route of exposure used in the study of the \nsubstance compared to the route of human exposure shall also be  \ntaken into account.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 149}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 151  \n3.5.3.  Classification criteria for mixtures  \n3.5.3.1.  Classification of mixtures when data are available for all \ningredients or only for some ingredients of the mixture  \n3.5.3.1.1. The mixture shall be classified as a mutagen when at  least one \ningredient has been classified as a Category 1A, Category 1B or  \nCategory 2 mutagen and is present at or above the appropriate \ngeneric concentration limit as shown in Table 3.5.2 for Categor y \n1A, Category 1B and Category 2 respectively.  \n▼M4 \nTable 3.5.2  \nGeneric concentration limits of ingredients of a mixture clas \xad\nsified as germ cell mutagens that trigger classification of the \nmixture  \nIngredient classified \nas: Concentration limits triggering classification of a \nmixture as:  \nCategory 1 mutagen  Category 2 \nmutagen  Category 1A  Category 1B  \nCategory 1A \nmutagen  ≥ 0,1 %  —  —  \nCategory 1B \nmutagen  — ≥ 0,1 %  —  \nCategory 2 mutagen  —  —  ≥ 1,0 %  \n▼B \nNote  \nThe concentration limits in the table above apply to solids and  \nliquids (w/w units) as well as gases (v/v units).  \n3.5.3.2.  Classification of mixtures when data are available for the complete \nmixture  \n3.5.3.2.1. Classification of mixtures will be based on the avai lable test data \nfor the individual ingredients of the mixture using concentrati on \nlimits for the ingredients classified as germ cell mutagens. On  a  \ncase-by-case basis, test data on mixtures may be used for class ifi\xad\ncation when demonstrating effects that have not been establishe d \nfrom the evaluation based on the individual ingredients. In suc h \ncases, the test results for the mixture as a whole must be show n to \nbe conclusive taking into account dose and other factors such a s \nduration, observations, sensitivity and statistical analysis of  germ \ncell mutagenicity test systems. Adequate documentation supporti ng \nthe classification shall be retained and made available for rev iew \nupon request.  \n3.5.3.3.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.5.3.3.1. Where the mixture itself has not been tested to dete rmine its germ \ncell mutagenicity hazard, but there are sufficient data on the indi\xad\nvidual ingredients and similar tested mixtures (subject to para graph \n3.5.3.2.1), to adequately characterise the hazards of the mixtu re, \nthese data shall be used in accordance with the applicable \nbridging rules set out in section 1.1.3.  \n3.5.4.  Hazard communication  \n3.5.4.1. Label elements shall be used in accordance with Table 3.5.3, for \nsubstances or mixtures meeting the criteria for classification in this \nhazard class.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 150}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 152  \nTable 3.5.3  \nLabel elements of germ cell mutagenicity  \nClassification  Category 1 \n(Category 1A, 1B)  Category 2  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  \nHazard Statement  H340: May cause \ngenetic defects (state \nroute of exposure if \nit is conclusively \nproven that no other \nroutes of exposure \ncause the hazard)  H341: Suspected of \ncausing genetic \ndefects (state route \nof exposure if it is \nconclusively proven \nthat no other routes \nof exposure cause \nthe hazard)  \nPrecautionary \nStatement \nPrevention  P201 \nP202 \nP280  P201 \nP202 \nP280  \nPrecautionary \nStatement Response  P308 + P313  P308 + P313  \nPrecautionary \nStatement Storage  P405  P405  \nPrecautionary \nStatement Disposal  P501  P501  \n▼B \n3.5.5.  Additional classification considerations  \nIt is increasingly accepted that the process of chemical-induce d \ntumorigenesis in humans and animals involves genetic changes \nfor example in proto-oncogenes and/or tumour suppresser genes \nof somatic cells. Therefore, the demonstration of mutagenic pro p\xad\nerties of substances in somatic and/or germ cells of mammals in  \nvivo may have implications for the potential classification of these \nsubstances as carcinogens (see also Carcinogenicity, section 3. 6, \nparagraph 3.6.2.2.6).  \n3.6. Carcinogenicity  \n3.6.1.  Definition  \n▼M19  \n3.6.1.1. Carcinogenicity means the induction of cancer or an in crease in the \nincidence of cancer occurring after exposure to a substance or \nmixture. Substances and mixtures which have induced benign and \nmalignant tumours in well performed experimental studies on \nanimals are considered also to be presumed or suspected human \ncarcinogens unless there is strong evidence that the mechanism of \ntumour formation is not relevant for humans.  \nClassification of a substance or mixture as posing a carcinogenic \nhazard is based on its intrinsic properties and does not provide \ninformation on the level of the human cancer risk which the use of \nthe substance or mixture may represent.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 151}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 153  \n3.6.2.  Classification criteria for substances  \n3.6.2.1. For the purpose of classification for carcinogenicity,  substances are \nallocated to one of two categories based on strength of evidenc e \nand additional considerations (weight of evidence). In certain \ninstances, route-specific classification may be warranted, if i t can \nbe conclusively proved that no other route of exposure exhibits  the \nhazard.  \nTable 3.6.1  \nHazard categories for carcinogens  \nCategories  Criteria  \nCATEGORY 1:  Known or presumed human carcinogens \nA substance is classified in Category 1 for \ncarcinogenicity on the basis of epidemiological \nand/or animal data. A substance may be further \ndistinguished as:  \nCategory 1A:  Category 1A, known to have carcinogenic \npotential for humans, classification is largely \nbased on human evidence, or  \nCategory 1B:  Category 1B, presumed to have carcinogenic \npotential for humans, classification is largely \nbased on animal evidence.  \nThe classification in Category 1A and 1B is \nbased on strength of evidence together with \nadditional considerations (see section 3.6.2.2). \nSuch evidence may be derived from: \n— human studies that establish a causal rela\xad\ntionship between human exposure to a \nsubstance and the development of cancer \n(known human carcinogen); or \n— animal experiments for which there is suffi\xad\ncient (  1 ) evidence to demonstrate animal \ncarcinogenicity (presumed human carci\xad\nnogen).  \nIn addition, on a case-by-case basis, scientific \njudgement may warrant a decision of presumed \nhuman carcinogenicity derived from studies \nshowing limited evidence of carcinogenicity in \nhumans together with limited evidence of carci\xad\nnogenicity in experimental animals.  \nCATEGORY 2:  Suspected human carcinogens \nThe placing of a substance in Category 2 is \ndone on the basis of evidence obtained from \nhuman and/or animal studies, but which is not \nsufficiently convincing to place the substance in \nCategory 1A or 1B, based on strength of \nevidence together with additional considerations \n(see section 3.6.2.2). Such evidence may be \nderived either from limited (  1 ) evidence of \ncarcinogenicity in human studies or from \nlimited evidence of carcinogenicity in animal \nstudies.  \n( 1 ) Note: See 3.6.2.2.4.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 152}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 154  \n3.6.2.2.  Specific considerations for classification of substances as carci \xad\nnogens  \n3.6.2.2.1. Classification as a carcinogen is made on the basis of evidence \nfrom reliable and acceptable studies and is intended to be used  \nfor substances which have an intrinsic property to cause cancer . \nThe evaluations shall be based on all existing data, peer-revie wed \npublished studies and additional acceptable data.  \n3.6.2.2.2. Classification of a substance as a carcinogen is a p rocess that \ninvolves two interrelated determinations: evaluations of streng th \nof evidence and consideration of all other relevant information  to \nplace substances with human cancer potential into hazard \ncategories.  \n3.6.2.2.3. Strength of evidence involves the enumeration of tum ours in human \nand animal studies and determination of their level of statisti cal \nsignificance. Sufficient human evidence demonstrates causality \nbetween human exposure and the development of cancer, whereas \nsufficient evidence in animals shows a causal relationship betw een \nthe substance and an increased incidence of tumours. Limited \nevidence in humans is demonstrated by a positive association \nbetween exposure and cancer, but a causal relationship cannot b e \nstated. Limited evidence in animals is provided when data sugge st a \ncarcinogenic effect, but are less than sufficient. The terms ‘s uffi\xad\ncient’ and ‘limited’ have been used here as they have been defi ned \nby the International Agency for Research on Cancer (IARC) and \nread as follows:  \n(a) Carcinogenicity in humans  \nThe evidence relevant to carcinogenicity from studies in \nhumans is classified into one of the following categories:  \n— sufficient evidence of carcinogenicity: a causal relationship  \nhas been established between exposure to the agent and \nhuman cancer. That is, a positive relationship has been \nobserved between the exposure and cancer in studies in \nwhich chance, bias and confounding could be ruled out \nwith reasonable confidence;  \n— limited evidence of carcinogenicity: a positive association \nhas been observed between exposure to the agent and \ncancer for which a causal interpretation is considered to \nbe credible, but chance, bias or confounding could not be \nruled out with reasonable confidence.  \n(b) Carcinogenicity in experimental animals  \nCarcinogenicity in experimental animals can be evaluated using \nconventional bioassays, bioassays that employ genetically \nmodified animals, and other in-vivo bioassays that focus on \none or more of the critical stages of carcinogenesis. In the \nabsence of data from conventional long-term bioassays or \nfrom assays with neoplasia as the end-point, consistently \npositive results in several models that address several stages \nin the multistage process of carcinogenesis should be \nconsidered in evaluating the degree of evidence of carcinoge\xad\nnicity in experimental animals. The evidence relevant to carci\xad\nnogenicity in experimental animals is classified into one of th e \nfollowing categories:  \n— sufficient evidence of carcinogenicity: a causal relationship  \nhas been established between the agent and an increased \nincidence of malignant neoplasms or of an appropriate \ncombination of benign and malignant neoplasms in (a) \ntwo or more species of animals or (b) two or more inde\xad\npendent studies in one species carried out at different times \nor in different laboratories or under different protocols. An \nincreased incidence of tumours in both sexes of a single  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 153}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 155  \nspecies in a well-conducted study, ideally conducted under \nGood Laboratory Practices, can also provide sufficient \nevidence. A single study in one species and sex might be \nconsidered to provide sufficient evidence of carcinogenicity \nwhen malignant neoplasms occur to an unusual degree with \nregard to incidence, site, type of tumour or age at onset, or \nwhen there are strong findings of tumours at multiple sites;  \n— limited evidence of carcinogenicity: the data suggest a \ncarcinogenic effect but are limited for making a definitive \nevaluation because, e.g. (a) the evidence of carcinogenicity \nis restricted to a single experiment; (b) there are unresolved \nquestions regarding the adequacy of the design, conduct or \ninterpretation of the studies; (c) the agent increases the \nincidence only of benign neoplasms or lesions of \nuncertain neoplastic potential; or (d) the evidence of carci\xad\nnogenicity is restricted to studies that demonstrate only \npromoting activity in a narrow range of tissues or organs.  \n3.6.2.2.4. Additional considerations (as part of the weight of evidence \napproach (see 1.1.1)). Beyond the determination of the strength  \nof evidence for carcinogenicity, a number of other factors need  to \nbe considered that influence the overall likelihood that a subs tance \nposes a carcinogenic hazard in humans. The full list of factors  that \ninfluence this determination would be very lengthy, but some of  the \nmore important ones are considered here.  \n3.6.2.2.5. The factors can be viewed as either increasing or de creasing the \nlevel of concern for human carcinogenicity. The relative emphas is \naccorded to each factor depends upon the amount and coherence o f \nevidence bearing on each. Generally there is a requirement for more \ncomplete information to decrease than to increase the level of \nconcern. Additional considerations should be used in evaluating  \nthe tumour findings and the other factors in a case-by-case man ner. \n3.6.2.2.6. Some important factors which may be taken into consi deration, \nwhen assessing the overall level of concern are:  \n(a) tumour type and background incidence;  \n(b) multi-site responses;  \n(c) progression of lesions to malignancy;  \n(d) reduced tumour latency;  \n(e) whether responses are in single or both sexes;  \n(f) whether responses are in a single species or several specie s; \n(g) structural similarity to a substance(s) for which there is good \nevidence of carcinogenicity;  \n(h) routes of exposure;  \n(i) comparison of absorption, distribution, metabolism and \nexcretion between test animals and humans;  \n(j) the possibility of a confounding effect of excessive toxici ty at \ntest doses;  \n(k) mode of action and its relevance for humans, such as cytot\xad\noxicity with growth stimulation, mitogenesis, immunosup\xad\npression, mutagenicity.  \nMutagenicity: it is recognised that genetic events are central in \nthe overall process of cancer development. Therefore evidence \nof mutagenic activity in vivo may indicate that a substance has  \na potential for carcinogenic effects.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 154}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 156  \n3.6.2.2.7. A substance that has not been tested for carcinogeni city may in \ncertain instances be classified in Category 1A, Category 1B or \nCategory 2 based on tumour data from a structural analogue \ntogether with substantial support from consideration of other \nimportant factors such as formation of common significant meta\xad\nbolites, e.g. for benzidine congener dyes.  \n3.6.2.2.8. The classification shall take into consideration whe ther or not the \nsubstance is absorbed by a given route(s); or whether there are  only \nlocal tumours at the site of administration for the tested rout e(s), \nand adequate testing by other major route(s) show lack of carci no\xad\ngenicity.  \n3.6.2.2.9. It is important that whatever is known of the physic o-chemical, \ntoxicokinetic and toxicodynamic properties of the substances, a s \nwell as any available relevant information on chemical analogue s, \ni.e. structure activity relationship, is taken into considerati on when \nundertaking classification.  \n3.6.3.  Classification criteria for mixtures  \n3.6.3.1.  Classification of mixtures when data are available for all \ningredients or only for some ingredients of the mixture  \n3.6.3.1.1. The mixture will be classified as a carcinogen when at least one \ningredient has been classified as a Category 1A, Category 1B or  \nCategory 2 carcinogen and is present at or above the appropriat e \ngeneric concentration limit as shown in Table 3.6.2 for Categor y \n1A, Category 1B and Category 2 respectively.  \n▼M4 \nTable 3.6.2  \nGeneric concentration limits of ingredients of a mixture clas \xad\nsified as carcinogen that trigger classification of the mixture  \nIngredient \nclassified as:  Generic concentration limits triggering classification of \na mixture as:  \nCategory 1 carcinogen  Category 2 carci\xad\nnogen  Category 1A  Category 1B  \nCategory 1A \ncarcinogen  ≥ 0,1 %  —  —  \nCategory 1B \ncarcinogen  — ≥ 0,1 %  —  \nCategory 2 carci\xad\nnogen  — —  ≥ 1,0 % [Note \n1] \n▼B \nNote  \nThe concentration limits in the table above apply to solids and  \nliquids (w/w units) as well as gases (v/v units).  \nNote 1  \nIf a Category 2 carcinogen is present in the mixture as an ingr edient \nat a concentration ≥ 0,1 % a SDS shall be available for the mix ture \nupon request.  \n3.6.3.2.  Classification of mixtures when data are available for the complete \nmixture  \n3.6.3.2.1. Classification of mixtures will be based on the avai lable test data \nfor the individual ingredients of the mixture using concentrati on \nlimits for the ingredients classified as carcinogens. On a case -by- \ncase basis, test data on mixtures may be used for classificatio n \nwhen demonstrating effects that have not been established from \nthe evaluation based on the individual ingredients. In such cas es, \nthe test results for the mixture as a whole must be shown to be  \nconclusive taking into account dose and other factors such as \nduration, observations, sensitivity and statistical analysis of  carci\xad\nnogenicity test systems. Adequate documentation supporting the \nclassification shall be retained and made available for review \nupon request.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 155}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 157  \n3.6.3.3.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.6.3.3.1. Where the mixture itself has not been tested to dete rmine its carci\xad\nnogenic hazard, but there are sufficient data on the individual  \ningredients and similar tested mixtures (subject to paragraph \n3.6.3.2.1) to adequately characterise the hazards of the mixtur e, \nthese data shall be used in accordance with the applicable \nbridging rules set out in section 1.1.3.  \n3.6.4.  Hazard Communication  \n3.6.4.1. Label elements shall be used in accordance with Table 3.6.3, for \nsubstances or mixtures meeting the criteria for classification in this \nhazard class.  \n▼M4 \nTable 3.6.3  \nLabel elements for carcinogenicity  \nClassification  Category 1 \n(Category 1A, 1B)  Category 2  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  \nHazard Statement  H350: May cause \ncancer (state route of \nexposure if it is \nconclusively proven \nthat no other routes \nof exposure cause \nthe hazard)  H351: Suspected of \ncausing cancer (state \nroute of exposure if \nit is conclusively \nproven that no other \nroutes of exposure \ncause the hazard)  \nPrecautionary \nStatement \nPrevention  P201 \nP202 \nP280  P201 \nP202 \nP280  \nPrecautionary \nStatement Response  P308 + P313  P308 + P313  \nPrecautionary \nStatement Storage  P405  P405  \nPrecautionary \nStatement Disposal  P501  P501  \n▼B \n3.7. Reproductive toxicity  \n3.7.1.  Definitions and general considerations  \n▼M19  \n3.7.1.1. Reproductive toxicity means adverse effects on sexual function and \nfertility in adult males and females, as well as developmental \ntoxicity in the offspring, occurring after exposure to a substa nce \nor mixture. The definitions presented below are adapted from th ose \nagreed as working definitions in IPCS/EHC Document No 225, \nPrinciples for Evaluating Health Risks to Reproduction Associat ed \nwith Exposure to Chemicals. For classification purposes, the kn own ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 156}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 158  \ninduction of genetically based inheritable effects in the offsp ring is \naddressed in Germ Cell Mutagenicity (Section 3.5), since in the  \npresent classification system it is considered more appropriate  to \naddress such effects under the separate hazard class of germ ce ll \nmutagenicity.  \nIn this classification system, reproductive toxicity is subdivi ded into \ntwo main headings:  \n(a) adverse effects on sexual function and fertility;  \n(b) adverse effects on development of the offspring.  \nSome reproductive toxic effects cannot be clearly assigned to e ither \nimpairment of sexual function and fertility or to developmental  \ntoxicity. Nonetheless, substances and mixtures with these effec ts \nshall be classified as reproductive toxicants with a general ha zard \nstatement.  \n▼B \n3.7.1.2. For the purpose of classification the hazard class Rep roductive \nToxicity is differentiated into:  \n— adverse effects  \n— on sexual function and fertility, or  \n— on development;  \n— effects on or via lactation.  \n3.7.1.3.  Adverse effects on sexual function and fertility  \nAny effect of substances that has the potential to interfere wi th \nsexual function and fertility. This includes, but is not limite d to, \nalterations to the female and male reproductive system, adverse  \neffects on onset of puberty, gamete production and transport, r epro\xad\nductive cycle normality, sexual behaviour, fertility, parturiti on, \npregnancy outcomes, premature reproductive senescence, or modi\xad\nfications in other functions that are dependent on the integrit y of \nthe reproductive systems.  \n3.7.1.4.  Adverse effects on development of the offspring  \nDevelopmental toxicity includes, in its widest sense, any effec t \nwhich interferes with normal development of the conceptus, eith er \nbefore or after birth, and resulting from exposure of either pa rent \nprior to conception, or exposure of the developing offspring du ring \nprenatal development, or postnatally, to the time of sexual mat u\xad\nration. However, it is considered that classification under the  \nheading of developmental toxicity is primarily intended to \nprovide a hazard warning for pregnant women, and for men and \nwomen of reproductive capacity. Therefore, for pragmatic purpos es \nof classification, developmental toxicity essentially means adv erse \neffects induced during pregnancy, or as a result of parental \nexposure. These effects can be manifested at any point in the l ife \nspan of the organism. The major manifestations of developmental  \ntoxicity include (1) death of the developing organism, (2) stru ctural \nabnormality, (3) altered growth, and (4) functional deficiency.  \n3.7.1.5. Adverse effects on or via lactation are also included in reproductive \ntoxicity, but for classification purposes, such effects are tre ated \nseparately (see Table 3.7.1 (b)). This is because it is desirab le to \nbe able to classify substances specifically for an adverse effe ct on \nlactation so that a specific hazard warning about this effect c an be \nprovided for lactating mothers.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 157}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 159  \n3.7.2.  Classification criteria for substances  \n3.7.2.1.  Hazard categories  \n3.7.2.1.1. For the purpose of classification for reproductive t oxicity, \nsubstances are allocated to one of two categories. Within each \ncategory, effects on sexual function and fertility, and on deve l\xad\nopment, are considered separately. In addition, effects on lact ation \nare allocated to a separate hazard category.  \nTable 3.7.1(a)  \nHazard categories for reproductive toxicants  \nCategories  Criteria  \nCATEGORY 1  Known or presumed human reproductive \ntoxicant \nSubstances are classified in Category 1 for \nreproductive toxicity when they are known to \nhave produced an adverse effect on sexual \nfunction and fertility, or on development in \nhumans or when there is evidence from \nanimal studies, possibly supplemented with \nother information, to provide a strong \npresumption that the substance has the \ncapacity to interfere with reproduction in \nhumans. The classification of a substance is \nfurther distinguished on the basis of whether \nthe evidence for classification is primarily \nfrom human data (Category 1A) or from \nanimal data (Category 1B).  \nCategory 1A  Known human reproductive toxicant \nThe classification of a substance in Category \n1A is largely based on evidence from humans.  \nCategory 1B  Presumed human reproductive toxicant \nThe classification of a substance in Category \n1B is largely based on data from animal \nstudies. Such data shall provide clear evidence \nof an adverse effect on sexual function and \nfertility or on development in the absence of \nother toxic effects, or if occurring together \nwith other toxic effects the adverse effect on \nreproduction is considered not to be a \nsecondary non-specific consequence of other \ntoxic effects. However, when there is mech\xad\nanistic information that raises doubt about the \nrelevance of the effect for humans, classifi\xad\ncation in Category 2 may be more appropriate.  \nCATEGORY 2  Suspected human reproductive toxicant \nSubstances are classified in Category 2 for \nreproductive toxicity when there is some \nevidence from humans or experimental \nanimals, possibly supplemented with other \ninformation, of an adverse effect on sexual \nfunction and fertility, or on development, and \nwhere the evidence is not sufficiently \nconvincing to place the substance in Category \n1. If deficiencies in the study make the quality \nof evidence less convincing, Category 2 could \nbe the more appropriate classification.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 158}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 160  \nCategories  Criteria  \nSuch effects shall have been observed in the \nabsence of other toxic effects, or if occurring \ntogether with other toxic effects the adverse \neffect on reproduction is considered not to be \na secondary non-specific consequence of the \nother toxic effects.  \nTable 3.7.1(b)  \nHazard category for lactation effects  \nEFFECTS ON OR VIA LACTATION  \nEffects on or via lactation are allocated to a separate single \ncategory. It is recognised that for many substances there is no  \ninformation on the potential to cause adverse effects on the \noffspring via lactation. However, substances which are absorbed  \nby women and have been shown to interfere with lactation, or \nwhich may be present (including metabolites) in breast milk in \namounts sufficient to cause concern for the health of a breastf ed \nchild, shall be classified and labelled to indicate this proper ty \nhazardous to breastfed babies. This classification can be assig ned \non the: \n(a) human evidence indicating a hazard to babies during the \nlactation period; and/or \n(b) results of one or two generation studies in animals which p rovide \nclear evidence of adverse effect in the offspring due to transf er in \nthe milk or adverse effect on the quality of the milk; and/or \n(c) absorption, metabolism, distribution and excretion studies that \nindicate the likelihood that the substance is present in potent ially \ntoxic levels in breast milk.  \n3.7.2.2.  Basis of classification  \n3.7.2.2.1. Classification is made on the basis of the appropria te criteria, \noutlined above, and an assessment of the total weight of eviden ce \n(see 1.1.1). Classification as a reproductive toxicant is inten ded to \nbe used for substances which have an intrinsic, specific proper ty to \nproduce an adverse effect on reproduction and substances shall not \nbe so classified if such an effect is produced solely as a non-  \nspecific secondary consequence of other toxic effects.  \nThe classification of a substance is derived from the hazard \ncategories in the following order of precedence: Category 1A, \nCategory 1B, Category 2 and the additional Category for effects  \non or via lactation. If a substance meets the criteria for clas sifi\xad\ncation into both of the main categories (for example Category 1 B \nfor effects on sexual function and fertility and also Category 2 for \ndevelopment) then both hazard differentiations shall be \ncommunicated by the respective hazard statements. Classificatio n \nin the additional category for effects on or via lactation will  be \nconsidered irrespective of a classification into Category 1A, \nCategory 1B or Category 2.  \n3.7.2.2.2. In the evaluation of toxic effects on the developing  offspring, it is \nimportant to consider the possible influence of maternal toxici ty \n(see section 3.7.2.4).  \n3.7.2.2.3. For human evidence to provide the primary basis for a Category 1A \nclassification there must be reliable evidence of an adverse ef fect on \nreproduction in humans. Evidence used for classification shall \nideally be from well conducted epidemiological studies which \ninclude the use of appropriate controls, balanced assessment, a nd ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 159}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 161  \ndue consideration of bias or confounding factors. Less rigorous  data \nfrom studies in humans shall be supplemented with adequate data  \nfrom studies in experimental animals and classification in Cate gory \n1B shall be considered.  \n3.7.2.3.  Weight of evidence  \n3.7.2.3.1. Classification as a reproductive toxicant is made on  the basis of an \nassessment of the total weight of evidence, see section 1.1.1. This \nmeans that all available information that bears on the determin ation \nof reproductive toxicity is considered together, such as epidem i\xad\nological studies and case reports in humans and specific repro\xad\nduction studies along with sub-chronic, chronic and special stu dy \nresults in animals that provide relevant information regarding \ntoxicity to reproductive and related endocrine organs. Evaluati on \nof substances chemically related to the substance under study \nmay also be included, particularly when information on the \nsubstance is scarce. The weight given to the available evidence  \nwill be influenced by factors such as the quality of the studie s, \nconsistency of results, nature and severity of effects, the pre sence \nof maternal toxicity in experimental animal studies, level of s tat\xad\nistical significance for inter-group differences, number of end points \naffected, relevance of route of administration to humans and \nfreedom from bias. Both positive and negative results are \nassembled together into a weight of evidence determination. A \nsingle, positive study performed according to good scientific p rin\xad\nciples and with statistically or biologically significant posit ive \nresults may justify classification (see also 3.7.2.2.3).  \n3.7.2.3.2. Toxicokinetic studies in animals and humans, site of  action and \nmechanism or mode of action study results may provide relevant \ninformation which reduces or increases concerns about the hazar d \nto human health. If it is conclusively demonstrated that the cl early \nidentified mechanism or mode of action has no relevance for \nhumans or when the toxicokinetic differences are so marked that  \nit is certain that the hazardous property will not be expressed  in \nhumans then a substance which produces an adverse effect on \nreproduction in experimental animals should not be classified.  \n3.7.2.3.3. If, in some reproductive toxicity studies in experim ental animals the \nonly effects recorded are considered to be of low or minimal to xi\xad\ncological significance, classification may not necessarily be t he \noutcome. These effects include small changes in semen parameter s \nor in the incidence of spontaneous defects in the foetus, small  \nchanges in the proportions of common foetal variants such as ar e \nobserved in skeletal examinations, or in foetal weights, or sma ll \ndifferences in postnatal developmental assessments.  \n3.7.2.3.4. Data from animal studies ideally shall provide clear  evidence of \nspecific reproductive toxicity in the absence of other systemic  toxic \neffects. However, if developmental toxicity occurs together wit h \nother toxic effects in the dam, the potential influence of the gener\xad\nalised adverse effects shall be assessed to the extent possible . The \npreferred approach is to consider adverse effects in the embryo / \nfoetus first, and then evaluate maternal toxicity, along with a ny \nother factors which are likely to have influenced these effects , as \npart of the weight of evidence. In general, developmental effec ts \nthat are observed at maternally toxic doses shall not be auto\xad\nmatically discounted. Discounting developmental effects that ar e \nobserved at maternally toxic doses can only be done on a case- \nby-case basis when a causal relationship is established or refu ted. ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 160}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 162  \n3.7.2.3.5. If appropriate information is available it is import ant to try to \ndetermine whether developmental toxicity is due to a specific \nmaternally mediated mechanism or to a non-specific secondary \nmechanism, like maternal stress and the disruption of homeostas is. \nGenerally, the presence of maternal toxicity shall not be used to \nnegate findings of embryo/foetal effects, unless it can be clea rly \ndemonstrated that the effects are secondary non-specific effect s. \nThis is especially the case when the effects in the offspring a re \nsignificant, e.g. irreversible effects such as structural malfo rmations. \nIn some situations it can be assumed that reproductive toxicity  is \ndue to a secondary consequence of maternal toxicity and discoun t \nthe effects, if the substance is so toxic that dams fail to thr ive and \nthere is severe inanition, they are incapable of nursing pups; or they \nare prostrate or dying.  \n3.7.2.4.  Maternal toxicity  \n3.7.2.4.1. Development of the offspring throughout gestation an d during the \nearly postnatal stages can be influenced by toxic effects in th e \nmother either through non-specific mechanisms related to stress  \nand the disruption of maternal homeostasis, or by specific \nmaternally-mediated mechanisms. In the interpretation of the de vel\xad\nopmental outcome to decide classification for developmental eff ects \nit is important to consider the possible influence of maternal \ntoxicity. This is a complex issue because of uncertainties \nsurrounding the relationship between maternal toxicity and deve l\xad\nopmental outcome. Expert judgement and a weight of evidence \napproach, using all available studies, shall be used to determi ne \nthe degree of influence that shall be attributed to maternal \ntoxicity when interpreting the criteria for classification for devel\xad\nopmental effects. The adverse effects in the embryo/foetus shal l be \nfirst considered, and then maternal toxicity, along with any ot her \nfactors which are likely to have influenced these effects, as w eight \nof evidence, to help reach a conclusion about classification.  \n3.7.2.4.2. Based on pragmatic observation, maternal toxicity ma y, depending \non severity, influence development via non-specific secondary \nmechanisms, producing effects such as depressed foetal weight, \nretarded ossification, and possibly resorptions and certain \nmalformations in some strains of certain species. However, the \nlimited number of studies which have investigated the relations hip \nbetween developmental effects and general maternal toxicity hav e \nfailed to demonstrate a consistent, reproducible relationship a cross \nspecies. Developmental effects which occur even in the presence  of \nmaternal toxicity are considered to be evidence of developmenta l \ntoxicity, unless it can be unequivocally demonstrated on a case -by- \ncase basis that the developmental effects are secondary to mate rnal \ntoxicity. Moreover, classification shall be considered where th ere is \na significant toxic effect in the offspring, e.g. irreversible effects \nsuch as structural malformations, embryo/foetal lethality, sign ificant \npost-natal functional deficiencies.  \n3.7.2.4.3. Classification shall not automatically be discounted  for substances \nthat produce developmental toxicity only in association with \nmaternal toxicity, even if a specific maternally-mediated \nmechanism has been demonstrated. In such a case, classification  \nin Category 2 may be considered more appropriate than Category 1. \nHowever, when a substance is so toxic that maternal death or \nsevere inanition results, or the dams are prostrate and incapab le \nof nursing the pups, it is reasonable to assume that developmen tal ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 161}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 163  \ntoxicity is produced solely as a secondary consequence of mater nal \ntoxicity and discount the developmental effects. Classification  is not \nnecessarily the outcome in the case of minor developmental \nchanges, when there is only a small reduction in foetal/pup bod y \nweight or retardation of ossification when seen in association with \nmaternal toxicity.  \n3.7.2.4.4. Some of the end points used to assess maternal effec ts are provided \nbelow. Data on these end points, if available, need to be evalu ated \nin light of their statistical or biological significance and do se \nresponse relationship.  \nMaternal mortality:  \nan increased incidence of mortality among the treated dams over  \nthe controls shall be considered evidence of maternal toxicity if the \nincrease occurs in a dose-related manner and can be attributed to \nthe systemic toxicity of the test material. Maternal mortality greater \nthan 10 % is considered excessive and the data for that dose le vel \nshall not normally be considered for further evaluation.  \nMating index  \n(no. animals with seminal plugs or sperm/no. mated × 100) (  1 ) \nFertility index  \n(no. animals with implants/no. of matings × 100)  \nGestation length  \n(if allowed to deliver)  \nBody weight and body weight change:  \nConsideration of the maternal body weight change and/or adjuste d \n(corrected) maternal body weight shall be included in the evalu ation \nof maternal toxicity whenever such data are available. The calc u\xad\nlation of an adjusted (corrected) mean maternal body weight \nchange, which is the difference between the initial and termina l \nbody weight minus the gravid uterine weight (or alternatively, the \nsum of the weights of the foetuses), may indicate whether the e ffect \nis maternal or intrauterine. In rabbits, the body weight gain m ay not \nbe useful indicators of maternal toxicity because of normal flu ctu\xad\nations in body weight during pregnancy.  \nFood and water consumption (if relevant):  \nThe observation of a significant decrease in the average food o r \nwater consumption in treated dams compared to the control group  \nis useful in evaluating maternal toxicity, particularly when th e test \nmaterial is administered in the diet or drinking water. Changes  in \nfood or water consumption need to be evaluated in conjunction \nwith maternal body weights when determining if the effects note d \nare reflective of maternal toxicity or more simply, unpalatabil ity of \nthe test material in feed or water.  \nClinical evaluations (including clinical signs, markers, haemat ology \nand clinical chemistry studies):  \nThe observation of increased incidence of significant clinical signs \nof toxicity in treated dams relative to the control group is us eful in \nevaluating maternal toxicity. If this is to be used as the basi s for the  ▼B \n( 1 ) It is recognised that the Mating index and the Fertility inde x can also be affected by the \nmale.', metadata={'source': 'data/ycla_en.pdf', 'page': 162}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 164  \nassessment of maternal toxicity, the types, incidence, degree a nd \nduration of clinical signs shall be reported in the study. Clin ical \nsigns of maternal intoxication include: coma, prostration, hype r\xad\nactivity, loss of righting reflex, ataxia, or laboured breathin g. \nPost-mortem data:  \nIncreased incidence and/or severity of post-mortem findings may  be \nindicative of maternal toxicity. This can include gross or micr o\xad\nscopic pathological findings or organ weight data, including \nabsolute organ weight, organ-to-body weight ratio, or organ-to-  \nbrain weight ratio. When supported by findings of adverse histo \xad\npathological effects in the affected organ(s), the observation of a \nsignificant change in the average weight of suspected target \norgan(s) of treated dams, compared to those in the control grou p, \nmay be considered evidence of maternal toxicity.  \n3.7.2.5.  Animal and experimental data  \n▼M19  \n3.7.2.5.1. A number of internationally accepted test methods ar e available; \nthese include methods for developmental toxicity testing (e.g. \nOECD Test Guideline 414) and methods for one or two-generation \ntoxicity testing (e.g. OECD Test Guidelines 415, 416, 443).  \n▼B \n3.7.2.5.2. Results obtained from Screening Tests (e.g. OECD Gui delines 421 \n— Reproduction/Developmental Toxicity Screening Test, and 422 \n— Combined Repeated Dose Toxicity Study with Reproduction/ \nDevelopment Toxicity Screening Test) can also be used to justif y \nclassification, although it is recognised that the quality of t his \nevidence is less reliable than that obtained through full studi es. \n3.7.2.5.3. Adverse effects or changes, seen in short- or long-t erm repeated \ndose toxicity studies, which are judged likely to impair reprod uctive \nfunction and which occur in the absence of significant generali sed \ntoxicity, may be used as a basis for classification, e.g. histo path\xad\nological changes in the gonads.  \n3.7.2.5.4. Evidence from in vitro assays, or non-mammalian test s, and from \nanalogous substances using structure-activity relationship (SAR ), \ncan contribute to the procedure for classification. In all case s of \nthis nature, expert judgement must be used to assess the adequa cy \nof the data. Inadequate data shall not be used as a primary sup port \nfor classification.  \n3.7.2.5.5. It is preferable that animal studies are conducted u sing appropriate \nroutes of administration which relate to the potential route of  \nhuman exposure. However, in practice, reproductive toxicity \nstudies are commonly conducted using the oral route, and such \nstudies will normally be suitable for evaluating the hazardous prop\xad\nerties of the substance with respect to reproductive toxicity. \nHowever, if it can be conclusively demonstrated that the clearl y \nidentified mechanism or mode of action has no relevance for \nhumans or when the toxicokinetic differences are so marked that  \nit is certain that the hazardous property will not be expressed  in \nhumans then a substance which produces an adverse effect on \nreproduction in experimental animals shall not be classified.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 163}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 165  \n3.7.2.5.6. Studies involving routes of administration such as i ntravenous or \nintraperitoneal injection, which result in exposure of the repr o\xad\nductive organs to unrealistically high levels of the test subst ance, \nor elicit local damage to the reproductive organs, including ir ri\xad\ntation, must be interpreted with extreme caution and on their o wn \nare not normally the basis for classification.  \n3.7.2.5.7. There is general agreement about the concept of a li mit dose, above \nwhich the production of an adverse effect is considered to be \noutside the criteria which lead to classification, but not rega rding \nthe inclusion within the criteria of a specific dose as a limit  dose. \nHowever, some guidelines for test methods, specify a limit dose , \nothers qualify the limit dose with a statement that higher dose s may \nbe necessary if anticipated human exposure is sufficiently high  that \nan adequate margin of exposure is not achieved. Also, due to \nspecies differences in toxicokinetics, establishing a specific limit \ndose may not be adequate for situations where humans are more \nsensitive than the animal model.  \n3.7.2.5.8. In principle, adverse effects on reproduction seen o nly at very high \ndose levels in animal studies (for example doses that induce pr os\xad\ntration, severe inappetence, excessive mortality) would not nor mally \nlead to classification, unless other information is available, e.g. \ntoxicokinetics information indicating that humans may be more \nsusceptible than animals, to suggest that classification is app ro\xad\npriate. Please also refer to the section on maternal toxicity \n(3.7.2.4) for further guidance in this area.  \n3.7.2.5.9. However, specification of the actual ‘limit dose’ wi ll depend upon \nthe test method that has been employed to provide the test resu lts, \ne.g. in the OECD Test Guideline for repeated dose toxicity stud ies \nby the oral route, an upper dose of 1 000 mg/kg has been recom\xad\nmended as a limit dose, unless expected human response indicate s \nthe need for a higher dose level.  \n3.7.3.  Classification criteria for mixtures  \n3.7.3.1.  Classification of mixtures when data are available for all \ningredients or only for some ingredients of the mixture  \n3.7.3.1.1. The mixture shall be classified as a reproductive to xicant when at \nleast one ingredient has been classified as a Category 1A, Cate gory \n1B or Category 2 reproductive toxicant and is present at or abo ve \nthe appropriate generic concentration limit as shown in Table 3 .7.2 \nfor Category 1A, Category 1B and Category 2 respectively.  \n3.7.3.1.2. The mixture shall be classified for effects on or vi a lactation when \nat least one ingredient has been classified for effects on or v ia \nlactation and is present at or above the appropriate generic co ncen\xad\ntration limit as shown in Table 3.7.2 for the additional catego ry for \neffects on or via lactation.  \n▼M4 \nTable 3.7.2  \nGeneric concentration limits of ingredients of a mixture classified as reproduction toxicants or for \neffects on or via lactation that trigger classification of the mixture  \nIngredient classified as:  Generic concentration limits triggering classification of a mix ture as:  \nCategory 1 reproductive toxicant  Category 2 repro\xad\nductive toxicant  Additional category for \neffects on or via \nlactation  Category 1A  Category 1B  \nCategory 1A repro\xad\nductive toxicant  ≥ 0,3 % \n[Note 1]  \nCategory 1B repro\xad\nductive toxicant  ≥ 0,3 % \n[Note 1]  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 164}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 166  \nIngredient classified as:  Generic concentration limits triggering classification of a mix ture as:  \nCategory 1 reproductive toxicant  \nCategory 2 repro\xad\nductive toxicant  Additional category for \neffects on or via \nlactation  Category 1A  Category 1B  \nCategory 2 repro\xad\nductive toxicant  ≥ 3,0 % \n[Note 1]  \nAdditional category \nfor effects on or via \nlactation  ≥ 0,3 % \n[Note 1]  \nNote:  \nThe concentration limits in Table 3.7.2 apply to solids and liq uids (w/w units) as well as gases (v/v units).  \nNote 1:  \nIf a Category 1 or Category 2 reproductive toxicant or a substa nce classified for effects on or via lactation is present in \nthe mixture as an ingredient at a concentration at or above 0,1  %, a SDS shall be available for the mixture upon request.  \n▼B \n3.7.3.2.  Classification of mixtures when data are available for the complete \nmixture  \n3.7.3.2.1. Classification of mixtures will be based on the avai lable test data \nfor the individual ingredients of the mixture using concentrati on \nlimits for the ingredients of the mixture. On a case-by-case ba sis, \ntest data on mixtures may be used for classification when demon \xad\nstrating effects that have not been established from the evalua tion \nbased on the individual components. In such cases, the test res ults \nfor the mixture as a whole must be shown to be conclusive takin g \ninto account dose and other factors such as duration, observati ons, \nsensitivity and statistical analysis of reproduction test syste ms. \nAdequate documentation supporting the classification shall be \nretained and made available for review upon request.  \n3.7.3.3.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.7.3.3.1. Subject to paragraph 3.7.3.2.1, where the mixture it self has not \nbeen tested to determine its reproductive toxicity, but there a re \nsufficient data on the individual ingredients and similar teste d \nmixtures to adequately characterise the hazards of the mixture,  \nthese data shall be used in accordance with the applicable \nbridging rules set out in section 1.1.3.  \n3.7.4.  Hazard Communication  \n3.7.4.1. Label elements shall be used for substances or mixture s meeting the \ncriteria for classification in this hazard class in accordance with \nTable 3.7.3  \n▼M4 \nTable 3.7.3  \nLabel elements for reproductive toxicity  \nClassification  Category 1 \n(Category 1A, 1B)  Category 2  Additional category \nfor effects on or via \nlactation  \nGHS Pictograms\n  No pictogram  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 165}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 167  \nClassification  Category 1 \n(Category 1A, 1B)  Category 2  Additional category \nfor effects on or via \nlactation  \nSignal Word  Danger  Warning  No signal word  \nHazard \nStatement  H360: May damage \nfertility or the \nunborn child (state \nspecific effect if \nknown)(state route \nof exposure if it is \nconclusively proven \nthat no other routes \nof exposure cause \nthe hazard)  H361: Suspected of \ndamaging fertility or \nthe unborn child \n(state specific effect \nif known) (state \nroute of exposure if \nit is conclusively \nproven that no other \nroutes of exposure \ncause the hazard)  H362: May cause \nharm to breast-fed \nchildren.  \nPrecautionary \nStatement \nPrevention  P201 \nP202 \nP280  P201 \nP202 \nP280  P201 \nP260 \nP263 \nP264 \nP270  \nPrecautionary \nStatement \nResponse  P308 + P313  P308 + P313  P308 + P313  \nPrecautionary \nStatement \nStorage  P405  P405  \nPrecautionary \nStatement \nDisposal  P501  P501  \n▼B \n3.8. Specific target organ toxicity — single exposure  \n3.8.1.  Definitions and general considerations  \n▼M19  \n3.8.1.1. Specific target organ toxicity – single exposure means  specific, \nnon-lethal toxic effects on target organs occurring after a sin gle \nexposure to a substance or mixture. All significant health effe cts \nthat can impair function, both reversible and irreversible, imm ediate \nand/or delayed and not specifically addressed in sections 3.1 t o 3.7 \nand 3.10 are included (see also section 3.8.1.6).  \n▼B \n3.8.1.2. Classification identifies the substance or mixture as being a specific \ntarget organ toxicant and, as such, it may present a potential for \nadverse health effects in people who are exposed to it.  \n3.8.1.3. These adverse health effects produced by a single expo sure include \nconsistent and identifiable toxic effects in humans, or, in exp eri\xad\nmental animals, toxicologically significant changes which have \naffected the function or morphology of a tissue/organ, or have \nproduced serious changes to the biochemistry or haematology of \nthe organism, and these changes are relevant for human health.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 166}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 168  \n3.8.1.4. Assessment shall take into consideration not only sign ificant \nchanges in a single organ or biological system but also general ised \nchanges of a less severe nature involving several organs.  \n3.8.1.5. Specific target organ toxicity can occur by any route that is relevant \nfor humans, i.e. principally oral, dermal or inhalation.  \n3.8.1.6. Specific target organ toxicity following a repeated ex posure is clas\xad\nsified as described in Specific target organ toxicity — Repeate d \nexposure (section 3.9) and is therefore excluded from section 3 .8. \nOther specific toxic effects, listed below, are assessed separa tely \nand consequently are not included here:  \n(a) Acute toxicity (section 3.1);  \n(b) Skin corrosion/irritation (section 3.2);  \n(c) Serious eye damage/eye irritation (section 3.3);  \n(d) Respiratory or skin sensitisation (section 3.4);  \n(e) Germ cell mutagenicity (section 3.5);  \n(f) Carcinogenicity (section 3.6);  \n(g) Reproductive toxicity (section 3.7); and  \n(h) Aspiration toxicity (section 3.10).  \n3.8.1.7. The hazard class Specific Target Organ Toxicity — Sing le \nExposure is differentiated into:  \n— Specific target organ toxicity — single exposure, Category 1 \nand 2;  \n— Specific target organ toxicity — single exposure, Category 3.  \nSee Table 3.8.1.  \nTable 3.8.1  \nCategories for specific target organ toxicity-single exposure  \nCategories  Criteria  \nCategory 1  Substances that have produced significant toxicity \nin humans or that, on the basis of evidence from \nstudies in experimental animals, can be presumed \nto have the potential to produce significant toxicity \nin humans following single exposure \nSubstances are classified in Category 1 for specific \ntarget organ toxicity (single exposure) on the basis \nof: \n(a) reliable and good quality evidence from \nhuman cases or epidemiological studies; or \n(b) observations from appropriate studies in \nexperimental animals in which significant \nand/or severe toxic effects of relevance to \nhuman health were produced at generally low \nexposure concentrations. Guidance dose/ \nconcentration values are provided below (see \n3.8.2.1.9) to be used as part of weight-of- \nevidence evaluation.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 167}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 169  \nCategories  Criteria  \nCategory 2  Substances that, on the basis of evidence from \nstudies in experimental animals can be presumed \nto have the potential to be harmful to human \nhealth following single exposure \nSubstances are classified in Category 2 for specific \ntarget organ toxicity (single exposure) on the basis \nof observations from appropriate studies in experi\xad\nmental animals in which significant toxic effects, \nof relevance to human health, were produced at \ngenerally moderate exposure concentrations. \nGuidance dose/concentration values are provided \nbelow (see 3.8.2.1.9) in order to help in classifi\xad\ncation. \nIn exceptional cases, human evidence can also be \nused to place a substance in Category 2 (see \n3.8.2.1.6).  \nCategory 3  Transient target organ effects \nThis category only includes narcotic effects and \nrespiratory tract irritation. These are target organ \neffects for which a substance does not meet the \ncriteria to be classified in Categories 1 or 2 \nindicated above. These are effects which \nadversely alter human function for a short \nduration after exposure and from which humans \nmay recover in a reasonable period without \nleaving significant alteration of structure or \nfunction. Substances are classified specifically for \nthese effects as laid down in 3.8.2.2.  \nNote:  Attempts shall be made to determine the primary target organ o f toxicity \nand to classify for that purpose, such as hepatotoxicants, neur otoxicants. The \ndata shall be carefully evaluated and, where possible, secondar y effects should \nnot be included (e.g. a hepatotoxicant can produce secondary ef fects in the \nnervous or gastro-intestinal systems).  \n3.8.2.  Classification criteria for substances  \n3.8.2.1.  Substances of Category 1 and Category 2  \n3.8.2.1.1. Substances are classified for immediate or delayed e ffects separ\xad\nately, by the use of expert judgement (see 1.1.1) on the basis of the \nweight of all evidence available, including the use of recommen ded \nguidance values (see 3.8.2.1.9). Substances are then placed in \nCategory 1 or 2, depending upon the nature and severity of the \neffect(s) observed (Table 3.8.1).  \n3.8.2.1.2. The relevant route or routes of exposure by which th e classified \nsubstance produces damage shall be identified (see 3.8.1.5).  \n3.8.2.1.3. Classification is determined by expert judgement (se e section \n1.1.1), on the basis of the weight of all evidence available \nincluding the guidance presented below.  \n3.8.2.1.4. Weight of evidence of all data (see section 1.1.1), including human \nincidents, epidemiology, and studies conducted in experimental \nanimals, is used to substantiate specific target organ toxic ef fects \nthat merit classification.  \n3.8.2.1.5. The information required to evaluate specific target  organ toxicity \ncomes either from single exposure in humans, such as: exposure at \nhome, in the workplace or environmentally, or from studies \nconducted in experimental animals. The standard animal studies \nin rats or mice that provide this information are acute toxicit y ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 168}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 170  \nstudies which can include clinical observations and detailed ma cro\xad\nscopic and microscopic examination to enable the toxic effects on \ntarget tissues/organs to be identified. Results of acute toxici ty \nstudies conducted in other species may also provide relevant \ninformation.  \n3.8.2.1.6. In exceptional cases, based on expert judgement, it is appropriate to \nplace certain substances with human evidence of target organ \ntoxicity in Category 2:  \n(a) when the weight of human evidence is not sufficiently \nconvincing to warrant Category 1 classification, and/or  \n(b) based on the nature and severity of effects.  \nDose/concentration levels in humans shall not be considered in the \nclassification and any available evidence from animal studies s hall \nbe consistent with the Category 2 classification. In other word s, if \nthere are also animal data available on the substance that warr ant \nCategory 1 classification, the substance shall be classified as  \nCategory 1.  \n3.8.2.1.7. E f f e c t s c o n s i d e r e d t o s u p p o r t c l a s s i f i c a t i o n f o r \nC a t e g o r y 1 a n d 2  \n3.8.2.1.7.1. Classification is supported by evidence associatin g single exposure \nto the substance with a consistent and identifiable toxic effec t. \n3.8.2.1.7.2. Evidence from human experience/incidents is usuall y restricted to \nreports of adverse health consequence, often with uncertainty a bout \nexposure conditions, and may not provide the scientific detail that \ncan be obtained from well-conducted studies in experimental \nanimals.  \n3.8.2.1.7.3. Evidence from appropriate studies in experimental animals can \nfurnish much more detail, in the form of clinical observations,  \nand macroscopic and microscopic pathological examination, and \nthis can often reveal hazards that may not be life-threatening but \ncould indicate functional impairment. Consequently all availabl e \nevidence, and relevance to human health, must be taken into con \xad\nsideration in the classification process, including but not lim ited to \nthe following effects in humans and/or animals:  \n(a) morbidity resulting from single exposure;  \n(b) significant functional changes, more than transient in natu re, in \nthe respiratory system, central or peripheral nervous systems, \nother organs or other organ systems, including signs of central  \nnervous system depression and effects on special senses (such \nas sight, hearing and sense of smell);  \n(c) any consistent and significant adverse change in clinical \nbiochemistry, haematology, or urinalysis parameters;  \n(d) significant organ damage noted at necropsy and/or subsequen tly \nseen or confirmed at microscopic examination;  \n(e) multi-focal or diffuse necrosis, fibrosis or granuloma form ation \nin vital organs with regenerative capacity;  \n(f) morphological changes that are potentially reversible but \nprovide clear evidence of marked organ dysfunction;  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 169}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 171  \n(g) evidence of appreciable cell death (including cell degenera tion \nand reduced cell number) in vital organs incapable of regener\xad\nation.  \n3.8.2.1.8. E f f e c t s c o n s i d e r e d n o t t o s u p p o r t c l a s s i f i c a t i o n \nf o r C a t e g o r y 1 a n d 2  \nIt is recognised that effects may be seen that does not justify  \nclassification. Such effects in humans and/or animals include, but \nare not limited to:  \n(a) clinical observations or small changes in bodyweight gain, food \nconsumption or water intake that may have some toxicological \nimportance but that do not, by themselves, indicate ‘significan t’ \ntoxicity;  \n(b) small changes in clinical biochemistry, haematology or \nurinalysis parameters and/or transient effects, when such \nchanges or effects are of doubtful or minimal toxicological \nimportance;  \n(c) changes in organ weights with no evidence of organ \ndysfunction;  \n(d) adaptive responses that are not considered toxicologically \nrelevant;  \n(e) substance-induced species-specific mechanisms of toxicity, i.e. \ndemonstrated with reasonable certainty to be not relevant for \nhuman health, shall not justify classification.  \n3.8.2.1.9. G u i d a n c e v a l u e s t o a s s i s t w i t h c l a s s i f i c a t i o n \nb a s e d o n t h e r e s u l t s o b t a i n e d f r o m s t u  d i e s \nc o n d u c t e d i n e x p e r i m e n t a l a n i m a l s f o  r \nC a t e g o r y 1 a n d 2  \n3.8.2.1.9.1. In order to help reach a decision about whether a substance shall be \nclassified or not, and to what degree it shall be classified (C ategory \n1 or Category 2), dose/concentration ‘guidance values’ are prov ided \nfor consideration of the dose/concentration which has been show n \nto produce significant health effects. The principal argument f or \nproposing such guidance values is that all substances are poten tially \ntoxic and there has to be a reasonable dose/concentration above  \nwhich a degree of toxic effect is acknowledged.  \n3.8.2.1.9.2. Thus, in animal studies, when significant toxic ef fects are observed \nthat indicate classification, consideration of the dose/concent ration \nat which these effects were seen, in relation to the suggested \nguidance values, provides useful information to help assess the  \nneed to classify (since the toxic effects are a consequence of the \nhazardous property(ies) and also the dose/concentration).  \n3.8.2.1.9.3. The guidance value (C) ranges for single-dose expo sure which has \nproduced a significant non-lethal toxic effect are those applic able to \nacute toxicity testing, as indicated in Table 3.8.2.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 170}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 172  \nTable 3.8.2  \nGuidance value ranges for single-dose exposures  a \nGuidance value ranges for:  \nRoute of exposure  Units  Category 1  Category 2  Category 3  \nOral (rat)  mg/kg body \nweight  C ≤ 300  2 000 ≥ C > 300  \nGuidance values \ndo not apply  b Dermal (rat or rabbit)  mg/kg body \nweight  C ≤ 1 000  2 000 ≥ C > 1 000  \nInhalation (rat) gas  ppmV/4h  C ≤ 2 500  20 000 ≥ C > 2 500  \nInhalation (rat) vapour  mg/l/4h  C  ≤  1 0  20 ≥ C > 10  \nInhalation (rat) dust/mist/ \nfume  mg/l/4h  C ≤ 1,0  5,0 ≥ C > 1,0  \nNote  \n(a) The guidance values and ranges mentioned in Table 3.8.2 are  \nintended only for guidance purposes, i.e. to be used as part of  \nthe weight of evidence approach, and to assist with decision \nabout classification. They are not intended as strict demarcati on \nvalues.  \n(b) Guidance values are not provided for Category 3 substances \nsince this classification is primarily based on human data. \nAnimal data, if available, shall be included in the weight of \nevidence evaluation.  \n3.8.2.1.10. O t h e r c o n s i d e r a t i o n s  \n3.8.2.1.10.1. When a substance is characterised only by use of animal data \n(typical of new substances, but also true for many existing \nsubstances), the classification process includes reference to d ose/ \nconcentration guidance values as one of the elements that contr ibute \nto the weight of evidence approach.  \n3.8.2.1.10.2. When well-substantiated human data are available showing a \nspecific target organ toxic effect that can be reliably attribu ted to \nsingle exposure to a substance, the substance shall normally be  \nclassified. Positive human data, regardless of probable dose, \npredominates over animal data. Thus, if a substance is unclassi fied \nbecause specific target organ toxicity observed was considered not \nrelevant or significant to humans, if subsequent human incident  \ndata become available showing a specific target organ toxic \neffect, the substance shall be classified.  \n3.8.2.1.10.3. A substance that has not been tested for specific  target organ \ntoxicity may, where appropriate, be classified on the basis of data \nfrom a validated structure activity relationship and expert \njudgement-based extrapolation from a structural analogue that h as \npreviously been classified together with substantial support fr om \nconsideration of other important factors such as formation of \ncommon significant metabolites.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 171}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 173  \n3.8.2.1.10.4. Saturated vapour concentration shall be considere d, where appro\xad\npriate, as an additional element to provide for specific health  and \nsafety protection  \n3.8.2.2.  Substances of Category 3: Transient target organ effects  \n3.8.2.2.1. C r i t e r i a f o r r e s p i r a t o r y t r a c t i r r i t a t i o n  \nThe criteria for classifying substances as Category 3 for respi ratory \ntract irritation are:  \n(a) respiratory irritant effects (characterised by localised re dness, \noedema, pruritis and/or pain) that impair function with \nsymptoms such as cough, pain, choking, and breathing \ndifficulties are included. This evaluation will be based \nprimarily on human data;  \n(b) subjective human observations could be supported by objecti ve \nmeasurements of clear respiratory tract irritation (RTI) (such as \nelectrophysiological responses, biomarkers of inflammation in \nnasal or bronchoalveolar lavage fluids);  \n(c) the symptoms observed in humans shall also be typical of th ose \nthat would be produced in the exposed population rather than \nbeing an isolated idiosyncratic reaction or response triggered \nonly in individuals with hypersensitive airways. Ambiguous \nreports simply of ‘irritation’ shall be excluded as this term i s \ncommonly used to describe a wide range of sensations \nincluding those such as smell, unpleasant taste, a tickling \nsensation, and dryness, which are outside the scope of classifi \xad\ncation for respiratory irritation;  \n(d) there are currently no validated animal tests that deal \nspecifically with RTI, however, useful information may be \nobtained from the single and repeated inhalation toxicity tests . \nFor example, animal studies may provide useful information in \nterms of clinical signs of toxicity (dyspnoea, rhinitis etc) an d \nhistopathology (e.g. hyperemia, edema, minimal inflammation, \nthickened mucous layer) which are reversible and may be \nreflective of the characteristic clinical symptoms described \nabove. Such animal studies can be used as part of weight of \nevidence evaluation;  \n(e) this special classification would occur only when more seve re \norgan effects including in the respiratory system are not \nobserved.  \n3.8.2.2.2 C r i t e r i a f o r n a r c o t i c e f f e c t s  \nThe criteria for classifying substances as Category 3 for narco tic \neffects are:  \n(a) central nervous system depression including narcotic effect s in \nhumans such as drowsiness, narcosis, reduced alertness, loss of  \nreflexes, lack of coordination, and vertigo are included. These  \neffects can also be manifested as severe headache or nausea, \nand can lead to reduced judgment, dizziness, irritability, fati gue, \nimpaired memory function, deficits in perception and coor\xad\ndination, reaction time, or sleepiness;  \n(b) narcotic effects observed in animal studies may include \nlethargy, lack of coordination, loss of righting reflex, and \nataxia. If these effects are not transient in nature, then they  \nshall be considered to support classification for Category 1 or  \n2 specific target organ toxicity single exposure.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 172}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 174  \n3.8.3.  Classification criteria for mixtures  \n3.8.3.1. Mixtures are classified using the same criteria as for  substances, or \nalternatively as described below. As with substances, mixtures shall \nbe classified for specific target organ toxicity following sing le \nexposure.  \n3.8.3.2.  Classification of mixtures when data are available for the complete \nmixture  \n3.8.3.2.1. When reliable and good quality evidence from human e xperience or \nappropriate studies in experimental animals, as described in th e \ncriteria for substances, is available for the mixture, then the  \nmixture shall be classified by weight of evidence evaluation of  \nthese data (see 1.1.1.4). Care shall be exercised in evaluating  \ndata on mixtures, that the dose, duration, observation or analy sis, \ndo not render the results inconclusive.  \n3.8.3.3.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.8.3.3.1. Where the mixture itself has not been tested to dete rmine its \nspecific target organ toxicity, but there are sufficient data o n the \nindividual ingredients and similar tested mixtures to adequatel y \ncharacterise the hazards of the mixture, these data shall be us ed \nin accordance with the bridging principles set out in section 1 .1.3. \n3.8.3.4.  Classification of mixtures when data are available for all \ncomponents or only for some components of the mixture  \n▼M19  \n3.8.3.4.1. Where there is no reliable evidence or test data for  the specific \nmixture itself, and the bridging principles cannot be used to \nenable classification, then classification of the mixture is ba sed \non the classification of the ingredient substances. In this cas e, the \nmixture shall be classified as a specific target organ toxicant  \n(specific organ specified), following single exposure, when at \nleast one ingredient has been classified as a Category 1 or \nCategory 2 specific target organ toxicant (single exposure) and  is \npresent at or above the appropriate generic concentration limit  as \nmentioned in Table 3.8.3 for Category 1 and 2 respectively.  \n▼B \n3.8.3.4.2. These generic concentration limits and consequent cl assifications \nshall be applied appropriately to single-dose specific target o rgan \ntoxicants.  \n3.8.3.4.3. Mixtures shall be classified for either or both sing le- and repeated- \ndose toxicity independently.  \nTable 3.8.3  \nGeneric concentration limits of ingredients of a mixture clas \xad\nsified as a specific target organ toxicant that trigger classifi \xad\ncation of the mixture as Category 1 or 2  \nIngredient classified as:  Generic concentration limits triggering \nclassification of the mixture as:  \nCategory 1  Category 2  \nCategory 1 \nSpecific Target Organ \nToxicant  Concentration \n≥ 10 %  1,0 % ≤ concen\xad\ntration < 10 %  \nCategory 2 \nSpecific Target Organ \nToxicant  Concentration ≥ \n10 % [(Note 1)]  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 173}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 175  \nNote 1  \nIf a Category 2 specific target organ toxicant is present in th e \nmixture as an ingredient at a concentration ≥ 1,0 % a SDS shall  \nbe available for the mixture upon request.  \n3.8.3.4.4. Care shall be exercised when toxicants affecting mor e than one \norgan system are combined that the potentiation or synergistic inter\xad\nactions are considered, because certain substances can cause ta rget \norgan toxicity at < 1 % concentration when other ingredients in  the \nmixture are known to potentiate its toxic effect.  \n3.8.3.4.5. Care shall be exercised when extrapolating toxicity of a mixture \nthat contains Category 3 ingredient(s). A generic concentration  limit \nof 20 % is appropriate; however, it shall be recognised that th is \nconcentration limit may be higher or lower depending on the \nCategory 3 ingredient(s) and that some effects such as respirat ory \ntract irritation may not occur below a certain concentration wh ile \nother effects such as narcotic effects may occur below this 20 % \nvalue. Expert judgement shall be exercised.  ►M2 Respiratory tract \nirritation and narcotic effects are to be evaluated separately in \naccordance with the criteria given in section 3.8.2.2. When \nconducting classifications for these hazards, the contribution of \neach component should be considered additive, unless there is \nevidence that the effects are not additive. ◄  \n▼M19  \n3.8.3.4.6. In cases where the additivity approach is used for C ategory 3 \ningredients, the ‘relevant ingredients’ of a mixture are those \nwhich are present in concentrations ≥ 1 % (w/w for solids, \nliquids, dusts, mists, and vapours and v/v for gases), unless t here \nis a reason to suspect that an ingredient present at a concentr ation \n< 1 % is still relevant when classifying the mixture for respir atory \ntract irritation or narcotic effects.  \n▼B \n3.8.4.  Hazard Communication  \n3.8.4.1 Label elements shall be used in accordance with Table 3 .8.4., for \nsubstances or mixtures meeting the criteria for classification in this \nhazard class.  \n▼M4 \nTable 3.8.4  \nLabel elements for specific target organ toxicity after single exposure  \nClassification  Category 1  Category 2  Category 3  \nGHS Pictograms\n  \nSignal Word  Danger  Warning  Warning  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 174}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 176  \nClassification  Category 1  Category 2  Category 3  \nHazard Statement  H370: Causes \ndamage to organs \n(or state all organs \naffected, if known) \n(state route of \nexposure if it is \nconclusively proven \nthat no other routes \nof exposure cause \nthe hazard)  H371: May cause \ndamage to organs \n(or state all organs \naffected, if known) \n(state route of \nexposure if it is \nconclusively proven \nthat no other routes \nof exposure cause \nthe hazard)  H335: May cause \nrespiratory irritation; \nor \nH336: May cause \ndrowsiness or \ndizziness  \nPrecautionary \nStatement \nPrevention  P260 \nP264 \nP270  P260 \nP264 \nP270  P261 \nP271  \nPrecautionary \nStatement \nResponse  P308 + P311 \nP321  P308 + P311  P304 + P340 \nP312  \nPrecautionary \nStatement Storage  P405  P405  P403 + P233 \nP405  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  \n▼B \n3.9. Specific target organ toxicity — repeated exposure  \n3.9.1.  Definitions and general considerations  \n▼M19  \n3.9.1.1. Specific target organ toxicity-repeated exposure means  specific \ntoxic effects on target organs occurring after repeated exposur e to \na substances or mixture. All significant health effects that ca n \nimpair function, reversible and irreversible, immediate and/or \ndelayed are included. However, other specific toxic effects tha t \nare specifically addressed in sections 3.1 to 3.8 and 3.10 are not \nincluded here.  \n▼B \n3.9.1.2. Classification for target organ toxicity (repeated exp osure) identifies \nthe substance  ►M2 or mixture ◄ as being a specific target organ \ntoxicant and, as such, it may present a potential for adverse h ealth \neffects in people who are exposed to it.  \n3.9.1.3. These adverse health effects include consistent and id entifiable \ntoxic effects in humans, or, in experimental animals, toxicolog ically \nsignificant changes which have affected the function or morphol ogy \nof a tissue/organ, or have produced serious changes to the \nbiochemistry or haematology of the organism and these changes \nare relevant for human health.  \n3.9.1.4. Assessment shall take into consideration not only sign ificant \nchanges in a single organ or biological system but also general ised \nchanges of a less severe nature involving several organs.  \n3.9.1.5. Specific target organ toxicity can occur by any route that is relevant \nfor humans, i.e. principally oral, dermal or inhalation.  \n3.9.1.6. Non-lethal toxic effects observed after a single-event  exposure are \nclassified as described in Specific target organ toxicity — Sin gle \nexposure (section 3.8) and are therefore excluded from section 3.9. ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 175}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 177  \n3.9.2.  Classification criteria for substances  \n3.9.2.1. Substances are classified as specific target organ tox icants \nfollowing repeated exposure by the use of expert judgement (see  \n1.1.1), on the basis of the weight of all evidence available, \nincluding the use of recommended guidance values which take \ninto account the duration of exposure and the dose/concentratio n \nwhich produced the effect(s), (see 3.9.2.9), and are placed in one of \ntwo categories, depending upon the nature and severity of the \neffect(s) observed (Table 3.9.1).  \nTable 3.9.1  \nCategories for specific target organ toxicity-repeated exposure  \nCategories  Criteria  \nCategory 1  Substances that have produced significant toxicity \nin humans or that, on the basis of evidence from \nstudies in experimental animals, can be presumed \nto have the potential to produce significant toxicity \nin humans following repeated exposure. \nSubstances are classified in Category 1 for target \norgan toxicity (repeat exposure) on the basis of: \n— reliable and good quality evidence from \nhuman cases or epidemiological studies; or \n— observations from appropriate studies in \nexperimental animals in which significant \nand/or severe toxic effects, of relevance to \nhuman health, were produced at generally \nlow exposure concentrations. Guidance dose/ \nconcentration values are provided below (see \n3.9.2.9), to be used as part of a weight-of- \nevidence evaluation.  \nCategory 2  Substances that, on the basis of evidence from \nstudies in experimental animals can be presumed \nto have the potential to be harmful to human \nhealth following repeated exposure. \nSubstances are classified in category 2 for target \norgan toxicity (repeat exposure) on the basis of \nobservations from appropriate studies in experi\xad\nmental animals in which significant toxic effects, \nof relevance to human health, were produced at \ngenerally moderate exposure concentrations. \nGuidance dose/concentration values are provided \nbelow (see 3.9.2.9) in order to help in classifi\xad\ncation. \nIn exceptional cases human evidence can also be \nused to place a substance in Category 2 (see \n3.9.2.6).  \nNote  \nAttempts shall be made to determine the primary target organ of  \ntoxicity and classify for that purpose, such as hepatotoxicants , neur\xad\notoxicants. One shall carefully evaluate the data and, where \npossible, not include secondary effects (a hepatotoxicant can \nproduce secondary effects in the nervous or gastro-intestinal \nsystems).  \n3.9.2.2. The relevant route or routes of exposure by which the classified \nsubstance produces damage shall be identified.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 176}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 178  \n3.9.2.3. Classification is determined by expert judgement (see section \n1.1.1), on the basis of the weight of all evidence available \nincluding the guidance presented below.  \n3.9.2.4. Weight of evidence of all data (see section 1.1.1), in cluding human \nincidents, epidemiology, and studies conducted in experimental \nanimals, is used to substantiate specific target organ toxic ef fects \nthat merit classification. This taps the considerable body of \nindustrial toxicology data collected over the years. Evaluation  \nshall be based on all existing data, including peer-reviewed \npublished studies and additional acceptable data.  \n3.9.2.5. The information required to evaluate specific target o rgan toxicity \ncomes either from repeated exposure in humans, such as exposure  \nat home, in the workplace or environmentally, or from studies \nconducted in experimental animals. The standard animal studies \nin rats or mice that provide this information are 28 day, 90 da y \nor lifetime studies (up to 2 years) that include haematological , \nclinicochemical and detailed macroscopic and microscopic exami\xad\nnation to enable the toxic effects on target tissues/organs to be \nidentified. Data from repeat dose studies performed in other \nspecies shall also be used, if available. Other long-term expos ure \nstudies, such as on carcinogenicity, neurotoxicity or reproduct ive \ntoxicity, may also provide evidence of specific target organ to xicity \nthat could be used in the assessment of classification.  \n3.9.2.6. In exceptional cases, based on expert judgement, it is  appropriate to \nplace certain substances with human evidence of specific target  \norgan toxicity in Category 2:  \n(a) when the weight of human evidence is not sufficiently \nconvincing to warrant Category 1 classification; and/or  \n(b) based on the nature and severity of effects.  \nDose/concentration levels in humans shall not be considered in the \nclassification and any available evidence from animal studies s hall \nbe consistent with the Category 2 classification. In other word s, if \nthere are also animal data available on the substance that warr ant \nCategory 1 classification, the substance shall be classified as  \nCategory 1.  \n3.9.2.7.  Effects considered to support classification for specific target organ \ntoxicity following repeated exposure  \n3.9.2.7.1. Reliable evidence associating repeated exposure to t he substance \nwith a consistent and identifiable toxic effect demonstrates \nsupport for the classification.  \n3.9.2.7.2. Evidence from human experience/incidents is usually restricted to \nreports of adverse health consequence, often with uncertainty a bout \nexposure conditions, and may not provide the scientific detail that \ncan be obtained from well-conducted studies in experimental \nanimals.  \n3.9.2.7.3. Evidence from appropriate studies in experimental an imals can \nfurnish much more detail, in the form of clinical observations,  \nhaematology, clinical chemistry, and macroscopic and microscopi c \npathological examination, and this can often reveal hazards tha t \nmay not be life-threatening but could indicate functional \nimpairment. Consequently all available evidence, and relevance to \nhuman health, shall be taken into consideration in the classifi cation \nprocess, including but not limited to the following toxic effec ts in \nhumans and/or animals:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 177}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 179  \n(a) morbidity or death resulting from repeated or long-term \nexposure. Morbidity or death may result from repeated \nexposure, even to relatively low doses/concentrations, due to \nbioaccumulation of the substance or its metabolites, and/or due  \nto the overwhelming of the de-toxification process by repeated \nexposure to the substance or its metabolites;  \n(b) significant functional changes in the central or peripheral  \nnervous systems or other organ systems, including signs of \ncentral nervous system depression and effects on special \nsenses (e.g. sight, hearing and sense of smell);  \n(c) any consistent and significant adverse change in clinical \nbiochemistry, haematology, or urinalysis parameters;  \n(d) significant organ damage noted at necropsy and/or subsequen tly \nseen or confirmed at microscopic examination;  \n(e) multi-focal or diffuse necrosis, fibrosis or granuloma form ation \nin vital organs with regenerative capacity;  \n(f) morphological changes that are potentially reversible but \nprovide clear evidence of marked organ dysfunction (e.g., \nsevere fatty change in the liver);  \n(g) evidence of appreciable cell death (including cell degenera tion \nand reduced cell number) in vital organs incapable of regener\xad\nation.  \n3.9.2.8.  Effects considered not to support classification for specific target \norgan toxicity following repeated exposure  \n3.9.2.8.1. It is recognised that effects may be seen in humans and/or animals \nthat do not justify classification. Such effects include, but a re not \nlimited to:  \n(a) clinical observations or small changes in bodyweight gain, food \nconsumption or water intake that have toxicological importance \nbut that do not, by themselves, indicate ‘significant’ toxicity ; \n(b) small changes in clinical biochemistry, haematology or \nurinalysis parameters and/or transient effects, when such \nchanges or effects are of doubtful or minimal toxicological \nimportance;  \n(c) changes in organ weights with no evidence of organ \ndysfunction;  \n(d) adaptive responses that are not considered toxicologically \nrelevant;  \n(e) substance-induced species-specific mechanisms of toxicity, i.e. \ndemonstrated with reasonable certainty to be not relevant for \nhuman health, shall not justify classification.  \n3.9.2.9.  Guidance values to assist with classification based on the results \nobtained from studies conducted in experimental animals  \n3.9.2.9.1. In studies conducted in experimental animals, relian ce on obser\xad\nvation of effects alone, without reference to the duration of e xperi\xad\nmental exposure and dose/concentration, omits a fundamental \nconcept of toxicology, i.e. all substances are potentially toxi c, \nand what determines the toxicity is a function of the dose/conc en\xad\ntration and the duration of exposure. In most studies conducted  in \nexperimental animals the test guidelines use an upper limit dos e \nvalue.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 178}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 180  \n3.9.2.9.2. In order to help reach a decision about whether a su bstance shall be \nclassified or not, and to what degree it shall be classified (C ategory \n1 or Category 2), dose/concentration ‘guidance values’ are prov ided \nfor consideration of the dose/concentration which has been show n \nto produce significant health effects. The principal argument f or \nproposing such guidance values is that all substances are poten tially \ntoxic and there has to be a reasonable dose/concentration above  \nwhich a degree of toxic effect is acknowledged. Also, repeated-  \ndose studies conducted in experimental animals are designed to \nproduce toxicity at the highest dose used in order to optimise the \ntest objective and so most studies will reveal some toxic effec t at \nleast at this highest dose. What is therefore to be decided is not \nonly what effects have been produced, but also at what dose/con \xad\ncentration they were produced and how relevant is that for huma ns. \n3.9.2.9.3. Thus, in animal studies, when significant toxic effe cts are observed \nthat indicate classification, consideration of the duration of experi\xad\nmental exposure and the dose/concentration at which these effec ts \nwere seen, in relation to the suggested guidance values, can pr ovide \nuseful information to help assess the need to classify (since t he \ntoxic effects are a consequence of the hazardous property(ies) and \nalso the duration of exposure and the dose/concentration).  \n3.9.2.9.4. The decision to classify at all can be influenced by  reference to the \ndose/concentration guidance values at or below which a signific ant \ntoxic effect has been observed.  \n3.9.2.9.5. The guidance values refer to effects seen in a stand ard 90-day \ntoxicity study conducted in rats. They can be used as a basis t o \nextrapolate equivalent guidance values for toxicity studies of greater \nor lesser duration, using dose/exposure time extrapolation simi lar to \nHaber's rule for inhalation, which states essentially that the effective \ndose is directly proportional to the exposure concentration and  the \nduration of exposure. The assessment shall be done on a case-by - \ncase basis; for a 28-day study the guidance values below is \nincreased by a factor of three.  \n3.9.2.9.6. Thus classification in Category 1 is applicable, whe n significant \ntoxic effects observed in a 90-day repeated-dose study conducte d \nin experimental animals are seen to occur at or below the guida nce \nvalues (C) as indicated in Table 3.9.2:  \nTable 3.9.2  \nGuidance values to assist in Category 1 classification  \nRoute of exposure  Units  Guidance values (dose/ \nconcentration)  \nOral (rat)  mg/kg body \nweight/day  C ≤ 10  \nDermal (rat or rabbit)  mg/kg body \nweight/day  C ≤ 20  \nInhalation (rat)gas  ppmV/6h/day  C  ≤  5 0  \nInhalation (rat)vapour  mg/litre/6h/day  C ≤ 0,2  \nInhalation (rat) dust/ \nmist/fume  mg/litre/6h/day  C ≤ 0,02  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 179}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 181  \n3.9.2.9.7. Classification in Category 2 is applicable, when sig nificant toxic \neffects observed in a 90-day repeated-dose study conducted in \nexperimental animals are seen to occur within the guidance valu e \nranges as indicated in Table 3.9.3:  \nTable 3.9.3  \nGuidance values to assist in Category 2 classification  \nRoute of Exposure  Units  Guidance Value \nRanges: \n(dose/concentration)  \nOral (rat)  mg/kg body \nweight/day  10 < C ≤ 100  \nDermal (rat or rabbit)  mg/kg body \nweight/day  20 < C ≤ 200  \nInhalation (rat) gas  ppmV/6h/day  50 < C ≤ 250  \nInhalation (rat)vapour  mg/litre/6h/day  0,2 < C ≤ 1,0  \nInhalation (rat) dust/ \nmist/fume  mg/litre/6h/day  0,02 < C ≤ 0,2  \n3.9.2.9.8. The guidance values and ranges mentioned in paragrap hs 3.9.2.9.6 \nand 3.9.2.9.7 are intended only for guidance purposes, i.e. to be \nused as part of the weight of evidence approach, and to assist with \ndecisions about classification. They are not intended as strict  \ndemarcation values.  \n▼M4 \n3.9.2.9.9. Thus it is feasible that a specific profile of toxic ity occurs in repeat- \ndose animal studies at a dose/concentration below the guidance \nvalue, such as < 100 mg/kg bw/day by the oral route, however \nthe nature of the effect, such as nephrotoxicity seen only in m ale \nrats of a particular strain known to be susceptible to this eff ect may \nresult in the decision not to classify. Conversely, a specific profile \nof toxicity may be seen in animal studies occurring at or above  a  \nguidance value, such as ≥ 100 mg/kg bw/day by the oral route, a nd \nin addition there is supplementary information from other sourc es, \nsuch as other long-term administration studies, or human case \nexperience, which supports a conclusion that, in view of the \nweight of evidence, classification is the prudent action to tak e. \n▼B \n3.9.2.10.  Other considerations  \n3.9.2.10.1. When a substance is characterised only by use of an imal data \n(typical of new substances, but also true for many existing \nsubstances), the classification process includes reference to d ose/ \nconcentration guidance values as one of the elements that contr ibute \nto the weight of evidence approach.  \n3.9.2.10.2. When well-substantiated human data are available sh owing a \nspecific target organ toxic effect that can be reliably attribu ted to \nrepeated or prolonged exposure to a substance, the substance sh all \nnormally be classified. Positive human data, regardless of prob able \ndose, predominates over animal data. Thus, if a substance is un clas\xad\nsified because no specific target organ toxicity was seen at or  below  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 180}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 182  \nthe dose/concentration guidance value for animal testing, if \nsubsequent human incident data become available showing a \nspecific target organ toxic effect, the substance shall be clas sified.  \n3.9.2.10.3. A substance that has not been tested for specific t arget organ \ntoxicity may, where appropriate, be classified on the basis of data \nfrom a validated structure activity relationship and expert \njudgement-based extrapolation from a structural analogue that h as \npreviously been classified together with substantial support fr om \nconsideration of other important factors such as formation of \ncommon significant metabolites.  \n3.9.2.10.4. Saturated vapour concentration shall be considered,  where appro\xad\npriate, as an additional element to provide for specific health  and \nsafety protection  \n3.9.3.  Classification criteria for mixtures  \n3.9.3.1. Mixtures are classified using the same criteria as for  substances, or \nalternatively as described below. As with substances, mixtures shall \nbe classified for specific target organ toxicity following repe ated \nexposure.  \n3.9.3.2.  Classification of mixtures when data are available for the complete \nmixture  \n3.9.3.2.1. When reliable and good quality evidence from human e xperience or \nappropriate studies in experimental animals, as described in th e \ncriteria for substances, is available for the mixture (see 1.1. 1.4), \nthen the mixture shall be classified by weight of evidence \nevaluation of these data. Care shall be exercised in evaluating  \ndata on mixtures, that the dose, duration, observation or analy sis, \ndo not render the results inconclusive.  \n3.9.3.3.  Classification of mixtures when data are not available for the \ncomplete mixture: bridging principles  \n3.9.3.3.1. Where the mixture itself has not been tested to dete rmine its \nspecific target organ toxicity, but there are sufficient data o n the \nindividual ingredients and similar tested mixtures to adequatel y \ncharacterise the hazards of the mixture, these data shall be us ed \nin accordance with the bridging principles set out in section 1 .1.3. \n3.9.3.4.  Classification of mixtures when data are available for all \ncomponents or only for some components of the mixture  \n▼M19  \n3.9.3.4.1. Where there is no reliable evidence or test data for  the specific \nmixture itself, and the bridging principles cannot be used to \nenable classification, then classification of the mixture is ba sed \non the classification of the ingredient substances. In this cas e, the \nmixture shall be classified as a specific target organ toxicant  \n(specific organ specified), following repeated exposure when at  \nleast one ingredient has been classified as a Category 1 or \nCategory 2 specific target organ toxicant (repeated exposure) a nd \nis present at or above the appropriate generic concentration li mit as \nlaid out in Table 3.9.4 for Category 1 and 2 respectively.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 181}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 183  \nTable 3.9.4  \nGeneric concentration limits of ingredients of a mixture clas \xad\nsified as a specific target organ toxicant that trigger classifi \xad\ncation of the mixture  \nIngredient classified as:  Generic concentration limits triggering classifi\xad\ncation of the mixture as:  \nCategory 1  Category 2  \nCategory 1 \nSpecific Target Organ \nToxicant  Concentration ≥ \n10 %  1,0 % ≤ concen\xad\ntration < 10 %  \nCategory 2 \nSpecific Target Organ \nToxicant  Concentration ≥ \n10 % [(Note 1)]  \nNote 1  \nIf a Category 2 specific target organ toxicant is present in th e \nmixture as an ingredient at a concentration ≥ 1,0 % a SDS shall  \nbe available for the mixture upon request.  \n3.9.3.4.2. These generic concentration limits and consequent cl assifications \napply to repeated-dose target organ toxicants.  \n3.9.3.4.3. Mixtures shall be classified for either or both sing le- and repeated- \ndose toxicity independently.  \n3.9.3.4.4. Care shall be exercised when toxicants affecting mor e than one \norgan system are combined that the potentiation or synergistic inter\xad\nactions are considered, because certain substances can cause ta rget \norgan toxicity at < 1 % concentration when other ingredients in  the \nmixture are known to potentiate its toxic effect.  \n3.9.4.  Hazard Communication  \n3.9.4.1. Label elements shall be used in accordance with Table 3.9.5 for \nsubstances or mixtures meeting the criteria for classification in this \nhazard class.  \nTable 3.9.5  \nLabel elements for specific target organ toxicity after repeated \nexposure  \nClassification  Category 1  Category 2  \nGHS Pictograms\n  \nSignal word  Danger  Warning  \nHazard Statement  H372: Causes damage \nto organs (state all \norgans affected, if \nknown) through \nprolonged or repeated \nexposure (state route \nof exposure if it is \nconclusively proven \nthat no other routes of \nexposure cause the \nhazard)  H373: May cause \ndamage to organs \n(state all organs \naffected, if known) \nthrough prolonged or \nrepeated exposure \n(state route of \nexposure if it is \nconclusively proven \nthat no other routes of \nexposure cause the \nhazard)  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 182}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 184  \nClassification  Category 1  Category 2  \nPrecautionary \nStatement \nPrevention  P260 \nP264 \nP270  P260  \nPrecautionary \nStatement \nResponse  P314  P314  \nPrecautionary \nStatement Storage  \nPrecautionary \nStatement \nDisposal  P501  P501  \n3.10.  Aspiration hazard  \n3.10.1.  Definitions and general considerations  \n3.10.1.1. These criteria provide a means of classifying substan ces or mixtures \nthat may pose an aspiration toxicity hazard to humans.  \n3.10.1.2. ‘Aspiration’ means the entry of a liquid or solid sub stance or \nmixture directly through the oral or nasal cavity, or indirectl y \nfrom vomiting, into the trachea and lower respiratory system.  \n▼M19  \n3.10.1.3. Aspiration hazard means severe acute effects such as chemical \npneumonia, pulmonary injury or death occurring after aspiration  \nof a substance or mixture.  \n▼B \n3.10.1.4. Aspiration is initiated at the moment of inspiration,  in the time \nrequired to take one breath, as the causative material lodges a t \nthe crossroad of the upper respiratory and digestive tracts in the \nlaryngopharyngeal region.  \n3.10.1.5. Aspiration of a substance or mixture can occur as it is vomited \nfollowing ingestion. This has consequences for labelling, parti cu\xad\nlarly where, due to acute toxicity, a recommendation may be \nconsidered to induce vomiting after ingestion. However, if the \nsubstance/mixture also presents an aspiration toxicity hazard, the \nrecommendation to induce vomiting shall be modified.  \n3.10.1.6.  Specific considerations  \n3.10.1.6.1. A review of the medical literature on chemical aspi ration revealed \nthat some hydrocarbons (petroleum distillates) and certain chlo r\xad\ninated hydrocarbons have been shown to pose an aspiration \nhazard in humans.  \n3.10.1.6.2. The classification criteria refer to kinematic visc osity. The \nfollowing provides the conversion between dynamic and \nkinematic viscosity:  \nDynamic viscosity  ðmPa sÞ \nDensity ðg=cm 3 Þ ¼ Kinematic viscosity  ðmm  2=sÞ \n▼M2 \n3.10.1.6.2a Although the definition of aspiration in section 3. 10.1.2 includes \nthe entry of solids into the respiratory system, classification  \naccording to point (b) in Table 3.10.1 for Category 1 is intend ed \nto apply to liquid substances and mixtures only.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 183}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 185  \n3.10.1.6.3. C l a s s i f i c a t i o n o f a e r o s o l / m i  s t p r o d u c t s  \nAerosol and mist forms of a substance or a mixture (product) ar e \nusually dispensed in containers such as self-pressurised contai ners, \ntrigger and pump sprayers. The key to classifying these product s is \nwhether a pool of product is formed in the mouth, which then ma y \nbe aspirated. If the mist or aerosol from a pressurised contain er is \nfine, a pool may not be formed. On the other hand, if a pressur ised \ncontainer dispenses product in a stream, a pool may be formed t hat \nmay then be aspirated. Usually, the mist produced by trigger an d \npump sprayers is coarse and therefore, a pool may be formed tha t \nthen may be aspirated. When the pump mechanism may be \nremoved, and the contents are available to be swallowed then th e \nclassification of the substance or mixture shall be considered.  \n3.10.2.  Classification criteria for substances  \nTable 3.10.1  \nHazard category for aspiration toxicity  \nCategory  Criteria  \nCategory 1  Substances known to cause human aspiration \ntoxicity hazards or to be regarded as if they cause \nhuman aspiration toxicity hazard \nA substance is classified in Category 1: \n(a) based on reliable and good quality human \nevidence \nor \n(b) if it is a hydrocarbon and has a kinematic \nviscosity of 20,5 mm  2 /s or less, measured at \n40 o C. \nNote:  \nSubstances in Category 1 include but are not limited to certain  \nhydrocarbons, turpentine and pine oil.  \n3.10.3.  Classification criteria for mixtures  \n3.10.3.1.  Classification when data are available for the complete mixture  \nA mixture is classified in Category 1 based on reliable and goo d \nquality human evidence.  \n3.10.3.2.  Classification when data are not available for the complete mixture: \nbridging principles  \n3.10.3.2.1. Where the mixture itself has not been tested to det ermine its \naspiration toxicity, but there are sufficient data on the indiv idual \ningredients and similar tested mixtures to adequately character ise the \nhazard of the mixture, these data shall be used in accordance w ith \nthe bridging principles set out in section 1.1.3. However, in t he case \nof application of the dilution bridging principle, the concentr ation of \naspiration toxicant(s) shall be 10 % or more.  \n3.10.3.3.  Classification when data are available for all components or only \nsome components of the mixture  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 184}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 186  \n3.10.3.3.1. C a t e g o r y 1  \n▼M19  \n3.10.3.3.1.1. The ‘relevant ingredients’ of a mixture are those  which are present \nin concentrations ≥ 1 %.  \n3.10.3.3.1.2. A mixture is classified as Category 1 when the su m of the concen\xad\ntrations of Category 1 ingredients is ≥ 10 % and the mixture ha s a \nkinematic viscosity ≤ 20,5 mm  2 /s, measured at 40 °C.  \n3.10.3.3.1.3. In the case of a mixture which separates into two  or more distinct \nlayers, the entire mixture is classified as Category 1 if in an y \ndistinct layer the sum of the concentrations of Category \n1 ingredients is ≥ 10 %, and it has a kinematic viscosity \n≤ 20,5 mm  2 /s, measured at 40 °C.  \n▼B \n3.10.4.  Hazard Communication  \n3.10.4.1. Label elements shall be used for substances or mixtur es meeting the \ncriteria for classification in this hazard class in accordance with \nTable 3.10.2.  \nTable 3.10.2  \nAspiration toxicity label elements  \nClassification  Category 1  \nGHS Pictogram\n  \nSignal Word  Danger  \nHazard Statement  H304: May be fatal if \nswallowed and enters airways  \nPrecautionary Statement \nPrevention  \nPrecautionary Statement \nResponse  P301 + P310 \nP331  \nPrecautionary Statement \nStorage  P405  \nPrecautionary Statement \nDisposal  P501 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 185}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 187  \n4. PART 4: ENVIRONMENTAL HAZARDS  \n4.1. Hazardous to the aquatic environment  \n4.1.1.  Definitions and general considerations  \n4.1.1.1.  Definitions  \n(a) ‘acute aquatic toxicity’ means the intrinsic property of a \nsubstance to be injurious to an aquatic organism in a short- \nterm aquatic exposure to that substance.  \n(b) ‘►M12  short-term (acute) hazard ◄’ means for classification \npurposes the hazard of a substance or mixture caused by its \nacute toxicity to an organism during short-term aquatic \nexposure to that substance or mixture.  \n(c) ‘availability of a substance’ means the extent to which thi s \nsubstance becomes a soluble or disaggregate species. For \nmetal availability, the extent to which the metal ion portion \nof a metal (M°) compound can disaggregate from the rest of \nthe compound (molecule).  \n(d) ‘bioavailability’ or ‘biological availability’ means the ex tent to \nwhich a substance is taken up by an organism, and distributed \nto an area within the organism. It is dependent upon physico- \nchemical properties of the substance, anatomy and physiology \nof the organism, pharmacokinetics, and route of exposure. \nAvailability is not a prerequisite for bioavailability.  \n(e) ‘bioaccumulation’ means the net result of uptake, trans\xad\nformation and elimination of a substance in an organism due \nto all routes of exposure (i.e. air, water, sediment/soil and \nfood).  \n(f) ‘bioconcentration’ means the net result of uptake, trans\xad\nformation and elimination of a substance in an organism due \nto waterborne exposure.  \n(g) ‘chronic aquatic toxicity’ means the intrinsic property of a \nsubstance to cause adverse effects to aquatic organisms \nduring aquatic exposures which are determined in relation to \nthe life-cycle of the organism.  \n(h) ‘degradation’ means the decomposition of organic molecules \nto smaller molecules and eventually to carbon dioxide, water \nand salts.  \n(i) ‘EC  x ’ means the effect concentration associated with x% \nresponse.  \n(j) ‘►M12  long-term (chronic) hazard ◄’ means for classifi\xad\ncation purposes the hazard of a substance or mixture caused \nby its chronic toxicity following long-term exposure in the \naquatic environment.  \n(k) ‘no observed effect concentration (NOEC)’ means the test \nconcentration immediately below the lowest tested concen\xad\ntration with statistically significant adverse effect. The NOEC  \nhas no statistically significant adverse effect compared to the  \ncontrol.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 186}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 188  \n4.1.1.2.  Basic elements  \n4.1.1.2.0.  ►M12  Hazardous to the aquatic environment is differentiated \ninto: \n— short-term (acute) aquatic hazard  \n— long-term (chronic) aquatic hazard. ◄  \n4.1.1.2.1. The basic elements used for classification for aquat ic environmen\xad\ntal hazards are:  \n— acute aquatic toxicity,  \n— chronic aquatic toxicity,  \n— potential for or actual bioaccumulation, and  \n— degradation (biotic or abiotic) for organic chemicals.  \n4.1.1.2.2. Preferably data shall be derived using the standardi sed test \nmethods referred to in Article 8(3). In practice data from othe r \nstandardised test methods such as national methods shall also b e \nused where they are considered as equivalent. Where valid data are \navailable from non-standard testing and from non-testing method s, \nthese shall be considered in classification provided they fulfi l the \nrequirements specified in section 1 of Annex XI to Regulation \n(EC) No 1907/2006. In general, both freshwater and marine \nspecies toxicity data are considered suitable for use in classi fi\xad\ncation provided the test methods used are equivalent. Where \nsuch data are not available classification shall be based on th e \nbest available data. See also Part 1 of Annex I to Regulation \n(EC) No 1272/2008.  \n4.1.1.3.  Other considerations  \n4.1.1.3.1. Classification of substances and mixtures for enviro nmental \nhazards requires the identification of the hazards they present  to \nthe aquatic environment.  ►M12  The aquatic environment is \nconsidered in terms of the aquatic organisms that live in the \nwater, and the aquatic ecosystem of which they are part. The \nbasis, therefore, of the identification of short-term (acute) a nd \nlong-term (chronic) hazards is the aquatic toxicity of the \nsubstance or mixture, although this shall be modified by taking  \naccount of further information on the degradation and bioaccumu \xad\nlation behaviour, if appropriate. ◄  \n4.1.1.3.2. While the classification system applies to all subst ances and \nmixtures, it is recognised that for special cases (e.g. metals)  the \nEuropean Chemicals Agency has issued guidance.  \n4.1.2.  Classification criteria for substances  \n4.1.2.1.  ►M12  The system for classification recognises that the intrinsic \nhazard to aquatic organisms is represented by both the acute an d \nchronic toxicity of a substance. For the long-term (chronic) ha zard, \nseparate hazard categories are defined representing a gradation  in \nthe level of hazard identified. ◄ The lowest of the available \ntoxicity values between and within the different trophic levels  \n(fish, crustacean, algae/aquatic plants) shall normally be used  to \ndefine the appropriate hazard category(ies). There are circum\xad\nstances, however, when a weight of evidence approach is appro\xad\npriate.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 187}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 189  \n4.1.2.2.  ►M12  The core classification system for substances consists of \none short-term (acute) hazard classification category and three  \nlong-term (chronic) hazard classification categories. The short - \nterm (acute) and long-term (chronic) classification categories are \napplied independently. ◄  \n4.1.2.3.  ►M12  The criteria for classification of a substance in Acute 1 are \ndefined on the basis of acute aquatic toxicity data only (EC50 or \nLC 50). The criteria for classification of a substance into Chr onic 1 \nto 3 follow a tiered approach where the first step is to see if  \navailable information on chronic toxicity merits long-term \n(chronic) hazard classification. In absence of adequate chronic  \ntoxicity data, the subsequent step is to combine two types of \ninformation, i.e. acute aquatic toxicity data and environmental  \nfate data (degradability and bioaccumulation data) (see Figure \n4.1.1). ◄  \nFigure 4.1.1  \n▼M12  \nCategories for substances long-term (chronic) hazardous to the aquatic environment  \n▼M2\n \n4.1.2.4.  ►M12  The system also introduces a ‘safety net’ classification \n(referred to as Chronic 4) for use when the data available do n ot \nallow classification under the formal criteria for Acute 1 or \nChronic 1 to 3 but there are nevertheless some grounds for \nconcern (see example Table 4.1.0). ◄  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 188}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 190  \n4.1.2.5. Substances with acute toxicities below 1 mg/l or chron ic toxicities \nbelow 0,1 mg/l (if non-rapidly degradable) and 0,01 mg/l (if \nrapidly degradable) contribute as components of a mixture to th e \ntoxicity of the mixture even at a low concentration and shall \nnormally be given increased weight in applying the summation \nof classification approach (see note 1 of Table 4.1.0 and secti on \n4.1.3.5.5).  \n4.1.2.6. The criteria for classifying and categorising substanc es as ‘haz\xad\nardous to the aquatic environment’ are summarised in Table 4.1. 0. \n▼M12  \nTable 4.1.0  \nClassification categories for substances hazardous to the aquatic environment  \n(a) Short-term (acute) aquatic hazard  \nCategory Acute 1:  (Note 1)  \n96 hr LC  50 (for fish)  ≤ 1 mg/l and/or  \n48 hr EC  50 (for crustacea)  ≤ 1 mg/l and/or  \n72 or 96 hr ErC  50 (for algae \nor other aquatic plants)  ≤ 1 mg/l.  (Note 2)  \n(b) Long-term (chronic) aquatic hazard  \n(i) Non-rapidly degradable substances (Note 3) for which there are adequate \nchronic toxicity data available  \nCategory Chronic 1:  (Note 1)  \nChronic NOEC or EC  x \n(for fish)  ≤ 0,1 mg/l and/or  \nChronic NOEC or EC  x \n(for crustacea)  ≤ 0,1 mg/l and/or  \nChronic NOEC or EC  x \n(for algae or other \naquatic plants)  ≤ 0,1 mg/l.  \nCategory Chronic 2:  \nChronic NOEC or EC  x \n(for fish)  ≤ 1 mg/l and/or  \nChronic NOEC or EC  x \n(for crustacea)  ≤ 1 mg/l and/or  \nChronic NOEC or EC  x \n(for algae or other \naquatic plants)  ≤ 1 mg/l.  \n(ii) Rapidly degradable substances (Note 3) for which there are  adequate \nchronic toxicity data available  \nCategory Chronic 1:  (Note 1)  \nChronic NOEC or EC  x \n(for fish)  ≤ 0,01 mg/l and/or  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 189}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 191  \nChronic NOEC or EC  x \n(for crustacea)  ≤ 0,01 mg/l and/or  \nChronic NOEC or EC  x \n(for algae or other \naquatic plants)  ≤ 0,01 mg/l.  \nCategory Chronic 2:  \nChronic NOEC or EC  x \n(for fish)  ≤ 0,1 mg/l and/or  \nChronic NOEC or EC  x \n(for crustacea)  ≤ 0,1 mg/l and/or  \nChronic NOEC or EC  x \n(for algae or other \naquatic plants)  ≤ 0,1 mg/l.  \nCategory Chronic 3:  \nChronic NOEC or EC  x \n(for fish)  ≤ 1 mg/l and/or  \nChronic NOEC or EC  x \n(for crustacea)  ≤ 1 mg/l and/or  \nChronic NOEC or EC  x \n(for algae or other \naquatic plants)  ≤ 1 mg/l.  \n(iii) Substances for which adequate chronic toxicity data are n ot available  \nCategory Chronic 1:  (Note 1)  \n96 hr LC  50 (for fish)  ≤ 1 mg/l and/or  \n48 hr EC  50 (for crustacea)  ≤ 1 mg/l and/or  \n72 or 96 hr ErC  50 (for \nalgae or other aquatic \nplants)  ≤ 1 mg/l.  (Note 2)  \nand the substance is not rapidly degradable and/or the experime ntally \ndetermined BCF ≥ 500  \n(or, if absent, the log K  ow \n≥ 4).  (Note 3).  \nCategory Chronic 2:  \n96 hr LC  50 (for fish)  > 1 to ≤ 10 mg/l and/or  \n48 hr EC  50 (for crustacea)  > 1 to ≤ 10 mg/l and/or  \n72 or 96 hr ErC  50 (for \nalgae or other aquatic \nplants)  > 1 to ≤ 10 mg/l.  (Note 2)  \nand the substance is not rapidly degradable and/or the experime ntally \ndetermined BCF ≥ 500  \n(or, if absent, the log K  ow \n≥ 4).  (Note 3).  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 190}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 192  \nCategory Chronic 3:  \n96 hr LC  50 (for fish)  > 10 to ≤ 100 mg/l and/or  \n48 hr EC  50 (for crustacea)  > 10 to ≤ 100 mg/l and/or  \n72 or 96 hr ErC  50 (for \nalgae or other aquatic \nplants)  > 10 to ≤ 100 mg/l.  (Note 2)  \nand the substance is not rapidly degradable and/or the experime ntally \ndetermined BCF ≥ 500  \n(or, if absent, the log K  ow \n≥ 4).  (Note 3).  \n‘Safety net’ classification  \nCategory Chronic 4  \nCases when data do not allow classification under the above cri teria but there are \nnevertheless some grounds for concern. This includes, for examp le, poorly soluble \nsubstances for which no acute toxicity is recorded at levels up  to the water \nsolubility (note 4), and which are not rapidly degradable in ac cordance with \nSection 4.1.2.9.5 and have an experimentally determined BCF ≥ 5 00 (or, if \nabsent, a log Kow ≥ 4), indicating a potential to bioaccumulate , which will be \nclassified in this category unless other scientific evidence ex ists showing classifi\xad\ncation to be unnecessary. Such evidence includes chronic toxici ty NOECs > water \nsolubility or > 1 mg/l, or other evidence of rapid degradation in the environment \nthan the ones provided by any of the methods listed in Section 4.1.2.9.5.  \n▼M2 \nNote 1:  \nWhen classifying substances as Acute Category 1 and/or Chronic \nCategory 1 it is necessary at the same time to indicate the app ro\xad\npriate M-factor(s) (see Table 4.1.3).  \nNote 2:  \nClassification shall be based on the ErC  50 [= EC  50 (growth rate)]. \nIn circumstances where the basis of the EC  50 is not specified or no \nErC  50 is recorded, classification shall be based on the lowest EC  50 \navailable.  \nNote 3:  \nWhen no useful data on degradability are available, either expe ri\xad\nmentally determined or estimated data, the substance should be \nregarded as not rapidly degradable.  \nNote 4:  \n‘No acute toxicity’ is taken to mean that the L(E)C  50 (s) is/are \nabove the water solubility. Also for poorly soluble substances,  \n(water solubility < 1 mg/l), where there is evidence that the \nacute test does not provide a true measure of the intrinsic tox icity.  \n4.1.2.7.  Aquatic toxicity  \n4.1.2.7.1. Acute aquatic toxicity is normally determined using a fish 96-hour \nLC 50 , a crustacea species 48-hour EC  50 and/or an algal species 72- \nor 96-hour EC  50 . These species cover a range of trophic levels and \ntaxa and are considered as surrogate for all aquatic organisms.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 191}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 193  \nData on other species (e.g. Lemna spp.) shall also be considere d if \nthe test methodology is suitable. The aquatic plant growth \ninhibition tests are normally considered as chronic tests but t he \nEC 50 s are treated as acute values for classification purposes (see \nnote 2).  \n4.1.2.7.2. For determining chronic aquatic toxicity for classif ication purposes \ndata generated according to the standardised test methods refer red \nto in Article 8(3) shall be accepted, as well as results obtain ed \nfrom other validated and internationally accepted test methods.  The \nNOECs or other equivalent EC  x (e.g. EC  10 ) shall be used.  \n4.1.2.8.  Bioaccumulation  \n4.1.2.8.1. Bioaccumulation of substances within aquatic organis ms can give \nrise to toxic effects over longer time scales even when actual water \nconcentrations are low. For organic substances the potential fo r \nbioaccumulation shall normally be determined by using the \noctanol/water partition coefficient, usually reported as a log K ow . \nThe relationship between the log K  ow of an organic substance and \nits bioconcentration as measured by the bioconcentration factor  \n(BCF) in fish has considerable scientific literature support. U sing \na cut-off value of log K  ow ≥ 4 is intended to identify only those \nsubstances with a real potential to bioconcentrate. While this \nrepresents a potential to bioaccumulate, an experimentally \ndetermined BCF provides a better measure and shall be used in \npreference if available. A BCF in fish of ≥ 500 is indicative o f the \npotential to bioconcentrate for classification purposes. Some r ela\xad\ntionships can be observed between chronic toxicity and bioac\xad\ncumulation potential, as toxicity is related to the body burden . \n4.1.2.9.  Rapid degradability of organic substances  \n4.1.2.9.1. Substances that rapidly degrade can be quickly remov ed from the \nenvironment. While effects of such substances can occur, partic u\xad\nlarly in the event of a spillage or accident, they are localise d and \nof short duration. In the absence of rapid degradation in the e nvi\xad\nronment a substance in the water has the potential to exert tox icity \nover a wide temporal and spatial scale.  \n4.1.2.9.2. One way of demonstrating rapid degradation utilises the biodegra\xad\ndation screening tests designed to determine whether an organic  \nsubstance is ‘readily biodegradable’. Where such data are not \navailable, a BOD(5 days)/COD ratio ≥ 0,5 is considered as \nindicative of rapid degradation. Thus, a substance which passes  \nthis screening test is considered likely to biodegrade ‘rapidly ’ in \nthe aquatic environment, and is thus unlikely to be persistent.  \nHowever, a fail in the screening test does not necessarily mean  \nthat the substance will not degrade rapidly in the environment.  \nOther evidence of rapid degradation in the environment may \ntherefore also be considered and are of particular importance \nwhere the substances are inhibitory to microbial activity at th e \nconcentration levels used in standard testing. Thus, a further clas\xad\nsification criterion is included which allows the use of data t o \nshow that the substance did actually degrade biotically or \nabiotically in the aquatic environment by > 70 % in 28 days. \nThus, if degradation is demonstrated under environmentally \nrealistic conditions, then the criterion of ‘rapid degradabilit y’ is \nmet. \n4.1.2.9.3. Many degradation data are available in the form of d egradation \nhalf-lives and these can be used in defining rapid degradation \nprovided that ultimate biodegradation of the substance, i.e. fu ll \nmineralisation, is achieved. Primary biodegradation does not \nnormally suffice in the assessment of rapid degradability unles s \nit can be demonstrated that the degradation products do not \nfulfil the criteria for classification as hazardous to the aqua tic \nenvironment.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 192}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 194  \n4.1.2.9.4. The criteria used reflect the fact that environmenta l degradation \nmay be biotic or abiotic. Hydrolysis can be considered if the \nhydrolysis products do not fulfil the criteria for classificati on as \nhazardous to the aquatic environment.  \n4.1.2.9.5. Substances are considered rapidly degradable in the environment if \none of the following criteria holds true:  \n(a) if, in 28-day ready biodegradation studies, at least the \nfollowing levels of degradation are achieved:  \n(i) tests based on dissolved organic carbon: 70 %;  \n(ii) tests based on oxygen depletion or carbon dioxide gener\xad\nation: 60 % of theoretical maximum.  \nThese levels of biodegradation must be achieved within 10 \ndays of the start of degradation which point is taken as the \ntime when 10 % of the substance has been degraded, unless \nthe substance is identified as an UVCB or as a complex, multi- \nconstituent substance with structurally similar constituents. I n \nthis case, and where there is sufficient justification, the 10- day \nwindow condition may be waived and the pass level applied at \n28 days; or  \n(b) if, in those cases where only BOD and COD data are \navailable, when the ratio of BOD  5 /COD is ≥ 0,5; or  \n(c) if other convincing scientific evidence is available to dem on\xad\nstrate that the substance can be degraded (biotically and/or \nabiotically) in the aquatic environment to a level > 70 % \nwithin a 28-day period.  \n4.1.2.10.  Inorganic compounds and metals  \n4.1.2.10.1. For inorganic compounds and metals, the concept of degradability \nas applied to organic compounds has limited or no meaning. \nRather, such substances may be transformed by normal environ\xad\nmental processes to either increase or decrease the bioavailabi lity \nof the toxic species. Equally the use of bioaccumulation data s hall \nbe treated with care (  1 ). \n4.1.2.10.2. Poorly soluble inorganic compounds and metals may b e acutely or \nchronically toxic in the aquatic environment depending on the \nintrinsic toxicity of the bioavailable inorganic species and th e \nrate and amount of this species which enter solution. All \nevidence must be weighed in a classification decision. This \nwould be especially true for metals showing borderline results in \nthe Transformation/Dissolution Protocol.  \n4.1.3.  Classification criteria for mixtures  \n4.1.3.1. The classification system for mixtures covers all clas sification \ncategories which are used for substances, i.e. categories Acute  1  \nand Chronic 1 to 4. In order to make use of all available data for \npurposes of classifying the aquatic environmental hazards of th e \nmixture, the following is applied where appropriate:  \nThe ‘relevant components’ of a mixture are those which are clas \xad\nsified ‘Acute 1’or ‘Chronic 1’ and present in a concentration o f \n0,1 % (w/w) or greater, and those which are classified ‘Chronic  2’, \n‘Chronic 3’ or ‘Chronic 4’ and present in a concentration of 1 % \n(w/w) or greater, unless there is a presumption (such as in the  case ▼M2 \n( 1 ) Specific guidance has been issued by the European Chemicals A gency on how these data \nfor such substances may be used in meeting the requirements of the classification criteria.', metadata={'source': 'data/ycla_en.pdf', 'page': 193}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 195  \nof highly toxic components (see section 4.1.3.5.5.5)) that a \ncomponent present in a lower concentration can still be relevan t \nfor classifying the mixture for aquatic environmental hazards. \nGenerally, for substances classified as ‘Acute 1’ or ‘Chronic 1 ’ \nthe concentration to be taken into account is (0,1/M) %. (For \nexplanation M-factor see section 4.1.3.5.5.5.)  \n4.1.3.2. The approach for classification of aquatic environment al hazards is \ntiered, and is dependent upon the type of information available  for \nthe mixture itself and for its components. Figure 4.1.2 outline s the \nprocess to be followed.  \nElements of the tiered approach include:  \n— classification based on tested mixtures,  \n— classification based on bridging principles,  \n— the use of ‘summation of classified components’ and/or an \n‘additivity formula’.  \n▼M12  \nFigure 4.1.2  \nTiered approach to classification of mixtures for short-term (acute) and long-term (chronic) aquatic \nenvironmental hazards\n  \n▼M2 \n4.1.3.3.  Classification of mixtures when toxicity data are available for the \ncomplete mixture  \n4.1.3.3.1. When the mixture as a whole has been tested to deter mine its \naquatic toxicity, this information can be used for classifying the \nmixture according to the criteria that have been agreed for \nsubstances. The classification is normally based on the data fo r \nfish, crustacea and algae/plants (see sections 4.1.2.7.1 and \n4.1.2.7.2). When adequate acute or chronic toxicity data for th e \nmixture as a whole are lacking, ‘bridging principles’ or ‘sum\xad\nmation method’ should be applied (see sections 4.1.3.4 and \n4.1.3.5).  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 194}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 196  \n4.1.3.3.2.  ►M12  The long-term (chronic) hazard classification of mixtures \nrequires additional information on degradability and in certain  \ncases bioaccumulation. ◄ Degradability and bioaccumulation \ntests for mixtures are not used as they are usually difficult t o \ninterpret, and such tests may be meaningful only for single \nsubstances.  \n4.1.3.3.3. C l a s s i f i c a t i o n f o r c a t e g o r y A c u t e 1  \n(a) When there are adequate acute toxicity test data (LC  50 or \nEC 50 ) available for the mixture as a whole showing \nL(E)C  50 ≤ 1 mg/l:  \nClassify mixture as Acute 1 in accordance with point (a) of \nTable 4.1.0.  \n(b) When there are acute toxicity test data (LC  50 (s) or EC  50 (s)) \navailable for the mixture as a whole showing L(E)C  50 (s) > \n1 mg/l for normally all trophic levels:  \n▼M12  \nNo need to classify for short-term (acute) hazard.  \n▼M2 \n4.1.3.3.4. C l a s s i f i c a t i o n f o r c a t e g o r i e s C h r o n i c 1 , 2 a n d 3  \n(a) When there are adequate chronic toxicity data (EC  x x or \nNOEC) available for the mixture as a whole showing EC  x \nor NOEC of the tested mixture ≤ 1mg/l:  \n(i) Classify the mixture as Chronic 1, 2 or 3 in accordance \nwith point (b)(ii) of Table 4.1.0 as rapidly degradable if \nthe available information allows the conclusion that all \nrelevant components of the mixture are rapidly \ndegradable;  \n(ii) Classify the mixture as Chronic 1 or 2 in all other cases \nin accordance with point (b)(i) of Table 4.1.0 as non- \nrapidly degradable;  \n(b) When there are adequate chronic toxicity data (EC  x or \nNOEC) available for the mixture as a whole showing \nEC x (s) or NOEC(s) of the tested mixture > 1 mg/l for \nnormally all trophic levels:  \n▼M12  \nNo need to classify for long-term (chronic) hazard in \ncategories Chronic 1, 2 or 3.  \n▼M2 \n4.1.3.3.5. C l a s s i f i c a t i o n f o r c a t e g o r y C h r o n i c 4  \nIf there are nevertheless reasons for concern:  \nClassify the mixture as Chronic 4 (safety net classification) i n \naccordance with Table 4.1.0.  \n4.1.3.4.  Classification of mixtures when toxicity data are not available for \nthe complete mixture: bridging principles  \n4.1.3.4.1. Where the mixture itself has not been tested to dete rmine its \naquatic environmental hazard, but there are sufficient data on the \nindividual components and similar tested mixtures to adequately  \ncharacterise the hazards of the mixture, this data shall be use d in \naccordance with the bridging rules set out in section 1.1.3. \nHowever, in relation to application of the bridging rule for \ndilution, sections 4.1.3.4.2 and 4.1.3.4.3 shall be used.  \n4.1.3.4.2. Dilution: if a mixture is formed by diluting another  tested mixture \nor a substance classified for its aquatic environmental hazard with \na diluent which has an equivalent or lower aquatic hazard class ifi\xad\ncation than the least toxic original component and which is not  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 195}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 197  \nexpected to affect the aquatic hazards of other components, the n \nthe resulting mixture may be classified as equivalent to the or iginal \ntested mixture or substance. Alternatively, the method explaine d in \nsection 4.1.3.5 may be applied.  \n▼M4 \n4.1.3.4.3. If a mixture is formed by diluting another tested mi xture or \nsubstance with water or other totally non-toxic material, the \ntoxicity of the mixture can be calculated from the original \nmixture or substance.  \n▼M2 \n4.1.3.5.  Classification of mixtures when toxicity data are available for \nsome or all components of the mixture  \n4.1.3.5.1. The classification of a mixture is based on summatio n of the \nconcentration of its classified components. The percentage of \ncomponents classified as ‘Acute’ or ‘Chronic’ is fed straight i n \nto the summation method. Details of the summation method are \ndescribed in section 4.1.3.5.5.  \n4.1.3.5.2. Mixtures can be made of a combination of both compon ents that \nare classified (as Acute 1 and/or Chronic 1, 2, 3, 4) and other s for \nwhich adequate toxicity test data is available. When adequate \ntoxicity data are available for more than one component in the \nmixture, the combined toxicity of those components is calculate d \nusing the following additivity formulas (a) or (b), depending o n the \nnature of the toxicity data:  \n(a) Based on acute aquatic toxicity:  \nP Ci \nLðEÞC 50m ¼ X  \nn Ci \nLðEÞC 50i \nwhere:  \nC i = concentration of component i (weight \npercentage);  \nL(E)C  50i = (mg/l) LC  50 or EC  50 for component i;  \nη = number of components, and i is running \nfrom 1 to n;  \nL(E)C  50m = L(E) C  50 of the part of the mixture with \ntest data.  \n▼M12  \nThe calculated toxicity may be used to assign that portion of \nthe mixture a short-term (acute) hazard category which is then \nsubsequently used in applying the summation method;  \n▼M2 \n(b) Based on chronic aquatic toxicity:  \nP Ci þ P Cj \nEqNOECm ¼ X  \nn Ci \nNOECi þ X  \nn Cj \n0,1 Ü NOECj  \nwhere:  \nC i = concentration of component i (weight \npercentage) covering the rapidly \ndegradable components;  \nCj = concentration of component j (weight \npercentage) covering the non- rapidly \ndegradable components;  \nNOECi = NOEC (or other recognised measures for \nchronic toxicity) for component i covering \nthe rapidly degradable components, in \nmg/l;  \nNOECj = NOEC (or other recognised measures for \nchronic toxicity) for component j covering \nthe non-rapidly degradable components, in \nmg/l;  \nn = number of components, and i and j are \nrunning from 1 to n;  \nEqNOECm = Equivalent NOEC of the part of the \nmixture with test data.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 196}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 198  \nThe equivalent toxicity thus reflects the fact that non-rapidly  \ndegrading substances are classified one hazard category level \nmore ‘severe’ than rapidly degrading substances.  \n▼M12  \nThe calculated equivalent toxicity may be used to assign that \nportion of the mixture a long-term (chronic) hazard category, \nin accordance with the criteria for rapidly degradable \nsubstances (point (b)(ii) of Table 4.1.0), which is then \nsubsequently used in applying the summation method.  \n▼M2 \n4.1.3.5.3. When applying the additivity formula for part of the  mixture, it is \npreferable to calculate the toxicity of this part of the mixtur e using \nfor each substance toxicity values that relate to the same \ntaxonomic group (i.e. fish, crustacean, algae or equivalent) an d \nthen to use the highest toxicity (lowest value) obtained (i.e. use \nthe most sensitive of the three taxonomic groups). However, whe n \ntoxicity data for each component are not available in the same \ntaxonomic group, the toxicity value of each component is \nselected in the same manner that toxicity values are selected f or \nthe classification of substances, i.e. the higher toxicity (fro m the \nmost sensitive test organism) is used. The calculated acute and  \nchronic toxicity is then used to assess whether this part of th e \nmixture shall be classified as Acute 1 and/or Chronic 1, 2 or 3  \nusing the same criteria described for substances.  \n4.1.3.5.4. If a mixture is classified in more than one way, the  method \nyielding the more conservative result shall be used.  \n4.1.3.5.5. S u m m a t i o n m e t h o d  \n4.1.3.5.5.1.  R a t i o n a l e  \n4.1.3.5.5.1.1. In case of the substance classification categori es Chronic 1 to \nChronic 3, the underlying toxicity criteria differ by a factor of \n10 in moving from one category to another. Substances with a \nclassification in a high toxicity band therefore contribute to the \nclassification of a mixture in a lower band. The calculation of  \nthese classification categories therefore needs to consider the  \ncontribution of any substance classified as Chronic 1, 2 or 3.  \n4.1.3.5.5.1.2. When a mixture contains components classified as  Acute 1 or \nChronic 1, attention must be paid to the fact that such compone nts, \nwhen their acute toxicity is below 1 mg/l and/or chronic toxici ty is \nbelow 0,1 mg/l (if non rapidly degradable) and 0,01 mg/l (if \nrapidly degradable) contribute to the toxicity of the mixture e ven \nat a low concentration. Active ingredients in pesticides often \npossess such high aquatic toxicity but also some other substanc es \nlike organometallic compounds. Under these circumstances the \napplication of the normal generic concentration limits leads to  an \n‘under-classification’ of the mixture. Therefore, multiplying f actors \nshall be applied to account for highly toxic components, as \ndescribed in section 4.1.3.5.5.5.  \n4.1.3.5.5.2.  C l a s s i f i c a t i o n p r o c e d u r e  \n4.1.3.5.5.2.1. In general a more severe classification for mixt ures overrides a less \nsevere classification, e.g. a classification with Chronic 1 ove rrides \na classification with Chronic 2. As a consequence, in this exam ple, \nthe classification procedure is already completed if the result  of the \nclassification is Chronic 1. A more severe classification than \nChronic 1 is not possible. Therefore it is not necessary to \nundergo the further classification procedure.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 197}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 199  \n4.1.3.5.5.3.  C l a s s i f i c a t i o n f o r c a t e g o r y A c u t e 1  \n▼M19  \n4.1.3.5.5.3.1. First, all components classified as Acute 1 are considered. If the \nsum of the concentrations (in %) of these components multiplied  \nby their corresponding M-factors is ≥ 25 % the whole mixture is  \nclassified as Acute 1.  \n▼M2 \n4.1.3.5.5.3.2.  ►M12  The classification of mixtures for short-term (acute) \nhazards based on this summation of classified components is \nsummarised in Table 4.1.1. ◄  \nTable 4.1.1  \n▼M12  \nClassification of a mixture for short-term (acute) hazards \nbased on summation of classified components  \n▼M2 \nSum of components classified as:  Mixture is classified as:  \nAcute 1 × M (  a ) ≥ 25 %  Acute 1  \n( a ) For explanation of the M-factor, see 4.1.3.5.5.5.  \n4.1.3.5.5.4.  C l a s s i f i c a t i o n f o r t h e c a t e g o r i e s C h r o n i c 1 , 2 , \n3 a n d 4  \n4.1.3.5.5.4.1. First all components classified as Chronic 1 are  considered. If the \nsum of the concentrations (in %) of these components multiplied  \nby their corresponding M-factors is equal to or greater than 25  %, \nthe mixture is classified as Chronic 1. If the result of the ca lcu\xad\nlation is a classification of the mixture as Chronic 1, the cla ssifi\xad\ncation procedure is completed.  \n4.1.3.5.5.4.2. In cases where the mixture is not classified as Chronic 1, classifi\xad\ncation of the mixture as Chronic 2 is considered. A mixture is \nclassified as Chronic 2 if 10 times the sum of the concentratio ns \n(in %) of all components classified as Chronic 1 multiplied by \ntheir corresponding M-factors plus the sum of the concentration s \n(in %) of all components classified as Chronic 2 is equal to or  \ngreater than 25 %. If the result of the calculation is classifi cation of \nthe mixture as Chronic 2, the classification process is complet ed. \n4.1.3.5.5.4.3. In cases where the mixture is not classified eit her as Chronic 1 or \nChronic 2, classification of the mixture as Chronic 3 is consid ered. \nA mixture is classified as Chronic 3 if 100 times the sum of th e \nconcentrations (in %) of all components classified as Chronic 1  \nmultiplied by their corresponding M-factors plus 10 times the s um \nof the concentrations (in %) of all components classified with \nChronic 2 plus the sum of the concentrations (in %) of all \ncomponents classified as Chronic 3 is ≥ 25 %.  \n4.1.3.5.5.4.4. If the mixture is still not classified in Chroni c 1, 2 or 3, classifi\xad\ncation of the mixture as Chronic 4 shall be considered. A mixtu re \nis classified as Chronic 4 if the sum of the concentrations (in  %) of \ncomponents classified as Chronic 1, 2, 3 and 4 is equal to or \ngreater than 25 %.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 198}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 200  \n4.1.3.5.5.4.5.  ►M12  The classification of mixtures for long-term (chronic) \nhazards, based on this summation of the concentrations of clas\xad\nsified components, is summarised in Table 4.1.2. ◄  \nTable 4.1.2  \n▼M12  \nClassification of a mixture for long-term (chronic) hazards, \nbased on summation of the concentration of classified \ncomponents  \n▼M2 \nSum of components classified as:  Mixture is classified as:  \nChronic 1 × M (  a ) ≥ 25 %  Chronic 1  \n(M × 10 × Chronic 1) + Chronic 2 \n≥ 25 %  Chronic 2  \n(M × 100 × Chronic 1) + (10 × \nChronic 2) + Chronic 3 ≥ 25 %  Chronic 3  \nChronic 1 + Chronic 2 + Chronic \n3 + Chronic 4 ≥ 25 %  Chronic 4  \n( a ) For explanation of the M-factor, see 4.1.3.5.5.5.  \n4.1.3.5.5.5.  M i x t u r e s w i t h h i g h l y t o x i c c o m p o n e n t s  \n4.1.3.5.5.5.1. Acute 1 and Chronic 1 components with toxicities  below 1 mg/l \nand/or chronic toxicities below 0,1 mg/l (if non-rapidly degrad able) \nand 0,01 mg/l (if rapidly degradable) contribute to the toxicit y of \nthe mixture even at a low concentration and shall normally be \ngiven increased weight in applying the summation of classificat ion \napproach. When a mixture contains components classified as Acut e \nor Chronic 1, one of the following shall be applied:  \n— the tiered approach described in sections 4.1.3.5.5.3 and \n4.1.3.5.5.4 using a weighted sum by multiplying the concen\xad\ntrations of Acute 1 and Chronic 1 components by a factor, \ninstead of merely adding up the percentages. This means that \nthe concentration of ‘Acute 1’ in the left column of Table 4.1. 1 \nand the concentration of ‘Chronic 1’ in the left column of \nTable 4.1.2 are multiplied by the appropriate multiplying \nfactor. The multiplying factors to be applied to these \ncomponents are defined using the toxicity value, as \nsummarised in Table 4.1.3. Therefore, in order to classify a \nmixture containing Acute/Chronic 1 components, the classifier \nneeds to be informed of the value of the M-factor in order to \napply the summation method,  \n— the additivity formula (see section 4.1.3.5.2) provided that \ntoxicity data are available for all highly toxic components in \nthe mixture and there is convincing evidence that all other \ncomponents, including those for which specific acute and/or \nchronic toxicity data are not available, are of low or no \ntoxicity and do not significantly contribute to the environmen\xad\ntal hazard of the mixture.  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 199}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 201  \nTable 4.1.3  \nMultiplying factors for highly toxic components of mixtures  \nAcute toxicity  M factor  Chronic toxicity  M factor  \nL(E)C  50 value (mg/l)  NOEC value (mg/l)  NRD (  a ) \ncomponents  RD (  b ) components  \n0,1 < L(E)C  50 ≤ 1 1  0,01 < NOEC ≤ 0,1  1  —  \n0,01 < L(E)C  50 ≤ 0,1  1 0  0,001 < NOEC ≤ 0,01  1 0  1  \n0,001 < L(E)C  50 ≤ 0,01  100  0,0001 < NOEC ≤ \n0,001  100 1 0  \n0,0001 < L(E)C  50 ≤ \n0,001  1 000  0,00001 < NOEC ≤ \n0,0001  1 000  100  \n0,00001 < L(E)C  50 ≤ \n0,0001  10 000  0,000001 < NOEC ≤ \n0,00001  10 000  1 000  \n(continue in factor 10 intervals)  (continue in factor 10 intervals)  \n( a ) Non-rapidly degradable. \n( b ) Rapidly degradable.  \n▼M2 \n4.1.3.6.  Classification of mixtures with components without any useable \ninformation  \n4.1.3.6.1.  ►M12  In the event that no useable information on short-term \n(acute) and/or long-term (chronic) aquatic hazard is available for \none or more relevant components, it is concluded that the mixtu re \ncannot be attributed to one or more definitive hazard \ncategory(ies). ◄ In this situation the mixture shall be classif ied \nbased on the known components only, with the additional \nstatement on the label and in the SDS that: ‘Contains x % of \ncomponents with unknown hazards to the aquatic environment’.  \n4.1.4.  Hazard communication  \n4.1.4.1. Label elements shall be used for substances or mixture s meeting \nthe criteria for classification in this hazard class in accorda nce with \nTable 4.1.4.  \n▼M12  \nTable 4.1.4  \nLabel elements for hazardous to the aquatic environment  \nSHORT-TERM (ACUTE) AQUATIC HAZARD  \nAcute 1  \nGHS Pictogram\n  \nSignal Word  Warning  \nHazard Statement  H400: Very toxic to aquatic life  \nPrecautionary Statement \nPrevention  P273  \nPrecautionary Statement \nResponse  P391 ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 200}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 202  \nSHORT-TERM (ACUTE) AQUATIC HAZARD  \nAcute 1  \nPrecautionary Statement Storage  \nPrecautionary Statement \nDisposal  P501  \nLONG-TERM (CHRONIC) AQUATIC HAZARD  \nChronic 1  Chronic 2  Chronic 3  Chronic 4  \nGHS Pictograms\n  No pictogram \nis used  No pictogram \nis used  \nSignal Word  Warning  No signal \nword is used  No signal \nword is used  No signal \nword is used  \nHazard \nStatement  H410: Very \ntoxic to \naquatic life \nwith long \nlasting effects  H411: Toxic \nto aquatic life \nwith long \nlasting effects  H412: \nHarmful to \naquatic life \nwith long \nlasting effects  H413: May \ncause long \nlasting harmful \neffects to \naquatic life  \nPrecautionary \nStatement \nPrevention  P273  P273  P273  P273  \nPrecautionary \nStatement \nResponse  P391  P391  \nPrecautionary \nStatement \nStorage  \nPrecautionary \nStatement \nDisposal  P501  P501  P501  P501  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 201}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 203  \n5. PART 5: ADDITIONAL HAZARDS  \n5.1. Hazardous to the ozone layer  \n5.1.1.  Definitions and general considerations  \n5.1.1.1. Ozone depleting potential (ODP) is an integrative quan tity, distinct \nfor each halocarbon source species, that represents the extent of \nozone depletion in the stratosphere expected from the halocarbo n \non a mass-for-mass basis relative to CFC-11. The formal definit ion \nof ODP is the ratio of integrated perturbations to total ozone,  for a \ndifferential mass emission of a particular compound relative to  an \nequal emission of CFC-11.  \nSubstance hazardous to the ozone layer means a substance which,  \non the basis of the available evidence concerning its propertie s and \nits predicted or observed environmental fate and behaviour may \npresent a danger to the structure and/or the functioning of the  stra\xad\ntospheric ozone layer. This includes substances which are liste d in \nAnnex I to Regulation (EC) No 1005/2009 of the European \nParliament and of the Council of 16 September 2009 on substance s \nthat deplete the ozone layer (  1 ). \n5.1.2.  Classification criteria for substances  \n5.1.2.1. A substance shall be classified as hazardous to the oz one layer \n(Category 1) if the available evidence concerning its propertie s \nand its predicted or observed environmental fate and behaviour \nindicate that it may present a danger to the structure and/or t he \nfunctioning of the stratospheric ozone layer.  \n5.1.3.  Classification criteria for mixtures  \n5.1.3.1. Mixtures shall be classified as hazardous to the ozone  layer \n(Category 1) on the basis of the individual concentration of th e \nsubstance(s) contained therein that are also classified as haza rdous \nto the ozone layer (Category 1), in accordance with Table 5.1.  \nTable 5.1  \nGeneric concentration limits for substances (in a mixture), clas \xad\nsified as hazardous to the ozone layer (Category 1), that trigger \nclassification of the mixture as hazardous to the ozone layer \n(Category 1)  \nClassification of the substance  Classification of the mixture  \nHazardous to the ozone layer \n(Category 1)  C ≥ 0,1 %  \n5.1.4.  Hazard communication  \n5.1.4.1. Label elements shall be used for substances or mixture s meeting the \ncriteria for classification in this hazard class in accordance with \nTable 5.2.  \nTable 5.2  \nLabel elements for hazardous to the ozone layer  \nSymbol/pictogram\n  \nSignal word  Warning  ▼M2 \n( 1 ) OJ L 286, 31.10.2009, p. 1.', metadata={'source': 'data/ycla_en.pdf', 'page': 202}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 204  \nHazard statement  H420: Harms public health and \nthe environment by destroying \nozone in the upper atmosphere  \nPrecautionary statements  P502  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 203}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 205  \nANNEX II  \nSPECIAL RULES FOR LABELLING AND PACKAGING OF CERTAIN \nSUBSTANCES AND MIXTURES  \nThis Annex consists of 5 parts:  \n— Part 1 contains special rules for the labelling of certain cl assified substances \nand mixtures.  \n— Part 2 sets out rules for additional hazard statements to be included on the \nlabel of certain mixtures.  \n— Part 3 sets out special rules for packaging.  \n— Part 4 sets out a special rule for the labelling of plant pro tection products.  \n— Part 5 sets up a list of hazardous substances and mixtures to  which \nArticle 29(3) applies.  \n1. PART 1: SUPPLEMENTAL HAZARD INFORMATION  \nThe statements set out in sections 1.1 and 1.2 shall be assigne d in \naccordance with Article 25(1) to substances and mixtures classi fied for \nphysical, health or environmental hazards.  \n1.1. Physical properties  \n▼M19  __________  \n▼M4 __________  \n▼B \n►M19  1.1.1. ◄  EUH014 — ‘Reacts violently with water’  \nFor substances and mixtures which react violently with water, \nsuch as acetyl chloride, alkali metals, titanium tetrachloride.  \n►M19  1.1.2. ◄  EUH018 — ‘In use, may form flammable/explosive vapour- \nair mixture’  \nFor substances and mixtures not classified as flammable them\xad\nselves, which may form flammable/explosive vapour-air \nmixtures. For substances this might be the case for halogenated  \nhydrocarbons and for mixtures this might be the case due to a \nvolatile flammable component or due to the loss of a volatile \nnon-flammable component.  \n►M19  1.1.3. ◄  EUH019 — ‘May form explosive peroxides’  \nFor substances and mixtures which may form explosive \nperoxides during storage, such as diethyl ether, 1,4-dioxane.  \n►M19  1.1.4. ◄  EUH044 — ‘Risk of explosion if heated under confinement’  \nFor substances and mixtures not in themselves classified as \nexplosive in accordance with section 2.1 of Annex I, but \nwhich may nevertheless display explosive properties in \npractice if heated under sufficient confinement. In particular,  \nsubstances which decompose explosively if heated in a steel \ndrum do not show this effect if heated in less-strong container s. \n1.2. Health properties  \n1.2.1.  EUH029 — ‘Contact with water liberates toxic gas’  \nFor substances and mixtures which in contact with water or damp  air, \nevolve gases classified for acute toxicity in category 1, 2 or 3 in poten\xad\ntially dangerous amounts, such as aluminium phosphide, phosphor us \npentasulphide.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 204}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 206  \n1.2.2.  EUH031 — ‘Contact with acids liberates toxic gas’  \nFor substances and mixtures which react with acids to evolve ga ses \nclassified for acute toxicity in category 3 in dangerous amount s, such \nas sodium hypochlorite, barium polysulphide.  \n1.2.3.  EUH032 — ‘Contact with acids liberates very toxic gas’  \nFor substances and mixtures which react with acids to evolve ga ses \nclassified for acute toxicity in category 1 or 2 in dangerous a mounts, \nsuch as salts of hydrogen cyanide, sodium azide.  \n1.2.4.  EUH066 — ‘Repeated exposure may cause skin dryness or cracking’  \nFor substances and mixtures which may cause concern as a result  of skin \ndryness, flaking or cracking but which do not meet the criteria  for skin \nirritancy in section 3.2 of Annex I, based on either:  \n— practical observations; or  \n— relevant evidence concerning their predicted effects on the s kin. \n1.2.5.  EUH070 — ‘Toxic by eye contact’  \nFor substances or mixtures where an eye irritation test has res ulted in \novert signs of systemic toxicity or mortality among the animals  tested, \nwhich is likely to be attributed to absorption of the substance  or mixture \nthrough the mucous membranes of the eye. The statement shall al so be \napplied if there is evidence in humans for systemic toxicity af ter eye \ncontact.  \nThe statement shall also be applied where a substance or a mixt ure \ncontains another substance labelled for this effect, if the con centration \nof this substance is equal to, or greater than 0,1 %, unless ot herwise \nspecified in part 3 of Annex VI.  \n1.2.6.  EUH071 — ‘Corrosive to the respiratory tract’  \nFor substances and mixtures in addition to classification for i nhalation \ntoxicity, if data are available that indicate that the mechanis m of toxicity \nis corrosivity, in accordance with section 3.1.2.3.3 and Note 1  of Table \n3.1.3 in Annex I.  \nFor substances and mixtures in addition to classification for s kin \ncorrosivity, if no acute inhalation test data are available and  which \nmay be inhaled.  \n2. PART 2: SPECIAL RULES FOR SUPPLEMENTAL LABEL \nELEMENTS FOR CERTAIN MIXTURES  \n▼M22  \nThe statements set out in sections 2.1 to 2.10 and 2.12 shall b e assigned \nto mixtures in accordance with Article 25(6).  \n▼B \n2.1. Mixtures containing lead  \nThe label on the packaging of paints and varnishes containing l ead in \nquantities exceeding 0,15 % (expressed as weight of metal) of t he total \nweight of the mixture, as determined in accordance with ISO sta ndard \n6503, shall bear the following statement:  \nEUH201 — ‘Contains lead. Should not be used on surfaces liable to be \nchewed or sucked by children’  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 205}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 207  \nIn the case of packages the contents of which are less than 125  ml, the \nstatement may be as follows:  \nEUH201A — ‘Warning! Contains lead’  \n2.2. Mixtures containing cyanoacrylates  \nThe label on the immediate packaging of adhesives based on cyan oa\xad\ncrylate shall bear the following statement:  \nEUH202 — ‘Cyanoacrylate. Danger. Bonds skin and eyes in seconds . \nKeep out of the reach of children’  \nAppropriate advice on safety shall accompany the package.  \n2.3. Cements and cement mixtures  \nUnless cements or cement mixtures are already classified and la belled as \na sensitiser with the hazard statement H317, ‘May cause an alle rgic skin \nreaction’, the label on the packaging of cements and cement mix tures \nthat contain, when they are hydrated, more than 0,0002 % solubl e \nchromium (VI) of the total dry weight of the cement shall bear the \nstatement:  \nEUH203 — ‘Contains chromium (VI). May produce an allergic react ion’ \nIf reducing agents are used, then the packaging of cement or ce ment- \ncontaining mixtures shall include information on the packing da te, the \nstorage conditions and the storage period appropriate to mainta ining the \nactivity of the reducing agent and to keeping the content of so luble \nchromium VI below 0,0002 %.  \n2.4. Mixtures containing isocyanates  \nUnless already identified on the label of the packaging, mixtur es \ncontaining isocyanates (as monomers, oligomers, prepolymers, et c., or \nas mixtures thereof) shall bear the following statement:  \nEUH204 — ‘Contains isocyanates. May produce an allergic reactio n.’ \n2.5. Mixtures containing epoxy constituents with an average molecular \nweight ≤ 700  \nUnless already identified on the label of the packaging, mixtur es \ncontaining epoxy constituents with an average molecular weight ≤ 700 \nshall bear the following statement:  \nEUH205 — ‘Contains epoxy constituents. May produce an allergic reac\xad\ntion.’  \n2.6. Mixtures sold to the general public which contain active chlorine  \nThe label on the packaging of mixtures containing more than 1 %  of \nactive chlorine shall bear the following statement:  \nEUH206 — ‘Warning! Do not use together with other products. May  \nrelease dangerous gases (chlorine)’  \n2.7. Mixtures containing cadmium (alloys) and intended to be used for \nbrazing or soldering  \nThe label on the packaging of the above mentioned mixtures shal l bear \nthe following statement:  \nEUH207 — ‘Warning! Contains cadmium. Dangerous fumes are formed  \nduring use. See information supplied by the manufacturer. Compl y with \nthe safety instructions’  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 206}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 208  \n2.8. Mixtures containing at least one sensitising substance  \nThe label on the packaging of mixtures not classified as sensit ising but \ncontaining at least one substance classified as sensitising and  present in a \nconcentration equal to or greater than that specified in Table 3.4.6 of \nAnnex I shall bear the statement:  \nEUH208 — ‘Contains (name of sensitising substance). May produce  an \nallergic reaction’.  \nMixtures classified as sensitising containing other substance(s ) classified \nas sensitising (in addition to the one that leads to the classi fication of the \nmixture) and present in a concentration equal to or greater tha n that \nspecified in Table 3.4.6 of Annex I shall bear the name(s) of t hat/those \nsubstance(s) on the label.  \n▼M12  \nWhere a mixture is labelled in accordance with Section 2.4 or 2 .5, the \nstatement EUH208 may be omitted from the label for the substanc e \nconcerned.  \n▼B \n2.9. Liquid mixtures containing halogenated hydrocarbons  \nFor liquid mixtures which show no flashpoint or a flashpoint hi gher than \n60 o C but not more than 93  o C and contain a halogenated hydrocarbon \nand more than 5 % highly flammable or flammable substances, the  label \non the packaging shall bear one of the following statements, de pending \non whether the substances referred to above are highly flammabl e or \nflammable:  \nEUH209 — ‘Can become highly flammable in use’ or  \nEUH209A — ‘Can become flammable in use’  \n2.10.  Mixtures not intended for the general public  \nFor mixtures not classified as hazardous but which contain:  \n▼M2 \n— ≥ 0,1 % of a substance classified as skin sensitiser category  1, 1B, \nrespiratory sensitiser category 1, 1B, or carcinogenic category  2, or  \n— ≥ 0,01 % of a substance classified as skin sensitiser categor y 1A, \nrespiratory sensitiser category 1A, or  \n▼M19  \n— ≥ one tenth of the specific concentration limit for a substan ce clas\xad\nsified as skin sensitiser or respiratory sensitiser with a spec ific \nconcentration limit, or  \n▼B \n— ≥ 0,1 % of a substance classified as toxic to reproduction ca tegories \n1A, 1B or 2, or with effects on or via lactation; or  \n— at least one substance in an individual concentration of ≥ 1 % by \nweight for non-gaseous mixtures and ≥ 0,2 % by volume for gaseo us \nmixtures either:  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 207}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 209  \n— classified with other health or environmental hazards; or  \n— for which there are Community workplace exposure limits  \nthe label on the packaging shall bear the statement:  \nEUH210 — ‘Safety data sheet available on request’.  \n2.11 Aerosols  \nNote that aerosols are also subject to the labelling provisions  in \naccordance with points 2.2 and 2.3 in the Annex to Directive \n75/324/EEC.  \n▼M22  \n2.12.  Mixtures containing titanium dioxide  \nThe label on the packaging of liquid mixtures containing 1 % or  more of \ntitanium dioxide particles with aerodynamic diameter equal to o r below \n10 μm shall bear the following statement:  \nEUH211: ‘Warning! Hazardous respirable droplets may be formed w hen \nsprayed. Do not breathe spray or mist.’  \nThe label on the packaging of solid mixtures containing 1 % or more of \ntitanium dioxide shall bear the following statement:  \nEUH212: ‘Warning! Hazardous respirable dust may be formed when \nused. Do not breathe dust.’  \nIn addition, the label on the packaging of liquid and solid mix tures not \nintended for the general public and not classified as hazardous  which are \nlabelled with EUH211 or EUH212, shall bear statement EUH210.  \n▼B \n3. PART 3: SPECIAL RULES ON PACKAGING  \n3.1. Provisions relating to child-resistant fastenings  \n3.1.1.  Packaging to be fitted with child-resistant fastenings  \n3.1.1.1. Packaging of whatever capacity containing a substance or mixture \nsupplied to the general public and classified for acute toxicit y, categories \n1 to 3, STOT — single exposure category 1, STOT — repeated expo sure \ncategory 1, or skin corrosion category 1 shall be fitted with c hild- \nresistant fastenings.  \n3.1.1.2. Packaging of whatever capacity containing a substance or mixture \nsupplied to the general public presenting an aspiration hazard and clas\xad\nsified according to sections 3.10.2 and 3.10.3 of Annex I and l abelled \naccording to section 3.10.4.1 of Annex I, with the exception of  \nsubstances and mixtures placed on the market in the form of aer osols \nor in a container fitted with a sealed spray attachment, shall be fitted \nwith child-resistant fastenings.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 208}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 210  \n3.1.1.3 Where a substances or mixture has at least one of the s ubstances \nmentioned below present in a concentration equal to or greater than \nthe maximum individual concentrations specified, which are supp lied \nto the general public, the packaging of whatever capacity shall  be \nfitted with child-resistant fastenings.  \nNo Identification of the substance  Concentration \nlimit  CAS No  Name  EC No  \n1 67-56-1  methanol  200-659-6  ≥  3  %  \n2 75-09-2  dichlorome\xad\nthane  200-838-9  ≥  1  %  \n3.1.2  Reclosable packages  \nChild-resistant fastenings used on reclosable packages shall co mply with \nEN ISO standard 8317 as amended relating to ‘Child-resistant pa ckages \n— Requirements and methods of testing for reclosable packages’ \nadopted by the European Committee for standardisation (CEN) and  the \nInternational Standard Organisation (ISO).  \n3.1.3  Non-reclosable packages  \nChild-resistant fastenings used on non-reclosable packages shal l comply \nwith CEN standard EN 862 as amended relating to ‘Packaging — Ch ild- \nresistant packaging — Requirements and testing procedures for n on- \nreclosable packages for non-pharmaceutical products’ adopted by  the \nEuropean Committee for Standardisation (CEN).  \n3.1.4  Notes  \n3.1.4.1. Evidence of conformity with the above standards may be  certified only \nby laboratories which conform with Standard EN ISO/IEC 17025 as  \namended.  \n3.1.4.2.  Specific cases  \nIf it seems obvious that packaging is sufficiently safe for chi ldren \nbecause they cannot get access to the contents without the help  of a \ntool, the test referred to in section 3.1.2 or 3.1.3 does not n eed to be \nperformed.  \nIn all other cases and when there are sufficient grounds for do ubting the \nsecurity of the closure for a child, the national authority may  ask the \nperson responsible for putting the product on the market to giv e it a \ncertificate from a certifying laboratory, referred to in sectio n 3.1.4.1, \nstating that either:  \n— the type of closure is such that it is not necessary to perfo rm the test \nreferred to in section 3.1.2. or 3.1.3; or  \n— the closure has been tested and has been found to conform wit h the \nstandards referred to above.  \n▼M4 \n3.2 Tactile Warnings  \n3.2.1.  Packaging to be fitted with a tactile warning  \n3.2.1.1. Where substances or mixtures are supplied to the gener al public and \nclassified for acute toxicity, skin corrosion, germ cell mutage nicity \ncategory 2, carcinogenicity category 2, reproductive toxicity c ategory \n2, respiratory sensitisation, STOT categories 1 or 2, aspiratio n hazard, \nflammable gases, flammable liquids categories 1 or 2, or flamma ble \nsolids, the packaging of whatever capacity, shall be fitted wit h a \ntactile warning of danger.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 209}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 211  \n3.2.1.2. Section 3.2.1.1 does not apply to transportable gas re ceptacles. Aerosols \nand containers fitted with a sealed spray attachment and contai ning \nsubstances or mixtures classified as presenting an aspiration h azard \nneed not be fitted with a tactile warning unless they are class ified for \none or more of the other hazards in section 3.2.1.1.  \n3.2.2.  Provisions relating to tactile warning  \nThe technical specifications for tactile warning devices shall conform to \nEN ISO standard 11683 as amended ‘Packaging — Tactile warnings of \ndanger — Requirements’.  \n▼M10  \n3.3 Liquid consumer laundry detergents in soluble packaging for single \nuse \nWhere a liquid consumer laundry detergent in dosages for single  use is \ncontained in a soluble packaging, the following additional prov isions \nshall apply:  \n3.3.1. Liquid consumer laundry detergents contained in soluble packaging for \nsingle use shall be contained in an outer packaging. The outer packaging \nshall fulfil the requirements of section 3.3.2 and the soluble packaging \nshall fulfil the requirements of section 3.3.3.  \n3.3.2. The outer packaging shall:  \n(i) be opaque or obscure so that it impedes the visibility of t he product \nor individual doses;  \n(ii) without prejudice to Article 32(3), bear the precautionary  statement \nP102 ‘Keep out of reach of children’ at a visible place and in a \nformat that attracts attention;  \n(iii) be an easily reclosable, self-standing container;  \n(iv) without prejudice to the requirements of section 3.1, be f itted with a \nclosure that:  \n(a) impedes the ability of young children to open the packaging  by \nrequiring coordinated action of both hands with a strength that  \nmakes it difficult for young children to open it;  \n(b) maintains its functionality under conditions of repeated op ening \nand closing for the entire life span of the outer packaging.  \n3.3.3. The soluble packaging shall:  \n(i) contain an aversive agent in a concentration which is safe,  and \nwhich elicits oral repulsive behaviour within a maximum time of  \n6 seconds, in case of accidental oral exposure;  \n(ii) retain its liquid content for at least 30 seconds when the  soluble \npackaging is placed in water at 20 °C;  \n(iii) resist mechanical compressive strength of at least 300 N under \nstandard test conditions.  \n▼B \n4. PART 4: SPECIAL RULE FOR LABELLING OF PLANT \nPROTECTION PRODUCTS  \nWithout prejudice to the information required in accordance wit h \nArticle 16 of Directive 91/414/EEC and Annex V of that Directiv e, \nthe labelling for plant protection products subject to Directiv e \n91/414/EEC shall also include the following wording:  \nEUH401 — ‘To avoid risks to human health and the environment, \ncomply with the instructions for use’  \n5. PART 5: LIST OF HAZARDOUS SUBSTANCES AND MIXTURES \nTO WHICH ARTICLE 29(3) APPLIES  \n— Ready mixed cement and concrete in the wet state.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 210}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 212  \nANNEX III  \nLIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD \nINFORMATION AND SUPPLEMENTAL LABEL ELEMENTS  \n1. Part 1: hazard statements  \n▼M2 \nThe hazard statements shall be applied in accordance with Parts  2, 3, 4 and 5 of \nAnnex I.  \nIn selecting the hazard statements in accordance with Articles 21 and 27, \nsuppliers may use the combined hazard statements provided for i n this Annex.  \nIn accordance with Article 27 the following principles of prece dence for hazard \nstatements may apply to labelling:  \n(a) if the hazard statement H410 ‘Very toxic to aquatic life wi th long lasting \neffects’ is assigned, the statement H400 ‘Very toxic to aquatic  life’ may be \nomitted;  \n▼M12  \n(b) if the statement H314 ‘Causes severe skin burns and eye dam age’ is \nassigned, the statement H318 ‘Causes serious eye damage’ may be  omitted.  \n▼M2 \nIn order to indicate the route of administration or exposure th e combined hazard \nstatements in Table 1.2 may be used.  \n▼B \nTable 1.1  \nHazard statements for physical hazards  \nH200  \n►M2 ___ ◄ Language  2.1 — Explosives, Unstable explosives  \nBG Нестабилен експлозив.  \nES Explosivo inestable.  \nCS Nestabilní výbušnina.  \nDA Ustabilt eksplosiv.  \nDE Instabil, explosiv.  \nET Ebapüsiv lõhkeaine.  \nEL Ασταθή εκρηκτικά.  \nEN Unstable explosives.  \nFR Explosif instable.  \nGA Pléascáin éagobhsaí.  \n▼M5 \nHR Nestabilni eksplozivi.  \n▼B \nIT Esplosivo instabile.  \nLV Nestabili sprādzienbīstami materiāli.  \nLT Nestabilios sprogios medžiagos.  \nHU Instabil robbanóanyagok.  \nMT Splussivi instabbli.  \nNL Instabiele ontplofbare stof.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 211}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 213  \nH200  \n►M2 ___ ◄ Language  2.1 — Explosives, Unstable explosives  \nPL Materiały wybuchowe niestabilne.  \nPT Explosivo instável.  \nRO Exploziv instabil.  \nSK Nestabilné výbušniny.  \nSL Nestabilni eksplozivi.  \nFI Epästabiili räjähde.  \nSV Instabilt explosivt.  \n▼M2 __________  \n▼B \nH201  Language  2.1 — Explosives, Division 1.1  \nBG Експлозив; опасност от масова експлозия.  \nES Explosivo; peligro de explosión en masa.  \nCS Výbušnina; nebezpečí masivního výbuchu.  \nDA Eksplosiv, masseeksplosionsfare.  \nDE Explosiv, Gefahr der Massenexplosion.  \nET Plahvatusohtlik; massiplahvatusoht.  \nEL Εκρηκτικό· κίνδυνος μαζικής έκρηξης.  \nEN Explosive; mass explosion hazard.  \nFR Explosif; danger d'explosion en masse.  \nGA Pléascach; guais mhórphléasctha.  \n▼M5 \nHR Eksplozivno; opasnost od eksplozije ogromnih \nrazmjera.  \n▼B \nIT Esplosivo; pericolo di esplosione di massa.  \nLV Sprādzienbīstams; masveida sprādzienbīs- \ntamība.  \nLT Sprogios medžiagos, kelia masinio sprogimo \npavojų.  \nHU Robbanóanyag; teljes tömeg felrobbanásának \nveszélye.  \nMT Splussiv; periklu li jisplodu kollha f'daqqa.  \nNL Ontplofbare stof; gevaar voor massa-explosie.  \nPL Materiał wybuchowy; zagrożenie wybuchem \nmasowym.  \nPT Explosivo; perigo de explosão em massa.  \nRO Exploziv; pericol de explozie în masă.  \nSK Výbušnina, nebezpečenstvo rozsiahleho \nvýbuchu.  \nSL Eksplozivno; nevarnost eksplozije v masi.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 212}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 214  \nH201  Language  2.1 — Explosives, Division 1.1  \nFI Räjähde; massaräjähdysvaara.  \nSV Explosivt. Fara för massexplosion.  \nH202  Language  2.1 — Explosives, Division 1.2  \nBG Експлозив; сериозна опасност от разпр- \nъскване.  \nES Explosivo; grave peligro de proyección.  \nCS Výbušnina; vážné nebezpečí zasažení částicemi.  \nDA Eksplosiv, alvorlig fare for udslyngning af frag\xad\nmenter.  \nDE Explosiv; große Gefahr durch Splitter, Spreng- \nund Wurfstücke.  \nET Plahvatusohtlik; suur laialipaiskumisoht.  \nEL Εκρηκτικό· σοβαρός κίνδυνος εκτόξευσης.  \nEN Explosive, severe projection hazard.  \nFR Explosif; danger sérieux de projection.  \nGA Pléascach, guais throm teilgin.  \n▼M5 \nHR Eksplozivno; velika opasnost od rasprskavanja.  \n▼B \nIT Esplosivo; grave pericolo di proiezione.  \nLV Sprādzienbīstams; augsta izmetes bīstamība.  \nLT Sprogios medžiagos, kelia didelį išsvaidymo \npavojų.  \nHU Robbanóanyag; kivetés súlyos veszélye.  \nMT Splussiv, periklu serju ta' projezzjoni.  \nNL Ontplofbare stof, ernstig gevaar voor scherf\xad\nwerking.  \nPL Materiał wybuchowy, poważne zagrożenie \nrozrzutem.  \nPT Explosivo, perigo grave de projecções.  \nRO Exploziv; pericol grav de proiectare.  \nSK Výbušnina, závažné nebezpečenstvo rozletenia \núlomkov.  \nSL Eksplozivno, velika nevarnost za nastanek \ndrobcev.  \nFI Räjähde; vakava sirpalevaara.  \nSV Explosivt. Allvarlig fara för splitter och kast\xad\nstycken.  \nH203  Language  2.1 — Explosives, Division 1.3  \nBG Експлозив; опасност от пожар, взрив или \nразпръскване.  \nES Explosivo; peligro de incendio, de onda \nexpansiva o de proyección.  \nCS Výbušnina; nebezpečí požáru, tlakové vlny \nnebo zasažení částicemi.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 213}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 215  \nH203  Language  2.1 — Explosives, Division 1.3  \nDA Eksplosiv, fare for brand, eksplosion eller \nudslyngning af fragmenter.  \nDE Explosiv; Gefahr durch Feuer, Luftdruck oder \nSplitter, Spreng- und Wurfstücke.  \nET Plahvatusohtlik; süttimis-, plahvatus- või laiali\xad\npaiskumisoht.  \nEL Εκρηκτικό· κίνδυνος πυρκαγιάς, ανατίναξης ή \nεκτόξευσης.  \nEN Explosive; fire, blast or projection hazard.  \nFR Explosif; danger d'incendie, d'effet de souffle \nou de projection.  \nGA Pléascach; guais dóiteáin, phléasctha nó teilgin.  \n▼M5 \nHR Eksplozivno; opasnost od vatre, udarnog vala ili \nrasprskavanja.  \n▼B \nIT Esplosivo; pericolo di incendio, di spostamento \nd'aria o di proiezione.  \nLV Sprādzienbīstams; uguns, triecienviļņa vai \nizmetes bīstamība.  \nLT Sprogios medžiagos, kelia gaisro, sprogimo \narba išsvaidymo pavojų.  \nHU Robbanóanyag; tűz, robbanás vagy kivetés \nveszélye.  \nMT Splussiv; periklu ta' nar, blast jew projezzjoni.  \nNL Ontplofbare stof; gevaar voor brand, luchtdruk\xad\nwerking of scherfwerking.  \nPL Materiał wybuchowy; zagrożenie pożarem, \nwybuchem lub rozrzutem.  \nPT Explosivo; perigo de incêndio, sopro ou projec\xad\nções.  \nRO Exploziv; pericol de incendiu, detonare sau \nproiectare.  \nSK Výbušnina, nebezpečenstvo požiaru, výbuchu \nalebo rozletenia úlomkov.  \nSL Eksplozivno; nevarnost za nastanek požara, \nudarnega vala ali drobcev.  \nFI Räjähde; palo-, räjähdys- tai sirpalevaara.  \nSV Explosivt. Fara för brand, tryckvåg eller splitter \noch kaststycken.  \nH204  Language  2.1 — Explosives, Division 1.4  \nBG Опасност от пожар или разпръскване.  \nES Peligro de incendio o de proyección.  \nCS Nebezpečí požáru nebo zasažení částicemi.  \nDA Fare for brand eller udslyngning af fragmenter.  \nDE Gefahr durch Feuer oder Splitter, Spreng- und \nWurfstücke.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 214}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 216  \nH204  Language  2.1 — Explosives, Division 1.4  \nET Süttimis- või laialipaiskumisoht.  \nEL Κίνδυνος πυρκαγιάς ή εκτόξευσης.  \nEN Fire or projection hazard.  \nFR Danger d'incendie ou de projection.  \nGA Guais dóiteáin nó teilgin.  \n▼M5 \nHR Opasnost od vatre ili rasprskavanja.  \n▼B \nIT Pericolo di incendio o di proiezione.  \nLV Uguns vai izmetes bīstamība.  \nLT Gaisro arba išsvaidymo pavojus.  \nHU Tűz vagy kivetés veszélye.  \nMT Periklu ta' nar jew ta' projezzjoni.  \nNL Gevaar voor brand of scherfwerking.  \nPL Zagrożenie pożarem lub rozrzutem.  \nPT Perigo de incêndio ou projecções.  \nRO Pericol de incendiu sau de proiectare.  \nSK Nebezpečenstvo požiaru alebo rozletenia \núlomkov.  \nSL Nevarnost za nastanek požara ali drobcev.  \nFI Palo- tai sirpalevaara.  \nSV Fara för brand eller splitter och kaststycken.  \nH205  Language  2.1 — Explosives, Division 1.5  \nBG Може да предизвика масова експлозия при \nпожар.  \nES Peligro de explosión en masa en caso de \nincendio.  \nCS Při požáru může způsobit masivní výbuch.  \nDA Fare for masseeksplosion ved brand.  \nDE Gefahr der Massenexplosion bei Feuer.  \nET Süttimise korral massiplahvatusoht.  \nEL Κίνδυνος μαζικής έκρηξης σε περίπτωση \nπυρκαγιάς.  \nEN May mass explode in fire.  \nFR Danger d'explosion en masse en cas d'incendie.  \nGA D'fhéadfadh sé go mbeadh mórphléascadh i \ndtine.  \n▼M5 \nHR U vatri može izazvati eksploziju ogromnih \nrazmjera.  \n▼B \nIT Pericolo di esplosione di massa in caso d'in\xad\ncendio.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 215}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 217  \nH205  Language  2.1 — Explosives, Division 1.5  \nLV Ugunī var masveidā eksplodēt.  \nLT Per gaisrą gali sukelti masinį sprogimą.  \nHU Tűz hatására a teljes tömeg felrobbanhat.  \nMT Jista' jisplodi f'daqqa fin-nar.  \nNL Gevaar voor massa-explosie bij brand.  \nPL Może wybuchać masowo w przypadku pożaru.  \nPT Perigo de explosão em massa em caso de \nincêndio.  \nRO Pericol de explozie în masă în caz de incendiu.  \nSK Nebezpečenstvo rozsiahleho výbuchu pri \npožiari.  \nSL Pri požaru lahko eksplodira v masi.  \nFI Koko massa voi räjähtää tulessa.  \nSV Fara för massexplosion vid brand.  \n▼M19  \nH206  Language  2.17 — Desensitised explosives, Hazard Category 1  \nBG Опасност от пожар или разпръскване; \nповишен риск от експлозия при понижено \nсъдържание на десенсибилизиращ агент.  \nES Peligro de incendio, onda expansiva o \nproyección; mayor riesgo de explosión si se \nreduce el agente insensibilizante.  \nCS Nebezpečí požáru, tlakové vlny nebo zasažení \nčásticemi; zvýšené nebezpečí výbuchu, sníží-li \nse objem znecitlivujícího prostředku.  \nDA Fare for brand, eksplosion eller udslyngning af \nfragmenter; øget risiko for eksplosion, hvis det \ndesensibiliserende middel reduceres.  \nDE Gefahr durch Feuer, Druckstoß oder Spreng\xad\nstücke; erhöhte Explosionsgefahr wenn das \nDesensibilisierungsmittel reduziert wird.  \nET Süttimis-, plahvatus- või laialipaiskumisoht, \ndesensibilisaatori vähenemise korral suurenenud \nplahvatusoht.  \nEL Κίνδυνος πυρκαγιάς, ανατίναξης ή εκτόξευσης· \nαυξημένος κίνδυνος έκρηξης εάν μειωθεί ο \nπαράγοντας απευαισθητοποίησης.  \nEN Fire, blast or projection hazard; increased risk \nof explosion if desensitising agent is reduced.  \nFR Danger d'incendie, d'effet de souffle ou de \nprojection; risque accru d'explosion si la \nquantité d'agent désensibilisateur est réduite.  \nGA Guais dóiteáin, phléasctha nó teilgin; baol \nméadaithe pléasctha má laghdaítear an dí- \níogróir.  \nHR Opasnost od vatre, udarnog vala ili rasprs\xad\nkavanja; povećan rizik od eksplozije ako je \nsmanjen udio desenzitirajućeg agensa.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 216}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 218  \nH206  Language  2.17 — Desensitised explosives, Hazard Category 1  \nIT Pericolo d'incendio, di spostamento d'aria o di \nproiezione; maggior rischio di esplosione se \nl'agente desensibilizzante è ridotto.  \nLV Ugunsbīstamība, triecienviļņbīstamība vai \nizmetbīstamība; ja desensibilizācijas līdzekļa \ndaudzums samazinājies, palielinās eksplozijas \nrisks.  \nLT Gaisro, sprogimo arba išsvaidymo pavojus; \nsumažėjus desensibilizacijos veiksnio poveikiui \nkyla didesnė sprogimo rizika.  \nHU Tűz, robbanás vagy kivetés veszélye; fokozott \nrobbanásveszély a deszenzibilizáló szer csökke\xad\nnésével.  \nMT Periklu ta' nar, blast jew projjezzjoni; riskju \nikbar ta' splużjoni jekk l-aġent disensitizzanti \njitnaqqas.  \nNL Gevaar voor brand, luchtdrukwerking of scherf\xad\nwerking; toegenomen ontploffingsgevaar als de \nongevoeligheidsagens wordt verminderd.  \nPL Zagrożenie pożarem, wybuchem lub rozrzutem; \nzwiększone ryzyko wybuchu jeśli zawartość \nśrodka odczulającego została zmniejszona.  \nPT Perigo de incêndio, sopro ou projeções; risco \nacrescido de explosão se houver redução do \nagente dessensibilizante.  \nRO Pericol de incendiu, detonare sau proiectare; \nrisc sporit de explozie dacă se reduce agentul \nde desensibilizare.  \nSK Nebezpečenstvo požiaru, výbuchu alebo \nrozletenia úlomkov; zvýšené riziko výbuchu, \nak sa zníži obsah desenzibilizačného činidla.  \nSL Nevarnost za nastanek požara, udarnega vala ali \ndrobcev; povečana nevarnost eksplozije, če se \nzmanjša vsebnost desenzibilizatorja.  \nFI Palo-, räjähdys- tai sirpalevaara; suurentunut, \njos flegmatointitekijää vähennetään.  \nSV Fara för brand, tryckvåg eller splitter och kast\xad\nstycken, ökad explosionsrisk om det okänslig\xad\ngörande ämnet minskas.  \nH207  Language  2.17 — Desensitised explosives, Hazard Category 2, 3  \nBG Опасност от пожар или разпръскване; \nповишен риск от експлозия при понижено \nсъдържание на десенсибилизиращ агент.  \nES Peligro de incendio o proyección; mayor riesgo \nde explosión si se reduce el agente insensibiliz\xad\nante.  \nCS Nebezpečí požáru nebo zasažení částicemi; \nzvýšené nebezpečí výbuchu, sníží-li se objem \nznecitlivujícího prostředku.  ▼M19", metadata={'source': 'data/ycla_en.pdf', 'page': 217}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 219  \nH207  Language  2.17 — Desensitised explosives, Hazard Category 2, 3  \nDA Fare for brand eller udslyngning af fragmenter; \nøget risiko for eksplosion, hvis det desensibili\xad\nserende middel reduceres.  \nDE Gefahr durch Feuer oder Sprengstücke; erhöhte \nExplosionsgefahr wenn das Desensibilisierungs\xad\nmittel reduziert wird.  \nET Süttimis- või laialipaiskumisoht, desensibili\xad\nsaatori vähenemise korral suurenenud plahvatu\xad\nsoht.  \nEL Κίνδυνος πυρκαγιάς ή εκτόξευσης· αυξημένος \nκίνδυνος έκρηξης εάν μειωθεί ο παράγοντας \nαπευαισθητοποίησης.  \nEN Fire or projection hazard; increased risk of \nexplosion if desensitising agent is reduced.  \nFR Danger d'incendie ou de projection; risque \naccru d'explosion si la quantité d'agent désensi\xad\nbilisateur est réduite.  \nGA Guais dóiteáin nó teilgin; baol méadaithe \npléasctha má laghdaítear an dí-íogróir.  \nHR Opasnost od vatre ili rasprskavanja; povećan \nrizik od eksplozije ako je smanjen udio desen\xad\nzitirajućeg agensa.  \nIT Pericolo d'incendio o di proiezione; maggior \nrischio di esplosione se l'agente desensibi\xad\nlizzante è ridotto.  \nLV Ugunsbīstamība vai izmetbīstamība; ja desen\xad\nsibilizācijas līdzekļa daudzums samazinājies, \npalielinās eksplozijas risks.  \nLT Gaisro arba išsvaidymo pavojus; sumažėjus \ndesensibilizacijos veiksnio poveikiui kyla \ndidesnė sprogimo rizika.  \nHU Tűz vagy kivetés veszélye; fokozott robban\xad\násveszély a deszenzibilizáló szer csökkenésével.  \nMT Periklu ta' nar jew projezzjoni; riskju ikbar ta' \nsplużjoni jekk l-aġent disensitizzanti jitnaqqas.  \nNL Gevaar voor brand of scherfwerking; \ntoegenomen ontploffingsgevaar als de ongevoe\xad\nligheidsagens wordt verminderd.  \nPL Zagrożenie pożarem lub rozrzutem; zwiększone \nryzyko wybuchu jeśli zawartość środka odczu\xad\nlającego została zmniejszona.  \nPT Perigo de incêndio ou projeções; risco acrescido \nde explosão se houver redução do agente \ndessensibilizante.  \nRO Pericol de incendiu sau proiectare; risc sporit de \nexplozie dacă se reduce agentul de desensibil\xad\nizare.  \nSK Nebezpečenstvo požiaru alebo rozletenia \núlomkov; zvýšené riziko výbuchu, ak sa zníži \nobsah desenzibilizačného činidla.  ▼M19", metadata={'source': 'data/ycla_en.pdf', 'page': 218}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 220  \nH207  Language  2.17 — Desensitised explosives, Hazard Category 2, 3  \nSL Nevarnost za nastanek požara ali drobcev; \npovečana nevarnost eksplozije, če se zmanjša \nvsebnost desenzibilizatorja.  \nFI Palo- tai sirpalevaara; suurentunut, jos flegma\xad\ntointitekijää vähennetään.  \nSV Fara för brand eller splitter och kaststycken. \nökad explosionsrisk om det okänsliggörande \nämnet minskas.  \nH208  Language  2.17 — Desensitised explosives, Hazard Category 4  \nBG Опасност от пожар; повишен риск от \nексплозия при понижено съдържание на \nдесенсибилизиращ агент.  \nES Peligro de incendio; mayor riesgo de explosión \nsi se reduce el agente insensibilizante.  \nCS Nebezpečí požáru; zvýšené nebezpečí výbuchu, \nsníží-li se objem znecitlivujícího prostředku.  \nDA Brandfare; øget risiko for eksplosion, hvis det \ndesensibiliserende middel reduceres.  \nDE Gefahr durch Feuer; erhöhte Explosionsgefahr \nwenn das Desensibilisierungsmittel reduziert \nwird.  \nET Süttimisoht; desensibilisaatori vähenemise \nkorral suurenenud plahvatusoht.  \nEL Κίνδυνος πυρκαγιάς· αυξημένος κίνδυνος \nέκρηξης εάν μειωθεί ο παράγοντας \nαπευαισθητοποίησης.  \nEN Fire hazard; increased risk of explosion if \ndesensitising agent is reduced.  \nFR Danger d'incendie; risque accru d'explosion si \nla quantité d'agent désensibilisateur est réduite.  \nGA Guais dóiteáin; baol méadaithe pléasctha má \nlaghdaítear an dí-íogróir.  \nHR Opasnost od vatre; povećan rizik od eksplozije \nako je smanjen udio desenzitirajućeg agensa.  \nIT Pericolo d'incendio; maggior rischio di \nesplosione se l'agente desensibilizzante è \nridotto.  \nLV Ugunsbīstamība; ja desensibilizācijas līdzekļa \ndaudzums samazinājies, palielinās eksplozijas \nrisks.  \nLT Gaisro pavojus; sumažėjus desensibilizacijos \nveiksnio poveikiui kyla didesnė sprogimo \nrizika.  \nHU Tűz veszélye; fokozott robbanásveszély a \ndeszenzibilizáló szer csökkenésével.  \nMT Periklu ta' nar; riskju ikbar ta' splużjoni jekk l- \naġent disensitizzanti jitnaqqas.  ▼M19", metadata={'source': 'data/ycla_en.pdf', 'page': 219}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 221  \nH208  Language  2.17 — Desensitised explosives, Hazard Category 4  \nNL Gevaar voor brand; toegenomen ontploffings\xad\ngevaar als de ongevoeligheidsagens wordt \nverminderd.  \nPL Zagrożenie pożarem; zwiększone ryzyko \nwybuchu jeśli zawartość środka odczulającego \nzostała zmniejszona.  \nPT Perigo de incêndio; risco acrescido de explosão \nse houver redução do agente dessensibilizante.  \nRO Pericol de incendiu; risc sporit de explozie dacă \nse reduce agentul de desensibilizare.  \nSK Nebezpečenstvo požiaru; zvýšené riziko \nvýbuchu, ak sa zníži obsah desenzibilizačného \nčinidla.  \nSL Nevarnost za nastanek požara; povečana \nnevarnost eksplozije, če se zmanjša vsebnost \ndesenzibilizatorja.  \nFI Palovaara; suurentunut, jos flegmatointitekijää \nvähennetään.  \nSV Fara för brand, ökad explosionsrisk om det \nokänsliggörande ämnet minskas.  \nH220  Language  2.2 — Flammable gases, Hazard Category 1A  \n▼B \nBG Изключително запалим газ.  \nES Gas extremadamente inflamable.  \nCS Extrémně hořlavý plyn.  \nDA Yderst brandfarlig gas.  \nDE Extrem entzündbares Gas.  \nET Eriti tuleohtlik gaas.  \nEL Εξαιρετικά εύφλεκτο αέριο.  \nEN Extremely flammable gas.  \nFR Gaz extrêmement inflammable.  \nGA Gás fíor-inadhainte.  \n▼M5 \nHR Vrlo lako zapaljivi plin.  \n▼B \nIT Gas altamente infiammabile.  \nLV Īpaši viegli uzliesmojoša gāze.  \nLT Ypač degios dujos.  \nHU Rendkívül tűzveszélyes gáz.  \nMT Gass li jaqbad malajr ħafna.  \nNL Zeer licht ontvlambaar gas.  \nPL Skrajnie łatwopalny gaz.  \nPT Gás extremamente inflamável.  \nRO Gaz extrem de inflamabil.  \nSK Mimoriadne horľavý plyn.  \nSL Zelo lahko vnetljiv plin.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 220}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 222  \nH220  Language  2.2 — Flammable gases, Hazard Category 1A  \n▼B \nFI Erittäin helposti syttyvä kaasu.  \nSV Extremt brandfarlig gas.  \n▼M19  \nH221  Language  2.2 — Flammable gases, Hazard Category 1B, 2  \n▼B \nBG Запалим газ. \nES Gas inflamable.  \nCS Hořlavý plyn. \nDA Brandfarlig gas.  \nDE Entzündbares Gas.  \nET Tuleohtlik gaas.  \nEL Εύφλεκτο αέριο.  \nEN Flammable gas.  \nFR Gaz inflammable.  \nGA Gás inadhainte.  \n▼M5 \nHR Zapaljivi plin.  \n▼B \nIT Gas infiammabile.  \nLV Uzliesmojoša gāze.  \nLT Degios dujos. \nHU Tűzveszélyes gáz.  \nMT Gass li jaqbad.  \nNL Ontvlambaar gas.  \nPL Gaz łatwopalny.  \nPT Gás inflamável.  \nRO Gaz inflamabil.  \nSK Horľavý plyn.  \nSL Vnetljiv plin.  \nFI Syttyvä kaasu. \nSV Brandfarlig gas.  \n▼M4 \nH222  Language  2.3 — Aerosols, Hazard Category 1  \n▼B \nBG Изключително запалим аерозол.  \nES Aerosol extremadamente inflamable.  \nCS Extrémně hořlavý aerosol.  \nDA Yderst brandfarlig aerosol.  \nDE Extrem entzündbares Aerosol.  \nET Eriti tuleohtlik aerosool.  \nEL Εξαιρετικά εύφλεκτο αερόλυμα.  \nEN Extremely flammable aerosol.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 221}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 223  \nH222  Language  2.3 — Aerosols, Hazard Category 1  \n▼B \nFR Aérosol extrêmement inflammable.  \nGA Aerasól fíor-inadhainte.  \n▼M5 \nHR Vrlo lako zapaljivi aerosol.  \n▼B \nIT Aerosol altamente infiammabile.  \nLV Īpaši viegli uzliesmojošs aerosols.  \nLT Ypač degus aerozolis.  \nHU Rendkívül tűzveszélyes aeroszol.  \nMT Aerosol li jaqbad malajr ħafna.  \nNL Zeer licht ontvlambare aerosol.  \nPL Skrajnie łatwopalny aerozol.  \nPT Aerossol extremamente inflamável.  \nRO Aerosol extrem de inflamabil.  \nSK Mimoriadne horľavý aerosól.  \nSL Zelo lahko vnetljiv aerosol.  \nFI Erittäin helposti syttyvä aerosoli.  \nSV Extremt brandfarlig aerosol.  \n▼M4 \nH223  Language  2.3 — Aerosols, Hazard Category 2  \nBG Запалим аерозол.  \nES Aerosol inflamable.  \nCS Hořlavý aerosol.  \nDA Brandfarlig aerosol.  \nDE Entzündbares Aerosol.  \nET Tuleohtlik aerosool.  \nEL Εύφλεκτο αερόλυμα.  \nEN Flammable aerosol.  \nFR Aérosol inflammable.  \nGA Aerasól inadhainte.  \n▼M5 \nHR Zapaljivi aerosol.  \n▼M4 \nIT Aerosol infiammabile.  \nLV Uzliesmojošs aerosols.  \nLT Degus aerozolis.  \nHU Tűzveszélyes aeroszol.  \nMT Aerosol li jaqbad.  \nNL Ontvlambaar aerosol.  \nPL Łatwopalny aerozol.  \nPT Aerossol inflamável.  \nRO Aerosol inflamabil.  \nSK Horľavý aerosól.  \nSL Vnetljiv aerosol.  \nFI Syttyvä aerosoli.  \nSV Brandfarlig aerosol.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 222}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 224  \nH224  Language  2.6 — Flammable liquids, Hazard Category 1  \nBG Изключително запалими течност и пари.  \nES Líquido y vapores extremadamente inflamables.  \nCS Extrémně hořlavá kapalina a páry.  \nDA Yderst brandfarlig væske og damp.  \nDE Flüssigkeit und Dampf extrem entzündbar.  \nET Eriti tuleohtlik vedelik ja aur.  \nEL Υγρό και ατμοί εξαιρετικά εύφλεκτα.  \nEN Extremely flammable liquid and vapour.  \nFR Liquide et vapeurs extrêmement inflammables.  \nGA Leacht fíor-inadhainte agus gal fhíor-inadhainte.  \n▼M5 \nHR Vrlo lako zapaljiva tekućina i para.  \n▼B \nIT Liquido e vapori altamente infiammabili.  \nLV Īpaši viegli uzliesmojošs šķidrums un tvaiki.  \nLT Ypač degūs skystis ir garai.  \nHU Rendkívül tűzveszélyes folyadék és gőz.  \nMT Likwidu u fwar li jaqbdu malajr ħafna.  \nNL Zeer licht ontvlambare vloeistof en damp.  \nPL Skrajnie łatwopalna ciecz i pary.  \nPT Líquido e vapor extremamente inflamáveis.  \nRO Lichid și vapori extrem de inflamabili.  \nSK Mimoriadne horľavá kvapalina a pary.  \nSL Zelo lahko vnetljiva tekočina in hlapi.  \nFI Erittäin helposti syttyvä neste ja höyry.  \nSV Extremt brandfarlig vätska och ånga.  \nH225  Language  2.6 — Flammable liquids, Hazard Category 2  \nBG Силно запалими течност и пари.  \nES Líquido y vapores muy inflamables.  \nCS Vysoce hořlavá kapalina a páry.  \nDA Meget brandfarlig væske og damp.  \nDE Flüssigkeit und Dampf leicht entzündbar.  \nET Väga tuleohtlik vedelik ja aur.  \nEL Υγρό και ατμοί πολύ εύφλεκτα.  \nEN Highly flammable liquid and vapour.  \nFR Liquide et vapeurs très inflammables.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 223}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 225  \nH225  Language  2.6 — Flammable liquids, Hazard Category 2  \nGA Leacht an-inadhainte agus gal an-inadhainte.  \n▼M5 \nHR Lako zapaljiva tekućina i para.  \n▼B \nIT Liquido e vapori facilmente infiammabili.  \nLV Viegli uzliesmojošs šķidrums un tvaiki.  \nLT Labai degūs skystis ir garai.  \nHU Fokozottan tűzveszélyes folyadék és gőz.  \nMT Likwidu u fwar li jaqbdu malajr ħafna.  \nNL Licht ontvlambare vloeistof en damp.  \nPL Wysoce łatwopalna ciecz i pary.  \nPT Líquido e vapor facilmente inflamáveis.  \nRO Lichid și vapori foarte inflamabili.  \nSK Veľmi horľavá kvapalina a pary.  \nSL Lahko vnetljiva tekočina in hlapi.  \nFI Helposti syttyvä neste ja höyry.  \nSV Mycket brandfarlig vätska och ånga.  \nH226  Language  2.6 — Flammable liquids, Hazard Category 3  \nBG Запалими течност и пари.  \nES Líquidos y vapores inflamables.  \nCS Hořlavá kapalina a páry.  \nDA Brandfarlig væske og damp.  \nDE Flüssigkeit und Dampf entzündbar.  \nET Tuleohtlik vedelik ja aur.  \nEL Υγρό και ατμοί εύφλεκτα.  \nEN Flammable liquid and vapour.  \nFR Liquide et vapeurs inflammables.  \nGA Leacht inadhainte agus gal inadhainte.  \n▼M5 \nHR Zapaljiva tekućina i para.  \n▼B \nIT Liquido e vapori infiammabili.  \nLV Uzliesmojošs šķidrums un tvaiki.  \nLT Degūs skystis ir garai.  \nHU Tűzveszélyes folyadék és gőz.  \nMT Likwidu u fwar li jaqbdu.  \nNL Ontvlambare vloeistof en damp.  \nPL Łatwopalna ciecz i pary.  \nPT Líquido e vapor inflamáveis.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 224}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 226  \nH226  Language  2.6 — Flammable liquids, Hazard Category 3  \nRO Lichid și vapori inflamabili.  \nSK Horľavá kvapalina a pary.  \nSL Vnetljiva tekočina in hlapi.  \nFI Syttyvä neste ja höyry.  \nSV Brandfarlig vätska och ånga.  \nH228  Language  2.7 — Flammable solids, Hazard Category 1, 2  \nBG Запалимо твърдо вещество.  \nES Sólido inflamable.  \nCS Hořlavá tuhá látka.  \nDA Brandfarligt fast stof.  \nDE Entzündbarer Feststoff.  \nET Tuleohtlik tahke aine.  \nEL Εύφλεκτο στερεό.  \nEN Flammable solid.  \nFR Matière solide inflammable.  \nGA Solad inadhainte.  \n▼M5 \nHR Zapaljiva krutina.  \n▼B \nIT Solido infiammabile.  \nLV Uzliesmojoša cieta viela.  \nLT Degi kietoji medžiaga.  \nHU Tűzveszélyes szilárd anyag.  \nMT Solidu li jaqbad.  \nNL Ontvlambare vaste stof.  \nPL Substancja stała łatwopalna.  \nPT Sólido inflamável.  \nRO Solid inflamabil.  \nSK Horľavá tuhá látka.  \nSL Vnetljiva trdna snov.  \nFI Syttyvä kiinteä aine.  \nSV Brandfarligt fast ämne.  \n▼M4 \nH229  Language  2.3 — Aerosols, Hazard Category 1, 2, 3  \nBG Съд под налягане: може да експлодира при \nнагряване.  \nES Recipiente a presión: Puede reventar si se \ncalienta.  \nCS Nádoba je pod tlakem: při zahřívání se může \nroztrhnout.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 225}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 227  \nH229  Language  2.3 — Aerosols, Hazard Category 1, 2, 3  \nDA Beholder under tryk. Kan sprænges ved \nopvarmning.  \nDE Behälter steht unter Druck: Kann bei \nErwärmung bersten.  \nET Mahuti on rõhu all: kuumenemisel võib \nlõhkeda.  \nEL Δοχείο υπό πίεση. Κατά τη θέρμανση μπορεί \nνα διαρραγεί. \nEN Pressurised container: May burst if heated.  \nFR Récipient sous pression: peut éclater sous l’effet \nde la chaleur.  \nGA Coimeádán brúchóirithe: D’fhéadfadh sé \npléascadh, má théitear é.  \n▼M8 \nHR Spremnik pod tlakom: može se rasprsnuti ako \nse grije. \n▼M4 \nIT Contenitore pressurizzato: può esplodere se \nriscaldato.  \nLV Tvertne zem spiediena: karstumā var eksplodēt.  \nLT Slėginė talpykla. Kaitinama gali sprogti.  \nHU Az edényben túlnyomás uralkodik: hő hatására \nmegrepedhet.  \nMT Kontenitur taħt pressjoni. Jista jinfaqa meta \njissaħħan. \nNL Houder onder druk: kan open barsten bij verhit\xad\nting. \nPL Pojemnik pod ciśnieniem: Ogrzanie grozi \nwybuchem. \nPT Recipiente sob pressão: risco de explosão sob a \nação do calor.  \nRO Recipient sub presiune: Poate exploda daca este \nincalzit.  \nSK Nádoba je pod tlakom: Pri zahriatí sa môže \nroztrhnúť.  \nSL Posoda je pod tlakom: lahko eksplodira pri \nsegrevanju. \nFI Painesäiliö: Voi revetä kuumennettaessa.  \nSV Tryckbehållare: Kan sprängas vid uppvärmning.  \n▼M19  \nH230  Language  2.2 — Flammable gases, Hazard Category 1A, \nchemically unstable gas A  \n▼M4 \nBG Може да реагира експлозивно дори при \nотсъствие на въздух. \nES Puede explotar incluso en ausencia de aire.  \nCS Může reagovat výbušně i bez přítomnosti \nvzduchu. \nDA Kan reagere eksplosivt selv i fravær af luft.  \nDE Kann auch in Abwesenheit von Luft explo\xad\nsionsartig reagieren.  \nET Võib reageerida plahvatuslikult isegi õhuga \nkokku puutumata.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 226}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 228  \nH230  Language  2.2 — Flammable gases, Hazard Category 1A, \nchemically unstable gas A  \n▼M4 \nEL Δύναται να εκραγεί ακόμη και απουσία αέρος.  \nEN May react explosively even in the absence of \nair. \nFR Peut exploser même en l’absence d’air.  \nGA D’fhéadfadh sé imoibriú go pléascach fiú mura \nbhfuil aer ann.  \n▼M8 \nHR Može eksplozivno reagirati i bez prisustva \nzraka.  \n▼M4 \nIT Può esplodere anche in assenza di aria.  \nLV Var eksplodēt pat bezgaisa vidē.  \nLT Gali sprogti net ir nesant oro.  \nHU Még levegő hiányában is robbanásszerű \nreakcióba léphet.  \nMT Jista jisplodi anke fin-nuqqas ta’ l-arja.  \nNL Kan explosief reageren zelfs in afwezigheid van \nlucht.  \nPL Może reagować wybuchowo nawet bez dostępu \npowietrza.  \nPT Pode reagir explosivamente mesmo na ausência \nde ar. \nRO Pericol de explozie, chiar si in absenta aerului.  \nSK Môže reagovať výbušne aj bez prítomnosti \nvzduchu. \nSL Lahko reagira eksplozivno tudi v odsotnosti \nzraka. \nFI Voi reagoida räjähtäen jopa ilmattomassa \ntilassa.  \nSV Kan reagera explosivt även i frånvaro av luft.  \n▼M19  \nH231  Language  2.2 — Flammable gases, Hazard Category 1A, \nchemically unstable gas B  \n▼M4 \nBG Може да реагира експлозивно дори при \nотсъствие на въздух при повишено \nналягане и/или температура.  \nES Puede explotar incluso en ausencia de aire, a \npresión y/o temperatura elevadas.  \nCS Při zvýšeném tlaku a/nebo teplotě může \nreagovat výbušně i bez přítomnosti vzduchu.  \nDA Kan reagere eksplosivt selv i fravær af luft ved \nforhøjet tryk og/eller temperatur.  \nDE Kann auch in Abwesenheit von Luft bei \nerhöhtem Druck und/oder erhöhter Temperatur \nexplosionsartig reagieren.  \nET Võib reageerida plahvatuslikult isegi õhuga \nkokku puutumata kõrgenenud rõhul ja/või \ntemperatuuril.  \nEL Δύναται να εκραγεί σε υψηλή θερμοκρασία και/ \nή πίεση ακόμη και απουσία αέρος.  \nEN May react explosively even in the absence of \nair at elevated pressure and/or temperature.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 227}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 229  \nH231  Language  2.2 — Flammable gases, Hazard Category 1A, \nchemically unstable gas B  \n▼M4 \nFR Peut exploser même en l’absence d’air à une \npression et/ou température élevée(s).  \nGA D’fhéadfadh sé imoibriú go pléascach fiú mura \nbhfuil aer ann ag brú ardaithe agus/nó ag teocht \nardaithe.  \n▼M8 \nHR Može eksplozivno reagirati i bez prisustva \nzraka na povišenom tlaku i/ili temperaturi.  \n▼M4 \nIT Può esplodere anche in assenza di aria a \npressione e/o temperatura elevata.  \nLV Var eksplodēt pat bezgaisa vidē, paaugstinoties \nspiedienam un/vai temperatūrai.  \nLT Gali sprogti net ir nesant oro, esant didesniam \nslėgiui ir (arba) temperatūrai.  \nHU Magas nyomáson és/vagy hőmérsékleten még \nlevegő hiányában is robbanásszerű reakcióba \nléphet.  \nMT Jista jisplodi anke fin-nuqqas ta’ l-arja fi \npressjoni għolja u/jew f’temperatura għolja.  \nNL Kan explosief reageren zelfs in afwezigheid van \nlucht bij verhoogde druk en/of temperatuur.  \nPL Może reagować wybuchowo nawet bez dostępu \npowietrza pod zwiększonym ciśnieniem i/lub po \nogrzaniu.  \nPT Pode reagir explosivamente mesmo na ausência \nde ar a alta pressão e/ou temperatura.  \nRO Pericol de explozie, chiar și în absenţa aerului \nla presiune și/sau temperatură ridicată.  \nSK Môže reagovať výbušne aj bez prítomnosti \nvzduchu pri zvýšenom tlaku a/alebo teplote.  \nSL Lahko reagira eksplozivno tudi v odsotnosti \nzraka pri povišanem tlaku in/ali temperature.  \nFI Voi reagoida räjähtäen jopa ilmattomassa tilassa \nkohonneessa paineessa ja/tai lämpötilassa.  \nSV Kan reagera explosivt även i frånvaro av luft \nvid förhöjt tryck och/eller temperatur.  \n▼M19  \nH232  Language  2.2 — Flammable gases, Hazard Category 1A, pyro\xad\nphoric gas  \nBG Може да се запали спонтанно при контакт с \nвъздух. \nES Puede inflamarse espontáneamente en contacto \ncon el aire.  \nCS Při styku se vzduchem se může samovolně \nvznítit.  \nDA Kan selvantænde ved kontakt med luft.  \nDE Kann sich bei Kontakt mit Luft spontan \nentzünden.  \nET Kokkupuutel õhuga võib süttida iseenesest.  \nEL Ενδέχεται να αυτοαναφλεγεί εάν εκτεθεί στον \nαέρα.  \nEN May ignite spontaneously if exposed to air.  \nFR Peut s'enflammer spontanément au contact de \nl'air. ▼M19", metadata={'source': 'data/ycla_en.pdf', 'page': 228}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 230  \nH232  Language  2.2 — Flammable gases, Hazard Category 1A, pyro\xad\nphoric gas  \nGA D'fhéadfadh an ní uathadhaint i gcás nochtadh \ndon aer.  \nHR Može se spontano zapaliti u dodiru sa zrakom.  \nIT Spontaneamente infiammabile all'aria.  \nLV Saskarē ar gaisu var spontāni aizdegties.  \nLT Ore gali užsidegti savaime.  \nHU Levegővel érintkezve öngyulladásra hajlamos.  \nMT Jista' jieħu n-nar spontanjament jekk ikun \nespost għall-arja.  \nNL Kan spontaan ontbranden bij blootstelling aan \nlucht.  \nPL Może ulegać samozapaleniu w przypadku \nwystawienia na działanie powietrza.  \nPT Pode inflamar-se espontaneamente em contacto \ncom o ar.  \nRO Se poate aprinde spontan dacă intră în contact \ncu aerul.  \nSK Pri kontakte so vzduchom sa môže spontánne \nvznietit.  \nSL V stiku z zrakom lahko pride do samodejnega \nvžiga.  \nFI Voi syttyä itsestään palamaan joutuessaan \nkosketuksiin ilman kanssa.  \nSV Kan spontanantända vid kontakt med luft.  \n▼B \nH240  Language  2.8 — Self-Reactive Substances and Mixtures, Type A \n2.1.5 — Organic Peroxides, Type A  \nBG Може да предизвика експлозия при \nнагряване.  \nES Peligro de explosión en caso de calentamiento.  \nCS Zahřívání může způsobit výbuch.  \nDA Eksplosionsfare ved opvarmning.  \nDE Erwärmung kann Explosion verursachen.  \nET Kuumenemisel võib plahvatada.  \nEL Η θέρμανση μπορεί να προκαλέσει έκρηξη.  ▼M19", metadata={'source': 'data/ycla_en.pdf', 'page': 229}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 231  \nH240  Language  2.8 — Self-Reactive Substances and Mixtures, Type A \n2.1.5 — Organic Peroxides, Type A  \nEN Heating may cause an explosion.  \nFR Peut exploser sous l'effet de la chaleur.  \nGA D'fhéadfadh téamh a bheith ina chúis le pléas\xad\ncadh.  \n▼M5 \nHR Zagrijavanje može uzrokovati eksploziju.  \n▼B \nIT Rischio di esplosione per riscaldamento.  \nLV Sakaršana var izraisīt eksploziju.  \nLT Kaitinant gali sprogti.  \nHU Hő hatására robbanhat.  \nMT It-tisħin jista' jikkawża splużjoni.  \nNL Ontploffingsgevaar bij verwarming.  \nPL Ogrzanie grozi wybuchem.  \nPT Risco de explosão sob a acção do calor.  \nRO Pericol de explozie în caz de încălzire.  \nSK Zahrievanie môže spôsobiť výbuch.  \nSL Segrevanje lahko povzroči eksplozijo.  \nFI Räjähdysvaarallinen kuumennettaessa.  \nSV Explosivt vid uppvärmning.  \nH241  Language  2.8 — Self-Reactive Substances and Mixtures, Type B \n2.1.5 — Organic Peroxides, Type B  \nBG Може да предизвика пожар или експлозия \nпри нагряване.  \nES Peligro de incendio o explosión en caso de \ncalentamiento.  \nCS Zahřívání může způsobit požár nebo výbuch.  \nDA Brand- eller eksplosionsfare ved opvarmning.  \nDE Erwärmung kann Brand oder Explosion verurs\xad\nachen.  \nET Kuumenemisel võib süttida või plahvatada.  \nEL Η θέρμανση μπορεί να προκαλέσει πυρκαγιά ή \nέκρηξη.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 230}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 232  \nH241  Language  2.8 — Self-Reactive Substances and Mixtures, Type B \n2.1.5 — Organic Peroxides, Type B  \nEN Heating may cause a fire or explosion.  \nFR Peut s'enflammer ou exploser sous l'effet de la \nchaleur.  \nGA D'fhéadfadh téamh a bheith ina chúis le dóiteán \nnó le pléascadh.  \n▼M5 \nHR Zagrijavanje može uzrokovati požar ili \neksploziju.  \n▼B \nIT Rischio d'incendio o di esplosione per riscalda\xad\nmento.  \nLV Sakaršana var izraisīt degšanu vai eksploziju.  \nLT Kaitinant gali sukelti gaisrą arba sprogti.  \nHU Hő hatására meggyulladhat vagy robbanhat.  \nMT It-tisħin jista' jikkawża nar jew splużjoni.  \nNL Brand- of ontploffingsgevaar bij verwarming.  \nPL Ogrzanie może spowodować pożar lub wybuch.  \nPT Risco de explosão ou de incêndio sob a acção \ndo calor.  \nRO Pericol de incendiu sau de explozie în caz de \nîncălzire.  \nSK Zahrievanie môže spôsobiť požiar alebo \nvýbuch.  \nSL Segrevanje lahko povzroči požar ali eksplozijo.  \nFI Räjähdys- tai palovaarallinen kuumennettaessa.  \nSV Brandfarligt eller explosivt vid uppvärmning.  \nH242  Language  2.8 — Self-Reactive Substances and Mixtures, Types \nC, D, E, F \n2.1.5 — Organic Peroxides, Types C, D, E, F  \nBG Може да предизвика пожар при нагряване.  \nES Peligro de incendio en caso de calentamiento.  \nCS Zahřívání může způsobit požár.  \nDA Brandfare ved opvarmning.  \nDE Erwärmung kann Brand verursachen.  \nET Kuumenemisel võib süttida.  \nEL Η θέρμανση μπορεί να προκαλέσει πυρκαγιά.  \nEN Heating may cause a fire.  \nFR Peut s'enflammer sous l'effet de la chaleur.  \nGA D'fhéadfadh téamh a bheith ina chúis le \ndóiteán.  \n▼M5 \nHR Zagrijavanje može uzrokovati požar.  \n▼B \nIT Rischio d'incendio per riscaldamento.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 231}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 233  \nH242  Language  2.8 — Self-Reactive Substances and Mixtures, Types \nC, D, E, F \n2.1.5 — Organic Peroxides, Types C, D, E, F  \nLV Sakaršana var izraisīt degšanu.  \nLT Kaitinant gali sukelti gaisrą.  \nHU Hő hatására meggyulladhat.  \nMT It-tisħin jista' jikkawża nar.  \nNL Brandgevaar bij verwarming.  \nPL Ogrzanie może spowodować pożar.  \nPT Risco de incêndio sob a acção do calor.  \nRO Pericol de incendiu în caz de încălzire.  \nSK Zahrievanie môže spôsobiť požiar.  \nSL Segrevanje lahko povzroči požar.  \nFI Palovaarallinen kuumennettaessa.  \nSV Brandfarligt vid uppvärmning.  \nH250  Language  2.9 — Pyrophoric Liquids, Hazard Category 1 \n2.10 — Pyorphoric Solids, Hazard Category 1  \nBG Самозапалва се при контакт с въздух.  \nES Se inflama espontáneamente en contacto con el \naire. \nCS Při styku se vzduchem se samovolně vznítí.  \nDA Selvantænder ved kontakt med luft.  \nDE Entzündet sich in Berührung mit Luft von \nselbst.  \nET Kokkupuutel õhuga süttib iseenesest.  \nEL Αυταναφλέγεται εάν εκτεθεί στον αέρα.  \nEN Catches fire spontaneously if exposed to air.  \nFR S'enflamme spontanément au contact de l'air.  \nGA Téann trí thine go spontáineach má nochtar don \naer. \n▼M5 \nHR Samozapaljivo u dodiru sa zrakom.  \n▼B \nIT Spontaneamente infiammabile all'aria.  \nLV Spontāni aizdegas saskarē ar gaisu.  \nLT Veikiami oro savaime užsidega.  \nHU Levegővel érintkezve önmagától meggyullad.  \nMT Jieħu n-nar spontanjament jekk ikun espost \ngħall-arja.  \nNL Vat spontaan vlam bij blootstelling aan lucht.  \nPL Zapala się samorzutnie w przypadku wysta\xad\nwienia na działanie powietrza.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 232}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 234  \nH250  Language  2.9 — Pyrophoric Liquids, Hazard Category 1 \n2.10 — Pyorphoric Solids, Hazard Category 1  \nPT Risco de inflamação espontânea em contacto \ncom o ar.  \nRO Se aprinde spontan, în contact cu aerul.  \nSK Pri kontakte so vzduchuom sa spontánne \nvznieti.  \nSL Samodejno se vžge na zraku.  \nFI Syttyy itsestään palamaan joutuessaan koske\xad\ntuksiin ilman kanssa.  \nSV Spontanantänder vid kontakt med luft.  \nH251  Language  2.11 — Self-Heating Substances and Mixtures, Hazard \nCategory 1  \nBG Самонагряващо се: може да се запали.  \nES Se calienta espontáneamente; puede inflamarse.  \nCS Samovolně se zahřívá: může se vznítit.  \nDA Selvopvarmende, kan selvantænde.  \nDE Selbsterhitzungsfähig; kann in Brand geraten.  \nET Isekuumenev, võib süttida.  \nEL Αυτοθερμαίνεται: μπορεί να αναφλεγεί.  \nEN Self-heating: may catch fire.  \nFR Matière auto-échauffante; peut s'enflammer.  \nGA Féintéamh: d'fhéadfadh sé dul trí thine.  \n▼M5 \nHR Samozagrijavanje; može se zapaliti.  \n▼B \nIT Autoriscaldante; può infiammarsi.  \nLV Pašsasilstošs; var aizdegties.  \nLT Savaime kaistančios, gali užsidegti.  \nHU Önmelegedő: meggyulladhat.  \nMT Jisħon waħdu: jista' jieħu n-nar.  \nNL Vatbaar voor zelfverhitting: kan vlam vatten.  \nPL Substancja samonagrzewająca się: może się \nzapalić.  \nPT Susceptível de auto-aquecimento: risco de infla\xad\nmação.  \nRO Se autoîncălzește, pericol de aprindere.  \nSK Samovoľne sa zahrieva; môže sa vznietiť.  \nSL Samosegrevanje: lahko povzroči požar.  \nFI Itsestään kuumeneva; voi syttyä palamaan.  \nSV Självupphettande. Kan börja brinna.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 233}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 235  \nH252  Language  2.11 — Self-Heating Substances and Mixtures, Hazard \nCategory 2  \nBG Самонагряващо се в големи количества; \nможе да се запали.  \nES Se calienta espontáneamente en grandes canti\xad\ndades; puede inflamarse.  \nCS Ve velkém množství se samovolně zahřívá; \nmůže se vznítit.  \nDA Selvopvarmende i store mængder, kan selvant\xad\nænde.  \nDE In großen Mengen selbsterhitzungsfähig; kann \nin Brand geraten.  \nET Suurtes kogustes isekuumenev, võib süttida.  \nEL Σε μεγάλες ποσότητες αυτοθερμαίνεται: μπορεί \nνα αναφλεγεί.  \nEN Self-heating in large quantities; may catch fire.  \nFR Matière auto-échauffante en grandes quantités; \npeut s'enflammer.  \nGA Féintéamh ina mhórchainníochtaí; d'fhéadfadh \nsé dul trí thine.  \n▼M5 \nHR Samozagrijavanje u velikim količinama; može \nse zapaliti.  \n▼B \nIT Autoriscaldante in grandi quantità; può \ninfiammarsi.  \nLV Lielos apjomos pašsasilstošs; var aizdegties.  \nLT Laikant dideliais kiekiais savaime kaista, gali \nužsidegti.  \nHU Nagy mennyiségben önmelegedő; meggyul\xad\nladhat.  \nMT Jisħon waħdu f'kwantitajiet kbar; jista' jieħu n- \nnar. \nNL In grote hoeveelheden vatbaar voor zelfver\xad\nhitting; kan vlam vatten.  \nPL Substancja samonagrzewająca się w dużych \nilościach; może się zapalić.  \nPT Susceptível de auto-aquecimento em grandes \nquantidades: risco de inflamação.  \nRO ►C3 Se autoîncălzește în cantităţi mari; pericol \nde aprindere. ◄  \nSK Vo veľkých množstvách sa samovoľne \nzahrieva; môže sa vznietiť.  \nSL Samosegrevanje v velikih količinah; lahko \npovzroči požar.  \nFI Suurina määrinä itsestään kuumeneva; voi \nsyttyä palamaan.  \nSV Självupphettande i stora mängder. Kan börja \nbrinna.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 234}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 236  \nH260  Language  2.12 — Substances and Mixtures which, in contact \nwith water, emit flammable gases, Hazard Category 1  \nBG При контакт с вода отделя запалими газове, \nкоито могат да се самозапалят.  \nES En contacto con el agua desprende gases \ninflamables que pueden inflamarse espont\xad\náneamente.  \nCS Při styku s vodou uvolňuje hořlavé plyny, které \nse mohou samovolně vznítit.  \nDA Ved kontakt med vand udvikles brandfarlige \ngasser, som kan selvantænde.  \nDE In Berührung mit Wasser entstehen entzündbare \nGase, die sich spontan entzünden können.  \nET Kokkupuutel veega eraldab tuleohtlikke gaase, \nmis võivad iseenesest süttida.  \nEL Σε επαφή με το νερό ελευθερώνει εύφλεκτα \nαέρια τα οποία μπορούν να αυτοαναφλεγούν.  \nEN In contact with water releases flammable gases \nwhich may ignite spontaneously.  \nFR Dégage au contact de l'eau des gaz inflam\xad\nmables qui peuvent s'enflammer spontanément.  \nGA I dteagmháil le huisce scaoiltear gáis inadhainte \na d'fhéadfadh uathadhaint.  \n▼M5 \nHR U dodiru s vodom oslobađa zapaljive plinove \nkoji se mogu spontano zapaliti.  \n▼B \nIT A contatto con l'acqua libera gas infiammabili \nche possono infiammarsi spontaneamente.  \nLV Nonākot saskarē ar ūdeni, izdala uzliesmojošas \ngāzes, kas var spontāni aizdegties.  \nLT Kontaktuodami su vandeniu išskiria degias \ndujas, kurios gali savaime užsidegti.  \nHU Vízzel érintkezve öngyulladásra hajlamos \ntűzveszélyes gázokat bocsát ki.  \nMT Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu li \njistgħu jieħdu n-nar spontanjament.  \nNL In contact met water komen ontvlambare gassen \nvrij die spontaan kunnen ontbranden.  \nPL W kontakcie z wodą uwalniają łatwopalne \ngazy, które mogą ulegać samozapaleniu.  \nPT Em contacto com a água liberta gases que se \npodem inflamar espontaneamente.  \nRO În contact cu apa degajă gaze inflamabile care \nse pot aprinde spontan.  \nSK Pri kontakte s vodou uvoľňuje horľavé plyny, \nktoré sa môžu spontánne zapáliť.  \nSL V stiku z vodo se sproščajo vnetljivi plini, ki se \nlahko samodejno vžgejo.  \nFI Kehittää itsestään syttyviä kaasuja veden \nkanssa.  \nSV Vid kontakt med vatten utvecklas brandfarliga \ngaser som kan självantända.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 235}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 237  \nH261  Language  2.12 — Substances and Mixtures which, in contact \nwith water, emit flammable gases, Hazard Category 2  \nBG При контакт с вода отделя запалими газове.  \nES En contacto con el agua desprende gases \ninflamables.  \nCS Při styku s vodou uvolňuje hořlavé plyny.  \nDA Ved kontakt med vand udvikles brandfarlige \ngasser.  \nDE In Berührung mit Wasser entstehen entzündbare \nGase.  \nET Kokkupuutel veega eraldab tuleohtlikke gaase.  \nEL Σε επαφή με το νερό ελευθερώνει εύφλεκτα \nαέρια.  \nEN In contact with water releases flammable gases.  \nFR Dégage au contact de l'eau des gaz inflam\xad\nmables.  \nGA I dteagmháil le huisce scaoiltear gáis \ninadhainte.  \n▼M5 \nHR U dodiru s vodom oslobađa zapaljive plinove.  \n▼B \nIT A contatto con l'acqua libera gas infiammabili.  \nLV Nonākot saskarē ar ūdeni, izdala uzliesmojošu \ngāzi.  \nLT Kontaktuodami su vandeniu išskiria degias \ndujas  \nHU Vízzel érintkezve tűzveszélyes gázokat bocsát \nki. \nMT Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu.  \nNL In contact met water komen ontvlambare gassen \nvrij. \nPL W kontakcie z wodą uwalnia łatwopalne gazy.  \nPT Em contacto com a água liberta gases inflamá\xad\nveis. \nRO În contact cu apa degajă gaze inflamabile.  \nSK Pri kontakte s vodou uvoľňuje horľavé plyny.  \nSL V stiku z vodo se sproščajo vnetljivi plini.  \nFI Kehittää syttyviä kaasuja veden kanssa.  \nSV Vid kontakt med vatten utvecklas brandfarliga \ngaser.  \nH270  Language  2.4 — Oxidising Gases, Hazard Category 1  \nBG Може да предивзика или усили пожар; \nокислител.  \nES Puede provocar o agravar un incendio; \ncomburente.  \nCS Může způsobit nebo zesílit požár; oxidant.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 236}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 238  \nH270  Language  2.4 — Oxidising Gases, Hazard Category 1  \nDA Kan forårsage eller forstærke brand, brand\xad\nnærende.  \nDE Kann Brand verursachen oder verstärken; \nOxidationsmittel.  \nET Võib põhjustada süttimise või soodustada \npõlemist; oksüdeerija.  \nEL Μπορεί να προκαλέσει ή να αναζωπυρώσει \nπυρκαγιά· οξειδωτικό.  \nEN May cause or intensify fire; oxidiser.  \nFR Peut provoquer ou aggraver un incendie; \ncomburant.  \nGA D'fhéadfadh sé a bheith ina chúis le tine nó cur \nle tine; ocsaídeoir.  \n▼M5 \nHR Može uzrokovati ili pojačati požar; oksidans.  \n▼B \nIT Può provocare o aggravare un incendio; \ncomburente.  \nLV Var izraisīt vai pastiprināt degšanu, oksidētājs.  \nLT Gali sukelti arba padidinti gaisrą, oksidatorius.  \nHU Tüzet okozhat vagy fokozhatja a tűz intenzi\xad\ntását, oxidáló hatású.  \nMT Jista' jikkawża jew iżid in-nar; ossidant.  \nNL Kan brand veroorzaken of bevorderen; \noxiderend.  \nPL Może spowodować lub intensyfikować pożar; \nutleniacz.  \nPT Pode provocar ou agravar incêndios; \ncomburente.  \nRO Poate provoca sau agrava un incendiu; oxidant.  \nSK Môže spôsobiť alebo prispieť k rozvoju \npožiaru; oxidačné činidlo.  \nSL Lahko povzroči ali okrepi požar; oksidativna \nsnov.  \nFI Aiheuttaa tulipalon vaaran tai edistää tulipaloa; \nhapettava.  \nSV Kan orsaka eller intensifiera brand. Oxiderande.  \nH271  Language  2.13 — Oxidising Liquids, Hazard Category 1 \n2.14 — Oxidising Solids, Hazard Category 1  \nBG Може да предизвика пожар или експлозия; \nсилен окислител.  \nES Puede provocar un incendio o una explosión; \nmuy comburente.  \nCS Může způsobit požár nebo výbuch; silný \noxidant.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 237}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 239  \nH271  Language  2.13 — Oxidising Liquids, Hazard Category 1 \n2.14 — Oxidising Solids, Hazard Category 1  \nDA Kan forårsage brand eller eksplosion, stærkt \nbrandnærende.  \nDE Kann Brand oder Explosion verursachen; \nstarkes Oxidationsmittel.  \nET Võib põhjustada süttimise või plahvatuse; tugev \noksüdeerija.  \nEL Μπορεί να προκαλέσει πυρκαγιά ή έκρηξη· \nισχυρό οξειδωτικό.  \nEN May cause fire or explosion; strong oxidiser.  \nFR Peut provoquer un incendie ou une explosion; \ncomburant puissant.  \nGA D'fhéadfadh sé a bheith ina chúis le tine nó le \npléascadh; an-ocsaídeoir.  \n▼M5 \nHR Može uzrokovati požar ili eksploziju; jaki \noksidans.  \n▼B \nIT Può provocare un incendio o un'esplosione; \nmolto comburente.  \nLV Var izraisīt degšanu vai eksploziju, oksidētājs.  \nLT Gali sukelti gaisrą arba sprogimą, stiprus oksi\xad\ndatorius.  \nHU Tüzet vagy robbanást okozhat; erősen oxidáló \nhatású.  \nMT Jista' jikkawża nar jew splużjoni; ossidant \nqawwi.  \nNL Kan brand of ontploffingen veroorzaken; sterk \noxiderend.  \nPL Może spowodować pożar lub wybuch; silny \nutleniacz.  \nPT Risco de incêndio ou de explosão; muito \ncomburente.  \nRO Poate provoca un incendiu sau o explozie; \noxidant puternic.  \nSK Môže spôsobiť požiar alebo výbuch; silné \noxidačné činidlo.  \nSL Lahko povzroči požar ali eksplozijo; močna \noksidativna snov.  \nFI Aiheuttaa tulipalo- tai räjähdysvaaran; voimak\xad\nkaasti hapettava.  \nSV Kan orsaka brand eller explosion. Starkt oxider\xad\nande.  \nH272  Language  2.13 — Oxidising Liquids, Hazard Category 2, 3 \n2.14 — Oxidising Solids, Hazard Category 2, 3  \nBG Може да усили пожара; окислител.  \nES Puede agravar un incendio; comburente.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 238}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 240  \nH272  Language  2.13 — Oxidising Liquids, Hazard Category 2, 3 \n2.14 — Oxidising Solids, Hazard Category 2, 3  \nCS Může zesílit požár; oxidant.  \nDA Kan forstærke brand, brandnærende.  \nDE Kann Brand verstärken; Oxidationsmittel.  \nET Võib soodustada põlemist; oksüdeerija.  \nEL Μπορεί να αναζωπυρώσει την πυρκαγιά· \nοξειδωτικό.  \nEN May intensify fire; oxidiser.  \nFR Peut aggraver un incendie; comburant.  \nGA D'fhéadfadh sé cur le tine; ocsaídeoir.  \n▼M5 \nHR Može pojačati požar; oksidans.  \n▼B \nIT Può aggravare un incendio; comburente.  \nLV Var pastiprināt degšanu; oksidētājs.  \nLT Gali padidinti gaisrą, oksidatorius.  \nHU Fokozhatja a tűz intenzitását; oxidáló hatású.  \nMT Jista' jżid in-nar; ossidant.  \nNL Kan brand bevorderen; oxiderend.  \nPL Może intensyfikować pożar; utleniacz.  \nPT Pode agravar incêndios; comburente.  \nRO Poate agrava un incendiu; oxidant.  \nSK Môže prispieť k rozvoju požiaru; oxidačné \nčinidlo.  \nSL Lahko okrepi požar; oksidativna snov.  \nFI Voi edistää tulipaloa; hapettava.  \nSV Kan intensifiera brand. Oxiderande.  \nH280  Language  2.5 — Gases under pressure: \nCompressed gas \nLiquefied gas \nDissolved gas  \nBG Съдържа газ под налягане; може да \nексплодира при нагряване.  \nES Contiene gas a presión; peligro de explosión en \ncaso de calentamiento.  \nCS Obsahuje plyn pod tlakem; při zahřívání může \nvybuchnout.  \nDA Indeholder gas under tryk, kan eksplodere ved \nopvarmning.  \nDE Enthält Gas unter Druck; kann bei Erwärmung \nexplodieren.  \nET Sisaldab rõhu all olevat gaasi, kuumenemisel \nvõib plahvatada.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 239}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 241  \nH280  Language  2.5 — Gases under pressure: \nCompressed gas \nLiquefied gas \nDissolved gas  \nEL Περιέχει αέριο υπό πίεση· εάν θερμανθεί, \nμπορεί να εκραγεί.  \nEN Contains gas under pressure; may explode if \nheated.  \nFR Contient un gaz sous pression; peut exploser \nsous l'effet de la chaleur.  \nGA Gás istigh ann, faoi bhrú; d'fhéadfadh sé \npléascadh, má théitear.  \n▼M5 \nHR Sadrži stlačeni plin; zagrijavanje može uzro\xad\nkovati eksploziju.  \n▼B \nIT Contiene gas sotto pressione; può esplodere se \nriscaldato.  \nLV Satur gāzi zem spiediena; karstumā var \neksplodēt.  \nLT Turi slėgio veikiamų dujų, kaitinant gali \nsprogti.  \nHU Nyomás alatt lévő gázt tartalmaz; hő hatására \nrobbanhat.  \nMT Fih gass taħt pressjoni; jista' jisplodi jekk \njissaħħan.  \nNL Bevat gas onder druk; kan ontploffen bij \nverwarming.  \nPL Zawiera gaz pod ciśnieniem; ogrzanie grozi \nwybuchem.  \nPT Contém gás sob pressão; risco de explosão sob \na acção do calor.  \nRO Conţine un gaz sub presiune; pericol de \nexplozie în caz de încălzire.  \nSK Obsahuje plyn pod tlakom, pri zahriatí môže \nvybuchnúť.  \nSL Vsebuje plin pod tlakom; segrevanje lahko \npovzroči eksplozijo.  \nFI Sisältää paineen alaista kaasua; voi räjähtää \nkuumennettaessa.  \nSV Innehåller gas under tryck. Kan explodera vid \nuppvärmning.  \nH281  Language  2.5 — Gases under pressure: Refrigerated liquefied \ngas \nBG Съдържа охладен газ; може да причини \nкриогенни изгаряния или наранявания.  \nES ►C3 Contiene gas refrigerado; ◄ puede \nprovocar quemaduras o lesiones criogénicas.  \nCS Obsahuje zchlazený plyn; může způsobit \nomrzliny nebo poškození chladem.  \nDA Indeholder nedkølet gas, kan forårsage kuldes\xad\nkader.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 240}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 242  \nH281  Language  2.5 — Gases under pressure: Refrigerated liquefied \ngas \nDE ►C3 Enthält tiefgekühltes Gas; kann Kältever\xad\nbrennungen oder -verletzungen verursachen. ◄  \nET Sisaldab külmutatud gaasi; võib põhjustada \nkülmapõletusi või -kahjustusi.  \nEL Περιέχει αέριο υπό ψύξη· μπορεί να \nπροκαλέσει εγκαύματα ψύχους ή \nτραυματισμούς.  \nEN Contains refrigerated gas; may cause cryogenic \nburns or injury.  \nFR Contient un gaz réfrigéré; peut causer des \nbrûlures ou blessures cryogéniques.  \nGA Gás cuisnithe istigh ann; d'fhéadfadh sé a \nbheith ina chúis le dónna crióigineacha nó le \ndíobháil chrióigineach.  \n▼M5 \nHR Sadrži pothlađeni, ukapljeni plin; može uzro\xad\nkovati kriogene opekline ili ozljede.  \n▼B \nIT Contiene gas refrigerato; può provocare ustioni \no lesioni criogeniche.  \nLV Satur atdzesētu gāzi; var radīt kriogēnus \napdegumus vai ievainojumus.  \nLT Turi atšaldytų dujų, gali sukelti kriogeninius \nnušalimus arba pažeidimus.  \nHU Mélyhűtött gázt tartalmaz; fagymarást vagy \nsérülést okozhat.  \nMT Fih gass imkessaħ; jista' jikkawża ħruq jew \ndannu minn temperaturi baxxi.  \nNL Bevat sterk gekoeld gas; kan cryogene brand\xad\nwonden of letsel veroorzaken.  \nPL Zawiera schłodzony gaz; może spowodować \noparzenia kriogeniczne lub obrażenia.  \nPT Contém gás refrigerado; pode provocar quei\xad\nmaduras ou lesões criogénicas.  \nRO Conţine un gaz răcit; poate cauza arsuri sau \nleziuni criogenice.  \nSK Obsahuje schladený plyn; môže spôsobiť \nkryogénne popáleniny alebo poranenia.  \nSL Vsebuje ohlajen utekočinjen plin; lahko \npovzroči ozebline ali poškodbe.  \nFI Sisältää jäähdytettyä kaasua; voi aiheuttaa jääty\xad\nmisvamman.  \nSV Innehåller kyld gas. Kan orsaka svåra kölds\xad\nkador.  \nH290  Language  2.16 — Corrosive to metals, Hazard Category 1  \nBG Може да бъде корозивно за металите.  \nES Puede ser corrosivo para los metales.  \nCS Může být korozivní pro kovy.  \nDA Kan ætse metaller.  \nDE Kann gegenüber Metallen korrosiv sein.  \nET Võib söövitada metalle.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 241}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 243  \nH290  Language  2.16 — Corrosive to metals, Hazard Category 1  \nEL Μπορεί να διαβρώσει μέταλλα.  \nEN May be corrosive to metals.  \nFR Peut être corrosif pour les métaux.  \nGA D'fhéadfadh sé a bheith creimneach do mhio\xad\ntail. \n▼M5 \nHR Može nagrizati metale.  \n▼B \nIT Può essere corrosivo per i metalli.  \nLV Var kodīgi iedarboties uz metāliem.  \nLT Gali ėsdinti metalus.  \nHU Fémekre korrozív hatású lehet.  \nMT Jista' jkun korrużiv għall-metalli.  \nNL Kan bijtend zijn voor metalen.  \nPL Może powodować korozję metali.  \nPT Pode ser corrosivo para os metais.  \nRO Poate fi corosiv pentru metale.  \nSK Môže byť korozívna pre kovy.  \nSL Lahko je jedko za kovine.  \nFI Voi syövyttää metalleja.  \nSV Kan vara korrosivt för metaller.  \nTable 1.2  \nHazard statements for health hazards  \nH300  Language  3.1 — Acute toxicity (oral), Hazard Category 1, 2  \nBG Смъртоносeн при поглъщане.  \nES Mortal en caso de ingestión.  \nCS Při požití může způsobit smrt.  \nDA Livsfarlig ved indtagelse.  \nDE Lebensgefahr bei Verschlucken.  \nET Allaneelamisel surmav.  \nEL Θανατηφόρο σε περίπτωση κατάποσης.  \nEN Fatal if swallowed.  \nFR Mortel en cas d'ingestion.  \nGA Marfach má shlogtar.  \n▼M5 \nHR Smrtonosno ako se proguta.  \n▼B \nIT Letale se ingerito.  \nLV Norijot iestājas nāve.  \nLT Mirtina prarijus.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 242}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 244  \nH300  Language  3.1 — Acute toxicity (oral), Hazard Category 1, 2  \nHU Lenyelve halálos.  \nMT Fatali jekk jinbela’.  \nNL Dodelijk bij inslikken.  \nPL Połknięcie grozi śmiercią.  \nPT Mortal por ingestão.  \nRO Mortal în caz de înghiţire.  \nSK Smrteľný po požití.  \nSL Smrtno pri zaužitju.  \nFI Tappavaa nieltynä.  \nSV Dödligt vid förtäring.  \nH301  Language  3.1 — Acute toxicity (oral), Hazard Category 3  \nBG Токсичен при поглъщане.  \nES Tóxico en caso de ingestión.  \nCS Toxický při požití.  \nDA Giftig ved indtagelse.  \nDE Giftig bei Verschlucken.  \nET Allaneelamisel mürgine.  \nEL Τοξικό σε περίπτωση κατάποσης.  \nEN Toxic if swallowed.  \nFR Toxique en cas d'ingestion.  \nGA Tocsaineach má shlogtar.  \n▼M5 \nHR Otrovno ako se proguta.  \n▼B \nIT Tossico se ingerito.  \nLV Toksisks, ja norij.  \nLT Toksiška prarijus.  \nHU Lenyelve mérgező.  \nMT Tossiku jekk jinbela’.  \nNL Giftig bij inslikken.  \nPL Działa toksycznie po połknięciu.  \nPT Tóxico por ingestão.  \nRO Toxic în caz de înghiţire.  \nSK Toxický po požití.  \nSL Strupeno pri zaužitju.  \nFI Myrkyllistä nieltynä.  \nSV Giftigt vid förtäring.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 243}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 245  \nH302  Language  3.1 — Acute toxicity (oral), Hazard Category 4  \nBG Вреден при поглъщане.  \nES Nocivo en caso de ingestión.  \nCS Zdraví škodlivý při požití.  \nDA Farlig ved indtagelse.  \nDE Gesundheitsschädlich bei Verschlucken.  \nET Allaneelamisel kahjulik.  \nEL Επιβλαβές σε περίπτωση κατάποσης.  \nEN Harmful if swallowed.  \nFR Nocif en cas d'ingestion.  \nGA Díobhálach má shlogtar.  \n▼M5 \nHR Štetno ako se proguta.  \n▼B \nIT Nocivo se ingerito.  \nLV Kaitīgs, ja norij.  \nLT Kenksminga prarijus.  \nHU Lenyelve ártalmas.  \nMT Jagħmel il-ħsara jekk jinbela’.  \nNL Schadelijk bij inslikken.  \nPL Działa szkodliwie po połknięciu.  \nPT Nocivo por ingestão.  \nRO Nociv în caz de înghiţire.  \nSK Škodlivý po požití.  \nSL Zdravju škodljivo pri zaužitju.  \nFI Haitallista nieltynä.  \nSV Skadligt vid förtäring.  \nH304  Language  3.10 — Aspiration hazard, Hazard Category 1  \nBG Може да бъде смъртоносен при поглъщане и \nнавлизане в дихателните пътища.  \nES Puede ser mortal en caso de ingestión y \npenetración en las vías respiratorias.  \nCS Při požití a vniknutí do dýchacích cest může \nzpůsobit smrt.  \nDA Kan være livsfarligt, hvis det indtages og \nkommer i luftvejene.  \nDE Kann bei Verschlucken und Eindringen in die \nAtemwege tödlich sein.  \nET Allaneelamisel või hingamisteedesse sattumisel \nvõib olla surmav.  \nEL Μπορεί να προκαλέσει θάνατο σε περίπτωση \nκατάποσης και διείσδυσης στις αναπνευστικές \nοδούς.  \nEN May be fatal if swallowed and enters airways.  \nFR Peut être mortel en cas d'ingestion et de \npénétration dans les voies respiratoires.  \nGA D'fhéadfadh sé a bheith marfach má shlogtar é \nagus má théann sé isteach sna haerbhealaí.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 244}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 246  \nH304  Language  3.10 — Aspiration hazard, Hazard Category 1  \n▼M5 \nHR Može biti smrtonosno ako se proguta i uđe u \ndišni sustav.  \n▼B \nHU Lenyelve és a légutakba kerülve halálos lehet.  \nIT Può essere letale in caso di ingestione e di \npenetrazione nelle vie respiratorie.  \nLV Var izraisīt nāvi, ja norij vai iekļūst elpceļos.  \nLT Prarijus ir patekus į kvėpavimo takus, gali \nsukelti mirtį.  \nMT Jista’ jkun fatali jekk jinbela’ u jidħol fil- \npajpijiet tan-nifs.  \nNL Kan dodelijk zijn als de stof bij inslikken in de \nluchtwegen terechtkomt.  \nPL Połknięcie i dostanie się przez drogi oddechowe \nmoże grozić śmiercią.  \nPT Pode ser mortal por ingestão e penetração nas \nvias respiratórias.  \nRO Poate fi mortal în caz de înghiţire și de \npătrundere în căile respiratorii.  \nSK Môže byť smrteľný po požití a vniknutí do \ndýchacích ciest.  \nSL Pri zaužitju in vstopu v dihalne poti je lahko \nsmrtno.  \nFI Voi olla tappavaa nieltynä ja joutuessaan hengi\xad\ntysteihin.  \nSV Kan vara dödligt vid förtäring om det kommer \nner i luftvägarna.  \nH310  Language  3.1 — Acute toxicity (dermal), Hazard Category 1, 2  \nBG Смъртоносeн при контакт с кожата.  \nES Mortal en contacto con la piel.  \nCS Při styku s kůží může způsobit smrt.  \nDA Livsfarlig ved hudkontakt.  \nDE Lebensgefahr bei Hautkontakt.  \nET Nahale sattumisel surmav.  \nEL Θανατηφόρο σε επαφή με το δέρμα.  \nEN Fatal in contact with skin.  \nFR Mortel par contact cutané.  \nGA Marfach i dteagmháil leis an gcraiceann.  \n▼M5 \nHR Smrtonosno u dodiru s kožom.  \n▼B \nHU Bőrrel érintkezve halálos.  \nIT Letale per contatto con la pelle.  \nLV Nonākot saskarē ar ādu, iestājas nāve.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 245}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 247  \nH310  Language  3.1 — Acute toxicity (dermal), Hazard Category 1, 2  \nLT Mirtina susilietus su oda.  \nMT Fatali jekk imiss mal-ġilda.  \nNL Dodelijk bij contact met de huid.  \nPL Grozi śmiercią w kontacie ze skórą.  \nPT Mortal em contacto com a pele.  \nRO Mortal în contact cu pielea.  \nSK Smrteľný pri kontakte s pokožkou.  \nSL Smrtno v stiku s kožo.  \nFI Tappavaa joutuessaan iholle.  \nSV Dödligt vid hudkontakt.  \nH311  Language  3.1 — Acute toxicity (dermal), Hazard Category 3  \nBG Токсичен при контакт с кожата.  \nES Tóxico en contacto con la piel.  \nCS Toxický při styku s kůží.  \nDA Giftig ved hudkontakt.  \nDE Giftig bei Hautkontakt.  \nET Nahale sattumisel mürgine.  \nEL Τοξικό σε επαφή με το δέρμα.  \nEN Toxic in contact with skin.  \nFR Toxique par contact cutané.  \nGA Tocsaineach i dteagmháil leis an gcraiceann.  \n▼M5 \nHR Otrovno u dodiru s kožom.  \n▼B \nIT Tossico per contatto con la pelle.  \nLV Toksisks, ja nonāk saskarē ar ādu.  \nLT Toksiška susilietus su oda.  \nHU Bőrrel érintkezve mérgező.  \nMT Tossiku meta jmiss mal-ġilda.  \nNL Giftig bij contact met de huid.  \nPL Działa toksycznie w kontakcie ze skórą.  \nPT Tóxico em contacto com a pele.  \nRO Toxic în contact cu pielea.  \nSK Toxický pri kontakte s pokožkou.  \nSL Strupeno v stiku s kožo.  \nFI Myrkyllistä joutuessaan iholle.  \nSV Giftigt vid hudkontakt.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 246}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 248  \nH312  Language  3.1 — Acute toxicity (dermal), Hazard Category 4  \nBG Вреден при контакт с кожата.  \nES Nocivo en contacto con la piel.  \nCS Zdraví škodlivý při styku s kůží.  \nDA Farlig ved hudkontakt.  \nDE Gesundheitsschädlich bei Hautkontakt.  \nET Nahale sattumisel kahjulik.  \nEL Επιβλαβές σε επαφή με το δέρμα.  \nEN Harmful in contact with skin.  \nFR Nocif par contact cutané.  \nGA Díobhálach i dteagmháil leis an gcraiceann.  \n▼M5 \nHR Štetno u dodiru s kožom.  \n▼B \nIT Nocivo per contatto con la pelle.  \nLV Kaitīgs, ja nonāk saskarē ar ādu.  \nLT Kenksminga susilietus su oda.  \nHU Bőrrel érintkezve ártalmas.  \nMT Jagħmel il-ħsara meta jmiss mal-ġilda.  \nNL Schadelijk bij contact met de huid.  \nPL Działa szkodliwie w kontakcie ze skórą.  \nPT Nocivo em contacto com a pele.  \nRO Nociv în contact cu pielea.  \nSK Škodlivý pri kontakte s pokožkou.  \nSL Zdravju škodljivo v stiku s kožo.  \nFI Haitallista joutuessaan iholle.  \nSV Skadligt vid hudkontakt.  \n▼M12  \nH314  Language  3.2 — Skin corrosion/irritation, Hazard Category 1, \nSub-Categories 1A, 1B, 1C  \nBG Причинява тежки изгаряния на кожата и \nсериозно увреждане на очите.  \nES Provoca quemaduras graves en la piel y \nlesiones oculares graves.  \nCS Způsobuje těžké poleptání kůže a poškození \nočí. \nDA Forårsager svære ætsninger af huden og øjen\xad\nskader.  \nDE Verursacht schwere Verätzungen der Haut und \nschwere Augenschäden.  \nET Põhjustab rasket nahasöövitust ja silmakahjus\xad\ntusi. \nEL Προκαλεί σοβαρά δερματικά εγκαύματα και \nοφθαλμικές βλάβες.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 247}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 249  \nH314  Language  3.2 — Skin corrosion/irritation, Hazard Category 1, \nSub-Categories 1A, 1B, 1C  \nEN Causes severe skin burns and eye damage.  \n▼M19  \nFR Provoque de graves brûlures de la peau et de \ngraves lésions des yeux.  \n▼M12  \nGA Ina chúis le dónna tromchúiseacha craicinn \nagus le damáiste don tsúil.  \nHR Uzrokuje teške opekline kože i ozljede oka.  \nIT Provoca gravi ustioni cutanee e gravi lesioni \noculari.  \nLV Izraisa smagus ādas apdegumus un acu \nbojājumus.  \nLT Smarkiai nudegina odą ir pažeidžia akis.  \nHU Súlyos égési sérülést és szemkárosodást okoz.  \nMT Jagħmel ħruq serju lill-ġilda u ħsara lill- \ngħajnejn.  \nNL Veroorzaakt ernstige brandwonden en oogletsel.  \nPL Powoduje poważne oparzenia skóry oraz \nuszkodzenia oczu .  \nPT Provoca queimaduras na pele e lesões oculares \ngraves.  \nRO Provoacă arsuri grave ale pielii și lezarea \nochilor.  \nSK Spôsobuje vážne poleptanie kože a poškodenie \nočí. \nSL Povzroča hude opekline kože in poškodbe oči.  \nFI Voimakkaasti ihoa syövyttävää ja silmiä vaur\xad\nioittavaa.  \nSV Orsakar allvarliga frätskador på hud och ögon.  \n▼B \nH315  Language  3.2 — Skin corrosion/irritation, Hazard Category 2  \nBG Предизвиква дразнене на кожата.  \nES Provoca irritación cutánea.  \nCS Dráždí kůži.  \nDA Forårsager hudirritation.  \nDE Verursacht Hautreizungen.  \nET Põhjustab nahaärritust.  \nEL Προκαλεί ερεθισμό του δέρματος.  \nEN Causes skin irritation.  \nFR Provoque une irritation cutanée.  \nGA Ina chúis le greannú craicinn.  \n▼M5 \nHR Nadražuje kožu.  \n▼B \nIT Provoca irritazione cutanea.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 248}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 250  \nH315  Language  3.2 — Skin corrosion/irritation, Hazard Category 2  \nLV Kairina ādu.  \nLT Dirgina odą.  \nHU Bőrirritáló hatású.  \nMT Jagħmel irritazzjoni tal-ġilda.  \nNL Veroorzaakt huidirritatie.  \nPL Działa drażniąco na skórę.  \nPT Provoca irritação cutânea.  \nRO Provoacă iritarea pielii.  \nSK Dráždi kožu.  \nSL Povzroča draženje kože.  \nFI Ärsyttää ihoa.  \nSV Irriterar huden.  \nH317  Language  ►M2 3.4 — Sensitisation — Skin, hazard category 1, \n1A, 1B ◄  \nBG Може да причини алергична кожна реакция.  \nES Puede provocar una reacción alérgica en la piel.  \nCS Může vyvolat alergickou kožní reakci.  \nDA Kan forårsage allergisk hudreaktion.  \nDE Kann allergische Hautreaktionen verursachen.  \nET Võib põhjustada allergilist nahareaktsiooni.  \nEL Μπορεί να προκαλέσει αλλεργική δερματική \nαντίδραση.  \nEN May cause an allergic skin reaction.  \nFR Peut provoquer une allergie cutanée.  \nGA D'fhéadfadh sé a bheith ina chúis le frith\xad\nghníomh ailléirgeach craicinn.  \n▼M5 \nHR Može izazvati alergijsku reakciju na koži.  \n▼B \nIT Può provocare una reazione allergica cutanea.  \nLV Var izraisīt alerģisku ādas reakciju.  \nLT Gali sukelti alerginę odos reakciją.  \nHU Allergiás bőrreakciót válthat ki.  \nMT Jista’ jikkawża reazzjoni allerġika tal-ġilda.  \nNL Kan een allergische huidreactie veroorzaken.  \nPL Może powodować reakcję alergiczną skóry.  \nPT Pode provocar uma reacção alérgica cutânea.  \nRO Poate provoca o reacţie alergică a pielii.  \nSK Môže vyvolať alergickú kožnú reakciu.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 249}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 251  \nH317  Language  ►M2 3.4 — Sensitisation — Skin, hazard category 1, \n1A, 1B ◄  \nSL Lahko povzroči alergijski odziv kože.  \nFI Voi aiheuttaa allergisen ihoreaktion.  \nSV Kan orsaka allergisk hudreaktion.  \n▼M12  \nH318  Language  3.3 — Serious eye damage/eye irritation, Hazard \nCategory 1  \nBG Предизвиква сериозно увреждане на очите.  \nES Provoca lesiones oculares graves.  \nCS Způsobuje vážné poškození očí.  \nDA Forårsager alvorlig øjenskade.  \nDE Verursacht schwere Augenschäden.  \nET Põhjustab raskeid silmakahjustusi.  \nEL Προκαλεί σοβαρή οφθαλμική βλάβη.  \nEN Causes serious eye damage.  \nFR Provoque de graves lésions des yeux.  \nGA Ina chúis le damáiste tromchúiseach don tsúil.  \nHR Uzrokuje teške ozljede oka.  \nIT Provoca gravi lesioni oculari.  \nLV Izraisa nopietnus acu bojājumus.  \nLT Smarkiai pažeidžia akis.  \nHU Súlyos szemkárosodást okoz.  \nMT Jagħmel ħsara serja lill-għajnejn.  \nNL Veroorzaakt ernstig oogletsel.  \nPL Powoduje poważne uszkodzenie oczu.  \nPT Provoca lesões oculares graves.  \nRO Provoacă leziuni oculare grave.  \nSK Spôsobuje vážne poškodenie očí.  \nSL Povzroča hude poškodbe oči.  \nFI Vaurioittaa vakavasti silmiä.  \nSV Orsakar allvarliga ögonskador.  \n▼B \nH319  Language  3.3 — Serious eye damage/eye irritation, Hazard \nCategory 2  \nBG Предизвиква сериозно дразнене на очите.  \nES Provoca irritación ocular grave.  \nCS Způsobuje vážné podráždění očí.  \nDA Forårsager alvorlig øjenirritation.  \nDE Verursacht schwere Augenreizung.  \nET Põhjustab tugevat silmade ärritust.  \nEL Προκαλεί σοβαρό οφθαλμικό ερεθισμό.  \nEN Causes serious eye irritation.  \nFR Provoque une sévère irritation des yeux.  \nGA Ina chúis le greannú tromchúiseach don tsúil.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 250}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 252  \nH319  Language  3.3 — Serious eye damage/eye irritation, Hazard \nCategory 2  \n▼M5 \nHR Uzrokuje jako nadraživanje oka.  \n▼B \nIT Provoca grave irritazione oculare.  \nLV Izraisa nopietnu acu kairinājumu.  \nLT Sukelia smarkų akių dirginimą.  \nHU Súlyos szemirritációt okoz.  \nMT Jagħmel irritazzjoni serja lill-għajnejn.  \nNL Veroorzaakt ernstige oogirritatie.  \nPL Działa drażniąco na oczy.  \nPT Provoca irritação ocular grave.  \nRO Provoacă o iritare gravă a ochilor.  \nSK Spôsobuje vážne podráždenie očí.  \nSL Povzroča hudo draženje oči.  \nFI Ärsyttää voimakkaasti silmiä.  \nSV Orsakar allvarlig ögonirritation.  \nH330  Language  3.1 — Acute toxicity (inhal.), Hazard Category 1, 2  \nBG Смъртоносен при вдишване.  \nES Mortal en caso de inhalación.  \nCS Při vdechování může způsobit smrt.  \nDA Livsfarlig ved indånding.  \nDE Lebensgefahr bei Einatmen.  \nET Sissehingamisel surmav.  \nEL Θανατηφόρο σε περίπτωση εισπνοής.  \nEN Fatal if inhaled.  \nFR Mortel par inhalation.  \nGA Marfach má ionanálaítear.  \n▼M5 \nHR Smrtonosno ako se udiše.  \n▼B \nIT Letale se inalato.  \nLV Ieelpojot, iestājas nāve.  \nLT Mirtina įkvėpus.  \nHU Belélegezve halálos.  \nMT Fatali jekk jinxtamm.  \nNL Dodelijk bij inademing.  \nPL Wdychanie grozi śmiercią.  \nPT Mortal por inalação.  \nRO Mortal în caz de inhalare.  \nSK Smrteľný pri vdýchnutí.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 251}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 253  \nH330  Language  3.1 — Acute toxicity (inhal.), Hazard Category 1, 2  \nSL Smrtno pri vdihavanju.  \nFI Tappavaa hengitettynä.  \nSV Dödligt vid inandning.  \nH331  Language  3.1 — Acute toxicity (inhal.), Hazard Category 3  \nBG Токсичен при вдишване.  \nES Tóxico en caso de inhalación.  \nCS Toxický při vdechování.  \nDA Giftig ved indånding.  \nDE Giftig bei Einatmen.  \nET Sissehingamisel mürgine.  \nEL Τοξικό σε περίπτωση εισπνοής.  \nEN Toxic if inhaled.  \nFR Toxique par inhalation.  \nGA Tocsaineach má ionanálaítear.  \n▼M5 \nHR Otrovno ako se udiše.  \n▼B \nIT Tossico se inalato.  \nLV Toksisks ieelpojot.  \nLT Toksiška įkvėpus.  \nHU Belélegezve mérgező.  \nMT Tossiku jekk jinxtamm.  \nNL Giftig bij inademing.  \nPL Działa toksycznie w następstwie wdychania.  \nPT Tóxico por inalação.  \nRO Toxic în caz de inhalare.  \nSK Toxický pri vdýchnutí.  \nSL Strupeno pri vdihavanju.  \nFI Myrkyllistä hengitettynä.  \nSV Giftigt vid inandning.  \nH332  Language  3.1 — Acute toxicity (inhal.), Hazard Category 4  \nBG Вреден при вдишване.  \nES Nocivo en caso de inhalación.  \nCS Zdraví škodlivý při vdechování.  \nDA Farlig ved indånding.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 252}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 254  \nH332  Language  3.1 — Acute toxicity (inhal.), Hazard Category 4  \nDE Gesundheitsschädlich bei Einatmen.  \nET Sissehingamisel kahjulik.  \nEL Επιβλαβές σε περίπτωση εισπνοής.  \nEN Harmful if inhaled.  \nFR Nocif par inhalation.  \nGA Díobhálach má ionanálaítear.  \n▼M5 \nHR Štetno ako se udiše.  \n▼B \nIT Nocivo se inalato.  \nLV Kaitīgs ieelpojot.  \nLT Kenksminga įkvėpus.  \nHU Belélegezve ártalmas.  \nMT Jagħmel il-ħsara jekk jinxtamm.  \nNL Schadelijk bij inademing.  \nPL Działa szkodliwie w następstwie wdychania.  \nPT Nocivo por inalação.  \nRO Nociv în caz de inhalare.  \nSK Škodlivý pri vdýchnutí.  \nSL Zdravju škodljivo pri vdihavanju.  \nFI Haitallista hengitettynä.  \nSV Skadligt vid inandning.  \nH334  Language  ►M2 3.4 — Sensitisation — Respiratory, hazard \ncategory 1, 1A, 1B ◄  \nBG Може да причини алергични или астматични \nсимптоми или затруднения в дишането при \nвдишване.  \nES Puede provocar síntomas de alergia o asma o \ndificultades respiratorias en caso de inhalación.  \nCS Při vdechování může vyvolat příznaky alergie \nnebo astmatu nebo dýchací potíže.  \nDA Kan forårsage allergi- eller astmasymptomer \neller åndedrætsbesvær ved indånding.  \nDE Kann bei Einatmen Allergie, asthmaartige \nSymptome oder Atembeschwerden verursachen.  \nET Sissehingamisel võib põhjustada allergia- või \nastma sümptomeid või hingamisraskusi.  \nEL Μπορεί να προκαλέσει αλλεργία ή συμπτώματα \nάσθματος ή δύσπνοια σε περίπτωση εισπνοής.  \nEN May cause allergy or asthma symptoms or \nbreathing difficulties if inhaled.  \nFR Peut provoquer des symptômes allergiques ou \nd'asthme ou des difficultés respiratoires par \ninhalation.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 253}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 255  \nH334  Language  ►M2 3.4 — Sensitisation — Respiratory, hazard \ncategory 1, 1A, 1B ◄  \nGA D'fhéadfadh sé a bheith ina chúis le siomptóim \nailléirge nó asma nó le deacrachtaí análaithe má \nionanálaítear é.  \n▼M5 \nHR Ako se udiše može izazvati simptome alergije \nili astme ili poteškoće s disanjem.  \n▼B \nIT Può provocare sintomi allergici o asmatici o \ndifficoltà respiratorie se inalato.  \nLV Ja ieelpo, var izraisīt alerģiju vai astmas simp\xad\ntomus, vai apgrūtināt elpošanu.  \nLT Įkvėpus gali sukelti alerginę reakciją, astmos \nsimptomus arba apsunkinti kvėpavimą.  \nHU Belélegezve allergiás és asztmás tüneteket, és \nnehéz légzést okozhat.  \nMT Jista’ jikkawża sintomi ta' allerġija jew ta’ ażma \njew diffikultajiet biex jittieħed in-nifs jekk jinx\xad\ntamm.  \nNL Kan bij inademing allergie- of astmasymptomen \nof ademhalingsmoeilijkheden veroorzaken.  \nPL Może powodować objawy alergii lub astmy lub \ntrudności w oddychaniu w następstwie wdych\xad\nania.  \nPT Quando inalado, pode provocar sintomas de \nalergia ou de asma ou dificuldades respiratórias.  \nRO Poate provoca simptome de alergie sau astm \nsau dificultăţi de respiraţie în caz de inhalare.  \nSK Pri vdýchnutí môže vyvolať alergiu alebo \npríznaky astmy, alebo dýchacie ťažkosti.  \nSL Lahko povzroči simptome alergije ali astme ali \ntežave z dihanjem pri vdihavanju.  \nFI Voi aiheuttaa hengitettynä allergia- tai \nastmaoireita tai hengitysvaikeuksia.  \nSV Kan orsaka allergi- eller astmasymtom eller \nandningssvårigheter vid inandning.  \nH335  Language  3.8 — Specific target organ toxicity — Single \nexposure, Hazard Category 3, Respiratory tract irri\xad\ntation  \nBG Може да предизвика дразнене на \nдихателните пътища.  \nES Puede irritar las vías respiratorias.  \nCS Může způsobit podráždění dýchacích cest.  \nDA Kan forårsage irritation af luftvejene.  \nDE Kann die Atemwege reizen.  \nET Võib põhjustada hingamisteede ärritust.  \nEL Μπορεί να προκαλέσει ερεθισμό της \nαναπνευστικής οδού.  \nEN May cause respiratory irritation.  \nFR Peut irriter les voies respiratoires.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 254}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 256  \nH335  Language  3.8 — Specific target organ toxicity — Single \nexposure, Hazard Category 3, Respiratory tract irri\xad\ntation  \nGA D'fhéadfadh sé a bheith ina chúis le greannú \nriospráide.  \n▼M5 \nHR Može nadražiti dišni sustav.  \n▼B \nIT Può irritare le vie respiratorie.  \nLV Var izraisīt elpceļu kairinājumu.  \nLT Gali dirginti kvėpavimo takus.  \nHU Légúti irritációt okozhat.  \nMT Jista’ jikkawża irritazzjoni respiratorja.  \nNL Kan irritatie van de luchtwegen veroorzaken.  \nPL Może powodować podrażnienie dróg odde\xad\nchowych.  \nPT Pode provocar irritação das vias respiratórias.  \nRO Poate provoca iritarea căilor respiratorii.  \nSK Môže spôsobiť podráždenie dýchacích ciest.  \nSL Lahko povzroči draženje dihalnih poti.  \nFI Saattaa aiheuttaa hengitysteiden ärsytystä.  \nSV Kan orsaka irritation i luftvägarna.  \nH336  Language  3.8 — Specific target organ toxicity — Single \nexposure, Hazard Category 3, Narcosis  \nBG Може да предизвика сънливост или \nсветовъртеж.  \nES Puede provocar somnolencia o vértigo.  \nCS Může způsobit ospalost nebo závratě.  \nDA Kan forårsage sløvhed eller svimmelhed.  \nDE Kann Schläfrigkeit und Benommenheit verurs\xad\nachen.  \nET Võib põhjustada unisust või peapööritust.  \nEL Μπορεί να προκαλέσει υπνηλία ή ζάλη.  \nEN May cause drowsiness or dizziness.  \nFR Peut provoquer somnolence ou vertiges.  \nGA D'fhéadfadh sé a bheith ina chúis le codlatacht \nnó le meadhrán.  \n▼M5 \nHR Može izazvati pospanost ili vrtoglavicu.  \n▼B \nIT Può provocare sonnolenza o vertigini.  \nLV Var izraisīt miegainību vai reiboņus.  \nLT Gali sukelti mieguistumą arba galvos svaigimą.  \nHU Álmosságot vagy szédülést okozhat.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 255}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 257  \nH336  Language  3.8 — Specific target organ toxicity — Single \nexposure, Hazard Category 3, Narcosis  \nMT Jista’ jikkawża ħedla jew sturdament.  \nNL Kan slaperigheid of duizeligheid veroorzaken.  \nPL Może wywoływać uczucie senności lub zawroty \ngłowy.  \nPT Pode provocar sonolência ou vertigens.  \nRO Poate provoca somnolenţă sau ameţeală.  \nSK Môže spôsobiť ospalosť alebo závraty.  \nSL Lahko povzroči zaspanost ali omotico.  \nFI Saattaa aiheuttaa uneliaisuutta ja huimausta.  \nSV Kan göra att man blir dåsig eller omtöcknad.  \nH340  Language  3.5 — Germ cell mutagenicity, Hazard Category 1A, \n1B \nBG Може да причини генетични дефекти  < да \nсе посочи  пътят  на експозицията , ако е \nдоказано  убедително , че няма  друг път на \nекспозиция , който  води  до същата  \nопасност  >. \nES Puede provocar defectos genéticos  <Indíquese \nla vía de exposición si se ha demostrado \nconcluyentemente que el peligro no se \nproduce por ninguna otra vía > . \nCS Může vyvolat genetické poškození  <uveďte \ncestu expozice, je-li p řesvědčivě prokázáno, že \nostatní cesty expozice nejsou nebezpe čné>. \nDA Kan forårsage genetiske defekter < angiv ekspo \xad\nneringsvej, hvis det er endeligt påvist, at faren \nikke kan frembringes ad nogen anden eksponer \xad\ningsvej >. \nDE Kann genetische Defekte verursachen \n<Expositionsweg angeben, sofern schlüssig \nbelegt ist, dass diese Gefahr bei keinem \nanderen Expositionsweg besteht>.  \nET Võib põhjustada geneetilisi defekte  <märkida \nkokkupuuteviis, kui on veenvalt tõestatud, et \nmuud kokkupuuteviisid ei ole ohtlikud> . \nEL Μπορεί να προκαλέσει γενετικά ελαττώματα <  \nαναφέρεται  η οδός έκθεσης  αν έχει αποδειχθεί  \nαδιαμφισβήτητα  ότι δεν υπάρχει  κίνδυνος  από \nτις άλλες  οδούς  έκθεσης  > . \nEN May cause genetic defects  <state route of \nexposure if it is conclusively proven that no \nother routes of exposure cause the hazard> . \nFR Peut induire des anomalies génétiques  \n<indiquer la voie d'exposition s'il est formel \xad\nlement prouvé qu'aucune autre voie d'ex \xad\nposition ne conduit au même danger>.  \nGA D'fhéadfadh sé a bheith ina chúis le héalanga \ngéiniteacha  <tabhair an bealach nochta má tá \nsé cruthaithe go cinntitheach nach bealach \nnochta ar bith eile is cúis leis an nguais> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 256}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 258  \nH340  Language  3.5 — Germ cell mutagenicity, Hazard Category 1A, \n1B \n▼M5 \nHR Može izazvati genetska oštećenja < navesti \nnačin izloženosti ako je nedvojbeno dokazano \nda niti jedan drugi na čin izloženosti ne \nuzrokuje takvu opasnost >. \n▼B \nIT Può provocare alterazioni genetiche  <indicare \nla via di esposizione se è accertato che ness \xad\nun'altra via di esposizione comporta il \nmedesimo pericolo> . \nLV Var izraisīt ģenētiskus bojājumus  <norādīt \niedarbības ceļu, ja ir nep ārprotami pier ādīts, \nka citi iedarb ības ceļi nerada b īstamību>.  \nLT Gali sukelti genetinius defektus < nurodyti \nveikimo b ūdą, jeigu įtikinamai nustatyta, kad \nkiti veikimo b ūdai nepavojingi> . \nHU Genetikai károsodást okozhat  < meg kell adni \naz expozíciós útvonalat, ha meggy őzően bizony \xad\nított, hogy más expozíciós útvonal nem okozza a \nveszélyt >.  \nMT Jista’ jikkawża difetti ġenetiċi <semmi l-mod ta' \nespożizzjoni jekk ikun pruvat b'mod konklużiv \nli l-ebda mod ta' espożizzjoni ieħor ma \njikkawża l-periklu>.  \nNL Kan genetische schade veroorzaken \n<blootstellingsroute vermelden indien afdoende \nbewezen is dat het gevaar bij andere blootstel \xad\nlingsroutes niet aanwezig is >. \nPL Może powodować wady genetyczne  <podać \ndrogę narażenia, jeżeli definitywnie udowod \xad\nniono, że inna droga nara żenia nie powoduje \nzagrożenia> . \nPT Pode provocar anomalias genéticas < indicar a \nvia de exposição se existirem provas conclu \xad\ndentes de que o perigo não decorre de \nnenhuma outra via de exposição >. \nRO Poate provoca anomalii genetice  <indica ţi \ncalea de expunere, dac ă există probe \nconcludente c ă nicio alt ă cale de expunere nu \nprovoacă acest pericol> . \nSK Môže spôsobovať genetické poškodenie  \n<uveďte spôsob expozície, ak sa presved čivo \npreukáže, že iné spôsoby expozície nevy \xad\nvolávajú nebezpe čenstvo> . \nSL Lahko povzroči genetske okvare  <navesti na čin \nizpostavljenosti, če je prepri čljivo dokazano, da \nnoben drug na čin izpostavljenosti ne povzro ča \ntakšne nevarnosti> . \nFI Saattaa aiheuttaa perimävaurioita < mainitaan \naltistumisreitti, jos on kiistatta osoitettu, että \nvaara ei voi aiheutua muiden altistumisreittien \nkautta> . \nSV Kan orsaka genetiska defekter  <ange exponer \xad\ningsväg om det är definitivt bevisat att faran \ninte kan orsakas av några andra exponerings \xad\nvägar> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 257}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 259  \nH341  Language  3.5 — Germ cell mutagenicity, Hazard Category 2  \nBG Предполага се, че причинява генетични \nдефекти  < да се посочи  пътят  на \nекспозицията , ако е доказано  убедително , \nче няма  друг път на експозиция , който  \nводи  до същата  опасност  >. \nES Se sospecha que provoca defectos genéticos  \n<Indíquese la vía de exposición si se ha \ndemostrado concluyentemente que el peligro \nno se produce por ninguna otra vía> . \nCS Podezření na genetické poškození  <uveďte \ncestu expozice, je-li p řesvědčivě prokázáno, že \nostatní cesty expozice nejsou nebezpe čné>. \nDA Mistænkt for at forårsage genetiske defekter \n<angiv eksponeringsvej, hvis det er endeligt \npåvist, at faren ikke kan frembringes ad \nnogen anden eksponeringsvej >. \nDE Kann vermutlich genetische Defekte \nverursachen < Expositionsweg angeben, sofern \nschlüssig belegt ist, dass diese Gefahr bei \nkeinem anderen Expositionsweg besteht> . \nET Arvatavasti põhjustab geneetilisi defekte  \n<märkida kokkupuuteviis, kui on veenvalt tões \xad\ntatud, et muud kokkupuuteviisid ei ole ohtli \xad\nkud> . \nEL Ύποπτο για πρόκληση γενετικών ελαττωμάτων \n<αναφέρεται  η οδός έκθεσης  αν έχει αποδειχθεί  \nαδιαμφισβήτητα  ότι δεν υπάρχει  κίνδυνος  από \nτις άλλες  οδούς  έκθεσης >. \nEN Suspected of causing genetic defects  <state \nroute of exposure if it is conclusively proven \nthat no other routes of exposure cause the \nhazard> . \nFR Susceptible d'induire des anomalies génétiques  \n<indiquer la voie d'exposition s'il est formel \xad\nlement prouvé qu'aucune autre voie d'ex \xad\nposition ne conduit au même danger> . \nGA Ceaptar go bhféadfadh sé a bheith ina chúis le \nhéalanga géiniteacha < tabhair an bealach \nnochta má tá sé cruthaithe go cinntitheach \nnach bealach nochta ar bith eile is cúis leis \nan nguais> . \n▼M5 \nHR Sumnja na moguća genetska oštećenja < navesti \nnačin izloženosti ako je nedvojbeno dokazano \nda niti jedan drugi na čin izloženosti ne \nuzrokuje takvu opasnost >. \n▼B \nIT Sospettato di provocare alterazioni genetiche  \n<indicare la via di esposizione se è accertato \nche nessun'altra via di esposizione comporta il \nmedesimo pericolo> . \nLV Ir aizdomas, ka var izraisīt ģenētiskus \nbojājumus  <norādīt iedarbības ceļu, ja ir \nnepārprotami pier ādīts, ka citi iedarb ības ceļi \nnerada b īstamību>.  \nLT Įtariama, kad gali sukelti genetinius defektus \n<nurodyti veikimo b ūdą, jeigu įtikinamai \nnustatyta, kad kiti veikimo b ūdai nepavojingi> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 258}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 260  \nH341  Language  3.5 — Germ cell mutagenicity, Hazard Category 2  \nHU Feltehetően genetikai károsodást okoz  < meg \nkell adni az expozíciós útvonalat, ha \nmeggyőzően bizonyított, hogy más expozíciós \nútvonal nem okozza a veszélyt >.  \nMT Suspettat li jikkawża difetti ġenetiċi <semmi l- \nmod ta' espożizzjoni jekk ikun pruvat b'mod \nkonklużiv li l-ebda mod ta' espożizzjoni ieħor \nma jikkawża l-periklu>.  \nNL Verdacht van het veroorzaken van genetische \nschade < blootstellingsroute vermelden indien \nafdoende bewezen is dat het gevaar bij \nandere blootstellingsroutes niet aanwezig is >. \nPL Podejrzewa się, że powoduje wady genetyczne  \n<podać drogę narażenia, jeżeli definitywnie \nudowodniono, że inna droga nara żenia nie \npowoduje zagro żenia> . \nPT Suspeito de provocar anomalias genéticas \n<indicar a via de exposição se existirem \nprovas concludentes de que o perigo não \ndecorre de nenhuma outra via de exposição >. \nRO Susceptibil de a provoca anomalii genetice  < \nindicaţi calea de expunere, dac ă există probe \nconcludente c ă nicio alt ă cale de expunere nu \nprovoacă acest pericol> . \nSK Podozrenie, že spôsobuje genetické poškodenie  \n<uveďte spôsob expozície, ak sa presved čivo \npreukáže, že iné spôsoby expozície nevy \xad\nvolávajú nebezpe čenstvo> . \nSL Sum povzročitve genetskih okvar  <navesti \nnačin izpostavljenosti, če je prepri čljivo \ndokazano, da noben drug na čin izpostavljenosti \nne povzro ča takšne nevarnosti> . \nFI Epäillään aiheuttavan perimävaurioita \n<mainitaan altistumisreitti, jos on kiistatta osoi \xad\ntettu, että vaara ei voi aiheutua muiden altistu \xad\nmisreittien kautta> . \nSV Misstänks kunna orsaka genetiska defekter  \n<ange exponeringsväg om det är definitivt \nbevisat att faran inte kan orsakas av några \nandra exponeringsvägar> . \nH350  Language  3.6 — Carcinogenicity, Hazard Category 1A, 1B  \nBG Може да причини рак  < да се посочи  пътят  \nна експозицията , ако е доказано  \nубедително , че няма  друг път на експозиция , \nкойто  води  до същата  опасност  >. \nES Puede provocar cáncer  <indíquese la vía de \nexposición si se ha demostrado concluyen \xad\ntemente que el peligro no se produce por \nninguna otra vía> . \nCS Může vyvolat rakovinu  <uveďte cestu expozice, \nje-li přesvědčivě prokázáno, že ostatní cesty \nexpozice nejsou nebezpe čné>. \nDA Kan fremkalde kræft < angiv eksponeringsvej, \nhvis det er endeligt påvist, at faren ikke kan \nfrembringes ad nogen anden eksponeringsvej >. ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 259}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 261  \nH350  Language  3.6 — Carcinogenicity, Hazard Category 1A, 1B  \nDE Kann Krebs erzeugen < Expositionsweg \nangeben, sofern schlüssig belegt ist, dass \ndiese Gefahr bei keinem anderen Exposi \xad\ntionsweg besteht> . \nET Võib põhjustada vähktõbe  <märkida kokku \xad\npuuteviis, kui on veenvalt tõestatud, et muud \nkokkupuuteviisid ei ole ohtlikud> . \nEL Μπορεί να προκαλέσει καρκίνο < αναφέρεται  η \nοδός έκθεσης  αν έχει αποδειχθεί  αδιαμφισβήτητα  \nότι δεν υπάρχει  κίνδυνος  από τις άλλες  οδούς  \nέκθεσης >. \nEN May cause cancer  <state route of exposure if it \nis conclusively proven that no other routes of \nexposure cause the hazard> . \nFR Peut provoquer le cancer  <indiquer la voie \nd'exposition s'il est formellement prouvé \nqu'aucune autre voie d'exposition ne conduit \nau même danger> . \nGA D'fhéadfadh sé a bheith ina chúis le hailse  \n<tabhair an bealach nochta má tá sé cruthaithe \ngo cinntitheach nach bealach nochta ar bith \neile is cúis leis an nguais> . \n▼M5 \nHR Može uzrokovati rak < navesti na čin izloženosti \nako je nedvojbeno dokazano da niti jedan drugi \nnačin izloženosti ne uzrokuje takvu opasnost >. \n▼B \nIT Può provocare il cancro <indicare la via di \nesposizione se è accertato che nessun'altra via \ndi esposizione comporta il medesimo pericolo> . \nLV Var izraisīt vēzi  <norādīt iedarbības ceļu, ja ir \nnepārprotami pier ādīts, ka citi iedarb ības ceļi \nnerada b īstamību>.  \nLT Gali sukelti vėžį < nurodyti veikimo b ūdą, jeigu \nįtikinamai nustatyta, kad kiti veikimo b ūdai \nnepavojingi> . \nHU Rákot okozhat  < meg kell adni az expozíciós \nútvonalat, ha meggy őzően bizonyított, hogy más \nexpozíciós útvonal nem okozza a veszélyt >.  \nMT Jista’ jikkawża l-kanċer <semmi l-mod ta' \nespożizzjoni jekk ikun pruvat b'mod konklużiv \nli l-ebda mod ta' espożizzjoni ieħor ma \njikkawża l-periklu>.  \nNL Kan kanker veroorzaken < blootstellingsroute \nvermelden indien afdoende bewezen is dat het \ngevaar bij andere blootstellingsroutes niet \naanwezig is > \nPL Może powodować raka  <poda ć drogę \nnarażenia, jeżeli definitywnie udowodniono, że \ninna droga nara żenia nie powoduje \nzagrożenia> . \nPT Pode provocar cancro < indicar a via de \nexposição se existirem provas concludentes de \nque o perigo não decorre de nenhuma outra \nvia de exposição >. \nRO Poate provoca cancer  <indica ţi calea de \nexpunere, dac ă există probe concludente c ă \nnicio altă cale de expunere nu provoac ă acest \npericol> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 260}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 262  \nH350  Language  3.6 — Carcinogenicity, Hazard Category 1A, 1B  \nSK Môže spôsobiť rakovinu  <uveďte spôsob \nexpozície, ak sa presved čivo preukáže, že iné \nspôsoby expozície nevyvolávajú \nnebezpečenstvo> . \nSL Lahko povzroči raka  <navesti na čin izpostavlje \xad\nnosti, če je prepri čljivo dokazano, da noben \ndrug način izpostavljenosti ne povzro ča takšne \nnevarnosti> . \nFI Saattaa aiheuttaa syöpää < mainitaan altistumis \xad\nreitti, jos on kiistatta osoitettu, että vaara ei voi \naiheutua muiden altistumisreittien kautta> . \nSV Kan orsaka cancer  <ange exponeringsväg om \ndet är definitivt bevisat att faran inte kan \norsakas av några andra exponeringsvägar> . \nH351  Language  3.6 — Carcinogenicity, Hazard Category 2  \nBG Предполага се, че причинява рак  < да се \nпосочи  пътят  на експозицията , ако е \nдоказано  убедително , че няма  друг път на \nекспозиция , който  води  до същата  \nопасност  >. \nES Se sospecha que provoca cáncer  <indíquese la \nvía de exposición si se se ha demostrado \nconcluyentemente que el peligro no se \nproduce por ninguna otra vía>.  \nCS Podezření na vyvolání rakoviny  <uveďte cestu \nexpozice, je-li p řesvědčivě prokázáno, že ostatní \ncesty expozice nejsou nebezpe čné>. \nDA Mistænkt for at fremkalde kræft < angiv ekspo \xad\nneringsvej, hvis det er endeligt påvist, at faren \nikke kan frembringes ad nogen anden eksponer \xad\ningsvej >. \nDE Kann vermutlich Krebs erzeugen \n<Expositionsweg angeben, sofern schlüssig \nbelegt ist, dass diese Gefahr bei keinem \nanderen Expositionsweg besteht> . \nET Arvatavasti põhjustab vähktõbe  <märkida \nkokkupuuteviis, kui on veenvalt tõestatud, et \nmuud kokkupuuteviisid ei ole ohtlikud> . \nEL Ύποπτο για πρόκληση καρκίνου < αναφέρεται  η \nοδός έκθεσης  αν έχει αποδειχθεί  αδιαμφισβήτητα  \nότι δεν υπάρχει  κίνδυνος  από τις άλλες  οδούς  \nέκθεσης >. \nEN ►C3 Suspected of causing cancer < state route \nof exposure if it is conclusively proven that no \nother routes of exposure cause the hazard >. ◄  \nFR Susceptible de provoquer le cancer  <indiquer \nla voie d'exposition s'il est formellement \nprouvé qu'aucune autre voie d'exposition ne \nconduit au même danger> . \nGA Ceaptar go bhféadfadh sé a bheith ina chúis le \nhailse  <tabhair an bealach nochta má tá sé \ncruthaithe go cinntitheach nach bealach \nnochta ar bith eile is cúis leis an nguais> . \n▼M5 \nHR Sumnja na moguće uzrokovanje raka < navesti \nnačin izloženosti ako je nedvojbeno dokazano \nda niti jedan drugi na čin izloženosti ne \nuzrokuje takvu opasnost >. ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 261}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 263  \nH351  Language  3.6 — Carcinogenicity, Hazard Category 2  \nIT Sospettato di provocare il cancro  <indicare la \nvia di esposizione se è accertato che ness \xad\nun'altra via di esposizione comporta il \nmedesimo pericolo> . \nLV Ir aizdomas, ka var izraisīt vēzi  <norādīt \niedarbības ceļu, ja ir nep ārprotami pier ādīts, \nka citi iedarb ības ceļi nerada b īstamību>. \nLT Įtariama, kad sukelia vėžį < nurodyti veikimo \nbūdą, jeigu įtikinamai nustatyta, kad kiti \nveikimo b ūdai nepavojingi> . \nHU Feltehetően rákot okoz  < meg kell adni az \nexpozíciós útvonalat, ha meggy őzően bizony \xad\nított, hogy más expozíciós útvonal nem okozza \na veszélyt >.  \nMT Suspettat li jikkawża l-kanċer <ara l-mod ta’ \nespożizzjoni jekk ikun pruvat b'mod konklużiv \nli l-ebda mod ta' espożizzjoni ieħor ma \njikkawża l-periklu >.  \nNL Verdacht van het veroorzaken van kanker \n<blootstellingsroute vermelden indien afdoende \nbewezen is dat het gevaar bij andere blootstel \xad\nlingsroutes niet aanwezig is >. \nPL Podejrzewa się, że powoduje raka  <podać \ndrogę narażenia, jeżeli definitywnie udowod \xad\nniono, że inna droga nara żenia nie powoduje \nzagrożenia> . \nPT Suspeito de provocar cancro < indicar a via de \nexposição se existirem provas concludentes de \nque o perigo não decorre de nenhuma outra \nvia de exposição >. \nRO Susceptibil de a provoca cancer  <indicaţi calea \nde expunere, dac ă există probe concludente c ă \nnicio altă cale de expunere nu provoac ă acest \npericol> . \nSK Podozrenie, že spôsobuje rakovinu  <uveďte \nspôsob expozície, ak sa presved čivo preukáže, \nže iné spôsoby expozície nevyvolávajú \nnebezpečenstvo> . \nSL Sum povzročitve raka  <navesti na čin izpost\xad\navljenosti, če je prepri čljivo dokazano, da \nnoben drug na čin izpostavljenosti ne povzro ča \ntakšne nevarnosti> . \nFI Epäillään aiheuttavan syöpää < mainitaan altis \xad\ntumisreitti, jos on kiistatta osoitettu, että vaara \nei voi aiheutua muiden altistumisreittien \nkautta> . \nSV Misstänks kunna orsaka cancer < ange exponer \xad\ningsväg om det är definitivt bevisat att faran \ninte kan orsakas av några andra exponerings \xad\nvägar> . \nH360  Language  3.7 — Reproductive toxicity, Hazard Category 1A, 1B  \nBG Може да увреди оплодителната способност \nили плода <  да се посочи  конкретното  \nвъздействие , ако е известно  > < да се \nпосочи  пътят  на експозицията , ако е \nдоказано  убедително , че няма  друг път на \nекспозиция , който  води  до същата  \nопасност  >. ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 262}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 264  \nH360  Language  3.7 — Reproductive toxicity, Hazard Category 1A, 1B  \nES Puede perjudicar la fertilidad o dañar al feto  \n<indíquese el efecto específico si se conoce> \n<indíquese la vía de exposición si se ha \ndemostrado concluyentemente que el peligro \nno se produce por ninguna otra vía> . \nCS Může poškodit reprodukční schopnost nebo \nplod v těle matky  <uveďte specifický ú činek, \nje-li znám> <uve ďte cestu expozice, je-li \npřesvědčivě prokázáno, že ostatní cesty \nexpozice nejsou nebezpe čné>. \nDA Kan skade forplantningsevnen eller det ufødte \nbarn < angiv specifik effekt, hvis kendt > <angiv \neksponeringsvej, hvis det er endeligt påvist, at \nfaren ikke kan frembringes ad nogen anden \neksponeringsvej >. \nDE Kann die Fruchtbarkeit beeinträchtigen oder das \nKind im Mutterleib schädigen < konkrete \nWirkung angeben, sofern bekannt>  \n<Expositionsweg angeben, sofern schlüssig \nbelegt ist, dass die Gefahr bei keinem anderen \nExpositionsweg besteht>.  \nET Võib kahjustada viljakust või loodet  <märkida \nspetsiifiline toime, kui see on teada> <märkida \nkokkupuuteviis, kui on veenvalt tõestatud, et \nmuud kokkupuuteviisid ei ole ohtlikud> . \nEL Μπορεί να βλάψει τη γονιμότητα ή το έμβρυο  \n<αναφέρεται  η ειδική  επίπτωση  εάν είναι  \nγνωστή > <αναφέρεται  η οδός έκθεσης  αν έχει \nαποδειχθεί  αδιαμφισβήτητα  ότι δεν υπάρχει  \nκίνδυνος  από τις άλλες  οδούς  έκθεσης >. \nEN May damage fertility or the unborn child  <state \nspecific effect if known > <state route of \nexposure if it is conclusively proven that no \nother routes of exposure cause the hazard> . \nFR Peut nuire à la fertilité ou au fœtus  <indiquer \nl'effet spécifique s'il est connu> <indiquer la \nvoie d'exposition s'il est formellement prouvé \nqu'aucune autre voie d'exposition ne conduit \nau même danger> . \nGA D'fhéadfadh sé damáiste a dhéanamh do thor\xad\nthúlacht nó don leanbh sa bhroinn < tabhair an \ntsainéifeacht más eol  >  < tabhair an bealach \nnochta má tá sé cruthaithe go cinntitheach \nnach bealach nochta ar bith eile is cúis leis \nan nguais >. \n▼M5 \nHR Može štetno djelovati na plodnost ili naškoditi \nnerođenom djetetu < navesti konkretan u činak \nako je poznat  >  < navesti na čin izloženosti ako \nje nedvojbeno dokazano da niti jedan drugi \nnačin izloženosti ne uzrokuje takvu opasnost >. \n▼B \nIT Può nuocere alla fertilità o al feto  <indicare \nl'effetto specifico, se noto><indicare la via di \nesposizione se è accertato che nessun'altra via \ndi esposizione comporta il medesimo pericolo> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 263}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 265  \nH360  Language  3.7 — Reproductive toxicity, Hazard Category 1A, 1B  \nLV Var kaitēt auglībai vai nedzimušajam bērnam  \n<norādīt īpašo ietekmi, ja t ā ir zināma> \n<norādīt iedarbības ceļu, ja ir nep ārprotami \npierādīts, ka citi iedarb ības ceļi nerada \nbīstamību>.  \nLT Gali pakenkti vaisingumui arba negimusiam \nvaikui < nurodyti konkret ų poveikį, jeigu \nžinomas>  <nurodyti veikimo b ūdą, jeigu \nįtikinamai nustatyta, kad kiti veikimo b ūdai \nnepavojingi>.  \nHU Károsíthatja a termékenységet vagy a \nszületendő gyermeket  < ha ismert, meg kell \nadni a konkrét hatást > < meg kell adni az \nexpozíciós útvonalat, ha meggy őzően bizony \xad\nított, hogy más expozíciós útvonal nem okozza \na veszélyt >.  \nMT Jista' jagħmel ħsara lill-fertilità jew lit-tarbija li \ngħadha fil-ġuf < semmi l-effett spe ċifiku jekk \nikun mag ħruf> <semmi l-mod ta' espo żizzjoni \njekk ikun pruvat b'mod konklu żiv li l-ebda mod \nta' espożizzjoni ie ħor ma jikkaw ża l-periklu>.  \nNL Kan de vruchtbaarheid of het ongeboren kind \nschaden < specifiek effect vermelden indien \nbekend > <blootstellingsroute vermelden indien \nafdoende bewezen is dat het gevaar bij andere \nblootstellingsroutes niet aanwezig is >. \nPL Może działać szkodliwie na płodność lub na \ndziecko w łonie matki  <podać szczególny \nskutek, je żeli jest znany> <poda ć drogę \nnarażenia, jeżeli definitywnie udowodniono, że \ninne drogi nara żenia nie stwarzaj ą \nzagrożenia> . \nPT Pode afectar a fertilidade ou o nascituro \n<indicar o efeito específico se este for \nconhecido > <indicar a via de exposição se \nexistirem provas concludentes de que o perigo \nnão decorre de nenhuma outra via de exposi \xad\nção>. \nRO Poate dăuna fertilităţii sau fătului  <indica ţi \nefectul specific, dac ă este cunoscut><indica ţi \ncalea de expunere, dac ă există probe \nconcludente c ă nicio alt ă cale de expunere nu \nprovoacă acest pericol> . \nSK Môže spôsobiť poškodenie plodnosti alebo \nnenarodeného dieťaťa  <uveďte konkrétny \núčinok, ak je známy > <uve ďte spôsob \nexpozície, ak sa presved čivo preukáže, že iné \nspôsoby expozície nevyvolávajú \nnebezpečenstvo> . \nSL Lahko škoduje plodnosti ali nerojenemu otroku  \n<navesti posebni u činek, če je znan> <navesti \nnačin izpostavljenosti, če je prepri čljivo \ndokazano, da noben drug na čin izpostavljenosti \nne povzro ča takšne nevarnosti> . \nFI Saattaa heikentää hedelmällisyyttä tai vaur\xad\nioittaa sikiötä < mainitaan tiedetty spesifinen \nvaikutus>  <mainitaan altistumisreitti, jos on \nkiistatta osoitettu, että vaara ei voi aiheutua \nmuiden altistumisreittien kautta> . \nSV Kan skada fertiliteten eller det ofödda barnet  \n<ange specifik effekt om denna är känd> \n<ange exponeringsväg om det är definitivt \nbevisat att faran inte kan orsakas av några \nandra exponeringsvägar>.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 264}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 266  \nH361  Language  3.7 — Reproductive toxicity, Hazard Category 2  \nBG Предполага се, че уврежда оплодителната \nспособност или плода  < да се посочи  \nконкретното  въздействие , ако е известно  \n> < да се посочи  пътят  на експозицията , \nако е доказано  убедително , че няма  друг \nпът на експозиция , който  води  до същата  \nопасност  >. \nES ►C3 Se sospecha que puede perjudicar la \nfertilidad o dañar el feto ◄  <indíquese el \nefecto específico si se conoce> <indíquese la \nvía de exposición si se ha demostrado \nconcluyentemente que el peligro no se \nproduce por ninguna otra vía> . \nCS Podezření na poškození reprodukční schopnosti \nnebo plodu v těle matky  <uveďte specifický \núčinek, je-li znám> <uve ďte cestu expozice, \nje-li přesvědčivě prokázáno, že ostatní cesty \nexpozice nejsou nebezpe čné>. \nDA Mistænkt for at skade forplantningsevnen eller \ndet ufødte barn < angiv specifik effekt, hvis \nkendt > < angiv eksponeringsvej, hvis det er \nendeligt påvist, at faren ikke kan frembringes \nad nogen anden eksponeringsvej >. \nDE ►C3 Kann vermutlich die Fruchtbarkeit beein\xad\nträchtigen oder das Kind im Mutterleib \nschädigen < konkrete Wirkung angeben, sofern \nbekannt > ◄ < Expositionsweg angeben, sofern \nschlüssig belegt ist, dass die Gefahr bei \nkeinem anderen Expositionsweg besteht>  \nET Arvatavasti kahjustab viljakust või loodet  \n<märkida spetsiifiline toime, kui see on \nteada> <märkida kokkupuuteviis, kui on \nveenvalt tõestatud, et muud kokkupuuteviisid \nei ole ohtlikud> . \nEL Ύποπτο για πρόκληση βλάβης στη γονιμότητα \nή στο έμβρυο < αναφέρεται  η ειδική  επίπτωση  \nεάν είναι  γνωστή > <αναφέρεται  η οδός \nέκθεσης  αν έχει αποδειχθεί  αδιαμφισβήτητα  ότι \nδεν υπάρχει  κίνδυνος  από τις άλλες  οδούς  \nέκθεσης >. \nEN Suspected of damaging fertility or the unborn \nchild  <state specific effect if known> <state \nroute of exposure if it is conclusively proven \nthat no other routes of exposure cause the \nhazard> . \nFR Susceptible de nuire à la fertilité ou au fœtus  \n<indiquer l'effet s'il est connu> <indiquer la \nvoie d'exposition s'il est formellement prouvé \nqu'aucune autre voie d'exposition ne conduit \nau même danger> . \nGA Ceaptar go bhféadfadh sé damáiste a dhéanamh \ndo thorthúlacht nó don leanbh sa bhroinn \n<tabhair an tsainéifeacht más eol  >  < tabhair \nan bealach nochta má tá sé cruthaithe go \ncinntitheach nach bealach nochta ar bith eile \nis cúis leis an nguais >. \n▼M5 \nHR Sumnja na moguće štetno djelovanje na \nplodnost ili mogućnost štetnog djelovanja na \nnerođeno dijete < navesti konkretan u činak ako \nje poznat  >  < navesti na čin izloženosti ako je \nnedvojbeno dokazano da niti jedan drugi \nnačin izloženosti ne uzrokuje takvu opasnost >. ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 265}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 267  \nH361  Language  3.7 — Reproductive toxicity, Hazard Category 2  \nIT Sospettato di nuocere alla fertilità o al feto  \n<indicare l'effetto specifico, se noto> \n<indicare la via di esposizione se è accertato \nche nessun'altra via di esposizione comporta il \nmedesimo pericolo> . \nLV Ir aizdomas, ka var kaitēt auglībai vai \nnedzimušajam bērnam  <norādīt īpašo ietekmi, \nja tā ir zināma> <nor ādīt iedarbības ceļu, ja ir \nnepārprotami pier ādīts, ka citi iedarb ības ceļi \nnerada b īstamību>.  \nLT Įtariama, kad kenkia vaisingumui arba negi\xad\nmusiam vaikui < nurodyti konkret ų poveikį, \njeigu žinomas>  <nurodyti veikimo b ūdą, jeigu \nįtikinamai nustatyta, kad kiti veikimo b ūdai \nnepavojingi>.  \nHU Feltehetően károsítja a termékenységet vagy a \nszületendő gyermeket  < ha ismert, meg kell \nadni a konkrét hatást > < meg kell adni az \nexpozíciós útvonalat, ha meggy őzően bizony \xad\nított, hogy más expozíciós útvonal nem okozza \na veszélyt >.  \nMT Suspettat li jagħmel ħsara lill-fertilità jew lit- \ntarbija li għadha fil-ġuf  <semmi l-effett \nspeċifiku jekk ikun mag ħruf> <semmi l-mod \nta' espo żizzjoni jekk ikun pruvat b'mod \nkonklużiv li l-ebda mod ta' espo żizzjoni ie ħor \nma jikkaw ża l-periklu >.  \nNL Kan mogelijks de vruchtbaarheid of het \nongeboren kind schaden < specifiek effect \nvermelden indien bekend > <blootstellingsroute \nvermelden indien afdoende bewezen is dat het \ngevaar bij andere blootstellingsroutes niet \naanwezig is >. \nPL Podejrzewa się, że działa szkodliwie na \npłodność lub na dziecko w łonie matki  \n<podać szczególny skutek, je żeli jest znany> \n<podać drogę narażenia, jeżeli definitywnie \nudowodniono, że inne drogi nara żenia nie \nstwarzają zagrożenia> . \nPT Suspeito de afectar a fertilidade ou o nascituro \n<indicar o efeito específico se este for \nconhecido > <indicar a via de exposição se \nexistirem provas concludentes de que o perigo \nnão decorre de nenhuma outra via de exposi \xad\nção>. \nRO Susceptibil de a dăuna fertilităţii sau fătului  \n<indicaţi efectul specific, dac ă este cunos \xad\ncut><indica ţi calea de expunere, dac ă există \nprobe concludente c ă nicio alt ă cale de \nexpunere nu provoac ă acest pericol> . \nSK Podozrenie, že spôsobuje poškodenie plodnosti \nalebo nenarodeného dieťaťa  <uveďte konkrétny \núčinok, ak je známy > <uve ďte spôsob \nexpozície, ak sa presved čivo preukáže, že iné \nspôsoby expozície nevyvolávajú \nnebezpečenstvo> . \nSL Sum škodljivosti za plodnost ali nerojenega \notroka  <navesti posebni u činek, če je znan> \n<navesti na čin izpostavljenosti, če je \nprepričljivo dokazano, da noben drug na čin \nizpostavljenosti ne povzro ča takšne \nnevarnosti> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 266}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 268  \nH361  Language  3.7 — Reproductive toxicity, Hazard Category 2  \nFI Epäillään heikentävän hedelmällisyyttä tai vaur\xad\nioittavan sikiötä < mainitaan tiedetty spesifinen \nvaikutus>  <mainitaan altistumisreitti, jos on \nkiistatta osoitettu, että vaara ei voi aiheutua \nmuiden altistumisreittien kautta> . \nSV Misstänks kunna skada fertiliteten eller det \nofödda barnet  <ange specifik effekt om denna \när känd> <ange exponeringsväg om det är \ndefinitivt bevisat att faran inte kan orsakas av \nnågra andra exponeringsvägar>.  \nH362  Language  3.7 — Reproductive toxicity, Additional category, \nEffects on or via lactation  \nBG Може да бъде вреден за кърмачета.  \nES Puede perjudicar a los niños alimentados con \nleche materna.  \nCS Může poškodit kojence prostřednictvím \nmateřského mléka.  \nDA Kan skade børn, der ammes.  \nDE Kann Säuglinge über die Muttermilch schä\xad\ndigen.  \nET Võib kahjustada rinnaga toidetavat last.  \nEL Μπορεί να βλάψει τα βρέφη που τρέφονται με \nμητρικό γάλα.  \nEN May cause harm to breast-fed children.  \nFR Peut être nocif pour les bébés nourris au lait \nmaternel.  \nGA D'fhéadfadh sé díobháil a dhéanamh do leanaí \ndiúil. \n▼M5 \nHR Može štetno djelovati na djecu koja se hrane \nmajčinim mlijekom.  \n▼B \nIT Può essere nocivo per i lattanti allattati al seno.  \nLV Var radīt kaitējumu ar krūti barotam bērnam.  \nLT Gali pakenkti žindomam vaikui.  \nHU A szoptatott gyermeket károsíthatja.  \nMT Jista’ jagħmel ħsara lit-tfal imreddgħa.  \nNL Kan schadelijk zijn via borstvoeding.  \nPL Może działać szkodliwie na dzieci karmione \npiersią.  \nPT Pode ser nocivo para as crianças alimentadas \ncom leite materno.  \nRO Poate dăuna copiilor alăptaţi la sân.  \nSK Môže spôsobiť poškodenie u dojčených detí.  \nSL Lahko škoduje dojenim otrokom.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 267}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 269  \nH362  Language  3.7 — Reproductive toxicity, Additional category, \nEffects on or via lactation  \nFI Saattaa aiheuttaa haittaa rintaruokinnassa \noleville lapsille.  \nSV Kan skada spädbarn som ammas.  \nH370  Language  3.8 — Specific target organ toxicity — single \nexposure, Hazard Category 1  \nBG Причинява увреждане на органите  < или да \nсе посочат  всички  засегнати  органи , ако са \nизвестни > < да се посочи  пътят  на \nекспозицията , ако е доказано  убедително , \nче няма  друг път на експозиция , който  \nводи  до същата  опасност  >. \nES Provoca daños en los órganos  <o indíquense \ntodos los órganos afectados, si se conocen> \n<indíquese la vía de exposición si se ha \ndemostrado concluyentemente que el peligro \nno se produce por ninguna otra vía> . \nCS Způsobuje poškození orgánů  <nebo uvést \nvšechny postižené orgány, jsou-li známy> \n<uveďte cestu expozice, je-li p řesvědčivě \nprokázáno, že ostatní cesty expozice nejsou \nnebezpečné>. \nDA Forårsager organskader < eller angiv alle \nberørte organer, hvis de kendes > <angiv ekspo \xad\nneringsvej, hvis det er endeligt påvist, at faren \nikke kan frembringes ad nogen anden eksponer \xad\ningsvej >. \nDE Schädigt die Organe < oder alle betroffenen \nOrgane nennen, sofern bekannt>  \n<Expositionsweg angeben, sofern schlüssig \nbelegt ist, dass diese Gefahr bei keinem \nanderen Expositionsweg besteht> . \nET Kahjustab elundeid  <või märkida kõik \nmõjutatud elundid, kui need on teada> \n<märkida kokkupuuteviis, kui on veenvalt tões \xad\ntatud, et muud kokkupuuteviisid ei ole ohtli \xad\nkud> . \nEL Προκαλεί βλάβες στα όργανα < ή αναφέρονται  \nόλα τα όργανα  που βλάπτονται , εάν είναι  \nγνωστά > < αναφέρεται  η οδός έκθεσης  αν έχει \nαποδειχθεί  αδιαμφισβήτητα  ότι δεν υπάρχει  \nκίνδυνος  από τις άλλες  οδούς  έκθεσης  > . \nEN Causes damage to organs  <or state all organs \naffected, if known> <state route of exposure if \nit is conclusively proven that no other routes of \nexposure cause the hazard> . \nFR Risque avéré d'effets graves pour les organes  \n<ou indiquer tous les organes affectés, s'ils \nsont connus> <indiquer la voie d'exposition \ns'il est formellement prouvé qu'aucune autre \nvoie d'exposition ne conduit au même danger> . \nGA Déanann sé damáiste d'orgáin < nó tabhair na \nhorgáin go léir a bhuailtear, más eol > <tabhair \nan bealach nochta má tá sé cruthaithe go \ncinntitheach nach bealach nochta ar bith eile \nis cúis leis an nguais >. ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 268}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 270  \nH370  Language  3.8 — Specific target organ toxicity — single \nexposure, Hazard Category 1  \n▼M5 \nHR Uzrokuje oštećenje organa < ili navesti sve \norgane na koje djeluje ako je poznato > \n<navesti na čin izloženosti ako je nedvojbeno \ndokazano da niti jedan drugi na čin izloženosti \nne uzrokuje takvu opasnost >. \n▼B \nIT Provoca danni agli organi  <o indicare tutti gli \norgani interessati, se noti> <indicare la via di \nesposizione se è accertato che nessun'altra via \ndi esposizione comporta il medesimo pericolo> . \nLV Rada orgānu bojājumus  <vai nor ādīt visus \nskartos org ānus, ja tie ir zin āmi> <nor ādīt \niedarbības ceļu, ja ir nep ārprotami pier ādīts, \nka citi iedarb ības ceļi nerada b īstamību>.  \nLT Kenkia organams < arba nurodyti visus \nveikiamus organus, jeigu žinomi>  <nurodyti \nveikimo b ūdą, jeigu įtikinamai nustatyta, kad \nkiti veikimo b ūdai nepavojingi>.  \nHU Károsítja a szerveket  < vagy meg kell adni az \nösszes érintett szervet, ha ismertek > < meg \nkell adni az expozíciós útvonalat, ha \nmeggyőzően bizonyított, hogy más expozíciós \nútvonal nem okozza a veszélyt >.  \nMT Jagħmel ħsara lill-organi  <jew semmi l-organi \nkollha affettwati, jekk ikunu mag ħrufa> \n<semmi l-mod ta' espo żizzjoni jekk ikun \npruvat b'mod konklu żiv li l-ebda mod ta' \nespożizzjoni ieħor ma jikkaw ża l-periklu>.  \nNL Veroorzaakt schade aan organen < of alle \nbetrokken organen vermelden indien bekend > \n<blootstellingsroute vermelden indien afdoende \nbewezen is dat het gevaar bij andere blootstel \xad\nlingsroutes niet aanwezig is >. \nPL Powoduje uszkodzenie narządów  <poda ć \nszczególny skutek, je śli jest znany> <poda ć \ndrogę narażenia, jeżeli udowodniono, że inne \ndrogi nara żenia nie stwarzaj ą zagrożenia> . \nPT Afecta os órgãos < ou indicar todos os órgãos \nafectados, se forem conhecidos > <indicar a via \nde exposição se existirem provas concludentes \nde que o perigo não decorre de nenhuma outra \nvia de exposição >. \nRO Provoacă leziuni ale organelor  <sau indica ţi \ntoate organele afectate, dac ă sunt cunoscute> \n<indicaţi calea de expunere, dac ă există probe \nconcludente c ă nicio alt ă cale de expunere nu \nprovoacă acest pericol> . \nSK Spôsobuje poškodenie orgánov  <alebo uve ďte \nvšetky zasiahnuté orgány, ak sú známe> \n<uveďte spôsob expozície, ak sa presved čivo \npreukáže, že iné spôsoby expozície nevy \xad\nvolávajú nebezpe čenstvo> . \nSL Škoduje organom  <ali navesti vse organe, na \nkatere vpliva, če je znano> <navesti na čin \nizpostavljenosti, če je prepri čljivo dokazano, \nda noben drug na čin izpostavljenosti ne \npovzroča takšne nevarnosti> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 269}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 271  \nH370  Language  3.8 — Specific target organ toxicity — single \nexposure, Hazard Category 1  \nFI Vahingoittaa elimiä < tai mainitaan kaikki \ntiedetyt kohde-elimet>  <mainitaan altistumis \xad\nreitti, jos on kiistatta osoitettu, että vaara ei \nvoi aiheutua muiden altistumisreittien kautta>.  \nSV Orsakar organskador  <eller ange vilka organ \nsom påverkas om detta är känt> <ange \nexponeringsväg om det är definitivt bevisat att \nfaran inte kan orsakas av några andra \nexponeringsvägar>.  \nH371  Language  3.8 — Specific target organ toxicity — Single \nexposure, Hazard Category 2  \nBG Може да причини увреждане на органите  < \nили да се посочат  всички  засегнати  органи , \nако са известни > < да се посочи  пътят  на \nекспозицията , ако е доказано  убедително , \nче няма  друг път на експозиция , който  \nводи  до същата  опасност  >. \nES Puede provocar daños en los órganos  <o indí\xad\nquense todos los órganos afectados, si se \nconocen> <indíquese la vía de exposición si \nse ha demostrado concluyentemente que el \npeligro no se produce por ninguna otra vía> . \nCS Může způsobit poškození orgánů  <nebo uvést \nvšechny postižené orgány, jsou-li známy> \n<uveďte cestu expozice, je-li p řesvědčivě \nprokázáno, že ostatní cesty expozice nejsou \nnebezpečné>. \nDA Kan forårsage organskader < eller angiv alle \nberørte organer, hvis de kendes > <angiv ekspo \xad\nneringsvej, hvis det er endeligt påvist, at faren \nikke kan frembringes ad nogen anden eksponer \xad\ningsvej >. \nDE Kann die Organe schädigen < oder alle \nbetroffenen Organe nennen, sofern bekann>  \n<Expositionsweg angeben, sofern schlüssig \nbelegt ist, dass diese Gefahr bei keinem \nanderen Expositionsweg besteht> . \nET Võib kahjustada elundeid  <või märkida kõik \nmõjutatud elundid, kui need on teada> \n<märkida kokkupuuteviis, kui on veenvalt tões \xad\ntatud, et muud kokkupuuteviisid ei ole ohtli \xad\nkud> . \nEL Μπορεί να προκαλέσει βλάβες στα όργανα < ή \nαναφέρονται  όλα τα όργανα  που βλάπτονται , εάν \nείναι  γνωστά > <αναφέρεται  η οδός έκθεσης  αν \nέχει αποδειχθεί  αδιαμφισβήτητα  ότι δεν υπάρχει  \nκίνδυνος  από τις άλλες  οδούς  έκθεσης >. \nEN May cause damage to organs  <or state all \norgans affected, if known> <state route of \nexposure if it is conclusively proven that no \nother routes of exposure cause the hazard> . \nFR Risque présumé d'effets graves pour les organes  \n<ou indiquer tous les organes affectés, s'ils \nsont connus> <indiquer la voie d'exposition \ns'il est formellement prouvé qu'aucune autre \nvoie d'exposition ne conduit au même danger>.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 270}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 272  \nH371  Language  3.8 — Specific target organ toxicity — Single \nexposure, Hazard Category 2  \nGA D'fhéadfadh damáiste a dhéanamh d'orgáin < nó \ntabhair na horgáin go léir a bhuailtear, más \neol> <tabhair an bealach nochta má tá sé \ncruthaithe go cinntitheach nach bealach \nnochta ar bith eile is cúis leis an nguais >. \n▼M5 \nHR Može uzrokovati oštećenje organa < ili navesti \nsve organe na koje djeluje ako je poznato > \n<navesti na čin izloženosti ako je nedvojbeno \ndokazano da niti jedan drugi na čin izloženosti \nne uzrokuje takvu opasnost >. \n▼B \nIT Può provocare danni agli organi  <o indicare \ntutti gli organi interessati, se noti> <indicare \nla via di esposizione se è accertato che ness \xad\nun'altra via di esposizione comporta il \nmedesimo pericolo> . \nLV Var izraisīt orgānu bojājumus  <vai nor ādīt \nvisus skartos org ānus, ja tie ir zin āmi> \n<norādīt iedarbības ceļu, ja ir nep ārprotami \npierādīts, ka citi iedarb ības ceļi nerada \nbīstamību>.  \nLT Gali pakenkti organams < arba nurodyti visus \nveikiamus organus, jeigu žinomi>  <nurodyti \nveikimo b ūdą, jeigu įtikinamai nustatyta, kad \nkiti veikimo b ūdai nepavojingi> . \nHU Károsíthatja a szerveket  < vagy meg kell adni \naz összes érintett szervet, ha ismertek > < meg \nkell adni az expozíciós útvonalat, ha \nmeggyőzően bizonyított, hogy más expozíciós \nútvonal nem okozza a veszélyt >.  \nMT Jista’ jikkawża ħsara lill-organi  <jew semmi l- \norgani kollha affettwati, jekk ikunu mag ħrufa> \n<semmi l-mod ta' espo żizzjoni jekk ikun pruvat \nb'mod konklu żiv li l-ebda mod ta'’ espo żizzjoni \nieħor ma jikkaw ża l-periklu>.  \nNL Kan schade aan organen < of alle betrokken \norganen vermelden indien bekend > veroorzaken \n<blootstellingsroute vermelden indien afdoende \nbewezen is dat het gevaar bij andere blootstel \xad\nlingsroutes niet aanwezig is >. \nPL Może powodować uszkodzenie narządów  \n<podać wszystkie znane narz ądy, których to \ndotyczy> <poda ć drogę narażenia, jeżeli \nudowodniono, że inne drogi nara żenia nie \nstwarzają zagrożenia> . \nPT Pode afectar os órgãos < ou indicar todos os \nórgãos afectados, se forem conhecidos > \n<indicar a via de exposição se existirem \nprovas concludentes de que o perigo não \ndecorre de nenhuma outra via de exposição >. \nRO Poate provoca leziuni ale organelor  <sau \nindicaţi toate organele afectate, dac ă sunt \ncunoscute> <indica ţi calea de expunere, dac ă \nexistă probe concludente c ă nicio alt ă cale de \nexpunere nu provoac ă acest pericol> . \nSK Môže spôsobiť poškodenie orgánov  <alebo \nuveďte všetky zasiahnuté orgány, ak sú \nznáme> <uve ďte spôsob expozície, ak sa \npresvedčivo preukáže, že iné spôsoby \nexpozície nevyvolávajú nebezpe čenstvo> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 271}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 273  \nH371  Language  3.8 — Specific target organ toxicity — Single \nexposure, Hazard Category 2  \nSL Lahko škoduje organom  <ali navesti vse \norgane, na katere vpliva, če je znano> \n<navesti na čin izpostavljenosti, če je \nprepričljivo dokazano, da noben drug na čin \nizpostavljenosti ne povzro ča takšne \nnevarnosti> . \nFI Saattaa vahingoittaa elimiä < tai mainitaan \nkaikki tiedetyt kohde-elimet>  <mainitaan altis \xad\ntumisreitti, jos on kiistatta osoitettu, että vaara \nei voi aiheutua muiden altistumisreittien \nkautta>.  \nSV Kan orsaka organskador  <eller ange vilka \norgan som påverkas om detta är känt> <ange \nexponeringsväg om det är definitivt bevisat att \nfaran inte kan orsakas av några andra \nexponeringsvägar>.  \nH372  Language  3.9 — Specific target organ toxicity — Repeated \nexposure, Hazard Category 1  \nBG Причинява увреждане на органите  < или да \nсе посочат  всички  засегнати  органи , ако са \nизвестни  > посредством  продължителна  \nили повтаряща  се експозиция  < да се \nпосочи  пътят  на експозицията , ако е \nдоказано  убедително , че няма  друг път на \nекспозиция , който  води  до същата  \nопасност  >. \nES Provoca daños en los órganos  <indíquense \ntodos los órganos afectados, si se conocen>  \ntras exposiciones prolongadas o repetidas  \n<indíquese la vía de exposición si se ha \ndemostrado concluyentemente que el peligro \nno se produce por ninguna otra vía> . \nCS Způsobuje poškození orgánů  <nebo uvést \nvšechny postižené orgány, jsou-li známy>  p ř i  \nprodloužené nebo opakované expozici  \n<uveďte cestu expozice, je-li p řesvědčivě \nprokázáno, že ostatní cesty expozice nejsou \nnebezpečné>. \nDA Forårsager organskader < eller angiv alle \nberørte organer, hvis de kendes > ved længer\xad\nevarende eller gentagen eksponering < angiv \neksponeringsvej, hvis det er endeligt påvist, at \nfaren ikke kan frembringes ad nogen anden \neksponeringsvej >. \nDE Schädigt die Organe < alle betroffenen Organe \nnennen>  bei längerer oder wiederholter \nExposition < Expositionsweg angeben, wenn \nschlüssig belegt ist, dass diese Gefahr bei \nkeinem anderen Expositionsweg besteht> . \nET Kahjustab elundeid  <või märkida kõik \nmõjutatud elundid, kui need on teada>  pikaa\xad\njalisel või korduval kokkupuutel  <märkida \nkokkupuuteviis, kui on veenvalt tõestatud, et \nmuud kokkupuuteviisid ei ole ohtlikud> . \nEL Προκαλεί βλάβες στα όργανα < ή αναφέρονται  \nόλα τα όργανα  που βλάπτονται , εάν είναι  \nγνωστά > ύστερα από παρατεταμένη ή \nεπανειλημμένη έκθεση <  αναφέρεται  η οδός \nέκθεσης  αν έχει αποδειχθεί  αδιαμφισβήτητα  ότι \nδεν υπάρχει  κίνδυνος  από τις άλλες  οδούς  \nέκθεσης  > . ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 272}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 274  \nH372  Language  3.9 — Specific target organ toxicity — Repeated \nexposure, Hazard Category 1  \nEN Causes damage to organs  <or state all organs \naffected, if known>  through prolonged or \nrepeated exposure  <state route of exposure if \nit is conclusively proven that no other routes \nof exposure cause the hazard> . \nFR Risque avéré d'effets graves pour les organes  \n<indiquer tous les organes affectés, s'ils sont \nconnus>  à la suite d'expositions répétées ou \nd'une exposition prolongée  <indiquer la voie \nd'exposition s'il est formellement prouvé \nqu'aucune autre voie d'exposition ne conduit \nau même danger> . \nGA Déanann damáiste d'orgáin < nó tabhair na \nhorgáin go léir a bhuailtear, más eol > trí \nnochtadh fada nó ilnochtadh <tabhair  an \nbealach nochta má tá sé cruthaithe go cinnti \xad\ntheach nach bealach nochta ar bith eile is cúis \nleis an nguais >. \n▼M5 \nHR Uzrokuje oštećenje organa < ili navesti sve \norgane na koje djeluje ako je poznato > \ntijekom produljene ili ponavljane izloženosti \n<navesti na čin izloženosti ako je nedvojbeno \ndokazano da niti jedan drugi na čin izloženosti \nne uzrokuje takvu opasnost >. \n▼B \nIT Provoca danni agli organi  <o indicare tutti gli \norgani interessati, se noti>  in caso di espos\xad\nizione prolungata o ripetuta  <indicare la via \ndi esposizione se è accertato che nessun'altra \nvia di esposizione comporta il medesimo peri \xad\ncolo> . \nLV Izraisa orgānu bojājumus  <vai nor ādīt visus \nskartos org ānus, ja tie ir zin āmi> ilgstošas \nvai atkārtotas iedarbības rezultātā  <norādīt \niedarbības ceļu, ja ir nep ārprotami pier ādīts, \nka citi iedarb ības ceļi nerada b īstamību>.  \nLT Kenkia organams < arba nurodyti visus \nveikiamus organus, jeigu žinoma>,  jeigu \nmedžiaga veikia ilgai arba kartotinai < nurodyti \nveikimo b ūdą, jeigu įtikinamai nustatyta, kad \nkiti veikimo b ūdai nepavojingi>.  \nHU Ismétlődő vagy hosszabb expozíció esetén  < \nmeg kell adni az expozíciós útvonalat, ha \nmeggyőzően bizonyított, hogy más expozíciós \nútvonal nem okozza a veszélyt >  károsítja a \nszerveket  < vagy meg kell adni az összes \nérintett szervet, ha ismertek >.  \nMT Jikkawża ħsara lill-organi  <jew semmi l-organi \nkollha affettwati, jekk ikunu mag ħrufa> \nminħabba espo żizzjoni fit-tul jew ripetuta \n<semmi l-mod ta' espo żizzjoni jekk ikun \npruvat b'mod konklu żiv li l-ebda mod ta' \nespożizzjoni ieħor ma jikkaw ża l-periklu>.  \nNL Veroorzaakt schade aan organen < of alle \nbetrokken organen vermelden indien bekend > \nbij langdurige of herhaalde blootstelling \n<blootstellingsroute vermelden indien afdoende \nbewezen is dat het gevaar bij andere blootstel \xad\nlingsroutes niet aanwezig is >. ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 273}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 275  \nH372  Language  3.9 — Specific target organ toxicity — Repeated \nexposure, Hazard Category 1  \nPL Powoduje uszkodzenie narządów  <poda ć \nwszystkie znane narz ądy, których to dotyczy >  \npoprzez długotrwałe lub powtarzane narażenie  \n<podać drogę narażenia, jeżeli udowodniono, \nże inne drogi nara żenia nie stwarzaj ą \nzagrożenia> . \nPT Afecta os órgãos < ou indicar todos os órgãos \nafectados, se forem conhecidos > após \nexposição prolongada ou repetida < indicar a \nvia de exposição se existirem provas conclu \xad\ndentes de que o perigo não decorre de \nnenhuma outra via de exposição >. \nRO Provoacă leziuni ale organelor  <sau indica ţi \ntoate organele afectate, dac ă sunt cunoscute>  \nîn caz de expunere prelungită sau repetată  \n<indicaţi calea de expunere, dac ă există \nprobe concludente c ă nicio alt ă cale de \nexpunere nu provoac ă acest pericol> . \nSK Spôsobuje poškodenie orgánov  <alebo uve ďte \nvšetky zasiahnuté orgány, ak sú známe> pri \ndlhšej alebo opakovanej expozícii  <uveďte \nspôsob expozície, ak sa presved čivo preukáže, \nže iné spôsoby expozície nevyvolávajú \nnebezpečenstvo> . \nSL Škoduje organom  <ali navesti vse organe, na \nkatere vpliva, če je znano>  pri dolgotrajni ali \nponavljajoči se izpostavljenosti  <navesti na čin \nizpostavljenosti, če je prepri čljivo dokazano, da \nnoben drug na čin izpostavljenosti ne povzro ča \ntakšne nevarnosti> . \nFI Vahingoittaa elimiä < tai mainitaan kaikki \ntiedetyt kohde-elimet>  pitkäaikaisessa tai tois\xad\ntuvassa altistumisessa < mainitaan altistumis \xad\nreitti, jos on kiistatta osoitettu, että vaara ei \nvoi aiheutua muiden altistumisreittien kautta>.  \nSV Orsakar organskador  <eller ange vilka organ \nsom påverkas om detta är känt>  genom lång \neller upprepad exponering  <ange exponer \xad\ningsväg om det är definitivt bevisat att faran \ninte kan orsakas av några andra exponerings \xad\nvägar> . \nH373  Language  3.9 — Specific target organ toxicity — Repeated \nexposure, Hazard Category 2  \nBG Може да причини увреждане на органите  < \nили да се посочат  всички  засегнати  органи , \nако са известни  > при продължителна или \nповтаряща се експозиция  < да се посочи  \nпътят  на експозицията , ако е доказано  \nубедително , че няма  друг път на експозиция , \nкойто  води  до същата  опасност  >. \nES Puede provocar daños en los órganos  \n<indíquense todos los órganos afectados, si \nse conocen>  tras exposiciones prolongadas o \nrepetidas  <indíquese la vía de exposición si \nse ha demostrado concluyentemente que el \npeligro no se produce por ninguna otra vía> . ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 274}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 276  \nH373  Language  3.9 — Specific target organ toxicity — Repeated \nexposure, Hazard Category 2  \nCS Může způsobit poškození orgánů  <nebo uvést \nvšechny postižené orgány, jsou-li známy>  p ř i  \nprodloužené nebo opakované expozici  \n<uveďte cestu expozice, je-li p řesvědčivě \nprokázáno, že ostatní cesty expozice nejsou \nnebezpečné>. \nDA Kan forårsage organskader < eller angiv alle \nberørte organer, hvis de kendes > ved længer\xad\nevarende eller gentagen eksponering < angiv \neksponeringsvej, hvis det er endeligt påvist, at \nfaren ikke kan frembringes ad nogen anden \neksponeringsvej >. \nDE Kann die Organe schädigen < alle betroffenen \nOrgane nennen, sofern bekannt>  bei längerer \noder wiederholter Exposition < Expositionsweg \nangeben, wenn schlüssig belegt ist, dass diese \nGefahr bei keinem anderen Expositionsweg \nbesteht> . \nET Võib kahjustada elundeid  <või märkida kõik \nmõjutatud elundid, kui need on teada>  pikaa\xad\njalisel või korduval kokkupuutel  <märkida \nkokkupuuteviis, kui on veenvalt tõestatud, et \nmuud kokkupuuteviisid ei ole ohtlikud> . \nEL Μπορεί να προκαλέσει βλάβες στα όργανα < ή \nαναφέρονται  όλα τα όργανα  που βλάπτονται , εάν \nείναι  γνωστά > ύστερα από παρατεταμένη ή \nεπανειλημμένη έκθεση < αναφέρεται  η οδός \nέκθεσης  αν έχει αποδειχθεί  αδιαμφισβήτητα  ότι \nδεν υπάρχει  κίνδυνος  από τις άλλες  οδούς  \nέκθεσης >. \nEN May cause damage to organs  <or state all \norgans affected, if known>  through prolonged \nor repeated exposure  <state route of exposure if \nit is conclusively proven that no other routes of \nexposure cause the hazard> . \nFR Risque présumé d'effets graves pour les organes  \n<ou indiquer tous les organes affectés, s'ils \nsont connus>  à la suite d'expositions répétées \nou d'une exposition prolongée  <indiquer la \nvoie d'exposition s'il est formellement prouvé \nqu'aucune autre voie d'exposition ne conduit \nau même danger> . \nGA D'fhéadfadh sé damáiste a dhéanamh d'orgáin \n<nó tabhair na horgáin go léir a bhuailtear, \nmás eol > trí nochtadh fada nó ilnochtadh  \n<tabhair an bealach nochta má tá sé cruthaithe \ngo cinntitheach nach bealach nochta ar bith \neile is cúis leis an nguais >. \n▼M5 \nHR Može uzrokovati oštećenje organa < ili navesti \nsve organe na koje djeluje ako je poznato > \ntijekom produljene ili ponavljane izloženosti \n<navesti na čin izloženosti ako je nedvojbeno \ndokazano da niti jedan drugi na čin izloženosti \nne uzrokuje takvu opasnost >. \n▼B \nIT Può provocare danni agli organi  <o indicare \ntutti gli organi interessati, se noti>  in caso di \nesposizione prolungata o ripetuta  <indicare la \nvia di esposizione se è accertato che ness \xad\nun'altra via di esposizione comporta il \nmedesimo pericolo> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 275}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 277  \nH373  Language  3.9 — Specific target organ toxicity — Repeated \nexposure, Hazard Category 2  \nLV Var izraisīt orgānu bojājumus  <vai nor ādīt \nvisus skartos org ānus, ja tie ir zin āmi> \nilgstošas vai atkārtotas iedarbības rezultātā  \n<norādīt iedarbības ceļu, ja ir nep ārprotami \npierādīts, ka citi iedarb ības ceļi nerada \nbīstamību>.  \nLT Gali pakenkti organams < arba nurodyti visus \nveikiamus organus, jeigu žinomi> , jeigu \nmedžiaga veikia ilgai arba kartotinai < nurodyti \nveikimo b ūdą, jeigu įtikinamai nustatyta, kad \nkiti veikimo b ūdai nepavojingi>.  \nHU Ismétlődő vagy hosszabb expozíció esetén  < \nmeg kell adni az expozíciós útvonalat, ha \nmeggyőzően bizonyított, hogy más expozíciós \nútvonal nem okozza a veszélyt >  károsíthatja a \nszerveket  > vagy meg kell adni az összes \nérintett szervet, ha ismertek >.  \nMT Jista’ jikkawża ħsara lill-organi  <jew semmi l- \norgani kollha affettwati, jekk ikunu mag ħrufa> \nminħabba espo żizzjoni fit-tul jew ripetuta \n<semmi l-mod ta' espo żizzjoni jekk ikun \npruvat b'mod konklu żiv li l-ebda mod ta' \nespożizzjoni ieħor ma jikkaw ża l-periklu>.  \nNL Kan schade aan organen < of alle betrokken \norganen vermelden indien bekend > veroorzaken \nbij langdurige of herhaalde blootstelling \n<blootstellingsroute vermelden indien afdoende \nbewezen is dat het gevaar bij andere blootstel \xad\nlingsroutes niet aanwezig is >. \nPL Może powodować uszkodzenie narządów  \n<podać wszystkie znane narz ądy, których to \ndotyczy >  poprzez długotrwałe lub narażenie \npowtarzane  <podać drogę narażenia, jeśli \nudowodniono, że inne drogi nara żenia nie \nstwarzają zagrożenia> . \nPT Pode afectar os órgãos < ou indicar todos os \nórgãos afectados, se forem conhecidos > após \nexposição prolongada ou repetida < indicar a \nvia de exposição se existirem provas conclu \xad\ndentes de que o perigo não decorre de \nnenhuma outra via de exposição >. \nRO Poate provoca leziuni ale organelor  <sau \nindicaţi toate organele afectate, dac ă sunt \ncunoscute>  în caz de expunere prelungită sau \nrepetată  <indica ţi calea de expunere, dac ă \nexistă probe concludente c ă nicio alt ă cale de \nexpunere nu provoac ă acest pericol> . \nSK Môže spôsobiť poškodenie orgánov  <alebo \nuveďte všetky zasiahnuté orgány, ak sú \nznáme> pri dlhšej alebo opakovanej expozícii  \n<uveďte spôsob expozície, ak sa presved čivo \npreukáže, že iné spôsoby expozície nevy \xad\nvolávajú nebezpe čenstvo> . \nSL Lahko škoduje organom  <ali navesti vse \norgane, na katere vpliva, če je znano>  pri \ndolgotrajni ali ponavljajoči se izpostavljenosti  \n<navesti na čin izpostavljenosti, če je \nprepričljivo dokazano, da noben drug na čin \nizpostavljenosti ne povzro ča takšne \nnevarnosti> . ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 276}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 278  \nH373  Language  3.9 — Specific target organ toxicity — Repeated \nexposure, Hazard Category 2  \nFI Saattaa vahingoittaa elimiä < tai mainitaan \nkaikki tiedetyt kohde-elimet>  pitkäaikaisessa \ntai toistuvassa altistumisessa < mainitaan altistu \xad\nmisreitti, jos on kiistatta osoitettu, että vaara ei \nvoi aiheutua muiden altistumisreittien kautta>  \nSV Kan orsaka organskador  <eller ange vilka \norgan som påverkas om detta är känt>  \ngenom lång eller upprepad exponering  <ange \nexponeringsväg om det är definitivt bevisat att \nfaran inte kan orsakas av några andra \nexponeringsvägar> . \n▼M2 \nH300 \n+ \nH310  Language  3.1 — Acute toxicity (oral) and acute toxicity \n(dermal), hazard category 1, 2  \nBG Смъртоносен при поглъщане или при \nконтакт с кожата  \nES Mortal en caso de ingestión o en contacto con \nla piel  \nCS Při požití nebo při styku s kůží může způsobit \nsmrt \nDA Livsfarlig ved indtagelse eller hudkontakt  \nDE Lebensgefahr bei Verschlucken oder Haut\xad\nkontakt  \nET Allaneelamisel või nahale sattumisel surmav  \nEL Θανατηφόρο σε περίπτωση κατάποσης ή σε \nεπαφή με το δέρμα  \nEN Fatal if swallowed or in contact with skin  \nFR Mortel par ingestion ou par contact cutané  \nGA Ábhar marfach é seo má shlogtar é nó má \ntheagmhaíonn leis an gcraiceann  \n▼M5 \nHR Smrtonosno ako se proguta ili u dodiru s \nkožom.  \n▼M2 \nIT Mortale in caso di ingestione o a contatto con \nla pelle  \nLV Var izraisīt nāvi, ja norīts vai saskaras ar ādu  \nLT Mirtina prarijus arba susilietus su oda  \nHU Lenyelve vagy bőrrel érintkezve halálos  \nMT Fatali jekk tinbela' jew tmiss mal-ġilda  \nNL Dodelijk bij inslikken en bij contact met de \nhuid \nPL Grozi śmiercią po połknięciu lub w kontakcie \nze skórą  \nPT Mortal por ingestão ou contacto com a pele  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 277}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 279  \nH300 \n+ \nH310  Language  3.1 — Acute toxicity (oral) and acute toxicity \n(dermal), hazard category 1, 2  \nRO Mortal în caz de înghiţire sau în contact cu \npielea  \nSK Pri požití alebo styku s kožou môže spôsobiť \nsmrť  \nSL Smrtno pri zaužitju ali v stiku s kožo  \nFI Tappavaa nieltynä tai joutuessaan iholle  \nSV Dödligt vid förtäring eller vid hudkontakt  \nH300 \n+ \nH330  Language  3.1 — Acute toxicity (oral) and acute toxicity (inha\xad\nlation), hazard category 1, 2  \nBG Смъртоносен при поглъщане или при \nвдишване  \nES Mortal en caso de ingestión o inhalación  \nCS Při požití nebo při vdechování může způsobit \nsmrt \nDA Livsfarlig ved indtagelse eller indånding  \nDE Lebensgefahr bei Verschlucken oder Einatmen  \nET Allaneelamisel või sissehingamisel surmav  \nEL Θανατηφόρο σε περίπτωση κατάποσης ή σε \nπερίπτωση εισπνοής  \nEN Fatal if swallowed or if inhaled  \nFR Mortel par ingestion ou par inhalation  \nGA Ábhar marfach é seo má shlogtar nó má \nionanálaítear é  \n▼M5 \nHR Smrtonosno ako se proguta ili ako se udiše  \n▼M2 \nIT Mortale se ingerito o inalato  \nLV Var izraisīt nāvi, ja norīts vai iekļūst elpceļos  \nLT Mirtina prarijus arba įkvėpus  \nHU Lenyelve vagy belélegezve halálos  ▼M2', metadata={'source': 'data/ycla_en.pdf', 'page': 278}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 280  \nH300 \n+ \nH330  Language  3.1 — Acute toxicity (oral) and acute toxicity (inha\xad\nlation), hazard category 1, 2  \nMT Fatali jekk tinbela' jew tittieħed bin-nifs  \nNL Dodelijk bij inslikken en bij inademing  \nPL Grozi śmiercią po połknięciu lub w następstwie \nwdychania  \nPT Mortal por ingestão ou inalação  \nRO Mortal în caz de înghiţire sau inhalare  \nSK Pri požití alebo vdýchnutí môže spôsobiť smrť  \nSL Smrtno pri zaužitju ali vdihavanju  \nFI Tappavaa nieltynä tai hengitettynä  \nSV Dödligt vid förtäring eller inandning  \nH310 \n+ \nH330  Language  3.1 — Acute toxicity (dermal) and acute toxicity \n(inhalation), hazard category 1, 2  \nBG Смъртоносен при контакт с кожата или при \nвдишване  \nES Mortal en contacto con la piel o si se inhala  \nCS Při styku s kůží nebo při vdechování může \nzpůsobit smrt  \nDA Livsfarlig ved hudkontakt eller indånding  \nDE Lebensgefahr bei Hautkontakt oder Einatmen  \nET Nahale sattumisel või sissehingamisel surmav  \nEL Θανατηφόρο σε επαφή με το δέρμα ή σε \nπερίπτωση εισπνοής  \nEN Fatal in contact with skin or if inhaled  \nFR Mortel par contact cutané ou par inhalation  \nGA Ábhar marfach é seo má theagmhaíonn leis an \ngcraiceann nó má ionanálaítear é  \n▼M5 \nHR Smrtonosno u dodiru s kožom ili ako se udiše  \n▼M2 \nIT Mortale a contatto con la pelle o in caso di \ninalazione  \nLV Var izraisīt nāvi, ja saskaras ar ādu vai nonāk \nelpceļos  \nLT Mirtina susilietus su oda arba įkvėpus  \nHU Bőrrel érintkezve vagy belélegezve halálos  \nMT Fatali f'kuntatt mal-ġilda jew jekk tittieħed bin- \nnifs \nNL Dodelijk bij contact met de huid en bij \ninademing  \nPL Grozi śmiercią w kontakcie ze skórą lub w \nnastępstwie wdychania  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 279}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 281  \nH310 \n+ \nH330  Language  3.1 — Acute toxicity (dermal) and acute toxicity \n(inhalation), hazard category 1, 2  \nPT Mortal por contacto com a pele ou inalação  \nRO Mortal în contact cu pielea sau prin inhalare  \nSK Pri styku s kožou alebo pri vdýchnutí môže \nspôsobiť smrť  \nSL Smrtno v stiku s kožo ali pri vdihavanju  \nFI Tappavaa joutuessaan iholle tai hengitettynä  \nSV Dödligt vid hudkontakt eller inandning  \nH300 + \nH310 + \nH330  Language  3.1 — Acute toxicity (oral), acute toxicity (dermal) \nand acute toxicity (inhalation), hazard category 1, 2  \nBG Смъртоносен при поглъщане, при контакт с \nкожата или при вдишване  \nES Mortal en caso de ingestión, contacto con la \npiel o inhalación  \nCS Při požití, při styku s kůží nebo při vdechování \nmůže způsobit smrt  \nDA Livsfarlig ved indtagelse, hudkontakt eller \nindånding  \nDE Lebensgefahr bei Verschlucken, Hautkontakt \noder Einatmen  \nET Allaneelamisel, nahale sattumisel või sissehing\xad\namisel surmav  \nEL Θανατηφόρο σε περίπτωση κατάποσης, σε \nεπαφή με το δέρμα ή σε περίπτωση εισπνοής  \nEN Fatal if swallowed, in contact with skin or if \ninhaled  \nFR Mortel par ingestion, par contact cutané ou par \ninhalation  \nGA Ábhar marfach é seo má shlogtar, má \ntheagmhaíonn leis an gcraiceann nó má \nionanálaítear é  \n▼M5 \nHR Smrtonosno ako se proguta, u dodiru s kožom \nili ako se udiše  \n▼M2 \nIT Mortale se ingerito, a contatto con la pelle o se \ninalato  \nLV Var izraisīt nāvi, ja norīts, saskaras ar ādu vai \niekļūst elpceļos  \nLT Mirtina prarijus, susilietus su oda arba įkvėpus  \nHU Lenyelve, bőrrel érintkezve vagy belélegezve \nhalálos  \nMT Fatali jekk tinbela', tmiss mal-ġilda jew tittieħed \nbin-nifs  \nNL Dodelijk bij inslikken, bij contact met de huid \nen bij inademing  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 280}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 282  \nH300 + \nH310 + \nH330  Language  3.1 — Acute toxicity (oral), acute toxicity (dermal) \nand acute toxicity (inhalation), hazard category 1, 2  \nPL Grozi śmiercią po połknięciu, w kontakcie ze \nskórą lub w następstwie wdychania  \nPT Mortal por ingestão, contacto com a pele ou \ninalação  \nRO Mortal în caz de înghiţire, în contact cu pielea \nsau prin inhalare  \nSK Pri požití, pri styku s kožou alebo pri vdýchnutí \nmôže spôsobiť smrť  \nSL Smrtno pri zaužitju, v stiku s kožo ali pri \nvdihavanju  \nFI Tappavaa nieltynä, joutuessaan iholle tai hengi\xad\ntettynä  \nSV Dödligt vid förtäring, hudkontakt eller \ninandning  \nH301 \n+ \nH311  Language  3.1 — Acute toxicity (oral) and acute toxicity \n(dermal), hazard category 3  \nBG Токсичен при поглъщане или при контакт с \nкожата  \nES Tóxico en caso de ingestión o en contacto con \nla piel  \nCS Toxický při požití a při styku s kůží  \nDA Giftig ved indtagelse eller hudkontakt  \nDE Giftig bei Verschlucken oder Hautkontakt  \nET Allaneelamisel või nahale sattumisel mürgine  \nEL Τοξικό σε περίπτωση κατάποσης ή σε επαφή με \nτο δέρμα  \nEN Toxic if swallowed or in contact with skin  \nFR Toxique par ingestion ou par contact cutané  \nGA Ábhar tocsaineach má shlogtar é nó má \ntheagmhaíonn leis an gcraiceann  \n▼M5 \nHR Otrovno ako se proguta ili u dodiru s kožom  \n▼M2 \nIT Tossico se ingerito o a contatto con la pelle  \nLV Toksisks, ja norīts vai saskaras ar ādu  \nLT Toksiška prarijus arba susilietus su oda  \nHU Lenyelve vagy bőrrel érintkezve mérgező  \nMT Tossika jekk tinbela' jew tmiss mal-ġilda  \nNL Giftig bij inslikken en bij contact met de huid  \nPL Działa toksycznie po połknięciu lub w \nkontakcie ze skórą  \nPT Tóxico por ingestão ou contacto com a pele  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 281}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 283  \nH301 \n+ \nH311  Language  3.1 — Acute toxicity (oral) and acute toxicity \n(dermal), hazard category 3  \nRO Toxic în caz de înghiţire sau în contact cu \npielea  \nSK Toxický pri požití a pri styku s kožou  \nSL Strupeno pri zaužitju ali v stiku s kožo  \nFI Myrkyllistä nieltynä tai joutuessaan iholle  \nSV Giftigt vid förtäring eller hudkontakt  \nH301 \n+ \nH331  Language  3.1 — Acute toxicity (oral) and acute toxicity (inha\xad\nlation), hazard category 3  \nBG Токсичен при поглъщане или при вдишване  \nES Tóxico en caso de ingestión o inhalación  \nCS Toxický při požití a při vdechování  \nDA Giftig ved indtagelse eller indånding  \nDE Giftig bei Verschlucken oder Einatmen  \nET Allaneelamisel või sissehingamisel mürgine  \nEL Τοξικό σε περίπτωση κατάποσης ή σε \nπερίπτωση εισπνοής  \nEN Toxic if swallowed or if inhaled  \nFR Toxique par ingestion ou par inhalation  \nGA Ábhar tocsaineach má shlogtar nó má \nionanálaítear é  \n▼M5 \nHR Otrovno ako se proguta ili ako se udiše  \n▼M2 \nIT Tossico se ingerito o inalato  \nLV Toksisks, ja norīts vai iekļūst elpceļos  \nLT Toksiška prarijus arba įkvėpus  \nHU Lenyelve vagy belélegezve mérgező  \nMT Tossika jekk tinbela' jew tittieħed bin-nifs  \nNL Giftig bij inslikken en bij inademing  \nPL Działa toksycznie po połknięciu lub w \nnastępstwie wdychania  \nPT Tóxico por ingestão ou inalação  \nRO Toxic în caz de înghiţire sau prin inhalare  \nSK Toxický pri požití alebo vdýchnutí  \nSL Strupeno pri zaužitju ali vdihavanju  \nFI Myrkyllistä nieltynä tai hengitettynä  \nSV Giftigt vid förtäring eller inandning  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 282}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 284  \nH311 \n+ \nH331  Language  3.1 — Acute toxicity (dermal) and acute toxicity \n(inhalation), hazard category 3  \nBG Токсичен при контакт с кожата или при \nвдишване  \nES Tóxico en contacto con la piel o si se inhala  \nCS Toxický při styku s kůží a při vdechování  \nDA Giftig ved hudkontakt eller indånding  \nDE Giftig bei Hautkontakt oder Einatmen  \nET Nahale sattumisel või sissehingamisel mürgine  \nEL Τοξικό σε επαφή με το δέρμα ή σε περίπτωση \nεισπνοής  \nEN Toxic in contact with skin or if inhaled  \nFR Toxique par contact cutané ou par inhalation  \nGA Ábhar tocsaineach má theagmhaíonn leis an \ngcraiceann nó má ionanálaítear é  \nHR Otrovno u dodiru s kožom ili ako se udiše  \nIT Tossico a contatto con la pelle o se inalato  \nLV Toksisks saskarē ar ādu vai ja iekļūst elpceļos  \nLT Toksiška susilietus su oda arba įkvėpus  \nHU Bőrrel érintkezve vagy belélegezve mérgező  \nMT Tossika jekk tmiss mal-ġilda jew tittieħeb bin- \nnifs \nNL Giftig bij contact met de huid en bij inademing  \nPL Działa toksycznie w kontakcie ze skórą lub w \nnastępstwie wdychania  \nPT Tóxico em contacto com a pele ou por inalação  \nRO Toxic în contact cu pielea sau prin inhalare  \nSK Toxický pri styku s kožou alebo pri vdýchnutí  \nSL Strupeno v stiku s kožo ali pri vdihavanju  \nFI Myrkyllistä joutuessaan iholle tai hengitettynä  \nSV Giftigt vid hudkontakt eller förtäring  \n▼M2 \nH301 + \nH311 + \nH331  Language  3.1 — Acute toxicity (oral), acute toxicity (dermal) \nand acute toxicity (inhalation), hazard category 3  \nBG Токсичен при поглъщане, при контакт с \nкожата или при вдишване  \nES Tóxico en caso de ingestión, contacto con la \npiel o inhalación  \nCS Toxický při požití, při styku s kůží a při \nvdechování  \nDA Giftig ved indtagelse, hudkontakt eller \nindånding  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 283}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 285  \nH301 + \nH311 + \nH331  Language  3.1 — Acute toxicity (oral), acute toxicity (dermal) \nand acute toxicity (inhalation), hazard category 3  \nDE Giftig bei Verschlucken, Hautkontakt oder \nEinatmen  \nET Allaneelamisel, nahale sattumisel või sissehing\xad\namisel mürgine  \nEL Τοξικό σε περίπτωση κατάποσης, σε επαφή με \nτο δέρμα ή σε περίπτωση κατάποσης  \nEN Toxic if swallowed, in contact with skin or if \ninhaled  \nFR Toxique par ingestion, par contact cutané ou \npar inhalation  \nGA Ábhar tocsaineach má shlogtar, má \ntheagmhaíonn leis an gcraiceann nó má \nionanálaítear é  \n▼M5 \nHR Otrovno ako se proguta, u dodiru s kožom ili \nako se udiše  \n▼M2 \nIT Tossico se ingerito, a contatto con la pelle o se \ninalato  \nLV Toksisks, ja norīts, saskaras ar ādu vai iekļūst \nelpceļos  \nLT Toksiška prarijus, susilietus su oda arba įkvėpus  \nHU Lenyelve, bőrrel érintkezve vagy belélegezve \nmérgező  \nMT Tossika jekk tinbela', tmiss mal-ġilda jew \ntittieħed bin-nifs  \nNL Giftig bij inslikken, bij contact met de huid en \nbij inademing  \nPL Działa toksycznie po połknięciu, w kontakcie \nze skórą lub w następstwie wdychania  \nPT Tóxico por ingestão, contacto com a pele ou \ninalação  \nRO Toxic în caz de înghiţire, în contact cu pielea \nsau prin inhalare  \nSK Toxický pri požití, styku s kožou alebo pri \nvdýchnutí  \nSL Strupeno pri zaužitju, v stiku s kožo ali pri \nvdihavanju  \nFI Myrkyllistä nieltynä, joutuessaan iholle tai \nhengitettynä  \nSV Giftigt vid förtäring, hudkontakt eller inandning  \n▼M12  \nH302 \n+ \nH312  Language  3.1 — Acute toxicity (oral) and acute toxicity \n(dermal), hazard category 4  \nBG Вреден при поглъщане или при контакт с \nкожата  \nES Nocivo en caso de ingestión o en contacto con \nla piel  \nCS Zdraví škodlivý při požití a při styku s kůží  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 284}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 286  \nH302 \n+ \nH312  Language  3.1 — Acute toxicity (oral) and acute toxicity \n(dermal), hazard category 4  \nDA Farlig ved indtagelse eller hudkontakt  \nDE Gesundheitsschädlich bei Verschlucken oder \nHautkontakt  \nET Allaneelamisel või nahale sattumisel kahjulik  \nEL Επιβλαβές σε περίπτωση κατάποσης ή σε \nεπαφή με το δέρμα  \nEN Harmful if swallowed or in contact with skin  \nFR Nocif en cas d'ingestion ou de contact cutané  \nGA Ábhar dochrach má shlogtar é nó má \ntheagmhaíonn leis an gcraiceann  \nHR Štetno ako se proguta ili u dodiru s kožom  \nIT Nocivo se ingerito o a contatto con la pelle  \nLV Kaitīgs, ja norīts vai saskaras ar ādu  \nLT Kenksminga prarijus arba susilietus su oda  \nHU Lenyelve vagy bőrrel érintkezve ártalmas  \nMT Tagħmel ħsara jekk tinbela' jew jekk tmiss mal- \nġilda  \nNL Schadelijk bij inslikken en bij contact met de \nhuid \nPL Działa szkodliwie po połknięciu lub w \nkontakcie ze skórą  \nPT Nocivo por ingestão ou contacto com a pele  \nRO Nociv în caz de înghiţire sau în contact cu \npielea  \nSK Zdraviu škodlivý pri požití alebo pri styku s \nkožou  \nSL Zdravju škodljivo pri zaužitju ali v stiku s kožo  \nFI Haitallista nieltynä tai joutuessaan iholle  \nSV Skadligt vid förtäring eller hudkontakt  \n▼M2 \nH302 \n+ \nH332  Language  3.1 — Acute toxicity (oral) and acute toxicity (inha\xad\nlation), hazard category 4  \nBG Вреден при поглъщане или при вдишване  \nES Nocivo en caso de ingestión o inhalación  \nCS Zdraví škodlivý při požití a při vdechování  \nDA Farlig ved indtagelse eller indånding  \nDE Gesundheitsschädlich bei Verschlucken oder \nEinatmen  \nET Allaneelamisel või sissehingamisel kahjulik  \nEL Επιβλαβές σε περίπτωση κατάποσης ή σε \nπερίπτωση εισπνοής  \nEN Harmful if swallowed or if inhaled  \nFR Nocif en cas d'ingestion ou d'inhalation  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 285}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 287  \nH302 \n+ \nH332  Language  3.1 — Acute toxicity (oral) and acute toxicity (inha\xad\nlation), hazard category 4  \nGA Ábhar dochrach má shlogtar nó má \nionanálaítear é  \n▼M5 \nHR Štetno ako se proguta ili ako se udiše  \n▼M2 \nIT Nocivo se ingerito o inalato  \nLV Kaitīgs, ja norīts vai iekļūst elpceļos  \nLT Kenksminga prarijus arba įkvėpus  \nHU Lenyelve vagy belélegezve ártalmas  \nMT Tagħmel ħsara jekk tinbela' jew tittieħed bin- \nnifs \nNL Schadelijk bij inslikken en bij inademing  \nPL Działa szkodliwie po połknięciu lub w \nnastępstwie wdychania  \nPT Nocivo por ingestão ou inalação  \nRO Nociv în caz de înghiţire sau inhalare  \nSK Zdraviu škodlivý pri požití alebo vdýchnutí  \nSL Zdravju škodljivo pri zaužitju in vdihavanju  \nFI Haitallista nieltynä tai hengitettynä  \nSV Skadligt vid förtäring eller inandning  \nH312 \n+ \nH332  Language  3.1 — Acute toxicity (dermal) and acute toxicity \n(inhalation), hazard category 4  \nBG Вреден при контакт с кожата или при \nвдишване  \nES Nocivo en contacto con la piel o si se inhala  \nCS Zdraví škodlivý při styku s kůží a při \nvdechování  \nDA Farlig ved hudkontakt eller indånding  \nDE Gesundheitsschädlich bei Hautkontakt oder \nEinatmen  \nET Nahale sattumisel või sissehingamisel kahjulik  \nEL Επιβλαβές σε επαφή με το δέρμα ή σε \nπερίπτωση εισπνοής  \nEN Harmful in contact with skin or if inhaled  \nFR Nocif en cas de contact cutané ou d'inhalation  \nGA Ábhar dochrach má theagmhaíonn leis an \ngcraiceann nó má ionanálaítear é  \n▼M5 \nHR Štetno u dodiru s kožom ili ako se udiše  \n▼M2 \nIT Nocivo a contatto con la pelle o se inalato  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 286}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 288  \nH312 \n+ \nH332  Language  3.1 — Acute toxicity (dermal) and acute toxicity \n(inhalation), hazard category 4  \nLV Kaitīgs saskarē ar ādu vai ja iekļūst elpceļos  \nLT Kenksminga susilietus su oda arba įkvėpus  \nHU Bőrrel érintkezve vagy belélegezve ártalmas  \nMT Tagħmel ħsara jekk tmiss mal-ġilda jew jekk \ntittieħed bin-nifs  \nNL Schadelijk bij contact met de huid en bij \ninademing  \nPL Działa szkodliwie w kontakcie ze skórą lub w \nnastępstwie wdychania  \nPT Nocivo em contacto com a pele ou por inalação  \nRO Nociv în contact cu pielea sau prin inhalare  \nSK Zdraviu škodlivý pri styku s kožou alebo pri \nvdýchnutí  \nSL Zdravju škodljivo v stiku s kožo in pri \nvdihavanju  \nFI Haitallista joutuessaan iholle tai hengitettynä  \nSV Skadligt vid hudkontakt eller inandning  \nH302 + \nH312 + \nH332  Language  3.1 — Acute toxicity (oral), acute toxicity (dermal) \nand acute toxicity (inhalation), hazard category 4  \nBG Вреден при поглъщане, при контакт с \nкожата или при вдишване  \nES Nocivo en caso de ingestión, contacto con la \npiel o inhalación  \nCS Zdraví škodlivý při požití, při styku s kůží a při \nvdechování  \nDA Farlig ved indånding, hudkontakt eller \nindånding  \nDE Gesundheitsschädlich bei Verschlucken, Haut\xad\nkontakt oder Einatmen  \nET Allaneelamisel, nahale sattumisel või sissehing\xad\namisel kahjulik  \nEL Επιβλαβές σε περίπτωση κατάποσης, σε επαφή \nμε το δέρμα ή σε περίπτωση εισπνοής  \nEN Harmful if swallowed, in contact with skin or if \ninhaled  \nFR Nocif en cas d'ingestion, de contact cutané ou \nd'inhalation  \nGA Ábhar dochrach má shlogtar, má theagmhaíonn \nleis an gcraiceann nó má ionanálaítear é  \n▼M5 \nHR Štetno ako se proguta, u dodiru s kožom ili ako \nse udiše  \n▼M2 \nIT Nocivo se ingerito, a contatto con la pelle o se \ninalato  \nLV Kaitīgs, ja norīts, saskaras ar ādu vai nonāk \nelpceļos  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 287}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 289  \nH302 + \nH312 + \nH332  Language  3.1 — Acute toxicity (oral), acute toxicity (dermal) \nand acute toxicity (inhalation), hazard category 4  \nLT Kenksminga prarijus, susilietus su oda arba \nįkvėpus  \nHU Lenyelve, bőrrel érintkezve vagy belélegezve \nártalmas  \nMT Tagħmel il-ħsara jekk tinbela', tmiss mal-ġilda \njew tittiħed bin-nifs  \nNL Schadelijk bij inslikken, bij contact met de huid \nen bij inademing  \nPL Działa szkodliwie po połknięciu, w kontakcie \nze skórą lub w następstwie wdychania  \nPT Nocivo por ingestão, contacto com a pele ou \ninalação  \nRO Nociv în caz de înghiţire, în contact cu pielea \nsau prin inhalare  \nSK Zdraviu škodlivý pri požití, styku s kožou alebo \npri vdýchnutí  \nSL Zdravju škodljivo pri zaužitju, v stiku s kožo ali \npri vdihavanju  \nFI Haitallista nieltynä, joutuessaan iholle tai hengi\xad\ntettynä  \nSV Skadligt vid förtäring, hudkontakt eller \ninandning  \n▼B \nTable 1.3  \nHazard statements for environmental hazards  \nH400  Language  4.1 — Hazardous to the aquatic environment — \nAcuteHazard, Category 1  \nBG Силно токсичен за водните организми.  \nES Muy tóxico para los organismos acuáticos.  \nCS Vysoce toxický pro vodní organismy.  \nDA Meget giftig for vandlevende organismer.  \nDE Sehr giftig für Wasserorganismen.  \nET Väga mürgine veeorganismidele.  \nEL Πολύ τοξικό για τους υδρόβιους οργανισμούς.  \nEN Very toxic to aquatic life.  \nFR Très toxique pour les organismes aquatiques.  \nGA An-tocsaineach don saol uisceach.  \n▼M5 \nHR Vrlo otrovno za vodeni okoliš.  \n▼B \nIT Molto tossico per gli organismi acquatici.  \nLV Ļoti toksisks ūdens organismiem.  \nLT Labai toksiška vandens organizmams.  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 288}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 290  \nH400  Language  4.1 — Hazardous to the aquatic environment — \nAcuteHazard, Category 1  \nHU Nagyon mérgező a vízi élővilágra.  \nMT Tossiku ħafna għall-organiżmi akwatiċi.  \nNL Zeer giftig voor in het water levende organ\xad\nismen.  \nPL Działa bardzo toksycznie na organizmy wodne.  \nPT Muito tóxico para os organismos aquáticos.  \nRO Foarte toxic pentru mediul acvatic.  \nSK Veľmi toxický pre vodné organizmy.  \nSL Zelo strupeno za vodne organizme.  \nFI Erittäin myrkyllistä vesieliöille.  \nSV Mycket giftigt för vattenlevande organismer.  \nH410  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 1  \nBG Силно токсичен за водните организми, с \nдълготраен ефект.  \nES Muy tóxico para los organismos acuáticos, con \nefectos nocivos duraderos.  \nCS Vysoce toxický pro vodní organismy, s dlouho\xad\ndobými účinky.  \nDA Meget giftig med langvarige virkninger for \nvandlevende organismer.  \nDE Sehr giftig für Wasserorganismen mit lang\xad\nfristiger Wirkung.  \nET Väga mürgine veeorganismidele, pikaajaline \ntoime.  \nEL Πολύ τοξικό για τους υδρόβιους οργανισμούς, \nμε μακροχρόνιες επιπτώσεις.  \nEN Very toxic to aquatic life with long lasting \neffects.  \nFR Très toxique pour les organismes aquatiques, \nentraîne des effets néfastes à long terme.  \nGA An-tocsaineach don saol uisceach, le héifeachtaí \nfadtréimhseacha.  \n▼M5 \nHR Vrlo otrovno za vodeni okoliš, s dugotrajnim \nučincima.  \n▼B \nIT Molto tossico per gli organismi acquatici con \neffetti di lunga durata.  \nLV Ļoti toksisks ūdens organismiem ar ilgstošām \nsekām.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 289}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 291  \nH410  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 1  \nLT Labai toksiška vandens organizmams, sukelia \nilgalaikius pakitimus.  \nHU Nagyon mérgező a vízi élővilágra, hosszan tartó \nkárosodást okoz.  \nMT Tossiku ħafna għall-organiżmi akwatiċi b'mod \nli jħalli effetti dejjiema.  \nNL Zeer giftig voor in het water levende organ\xad\nismen, met langdurige gevolgen.  \nPL Działa bardzo toksycznie na organizmy wodne, \npowodując długotrwałe skutki.  \nPT Muito tóxico para os organismos aquáticos com \nefeitos duradouros.  \nRO Foarte toxic pentru mediul acvatic cu efecte pe \ntermen lung.  \nSK Veľmi toxický pre vodné organizmy, s dlho\xad\ndobými účinkami.  \nSL Zelo strupeno za vodne organizme, z dolgot\xad\nrajnimi učinki.  \nFI Erittäin myrkyllistä vesieliöille, pitkäaikaisia \nhaittavaikutuksia.  \nSV Mycket giftigt för vattenlevande organismer \nmed långtidseffekter.  \nH411  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 2  \nBG Токсичен за водните организми, с \nдълготраен ефект.  \nES Tóxico para los organismos acuáticos, con \nefectos nocivos duraderos.  \nCS Toxický pro vodní organismy, s dlouhodobými \núčinky.  \nDA Giftig for vandlevende organismer, med lang\xad\nvarige virkninger.  \nDE Giftig für Wasserorganismen, mit langfristiger \nWirkung.  \nET Mürgine veeorganismidele, pikaajaline toime.  \nEL Τοξικό για τους υδρόβιους οργανισμούς, με \nμακροχρόνιες επιπτώσεις.  \nEN Toxic to aquatic life with long lasting effects.  \nFR Toxique pour les organismes aquatiques, \nentraîne des effets néfastes à long terme.  \nGA Tocsaineach don saol uisceach, le héifeachtaí \nfadtréimhseacha.  \n▼M5 \nHR Otrovno za vodeni okoliš s dugotrajnim \nučincima.  \n▼B \nIT Tossico per gli organismi acquatici con effetti \ndi lunga durata.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 290}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 292  \nH411  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 2  \nLV Toksisks ūdens organismiem ar ilgstošām \nsekām.  \nLT Toksiška vandens organizmams, sukelia \nilgalaikius pakitimus.  \nHU Mérgező a vízi élővilágra, hosszan tartó káro\xad\nsodást okoz.  \nMT Tossiku għall-organiżmi akwatiċi b'mod li jħalli \neffetti dejjiema.  \nNL Giftig voor in het water levende organismen, \nmet langdurige gevolgen.  \nPL Działa toksycznie na organizmy wodne, \npowodując długotrwałe skutki.  \nPT Tóxico para os organismos aquáticos com \nefeitos duradouros.  \nRO Toxic pentru mediul acvatic cu efecte pe termen \nlung.  \nSK Toxický pre vodné organizmy, s dlhodobými \núčinkami.  \nSL Strupeno za vodne organizme, z dolgotrajnimi \nučinki.  \nFI Myrkyllistä vesieliöille, pitkäaikaisia haittavai\xad\nkutuksia.  \nSV Giftigt för vattenlevande organismer med lång\xad\ntidseffekter.  \nH412  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 3  \nBG Вреден за водните организми, с дълготраен \nефект.  \nES Nocivo para los organismos acuáticos, con \nefectos nocivos duraderos.  \nCS Škodlivý pro vodní organismy, s dlouhodobými \núčinky.  \nDA Skadelig for vandlevende organismer, med \nlangvarige virkninger.  \nDE Schädlich für Wasserorganismen, mit lang\xad\nfristiger Wirkung.  \nET ►C3 Kahjulik veeorganismidele, pikaajaline \ntoime. ◄  \nEL Επιβλαβές για τους υδρόβιους οργανισμούς, με \nμακροχρόνιες επιπτώσεις.  \nEN Harmful to aquatic life with long lasting effects.  \nFR Nocif pour les organismes aquatiques, entraîne \ndes effets néfastes à long terme.  \nGA Díobhálach don saol uisceach, le héifeachtaí \nfadtréimhseacha.  \n▼M5 \nHR Štetno za vodeni okoliš s dugotrajnim učincima.  \n▼B \nIT Nocivo per gli organismi acquatici con effetti di \nlunga durata.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 291}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 293  \nH412  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 3  \nLV Kaitīgs ūdens organismiem ar ilgstošām sekām.  \nLT Kenksminga vandens organizmams, sukelia \nilgalaikius pakitimus.  \nHU Ártalmas a vízi élővilágra, hosszan tartó káro\xad\nsodást okoz.  \nMT Jagħmel ħsara lill-organiżmi akwatiċi b'mod li \njħalli effetti dejjiema.  \nNL Schadelijk voor in het water levende organ\xad\nismen, met langdurige gevolgen.  \nPL Działa szkodliwie na organizmy wodne, \npowodując długotrwałe skutki.  \nPT Nocivo para os organismos aquáticos com \nefeitos duradouros.  \nRO Nociv pentru mediul acvatic cu efecte pe \ntermen lung.  \nSK Škodlivý pre vodné organizmy, s dlhodobými \núčinkami.  \nSL Škodljivo za vodne organizme, z dolgotrajnimi \nučinki.  \nFI Haitallista vesieliöille, pitkäaikaisia haittavaiku\xad\ntuksia.  \nSV Skadliga långtidseffekter för vattenlevande \norganismer.  \nH413  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 4  \nBG Може да причини дълготраен вреден ефект \nза водните организми.  \nES Puede ser nocivo para los organismos acuáticos, \ncon efectos nocivos duraderos.  \nCS Může vyvolat dlouhodobé škodlivé účinky pro \nvodní organismy.  \nDA Kan forårsage langvarige skadelige virkninger \nfor vandlevende organismer.  \nDE Kann für Wasserorganismen schädlich sein, mit \nlangfristiger Wirkung.  \nET Võib avaldada veeorganismidele pikaajalist \nkahjulikku toimet.  \nEL Μπορεί να προκαλέσει μακροχρόνιες \nεπιπτώσεις στους υδρόβιους οργανισμούς.  \nEN May cause long lasting harmful effects to \naquatic life.  \nFR Peut être nocif à long terme pour les \norganismes aquatiques.  \nGA D'fhéadfadh sé a bheith ina chúis le héifeachtaí \nfadtréimhseacha díobhálacha ar an saol \nuisceach.  \n▼M5 \nHR Može uzrokovati dugotrajne štetne učinke na \nvodeni okoliš.  \n▼B \nIT Può essere nocivo per gli organismi acquatici \ncon effetti di lunga durata.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 292}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 294  \nH413  Language  4.1 — Hazardous to the aquatic environment — \nChronic Hazard, Category 4  \nLV Var radīt ilgstošas kaitīgas sekas ūdens organ\xad\nismiem.  \nLT Gali sukelti ilgalaikį kenksmingą poveikį \nvandens organizmams.  \nHU Hosszan tartó ártalmas hatást gyakorolhat a vízi \nélővilágra.  \nMT Jista’ jikkawża effetti ta' ħsara dejjiema lill- \norganiżmi akwatiċi.  \nNL Kan langdurige schadelijke gevolgen voor in \nhet water levende organismen hebben.  \nPL Może powodować długotrwałe szkodliwe skutki \ndla organizmów wodnych.  \nPT Pode provocar efeitos nocivos duradouros nos \norganismos aquáticos.  \nRO Poate provoca efecte nocive pe termen lung \nasupra mediului acvatic.  \nSK Môže mať dlhodobé škodlivé účinky na vodné \norganizmy.  \nSL Lahko ima dolgotrajne škodljive učinke na \nvodne organizme.  \nFI Voi aiheuttaa pitkäaikaisia haittavaikutuksia \nvesieliöille.  \nSV Kan ge skadliga långtidseffekter på vatten\xad\nlevande organismer.  \n▼M2 \nH420  Language  5.1 – Hazardous to the ozone layer — hazard \ncategory 1  \nBG Вреди на общественото здраве и на околната \nсреда, като разрушава озона във високите \nслоеве на атмосферата  \nES Causa daños a la salud pública y el medio \nambiente al destruir el ozono en la atmósfera \nsuperior  \nCS Poškozuje veřejné zdraví a životní prostředí \ntím, že ničí ozon ve svrchních vrstvách \natmosféry  \nDA Skader folkesundheden og miljøet ved at \nødelægge ozon i den øvre atmosfære  \nDE Schädigt die öffentliche Gesundheit und die \nUmwelt durch Ozonabbau in der äußeren \nAtmosphäre  \nET Kahjustab rahvatervist ja keskkonda, hävitades \nkõrgatmosfääris asuvat osoonikihti  \nEL Βλάπτει τη δημόσια υγεία και το περιβάλλον \nκαταστρέφοντας το όζον στην ανώτερη \nατμόσφαιρα  \nEN Harms public health and the environment by \ndestroying ozone in the upper atmosphere  \nFR Nuit à la santé publique et à l'environnement en \ndétruisant l'ozone dans la haute atmosphère  \nGA Déanann an t-ábhar seo díobháil don tsláinte \nphoiblí agus don chomhshaol trí ózón san \natmaisféar uachtarach a scriosadh  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 293}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 295  \nH420  Language  5.1 – Hazardous to the ozone layer — hazard \ncategory 1  \n▼M5 \nHR Štetno za zdravlje ljudi i okoliš zbog \nuništavanja ozona u višoj atmosferi  \n▼M2 \nIT Nuoce alla salute pubblica e all'ambiente \ndistruggendo l'ozono dello strato superiore \ndell'atmosfera  \nLV Bīstams sabiedrības veselībai un videi, jo \niznīcina ozonu atmosfēras augšējā slānī  \nLT Kenkia visuomenės sveikatai ir aplinkai, nes \nnaikina ozono sluoksnį viršutinėje atmosferoje  \nHU Károsítja a közegészséget és a környezetet, mert \na légkör felső rétegeiben lebontja az ózont  \nMT Tagħmel ħsara lis-saħħa tal-pubbliku u lill- \nambjent billi teqred l-ożonu fl-atmosfera ta' fuq  \nNL Schadelijk voor de volksgezondheid en het \nmilieu door afbraak van ozon in de bovenste \nlagen van de atmosfeer  \nPL Szkodliwe dla zdrowia publicznego i \nśrodowiska w związku z niszczącym \noddziaływaniem na ozon w górnej warstwie \natmosfery  \nPT Prejudica a saúde pública e o ambiente ao \ndestruir o ozono na alta atmosfera  \nRO Dăunează sănătăţii publice și mediului încon\xad\njurător prin distrugerea ozonului în atmosfera \nsuperioară  \nSK Poškodzuje verejné zdravie a životné prostredie \ntým, že ničí ozón vo vrchných vrstvách \natmosféry  \nSL Škodljivo za javno zdravje in okolje zaradi \nuničevanja ozona v zgornji atmosferi  \nFI Vahingoittaa kansanterveyttä ja ympäristöä \ntuhoamalla otsonia ylemmässä ilmakehässä  \nSV Skadar folkhälsan och miljön genom förstöring \nav ozonet i övre delen av atmosfären  \n▼B \n2. Part 2: supplemental hazard information  \n▼M19  __________  \n▼M4 __________  \n▼B \nEUH 014  Language  \nBG Реагира бурно с вода.  \nES Reacciona violentamente con el agua.  \nCS Prudce reaguje s vodou.  \nDA Reagerer voldsomt med vand.  \nDE Reagiert heftig mit Wasser.  ▼M2", metadata={'source': 'data/ycla_en.pdf', 'page': 294}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 296  \nEUH 014  Language  \nET Reageerib ägedalt veega.  \nEL Αντιδρά βίαια με νερό.  \nEN Reacts violently with water.  \nFR Réagit violemment au contact de l'eau.  \nGA Imoibríonn go foirtil le huisce.  \n▼M5 \nHR Burno reagira s vodom.  \n▼B \nIT Reagisce violentemente con l'acqua.  \nLV Aktīvi reaģē ar ūdeni.  \nLT Smarkiai reaguoja su vandeniu.  \nHU Vízzel hevesen reagál.  \nMT Jirreaġixxi bil-qawwa meta jmiss l-ilma.  \nNL Reageert heftig met water.  \nPL Reaguje gwałtownie z wodą.  \nPT Reage violentamente em contacto com a água.  \nRO Reacţionează violent în contact cu apa.  \nSK Prudko reaguje s vodou.  \nSL Burno reagira z vodo.  \nFI Reagoi voimakkaasti veden kanssa.  \nSV Reagerar häftigt med vatten.  \nEUH 018  Language  \nBG При употреба може да се образува запалима/ \nексплозивна паровъздушнa смес.  \nES ►C3 Al usarlo, pueden formarse mezclas aire- \nvapor explosivas o inflamables. ◄  \nCS Při používání může vytvářet hořlavé nebo \nvýbušné směsi par se vzduchem.  \nDA Ved brug kan brandbarlige dampe/eksplosive \ndamp-luftblandinger dannes.  \nDE Kann bei Verwendung explosionsfähige/ \nentzündbare Dampf/Luft-Gemische bilden.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 295}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 297  \nEUH 018  Language  \nET Kasutamisel võib moodustuda tule-/plahvatu\xad\nsohtlik auru-õhu segu.  \nEL Κατά τη χρήση μπορεί να σχηματίσει \nεύφλεκτα/εκρηκτικά μείγματα ατμού-αέρος.  \nEN In use may form flammable/explosive vapour- \nair mixture.  \nFR Lors de l'utilisation, formation possible de \nmélange vapeur-air inflammable/explosif.  \nGA Agus é á úsáid d'fhéadfaí meascán inadhainte/ \npléascach gaile-aeir a chruthú.  \n▼M5 \nHR Pri uporabi može nastati zapaljiva/eksplozivna \nsmjesa para-zrak.  \n▼B \nIT Durante l'uso può formarsi una miscela vapore- \naria esplosiva/infiammabile.  \nLV Izmantojot var veidot uzliesmojošu vai \nsprādzienbīstamu tvaiku un gaisa maisījumu.  \nLT Naudojama gali sudaryti degius (sprogius) garų- \noro mišinius.  \nHU A használat során tűzveszélyes/robbanásves\xad\nzélyes gőz/levegő elegy keletkezhet.  \nMT Meta jintuża jista' jifforma taħlitiet esplussivi \njew li jaqbdu jekk jitħallat ma' l-arja.  \nNL Kan bij gebruik een ontvlambaar/ontplofbaar \ndamp-luchtmengsel vormen.  \nPL Podczas stosowania mogą powstawać \nłatwopalne lub wybuchowe mieszaniny par z \npowietrzem.  \nPT Pode formar mistura vapor-ar explosiva/ \ninflamável durante a utilização.  \nRO În timpul utilizării poate forma un amestec \nvapori-aer, inflamabil/exploziv.  \nSK Pri použití môže vytvárat’ horľavú/výbušnú \nzmes pár so vzduchom.  \nSL Pri uporabi lahko tvori vnetljivo/eksplozivno \nzmes hlapi-zrak.  \nFI Käytössä voi muodostua syttyvä/räjähtävä \nhöyry-ilmaseos.  \nSV Vid användning kan brännbara/explosiva ång- \nluftblandningar bildas.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 296}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 298  \nEUH 019  Language  \nBG Може да образува експлозивни пероксиди.  \nES Puede formar peróxidos explosivos.  \nCS Může vytvářet výbušné peroxidy.  \nDA Kan danne eksplosive peroxider.  \nDE Kann explosionsfähige Peroxide bilden.  \nET Võib moodustada plahvatusohtlikke peroksiide.  \nEL Μπορεί να σχηματίσει εκρηκτικά υπεροξείδια.  \nEN May form explosive peroxides.  \nFR Peut former des peroxydes explosifs.  \nGA D'fhéadfadh sé sárocsaídí pléascacha a chruthú.  \n▼M5 \nHR Može stvarati eksplozivne perokside.  \n▼B \nIT Può formare perossidi esplosivi.  \nLV Var veidot sprādzienbīstamus peroksīdus.  \nLT Gali sudaryti sprogius peroksidus.  \nHU Robbanásveszélyes peroxidokat képezhet.  \nMT Jista' jifforma perossidi esplussivi.  \nNL Kan ontplofbare peroxiden vormen.  \nPL Może tworzyć wybuchowe nadtlenki.  \nPT Pode formar peróxidos explosivos.  \nRO Poate forma peroxizi explozivi.  \nSK Môže vytvárat’ výbušné peroxidy.  \nSL Lahko tvori eksplozivne perokside.  \nFI Saattaa muodostaa räjähtäviä peroksideja.  \nSV Kan bilda explosiva peroxider.  \nEUH 044  Language  \nBG Риск от експлозия при нагряване в затворено \nпространство.  \nES Riesgo de explosión al calentarlo en ambiente \nconfinado.  \nCS Nebezpečí výbuchu při zahřátí v uzavřeném \nobalu.  \nDA Eksplosionsfarlig ved opvarmning under indes\xad\nlutning.  \nDE Explosionsgefahr bei Erhitzen unter Einschluss.  \nET Plahvatusohtlik kuumutamisel kinnises mahutis.  \nEL Κίνδυνος εκρήξεως εάν θερμανθεί υπό \nπεριορισμό.  \nEN Risk of explosion if heated under confinement.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 297}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 299  \nEUH 044  Language  \nFR Risque d'explosion si chauffé en ambiance \nconfinée.  \nGA Baol pléasctha arna théamh i limistéar iata.  \n▼M5 \nHR Opasnost od eksplozije ako se zagrijava u \nzatvorenom prostoru.  \n▼B \nIT Rischio di esplosione per riscaldamento in \nambiente confinato.  \nLV Sprādziena draudi, karsējot slēgtā vidē.  \nLT Gali sprogti, jei kaitinama sandariai uždaryta.  \nHU Zárt térben hő hatására robbanhat.  \nMT Riskju ta' splużjoni jekk jissaħħan fil-magħluq.  \nNL Ontploffingsgevaar bij verwarming in \nafgesloten toestand.  \nPL Zagrożenie wybuchem po ogrzaniu w \nzamkniętym pojemniku.  \nPT Risco de explosão se aquecido em ambiente \nfechado.  \nRO Risc de explozie, dacă este încălzit în spaţiu \nînchis.  \nSK Riziko výbuchu pri zahrievaní v uzavretom \npriestore.  \nSL Nevarnost eksplozije ob segrevanju v zaprtem \nprostoru.  \nFI Räjähdysvaara kuumennettaessa suljetussa \nastiassa.  \nSV Explosionsrisk vid uppvärmning i sluten behål\xad\nlare. \nTable 2.2  \nHealth properties  \nEUH 029  Language  \nBG При контакт с вода се отделя токсичен газ.  \nES En contacto con agua libera gases tóxicos.  \nCS Uvolňuje toxický plyn při styku s vodou.  \nDA Udvikler giftig gas ved kontakt med vand.  \nDE Entwickelt bei Berührung mit Wasser giftige \nGase.  \nET Kokkupuutel veega eraldub mürgine gaas.  \nEL Σε επαφή με το νερό ελευθερώνονται τοξικά \nαέρια.  \nEN Contact with water liberates toxic gas.  \nFR Au contact de l'eau, dégage des gaz toxiques.  \nGA I dteagmháil le huisce scaoiltear gás tocsai\xad\nneach.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 298}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 300  \nEUH 029  Language  \n▼M5 \nHR U dodiru s vodom oslobađa otrovni plin.  \n▼B \nIT A contatto con l'acqua libera un gas tossico.  \nLV Saskaroties ar ūdeni, izdala toksiskas gāzes.  \nLT Kontaktuodama su vandeniu išskiria toksiškas \ndujas.  \nHU Vízzel érintkezve mérgező gázok képződnek.  \nMT Jitfa' gass tossiku meta jmiss l-ilma.  \nNL Vormt giftig gas in contact met water.  \nPL W kontakcie z wodą uwalnia toksyczne gazy.  \nPT Em contacto com a água liberta gases tóxicos.  \nRO În contact cu apa, degajă un gaz toxic.  \nSK Pri kontakte s vodou uvoľňuje toxický plyn.  \nSL V stiku z vodo se sprošča strupen plin.  \nFI Kehittää myrkyllistä kaasua veden kanssa.  \nSV Utvecklar giftig gas vid kontakt med vatten.  \nEUH 031  Language  \nBG При контакт с киселини се отделя токсичен \nгаз. \nES En contacto con ácidos libera gases tóxicos.  \nCS Uvolňuje toxický plyn při styku s kyselinami.  \nDA Udvikler giftig gas ved kontakt med syre.  \nDE Entwickelt bei Berührung mit Säure giftige \nGase.  \nET Kokkupuutel hapetega eraldub mürgine gaas.  \nEL Σε επαφή με οξέα ελευθερώνονται τοξικά \nαέρια.  \nEN Contact with acids liberates toxic gas.  \nFR Au contact d'un acide, dégage un gaz toxique.  \nGA I dteagmháil le haigéid scaoiltear gás tocsai\xad\nneach.  \n▼M5 \nHR U dodiru s kiselinama oslobađa otrovni plin.  \n▼B \nIT A contatto con acidi libera gas tossici.  \nLV Saskaroties ar skābēm, izdala toksiskas gāzes.  \nLT Kontaktuodama su rūgštimis išskiria toksiškas \ndujas.  \nHU Savval érintkezve mérgező gázok képződnek.  \nMT Jitfa' gass tossiku meta jmiss l-aċidi.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 299}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 301  \nEUH 031  Language  \nNL Vormt giftig gas in contact met zuren.  \nPL W kontakcie z kwasami uwalnia toksyczne \ngazy.  \nPT Em contacto com ácidos liberta gases tóxicos.  \nRO În contact cu acizi, degajă un gaz toxic.  \nSK Pri kontakte s kyselinami uvoľňuje toxický \nplyn.  \nSL V stiku s kislinami se sprošča strupen plin.  \nFI Kehittää myrkyllistä kaasua hapon kanssa.  \nSV Utvecklar giftig gas vid kontakt med syra.  \nEUH 032  Language  \nBG При контакт с киселини се отделя силно \nтоксичен газ.  \nES En contacto con ácidos libera gases muy \ntóxicos.  \nCS Uvolňuje vysoce toxický plyn při styku s \nkyselinami.  \nDA Udvikler meget giftig gas ved kontakt med \nsyre.  \nDE Entwickelt bei Berührung mit Säure sehr giftige \nGase.  \nET Kokkupuutel hapetega eraldub väga mürgine \ngaas.  \nEL Σε επαφή με οξέα ελευθερώνονται πολύ τοξικά \nαέρια.  \nEN Contact with acids liberates very toxic gas.  \nFR Au contact d'un acide, dégage un gaz très \ntoxique.  \nGA I dteagmháil le haigéid scaoiltear gás an-tocsai\xad\nneach.  \n▼M5 \nHR U dodiru s kiselinama oslobađa vrlo otrovni \nplin. \n▼B \nIT A contatto con acidi libera gas molto tossici.  \nLV Saskaroties ar skābēm, izdala ļoti toksiskas \ngāzes.  \nLT Kontaktuodama su rūgštimis išskiria labai \ntoksiškas dujas.  \nHU Savval érintkezve nagyon mérgező gázok \nképződnek.  \nMT Jitfa' gass tossiku ħafna meta jmiss l-aċidi.  \nNL Vormt zeer giftig gas in contact met zuren.  \nPL W kontakcie z kwasami uwalnia bardzo \ntoksyczne gazy.  \nPT Em contacto com ácidos liberta gases muito \ntóxicos.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 300}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 302  \nEUH 032  Language  \nRO În contact cu acizi, degajă un gaz foarte toxic.  \nSK Pri kontakte s kyselinami uvoľňuje veľmi \ntoxický plyn.  \nSL V stiku s kislinami se sprošča zelo strupen plin.  \nFI Kehittää erittäin myrkyllistä kaasua hapon \nkanssa.  \nSV Utvecklar mycket giftig gas vid kontakt med \nsyra.  \nEUH 066  Language  \nBG Повтарящата се експозиция може да \nпредизвика изсушаване или напукване на \nкожата.  \nES La exposición repetida puede provocar \nsequedad o formación de grietas en la piel.  \nCS Opakovaná expozice může způsobit vysušení \nnebo popraskání kůže.  \nDA Gentagen kontakt kan give tør eller revnet hud.  \nDE Wiederholter Kontakt kann zu spröder oder \nrissiger Haut führen.  \nET Korduv kokkupuude võib põhjustada naha \nkuivust või lõhenemist.  \nEL Παρατεταμένη έκθεση μπορεί να προκαλέσει \nξηρότητα δέρματος ή σκάσιμο.  \nEN Repeated exposure may cause skin dryness or \ncracking.  \nFR L'exposition répétée peut provoquer \ndessèchement ou gerçures de la peau.  \nGA D'fhéadfadh tirimeacht chraicinn nó scoilteadh \ncraicinn a bheith mar thoradh ar ilnochtadh.  \n▼M5 \nHR Ponavljano izlaganje može prouzročiti sušenje \nili pucanje kože.  \n▼B \nIT L'esposizione ripetuta può provocare secchezza \no screpolature della pelle.  \nLV Atkārtota iedarbība var radīt sausu ādu vai \nizraisīt tās sprēgāšanu.  \nLT Pakartotinis poveikis gali sukelti odos džiūvimą \narba skilinėjimą.  \nHU Ismétlődő expozíció a bőr kiszáradását vagy \nmegrepedezését okozhatja.  \nMT Espożizzjoni ripetuta tista' tikkaġuna nxif jew \nqsim tal-ġilda.  \nNL Herhaalde blootstelling kan een droge of een \ngebarsten huid veroorzaken.  \nPL Powtarzające się narażenie może powodować \nwysuszanie lub pękanie skóry.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 301}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 303  \nEUH 066  Language  \nPT Pode provocar pele seca ou gretada, por \nexposição repetida.  \nRO Expunerea repetată poate provoca uscarea sau \ncrăparea pielii.  \nSK Opakovaná expozícia môže spôsobit’ vysušenie \nalebo popraskanie pokožky.  \nSL Ponavljajoča izpostavljenost lahko povzroči \nnastanek suhe ali razpokane kože.  \nFI Toistuva altistus voi aiheuttaa ihon kuivumista \ntai halkeilua.  \nSV Upprepad kontakt kan ge torr hud eller \nhudsprickor.  \nEUH 070  Language  \nBG Токсично при контакт с очите.  \nES Tóxico en contacto con los ojos.  \nCS Toxický při styku s očima.  \nDA Giftig ved kontakt med øjnene.  \nDE Giftig bei Berührung mit den Augen.  \nET Silma sattumisel mürgine.  \nEL Τοξικό σε επαφή με τα μάτια.  \nEN Toxic by eye contact.  \nFR Toxique par contact oculaire.  \nGA Tocsaineach trí theagmháil leis an tsúil.  \n▼M5 \nHR Otrovno u dodiru s očima.  \n▼B \nIT Tossico per contatto oculare.  \nLV Toksisks saskarē ar acīm.  \nLT Toksiška patekus į akis.  \nHU Szembe kerülve mérgező.  \nMT Tossiku meta jmiss ma’ l-għajnejn.  \nNL Giftig bij oogcontact.  \nPL Działa toksycznie w kontakcie z oczami.  \nPT Tóxico por contacto com os olhos.  \nRO Toxic în caz de contact cu ochii.  \nSK Toxické pri kontakte s očami.  \nSL Strupeno ob stiku z očmi.  \nFI Myrkyllistä joutuessaan silmään.  \nSV Giftigt vid kontakt med ögonen.  \nEUH 071  Language  \nBG Корозивен за дихателните пътища.  \nES Corrosivo para las vías respiratorias.  \nCS Způsobuje poleptání dýchacích cest.  \nDA Ætsende for luftvejene.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 302}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 304  \nEUH 071  Language  \nDE Wirkt ätzend auf die Atemwege.  \nET Söövitav hingamisteedele.  \nEL Διαβρωτικό της αναπνευστικής οδού.  \nEN Corrosive to the respiratory tract.  \nFR Corrosif pour les voies respiratoires.  \nGA Creimneach don chonair riospráide.  \n▼M5 \nHR Nagrizajuće za dišni sustav.  \n▼B \nIT Corrosivo per le vie respiratorie.  \nLV Kodīgs elpceļiem.  \nLT Ėsdina kvėpavimo takus.  \nHU Maró hatású a légutakra.  \nMT Korrużiv għas-sistema respiratorja.  \nNL Bijtend voor de luchtwegen.  \nPL Działa żrąco na drogi oddechowe.  \nPT Corrosivo para as vias respiratórias.  \nRO Corosiv pentru căile respiratorii.  \nSK Žieravé pre dýchacie cesty.  \nSL Jedko za dihalne poti.  \nFI Hengityselimiä syövyttävää.  \nSV Frätande på luftvägarna.  \n▼M2 __________  \n▼B \n3. Part 3: supplemental label elements/information on certain \n►M2 __________  ◄ mixtures  \nEUH 201/ \n201A  Language  \n►M2 ___ ◄ \n►M2 ___ ◄ BG Съдържа олово. Да не се използва върху \nповърхност, която евентуално може да се \nдъвче или смуче от деца. \nВнимание! Съдържа олово.  \n►M2 ___ ◄ \n►M2 ___ ◄ ES Contiene plomo. No utilizar en objetos que los \nniños puedan masticar o chupar. \n¡Atención! Contiene plomo.  \n►M2 ___ ◄ \n►M2 ___ ◄ CS Obsahuje olovo. Nemá se používat na povrchy, \nkteré mohou okusovat nebo olizovat děti. \nPozor! Obsahuje olovo.  \n►M2 ___ ◄ \n►M2 ___ ◄ DA Indeholder bly. Må ikke anvendes på \ngenstande, som børn vil kunne tygge eller \nsutte på. \nAdvarsel! Indeholder bly.  \n►M2 ___ ◄ \n►M2 ___ ◄ DE Enthält Blei. Nicht für den Anstrich von Gegen\xad\nständen verwenden, die von Kindern gekaut \noder gelutscht werden könnten. \nAchtung! Enthält Blei.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 303}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 305  \nEUH 201/ \n201A  Language  \n►M2 ___ ◄ \n►M2 ___ ◄ ET ►C3 Sisaldab pliid. Mitte kasutada pindadel, \nmida lapsed võivad närida või imeda. \nHoiatus! Sisaldab pliid. ◄  \n►M2 ___ ◄ \n►M2 ___ ◄ EL Περιέχει μόλυβδο. Να μη χρησιμοποιείται σε \nεπιφάνειες που είναι πιθανόν να μασήσουν ή \nνα πιπιλίσουν τα παιδιά. \nΠροσοχή! Περιέχει μόλυβδο.  \n►M2 ___ ◄ \n►M2 ___ ◄ EN Contains lead. Should not be used on surfaces \nliable to be chewed or sucked by children. \nWarning! Contains lead.  \n►M2 ___ ◄ \n►M2 ___ ◄ FR Contient du plomb. Ne pas utiliser sur les \nobjets susceptibles d'être mâchés ou sucés par \ndes enfants. \nAttention! Contient du plomb.  \n►M2 ___ ◄ \n►M2 ___ ◄ GA Luaidhe ann. Níor chóir a úsáid ar dhromchlaí a \nd'fhéadfadh a bheith á gcogaint nó á sú ag \nleanaí. \nRabhadh! Luaidhe ann.  \n▼M5 \nHR Sadrži olovo. Ne smije se koristiti na \npovršinama koje mogu žvakati ili sisati djeca. \nUpozorenje! Sadrži olovo.  \n▼B \n►M2 ___ ◄ \n►M2 ___ ◄ IT Contiene piombo. Non utilizzare su oggetti che \npossono essere masticati o succhiati dai \nbambini. \nAttenzione! Contiene piombo.  \n►M2 ___ ◄ \n►M2 ___ ◄ LV Satur svinu. Nedrīkst lietot uz virsmām, kuras \nvar nonākt bērnam mutē. \nBrīdinājums! Satur svinu.  \n►M2 ___ ◄ \n►M2 ___ ◄ LT Sudėtyje yra švino. Nenaudoti paviršiams, kurie \ngali būti vaikų kramtomi arba čiulpiami. \nAtsargiai! Sudėtyje yra švino.  \n►M2 ___ ◄ \n►M2 ___ ◄ HU Ólmot tartalmaz. Tilos olyan felületeken \nhasználni, amelyeket gyermekek szájukba \nvehetnek. \nFigyelem! Ólmot tartalmaz.  \n►M2 ___ ◄ \n►M2 ___ ◄ MT Fih iċ-ċomb. M'għandux jintuża' fuq uċuh li \nx'aktarx jomogħduhom jew jerdgħuhom it-tfal. \nTwissija! Fih iċ-ċomb.  \n►M2 ___ ◄ \n►M2 ___ ◄ NL Bevat lood. Mag niet worden gebruikt voor \nvoorwerpen waarin kinderen kunnen bijten of \nwaaraan kinderen kunnen zuigen. \nLet op! Bevat lood.  \n►M2 ___ ◄ \n►M2 ___ ◄ PL Zawiera ołów. Nie należy stosować na \npowierzchniach, które mogą być gryzione lub \nssane przez dzieci. \nUwaga! Zawiera ołów.  \n►M2 ___ ◄ \n►M2 ___ ◄ PT Contém chumbo. Não utilizar em superfícies \nque possam ser mordidas ou chupadas por \ncrianças. \nAtenção! Contém chumbo.  \n►M2 ___ ◄ \n►M2 ___ ◄ RO Conţine plumb. A nu se utiliza pe obiecte care \npot fi mestecate sau supte de copii. \nAtenţie! Conţine plumb.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 304}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 306  \nEUH 201/ \n201A  Language  \n►M2 ___ ◄ \n►M2 ___ ◄ SK Obsahuje olovo. Nepoužívajte na povrchy, \nktoré by mohli žuť alebo oblizovať deti. \nPozor! Obsahuje olovo.  \n►M2 ___ ◄ \n►M2 ___ ◄ SL Vsebuje svinec. Ne sme se nanašati na \npovršine, ki bi jih lahko žvečili ali sesali otroci. \nPozor! Vsebuje svinec.  \n►M2 ___ ◄ \n►M2 ___ ◄ FI Sisältää lyijyä. Ei saa käyttää pintoihin, joita \nlapset voivat pureskella tai imeä. \nVaroitus! Sisältää lyijyä.  \n►M2 ___ ◄ \n►M2 ___ ◄ SV Innehåller bly. Bör inte användas på ytor där \nbarn kan komma åt att tugga eller suga. \nVarning! Innehåller bly.  \nEUH 202  Language  \nBG Цианокрилат. Опасно. Залепва кожата и \nочите за секунди. Да се съхранява извън \nобсега на деца.  \nES Cianoacrilato. Peligro. Se adhiere a la piel y a \nlos ojos en pocos segundos. Mantener fuera del \nalcance de los niños.  \nCS Kyanoakrylát. Nebezpečí. Okamžitě slepuje \nkůži a oči. Uchovávejte mimo dosah dětí.  \nDA Cyanoacrylat. Farligt. Klæber til huden og \nøjnene på få sekunder. Opbevares utilgængeligt \nfor børn.  \nDE Cyanacrylat. Gefahr. Klebt innerhalb von \nSekunden Haut und Augenlider zusammen. \nDarf nicht in die Hände von Kindern gelangen.  \nET Tsüanoakrülaat. Ohtlik. Liimib naha ja silmad \nhetkega. Hoida lastele kättesaamatus kohas.  \nEL Κυανοακρυλική ένωση. Κίνδυνος. Κολλάει \nστην επιδερμίδα και στα μάτια μέσα σε λίγα \nδευτερόλεπτα. Να φυλάσσεται μακριά από \nπαιδιά.  \nEN Cyanoacrylate. Danger. Bonds skin and eyes in \nseconds. Keep out of the reach of children.  \nFR Cyanoacrylate. Danger. Colle à la peau et aux \nyeux en quelques secondes. À conserver hors \nde portée des enfants.  \nGA Cianaicrioláit. Contúirt. Nascann craiceann agus \nsúile laistigh de shoicindí. Coimeád as aimsiú \nleanaí.  \n▼M5 \nHR Cianoakrilat. Opasnost. Trenutno lijepi kožu i \noči. Čuvati izvan dohvata djece.  \n▼B \nIT Cianoacrilato. Pericolo. Incolla la pelle e gli \nocchi in pochi secondi. Tenere fuori dalla \nportata dei bambini.  \nLV Ciānakrilāts. Bīstami. Iedarbība uz acīm un ādu \ntūlītēja. Sargāt no bērniem.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 305}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 307  \nEUH 202  Language  \nLT Cianakrilatas. Pavojinga. Staigiai suklijuoja odą \nir akis. Laikyti vaikams neprieinamoje vietoje.  \nHU Cianoakrilát. Veszély! Néhány másodperc alatt \na bőrre és a szembe ragad. Gyermekektől \nelzárva tartandó.  \nMT Cyanoacrylate. Periklu. Iwaħħal il-ġilda u l- \ngħajnejn fi ftit sekondi. Żomm ‘il bogħod \nminn fejn jistgħu jilħquh it-tfal.  \nNL Cyanoacrylaat. Gevaarlijk. Kleeft binnen enkele \nseconden aan huid en oogleden. Buiten het \nbereik van kinderen houden.  \nPL Cyjanoakrylany. Niebezpieczeństwo. Skleja \nskórę i powieki w ciągu kilku sekund. \nChronić przed dziećmi.  \nPT Cianoacrilato. Perigo. Cola à pele e aos olhos \nem poucos segundos. Manter fora do alcance \ndas crianças.  \nRO Cianoacrilat. Pericol. Se lipește de piele și ochi \nîn câteva secunde. A nu se lăsa la îndemâna \ncopiilor.  \nSK Kyanoakrylát. Nebezpečenstvo. V priebehu \nniekoľkých sekúnd zlepí pokožku a oči. Ucho\xad\nvávajte mimo dosahu detí.  \nSL Cianoakrilat. Nevarno. Kožo in oči zlepi v \nnekaj sekundah. Hraniti zunaj dosega otrok.  \nFI Syanoakrylaattia. Vaara. Liimaa ihon ja silmät \nhetkessä. Säilytettävä lasten ulottumattomissa.  \nSV Cyanoakrylat. Fara. Fäster snabbt på hud och \nögon. Förvaras oåtkomligt för barn.  \nEUH 203  Language  \nBG Съдържа хром (VI). Може да причини \nалергична реакция.  \nES Contiene cromo (VI). Puede provocar una \nreacción alérgica.  \nCS Obsahuje chrom (VI). Může vyvolat alergickou \nreakci.  \nDA Indeholder krom (VI). Kan udløse allergisk \nreaktion.  \nDE Enthält Chrom (VI). Kann allergische Reak\xad\ntionen hervorrufen.  \nET Sisaldab kroomi (VI). Võib esile kutsuda aller\xad\ngilise reaktsiooni.  \nEL Περιέχει χρώμιο (VI). Μπορεί να προκαλέσει \nαλλεργική αντίδραση.  \nEN Contains chromium (VI). May produce an \nallergic reaction.  \nFR Contient du chrome (VI). Peut produire une \nréaction allergique.  \nGA Cróimiam (VI) ann. D'fhéadfadh sé a bheith ina \nchúis le frithghníomh ailléirgeach.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 306}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 308  \nEUH 203  Language  \n▼M5 \nHR Sadrži krom (VI). Može izazvati alergijsku \nreakciju.  \n▼B \nIT Contiene cromo (VI). Può provocare una \nreazione allergica.  \nLV Satur hromu (VI). Var izraisīt alerģisku reak\xad\nciju. \nLT Sudėtyje yra chromo (VI). Gali sukelti alerginę \nreakciją.  \nHU Krómot (VI) tartalmaz. Allergiás reakciót \nválthat ki.  \nMT Fih il-kromju (VI). Jista’ joħloq reazzjoni \nallerġika.  \nNL Bevat zeswaardig chroom. Kan een allergische \nreactie veroorzaken.  \nPL Zawiera chrom (VI). Może powodować \nwystąpienie reakcji alergicznej.  \nPT Contém crómio (VI). Pode provocar uma \nreacção alérgica.  \nRO Conţine crom (VI). Poate provoca o reacţie \nalergică.  \nSK Obsahuje chróm (VI). Môže vyvolať alergickú \nreakciu.  \nSL Vsebuje krom (VI). Lahko povzroči alergijski \nodziv.  \nFI Sisältää kromi(VI)-yhdisteitä. Voi aiheuttaa \nallergisen reaktion.  \nSV Innehåller krom (VI). Kan orsaka en allergisk \nreaktion.  \nEUH 204  Language  \nBG Съдържа изоцианати. Може да причини \nалергична реакция.  \nES Contiene isocianatos. Puede provocar una \nreacción alérgica.  \nCS Obsahuje isokyanáty. Může vyvolat alergickou \nreakci.  \nDA Indeholder isocyanater. Kan udløse allergisk \nreaktion.  \nDE Enthält Isocyanate. Kann allergische Reak\xad\ntionen hervorrufen.  \nET Sisaldab isotsüanaate. Võib esile kutsuda aller\xad\ngilise reaktsiooni.  \nEL Περιέχει ισοκυανικές ενώσεις. Μπορεί να \nπροκαλέσει αλλεργική αντίδραση.  \nEN Contains isocyanates. May produce an allergic \nreaction.  \nFR Contient des isocyanates. Peut produire une \nréaction allergique.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 307}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 309  \nEUH 204  Language  \nGA Isicianaítí ann. D'fhéadfadh sé a bheith ina \nchúis le frithghníomh ailléirgeach.  \n▼M5 \nHR Sadrži izocianate. Može izazvati alergijsku \nreakciju.  \n▼B \nIT Contiene isocianati. Può provocare una reazione \nallergica.  \nLV Satur izocianātus. Var izraisīt alerģisku reak\xad\nciju. \nLT Sudėtyje yra izocianatų. Gali sukelti alerginę \nreakciją.  \nHU Izocianátokat tartalmaz. Allergiás reakciót \nválthat ki.  \nMT Fih l-isocyanates. Jista’ jagħmel reazzjoni \nallerġika.  \nNL Bevat isocyanaten. Kan een allergische reactie \nveroorzaken.  \nPL Zawiera izocyjaniany. Może powodować \nwystąpienie reakcji alergicznej.  \nPT Contém isocianatos. Pode provocar uma \nreacção alérgica.  \nRO Conţine izocianaţi. Poate provoca o reacţie aler\xad\ngică.  \nSK Obsahuje izokyanáty. Môže vyvolať alergickú \nreakciu.  \nSL Vsebuje izocianate. Lahko povzroči alergijski \nodziv.  \nFI Sisältää isosyanaatteja. Voi aiheuttaa allergisen \nreaktion.  \nSV Innehåller isocyanater. Kan orsaka en allergisk \nreaktion.  \nEUH 205  Language  \nBG Съдържа епоксидни съставки. Може да \nпричини алергична реакция.  \nES Contiene componentes epoxídicos. Puede \nprovocar una reacción alérgica.  \nCS Obsahuje epoxidové složky. Může vyvolat aler\xad\ngickou reakci.  \nDA Indeholder epoxyforbindelser. Kan udløse \nallergisk reaktion.  \nDE Enthält epoxidhaltige Verbindungen. Kann \nallergische Reaktionen hervorrufen.  \nET Sisaldab epoksükomponente. Võib esile kutsuda \nallergilise reaktsiooni.  \nEL Περιέχει εποξειδικές ενώσεις. Μπορεί να \nπροκαλέσει αλλεργική αντίδραση.  \nEN Contains epoxy constituents. May produce an \nallergic reaction.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 308}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 310  \nEUH 205  Language  \nFR Contient des composés époxydiques. Peut \nproduire une réaction allergique.  \nGA Comhábhair eapocsacha ann. D'fhéadfadh sé a \nbheith ina chúis le frithghníomh ailléirgeach.  \n▼M5 \nHR Sadrži epoksidne sastojke. Može izazvati aler\xad\ngijsku reakciju.  \n▼B \nIT Contiene componenti epossidici. Può provocare \nuna reazione allergica.  \nLV Satur epoksīda sastāvdaļas. Var izraisīt \nalerģisku reakciju.  \nLT Sudėtyje yra epoksidinių komponentų. Gali \nsukelti alerginę reakciją.  \nHU Epoxid tartalmú vegyületeket tartalmaz. \nAllergiás reakciót válthat ki.  \nMT Fih kostitwenti ta’ l-eposside. Jista’ jagħmel \nreazzjoni allerġika.  \nNL Bevat epoxyverbindingen. Kan een allergische \nreactie veroorzaken.  \nPL Zawiera składniki epoksydowe. Może \npowodować wystąpienie reakcji alergicznej.  \nPT Contém componentes epoxídicos. Pode \nprovocar uma reacção alérgica.  \nRO Conţine componenţi epoxidici. Poate provoca o \nreacţie alergică.  \nSK Obsahuje epoxidové zložky. Môže vyvolať \nalergickú reakciu.  \nSL Vsebuje epoksidne sestavine. Lahko povzroči \nalergijski odziv.  \nFI Sisältää epoksihartseja. Voi aiheuttaa allergisen \nreaktion.  \nSV Innehåller epoxiförening. Kan orsaka en \nallergisk reaktion.  \nEUH 206  Language  \nBG Внимание! Да не се използва заедно с други \nпродукти. Може да отдели опасни газове \n(хлор).  \nES ¡Atención! No utilizar junto con otros prod\xad\nuctos. Puede desprender gases peligrosos \n(cloro).  \nCS Pozor! Nepoužívejte společně s jinými výrobky. \nMůže uvolňovat nebezpečné plyny (chlor).  \nDA Advarsel! Må ikke anvendes i forbindelse med \nandre produkter. Farlige luftarter (chlor) kan \nfrigøres.  \nDE Achtung! Nicht zusammen mit anderen \nProdukten verwenden, da gefährliche Gase \n(Chlor) freigesetzt werden können.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 309}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 311  \nEUH 206  Language  \nET ►C3 Hoiatus! Mitte kasutada koos teiste \ntoodetega. Segust võib eralduda ohtlikke gaase \n(kloori). ◄  \nEL Προσοχή! Να μην χρησιμοποιείται σε \nσυνδυασμό με άλλα προϊόντα. Μπορεί να \nελευθερωθούν επικίνδυνα αέρια (χλώριο).  \nEN Warning! Do not use together with other \nproducts. May release dangerous gases (chlor\xad\nine). \nFR Attention! Ne pas utiliser en combinaison avec \nd'autres produits. Peut libérer des gaz \ndangereux (chlore).  \nGA Rabhadh! Ná húsáid in éineacht le táirgí eile. \nD'fhéadfadh sé go scaoilfí gáis chontúirteacha \n(clóirín).  \n▼M5 \nHR Upozorenje! Ne koristiti s drugim proizvodima. \nMogu se osloboditi opasni plinovi (klor).  \n▼B \nIT Attenzione! Non utilizzare in combinazione con \naltri prodotti. Possono liberarsi gas pericolosi \n(cloro).  \nLV Brīdinājums! Nelietot kopā ar citiem \nproduktiem. Var izdalīt bīstamas gāzes (hloru).  \nLT Atsargiai! Nenaudoti kartu su kitais produktais. \nGali išskirti pavojingas dujas (chlorą).  \nHU Figyelem! Tilos más termékekkel együtt \nhasználni. Veszélyes gázok (klór) szabadul\xad\nhatnak fel.  \nMT Twissija! Tużahx flimkien ma’ prodotti oħra. \nJista’ jerħi gassijiet perikolużi (kloru).  \nNL Let op! Niet in combinatie met andere \nproducten gebruiken. Er kunnen gevaarlijke \ngassen (chloor) vrijkomen.  \nPL Uwaga! Nie stosować razem z innymi \nproduktami. Może wydzielać niebezpieczne \ngazy (chlor).  \nPT Atenção! Não utilizar juntamente com outros \nprodutos. Podem libertar-se gases perigosos \n(cloro).  \nRO Atenţie! A nu se folosi împreună cu alte \nproduse. Poate elibera gaze periculoase (clor).  \nSK Pozor! Nepoužívajte spolu s inými výrobkami. \nMôžu uvoľňovať nebezpečné plyny (chlór).  \nSL Pozor! Ne uporabljajte skupaj z drugimi izdelki. \nLahko se sproščajo nevarni plini (klor).  \nFI Varoitus! Älä käytä yhdessä muiden tuotteiden \nkanssa. Tuotteesta voi vapautua vaarallista \nkaasua (klooria).  \nSV Varning! Får ej användas tillsammans med \nandra produkter. Kan avge farliga gaser (klor).  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 310}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 312  \nEUH 207  Language  \nBG Внимание! Съдържа кадмий. При употреба \nсе образуват опасни пари. Вижте \nинформацията, предоставена от \nпроизводителя. Спазвайте инструкциите за \nбезопасност.  \nES ¡Atención! Contiene cadmio. Durante su util\xad\nización se desprenden vapores peligrosos. Ver \nla información facilitada por el fabricante. \nSeguir las instrucciones de seguridad.  \nCS Pozor! Obsahuje kadmium. Při používání \nvznikají nebezpečné výpary. Viz informace \ndodané výrobcem. Dodržujte bezpečnostní \npokyny.  \nDA Advarsel! Indeholder cadmium. Der udvikles \nfarlige dampe under anvendelsen. Se \nproducentens oplysninger. Overhold sikkerheds\xad\nforskrifterne.  \nDE Achtung! Enthält Cadmium. Bei der \nVerwendung entstehen gefährliche Dämpfe. \nHinweise des Herstellers beachten. Sicherheits\xad\nanweisungen einhalten.  \nET ►C3 Hoiatus! Sisaldab kaadmiumi. Kasu\xad\ntamisel moodustuvad ohtlikud aurud. Vt tootja \nesitatud teavet. Järgida ohutuseeskirju. ◄  \nEL Προσοχή! Περιέχει κάδμιο. Κατά τη χρήση \nαναπτύσσονται επικίνδυνες αναθυμιάσεις. \nΒλέπετε πληροφορίες του κατασκευαστή. \nΤηρείτε τις οδηγίες ασφαλείας.  \nEN Warning! Contains cadmium. Dangerous fumes \nare formed during use. See information \nsupplied by the manufacturer. Comply with \nthe safety instructions.  \nFR Attention! Contient du cadmium. Des fumées \ndangereuses se développent pendant l'utili\xad\nsation. Voir les informations fournies par le \nfabricant. Respectez les consignes de sécurité.  \nGA Rabhadh! Caidmiam ann. Cruthaítear múch \nchontúirteach le linn a úsáide. Féach an \nfhaisnéis atá curtha ar fáil ag an monaróir. \nCloígh leis na treoracha sábháilteachta.  \n▼M5 \nHR Upozorenje! Sadrži kadmij. Tijekom uporabe \nstvara se opasni dim. Vidi podatke dostavljene \nod proizvođača. Postupati prema uputama o \nmjerama sigurnosti.  \n▼B \nIT Attenzione! Contiene cadmio. Durante l'uso si \nsviluppano fumi pericolosi. Leggere le inform\xad\nazioni fornite dal fabbricante. Rispettare le \ndisposizioni di sicurezza.  \nLV Brīdinājums! Satur kadmiju. Lietojot veidojas \nbīstami izgarojumi. Sk. ražotāja sniegto \ninformāciju. Ievērot drošības instrukcijas.  \nLT Atsargiai! Sudėtyje yra kadmio. Naudojant \nsusidaro pavojingi garai. Žiūrėti gamintojo \npateiktą informaciją. Vykdyti saugos instruk\xad\ncijas.  \nHU Figyelem! Kadmiumot tartalmaz! A használat \nsorán veszélyes füstök képződnek. Lásd a \ngyártó által közölt információt. Be kell tartani \na biztonsági előírásokat.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 311}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 313  \nEUH 207  Language  \nMT Twissija! Fih il-kadmju. Waqt li jintuża \njiffurmaw dħaħen perikolużi. Ara l-inform\xad\nazzjoni mogħtija mill-fabbrikant. Ħares l- \nistruzzjonijiet dwar is-sigurtà.  \nNL Let op! Bevat cadmium. Bij het gebruik \nontwikkelen zich gevaarlijke dampen. Zie de \naanwijzingen van de fabrikant. Neem de veilig\xad\nheidsvoorschriften in acht.  \nPL Uwaga! Zawiera kadm. Podczas stosowania \nwydziela niebezpieczne pary. Zapoznaj się z \ninformacją dostarczoną przez producenta. Przes\xad\ntrzegaj instrukcji bezpiecznego stosowania.  \nPT Atenção! Contém cádmio. Libertam-se fumos \nperigosos durante a utilização. Ver as \ninformações fornecidas pelo fabricante. \nRespeitar as instruções de segurança.  \nRO Atenţie! Conţine cadmiu. În timpul utilizării se \ndegajă un fum periculos. A se vedea \ninformaţiile furnizate de producător. A se \nrespecta instrucţiunile privind siguranţa.  \nSK Pozor! Obsahuje kadmium. Pri používaní sa \ntvorí nebezpečný dym. Pozri informácie od \nvýrobcu. Dodržiavajte bezpečnostné pokyny.  \nSL Pozor! Vsebuje kadmij. Med uporabo nastajajo \nnevarni dimi. Preberite informacije proizvajalca. \nUpoštevajte navodila za varno uporabo.  \nFI Varoitus! Sisältää kadmiumia. Käytettäessä \nmuodostuu vaarallisia huuruja. Noudata \nvalmistajan antamia ohjeita. Noudata turvalli\xad\nsuusohjeita.  \nSV Varning! Innehåller kadmium. Farliga ångor \nbildas vid användning. Se information från till\xad\nverkaren. Följ skyddsanvisningarna.  \nEUH 208  Language  \nBG Съдържа < наименование на сенсибилизи- \nращото вещество>. Може да предизвика \nалергична реакция.  \nES Contiene <nombre de la sustancia sensibiliz\xad\nante>. Puede provocar una reacción alérgica.  \nCS Obsahuje <název senzibilizující látky>. Může \nvyvolat alergickou reakci.  \nDA Indeholder <navn på det sensibiliserende stof>. \nKan udløse allergisk reaktion.  \nDE Enthält <Name des sensibilisierenden Stoffes>. \nKann allergische Reaktionen hervorrufen.  \nET Sisaldab <sensibiliseeriva aine nimetus>. Võib \nesile kutsuda allergilise reaktsiooni.  \nEL Περιέχει <όνομα της ευαισθητοποιητικής \nουσίας>. Μπορεί να προκαλέσει αλλεργική \nαντίδραση.  \nEN Contains <name of sensitising substance>. May \nproduce an allergic reaction.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 312}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 314  \nEUH 208  Language  \nFR Contient <nom de la substance sensibilisante>. \nPeut produire une réaction allergique.  \nGA <Ainm na substainte íograithe> ann. \nD'fhéadfadh sé a bheith ina chúis le frith\xad\nghníomh ailléirgeach.  \n▼M5 \nHR Sadrži <naziv tvari koja dovodi do preosjetlji\xad\nvosti>. Može izazvati alergijsku reakciju.  \n▼B \nIT Contiene <denominazione della sostanza \nsensibilizzante>. Può provocare una reazione \nallergica.  \nLV Satur <sensibilizējošās vielas nosaukums>. Var \nizraisīt alerģisku reakciju.  \nLT Sudėtyje yra <jautrinančios medžiagos pava\xad\ndinimas>. Gali sukelti alerginę reakciją.  \nHU <Allergén anyag neve>-t tartalmaz. Allergiás \nreakciót válthat ki.  \nMT Fih <l-isem tas-sustanza sensibbli>. Jista’ \njagħmel reazzjoni allerġika.  \nNL Bevat <naam van de sensibiliserende stof>. Kan \neen allergische reactie veroorzaken.  \nPL Zawiera <nazwa substancji uczulającej>. Może \npowodować wystąpienie reakcji alergicznej.  \nPT Contém <nome da substância sensibilizante em \nquestão>. Pode provocar uma reacção alérgica.  \nRO Conţine <denumirea substanţei sensibilizante>. \nPoate provoca o reacţie alergică.  \nSK Obsahuje <názov senzibilizujúcej látky>. Môže \nvyvolať alergickú reakciu.  \nSL Vsebuje <ime snovi, ki povzroča preobč- \nutljivost>. Lahko povzroči alergijski odziv.  \nFI Sisältää <herkistävän aineen nimi>. Voi \naiheuttaa allergisen reaktion.  \nSV Innehåller <namnet på det sensibiliserande \nämnet>. Kan orsaka en allergisk reaktion.  \nEUH 209/ \n209A  Language  \n►M2 ___ ◄ \n►M2 ___ ◄ BG При употреба може да стане силно \nзапалимо. \nПри употреба може да стане запалимо.  \n►M2 ___ ◄ \n►M2 ___ ◄ ES Puede inflamarse fácilmente al usarlo \nPuede inflamarse al usarlo.  \n►M2 ___ ◄ \n►M2 ___ ◄ CS Při používání se může stát vysoce hořlavým. \nPři používání se může stát hořlavým.  \n►M2 ___ ◄ \n►M2 ___ ◄ DA Kan blive meget brandfarlig ved brug. \nKan blive brandfarlig ved brug.  \n►M2 ___ ◄ \n►M2 ___ ◄ DE Kann bei Verwendung leicht entzündbar \nwerden. \nKann bei Verwendung entzündbar werden.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 313}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 315  \nEUH 209/ \n209A  Language  \n►M2 ___ ◄ \n►M2 ___ ◄ ET Kasutamisel võib muutuda väga tuleohtlikuks. \nKasutamisel võib muutuda tuleohtlikuks.  \n►M2 ___ ◄ \n►M2 ___ ◄ EL Μπορεί να γίνει πολύ εύφλεκτο κατά τη χρήση. \nMπορεί να γίνει εύφλεκτο κατά τη χρήση.  \n►M2 ___ ◄ \n►M2 ___ ◄ EN Can become highly flammable in use. \nCan become flammable in use.  \n►M2 ___ ◄ \n►M2 ___ ◄ FR Peut devenir facilement inflammable en cours \nd'utilisation. \nPeut devenir inflammable en cours d'utilisation.  \n►M2 ___ ◄ \n►M2 ___ ◄ GA D'fhéadfadh sé éirí an-inadhainte agus é á \núsáid. \nD'fhéadfadh sé éirí inadhainte agus é á úsáid.  \n▼M5 \nHR Pri uporabi može postati lako zapaljivo. \nPri uporabi može postati zapaljivo.  \n▼B \n►M2 ___ ◄ \n►M2 ___ ◄ IT Può diventare facilmente infiammabile durante \nl'uso. \nPuò diventare infiammabile durante l'uso.  \n►M2 ___ ◄ \n►M2 ___ ◄ LV Lietojot var viegli uzliesmot. \nKļūt uzliesmojošs.  \n►M2 ___ ◄ \n►M2 ___ ◄ LT Naudojama gali tapti labai degi. \nNaudojama gali tapti degi.  \n►M2 ___ ◄ \n►M2 ___ ◄ HU A használat során fokozottan tűzveszélyessé \nválhat. \nA használat során tűzveszélyessé válhat.  \n►M2 ___ ◄ \n►M2 ___ ◄ MT Jista’ jieħu n-nar faċilment meta jintuża. \nJista’ jieħu n-nar meta jintuża.  \n►M2 ___ ◄ \n►M2 ___ ◄ NL Kan bij gebruik licht ontvlambaar worden. \nKan bij gebruik ontvlambaar worden.  \n►M2 ___ ◄ \n►M2 ___ ◄ PL Podczas stosowania może przekształcić się w \nsubstancję wysoce łatwopalną. \nPodczas stosowania może przekształcić się w \nsubstancję łatwopalną.  \n►M2 ___ ◄ \n►M2 ___ ◄ PT Pode tornar-se facilmente inflamável durante o \nuso. \nPode tornar-se inflamável durante o uso.  \n►M2 ___ ◄ \n►M2 ___ ◄ RO Poate deveni foarte inflamabil în timpul \nutilizării. \nPoate deveni inflamabil în timpul utilizării.  \n►M2 ___ ◄ \n►M2 ___ ◄ SK Pri používaní sa môže stať veľmi horľavou. \nPri používaní sa môže stať horľavou.  \n►M2 ___ ◄ \n►M2 ___ ◄ SL Med uporabo utegne postati lahko vnetljivo. \nMed uporabo utegne postati vnetljivo.  \n►M2 ___ ◄ \n►M2 ___ ◄ FI Voi muuttua helposti syttyväksi käytössä. \nVoi muuttua syttyväksi käytössä.  \n►M2 ___ ◄ \n►M2 ___ ◄ SV Kan bli mycket brandfarligt vid användning. \nKan bli brandfarligt vid användning.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 314}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 316  \nEUH 210  Language  \nBG Информационен лист за безопасност ще \nбъде представен при поискване.  \nES Puede solicitarse la ficha de datos de seguridad.  \nCS Na vyžádání je k  o dispozici bezpečnostní list.  \nDA Sikkerhedsdatablad kan på anmodning rekvi\xad\nreres.  \nDE Sicherheitsdatenblatt auf Anfrage erhältlich.  \nET Ohutuskaart nõudmisel kättesaadav.  \nEL Δελτίο δεδομένων ασφαλείας παρέχεται εφόσον \nζητηθεί.  \nEN Safety data sheet available on request.  \nFR Fiche de données de sécurité disponible sur \ndemande.  \nGA Bileog sonraí sábháilteachta ar fáil arna iarraidh \nsin. \n▼M5 \nHR Sigurnosno-tehnički list dostupan na zahtjev.  \n▼B \nIT Scheda dati di sicurezza disponibile su \nrichiesta.  \nLV Drošības datu lapa ir pieejama pēc \npieprasījuma.  \nLT Saugos duomenų lapą galima gauti paprašius.  \nHU Kérésre biztonsági adatlap kapható.  \nMT Il-karta tad-data dwar is-sikurezza hija \ndisponibbli meta tintalab.  \nNL Veiligheidsinformatieblad op verzoek verk\xad\nrijgbaar.  \nPL Karta charakterystyki dostępna na żądanie.  \nPT Ficha de segurança fornecida a pedido.  \nRO Fișa cu date de securitate disponibilă la cerere.  \nSK Na požiadanie možno poskytnúť kartu \nbezpečnostných údajov.  \nSL Varnosti list na voljo na zahtevo.  \nFI Käyttöturvallisuustiedote toimitetaan pyynnöstä.  \nSV Säkerhetsdatablad finns att rekvirera.  \n▼M22  \nEUH 211  Language  \nBG Внимание! При пулверизация могат да се \nобразуват опасни респирабилни капки. Не \nвдишвайте пулверизираната струя или \nмъгла.  \nES ¡Atención! Al rociar pueden formarse gotas \nrespirables peligrosas. No respirar el aerosol.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 315}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 317  \nEUH 211  Language  \nCS Pozor! Při postřiku se mohou vytvářet \nnebezpečné respirabilní kapičky. Nevdechujte \naerosoly nebo mlhu.  \nDA Advarsel! Der kan danne sig farlige respirable \ndråber, når der sprayes. Undgå indånding af \nspray eller tåge.  \nDE Achtung! Beim Sprühen können gefährliche \nlungengängige Tröpfchen entstehen. Aerosol \noder Nebel nicht einatmen.  \nET Hoiatus! Pihustamisel võivad tekkida ohtlikud \nsissehingatavad piisad. Pihustatud ainet või \nudu mitte sisse hingata.  \nEL Προσοχή! Κατά τον ψεκασμό μπορούν να \nσχηματιστούν επικίνδυνα εισπνεύσιμα \nσταγονίδια. Μην αναπνέετε το εκνέφωμα ή τα \nσταγονίδια.  \nEN Warning! Hazardous respirable droplets may be \nformed when sprayed. Do not breathe spray or \nmist.  \nFR Attention! Des gouttelettes respirables dange\xad\nreuses peuvent se former lors de la pulvéri\xad\nsation. Ne pas respirer les aérosols ni les brouil\xad\nlards.  \nGA Aire! D’fhéadfaí braoiníní guaiseacha \ninanálaithe a chruthú nuair a spraeáiltear an \ntáirge seo. Ná hanálaigh sprae ná ceo.  \nHR Upozorenje! Pri prskanju mogu nastati opasne \nrespirabilne kapljice. Ne udisati aerosol ni \nmaglicu.  \nIT Attenzione! In caso di vaporizzazione possono \nformarsi goccioline respirabili pericolose. Non \nrespirare i vapori o le nebbie.  \nLV Uzmanību! Izsmidzinot var veidoties bīstami \nieelpojami pilieni. Ne smidzinājumu, ne miglu \nneieelpot.  \nLT Atsargiai! Purškiant gali susidaryti pavojingų \nįkvepiamų lašelių. Neįkvėpti rūko ar aerozolio.  \nHU Figyelem! Permetezés közben veszélyes, beléle\xad\ngezhető cseppek képződhetnek. A permetet \nvagy a ködöt nem szabad belélegezni.  \nMT Twissija! Jista’ jifforma qtar perikoluż li \njinġibed man-nifs meta tisprejja minn dan. \nTiġbidx l-isprej jew l-irxiex man-nifs.  \nNL Let op! Bij verneveling kunnen gevaarlijke \ninhaleerbare druppels worden gevormd. \nSpuitnevel niet inademen.  \nPL Uwaga! W przypadku rozpylania mogą się \ntworzyć niebezpieczne respirabilne kropelki. \nNie wdychać rozpylonej cieczy lub mgły.  \nPT Atenção! Podem formar-se gotículas inaláveis \nperigosas ao pulverizar. Não respirar a pulver\xad\nização ou névoas.  ▼M22', metadata={'source': 'data/ycla_en.pdf', 'page': 316}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 318  \nEUH 211  Language  \nRO Avertizare! Se pot forma picături respirabile \npericuloase la pulverizare. Nu respiraţi prin \npulverizare sau ceaţă.  \nSK Pozor! Pri rozprašovaní sa môžu vytvárať \nnebezpečné respirabilné kvapôčky. Nevdychujte \naerosóly ani hmlu.  \nSL Pozor! Pri razprševanju lahko nastanejo nevarne \nvdihljive kapljice. Ne vdihavajte razpršila ali \nmeglic.  \nFI Varoitus! Vaarallisia keuhkorakkuloihin \nkulkeutuvia pisaroita saattaa muodostua suihku\xad\ntuksen yhteydessä. Älä hengitä suihketta tai \nsumua.  \nSV Varning! Farliga respirabla droppar kan bildas \nvid sprejning. Inandas inte sprej eller dimma.  \nEUH 212  Language  \nBG Внимание! При употреба може да се \nобразува опасен респирабилен прах. Не \nвдишвайте праха.  \nES ¡Atención! Al utilizarse, puede formarse polvo \nrespirable peligroso. No respirar el polvo.  \nCS Pozor! Při použití se může vytvářet nebezpečný \nrespirabilní prach. Nevdechujte prach.  \nDA Advarsel! Der kan danne sig farligt respirabelt \nstøv ved anvendelsen. Undgå indånding af støv.  \nDE Achtung! Bei der Verwendung kann gefähr\xad\nlicher lungengängiger Staub entstehen. Staub \nnicht einatmen.  \nET Hoiatus! Kasutamisel võib tekkida ohtlik \nsissehingatav tolm. Tolmu mitte sisse hingata.  \nEL Προσοχή! Κατά τη χρήση μπορεί να \nσχηματιστεί επικίνδυνη εισπνεύσιμη σκόνη. \nΜην αναπνέετε τη σκόνη.  \nEN Warning! Hazardous respirable dust may be \nformed when used. Do not breathe dust.  \nFR Attention! Une poussière respirable dangereuse \npeut se former lors de l’utilisation. Ne pas \nrespirer cette poussière.  \nGA Aire! D’fhéadfaí deannach guaiseach \ninanálaithe a chruthú nuair a úsáidtear an \ntáirge seo. Ná hanálaigh deannach.  \nHR Upozorenje! Pri prskanju može nastati opasna \nrespirabilna prašina. Ne udisati prašinu.  \nIT Attenzione! In caso di utilizzo possono formarsi \npolveri respirabili pericolose. Non respirare le \npolveri.  ▼M22', metadata={'source': 'data/ycla_en.pdf', 'page': 317}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 319  \nEUH 212  Language  \nLV Uzmanību! Izmantojot var veidoties bīstami \nieelpojami putekļi. Putekļus neieelpot.  \nLT Atsargiai! Naudojant gali susidaryti pavojingų \nįkvepiamų dulkių. Neįkvėpti dulkių.  \nHU Figyelem! Használatkor veszélyes, beléle\xad\ngezhető por képződhet. A port nem szabad \nbelélegezni.  \nMT Twissija! Meta jintuża dan, jista’ jifforma trab \nperikoluż li jinġibed man-nifs. Tiġbidx it-trab \nman-nifs.  \nNL Let op! Bij gebruik kunnen gevaarlijke inha\xad\nleerbare stofdeeltjes worden gevormd. Stof \nniet inademen.  \nPL Uwaga! W przypadku stosowania może się \ntworzyć niebezpieczny pył respirabilny. Nie \nwdychać pyłu.  \nPT Atenção! Podem formar-se poeiras inaláveis \nperigosas ao pulverizar. Não respirar as poeiras.  \nRO Avertizare! Se poate forma pulbere respirabilă \npericuloasă în timpul utilizării. Nu inspiraţi \npulberea.  \nSK Pozor! Pri použití sa môže vytvárať nebezpečný \nrespirabilný prach. Nevdychujte prach.  \nSL Pozor! Pri uporabi lahko nastane nevaren \nvdihljiv prah. Prahu ne vdihavajte.  \nFI Varoitus! Vaarallista keuhkorakkuloihin \nkulkeutuvaa pölyä saattaa muodostua käytön \nyhteydessä. Älä hengitä pölyä.  \nSV Varning! Farligt respirabelt damm kan bildas \nvid användning. Inandas inte damm.  \n▼B \nEUH 401  Language  \nBG За да се избегнат рискове за човешкото \nздраве и околната среда, спазвайте \nинструкциите за употреба.  \nES A fin de evitar riesgos para las personas y el \nmedio ambiente, siga las instrucciones de uso.  \nCS Dodržujte pokyny pro používání, abyste se \nvyvarovali rizik pro lidské zdraví a životní \nprostředí.  ▼M22', metadata={'source': 'data/ycla_en.pdf', 'page': 318}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 320  \nEUH 401  Language  \nDA Brugsanvisningen skal følges for ikke at bringe \nmenneskers sundhed og miljøet i fare.  \nDE Zur Vermeidung von Risiken für Mensch und \nUmwelt die Gebrauchsanleitung einhalten.  \nET Inimeste tervise ja keskkonna ohustamise välti\xad\nmiseks järgida kasutusjuhendit.  \nEL Για να αποφύγετε τους κινδύνους για την \nανθρώπινη υγεία και το περιβάλλον, \nακολουθήστε τις οδηγίες χρήσης.  \nEN To avoid risks to human health and the \nenvironment, comply with the instructions for \nuse. \nFR Respectez les instructions d'utilisation pour \néviter les risques pour la santé humaine et l'en\xad\nvironnement.  \nGA Chun priacail do shláinte an duine agus don \nchomhshaol a sheachaint, cloígh leis na \ntreoracha maidir le húsáid.  \n▼M5 \nHR Da bi se izbjegli rizici za zdravlje ljudi i okoliš, \ntreba se pridržavati uputa za uporabu.  \n▼B \nIT Per evitare rischi per la salute umana e per \nl'ambiente, seguire le istruzioni per l'uso.  \nLT Siekiant išvengti žmonių sveikatai ir aplinkai \nkeliamos rizikos, būtina vykdyti naudojimo \ninstrukcijos nurodymus.  \nLV Lai izvairītos no riska cilvēku veselībai un \nvidei, ievērojiet lietošanas pamācību.  \nHU Az emberi egészség és a környezet veszélyez\xad\ntetésének elkerülése érdekében be kell tartani a \nhasználati utasítás előírásait.  \nMT Biex jiġu evitati r-riskji għal saħħet il-bniedem \nu għall-ambjent, ħares l-istruzzjonijiet dwar l- \nużu. \nNL Volg de gebruiksaanwijzing om gevaar voor de \nmenselijke gezondheid en het milieu te voor\xad\nkomen.  \nPL W celu uniknięcia zagrożeń dla zdrowia ludzi i \nśrodowiska, należy postępować zgodnie z \ninstrukcją użycia.  \nPT Para evitar riscos para a saúde humana e para o \nambiente, respeitar as instruções de utilização.  \nRO Pentru a evita riscurile pentru sănătatea umană \nși mediu, a se respecta instrucţiunile de util\xad\nizare.  \nSK Dodržiavajte návod na používanie, aby ste \nzabránili vzniku rizík pre zdravie ľudí a \nživotné prostredie.  \nSL Da bi se izognili tveganjem za ljudi in okolje, \nravnajte v skladu z navodili za uporabo.  \nFI Noudata käyttöohjeita ihmisen terveydelle ja \nympäristölle aiheutuvien vaarojen välttämiseksi.  \nSV För att undvika risker för människors hälsa och \nför miljön, följ bruksanvisningen.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 319}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 321  \nANNEX IV  \nLIST OF PRECAUTIONARY STATEMENTS  \n▼M19  \nThis Annex sets out a matrix listing the recommended precaution ary statements \nfor each hazard class and hazard category by type of precaution ary statement. \nThe matrix guides the selection of appropriate precautionary st atements, and \nincludes elements for all categories of precautionary action. A ll specific \nelements relating to particular hazard classes shall be used. I n addition, general \nprecautionary statements not linked to a certain hazard class o r category shall \nalso be used where relevant.  \nTo provide flexibility in the application of precautionary phra ses, combinations \nor consolidations of precautionary statements are encouraged to  save label space \nand improve readability. The matrix and the Tables in Part 1 of  this Annex \ninclude a number of combined precautionary statements. However,  these are \nonly examples and suppliers may further combine and consolidate  phrases \nwhere this contributes to clarity and comprehensibility of labe l information in \naccordance with Articles 22 and 28(3).  \nNotwithstanding Article 22 the precautionary statements that ap pear on labels or \nin safety data sheets may incorporate minor textual variations from those set out \nin this Annex where these variations assist in communicating sa fety information \nand the safety advice is not diluted or compromised. These may include spelling \nvariations, synonyms or other equivalent terms appropriate to t he region where \nthe product is supplied and used.  \n▼M4 \nWhere square brackets […] appear around some text in a precauti onary statement \nin column (2), this indicates that the text in square brackets is not appropriate in \nevery case and should be used only in certain circumstances. In  these cases, \nconditions for use explaining when the text should be used are given in \ncolumn (5).  \n▼M12  \nWhen a forward slash or diagonal mark [/] appears in a precauti onary statement \ntext in column (2), this indicates that a choice has to be made  between the \nphrases they separate in accordance with the indications provid ed in column (5).  \n▼M4 \nWhen three full stops […] appear in a precautionary statement t ext in column (2), \ndetails on the information to be provided are indicated in colu mn (5).  \n▼M12  \nWhere the text in column 5 indicates that a precautionary state ment may be \nomitted if another precautionary statement is given on the labe l, this information \nmay be used in selecting precautionary statements in accordance  with Articles 22 \nand 28.  \n▼B \n1. Part 1: Criteria for the selection of precautionary statements  \nTable 6.1  \nPrecautionary statements — General  \nCode \n(1) General precautionary statements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP101  If medical advice is needed, \nhave product container or \nlabel at hand.  as appropriate  Consumer products  \nP102  Keep out of reach of \nchildren.  as appropriate  Consumer products  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 320}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 322  \nCode \n(1) General precautionary statements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M19  \nP103  Read carefully and follow \nall instructions.  as appropriate  Consumer products –  omit \nwhere P202 is used  \n▼B \nTable 6.2  \nPrecautionary statements — Prevention  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M19  \nP201  Obtain special instructions \nbefore use.  Explosives (section 2.1)  Unstable \nexplosive  \nGerm cell mutagenicity \n(section 3.5)  1A,1B, 2  Consumer products –  omit \nwhere P202 is used  \nCarcinogenicity (section \n3.6) 1A,1B, 2  \nReproductive toxicity \n(section 3.7)  1A,1B, 2  \nReproductive toxicity — \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \nP202  Do not handle until all \nsafety precautions have \nbeen read and understood.  Flammable gases (section \n2.2) A, B (chemically \nunstable gases)  \nGerm cell mutagenicity \n(section 3.5)  1A,1B, 2  \nCarcinogenicity (section \n3.6) 1A,1B, 2  \nReproductive toxicity \n(section 3.7)  1A,1B, 2  \nReproductive toxicity, \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \nP210  Keep away from heat, hot \nsurfaces, sparks, open \nflames and other ignition \nsources. No smoking.  Explosives (section 2.1)  Divisions 1.1, \n1.2, 1.3, 1.4, 1.5  \nFlammable gases (section \n2.2) 1A, 1B, 2  \nAerosols (section 2.3)  1, 2, 3  \nFlammable liquids (section \n2.6) 1, 2, 3  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 321}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 323  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nFlammable solids (section \n2.7) 1, 2 \nSelf-reactive substances and \nmixtures (section 2.8)  Types A, B, C, \nD, E, F  \nPyrophoric liquids \n(section 2.9)  1 \nPyrophoric solids \n(section 2.10)  1 \nOxidising liquids (section \n2.13)  1, 2, 3  \nOxidising solids (section \n2.14)  1, 2, 3  \nOrganic peroxides \n(section 2.15)  Types A, B, C, \nD, E, F  \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  \n▼M4 \nP211  Do not spray on an open \nflame or other ignition \nsource.  Aerosols (section 2.3)  1, 2  \n▼M19  \nP212  Avoid heating under \nconfinement or reduction \nof the desensitising agent.  Desensitised explosives \n(section 2.17)  1, 2, 3, 4  \n▼M12  \nP220  Keep away from clothing \nand other combustible \nmaterials.  Oxidising gases (Section \n2.4) 1 \nOxidising liquids (Section \n2.13)  1, 2, 3  \nOxidising solids (Section \n2.14)  1, 2, 3  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 322}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 324  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n_____  \n▼M19  \nP222  Do not allow contact with \nair. Flammable gases (section \n2.2) Pyrophoric gas  —  if emphasis of the hazard \nstatement is deemed \nnecessary . \nPyrophoric liquids \n(section 2.9)  1 \nPyrophoric solids \n(section 2.10)  1 \n▼M12  \nP223  Do not allow contact with \nwater.  Substances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (Section 2.12)  1, 2 — if emphasis of the hazard \nstatement is deemed \nnecessary  \n▼M19  \nP230  Keep wetted with …  Explosives (section 2.1)  Divisions 1.1, \n1.2, 1.3, 1.5  Manufacturer/supplier to \nspecify appropriate material \n— for substances and \nmixtures which are \nwetted, diluted, \ndissolved or suspended \nwith a phlegmatiser in \norder to suppress their \nexplosive properties  \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  Manufacturer/supplier to \nspecify appropriate material  \n▼M12  \nP231  Handle and store contents \nunder inert gas/…  Pyrophoric liquids (Section \n2.9) 1 … Manufacturer/supplier to \nspecify appropriate liquid or \ngas if ‘inert gas’ is not \nappropriate.  \nPyrophoric solids (Section \n2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (Section 2.12)  1, 2, 3  — if the substance or \nmixture reacts readily \nwith moisture in air. \n… Manufacturer/supplier to \nspecify appropriate liquid or \ngas if ‘inert gas’ is not \nappropriate.  \n▼B \nP232  Protect from moisture.  Substances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2, 3  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 323}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 325  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M19  \nP233  Keep container tightly \nclosed.  Flammable liquids (section \n2.6) 1, 2, 3  — if the liquid is volatile \nand may generate an \nexplosive atmosphere  \nPyrophoric liquids \n(section 2.9)  1 \nPyrophoric solids \n(section 2.10)  1 \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  \nAcute toxicity – inhalation \n(section 3.1)  1, 2, 3  — if the chemical is volatile \nand may generate a \nhazardous atmosphere  \nSpecific target organ \ntoxicity – single exposure; \nrespiratory tract irritation \n(section 3.8)  3 \nSpecific target organ \ntoxicity – single exposure; \nnarcotic effects (section 3.8)  3 \n▼M12  \nP234  Keep only in original pack\xad\naging.  Explosives (Section 2.1)  Divisions 1.1, \n1.2, 1.3, 1.4, 1.5  \nSelf-reactive substances and \nmixtures (Section 2.8)  Types A, B, C, \nD, E, F  \nOrganic peroxides (Section \n2.15)  Types A, B, C, \nD, E, F  \nCorrosive to metals \n(Section 2.16)  1 \nP235  Keep cool.  Flammable liquids (Section \n2.6) 1, 2, 3  — for flammable liquids \ncategory 1 and other \nflammable liquids that \nare volatile and may \ngenerate an explosive \natmosphere  \nSelf-reactive substances and \nmixtures (Section 2.8)  Types A, B, C, \nD, E, F  — may be omitted if P411 \nis given on the label  \nSelf-heating substances and \nmixtures (Section 2.11)  1, 2 — may be omitted if P413 \nis given on the label  \nOrganic peroxides \n(Section 2.15)  Types A, B, C, \nD, E, F  — may be omitted if P411 \nis given on the label  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 324}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 326  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP240  Ground and bond container \nand receiving equipment.  Explosives (Section 2.1)  Divisions 1.1, \n1.2, 1.3, 1.4, 1.5  — if the explosive is elec\xad\ntrostatically sensitive  \nFlammable liquids \n(Section 2.6)  1, 2, 3  — if the liquid is volatile \nand may generate an \nexplosive atmosphere  \nFlammable solids (Section \n2.7) 1, 2 — if the solid is electros\xad\ntatically sensitive  \nSelf-reactive substances and \nmixtures (Section 2.8)  Types A,B,C, D, \nE, F — if electrostatically \nsensitive and able to \ngenerate an explosive \natmosphere  \nOrganic peroxides (Section \n2.15)  \nP241  Use explosion-proof [elec\xad\ntrical/ventilating/lighting/ \n…] equipment.  Flammable liquids (Section \n2.6) 1, 2, 3  — if the liquid is volatile \nand may generate an \nexplosive atmosphere. \n— text in square brackets \nmay be used to specify \nspecific electrical, venti\xad\nlating, lighting or other \nequipment if necessary \nand as appropriate.  \nFlammable solids (Section \n2.7) 1, 2 — if dust clouds can occur. \n— text in square brackets \nmay be used to specify \nspecific electrical, venti\xad\nlating, lighting or other \nequipment if necessary \nand as appropriate.  \nP242  Use non-sparking tools.  Flammable liquids (Section \n2.6) 1, 2, 3  — if the liquid is volatile \nand may generate an \nexplosive atmosphere \nand if the minimum \nignition energy is very \nlow. (This applies to \nsubstances and mixtures \nwhere the ignition \nenergy is < 0,1 mJ, e.g. \ncarbon disulphide).  \nP243  Take action to prevent static \ndischarges.  Flammable liquids (Section \n2.6) 1, 2, 3  — if the liquid is volatile \nand may generate an \nexplosive atmosphere.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 325}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 327  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M4 \nP244  Keep valves and fittings \nfree from oil and grease.  Oxidising gases (section \n2.4) 1 \n▼M12  \nP250  Do not subject to grinding/ \nshock/friction …  Explosives (Section 2.1)  Unstable \nexplosives and \ndivisions 1.1, \n1.2, 1.3, 1.4, 1.5  — if the explosive is mech\xad\nanically sensitive \n… Manufacturer/supplier to \nspecify applicable rough \nhandling.  \n▼M4 \nP251  Do not pierce or burn, even \nafter use.  Aerosols (section 2.3)  1, 2, 3  \n▼B \nP260  Do not breathe dust/fume/ \ngas/mist/vapours/spray.  Acute toxicity — inhalation \n(section 3.1)  1, 2 Manufacturer/supplier to \nspecify applicable conditions.  \nSpecific target organ \ntoxicity — single exposure \n(section 3.8)  1, 2 \nSpecific target organ \ntoxicity — repeated \nexposure (section 3.9)  1, 2 \nSkin corrosion (section 3.2)  1A, 1B, 1C  — Specify do not breathe \ndusts or mists. \n— if inhalable particles of \ndusts or mists may \noccur during use.  Reproductive toxicity — \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \n▼M12  \nP261  Avoid breathing dust/fume/ \ngas/mist/vapours/spray.  Acute toxicity — inhalation \n(Section 3.1)  3, 4 — may be omitted if P260 \nis given on the label \nManufacturer/supplier to \nspecify applicable conditions.  Respiratory sensitisation \n(Section 3.4)  1, 1A, 1B  \nSkin sensitisation (Section \n3.4) 1, 1A, 1B  \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(Section 3.8)  3 \nSpecific target organ \ntoxicity — single exposure; \nnarcotic effects (Section \n3.8) 3 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 326}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 328  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP262  Do not get in eyes, on skin, \nor on clothing.  Acute toxicity — dermal \n(section 3.1)  1, 2 \n▼M12  \nP263  Avoid contact during \npregnancy and while \nnursing.  Reproductive \ntoxicity — effects on or via \nlactation (Section 3.7)  Additional \ncategory  \n▼B \nP264  Wash … thoroughly after \nhandling.  Acute toxicity — oral \n(section 3.1)  1, 2, 3, 4  Manufacturer/supplier to \nspecify parts of the body to \nbe washed after handling.  \nAcute toxicity — dermal \n(section 3.1)  1, 2 \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nSkin irritation (section 3.2)  2  \nEye irritation (section 3.3)  2  \nReproductive toxicity — \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \nSpecific target organ \ntoxicity — single exposure \n(section 3.8)  1, 2 \nSpecific target organ \ntoxicity — repeated \nexposure (section 3.9)  1 \nP270  Do not eat, drink or smoke \nwhen using this product.  Acute toxicity — oral \n(section 3.1)  1, 2, 3, 4  \nAcute toxicity — dermal \n(section 3.1)  1, 2 \nReproductive toxicity — \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \nSpecific target organ \ntoxicity — single exposure \n(section 3.8)  1, 2 \nSpecific target organ \ntoxicity — repeated \nexposure (section 3.9)  1 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 327}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 329  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP271  Use only outdoors or in a \nwell-ventilated area.  Acute toxicity — inhalation \n(section 3.1)  1, 2, 3, 4  \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(section 3.8)  3 \nSpecific target organ \ntoxicity — single exposure; \nnarcosis (section 3.8)  3 \n▼M2 \nP272  Contaminated work clothing \nshould not be allowed out \nof the workplace.  Skin sensitisation (section \n3.4) 1, 1A, 1B  \n▼B \nP273  Avoid release to the \nenvironment.  Hazardous to the aquatic \nenvironment — acute \naquatic hazard (section 4.1)  1 — if this is not the intended \nuse. \nHazardous to the \naquatic environment —  \n►M2 long-term aquatic \nhazard (section 4.1) ◄  1, 2, 3, 4  \n▼M2 \n_____  \n▼M19  \nP280  Wear protective gloves/ \nprotective clothing/eye \nprotection/face protection/ \nhearing protection/…  Explosives (section 2.1)  Unstable \nexplosive and \ndivisions 1.1, \n1.2, 1.3, 1.4, 1.5  Manufacturer/supplier to \nspecify the appropriate type \nof personal protective equip\xad\nment.  \nFlammable gases (section \n2.2) Pyrophoric gas  \nFlammable liquids (section \n2.6) 1, 2, 3  \nFlammable solids (section \n2.7) 1, 2 \nSelf-reactive substances and \nmixtures (section 2.8)  Types A, B, C, \nD, E, F  \nPyrophoric liquids \n(section 2.9)  1 \nPyrophoric solids \n(section 2.10)  1 \nSelf-heating substances and \nmixtures (section 2.11)  1, 2 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 328}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 330  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2, 3  \nOxidizing liquids \n(section 2.13)  1, 2, 3  \nOxidizing solids (section \n2.14)  1, 2, 3  \nOrganic peroxides \n(section 2.15)  Types A, B, C, \nD, E, F  \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  \nAcute toxicity – dermal \n(section 3.1)  1, 2, 3, 4  —  Specify protective \ngloves/clothing.  \nManufacturer/ \nsupplier may further specify \ntype of equipment where \nappropriate.  \nSkin corrosion (section 3.2)  1A, 1B, 1C  —  Specify protective \ngloves/clothing and eye/ \nface protection.  \nManufacturer/ \nsupplier may further specify \ntype of equipment where \nappropriate.  \nSkin irritation (section 3.2)  2  —  Specify protective gloves.  \nManufacturer/ \nsupplier may further specify \ntype of equipment where \nappropriate.  Skin sensitisation (section \n3.4) 1, 1A, 1B  \nSerious eye damage \n(section 3.3)  1 —  Specify eye/face \nprotection.  \nManufacturer/ \nsupplier may further specify \ntype of equipment where \nappropriate.  Eye irritation (section 3.3)  2  \nGerm cell mutagenicity \n(section 3.5)  1A, 1B, 2  Manufacturer/supplier to \nspecify the appropriate type \nof personal protective equip\xad\nment.  \nCarcinogenicity (section \n3.6) 1A, 1B, 2  \nReproductive toxicity \n(section 3.7)  1A, 1B, 2  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 329}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 331  \nCode \n(1) Prevention precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M4 \n_____  \n▼M12  \nP282  Wear cold insulating gloves \nand either face shield or eye \nprotection.  Gases under pressure \n(Section 2.5)  Refrigerated \nliquefied gas  \nP283  Wear fire resistant or flame \nretardant clothing.  Oxidising liquids (Section \n2.13)  1 \nOxidising solids (Section \n2.14)  1 \nP284  [In case of inadequate \nventilation] wear respiratory \nprotection.  Acute toxicity — inhalation \n(Section 3.1)  1, 2 — text in square brackets \nmay be used if ad\xad\nditional information is \nprovided with the \nchemical at the point of \nuse that explains what \ntype of ventilation \nwould be adequate for \nsafe use. \nManufacturer/supplier to \nspecify equipment.  Respiratory sensitisation \n(Section 3.4)  1, 1A, 1B  \n▼M4 \n_____  \n▼M12  \nP231 + \nP232  Handle and store contents \nunder inert gas/… \nProtect from moisture.  Pyrophoric liquids (Section \n2.9) 1 … Manufacturer/supplier to \nspecify the appropriate \nliquid or gas if ‘inert gas’ is \nnot appropriate.  \nPyrophoric solids (Section \n2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (Section 2.12)  1, 2, 3  — if the substance or \nmixture reacts readily \nwith moisture in air. \n… Manufacturer/supplier to \nspecify appropriate liquid or \ngas if ‘inert gas’ is not \nappropriate.  \n_____  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 330}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 332  \nTable 6.3  \nPrecautionary statements — Response  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M19  \nP301  IF SWALLOWED:  Acute toxicity – oral \n(section 3.1)  1, 2, 3, 4  \nSkin corrosion (section 3.2)  1, 1A, 1B, 1C  \nAspiration Hazard \n(section 3.10)  1 \nP302  IF ON SKIN:  Pyrophoric liquids \n(section 2.9)  1 \nPyrophoric solids \n(section 2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2 \nAcute toxicity – dermal \n(section 3.1)  1, 2, 3, 4  \nSkin irritation (section 3.2)  2  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \n▼B \nP303  IF ON SKIN (or hair):  Flammable liquids (section \n2.6) 1, 2, 3  \nSkin corrosion (section 3.2)  1A, 1B, 1C  \n▼M2 \nP304  IF INHALED:  Acute toxicity — inhalation \n(section 3.1)  1, 2, 3, 4  \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nRespiratory sensitisation \n(section 3.4)  1, 1A, 1B  \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(section 3.8)  3 \nSpecific target organ \ntoxicity — single exposure; \nnarcosis (section 3.8)  3 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 331}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 333  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP305  IF IN EYES:  Skin corrosion (section 3.2)  1A, 1B, 1C  \nSerious eye damage/eye \nirritation (section 3.3)  1 \nEye irritation (section 3.3)  2  \nP306  IF ON CLOTHING:  Oxidising liquids (section \n2.13)  1 \nOxidising solids (section \n2.14)  1 \n▼M4 \n_____  \nP308  IF exposed or concerned:  Germ cell mutagenicity \n(section 3.5)  1A, 1B, 2  \nCarcinogenicity (section \n3.6) 1A, 1B, 2  \nReproductive toxicity \n(section 3.7)  1A, 1B, 2  \nReproductive toxicity — \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \nSpecific target organ \ntoxicity, single exposure \n(section 3.8)  1, 2 \n_____  \nP310  Immediately call a POISON \nCENTER/doctor/…  Acute toxicity — oral \n(section 3.1)  1, 2, 3  …Manufacturer/supplier to \nspecify the appropriate \nsource of emergency \nmedical advice.  Acute toxicity — dermal \n(section 3.1)  1, 2 \nAcute toxicity — inhalation \n(section 3.1)  1, 2 \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nSerious eye damage/eye \nirritation (section 3.3)  1 \nAspiration hazard (section \n3.10)  1 \nP311  Call a POISON CENTER/ \ndoctor/…  Acute toxicity — inhalation \n(section 3.1)  3 …Manufacturer/supplier to \nspecify the appropriate \nsource of emergency \nmedical advice.  Respiratory sensitisation \n(section 3.4)  1, 1A, 1B  \nSpecific target organ \ntoxicity — single exposure \n(section 3.8)  1, 2 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 332}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 334  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M12  \nP312  Call a POISON CENTRE/ \ndoctor/… if you feel \nunwell.  Acute toxicity — oral \n(Section 3.1)  4 … Manufacturer/supplier to \nspecify the appropriate \nsource of emergency \nmedical advice.  \nAcute toxicity — dermal \n(Section 3.1)  3, 4 \nAcute toxicity — inhalation \n(Section 3.1)  4 \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(Section 3.8)  3 \nSpecific target organ \ntoxicity — single exposure; \nnarcotic effects (Section \n3.8) 3 \n▼M2 \nP313  Get medical advice/atten\xad\ntion. Skin irritation (section 3.2)  2, 3  \nEye irritation (section 3.3)  2  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \nGerm cell mutagenicity \n(section 3.5)  1A, 1B, 2  \nCarcinogenicity (section \n3.6) 1A, 1B, 2  \nReproductive toxicity \n(section 3.7)  1A, 1B, 2  \nReproductive toxicity — \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \n▼B \nP314  Get medical advice/ \nattention if you feel unwell.  Specific target organ \ntoxicity — repeated \nexposure (section 3.9)  1, 2 \nP315  Get immediate medical \nadvice/attention.  Gases under pressure \n(section 2.5)  Refrigerated \nliquefied gas  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 333}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 335  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M12  \nP320  Specific treatment is urgent \n(see … on this label).  Acute toxicity — inhalation \n(Section 3.1)  1, 2 — if immediate administra\xad\ntion of antidote is \nrequired. \n… Reference to supplemental \nfirst aid instruction.  \nP321  Specific treatment (see … \non this label).  Acute toxicity — oral \n(Section 3.1)  1, 2, 3  — if immediate administra\xad\ntion of antidote is \nrequired. \n… Reference to supplemental \nfirst aid instruction.  \nAcute toxicity, dermal \n(Section 3.1)  1, 2, 3, 4  — if immediate measures \nsuch as specific \ncleansing agent are \nadvised. \n… Reference to supplemental \nfirst aid instruction.  \nAcute toxicity — inhalation \n(Section 3.1)  3 — if immediate specific \nmeasures are required. \n… Reference to supplemental \nfirst aid instruction.  \nSkin corrosion (Section 3.2)  1, 1A, 1B, 1C  … Reference to supplemental \nfirst aid instruction. \nManufacturer/supplier may \nspecify a cleansing agent if \nappropriate.  Skin irritation (Section 3.2)  2  \nSkin sensitisation (Section \n3.4) 1, 1A, 1B  \nSpecific target organ \ntoxicity — single exposure \n(Section 3.8)  1 — if immediate measures \nare required. \n… Reference to supplemental \nfirst aid instruction.  \n▼M4 \n_____  \n▼B \nP330  Rinse mouth.  Acute toxicity — oral \n(section 3.1)  1, 2, 3, 4  \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nP331  Do NOT induce vomiting.  Skin corrosion (section 3.2)  1A, 1B, 1C  \nAspiration hazard (section \n3.10)  1 \n▼M19  \nP332  If skin irritation occurs:  Skin irritation (section 3.2)  2  may be omitted if P333 is \ngiven on the label.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 334}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 336  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M2 \nP333  If skin irritation or rash \noccurs:  Skin sensitisation (section \n3.4) 1, 1A, 1B  \n▼M12  \nP334  Immerse in cool water [or \nwrap in wet bandages].  Pyrophoric liquids (Section \n2.9) 1 — text in square brackets to \nbe used for pyrophoric \nliquids and solids  \nPyrophoric solids (Section \n2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (Section 2.12)  1, 2 Use only ‘immerse in cool \nwater.’ Text in square \nbrackets should not be used.  \n▼B \nP335  Brush off loose particles \nfrom skin.  Pyrophoric solids (section \n2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2 \nP336  Thaw frosted parts with \nlukewarm water. Do not \nrub affected area.  Gases under pressure \n(section 2.5)  Refrigerated \nliquefied gas  \nP337  If eye irritation persists:  Eye irritation (section 3.3)  2  \nP338  Remove contact lenses, if \npresent and easy to do. \nContinue rinsing.  Skin corrosion (section 3.2)  1A, 1B, 1C  \nSerious eye damage/eye \nirritation (section 3.3)  1 \nEye irritation (section 3.3)  2  \n▼M4 \nP340  Remove person to fresh air \nand keep comfortable for \nbreathing.  Acute toxicity — inhalation \n(section 3.1)  1, 2, 3, 4  \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nRespiratory sensitisation \n(section 3.4)  1, 1A, 1B  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 335}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 337  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(section 3.8)  3 \nSpecific target organ \ntoxicity — single exposure; \nnarcosis (section 3.8)  3 \n_____  \n▼M2 \nP342  If experiencing respiratory \nsymptoms:  Respiratory sensitisation \n(section 3.4)  1, 1A, 1B  \n▼M4 \n_____  \n▼B \nP351  Rinse cautiously with water \nfor several minutes.  Skin corrosion (section 3.2)  1A, 1B, 1C  \nSerious eye damage/eye \nirritation (section 3.3)  1 \nEye irritation (section 3.3)  2  \n▼M4 \nP352  Wash with plenty of water/ \n… Acute toxicity — dermal \n(section 3.1)  1, 2, 3, 4  …Manufacturer/supplier may \nspecify a cleansing agent if \nappropriate, or may \nrecommend an alternative \nagent in exceptional cases if \nwater is clearly inappropriate.  Skin irritation (section 3.2)  2  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \n▼M12  \nP353  Rinse skin with water [or \nshower].  Flammable liquids (Section \n2.6) 1, 2, 3  — text in square brackets to \nbe included where the \nmanufacturer/supplier \nconsiders it appropriate \nfor the specific chemical.  Skin corrosion (Section 3.2)  1, 1A, 1B, 1C  \n▼B \nP360  Rinse immediately \ncontaminated clothing and \nskin with plenty of water \nbefore removing clothes.  Oxidising liquids (section \n2.13)  1 \nOxidising solids (section \n2.14)  1 \n▼M4 \nP361  Take off immediately all \ncontaminated clothing.  Flammable liquids (section \n2.6) 1, 2, 3  \nAcute toxicity — dermal \n(section 3.1)  1, 2, 3  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 336}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 338  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nP362  Take off contaminated \nclothing.  Acute toxicity, dermal \n(section 3.1)  4 \nSkin irritation (section 3.2)  2  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \nP363  Wash contaminated clothing \nbefore reuse.  Skin corrosion (section 3.2)  1A, 1B, 1C  \nP364  And wash it before reuse.  Acute toxicity, dermal \n(section 3.1)  1, 2, 3, 4  \nSkin irritation (section 3.2)  2  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \n▼M19  \nP370  In case of fire:  Explosives (section 2.1)  Unstable \nexplosives and \ndivisions 1.1, \n1.2, 1.3, 1.4, 1.5  \nOxidising gases (section \n2.4) 1 \nFlammable liquids (section \n2.6) 1, 2, 3  \nFlammable solids (section \n2.7) 1, 2 \nSelf-reactive substances and \nmixtures (section 2.8)  Types A, B, C, \nD, E, F  \nPyrophoric liquids \n(section 2.9)  1 \nPyrophoric solids \n(section 2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2, 3  \nOxidising liquids (section \n2.13)  1, 2, 3  \nOxidising solids (section \n2.14)  1, 2, 3  \nOrganic Peroxides \n(section 2.15)  Types A, B, C, \nD, E, F  \nDesensitised explosives \n(section 2.17)  1, 2, 3  \nP371  In case of major fire and \nlarge quantities:  Oxidising liquids (section \n2.13)  1 \nOxidising solids (section \n2.14)  1 \nDesensitised explosives \n(section 2.17)  4 ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 337}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 339  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M12  \nP372  Explosion risk.  Explosives (Section 2.1)  Unstable \nexplosives and \nDivisions 1.1, \n1.2, 1.3, and 1.5  \nDivision 1.4  — except for explosives of \ndivision 1.4 (compati\xad\nbility group S) in \ntransport packaging.  \nSelf-reactive substances and \nmixtures (Section 2.8)  Type A  \nOrganic peroxides (Section \n2.15)  Type A  \nP373  DO NOT fight fire when \nfire reaches explosives.  Explosives (Section 2.1)  Unstable \nexplosives and \nDivisions 1.1, \n1.2, 1.3, 1.5  \nDivision 1.4  — except for explosives of \ndivision 1.4 (compati\xad\nbility group S) in \ntransport packaging.  \nSelf-reactive substances and \nmixtures (Section 2.8)  Type A  \nOrganic peroxides (Section \n2.15)  Type A  \n_____  \n▼M19  \nP375  Fight fire remotely due to \nthe risk of explosion.  Explosives (section 2.1)  Division 1.4  — for explosives of \ndivision 1.4 (compati\xad\nbility group S) in \ntransport packaging.  \nSelf-reactive substances and \nmixtures (section 2.8)  Type B  \nOxidising liquids (section \n2.13)  1 \nOxidising solids (section \n2.14)  1 \nOrganic peroxides \n(section 2.15)  Type B  \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 338}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 340  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP376  Stop leak if safe to do so.  Oxidising gases (section \n2.4) 1 \n▼M19  \nP377  Leaking gas fire: Do not \nextinguish, unless leak can \nbe stopped safely.  Flammable gases (section \n2.2) 1A, 1B, 2  \n▼M12  \nP378  Use … to extinguish.  Flammable liquids (Section \n2.6) 1, 2, 3  — if water increases risk \n… Manufacturer/supplier to \nspecify appropriate media  Flammable solids (Section \n2.7) 1, 2 \nSelf-reactive substances and \nmixtures (Section 2.8)  Types B, C, D, \nE, F \nPyrophoric liquids (Section \n2.9) 1 \nPyrophoric solids (Section \n2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (Section 2.12)  1, 2, 3  \nOxidising liquids (Section \n2.13)  1, 2, 3  \nOxidising solids (Section \n2.14)  1, 2, 3  \nOrganic peroxides (Section \n2.15)  Types B, C, D, \nE, F \n▼M19  \nP380  Evacuate area.  Explosives (section 2.1)  Unstable \nexplosives and \nDivisions 1.1, \n1.2, 1.3, 1.4, 1.5  \nSelf-reactive substances and \nmixtures (section 2.8)  Types A, B  \nOxidising liquids (section \n2.13)  1 \nOxidising solids (section \n2.14)  1 \nOrganic peroxides \n(section 2.15)  Types A, B  \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  \nP381  In case of leakage, \neliminate all ignition \nsources  Flammable gases (section \n2.2) 1A, 1B, 2  \n▼B \nP390  Absorb spillage to prevent \nmaterial damage.  Corrosive to metals (section \n2.16)  1 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 339}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 341  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP391  Collect spillage.  Hazardous to the aquatic \nenvironment – acute \naquatic hazard (section 4.1)  1 \nHazardous to the \naquatic environment –  \n►M2 long-term aquatic \nhazard (section 4.1) ◄  1, 2 \n▼M4 \nP301 + \nP310  IF SWALLOWED: Im\xad\nmediately call a POISON \nCENTER/doctor/…  Acute toxicity — oral \n(section 3.1)  1, 2, 3  …Manufacturer/supplier to \nspecify the appropriate \nsource of emergency \nmedical advice.  Aspiration hazard (section \n3.10)  1 \n▼M19  \nP301 + \nP312  IF SWALLOWED: Call a \nPOISON CENTER/doctor/ \n… if you feel unwell  Acute toxicity – oral \n(section 3.1)  4 … Manufacturer/supplier to \nspecify the appropriate \nsource of emergency \nmedical advice  \n▼M12  \n_____  \nP302 + \nP334  IF ON SKIN: Immerse in \ncool water or wrap in wet \nbandages.  Pyrophoric liquids (Section \n2.9) 1 \n▼M4 \n_____  \nP302 + \nP352  IF ON SKIN: Wash with \nplenty of water/…  Acute toxicity — dermal \n(section 3.1)  1, 2, 3, 4  …Manufacturer/supplier may \nspecify a cleansing agent if \nappropriate, or may \nrecommend an alternative \nagent in exceptional cases if \nwater is clearly inappropriate.  Skin irritation (section 3.2)  2  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \n▼M12  \n_____  \n▼M4 \nP304 + \nP340  IF INHALED: Remove \nperson to fresh air and \nkeep comfortable for \nbreathing.  Acute toxicity — inhalation \n(section 3.1)  1, 2, 3, 4  \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nRespiratory sensitisation \n(section 3.4)  1, 1A, 1B  \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(section 3.8)  3 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 340}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 342  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nSpecific target organ \ntoxicity — single exposure; \nnarcosis (section 3.8)  3 \n_____  \n▼M12  \n_____  \n▼B \nP306 + \nP360  IF ON CLOTHING: Rinse \nimmediately contaminated \nclothing and skin with \nplenty of water before \nremoving clothes.  Oxidising liquids (section \n2.13)  1 \nOxidising solids (section \n2.14)  1 \n▼M4 \nP308 + \nP311  IF exposed or concerned: \nCall a POISON CENTER/ \ndoctor/…  Specific target organ \ntoxicity — single exposure \n(section 3.8)  1, 2 …Manufacturer/supplier to \nspecify the appropriate \nsource of emergency \nmedical advice.  \n▼B \nP308 + \nP313  IF exposed or concerned: \nGet medical advice/atten\xad\ntion. Germ cell mutagenicity \n(section 3.5)  1A, 1B, 2  \nCarcinogenicity (section \n3.6) 1A, 1B, 2  \nReproductive toxicity \n(section 3.7)  1A, 1B, 2  \nReproductive toxicity — \neffects on or via lactation \n(section 3.7)  Additional \ncategory  \n▼M4 \n_____  \n▼M12  \nP332 + \nP313  If skin irritation occurs: Get \nmedical advice/attention.  Skin irritation (Section 3.2)  2  — may be omitted when \nP333 + P313 is given \non the label.  \n▼M2 \nP333 + \nP313  If skin irritation or rash \noccurs: Get medical \nadvice/attention.  Skin sensitisation (section \n3.4) 1, 1A, 1B  \n▼M12  \nP336 + \nP315  Thaw frosted parts with \nlukewarm water. Do not \nrub affected area. Get \nimmediate medical advice/ \nattention.  Gases under pressure \n(Section 2.5)  Refrigerated \nliquefied gas  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 341}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 343  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n_____  \n▼B \nP337 + \nP313  If eye irritation persists: Get \nmedical advice/attention.  Eye irritation (section 3.3)  2  \n▼M4 \nP342 + \nP311  If experiencing respiratory \nsymptoms: Call a POISON \nCENTER/doctor/…  Respiratory sensitisation \n(section 3.4)  1, 1A, 1B  …Manufacturer/supplier to \nspecify the appropriate \nsource of emergency \nmedical advice.  \nP361 + \nP364  Take off immediately all \ncontaminated clothing and \nwash it before reuse.  Acute toxicity, dermal \n(section 3.1)  1, 2, 3  \nP362 + \nP364  Take off contaminated \nclothing and wash it before \nreuse.  Acute toxicity, dermal \n(section 3.1)  4 \nSkin irritation (section 3.2)  2  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \n▼B \nP370 + \nP376  In case of fire: Stop leak if \nsafe to do so.  Oxidizing gases (section \n2.4) 1 \n▼M12  \nP370 + \nP378  In case of fire: Use … to \nextinguish.  Flammable liquids (Section \n2.6) 1, 2, 3  — if water increases risk. \n… Manufacturer/sup-plier to \nspecify appropriate media.  \nFlammable solids (Section \n2.7) 1, 2 \nSelf-reactive substances and \nmixtures (Section 2.8)  Types C, D, E, \nF \nPyrophoric liquids (Section \n2.9) 1 \nPyrophoric solids (Section \n2.10)  1 \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (Section 2.12)  1, 2, 3  \nOxidising liquids (Section \n2.13)  1, 2, 3  \nOxidising solids (Section \n2.14)  1, 2, 3  \nOrganic peroxides (Section \n2.15)  Types C, D, E, \nF ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 342}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 344  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP301 + \nP330 + \nP331  IF SWALLOWED: Rinse \nmouth. Do NOT induce \nvomiting.  Skin corrosion (Section 3.2)  1, 1A, 1B, 1C  \nP302 + \nP335 + \nP334  IF ON SKIN: Brush off \nloose particles from skin. \nImmerse in cool water [or \nwrap in wet bandages].  Pyrophoric solids (Section \n2.10)  1 — text in square brackets to \nbe used for pyrophoric \nsolids  \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (Section 2.12)  1, 2 — use only ‘Immerse in \ncold water’. Text in \nsquare brackets should \nnot be used.  \nP303 + \nP361 + \nP353  IF ON SKIN (or hair): Take \noff immediately all \ncontaminated clothing. \nRinse skin with water [or \nshower].  Flammable liquids (Section \n2.6) 1, 2, 3  — text in square brackets to \nbe included where the \nmanufacturer/supplier \nconsiders it appropriate \nfor the specific chemical.  Skin corrosion (Section 3.2)  1, 1A, 1B, 1C  \nP305 + \nP351 + \nP338  IF IN EYES: Rinse \ncautiously with water for \nseveral minutes. Remove \ncontact lenses, if present \nand easy to do. Continue \nrinsing.  Skin corrosion (Section 3.2)  1, 1A, 1B, 1C  \nSerious eye damage/eye \nirritation (Section 3.3)  1 \nEye irritation (Section 3.3)  2  \n_____  \n▼M19  \nP370 + \nP380 + \nP375  In case of fire: Evacuate \narea. Fight fire remotely \ndue to the risk of explosion.  Explosives (section 2.1)  Division 1.4  — for explosives of \ndivision 1.4 (compati\xad\nbility group S) in \ntransport packaging  \nDesensitised explosives \n(section 2.17)  1, 2, 3  \nP371 + \nP380 + \nP375  In case of major fire and \nlarge quantities: Evacuate \narea. Fight fire remotely \ndue to the risk of explosion.  Oxidising liquids (section \n2.13)  1 \nOxidising solids (section \n2.14)  1 \nDesensitised explosives \n(section 2.17)  4 ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 343}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 345  \nCode \n(1) Response precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M12  \nP370 + \nP372 + \nP380 + \nP373  In case of fire: Explosion \nrisk. Evacuate area. DO \nNOT fight fire when fire \nreaches explosives  Explosives (Section 2.1)  Unstable \nexplosives and \ndivisions 1.1, \n1.2, 1.3, 1.5  \nDivision 1.4  — except for explosives of \ndivision 1.4 (compati\xad\nbility group S) in \ntransport packaging.  \nSelf-reactive substances and \nmixtures (Section 2.8)  Type A  \nOrganic peroxides (Section \n2.15)  Type A  \nP370 + \nP380 + \nP375 + \n[P378]  In case of fire: Evacuate \narea. Fight fire remotely \ndue to the risk of explosion. \n[Use … to extinguish].  Self-reactive substances and \nmixtures (Section 2.8)  Type B  — text in square brackets to \nbe used if water \nincreases risk. \n… Manufacturer/supplier to \nspecify appropriate media.  Organic peroxides (Section \n2.15)  Type B  \n▼B \nTable 6.4  \nPrecautionary statements — Storage  \nCode \n(1) Storage precautionary statements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M19  \nP401  Store in accordance with …  Explosives (section 2.1)  Unstable \nexplosives and \nDivisions 1.1, \n1.2, 1.3, 1.4, 1.5  … Manufacturer/ \nsupplier to specify local/ \nregional/national/international \nregulations as applicable.  \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  \n▼B \nP402  Store in a dry place.  Substances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2, 3  \n▼M19  \nP403  Store in a well-ventilated \nplace.  Flammable gases (section \n2.2) 1A, 1B, 2  \nOxidising gases (section \n2.4) 1 \nGases under pressure \n(section 2.5)  Compressed gas  \nLiquefied gas  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 344}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 346  \nCode \n(1) Storage precautionary statements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nRefrigerated \nliquefied gas  \nDissolved gas  \nFlammable liquids (section \n2.6) 1, 2, 3  — for flammable liquids \nCategory 1 and other \nflammable liquids that \nare volatile and may \ngenerate an explosive \natmosphere.  \nSelf-reactive substances and \nmixtures (section 2.8)  Types A, B, C, \nD, E, F  — except for temperature \ncontrolled self-reactive \nsubstances and mixtures \nor organic peroxides \nbecause condensation \nand consequent freezing \nmay take place.  Organic peroxides \n(section 2.15)  \nAcute toxicity – inhalation \n(section 3.1)  1, 2, 3  — if the substance or \nmixture is volatile and \nmay generate a \nhazardous atmosphere.  Specific target organ \ntoxicity – single exposure; \nrespiratory tract irritation \n(section 3.8)  3 \nSpecific target organ \ntoxicity – single exposure; \nnarcotic effects (section 3.8)  3 \n▼B \nP404  Store in a closed container.  Substances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2, 3  \nP405  Store locked up.  Acute toxicity — oral \n(section 3.1)  1, 2, 3  \nAcute toxicity — dermal \n(section 3.1)  1, 2, 3  \nAcute toxicity — inhalation \n(section 3.1)  1, 2, 3  \nSkin corrosion (section 3.2)  1A, 1B, 1C  \nGerm cell mutagenicity \n(section 3.5)  1A, 1B, 2  \nCarcinogenicity (section \n3.6) 1A, 1B, 2  \nReproductive toxicity \n(section 3.7)  1A, 1B, 2  \nSpecific target organ \ntoxicity — single exposure \n(section 3.8)  1, 2 ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 345}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 347  \nCode \n(1) Storage precautionary statements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(section 3.8)  3 \nSpecific target organ \ntoxicity — single exposure; \nnarcosis (section 3.8)  3 \nAspiration hazard (section \n3.10)  1 \n▼M12  \nP406  Store in a corrosion- \nresistant/… container with \na resistant inner liner.  Corrosive to metals (Section \n2.16)  1 — may be omitted if P234 \nis given on the label \n… Manufacturer/supplier to \nspecify other compatible \nmaterials.  \nP407  Maintain air gap between \nstacks or pallets.  Self-heating substances and \nmixtures (Section 2.11)  1, 2 \n▼M4 \nP410  Protect from sunlight.  Aerosols (section 2.3)  1,2, 3  \nGases under pressure \n(section 2.5)  Compressed gas \nLiquefied gas \nDissolved gas  — may be omitted for gases \nfilled in transportable \ngas cylinders in \naccordance with \npacking instruction \nP200 of the UN RTDG, \nModel Regulations, \nunless those gases are \nsubject to (slow) decom \xad\nposition or polymeri \xad\nsation  \nSelf-heating substances and \nmixtures (section 2.11)  1, 2 \nOrganic peroxides (section \n2.15)  Types A, B, C, \nD, E, F  \n▼M12  \nP411  Store at temperatures not \nexceeding … °C/… °F.  Self-reactive substances and \nmixtures (Section 2.8)  Types A, B, C, \nD, E, F  — if temperature control is \nrequired (according to \nAnnex I, Section 2.8.2.4 \nor 2.15.2.3) or if \notherwise deemed \nnecessary. \n… Manufacturer/supplier to \nspecify temperature using \nthe applicable temperature \nscale.  Organic peroxides (Section \n2.15)  Types A, B, C, \nD, E, F  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 346}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 348  \nCode \n(1) Storage precautionary statements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP412  Do not expose to \ntemperatures exceeding \n50 °C/ 122 °F.  Aerosols (Section 2.3)  1, 2, 3  Manufacturer/supplier to use \napplicable temperature scale.  \nP413  Store bulk masses greater \nthan … kg/… lbs at \ntemperatures not exceeding \n… °C/… °F.  Self-heating substances and \nmixtures (Section 2.11)  1, 2 … Manufacturer/supplier to \nspecify mass and temperature \nusing applicable scale.  \nP420  Store separately.  Self-reactive substances and \nmixtures (Section 2.8)  Types A, B, C, \nD, E, F  \nSelf-heating substances and \nmixtures (Section 2.11)  1,2 \nOxidising liquids (Section \n2.13)  1 \nOxidising solids (Section \n2.14)  1 \nOrganic peroxides (Section \n2.15)  Types \nA,B,C,D,E,F  \n_____  \n▼B \nP402 + \nP404  Store in a dry place. Store \nin a closed container.  Substances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2, 3  \n▼M12  \nP403 + \nP233  Store in a well-ventilated \nplace. Keep container \ntightly closed.  Acute toxicity — inhalation \n(Section 3.1)  1, 2, 3  — if the substance or \nmixture is volatile and \nmay generate a \nhazardous atmosphere.  \nSpecific target organ \ntoxicity — single exposure; \nrespiratory tract irritation \n(Section 3.8)  3 \nSpecific target organ \ntoxicity — single exposure; \nnarcosis (Section 3.8)  3 \nP403 + \nP235  Store in a well-ventilated \nplace. Keep cool.  Flammable liquids (Section \n2.6) 1, 2, 3  — for flammable liquids \nCategory 1 and other \nflammable liquids that \nare volatile and may \ngenerate an explosive \natmosphere.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 347}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 349  \nCode \n(1) Storage precautionary statements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nP410 + \nP403  Protect from sunlight. Store \nin a well-ventilated place.  Gases under pressure \n(Section 2.5)  Compressed gas  — P410 may be omitted for \ngases filled in trans\xad\nportable gas cylinders in \naccordance with packing \ninstruction P200 of the \nUN RTDG, unless those \ngases are subject to \n(slow) decomposition or \npolymerisation.  Liquefied gas  \nDissolved gas  \nP410 + \nP412  Protect from sunlight. Do \nnot expose to temperatures \nexceeding 50 °C/122 °F.  Aerosols (Section 2.3)  1, 2, 3  Manufacturer/ supplier to use \napplicable temperature scale.  \n_____  \n▼M2 \nTable 6.5  \nPrecautionary statements — Disposal  \nCode \n(1) Disposal precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \n▼M19  \nP501  Dispose of contents/ \ncontainer to …  Flammable liquids (section \n2.6) 1, 2, 3  … in accordance with local/ \nregional/national/international \nregulation (to be specified). \nManufacturer/supplier to \nspecify whether disposal \nrequirements apply to \ncontents, container or both.  Self-reactive substances and \nmixtures (section 2.8)  Types A, B, C, \nD, E, F  \nSubstances and mixtures \nwhich, in contact with \nwater, emit flammable \ngases (section 2.12)  1, 2, 3  \nOxidising liquids (section \n2.13)  1, 2, 3  \nOxidising solids (section \n2.14)  1, 2, 3  \nOrganic peroxides \n(section 2.15)  Types A, B, C, \nD, E, F  \nDesensitised explosives \n(section 2.17)  1, 2, 3, 4  \nAcute toxicity – oral \n(section 3.1)  1, 2, 3, 4  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 348}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 350  \nCode \n(1) Disposal precautionary \nstatements \n(2) Hazard class \n(3) Hazard category \n(4) Conditions for use \n(5) \nAcute toxicity – dermal \n(section 3.1)  1, 2, 3, 4  \nAcute toxicity – inhalation \n(section 3.1)  1, 2, 3  \nSkin corrosion (section 3.2)  1, 1A, 1B, 1C  \nRespiratory sensitisation \n(section 3.4)  1, 1A, 1B  \nSkin sensitisation (section \n3.4) 1, 1A, 1B  \nGerm cell mutagenicity \n(section 3.5)  1A, 1B, 2  \nCarcinogenicity (section \n3.6) 1A, 1B, 2  \nReproductive toxicity \n(section 3.7)  1A, 1B, 2  \nSpecific target organ \ntoxicity – single exposure \n(section 3.8)  1, 2 \nSpecific target organ \ntoxicity – single exposure; \nrespiratory tract irritation \n(section 3.8)  3 \nSpecific target organ \ntoxicity – single exposure; \nnarcotic effects (section 3.8)  3 \nSpecific target organ \ntoxicity – repeated \nexposure (section 3.9)  1, 2 \nAspiration hazard \n(section 3.10)  1 \nHazardous to the aquatic \nenvironment – acute \naquatic hazard (section 4.1)  1 \nHazardous to the aquatic \nenvironment – chronic \naquatic hazard (section 4.1)  1, 2, 3, 4  \n▼M12  \nP502  Refer to manufacturer or \nsupplier for information on \nrecovery or recycling  Hazardous to the ozone \nlayer (Section 5.1)  1 \n▼M19  \nP503  Refer to manufacturer/ \nsupplier/… for information \non disposal/recovery/ \nrecycling  Explosives (section 2.1)  Unstable \nexplosives and \nDivisions 1.1, \n1.2, 1.3, 1.4, 1.5  … Manufacturer/supplier to \nspecify appropriate source \nof information in accordance \nwith local/regional/national/ \ninternational regulations as \napplicable.  ▼M19', metadata={'source': 'data/ycla_en.pdf', 'page': 349}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 351  \n2. Part 2: precautionary statements  \nThe precautionary statements shall be taken from this part of A nnex IV and \nselected in accordance with Part 1.  \nTable 1.1  \nPrecautionary statements — General  \nP101  Language  \nBG При необходимост от медицинска помощ, \nносете опаковката или етикета на продукта.  \nES Si se necesita consejo médico, tener a mano el \nenvase o la etiqueta.  \nCS Je-li nutná lékařská pomoc, mějte po ruce obal \nnebo štítek výrobku.  \nDA Hvis der er brug for lægehjælp, medbring da \nbeholderen eller etiketten.  \nDE Ist ärztlicher Rat erforderlich, Verpackung oder \nKennzeichnungsetikett bereithalten.  \nET Arsti poole pöördudes võtta kaasa toote pakend \nvõi etikett.  \nEL Εάν ζητήσετε ιατρική συμβουλή, να έχετε μαζί \nσας τον περιέκτη του προϊόντος ή την ετικέτα.  \nEN If medical advice is needed, have product \ncontainer or label at hand.  \nFR En cas de consultation d’un médecin, garder à \ndisposition le récipient ou l’étiquette.  \nGA Más gá comhairle liachta, bíodh coimeádán nó \nlipéad an táirge ina aice láimhe.  \n▼M5 \nHR Ako je potrebna liječnička pomoć pokazati \nspremnik ili naljepnicu.  \n▼B \nIT In caso di consultazione di un medico, tenere a \ndisposizione il contenitore o l'etichetta del \nprodotto.  \nLV Medicīniska padoma nepieciešamības gadījumā \nattiecīgā informācija ir norādīta uz iepakojuma \nvai etiķetes.  \nLT Jei reikalinga gydytojo konsultacija, su savimi \nturėkite produkto talpyklą ar jo etiketę.  \nHU Orvosi tanácsadás esetén tartsa kéznél a termék \nedényét vagy címkéjét.  \nMT Jekk ikun meħtieġ parir mediku, ara li jkollok \nil-kontenitur jew it-tikketta tal-prodott fil-qrib.  \nNL Bij het inwinnen van medisch advies, de \nverpakking of het etiket ter beschikking \nhouden.  \nPL W razie konieczności zasięgnięcia porady \nlekarza należy pokazać pojemnik lub etykietę.  \nPT Se for necessário consultar um médico, mostre- \nlhe a embalagem ou o rótulo.  \nRO Dacă este necesară consultarea medicului, ţineţi \nla îndemână recipientul sau eticheta produsului.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 350}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 352  \nP101  Language  \nSK Ak je potrebná lekárska pomoc, majte k \ndispozícii obal alebo etiketu výrobku.  \nSL Če je potreben zdravniški nasvet, mora biti na \nvoljo posoda ali etiketa proizvoda.  \nFI Jos tarvitaan lääkinnällistä apua, näytä pakkaus \ntai varoitusetiketti.  \nSV Ha förpackningen eller etiketten till hands om \ndu måste söka läkarvård.  \nP102  Language  \nBG Да се съхранява извън обсега на деца.  \nES Mantener fuera del alcance de los niños.  \nCS Uchovávejte mimo dosah dětí.  \nDA Opbevares utilgængeligt for børn.  \nDE Darf nicht in die Hände von Kindern gelangen.  \nET Hoida lastele kättesaamatus kohas.  \nEL Μακριά από παιδιά.  \nEN Keep out of reach of children.  \nFR Tenir hors de portée des enfants.  \nGA Coimeád as aimsiú leanaí.  \n▼M5 \nHR Čuvati izvan dohvata djece.  \n▼B \nIT Tenere fuori dalla portata dei bambini.  \nLV Sargāt no bērniem.  \nLT Laikyti vaikams neprieinamoje vietoje.  \nHU Gyermekektől elzárva tartandó.  \nMT Żommu ‘l bogħod minn fejn jistgħu jilħquh it- \ntfal. \nNL Buiten het bereik van kinderen houden.  \nPL Chronić przed dziećmi.  \nPT Manter fora do alcance das crianças.  \nRO A nu se lăsa la îndemâna copiilor.  \nSK Uchovávajte mimo dosahu detí.  \nSL Hraniti zunaj dosega otrok.  \nFI Säilytä lasten ulottumattomissa.  \nSV Förvaras oåtkomligt för barn.  \nP103  Language  \nBG Преди употреба прочетете етикета.  \nES Leer la etiqueta antes del uso.  \nCS Před použitím si přečtěte údaje na štítku.  \nDA Læs etiketten før brug.  \nDE Vor Gebrauch Kennzeichnungsetikett lesen.  \nET Enne kasutamist tutvuda etiketil oleva infoga.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 351}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 353  \nP103  Language  \nEL Διαβάστε την ετικέτα πριν από τη χρήση.  \nEN Read label before use.  \nFR Lire l’étiquette avant utilisation.  \nGA Léigh an lipéad roimh úsáid.  \n▼M5 \nHR Prije uporabe pročitati naljepnicu.  \n▼B \nIT Leggere l’etichetta prima dell’uso.  \nLV Pirms izmantošanas izlasīt etiķeti.  \nLT Prieš naudojimą perskaityti etiketę.  \nHU Használat előtt olvassa el a címkén közölt \ninformációkat.  \nMT Aqra t-tikketta qabel l-użu.  \nNL Alvorens te gebruiken, het etiket lezen.  \nPL Przed użyciem przeczytać etykietę.  \nPT Ler o rótulo antes da utilização.  \nRO Citiţi eticheta înainte de utilizare.  \nSK Pred použitím si prečítajte etiketu.  \nSL Pred uporabo preberite etiketo.  \nFI Lue merkinnät ennen käyttöä.  \nSV Läs etiketten före användning.  \nTable 1.2  \nPrecautionary statements — Prevention  \nP201  Language  \nBG Преди употреба се снабдете със специални \nинструкции.  \nES ►C3 Solicitar instrucciones especiales antes \ndel uso. ◄  \nCS Před použitím si obstarejte speciální instrukce.  \nDA Indhent særlige anvisninger før brug.  \nDE Vor Gebrauch besondere Anweisungen \neinholen.  \nET Enne kasutamist tutvuda erijuhistega.  \nEL Εφοδιαστείτε με τις ειδικές οδηγίες πριν από τη \nχρήση.  \nEN Obtain special instructions before use.  \nFR ►C3 Se procurer les instructions spéciales \navant utilisation. ◄  \nGA Faigh treoracha speisialta roimh úsáid.  \n▼M5 \nHR Prije uporabe pribaviti posebne upute.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 352}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 354  \nP201  Language  \nIT Procurarsi istruzioni specifiche prima dell’uso.  \nLV Pirms lietošanas saņemt speciālu instruktāžu.  \nLT Prieš naudojimą gauti specialias instrukcijas.  \nHU Használat előtt ismerje meg az anyagra \nvonatkozó különleges utasításokat.  \nMT Ikseb struzzjonijiet speċjali qabel l-użu.  \nNL Alvorens te gebruiken de speciale aanwijzingen \nraadplegen.  \nPL Przed użyciem zapoznać się ze specjalnymi \nśrodkami ostrożności.  \nPT Pedir instruções específicas antes da utilização.  \nRO Procuraţi instrucţiuni speciale înainte de util\xad\nizare.  \nSK Pred použitím sa oboznámte s osobitnými \npokynmi.  \nSL Pred uporabo pridobiti posebna navodila.  \nFI Lue erityisohjeet ennen käyttöä.  \nSV Inhämta särskilda instruktioner före använd\xad\nning.  \nP202  Language  \nBG Не използвайте преди да сте прочели и \nразбрали всички предпазни мерки за \nбезопасност.  \nES No manipular la sustancia antes de haber leído \ny comprendido todas las instrucciones de \nseguridad.  \nCS Nepoužívejte, dokud jste si nepřečetli všechny \nbezpečnostní pokyny a neporozuměli jim.  \nDA Anvend ikke produktet, før alle advarsler er \nlæst og forstået.  \nDE Vor Gebrauch alle Sicherheitshinweise lesen \nund verstehen.  \nET Mitte käidelda enne ohutusnõuetega tutvumist \nja nendest arusaamist.  \nEL Μην το χρησιμοποιήσετε πριν διαβάσετε και \nκατανοήσετε τις οδηγίες προφύλαξης.  \nEN Do not handle until all safety precautions have \nbeen read and understood.  \nFR Ne pas manipuler avant d’avoir lu et compris \ntoutes les précautions de sécurité.  \nGA Ná láimhsigh go dtí go léifear agus go dtuigfear \ngach ráiteas réamhchúraim sábháilteachta.  \n▼M5 \nHR Ne rukovati prije upoznavanja i razumijevanja \nsigurnosnih mjera predostrožnosti.  \n▼B \nIT Non manipolare prima di avere letto e \ncompreso tutte le avvertenze.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 353}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 355  \nP202  Language  \nLV Neizmantot pirms nav izlasīti un saprasti visi \napzīmējumi.  \nLT Nenaudoti, jeigu neperskaityti ar nesuprasti visi \nsaugos įspėjimai.  \nHU Ne használja addig, amíg az összes biztonsági \nóvintézkedést el nem olvasta és meg nem \nértette.  \nMT Tmissux qabel ma tkun qrajt u fhimt l- \nistruzzjonijiet kollha ta' prekawzjoni.  \nNL Pas gebruiken nadat u alle veiligheidsvoorsch\xad\nriften gelezen en begrepen heeft  \nPL Nie używać przed zapoznaniem się i zrozu\xad\nmieniem wszystkich środków bezpieczeństwa.  \nPT Não manuseie o produto antes de ter lido e \npercebido todas as precauções de segurança.  \nRO A nu se manipula decât după ce au fost citite și \nînţelese toate măsurile de securitate.  \nSK Nepoužívajte, kým si neprečítate a nepochopíte \nvšetky bezpečnostné opatrenia.  \nSL Ne uporabljajte, dokler se ne seznanite z vsemi \nvarnostnimi ukrepi.  \nFI Lue varoitukset huolellisesti ennen käsittelyä.  \nSV Använd inte produkten innan du har läst och \nförstått säkerhetsanvisningarna  \n▼M4 \nP210  Language  \nBG Да се пази от топлина, нагорещени \nповърхности, искри, открит пламък, и \nдруги източници на запалване. \nТютюнопушенето забранено.  \nES Mantener alejado del calor, de superficies \ncalientes, de chispas, de llamas abiertas y de \ncualquier otra fuente de ignición. No fumar.  \nCS Chraňte před teplem, horkými povrchy, \njiskrami, otevřeným ohněm a jinými zdroji \nzapálení. Zákaz kouření.  \nDA Holdes væk fra varme, varme overflader, \ngnister, åben ild og andre antændelseskilder. \nRygning forbudt.  \nDE Von Hitze, heißen Oberflächen, Funken, \noffenen Flammen sowie anderen Zündquel\xad\nlenarten fernhalten. Nicht rauchen.  \nET Hoida eemal soojusallikast, kuumadest \npindadest, sädemetest, leekidest ja muudest \nsüüteallikatest. Mitte suitsetada.  \nEL Μακριά από θερμότητα, θερμές επιφάνειες, \nσπινθήρες, γυμνές φλόγες και άλλες πηγές \nανάφλεξης. Μην καπνίζετε.  \nEN Keep away from heat, hot surfaces, sparks, \nopen flames and other ignition sources. No \nsmoking.  \nFR Tenir à l’écart de la chaleur, des surfaces \nchaudes, des étincelles, des flammes nues et \nde toute autre source d’inflammation. Ne pas \nfumer.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 354}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 356  \nP210  Language  \nGA Coimeád ó theas, dromchlaí te, splancacha, \nlasair gan chosaint agus foinsí eile adhainte. \nNá caitear tobac.  \n▼M8 \nHR Čuvati odvojeno od topline, vrućih površina, \niskri, otvorenih plamena i ostalih izvora \npaljenja. Ne pušiti.  \n▼M4 \nIT Tenere lontano da fonti di calore, superfici \ncalde, scintille, fiamme libere o altre fonti di \naccensione. Non fumare.  \nLV Sargāt no karstuma, karstām virsmām, dzirk\xad\nstelēm, atklātas uguns un citiem aizdegšanās \navotiem. Nesmēķēt.  \nLT Laikyti atokiau nuo šilumos šaltinių, karštų \npaviršių, žiežirbų, atviros liepsnos arba kitų \ndegimo šaltinių. Nerūkyti.  \nHU Hőtől, forró felületektől, szikrától, nyílt lángtól \nés más gyújtóforrástól távol tartandó. Tilos a \ndohányzás.  \nMT Biegħed mis-sħana, uċuħ jaħarqu, xrar tan-nar, \nfjammi miftuħa u sorsi oħra li jaqbdu. Tpejjipx.  \nNL Verwijderd houden van warmte, hete opper\xad\nvlakken, vonken, open vuur en andere ontstek\xad\ningsbronnen. Niet roken.  \nPL Przechowywać z dala od źródeł ciepła, \ngorących powierzchni, źródeł iskrzenia, \notwartego ognia i innych źródeł zapłonu. Nie \npalić.  \nPT Manter afastado do calor, superfícies quentes, \nfaísca, chama aberta e outras fontes de \nignição. Não fumar.  \nRO A se păstra departe de surse de căldură, \nsuprafeţe fierbinţi, scântei, flăcări și alte surse \nde aprindere. Fumatul interzis.  \nSK Uchovávajte mimo dosahu tepla, horúcich \npovrchov, iskier, otvoreného ohňa a iných \nzdrojov zapálenia. Nefajčite.  \nSL Hraniti ločeno od vročine, vročih površin, isker, \nodprtega ognja in drugih virov vžiga. Kajenje \nprepovedano.  \nFI Suojaa lämmöltä, kuumilta pinnoilta, kipinöiltä, \navotulelta ja muilta sytytyslähteiltä. Tupakointi \nkielletty.  \nSV Får inte utsättas för värme, heta ytor, gnistor, \nöppen låga eller andra antändningskällor. \nRökning förbjuden.  \n▼B \nP211  Language  \nBG Да не се пръска към открит пламък или друг \nизточник на запалване.  \nES No pulverizar sobre una llama abierta u otra \nfuente de ignición.  \nCS Nestříkejte do otevřeného ohně nebo jiných \nzdrojů zapálení.  \nDA Spray ikke mod åben ild eller andre antændel\xad\nseskilder.  \nDE Nicht gegen offene Flamme oder andere Zünd\xad\nquelle sprühen.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 355}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 357  \nP211  Language  \nET Mitte pihustada leekidesse või muusse süüteal\xad\nlikasse.  \nEL Μην ψεκάζετε κοντά σε γυμνή φλόγα ή άλλη \nπηγή ανάφλεξης.  \nEN Do not spray on an open flame or other ignition \nsource.  \nFR Ne pas vaporiser sur une flamme nue ou sur \ntoute autre source d’ignition.  \nGA Ná spraeáil ar lasair gan chosaint ná ar fhoinse \neile adhainte.  \n▼M5 \nHR Ne prskati u otvoreni plamen ili drugi izvor \npaljenja.  \n▼B \nIT Non vaporizzare su una fiamma libera o altra \nfonte di accensione.  \nLV Neizsmidzināt uz atklātas uguns vai citiem \naizdegšanās avotiem.  \nLT Nepurkšti į atvirą liepsną arba kitus degimo \nšaltinius.  \nHU Tilos nyílt lángra vagy más gyújtóforrásra \npermetezni.  \nMT Tisprejjax fuq fjamma mikxufa jew sors ieħor li \njaqbad.  \nNL Niet in een open vuur of op andere ontstekings\xad\nbronnen spuiten.  \nPL Nie rozpylać nad otwartym ogniem lub innym \nźródłem zapłonu.  \nPT Não pulverizar sobre chama aberta ou outra \nfonte de ignição.  \nRO Nu pulverizaţi deasupra unei flăcări deschise \nsau unei alte surse de aprindere.  \nSK Nestriekajte na otvorený oheň ani iný zdroj \nzapálenia.  \nSL Ne pršiti proti odprtemu ognju ali drugemu viru \nvžiga.  \nFI Ei saa suihkuttaa avotuleen tai muuhun sytytys\xad\nlähteeseen.  \nSV Spreja inte över öppen låga eller andra antänd\xad\nningskällor.  \n▼M19  \nP212  Language  \nBG Да се избягва нагряване в затворено \nпространство или понижаване на \nсъдържанието на десенсибилизиращия агент.  \nES Evitar el calentamiento en condiciones de aisla\xad\nmiento o la reducción del agente insensibiliz\xad\nante.  \nCS Zamezte zahřívání v uzavřeném obalu nebo \nsnížení objemu znecitlivujícího prostředku.  \nDA Undgå opvarmning under indeslutning eller \nreduktion af det desensibiliserende middel."  \nDE Erhitzen unter Einschluss und Reduzierung des \nDesensibilisierungsmittels vermeiden.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 356}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 358  \nP212  Language  \nET Vältida suletuna kuumutamist ja desensibili\xad\nsaatori vähenemist.  \nEL Να αποφεύγεται η θέρμανση σε περιορισμένο \nχώρο και η μείωση του παράγοντα \nαπευαισθητοποίησης.  \nEN Avoid heating under confinement or reduction \nof the desensitising agent.  \nFR Éviter d'échauffer en milieu confiné ou en cas \nde diminution de la quantité d'agent désensibili\xad\nsateur.  \nGA Seachain an téamh i limistéar iata nó i gcás \nlaghdú ar an dí-íogróir.  \nHR Izbjegavati zagrijavanje u zatvorenom prostoru \nili smanjenje udjela desenzitirajućeg agensa.  \nIT Evitare di riscaldare sotto confinamento o di \nridurre l'agente desensibilizzante.  \nLV Nepieļaut karsēšanu slēgtā vidē vai desensibi\xad\nlizējošā aģenta daudzuma samazināšanos.”  \nLT Vengti kaitimo uždaroje talpykloje arba desen\xad\nsibilizacijos veiksnio poveikio sumažėjimo.  \nHU Kerülje a hevítést zárt térben vagy a deszenzi\xad\nbilizáló szer mennyiségének csökkenése esetén.  \nMT Evita t-tisħin fil-magħluq jew it-tnaqqis tal- \naġenti disensitizzanti.  \nNL Vermijd verwarming onder opsluiting of \nvermindering van de ongevoeligheidsagens.  \nPL Unikać ogrzewania pod zamknięciem lub w \nsytuacji zmniejszonej zawartości środka odczu\xad\nlającego.”  \nPT Evitar o aquecimento em ambiente fechado ou \na redução do agente dessensibilizado.»  \nRO A se evita încălzirea în mediu confinat sau în \ncaz de scădere a agentului de desensibilizare  \nSK Zabráňte zahrievaniu v ohraničenom priestore \nalebo zníženiu obsahu desenzibilizačného \nčinidla.  \nSL Izogibati se segrevanju v zaprtem prostoru ali \nzmanjšanju vsebnosti desenzibilizatorja.“.  \nFI Vältettävä kuumentamista suljetussa astiassa tai \nflegmatointiaineen vähentämistä.  \nSV Undvik uppvärmning i sluten behållare eller \nreducering av det okänsliggörande ämnet.  \n▼M12  \nP220  Language  \nBG Да се държи далеч от облекло и други \nгорими материали.  \nES Mantener alejado de la ropa y otros materiales \ncombustibles.  \nCS Uchovávejte odděleně od oděvů a jiných \nhořlavých materiálů.  \nDA Holdes væk fra beklædningsgenstande og andre \nbrændbare materialer.  \nDE Von Kleidung und anderen brennbaren \nMaterialien fernhalten.  ▼M19", metadata={'source': 'data/ycla_en.pdf', 'page': 357}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 359  \nP220  Language  \nET Hoida eemal rõivastest ja muust süttivast mater\xad\njalist.  \nEL Να φυλάσσεται μακριά από ενδύματα και άλλα \nκαύσιμα υλικά.  \nEN Keep away from clothing and other \ncombustible materials.  \nFR Tenir à l'écart des vêtements et d'autres matières \ncombustibles.  \nGA Coimeád glan ar éadaí agus ar ábhair indóite \neile. \nHR Čuvati odvojeno od odjeće i drugih zapaljivih \nmaterijala.  \nIT Tenere lontano da indumenti e altri materiali \ncombustibili.  \nLV Nepieļaut saskari ar apģērbu un citiem uzlies\xad\nmojošiem materiāliem.  \nLT Laikyti atokiau nuo drabužių bei kitų degiųjų \nmedžiagų.  \nHU Ruhától és más éghető anyagoktól távol tart\xad\nandó.  \nMT Żomm 'il bogħod mill-ħwejjeġ u materjali oħra \nli jaqbdu.  \nNL Verwijderd houden van kleding en andere \nbrandbare materialen.  \nPL Trzymać z dala od odzieży i innych materiałów \nzapalnych.  \nPT Manter afastado da roupa e de outras matérias \ncombustíveis.  \nRO A se păstra departe de îmbrăcăminte și de alte \nmateriale combustibile.  \nSK Uchovávajte mimo odevov a iných horľavých \nmateriálov.  \nSL Hraniti ločeno od oblačil in drugih vnetljivih \nmaterialov.  \nFI Pidä erillään vaatetuksesta ja muista syttyvistä \nmateriaaleista.  \nSV Hålls åtskilt från kläder och andra brännbara \nmaterial.  \n__________  \n▼B \nP222  Language  \nBG Не допускайте конктакт с въздух.  \nES No dejar que entre en contacto con el aire.  \nCS Zabraňte styku se vzduchem.  \nDA Undgå kontakt med luft.  \nDE ►C3 Keinen Kontakt mit Luft zulassen. ◄  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 358}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 360  \nP222  Language  \nET Hoida õhuga kokkupuute eest.  \nEL Να μην έρθει σε επαφή με τον αέρα.  \nEN Do not allow contact with air.  \nFR Ne pas laisser au contact de l’air.  \nGA Ná ceadaigh teagmháil le haer.  \n▼M5 \nHR Spriječiti dodir sa zrakom.  \n▼B \nIT Evitare il contatto con l’aria.  \nLV Nepieļaut kontaktu ar gaisu.  \nLT Saugoti nuo kontakto su oru.  \nHU Nem érintkezhet levegővel.  \nMT Tħallix li jkun hemm kuntatt ma' l-arja.  \nNL Contact met de lucht vermijden.  \nPL Nie dopuszczać do kontaktu z powietrzem.  \nPT Não deixar entrar em contacto com o ar.  \nRO A nu se lăsa în contact cu aerul.  \nSK Zabráňte kontaktu so vzduchom.  \nSL Preprečiti stik z zrakom.  \nFI Ei saa joutua kosketuksiin ilman kanssa.  \nSV Undvik kontakt med luft.  \n▼M4 \nP223  Language  \nBG Не допускайте контакт с вода.  \nES Evitar el contacto con el agua.  \nCS Zabraňte styku s vodou.  \nDA Undgå kontakt med vand.  \nDE Keinen Kontakt mit Wasser zulassen.  \nET Vältida kokkupuudet veega.  \nEL Μην επιτρέπετε την επαφή με το νερό.  \nEN Do not allow contact with water.  \nFR Éviter tout contact avec l’eau.  \nGA Ná bíodh aon teagmháil le huisce.  \n▼M8 \nHR Spriječiti dodir s vodom.  \n▼M4 \nIT Evitare qualunque contatto con l’acqua.  \nLV Nepieļaut saskari ar ūdeni.  \nLT Saugoti nuo sąlyčio su vandeniu.  \nHU Nem érintkezhet vízzel.  \nMT Tħallihx imiss mal-ilma.  \nNL Contact met water vermijden.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 359}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 361  \nP223  Language  \nPL Nie dopuszczać do kontaktu z wodą.  \nPT Não deixar entrar em contacto com a água.  \nRO A nu se lăsa în contact cu apa.  \nSK Zabráňte kontaktu s vodou.  \nSL Preprečiti stik z vodo.  \nFI Ei saa joutua kosketuksiin veden kanssa.  \nSV Undvik all kontakt med vatten.  \n▼B \nP230  Language  \nBG Да се държи навлажнен с…  \nES Mantener humedecido con…  \nCS Uchovávejte ve zvlhčeném stavu…  \nDA Holdes befugtet med…  \nDE Feucht halten mit …  \nET Niisutada …-ga.  \nEL Να διατηρείται υγρό με …  \nEN Keep wetted with…  \nFR Maintenir humidifié avec…  \nGA Coimeád fliuchta le…  \n▼M5 \nHR Čuvati navlaženo s …  \n▼B \nIT Mantenere umido con…  \nLV Vienmēr samitrināt ar …  \nLT Laikyti sudrėkintą (kuo)  \nHU …-val/-vel nedvesítve tartandó.  \nMT Żommu mxarrab bi …  \nNL Vochtig houden met…  \nPL Przechowywać produkt zwilżony…  \nPT Manter húmido com…  \nRO A se păstra umezit cu…  \nSK Uchovávajte zvlhčené …  \nSL Hraniti prepojeno z …  \nFI Säilytä kostutettuna …  \nSV Ska hållas fuktigt med…  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 360}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 362  \nP231  Language  \nBG Да се използва и съхранява съдържанието \nпод инертен газ/…  \nES Manipular y almacenar el contenido en un \nmedio de gas inerte /…  \nCS Manipulace a skladování pod inertním \nplynem /…  \nDA Håndteres og opbevares under inert gas/…  \nDE Inhalt unter inertem Gas/… handhaben und \naufbewahren.  \nET Sisu käidelda ja hoida inertgaasis/…  \nEL Ο χειρισμός και η αποθήκευση του υλικού \nνα γίνεται υπό αδρανές αέριο/ …  \nEN Handle and store contents under inert gas/…  \nFR Manipuler et stocker le contenu sous gaz \ninerte/…  \nGA Láimhsigh agus stóráil an t-ábhar faoi \nthriathghás/…  \nHR Rukovati i skladištiti u inertnom plinu /…  \nIT Manipolare e conservare in atmosfera di gas \ninerte/…  \nLV Saturu izmantot un glabāt tikai inertas gāzes \nvidē/…  \nLT Turinį tvarkyti ir laikyti inertinėse dujose/…  \nHU Tartalma inert gázban /… használandó és \ntárolandó.  \nMT Uża u aħżen il-kontenut taħt gass inerti /…  \nNL Inhoud onder inert gas/… gebruiken en \nbewaren.  \nPL Używać i przechowywać zawartość w \natmosferze obojętnego gazu /…  \nPT Manusear e armazenar o conteúdo em \natmosfera de gás inerte/…  \nRO A se manipula și a se depozita conţinutul \nsub un gaz inert/…  \nSK Manipulujte s obsahom a skladujte ho \nv prostredí s inertným plynom/…  \nSL Ravnati z vsebino in jo hraniti v inertnem \nplinu/…  \nFI Käsittele ja varastoi sisältö inertissä \nkaasussa/…  \nSV Hantera och förvara innehållet under inert \ngas/…  \n▼B \nP232  Language  \nBG Да се пази от влага.  \nES Proteger de la humedad.  \nCS Chraňte před vlhkem.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 361}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 363  \nP232  Language  \nDA Beskyttes mod fugt.  \nDE Vor Feuchtigkeit schützen.  \nET Hoida niiskuse eest.  \nEL Προστετέψτε από την υγρασία.  \nEN Protect from moisture.  \nFR Protéger de l’humidité.  \nGA Cosain ar thaise.  \n▼M5 \nHR Zaštititi od vlage.  \n▼B \nIT Proteggere dall’umidità.  \nLV Aizsargāt no mitruma.  \nLT Saugoti nuo drėgmės.  \nHU Nedvességtől védendő.  \nMT Ipproteġi mill-umdità.  \nNL Tegen vocht beschermen.  \nPL Chronić przed wilgocią.  \nPT Manter ao abrigo da humidade.  \nRO A se proteja de umiditate.  \nSK Chráňte pred vlhkosťou.  \nSL Zaščititi pred vlago.  \nFI Suojaa kosteudelta.  \nSV Skyddas från fukt.  \nP233  Language  \nBG Съдът да се съхранява плътно затворен.  \nES Mantener el recipiente herméticamente cerrado.  \nCS Uchovávejte obal těsně uzavřený.  \nDA Hold beholderen tæt lukket.  \nDE Behälter dicht verschlossen halten.  \nET Hoida pakend tihedalt suletuna.  \nEL Να διατηρείται ο περιέκτης ερμητικά κλειστός.  \nEN Keep container tightly closed.  \nFR Maintenir le récipient fermé de manière \nétanche.  \nGA Coimeád an coimeádán dúnta go docht.  \n▼M5 \nHR Čuvati u dobro zatvorenom spremniku.  \n▼B \nIT Tenere il recipiente ben chiuso.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 362}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 364  \nP233  Language  \nLV Tvertni stingri noslēgt.  \nLT Talpyklą laikyti sandariai uždarytą.  \nHU Az edény szorosan lezárva tartandó.  \nMT Żomm il-kontenitur magħluq sew.  \nNL In goed gesloten verpakking bewaren.  \nPL Przechowywać pojemnik szczelnie zamknięty.  \nPT Manter o recipiente bem fechado.  \nRO Păstraţi recipientul închis etanș.  \nSK Nádobu uchovávajte tesne uzavretú.  \nSL Hraniti v tesno zaprti posodi.  \nFI Säilytä tiiviisti suljettuna.  \nSV Behållaren ska vara väl tillsluten.  \n▼M12  \nP234  Language  \nBG Да се съхранява само в оригиналната \nопаковка.  \nES Conservar únicamente en el embalaje original.  \nCS Uchovávejte pouze v původním balení.  \nDA Opbevares kun i originalemballagen.  \nDE Nur in Originalverpackung aufbewahren.  \nET Hoida üksnes originaalpakendis.  \nEL Να διατηρείται μόνο στην αρχική συσκευασία.  \nEN Keep only in original packaging.  \nFR Conserver uniquement dans l'emballage d'ori\xad\ngine.  \nGA Coimeád sa phacáistiú bunaidh amháin.  \nHR Čuvati samo u originalnom pakiranju.  \nIT Conservare soltanto nell'imballaggio originale.  \nLV Turēt tikai oriģināliepakojumā.  \nLT Laikyti tik originalioje pakuotėje.  \nHU Az eredeti csomagolásban tartandó.  \nMT Żomm biss fl-imballaġġ oriġinali.  \nNL Uitsluitend in de oorspronkelijke verpakking \nbewaren.  \nPL Przechowywać wyłącznie w oryginalnym \nopakowaniu.  \nPT Mantenha sempre o produto na sua embalagem \noriginal.  \nRO A se păstra numai în ambalajul original.  \nSK Uchovávajte iba v pôvodnom balení.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 363}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 365  \nP234  Language  \nSL Hraniti samo v originalni embalaži.  \nFI Säilytä alkuperäispakkauksessa.  \nSV Förvaras endast i originalförpackningen.  \n▼B \nP235  Language  \nBG Да се държи на хладно.  \nES Mantener en lugar fresco.  \nCS Uchovávejte v chladu.  \nDA Opbevares køligt.  \nDE Kühl halten.  \nET Hoida jahedas.  \nEL Να διατηρείται δροσερό.  \nEN Keep cool.  \nFR Tenir au frais.  \nGA Coimeád fionnuar é  \n▼M5 \nHR Održavati hladnim.  \n▼B \nIT Conservare in luogo fresco.  \nLV Turēt vēsumā.  \nLT Laikyti vėsioje vietoje.  \nHU Hűvös helyen tartandó.  \nMT Żomm frisk.  \nNL Koel bewaren.  \nPL Przechowywać w chłodnym miejscu.  \nPT Conservar em ambiente fresco.  \nRO A se păstra la rece.  \nSK Uchovávajte v chlade.  \nSL Hraniti na hladnem.  \nFI Säilytä viileässä.  \nSV Förvaras svalt.  \n▼M12  \nP240  Language  \nBG Заземяване и еквипотенциална връзка на \nсъда и приемателното устройство.  \nES Toma de tierra y enlace equipotencial del \nrecipiente y del equipo receptor.  \nCS Uzemněte a upevněte obal a odběrové zařízení.  \nDA Beholder og modtageudstyr jordforbindes/ \npotentialudlignes.  \nDE Behälter und zu befüllende Anlage erden.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 364}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 366  \nP240  Language  \nET Mahuti ja vastuvõtuseade maandada ja ühen\xad\ndada.  \nEL Γείωση και ισοδυναμική σύνδεση του περιέκτη \nκαι του εξοπλισμού του δέκτη.  \nEN Ground and bond container and receiving \nequipment.  \nFR Mise à la terre et liaison équipotentielle du \nrécipient et du matériel de réception.  \nGA Nasc an coimeádán agus an trealamh glactha \nleis an talamh.  \nHR Uzemljiti i učvrstiti spremnik i opremu za \nprihvat kemikalije.  \nIT Mettere a terra e a massa il contenitore e il \ndispositivo ricevente.  \nLV Tvertnes un saņēmējiekārtas iezemēt un \nsavienot.  \nLT Įžeminti ir įtvirtinti talpyklą ir priėmimo įrangą.  \nHU A tárolóedényt és a fogadóedényt le kell \nföldelni és át kell kötni.  \nMT Poġġi mal-art u waħħal il-kontenitur u t-tagħmir \nriċevitur.  \nNL Opslag- en opvangreservoir aarden.  \nPL Uziemić i połączyć pojemnik i sprzęt \nodbiorczy.  \nPT Ligação à terra/equipotencial do recipiente e do \nequipamento recetor.  \nRO Legătură la pământ și conexiune echipotenţială \ncu recipientul și cu echipamentul de recepţie.  \nSK Uzemnite a upevnite nádobu a plniace \nzariadenie.  \nSL Ozemljiti posodo in opremo za sprejem \ntekočine ter izenačiti potenciale.  \nFI Maadoita ja yhdistä säiliö ja vastaanottavat lait\xad\nteet. \nSV Jorda och potentialförbind behållare och motta\xad\ngarutrustning.  \nP241  Language  \nBG Използвайте [електрическо/вентилационно/ \nосветително/…] оборудване, обезопасено \nсрещу експлозия.  \nES Utilizar material [eléctrico / de ventilación/ \niluminación / …] antideflagrante.  \nCS Používejte [elektrické/ventilační/osvětlovací/…] \nzařízení do výbušného prostředí.  \nDA Anvend eksplosionssikkert [elektrisk/venti\xad\nlations-/lys-/…] udstyr.  \nDE Explosionsgeschützte [elektrische/Lüftungs-/ \nBeleuchtungs-/…] Geräte verwenden.  \nET Kasutada plahvatuskindlaid [elektri-/ventil\xad\natsiooni-/valgustus-/…] seadmeid.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 365}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 367  \nP241  Language  \nEL Να χρησιμοποιείται αντιεκρηκτικός εξοπλισμός \n[ηλεκτρολογικός /εξαερισμού/φωτιστικός/…].  \nEN Use explosion-proof [electrical/ventilating/ \nlighting/…] equipment.  \nFR Utiliser du matériel [électrique/de ventilation/ \nd'éclairage/…] antidéflagrant.  \nGA Bain úsáid as trealamh pléascdhíonach [leic\xad\ntreach/ aerála/soilsiúcháin/…].  \nHR Rabiti [električnu/ventilacijsku/rasvjetnu/…] \nopremu koja neće izazvati eksploziju.  \nIT Utilizzare impianti [elettrici/di ventilazione/d'il\xad\nluminazione/…] a prova di esplosione.  \nLV Izmantot sprādziendrošas [elektriskās/ \nventilācijas/apgaismošanas/…] iekārtas.  \nLT Naudoti sprogimui atsparią [elektros/venti\xad\nliacijos/apšvietimo/…] įrangą.  \nHU Robbanásbiztos [elektromos/szellőztető/világító/ \n…] berendezés használandó.  \nMT Uża' tagħmir [elettriku / ta' ventilazzjoni / ta' \ndawl/…] li jiflaħ għal splużjoni.  \nNL Explosieveilige [elektrische/ventilatie-/verlich\xad\ntings-/…]apparatuur gebruiken.  \nPL Używać [elektrycznego/wentylującego/ \noświetleniowego/…/] przeciwwybuchowego \nsprzętu.  \nPT Utilizar equipamento [elétrico/de ventilação/de \niluminação/…] à prova de explosão.  \nRO Utilizaţi echipamente [electrice/de ventilare/de \niluminat/…] antideflagrante.  \nSK Používajte [elektrické/ventilačné/osvetľovacie/ \n…] zariadenie do výbušného prostredia.  \nSL Uporabiti [električno opremo/prezračevalno \nopremo/ opremo za razsvetljavo/…], odporno \nproti eksplozijam.  \nFI Käytä räjähdysturvallisia [sähkö/ilmanvaihto/ \nvalaisin/…]laitteita.  \nSV Använd explosionssäker [elektrisk/ventilations-/ \nbelysnings-/…]utrustning.  \nP242  Language  \nBG Използвайте инструменти, които не \nпредизвикват искри.  \nES No utilizar herramientas que produzcan chispas.  \nCS Používejte nářadí z nejiskřícího kovu.  \nDA Anvend værktøj, som ikke frembringer gnister.  \nDE Funkenarmes Werkzeug verwenden.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 366}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 368  \nP242  Language  \nET Mitte kasutada seadmeid, mis võivad tekitada \nsädemeid.  \nEL Να χρησιμοποιούνται μη σπινθηρογόνα \nεργαλεία.  \nEN Use non-sparking tools.  \nFR Utiliser des outils ne produisant pas d'étincelles.  \nGA Bain úsáid as uirlisí neamhspréachta.  \nHR Rabiti neiskreći alat.  \nIT Utilizzare utensili antiscintillamento.  \nLV Izmantot instrumentus, kas nerada dzirksteles.  \nLT Naudoti kibirkščių nekeliančius įrankius.  \nHU Szikramentes eszközök használandók.  \nMT Uża għodda li ma ttajjarx żnied.  \nNL Vonkvrij gereedschap gebruiken.  \nPL Używać nieiskrzących narzędzi.  \nPT Utilizar ferramentas antichispa.  \nRO Nu utilizaţi unelte care produc scântei.  \nSK Používajte neiskriace prístroje.  \nSL Uporabiti orodje, ki ne povzroča isker.  \nFI Käytä kipinöimättömiä työkaluja.  \nSV Använd verktyg som inte ger upphov till \ngnistor.  \nP243  Language  \nBG Предприемете действия за предотвратяване \nна освобождаването на статично \nелектричество.  \nES Tomar medidas de precaución contra las \ndescargas electrostáticas.  \nCS Proveďte opatření proti výbojům statické \nelektřiny.  \nDA Træf foranstaltninger mod statisk elektricitet.  \nDE Maßnahmen gegen elektrostatische Entladungen \ntreffen.  \nET Rakendada abinõusid staatilise elektri välti\xad\nmiseks.  \nEL Λάβετε μέτρα για την αποτροπή ηλεκτροστ- \nατικών εκκενώσεων.  \nEN Take action to prevent static discharges.  \nFR Prendre des mesures de précaution contre les \ndécharges électrostatiques.  \nGA Déan bearta in aghaidh díluchtú statach.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 367}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 369  \nP243  Language  \nHR Poduzeti mjere za sprečavanje statičkog elektri\xad\nciteta.  \nIT Fare in modo di prevenire le scariche elettros\xad\ntatiche.  \nLV Nodrošināties pret statiskās enerģijas izlādi.  \nLT Imtis veiksmų statinei iškrovai išvengti.  \nHU Az elektrosztatikus kisülés megakadályozására \nóvintézkedéseket kell tenni.  \nMT Ħu azzjoni biex tipprevjeni l-ħruġ ta' elettriku \nstatiku.  \nNL Maatregelen treffen om ontladingen van \nstatische elektriciteit te voorkomen.  \nPL Podjąć działania zapobiegające wyładowaniom \nelektrostatycznym.  \nPT Tomar medidas para evitar acumulação de \ncargas eletrostáticas.  \nRO Luaţi măsuri de precauţie împotriva \ndescărcărilor electrostatice.  \nSK Vykonajte opatrenia na zabránenie výbojom \nstatickej elektriny.  \nSL Ukrepati za preprečitev statičnega naelektrenja.  \nFI Estä staattisen sähkön aiheuttama kipinöinti.  \nSV Vidta åtgärder mot statisk elektricitet.  \n▼M4 \nP244  Language  \nBG Поддържайте вентилите и фитингите чисти \nот масло и смазка.  \nES Mantener las valvulas y los racores libres de \naceite y grasa.  \nCS Udržujte ventily i příslušenství čisté — bez \nolejů a maziv.  \nDA Hold ventiler og tilslutninger frie for olie og \nfedt. \nDE Ventile und Ausrüstungsteile öl- und fettfrei \nhalten.  \nET Hoida ventiilid ja liitmikud õlist ja rasvast \npuhtad.  \nEL Διατηρείτε τα κλείστρα και τους συνδέσμους \nκαθαρά από λάδια και γράσα.  \nEN Keep valves and fittings free from oil and \ngrease.  \nFR Ni huile, ni graisse sur les robinets et raccords.  \nGA Coinnigh comhlaí agus feistis saor ó ola agus ó \nghréisc.  \n▼M8 \nHR Spriječiti dodir ventila i spojnica s uljem i \nmasti.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 368}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 370  \nP244  Language  \nIT Mantenere le valvole e i raccordi liberi da olio \ne grasso.  \nLV Uzturēt ventiļus un savienojumus tīrus no eļļas \nun taukvielām.  \nLT Saugoti, kad ant vožtuvų ir jungiamųjų detalių \nnepatektų alyvos ir tepalų.  \nHU A szelepeket és szerelvényeket zsírtól és olajtól \nmentesen kell tartani.  \nMT Żomm il-valvi u  fittings  ħielsa miż-żejt u l-  \ngrease . \nNL Houd afsluiters en fittingen vrij van olie en vet.  \nPL Chronić zawory i przyłącza przed olejem i \ntłuszczem.  \nPT Manter válvulas e conexões isentas de óleo e \ngordura.  \nRO Feriţi valvele și racordurile de ulei și grăsime.  \nSK Udržujte ventily a príslušenstvo čisté, bez \nolejov a mazív.  \nSL Preprečiti stik ventilov in opreme z oljem in \nmastjo.  \nFI Pidä venttiilit ja liittimet vapaana öljystä ja \nrasvasta.  \nSV Håll ventiler och anslutningar fria från olja och \nfett. \n▼M12  \nP250  Language  \nBG Да не се подлага на стържене/удар/триене…  \nES Evitar abrasiones/choques/fricciones/… .  \nCS Nevystavujte obrušování/nárazům/tření/… .  \nDA Må ikke udsættes for slibning/stød/gnidning/….  \nDE Nicht schleifen/stoßen/reiben/… .  \nET Hoida kriimustamise/põrutuse/hõõrdumise/… \neest. \nEL Να αποφεύγεται άλεση/κρούση/τριβή/… .  \nEN Do not subject to grinding/shock/friction/… .  \nFR Éviter les abrasions/les chocs/les frottements/… .  \nGA Ná nocht do mheilt/do thurraing/do fhrith\xad\nchuimilt/… .  \nHR Ne izlagati mrvljenju/udarcima/trenju/…  \nIT Evitare le abrasioni/gli urti/gli attriti/… .  \nLV Nepakļaut drupināšanai/triecienam/berzei/… .  \nLT Nešlifuoti/netrankyti/…/netrinti.  \nHU Tilos csiszolásnak/ütésnek/súrlódásnak/… \nkitenni.  \nMT Tissottoponix għal brix / xokk / frizzjoni /… .  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 369}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 371  \nP250  Language  \nNL Malen/schokken/wrijving/… vermijden.  \nPL Nie poddawać szlifowaniu/wstrząsom/tarciu/….  \nPT Não submeter a trituração/choque/fricção/… .  \nRO A nu se supune la abraziuni/șocuri/frecare/… .  \nSK Nevystavujte brúseniu/nárazu/treniu/… .  \nSL Ne izpostavljati drgnjenju/udarcem/trenju/… .  \nFI Suojele rasitukselta/iskuilta/hankaukselta/….  \nSV Får inte utsättas för malning/stötar/friktion/… .  \n▼M4 \nP251  Language  \nBG Да не се пробива и изгаря дори след \nупотреба.  \nES No perforar ni quemar, incluso después de su \nuso. \nCS Nepropichujte nebo nespalujte ani po použití.  \nDA Må ikke punkteres eller brændes, heller ikke \nefter brug.  \nDE Nicht durchstechen oder verbrennen, auch nicht \nnach Gebrauch.  \nET Mitte purustada ega põletada isegi pärast kasu\xad\ntamist.  \nEL Να μην τρυπηθεί ή καεί ακόμη και μετά τη \nχρήση.  \nEN Do not pierce or burn, even after use.  \nFR Ne pas perforer, ni brûler, même après usage.  \nGA Ná toll agus ná dóigh, fiú tar éis úsáide.  \n▼M8 \nHR Ne bušiti, niti paliti čak niti nakon uporabe.  \n▼M4 \nIT Non perforare né bruciare, neppure dopo l’uso.  \nLV Nedurt vai nededzināt, arī pēc izlietošanas.  \nLT Nepradurti ir nedeginti net panaudoto.  \nHU Ne lyukassza ki vagy égesse el, még használat \nután sem.  \nMT Ittaqqbux u taħarqux, anki wara li tużah.  \nNL Ook na gebruik niet doorboren of verbranden.  \nPL Nie przekłuwać ani nie spalać, nawet po \nzużyciu.  \nPT Não furar nem queimar, mesmo após utilização.  \nRO Nu perforaţi sau ardeţi, chiar și după utilizare.  \nSK Neprepichujte alebo nespaľujte ju, a to ani po \nspotrebovaní obsahu.  \nSL Ne preluknjajte ali sežigajte je niti, ko je \nprazna.  \nFI Ei saa puhkaista tai polttaa edes tyhjänä.  \nSV Får inte punkteras eller brännas, gäller även \ntömd behållare.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 370}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 372  \nP260  Language  \nBG Не вдишвайте прах/пушек/газ/дим/ \nизпарения/аерозоли  \nES No respirar el polvo/el humo/el gas/la niebla/los \nvapores/el aerosol.  \nCS Nevdechujte prach/dým/plyn/mlhu/páry/ \naerosoly.  \nDA Indånd ikke pulver/røg/gas/tåge/damp/spray.  \nDE Staub/Rauch/Gas/Nebel/Dampf/Aerosol nicht \neinatmen.  \nET Tolmu/suitsu/gaasi/udu/auru/pihustatud ainet \nmitte sisse hingata.  \nEL Μην αναπνέετε σκόνη/αναθυμιάσεις/αέρια/ \nσταγονίδια/ατμούς/εκνεφώματα  \nEN Do not breathe dust/fume/gas/mist/vapours/ \nspray.  \nFR Ne pas respirer les poussières/fumées/gaz/ \nbrouillards/vapeurs/aérosols.  \nGA Ná hanálaigh deannach/múch/gás/ceo/gala/ \nsprae.  \n▼M5 \nHR Ne udisati prašinu/dim/plin/maglu/pare/aerosol.  \n▼B \nIT Non respirare la polvere/i fumi/i gas/la nebbia/i \nvapori/gli aerosol.  \nLV Neieelpot putekļus/tvaikus/gāzi/dūmus/izgaro\xad\njumus/smidzinājumu.  \nLT Neįkvėpti dulkių/dūmų/dujų/rūko/garų/aero\xad\nzolio.  \nHU A por/füst/gáz/köd/gőzök/permet belélegzése \ntilos.  \nMT Tiblax bin-nifs trabijiet/dħaħen/gass/raxx/fwar/ \nsprej.  \nNL Stof/rook/gas/nevel/damp/spuitnevel niet \ninademen.  \nPL Nie wdychać pyłu/dymu/gazu/mgły/par/ \nrozpylonej cieczy.  \nPT Não respirar as poeiras/fumos/gases/névoas/ \nvapores/aerossóis.  \nRO Nu inspiraţi praful/fumul/gazul/ceaţa/vaporii/ \nspray-ul.  \nSK Nevdychujte prach/dym/plyn/hmlu/pary/ \naerosóly.  \nSL Ne vdihavati prahu/dima/plina/meglice/hlapov/ \nrazpršila.  \nFI Älä hengitä pölyä/savua/kaasua/sumua/höyryä/ \nsuihketta.  \nSV Inandas inte damm/rök/gaser/dimma/ångor/ \nsprej.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 371}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 373  \nP261  Language  \nBG Избягвайте вдишване на прах/пушек/газ/дим/ \nизпарения/аерозоли  \nES Evitar respirar el polvo/el humo/el gas/la niebla/ \nlos vapores/el aerosol.  \nCS Zamezte vdechování prachu/dýmu/plynu/mlhy/ \npar/aerosolů.  \nDA Undgå indånding af pulver/røg/gas/tåge/damp/ \nspray.  \nDE Einatmen von Staub/Rauch/Gas/Nebel/Dampf/ \nAerosol vermeiden.  \nET Vältida tolmu/suitsu/gaasi/udu/auru/pihustatud \naine sissehingamist.  \nEL Aποφεύγετε να αναπνέετε σκόνη/αναθυμιάσεις/ \nαέρια/σταγονίδια/ατμούς/εκνεφώματα.  \nEN Avoid breathing dust/fume/gas/mist/vapours/ \nspray.  \nFR Éviter de respirer les poussières/fumées/gaz/ \nbrouillards/vapeurs/aérosols.  \nGA Seachain deannach/múch/gás/ceo/gala/sprae a \nanálú.  \n▼M5 \nHR Izbjegavati udisanje prašine/dima/plina/magle/ \npare/aerosola.  \n▼B \nIT Evitare di respirare la polvere/i fumi/i gas/la \nnebbia/i vapori/gli aerosol.  \nLV Izvairīties ieelpot putekļus/tvaikus/gāzi/dūmus/ \nizgarojumus/smidzinājumu.  \nLT Stengtis neįkvėpti dulkių/dūmų/dujų/rūko/garų/ \naerozolio.  \nHU Kerülje a por/füst/gáz/köd/gőzök/permet belé\xad\nlegzését.  \nMT Evita li tibla' bin-nifs trabijiet/dħaħen/gass/raxx/ \nfwar/sprej.  \nNL Inademing van stof/rook/gas/nevel/damp/ \nspuitnevel vermijden.  \nPL Unikać wdychania pyłu/dymu/gazu/mgły/par/ \nrozpylonej cieczy.  \nPT Evitar respirar as poeiras/fumos/gases/névoas/ \nvapores/aerossóis.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 372}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 374  \nP261  Language  \nRO Evitaţi să inspiraţi praful/fumul/gazul/ceaţa/ \nvaporii/spray-ul.  \nSK Zabráňte vdychovaniu prachu/dymu/plynu/ \nhmly/pár/aerosólov.  \nSL Ne vdihavati prahu/dima/plina/meglice/hlapov/ \nrazpršila.  \nFI Vältä pölyn/savun/kaasun/sumun/höyryn/ \nsuihkeen hengittämistä.  \nSV Undvik att inandas damm/rök/gaser/dimma/ \nångor/sprej.  \nP262  Language  \nBG Да се избягва контакт с очите, кожата или \nоблеклото.  \nES Evitar el contacto con los ojos, la piel o la ropa.  \nCS Zabraňte styku s očima, kůží nebo oděvem.  \nDA Må ikke komme i kontakt med øjne, hud eller \ntøj. \nDE Nicht in die Augen, auf die Haut oder auf die \nKleidung gelangen lassen.  \nET Vältida silma, nahale või rõivastele sattumist.  \nEL Να μην έρθει σε επαφή με τα μάτια, με το \nδέρμα ή με τα ρούχα.  \nEN Do not get in eyes, on skin, or on clothing.  \nFR Éviter tout contact avec les yeux, la peau ou les \nvêtements.  \nGA Ná lig sna súile, ar an gcraiceann, ná ar éadaí.  \n▼M5 \nHR Spriječiti dodir s očima, kožom ili odjećom.  \n▼B \nIT Evitare il contatto con gli occhi, la pelle o gli \nindumenti.  \nLV Nepieļaut nokļūšanu acīs, uz ādas vai uz \ndrēbēm.  \nLT Saugotis, kad nepatektų į akis, ant odos ar \ndrabužių.  \nHU Szembe, bőrre vagy ruhára nem kerülhet.  \nMT Iddaħħalx fl-għajnejn, fuq il-ġilda, jew fuq il- \nħwejjeġ.  \nNL Contact met de ogen, de huid of de kleding \nvermijden.  \nPL Nie wprowadzać do oczu, na skórę lub na \nodzież.  \nPT Não pode entrar em contacto com os olhos, a \npele ou a roupa.  \nRO Evitaţi orice contact cu ochii, pielea sau \nîmbrăcămintea.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 373}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 375  \nP262  Language  \nSK Zabráňte kontaktu s očami, pokožkou alebo \nodevom.  \nSL Preprečiti stik z očmi, kožo ali oblačili.  \nFI Varo kemikaalin joutumista silmiin, iholle tai \nvaatteisiin.  \nSV Får inte komma i kontakt med ögonen, huden \neller kläderna.  \n▼M12  \nP263  Language  \nBG Да се избягва контакт по време на \nбременност и при кърмене.  \nES Evitar todo contacto con la sustancia durante el \nembarazo y la lactancia.  \nCS Zabraňte styku během těhotenství a kojení.  \nDA Undgå kontakt under graviditet/amning.  \nDE Berührung während Schwangerschaft und \nStillzeit vermeiden.  \nET Vältida kokkupuudet raseduse ja imetamise ajal.  \nEL Αποφεύγετε την επαφή στη διάρκεια της \nεγκυμοσύνης και της γαλουχίας.  \nEN Avoid contact during pregnancy and while \nnursing.  \nFR Éviter tout contact avec la substance au cours \nde la grossesse et pendant l'allaitement.  \nGA Seachain teagmháil le linn toirchis agus fad \nagus atá an chíoch á tabhairt.  \nHR Izbjegavati dodir tijekom trudnoće i dojenja.  \nIT Evitare il contatto durante la gravidanza e l'al\xad\nlattamento.  \nLV Izvairīties no saskares grūtniecības laikā un \nbarojot bērnu ar krūti.  \nLT Vengti kontakto nėštumo metu/maitinant \nkrūtimi.  \nHU Terhesség és szoptatás alatt kerülni kell az \nanyaggal való érintkezést.  \nMT Evita l-kuntatt waqt it-tqala u t-treddigħ.  \nNL Bij zwangerschap of borstvoeding aanraking \nvermijden.  \nPL Unikać kontaktu w czasie ciąży i podczas \nkarmienia piersią.  \nPT Evitar o contacto durante a gravidez e o aleita\xad\nmento.  \nRO Evitaţi contactul în timpul sarcinii și alăptării.  \nSK Zabráňte kontaktu počas tehotenstva a dojčenia.  \nSL Preprečiti stik med nosečnostjo in dojenjem.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 374}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 376  \nP263  Language  \nFI Vältä kosketusta raskauden ja imetyksen \naikana.  \nSV Undvik kontakt under graviditet och amning.  \n▼B \nP264  Language  \nBG Да се измие… старателно след употреба.  \nES Lavarse … concienzudamente tras la manipu\xad\nlación.  \nCS Po manipulaci důkladně omyjte …  \nDA Vask … grundigt efter brug.  \nDE Nach Gebrauch … gründlich waschen.  \nET Pärast käitlemist pesta hoolega …  \nEL Πλύνετε … σχολαστικά μετά το χειρισμό.  \nEN Wash … thoroughly after handling.  \nFR Se laver … soigneusement après manipulation.  \nGA Nigh … go lánchúramach tar éis láimhsithe.  \n▼M5 \nHR Nakon uporabe temeljito oprati …  \n▼B \nIT Lavare accuratamente … dopo l’uso.  \nLV Pēc izmantošanas … kārtīgi nomazgāt.  \nLT Po naudojimo kruopščiai nuplauti …  \nHU A használatot követően a(z) … -t alaposan meg \nkell mosni.  \nMT Aħsel … sew wara li timmaniġġjah.  \nNL Na het werken met dit product … grondig \nwassen.  \nPL Dokładnie umyć … po użyciu.  \nPT Lavar … cuidadosamente após manuseamento.  \nRO Spălaţi-vă … bine după utilizare.  \nSK Po manipulácii starostlivo umyte…  \nSL Po uporabi temeljito umiti …  \nFI Pese … huolellisesti käsittelyn jälkeen.  \nSV Tvätta … grundligt efter användning.  \nP270  Language  \nBG Да не се яде, пие или пуши при употреба на \nпродукта.  \nES No comer, beber ni fumar durante su utiliza\xad\nción.  \nCS Při používání tohoto výrobku nejezte, nepijte \nani nekuřte.  \nDA Der må ikke spises, drikkes eller ryges under \nbrugen af dette produkt.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 375}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 377  \nP270  Language  \nDE Bei Gebrauch nicht essen, trinken oder rauchen.  \nET Toote käitlemise ajal mitte süüa, juua ega suit\xad\nsetada.  \nEL ►C3 Μην τρώτε, πίνετε ή καπνίζετε, όταν \nχρησιμοποιείτε αυτό το προϊόν. ◄  \nEN ►C3 Do not eat, drink or smoke when using \nthis product. ◄  \nFR Ne pas manger, boire ou fumer en manipulant \nce produit.  \nGA Ná hith, ná hól agus ná caitear tobac agus an \ntáirge seo á úsáid.  \n▼M5 \nHR Pri rukovanju proizvodom ne jesti, piti niti \npušiti.  \n▼B \nIT Non mangiare, né bere, né fumare durante \nl’uso.  \nLV Neēst, nedzert un nesmēķēt produkta \nizmantošanas laikā.  \nLT Naudojant šį produktą, nevalgyti, negerti ir \nnerūkyti.  \nHU A termék használata közben tilos enni, inni \nvagy dohányozni.  \nMT Tikolx, tixrobx u tpejjipx waqt li tuża’ dan il- \nprodott.  \nNL Niet eten, drinken of roken tijdens het gebruik \nvan dit product.  \nPL Nie jeść, nie pić i nie palić podczas używania \nproduktu.  \nPT Não comer, beber ou fumar durante a utilização \ndeste produto.  \nRO A nu mânca, bea sau fuma în timpul utilizării \nprodusului.  \nSK Pri používaní výrobku nejedzte, nepite ani \nnefajčite.  \nSL Ne jesti, piti ali kaditi med uporabo tega \nizdelka.  \nFI Syöminen, juominen ja tupakointi kielletty \nkemikaalia käytettäessä.  \nSV Ät inte, drick inte och rök inte när du använder \nprodukten.  \nP271  Language  \nBG Да се използва само на открито или на добре \nпроветривомясто.  \nES Utilizar únicamente en exteriores o en un lugar \nbien ventilado.  \nCS Používejte pouze venku nebo v dobře větraných \nprostorách.  \nDA Brug kun udendørs eller i et rum med god \nudluftning.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 376}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 378  \nP271  Language  \nDE Nur im Freien oder in gut belüfteten Räumen \nverwenden.  \nET Käidelda üksnes välitingimustes või hästi venti\xad\nleeritavas kohas.  \nEL Να χρησιμοποιείται μόνο σε ανοικτό ή καλά \nαεριζόμενο χώρο.  \nEN Use only outdoors or in a well-ventilated area.  \nFR Utiliser seulement en plein air ou dans un \nendroit bien ventilé.  \nGA Úsáid amuigh faoin aer nó i limistéar dea-aerá\xad\nlaithe amháin.  \n▼M5 \nHR Rabiti samo na otvorenom ili u dobro \nprozračenom prostoru.  \n▼B \nIT Utilizzare soltanto all’aperto o in luogo ben \nventilato.  \nLV Izmantot tikai ārā vai labi vēdināmās telpās.  \nLT Naudoti tik lauke arba gerai vėdinamoje \npatalpoje.  \nHU Kizárólag szabadban vagy jól szellőző hely\xad\niségben használható.  \nMT Uża biss barra jew f’post ventilat sew.  \nNL Alleen buiten of in een goed geventileerde \nruimte gebruiken.  \nPL Stosować wyłącznie na zewnątrz lub w dobrze \nwentylowanym pomieszczeniu  \nPT Utilizar apenas ao ar livre ou em locais bem \nventilados.  \nRO A se utiliza numai în aer liber sau în spaţii bine \nventilate.  \nSK Používajte iba na voľnom priestranstve alebo v \ndobre vetranom priestore.  \nSL Uporabljati le zunaj ali v dobro prezračevanem \nprostoru.  \nFI Käytä ainoastaan ulkona tai tiloissa, joissa on \nhyvä ilmanvaihto.  \nSV Används endast utomhus eller i väl ventilerade \nutrymmen.  \nP272  Language  \nBG Да не се изнася замърсено работно облекло \nизвън работното помещение.  \nES Las prendas de trabajo contaminadas no podrán \nsacarse del lugar de trabajo.  \nCS Kontaminovaný pracovní oděv neodnášejte z \npracoviště.  \nDA Tilsmudset arbejdstøj bør ikke fjernes fra \narbejdspladsen.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 377}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 379  \nP272  Language  \nDE Kontaminierte Arbeitskleidung nicht außerhalb \ndes Arbeitsplatzes tragen.  \nET Saastunud töörõivaid töökohast mitte välja viia.  \nEL Τα μολυσμένα ενδύματα εργασίας δεν πρέπει \nνα βγαίνουν από το χώρο εργασίας.  \nEN Contaminated work clothing should not be \nallowed out of the workplace.  \nFR Les vêtements de travail contaminés ne \ndevraient pas sortir du lieu de travail.  \nGA Níor chóir éadaí éillithe oibre a ligean amach as \nan láthair oibre.  \n▼M5 \nHR Zagađena radna odjeća ne smije se iznositi \nizvan radnog prostora.  \n▼B \nIT Gli indumenti da lavoro contaminati non \ndevono essere portati fuori dal luogo di lavoro.  \nLV Piesārņoto darba apģērbu neiznest ārpus darba \ntelpām.  \nLT Užterštų darbo drabužių negalima išnešti iš \ndarbo vietos.  \nHU Szennyezett munkaruhát tilos kivinni a \nmunkahely területéről.  \nMT Ilbies tax-xogħol kontaminat m’għandux jitħalla \njoħroġ mill-post tax-xogħol.  \nNL Verontreinigde werkkleding mag de werkruimte \nniet verlaten.  \nPL Zanieczyszczonej odzieży ochronnej nie \nwynosić poza miejsce pracy.  \nPT A roupa de trabalho contaminada não pode sair \ndo local de trabalho.  \nRO Nu scoateţi îmbrăcămintea de lucru contaminată \nîn afara locului de muncă.  \nSK Je zakázané vyniesť kontaminovaný pracovný \nodev z pracoviska.  \nSL Kontaminirana delovna oblačila niso dovoljena \nzunaj delovnega mesta.  \nFI Saastuneita työvaatteita ei saa viedä työpaikalta.  \nSV Nedstänkta arbetskläder får inte avlägsnas från \narbetsplatsen.  \nP273  Language  \nBG Да се избягва изпускане в околната среда.  \nES Evitar su liberación al medio ambiente.  \nCS Zabraňte uvolnění do životního prostředí.  \nDA Undgå udledning til miljøet.  \nDE Freisetzung in die Umwelt vermeiden.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 378}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 380  \nP273  Language  \nET Vältida sattumist keskkonda.  \nEL Να αποφεύγεται η ελευθέρωση στο περιβάλλον.  \nEN Avoid release to the environment.  \nFR Éviter le rejet dans l’environnement.  \nGA Ná scaoiltear amach sa chomhshaol.  \n▼M5 \nHR Izbjegavati ispuštanje u okoliš.  \n▼B \nIT Non disperdere nell’ambiente.  \nLV Izvairīties no izplatīšanas apkārtējā vidē.  \nLT Saugoti, kad nepatektų į aplinką.  \nHU Kerülni kell az anyagnak a környezetbe való \nkijutását.  \nMT Evita r-rilaxx fl-ambjent.  \nNL Voorkom lozing in het milieu.  \nPL Unikać uwolnienia do środowiska.  \nPT Evitar a libertação para o ambiente.  \nRO Evitaţi dispersarea în mediu.  \nSK Zabráňte uvoľneniu do životného prostredia.  \nSL Preprečiti sproščanje v okolje.  \nFI Vältettävä päästämistä ympäristöön.  \nSV Undvik utsläpp till miljön.  \nP280  Language  \nBG Използвайте предпазни ръкавици/предпазно \nоблекло/предпазни очила/предпазна маска \nза лице.  \nES Llevar guantes/prendas/gafas/máscara de protec\xad\nción.  \nCS Používejte ochranné rukavice/ochranný oděv/ \nochranné brýle/obličejový štít.  \nDA Bær beskyttelseshandsker/beskyttelsestøj/øjen\xad\nbeskyttelse/ansigtsbeskyttelse  \nDE Schutzhandschuhe/Schutzkleidung/Augen\xad\nschutz/Gesichtsschutz tragen.  \nET Kanda kaitsekindaid/kaitserõivastust/kaitse\xad\nprille/kaitsemaski.  \nEL Να φοράτε προστατευτικά γάντια/ \nπροστατευτικά ενδύματα/μέσα ατομικής \nπροστασίας για τα μάτια/πρόσωπο.  \nEN Wear protective gloves/protective clothing/eye \nprotection/face protection.  \nFR Porter des gants de protection/des vêtements de \nprotection/un équipement de protection des \nyeux/du visage.  \nGA Caith lámhainní cosanta/éadaí cosanta/cosaint \nsúile/cosaint aghaidhe.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 379}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 381  \nP280  Language  \n▼M5 \nHR Nositi zaštitne rukavice/zaštitno odijelo/zaštitu \nza oči/zaštitu za lice.  \n▼B \nIT Indossare guanti/indumenti protettivi/Proteggere \ngli occhi/il viso.  \nLV Izmantot aizsargcimdus/aizsargdrēbes/acu \naizsargus/sejas aizsargus.  \nLT Mūvėti apsaugines pirštines/dėvėti apsauginius \ndrabužius/naudoti akių (veido) apsaugos prie\xad\nmones.  \nHU Védőkesztyű/védőruha/szemvédő/arcvédő \nhasználata kötelező.  \nMT Ilbes ingwanti protettivi/ilbies protettiv/ \nprotezzjoni għall-għajnejn/protezzjoni għall- \nwiċċ.  \nNL Beschermende handschoenen/beschermende \nkleding/oogbescherming/gelaatsbescherming \ndragen.  \nPL Stosować rękawice ochronne/odzież ochronną/ \nochronę oczu/ochronę twarzy.  \nPT Usar luvas de protecção/vestuário de protecção/ \nprotecção ocular/protecção facial.  \nRO Purtaţi mănuși de protecţie/îmbrăcăminte de \nprotecţie/echipament de protecţie a ochilor/echi\xad\npament de protecţie a feţei.  \nSK Noste ochranné rukavice/ochranný odev/ \nochranné okuliare/ochranu tváre.  \nSL Nositi zaščitne rokavice/zaščitno obleko/zaščito \nza oči/zaščito za obraz.  \nFI Käytä suojakäsineitä/suojavaatetusta/silmien\xad\nsuojainta/kasvonsuojainta.  \nSV Använd skyddshandskar/skyddskläder/ \nögonskydd/ansiktsskydd.  \n▼M4 __________  \n▼M12  \nP282  Language  \nBG Носете предпазващи от студ ръкавици, както и \nмаска за лице или защитни очила.  \nES Usar guantes aislantes contra el frío y equipo de \nprotección para la cara o los ojos.  \nCS Používejte ochranné rukavice proti chladu a buď \nobličejový štít, nebo ochranné brýle.  \nDA Bær kuldeisolerende handsker og enten \nansigtsskærm eller øjenbeskyttelse.  \nDE Schutzhandschuhe mit Kälteisolierung und \nzusätzlich Gesichtsschild oder Augenschutz tragen.  \nET Kanda külmakaitsekindaid ning kaitsemaski või \nkaitseprille.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 380}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 382  \nP282  Language  \nEL Να φοράτε μονωτικά γάντια και προστατευτικό \nκάλυμμα προσώπου ή εξοπλισμό προστασίας \nματιών.  \nEN Wear cold insulating gloves and either face shield \nor eye protection.  \nFR Porter des gants isolants contre le froid et un \néquipement de protection du visage ou des yeux.  \nGA Caith lámhainní inslithe fuachta agus aghaidhsciath \nnó cosaint súile.  \nHR Nositi zaštitne rukavice za hladnoću i zaštitu za \nlice ili zaštitu za oči.  \nIT Utilizzare guanti termici e schermo facciale o \nprotezione per gli occhi.  \nLV Izmantot aukstumizolējošus aizsargcimdus un sejas \nvai acu aizsargu.  \nLT Mūvėti nuo šalčio izoliuojančias pirštines ir \nnaudoti veido skydelį arba akių apsaugos prie\xad\nmones.  \nHU Hidegszigetelő kesztyű és arcvédő vagy szemvédő \nhasználata kötelező.  \nMT Ilbes ingwanti kiesħa li ma jinfidx minnhom u jew \nilqugħ għall-wiċċ jew protezzjoni għall-għajnejn.  \nNL Koude-isolerende handschoenen en hetzij gelaats\xad\nbescherming hetzij oogbescherming dragen.  \nPL Nosić rękawice izolujące od zimna oraz albo \nmaski na twarz albo ochronę oczu.  \nPT Usar luvas de proteção contra o frio e escudo \nfacial ou proteção ocular.  \nRO Purtaţi mănuși izolante împotriva frigului și echi\xad\npament de protecţie a feţei sau a ochilor.  \nSK Používajte termostabilné rukavice a buď ochranný \nštít alebo ochranné okuliare.  \nSL Nositi izolirne rokavice za zaščito pred mrazom in \nzaščito za obraz oziroma zaščito za oči.  \nFI Käytä kylmäeristäviä suojakäsineitä ja joko \nkasvonsuojainta tai silmiensuojainta.  \nSV Använd köldisolerande handskar och antingen visir \neller ögonskydd.  \nP283  Language  \nBG Носете огнеупорно или огнезащитно \nоблекло.  \nES Llevar ropa resistente al fuego o retardante de \nlas llamas.  \nCS Používejte ohnivzdorný oděv nebo oděv \nzpomalující hoření.  \nDA Bær brandbestandig eller brandhæmmende \nbeklædning.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 381}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 383  \nP283  Language  \nDE Schwer entflammbare oder flammhemmende \nKleidung tragen.  \nET Kanda tulekindlat või tule levikut aeglustavat \nrõivastust.  \nEL Να φοράτε αντιπυρικό ρουχισμό ή ρουχισμό με \nεπιβραδυντικό φλόγας.  \nEN Wear fire resistant or flame retardant clothing.  \nFR Porter des vêtements résistant au feu ou à retard \nde flamme.  \nGA Caith éadaí dódhíonacha nó lasairmhoilli\xad\ntheacha.  \nHR Nositi odjeću otpornu na vatru ili nezapaljivu \nodjeću.  \nIT Indossare indumenti completamente ignifughi o \nin tessuti ritardanti di fiamma.  \nLV Izmantot ugunsizturīgu vai liesmas aizturošu \napģērbu.  \nLT Dėvėti ugniai atsparius arba antipireninius \ndrabužius.  \nHU Tűzálló vagy lángkésleltető ruházat viselése \nkötelező.  \nMT Ilbes ħwejjeġ reżistenti għan-nar u retardanti \ntal-fjammi.  \nNL Vuurbestendige of vlamvertragende kleding \ndragen.  \nPL Nosić odzież ognioodporną lub opóźniającą \nzapalenie.  \nPT Usar vestuário ignífugo ou retardador de \nchamas.  \nRO Purtaţi îmbrăcăminte rezistentă la foc sau igni\xad\nfugă.  \nSK Noste ohňovzdorný odev alebo odev so \nzníženou horľavosťou.  \nSL Nositi negorljiva oblačila ali oblačila, odporna \nproti ognju.  \nFI Käytä palosuojattua tai paloturvallista vaate\xad\ntusta.  \nSV Använd brandsäkra eller flamhämmande kläder.  \n▼M4 \nP284  Language  \nBG [При недостатъчна вентилация] носете \nсредства за защита на дихателните пътища.  \nES [En caso de ventilación insuficiente,] llevar \nequipo de protección respiratoria.  \nCS [V případě nedostatečného větrání] používejte \nvybavení pro ochranu dýchacích cest.  \nDA [I tilfælde af utilstrækkelig ventilation], anvend \nåndedrætsværn.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 382}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 384  \nP284  Language  \nDE [Bei unzureichender Belüftung] Atemschutz \ntragen.  \nET [Ebapiisava ventilatsiooni korral] kanda \nhingamisteede kaitsevahendit.  \nEL [Σε περίπτωση ανεπαρκούς αερισμού] \nχρησιμοποιείστε μέσα ατομικής προστασίας \nτης αναπνοής.  \nEN [In case of inadequate ventilation] wear \nrespiratory protection.  \nFR [Lorsque la ventilation du local est insuffisante] \nporter un équipement de protection respiratoire.  \nGA [Mura leor an aeráil] caith cosaint riospráide.  \n▼M8 \nHR [U slučaju nedovoljne ventilacije] nositi \nsredstva za zaštitu dišnog sustava.  \n▼M4 \nIT [Quando la ventilazione del locale è insuffi\xad\nciente] indossare un apparecchio di protezione \nrespiratoria.  \nLV [Neatbilstošas ventilācijas gadījumā] lietot \nelpošanas orgānu aizsargierīces.  \nLT [Esant nepakankamam vėdinimui] naudoti \nkvėpavimo takų apsaugos priemones.  \nHU [Nem megfelelő szellőzés esetén] légzés\xad\nvédelem kötelező.  \nMT [F’każ ta’ ventilazzjoni inadegwata] ilbes \nprotezzjoni respiratorja.  \nNL [Bij ontoereikende ventilatie] adembescherming \ndragen.  \nPL [W przypadku nieodpowiedniej wentylacji] \nstosować indywidualne środki ochrony dróg \noddechowych.  \nPT [Em caso de ventilação inadequada] usar \nproteção respiratória.  \nRO [În cazul în care ventilarea este necore\xad\nspunzătoare] purtaţi echipament de protecţie \nrespiratorie.  \nSK [V prípade nedostatočného vetrania] používajte \nochranu dýchacích ciest.  \nSL [Ob nezadostnem prezračevanju] nositi opremo \nza zaščito dihal.  \nFI Käytä hengityksensuojainta [jos ilmanvaihto on \nriittämätön].  \nSV [Vid otillräcklig ventilation], använd andningss\xad\nkydd.  \n__________  \n▼M12  \nP231 + P232  Language  \nBG Да се използва и съхранява съдържанието \nпод инертен газ/… Да се пази от влага.  \nES Manipular y almacenar el contenido en un \nmedio de gas inerte/…. Proteger de la \nhumedad.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 383}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 385  \nP231 + P232  Language  \nCS Manipulace a skladování pod inertním plynem \n/…. Chraňte před vlhkem.  \nDA Håndteres og opbevares under inert gas/…. \nBeskyt mod fugt.  \nDE Inhalt unter inertem Gas/… handhaben und \naufbewahren. Vor Feuchtigkeit schützen.  \nET Sisu käidelda ja hoida inertgaasis/…. Hoida \nniiskuse eest.  \nEL Ο χειρισμός και η αποθήκευση του υλικού να \nγίνεται υπό αδρανές αέριο/ …. Προστασία από \nτην υγρασία.  \nEN Handle and store contents under inert gas/…. \nProtect from moisture.  \nFR Manipuler et stocker le contenu sous gaz inerte/ \n… Protéger de l'humidité.  \nGA Láimhsigh agus stóráil an t-ábhar faoi \nthriathghás/…. Cosain ó thaise.  \nHR Rukovati i skladištiti u inertnom plinu / … \nZaštititi od vlage.  \nIT Manipolare e conservare in atmosfera di gas \ninerte/…. Tenere al riparo dall'umidità.  \nLV Saturu izmantot un glabāt tikai inertas gāzes \nvidē/… Sargāt no mitruma.  \nLT Turinį tvarkyti ir laikyti inertinėse dujose/ \n…Saugoti nuo drėgmės.  \nHU Tartalma inert gázban / … használandó és táro\xad\nlandó. Nedvességtől védendő.  \nMT Uża u aħżen il-kontenut taħt gass inerti /…. \nIpproteġi mill-umdità.  \nNL Inhoud onder inert gas/… gebruiken en \nbewaren. Tegen vocht beschermen.  \nPL Używać i przechowywać zawartość w \natmosferze obojętnego gazu /…. Chronić \nprzed wilgocią.  \nPT Manusear e armazenar o conteúdo em \natmosfera de gás inerte/…. Manter ao abrigo \nda humidade.  \nRO A se manipula și a se depozita conţinutul sub \nun gaz inert/…. A se proteja de umiditate.  \nSK Manipulujte s obsahom a skladujte ho \nv prostredí s inertným plynom/… Chráňte \npred vlhkosťou.  \nSL Ravnati z vsebino in jo hraniti v ustreznem \ninertnem plinu/…. Zaščititi pred vlago.  \nFI Käsittele ja varastoi sisältö inertissä kaasussa \n/…. Suojaa kosteudelta.  \nSV Hantera och förvara innehållet under inert gas/ \n…. Skyddas från fukt.  \n__________  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 384}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 386  \nTable 1.3  \nPrecautionary statements — Response  \nP301  Language  \nBG ПРИ ПОГЛЪЩАНЕ:  \nES EN CASO DE INGESTIÓN:  \nCS PŘI POŽITÍ:  \nDA I TILFÆLDE AF INDTAGELSE:  \nDE BEI VERSCHLUCKEN:  \nET ALLANEELAMISE KORRAL:  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ:  \nEN IF SWALLOWED:  \nFR EN CAS D’INGESTION:  \nGA MÁ SHLOGTAR:  \n▼M5 \nHR AKO SE PROGUTA:  \n▼B \nIT IN CASO DI INGESTIONE:  \nLV NORĪŠANAS GADĪJUMĀ:  \nLT PRARIJUS:  \nHU LENYELÉS ESETÉN:  \nMT JEKK JINBELA’:  \nNL NA INSLIKKEN:  \nPL W PRZYPADKU POŁKNIĘCIA:  \nPT EM CASO DE INGESTÃO:  \nRO ÎN CAZ DE ÎNGHIŢIRE:  \nSK PO POŽITÍ:  \nSL PRI ZAUŽITJU:  \nFI JOS KEMIKAALIA ON NIELTY:  \nSV VID FÖRTÄRING:  \nP302  Language  \nBG ПРИ КОНТАКТ С КОЖАТА:  \nES EN CASO DE CONTACTO CON LA PIEL:  \nCS PŘI STYKU S KŮŽÍ:  \nDA VED KONTAKT MED HUDEN:  \nDE BEI BERÜHRUNG MIT DER HAUT:  \nET NAHALE SATTUMISE KORRAL:  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ:  \nEN IF ON SKIN:  \nFR EN CAS DE CONTACT AVEC LA PEAU:  \nGA I gCÁS TEAGMHÁLA LEIS AN \ngCRAICEANN:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 385}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 387  \nP302  Language  \n▼M5 \nHR U SLUČAJU DODIRA S KOŽOM:  \n▼B \nIT IN CASO DI CONTATTO CON LA PELLE:  \nLV SASKARĒ AR ĀDU:  \nLT PATEKUS ANT ODOS:  \nHU HA BŐRRE KERÜL:  \nMT F'KAŻ TA' KUNTATT MAL-ĠILDA:  \nNL BIJ CONTACT MET DE HUID:  \nPL W PRZYPADKU KONTAKTU ZE SKÓRĄ:  \nPT SE ENTRAR EM CONTACTO COM A \nPELE:  \nRO ÎN CAZ DE CONTACT CU PIELEA:  \nSK PRI KONTAKTE S POKOŽKOU:  \nSL PRI STIKU S KOŽO:  \nFI JOS KEMIKAALIA JOUTUU IHOLLE:  \nSV VID HUDKONTAKT:  \nP303  Language  \nBG ПРИ КОНТАКТ С КОЖАТА (или косата):  \nES EN CASO DE CONTACTO CON LA PIEL (o \nel pelo):  \nCS PŘI STYKU S KŮŽÍ (nebo s vlasy):  \nDA VED KONTAKT MED HUDEN (eller håret):  \nDE BEI BERÜHRUNG MIT DER HAUT (oder \ndem Haar):  \nET NAHALE (või juustele) SATTUMISE \nKORRAL:  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ \n(ή με τα μαλλιά):  \nEN IF ON SKIN (or hair):  \nFR EN CAS DE CONTACT AVEC LA PEAU (ou \nles cheveux):  \nGA I gCÁS TEAGMHÁLA LEIS AN \ngCRAICEANN (nó le gruaig):  \n▼M5 \nHR U SLUČAJU DODIRA S KOŽOM (ili kosom):  \n▼B \nIT IN CASO DI CONTATTO CON LA PELLE (o \ncon i capelli):  \nLV SASKARĒ AR ĀDU (vai matiem):  \nLT PATEKUS ANT ODOS (arba plaukų):  \nHU HA BŐRRE (vagy hajra) KERÜL:  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 386}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 388  \nP303  Language  \nMT F'KAŻ TA' KUNTATT MAL-ĠILDA (jew ix- \nxagħar):  \nNL BIJ CONTACT MET DE HUID (of het haar):  \nPL W PRZYPADKU KONTAKTU ZE SKÓRĄ \n(lub z włosami):  \nPT SE ENTRAR EM CONTACTO COM A PELE \n(ou o cabelo):  \nRO ÎN CAZ DE CONTACT CU PIELEA (sau \npărul):  \nSK PRI KONTAKTE S POKOŽKOU (alebo \nvlasmi):  \nSL PRI STIKU S KOŽO (ali lasmi):  \nFI JOS KEMIKAALIA JOUTUU IHOLLE (tai \nhiuksiin):  \nSV VID HUDKONTAKT (även håret):  \nP304  Language  \nBG ПРИ ВДИШВАНЕ:  \nES EN CASO DE INHALACIÓN:  \nCS PŘI VDECHNUTÍ:  \nDA VED INDÅNDING:  \nDE BEI EINATMEN:  \nET SISSEHINGAMISE KORRAL:  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ:  \nEN IF INHALED:  \nFR EN CAS D’INHALATION:  \nGA MÁ IONANÁLAÍTEAR:  \n▼M5 \nHR AKO SE UDIŠE:  \n▼B \nIT IN CASO DI INALAZIONE:  \nLV IEELPOJOT:  \nLT ĮKVĖPUS:  \nHU BELÉLEGZÉS ESETÉN:  \nMT JEKK JINĠIBED MAN-NIFS:  \nNL NA INADEMING:  \nPL W PRZYPADKU DOSTANIA SIĘ DO DRÓG \nODDECHOWYCH:  \nPT EM CASO DE INALAÇÃO:  \nRO ÎN CAZ DE INHALARE:  \nSK PO VDÝCHNUTÍ:  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 387}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 389  \nP304  Language  \nSL PRI VDIHAVANJU:  \nFI JOS KEMIKAALIA ON HENGITETTY:  \nSV VID INANDNING:  \nP305  Language  \nBG ПРИ КОНТАКТ С ОЧИТЕ:  \nES EN CASO DE CONTACTO CON LOS OJOS:  \nCS PŘI ZASAŽENÍ OČÍ:  \nDA VED KONTAKT MED ØJNENE:  \nDE BEI KONTAKT MIT DEN AUGEN:  \nET SILMA SATTUMISE KORRAL:  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ:  \nEN IF IN EYES:  \nFR EN CAS DE CONTACT AVEC LES YEUX:  \nGA I gCÁS TEAGMHÁLA LEIS NA SÚILE:  \n▼M5 \nHR U SLUČAJU DODIRA S OČIMA:  \n▼B \nIT IN CASO DI CONTATTO CON GLI OCCHI:  \nLV IEKĻŪSTOT ACĪS:  \nLT PATEKUS Į AKIS:  \nHU SZEMBE KERÜLÉS ESETÉN:  \nMT JEKK JIDĦOL FL-GĦAJNEJN:  \nNL BIJ CONTACT MET DE OGEN:  \nPL W PRZYPADKU DOSTANIA SIĘ DO OCZU:  \nPT SE ENTRAR EM CONTACTO COM OS \nOLHOS:  \nRO ÎN CAZ DE CONTACT CU OCHII:  \nSK PO ZASIAHNUTÍ OČÍ:  \nSL PRI STIKU Z OČMI:  \nFI JOS KEMIKAALIA JOUTUU SILMIIN:  \nSV VID KONTAKT MED ÖGONEN:  \nP306  Language  \nBG ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО:  \nES EN CASO DE CONTACTO CON LA ROPA:  \nCS PŘI STYKU S ODĚVEM:  \nDA VED KONTAKT MED TØJET:  \nDE ►C3 BEI KONTAKT MIT DER \nKLEIDUNG: ◄  \nET RÕIVASTELE SATTUMISE KORRAL:  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 388}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 390  \nP306  Language  \nEN IF ON CLOTHING:  \nFR EN CAS DE CONTACT AVEC LES VÊTE\xad\nMENTS:  \nGA I gCÁS TEAGMHÁLA LE hÉADAÍ:  \n▼M5 \nHR U SLUČAJU DODIRA S ODJEĆOM:  \n▼B \nIT IN CASO DI CONTATTO CON GLI INDU\xad\nMENTI:  \nLV SASKARĒ AR APĢĒRBU:  \nLT PATEKUS ANT DRABUŽIŲ:  \nHU HA RUHÁRA KERÜL:  \nMT F'KAŻ TA' KUNTATT MA' L-ILBIES:  \nNL NA MORSEN OP KLEDING:  \nPL W PRZYPADKU KONTAKTU Z ODZIEŻĄ:  \nPT SE ENTRAR EM CONTACTO COM A \nROUPA:  \nRO ÎN CAZ DE CONTACT CU ÎMBRĂCĂ- \nMINTEA:  \nSK PRI KONTAKTE S ODEVOM:  \nSL PRI STIKU Z OBLAČILI:  \nFI JOS KEMIKAALIA JOUTUU VAATTEISIIN:  \nSV VID KONTAKT MED KLÄDERNA:  \n▼M4 __________  \n▼B \nP308  Language  \nBG ПРИ явна или предполагаема експозиция:  \nES EN CASO DE exposición manifiesta o \npresunta:  \nCS PŘI expozici nebo podezření na ni:  \nDA VED eksponering eller mistanke om ekspo\xad\nnering:  \nDE BEI Exposition oder falls betroffen  \nET Kokkupuute või kokkupuutekahtluse korral:  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης:  \nEN IF exposed or concerned:  \nFR EN CAS d’exposition prouvée ou suspectée:  \nGA I gCÁS nochta nó má mheastar a bheith noch\xad\ntaithe:  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 389}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 391  \nP308  Language  \n▼M5 \nHR U SLUČAJU izloženosti ili sumnje na \nizloženost:  \n▼B \nIT IN CASO di esposizione o di possibile espos\xad\nizione:  \nLV Ja saskaras vai saistīts ar:  \nLT Esant sąlyčiui arba jeigu numanomas sąlytis:  \nHU Expozíció vagy annak gyanúja esetén:  \nMT JEKK espost jew konċernat:  \nNL NA (mogelijke) blootstelling:  \nPL W PRZYPADKU narażenia lub styczności:  \nPT EM CASO DE exposição ou suspeita de \nexposição:  \nRO ÎN CAZ DE expunere sau de posibilă expunere:  \nSK Po expozícii alebo podozrení z nej:  \nSL PRI izpostavljenosti ali sumu izpostavljenosti:  \nFI Altistumisen tapahduttua tai jos epäillään altis\xad\ntumista:  \nSV Vid exponering eller misstanke om exponering:  \n▼M4 __________  \nP310  Language  \nBG Незабавно се обадете в ЦЕНТЪР ПО \nТОКСИКОЛОГИЯ/на лекар/…  \nES Llamar inmediatamente a un CENTRO DE \nTOXICOLOGĺA/médico/…  \nCS Okamžitě volejte TOXIKOLOGICKÉ \nINFORMAČNÍ STŘEDISKO/lékaře/…  \nDA Ring omgående til en GIFTINFORMATION/ \nlæge/…  \nDE Sofort GIFTINFORMATIONSZENTRUM/ \nArzt/…/anrufen.  \nET Võtta viivitamata ühendust MÜRGISTUS\xad\nTEABEKESKUSE/arstiga…  \nEL Καλέστε αμέσως το ΚΕΝΤΡΟ \nΔΗΛΗΤΗΡΙΑΣΕΩΝ/γιατρό/…  \nEN Immediately call a POISON CENTER/doctor/ \n… \nFR Appeler immédiatement un CENTRE ANTI\xad\nPOISON/un médecin/…  \nGA Cuir glao láithreach ar IONAD NIMHE/ar \ndhoctúir/…  \n▼M8 \nHR Odmah nazvati CENTAR ZA KONTROLU \nOTROVANJA/liječnika/…  \n▼M4 \nIT Contattare immediatamente un CENTRO \nANTIVELENI/un medico…  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 390}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 392  \nP310  Language  \nLV Nekavējoties sazinieties ar SAINDĒŠANĀS \nINFORMĀCIJAS CENTRU/ārstu/…  \nLT Nedelsiant skambinti į APSINUODIJIMŲ \nKONTROLĖS IR INFORMACIJOS BIURĄ/ \nkreiptis į gydytoją/….  \nHU Azonnal forduljon TOXIKOLÓGIAI \nKÖZPONTHOZ/orvoshoz/….  \nMT Sejjaħ minnufih ĊENTRU TAL-AVVEL\xad\nENAMENT/tabib/…  \nNL Onmiddellijk een ANTIGIFCENTRUM/arts/… \nraadplegen.  \nPL Natychmiast skontaktować się z OŚRODKIEM \nZATRUĆ/lekarzem/…  \nPT Contacte imediatamente um CENTRO DE \nINFORMAÇÃO ANTIVENENOS/médico/…  \nRO Sunaţi imediat la un CENTRU DE \nINFORMARE TOXICOLOGICĂ/un medic/…  \nSK Okamžite volajte TOXIKOLOGICKÉ \nINFORMAČNÉ CENTRUM/lekára/…  \nSL Takoj pokličite CENTER ZA ZASTRUPITVE/ \nzdravnika/…  \nFI Ota välittömästi yhteys MYRKYTYSTIETO\xad\nKESKUKSEEN/lääkäriin/…  \nSV Kontakta genast GIFTINFORMATIONSCEN\xad\nTRALEN/läkare…  \nP311  Language  \nBG Обадете се в ЦЕНТЪР ПО \nТОКСИКОЛОГИЯ/на лекар/…  \nES Llamar a un CENTRO DE TOXICOLOGĺA/ \nmédico/…  \nCS Volejte TOXIKOLOGICKÉ INFORMAČNÍ \nSTŘEDISKO/lékaře/….  \nDA Ring til en GIFTINFORMATION/læge/…  \nDE GIFTINFORMATIONSZENTRUM/Arzt/…/an\xad\nrufen.  \nET Võtta ühendust MÜRGISTUSTEABE\xad\nKESKUSE/arstiga…  \nEL Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ/ \nγιατρό/…  \nEN Call a POISON CENTER/doctor/…  \nFR Appeler un CENTRE ANTIPOISON/un \nmédecin/…  \nGA Cuir glao ar IONAD NIMHE/ar dhoctúir/…  \n▼M8 \nHR Nazvati CENTAR ZA KONTROLU OTROV- \nANJA/liječnika/…  \n▼M4 \nIT Contattare un CENTRO ANTIVELENI/un me- \ndico/…  \nLV Sazinieties ar SAINDĒŠANĀS INFORMĀ- \nCIJAS CENTRU/ārstu/…  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 391}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 393  \nP311  Language  \nLT Skambinti į APSINUODIJIMŲ KONTROLĖS \nIR INFORMACIJOS BIURĄ/kreiptis į \ngydytoją/….  \nHU Forduljon TOXIKOLÓGIAI KÖZPONTHOZ/ \norvoshoz/….  \nMT Sejjaħ ĊENTRU TAL-AVVELENAMENT/ \ntabib/…  \nNL Een ANTIGIFCENTRUM/arts/… raadplegen.  \nPL Skontaktować się z OŚRODKIEM ZATRUĆ/ \nlekarzem/…  \nPT Contacte um CENTRO DE INFORMAÇÃO \nANTIVENENOS/médico/…  \nRO Sunaţi la un CENTRU DE INFORMARE \nTOXICOLOGICĂ/un medic…  \nSK Volajte TOXIKOLOGICKÉ INFORMAČNÉ \nCENTRUM/lekára/…  \nSL Pokličite CENTER ZA ZASTRUPITVE/ \nzdravnika/…  \nFI Ota yhteys MYRKYTYSTIETOKES\xad\nKUKSEEN/lääkäriin/…  \nSV Kontakta GIFTINFORMATIONSCEN\xad\nTRALEN/läkare/…  \n▼M12  \nP312  Language  \nBG При неразположение се обадете в \nЦЕНТЪР ПО ТОКСИКОЛОГИЯ/на \nлекар/…  \nES Llamar a un CENTRO DE TOXI\xad\nCOLOGÍA / médico/… si la persona se \nencuentra mal.  \nCS Necítíte-li se dobře, volejte TOXIKO\xad\nLOGICKÉ INFORMAČNÍ STŘEDISKO \n/ lékaře /… .  \nDA Kontakt GIFTLINJEN/læge/… i tilfælde \naf ubehag.  \nDE Bei Unwohlsein GIFTINFORMATIONS\xad\nZENTRUM/Arzt/… anrufen.  \nET Halva enesetunde korral võtta ühendust \nMÜRGISTUSTEABEKESKUSEGA/ \narstiga/….  \nEL Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣ- \nΕΩΝ/γιατρό/…, αν αισθανθείτε αδιαθ- \nεσία.  \nEN Call a POISON CENTRE/doctor/… if \nyou feel unwell.  \nFR Appeler un CENTRE ANTIPOISON/un \nmédecin/… en cas de malaise.  \nGA Cuir glao ar IONAD NIMHE/dochtúir/… \nmá bhraitheann tú tinn.  \nHR U slučaju zdravstvenih tegoba nazvati \nCENTAR ZA KONTROLU \nOTROVANJA / liječnika / …  \nIT In caso di malessere, contattare un \nCENTRO ANTIVELENI/un medico/… .  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 392}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 394  \nP312  Language  \nLV Sazinieties ar SAINDĒŠANĀS \nINFORMĀCIJAS CENTRU/ārstu/…, ja \njums ir slikta pašsajūta.  \nLT Pasijutus blogai, skambinti į APSI\xad\nNUODIJIMŲ KONTROLĖS IR \nINFORMACIJOS BIURĄ / kreiptis į \ngydytoją / …  \nHU Rosszullét esetén forduljon TOXIKO\xad\nLÓGIAI KÖZPONTHOZ/orvoshoz/….  \nMT Ikkuntattja ĊENTRU TAL-AVVEL\xad\nENAMENT / tabib / … jekk tħossok \nma tiflaħx.  \nNL Bij onwel voelen een ANTIGIF\xad\nCENTRUM/arts/… raadplegen.  \nPL W przypadku złego samopoczucia skon\xad\ntaktować się z OŚRODKIEM ZATRUĆ/ \nlekarzem/….  \nPT Caso sinta indisposição, contacte um \nCENTRO DE INFORMAÇÃO ANTI\xad\nVENENOS/médico/… .  \nRO Sunaţi la un CENTRU DE INFORMARE \nTOXICOLOGICĂ/un medic/… dacă nu \nvă simţiţi bine.  \nSK Pri zdravotných problémoch volajte \nNÁRODNÉ TOXIKOLOGICKÉ \nINFORMAČNÉ CENTRUM/lekára/… .  \nSL Ob slabem počutju pokličite CENTER \nZA ZASTRUPITVE/ zdravnika/… .  \nFI Ota yhteys MYRKYTYSTIETOKES\xad\nKUKSEEN/lääkäriin/…, jos ilmenee \npahoinvointia.  \nSV Vid obehag, kontakta GIFTINFORMA\xad\nTIONSCENTRALEN/läkare… .  \n▼B \nP313  Language  \nBG Потърсете медицински съвет/помощ.  \nES Consultar a un médico.  \nCS Vyhledejte lékařskou pomoc/ošetření.  \nDA Søg lægehjælp.  \nDE Ärztlichen Rat einholen/ärztliche Hilfe hinzu\xad\nziehen.  \nET Pöörduda arsti poole.  \nEL Συμβουλευθείτε/Επισκεφθείτε γιατρό.  \nEN Get medical advice/attention.  \nFR Consulter un médecin.  \nGA Faigh comhairle/cúram liachta.  \n▼M5 \nHR Zatražiti savjet/pomoć liječnika.  \n▼B \nIT Consultare un medico.  \nLV Lūdziet palīdzību mediķiem.  \nLT Kreiptis į gydytoją.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 393}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 395  \nP313  Language  \nHU Orvosi ellátást kell kérni.  \nMT Ikkonsulta tabib.  \nNL Een arts raadplegen.  \nPL Zasięgnąć porady/zgłosić się pod opiekę \nlekarza.  \nPT Consulte um médico.  \nRO Consultaţi medicul.  \nSK Vyhľadajte lekársku pomoc/starostlivosť.  \nSL Poiščite zdravniško pomoč/oskrbo.  \nFI Hakeudu lääkäriin.  \nSV Sök läkarhjälp.  \nP314  Language  \nBG При неразположение потърсете медицински \nсъвет/помощ.  \nES Consultar a un médico en caso de malestar.  \nCS Necítíte-li se dobře, vyhledejte lékařskou \npomoc/ošetření.  \nDA Søg lægehjælp ved ubehag.  \nDE Bei Unwohlsein ärztlichen Rat einholen/ \närztliche Hilfe hinzuziehen.  \nET Halva enesetunde korral pöörduda arsti poole.  \nEL Συμβουλευθείτε/Επισκεφθείτε γιατρό εάν \nαισθανθείτε αδιαθεσία.  \nEN Get medical advice/attention if you feel unwell.  \nFR Consulter un médecin en cas de malaise.  \nGA Faigh comhairle/cúram liachta má bhraitheann \ntú tinn.  \n▼M5 \nHR U slučaju zdravstvenih tegoba zatražiti savjet/ \npomoć liječnika.  \n▼B \nIT In caso di malessere, consultare un medico.  \nLV Lūdziet palīdzību mediķiem, ja jums ir slikta \npašsajūta.  \nLT Pasijutus blogai, kreiptis į gydytoją.  \nHU Rosszullét esetén orvosi ellátást kell kérni.  \nMT Ikkonsulta tabib jekk tħossok ma tiflaħx.  \nNL Bij onwel voelen een arts raadplegen.  \nPL W przypadku złego samopoczucia zasięgnąć \nporady/zgłosić się pod opiekę lekarza.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 394}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 396  \nP314  Language  \nPT Em caso de indisposição, consulte um médico.  \nRO Consultaţi medicul, dacă nu vă simţiţi bine.  \nSK Ak pociťujete zdravotné problémy, vyhľadajte \nlekársku pomoc/starostlivosť.  \nSL Ob slabem počutju poiščite zdravniško pomoč/ \noskrbo.  \nFI Hakeudu lääkäriin, jos ilmenee pahoinvointia.  \nSV Sök läkarhjälp vid obehag.  \nP315  Language  \nBG Незабавно потърсете медицински съвет/ \nпомощ.  \nES Consultar a un médico inmediatamente.  \nCS Okamžitě vyhledejte lékařskou pomoc/ošetření.  \nDA Søg omgående lægehjælp.  \nDE Sofort ärztlichen Rat einholen/ärztliche Hilfe \nhinzuziehen.  \nET Pöörduda viivitamata arsti poole.  \nEL Συμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.  \nEN Get immediate medical advice/attention.  \nFR Consulter immédiatement un médecin.  \nGA Faigh comhairle/cúram liachta láithreach.  \n▼M5 \nHR Hitno zatražiti savjet/pomoć liječnika.  \n▼B \nIT Consultare immediatamente un medico.  \nLV Nekavējoties lūdziet palīdzību mediķiem.  \nLT Nedelsiant kreiptis į gydytoją.  \nHU Azonnal orvosi ellátást kell kérni.  \nMT Ikkonsulta tabib minnufih.  \nNL Onmiddellijk een arts raadplegen.  \nPL Natychmiast zasięgnąć porady/zgłosić się pod \nopiekę lekarza.  \nPT Consulte imediatamente um médico.  \nRO Consultaţi imediat medicul.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 395}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 397  \nP315  Language  \nSK Okamžite vyhľadajte lekársku pomoc/starostli\xad\nvosť.  \nSL Takoj poiščite zdravniško pomoč/oskrbo.  \nFI Hakeudu välittömästi lääkäriin.  \nSV Sök omedelbart läkarhjälp.  \nP320  Language  \nBG Спешна нужда от специализирано лечение \n(вж… на този етикет).  \nES Se necesita urgentemente un tratamiento espe\xad\ncífico (ver … en esta etiqueta).  \nCS Je nutné odborné ošetření (viz … na tomto \nštítku).  \nDA Særlig behandling straks påkrævet (se … på \ndenne etiket).  \nDE Besondere Behandlung dringend erforderlich \n(siehe … auf diesem Kennzeichnungsetikett).  \nET Nõuab viivitamatut eriravi (vt … käesoleval \netiketil).  \nEL Χρειάζεται επειγόντως ειδική αγωγή (βλέπε … \nστην ετικέτα).  \nEN Specific treatment is urgent (see … on this \nlabel).  \nFR Un traitement spécifique est urgent (voir … sur \ncette étiquette).  \nGA Tá sé práinneach go bhfaightear cóir leighis ar \nleith (féach … ar an lipéad seo).  \n▼M5 \nHR Hitno je potrebna posebna liječnička obrada \n(vidi … na ovoj naljepnici).  \n▼B \nIT Trattamento specifico urgente (vedere… su \nquesta etichetta).  \nLV Steidzami nepieciešama īpaša medicīniskā \npalīdzība (skat. … uz šīs etiķetes).  \nLT Būtinas skubus specialus gydymas (žr. … šioje \netiketėje).  \nHU Sürgős szakellátás szükséges (lásd … a \ncímkén).  \nMT Trattament speċifiku hu urġenti (ara … fuq din \nit-tikketta).  \nNL Specifieke behandeling dringend vereist (zie … \nop dit etiket).  \nPL Pilnie zastosować określone leczenie (patrz … \nna etykiecie).  \nPT É urgente um tratamento específico (ver … no \npresente rótulo).  \nRO Un tratament specific este urgent (a se vedea … \nde pe această etichetă).  \nSK Odborné ošetrenie je naliehavé (pozri … na \netikete).  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 396}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 398  \nP320  Language  \nSL Posebno zdravljenje je nujno (glejte … na tej \netiketi).  \nFI Erityishoitoa tarvitaan välittömästi (katso … \npakkauksen merkinnöissä).  \nSV Särskild behandling krävs omedelbart (se … på \netiketten).  \nP321  Language  \nBG Специализирано лечение (вж… на този \nетикет).  \nES Se necesita un tratamiento específico (ver … en \nesta etiqueta).  \nCS Odborné ošetření (viz … na tomto štítku).  \nDA Særlig behandling (se … på denne etiket).  \nDE Besondere Behandlung (siehe … auf diesem \nKennzeichnungsetikett).  \nET Nõuab eriravi (vt … käesoleval etiketil).  \nEL Χρειάζεται ειδική αγωγή (βλέπε … στην \nετικέτα).  \nEN Specific treatment (see … on this label).  \nFR Traitement spécifique (voir … sur cette \nétiquette).  \nGA Cóir liachta ar leith (féach … ar an lipéad seo).  \n▼M5 \nHR Potrebna je posebna liječnička obrada (vidi … \nna ovoj naljepnici).  \n▼B \nIT Trattamento specifico (vedere …su questa \netichetta).  \nLV Īpaša medicīniskā palīdzība (skat. … uz šīs \netiķetes).  \nLT Specialus gydymas (žr. … šioje etiketėje).  \nHU Szakellátás (lásd … a címkén).  \nMT Trattament speċifiku (ara … fuq din it-tikketta).  \nNL Specifieke behandeling vereist (zie … op dit \netiket).  \nPL Zastosować określone leczenie (patrz … na \netykiecie).  \nPT Tratamento específico (ver … no presente \nrótulo).  \nRO Tratament specific (a se vedea … de pe această \netichetă).  \nSK Odborné ošetrenie (pozri … na etikete).  \nSL Posebno zdravljenje (glejte … na tej etiketi).  \nFI Erityishoitoa tarvitaan (katso … pakkauksen \nmerkinnöissä).  \nSV Särskild behandling (se … på etiketten).  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 397}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 399  \n__________  \n▼B \nP330  Language  \nBG Изплакнете устата.  \nES Enjuagarse la boca.  \nCS Vypláchněte ústa.  \nDA Skyl munden.  \nDE Mund ausspülen.  \nET Loputada suud.  \nEL Ξεπλύνετε το στόμα.  \nEN Rinse mouth.  \nFR Rincer la bouche.  \nGA Sruthlaítear an béal.  \n▼M5 \nHR Isprati usta.  \n▼B \nIT Sciacquare la bocca.  \nLV Izskalot muti.  \nLT Išskalauti burną.  \nHU A szájat ki kell öblíteni.  \nMT Laħlaħ ħalqek.  \nNL De mond spoelen.  \nPL Wypłukać usta.  \nPT Enxaguar a boca.  \nRO Clătiţi gura.  \nSK Vypláchnite ústa.  \nSL Izprati usta.  \nFI Huuhdo suu.  \nSV Skölj munnen.  \nP331  Language  \nBG НЕ предизвиквайте повръщане.  \nES NO provocar el vómito.  \nCS NEVYVOLÁVEJTE zvracení.  \nDA Fremkald IKKE opkastning.  \nDE KEIN Erbrechen herbeiführen.  \nET MITTE kutsuda esile oksendamist.  \nEL ΜΗΝ προκαλέσετε εμετό.  \nEN Do NOT induce vomiting.  \nFR NE PAS faire vomir.  \nGA NÁ spreagtar urlacan.  \n▼M5 \nHR NE izazivati povraćanje.  \n▼B \nIT NON provocare il vomito.  \nLV NEIZRAISĪT vemšanu.  \nLT NESKATINTI vėmimo.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 398}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 400  \nP331  Language  \nHU TILOS hánytatni.  \nMT TIPPROVOKAX ir-remettar.  \nNL GEEN braken opwekken.  \nPL NIE wywoływać wymiotów.  \nPT NÃO provocar o vómito.  \nRO NU provocaţi voma.  \nSK Nevyvolávajte zvracanie.  \nSL NE izzvati bruhanja.  \nFI EI saa oksennuttaa.  \nSV Framkalla INTE kräkning.  \nP332  Language  \nBG При поява на кожно дразнене:  \nES En caso de irritación cutánea:  \nCS Při podráždění kůže:  \nDA Ved hudirritation:  \nDE Bei Hautreizung:  \nET Nahaärrituse korral:  \nEL Εάν παρατηρηθεί ερεθισμός του δέρματος:  \nEN If skin irritation occurs:  \nFR En cas d’irritation cutanée:  \nGA I gcás greannú craicinn:  \n▼M5 \nHR U slučaju nadražaja kože:  \n▼B \nIT In caso di irritazione della pelle:  \nLV Ja rodas ādas iekaisums:  \nLT Jeigu sudirginama oda:  \nHU Bőrirritáció esetén:  \nMT Jekk ikun hemm irritazzjoni tal-ġilda:  \nNL Bij huidirritatie:  \nPL W przypadku wystąpienia podrażnienia skóry:  \nPT Em caso de irritação cutânea:  \nRO În caz de iritare a pielii:  \nSK Ak sa prejaví podráždenie pokožky:  \nSL Če nastopi draženje kože:  \nFI Jos ilmenee ihoärsytystä:  \nSV Vid hudirritation:  \nP333  Language  \nBG При поява на кожно дразнене или обрив на \nкожата:  \nES En caso de irritación o erupción cutánea:  \nCS Při podráždění kůže nebo vyrážce:  \nDA Ved hudirritation eller udslet:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 399}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 401  \nP333  Language  \nDE Bei Hautreizung oder -ausschlag:  \nET ►C3 Nahaärrituse või lööbe korral: ◄  \nEL Εάν παρατηρηθεί ερεθισμός του δέρματος ή \nεμφανιστεί εξάνθημα:  \nEN If skin irritation or rash occurs:  \nFR En cas d’irritation ou d’éruption cutanée:  \nGA I gcás greannú nó grís craicinn:  \n▼M5 \nHR U slučaju nadražaja ili osipa na koži:  \n▼B \nIT In caso di irritazione o eruzione della pelle:  \nLV Ja rodas ādas iekaisums vai izsitumi:  \nLT Jeigu sudirginama oda arba ją išberia.  \nHU Bőrirritáció vagy kiütések megjelenése esetén:  \nMT Jekk ikun hemm irritazzjoni jew raxx tal-ġilda:  \nNL Bij huidirritatie of uitslag:  \nPL W przypadku wystąpienia podrażnienia skóry \nlub wysypki:  \nPT Em caso de irritação ou erupção cutânea:  \nRO În caz de iritare a pielii sau de erupţie cutanată:  \nSK Ak sa prejaví podráždenie pokožky alebo sa \nvytvoria vyrážky:  \nSL Če nastopi draženje kože ali se pojavi izpuščaj:  \nFI Jos ilmenee ihoärsytystä tai ihottumaa:  \nSV Vid hudirritation eller utslag:  \n▼M12  \nP334  Language  \nBG Потопете в хладка вода [или сложете мокри \nкомпреси].  \nES Sumergir en agua fría [o envolver en vendas \nhúmedas].  \nCS Ponořte do studené vody [nebo zabalte do \nvlhkého obvazu].  \nDA Hold under koldt vand [eller anvend våde \nomslag].  \nDE In kaltes Wasser tauchen [oder nassen Verband \nanlegen].  \nET Hoida jahedas vees [või panna peale niiske \nkompress].  \nEL Βυθίστε σε δροσερό νερό [ή τυλίξτε με \nβρεγμένους επιδέσμους].  \nEN Immerse in cool water [or wrap in wet \nbandages].  \nFR Rincer à l'eau fraîche [ou poser une compresse \nhumide].  \nGA Tum in uisce fionnuar [nó cuir bréid fliuch air].  \nHR Uroniti u hladnu vodu [ili omotati vlažnim \nzavojem].  \nIT Immergere in acqua fredda [o avvolgere con un \nbendaggio umido].  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 400}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 402  \nP334  Language  \nLV Iegremdēt vēsā ūdenī [vai ietīt mitros apsējos].  \nLT Įmerkti į vėsų vandenį [arba apvynioti šlapiais \ntvarsčiais].  \nHU Hideg vízzel [vagy nedves kötéssel] kell hűteni.  \nMT Daħħal fl-ilma kiesaħ [jew kebbeb f'faxex \nimxarrbin].  \nNL In koud water onderdompelen [of nat verband \naanbrengen].  \nPL Zanurzyć w zimnej wodzie [lub owinąć \nmokrym bandażem].  \nPT Mergulhar em água fria [ou aplicar compressas \nhúmidas].  \nRO Introduceţi în apă rece [sau acoperiţi cu o \ncompresă umedă].  \nSK Ponorte do studenej vody [alebo obviažte \nmokrými obväzmi].  \nSL Potopiti v hladno vodo [ali zaviti v mokre \npovoje].  \nFI Upota kylmään veteen [tai kääri märkiin sitei\xad\nsiin].  \nSV Skölj under kallt vatten [eller använd våta \nomslag].  \n▼B \nP335  Language  \nBG Отстранете от кожата посипаните частици.  \nES Sacudir las partículas que se hayan depositado \nen la piel.  \nCS Volné částice odstraňte z kůže.  \nDA Børst løse partikler bort fra huden.  \nDE Lose Partikel von der Haut abbürsten.  \nET Pühkida lahtised osakesed nahalt maha.  \nEL Αφαιρέστε προσεκτικά τα σωματίδια που έχουν \nμείνει στο δέρμα.  \nEN Brush off loose particles from skin.  \nFR Enlever avec précaution les particules déposées \nsur la peau.  \nGA Glan cáithníní scaoilte den chraiceann.  \n▼M5 \nHR Izmesti zaostale čestice s kože.  \n▼B \nIT Rimuovere le particelle depositate sulla pelle.  \nLV Noberzt no ādas nepiestiprinātās daļiņas.  \nLT Neprilipusias daleles nuvalyti nuo odos.  \nHU A bőrre lazán tapadó szemcséket óvatosan le \nkell kefélni.  \nMT Farfar il-frak mhux imwaħħla minn fuq il-ġilda.  \nNL Losse deeltjes van de huid afvegen.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 401}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 403  \nP335  Language  \nPL Nie związaną pozostałość strzepnąć ze skóry.  \nPT Sacudir da pele as partículas soltas.  \nRO Îndepărtaţi particulele depuse pe piele.  \nSK Z pokožky oprášte sypké čiastočky.  \nSL S krtačo odstraniti razsute delce s kože.  \nFI Poista irtohiukkaset iholta.  \nSV Borsta bort lösa partiklar från huden.  \nP336  Language  \nBG Размразете замръзналите части в хладка \nвода. Не разтривайте засегнатото място.  \nES Descongelar las partes heladas con agua tibia. \nNo frotar la zona afectada.  \nCS Omrzlá místa ošetřete vlažnou vodou. Postižené \nmísto netřete.  \nDA Forsigtig opvarmning af frostskadede \nlegemsdele i lunkent vand. Gnid ikke det \nangrebne område.  \nDE Vereiste Bereiche mit lauwarmem Wasser \nauftauen. Betroffenen Bereich nicht reiben.  \nET Sulatada külmunud piirkonnad leige veega. \nKannatada saanud piirkonda mitte hõõruda.  \nEL Ξεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. \nΜην τρίβετε την περιοχή που πάγωσε.  \nEN Thaw frosted parts with lukewarm water. Do no \nrub affected area.  \nFR Dégeler les parties gelées avec de l’eau tiède. \nNe pas frotter les zones touchées.  \nGA Leáigh codanna sioctha le huisce alabhog. Ná \ncuimil an réimse lena mbaineann.  \n▼M5 \nHR Zamrznute dijelove odmrznuti mlakom vodom. \nNe trljati oštećeno mjesto.  \n▼B \nIT Sgelare le parti congelate usando acqua tiepida. \nNon sfregare la parte interessata.  \nLV Atkausēt sasalušās daļas ar remdenu ūdeni. \nSkarto zonu neberzt.  \nLT Prišalusias daleles atitirpinti drungnu vandeniu. \nNetrinti paveiktos zonos.  \nHU A fagyott részeket langyos vízzel fel kell \nmelegíteni. Tilos az érintett terület dörzsölése.  \nMT Ħoll il-partijiet kiesħa bl-ilma fietel. Togħrokx \nil-parti affettwata.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 402}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 404  \nP336  Language  \nNL Bevroren lichaamsdelen met lauw water \nontdooien. Niet wrijven op de betrokken \nplaatsen.  \nPL Rozmrozić oszronione obszary letnią wodą. Nie \ntrzeć oszronionego obszaru.  \nPT Derreter as zonas congeladas com água morna. \nNão friccionar a zona afectada.  \nRO Dezgheţaţi părţile degerate cu apă călduţă. Nu \nfrecaţi zona afectată.  \nSK Zmrznuté časti ošetrite vlažnou vodou. \nPostihnuté miesto netrite.  \nSL Zamrznjene dele odtaliti z mlačno vodo. Ne \ndrgniti prizadetega mesta.  \nFI Sulata jäätyneet alueet haalealla vedellä. \nVahingoittunutta aluetta ei saa hangata.  \nSV Värm det köldskadade området med ljummet \nvatten. Gnid inte det skadade området.  \nP337  Language  \nBG При продължително дразнене на очите:  \nES Si persiste la irritación ocular:  \nCS Přetrvává-li podráždění očí:  \nDA Ved vedvarende øjenirritation:  \nDE Bei anhaltender Augenreizung:  \nET Kui silmade ärritus ei möödu:  \nEL Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός:  \nEN If eye irritation persists:  \nFR Si l’irritation oculaire persiste:  \nGA Má mhaireann an greannú súile:  \n▼M5 \nHR Ako nadražaj oka ne prestaje:  \n▼B \nIT Se l’irritazione degli occhi persiste:  \nLV Ja acu iekaisums nepāriet:  \nLT Jei akių dirginimas nepraeina:  \nHU Ha a szemirritáció nem múlik el:  \nMT Jekk l-irritazzjoni ta' l-għajnejn tibqa’:  \nNL Bij aanhoudende oogirritatie:  \nPL W przypadku utrzymywania się działania \ndrażniącego na oczy:  \nPT Caso a irritação ocular persista:  \nRO Dacă iritarea ochilor persistă:  \nSK Ak podráždenie očí pretrváva:  \nSL Če draženje oči ne preneha:  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 403}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 405  \nP337  Language  \nFI Jos silmä-ärsytys jatkuu:  \nSV Vid bestående ögonirritation:  \nP338  Language  \nBG Свалете контактните лещи, ако има такива и \nдоколкото това е възможно. Продължете с \nизплакването.  \nES Quitar las lentes de contacto, si lleva y resulta \nfácil. Seguir aclarando.  \nCS Vyjměte kontaktní čočky, jsou-li nasazeny a \npokud je lze vyjmout snadno. Pokračujte ve \nvyplachování.  \nDA Fjern eventuelle kontaktlinser, hvis dette kan \ngøres let. Fortsæt skylning.  \nDE Eventuell Vorhandene Kontaktlinsen nach \nMöglichkeit entfernen. Weiter ausspülen.  \nET Eemaldada kontaktläätsed, kui neid kasutatakse \nja kui neid on kerge eemaldada. Loputada veel \nkord.  \nEL Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, \nεφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.  \nEN Remove contact lenses, if present and easy to \ndo. Continue rinsing.  \nFR Enlever les lentilles de contact si la victime en \nporte et si elles peuvent être facilement \nenlevées. Continuer à rincer.  \nGA Tóg amach na tadhall-lionsaí, más ann dóibh \nagus más furasta é sin a dhéanamh. Lean den \nsruthlú.  \n▼M5 \nHR Ukloniti kontaktne leće ukoliko ih nosite i ako \nse one lako uklanjaju. Nastaviti ispiranje.  \n▼B \nIT Togliere le eventuali lenti a contatto se è \nagevole farlo. Continuare a sciacquare.  \nLV Izņemiet kontaktlēcas, ja tās ir ievietotas un to \nir viegli izdarīt. Turpiniet skalot.  \nLT Išimti kontaktinius lęšius, jeigu jie yra ir jeigu \nlengvai galima tai padaryti. Toliau plauti akis.  \nHU Adott esetben kontaktlencsék eltávolítása, ha \nkönnyen megoldható. Az öblítés folytatása.  \nMT Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u \njkunu faċli biex tneħħihom. Kompli laħlaħ.  \nNL Contactlenzen verwijderen, indien mogelijk. \nBlijven spoelen.  \nPL Wyjąć soczewki kontaktowe, jeżeli są i można \nje łatwo usunąć. Nadal płukać.  \nPT Se usar lentes de contacto, retire-as, se tal lhe \nfor possível. Continue a enxaguar.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 404}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 406  \nP338  Language  \nRO Scoateţi lentilele de contact, dacă este cazul și \ndacă acest lucru se poate face cu ușurinţă. \nContinuaţi să clătiţi.  \nSK Ak používate kontaktné šošovky a ak je to \nmožné, odstráňte ich. Pokračujte vo vypla\xad\nchovaní.  \nSL Odstranite kontaktne leče, če jih imate in če to \nlahko storite brez težav. Nadaljujte z izpir\xad\nanjem.  \nFI Poista piilolinssit, jos sen voi tehdä helposti. \nJatka huuhtomista.  \nSV Ta ur eventuella kontaktlinser om det går lätt. \nFortsätt att skölja.  \n▼M4 \nP340  Language  \nBG Изведете лицето на чист въздух и го \nпоставете в позиция, улесняваща дишането.  \nES Transportar a la persona al aire libre y \nmantenerla en una posición que le facilite la \nrespiración.  \nCS Přeneste osobu na čerstvý vzduch a ponechte ji \nv poloze usnadňující dýchání.  \nDA Flyt personen til et sted med frisk luft og sørg \nfor, at vejrtrækningen lettes.  \nDE Die Person an die frische Luft bringen und für \nungehinderte Atmung sorgen.  \nET Toimetada isik värske õhu kätte ja hoida \nasendis, mis võimaldab kergesti hingata.  \nEL Μεταφέρετε τον παθόντα στον καθαρό αέρα \nκαι αφήστε τον να ξεκουραστεί σε στάση που \nδιευκολύνει την αναπνοή.  \nEN Remove person to fresh air and keep \ncomfortable for breathing.  \nFR Transporter la personne à l’extérieur et la \nmaintenir dans une position où elle peut \nconfortablement respirer.  \nGA Tabhair an duine amach faoin aer úr agus \ncoinnigh é i riocht ina bhféadfadh sé anáil a \ntharraingt go réidh.  \n▼M8 \nHR Premjestiti osobu na svježi zrak i postaviti ju u \npoložaj koji olakšava disanje.  \n▼M4 \nIT Trasportare l’infortunato all’aria aperta e \nmantenerlo a riposo in posizione che favorisca \nla respirazione.  \nLV Nogādāt cietušo svaigā gaisā un nodrošināt \nnetraucētu elpošanu.  \nLT Išnešti nukentėjusįjį į gryną orą; jam būtina \npatogi padėtis, leidžianti laisvai kvėpuoti.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 405}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 407  \nP340  Language  \nHU Az érintett személyt friss levegőre kell vinni, és \nolyan nyugalmi testhelyzetbe kell helyezni, \nhogy könnyen tudjon lélegezni.  \nMT Qiegħed lill-persuna għall-arja friska \nf’pożizzjoni komda biex tieħu n-nifs.  \nNL De persoon in de frisse lucht brengen en ervoor \nzorgen dat deze gemakkelijk kan ademen.  \nPL Wyprowadzić lub wynieść poszkodowanego na \nświeże powietrze i zapewnić mu warunki do \nswobodnego oddychania.  \nPT Retirar a pessoa para uma zona ao ar livre e \nmantê-la numa posição que não dificulte a \nrespiração.  \nRO Transportaţi persoana la aer liber și menţineţi-o \nîntr-o poziţie confortabilă pentru respiraţie.  \nSK Presuňte osobu na čerstvý vzduch a umožnite \njej pohodlne dýchať.  \nSL Prenesti osebo na svež zrak in jo pustiti v \nudobnem položaju, ki olajša dihanje.  \nFI Siirrä henkilö raittiiseen ilmaan ja varmista \nvaivaton hengitys.  \nSV Flytta personen till frisk luft och se till att \nandningen underlättas.  \n__________  \n▼B \nP342  Language  \nBG При симптоми на затруднено дишане:  \nES En caso de síntomas respiratorios:  \nCS Při dýchacích potížích:  \nDA Ved luftvejssymptomer:  \nDE Bei Symptomen der Atemwege:  \nET Hingamisteede probleemide ilmnemise korral:  \nEL Εάν παρουσιάζονται αναπνευστικά συμπτ- \nώματα:  \nEN If experiencing respiratory symptoms:  \nFR En cas de symptômes respiratoires:  \nGA I gcás siomptóm riospráide:  \n▼M5 \nHR Pri otežanom disanju:  \n▼B \nIT In caso di sintomi respiratori:  \nLV Ja rodas elpošanas traucējumu simptomi:  \nLT ►C3 Jeigu pasireiškia kvėpavimo sutrikimo \nsimptomai: ◄  \nHU Légzési problémák esetén:  \nMT Jekk tkun qed tbati minn sintomi respiratorji:  \nNL Bij ademhalingssymptomen:  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 406}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 408  \nP342  Language  \nPL W przypadku wystąpienia objawów ze strony \nukładu oddechowego:  \nPT Em caso de sintomas respiratórios:  \nRO În caz de simptome respiratorii:  \nSK Pri sťaženom dýchaní:  \nSL Pri respiratornih simptomih:  \nFI Jos ilmenee hengitysoireita:  \nSV Vid besvär i luftvägarna:  \n▼M4 __________  \n▼B \nP351  Language  \nBG Промивайте внимателно с вода в \nпродължение на няколко минути.  \nES Aclarar cuidadosamente con agua durante \nvarios minutos.  \nCS Několik minut opatrně oplachujte vodou.  \nDA Skyl forsigtigt med vand i flere minutter.  \nDE Einige Minuten lang behutsam mit Wasser \nausspülen.  \nET Loputada mitme minuti jooksul ettevaatlikult \nveega.  \nEL Ξεπλύνετε προσεκτικά με νερό για αρκετά \nλεπτά.  \nEN Rinse cautiously with water for several minutes.  \nFR Rincer avec précaution à l’eau pendant \nplusieurs minutes.  \nGA Sruthlaítear go faichilleach le huisce ar feadh \nroinnt nóiméad.  \n▼M5 \nHR Oprezno ispirati vodom nekoliko minuta.  \n▼B \nIT Sciacquare accuratamente per parecchi minuti.  \nLV Uzmanīgi skalot ar ūdeni vairākas minūtes.  \nLT Atsargiai plauti vandeniu kelias minutes.  \nHU Óvatos öblítés vízzel több percen keresztül.  \nMT Laħlaħ b'attenzjoni bl-ilma għal diversi minuti.  \nNL Voorzichtig afspoelen met water gedurende een \naantal minuten.  \nPL Ostrożnie płukać wodą przez kilka minut.  \nPT Enxaguar cuidadosamente com água durante \nvários minutos.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 407}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 409  \nP351  Language  \nRO Clătiţi cu atenţie cu apă, timp de mai multe \nminute.  \nSK Opatrne niekoľko minút oplachujte vodou.  \nSL Previdno izpirati z vodo nekaj minut.  \nFI Huuhdo huolellisesti vedellä usean minuutin \najan.  \nSV Skölj försiktigt med vatten i flera minuter.  \n▼M4 \nP352  Language  \nBG Измийте обилно с вода/…  \nES Lavar con abundante agua/…  \nCS Omyjte velkým množstvím vody/…  \nDA Vask med rigeligt vand/…  \nDE Mit viel Wasser/…/waschen.  \nET Pesta rohke veega/…  \nEL Πλύντε με άφθονο νερό/…  \nEN Wash with plenty of water/…  \nFR Laver abondamment à l’eau/…  \nGA Nigh le neart uisce/…  \n▼M8 \nHR Oprati velikom količinom vode/…  \n▼M4 \nIT Lavare abbondantemente con acqua/…  \nLV Nomazgāt ar lielu ūdens/.. daudzumu.  \nLT Plauti dideliu vandens kiekiu/…  \nHU Lemosás bő vízzel/….  \nMT Baħbaħ b’ħafna ilma/…  \nNL Met veel water/… wassen.  \nPL Umyć dużą ilością wody/…  \nPT Lavar abundantemente com água/…  \nRO Spălaţi cu multă apă/…  \nSK Umyte veľkým množstvom vody/…  \nSL Umiti z veliko vode/…  \nFI Pese runsaalla vedellä/…  \nSV Tvätta med mycket vatten/…  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 408}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 410  \nP353  Language  \nBG Облейте кожата с вода [или вземете душ].  \nES Enjuagar la piel con agua [o ducharse].  \nCS Opláchněte kůži vodou [nebo osprchujte].  \nDA Skyl [eller brus] huden med vand.  \nDE Haut mit Wasser abwaschen [oder duschen].  \nET Loputada nahka veega [või loputada duši all].  \nEL Ξεπλύνετε την επιδερμίδα με νερό [ή στο \nντους].  \nEN Rinse skin with water [or shower].  \nFR Rincer la peau à l'eau [ou se doucher].  \nGA Sruthlaítear an craiceann le huisce [nó glac \ncithfholcadh].  \nHR Isprati kožu vodom [ili tuširanjem].  \nIT Sciacquare la pelle [o fare una doccia].  \nLV Noskalot ādu ar ūdeni [vai iet dušā].  \nLT Odą nuplauti vandeniu [arba čiurkšle].  \nHU A bőrt le kell öblíteni vízzel [vagy zuhanyozás].  \nMT Laħlaħ il-ġilda bl-ilma [jew bix-xawer].  \nNL Huid met water afspoelen [of afdouchen].  \nPL Spłukać skórę pod strumieniem wody [lub \nprysznicem].  \nPT Enxaguar a pele com água [ou tomar um \nduche].  \nRO Clătiţi pielea cu apă [sau faceţi duș].  \nSK Pokožku ihneď opláchnite vodou [alebo \nsprchou].  \nSL Kožo izprati z vodo [ali prho].  \nFI Huuhdo iho vedellä [tai suihkuta].  \nSV Skölj huden med vatten [eller duscha].  \n▼B \nP360  Language  \nBG Незабавно облейте замърсеното облекло и \nкожата обилно с вода, преди да свалите \nдрехите.  \nES Aclarar inmediatamente con agua abundante las \nprendas y la piel contaminadas antes de quitarse \nla ropa.  \nCS Kontaminovaný oděv a kůži okamžitě omyjte \nvelkým množstvím vody a potom oděv odložte.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 409}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 411  \nP360  Language  \nDA Skyl omgående tilsmudset tøj og hud med \nrigeligt vand, før tøjet fjernes.  \nDE Kontaminierte Kleidung und Haut sofort mit \nviel Wasser abwaschen und danach Kleidung \nausziehen.  \nET Saastunud rõivad ja nahk loputada viivitamata \nrohke veega ning alles seejärel rõivad \neemaldada.  \nEL Ξεπλύνετε αμέσως τα μολυσμένα ρούχα και \nτην επιδερμίδα με άφθονο νερό πριν \nαφαιρέσετε τα ρούχα.  \nEN Rinse immediately contaminated clothing and \nskin with plenty of water before removing \nclothes.  \nFR Rincer immédiatement et abondamment avec de \nl’eau les vêtements contaminés et la peau avant \nde les enlever.  \nGA Sruthlaítear éadaí éillithe agus an craiceann \nláithreach le neart uisce sula mbaineann an \nduine na héadaí de.  \n▼M5 \nHR Odmah isprati zagađenu odjeću i kožu velikom \nkoličinom vode prije uklanjanja odjeće.  \n▼B \nIT Sciacquare immediatamente e abbondantemente \ngli indumenti contaminati e la pelle prima di \ntogliersi gli indumenti.  \nLV Nekavējoties noskalot piesārņoto apģērbu un \nskarto ādu ar lielu daudzumu ūdens pirms \napģērba novilkšanas.  \nLT Prieš nuvelkant užterštus drabužius, nedelsiant \njuos ir odą nuplauti dideliu kiekiu vandens.  \nHU A ruhák levetése előtt a szennyezett ruházatot \nés a bőrt bő vízzel azonnal le kell öblíteni.  \nMT Laħlaħ mall-ewwel l-ilbies ikkontaminat u l- \nġilda b’ħafna ilma qabel ma tneħħi l-ilbies.  \nNL Verontreinigde kleding en huid onmiddellijk \nmet veel water afspoelen en pas daarna \nkleding uittrekken.  \nPL Natychmiast spłukać zanieczyszczoną odzież i \nskórę dużą ilością wody przed zdjęciem \nodzieży.  \nPT Enxaguar imediatamente com muita água a \nroupa e a pele contaminadas antes de se despir.  \nRO Clătiţi imediat îmbrăcămintea contaminată și \npielea cu multă apă, înainte de scoaterea \nîmbrăcămintei.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 410}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 412  \nP360  Language  \nSK Kontaminovaný odev a pokožku ihneď \nopláchnite veľkým množstvom vody a potom \nodev odstráňte.  \nSL Takoj izprati kontaminirana oblačila in kožo z \nveliko vode pred odstranitvijo oblačil.  \nFI Huuhdo saastunut vaatetus ja iho välittömästi \nrunsaalla vedellä ennen vaatetuksen riisumista.  \nSV Skölj genast nedstänkta kläder och hud med \nmycket vatten innan du tar av dig kläderna.  \n▼M4 \nP361  Language  \nBG Незабавно свалете цялото замърсено \nоблекло.  \nES Quitar inmediatamente todas las prendas \ncontaminadas.  \nCS Veškeré kontaminované části oděvu okamžitě \nsvlékněte.  \nDA Alt tilsmudset tøj tages straks af.  \nDE Alle kontaminierten Kleidungsstücke sofort \nausziehen.  \nET Võtta viivitamata seljast kõik saastunud rõivad.  \nEL Βγάλτε αμέσως όλα τα μολυσμένα ρούχα.  \nEN Take off immediately all contaminated clothing.  \nFR Enlever immédiatement tous les vêtements \ncontaminés.  \nGA Bain díot láithreach na héadaí éillithe go léir.  \n▼M8 \nHR Odmah skinuti svu zagađenu odjeću.  \n▼M4 \nIT Togliere immediatamente tutti gli indumenti \ncontaminati.  \nLV Novilkt nekavējoties visu piesārņoto apģērbu.  \nLT Nedelsiant nuvilkti visus užterštus drabužius.  \nHU Az összes szennyezett ruhadarabot azonnal le \nkell vetni.  \nMT Neħħi minnufih il-ħwejjeg kontaminati kollha.  \nNL Verontreinigde kleding onmiddellijk uittrekken.  \nPL Natychmiast zdjąć całą zanieczyszczoną odzież.  \nPT Retirar imediatamente toda a roupa contami\xad\nnada.  \nRO Scoateţi imediat toată îmbrăcămintea contami\xad\nnată.  \nSK Všetky kontaminované časti odevu okamžite \nvyzlečte.  \nSL Takoj sleči vsa kontaminirana oblačila.  \nFI Riisu saastunut vaatetus välittömästi.  \nSV Ta omedelbart av alla nedstänkta kläder.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 411}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 413  \nP362  Language  \nBG Свалете замърсеното облекло.  \nES Quitar las prendas contaminadas.  \nCS Kontaminovaný oděv svlékněte.  \nDA Alt tilsmudset tøj tages af.  \nDE Kontaminierte Kleidung ausziehen.  \nET Võtta saastunud rõivad seljast.  \nEL Βγάλτε τα μολυσμένα ρούχα.  \nEN Take off contaminated clothing.  \nFR Enlever les vêtements contaminés.  \nGA Bain díot aon éadaí éillithe.  \n▼M8 \nHR Skinuti zagađenu odjeću.  \n▼M4 \nIT Togliere gli indumenti contaminati.  \nLV Novilkt piesārņoto apģērbu.  \nLT Nuvilkti užterštus drabužius.  \nHU A szennyezett ruhadarabot le kell vetni.  \nMT Neħħi l-ħwejjeġ kontaminati.  \nNL Verontreinigde kleding uittrekken.  \nPL Zdjąć zanieczyszczoną odzież.  \nPT Retirar a roupa contaminada.  \nRO Scoateţi îmbrăcămintea contaminată.  \nSK Kontaminovaný odev vyzlečte.  \nSL Sleči kontaminirana oblačila.  \nFI Riisu saastunut vaatetus.  \nSV Ta av nedstänkta kläder.  \n▼B \nP363  Language  \nBG Изперете замърсеното облекло преди \nповторна употреба.  \nES Lavar las prendas contaminadas antes de volver \na usarlas.  \nCS Kontaminovaný oděv před opětovným použitím \nvyperte.  \nDA Tilsmudset tøj skal vaskes, før det kan \nanvendes igen.  \nDE Kontaminierte Kleidung vor erneutem Tragen \nwaschen.  \nET Saastunud rõivad enne järgmist kasutamist \npesta.  \nEL Πλύνετε τα μολυσμένα ενδύματα πριν τα \nξαναχρησιμοποιήσετε.  \nEN Wash contaminated clothing before reuse.  \nFR Laver les vêtements contaminés avant réutili\xad\nsation.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 412}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 414  \nP363  Language  \nGA Nigh éadaí éillithe sula ndéanfar iad a athúsáid.  \n▼M5 \nHR Oprati zagađenu odjeću prije ponovne uporabe.  \n▼B \nIT Lavare gli indumenti contaminati prima di \nindossarli nuovamente.  \nLV Pirms atkārtotas lietošanas piesārņoto apģērbu \nizmazgāt.  \nLT Užterštus drabužius išskalbti prieš vėl juos apsi\xad\nvelkant.  \nHU A szennyezett ruhát újbóli használat előtt ki kell \nmosni.  \nMT Aħsel il-ħwejjeġ kontaminati qabel terġa’ \ntużahom.  \nNL Verontreinigde kleding wassen alvorens deze \nopnieuw te gebruiken.  \nPL Wyprać zanieczyszczoną odzież przed \nponownym użyciem.  \nPT Lavar a roupa contaminada antes de a voltar a \nusar.  \nRO Spălaţi îmbracămintea contaminată, înainte de \nreutilizare.  \nSK Kontaminovaný odev pred ďalším použitím \nvyperte.  \nSL Kontaminirana oblačila oprati pred ponovno \nuporabo.  \nFI Pese saastunut vaatetus ennen uudelleenkäyttöä.  \nSV Nedstänkta kläder ska tvättas innan de används \nigen. \n▼M4 \nP364  Language  \nBG И го изперете преди повторна употреба.  \nES Y lavarlas antes de volver a usarlas.  \nCS A před opětovným použitím vyperte.  \nDA Og vaskes inden genanvendelse.  \nDE Und vor erneutem Tragen waschen.  \nET Ja pesta enne korduskasutust.  \nEL Και πλύντε τα πριν τα ξαναχρησιμοποιήσετε.  \nEN And wash it before reuse.  \nFR Et les laver avant réutilisation.  \nGA Agus nigh iad sula ndéanfar iad a athúsáid.  \n▼M8 \nHR I oprati je prije ponovne uporabe.  \n▼M4 \nIT E lavarli prima di indossarli nuovamente.  \nLV Un pirms atkārtotas lietošanas izmazgāt.  \nLT Taip pat išskalbti prieš vėl apsivelkant.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 413}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 415  \nP364  Language  \nHU És újbóli használat előtt ki kell mosni.  \nMT U aħslu qabel terġa’ tużah.  \nNL En wassen alvorens deze opnieuw te gebruiken.  \nPL I wyprać przed ponownym użyciem.  \nPT E lavar antes de voltar a usar.  \nRO Și spălaţi înainte de reutilizare.  \nSK A pred ďalším použitím vyperte.  \nSL In jih oprati pred ponovno uporabo.  \nFI Ja pese ennen uudelleenkäyttöä.  \nSV Och tvätta dem innan de används igen.  \n▼B \nP370  Language  \nBG При пожар:  \nES En caso de incendio:  \nCS V případě požáru:  \nDA Ved brand:  \nDE Bei Brand:  \nET Tulekahju korral:  \nEL Σε περίπτωση πυρκαγιάς:  \nEN In case of fire:  \nFR En cas d’incendie:  \nGA I gcás dóiteáin:  \n▼M5 \nHR U slučaju požara:  \n▼B \nIT In caso di incendio:  \nLV Ugunsgrēka gadījumā:  \nLT Gaisro atveju:  \nHU Tűz esetén:  \nMT F’każ ta' nar:  \nNL In geval van brand:  \nPL W przypadku pożaru:  \nPT Em caso de incêndio:  \nRO În caz de incendiu:  ▼M4", metadata={'source': 'data/ycla_en.pdf', 'page': 414}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 416  \nP370  Language  \nSK V prípade požiaru:  \nSL Ob požaru:  \nFI Tulipalon sattuessa:  \nSV Vid brand:  \nP371  Language  \nBG При голям пожар и значителни количества:  \nES En caso de incendio importante y en grandes \ncantidades:  \nCS V případě velkého požáru a velkého množství:  \nDA Ved større brand og store mængder:  \nDE Bei Großbrand und großen Mengen:  \nET Suure tulekahju korral ning kui on tegemist \nsuurte kogustega:  \nEL Σε περίπτωση σοβαρής πυρκαγιάς και εάν \nπρόκειται για μεγάλες ποσότητες:  \nEN In case of major fire and large quantities:  \nFR En cas d’incendie important et s’il s’agit de \ngrandes quantités:  \nGA I gcás mórdhóiteáin agus má tá cainníochtaí \nmóra i gceist:  \n▼M5 \nHR U slučaju velikog požara i velikih količina:  \n▼B \nIT In caso di incendio grave e di quantità rilevanti:  \nLV Ugunsgrēka un lielu apjomu gadījumā:  \nLT Didelio gaisro ir didelių kiekių atveju:  \nHU Nagyobb tűz és nagy mennyiség esetén:  \nMT F’każ ta' nar kbir u kwantitajiet kbar:  \nNL In geval van grote brand en grote hoeveel\xad\nheden:  \nPL W przypadku poważnego pożaru i dużych \nilości:  \nPT Em caso de incêndio importante e de grandes \nquantidades:  \nRO În caz de incendiu de proporţii și de cantităţi \nmari de produs:  \nSK V prípade veľkého požiaru a veľkého \nmnožstva:  \nSL Ob velikem požaru in velikih količinah:  \nFI Jos tulipalo ja ainemäärät ovat suuret:  \nSV Vid större brand och stora mängder:  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 415}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 417  \nP372  Language  \nBG Опасност от експлозия.  \nES Riesgo de explosión.  \nCS Nebezpečí výbuchu.  \nDA Eksplosionsfare.  \nDE Explosionsgefahr.  \nET Plahvatusoht.  \nEL Κίνδυνος έκρηξης.  \nEN Explosion risk.  \nFR Risque d'explosion.  \nGA Baol pléasctha.  \nHR Opasnost od eksplozije.  \nIT Rischio di esplosione.  \nLV Eksplozijas risks.  \nLT Sprogimo pavojus.  \nHU Robbanásveszély.  \nMT Riskju ta' splużjoni.  \nNL Ontploffingsgevaar.  \nPL Zagrożenie wybuchem.  \nPT Risco de explosão.  \nRO Risc de explozie.  \nSK Riziko výbuchu.  \nSL Nevarnost eksplozije.  \nFI Räjähdysvaara.  \nSV Explosionsrisk.  \n▼B \nP373  Language  \nBG НЕ се опитвайте да гасите пожара, ако \nогънят наближи експлозиви.  \nES NO luchar contra el incendio cuando el fuego \nllega a los explosivos.  \nCS Požár NEHASTE, dostane-li se k výbušninám.  \nDA BEKÆMP IKKE branden, hvis denne når \neksplosiverne.  \nDE KEINE Brandbekämpfung, wenn das Feuer \nexplosive Stoffe/Gemische/Erzeugnisse erreicht.  \nET Kui tuli jõuab lõhkeaineteni, MITTE teha \nkustutustöid.  \nEL ΜΗΝ προσπαθείτε να σβήσετε την πυρκαγιά, \nόταν η φωτιά πλησιάζει σε εκρηκτικά.  \nEN DO NOT fight fire when fire reaches explos\xad\nives. \nFR NE PAS combattre l’incendie lorsque le feu \natteint les explosifs.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 416}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 418  \nP373  Language  \nGA NÁ DÉAN an dóiteán a chomhrac má shroi\xad\ncheann sé pléascáin.  \n▼M5 \nHR NE gasiti vatru kada plamen može zahvatiti \neksplozive.  \n▼B \nIT NON utilizzare mezzi estinguenti se l’incendio \nraggiunge materiali esplosivi.  \nLV NECENSTIES dzēst ugunsgrēku, ja uguns \npiekļūst sprādzienbīstamām vielām.  \nLT NEGESINTI gaisro, jeigu ugnis pasiekia sprog\xad\nmenis.  \nHU TILOS a tűz oltása, ha az robbanóanyagra átter\xad\njedt. \nMT TIPPRUVAX TITFI n-nar meta n-nar jilħaq l- \nisplussivi.  \nNL NIET blussen wanneer het vuur de ontplofbare \nstoffen bereikt.  \nPL NIE gasić pożaru, jeżeli ogień dosięgnie \nmateriały wybuchowe  \nPT Se o fogo atingir os explosivos, NÃO tentar \ncombatê-lo.  \nRO NU încercaţi să stingeţi incendiul atunci când \nfocul a ajuns la explozivi.  \nSK Požiar NEHASTE, ak sa oheň priblížil k \nvýbušninám.  \nSL NE gasiti, ko ogenj doseže eksploziv.  \nFI Tulta EI SAA yrittää sammuttaa sen saavutettua \nräjähteet.  \nSV Försök INTE bekämpa branden när den når \nexplosiva varor.  \n▼M12  __________  \n▼B \nP375  Language  \nBG Гасете пожара от разстояние поради \nопасност от експлозия.  \nES Luchar contra el incendio a distancia, dado el \nriesgo de explosión.  \nCS Kvůli nebezpečí výbuchu haste z dostatečné \nvzdálenosti.  \nDA Bekæmp branden på afstand på grund af \neksplosionsfare.  \nDE Wegen Explosionsgefahr Brand aus der \nEntfernung bekämpfen.  \nET Plahvatusohu tõttu teha kustutustöid eemalt.  \nEL Προσπαθήστε να σβήσετε την πυρκαγιά από \nαπόσταση, επειδή υπάρχει κίνδυνος έκρηξης.  \nEN Fight fire remotely due to the risk of explosion.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 417}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 419  \nP375  Language  \nFR Combattre l’incendie à distance à cause du \nrisque d’explosion.  \nGA Téigh i gcianghleic leis an dóiteán mar gheall \nar an mbaol pléasctha.  \n▼M5 \nHR Gasiti s veće udaljenosti zbog opasnosti od \neksplozije.  \n▼B \nIT Rischio di esplosione. Utilizzare i mezzi \nestinguenti a grande distanza.  \nLV Dzēst ugunsgrēku no attāluma eksplozijas riska \ndēļ. \nLT Gaisrą gesinti iš toli dėl sprogimo pavojaus.  \nHU A tűz oltását robbanásveszély miatt távolból \nkell végezni.  \nMT Itfi n-nar mill-bogħod minħabba r-riskju ta' \nsplużjoni.  \nNL Op afstand blussen omwille van ontploffings\xad\ngevaar.  \nPL Z powodu ryzyka wybuchu gasić pożar z \nodległości.  \nPT Combater o incêndio à distância, devido ao \nrisco de explosão.  \nRO Stingeţi incendiul de la distanţă din cauza peri\xad\ncolului de explozie.  \nSK Z dôvodu nebezpečenstva výbuchu požiar haste \nz diaľky.  \nSL Gasiti z večje razdalje zaradi nevarnosti eksplo\xad\nzije. \nFI Sammuta palo etäältä räjähdysvaaran takia.  \nSV Bekämpa branden på avstånd på grund av \nexplosionsrisken.  \nP376  Language  \nBG Спрете теча, ако е безопасно.  \nES Detener la fuga, si no hay peligro en hacerlo.  \nCS Zastavte únik, můžete-li tak učinit bez rizika.  \nDA Stands lækagen, hvis dette er sikkert.  \nDE Undichtigkeit beseitigen, wenn gefahrlos \nmöglich.  \nET Leke peatada, kui seda on võimalik teha \nohutult.  \nEL Σταματήστε τη διαρροή, εφόσον δεν υπάρχει \nκίνδυνος.  \nEN Stop leak if safe to do so.  \nFR Obturer la fuite si cela peut se faire sans \ndanger.  \nGA Cuir stop leis an sceitheadh má tá sé sábháilte é \nsin a dhéanamh.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 418}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 420  \nP376  Language  \n▼M5 \nHR Ako je sigurno, zaustaviti istjecanje.  \n▼B \nIT Bloccare la perdita se non c’è pericolo.  \nLV Apstādināt noplūdi, ja to var izdarīt drošā \nveidā.  \nLT Sustabdyti nuotėkį, jeigu galima saugiai tai \npadaryti.  \nHU Meg kell szüntetni a szivárgást, ha ez bizton\xad\nságosan megtehető.  \nMT Waqqaf it-tnixxija jekk ma jkunx hemm \nperiklu.  \nNL Het lek dichten als dat veilig gedaan kan \nworden.  \nPL Jeżeli jest to bezpieczne zahamować wyciek.  \nPT Deter a fuga se tal puder ser feito em segur\xad\nança.  \nRO Opriţi scurgerea, dacă acest lucru se poate face \nîn siguranţă.  \nSK Zastavte únik, ak je to bezpečné.  \nSL Zaustaviti puščanje, če je varno.  \nFI Sulje vuoto, jos sen voi tehdä turvallisesti.  \nSV Stoppa läckan om det kan göras på ett säkert \nsätt. \nP377  Language  \nBG Пожар от изтекъл газ: \nНе гасете освен при възможност за \nбезопасно отстраняване на теча.  \nES Fuga de gas en llamas: \nNo apagar, salvo si la fuga puede detenerse sin \npeligro.  \nCS Požár unikajícího plynu: \nNehaste, nelze-li únik bezpečně zastavit.  \nDA Brand fra udsivende gas: \nSluk ikke, medmindre det er sikkert at stoppe \nlækagen.  \nDE Brand von ausströmendem Gas: \nNicht löschen, bis Undichtigkeit gefahrlos \nbeseitigt werden kann.  \nET Lekkiva gaasi põlemise korral mitte kustutada, \nvälja arvatud juhul, kui leket on võimalik \nohutult peatada.  \nEL Διαρροή φλεγόμενου αερίου: \nΜην την σβήσετε, εκτός εάν μπορείτε να \nσταματήσετε τη διαρροή χωρίς κίνδυνο.  \nEN Leaking gas fire: \nDo not extinguish, unless leak can be stopped \nsafely.  \nFR Fuite de gaz enflammé: \nNe pas éteindre si la fuite ne peut pas être \narrêtée sans danger.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 419}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 421  \nP377  Language  \nGA Tine gháis ag sceitheadh: \nNá múch, mura i ndán agus gur féidir stop a \nchur leis an sceitheadh go sábháilte.  \n▼M5 \nHR Požar zbog istjecanja plina: \nne gasiti ako nije moguće sa sigurnošću zaus\xad\ntaviti istjecanje.  \n▼B \nIT In caso d’incendio dovuto a perdita di gas, non \nestinguere a meno che non sia possibile \nbloccare la perdita senza pericolo.  \nLV Degšanas gāzes noplūde: \nNedzēst, ja vien noplūdi var apstādināt drošā \nveidā.  \nLT Dujų nuotėkio sukeltas gaisras: \nNegesinti, nebent nuotėkį būtų galima saugiai \nsustabdyti.  \nHU Égő szivárgó gáz: \nCsak akkor szabad a tüzet oltani, ha a szivárgás \nbiztonságosan megszüntethető.  \nMT Tnixxija ta' gass tan-nar: \nTippruvax titfiha, sakemm it-tnixxija ma tkunx \ntista' titwaqqaf bla periklu.  \nNL Brand door lekkend gas: \nniet blussen, tenzij het lek veilig gedicht kan \nworden.  \nPL W przypadku płonięcia wyciekającego gazu: \nNie gasić, jeżeli nie można bezpiecznie \nzahamować wycieku.  \nPT Incêndio por fuga de gás: não apagar, a menos \nque se possa deter a fuga em segurança.  \nRO Incendiu cauzat de o scurgere de gaz: nu \nîncercaţi să stingeţi, decât dacă scurgerea \npoate fi oprită în siguranţă.  \nSK Požiar unikajúceho plynu: Nehaste, pokiaľ únik \nnemožno bezpečne zastaviť.  \nSL Požar zaradi uhajanja plina: \nNe gasiti, če puščanja ni mogoče varno zausta\xad\nviti. \nFI Vuotavasta kaasusta johtuva palo: \nEi saa sammuttaa, jollei vuotoa voida pysäyttää \nturvallisesti.  \nSV Läckande gas som brinner: \nFörsök inte släcka branden om inte läckan kan \nstoppas på ett säkert sätt.  \n▼M4 \nP378  Language  \nBG Използвайте…, за да загасите.  \nES Utilizar… para la extinción.  \nCS K uhašení použijte…  \nDA Anvend…til brandslukning.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 420}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 422  \nP378  Language  \nDE … zum Löschen verwenden.  \nET Kustutamiseks kasutada…  \nEL Χρησιμοποιείστε… για να κατασβήσετε.  \nEN Use… to extinguish.  \nFR Utiliser… pour l’extinction.  \nGA Úsáid … le haghaidh múchta.  \n▼M8 \nHR Za gašenje rabiti …  \n▼M4 \nIT Utilizzare….per estinguere.  \nLV Dzēšanai izmantojiet ….  \nLT Gesinimui naudoti …  \nHU Oltásra …használandó.  \nMT Uża… biex titfi.  \nNL Blussen met …  \nPL Użyć… do gaszenia.  \nPT Para extinguir utilizar….  \nRO A se utiliza… pentru a stinge.  \nSK Na hasenie použite…  \nSL Za gašenje se uporabi…  \nFI Käytä palon sammuttamiseen…  \nSV Släck med…  \n▼B \nP380  Language  \nBG Евакуирайте зоната.  \nES Evacuar la zona.  \nCS Vykliďte _roctor.  \nDA Evakuer området.  \nDE Umgebung räumen.  \nET Ala evakueerida.  \nEL Εκκενώστε την περιοχή.  \nEN Evacuate area.  \nFR Évacuer la zone.  \nGA Aslonnaigh gach duine as an limistéar.  \n▼M5 \nHR Evakuirati područje.  \n▼B \nIT Evacuare la zona.  \nLV Evakuēt zonu.  \nLT Evakuoti zoną.  \nHU A területet ki kell üríteni.  \nMT Evakwa ż-żona.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 421}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 423  \nP380  Language  \nNL Evacueren.  \nPL Ewakuować teren.  \nPT Evacuar a zona.  \nRO Evacuaţi zona.  \nSK Priestory evakuujte.  \nSL Izprazniti območje.  \nFI Evakuoi alue.  \nSV Utrym området.  \n▼M12  \nP381  Language  \nBG В случай на изтичане премахнете всички \nизточници на запалване.  \nES En caso de fuga, eliminar todas las fuentes de \nignición.  \nCS V případě úniku odstraňte všechny zdroje zapá\xad\nlení. \nDA I tilfælde af lækage fjernes alle antændelses\xad\nkilder.  \nDE Bei Undichtigkeit alle Zündquellen entfernen.  \nET Lekke korral eemaldada kõik süüteallikad.  \nEL Σε περίπτωση διαρροής, εξαλείψτε όλες τις \nπηγές ανάφλεξης.  \nEN In case of leakage, eliminate all ignition \nsources.  \nFR En cas de fuite, éliminer toutes les sources d'ig\xad\nnition.  \nGA I gcás sceite, díothaigh gach foinse adhainte.  \nHR U slučaju istjecanja ukloniti sve izvore paljenja.  \nIT In caso di perdita, eliminare ogni fonte di \naccensione.  \nLV Noplūdes gadījumā novērst visus uzliesmošanas \navotus.  \nLT Nuotėkio atveju, pašalinti visus uždegimo \nšaltinius.  \nHU Szivárgás esetén meg kell szüntetni az összes \ngyújtóforrást.  \nMT F'każ ta' tnixxija, elimina s-sorsi kollha li \njqabbdu.  \nNL In geval van lekkage alle ontstekingsbronnen \nwegnemen.  \nPL W przypadku wycieku wyeliminować wszystkie \nźródła zapłonu.  \nPT Em caso de fuga, eliminar todas as fontes de \nignição.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 422}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 424  \nP381  Language  \nRO În caz de scurgeri, eliminaţi toate sursele de \naprindere.  \nSK V prípade úniku odstráňte všetky zdroje \nzapálenia.  \nSL V primeru uhajanja odstraniti vse vire vžiga.  \nFI Vuototapauksessa poista kaikki sytytyslähteet.  \nSV Vid läckage, avlägsna alla antändningskällor.  \n▼B \nP390  Language  \nBG Попийте разлятото, за да се предотвратят \nматериални вреди.  \nES Absorber el vertido para que no dañe otros \nmateriales.  \nCS Uniklý produkt absorbujte, aby se zabránilo \nmateriálním škodám.  \nDA Absorber udslip for at undgå materielskade.  \nDE Verschüttete Mengen aufnehmen, um Materi\xad\nalschäden zu vermeiden.  \nET Mahavoolanud toode absorbeerida, et see ei \nkahjustaks teisi materjale.  \nEL Σκουπίστε τη χυμένη ποσότητα για να \nπρολάβετε υλικές ζημιές.  \nEN Absorb spillage to prevent material damage.  \nFR Absorber toute substance répandue pour éviter \nqu’elle attaque les matériaux environnants.  \nGA Ionsúigh doirteadh chun damáiste d’ábhar a \nchosc.  \n▼M5 \nHR Apsorbirati proliveno kako bi se spriječila \nmaterijalna šteta.  \n▼B \nIT Assorbire la fuoriuscita per evitare danni \nmateriali.  \nLV Uzsūkt izšļakstījumus, lai novērstu materiālus \nzaudējumus.  \nLT Absorbuoti išsiliejusią medžiagą, siekiant \nišvengti materialinės žalos.  \nHU A kiömlött anyagot fel kell itatni a körülvevő \nanyagok károsodásának megelőzése érdekében.  \nMT Assorbi t-tixrid biex tipprevjeni ħsara fil- \nmaterjal.  \nNL Gelekte/gemorste stof opnemen om materiële \nschade te vermijden.  \nPL Usunąć wyciek, aby zapobiec szkodom materi\xad\nalnym.  \nPT Absorver o produto derramado a fim de evitar \ndanos materiais.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 423}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 425  \nP390  Language  \nRO Absorbiţi scurgerile de produs, pentru a nu \nafecta materialele din apropiere.  \nSK Absorbujte uniknutý produkt, aby sa zabránilo \nmateriálnym škodám.  \nSL Odpraviti razlitje, da se prepreči materialna \nškoda.  \nFI Imeytä valumat vahinkojen estämiseksi.  \nSV Sug upp spill för att undvika materiella skador.  \nP391  Language  \nBG Съберете разлятото.  \nES Recoger el vertido.  \nCS Uniklý produkt seberte.  \nDA Udslip opsamles.  \nDE Verschüttete Mengen aufnehmen.  \nET Mahavoolanud toode kokku koguda.  \nEL Μαζέψτε τη χυμένη ποσότητα.  \nEN Collect spillage.  \nFR Recueillir le produit répandu.  \nGA Bailigh doirteadh.  \n▼M5 \nHR Sakupiti proliveno/rasuto.  \n▼B \nIT Raccogliere il materiale fuoriuscito.  \nLV Savākt izšļakstīto šķidrumu.  \nLT Surinkti ištekėjusią medžiagą.  \nHU A kiömlött anyagot össze kell gyűjteni.  \nMT Iġbor it-tixrid.  \nNL Gelekte/gemorste stof opruimen.  \nPL Zebrać wyciek.  \nPT Recolher o produto derramado.  \nRO Colectaţi scurgerile de produs.  \nSK Zozbierajte uniknutý produkt.  \nSL Prestreči razlito tekočino.  \nFI Valumat on kerättävä.  \nSV Samla upp spill.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 424}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 426  \nP301 + P310  Language  \nBG ПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в \nЦЕНТЪР ПО ТОКСИКОЛОГИЯ/на лекар/…  \nES EN CASO DE INGESTIÓN: Llamar inmedi\xad\natamente a un CENTRO DE TOXICOLOGĺA/ \nmédico/…  \nCS PŘI POŽITÍ: Okamžitě volejte TOXIKO\xad\nLOGICKÉ INFORMAČNÍ STŘEDISKO/ \nlékaře/….  \nDA I TILFÆLDE AF INDTAGELSE: Ring \nomgående til en GIFTINFORMATION/læge/…  \nDE BEI VERSCHLUCKEN: Sofort GIFTIN\xad\nFORMATIONSZENTRUM/Arzt/…/anrufen.  \nET ALLANEELAMISE KORRAL: võtta viivi\xad\ntamata ühendust MÜRGISTUSTEABE\xad\nKESKUSE/arstiga…  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: καλέστε \nαμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ/ \nγιατρό/…  \nEN IF SWALLOWED: Immediately call a \nPOISON CENTER/doctor/…  \nFR EN CAS D’INGESTION: Appeler immédi\xad\natement un CENTRE ANTIPOISON/un \nmédecin/…  \nGA MÁ SHLOGTAR: Cuir glao láithreach ar \nIONAD NIMHE/ar dhoctúir/…  \n▼M8 \nHR AKO SE PROGUTA: odmah nazvati CENTAR \nZA KONTROLU OTROVANJA/liječnika/…  \n▼M4 \nIT IN CASO DI INGESTIONE: contattare \nimmediatamente un CENTRO ANTIVELENI/ \nun medico/…  \nLV NORĪŠANAS GADĪJUMĀ: Nekavējoties sazi\xad\nnieties ar SAINDĒŠANĀS INFORMĀCIJAS \nCENTRU/ārstu/…  \nLT PRARIJUS: nedelsiant skambinti į APSI\xad\nNUODIJIMŲ KONTROLĖS IR INFORM\xad\nACIJOS BIURĄ/kreiptis į gydytoją/…  \nHU LENYELÉS ESETÉN: Azonnal forduljon \nTOXIKOLÓGIAI KÖZPONTHOZ/orvoshoz/ \n…. \nMT JEKK JINBELA’: Sejjaħ minnufih ĊENTRU \nTAL-AVVELENAMENT/tabib/…  \nNL NA INSLIKKEN: onmiddellijk een ANTIGIF\xad\nCENTRUM/arts/… raadplegen.  \nPL W PRZYPADKU POŁKNIĘCIA: Natychmiast \nskontaktować się z OŚRODKIEM ZATRUĆ/ \nlekarzem/…  \nPT EM CASO DE INGESTÃO: contacte imedi\xad\natamente um CENTRO DE INFORMAÇÃO \nANTIVENENOS/médico/…  \nRO ÎN CAZ DE ÎNGHIŢIRE: sunaţi imediat la un \nCENTRU DE INFORMARE TOXICO\xad\nLOGICĂ/un medic/…  \nSK PO POŽITÍ: Okamžite volajte TOXIKO\xad\nLOGICKÉ INFORMAČNÉ CENTRUM/ \nlekára/…  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 425}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 427  \nP301 + P310  Language  \nSL PRI ZAUŽITJU: Takoj pokličite CENTER ZA \nZASTRUPITVE/zdravnika/…  \nFI JOS KEMIKAALIA ON NIELTY: Ota \nvälittömästi yhteys MYRKYTYSTIETOKES\xad\nKUKSEEN/lääkäriin/…  \nSV VID FÖRTÄRING: Kontakta genast GIFTIN\xad\nFORMATIONSCENTRALEN/läkare/…  \n▼M12  \nP301 + P312  Language  \nBG ПРИ ПОГЛЪЩАНЕ: при неразположение се \nобадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ/на \nлекар/…  \nES EN CASO DE INGESTIÓN: Llamar a un \nCENTRO DE TOXICOLOGÍA / médico /… si \nla persona se encuentra mal.  \nCS PŘI POŽITÍ: Necítíte-li se dobře, volejte TOXI\xad\nKOLOGICKÉ INFORMAČNÍ STŘEDISKO / \nlékaře / … .  \nDA I TILFÆLDE AF INDTAGELSE: Kontakt \nGIFTLINJEN/læge/… i tilfælde af ubehag.  \nDE BEI VERSCHLUCKEN: Bei Unwohlsein \nGIFTINFORMATIONSZENTRUM/Arzt/… \nanrufen.  \nET ALLANEELAMISE KORRAL: halva enesetunde \nkorral võtta ühendust MÜRGISTUSTEABEKES\xad\nKUSEGA/arstiga/…/.  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε το \nΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ/γιατρό/…, αν \nαισθανθείτε αδιαθεσία.  \nEN IF SWALLOWED: Call a POISON CENTRE/ \ndoctor/… if you feel unwell.  \nFR EN CAS D'INGESTION: Appeler un CENTRE \nANTIPOISON/un médecin/…/ en cas de malaise.  \nGA MÁ SHLOGTAR: Cuir glao ar IONAD NIMHE/ \ndochtúir/… má bhraitheann tú tinn.  \nHR AKO SE PROGUTA: u slučaju zdravstvenih \ntegoba nazvati CENTAR ZA KONTROLU \nOTROVANJA / liječnika / …  \nIT IN CASO DI INGESTIONE: in presenza di \nmalessere, contattare un CENTRO \nANTIVELENI/un medico/… .  \nLV NORĪŠANAS GADĪJUMĀ: Sazinieties ar \nSAINDĒŠANĀS INFORMĀCIJAS CENTRU/ \nārstu/…, ja jums ir slikta pašsajūta.  \nLT PRARIJUS: pasijutus blogai, skambinti į APSI\xad\nNUODIJIMŲ KONTROLĖS IR INFORM\xad\nACIJOS BIURĄ / kreiptis į gydytoją / …  \nHU LENYELÉS ESETÉN: Rosszullét esetén \nforduljon TOXIKOLÓGIAI KÖZPONTHOZ/ \norvoshoz/….  \nMT JEKK JINBELA': Ikkuntattja ĊENTRU TAL- \nAVVELENAMENT / tabib /… jekk tħossok \nma tiflaħx.  ▼M4", metadata={'source': 'data/ycla_en.pdf', 'page': 426}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 428  \nP301 + P312  Language  \nNL NA INSLIKKEN: bij onwel voelen een ANTI\xad\nGIFCENTRUM/arts/… raadplegen.  \nPL W PRZYPADKU POŁKNIĘCIA: W przypadku \nzłego samopoczucia skontaktować się z \nOŚRODKIEM ZATRUĆ/ lekarzem/….  \nPT EM CASO DE INGESTÃO: Caso sinta indis\xad\nposição, contacte um CENTRO DE \nINFORMAÇÃO ANTIVENENOS/médico/… .  \nRO ÎN CAZ DE ÎNGHIŢIRE: Sunaţi la un CENTRU \nDE INFORMARE TOXICOLOGICĂ/un medic/ \n… dacă nu vă simţiţi bine.  \nSK PO POŽITÍ: Pri zdravotných problémoch volajte \nNÁRODNÉ TOXIKOLOGICKÉ \nINFORMAČNÉ CENTRUM/lekára/… .  \nSL PRI ZAUŽITJU: Ob slabem počutju pokličite \nCENTER ZA ZASTRUPITVE/zdravnika/… .  \nFI JOS KEMIKAALIA ON NIELTY: Ota yhteys \nMYRKYTYSTIETOKESKUKSEEN/lääkäriin/ \n…, jos ilmenee pahoinvointia.  \nSV VID FÖRTÄRING: Vid obehag, kontakta \nGIFTINFORMATIONSCENTRALEN/läkare… .  \n__________  \nP302 + P334  Language  \nBG ПРИ КОНТАКТ С КОЖАТА: потопете в \nхладка вода или сложете мокри компреси.  \nES EN CASO DE CONTACTO CON LA PIEL: \nSumergir en agua fría o envolver en vendas \nhúmedas.  \nCS PŘI STYKU S KŮŽÍ: Ponořte do studené vody \nnebo zabalte do vlhkého obvazu.  \nDA VED KONTAKT MED HUDEN: Hold under \nkoldt vand eller anvend våde omslag.  \nDE BEI BERÜHRUNG MIT DER HAUT: In \nkaltes Wasser tauchen oder nassen Verband \nanlegen.  \nET NAHALE SATTUMISE KORRAL: hoida \njahedas vees või panna peale niiske kompress.  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: \nΒυθίστε σε δροσερό νερό ή τυλίξτε με \nβρεγμένους επιδέσμους.  \nEN IF ON SKIN: Immerse in cool water or wrap in \nwet bandages.  \nFR EN CAS DE CONTACT AVEC LA PEAU: \nRincer à l'eau fraîche ou poser une compresse \nhumide.  \nGA I gCÁS TEAGMHÁLA LEIS AN \ngCRAICEANN: Tum in uisce fionnuar nó \ncuir bréid fliuch air.  \nHR U SLUČAJU DODIRA S KOŽOM: uroniti u \nhladnu vodu ili omotati vlažnim zavojem.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 427}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 429  \nP302 + P334  Language  \nIT IN CASO DI CONTATTO CON LA PELLE: \nimmergere in acqua fredda o avvolgere con un \nbendaggio umido.  \nLV SASKARĒ AR ĀDU: Iegremdēt vēsā ūdenī vai \nietīt mitros apsējos.  \nLT PATEKUS ANT ODOS: įmerkti į vėsų vandenį \narba apvynioti šlapiais tvarsčiais.  \nHU HA BŐRRE KERÜL: Hideg vízzel vagy \nnedves kötéssel kell hűteni.  \nMT JEKK FUQ IL-ĠILDA: Daħħal fl-ilma frisk \njew kebbeb f'faxex imxarrbin.  \nNL BIJ CONTACT MET DE HUID: in koud water \nonderdompelen of nat verband aanbrengen.  \nPL W PRZYPADKU KONTAKTU ZE SKÓRĄ: \nZanurzyć w zimnej wodzie lub owinąć \nmokrym bandażem.  \nPT SE ENTRAR EM CONTACTO COM A \nPELE: Mergulhar em água fria ou aplicar \ncompressas húmidas.  \nRO ÎN CAZ DE CONTACT CU PIELEA: Intro\xad\nduceţi în apă rece sau acoperiţi cu o compresă \numedă.  \nSK PRI KONTAKTE S POKOŽKOU: Ponorte do \nstudenej vody alebo obviažte mokrými \nobväzmi.  \nSL PRI STIKU S KOŽO: Potopiti v hladno vodo \nali zaviti v mokre povoje.  \nFI JOS KEMIKAALIA JOUTUU IHOLLE: Upota \nkylmään veteen tai kääri märkiin siteisiin.  \nSV VID HUDKONTAKT: Skölj under kallt vatten \neller använd våta omslag.  \n▼M4 __________  \nP302 + P352  Language  \nBG ПРИ КОНТАКТ С КОЖАТА: Измийте \nобилно с вода/…  \nES EN CASO DE CONTACTO CON LA PIEL: \nLavar con abundante agua/…  \nCS PŘI STYKU S KŮŽÍ: Omyjte velkým \nmnožstvím vody/…  \nDA VED KONTAKT MED HUDEN: Vask med \nrigeligt vand/…  \nDE BEI BERÜHRUNG MIT DER HAUT: Mit viel \nWasser/…/waschen.  \nET NAHALE SATTUMISE KORRAL: pesta \nrohke veega/…  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: \nΠλύντε με άφθονο νερό/…  \nEN IF ON SKIN: Wash with plenty of water/…  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 428}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 430  \nP302 + P352  Language  \nFR EN CAS DE CONTACT AVEC LA PEAU: \nLaver abondamment à l’eau/…  \nGA I gCÁS TEAGMHÁLA LEIS AN \ngCRAICEANN: Nigh le neart gallúnaí agus \nuisce é.  \n▼M8 \nHR U SLUČAJU DODIRA S KOŽOM: oprati \nvelikom količinom vode/…  \n▼M4 \nIT IN CASO DI CONTATTO CON LA PELLE: \nlavare abbondantemente con acqua/…  \nLV SASKARĒ AR ĀDU: nomazgāt ar lielu ūdens/ \n.. daudzumu.  \nLT PATEKUS ANT ODOS: plauti dideliu vandens \nkiekiu/…  \nHU HA BŐRRE KERÜL: Lemosás bő vízzel/….  \nMT JEKK JIĠI FUQ IL-ĠILDA: Baħbaħ b’ħafna \nilma/…  \nNL BIJ CONTACT MET DE HUID: met veel \nwater/… wassen.  \nPL W PRZYPADKU KONTAKTU ZE SKÓRĄ: \nUmyć dużą ilością wody/…  \nPT SE ENTRAR EM CONTACTO COM A \nPELE: lavar abundantemente com água/…  \nRO ÎN CAZ DE CONTACT CU PIELEA: spălaţi \ncu multă apă/…  \nSK PRI KONTAKTE S POKOŽKOU: Umyte \nveľkým množstvom vody/…  \nSL PRI STIKU S KOŽO: Umiti z veliko vode/…  \nFI JOS KEMIKAALIA JOUTUU IHOLLE: Pese \nrunsaalla vedellä/…  \nSV VID HUDKONTAKT: Tvätta med mycket \nvatten/…  \n▼M12  __________  \n▼M4 \nP304 + P340  Language  \nBG ПРИ ВДИШВАНЕ: Изведете лицето на чист \nвъздух и го поставете в позиция, улесняваща \nдишането.  \nES EN CASO DE INHALACIÓN: Transportar a la \npersona al aire libre y mantenerla en una \nposición que le facilite la respiración.  \nCS PŘI VDECHNUTÍ: Přeneste osobu na čerstvý \nvzduch a ponechte ji v poloze usnadňující \ndýchání.  \nDA VED INDÅNDING: Flyt personen til et sted \nmed frisk luft og sørg for, at vejrtrækningen \nlettes.  \nDE BEI EINATMEN: Die Person an die frische \nLuft bringen und für ungehinderte Atmung \nsorgen.  \nET SISSEHINGAMISE KORRAL: toimetada isik \nvärske õhu kätte ja hoida asendis, mis \nvõimaldab kergesti hingata.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 429}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 431  \nP304 + P340  Language  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Μεταφέρατε \nτον παθόντα στον καθαρό αέρα και αφήστε \nτον να ξεκουραστεί σε στάση που διευκολύνει \nτην αναπνοή.  \nEN IF INHALED: Remove person to fresh air and \nkeep comfortable for breathing.  \nFR EN CAS D’INHALATION: transporter la \npersonne à l’extérieur et la maintenir dans une \nposition où elle peut confortablement respirer.  \nGA MÁ IONANÁILTEAR: Tabhair an duine \namach faoin aer úr agus coinnigh é compor\xad\ndach.  \n▼M8 \nHR AKO SE UDIŠE: premjestiti osobu na svježi \nzrak i postaviti ju u položaj koji olakšava \ndisanje.  \n▼M4 \nIT IN CASO DI INALAZIONE: trasportare l’in\xad\nfortunato all’aria aperta e mantenerlo a riposo \nin posizione che favorisca la respirazione.  \nLV IEELPOŠANAS GADĪJUMĀ: nogādāt cietušo \nsvaigā gaisā un nodrošināt netraucētu elpošanu.  \nLT ĮKVĖPUS: išnešti nukentėjusįjį į gryną orą; jam \nbūtina patogi padėtis, leidžianti laisvai \nkvėpuoti.  \nHU BELÉLEGZÉS ESETÉN: Az érintett személyt \nfriss levegőre kell vinni, és olyan nyugalmi \ntesthelyzetbe kell helyezni, hogy könnyen \ntudjon lélegezni.  \nMT JEKK JINĠIBED MAN-NIFS: Qiegħed lill- \npersuna għall-arja friska f’pożizzjoni komda \nbiex tieħu n-nifs.  \nNL NA INADEMING: de persoon in de frisse lucht \nbrengen en ervoor zorgen dat deze gemakkelijk \nkan ademen.  \nPL W PRZYPADKU DOSTANIA SIĘ DO DRÓG \nODDECHOWYCH: wyprowadzić lub wynieść \nposzkodowanego na świeże powietrze i \nzapewnić mu warunki do swobodnego oddych\xad\nania.  \nPT EM CASO DE INALAÇÃO: retirar a pessoa \npara uma zona ao ar livre e mantê-la numa \nposição que não dificulte a respiração.  \nRO ÎN CAZ DE INHALARE: transportaţi persoana \nla aer liber și menţineţi-o într-o poziţie confor\xad\ntabilă pentru respiraţie.  \nSK PO VDÝCHNUTÍ: Presuňte osobu na čerstvý \nvzduch a umožnite jej pohodlne dýchať.  \nSL PRI VDIHAVANJU: Prenesti osebo na svež \nzrak in jo pustiti v udobnem položaju, ki \nolajša dihanje.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 430}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 432  \nP304 + P340  Language  \nFI JOS KEMIKAALIA ON HENGITETTY: Siirrä \nhenkilö raittiiseen ilmaan ja varmista vaivaton \nhengitys.  \nSV VID INANDNING: Flytta personen till frisk \nluft och se till att andningen underlättas.  \n__________  \n▼M12  __________  \n▼B \nP306 + P360  Language  \nBG ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: \nнезабавно облейте замърсеното облекло и \nкожата обилно с вода, преди да свалите \nдрехите.  \nES EN CASO DE CONTACTO CON LA ROPA: \nAclarar inmediatamente con agua abundante las \nprendas y la piel contaminadas antes de quitarse \nla ropa.  \nCS PŘI STYKU S ODĚVEM: Kontaminovaný \noděv a kůži oklamžitě omyjte velkým \nmnožstvím vody a potom oděv odložte.  \nDA VED KONTAKT MED TØJET: Skyl \nomgående tilsmudset tøj og hud med rigeligt \nvand, før tøjet fjernes.  \nDE BEI KONTAKT MIT DER KLEIDUNG: \nKontaminierte Kleidung und Haut sofort mit \nviel Wasser abwaschen und danach Kleidung \nausziehen.  \nET RÕIVASTELE SATTUMISE KORRAL: \nsaastunud rõivad ja nahk loputada viivitamata \nrohke veega ning alles seejärel rõivad \neemaldada.  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: \nΞεπλύντε αμέσως τα μολυσμένα ρούχα και την \nεπιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα \nρούχα.  \nEN IF ON CLOTHING: rinse immediately \ncontaminated clothing and skin with plenty of \nwater before removing clothes.  \nFR EN CAS DE CONTACT AVEC LES VÊTE\xad\nMENTS: rincer immédiatement et abond\xad\namment avec de l’eau les vêtements contaminés \net la peau avant de les enlever.  \nGA I gCÁS TEAGMHÁLA LE hÉADAÍ: sruth\xad\nlaítear éadaí éillithe agus an craiceann \nláithreach le neart uisce sula ndéantar na \nhéadaí a bhaint den duine.  \n▼M5 \nHR U SLUČAJU DODIRA S ODJEĆOM: odmah \nisprati zagađenu odjeću i kožu velikom \nkoličinom vode prije uklanjanja odjeće.  \n▼B \nIT IN CASO DI CONTATTO CON GLI INDU\xad\nMENTI: sciacquare immediatamente e abbond\xad\nantemente gli indumenti contaminati e la pelle \nprima di togliersi gli indumenti.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 431}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 433  \nP306 + P360  Language  \nLV SASKARĒ AR APĢĒRBU: nekavējoties \nizskalot piesārņoto apģērbu un ādu ar lielu \ndaudzumu ūdeni, pirms apģērba novilkšanas.  \nLT PATEKUS ANT DRABUŽIŲ: Prieš nuvelkant \nužterštus drabužius, nedelsiant juos ir odą \nnuplauti dideliu kiekiu vandens.  \nHU HA RUHÁRA KERÜL: A ruhák levetése előtt \na szennyezett ruházatot és a bőrt bő vízzel \nazonnal le kell öblíteni.  \nMT JEKK FUQ L-ILBIES: laħlaħ mall-ewwel l- \nilbies ikkontaminat u l-ġilda b’ħafna ilma \nqabel ma tneħħi l-ilbies.  \nNL NA MORSEN OP KLEDING: verontreinigde \nkleding en huid onmiddellijk met veel water \nafspoelen en pas daarna kleding uittrekken.  \nPL W PRZYPADKU KONTAKTU Z ODZIEŻĄ: \nnatychmiast spłukać zanieczyszczoną odzież i \nskórę dużą ilością wody przed zdjęciem \nodzieży.  \nPT SE ENTRAR EM CONTACTO COM A \nROUPA: enxaguar imediatamente com muita \nágua a roupa e a pele contaminadas antes de \nse despir.  \nRO ÎN CAZ DE CONTACT CU ÎMBRĂCĂ- \nMINTEA: clătiţi imediat îmbrăcămintea \ncontaminată și pielea cu multă apă, înainte de \nscoaterea îmbrăcămintei.  \nSK PRI KONTAKTE S ODEVOM: kontami\xad\nnovaný odev a pokožku opláchnite veľkým \nmnožstvom vody a potom odev odstráňte.  \nSL PRI STIKU Z OBLAČILI: takoj izprati \nkontaminirana oblačila in kožo z veliko vode \npred odstranitvijo oblačil.  \nFI JOS KEMIKAALIA JOUTUU VAATTEISIIN: \nHuuhdo saastunut vaatetus ja iho välittömästi \nrunsaalla vedellä ennen vaatetuksen riisumista.  \nSV VID KONTAKT MED KLÄDERNA: Skölj \nomedelbart nedstänkta kläder och hud med \nmycket vatten innan du tar av dig kläderna.  \n▼M4 \nP308 + P311  Language  \nBG ПРИ явна или предполагаема експозиция: \nОбадете се в ЦЕНТЪР ПО \nТОКСИКОЛОГИЯ/на лекар/…  \nES EN CASO DE exposición manifiesta o \npresunta: Llamar a un CENTRO DE TOXICO\xad\nLOGĺA/médico/…  \nCS PŘI expozici nebo podezření na ni: Volejte \nTOXIKOLOGICKÉ INFORMAČNÍ STŘEDI- \nSKO/lékaře/….  \nDA VED eksponering eller mistanke om ekspo\xad\nnering: Ring til en GIFTINFORMATION/ \nlæge/…  \nDE BEI Exposition oder falls betroffen: GIFTIN\xad\nFORMATIONSZENTRUM/Arzt/…/anrufen.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 432}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 434  \nP308 + P311  Language  \nET Kokkupuute korral: võtta ühendust MÜRGIS\xad\nTUSTEABEKESKUSE/arstiga…  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης: \nΚαλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ/ \nγιατρό/…  \nEN IF exposed or concerned: Call a POISON \nCENTER/doctor/…  \nFR EN CAS d’exposition prouvée ou suspectée: \nAppeler un CENTRE ANTIPOISON/un \nmédecin/…  \nGA I gCÁS nochta nó má mheastar a bheith noch\xad\ntaithe: Cuir glao ar IONAD NIMHE/ar \ndhoctúir/…  \n▼M8 \nHR U SLUČAJU izloženosti ili sumnje na \nizloženost: nazvati CENTAR ZA \nKONTROLU OTROVANJA/liječnika/…  \n▼M4 \nIT In caso di esposizione o di possibile espos\xad\nizione: contattare un CENTRO ANTIVELENI/ \nun medico/…  \nLV JA saskaras vai saistīts ar: sazinieties ar \nSAINDĒŠANĀS INFORMĀCIJAS CENTRU/ \nārstu/…  \nLT Esant poveikiui arba jeigu numanomas \npoveikis: skambinti į APSINUODIJIMŲ \nKONTROLĖS IR INFORMACIJOS BIURĄ/ \nkreiptis į gydytoją/…  \nHU Expozíció vagy annak gyanúja esetén: \nForduljon TOXIKOLÓGIAI KÖZPONTHOZ/ \norvoshoz/….  \nMT JEKK espost jew konċernat: Sejjaħ ĊENTRU \nTAL-AVVELENAMENT/tabib/…  \nNL NA (mogelijke) blootstelling: Een ANTIGIF\xad\nCENTRUM/arts/… raadplegen.  \nPL W przypadku narażenia lub styczności: Skon\xad\ntaktować się z OŚRODKIEM ZATRUĆ/ \nlekarzem/…  \nPT EM CASO DE exposição ou suspeita de \nexposição: contacte um CENTRO DE \nINFORMAÇÃO ANTIVENENOS/médico/…  \nRO ÎN CAZ de expunere sau de posibilă expunere: \nsunaţi la un CENTRU DE INFORMARE \nTOXICOLOGICĂ/un medic/…  \nSK PO expozícii alebo podozrení z nej: Volajte \nTOXIKOLOGICKÉ INFORMAČNÉ \nCENTRUM/lekára/…  \nSL Pri izpostavljenosti ali sumu izpostavljenosti: \nPokličite CENTER ZA ZASTRUPITVE/ \nzdravnika/…  \nFI Altistumisen tapahduttua tai jos epäillään altis\xad\ntumista: Ota yhteys MYRKYTYSTIETOKES\xad\nKUKSEEN/lääkäriin/…  \nSV Vid exponering eller misstanke om exponering: \nKontakta GIFTINFORMATIONSCEN\xad\nTRALEN/läkare/…  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 433}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 435  \nP308 + P313  Language  \nBG ПРИ явна или предполагаема експозиция: \nПотърсете медицински съвет/помощ.  \nES EN CASO DE exposición manifiesta o \npresunta: Consultar a un médico.  \nCS PŘI expozici nebo podezření na ni: Vyhledejte \nlékařskou pomoc/ošetření.  \nDA VED eksponering eller mistanke om ekspo\xad\nnering: Søg lægehjælp.  \nDE BEI Exposition oder falls betroffen: Ärztlichen \nRat einholen/ärztliche Hilfe hinzuziehen.  \nET Kokkupuute või kokkupuutekahtluse korral: \npöörduda arsti poole.  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανότητας \nέκθεσης: Συμβουλευθείτε/Επισκεφθείτε γιατρό.  \nEN IF exposed or concerned: Get medical advice/ \nattention.  \nFR EN CAS d’exposition prouvée ou suspectée: \nconsulter un médecin.  \nGA I gCÀS nochta nó má mheastar a bheith noch\xad\ntaithe: Faigh comhairle/cúram liachta.  \n▼M5 \nHR U SLUČAJU izloženosti ili sumnje na \nizloženost: zatražiti savjet/pomoć liječnika.  \n▼B \nIT IN CASO di esposizione o di possibile espos\xad\nizione, consultare un medico.  \nLV Ja nokļūst saskarē vai saistīts ar to: lūdziet \nmediķu palīdzību.  \nLT Esant sąlyčiui arba jeigu numanomas sąlytis: \nkreiptis į gydytoją.  \nHU Expozíció vagy annak gyanúja esetén: orvosi \nellátást kell kérni.  \nMT Jekk espost jew konċernat: Ikkonsulta tabib.  \nNL NA (mogelijke) blootstelling: een arts raad\xad\nplegen.  \nPL W przypadku narażenia lub styczności: \nZasięgnąć porady/zgłosić się pod opiekę \nlekarza.  \nPT EM CASO DE exposição ou suspeita de \nexposição: consulte um médico.  \nRO ÎN CAZ DE expunere sau de posibilă expunere: \nconsultaţi medicul.  \nSK Po expozícii alebo podozrení z nej: Vyhľadajte \nlekársku pomoc/starostlivosť.  \nSL PRI izpostavljenosti ali sumu izpostavljenosti: \npoiščite zdravniško pomoč/oskrbo.  \nFI Altistumisen tapahduttua tai jos epäillään altis\xad\ntumista: Hakeudu lääkäriin.  \nSV Vid exponering eller misstanke om exponering \nSök läkarhjälp.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 434}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 436  \n__________  \n▼B \nP332 + P313  Language  \nBG При поява на кожно дразнене: Потърсете \nмедицински съвет/помощ.  \nES En caso de irritación cutánea: Consultar a un \nmédico.  \nCS Při podráždění kůže: Vyhledejte lékařskou \npomoc/ošetření.  \nDA Ved hudirritation: Søg lægehjælp.  \nDE Bei Hautreizung: Ärztlichen Rat einholen/ \närztliche Hilfe hinzuziehen.  \nET Nahaärrituse korral: pöörduda arsti poole.  \nEL Εάν παρατηρηθεί ερεθισμός του δέρματος: \nΣυμβουλευθείτε/Επισκεφθείτε γιατρό.  \nEN If skin irritation occurs: Get medical advice/ \nattention.  \nFR En cas d’irritation cutanée: consulter un \nmédecin.  \nGA I gcás greannú craicinn: Faigh comhairle/cúram \nliachta.  \n▼M5 \nHR U slučaju nadražaja kože: zatražiti savjet/pomoć \nliječnika.  \n▼B \nIT In caso di irritazione della pelle: consultare un \nmedico.  \nLV Ja rodas ādas iekaisums: lūdziet mediķu \npalīdzību.  \nLT Jeigu sudirginama oda: kreiptis į gydytoją.  \nHU Bőrirritáció esetén: orvosi ellátást kell kérni.  \nMT Jekk ikun hemm irritazzjoni tal-ġilda: \nIkkonsulta tabib.  \nNL Bij huidirritatie: een arts raadplegen.  \nPL W przypadku wystąpienia podrażnienia skóry: \nZasięgnąć porady/zgłosić się pod opiekę \nlekarza.  \nPT Em caso de irritação cutânea: consulte um \nmédico.  \nRO În caz de iritare a pielii: consultaţi medicul.  \nSK Ak sa objaví podráždenie pokožky, vyhľadajte \nlekársku pomoc/starostlivosť.  \nSL Če nastopi draženje kože: poiščite zdravniško \npomoč/oskrbo.  \nFI Jos ilmenee ihoärsytystä: Hakeudu lääkäriin.  \nSV Vid hudirritation: Sök läkarhjälp.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 435}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 437  \nP333 + P313  Language  \nBG При поява на кожно дразнене или обрив на \nкожата: Потърсете медицински съвет/помощ.  \nES En caso de irritación o erupción cutánea: \nConsultar a un médico.  \nCS Při podráždění kůže nebo vyrážce: Vyhledejte \nlékařskou pomoc/ošetření.  \nDA Ved hudirritation eller udslet: Søg lægehjælp.  \nDE Bei Hautreizung oder -ausschlag: Ärztlichen \nRat einholen/ärztliche Hilfe hinzuziehen.  \nET Nahaärrituse või _obe korral: pöörduda arsti \npoole.  \nEL Εάν παρατηρηθεί ερεθισμός του δέρματος ή \nεμφανιστεί εξάνθημα: Συμβουλευθείτε/ \nΕπισκεφθείτε γιατρό.  \nEN If skin irritation or rash occurs: Get medical \nadvice/attention.  \nFR En cas d’irritation ou d'éruption cutanée: \nconsulter un médecin.  \nGA Má tharlaíonn greannú nó gríos craicinn: Faigh \ncomhairle/cúram liachta.  \n▼M5 \nHR U slučaju nadražaja ili osipa na koži: zatražiti \nsavjet/pomoć liječnika.  \n▼B \nIT In caso di irritazione o eruzione della pelle: \nconsultare un medico.  \nLV Ja rodas ādas iekaisums vai izsitumi: lūdziet \nmediķu palīdzību.  \nLT Jeigu sudirginama oda arba ją išberia: kreiptis į \ngydytoją.  \nHU Bőrirritáció vagy kiütések megjelenése esetén: \norvosi ellátást kell kérni.  \nMT Jekk ikun hemm irritazzjoni jew raxx tal-ġilda: \nIkkonsulta tabib.  \nNL Bij huidirritatie of uitslag: een arts raadplegen.  \nPL W przypadku wystąpienia podrażnienia skóry \nlub wysypki: Zasięgnąć porady/zgłosić się pod \nopiekę lekarza.  \nPT Em caso de irritação ou erupção cutânea: \nconsulte um médico.  \nRO În caz de iritare a pielii sau de erupţie cutanată: \nconsultaţi medicul.  \nSK Ak sa prejaví podráždenie pokožky alebo sa \nvytvoria vyrážky: vyhľadajte lekársku pomoc/ \nstarostlivosť.  \nSL Če nastopi draženje kože ali se pojavi izpuščaj: \npoiščite zdravniško pomoč/oskrbo.  \nFI Jos ilmenee ihoärsytystä tai ihottumaa: \nHakeudu lääkäriin.  \nSV Vid hudirritation eller utslag: Sök läkarhjälp.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 436}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 438  \nP336 + P315  Language  \nBG Размразете замръзналите части в хладка \nвода. Не разтривайте засегнатото място. \nНезабавно потърсете медицински съвет/ \nпомощ.  \nES Descongelar las partes congeladas con agua \ntibia. No frotar la parte afectada. Buscar \nasistencia médica inmediata.  \nCS Omrzlá místa ošetřete vlažnou vodou. Postižené \nmísto netřete. Okamžitě vyhledejte lékařskou \npomoc/ošetření.  \nDA Opvarm forsigtigt af frostskadede legemsdele i \nlunkent vand. Gnid ikke det angrebne område. \nSøg omgående lægehjælp.  \nDE Vereiste Bereiche mit lauwarmem Wasser \nauftauen. Betroffenen Bereich nicht reiben. \nSofort ärztlichen Rat einholen/ärztliche Hilfe \nhinzuziehen.  \nET Sulatada külmunud piirkonnad leige veega. \nKannatada saanud piirkonda mitte hõõruda. \nPöörduda viivitamata arsti poole.  \nEL Ξεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. \nΜην τρίβετε την περιοχή που πάγωσε. \nΣυμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.  \nEN Thaw frosted parts with lukewarm water. Do \nnot rub affected area. Get immediate medical \nadvice/attention.  \nFR Dégeler les parties gelées avec de l'eau tiède. \nNe pas frotter les zones touchées. Consulter \nimmédiatement un médecin.  \nGA Leáigh codanna sioctha le huisce alabhog. Ná \ncuimil an réimse lena mbaineann. Faigh \ncomhairle/cúram liachta láithreach.  \nHR Zamrznute dijelove odmrznuti mlakom vodom. \nNe trljati oštećeno mjesto. Hitno zatražiti savjet/ \npomoć liječnika.  \nIT Sgelare le parti congelate usando acqua tiepida. \nNon sfregare la parte interessata. Consultare \nimmediatamente un medico.  \nLV Atkausēt sasalušās daļas ar remdenu ūdeni. \nSkarto zonu neberzt. Nekavējoties lūgt \npalīdzību mediķiem.  \nLT Prišalusias daleles atitirpinti drungnu vandeniu. \nNetrinti paveiktos zonos. Nedelsiant kreiptis į \ngydytoją.  \nHU A fagyott részeket langyos vízzel fel kell \nmelegíteni. Tilos az érintett terület dörzsölése. \nAzonnal orvosi ellátást kell kérni.  \nMT Ħoll il-partijiet kiesħa bl-ilma fietel. Togħrokx \nil-parti affettwata. Ikkonsulta tabib minnufih.  \nNL Bevroren lichaamsdelen met lauw water \nontdooien. Niet wrijven. Onmiddellijk een arts \nraadplegen.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 437}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 439  \nP336 + P315  Language  \nPL Rozmrozić oszronione obszary letnią wodą. Nie \ntrzeć oszronionego obszaru. Natychmiast \nzasięgnąć porady/zgłosić się pod opiekę \nlekarza.  \nPT Derreter as zonas congeladas com água morna. \nNão friccionar a zona afetada. Consulte imedi\xad\natamente um médico.  \nRO Dezgheţaţi părţile degerate cu apă călduţă. Nu \nfrecaţi zona afectată. Consultaţi imediat \nmedicul.  \nSK Zmrznuté časti ošetrite vlažnou vodou. \nPostihnuté miesto netrite. Okamžite vyhľadajte \nlekársku pomoc/starostlivosť.  \nSL Zamrznjene dele odtaliti z mlačno vodo. Ne \ndrgniti prizadetega mesta. Takoj poiščite \nzdravniško pomoč/oskrbo.  \nFI Sulata jäätyneet alueet haalealla vedellä. \nVahingoittunutta aluetta ei saa hangata. \nHakeudu välittömästi lääkäriin.  \nSV Värm det köldskadade området med ljummet \nvatten. Gnid inte det skadade området. Sök \nomedelbart läkarhjälp.  \n__________  \n▼B \nP337 + P313  Language  \nBG При продължително дразнене на очите: \nПотърсете медицински съвет/помощ.  \nES Si persiste la irritación ocular: Consultar a un \nmédico.  \nCS Přetrvává-li podráždění očí: Vyhledejte \nlékařskou pomoc/ošetření.  \nDA Ved vedvarende øjenirritation: Søg lægehjælp.  \nDE Bei anhaltender Augenreizung: Ärztlichen Rat \neinholen/ärztliche Hilfe hinzuziehen.  \nET Kui silmade ärritus ei möödu: pöörduda arsti \npoole.  \nEL Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός: \nΣυμβουλευθείτε/Επισκεφθείτε γιατρό.  \nEN If eye irritation persists: Get medical advice/ \nattention.  \nFR Si l’irritation oculaire persiste: consulter un \nmédecin.  \nGA Má mhaireann an greannú súile: Faigh \ncomhairle/cúram liachta.  \n▼M5 \nHR Ako nadražaj oka ne prestaje: zatražiti savjet/ \npomoć liječnika.  \n▼B \nIT Se l’irritazione degli occhi persiste, consultare \nun medico.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 438}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 440  \nP337 + P313  Language  \nLV Ja acu iekaisums nepāriet: lūdziet mediķu \npalīdzību.  \nLT Jei akių dirginimas nepraeina: kreiptis į gydy\xad\ntoją. \nHU Ha a szemirritáció nem múlik el: orvosi ellátást \nkell kérni.  \nMT Jekk l-irritazzjoni ta' l-għajnejn tippersisti: \nIkkonsulta tabib.  \nNL Bij aanhoudende oogirritatie: een arts raad\xad\nplegen.  \nPL W przypadku utrzymywania się działania \ndrażniącego na oczy: Zasięgnąć porady/zgłosić \nsię pod opiekę lekarza.  \nPT Caso a irritação ocular persista: consulte um \nmédico.  \nRO Dacă iritarea ochilor persistă: consultaţi \nmedicul.  \nSK Ak podráždenie očí pretrváva: vyhľadajte \nlekársku pomoc/starostlivosť.  \nSL Če draženje oči ne preneha: poiščite zdravniško \npomoč/oskrbo.  \nFI Jos silmä-ärsytys jatkuu: Hakeudu lääkäriin.  \nSV Vid bestående ögonirritation: Sök läkarhjälp.  \n▼M4 \nP342 + P311  Language  \nBG При симптоми на затруднено дишане: \nОбадете се в ЦЕНТЪР ПО \nТОКСИКОЛОГИЯ/на лекар/…  \nES En caso de síntomas respiratorios: Llamar a un \nCENTRO DE TOXICOLOGĺA/médico/…  \nCS Při dýchacích potížích: Volejte TOXIKO\xad\nLOGICKÉ INFORMAČNÍ STŘEDISKO/ \nlékaře/…  \nDA Ved luftvejssymptomer: Ring til en GIFTIN\xad\nFORMATION/læge/…  \nDE Bei Symptomen der Atemwege: GIFTIN\xad\nFORMATIONSZENTRUM/Arzt/…/anrufen.  \nET Hingamisteede probleemide ilmnemise korral: \nvõtta ühendust MÜRGISTUSTEABE\xad\nKESKUSE/arstiga…  \nEL Εάν παρουσιάζονται αναπνευστικά \nσυμπτώματα: Καλέστε το ΚΕΝΤΡΟ \nΔΗΛΗΤΗΡΙΑΣΕΩΝ/γιατρό/…  \nEN If experiencing respiratory symptoms: Call a \nPOISON CENTER/doctor/…  \nFR En cas de symptômes respiratoires: Appeler un \nCENTRE ANTIPOISON/un médecin/…  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 439}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 441  \nP342 + P311  Language  \nGA I gCÁS siomtóm riospráide: Cuir glao ar \nIONAD NIMHE/ar dhoctúir/…  \n▼M8 \nHR Pri otežanom disanju: nazvati CENTAR ZA \nKONTROLU OTROVANJA/liječnika/…  \n▼M4 \nIT In caso di sintomi respiratori: contattare un \nCENTRO ANTIVELENI/un medico/…  \nLV Ja rodas elpas trūkuma simptomi: sazinieties ar \nSAINDĒŠANĀS INFORMĀCIJAS CENTRU/ \nārstu/…  \nLT Jeigu pasireiškia respiraciniai simptomai: \nskambinti į APSINUODIJIMŲ KONTROLĖS \nIR INFORMACIJOS BIURĄ/kreiptis į \ngydytoją/…  \nHU Légzési problémák esetén: Forduljon TOXIKO\xad\nLÓGIAI KÖZPONTHOZ/orvoshoz/….  \nMT Jekk ikollok sintomi respiratorji: Sejjaħ \nĊENTRU TAL-AVVELENAMENT/tabib/…  \nNL Bij ademhalingssymptomen: Een ANTIGIF\xad\nCENTRUM/arts/… raadplegen.  \nPL W przypadku wystąpienia objawów ze strony \nukładu oddechowego: Skontaktować się z \nOŚRODKIEM ZATRUĆ/lekarzem/…  \nPT Em caso de sintomas respiratórios: contacte um \nCENTRO DE INFORMAÇÃO ANTI\xad\nVENENOS/médico/…  \nRO În caz de simptome respiratorii: sunaţi la un \nCENTRU DE INFORMARE TOXICO\xad\nLOGICĂ/un medic/…  \nSK Pri sťaženom dýchaní: Volajte TOXIKO\xad\nLOGICKÉ INFORMAČNÉ CENTRUM/ \nlekára/…  \nSL Pri respiratornih simptomih: Pokličite CENTER \nZA ZASTRUPITVE/zdravnika/…  \nFI Jos ilmenee hengitysoireita: Ota yhteys \nMYRKYTYSTIETOKESKUKSEEN/lääkäriin/ \n… \nSV Vid besvär i luftvägarna: Kontakta GIFTIN\xad\nFORMATIONSCENTRALEN/läkare/…  \nP361 + P364  Language  \nBG Незабавно свалете цялото замърсено облекло \nи го изперете преди повторна употреба.  \nES Quitar inmediatamente todas las prendas \ncontaminadas y lavarlas antes de volver a \nusarlas.  \nCS Veškeré kontaminované části oděvu okamžitě \nsvlékněte a před opětovným použitím vyperte.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 440}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 442  \nP361 + P364  Language  \nDA Alt tilsmudset tøj tages straks af og vaskes \ninden genanvendelse.  \nDE Alle kontaminierten Kleidungsstücke sofort \nausziehen und vor erneutem Tragen waschen.  \nET Võtta viivitamata seljast kõik saastunud rõivad \nja pesta enne korduskasutust.  \nEL Βγάλτε αμέσως όλα τα μολυσμένα ρούχα και \nπλύντε τα πριν τα ξαναχρησιμοποιήσετε.  \nEN Take off immediately all contaminated clothing \nand wash it before reuse.  \nFR Enlever immédiatement tous les vêtements \ncontaminés et les laver avant réutilisation.  \nGA Bain díot láithreach na héadaí éillithe go léir \nagus nigh iad roimh iad a athúsáid.  \n▼M8 \nHR Odmah skinuti svu zagađenu odjeću i oprati je \nprije ponovne uporabe.  \n▼M4 \nIT Togliere immediatamente tutti gli indumenti \ncontaminati e lavarli prima di indossarli nuova\xad\nmente.  \nLV Nekavējoties novilkt visu piesārņoto apģērbu un \npirms atkārtotas lietošanas izmazgāt.  \nLT Nedelsiant nusivilkti visus užterštus drabužius \nir išskalbti prieš vėl apsivelkant.  \nHU Az összes szennyezett ruhadarabot azonnal le \nkell vetni és újbóli használat előtt ki kell mosni.  \nMT Neħħi minnufih il-ħwejjeġ kontaminati kollha u \naħsilhom qabel terġa’ tilbishom.  \nNL Verontreinigde kleding onmiddellijk uittrekken \nen wassen alvorens deze opnieuw te gebruiken.  \nPL Natychmiast zdjąć całą zanieczyszczoną odzież \ni wyprać przed ponownym użyciem.  \nPT Retirar imediatamente a roupa contaminada e \nlavá-la antes de a voltar a usar.  \nRO Scoateţi imediat toată îmbrăcămintea \ncontaminată și spalaţi-o înainte de reutilizare.  \nSK Všetky kontaminované časti odevu okamžite \nvyzlečte a pred ďalším použitím vyperte.  \nSL Takoj sleči vsa kontaminirana oblačila in jih \noprati pred ponovno uporabo.  \nFI Riisu saastunut vaatetus välittömästi ja pese \nennen uudelleenkäyttöä.  \nSV Ta omedelbart av alla nedstänkta kläder och \ntvätta dem innan de används igen.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 441}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 443  \nP362 + P364  Language  \nBG Свалете замърсеното облекло и го изперете \nпреди повторна употреба.  \nES Quitar las prendas contaminadas y lavarlas \nantes de volver a usarlas.  \nCS Kontaminovaný oděv svlékněte a před \nopětovným použitím vyperte.  \nDA Alt tilsmudset tøj tages af og vaskes inden \ngenanvendelse.  \nDE Kontaminierte Kleidung ausziehen und vor \nerneutem Tragen waschen.  \nET Võtta seljast saastunud rõivad ja pesta enne \nkorduskasutust.  \nEL Βγάλτε τα μολυσμένα ρούχα και πλύντε τα πριν \nτα ξαναχρησιμοποιήσετε.  \nEN Take off contaminated clothing and wash it \nbefore reuse.  \nFR Enlever les vêtements contaminés et les laver \navant réutilisation.  \nGA Bain díot aon éadaí éillithe agus nigh iad roimh \niad a athúsáid.  \n▼M8 \nHR Skinuti zagađenu odjeću i oprati je prije \nponovne uporabe.  \n▼M4 \nIT Togliere tutti gli indumenti contaminati e lavarli \nprima di indossarli nuovamente.  \nLV Novilkt piesārņoto apģērbu un pirms atkārtotas \nlietošanas izmazgāt.  \nLT Nusivilkti užterštus drabužius ir išskalbti prieš \nvėl apsivelkant.  \nHU A szennyezett ruhadarabot le kell vetni és \nújbóli használat előtt ki kell mosni.  \nMT Neħħi l-ħwejjeġ kontaminati kollha u aħsilhom \nqabel terġa’ tilbishom.  \nNL Verontreinigde kleding uittrekken en wassen \nalvorens deze opnieuw te gebruiken.  \nPL Zanieczyszczoną odzież zdjąć i wyprać przed \nponownym użyciem.  \nPT Retirar a roupa contaminada e lavá-la antes de a \nvoltar a usar.  \nRO Scoateţi îmbrăcămintea contaminată și spalaţi-o \nînainte de reutilizare.  \nSK Kontaminovaný odev vyzlečte a pred ďalším \npoužitím vyperte.  \nSL Sleči kontaminirana oblačila in jih oprati pred \nponovno uporabo.  \nFI Riisu saastunut vaatetus ja pese ennen uudel\xad\nleenkäyttöä.  \nSV Ta av nedstänkta kläder och tvätta dem innan \nde används igen.  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 442}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 444  \nP370 + P376  Language  \nBG При пожар: Спрете теча, ако е безопасно.  \nES En caso de incendio: Detener la fuga, si no hay \npeligro en hacerlo.  \nCS V případě požáru: Zastavte únik, můžete-li tak \nučinit bez rizika.  \nDA Ved brand: Stands lækagen, hvis dette er \nsikkert.  \nDE Bei Brand: Undichtigkeit beseitigen, wenn \ngefahrlos möglich.  \nET Tulekahju korral: leke peatada, kui seda on \nvõimalik teha ohutult.  \nEL Σε περίπτωση πυρκαγιάς: Σταματήστε τη \nδιαρροή, εφόσον δεν υπάρχει κίνδυνος.  \nEN In case of fire: Stop leak if safe to do so.  \nFR En cas d’incendie: obturer la fuite si cela peut \nse faire sans danger.  \nGA I gcás dóiteáin: Cuir stop leis an sceitheadh má \ntá sé sábháilte é sin a dhéanamh.  \n▼M5 \nHR U slučaju požara: ako je sigurno, zaustaviti \nistjecanje.  \n▼B \nIT In caso di incendio: bloccare la perdita se non \nc’è pericolo.  \nLV Ugunsgrēka gadījumā: apturiet noplūdi, ja to \ndarīt ir droši.  \nLT Gaisro atveju: sustabdyti nuotėkį, jeigu galima \nsaugiai tai padaryti.  \nHU Tűz esetén: Meg kell szüntetni a szivárgást, ha \nez biztonságosan megtehető.  \nMT F’każ ta' nar: Waqqaf it-tnixxija sakemm ma \njkunx ta' periklu.  \nNL In geval van brand: het lek dichten als dat \nveilig gedaan kan worden.  \nPL W przypadku pożaru: Jeżeli jest to bezpieczne \nzahamować wyciek.  \nPT Em caso de incêndio: deter a fuga se tal puder \nser feito em segurança.  \nRO În caz de incendiu: opriţi scurgerea, dacă acest \nlucru se poate face în siguranţă.  \nSK V prípade požiaru: ak je to bezpečné, zastavte \núnik.  \nSL Ob požaru: zaustaviti puščanje, če je varno.  \nFI Tulipalon sattuessa: Sulje vuoto, jos sen voi \ntehdä turvallisesti.  \nSV Vid brand: Stoppa läckan om det kan göras på \nett säkert sätt.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 443}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 445  \nP370 + P378  Language  \nBG При пожар: Използвайте…, за да загасите.  \nES En caso de incendio: Utilizar… para la extin\xad\nción.  \nCS V případě požáru: K uhašení použijte…  \nDA Ved brand: Anvend… til brandslukning.  \nDE Bei Brand: … zum Löschen verwenden.  \nET Tulekahju korral: kasutada kustutamiseks…  \nEL Σε περίπτωση πυρκαγιάς: Χρησιμοποιήστε… \nγια να κατασβήσετε.  \nEN In case of fire: Use… to extinguish.  \nFR En cas d’incendie: Utiliser… pour l’extinction.  \nGA I gcás dóiteáin: Úsáid … le haghaidh múchta.  \n▼M8 \nHR U slučaju požara: za gašenje rabiti …  \n▼M4 \nIT In caso d’incendio: utilizzare…per estinguere.  \nLV Ugunsgrēka gadījumā: dzēšanai izmantojiet …  \nLT Gaisro atveju: gesinimui naudoti …  \nHU Tűz esetén: oltásra …használandó.  \nMT F’każ ta’ nar: Uża… biex titfi.  \nNL In geval van brand: blussen met …  \nPL W przypadku pożaru: Użyć… do gaszenia.  \nPT Em caso de incêndio: para extinguir utilizar….  \nRO În caz de incendiu: a se utiliza… pentru a \nstinge.  \nSK V prípade požiaru: Na hasenie použite…  \nSL Ob požaru: Za gašenje se uporabi …  \nFI Tulipalon sattuessa: Käytä palon sammutta\xad\nmiseen…  \nSV Vid brand: Släck med…  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 444}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 446  \nP301 + P330 \n+ P331  Language  \nBG ПРИ ПОГЛЪЩАНЕ: изплакнете устата. НЕ \nпредизвиквайте повръщане.  \nES EN CASO DE INGESTIÓN: Enjuagar la boca. \nNO provocar el vómito.  \nCS PŘI POŽITÍ: Vypláchněte ústa. NEVYVOL\xad\nÁVEJTE zvracení.  \nDA I TILFÆLDE AF INDTAGELSE: Skyl \nmunden. Fremkald IKKE opkastning.  \nDE BEI VERSCHLUCKEN: Mund ausspülen. \nKEIN Erbrechen herbeiführen.  \nET ALLANEELAMISE KORRAL: loputada suud. \nMITTE kutsuda esile oksendamist.  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Ξεπλύνετε το \nστόμα. ΜΗΝ προκαλέσετε εμετό.  \nEN IF SWALLOWED: Rinse mouth. Do NOT \ninduce vomiting.  \nFR EN CAS D'INGESTION: Rincer la bouche. NE \nPAS faire vomir.  \nGA MÁ SHLOGTAR: Sruthlaítear an béal. NÁ \nspreagtar urlacan.  \nHR AKO SE PROGUTA: isprati usta. NE izazivati \npovraćanje.  \nIT IN CASO DI INGESTIONE: sciacquare la \nbocca. NON provocare il vomito.  \nLV NORĪŠANAS GADĪJUMĀ: Izskalot muti. \nNEIZRAISĪT vemšanu.  \nLT PRARIJUS: išskalauti burną. NESKATINTI \nvėmimo.  \nHU LENYELÉS ESETÉN: A szájat ki kell öblíteni. \nTILOS hánytatni.  \nMT JEKK JINBELA': Laħlaħ il-ħalq. \nTIPPROVOKAX ir-remettar.  \nNL NA INSLIKKEN: de mond spoelen. GEEN \nbraken opwekken.  \nPL W PRZYPADKU POŁKNIĘCIA: wypłukać \nusta. NIE wywoływać wymiotów.  \nPT EM CASO DE INGESTÃO: Enxaguar a boca. \nNÃO provocar o vómito.  \nRO ÎN CAZ DE ÎNGHIŢIRE: Clătiţi gura. NU \nprovocaţi voma.  \nSK PO POŽITÍ: vypláchnite ústa. NEVYVOL\xad\nÁVAJTE zvracanie.  \nSL PRI ZAUŽITJU: Izprati usta. Ne izzivati \nbruhanja.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 445}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 447  \nP301 + P330 \n+ P331  Language  \nFI JOS KEMIKAALIA ON NIELTY: Huuhdo \nsuu. EI saa oksennuttaa.  \nSV VID FÖRTÄRING: Skölj munnen. Framkalla \nINTE kräkning.  \nP302 + P335 \n+ P334  Language  \nBG ПРИ КОНТАКТ С КОЖАТА: отстранете от \nкожата посипаните частици. Потопете в \nхладка вода [или сложете мокри компреси].  \nES EN CASO DE CONTACTO CON LA PIEL: \nCepillar las partículas sueltas depositadas en la \npiel; sumergir en agua fría [o envolver en \nvendas húmedas].  \nCS PŘI STYKU S KŮŽÍ: Volné částečky odstraňte \nz kůže. Ponořte do studené vody [nebo zabalte \ndo vlhkého obvazu].  \nDA VED KONTAKT MED HUDEN: Børst løse \npartikler bort fra huden. Hold under koldt \nvand [eller anvend våde omslag].  \nDE BEI BERÜHRUNG MIT DER HAUT: Lose \nPartikel von der Haut abbürsten. In kaltes \nWasser tauchen [oder nassen Verband anlegen].  \nET NAHALE SATTUMISE KORRAL: pühkida \nlahtised osakesed nahalt maha. Hoida jahedas \nvees [või panna peale niiske kompress].  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: \nΑφαιρέστε προσεκτικά τα σωματίδια που έχουν \nμείνει στο δέρμα με μια βούρτσα. Βυθίστε σε \nδροσερό νερό [ή τυλίξτε με βρεγμένους \nεπιδέσμους].  \nEN IF ON SKIN: Brush off loose particles from \nskin. Immerse in cool water [or wrap in wet \nbandages].  \nFR EN CAS DE CONTACT AVEC LA PEAU: \nEnlever avec précaution les particules \ndéposées sur la peau. Rincer à l'eau fraîche \n[ou poser une compresse humide].  \nGA I gCÁS TEAGMHÁLA LEIS AN \ngCRAICEANN: Glan cáithníní scaoilte den \nchraiceann. Tum in uisce fionnuar [nó cuir \nbréid fliuch air].  \nHR U SLUČAJU DODIRA S KOŽOM: izmesti \nzaostale čestice s kože. Uroniti u hladnu vodu \n[ili omotati vlažnim zavojem].  \nIT IN CASO DI CONTATTO CON LA PELLE: \nrimuovere le particelle depositate sulla pelle. \nImmergere in acqua fredda [o avvolgere con \nun bendaggio umido].  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 446}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 448  \nP302 + P335 \n+ P334  Language  \nLV SASKARĒ AR ĀDU: Noslaucīt brīvās daļiņas \nno ādas. Iegremdēt vēsā ūdenī [vai ietīt mitros \napsējos].  \nLT PATEKUS ANT ODOS: neprilipusias daleles \nnuvalyti nuo odos. Įmerkti į vėsų vandenį \n[arba apvynioti šlapiais tvarsčiais].  \nHU HA BŐRRE KERÜL: A bőrre lazán tapadó \nszemcséket óvatosan le kell kefélni. Hideg \nvízzel [vagy nedves kötéssel] kell hűteni.  \nMT JEKK FUQ IL-ĠILDA: Farfar il-frak mhux \nimwaħħal minn mal-ġilda. Daħħal fl-ilma frisk \n[jew kebbeb f'faxex imxarrbin].  \nNL BIJ CONTACT MET DE HUID: losse deeltjes \nvan de huid afvegen. In koud water onder\xad\ndompelen [of nat verband aanbrengen].  \nPL W PRZYPADKU KONTAKTU ZE SKÓRĄ: \nNiezwiązaną pozostałość strzepnąć ze skóry. \nZanurzyć w zimnej wodzie [lub owinąć \nmokrym bandażem].  \nPT SE ENTRAR EM CONTACTO COM A \nPELE: Sacudir da pele as partículas soltas. \nMergulhar em água fria [ou aplicar compressas \nhúmidas].  \nRO ÎN CAZ DE CONTACT CU PIELEA: \nÎndepărtaţi particulele depuse pe piele. Intro\xad\nduceţi în apă rece [sau acoperiţi cu o \ncompresă umedă].  \nSK PRI KONTAKTE S POKOŽKOU: Z pokožky \noprášte sypké čiastočky. Ponorte do studenej \nvody [alebo obviažte mokrými obväzmi].  \nSL PRI STIKU S KOŽO: S krtačo odstraniti \nrazsute delce s kože. Potopiti v hladno vodo \n[ali zaviti v mokre povoje].  \nFI JOS KEMIKAALIA JOUTUU IHOLLE: Poista \nirtohiukkaset iholta. Upota kylmään veteen [tai \nkääri märkiin siteisiin].  \nSV VID HUDKONTAKT: Borsta bort lösa \npartiklar från huden. Skölj under kallt vatten \n[eller använd våta omslag].  \nP303 + P361 \n+ P353  Language  \nBG ПРИ КОНТАКТ С КОЖАТА (или косата): \nнезабавно свалете цялото замърсено \nоблекло. Облейте кожата с вода [или \nвземете душ].  \nES EN CASO DE CONTACTO CON LA PIEL (o \nel pelo): Quitar inmediatamente toda la ropa \ncontaminada. Enjuagar la piel con agua [o \nducharse].  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 447}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 449  \nP303 + P361 \n+ P353  Language  \nCS PŘI STYKU S KŮŽÍ (nebo s vlasy): Veškeré \nkontaminované části oděvu okamžitě svlékněte. \nOpláchněte kůži vodou [nebo osprchujte].  \nDA VED KONTAKT MED HUDEN (eller håret): \nTilsmudset tøj tages straks af/fjernes. Skyl [eller \nbrus] huden med vand.  \nDE BEI BERÜHRUNG MIT DER HAUT (oder \ndem Haar): Alle kontaminierten Kleidungs\xad\nstücke sofort ausziehen. Haut mit Wasser \nabwaschen [oder duschen].  \nET NAHALE (või juustele) SATTUMISE \nKORRAL: kõik saastunud rõivad viivitamata \nseljast võtta. Loputada nahka veega [või \nloputada duši all].  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ \n(ή με τα μαλλιά): Βγάλτε αμέσως όλα τα \nμολυσμένα ρούχα. Ξεπλύνετε την επιδερμίδα \nμε νερό [ή στο ντους].  \nEN IF ON SKIN (or hair): Take off immediately all \ncontaminated clothing. Rinse skin with water \n[or shower].  \nFR EN CAS DE CONTACT AVEC LA PEAU (ou \nles cheveux): Enlever immédiatement tous les \nvêtements contaminés. Rincer la peau à l'eau \n[ou se doucher].  \nGA I gCÁS TEAGMHÁLA LEIS AN \ngCRAICEANN (nó le gruaig): Bain díot \nláithreach na héadaí éillithe go léir. Sruthlaítear \nan craiceann le huisce [nó glac cithfholcadh].  \nHR U SLUČAJU DODIRA S KOŽOM (ili kosom): \nodmah skinuti svu zagađenu odjeću. Isprati \nkožu vodom [ili tuširanjem].  \nIT IN CASO DI CONTATTO CON LA PELLE (o \ncon i capelli): togliersi di dosso immedi\xad\natamente tutti gli indumenti contaminati. \nSciacquare la pelle [o fare una doccia].  \nLV SASKARĒ AR ĀDU (vai matiem): \nNekavējoties novilkt visu piesārņoto apģērbu. \nNoskalot ādu ar ūdeni [vai iet dušā].  \nLT PATEKUS ANT ODOS (arba plaukų): \nnedelsiant nuvilkti visus užterštus drabužius. \nOdą nuplauti vandeniu [arba čiurkšle].  \nHU HA BŐRRE (vagy hajra) KERÜL: Az összes \nszennyezett ruhadarabot azonnal le kell vetni. A \nbőrt le kell öblíteni vízzel [vagy zuhanyozás].  \nMT JEKK FUQ IL-ĠILDA (jew ix-xagħar): Inża' \nminnufih l-ilbies kontaminat. Laħlaħ il-ġilda \nbl-ilma [jew bix-xawer].  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 448}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 450  \nP303 + P361 \n+ P353  Language  \nNL BIJ CONTACT MET DE HUID (of het haar): \nverontreinigde kleding onmiddellijk uittrekken. \nHuid met water afspoelen [of afdouchen].  \nPL W PRZYPADKU KONTAKTU ZE SKÓRĄ \n(lub z włosami): Natychmiast zdjąć całą \nzanieczyszczoną odzież. Spłukać skórę pod \nstrumieniem wody [lub prysznicem].  \nPT SE ENTRAR EM CONTACTO COM A PELE \n(ou o cabelo): Retirar imediatamente toda a \nroupa contaminada. Enxaguar a pele com água \n[ou tomar um duche].  \nRO ÎN CAZ DE CONTACT CU PIELEA (sau cu \npărul): Scoateţi imediat toată îmbrăcămintea \ncontaminată. Clătiţi pielea cu apă [sau faceţi \nduș].  \nSK PRI KONTAKTE S POKOŽKOU (alebo \nvlasmi): Vyzlečte všetky kontaminované časti \nodevu. Pokožku ihneď opláchnite vodou \n[alebo sprchou].  \nSL PRI STIKU S KOŽO (ali lasmi): Takoj sleči \nvsa kontaminirana oblačila. Kožo izprati z \nvodo [ali prho].  \nFI JOS KEMIKAALIA JOUTUU IHOLLE (tai \nhiuksiin): Riisu saastunut vaatetus välittömästi. \nHuuhdo iho vedellä [tai suihkuta].  \nSV VID HUDKONTAKT (även håret): Ta \nomedelbart av alla nedstänkta kläder. Skölj \nhuden med vatten [eller duscha].  \nP305 + P351 \n+ P338  Language  \nBG ПРИ КОНТАКТ С ОЧИТЕ: промивайте \nвнимателно с вода в продължение на \nняколко минути. Свалете контактните \nлещи, ако има такива и доколкото това е \nвъзможно. Продължете с изплакването.  \nES EN CASO DE CONTACTO CON LOS OJOS: \nEnjuagar con agua cuidadosamente durante \nvarios minutos. Quitar las lentes de contacto \ncuando estén presentes y pueda hacerse con \nfacilidad. Proseguir con el lavado.  \nCS PŘI ZASAŽENÍ OČÍ: Několik minut opatrně \nvyplachujte vodou. Vyjměte kontaktní čočky, \njsou-li nasazeny a pokud je lze vyjmout \nsnadno. Pokračujte ve vyplachování.  \nDA VED KONTAKT MED ØJNENE: Skyl \nforsigtigt med vand i flere minutter. Fjern \neventuelle kontaktlinser, hvis dette kan gøres \nlet. Fortsæt skylning.  \nDE BEI KONTAKT MIT DEN AUGEN: Einige \nMinuten lang behutsam mit Wasser spülen. \nEventuell vorhandene Kontaktlinsen nach \nMöglichkeit entfernen. Weiter spülen.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 449}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 451  \nP305 + P351 \n+ P338  Language  \nET SILMA SATTUMISE KORRAL: loputada \nmitme minuti jooksul ettevaatlikult veega. \nEemaldada kontaktläätsed, kui neid kasutatakse \nja kui neid on kerge eemaldada. Loputada veel \nkord.  \nEL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: \nΞεπλύνετε προσεκτικά με νερό για αρκετά \nλεπτά. Αν υπάρχουν φακοί επαφής, αφαιρέστε \nτους, αν είναι εύκολο. Συνεχίστε να ξεπλένετε.  \nEN IF IN EYES: Rinse cautiously with water for \nseveral minutes. Remove contact lenses, if \npresent and easy to do. Continue rinsing.  \nFR EN CAS DE CONTACT AVEC LES YEUX: \nRincer avec précaution à l'eau pendant plusieurs \nminutes. Enlever les lentilles de contact si la \nvictime en porte et si elles peuvent être \nfacilement enlevées. Continuer à rincer.  \nGA I gCÁS TEAGMHÁLA LEIS NA SÚILE: \nSruthlaítear go cúramach le huisce ar feadh \nroinnt nóiméad. Tóg amach na tadhall-lionsaí, \nmás ann dóibh agus más furasta é sin a \ndhéanamh. Lean den sruthlú.  \nHR U SLUČAJU DODIRA S OČIMA: oprezno \nispirati vodom nekoliko minuta. Ukloniti \nkontaktne leće ako ih nosite i ako se one lako \nuklanjaju. Nastaviti ispirati.  \nIT IN CASO DI CONTATTO CON GLI OCCHI: \nsciacquare accuratamente per parecchi minuti. \nTogliere le eventuali lenti a contatto se è \nagevole farlo. Continuare a sciacquare.  \nLV SASKARĒ AR ACĪM: Uzmanīgi izskalot ar \nūdeni vairākas minūtes. Izņemt kontaktlēcas, \nja tās ir ievietotas un ja to var vienkārši \nizdarīt. Turpināt skalot.  \nLT PATEKUS Į AKIS: atsargiai plauti vandeniu \nkelias minutes. Išimti kontaktinius lęšius, jeigu \njie yra ir jeigu lengvai galima tai padaryti. \nToliau plauti akis.  \nHU SZEMBE KERÜLÉS ESETÉN: Több percig \ntartó óvatos öblítés vízzel. Adott esetben a \nkontaktlencsék eltávolítása, ha könnyen \nmegoldható. Az öblítés folytatása.  \nMT JEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'at\xad\ntenzjoni bl-ilma għal diversi minuti. Neħħi l- \nlentijiet tal-kuntatt, jekk ikun hemm u jkunu \nfaċli biex tneħħihom. Kompli laħlaħ.  \nNL BIJ CONTACT MET DE OGEN: voorzichtig \nafspoelen met water gedurende een aantal \nminuten; contactlenzen verwijderen, indien \nmogelijk; blijven spoelen.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 450}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 452  \nP305 + P351 \n+ P338  Language  \nPL W PRZYPADKU DOSTANIA SIĘ DO OCZU: \nOstrożnie płukać wodą przez kilka minut. \nWyjąć soczewki kontaktowe, jeżeli są i można \nje łatwo usunąć. Nadal płukać.  \nPT SE ENTRAR EM CONTACTO COM OS \nOLHOS: Enxaguar cuidadosamente com água \ndurante vários minutos. Se usar lentes de \ncontacto, retire-as, se tal lhe for possível. \nContinue a enxaguar.  \nRO ÎN CAZ DE CONTACT CU OCHII: Clătiţi cu \natenţie cu apă timp de mai multe minute. \nScoateţi lentilele de contact, dacă este cazul și \ndacă acest lucru se poate face cu ușurinţă. \nContinuaţi să clătiţi.  \nSK PO ZASIAHNUTÍ OČÍ: Niekoľko minút ich \nopatrne vyplachujte vodou. Ak používate \nkontaktné šošovky a je to možné, odstráňte \nich. Pokračujte vo vyplachovaní.  \nSL PRI STIKU Z OČMI: Previdno izpirati z vodo \nnekaj minut. Odstranite kontaktne leče, če jih \nimate in če to lahko storite brez težav. \nNadaljujte z izpiranjem.  \nFI JOS KEMIKAALIA JOUTUU SILMIIN: \nHuuhdo huolellisesti vedellä usean minuutin \najan. Poista mahdolliset piilolinssit, jos sen \nvoi tehdä helposti. Jatka huuhtomista.  \nSV VID KONTAKT MED ÖGONEN: Skölj \nförsiktigt med vatten i flera minuter. Ta ur \neventuella kontaktlinser om det går lätt. \nFortsätt att skölja.  \n__________  \n▼B \nP370 + P380 \n+ P375  Language  \nBG При пожар: Евакуирайте зоната. Гасете \nпожара от разстояние поради опасност от \nексплозия.  \nES En caso de incendio: Evacuar la zona. Luchar \ncontra el incendio a distancia, dado el riesgo de \nexplosión.  \nCS V případě požáru: Vykliďte prostor. Kvůli \nnebezpečí výbuchu haste z dostatečné vzdále\xad\nnosti.  \nDA Ved brand: Evakuer området. Bekæmp branden \npå afstand på grund af eksplosionsfare.  \nDE Bei Brand: Umgebung räumen. Wegen Explo\xad\nsionsgefahr Brand aus der Entfernung \nbekämpfen.  \nET Tulekahju korral: ala evakueerida. Plahvatusohu \ntõttu teha kustutustöid eemalt.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 451}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 453  \nP370 + P380 \n+ P375  Language  \nEL Σε περίπτωση πυρκαγιάς: Εκκενώστε την \nπεριοχή. Προσπαθήστε να σβήσετε την \nπυρκαγιά από απόσταση, επειδή υπάρχει \nκίνδυνος έκρηξης.  \nEN In case of fire: Evacuate area. Fight fire \nremotely due to the risk of explosion.  \nFR En cas d’incendie: évacuer la zone. Combattre \nl’incendie à distance à cause du risque d’explo\xad\nsion.  \nGA I gcás dóiteáin: Aslonnaigh gach duine as an \nlimistéar. Téigh i gcianghleic leis an dóiteán \nmar gheall ar an mbaol pléasctha.  \n▼M5 \nHR U slučaju požara: evakuirati područje. Gasiti s \nveće udaljenosti zbog opasnosti od eksplozije.  \n▼B \nIT In caso di incendio: evacuare la zona. Rischio \ndi esplosione. Utilizzare i mezzi estinguenti a \ngrande distanza.  \nLV Ugunsgrēka gadījumā: evakuēt zonu. Dzēst \nuguni no attāluma eksplozijas riska dēļ.  \nLT Gaisro atveju: evakuoti zoną. Gaisrą gesinti iš \ntoli dėl sprogimo pavojaus.  \nHU Tűz esetén: Ki kell üríteni a területet. A tűz \noltását robbanásveszély miatt távolból kell \nvégezni.  \nMT F’każ ta' nar: Evakwa ż-żona. Itfi n-nar mill- \nbogħod minħabba r-riskju ta' splużjoni.  \nNL In geval van brand: evacueren. Op afstand \nblussen omwille van ontploffingsgevaar.  \nPL W przypadku pożaru: Ewakuować teren. Z \npowodu ryzyka wybuchu gasić pożar z \nodległości.  \nPT Em caso de incêndio: evacuar a zona. Combater \no incêndio à distância, devido ao risco de \nexplosão.  \nRO În caz de incendiu: evacuaţi zona. Stingeţi \nincendiul de la distanţă din cauza pericolului \nde explozie.  \nSK V prípade požiaru: priestory evakuujte. Z \ndôvodu nebezpečenstva výbuchu požiar haste \nz diaľky.  \nSL Ob požaru: izprazniti območje. Gasiti z večje \nrazdalje zaradi nevarnosti eksplozije.  \nFI Tulipalon sattuessa: Evakuoi alue. Sammuta \npalo etäältä räjähdysvaaran takia.  \nSV Vid brand: Utrym området. Bekämpa branden \npå avstånd på grund av explosionsrisken.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 452}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 454  \nP371 + P380 \n+ P375  Language  \nBG При голям пожар и значителни количества: \nЕвакуирайте зоната. Гасете пожара от \nразстояние поради опасност от експлозия.  \nES En caso de incendio importante y en grandes \ncantidades: Evacuar la zona. Luchar contra el \nincendio a distancia, dado el riesgo de explo\xad\nsión.  \nCS V případě velkého požáru a velkého množství: \nVykliďte prostor. Kvůli nebezpečí výbuchu \nhaste z dostatečné vzdálenosti.  \nDA Ved større brand og store mængder: Evakuer \nområdet. Bekæmp branden på afstand på \ngrund af eksplosionsfare.  \nDE Bei Großbrand und großen Mengen: Umgebung \nräumen. Wegen Explosionsgefahr Brand aus \nder Entfernung bekämpfen.  \nET Suure tulekahju korral ning kui on tegemist \nsuurte kogustega: ala evakueerida. Plahvatusohu \ntõttu teha kustutustöid eemalt.  \nEL Σε περίπτωση σοβαρής πυρκαγιάς και εάν \nπρόκειται για μεγάλες ποσότητες: Εκκενώστε \nτην περιοχή. Προσπαθήστε να σβήσετε την \nπυρκαγιά από απόσταση, επειδή υπάρχει \nκίνδυνος έκρηξης.  \nEN In case of major fire and large quantities: \nEvacuate area. Fight fire remotely due to the \nrisk of explosion.  \nFR En cas d’incendie important et s’il s’agit de \ngrandes quantités: évacuer la zone. Combattre \nl’incendie à distance à cause du risque d’explo\xad\nsion.  \nGA I gcás mórdhóiteáin agus mórchainníochtaí: \nAslonnaigh gach duine as an limistéar. Téigh \ni gcianghleic leis an dóiteán mar gheall ar an \nmbaol pléasctha.  \n▼M5 \nHR U slučaju velikog požara i velikih količina: \nevakuirati područje. Gasiti s veće udaljenosti \nzbog opasnosti od eksplozije.  \n▼B \nIT In caso di incendio grave e di grandi quantità: \nevacuare la zona. Rischio di esplosione. \nUtilizzare i mezzi estinguenti a grande distanza.  \nLV Ugunsgrēka vai liela apjoma gadījumā: evakuēt \nzonu. Dzēst uguni no attāluma eksplozijas riska \ndēļ. \nLT Didelio gaisro ir didelių kiekių atveju: evakuoti \nzoną. Gaisrą gesinti iš toli dėl sprogimo pavo\xad\njaus. \nHU Nagyobb tűz és nagy mennyiség esetén: Ki kell \nüríteni a területet. A tűz oltását robbanásveszély \nmiatt távolból kell végezni.  \nMT F’każ ta' nar kbir u kwantitajiet kbar: Evakwa \nż-żona. Itfi n-nar mill-bogħod minħabba r-riskju \nta' splużjoni.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 453}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 455  \nP371 + P380 \n+ P375  Language  \nNL In geval van grote brand en grote hoeveel\xad\nheden: evacueren. Op afstand blussen omwille \nvan ontploffingsgevaar.  \nPL W przypadku poważnego pożaru i dużych \nilości: Ewakuować teren. Z powodu ryzyka \nwybuchu gasić pożar z odległości.  \nPT Em caso de incêndio importante e de grandes \nquantidades: evacuar a zona. Combater o \nincêndio à distância, devido ao risco de \nexplosão.  \nRO În caz de incendiu de proporţii și de cantităţi \nmari de produs: evacuaţi zona. Stingeţi \nincendiul de la distanţă din cauza pericolului \nde explozie.  \nSK V prípade veľkého požiaru a značného \nmnožstva: priestory evakuujte. Z dôvodu \nnebezpečenstva výbuchu požiar haste z diaľky.  \nSL Ob velikem požaru in velikih količinah: \nizprazniti območje. Gasiti z večje razdalje \nzaradi nevarnosti eksplozije.  \nFI Jos tulipalo ja ainemäärät ovat suuret: Evakuoi \nalue. Sammuta palo etäältä räjähdysvaaran \ntakia.  \nSV Vid större brand och stora mängder: Utrym \nområdet. Bekämpa branden på avstånd på \ngrund av explosionsrisken.  \n▼M12  \nP370 + P372 \n+ P380 + \nP373  Language  \nBG При пожар: опасност от експлозия. \nЕвакуирайте зоната. НЕ се опитвайте да \nгасите пожара, ако огънят наближи \nексплозиви.  \nES En caso de incendio: Riesgo de explosión. \nEvacuar la zona. NO combatir el incendio \ncuando este afecte a la carga.  \nCS V případě požáru: Nebezpečí výbuchu. \nVykliďte prostor. Požár NEHASTE, dostane-li \nse k výbušninám.  \nDA Ved brand: Eksplosionsfare. Evakuer området. \nBEKÆMP IKKE branden, hvis denne når \neksplosiverne.  \nDE Bei Brand: Explosionsgefahr. Umgebung \nräumen. KEINE Brandbekämpfung, wenn das \nFeuer explosive Stoffe/Gemische/Erzeugnisse \nerreicht.  \nET Tulekahju korral: plahvatusoht. Ala evaku\xad\neerida. Kui tuli jõuab lõhkeaineteni, MITTE \nteha kustutustöid.  \nEL Σε περίπτωση πυρκαγιάς: Κίνδυνος έκρηξης. \nΕκκενώστε την περιοχή. ΜΗΝ προσπαθείτε \nνα σβήσετε την πυρκαγιά, όταν η φωτιά \nπλησιάζει σε εκρηκτικά.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 454}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 456  \nP370 + P372 \n+ P380 + \nP373  Language  \nEN In case of fire: Explosion risk. Evacuate area. \nDO NOT fight fire when fire reaches explos\xad\nives. \nFR En cas d'incendie: Risque d'explosion. Évacuer \nla zone. NE PAS combattre l'incendie lorsque le \nfeu atteint les explosifs.  \nGA I gcás dóiteáin: Baol pléasctha. Aslonnaigh \ngach duine as an limistéar. NÁ DÉAN an \ndóiteán a chomhrac má shroicheann sé pléas\xad\ncáin.  \nHR U slučaju požara: opasnost od eksplozije. \nEvakuirati područje. NE gasiti vatru kada \nplamen zahvati eksplozive.  \nIT Rischio di esplosione in caso di incendio. \nEvacuare la zona. NON utilizzare mezzi \nestinguenti se l'incendio raggiunge materiali \nesplosivi.  \nLV Ugunsgrēka gadījumā: Eksplozijas risks. \nEvakuēt zonu. NECENSTIES dzēst \nugunsgrēku, ja uguns piekļūst \nsprādzienbīstamām vielām.  \nLT Gaisro atveju: sprogimo pavojus. Evakuoti \nzoną. NEGESINTI gaisro, jeigu ugnis pasiekia \nsprogmenis.  \nHU Tűz esetén: Robbanásveszély. A területet ki kell \nüríteni. TILOS a tűz oltása, ha az robbanóa\xad\nnyagra átterjedt.  \nMT F'każ ta' nar: Riskju ta' splużjoni. Evakwa ż- \nżona. TIPPRUVAX TITFI n-nar meta n-nar \njilħaq l-isplussivi.  \nNL In geval van brand: ontploffingsgevaar. \nEvacueren. NIET blussen wanneer het vuur de \nontplofbare stoffen bereikt.  \nPL W przypadku pożaru: Zagrożenie wybuchem. \nEwakuować teren. NIE gasić pożaru, jeżeli \nogień dosięgnie materiały wybuchowe.  \nPT Em caso de incêndio: Risco de explosão. \nEvacuar a zona. Se o fogo atingir os \nexplosivos, NÃO tentar combatê-lo.  \nRO În caz de incendiu: Risc de explozie. Evacuaţi \nzona. NU încercaţi să stingeţi incendiul atunci \ncând focul a ajuns la explozivi.  \nSK V prípade požiaru: Riziko výbuchu. Priestory \nevakuujte. Požiar NEHASTE, ak sa oheň \npriblížil k výbušninám.  \nSL Ob požaru: Nevarnost eksplozije. Izprazniti \nobmočje. NE gasiti, ko ogenj doseže eksploziv.  \nFI Tulipalon sattuessa: Räjähdysvaara. Evakuoi \nalue. Tulta EI SAA yrittää sammuttaa sen \nsaavutettua räjähteet.  \nSV Vid brand: Explosionsrisk. Utrym området. \nFörsök INTE bekämpa branden när den når \nexplosiva varor.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 455}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 457  \nP370 + P380 \n+ P375[+ \nP378]  Language  \nBG При пожар: евакуирайте зоната. Гасете \nпожара от разстояние поради опасност от \nексплозия. [Използвайте…, за да загасите].  \nES En caso de incendio: Evacuar la zona. Combatir \nel incendio a distancia, debido al riesgo de \nexplosión. [Utilizar … en la extinción].  \nCS V případě požáru: Vykliďte prostor. Kvůli \nnebezpečí výbuchu haste z dostatečné vzdále\xad\nnosti. [K uhašení použijte …].  \nDA Ved brand: Evakuer området. Bekæmp branden \npå afstand på grund af eksplosionsfare. \n[Anvend … til brandslukning].  \nDE Bei Brand: Umgebung räumen. Wegen Explo\xad\nsionsgefahr Brand aus der Entfernung \nbekämpfen. [… zum Löschen verwenden.]  \nET Tulekahju korral: ala evakueerida. Plahvatusohu \ntõttu teha kustutustöid eemalt. [Kustutamiseks \nkasutada ….].  \nEL Σε περίπτωση πυρκαγιάς: Εκκενώστε την \nπεριοχή. Προσπαθήστε να σβήσετε την \nπυρκαγιά από απόσταση, επειδή υπάρχει \nκίνδυνος έκρηξης [Χρησιμοποιήστε … για την \nκατάσβεση].  \nEN In case of fire: Evacuate area. Fight fire \nremotely due to the risk of explosion. [Use … \nto extinguish].  \nFR En cas d'incendie: Évacuer la zone. Combattre \nl'incendie à distance à cause du risque d'ex\xad\nplosion. [Utiliser … pour l'extinction].  \nGA I gcás dóiteáin: Aslonnaigh gach duine as an \nlimistéar. Téigh i gcianghleic leis an dóiteán \nmar gheall ar an mbaol pléasctha. [Úsáid … \nle haghaidh múchta].  \nHR U slučaju požara: evakuirati područje. Gasiti s \nveće udaljenosti zbog opasnosti od eksplozije. \n[Za gašenje rabiti…].  \nIT In caso di incendio: evacuare la zona. Rischio \ndi esplosione. Utilizzare i mezzi estinguenti a \ngrande distanza. [Estinguere con…].  \nLV Ugunsgrēka gadījumā: Evakuēt zonu. Dzēst \nuguni no attāluma eksplozijas riska dēļ. \n[Dzēšanai lietot …].  \nLT Gaisro atveju: evakuoti zoną. Gaisrą gesinti iš \ntoli dėl sprogimo pavojaus. [Gesinimui naudoti \n…]. \nHU Tűz esetén: A területet ki kell üríteni. A tűz \noltását robbanásveszély miatt távolból kell \nvégezni. [Az oltáshoz … használandó].  \nMT F'każ ta' nar: Evakwa ż-żona. Itfi n-nar mill- \nbogħod minħabba r-riskju ta' splużjoni. [Uża \n… biex titfi].  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 456}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 458  \nP370 + P380 \n+ P375[+ \nP378]  Language  \nNL In geval van brand: evacueren. Op afstand \nblussen in verband met ontploffingsgevaar. \n[Blussen met …].  \nPL W przypadku pożaru: Ewakuować teren. Z \npowodu ryzyka wybuchu gasić pożar z \nodległości. [Użyć … do gaszenia].  \nPT Em caso de incêndio: Evacuar a zona. \nCombater o incêndio à distância, devido ao \nrisco de explosão. [Para extinguir utilizar…].  \nRO În caz de incendiu: Evacuaţi zona. Stingeţi \nincendiul de la distanţă din cauza pericolului \nde explozie. [Utilizaţi … pentru stingere].  \nSK V prípade požiaru: Priestory evakuujte. \nZ dôvodu nebezpečenstva výbuchu požiar \nhaste z diaľky. [Na hasenie použite…].  \nSL Ob požaru: Izprazniti območje. Gasiti z večje \nrazdalje zaradi nevarnosti eksplozije. [Za \ngašenje uporabiti …].  \nFI Tulipalon sattuessa: Evakuoi alue. Sammuta \npalo etäältä räjähdysvaaran takia. [Käytä palon \nsammuttamiseen …].  \nSV Vid brand: Utrym området. Bekämpa branden \npå avstånd på grund av explosionsrisken. [Släck \nmed …].  \n▼B \nTable 1.4  \nPrecautionary statements — Storage  \n▼M12  \nP401  Language  \nBG Да се съхранява съгласно…  \nES Almacenar conforme a … .  \nCS Skladujte v souladu s … .  \nDA Opbevares i overensstemmelse med … .  \nDE Aufbewahren gemäß … .  \nET Hoida kooskõlas … .  \nEL Αποθηκεύεται σύμφωνα με… .  \nEN Store in accordance with… .  \nFR Stocker conformément à… .  \nGA Stóráil i gcomhréir le… .  \nHR Skladištiti u skladu s…  \nIT Conservare secondo… .  \nLV Glabāt saskaņā ar … .  \nLT Laikyti, vadovaujantis…  \nHU A … -nak/-nek megfelelően tárolandó.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 457}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 459  \nP401  Language  \nMT Aħżen skont… .  \nNL Overeenkomstig … bewaren.  \nPL Przechowywać zgodnie z … .  \nPT Armazenar em conformidade com… .  \nRO A se depozita în conformitate cu… .  \nSK Skladujte v súlade s… .  \nSL Hraniti v skladu s/z… .  \nFI Varastoi … mukaisesti.  \nSV Förvaras enligt … .  \n▼B \nP402  Language  \nBG Да се съхранява на сухо място.  \nES Almacenar en un lugar seco.  \nCS Skladujte na suchém místě.  \nDA Opbevares et tørt sted.  \nDE An einem trockenen Ort aufbewahren.  \nET Hoida kuivas.  \nEL Αποθηκεύεται σε στεγνό μέρος.  \nEN Store in a dry place.  \nFR Stocker dans un endroit sec.  \nGA Stóráil in áit thirim.  \n▼M5 \nHR Skladištiti na suhom mjestu.  \n▼B \nIT Conservare in luogo asciutto.  \nLV Glabāt sausā vietā.  \nLT Laikyti sausoje vietoje.  \nHU Száraz helyen tárolandó.  \nMT Aħżen f’post niexef.  \nNL Op een droge plaats bewaren.  \nPL Przechowywać w suchym miejscu.  \nPT Armazenar em local seco.  \nRO A se depozita într-un loc uscat.  \nSK Uchovávajte na suchom mieste.  \nSL Hraniti na suhem.  \nFI Varastoi kuivassa paikassa.  \nSV Förvaras torrt.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 458}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 460  \nP403  Language  \nBG Да се съхранява на добре проветриво място.  \nES Almacenar en un lugar bien ventilado.  \nCS Skladujte na dobře větraném místě.  \nDA Opbevares på et godt ventileret sted.  \nDE An einem gut belüfteten Ort aufbewahren.  \nET Hoida hästi ventileeritavas kohas.  \nEL Αποθηκεύεται σε καλά αεριζόμενο χώρο.  \nEN Store in a well-ventilated place.  \nFR Stocker dans un endroit bien ventilé.  \nGA Stóráil in áit dhea-aeráilte.  \n▼M5 \nHR Skladištiti na dobro prozračenom mjestu.  \n▼B \nIT Conservare in luogo ben ventilato.  \nLV Glabāt labi vēdināmā vietā.  \nLT Laikyti gerai vėdinamoje vietoje.  \nHU Jól szellőző helyen tárolandó.  \nMT Aħżen f’post b'ventilazzjoni tajba.  \nNL Op een goed geventileerde plaats bewaren.  \nPL Przechowywać w dobrze wentylowanym \nmiejscu.  \nPT Armazenar em local bem ventilado.  \nRO A se depozita într-un spaţiu bine ventilat.  \nSK Uchovávajte na dobre vetranom mieste.  \nSL Hraniti na dobro prezračevanem mestu.  \nFI Varastoi paikassa, jossa on hyvä ilmanvaihto.  \nSV Förvaras på väl ventilerad plats.  \nP404  Language  \nBG Да се съхранява в затворен съд.  \nES Almacenar en un recipiente cerrado.  \nCS Skladujte v uzavřeném obalu.  \nDA Opbevares i en lukket beholder.  \nDE In einem geschlossenen Behälter aufbewahren.  \nET Hoida suletud mahutis.  \nEL Φυλάσσεται σε κλειστό περιέκτη.  \nEN Store in a closed container.  \nFR Stocker dans un récipient fermé.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 459}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 461  \nP404  Language  \nGA Stóráil i gcoimeádán iata.  \n▼M5 \nHR Skladištiti u zatvorenom spremniku.  \n▼B \nIT Conservare in un recipiente chiuso.  \nLV Glabāt slēgtā tvertnē.  \nLT Laikyti uždaroje talpykloje.  \nHU Zárt edényben tárolandó.  \nMT Aħżen f’kontenitur magħluq.  \nNL In gesloten verpakking bewaren.  \nPL Przechowywać w zamkniętym pojemniku.  \nPT Armazenar em recipiente fechado.  \nRO A se depozita într-un recipient închis.  \nSK Uchovávajte v uzavretej nádobe.  \nSL Hraniti v zaprti posodi.  \nFI Varastoi suljettuna.  \nSV Förvaras i sluten behållare.  \nP405  Language  \nBG Да се съхранява под ключ.  \nES Guardar bajo llave.  \nCS Skladujte uzamčené.  \nDA Opbevares under lås.  \nDE Unter Verschluss aufbewahren.  \nET Hoida lukustatult.  \nEL Φυλάσσεται κλειδωμένο.  \nEN Store locked up.  \nFR Garder sous clef.  \nGA Stóráil faoi ghlas.  \n▼M5 \nHR Skladištiti pod ključem.  \n▼B \nIT Conservare sotto chiave.  \nLV Glabāt slēgtā veidā.  \nLT Laikyti užrakintą.  \nHU Elzárva tárolandó.  \nMT Aħżen f'post imsakkar.  \nNL Achter slot bewaren.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 460}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 462  \nP405  Language  \nPL Przechowywać pod zamknięciem.  \nPT Armazenar em local fechado à chave.  \nRO A se depozita sub cheie.  \nSK Uchovávajte uzamknuté.  \nSL Hraniti zaklenjeno.  \nFI Varastoi lukitussa tilassa.  \nSV Förvaras inlåst.  \n▼M12  \nP406  Language  \nBG Да се съхранява в устойчив на разяждане \nсъд/… съд с устойчива вътрешна облицовка.  \nES Almacenar en un recipiente resistente a la \ncorrosión /… en un recipiente con revestimiento \ninterior resistente.  \nCS Skladujte v obalu odolném proti korozi/… s \nodolnou vnitřní vrstvou.  \nDA Opbevares i ætsningsbestandig/… beholder med \nmodstandsdygtig foring.  \nDE In korrosionsbeständigem/… Behälter mit \nkorrosionsbeständiger Innenauskleidung \naufbewahren.  \nET Hoida sööbekindlas/…sööbekindla sisevooder\xad\ndisega mahutis.  \nEL Αποθηκεύεται σε ανθεκτικό στη διάβρωση/… \nπεριέκτη με ανθεκτική εσωτερική επένδυση.  \nEN Store in a corrosion-resistant/… container with \na resistant inner liner.  \nFR Stocker dans un récipient résistant à la \ncorrosion/… avec doublure intérieure.  \nGA Stóráil i gcoimeádán/ … frithchreimneach le \nlíneáil fhrithchreimneach laistigh.  \nHR Skladištiti u spremniku otpornom na nagrizanje/ \n… s otpornom unutarnjom oblogom.  \nIT Conservare in recipiente resistente alla \ncorrosione/… provvisto di rivestimento interno \nresistente.  \nLV Glabāt korozijizturīgā/… tvertnē ar iekšējo pret\xad\nkorozijas izolāciju.  \nLT Laikyti korozijai atsparioje talpykloje/…, \nturinčioje atsparią vidinę dangą.  \nHU Saválló/saválló bélésű … edényben tárolandó.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 461}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 463  \nP406  Language  \nMT Aħżen f'post reżistenti għall-korrużjoni /… \nkontenitur li huwa infurrat minn ġewwa b'ma\xad\nterjal reżistenti.  \nNL In corrosiebestendige/… houder met corrosiebe\xad\nstendige binnenbekleding bewaren.  \nPL Przechowywać w pojemniku odpornym na \nkorozję /… o odpornej powłoce wewnętrznej.  \nPT Armazenar num recipiente resistente à corrosão/ \n… com um revestimento interior resistente.  \nRO A se depozita într-un recipient rezistent la coro\xad\nziune/recipient din… cu dublură interioară \nrezistentă la coroziune.  \nSK Uchovávajte v nádobe odolnej proti korózii/… \nnádobe s odolnou vnútornou vrstvou.  \nSL Hraniti v posodi, odporni proti koroziji/…, z \nodporno notranjo oblogo.  \nFI Varastoi syöpymättömässä/… säiliössä, jossa on \nkestävä sisävuoraus.  \nSV Förvaras i korrosionsbeständig/… behållare \nmed beständigt innerhölje.  \nP407  Language  \nBG Да се остави въздушно пространство между \nкупчините или палетите.  \nES Dejar un espacio de aire entre las pilas o \nbandejas.  \nCS Mezi stohy nebo paletami ponechte vzdu\xad\nchovou mezeru.  \nDA Opbevares med luftmellemrum mellem \nstakkene/pallerne.  \nDE Luftspalt zwischen Stapeln oder Paletten lassen.  \nET Jätta virnade või kaubaaluste vahele õhuvahe.  \nEL Να υπάρχει κενό αέρος μεταξύ των σωρών ή \nπαλετών.  \nEN Maintain air gap between stacks or pallets.  \nFR Maintenir un intervalle d'air entre les piles ou \nles palettes.  \nGA Coimeád bearna aeir idir cruacha nó idir pail\xad\nléid. \nHR Osigurati razmak između polica ili paleta.  \nIT Mantenere uno spazio libero tra gli scaffali o i \npallet.  ▼M12", metadata={'source': 'data/ycla_en.pdf', 'page': 462}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 464  \nP407  Language  \nLV Saglabāt gaisa spraugu starp krāvumiem vai \npaletēm.  \nLT Palikti oro tarpą tarp eilių arba palečių.  \nHU A rakatok vagy raklapok között térközt kell \nhagyni.  \nMT Ħalli l-arja tgħaddi bejn l-imniezel jew il-palits.  \nNL Ruimte laten tussen stapels of pallets.  \nPL Zachować szczelinę powietrzną pomiędzy \nstosami lub paletami.  \nPT Respeitar as distâncias mínimas entre pilhas ou \npaletes.  \nRO Păstraţi un spaţiu gol între stive sau paleţi.  \nSK Medzi regálmi alebo paletami ponechajte \nvzduchovú medzeru.  \nSL Ohraniti zračno režo med skladi ali paletami.  \nFI Jätä pinojen tai kuormalavojen väliin ilmarako.  \nSV Se till att det finns luft mellan staplar eller \npallar.  \n▼B \nP410  Language  \nBG Да се пази от пряка слънчева светлина.  \nES Proteger de la luz del sol.  \nCS Chraňte před slunečním zářením.  \nDA Beskyttes mod sollys.  \nDE Vor Sonnenbestrahlung schützen.  \nET Hoida päikesevalguse eest.  \nEL Να προστατεύεται από τις ηλιακές ακτίνες.  \nEN Protect from sunlight.  \nFR Protéger du rayonnement solaire.  \nGA Cosain ó sholas na gréine.  \n▼M5 \nHR Zaštititi od sunčevog svjetla.  \n▼B \nIT Proteggere dai raggi solari.  \nLV Aizsargāt no saules gaismas.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 463}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 465  \nP410  Language  \nLT Saugoti nuo saulės šviesos.  \nHU Napfénytől védendő.  \nMT Ipproteġi mid-dawl tax-xemx.  \nNL Tegen zonlicht beschermen.  \nPL Chronić przed światłem słonecznym.  \nPT Manter ao abrigo da luz solar.  \nRO A se proteja de lumina solară.  \nSK Chráňte pred slnečným žiarením.  \nSL Zaščititi pred sončno svetlobo.  \nFI Suojaa auringonvalolta.  \nSV Skyddas från solljus.  \nP411  Language  \nBG Да се съхранява при температури, не по- \nвисоки от …  o C/…  o F. \nES Almacenar a temperaturas no superiores a …  \no C/…  o F. \nCS Skladujte při teplotě nepřesahující …  o C/…  o F. \nDA Opbevares ved en temperatur, som ikke over\xad\nstiger …  o C/…  o F. \nDE ►C3 Bei Temperaturen nicht über …  o C/…  o F \naufbewahren. ◄  \nET Hoida temperatuuril mitte üle …  o C/…  o F. \nEL Αποθηκεύεται σε θερμοκρασίες που δεν \nυπερβαίνουν τους …  o C/…  o F. \nEN Store at temperatures not exceeding …  o C/ \n… o F. \nFR Stocker à une température ne dépassant pas …  \no C/…  o F. \nGA Stóráil ag teocht nach airde ná …  o C/…  o F. \n▼M5 \nHR Skladištiti na temperaturi koja ne prelazi …  o C/ \n… o F. \n▼B \nIT Conservare a temperature non superiori a …  \no C/…  o F. \nLV Uzglabāt temperatūrā, kas nepārsniedz …  o C/ \n… o F. \nLT Laikyti ne aukštesnėje kaip …  o C/…  o F \ntemperatūroje.  \nHU A tárolási hőmérséklet legfeljebb …  o C/…  o F \nlehet.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 464}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 466  \nP411  Language  \nMT Aħżen f’temperaturi li ma jeċċedux …  o C/…  o F. \nNL Bij maximaal …  o C/…  o F bewaren.  \nPL Przechowywać w temperaturze nieprzekrac\xad\nzającej …  o C/…  o F. \nPT Armazenar a uma temperatura não superior a …  \no C/…  o F. \nRO A se depozita la temperaturi care să nu \ndepășească …  o C/…  o F. \nSK Uchovávajte pri teplotách do …  o C/…  o F \nSL Hraniti pri temperaturi do …  o C/…  o F. \nFI Varastoi alle …  o C/…  o F lämpötilassa.  \nSV Förvaras vid högst …  o C/…  o F. \nP412  Language  \nBG Да не се излага на температури, по-високи \nот 50  o C/122  o F. \nES No exponer a temperaturas superiores a 50  o C/ \n122  o F. \nCS Nevystavujte teplotě přesahující 50  o C/122  o F. \nDA Må ikke udsættes for en temperatur, som over\xad\nstiger 50  o C/122  o F. \nDE ►C3 Nicht Temperaturen über 50  o C/122  o F \naussetzen. ◄  \nET Mitte hoida temperatuuril üle 50  o C/122  o F. \nEL Να μην εκτίθεται σε θερμοκρασίες που \nυπερβαίνουν τους 50  o C/122  o F. \nEN Do not expose to temperatures exceeding \n50 o C/122  o F. \nFR Ne pas exposer à une température supérieure à \n50 o C/122  o F. \nGA Ná nocht do theocht níos airde ná 50  o C/122  o F. \n▼M5 \nHR Ne izlagati temperaturi višoj od 50  o C/122  o F. \n▼B \nIT Non esporre a temperature superiori a 50  o C/ \n122  o F. \nLV Nepakļaut temperatūrai, kas pārsniedz 50  o C/ \n122  o F. \nLT Nelaikyti aukštesnėje kaip 50  o C/122  o F \ntemperatūroje.  \nHU Nem érheti 50  o C/122  o F hőmérsékletet \nmeghaladó hő.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 465}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 467  \nP412  Language  \nMT Tesponix għal temperaturi li jeċċedu l-50  o C/ \n122  o F. \nNL Niet blootstellen aan temperaturen boven 50  o C/ \n122  o F. \nPL Nie wystawiać na działanie temperatury przek\xad\nraczającej 50  o C/122  o F. \nPT Não expor a temperaturas superiores a 50  o C/ \n122  o F. \nRO Nu expuneţi la temperaturi care depășesc 50  o C/ \n122  o F. \nSK Nevystavujte teplotám nad 50  o C/122  o F. \nSL Ne izpostavljati temperaturam nad 50  o C/ \n122  o F. \nFI Ei saa altistaa yli 50  o C/122  o F lämpötiloille.  \nSV Får inte utsättas för temperaturer över 50  o C/ \n122  o F. \nP413  Language  \nBG При насипни количества, по-големи от … \nkg/… фунта, да се съхранява при \nтемператури, не по-високи от …  o C/…  o F. \nES Almacenar las cantidades a granel superiores a \n… kg/… lbs a temperaturas no superiores a …  \no C/…  o F. \nCS Množství větší než … kg/… liber skladujte při \nteplotě nepřesahující …  o C/…  o F. \nDA Bulkmængder på over … kg/…lbs opbevares \nved en temperatur, som ikke overstiger …  o C/ \n… o F. \nDE ►C3 Schüttgut in Mengen von mehr als … kg/ \n… lbs bei Temperaturen nicht über …  o C/…  o F \naufbewahren. ◄  \nET Kogust, mis on suurem kui … kg/… naela, \nhoida temperatuuril mitte üle …  o C/…  o F. \nEL Οι σωροί χύδην με βάρος άνω των … kg/… lbs \nαποθηκεύονται σε θερμοκρασίες που δεν \nυπερβαίνουν τους …  o C/…  o F. \nEN Store bulk masses greater than … kg/… lbs at \ntemperatures not exceeding …  o C/…  o F. \nFR Stocker les quantités en vrac de plus de … kg/ \n… lb à une température ne dépassant pas …  \no C/…  o F. \nGA Stóráil bulcmhaiseanna os cionn … kg/… lb ag \nteocht nach airde ná …  o C/…  o F. \n▼M5 \nHR Skladištiti količine veće od … kg/ … lbs na \ntemperaturi koja ne prelazi …  o C/…  o F. ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 466}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 468  \nP413  Language  \nIT Conservare le rinfuse di peso superiore a …kg/ \n…lb a temperature non superiori a …  o C/ o F. \nLV Lielus apjomus, kas pārsniedz … kg/… lbs, \nuzglabāt temperatūrā, kas nepārsniedz …  o C/ \n… o F. \nLT Didesnius kaip … kg/… lbs medžiagos kiekius \nlaikyti ne aukštesnėje kaip …  o C/…  o F \ntemperatūroje.  \nHU A … kg/… lb tömeget meghaladó ömlesztett \nanyag tárolási hőmérséklete legfeljebb …  o C/ \n… o F lehet.  \nMT Aħżen il-kwantitajiet f’massa ta' akbar minn … \nkg/… lbs f’temperaturi ta' mhux aktar minn …  \no C/…  o F. \nNL Bulkmateriaal, indien meer dan … kg/… lbs, \nbij temperaturen van maximaal …  o C bewaren.  \nPL Przechowywać luzem masy przekraczające … \nkg/… funtów w temperaturze nieprzekrac\xad\nzającej …  o C/…  o F. \nPT Armazenar quantidades a granel superiores a … \nkg/… lbs a uma temperatura não superior a …  \no C/…  o F. \nRO Depozitaţi cantităţile în vrac mai mari de … kg/ \n… lbs la temperaturi care să nu depășească …  \no C/…  o F. \nSK Veľké množstvo s hmotnosťou nad … kg/… \nlbs uchovávajte pri teplote do …  o C/…  o F. \nSL Razsute količine, večje od … kg/… lbs, hraniti \npri temperaturi do …  o C/…  o F. \nFI Säilytä yli … kg/…lbs painoinen irtotavara \nenintään …  o C/…  o F lämpötilassa.  \nSV Bulkprodukter som väger mer än … kg/… lbs \nförvaras vid högst …  o C/…  o F. \n▼M12  \nP420  Language  \nBG Да се съхранява отделно.  \nES Almacenar separadamente.  \nCS Skladujte odděleně.  \nDA Opbevares separat.  \nDE Getrennt aufbewahren.  \nET Hoida eraldi.  \nEL Αποθηκεύεται χωριστά.  \nEN Store separately.  \nFR Stocker séparément.  \nGA Stóráil as féin.  \nHR Skladištiti odvojeno.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 467}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 469  \nP420  Language  \nIT Conservare separatamente.  \nLV Glabāt atsevišķi.  \nLT Laikyti atskirai.  \nHU Elkülönítve tárolandó.  \nMT Aħżen separatament.  \nNL Gescheiden bewaren.  \nPL Przechowywać oddzielnie.  \nPT Armazenar separadamente.  \nRO A se depozita separat.  \nSK Skladujte jednotlivo.  \nSL Hraniti ločeno.  \nFI Varastoi erillään.  \nSV Förvaras separat.  \n__________  \n▼B \nP402 + P404  Language  \nBG Да се съхранява на сухо място. Да се \nсъхранява в затворен съд.  \nES Almacenar en un lugar seco. Almacenar en un \nrecipiente cerrado.  \nCS Skladujte na suchém místě. Skladujte v \nuzavřeném obalu.  \nDA Opbevares et tørt sted. Opbevares i en lukket \nbeholder.  \nDE ►C3 An einem trockenen Ort aufbewahren. In \neinem geschlossenen Behälter aufbewahren. ◄  \nET Hoida kuivas. Hoida suletud mahutis.  \nEL Αποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε \nκλειστό περιέκτη.  \nEN Store in a dry place. Store in a closed container.  \nFR Stocker dans un endroit sec. Stocker dans un \nrécipient fermé.  \nGA Stóráil in áit thirim. Stóráil i gcoimeádán iata.  \n▼M5 \nHR Skladištiti na suhom mjestu. Skladištiti u \nzatvorenom spremniku.  \n▼B \nIT Conservare in luogo asciutto e in recipiente \nchiuso.  \nLV Glabāt sausā vietā. Glabāt aizvērtā tvertnē.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 468}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 470  \nP402 + P404  Language  \nLT Laikyti sausoje vietoje. Laikyti uždaroje \ntalpykloje.  \nHU Száraz helyen tárolandó. Zárt edényben táro\xad\nlandó.  \nMT Aħżen f’post niexef. Aħżen f’kontenitur \nmagħluq.  \nNL Op een droge plaats bewaren. In gesloten \nverpakking bewaren.  \nPL Przechowywać w suchym miejscu. Prze\xad\nchowywać w zamkniętym pojemniku.  \nPT Armazenar em local seco. Armazenar em \nrecipiente fechado.  \nRO A se depozita într-un loc uscat, într-un recipient \nînchis.  \nSK Uchovávajte na suchom mieste. Uchovávajte v \nuzavretej nádobe.  \nSL Hraniti na suhem. Hraniti v zaprti posodi.  \nFI Varastoi kuivassa paikassa. Varastoi suljettuna.  \nSV Förvaras torrt. Förvaras i sluten behållare.  \nP403 + P233  Language  \nBG Да се съхранява на добре проветриво място. \nСъдът да се съхранява плътно затворен.  \nES Almacenar en un lugar bien ventilado. \nMantener el recipiente cerrado herméticamente.  \nCS Skladujte na dobře větraném místě. Ucho\xad\nvávejte obal těsně uzavřený.  \nDA Opbevares på et godt ventileret sted. Hold \nbeholderen tæt lukket.  \nDE ►C3 An einem gut belüfteten Ort \naufbewahren. Behälter dicht verschlossen \nhalten. ◄  \nET Hoida hästi ventileeritavas kohas. Hoida mahuti \ntihedalt suletuna.  \nEL Αποθηκεύεται σε καλά αεριζόμενο χώρο. Ο \nπεριέκτης διατηρείται ερμητικά κλειστός.  \nEN Store in a well-ventilated place. Keep container \ntightly closed.  \nFR Stocker dans un endroit bien ventilé. Maintenir \nle récipient fermé de manière étanche.  \nGA Stóráil in áit dhea-aeráilte. Coimeád an \ncoimeádán dúnta go docht.  \n▼M5 \nHR Skladištiti na dobro prozračenom mjestu. Čuvati \nu dobro zatvorenom spremniku.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 469}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 471  \nP403 + P233  Language  \nIT Tenere il recipiente ben chiuso e in luogo ben \nventilato.  \nLV Glabāt labi vēdināmās telpās. Tvertni turēt cieši \nnoslēgtu.  \nLT Laikyti gerai vėdinamoje vietoje. Talpyklą \nlaikyti sandariai uždarytą.  \nHU Jól szellőző helyen tárolandó. Az edény \nszorosan lezárva tartandó.  \nMT Aħżen f'post b'ventilazzjoni tajba. Żomm il- \nkontenitur magħluq sew.  \nNL Op een goed geventileerde plaats bewaren. In \ngoed gesloten verpakking bewaren.  \nPL Przechowywać w dobrze wentylowanym \nmiejscu. Przechowywać pojemnik szczelnie \nzamknięty.  \nPT Armazenar em local bem ventilado. Manter o \nrecipiente bem fechado.  \nRO A se depozita într-un spaţiu bine ventilat. \nPăstraţi recipientul închis etanș.  \nSK Uchovávajte na dobre vetranom mieste. Nádobu \nuchovávajte tesne uzavretú.  \nSL Hraniti na dobro prezračevanem mestu. Hraniti \nv tesno zaprti posodi.  \nFI Varastoi paikassa, jossa on hyvä ilmanvaihto. \nSäilytä tiiviisti suljettuna.  \nSV Förvaras på väl ventilerad plats. Förpackningen \nska förvaras väl tillsluten.  \nP403 + P235  Language  \nBG Да се съхранява на добре проветриво място. \nДа се съхранява на хладно.  \nES Almacenar en un lugar bien ventilado. \nMantener en lugar fresco.  \nCS Skladujte na dobře větraném místě. Ucho\xad\nvávejte v chladu.  \nDA Opbevares på et godt ventileret sted. Opbevares \nkøligt.  \nDE ►C3 An einem gut belüfteten Ort aufbewah- \nren. Kühl halten. ◄  \nET Hoida hästi ventileeritavas kohas. Hoida \njahedas.  \nEL Αποθηκεύεται σε καλά αεριζόμενο χώρο. \nΔιατηρείται δροσερό.  \nEN Store in a well-ventilated place. Keep cool.  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 470}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 472  \nP403 + P235  Language  \nFR Stocker dans un endroit bien ventilé. Tenir au \nfrais.  \nGA Stóráil in áit dhea-aeráilte. Coimeád fionnuar.  \n▼M5 \nHR Skladištiti na dobro prozračenom mjestu. \nOdržavati hladnim.  \n▼B \nIT Conservare in luogo fresco e ben ventilato.  \nLV Glabāt labi vēdināmās telpās. Turēt vēsumā.  \nLT Laikyti gerai vėdinamoje vietoje. Laikyti \nvėsioje vietoje.  \nHU Jól szellőző helyen tárolandó. Hűvös helyen \ntartandó.  \nMT Aħżen f'post b'ventilazzjoni tajba. Żomm frisk.  \nNL Op een goed geventileerde plaats bewaren. \nKoel bewaren.  \nPL Przechowywać w dobrze wentylowanym \nmiejscu. Przechowywać w chłodnym miejscu.  \nPT Armazenar em local bem ventilado. Conservar \nem ambiente fresco.  \nRO A se depozita într-un spaţiu bine ventilat. A se \npăstra la rece.  \nSK Uchovávajte na dobre vetranom mieste. Ucho\xad\nvávajte v chlade.  \nSL Hraniti na dobro prezračevanem mestu. Hraniti \nna hladnem.  \nFI Varastoi paikassa, jossa on hyvä ilmanvaihto. \nSäilytä viileässä.  \nSV Förvaras på väl ventilerad plats. Förvaras svalt.  \nP410 + P403  Language  \nBG Да се пази от пряка слънчева светлина. Да се \nсъхранява на добре проветриво място.  \nES Proteger de la luz del sol. Almacenar en un \nlugar bien ventilado.  \nCS Chraňte před slunečním zářením. Skladujte na \ndobře větraném místě.  \nDA Beskyttes mod sollys. Opbevares på et godt \nventileret sted.  \nDE ►C3 Vor Sonnenbestrahlung schützen. An \neinem gut belüfteten Ort aufbewahren. ◄  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 471}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 473  \nP410 + P403  Language  \nET Hoida päikesevalguse eest. Hoida hästi venti\xad\nleeritavas kohas.  \nEL Να προστατεύεται από τις ηλιακές ακτίνες. \nΑποθηκεύεται σε καλά αεριζόμενο χώρο.  \nEN Protect from sunlight. Store in a well-ventilated \nplace.  \nFR Protéger du rayonnement solaire. Stocker dans \nun endroit bien ventilé.  \nGA Cosain ó sholas na gréine. Stóráil in áit dhea- \naeráilte.  \n▼M5 \nHR Zaštititi od sunčevog svjetla. Skladištiti na \ndobro prozračenom mjestu.  \n▼B \nIT Proteggere dai raggi solari. Conservare in luogo \nben ventilato.  \nLV Aizsargāt no saules gaismas. Glabāt labi \nvēdināmās telpās.  \nLT Saugoti nuo saulės šviesos. Laikyti gerai \nvėdinamoje vietoje.  \nHU Napfénytől védendő. Jól szellőző helyen táro\xad\nlandó.  \nMT Ipproteġi mid-dawl tax-xemx. Aħżen f'post \nb'ventilazzjoni tajba.  \nNL Tegen zonlicht beschermen. Op een goed \ngeventileerde plaats bewaren.  \nPL Chronić przed światłem słonecznym. Prze\xad\nchowywać w dobrze wentylowanym miejscu.  \nPT Manter ao abrigo da luz solar. Armazenar em \nlocal bem ventilado.  \nRO A se proteja de lumina solară. A se depozita \nîntr-un spaţiu bine ventilat.  \nSK Chráňte pred slnečným žiarením. Uchovávajte \nna dobre vetranom mieste.  \nSL Zaščititi pred sončno svetlobo. Hraniti na dobro \nprezračevanem mestu.  \nFI Suojaa auringonvalolta. Varastoi paikassa, jossa \non hyvä ilmanvaihto.  \nSV Skyddas från solljus. Förvaras på väl ventilerad \nplats.  \nP410 + P412  Language  \nBG Да се пази от пряка слънчева светлина. Да \nне се излага на температури, по-високи от 50  \no C/122  o F. \nES Proteger de la luz del sol. No exponer a \ntemperaturas superiores a 50  o C/122  o F. \nCS Chraňte před slunečním zářením. Nevystavujte \nteplotě přesahující 50  o C/122  o F. ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 472}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 474  \nP410 + P412  Language  \nDA Beskyttes mod sollys. Må ikke udsættes for en \ntemperatur, som overstiger 50  o C/122  o F. \nDE ►C3 Vor Sonnenbestrahlung schützen und \nnicht Temperaturen über 50  o C/122  o F \naussetzen. ◄  \nET Hoida päikesevalguse eest. Mitte hoida \ntemperatuuril üle 50  o C/122  o F. \nEL Να προστατεύεται από τις ηλιακές ακτίνες. Να \nμην εκτίθεται σε θερμοκρασίες που \nυπερβαίνουν τους 50  o C/122  o F. \nEN Protect from sunlight. Do no expose to \ntemperatures exceeding 50  o C/122  o F. \nFR Protéger du rayonnement solaire. Ne pas \nexposer à une température supérieure à 50  o C/ \n122  o F. \nGA Cosain ó sholas na gréine. Ná nocht do theocht \nníos airde ná 50  o C/122  o F. \n▼M5 \nHR Zaštititi od sunčevog svjetla. Ne izlagati \ntemperaturi višoj od 50  o C/122  o F. \n▼B \nIT Proteggere dai raggi solari. Non esporre a \ntemperature superiori a 50  o C/122  o F. \nLV Aizsargāt no saules gaismas. Nepakļaut \ntemperatūrai, kas pārsniedz 50  o C/122  o F. \nLT Saugoti nuo saulės šviesos. Nelaikyti \naukštesnėje kaip 50  o C/122  o F temperatūroje.  \nHU Napfénytől védendő. Nem érheti 50  o C/122  o F \nhőmérsékletet meghaladó hő.  \nMT Ipproteġi mid-dawl tax-xemx. Tesponix għal \ntemperatura li teċċedi l-50  o C/122  o F. \nNL Tegen zonlicht beschermen. Niet blootstellen \naan temperaturen boven 50  o C/122  o F. \nPL Chronić przed światłem słonecznym. Nie \nwystawiać na działanie temperatury przekrac\xad\nzającej 50  o C/122  o F. \nPT Manter ao abrigo da luz solar. Não expor a \ntemperaturas superiores a 50  o C/122  o F. \nRO A se proteja de lumina solară. Nu expuneţi la \ntemperaturi care depășesc 50  o C/122  o F. \nSK Chráňte pred slnečným žiarením. Nevystavujte \nteplotám nad 50  o C/122  o F. \nSL Zaščititi pred sončno svetlobo. Ne izpostavljati \ntemperaturam nad 50  o C/122  o F. \nFI Suojaa auringonvalolta. Ei saa altistaa yli 50  \no C/122  o F lämpötiloille.  \nSV Skyddas från solljus. Får inte utsättas för \ntemperaturer över 50  o C/122  o F. \n▼M12  __________  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 473}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 475  \nTable 1.5  \nPrecautionary statements — Disposal  \nP501  Language  \nBG Съдържанието/съдът да се изхвърли в …  \nES Eliminar el contenido/el recipiente en …  \nCS Odstraňte obsah/obal …  \nDA Indholdet/beholderen bortskaffes i …  \nDE Inhalt/Behälter … zuführen.  \nET Sisu/mahuti kõrvaldada …  \nEL Διάθεση του περιεχομένου/περιέκτη σε …  \nEN Dispose of contents/container to …  \nFR Éliminer le contenu/récipient dans …  \nGA Diúscair an t-ábhar/an coimeádán i …  \n▼M5 \nHR Odložiti sadržaj/spremnik u/na …  \n▼B \nIT Smaltire il prodotto/recipiente in …  \nLV Atbrīvoties no satura/tvertnes…  \nLT ►C4 Turinį/talpyklą šalinti … ◄  \nHU A tartalom/edény elhelyezése hulladékként: …  \nMT Armi l-kontenut/il-kontenitur fi …  \nNL Inhoud/verpakking afvoeren naar …  \nPL Zawartość/pojemnik usuwać do …  \nPT Eliminar o conteúdo/recipiente em …  \nRO Aruncaţi conţinutul/recipientul la …  \nSK Zneškodnite obsah/nádobu …  \nSL Odstraniti vsebino/posodo …  \nFI Hävitä sisältö/pakkaus …  \nSV Innehållet/behållaren lämnas till…  \n▼M12  \nP502  Language  \nBG Обърнете се към производителя или \nдоставчика за информация относно \nоползотворяването или рециклирането.  \nES Pedir información al fabricante o proveedor \nsobre la recuperación o el reciclado.  \nCS Informujte se u výrobce nebo dodavatele \no regeneraci nebo recyklaci.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 474}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 476  \nP502  Language  \nDA Indhent oplysninger om genindvinding/ \ngenanvendelse hos fabrikanten/leverandøren.  \nDE Informationen zur Wiederverwendung oder \nWiederverwertung beim Hersteller oder \nLieferanten erfragen.  \nET Hankida valmistajalt või tarnijalt teavet \nkemikaali taaskasutamise või ringlussevõtu \nkohta.  \nEL Ανατρέξτε στον παρασκευαστή ή τον \nπρομηθευτή για πληροφορίες όσον αφορά την \nανάκτηση ή την ανακύκλωση.  \nEN Refer to manufacturer or supplier for \ninformation on recovery or recycling.  \nFR Consulter le fabricant ou le fournisseur pour \ndes informations relatives à la récupération ou \nau recyclage.  \nGA Téigh i dteagmháil leis an monaróir nó leis an \nsoláthróir chun faisnéis a fháil faoi aisghabháil \nnó athchúrsáil.  \nHR Za informacije o oporabi ili recikliranju obratiti \nse proizvođaču ili dobavljaču.  \nIT Chiedere informazioni al produttore o fornitore \nper il recupero o il riciclaggio.  \nLV Informācija par rekuperāciju vai pārstrādi \nsaņemama pie ražotāja vai piegādātāja.  \nLT Kreiptis į gamintoją arba tiekėją dėl inform\xad\nacijos apie surinkimą arba recirkuliavimą.  \nHU A gyártó vagy a szállító határozza meg a \nhasznosításra vagy az újrafeldolgozásra \nvonatkozó információkat.  \nMT Irreferi għall-manifattur jew il-fornitur għal \ninformazzjoni dwar l-irkupru jew ir-riċiklaġġ.  \nNL Raadpleeg fabrikant of leverancier voor \ninformatie over terugwinning of recycling.  \nPL Przestrzegać wskazówek producenta lub \ndostawcy dotyczących odzysku lub wtórnego \nwykorzystania.  \nPT Solicitar ao fabricante ou fornecedor \ninformações relativas à recuperação ou reci\xad\nclagem.  \nRO Adresaţi-vă producătorului sau furnizorului \npentru informaţii privind recuperarea/reciclarea.  \nSK Obráťte sa na výrobcu alebo dodávateľa \ns požiadavkou o informácie týkajúce sa \nobnovenia alebo recyklácie.  \nSL Za podatke glede predelave ali reciklaže se \nobrnite na proizvajalca ali dobavitelja.  \nFI Hanki valmistajalta tai toimittajalta tietoja \nuudelleenkäytöstä tai kierrätyksestä.  \nSV Rådfråga tillverkare eller leverantör om åter\xad\nvinning eller återanvändning.  ▼M12', metadata={'source': 'data/ycla_en.pdf', 'page': 475}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 477  \nANNEX V  \nHAZARD PICTOGRAMS  \nINTRODUCTION  \n▼M2 \nThe hazard pictograms for each hazard class, differentiation of  a hazard class and \nhazard category shall satisfy the provisions of this Annex and Annex I, section \n1.2 and conform in terms of symbols and general format, to the specimens \nshown.  \n▼B \n1. PART 1: PHYSICAL HAZARDS  \n1.1. Symbol: exploding bomb  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS01\n  Section 2.1 \nUnstable explosives \nExplosives of Divisions 1.1, 1.2, 1.3, 1.4 \nSection 2.8 \nSelf reactive substances and mixtures, Types A, B \nSection 2.15 \nOrganic peroxides, Types A, B  \n1.2. Symbol: flame  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS02\n  Section 2.2  \n►M19  Flammable gases, hazard categories 1A, 1B. ◄ \nSection 2.3  \n►M4 Aerosols, hazard categories 1, 2 ◄ \nSection 2.6 \nFlammable liquids, hazard categories 1, 2, 3 \nSection 2.7 \nFlammable solids, hazard categories 1, 2 \nSection 2.8 \nSelf-reactive substances and mixtures, Types B, C, D, E, \nF \nSection 2.9 \nPyrophoric liquids, hazard category 1 \nSection 2.10 \nPyrophoric solids, hazard category 1 \nSection 2.11 \nSelf-heating substances and mixtures, hazard categories \n1, 2 \nSection 2.12 \nSubstances and mixtures, which in contact with water, \nemit flammable gases, hazard categories 1, 2, 3 \nSection 2.15 \nOrganic peroxides, Types B, C, D, E, F  \n►M19  Section 2.17 \nDesensitised explosives, hazard categories 1, 2, 3, 4 ◄  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 476}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 478  \n1.3. Symbol: flame over circle  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS03\n  Section 2.4 \nOxidising gases, hazard category 1 \nSection 2.13 \nOxidising liquids, hazard categories 1, 2, 3 \nSection 2.14 \nOxidising solids, hazard categories 1, 2, 3  \n1.4. Symbol: gas cylinder  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS04\n  Section 2.5 \nGases under pressure: \nCompressed gases; \nLiquefied gases; \nRefrigerated liquefied gases; \nDissolved gases  \n1.5. Symbol: corrosion  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS05\n  Section 2.16 \nCorrosive to metals, hazard category 1  \n1.6. A pictogram is not required for the following physical hazard classes \nand hazard categories:  \nSection 2.1: Explosives of Division 1.5  \nSection 2.1: Explosives of Division 1.6  \nSection 2.2: Flammable gases, hazard Category 2  \n▼M4 \nSection 2.3: Aerosols, hazard Category 3  \n▼B \nSection 2.8: Self-reactive substances and mixtures, Type G  \nSection 2.15: Organic peroxides, Type G  \n2. PART 2: HEALTH HAZARDS  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 477}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 479  \n2.1. Symbol: skull and crossbones  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS06\n  Section 3.1 \nAcute toxicity (oral, dermal, inhalation), hazard \ncategories 1, 2, 3  \n▼M12  \n2.2. Symbol: corrosion  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS05\n  Section 3.2 \nSkin corrosion, hazard category 1 and sub-categories 1A, \n1B, 1C  \nSection 3.3 \nSerious eye damage, hazard category 1  \n▼B \n2.3. Symbol: exclamation mark  \nPictogram \n(1) Hazard class and hazard category \n(2) \n►M2 GHS07\n  \n◄ Section 3.1 \nAcute toxicity (oral, dermal, inhalation), hazard \ncategory 4 \nSection 3.2 \nSkin irritation, hazard category 2 \nSection 3.3 \nEye irritation, hazard category 2 \nSection 3.4  \n►M2 Skin sensitisation, hazard categories 1, 1A, 1B ◄ \nSection 3.8 \nSpecific Target Organ Toxicity — Single exposure, \nhazard category 3 \nRespiratory tract irritation \nNarcotic effects  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 478}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 480  \n2.4. Symbol: health hazard  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS08\n  Section 3.4  \n►M2 Respiratory sensitisation, hazard categories 1, 1A, \n1B ◄ \nSection 3.5 \nGerm cell mutagenicity, hazard categories 1A, 1B, 2 \nSection 3.6 \nCarcinogenicity, hazard categories 1A, 1B, 2 \nSection 3.7 \nReproductive toxicity, hazard categories 1A, 1B, 2 \nSection 3.8 \nSpecific Target Organ Toxicity — Single exposure, \nhazard categories 1, 2 \nSection 3.9 \nSpecific Target Organ Toxicity — Repeated exposure, \nhazard categories 1, 2 \nSection 3.10 \nAspiration hazard, hazard category 1  \n2.5. A pictogram is not required for the following health hazard categories:  \nSection 3.7: Reproductive toxicity, Effects on or via lactation , additional \nhazard category  \n3. PART 3: ENVIRONMENTAL HAZARDS  \n▼M4 \n3.1. Symbol: environment  \nPictogram \n(1) Hazard class and hazard category \n(2) \nGHS09\n  Section 4.1 \nHazardous to the aquatic environment \n— Acute hazard category: Acute 1 \n— Long-term hazard categories: Chronic 1, Chronic 2  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 479}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 481  \nA pictogram is not required for the following environmental haz ard classes \nand hazard categories:  \nSection 4.1: Hazardous to the aquatic environment — Long-term h azard \ncategories: Chronic 3, Chronic 4.  \n▼M2 \n4. PART 4: ADDITIONAL HAZARDS  \n4.1. Symbol: exclamation mark  \nPictogram  Hazard class and hazard category  \n(1) (2)  \nGHS07\n  Section 5.1 \nHazardous to the ozone layer, hazard category 1  ▼M4', metadata={'source': 'data/ycla_en.pdf', 'page': 480}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 482  \nANNEX VI  \nHarmonised classification and labelling for certain hazardous substances  \n▼M15  \nPart 1 of this Annex provides an introduction to the list of ha rmonised classifi\xad\ncation and labelling, including information listed for each ent ry and related \nclassifications and hazard statements in Table 3.  \nPart 2 of this Annex lays down general principles for preparing  dossiers to \npropose and justify harmonised classification and labelling of substances at \nUnion level.  \nPart 3 of this Annex lists hazardous substances for which harmo nised classifi\xad\ncation and labelling have been established at Union level. In T able 3 the clas\xad\nsification and labelling are based on the criteria in Annex I t o this Regulation.  \n▼B \n1. PART 1: INTRODUCTION TO THE LIST OF HARMONISED \nCLASSIFICATIONS AND LABELLING  \n1.1. Information listed for each entry  \n1.1.1.  Numbering of entries and identification of a substance  \n1.1.1.1.  Index numbers  \nEntries in Part 3 are listed according to the atomic number of the \nelement most characteristic of the properties of the substance.  \nOrganic substances, because of their variety, have been placed in \nclasses. The Index number for each substance is in the form of a \ndigit sequence of the type ABC-RST-VW-Y. ABC corresponds to \nthe atomic number of the most characteristic element or the mos t \ncharacteristic organic group in the molecule. RST is the consec utive \nnumber of the substance in the series ABC. VW denotes the form in \nwhich the substance is produced or placed on the market. Y is t he \ncheck-digit calculated in accordance with the 10-digit ISBN met hod. \nThis number is indicated in the column entitled ‘Index No’.  \n1.1.1.2.  EC numbers  \nThe EC number, i.e. EINECS, ELINCS or NLP, is the official \nnumber of the substance within the European Union. The \nEINECS number can be obtained from the European Inventory of \nExisting Commercial Chemical Substance (EINECS) (  1 ). The \nELINCS number can be obtained from the European List of \nNotified Substances (as amended) (EUR 22543 EN, Office for \nOfficial Publications of the European Communities, 2006, ISSN \n1018-5593). The NLP number can be obtained from the list of \n‘No-longer-polymers’ (as amended) (Document, Office for Officia l \nPublications of the European Communities, 1997, ISBN 92-827- \n8995-0). The EC number is a seven-digit system of the type \nXXX-XXX-X which starts at 200-001-8 (EINECS), at 400-010-9 \n(ELINCS) and at 500-001-0 (NLP). This number is indicated in th e \ncolumn entitled ‘EC No’.  \n1.1.1.3.  CAS number  \nThe Chemical Abstracts Service (CAS) number is also included to  \nassist identification of the entry. It should be noted that the  EINECS \nnumber includes both anhydrous and hydrated forms of a substanc e, \nand there are frequently different CAS numbers for anhydrous an d \nhydrated forms. The CAS number included is for the anhydrous \nform only, and therefore the CAS number shown does not always \ndescribe the entry as accurately as the EINECS number. This \nnumber is indicated in the column entitled ‘CAS No’.  ▼B \n( 1 ) OJ C 146A, 15.6.1990.', metadata={'source': 'data/ycla_en.pdf', 'page': 481}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 483  \n1.1.1.4.  ►M18  Chemical name ◄ \nWherever possible, hazardous substances are designated by their  \nIUPAC names. Substances listed in EINECS, ELINCS or the list \nof ‘No-longer-polymers’ are designated using the names in these  \nlists. Other names, such as usual or common names, are included  \nin some cases. Whenever possible, plant protection products and  \nbiocides are designated by their ISO names.  \nImpurities, additives and minor components are normally not \nmentioned unless they contribute significantly to the classific ation \nof the substance.  \nSome substances are described with a specific percentage of pur ity. \nSubstances containing a higher content of active material (e.g.  \norganic peroxide) than this percentage are not included in the \nentry in Part 3 and may have other hazardous properties (e.g. \nexplosive) and should be classified and labelled accordingly.  \nWhere specific concentration limits are shown, these apply to t he \nsubstance or substances shown in the entry. In particular, in t he case \nof entries which are mixtures of substances or substances descr ibed \nwith a specific percentage of purity, the limits apply to the \nsubstance as described in Part 3 and not the pure substance.  \nWithout prejudice to Article 17(2), for substances appearing in  Part \n3, the name of the substance to be used on the label shall be o ne of \nthe designations given there. For certain substances, additiona l \ninformation has been added in square brackets in order to help \nidentify the substance. This additional information need not be  \nincluded on the label.  \nCertain entries contain a reference to impurities; in these cas es the \nname of the substance is followed by the text: ‘(containing ≥ x x % \nimpurity)’. The reference in brackets is then to be considered as a \npart of the name, and must be included on the label.  \n1.1.1.5.  Entries for groups of substances  \nA number of group entries are included in Part 3. In these case s, the \nclassification and labelling requirements will apply to all sub stances \ncovered by the description.  \nIn some cases, there are classification and labelling requireme nts for \nspecific substances that would be covered by the group entry. I n \nsuch cases a specific entry is included in Part 3 for the subst ance \nand the group entry will be annotated with the phrase ‘except t hose \nspecified elsewhere in this Annex’.  \nIn some cases, individual substances may be covered by more tha n \none group entry. In these cases, the classification of the subs tance \nreflects the classification for each of the two group entries. In cases \nwhere different classifications for the same hazard are given, the \nmost severe classification shall be applied.  \nEntries in Part 3 for salts (under any denomination) cover both  \nanhydrous and hydrous forms, unless specified otherwise.  \nEC or CAS numbers are not usually included for entries which \ncomprise more than four individual substances.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 482}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 484  \n1.1.2.  Information related to the classification and labelling of each \nentry in Table 3  \n▼B \n1.1.2.1.  Classification codes  \n1.1.2.1.1. H a z a r d c l a s s a n d c a t e g o r y c o d e s \nThe classification for each entry is based on the criteria set out in \nAnnex I, in accordance with Article 13(a) and is presented in t he \nform of a code representing the hazard class and the category o r \ncategories/divisions/types within this hazard class.  \nThe Hazard class and category codes used for each of the hazard  \ncategories/divisions/types included in a class are shown in Tab le \n1.1. \nTable 1.1  \nHazard Class  Hazard Class and Category Code  \nExplosive  Unst. Expl. \nExpl. 1.1 \nExpl. 1.2 \nExpl. 1.3 \nExpl. 1.4 \nExpl. 1.5 \nExpl. 1.6  \n▼M19  \nFlammable gases  Flam. Gas 1A \nFlam. Gas 1B \nFlam. Gas 2 \nPyr. Gas \nChem. Unst. Gas A \nChem. Unst. Gas B  \n▼M4 \nAerosol  Aerosol 1 \nAerosol 2 \nAerosol 3  \n▼B \nOxidising gas  Ox. Gas 1  \nGases under pressure  Press. Gas (  1 ) \nFlammable liquid  Flam. Liq. 1 \nFlam. Liq. 2 \nFlam. Liq. 3  \nFlammable solid  Flam. Sol. 1 \nFlam. Sol. 2  \nSelf-reactive substance or \nmixture  Self-react. A \nSelf-react. B \nSelf-react. CD \nSelf-react. EF \nSelf-react. G  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 483}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 485  \nHazard Class  Hazard Class and Category Code  \nPyrophoric liquid  Pyr. Liq. 1  \nPyrophoric solid  Pyr. Sol. 1  \nSelf-heating substance or \nmixture  Self-heat. 1 \nSelf-heat. 2  \nSubstance or mixture which in \ncontact with water emits \nflammable gas  Water-react. 1 \nWater-react. 2 \nWater-react. 3  \nOxidising liquid  Ox. Liq. 1 \nOx. Liq. 2 \nOx. Liq. 3  \nOxidising solid  Ox. Sol. 1 \nOx. Sol. 2 \nOx. Sol. 3  \nOrganic peroxide  Org. Perox. A \nOrg. Perox. B \nOrg. Perox. CD \nOrg. Perox. EF \nOrg. Perox. G  \nSubstance or mixture corrosive \nto metals  Met. Corr. 1  \n▼M19  \nDesensitised explosives  Desen. Expl. 1 \nDesen. Expl. 2 \nDesen. Expl. 3 \nDesen. Expl. 4  \n▼B \nAcute toxicity  Acute Tox. 1 \nAcute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 4  \n▼M12  \nSkin corrosion/irritation  Skin Corr. 1 \nSkin Corr. 1A \nSkin Corr. 1B \nSkin Corr. 1C \nSkin Irrit. 2  \n▼B \nSerious eye damage/eye irri\xad\ntation  Eye Dam. 1 \nEye Irrit. 2  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 484}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 486  \nHazard Class  Hazard Class and Category Code  \nRespiratory/skin sensitization  ►M2 Resp. Sens. 1, 1A, 1B ◄  \n►M2 Skin. Sens. 1, 1A, 1B ◄  \nGerm cell mutagenicity  Muta. 1A \nMuta. 1B \nMuta. 2  \nCarcinogenicity  Carc. 1A \nCarc. 1B \nCarc. 2  \nReproductive toxicity  Repr. 1A \nRepr. 1B \nRepr. 2 \nLact.  \nSpecific target organ toxicity — \nsingle exposure  STOT SE 1 \nSTOT SE 2 \nSTOT SE 3  \nSpecific target organ toxicity — \nrepeated exposure  STOT RE 1 \nSTOT RE 2  \nAspiration hazard  Asp. Tox. 1  \nHazardous to the aquatic \nenvironment  Aquatic Acute 1 \nAquatic Chronic 1 \nAquatic Chronic 2 \nAquatic Chronic 3 \nAquatic Chronic 4  \nHazardous for the ozone layer  ►M2 Ozone 1 ◄  \n( 1 ) see Note U in 1.1.3.  \n1.1.2.1.2. H a z a r d s t a t e m e n t c o d e s  \n▼M4 \nThe hazard statements assigned in accordance with Article 13(b)  are \nindicated in accordance with Annex III. In addition, for certai n \nhazard statements, letters are added to the 3-digit hazard stat ement \ncode for further differentiations. The following additional cod es are \nused:  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 485}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 487  \nH350i  May cause cancer by inhalation.  \nH360F  May damage fertility.  \nH360D  May damage the unborn child.  \nH361f  Suspected of damaging fertility.  \nH361d  Suspected of damaging the \nunborn child.  \nH360FD  May damage fertility. May \ndamage the unborn child.  \nH361fd  Suspected of damaging fertility. \nSuspected of damaging the \nunborn child.  \nH360Fd  May damage fertility. Suspected \nof damaging the unborn child.  \nH360Df  May damage the unborn child. \nSuspected of damaging fertility.  \n1.1.2.2.  Labelling codes  \nIn the labelling column, the following elements are listed:  \n(i) the hazard pictogram codes as specified in Annex V, in \naccordance with the precedence rules in Article 26;  \n(ii) the signal word code ‘Dgr’ for ‘Danger’or ‘Wng’ for \n‘Warning’, in accordance with the precedence rule in \nArticle 20(3);  \n(iii) the hazard statement codes as specified in Annex III, in \naccordance with the classification;  \n(iv) the codes for the supplemental statements assigned in \naccordance with Article 25(1) and the rules specified in \nAnnex II, part 1.  \n▼M15  \n1.1.2.3.  Specific concentration limits, M-factors and Acute Toxicity \nEstimates (ATE)  \nSpecific concentration limits (SCL), where different from the \ngeneric concentration limits given in Annex I for a certain \ncategory, are given in a separate column together with the clas sifi\xad\ncation concerned using the same codes as under 1.1.2.1.1. Also \nharmonised ATEs are listed in the same column of table 3. The \nSCLs and harmonised ATEs must be used by the manufacturer, \nimporter or downstream user for the classification of a mixture  \ncontaining this substance. When applying an ATE, the additivity  \nformula as described in 3.1.3.6 of Annex I shall be used. Where  \nno specific concentration limits are given in this Annex for a certain \ncategory, the generic concentration limits given in Annex I mus t be \napplied for the classification of substances containing impurit ies, \nadditives or individual constituents or for mixtures. If harmon ised \nATE values are missing for acute toxicity the correct value has  to \nbe established by using the available data.  \nUnless otherwise shown, the concentration limits are a percenta ge \nby weight of the substance calculated with reference to the tot al \nweight of the mixture.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 486}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 488  \nIn case an M-factor has been harmonised for substances classifi ed \nas hazardous to the aquatic environment in the categories Aquat ic \nAcute 1 or Aquatic Chronic 1, that M-factor is given in Table 3  in \nthe same column as the specific concentration limits. In case a n M- \nfactor for Aquatic Acute 1 and an M-factor for Aquatic Chronic 1 \nhave been harmonised, each M-factor shall be listed in the same  line \nas its corresponding differentiation. Where a single M-factor i s \ngiven in Table 3 and the substance is classified as Aquatic Acu te \n1 and Aquatic Chronic 1, that M-factor shall be used by the man u\xad\nfacturer, importer or downstream user for the classification of  a  \nmixture containing this substance for acute and long-term aquat ic \nhazards using the summation method. Where no M-factor is given \nin Table 3, M-factor(s) based on available data for the substan ce \nshall be set by the manufacturer, importer or downstream user. For \nthe setting and use of M-factors, see Section 4.1.3.5.5.5 of An nex I.  \n▼B \n1.1.3.  Notes assigned to an entry  \nThe note(s) assigned to an entry are listed in the column entit led \n‘Notes’. The meaning of the notes is as follows:  \n1.1.3.1.  Notes relating to the identification, classification and labelling of \nsubstances  \nN o t e A :  \nWithout prejudice to Article 17(2), the name of the substance m ust \nappear on the label in the form of one of the designations give n in \nPart 3.  \nIn Part 3, use is sometimes made of a general description such as \n‘... compounds’ or ‘... salts’. In this case, the supplier is r equired to \nstate on the label the correct name, due account being taken of  \nsection 1.1.1.4.  \nN o t e B :  \nSome substances (acids, bases, etc.) are placed on the market i n \naqueous solutions at various concentrations and, therefore, the se \nsolutions require different classification and labelling since the \nhazards vary at different concentrations.  \nIn Part 3 entries with Note B have a general designation of the  \nfollowing type: ‘nitric acid … %’.  \nIn this case the supplier must state the percentage concentrati on of \nthe solution on the label. Unless otherwise stated, it is assum ed that \nthe percentage concentration is calculated on a weight/weight b asis. \nN o t e C :  \nSome organic substances may be marketed either in a specific \nisomeric form or as a mixture of several isomers.  \nIn this case the supplier must state on the label whether the \nsubstance is a specific isomer or a mixture of isomers.  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 487}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 489  \nN o t e D :  \nCertain substances which are susceptible to spontaneous polymer i\xad\nsation or decomposition are generally placed on the market in a  \nstabilised form. It is in this form that they are listed in Par t 3. \nHowever, such substances are sometimes placed on the market in a \nnon-stabilised form. In this case, the supplier must state on t he label \nthe name of the substance followed by the words ‘non-stabilised ’. \n▼M15  __________  \n▼B \nN o t e F :  \nThis substance may contain a stabiliser. If the stabiliser chan ges the \nhazardous properties of the substance, as indicated by the clas sifi\xad\ncation in Part 3, classification and labelling should be provid ed in \naccordance with the rules for classification and labelling of \nhazardous mixtures.  \nN o t e G :  \nThis substance may be marketed in an explosive form in which ca se \nit must be evaluated using the appropriate test methods. The cl as\xad\nsification and labelling provided shall reflect the explosive p rop\xad\nerties.  \n▼M2 __________  \n▼M27  \nN o t e J :  \nThe harmonised classification as a carcinogen or mutagen applie s \nunless it can be shown that the substance contains less than 0, 1 % \nw/w benzene (Einecs No 200-753-7), in which case a classificati on \nin accordance with Title II of this Regulation shall be perform ed \nalso for those hazard classes.  \nN o t e K :  \nThe harmonised classification as a carcinogen or mutagen applie s \nunless it can be shown that the substance contains less than 0, 1 % \nw/w 1,3- butadiene (Einecs No 203-450-8), in which case a clas\xad\nsification in accordance with Title II of this Regulation shall  be \nperformed also for those hazard classes. Where the substance is  \nnot classified as a carcinogen or mutagen, at least the precaut ionary \nstatements (P102-)P210-P403 shall apply.  \nN o t e L :  \nThe harmonised classification as a carcinogen applies unless it  can \nbe shown that the substance contains less than 3 % of dimethyl \nsulphoxide extract as measured by IP 346 (‘Determination of pol y\xad\ncyclic aromatics in unused lubricating base oils and asphaltene  free \npetroleum fractions – Dimethyl sulphoxide extraction refractive  \nindex method’ Institute of Petroleum, London), in which case a \nclassification in accordance with Title II of this Regulation s hall \nbe performed also for that hazard class.  \nN o t e M :  \nThe harmonised classification as a carcinogen applies unless it  can \nbe shown that the substance contains less than 0,005 % w/w \nbenzo[a]-pyrene (Einecs No 200-028-5), in which case a classifi \xad\ncation in accordance with Title II of this Regulation shall be \nperformed also for that hazard class.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 488}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 490  \nN o t e N :  \nThe harmonised classification as a carcinogen applies unless th e full \nrefining history is known and it can be shown that the substanc e \nfrom which it is produced is not a carcinogen, in which case a \nclassification in accordance with Title II of this Regulation s hall \nbe performed also for that hazard class.  \nN o t e P :  \nThe harmonised classification as a carcinogen or mutagen applie s \nunless it can be shown that the substance contains less than 0, 1 % \nw/w benzene (Einecs No 200-753-7), in which case a classificati on \nin accordance with Title II of this Regulation shall be perform ed \nalso for those hazard classes.  \nWhere the substance is not classified as a carcinogen or mutage n, at \nleast the precautionary statements (P102-)P260-P262-P301 + P310 - \nP331 shall apply.  \nN o t e Q :  \nThe harmonised classification as a carcinogen applies unless on e of \nthe following conditions is fulfilled:  \n— a short term biopersistence test by inhalation has shown that  \nfibres longer than 20 μm have a weighted half-life less than \n10 days; or  \n— a short term biopersistence test by intratracheal instillatio n has \nshown that the fibres longer than 20 μm have a weighted half- \nlife less than 40  \ndays; or  \n— an appropriate intra-peritoneal test has provided no evidence  of \nexcess carcinogenicity; or  \n— no relevant pathogenicity or neoplastic changes are noted in a \nsuitable long term inhalation test  \nN o t e R :  \nThe harmonised classification as a carcinogen applies except in  the \ncase of fibres with a Length Weighted Geometric Mean Diameter \n(LWGMD) minus two geometric standard errors greater than 6 μm, \nas measured in accordance with Test method A.22 in the Annex to  \nCommission Regulation (EC) No 440/2008 (  1 ). \n▼M15  \nN o t e S :  \nThis substance may not require a label according to Article 17 (see \nSection 1.3 of Annex I) (Table 3).  \n▼B \nN o t e T :  \nThis substance may be marketed in a form which does not have th e \nphysical hazards as indicated by the classification in the entr y in \nPart 3. If the results of the relevant method or methods in \naccordance with Part 2 of Annex I of this Regulation show that \nthe specific form of substance marketed does not exhibit this \nphysical property or these physical hazards, the substance shal l be \nclassified in accordance with the result or results of this tes t or these \ntests. Relevant information, including reference to the relevan t test \nmethod(s) shall be included in the safety data sheet.  ▼M27  \n( 1 ) Commission Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods \npursuant to Regulation (EC) No 1907/2006 of the European Parlia ment and of the \nCouncil on the Registration, Evaluation, Authorisation and Rest riction of Chemicals \n(REACH) (OJ L 142, 31.5.2008, p. 1).', metadata={'source': 'data/ycla_en.pdf', 'page': 489}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 491  \nN o t e U ( T a b l e 3 ) :  \n▼M12  \nWhen put on the market gases have to be classified as ‘Gases un der \npressure’, in one of the groups compressed gas, liquefied gas, refrig\xad\nerated liquefied gas or dissolved gas. The group depends on the  \nphysical state in which the gas is packaged and therefore has t o be \nassigned case by case. The following codes are assigned:  \nPress. Gas (Comp.)  \nPress. Gas (Liq.)  \nPress. Gas (Ref. Liq.)  \nPress. Gas (Diss.)  \nAerosols shall not be classified as gases under pressure (See A nnex \nI, Part 2, Section 2.3.2.1, Note 2).  \n▼M22  \nN o t e V :  \nIf the substance is to be placed on the market as fibres (with \ndiameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1) or \nparticles of the substance fulfilling the WHO fibre criteria or  as \nparticles with modified surface chemistry, their hazardous prop erties \nmust be evaluated in accordance with Title II of this Regulatio n, to \nassess whether a higher category (Carc. 1B or 1A) and/or additi onal \nroutes of exposure (oral or dermal) should be applied.  \nN o t e W :  \nIt has been observed that the carcinogenic hazard of this subst ance \narises when respirable dust is inhaled in quantities leading to  \nsignificant impairment of particle clearance mechanisms in the lung.  \nThis note aims to describe the particular toxicity of the subst ance; it \ndoes not constitute a criterion for classification according to  this \nRegulation.  \n▼B \n1.1.3.2.  Notes relating to the classification and labelling of mixtures  \n▼M15  \nN o t e 1 :  \nThe concentration stated or, in the absence of such concentrati ons, \nthe generic concentrations set out in this Regulation are the \npercentages by weight of the metallic element calculated with \nreference to the total weight of the mixture.  \n▼B \nN o t e 2 :  \nThe concentration of isocyanate stated is the percentage by wei ght \nof the free monomer calculated with reference to the total weig ht of \nthe mixture.  \nN o t e 3 :  \nThe concentration stated is the percentage by weight of chromat e \nions dissolved in water calculated with reference to the total weight \nof the mixture.  \nN o t e 5 :  \nThe concentration limits for gaseous mixtures are expressed as \nvolume per volume percentage.  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 490}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 492  \nN o t e 7 :  \nAlloys containing nickel are classified for skin sensitisation when \nthe release rate of 0,5 μg Ni/cm  2 /week, as measured by the \nEuropean Standard reference test method EN 1811, is exceeded.  \n▼M27  \nN o t e 8 :  \nThe classification as a carcinogen shall apply unless it can be  shown \nthat the maximum theoretical concentration of releasable formal \xad\ndehyde, irrespective of the source, in the mixture as placed on  the \nmarket is less than 0,1 %.  \nN o t e 9 :  \nThe classification as a mutagen shall apply unless it can be sh own \nthat the maximum theoretical concentration of releasable formal \xad\ndehyde, irrespective of the source, in the mixture as placed on  the \nmarket is less than 1 %.  \n▼M22  \nN o t e 1 0 :  \nThe classification as a carcinogen by inhalation applies only t o \nmixtures in powder form containing 1 % or more of titanium \ndioxide which is in the form of or incorporated in particles wi th \naerodynamic diameter ≤ 10 μm.  \n▼M15  __________  \n1.2. Classifications and hazard statements in Table 3 arising from \ntranslation of classifications listed in Annex I to directive \n67/548/EEC  \n1.2.1.  Minimum classification  \nFor certain hazard classes, including acute toxicity and STOT \nrepeated exposure, the classification according to the criteria  in \nDirective 67/548/EEC does not correspond directly to the classi fi\xad\ncation in a hazard class and category under this Regulation. In  these \ncases the classification in this Annex shall be considered as a  \nminimum classification. This classification shall be applied if  \nnone of the following conditions are fulfilled:  \n— the manufacturer or importer has access to data or other \ninformation, as specified in Part 1 of Annex I, that lead to \nclassification in a more severe category compared to the \nminimum classification. Classification in the more severe \ncategory must then be applied,  \n— the minimum classification can be further refined based on th e \ntranslation table in Annex VII when the physical state of the \nsubstance used in the acute inhalation toxicity test is known t o \nthe manufacturer or importer. The classification as obtained \nfrom Annex VII shall then substitute the minimum classification  \nindicated in this Annex if it differs from it.  \nMinimum classification for a category is indicated by the refer ence \n* in the column ‘Classification’ in Table 3.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 491}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 493  \nThe reference * can also be found in the column ‘Specific Conc.  \nLimits and M-factors and Acute Toxicity Estimates (ATE)’ where it \nindicates that the entry concerned had specific concentration l imits \nunder Directive 67/548/EEC for acute toxicity. These concentrat ion \nlimits cannot be ‘translated’ into concentration limits under t his \nRegulation, especially when a minimum classification is given. \nHowever, when the reference * is shown, the classification for \nacute toxicity for this entry may be of special concern.  \n1.2.2.  Route of exposure cannot be excluded  \nFor certain hazard classes, e.g. STOT, the route of exposure sh ould \nbe indicated in the hazard statement only if it is conclusively  proven \nthat no other route of exposure can cause the hazard in accorda nce \nto the criteria in Annex I. Under Directive 67/548/EEC the rout e of \nexposure was indicated for classifications with R48 when there was \ndata justifying the classification for this route of exposure. The \nclassification under 67/548/EEC indicating the route of exposur e \nhas been translated into the corresponding class and category \naccording to this Regulation, but with a general hazard stateme nt \nnot specifying the route of exposure as the necessary informati on is \nnot available.  \nThese hazard statements are indicated by the reference ** in \nTable 3.  \n1.2.3.  Hazard statements for reproductive toxicity  \nHazard statements H360 and H361 indicate a general concern for \neffects on fertility and/or development: ‘May damage/Suspected of \ndamaging fertility or the unborn child’. According to the crite ria, the \ngeneral hazard statement can be replaced by the hazard statemen t \nindicating the specific effect of concern in accordance with Se ction \n1.1.2.1.2. When the other differentiation is not mentioned, thi s is \ndue to evidence proving no such effect, inconclusive data or no  data \nand the obligations in Article 4(3) shall apply for that differ enti\xad\nation.  \nIn order not to lose information from the harmonised classifica tions \nfor fertility and developmental effects under Directive 67/548/ EEC, \nthe classifications have been translated only for those effects  clas\xad\nsified under that Directive.  \nThese hazard statements are indicated by the reference *** in \nTable 3.  \n1.2.4.  Correct classification for physical hazards could not be established  \nFor some entries the correct classification for physical hazard s could \nnot be established because sufficient data are not available fo r the \napplication of the classification criteria in this Regulation. The entry \nmight be assigned to a different (also higher) category or even  \nanother hazard class than indicated. The correct classification  shall \nbe confirmed by testing.  \nThe entries with physical hazards that need to be confirmed by \ntesting are indicated by the reference **** in Table 3.  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 492}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 494  \n2. PART 2: DOSSIERS FOR HARMONISED CLASSIFICATION \nAND LABELLING  \nThis Part lays down general principles for preparing dossiers t o \npropose and justify harmonised classification and labelling.  \nThe relevant parts of sections 1, 2 and 3 of Annex I to Regulat ion \n(EC) No 1907/2006 shall be used for the methodology and format \nof any dossier.  \nFor all dossiers any relevant information from registration dos siers \nshall be considered and other available information may be used . \nFor hazard information which has not been previously submitted to \nthe Agency, a robust study summary shall be included in the \ndossier.  \nA dossier for harmonised classification and labelling shall con tain \nthe following:  \n— Proposal  \nThe proposal shall include the identity of the substance or \nsubstances concerned and the harmonised classification and \nlabelling proposed.  \n— Justification for the proposed harmonised classification and \nlabelling  \nA comparison of the available information with the criteria \ncontained in Parts 2 to 5, taking into account the general prin \xad\nciples in Part 1, of Annex I to this Regulation shall be \ncompleted and documented in the format set out in Part B of \nthe Chemical Safety Report in Annex I to Regulation (EC) No \n1907/2006.  \n— Justification for other effects at Community level  \nFor other effects than carcinogenity, mutagenicity, reprotoxici ty \nand respiratory sensitisation a justification shall be provided  that \nthere is a need for action demonstrated at Community level. \nThis does not apply for an active substance in the meaning of \nDirective 91/414/EEC or Directive 98/8/EC.  \n▼M15  \n3. PART 3: HARMONISED CLASSIFICATION AND LABELLING \nTABLE  \n__________  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 493}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 495\n Table 3  \nList of harmonised classification and labelling of hazardous substances  ▼B \nIndex No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n001-001-00-9  hydrogen  215-605-7  1333-74-0  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  \n001-002-00-4  aluminium lithium hydride  240-877-9  16853-85-3  Water-react. 1 \nSkin Corr. 1A  H260 \nH314  GHS02 \nGHS05 \nDgr H260 \nH314  \n001-003-00-X  sodium hydride  231-587-3  7646-69-7  Water-react. 1  H260  GHS02 \nDgr H260  \n001-004-00-5  calcium hydride  232-189-2  7789-78-8  Water-react. 1  H260  GHS02 \nDgr H260  \n003-001-00-4  lithium  231-102-5  7439-93-2  Water-react. 1 \nSkin Corr. 1B  H260 \nH314  GHS02 \nGHS05 \nDgr H260 \nH314  EUH014  \n003-002-00-X  n-hexyllithium  404-950-0  21369-64-2  Water-react. 1 \nPyr. Sol. 1 \nSkin Corr. 1A  H260 \nH250 \nH314  GHS02 \nGHS05 \nDgr H260 \nH250 \nH314  EUH014  \n003-003-00-5  (2-methylpropyl)lithium; isobu\xad\ntyllithium  440-620-2  920-36-5  Water-react. 1 \nPyr. Liq. 1 \nSkin Corr. 1A \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H260 \nH250 \nH314 \nH336 \nH400 \nH410  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H260 \nH250 \nH314 \nH336 \nH410  EUH014  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 494}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 496\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n004-001-00-7  beryllium  231-150-7  7440-41-7  Carc. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H350i \nH330 \nH301 \nH372 ** \nH319 \nH335 \nH315 \nH317  GHS06 \nGHS08 \nDgr H350i \nH330 \nH301 \nH372 ** \nH319 \nH335 \nH315 \nH317  \n004-002-00-2  beryllium compounds with the \nexception of aluminium \nberyllium silicates, and with \nthose specified elsewhere in this \nAnnex  — —  Carc. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H350i \nH330 \nH301 \nH372 ** \nH319 \nH335 \nH315 \nH317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350i \nH330 \nH301 \nH372 ** \nH319 \nH335 \nH315 \nH317 \nH411  A \n004-003-00-8  beryllium oxide  215-133-1  1304-56-9  Carc. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H350i \nH330 \nH301 \nH372 ** \nH319 \nH335 \nH315 \nH317  GHS06 \nGHS08 \nDgr H350i \nH330 \nH301 \nH372 ** \nH319 \nH335 \nH315 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 495}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 497\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n005-001-00-X  boron trifluoride  231-569-5  7637-07-2  Press. Gas \nAcute Tox. 2 * \nSkin Corr. 1A  H330 \nH314  GHS04 \nGHS06 \nGHS05 \nDgr H330 \nH314  EUH014  U  \n005-002-00-5  boron trichloride  233-658-4  10294-34-5  Press. Gas \nAcute Tox. 2 * \nAcute Tox. 2 * \nSkin Corr. 1B  H330 \nH300 \nH314  GHS04 \nGHS06 \nGHS05 \nDgr H330 \nH300 \nH314  EUH014  U  \n005-003-00-0  boron tribromide  233-657-9  10294-33-4  Acute Tox. 2 * \nAcute Tox. 2 * \nSkin Corr. 1A  H330 \nH300 \nH314  GHS06 \nGHS05 \nDgr H330 \nH300 \nH314  EUH014  \n005-004-00-6  trialkylboranes, solid  —  —  Pyr. Sol. 1 \nSkin Corr. 1B  H250 \nH314  GHS02 \nGHS05 \nDgr H250 \nH314  A \n005-004-01-3  trialkylboranes, liquid  —  —  Pyr. Liq. 1 \nSkin Corr. 1B  H250 \nH314  GHS02 \nGHS05 \nDgr H250 \nH314  A \n005-005-00-1  trimethyl borate  204-468-9  121-43-7  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH312  GHS02 \nGHS07 \nWng  H226 \nH312  \n005-006-00-7  dibutyltin hydrogen borate  401-040-5  75113-37-0  Repr. 1B \nMuta. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360FD \nH341 \nH372** \nH312 \nH302 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H360FD \nH341 \nH372** \nH312 \nH302 \nH318 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 496}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 498\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n005-007-00-2  boric acid; [1] \nboric acid; [2]  233-139-2 [1] \n234-343-4 [2]  10043-35-3 [1] \n11113-50-1 [2]  Repr. 1B  H360FD  GHS08 \nDgr H360FD  Repr.1B; \nH360FD: C ≥ \n5,5 %  \n005-008-00-8  diboron trioxide; \nboric oxide  215-125-8  1303-86-2  Repr. 1B  H360FD  GHS08 \nDgr H360FD  Repr.1B; \nH360FD:C ≥ 3,1 %  \n005-009-00-3  tetrabutylammonium butyltriphe\xad\nnylborate  418-080-4  120307-06-4  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n005-010-00-9  N, N -dimethylanilinium tetra\xad\nkis(pentafluorophenyl)borate  422-050-6  118612-00-3  Carc. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1  H351 \nH302 \nH315 \nH318  GHS08 \nGHS05 \nGHS07 \nDgr H351 \nH302 \nH315 \nH318  \n005-011-00-4  disodium tetraborate, anhydrous; \nboric acid, disodium salt; [1] \ntetraboron disodium heptaoxide, \nhydrate; [2] \northoboric acid, sodium salt [3]  215-540-4 [1] \n235-541-3 [2] \n237-560-2 [3]  1330-43-4 [1] \n12267-73-1 [2] \n13840-56-7 [3]  Repr. 1B  H360FD  GHS08 \nDgr H360FD  Repr. 1B; H360FD: \nC ≥4,5 %  \n005-011-01-1  disodium tetraborate decahydrate; \nborax decahydrate  215-540-4  1303-96-4  Repr. 1B  H360FD  GHS08 \nDgr H360FD  Repr.1B; H360FD: \nC ≥ 8,5 %  \n005-011-02-9  disodium tetraborate pentahy\xad\ndrate; \nborax pentahydrate  215-540-4  12179-04-3  Repr. 1B  H360FD  GHS08 \nDgr H360FD  Repr.B; H360FD: \nC ≥ 6,5 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 497}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 499\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n005-012-00-X  diethyl{4-[1,5,5-tris(4-diethylam\xad\ninophenyl)penta-2,4-dienyli\xad\ndene]cyclohexa-2,5-dienyli\xad\ndene}ammonium butyltriphe\xad\nnylborate  418-070-1  141714-54-7  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n005-013-00-5  diethylmethoxyborane  425-380-9  7397-46-8  Pyr. Liq. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 4  H250 \nH332 \nH312 \nH302 \nH373** \nH314 \nH317 \nH413  GHS02 \nGHS05 \nGHS08 \nGHS07 \nDgr H250 \nH332 \nH312 \nH302 \nH373** \nH314 \nH317 \nH413  \n005-014-00-0  4-formylphenylboronic acid  438-670-5  87199-17-5  Skin Sens. 1  H317  GHS07 \nWng  H317  \n005-015-00-6  1-chloromethyl-4-fluoro-1,4- \ndiazoniabicyclo[2.2.2]octane \nbis(tetrafluoroborate)  414-380-4  140681-55-6  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317 \nH412  \n005-016-00-1  tetrabutylammonium butyl tris- \n(4-tert-butylphenyl)borate  431-370-5  —  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 498}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 500\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n005-017-00-7  sodium perborate; [1] \nsodium peroxometaborate; [2] \nsodium peroxoborate; \n[containing < 0,1 % (w/w) of \nparticles with an aerodynamic \ndiameter of below 50 μm]  239-172-9 [1] \n231-556-4 [2]  15120-21-5 [1] \n7632-04-4 [2]  Ox. Sol. 2 \nRepr. 1B \nAcute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1  H272 \nH360Df \nH302 \nH335 \nH318  GHS03 \nGHS05 \nGHS08 \nGHS07 \nDgr H272 \nH360Df \nH302 \nH335 \nH318  Repr.1B; H360Df: \nC ≥9 % Repr.1B; \nH360 D: 6,5 % ≤ C \n<9 % Eye Dam. 1; \nH318: C ≥ 22 % \nEye Irrit. 2; H319: \n14 % ≤ C < 22 %  \n005-017-01-4  sodium perborate; [1] \nsodium peroxometaborate; [2] \nsodium peroxoborate; \n[containing ≥ 0,1 % (w/w) of \nparticles with an aerodynamic \ndiameter of below 50 μm]  239-172-9 [1] \n231-556-4 [2]  15120-21-5 [1] \n7632-04-4 [2]  Ox. Sol. 2 \nRepr. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1  H272 \nH360Df \nH331 \nH302 \nH335 \nH318  GHS03 \nGHS06 \nGHS05 \nGHS08 \nDgr H272 \nH360Df \nH331 \nH302 \nH335 \nH318  Repr. 1B; H360Df: \nC ≥9 % Repr. 1B; \nH360D: 6,5 % ≤ C \n< 9 % Eye Dam. 1; \nH318: C ≥ 22 % \nEye Irrit. 2; H319: \n14 % ≤ C < 22 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 499}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 501\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n005-018-00-2  perboric acid (H3BO2(O2)), \nmonosodium salt trihydrate; [1] \nperboric acid, sodium salt, \ntetrahydrate; [2] \nperboric acid (HBO(O2)), \nsodium salt, tetrahydrate; [3] \nsodium peroxoborate hexahy\xad\ndrate; [containing < 0,1 % (w/ \nw) of particles with an \naerodynamic diameter of below \n50 μm]  239-172-9 [1] \n234-390-0 [2] \n231-556-4 [3]  13517-20-9 [1] \n37244-98-7 [2] \n10486-00-7 [3]  Repr. 1B \nSTOT SE 3 \nEye Dam. 1  H360Df \nH335 \nH318  GHS05 \nGHS08 \nGHS07 \nDgr H360Df \nH335 \nH318  Repr. 1B; \nH360Df: C ≥ 14 % \nRepr. 1B; \nH360D: 10 % ≤ C \n< 14 % Eye Dam. \n1; H318: C ≥ 36 % \nEye Irrit. 2; \nH319: 22 % ≤ C < \n36 %  \n005-018-01-X  perboric acid (H3BO2(O2)), \nmonosodium salt, trihydrate; [1] \nperboric acid, sodium salt, \ntetrahydrate; [2] \nperboric acid (HBO(O2)), \nsodium salt, tetrahydrate; [3] \nsodium peroxoborate hexahy\xad\ndrate; [containing ≥ 0,1 % (w/w) \nof particles with an aerodynamic \ndiameter of below 50 μm]  239-172-9 [1] \n234-390-0 [2] \n231-556-4 [3]  13517-20-9 [1] \n37244-98-7 [2] \n10486-00-7 [3]  Repr. 1B \nAcute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1  H360Df \nH332 \nH335 \nH318  GHS05 \nGHS08 \nGHS07 \nDgr H360Df \nH332 \nH335 \nH318  Repr. 1B; H360 \nDf: C ≥ 14 % \nRepr. 1B; H360D: \n10 % ≤ C < 14 % \nEye Dam. 1; H318: \nC ≥ 36 % Eye Irrit. \n2; H319: 22 % ≤ C \n< 36 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 500}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 502\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n005-019-00-8  perboric acid, sodium salt; [1] \nperboric acid, sodium salt, \nmonohydrate; [2] \nperboric acid (HBO(O2)), \nsodium salt, monohydrate; [3] \nsodium peroxoborate; \n[containing < 0,1 % (w/w) of \nparticles with an aerodynamic \ndiameter of below 50 μm]  234-390-0 [1] \n234-390-0 [2] \n231-556-4 [3]  11138-47-9 [1] \n12040-72-1 [2] \n10332-33-9 [3]  Ox. Sol. 3 \nRepr. 1B \nAcute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1  H272 \nH360Df \nH302 \nH335 \nH318  GHS03 \nGHS05 \nGHS08 \nGHS07 \nDgr H272 \nH360Df \nH302 \nH335 \nH318  Repr. 1B; H360Df: \nC ≥ 9 % \nRepr. 1B; H360D: \n6,5 % ≤ C < 9 % \nEye Dam. 1; H318: \nC ≥ 22 % \nEye Irrit. 2; H319: \n14 % ≤ C < 22 %  \n005-019-01-5  perboric acid, sodium salt; [1] \nperboric acid, sodium salt, \nmonohydrate; [2] \nperboric acid (HBO(O2)), \nsodium salt, monohydrate;[3] \nsodium peroxoborate; \n[containing ≥ 0,1 % (w/w) of \nparticles with an aerodynamic \ndiameter of below 50 μm]  234-390-0 [1] \n234-390-0 [2] \n231-556-4 [3]  11138-47-9 [1] \n12040-72-1 [2] \n10332-33-9 [3]  Ox. Sol. 3 \nRepr. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1  H272 \nH360Df \nH331 \nH302 \nH335 \nH318  GHS03 \nGHS06 \nGHS05 \nGHS08 \nDgr H272 \nH360Df \nH331 \nH302 \nH335 \nH318  Repr. 1B; H360Df: \nC ≥ 9 % \nRepr. 1B; H360D: \n6,5 % \n≤ C < 9 % \nEye Dam. 1; H318: \nC ≥ 22 % \nEye Irrit. 2; H319: \n14 % ≤ C < 22 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 501}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 503\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n005-020-00-3  disodium octaborate anhydrous; \n[1] \ndisodium octaborate tetrahydrate \n[2] 234-541-0 [1] \n234-541-0 [2]  12008-41-2 [1] \n12280-03-4 [2]  Repr. 1B  H360FD  GHS08 \nDgr H360FD  \n▼M16  \n006-001-00-2  carbon monoxide  211-128-3  630-08-0  Flam. Gas 1 \nPress. Gas \nRepr. 1A \nAcute Tox. 3 * \nSTOT RE 1  H220 \nH360D *** \nH331 \nH372 **  GHS02 \nGHS04 \nGHS06 \nGHS08 \nDgr H220 \nH360D *** \nH331 \nH372 **  U \n006-002-00-8  phosgene; carbonyl chloride  200-870-3  75-44-5  Press. Gas \nAcute Tox. 2 * \nSkin Corr. 1B  H330 \nH314  GHS04 \nGHS06 \nGHS05 \nDgr H330 \nH314  U \n006-003-00-3  carbon disulphide  200-843-6  75-15-0  Flam. Liq. 2 \nRepr. 2 \nSTOT RE 1 \nEye Irrit. 2 \nSkin Irrit. 2  H225 \nH361fd \nH372 ** \nH319 \nH315  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH361fd \nH372 ** \nH319 \nH315  Repr. 2; H361fd: C \n≥ 1 % \nSTOT RE 1; H372: \nC ≥ 1 % \nSTOT RE 2; H373: \n0,2 % \n≤ C < 1 %  \n006-004-00-9  calcium carbide  200-848-3  75-20-7  Water-react. 1  H260  GHS02 \nDgr H260  T  \n006-005-00-4  thiram (ISO); \ntetramethylthiuram disulphide  205-286-2  137-26-8  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH373 ** \nH319 \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H332 \nH302 \nH373 ** \nH319 \nH315 \nH317 \nH410  M = 10  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 502}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 504\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-006-00-X  hydrogen cyanide; \nhydrocyanic acid  200-821-6  74-90-8  Flam. Liq. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H224 \nH330 \nH400 \nH410  GHS02 \nGHS06 \nGHS09 \nDgr H224 \nH330 \nH410  \n006-006-01-7  hydrogen cyanide … %; \nhydrocyanic acid … %  200-821-6  74-90-8  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  B \n006-007-00-5  salts of hydrogen cyanide with \nthe exception of complex \ncyanides such as ferrocyanides, \nferricyanides and mercuric \noxycyanide and those specified \nelsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  EUH032  A  \n006-008-00-0  antu (ISO); \n1-(1-naphthyl)-2-thiourea  201-706-3  86-88-4  Acute Tox. 2 * \nCarc. 2  H300 \nH351  GHS06 \nGHS08 \nDgr H300 \nH351  \n006-009-00-6  1-isopropyl-3-methylpyrazol-5-yl \ndimethylcarbamate; \nisolan  204-318-2  119-38-0  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n006-010-00-1  5,5-dimethyl-3-oxocyclohex-1- \nenyl dimethylcarbamate 5,5- \ndimethyldihydroresorcinol \ndimethylcarbamate; dimetan  204-525-8  122-15-6  Acute Tox. 3 *  H301  GHS06 \nDgr H301  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 503}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 505\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-011-00-7  carbaryl (ISO); \n1-naphthyl methylcarbamate  200-555-0  63-25-2  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1  H351 \nH332 \nH302 \nH400  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH332 \nH302 \nH400  M=100  \n006-012-00-2  ziram (ISO); \nzinc bis dimethyldithiocarbamate  205-288-3  137-30-4  Acute Tox. 2 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSTOT SE 3 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH302 \nH373 ** \nH335 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H330 \nH302 \nH373 ** \nH335 \nH318 \nH317 \nH410  M = 100  \n006-013-00-8  metam-sodium (ISO); \nsodium methyldithiocarbamate  205-293-0  137-42-8  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH317 \nH410  EUH031  \n006-014-00-3  nabam (ISO); \ndisodium ethylenebis( N, N' - \ndithiocarbamate)  205-547-0  142-59-6  Acute Tox. 4 * \nSTOT SE 3 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH335 \nH317 \nH410  GHS07 \nGHS09 \nWng  H302 \nH335 \nH317 \nH410  \n006-015-00-9  diuron (ISO); \n3-(3,4-dichlorophenyl)-1,1- \ndimethylurea  206-354-4  330-54-1  Carc. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH373** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH373** \nH410  M = 10  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 504}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 506\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-016-00-4  propoxur (ISO); \n2-isopropyloxyphenyl  N-methyl\xad\ncarbamate; \n2-isopropoxyphenyl methylcar\xad\nbamate  204-043-8  114-26-1  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  \n006-017-00-X  aldicarb (ISO); \n2-methyl-2-(methylthio)propanal-  \nO-(N-methylcarbamoyl)oxime  204-123-2  116-06-3  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH311 \nH410  \n006-018-00-5  aminocarb (ISO); \n4-dimethylamino-3-tolyl methyl\xad\ncarbamate  217-990-7  2032-59-9  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  \n006-019-00-0  di-allate (ISO);  \nS-(2,3-dichloroallyl)- N,N- \ndiisopropylthiocarbamate  218-961-1  2303-16-4  Carc. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH410  \n006-020-00-6  barban (ISO); \n4-chlorbut-2-ynyl  N -(3-chloro\xad\nphenyl)carbamate  202-930-4  101-27-9  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n006-021-00-1  linuron (ISO); \n3-(3,4-dichlorophenyl)-1- \nmethoxy-1-methylurea  206-356-5  330-55-2  Repr. 1B Carc. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH351 \nH302 \nH373 ** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360Df \nH351 \nH302 \nH373 ** \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 505}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 507\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-022-00-7  decarbofuran (ISO); \n2,3-dihydro-2-methylbenzofuran- \n7-yl methylcarbamate  — 1563-67-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  \n006-023-00-2  mercaptodimethur (ISO); \nmethiocarb (ISO); \n3,5-dimethyl-4-methylthiophenyl  \nN-methylcarbamate  217-991-2  2032-65-7  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  \n006-024-00-8  proxan-sodium (ISO); \nsodium  O -isopropyldithiocar\xad\nbonate  205-443-5  140-93-2  Acute Tox. 4 * \nSkin Irrit. 2 \nAquatic Chronic 2  H302 \nH315 \nH411  GHS07 \nGHS09 \nWng  H302 \nH315 \nH411  \n006-025-00-3  allethrin; \n(RS)-3-allyl-2-methyl-4- \noxocyclopent-2-enyl \n(1RS,3RS;1RS,3SR)-2,2-dimethyl- \n3-(2-methylprop-1-enyl)cyclopro\xad\npanecarboxylate; bioallethrin; \n(RS)-3-allyl-2-methyl-4- \noxocyclopent-2-enyl (1 R,3R)-2,2- \ndimethyl-3-(2-methylprop-1- \nenyl)cyclopropanecarboxylate; \n[1] \nS-bioallethrin; [3] \n(S)-3-allyl-2-methyl-4- \noxocyclopent-2-enyl (1 R,3R)-2,2- \ndimethyl-3-(2-methylprop-1- \nenyl)cyclopropanecarboxylate; \n[2] \nesbiothrin;  209-542-4 [1] \n249-013-5 [2]- \n[3] 584-79-2 [1] \n28434-00-6 [2] \n84030-86-4 [3]  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH302 \nH410  C ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 506}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 508\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n(RS)-3-allyl-2-methyl-4- \noxocyclopent-2-enyl(1 R,3R)-2,2- \ndimethyl-3-(2-methylprop-1- \nenyl)cyclopropanecarboxylate [3]  \n006-026-00-9  carbofuran (ISO); \n2,3-dihydro-2,2-dimethylbenzo\xad\nfuran-7-yl  N-methylcarbamate  216-353-0  1563-66-2  Acute Tox. 2 * \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH410  \n006-028-00-X  dinobuton (ISO); \n2-(1-methylpropyl)-4,6-dinitro\xad\nphenyl isopropyl carbonate  213-546-1  973-21-7  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  \n006-029-00-5  dioxacarb (ISO); \n2-(1,3-dioxolan-2-yl)phenyl  N - \nmethylcarbamate  230-253-4  6988-21-2  Acute Tox. 3 * \nAquatic Chronic 2  H301 \nH411  GHS06 \nGHS09 \nDgr H301 \nH411  \n006-030-00-0  EPTC (ISO);  \nS-ethyl dipropylthiocarbamate  212-073-8  759-94-4  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n006-031-00-6  formetanate (ISO); \n3-[(EZ)-dimethylaminomethyl\xad\neneamino]phenyl methylcar\xad\nbamate  244-879-0  22259-30-9  Acute Tox. 2 * \nAcute Tox. 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH317 \nH410  \n006-032-00-1  monolinuron (ISO); \n3-(4-chlorophenyl)-1-methoxy-1- \nmethylurea  217-129-5  1746-81-2  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH410  \n006-033-00-7  metoxuron (ISO); \n3-(3-chloro-4-methoxyphenyl)- \n1,1-dimethylurea  243-433-2  19937-59-8  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 507}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 509\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-034-00-2  pebulate (ISO);  \nN-butyl- N-ethyl- S-propylthioc\xad\narbamate  214-215-4  1114-71-2  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n▼M13  \n006-035-00-8  pirimicarb (ISO); 2-(dimethyl\xad\namino)-5,6-dimethylpyrimidin-4- \nyl dimethylcarbamate  245-430-1  23103-98-2  Carc. 2 \nAcute Tox. 3 \nAcute Tox. 3 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH331 \nH301 \nH317 \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H351 \nH331 \nH301 \nH317 \nH410  M = 10 \nM = 100  \n▼M16  \n006-036-00-3  benzthiazuron (ISO); \n1-benzothiazol-2-yl-3-methylurea  217-685-9  1929-88-0  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n006-037-00-9  promecarb (ISO); \n3-isopropyl-5-methylphenyl  N - \nmethylcarbamate  220-113-0  2631-37-0  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  \n006-038-00-4  sulfallate (ISO); \n2-chloroallyl  N, N -dimethyl\xad\ndithiocarbamate  202-388-9  95-06-7  Carc. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH410  \n006-039-00-X  tri-allate (ISO);  \nS-2,3,3-trichloroallyl diisopro\xad\npylthiocarbamate  218-962-7  2303-17-5  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH317 \nH410  \n006-040-00-5  3-methylpyrazol-5-yl-dimethyl\xad\ncarbamate; monometilan  — 2532-43-6  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 508}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 510\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-041-00-0  dimethylcarbamoyl chloride  201-208-6  79-44-7  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H350 \nH331 \nH302 \nH319 \nH335 \nH315  GHS06 \nGHS08 \nDgr H350 \nH331 \nH302 \nH319 \nH335 \nH315  Carc. 1B; \nH350: C ≥ 0,001 %  \n006-042-00-6  monuron (ISO); \n3-(4-chlorophenyl)-1,1- \ndimethylurea  205-766-1  150-68-5  Carc. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH410  \n006-043-00-1  3-(4-chlorophenyl)-1,1-dimethyl\xad\nuronium trichloroacetate; \nmonuron-TCA  — 140-41-0  Carc. 2 \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH319 \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH319 \nH315 \nH410  \n▼M18  \n006-044-00-7  isoproturon (ISO); \n3-(4-isopropylphenyl)-1,1- \ndimethylurea  251-835-4  34123-59-6  Carc. 2 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH373 (blood) \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH373 (blood) \nH410  M = 10 \nM = 10  \n▼M16  \n006-045-00-2  methomyl (ISO); \n1-(methylthio)ethylideneamino  \nN-methylcarbamate  240-815-0  16752-77-5  Acute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH410  M=100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 509}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 511\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M15  \n006-046-00-8  bendiocarb (ISO); \n2,2-dimethyl-1,3-benzodioxol-4- \nyl N-methylcarbamate; \n2,2-dimethyl-1,3-benzodioxol-4- \nyl methylcarbamate  245-216-8  22781-23-3  Acute Tox. 3 \nAcute Tox. 3 \nAcute Tox. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH300 \nH410  M = 10 \nM = 100  \n▼M16  \n006-047-00-3  bufencarb (ISO); \nreaction mass of 3-(1-methyl\xad\nbutyl)phenyl  N-methylcarbamate \nand 3-(1-ethylpropyl)phenyl  N- \nmethylcarbamate  — 8065-36-9  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  \n006-048-00-9  ethiofencarb (ISO); \n2-(ethylthiomethyl)phenyl  N - \nmethylcarbamate  249-981-9  29973-13-5  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n006-049-00-4  dixanthogen;  \nO, O -diethyl dithiobis(thio\xad\nformate)  207-944-4  502-55-6  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n006-050-00-X  1,1-dimethyl-3-phenyluronium \ntrichloroacetate; \nfenuron-TCA  — 4482-55-7  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n006-051-00-5  ferbam (ISO); \niron tris(dimethyldithiocarba\xad\nmate)  238-484-2  14484-64-1  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH335 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH410  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 510}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 512\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-052-00-0  formetanate hydrochloride; \n3-(N, N -dimethylaminomethyl\xad\neneamino)phenyl  N -methylcar\xad\nbamate  245-656-0  23422-53-9  Acute Tox. 2 * \nAcute Tox. 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH317 \nH410  \n006-053-00-6  isoprocarb (ISO); \n2-isopropylphenyl  N-methylcar\xad\nbamate  220-114-6  2631-40-5  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n006-054-00-1  mexacarbate (ISO); \n3,5-dimethyl-4-dimethylamin\xad\nophenyl  N-methylcarbamate  206-249-3  315-18-4  Acute Tox. 2 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH312 \nH410  \n006-055-00-7  xylylcarb (ISO); \n3,4-dimethylphenyl  N-methylcar\xad\nbamate; \n3,4-xylyl methylcarbamate; \nMPMC  219-364-9  2425-10-7  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n006-056-00-2  metolcarb (ISO);  \nm-tolyl methylcarbamate; \nMTMC  214-446-0  1129-41-5  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n006-057-00-8  nitrapyrin (ISO); \n2-chloro-6-trichloromethyl\xad\npyridine  217-682-2  1929-82-4  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 511}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 513\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-058-00-3  noruron (ISO); \n1,1-dimethyl-3-(perhydro-4,7- \nmethanoinden-5-yl)urea  — 2163-79-3  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n006-059-00-9  oxamyl (ISO);  \nN',N' -dimethylcarbamoyl(methyl\xad\nthio)methylenamine  N-methylcar\xad\nbamate;  245-445-3  23135-22-0  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 4 * \nAquatic Chronic 2  H330 \nH300 \nH312 \nH411  GHS06 \nGHS09 \nDgr H330 \nH300 \nH312 \nH411  \n006-060-00-4  oxycarboxin (ISO); \n2,3-dihydro-6-methyl-5-( N- \nphenylcarbamoyl)-1,4-oxothiine \n4,4-dioxide  226-066-2  5259-88-1  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n006-061-00-X  S-ethyl  N -(dimethylaminopro\xad\npyl)thiocarbamatehydrochloride; \nprothiocarb hydrochloride  243-193-9  19622-19-6  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n006-062-00-5  methyl 3,4-dichlorophenylcarb\xad\nanilate; \nSWEP.  — 1918-18-9  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n006-063-00-0  thiobencarb (ISO);  \nS-4-chlorobenzyl diethylthioc\xad\narbamate  248-924-5  28249-77-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n006-064-00-6  thiofanox (ISO); \n3,3-dimethyl-1-(methylthio)but\xad\nanone- O-(N-methylcarba\xad\nmoyl)oxime  254-346-4  39196-18-4  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 512}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 514\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-065-00-1  3-chloro-6-cyano- \nbicyclo(2,2,1)heptan-2-one- O-(N- \nmethylcarbamoyl)oxime; \ntriamid  — 15271-41-7  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Chronic 2  H300 \nH311 \nH411  GHS06 \nGHS09 \nDgr H300 \nH311 \nH411  \n006-066-00-7  vernolate (ISO);  \nS-propyl dipropylthiocarbamate  217-681-7  1929-77-7  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n006-067-00-2  XMC; \n3,5-xylyl methylcarbamate  — 2655-14-3  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n006-068-00-8  diazomethane  206-382-7  334-88-3  Carc. 1B  H350  GHS08 \nDgr H350  \n006-069-00-3  thiophanate-methyl (ISO); \n1,2-di-(3-methoxycarbonyl-2- \nthioureido)benzene  245-740-7  23564-05-8  Muta. 2 \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH332 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH332 \nH317 \nH410  \n006-070-00-9  furmecyclox (ISO);  \nN-cyclohexyl- N-methoxy-2,5- \ndimethyl-3-furamide  262-302-0  60568-05-0  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n006-071-00-4  cyclooct-4-en-1-yl methyl \ncarbonate  401-620-8  87731-18-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n006-072-00-X  prosulfocarb (ISO);  \nS-benzyl  N, N -dipropylthioc\xad\narbamate  401-730-6  52888-80-9  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 513}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 515\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-073-00-5  3-(dimethylamino)propylurea  401-950-2  31506-43-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n006-074-00-0  2-(3-(prop-1-en-2-yl)phe\xad\nnyl)prop-2-yl isocyanate  402-440-2  2094-99-7  Acute Tox. 2 * \nSkin Corr. 1B \nSTOT RE 2 * \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH314 \nH373 ** \nH334 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H330 \nH314 \nH373 ** \nH334 \nH317 \nH410  \n006-076-00-1  mancozeb (ISO); \nmanganese \nethylenebis(dithiocarbamate) \n(polymeric) complex with zinc \nsalt — 8018-01-7  Repr. 2 \nSkin Sens. 1 \nAquatic Acute 1  H361d*** \nH317 \nH400  GHS08 \nGHS07 \nGHS09 \nWng  H361d*** \nH317 \nH400  M=10  \n006-077-00-7  maneb (ISO); \nmanganese \nethylenebis(dithiocarbamate) \n(polymeric)  235-654-8  12427-38-2  Repr. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d*** \nH332 \nH319 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d*** \nH332 \nH319 \nH317 \nH410  M=10  \n006-078-00-2  zineb (ISO); \nzinc ethylenebis(dithiocarbamate) \n(polymeric)  235-180-1  12122-67-7  STOT SE 3 \nSkin Sens. 1  H335 \nH317  GHS07 \nWng  H335 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 514}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 516\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-079-00-8  disulfiram; \ntetraethylthiuramdisulfide  202-607-8  97-77-8  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH317 \nH410  \n006-080-00-3  tetramethylthiuram monosulphide  202-605-7  97-74-5  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n006-081-00-9  zinc bis(dibutyldithiocarbamate)  205-232-8  136-23-2  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH335 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH317 \nH410  \n006-082-00-4  zinc bis(diethyldithiocarbamate)  238-270-9  14324-55-1  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH335 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH335 \nH315 \nH317 \nH410  \n006-083-00-X  butocarboxim (ISO); \n3-(methylthio)-2-butanone  O - \n[(methylamino)carbonyl]oxime  252-139-3  34681-10-2  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH331 \nH311 \nH301 \nH319 \nH400 \nH410  GHS02 \nGHS06 \nGHS09 \nDgr H226 \nH331 \nH311 \nH301 \nH319 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 515}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 517\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-084-00-5  carbosulfan (ISO); \n2,3-dihydro-2,2-dimethyl-7- \nbenzofuryl [(dibuty\xad\nlamino)thio]methylcarbamate  259-565-9  55285-14-8  Acute Tox. 2 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH301 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH301 \nH317 \nH410  \n006-085-00-0  fenobucarb (ISO); \n2-butylphenyl methylcarbamate  223-188-8  3766-81-2  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n006-086-00-6  fenoxycarb (ISO); \nethyl [2-(4-phenoxyphen\xad\noxy)ethyl]carbamate  276-696-7  72490-01-8  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  M = 1 \nM = 10 000  \n006-087-00-1  furathiocarb (ISO); \n2,3-dihydro-2,2-dimethyl-7- \nbenzofuryl 2,4-dimethyl-6-oxa-5- \noxo-3-thia-2,4-diazadecanoate  265-974-3  65907-30-4  Acute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH301 \nH373** \nH319 \nH315 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH301 \nH373** \nH319 \nH315 \nH317 \nH410  M = 100  \n006-088-00-7  benfuracarb (ISO); \nethyl  N -[2,3-dihydro-2,2- \ndimethylbenzofuran-7-yloxycar\xad\nbonyl(methyl)aminothio]- N- \nisopropyl-β-alaninate  — 82560-54-1  Repr. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H361f*** \nH331 \nH302 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361f*** \nH331 \nH302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 516}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 518\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M1 __________  \n▼M16  \n006-090-00-8  2-(3-iodoprop-2-yn-1-yloxy)ethyl \nphenylcarbamate  408-010-0  88558-41-2  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H332 \nH318 \nH412  GHS05 \nGHS07 \nDgr H332 \nH318 \nH412  \n006-091-00-3  propineb (ISO); \npolymeric zinc propylenebis(di\xad\nthiocarbamate)  — 9016-72-2  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1  H332 \nH373** \nH317 \nH400  GHS08 \nGHS07 \nGHS09 \nWng  H332 \nH373** \nH317 \nH400  \n006-092-00-9  tert -butyl (1 S)-N-[1-((2S)-2- \noxiranyl)-2-phenylethyl]car\xad\nbamate  425-420-5  98737-29-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n006-093-00-4  2,2'-dithio di(ethylammonium)- \nbis(dibenzyldithiocarbamate)  427-180-7  —  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n006-094-00-X  O-isobutyl- N-ethoxy carbonyl\xad\nthiocarbamate  434-350-4  103122-66-3  Flam. Liq. 3 \nCarc. 1B \nMuta. 1B \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H226 \nH350 \nH340 \nH302 \nH373** \nH317 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H226 \nH350 \nH340 \nH302 \nH373** \nH317 \nH411  \n006-095-00-5  fosetyl-aluminium (ISO); \naluminium triethyl triphos\xad\nphonate  254-320-2  39148-24-8  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 517}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 519\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-096-00-0  chlorpropham (ISO); \nisopropyl 3-chlorocarbanilate  202-925-7  101-21-3  Carc. 2 \nSTOT RE 2 * \nAquatic Chronic 2  H351 \nH373** \nH411  GHS08 \nGHS09 \nWng  H351 \nH373** \nH411  \n006-097-00-6  1-phenyl-3-(p-toluenesulfo\xad\nnyl)urea  424-620-1  13909-63-2  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 3  H302 \nH373** \nH412  GHS08 \nGHS07 \nWng  H302 \nH373** \nH412  \n006-098-00-1  tert -butyl (1 R,5S)-3-azabi\xad\ncyclo[3.1.0]hex-6-ylcarbamate  429-170-8  134575-17-0  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH373** \nH318 \nH317  GHS05 \nGHS08 \nGHS07 \nDgr H302 \nH373** \nH318 \nH317  \n006-099-00-7  N-(p-toluenesulfonyl)- N'-(3-(p- \ntoluenesulfonyloxy)phenyl)urea; \n3-][(4-methylphenyl)sulfonyl]car\xad\nbamoyl}amino)phenyl4-methyl\xad\nbenzenesulfonate  520-2  232938-43-1  Aquatic Chronic 2  H411  GHS09  H411  \n006-101-00-6  reaction mass of:  N, N'' -(methyl\xad\nenedi-4,1-phenylene)bis[ N'- \nphenylurea];  \nN-(4-[[4-[[(phenylamino)car\xad\nbonyl]amino]phenylme\xad\nthyl]phenyl]- N'-cyclohexylurea;  \nN, N'' -(methylenedi-4,1-pheny\xad\nlene)bis[ N'-cyclohexylurea]  423-070-8  —  Aquatic Chronic 4  H413  —  H413  \n006-102-00-1  O-hexyl- N-ethoxycarbonylthioc\xad\narbamate  432-750-3  —  Carc. 1B \nMuta. 1B \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H350 \nH340 \nH302 \nH373** \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH340 \nH302 \nH373** \nH317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 518}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 520\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n006-103-00-7  N, N'' -(methylenedi-4,1-pheny\xad\nlene)bis[ N'-octyl]urea  445-760-8  —  Eye Dam. 1 \nResp. Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH334 \nH400 \nH410  GHS05 \nGHS08 \nGHS09 \nDgr H318 \nH334 \nH410  M=100  \n007-001-00-5  ammonia, anhydrous  231-635-3  7664-41-7  Flam. Gas 2 \nPress. Gas \nAcute Tox. 3 * \nSkin Corr. 1B \nAquatic Acute 1  H221 \nH331 \nH314 \nH400  GHS04 \nGHS06 \nGHS05 \nGHS09 \nDgr H221 \nH331 \nH314 \nH400  U \n007-001-01-2  ammonia ….%  215-647-6  1336-21-6  Skin Corr. 1B \nAquatic Acute 1  H314 \nH400  GHS05 \nGHS09 \nDgr H314 \nH400  STOT SE 3; H335: \nC ≥ 5 %  B \n007-002-00-0  nitrogen dioxide; [1] \ndinitrogen tetraoxide [2]  233-272-6 [1] \n234-126-4 [2]  10102-44-0 [1] \n10544-72-6 [2]  Press. Gas \nOx. Gas 1 \nAcute Tox. 2 * \nSkin Corr. 1B  H270 \nH330 \nH314  GHS04 \nGHS03 \nGHS06 \nGHS05 \nDgr H270 \nH330 \nH314  * \nSTOT SE 3; H335: \nC ≥0,5 %  5 \n007-003-00-6  chlormequat chloride (ISO); \n2-chloroethyltrimethylammonium \nchloride  213-666-4  999-81-5  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 519}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 521\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M23  \n007-004-00-1  nitric acid …% [C > 70 %]  231-714-2  7697-37-2  Ox. Liq. 2 \nAcute Tox. 1 \nSkin Corr. 1A  H272 \nH330 \nH314  GHS03 \nGHS06 \nGHS05 \nDgr H272 \nH330 \nH314  EUH071  Ox. Liq. 2; H272: \nC ≥ 99 % \nOx. Liq. 3; H272: \n70 % ≤ C < 99 %  B \n▼M16  \n007-006-00-2  ethyl nitrite  203-722-6  109-95-5  Flam. Gas 1 \nPress. Gas \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H220 \nH332 \nH312 \nH302  GHS02 \nGHS04 \nGHS07 \nDgr H220 \nH332 \nH312 \nH302  U \n007-007-00-8  ethyl nitrate  210-903-3  625-58-1  Unst. Expl.  H200  GHS01 \nDgr H200  \n007-008-00-3  hydrazine  206-114-9  302-01-2  Flam. Liq. 3 \nCarc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH350 \nH331 \nH311 \nH301 \nH314 \nH317 \nH400 \nH410  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H226 \nH350 \nH331 \nH311 \nH301 \nH314 \nH317 \nH410  Skin Corr. 1B; \nH314: C ≥ 10 % \nSkin Irrit. 2; H315: \n3 % ≤ C < 10 % \nEye Irrit. 2; H319: \n3 % ≤ C < 10 %  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 520}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 522\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n007-009-00-9  dicyclohexylammonium nitrite  221-515-9  3129-91-7  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH302  GHS07 \nWng  H332 \nH302  * \n007-010-00-4  sodium nitrite  231-555-9  7632-00-0  Ox. Sol. 3 \nAcute Tox. 3 * \nAquatic Acute 1  H272 \nH301 \nH400  GHS03 \nGHS06 \nGHS09 \nDgr H272 \nH301 \nH400  * \n007-011-00-X  potassium nitrite  231-832-4  7758-09-0  Ox. Sol. 2 \nAcute Tox. 3 * \nAquatic Acute 1  H272 \nH301 \nH400  GHS03 \nGHS06 \nGHS09 \nDgr H272 \nH301 \nH400  * \n007-012-00-5  N,N-dimethylhydrazine  200-316-0  57-14-7  Flam. Liq. 2 \nCarc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nAquatic Chronic 2  H225 \nH350 \nH331 \nH301 \nH314 \nH411  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H225 \nH350 \nH331 \nH301 \nH314 \nH411  \n007-013-00-0  1,2-dimethylhydrazine  —  540-73-8  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H350 \nH331 \nH311 \nH301 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH311 \nH301 \nH411  Carc. 1B; H350: C \n≥ 0,01 %  \n007-014-00-6  salts of hydrazine  —  —  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH331 \nH311 \nH301 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH311 \nH301 \nH317 \nH410  A ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 521}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 523\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n007-015-00-1  O-ethylhydroxylamine  402-030-3  624-86-2  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H225 \nH331 \nH311 \nH301 \nH372 ** \nH319 \nH317 \nH400  GHS02 \nGHS06 \nGHS08 \nGHS09 \nDgr H225 \nH331 \nH311 \nH301 \nH372 ** \nH319 \nH317 \nH400  \n007-016-00-7  butyl nitrite  208-862-1  544-16-1  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 *  H225 \nH331 \nH301  GHS02 \nGHS06 \nDgr H225 \nH331 \nH301  \n007-017-00-2  isobutyl nitrite  208-819-7  542-56-3  Flam. Liq. 2 \nCarc. 1B \nMuta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH350 \nH341 \nH332 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH350 \nH341 \nH332 \nH302  \n007-018-00-8  sec -butyl nitrite  213-104-8  924-43-6  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH332 \nH302  GHS02 \nGHS07 \nDgr H225 \nH332 \nH302  \n007-019-00-3  tert -butyl nitrite  208-757-0  540-80-7  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH332 \nH302  GHS02 \nGHS07 \nDgr H225 \nH332 \nH302  \n007-020-00-9  pentyl nitrite; [1] \n‘amyl nitrite’, mixed isomers [2]  207-332-7 [1] \n203-770-8 [2]  463-04-7 [1] \n110-46-3 [2]  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH332 \nH302  GHS02 \nGHS07 \nDgr H225 \nH332 \nH302  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 522}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 524\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n007-021-00-4  hydrazobenzene; \n1,2-diphenylhydrazine  204-563-5  122-66-7  Carc. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH410  \n007-022-00-X  hydrazine bis(3-carboxy-4- \nhydroxybenzensulfonate)  405-030-1  —  Carc. 1B \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H350 \nH302 \nH314 \nH317 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H350 \nH302 \nH314 \nH317 \nH412  \n007-023-00-5  sodium 3,5-bis(3-(2,4-di- tert- \npentylphenoxy)propylcarba\xad\nmoyl)benzenesulfonate  405-510-0  —  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n007-024-00-0  2-(decylthio)ethylammonium \nchloride  405-640-8  36362-09-1  STOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH315 \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H373 ** \nH315 \nH318 \nH410  \n007-025-00-6  (4-hydrazinophenyl)- N-methyl\xad\nmethanesulfonamide hydro\xad\nchloride  406-090-1  81880-96-8  Muta. 2 \nAcute Tox. 3 * \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH301 \nH372 ** \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H341 \nH301 \nH372 ** \nH317 \nH410  \n007-026-00-1  oxo-((2,2,6,6-tetramethyl\xad\npiperidin-4-yl)amino)carbony\xad\nlacetohydrazide  413-230-5  122035-71-6  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 523}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 525\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n007-027-00-7  1,6-bis(3,3-bis((1-methylpenty\xad\nlidenimino)propyl)ureido)hexane  420-190-2  771478-66-1  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH373 ** \nH314 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH373 ** \nH314 \nH317 \nH410  \n007-028-00-2  hydroxylammonium nitrate  236-691-2  13465-08-2  Expl. 1.1 **** \nCarc. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H201 \nH351 \nH311 \nH302 \nH373** \nH319 \nH315 \nH317 \nH400  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH351 \nH311 \nH302 \nH373** \nH319 \nH315 \nH317 \nH400  \n007-029-00-8  diethyldimethylammonium \nhydroxide  419-400-5  95500-19-9  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  \n▼M23  \n007-030-00-3  nitric acid …% [C ≤ 70 %]  231-714-2  7697-37-2.  Ox. Liq. 3 \nAcute Tox. 3 \nSkin Corr. 1A  H272 \nH331 \nH314  GHS03 \nGHS06 \nGHS05 \nDgr H272 \nH331 \nH314  EUH071  Ox. Liq. 3; H272: \nC ≥ 65 % \ninhalation: ATE = \n2,65 mg/L \n(vapours) \nSkin Corr. 1A; \nH314: C ≥ 20 % \nSkin Corr. 1B; \nH314: 5 % ≤ C < \n20 %  B ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 524}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 526\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n008-001-00-8  oxygen  231-956-9  7782-44-7  Ox. Gas 1 \nPress. Gas  H270  GHS03 \nGHS04 \nDgr H270  U  \n008-003-00-9  hydrogen peroxide solution… %  231-765-0  7722-84-1  Ox. Liq. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H271 \nH332 \nH302 \nH314  GHS03 \nGHS05 \nGHS07 \nDgr H271 \nH332 \nH302 \nH314  Ox. Liq. 1; H271: \nC ≥70 %**** \nOx. Liq. 2; H272: \n50 % ≤ C < 70 % \n**** \n* \nSkin Corr. 1A; \nH314: C ≥ 70 % \nSkin Corr. 1B; \nH314: 50 % ≤ C < \n70 % \nSkin Irrit. 2; H315: \n35 % ≤ C < 50 % \nEye Dam. 1; H318: \n8 % ≤ C < 50 % \nEye Irrit. 2; H319: \n5 % ≤ C< 8 % \nSTOT SE 3; H335; \nC ≥ 35 %  B \n009-001-00-0  fluorine  231-954-8  7782-41-4  Press. Gas \nOx. Gas 1 \nAcute Tox. 2 * \nSkin Corr. 1A  H270 \nH330 \nH314  GHS04 \nGHS03 \nGHS06 \nGHS05 \nDgr H270 \nH330 \nH314  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 525}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 527\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n009-002-00-6  hydrogen fluoride  231-634-8  7664-39-3  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSkin Corr. 1A  H330 \nH310 \nH300 \nH314  GHS06 \nGHS05 \nDgr H330 \nH310 \nH300 \nH314  \n009-003-00-1  hydrofluoric acid … %  231-634-8  7664-39-3  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSkin Corr. 1A  H330 \nH310 \nH300 \nH314  GHS06 \nGHS05 \nDgr H330 \nH310 \nH300 \nH314  Skin Corr. 1A; \nH314: C ≥ 7 % \nSkin Corr. 1B; \nH314: 1 % ≤ C< \n7 % Eye Irrit. 2; \nH319: 0,1 % ≤C < \n1 % B \n009-004-00-7  sodium fluoride  231-667-8  7681-49-4  Acute Tox. 3 * \nEye Irrit. 2 \nSkin Irrit. 2  H301 \nH319 \nH315  GHS06 \nDgr H301 \nH319 \nH315  EUH032  \n009-005-00-2  potassium fluoride  232-151-5  7789-23-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  \n009-006-00-8  ammonium fluoride  235-185-9  12125-01-8  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  \n009-007-00-3  sodium bifluoride; \nsodium hydrogen difluoride  215-608-3  1333-83-1  Acute Tox. 3 * \nSkin Corr. 1B  H301 \nH314  GHS06 \nGHS05 \nDgr H301 \nH314  *Skin Corr. 1B; \nH314: C ≥ 1 % \nSkin Irrit. 2; H315: \n0,1 % ≤ C < % \nEye Irrit. 2; \nH319: 0,1 % ≤ \nC < 1 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 526}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 528\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n009-008-00-9  potassium bifluoride; \npotassium hydrogen difluoride  232-156-2  7789-29-9  Acute Tox. 3 * \nSkin Corr. 1B  H301 \nH314  GHS06 \nGHS05 \nDgr H301 \nH314  * \nSkin Corr. 1B; \nH314: C ≥ 1 % \nSkin Irrit. 2; H315: \n0,1 % ≤ C < 1 % \nEye Irrit. 2; H319: \n0,1 % ≤ C < 1 %  \n009-009-00-4  ammonium bifluoride; \nammonium hydrogen difluoride  215-676-4  1341-49-7  Acute Tox. 3 * \nSkin Corr. 1B  H301 \nH314  GHS06 \nGHS05 \nDgr H301 \nH314  * \nSkin Corr. 1B; \nH314: C ≥ 1 % \nSkin Irrit.2; H315: \n0,1 % ≤ C < 1 % \nEye Irrit. 2; H319: \n0,1 % ≤ C < 1 %  \n009-010-00-X  fluoroboric acid … %  240-898-3  16872-11-0  Skin Corr. 1B  H314  GHS05 \nDgr H314  Skin Corr. 1B; \nH314: C ≥ 25 % \nSkin Irrit. 2; H315: \n10 % ≤ C < 25 % \nEye Irrit. 2; H319: \n10 % ≤ C < 25 %  B \n009-011-00-5  fluorosilicic acid … %  241-034-8  16961-83-4  Skin Corr. 1B  H314  GHS05 \nDgr H314  B  \n009-012-00-0  alkali fluorosilicates(Na); [1] \nalkali fluorosilicates(K); [2] \nalkali fluorosilicates(NH4) [3]  240-934-8 [1] \n240-896-2 [2] \n240-968-3 [3]  16893-85-9 [1] \n16871-90-2 [2] \n16919-19-0 [3]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  * A  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 527}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 529\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n009-013-00-6  fluorosilicates, with the exception \nof those specified elsewhere in \nthis Annex  — —  Acute Tox. 4 *  H302  GHS07 \nWng  H302  *  A  \n009-014-00-1  lead hexafluorosilicate  247-278-1  25808-74-6  Repr. 1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH332 \nH302 \nH373 ** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360Df \nH332 \nH302 \nH373 ** \nH410  1 \n009-015-00-7  sulphuryl difluoride  220-281-5  2699-79-8  Press. Gas \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1  H331 \nH373 ** \nH400  GHS04 \nGHS06 \nGHS08 \nGHS09 \nDgr H331 \nH373 ** \nH400  U \n009-016-00-2  trisodium hexafluoroaluminate \n[1] \ntrisodium hexafluoroalumi\xad\nnate(cryolite) [2]  237-410-6 [1] \n239-148-8 [2]  13775-53-6 [1] \n15096-52-3 [2]  STOT RE 1 \nAcute Tox. 4 \nAquatic Chronic 2  H372 \nH332 \nH411  GHS07 \nGHS08 \nGHS09 \nDgr H372 \nH332 \nH411  \n009-017-00-8  potassium mu-fluoro-bis(triethy\xad\nlaluminium)  400-040-2  12091-08-6  Flam. Sol. 1 \nWater-react. 1 \nSkin Corr. 1A \nAcute Tox. 4 *  H228 \nH270 \nH314 \nH332  GHS02 \nGHS05 \nGHS07 \nDgr H228 \nH270 \nH314 \nH332  EUH014  T  \n009-018-00-3  magnesium hexafluorosilicate  241-022-2  16949-65-8  Acute Tox. 3 *  H301  GHS06 \nDgr H301  *  \n011-001-00-0  sodium  231-132-9  7440-23-5  Water-react. 1 \nSkin Corr. 1B  H260 \nH314  GHS02 \nGHS05 \nDgr H260 \nH314  EUH014  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 528}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 530\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n011-002-00-6  sodium hydroxide; \ncaustic soda  215-185-5  1310-73-2  Skin Corr. 1A  H314  GHS05 \nDgr H314  Skin Corr. 1A; \nH314: C ≥ 5 % \nSkin Corr. 1B; \nH314 2 % ≤ C < \n5 % Skin Irrit. 2; \nH315: 0,5 % ≤ C < \n2 % Eye Irrit.2; \nH319: 0,5 % ≤ C < \n2 % \n011-003-00-1  sodium peroxide  215-209-4  1313-60-6  Ox. Sol. 1 \nSkin Corr. 1A  H271 \nH314  GHS03 \nGHS05 \nDgr H271 \nH314  \n011-004-00-7  sodium azide  247-852-1  26628-22-8  Acute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH400 \nH410  EUH032  \n011-005-00-2  sodium carbonate  207-838-8  497-19-8  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n011-006-00-8  sodium cyanate  213-030-6  917-61-3  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n011-007-00-3  propoxycarbazone-sodium  —  181274-15-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1 0  \n012-001-00-3  magnesium powder (pyrophoric)  231-104-6  7439-95-4  Water-react. 1 \nPyr. Sol. 1  H260 \nH250  GHS02 \nDgr H260 \nH250  T ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 529}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 531\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n012-002-00-9  magnesium, powder or turnings  231-104-6  —  Flam. Sol. 1 \nWater-react. 2 \nSelf-heat. 1  H228 \nH261 \nH252  GHS02 \nDgr H228 \nH261 \nH252  T \n012-003-00-4  magnesium alkyls  —  —  Pyr. Liq. 1 \nWater-react. 1 \nSkin Corr. 1B  H250 \nH260 \nH314  GHS02 \nGHS05 \nDgr H250 \nH260 \nH314  EUH014  A  \n012-004-00-X  aluminium-magnesium- \ncarbonate-hydroxide-perchlorate- \nhydrate  422-150-1  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n013-001-00-6  aluminium powder (pyrophoric)  231-072-3  7429-90-5  Water-react. 2 \nPyr. Sol. 1  H261 \nH250  GHS02 \nDgr H261 \nH250  T \n013-002-00-1  aluminium powder (stabilised)  231-072-3  7429-90-5  Water-react. 2 \nFlam. Sol. 1  H261 \nH228  GHS02 \nDgr H261 \nH228  T \n013-003-00-7  aluminium chloride, anhydrous  231-208-1  7446-70-0  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n013-004-00-2  aluminium alkyls  —  —  Pyr. Liq. 1 \nWater-react. 1 \nSkin Corr. 1B  H250 \nH260 \nH314  GHS02 \nGHS05 \nDgr H250 \nH260 \nH314  EUH014  A  \n013-005-00-8  diethyl(ethyldimethylsilanolato) \naluminium  401-160-8  55426-95-4  Water-react. 1 \nPyr. Liq. 1 \nSkin Corr. 1A  H260 \nH250 \nH314  GHS02 \nGHS05 \nDgr H260 \nH250 \nH314  EUH014  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 530}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 532\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n013-006-00-3  (ethyl-3-oxobutanoato-  \nO'1,O'3)(2-dimethylaminoethano\xad\nlato)(1-methoxypropan-2- \nolato)aluminium(III), dimerised  402-370-2  —  Flam. Liq. 3 \nEye Dam. 1  H226 \nH318  GHS02 \nGHS05 \nDgr H226 \nH318  \n013-007-00-9  poly(oxo(2-butoxyethyl-3-oxobu\xad\ntanoato- O'1,O'3)aluminium)  403-430-0  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n013-008-00-4  di- n-octylaluminium iodide  408-190-0  7585-14-0  Pyr. Liq. 1 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H250 \nH314 \nH400 \nH410  GHS02 \nGHS05 \nGHS09 \nDgr H250 \nH314 \nH410  EUH014  \n013-009-00-X  sodium ( n-butyl)x(ethyl)y-1,5- \ndihydro)aluminate x = 0,5 y =1,5  418-720-2  —  Flam. Sol. 1 \nWater-react. 1 \nPyr. Sol. 1 \nAcute Tox. 4 * \nSkin Corr. 1A  H228 \nH260 \nH250 \nH332 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H228 \nH260 \nH250 \nH332 \nH314  EUH014  T  \n013-010-00-5  hydroxy aluminium bis(2,4,8,10- \ntetra- tert-butyl-6-hydroxy-12 H- \ndibenzo[ d, g ][1.3.2]dioxaphosp\xad\nhocin-6-oxide)  430-650-4  151841-65-5  Aquatic Chronic 2  H411  GHS09  H411  \n014-001-00-9  trichlorosilane  233-042-5  10025-78-2  Flam. Liq. 1 \nPyr. Liq. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H224 \nH250 \nH332 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H224 \nH250 \nH332 \nH302 \nH314  EUH014 \nEUH029  * \nSTOT SE 3; H335: \nC ≥ 1 %  T \n014-002-00-4  silicon tetrachloride  233-054-0  10026-04-7  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  EUH014  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 531}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 533\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n014-003-00-X  dimethyldichlorosilane  200-901-0  75-78-5  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H225 \nH319 \nH335 \nH315  GHS02 \nGHS07 \nDgr H225 \nH319 \nH335 \nH315  \n014-004-00-5  trichloro(methyl)silane; methyl\xad\ntrichlorosilane  200-902-6  75-79-6  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H225 \nH319 \nH335 \nH315  GHS02 \nGHS07 \nDgr H225 \nH319 \nH335 \nH315  EUH014  Skin Irrit.2; H315: \nC ≥ 1 % Eye Irrit. \n2; H319: C ≥ 1 % \nSTOT SE 3; H335: \nC ≥ 1 %  \n014-005-00-0  tetraethyl silicate; \nethyl silicate  201-083-8  78-10-4  Flam. Liq. 3 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3  H226 \nH332 \nH319 \nH335  GHS02 \nGHS07 \nWng  H226 \nH332 \nH319 \nH335  \n014-006-00-6  bis(4-fluorophenyl)-methyl- \n(1,2,4-triazol-4-ylmethyl)silane \nhydrochloride  401-380-4  —  Eye Irrit. 2 \nAquatic Chronic 2  H319 \nH411  GHS07 \nGHS09 \nWng  H319 \nH411  \n014-007-00-1  triethoxyisobutylsilane  402-810-3  17980-47-1  Skin Irrit. 2  H315  GHS07 \nWng  H315  \n014-008-00-7  (chloromethyl)bis(4-fluorophe\xad\nnyl)methylsilane  401-200-4  85491-26-5  Aquatic Chronic 2  H411  GHS09  H411  \n014-009-00-2  isobutylisopropyldimethoxysilane  402-580-4  111439-76-0  Flam. Liq. 3 \nAcute Tox. 4 * \nSkin Irrit. 2  H226 \nH332 \nH315  GHS02 \nGHS07 \nWng  H226 \nH332 \nH315  \n014-010-00-8  disodium metasilicate  229-912-9  6834-92-0  Skin Corr. 1B \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 532}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 534\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n014-011-00-3  cyclohexyldimethoxymethyl\xad\nsilane  402-140-1  17865-32-6  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n014-012-00-9  bis(3-(trimethoxysilyl)pro\xad\npyl)amine  403-480-3  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n014-013-00-4  α-hydroxypoly(methyl-(3- \n(2,2,6,6-tetramethylpiperidin-4- \nyloxy)propyl)siloxane)  404-920-7  —  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H312 \nH302 \nH314 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH314 \nH411  \n014-014-00-X  etacelasil (ISO); \n6-(2-chloroethyl)-6-(2-methoxye\xad\nthoxy)-2,5,7,10-tetraoxa-6-silaun\xad\ndecane  253-704-7  37894-46-5  Repr. 1B \nAcute Tox. 4 * \nSTOT RE 2 *  H360D *** \nH302 \nH373 **  GHS08 \nGHS07 \nDgr H360D *** \nH302 \nH373 **  \n014-015-00-5  α-trimethylsilanyl-ω-trimethylsil\xad\noxypoly[oxy(methyl-3-(2-(2- \nmethoxypropoxy)propoxy)pro\xad\npylsilanediyl]-co-oxy(dimethylsil\xad\nane))  406-420-4  69430-40-6  Aquatic Chronic 4  H413  —  H413  \n014-016-00-0  reaction mass of: 1,3-dihex-5-en- \n1-yl-1,1,3,3-tetramethyldis\xad\niloxane; \n1,3-dihex-n-en-1-yl-1,1,3,3-tetra\xad\nmethyldisiloxane  406-490-6  —  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 533}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 535\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n014-017-00-6  flusilazole (ISO); \nbis(4-fluorophenyl)(methyl)(1 H- \n1,2,4-triazol-1-ylmethyl)silane  — 85509-19-9  Carc. 2 \nRepr. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H351 \nH360D *** \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H351 \nH360D *** \nH302 \nH411  \n▼M23  \n014-018-00-1  octamethylcyclotetrasiloxane; \n[D4]  209-136-7  556-67-2  Repr. 2 \nAquatic Chronic 1  H361f *** \nH410  GHS08 \nGHS09 \nWng  H361f *** \nH410  M = 10  \n▼M16  \n014-019-00-7  reaction mass of: 4-[[bis-(4-fluor\xad\nophenyl)methylsilyl]methyl]-4 H- \n1,2,4-triazole; \n1-[[bis-(4-fluorophenyl)methyl\xad\nsilyl]methyl]-1 H-1,2,4-triazole  403-250-2  —  Carc. 2 \nRepr. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H351 \nH360D *** \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H351 \nH360D *** \nH302 \nH411  \n014-020-00-2  bis(1,1-dimethyl-2-propyny\xad\nloxy)dimethylsilane  414-960-7  53863-99-3  Acute Tox. 4 *  H332  GHS07 \nWng  H332  \n014-021-00-8  tris(isopropenyloxy)phenyl silane  411-340-8  52301-18-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H400 \nH410  \n014-022-00-3  reaction product of: (2-hydroxy- \n4-(3-propenoxy)benzophenone \nand triethoxysilane) with \n(hydrolysis product of silica and \nmethyltrimethoxysilane)  401-530-9  —  Flam. Sol. 1 \nSTOT SE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H228 \nH370 ** \nH332 \nH312 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H228 \nH370 ** \nH332 \nH312 \nH302  T \n014-023-00-9  α, ω-dihydroxypoly(hex-5-en-1- \nylmethylsiloxane)hoxysilane \nwith (hydrolysis product of silica \nand methyltrimethoxysil\xad\nane)iazole  408-160-7  125613-45-8  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 534}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 536\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n014-024-00-4  1-((3-(3-chloro-4-fluorophe\xad\nnyl)propyl)dimethylsilanyl)-4- \nethoxybenzene  412-620-2  121626-74-2  Aquatic Chronic 2  H411  GHS09  H411  \n014-025-00-X  4-[3-(diethoxymethylsilylp\xad\nropoxy)-2,2,6,6-tetramethyl]pi\xad\nperidine  411-400-3  102089-33-8  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH373 ** \nH315 \nH318 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH373 ** \nH315 \nH318 \nH412  \n014-026-00-5  dichloro-(3-(3-chloro-4-fluor\xad\nophenyl)propyl)methylsilane  407-180-3  770722-36-6  Skin Corr. 1A  H314  GHS05 \nDgr H314  \n014-027-00-0  chloro(3-(3-chloro-4-fluorophe\xad\nnyl)propyl)dimethylsilane  410-270-5  770722-46-8  Skin Corr. 1A  H314  GHS05 \nDgr H314  \n014-028-00-6  α-[3-(1-oxoprop-2-enyl)l-1- \noxypropyl]dimethoxysilyloxy-ω- \n[3(1-oxoprop-2-enyl)-1-oxypro\xad\npyl]dimethoxysilyl poly(di\xad\nmethylsiloxane)  415-290-8  193159-06-7  Skin Sens. 1  H317  GHS07 \nWng  H317  \n014-029-00-1  O, O' -(ethenylmethylsily\xad\nlene)di[(4-methylpentan-2- \none)oxime]  421-870-1  156145-66-3  Repr. 2 \nAcute Tox. 4 * \nSTOT RE 2 *  H361f *** \nH302 \nH373 **  GHS08 \nGHS07 \nWng  H361f *** \nH302 \nH373 **  \n014-030-00-7  [(dimethylsily\xad\nlene)bis((1,2,3,3a,7a-η)-1 H- \ninden-1-ylidene)di\xad\nmethyl]hafnium  422-060-0  137390-08-0  Acute Tox. 2 *  H300  GHS06 \nDgr H300  \n014-031-00-2  bis(1-methylethyl)-dimethoxy\xad\nsilane  421-540-7  18230-61-0  Flam. Liq. 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H226 \nH315 \nH317 \nH412  GHS02 \nGHS07 \nWng  H226 \nH315 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 535}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 537\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n014-032-00-8  dicyclopentyldimethoxysilane  404-370-8  126990-35-0  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  \n014-033-00-3  2-methyl-3-(trimethoxys\xad\nilyl)propyl-2-propenoate \nhydrolysis product with silica  419-030-4  125804-20-8  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH336  \n014-034-00-9  3-hexylheptamethyltrisiloxane  428-700-5  1873-90-1  Acute Tox. 4 * \nAquatic Chronic 4  H332 \nH413  GHS07 \nWng  H332 \nH413  \n014-035-00-4  2-(3,4-epoxycyclohexyl)ethyl\xad\ntriethoxy silane  425-050-4  10217-34-2  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n014-036-00-X  (4-ethoxyphenyl)(3-(4-fluoro-3- \nphenoxyphenyl)propyl)dimethyl\xad\nsilane  405-020-7  105024-66-6  Repr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360F*** \nH400 \nH410  GHS08 \nGHS09 \nDgr H360F*** \nH410  M=1000  \n014-037-00-5  2-butanone- O, O',O'' -(phenyls\xad\nilylidyne)trioxime  433-360-6  34036-80-1  STOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 3  H373** \nH317 \nH412  GHS08 \nGHS07 \nWng  H373** \nH317 \nH412  \n014-038-00-0  S-(3-(triethoxysilyl)propyl)oct\xad\nanethioate  436-690-9  220727-26-4  Skin Sens. 1  H317  GHS07 \nWng  H317  \n014-039-00-6  (2,3-dimethylbut-2-yl)-trime\xad\nthoxysilane  439-360-2  142877-45-0  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H315 \nH318 \nH412  GHS05 \nDgr H315 \nH318 \nH412  \n014-041-00-7  N, N -bis(trimethylsilyl)aminopro\xad\npylmethyldiethoxysilane  445-890-5  201290-01-9  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 536}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 538\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n014-042-00-2  reaction mass of:  O,O',O'',O'''- \nsilanetetrayl tetrakis(4-methyl-2- \npentanone oxime) (3 stereoi\xad\nsomers)  423-010-0  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n014-043-00-8  reaction product of amorphous \nsilica (50-85 %), butyl (1-methyl\xad\npropyl) magnesium (3-15 %), \ntetraethyl orthosilicate (5-15 %) \nand titanium tetrachloride (5- \n20 %)  432-200-2  —  STOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H335 \nH315 \nH318 \nH412  GHS05 \nGHS07 \nDgr H335 \nH315 \nH318 \nH412  \n014-044-00-3  3-[(4'-acetoxy-3'-methoxyphenyl) \npropyl]trimethoxysilane  433-050-0  —  Aquatic Chronic 2  H411  GHS09  H411  \n014-045-00-9  magnesium sodium fluoride \nsilicate  442-650-1  —  STOT RE 2 *  H373**  GHS08 \nWng  H373**  \n▼M13  \n014-046-00-4  e-glass microfibres of representa\xad\ntive composition; [Calcium- \naluminium-silicate fibres with \nrandom orientation with the \nfollowing representative \ncomposition (% given by \nweight): SiO  2 50,0-56,0 %, \nAl 2O 3 13,0-16,0 %, B  2O 3 5,8- \n10,0 %, Na  2O < 0,6 %, K  2O \n< 0,4 %, CaO 15,0-24,0 %, \nMgO < 5,5 %, Fe  2O 3 < 0,5 %, \nF 2 < 1,0 %. Process: typically \nproduced by flame attenuation \nand rotary process. (Additional  — —  Carc. 1B  H350i  GHS08 \nDgr H350i  A  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 537}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 539\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nindividual elements may be pre- \nsent at low levels; the process list \ndoes not preclude innovation).]  \n014-047-00-X  glass microfibres of representa\xad\ntive composition; [Calcium- \naluminium-silicate fibres with \nrandom orientation with the \nfollowing composition (% given \nby weight): SiO  2 55,0-60,0 %, \nAl 2O 3 4,0-7,0 %, B  2O 3 8,0- \n11,0 %, ZrO  2 0,0-4,0 %, Na  2O \n9,5-13,5 %, K  2O 0,0-4,0 %, \nCaO 1,0-5,0 %, MgO 0,0-2,0 %, \nFe 2O 3 < 0,2 %, ZnO 2,0-5,0 %, \nBaO 3,0-6,0 %, F  2 < 1,0 %. \nProcess: typically produced by \nflame attenuation and rotary \nprocess. (Additional individual \nelements may be present at low \nlevels; the process list does not \npreclude innovation).]  — —  Carc. 2  H351 (inha\xad\nlation)  GHS08 \nWng  H351 (inha\xad\nlation)  A \n▼M23  \n014-048-00-5  silicon carbide fibres (with \ndiameter < 3 μm, length > 5 \nμm and aspect ratio ≥ 3:1)  206-991-8  409-21-2 \n308076-74-6  Carc. 1B  H350i  GHS08 \nDgr H350i  \n014-049-00-0  trimethoxyvinylsilane; trime\xad\nthoxy(vinyl)silane  220-449-8  2768-02-7  Skin Sens. 1B  H317  GHS07 \nWng  H317  ▼M13', metadata={'source': 'data/ycla_en.pdf', 'page': 538}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 540\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n014-050-00-6  tris(2-methoxyethoxy)vinylsilane; \n6-(2-methoxyethoxy)-6-vinyl- \n2,5,7,10-tetraoxa-6-silaundecane  213-934-0  1067-53-4  Repr. 1B  H360FD  GHS08 \nDgr H360FD  \n▼M16  \n015-001-00-1  white phosphorus  231-768-7  12185-10-3  Pyr. Sol. 1 \nAcute Tox. 2 * \nAcute Tox. 2 * \nSkin Corr. 1A \nAquatic Acute 1  H250 \nH330 \nH300 \nH314 \nH400  GHS02 \nGHS06 \nGHS05 \nGHS09 \nDgr H250 \nH330 \nH300 \nH314 \nH400  \n015-002-00-7  red phosphorus  231-768-7  7723-14-0  Flam. Sol. 1 \nAquatic Chronic 3  H228 \nH412  GHS02 \nDgr H228 \nH412  \n▼M11  \n015-003-00-2  calcium phosphide; tricalcium \ndiphosphide  215-142-0  1305-99-3  Water-react. 1 \nAcute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 1 \nEye Dam. 1 \nAquatic Acute 1  H260 \nH300 \nH311 \nH330 \nH318 \nH400  GHS02 \nGHS06 \nGHS05 \nGHS09 \nDgr H260 \nH300 \nH311 \nH330 \nH318 \nH400  EUH029 \nEUH032  M = 100  ▼M23', metadata={'source': 'data/ycla_en.pdf', 'page': 539}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 541\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n015-004-00-8  aluminium phosphide  244-088-0  20859-73-8  Water-react. 1 \nAcute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 1 \nAquatic Acute 1  H260 \nH300 \nH311 \nH330 \nH400  GHS02 \nGHS06 \nGHS09 \nDgr H260 \nH300 \nH311 \nH330 \nH400  EUH029 \nEUH032  M = 100  \n015-005-00-3  magnesium phosphide; \ntrimagnesium diphosphide  235-023-7  12057-74-8  Water-react. 1 \nAcute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 1 \nAquatic Acute 1  H260 \nH300 \nH311 \nH330 \nH400  GHS02 \nGHS06 \nGHS09 \nDgr H260 \nH300 \nH311 \nH330 \nH400  EUH029 \nEUH032  M = 100  \n015-006-00-9  trizinc diphosphide; \nzinc phosphide  215-244-5  1314-84-7  Water-react. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H260 \nH300 \nH400 \nH410  GHS02 \nGHS06 \nGHS09 \nDgr H260 \nH300 \nH410  EUH029 \nEUH032  M=100  T  \n015-007-00-4  phosphorus trichloride  231-749-3  7719-12-2  Acute Tox. 2 * \nAcute Tox. 2 * \nSTOT RE 2 * \nSkin Corr. 1A  H330 \nH300 \nH373 ** \nH314  GHS06 \nGHS08 \nGHS05 \nDgr H330 \nH300 \nH373 ** \nH314  EUH014 \nEUH029  \n015-008-00-X  phosphorus pentachloride  233-060-3  10026-13-8  Acute Tox. 2 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B  H330 \nH302 \nH373 ** \nH314  GHS06 \nGHS08 \nGHS05 \nDgr H330 \nH302 \nH373 ** \nH314  EUH014 \nEUH029  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 540}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 542\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-009-00-5  phosphoryl trichloride  233-046-7  10025-87-3  Acute Tox. 2 * \nSTOT RE 1 \nAcute Tox. 4 * \nSkin Corr. 1A  H330 \nH372 ** \nH302 \nH314  GHS06 \nGHS08 \nGHS05 \nDgr H330 \nH372 ** \nH302 \nH314  EUH014 \nEUH029  \n015-010-00-0  phosphorus pentoxide  215-236-1  1314-56-3  Skin Corr. 1A  H314  GHS05 \nDgr H314  \n015-011-00-6  phosphoric acid . %, orthophos\xad\nphoric acid . %  231-633-2  7664-38-2  Skin Corr. 1B  H314  GHS05 \nDgr H314  Skin Corr. 1B; \nH314: C ≥ 25 % \nSkin Irrit. 2; H315: \n10 % ≤ C < 25 % \nEye Irrit. 2; H319: \n10 % ≤ C < 25 %  B \n015-012-00-1  tetraphosphorus trisulphide; \nphosphorus sesquisulphid  215-245-0  1314-85-8  Flam. Sol. 2 \nWater-react. 1 \nAcute Tox. 4 * \nAquatic Acute 1  H228 \nH260 \nH302 \nH400  GHS02 \nGHS07 \nGHS09 \nDgr H228 \nH260 \nH302 \nH400  T \n015-013-00-7  triethyl phosphate  201-114-5  78-40-0  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n015-014-00-2  tributyl phosphate  204-800-2  126-73-8  Carc. 2 \nAcute Tox. 4 * \nSkin Irrit. 2  H351 \nH302 \nH315  GHS08 \nGHS07 \nWng  H351 \nH302 \nH315  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 541}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 543\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-015-00-8  tricresyl phosphate ( o-o-o-, o-o- \nm-, o-o-p-, o-m-m-, o-m-p-, o-p- \np-); tritolyl phosphate ( o-o-o-, o- \no-m-, o-o-p-, o-m-m-, o-m-p-, o- \np-p-); 201-103-5  78-30-8  STOT SE 1 \nAquatic Chronic 2  H370 ** \nH411  GHS08 \nGHS09 \nDgr H370 ** \nH411  STOT SE 1; H370: \nC ≥ 1 % STOT SE \n2; H371: 0,2 % ≤ \nC < 1 %  C \n015-016-00-3  tricresyl phosphate ( m-m-m-, m- \nm-p-, m-p-p-, p-p-p-); \ntritolyl phosphate ( m-m-m-, m-m- \np-, m-p-p-, p-p-p-); 201-105-6  78-32-0  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H312 \nH302 \nH411  GHS07 \nGHS09 \nWng  H312 \nH302 \nH411  * C  \n015-019-00-X  dichlorvos (ISO); \n2,2-dichlorovinyl dimethyl phos\xad\nphate  200-547-7  62-73-7  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1  H330 \nH311 \nH301 \nH317 \nH400  GHS06 \nGHS09 \nDgr H330 \nH311 \nH301 \nH317 \nH400  M=1000  \n015-020-00-5  mevinphos (ISO); \n2-methoxycarbonyl-1- \nmethylvinyl dimethyl phosphate  232-095-1  7786-34-7  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  M = 10000  \n015-021-00-0  trichlorfon (ISO); \ndimethyl 2,2,2-trichloro-1-hydro\xad\nxyethylphosphonate  200-149-3  52-68-6  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH400 \nH410  M = 1000  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 542}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 544\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-022-00-6  phosphamidon (ISO); \n2-chloro-2-diethylcarbamoyl-1- \nmethylvinyl dimethyl phosphate  236-116-5  13171-21-6  Muta. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH300 \nH311 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H341 \nH300 \nH311 \nH410  \n015-023-00-1  pyrazoxon; \ndiethyl 3-methylpyrazol-5-yl \nphosphate  — 108-34-9  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 *  H330 \nH310 \nH300  GHS06 \nDgr H330 \nH310 \nH300  \n015-024-00-7  triamiphos (ISO); \n5-amino-3-phenyl-1,2,4-triazol-1- \nyl-N, N,N',N' -tetramethylphos\xad\nphonic diamide  — 1031-47-6  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n015-025-00-2  TEPP (ISO); \ntetraethyl pyrophosphate  203-495-3  107-49-3  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1  H310 \nH300 \nH400  GHS06 \nGHS09 \nDgr H310 \nH300 \nH400  \n015-026-00-8  schradan (ISO); octamethyl\xad\npyrophosphoramide  205-801-0  152-16-9  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n015-027-00-3  sulfotep (ISO);  \nO, O,O, O -tetraethyl dithiopyrop\xad\nhosphate  222-995-2  3689-24-5  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  M = 1000  \n015-028-00-9  demeton- O (ISO);  \nO,O-diethyl- O-2-ethylthioethyl \nphosphorothioate  206-053-8  298-03-3  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1  H310 \nH300 \nH400  GHS06 \nGHS09 \nDgr H310 \nH300 \nH400  \n015-029-00-4  demeton- S (ISO); \ndiethyl- S-2-ethylthioethyl phos\xad\nphorothioate  204-801-8  126-75-0  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 543}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 545\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-030-00-X  demeton- O-methyl (ISO);  \nO-2-ethylthioethyl  O,O-dimethyl \nphosphorothioate  212-758-1  867-27-6  Acute Tox. 3 *  H301  GHS06 \nDgr H301  \n015-031-00-5  demeton- S-methyl (ISO);  \nS-2-ethylthioethyl dimethyl phos\xad\nphorothioate  213-052-6  919-86-8  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H311 \nH301 \nH411  GHS06 \nGHS09 \nDgr H311 \nH301 \nH411  \n015-032-00-0  prothoate (ISO);  \nO,O-diethyl isopropylcarba\xad\nmoylmethyl phosphorodithioate  218-893-2  2275-18-5  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Chronic 3  H310 \nH300 \nH412  GHS06 \nDgr H310 \nH300 \nH412  \n015-033-00-6  phorate (ISO);  \nO,O-diethyl ethylthiomethyl \nphosphorodithioate  206-052-2  298-02-2  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  M = 1000  \n015-034-00-1  parathion (ISO);  \nO,O-diethyl  O -4-nitrophenyl \nphosphorothioate  200-271-7  56-38-2  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH311 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH300 \nH311 \nH372 ** \nH410  M = 100  \n015-035-00-7  parathion — methyl (ISO);  \nO,O-dimethyl  O -4-nitrophenyl \nphosphorothioate  206-050-1  298-00-0  Flam. Liq. 3 \nAcute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH330 \nH300 \nH311 \nH373 ** \nH400 \nH410  GHS02 \nGHS06 \nGHS08 \nGHS09 \nDgr H226 \nH330 \nH300 \nH311 \nH373 ** \nH410  M = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 544}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 546\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-036-00-2  O-ethyl  O -4-nitrophenyl \nphenylphosphonothioate; \nEPN  218-276-8  2104-64-5  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  \n015-037-00-8  phenkapton (ISO);  \nS-(2,5-dichlorophenylthiomethyl)  \nO, O -diethyl phosphorodithioate  218-892-7  2275-14-1  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  \n015-038-00-3  coumaphos (ISO);  \nO-3-chloro-4-methylcoumarin-7- \nyl O,O-diethyl phosphorothioate  200-285-3  56-72-4  Acute Tox. 2 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH312 \nH410  \n015-039-00-9  azinphos-methyl (ISO);  \nO,O-dimethyl-4-oxobenzotriazin- \n3-ylmethyl phosphorodithioate  201-676-1  86-50-0  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH311 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH311 \nH317 \nH410  \n015-040-00-4  diazinon (ISO);  \nO,O-diethyl  O -2-isopropyl-6- \nmethylpyrimidin-4-yl phosphoro\xad\nthioate  206-373-8  333-41-5  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH400 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 545}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 547\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-041-00-X  malathion (ISO); \n1,2-bis(ethoxycarbonyl)ethyl  O, \nO-dimethyl phosphorodithioate; \n[containing ≤ 0,03 % isomal\xad\nathion]  204-497-7  121-75-5  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  M=1000  \n015-042-00-5  chlorthion  O -(3-chloro-4-nitro\xad\nphenyl)  O, O -dimethyl phospho\xad\nrothioate  207-902-5  500-28-7  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  M = 100  \n015-043-00-0  phosnichlor (ISO);  \nO-4-chloro-3-nitrophenyl  O, O - \ndimethyl phosphorothioate  — 5826-76-6  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H332 \nH312 \nH302  GHS07 \nWng  H332 \nH312 \nH302  \n015-044-00-6  carbophenothion (ISO); \n4-chlorophenylthiomethyl  O, O - \ndiethyl phosphorodithioate  212-324-1  786-19-6  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  \n015-045-00-1  mecarbam (ISO);  \nN-ethoxycarbonyl- N-methylcar\xad\nbamoylmethyl  O, O -diethyl \nphosphorodithioate  219-993-9  2595-54-2  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH400 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 546}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 548\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-046-00-7  oxydemeton-methyl;  \nS-2-(ethylsulphinyl)ethyl  O ,O- \ndimethyl phosphorothioate  206-110-7  301-12-2  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1  H311 \nH301 \nH400  GHS06 \nGHS09 \nDgr H311 \nH301 \nH400  \n015-047-00-2  ethion (ISO);  \nO, O,O',O' -tetraethyl  S, S' - \nmethylenedi (phosphorodi\xad\nthioate); \ndiethion  209-242-3  563-12-2  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH312 \nH410  M = 10000  \n015-048-00-8  fenthion (ISO);  \nO, O -dimethyl- O-(4-methylthion-  \nm-tolyl) phosphorothioate  200-231-9  55-38-9  Muta. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH331 \nH312 \nH302 \nH372** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H341 \nH331 \nH312 \nH302 \nH372** \nH410  M=100  \n015-049-00-3  endothion (ISO);  \nS-5-methoxy-4-oxopyran-2- \nylmethyl dimethyl phosphoro\xad\nthioate  220-472-3  2778-04-3  Acute Tox. 3 * \nAcute Tox. 3 *  H311 \nH301  GHS06 \nDgr H311 \nH301  \n015-050-00-9  thiometon (ISO);  \nS-2-ethylthioethyl  O,O-dimethyl \nphosphorodithioate  211-362-6  640-15-3  Acute Tox. 3 * \nAcute Tox. 4 *  H301 \nH312  GHS06 \nDgr H301 \nH312  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 547}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 549\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-051-00-4  dimethoate (ISO);  \nO, O -dimethyl methylcarba\xad\nmoylmethyl phosphorodithioate  200-480-3  60-51-5  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  \n015-052-00-X  fenchlorphos (ISO);  \nO, O -dimethyl  O -2,4,5-trich\xad\nlorophenyl phosphorothioate  206-082-6  299-84-3  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  \n015-053-00-5  menazon (ISO);  \nS-[(4,6-diamino-1,3,5-triazin-2- \nyl)methyl]  O, O -dimethyl phos\xad\nphorodithioate  201-123-4  78-57-9  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n015-054-00-0  fenitrothion (ISO);  \nO, O -dimethyl  O-4-nitro- m-tolyl \nphosphorothioate  204-524-2  122-14-5  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n015-055-00-6  naled (ISO); \n1,2-dibromo-2,2-dichloroethyl \ndimethyl phosphate  206-098-3  300-76-5  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1  H312 \nH302 \nH319 \nH315 \nH400  GHS07 \nGHS09 \nWng  H312 \nH302 \nH319 \nH315 \nH400  M = 1000  \n015-056-00-1  azinphos-ethyl (ISO);  \nO,O-diethyl 4-oxobenzotriazin-3- \nylmethyl phosphorodithioate  220-147-6  2642-71-9  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH410  M=100  \n015-057-00-7  formothion (ISO);  \nN-formyl- N-methylcarba\xad\nmoylmethyl  O, O -dimethyl phos\xad\nphorodithioate  219-818-6  2540-82-1  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 548}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 550\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-058-00-2  morphothion (ISO);  \nO, O -dimethyl- S-(morpholinocar\xad\nbonylmethyl) phosphorodithioate  205-628-0  144-41-2  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  \n015-059-00-8  vamidothion (ISO);  \nO,O-dimethyl  S-2-(1-methylcar\xad\nbamoylethylthio) ethyl phospho\xad\nrothioate  218-894-8  2275-23-2  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1  H301 \nH312 \nH400  GHS06 \nGHS09 \nDgr H301 \nH312 \nH400  \n015-060-00-3  disulfoton (ISO);  \nO,O-diethyl 2-ethylthioethyl \nphosphorodithioate  206-054-3  298-04-4  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  \n015-061-00-9  dimefox (ISO); tetramethylphos\xad\nphorodiamidic fluoride  204-076-8  115-26-4  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n015-062-00-4  mipafox (ISO);  \nN,N'-di-isopropylphosphoro\xad\ndiamidic fluoride  206-742-3  371-86-8  STOT SE 1  H370 **  GHS08 \nDgr H370 **  \n015-063-00-X  dioxathion (ISO); \n1,4-dioxan-2,3-diyl- O,O,O',O'- \ntetraethyl di(phosphorodithioate)  201-107-7  78-34-2  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH311 \nH410  M = 1000  \n015-064-00-5  bromophos-ethyl (ISO);  \nO-4-bromo-2,5-dichlorophenyl  \nO,O-diethyl phosphorothioate  225-399-0  4824-78-6  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH312 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 549}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 551\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-065-00-0  S-[2-(ethylsulphinyl)ethyl]  O,O- \ndimethyl phosphorodithioate  — 2703-37-9  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Chronic 2  H330 \nH310 \nH300 \nH411  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH411  \n015-066-00-6  omethoate (ISO);  \nO, O -dimethyl  S-methylcarba\xad\nmoylmethyl phosphorothioate  214-197-8  1113-02-6  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1  H301 \nH312 \nH400  GHS06 \nGHS09 \nDgr H301 \nH312 \nH400  \n015-067-00-1  phosalone (ISO);  \nS-(6-chloro-2-oxobenzoxazolin- \n3-ylmethyl)  O, O -diethyl phos\xad\nphorodithioate  218-996-2  2310-17-0  Acute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH332 \nH312 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH332 \nH312 \nH317 \nH410  M=1000  \n015-068-00-7  dichlofenthion (ISO);  \nO—2,4-dichlorophenyl  O ,O- \ndiethyl phosphorothioate  202-564-5  97-17-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH400 \nH410  \n015-069-00-2  methidathion (ISO); \n2,3-dihydro-5-methoxy-2-oxo- \n1,3,4-thiadiazol-3-ylmethyl- O,O- \ndimethylphosphorodithioate  213-449-4  950-37-8  Acute Tox. 2 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH312 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 550}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 552\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-070-00-8  cyanthoate (ISO);  \nS-(N-(1-cyano-1-methylethyl)car\xad\nbamoylmethyl)  O ,O-diethyl \nphosphorothioate  223-099-4  3734-95-0  Acute Tox. 2 * \nAcute Tox. 3 *  H300 \nH311  GHS06 \nDgr H300 \nH311  \n015-071-00-3  chlorfenvinphos (ISO); \n2-chloro-1-(2,4 dichlorophe\xad\nnyl)vinyl diethyl phosphate  207-432-0  470-90-6  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH410  \n015-072-00-9  monocrotophos (ISO); \ndimethyl-1-methyl-2-(methylcar\xad\nbamoyl)vinyl phosphate  230-042-7  6923-22-4  Muta. 2 \nAcute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH330 \nH300 \nH311 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H341 \nH330 \nH300 \nH311 \nH410  \n015-073-00-4  dicrotophos (ISO); \n(Z)-2-dimethylcarbamoyl-1- \nmethylvinyl dimethyl phosphate  205-494-3  141-66-2  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH410  \n015-074-00-X  crufomate (ISO); \n4-tert-butyl-2-chlorophenyl \nmethyl methylphosphoramidate  206-083-1  299-86-5  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 551}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 553\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-075-00-5  S-[2-(isopropylsulphinyl)ethyl]  \nO,O-dimethyl phosphorothioate  — 2635-50-9  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  \n015-076-00-0  potasan;  \nO, O -diethyl O-(4-methylcou\xad\nmarin-7-yl) phosphorothioate  — 299-45-6  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  M = 1000  \n015-077-00-6  2,2-dichlorovinyl 2-ethylsulphi\xad\nnylethyl methyl phosphate  — 7076-53-1  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  \n015-078-00-1  demeton- S-methylsulphon(ISO);  \nS-2-ethylsulphonylethyl dimethyl \nphosphorothioate  241-109-5  17040-19-6  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Chronic 2  H301 \nH312 \nH411  GHS06 \nGHS09 \nDgr H301 \nH312 \nH411  \n015-079-00-7  acephate (ISO);  \nO, S-dimethyl acetylphosphora\xad\nmidothioate  250-241-2  30560-19-1  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n015-080-00-2  amidithion (ISO); \n2-methoxyethylcarbamoylmethyl  \nO,O-dimethyl phosphorodithioate  — 919-76-6  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n015-081-00-8  O,O,O',O'-tetrapropyl dithiopy\xad\nrophosphate  221-817-0  3244-90-4  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 552}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 554\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-082-00-3  azothoate (ISO);  \nO-4-(4-chlorophenylazo)phenyl  \nO,O-dimethyl phosphorothioate  227-419-3  5834-96-8  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH302  GHS07 \nWng  H332 \nH302  \n015-083-00-9  bensulide (ISO);  \nO, O -diisopropyl 2-phenylsul\xad\nphonylaminoethyl phosphorodi\xad\nthioate  212-010-4  741-58-2  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n015-084-00-4  chlorpyrifos (ISO);  \nO,O-diethyl  O-3,5,6-trichloro-2- \npyridyl phosphorothioate  220-864-4  2921-88-2  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH400 \nH410  M = 10000  \n015-085-00-X  chlorphonium chloride (ISO); \ntributyl (2,4-dichlorobenzyl) \nphosphonium chloride  204-105-4  115-78-6  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2  H301 \nH312 \nH319 \nH315  GHS06 \nDgr H301 \nH312 \nH319 \nH315  \n015-086-00-5  coumithoate (ISO);  \nO,O-diethyl  O -7,8,9,10- \ntetrahydro-6-oxo- \nbenzo(c)chromen-3-yl phospho\xad\nrothioate  — 572-48-5  Acute Tox. 3 *  H301  GHS06 \nDgr H301  \n015-087-00-0  cyanophos (ISO);  \nO-4-cyanophenyl  O,O-dimethyl \nphosphorothioate  220-130-3  2636-26-2  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  \n015-088-00-6  dialifos (ISO); \n2-chloro-1-phthalimidoethyl  O,O- \ndiethyl phosphorodithioate  233-689-3  10311-84-9  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH400 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 553}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 555\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-089-00-1  ethoate-methyl (ISO); ethylcarba\xad\nmoylmethyl  O,O-dimethyl phos\xad\nphorodithioate  204-121-1  116-01-8  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  \n015-090-00-7  fensulfothion (ISO);  \nO,O-diethyl O-4-methylsulfi\xad\nnylphenyl phosphorothioate  204-114-3  115-90-2  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  \n015-091-00-2  fonofos (ISO);  \nO-ethyl phenyl ethylphospho\xad\nnodithioate  213-408-0  944-22-9  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  \n015-092-00-8  phosacetim (ISO);  \nO,O-bis(4-chlorophenyl)  N-acet\xad\nimidoylphosphoramidothioate  223-874-7  4104-14-7  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  \n015-093-00-3  leptophos (ISO);  \nO-4-bromo-2,5-dichlorophenyl  \nO-methyl phenylphosphoro\xad\nthioate  244-472-8  21609-90-5  Acute Tox. 3 * \nSTOT SE 1 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH370 ** \nH312 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH370 ** \nH312 \nH410  \n015-094-00-9  mephosfolan (ISO); \ndiethyl 4-methyl-1,3-dithiolan-2- \nylidenephosphoramidate  213-447-3  950-10-7  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Chronic 2  H310 \nH300 \nH411  GHS06 \nGHS09 \nDgr H310 \nH300 \nH411  \n015-095-00-4  methamidophos (ISO);  \nO,S-dimethyl phosphoramid\xad\nothioate  233-606-0  10265-92-6  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1  H330 \nH300 \nH311 \nH400  GHS06 \nGHS09 \nDgr H330 \nH300 \nH311 \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 554}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 556\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-096-00-X  oxydisulfoton (ISO);  \nO, O -diethyl S-2-ethylsulphi\xad\nnylethyl phosphorodithioate  219-679-1  2497-07-6  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH410  M = 10  \n015-097-00-5  phenthoate (ISO); \nethyl 2-(dimethoxyphosphino\xad\nthioylthio)-2-phenylacetate  219-997-0  2597-03-7  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  M = 100  \n015-098-00-0  trichloronate (ISO);  \nO-ethyl  O-2,4,5-trichlorophenyl \nethylphosphonothioate  206-326-1  327-98-0  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH410  \n015-099-00-6  pirimiphos-ethyl (ISO);  \nO, O -diethyl  O-2-diethylamino- \n6-methylpyrimidin-4-yl phospho\xad\nrothioate  245-704-0  23505-41-1  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH312 \nH410  \n015-100-00-X  phoxim (ISO); \nα-(diethoxyphosphinothioy\xad\nlimino) phenylacetonitrile  238-887-3  14816-18-3  Repr. 2 \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f*** \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361f*** \nH302 \nH317 \nH410  M=1000  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 555}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 557\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M18  \n015-101-00-5  phosmet (ISO);  \nS-[(1,3-dioxo-1,3-dihydro-2 H- \nisoindol-2-yl)methyl]  O ,O- \ndimethyl phosphorodithioate;  \nO,O-dimethyl- S-phthalimid\xad\nomethyl phosphorodithioate  211-987-4  732-11-6  Repr. 2 \nAcute Tox. 4 \nAcute Tox. 3 \nSTOT SE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f \nH332 \nH301 \nH370 (nervous \nsystem) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H361f \nH332 \nH301 \nH370 \n(nervous \nsystem) \nH410  M = 100 \nM = 100  \n▼M16  \n015-102-00-0  tris(2-chloroethyl)phosphate  204-118-5  115-96-8  Carc. 2 \nRepr. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H351 \nH360F*** \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H351 \nH360F*** \nH302 \nH411  \n015-103-00-6  phosphorus tribromide  232-178-2  7789-60-8  Skin Corr. 1B \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  EUH014  \n015-104-00-1  diphosphorus pentasulphide; \nphosphorus pentasulphide  215-242-4  1314-80-3  Flam. Sol. 1 \nWater-react. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1  H228 \nH260 \nH332 \nH302 \nH400  GHS02 \nGHS07 \nGHS09 \nDgr H228 \nH260 \nH332 \nH302 \nH400  EUH029  T  \n015-105-00-7  triphenyl phosphite  202-908-4  101-02-0  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH410  Skin Irrit. 2; H315: \nC ≥ 5 % Eye Irrit. \n2; H319: C ≥ 5 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 556}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 558\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-106-00-2  hexamethylphosphoric triamide; \nhexamethylphosphoramide  211-653-8  680-31-9  Carc. 1B \nMuta. 1B  H350 \nH340  GHS08 \nDgr H350 \nH340  Carc. 1B; \nH350: C ≥ 0,01 %  \n015-107-00-8  ethoprophos (ISO); \nethyl- S,S-dipropyl phosphorodi\xad\nthioate  236-152-1  13194-48-4  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH301 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH301 \nH317 \nH410  \n015-108-00-3  bromophos (ISO);  \nO-4-bromo-2,5-dichlorophenyl  \nO,O-dimethyl phosphorothioate  218-277-3  2104-96-3  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M = 100  \n015-109-00-9  crotoxyphos (ISO); \n1-phenylethyl 3-(dimethoxyp\xad\nhosphinyloxy) isocrotonate  231-720-5  7700-17-6  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  M = 10  \n015-110-00-4  cyanofenphos (ISO);  \nO-4-cyanophenyl  O -ethyl \nphenylphosphonothioate  — 13067-93-1  Acute Tox. 3 * \nSTOT SE 1 \nAcute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 2  H301 \nH370 ** \nH312 \nH319 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH370 ** \nH312 \nH319 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 557}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 559\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-111-00-X  phosfolan (ISO); \ndiethyl 1,3-dithiolan-2-ylidenep\xad\nhosphoramidate  213-423-2  947-02-4  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n015-112-00-5  thionazin (ISO);  \nO,O-diethyl  O-pyrazin-2-yl phos\xad\nphorothioate;  206-049-6  297-97-2  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n015-113-00-0  tolclofos-methyl (ISO);  \nO-(2,6-dichloro- p-tolyl)- O,O- \ndimethyl thiophosphate  260-515-3  57018-04-9  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n015-114-00-6  chlormephos (ISO);  \nS-chloromethyl  O ,O-diethyl \nphosphorodithioate  246-538-1  24934-91-6  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  M = 10  \n015-115-00-1  chlorthiophos (ISO); \n[isomeric reaction mass in which  \nO-2,5-dichlorophenyl-4-methyl\xad\nthiophenyl  O, O -diethyl phos\xad\nphorothioate predominates]  244-663-6  21923-23-9  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH410  M = 1000  \n015-116-00-7  demephion-O (ISO);  \nO, O -dimethyl  O -2-methyl\xad\nthioethyl phosphorothioate  211-666-9  682-80-4  Acute Tox. 2 * \nAcute Tox. 3 *  H300 \nH311  GHS06 \nDgr H300 \nH311  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 558}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 560\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-117-00-2  demephion- S (ISO);  \nO, O -dimethyl  S -2-methyl\xad\nthioethyl phosphorothioate  219-971-9  2587-90-8  Acute Tox. 2 * \nAcute Tox. 3 *  H300 \nH311  GHS06 \nDgr H300 \nH311  \n015-118-00-8  demeton  —  8065-48-3  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1  H310 \nH300 \nH400  GHS06 \nGHS09 \nDgr H310 \nH300 \nH400  \n015-119-00-3  dimethyl 4-(methylthio)phenyl \nphosphate  — 3254-63-5  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n015-120-00-9  ditalimfos (ISO);  \nO, O -diethyl phthalimidophos\xad\nphonothioate  225-875-8  5131-24-8  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n015-121-00-4  edifenphos (ISO);  \nO-ethyl  S, S -diphenyl phospho\xad\nrodithioate  241-178-1  17109-49-8  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH312 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH312 \nH317 \nH410  \n015-122-00-X  etrimfos (ISO);  \nO-6-ethoxy-2-ethylpyrimidin-4-yl  \nO, O -dimethylphosphorothioate  253-855-9  38260-54-7  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M = 10  \n015-123-00-5  fenamiphos (ISO); \nethyl-4-methylthio- m-tolyl \nisopropyl phosphoramidate  244-848-1  22224-92-6  Acute Tox. 2 \nAcute Tox. 2 \nAcute Tox. 2 \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH310 \nH330 \nH319 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH310 \nH330 \nH319 \nH410  M = 100 \nM = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 559}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 561\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-124-00-0  fosthietan (ISO); \ndiethyl 1,3-dithietan-2-ylidenep\xad\nhosphoramidate  244-437-7  21548-32-3  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n015-125-00-6  glyphosine (ISO);  \nN,N-bis(phosphono\xad\nmethyl)glycine  219-468-4  2439-99-8  Eye Dam. 1  H318  GHS05 \nDgr H318  \n015-126-00-1  heptenophos (ISO); \n7-chlorobicyclo(3.2.0)hepta-2,6- \ndien-6-yl dimethyl phosphate  245-737-0  23560-59-0  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  M = 100  \n015-127-00-7  iprobenfos(ISO);  \nS-benzyl diisopropyl phosphoro\xad\nthioate  247-449-0  26087-47-8  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n015-128-00-2  IPSP;  \nS-ethylsulphinylmethyl  O ,O- \ndiisopropylphosphorodithioate  — 5827-05-4  Acute Tox. 1 \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH301 \nH410  M = 100  \n015-129-00-8  isofenphos (ISO);  \nO-ethyl  O-2-isopropoxycarbonyl\xad\nphenyl-isopropylphosphoramid\xad\nothioate  246-814-1  25311-71-1  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  M = 100  \n015-130-00-3  isothioate (ISO);  \nS-2-isopropylthioethyl  O ,O- \ndimethyl phosphorodithioate;  — 36614-38-7  Acute Tox. 3 * \nAcute Tox. 3 *  H311 \nH301  GHS06 \nDgr H311 \nH301  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 560}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 562\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-131-00-9  isoxathion (ISO);  \nO,O-diethyl  O-5-phenylisoxazol- \n3-ylphosphorothioate  242-624-8  18854-01-8  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  \n015-132-00-4  S-(chlorophenylthiomethyl)  O,O- \ndimethylphosphorodithioate; \nmethylcarbophenothione  — 953-17-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  M = 1000  \n015-133-00-X  piperophos (ISO);  \nS-2-methylpiperidinocarbonyl\xad\nmethyl- O, O -dipropyl phospho\xad\nrodithioate  — 24151-93-7  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M = 10  \n▼M23  \n015-134-00-5  pirimiphos-methyl (ISO);  \nO-[2-(diethylamino)-6-methyl\xad\npyrimidin-4-yl]  O ,O-dimethyl \nphosphorothioate  249-528-5  29232-93-7  Acute Tox. 4 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH372 (nervous \nsystem) \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nDgr H302 \nH372 \n(nervous \nsystem) \nH410  oral: ATE = \n1414 mg/kg bw \nM = 1000 \nM = 1000  \n▼M16  \n015-135-00-0  profenofos (ISO) O-(4-bromo-2- \nchlorophenyl)  O-ethyl  S-propyl \nphosphorothioate;  255-255-2  41198-08-7  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  M = 1000  \n015-136-00-6  trans-isopropyl-3-[[(ethy\xad\nlamino)methoxyfosfino\xad\nthioyl]oxy]crotonate; \nisopropyl 3-[[(ethylamino)metho\xad\nxyphosphinothioyl]oxy]isocro\xad\ntonate; propetamphos (ISO)  250-517-2  31218-83-4  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  M = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 561}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 563\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-137-00-1  pyrazophos (ISO);  \nO, O -diethyl  O -(6-ethoxycar\xad\nbonyl-5-methylpyrazolo[2,3- \na]pyrimidin-2-yl) phosphoro\xad\nthioate  236-656-1  13457-18-6  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH302 \nH410  \n015-138-00-7  quinalphos (ISO);  \nO, O -diethyl- O-quinoxalin-2-yl \nphosphorothioate  237-031-6  13593-03-8  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH312 \nH410  M = 1000  \n015-139-00-2  terbufos (ISO); \nS-tert-butylthiomethyl  O, O - \ndiethylphosphorodithioate;  235-963-8  13071-79-9  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  M = 1000  \n015-140-00-8  triazophos (ISO);  \nO, O -diethyl- O-1-phenyl-1 H- \n1,2,4-triazol-3-yl phosphoro\xad\nthioate  245-986-5  24017-47-8  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH312 \nH410  M=100  \n015-141-00-3  ethylenediammonium  O, O - \nbis(octyl) phosphorodithioate, \nmixed isomers  400-520-1  —  Skin Corr. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH302 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 562}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 564\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-142-00-9  butyl (dialkyloxy(dibutoxyphos\xad\nphoryloxy))titanium (trialky\xad\nloxy)titanium phosphate  401-100-0  —  Flam. Liq. 2 \nEye Irrit. 2 \nAquatic Chronic 2  H225 \nH319 \nH411  GHS02 \nGHS07 \nGHS09 \nDgr H225 \nH319 \nH411  T \n015-143-00-4  reaction mass of 2-chloroethyl \nchloropropyl 2-chloroethylphos\xad\nphonate, reaction mass of \nisomers and 2-chloroethyl \nchloropropyl 2-chloropropylphos\xad\nphonate, reaction mass of \nisomers  401-740-0  —  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n015-144-00-X  reaction mass of pentyl methyl\xad\nphosphinate and 2-methylbutyl \nmethylphosphinate  402-090-0  87025-52-3  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n015-145-00-5  reaction mass of copper(I)  O, O-  \ndiisopropyl phosphorodithioate \nand copper(I)  O-isopropyl  O-(4- \nmethylpent-2-yl) phosphorodi\xad\nthioate and copper(I)  O, O - \nbis(4-methylpent-2-yl) phospho\xad\nrodithioate  401-520-4  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n015-146-00-0  S-(tricyclo(5.2.1.0  2,6 )deca-3-en- \n8(or 9)-yl O-(isopropyl or \nisobutyl or 2-ethylhexyl)  O-(iso\xad\npropyl or isobutyl or 2- \nethylhexyl) phosphorodithioate  401-850-9  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n015-147-00-6  reaction mass of C  12-14-tert-alky\xad\nlammonium diphenyl phosphoro\xad\nthioate and dinonyl sulphide (or \ndisulphide)  400-930-0  —  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 563}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 565\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-148-00-1  2-(diphosphonomethyl)succinic \nacid 403-070-4  51395-42-7  Skin Corr. 1B \nSkin Sens. 1  H314 \nH317  GHS05 \nGHS07 \nDgr H314 \nH317  \n015-149-00-7  reaction mass of: hexyldioctylp\xad\nhosphineoxide; dihexyloctylp\xad\nhosphineoxide; trioctylphosphi\xad\nneoxide  403-470-9  —  Skin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  \n015-150-00-2  (2-(1,3-dioxolan-2-yl)ethyl)trip\xad\nhenylphosphonium bromide  404-940-6  86608-70-0  Acute Tox. 4 * \nEye Dam. 1 \nSTOT RE 2 * \nAquatic Chronic 3  H302 \nH318 \nH373 ** \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH318 \nH373 ** \nH412  \n015-151-00-8  tris(isopropyl/ tert-butylphe\xad\nnyl)phosphate  405-010-2  —  Aquatic Chronic 2  H411  GHS09  H411  \n015-152-00-3  dioxabenzofos (ISO); \n2-methoxy-4 H-1,3,2-benzodio\xad\nxaphosphorin 2-sulphide  223-292-3  3811-49-2  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT SE 1 \nAquatic Chronic 2  H311 \nH301 \nH370 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H311 \nH301 \nH370 ** \nH411  \n015-153-00-9  isazofos (ISO);  \nO-(5-chloro-1-isopropyl-1,2,4- \ntriazol-3-yl)  O, O -diethyl phos\xad\nphorothioate  255-863-8  42509-80-8  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH311 \nH301 \nH373 ** \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH311 \nH301 \nH373 ** \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 564}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 566\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-154-00-4  ethephon; \n2-chloroethylphosphonic acid  240-718-3  16672-87-0  Acute Tox. 3 \nAcute Tox. 4 \nAcute Tox. 4 \nSkin Corr. 1C \nAquatic Chronic 2  H311 \nH332 \nH302 \nH314 \nH411  GHS06 \nGHS05 \nGHS09 \nDgr H311 \nH332 \nH302 \nH314 \nH411  EUH071  \n015-155-00-X  glufosinate ammonium (ISO); \nammonium 2-amino-4-(hydroxy\xad\nmethylphosphinyl)butyrate  278-636-5  77182-82-2  Repr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 *  H360Fd \nH332 \nH312 \nH302 \nH373**  GHS08 \nGHS07 \nDgr H360Fd \nH332 \nH312 \nH302 \nH373**  \n015-156-00-5  methyl 3-[(dimethoxyphosphino\xad\nthioyl)oxy]methacrylate; [1] \nmethacrifos (ISO); \nmethyl ( E)-3-[(dimethoxyphosp\xad\nhinothioyl)oxy]methacrylate [2]  250-366-9 [1]- \n[2] 30864-28-9 [1] \n62610-77-9 [2]  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n015-157-00-0  phosphonic acid; [1] \nphosphorous acid [2]  237-066-7 [1] \n233-663-1 [2]  13598-36-2 [1] \n10294-56-1 [2]  Acute Tox. 4 * \nSkin Corr. 1A  H302 \nH314  GHS05 \nGHS07 \nDgr H302 \nH314  \n015-158-00-6  (η-cyclopentadienyl)(η-cume\xad\nnyl)iron(1+)hexafluorophos\xad\nphate(1-)  402-340-9  32760-80-8  Aquatic Chronic 3  H412  —  H412  \n015-159-00-1  hydroxyphosphonoacetic acid  405-710-8  23783-26-8  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1  H302 \nH373 ** \nH314 \nH317  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH373 ** \nH314 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 565}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 567\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-160-00-7  vanadyl pyrophosphate  406-260-5  58834-75-6  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H319 \nH317 \nH412  GHS07 \nWng  H319 \nH317 \nH412  \n015-161-00-2  divanadyl pyrophosphate  407-130-0  65232-89-5  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n015-162-00-8  vanadium(IV) oxide hydrogen \nphosphate hemihydrate, lithium, \nzinc, molybdenum, iron and \nchlorine-doped  407-350-7  —  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nAquatic Chronic 2  H332 \nH373 ** \nH318 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H332 \nH373 ** \nH318 \nH411  \n015-163-00-3  bis(2,6-dimethoxybenzoyl)-2,4,4- \ntrimethylpentylphosphinoxide  412-010-6  145052-34-2  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n015-164-00-9  calcium  P, P' -(1-hydroxyethy\xad\nlene)bis(hydrogen phosphon\xad\nate)dihydrate  400-480-5  36669-85-9  Aquatic Chronic 3  H412  —  H412  \n015-165-00-4  reaction mass of: thiobis(4,1- \nphenylene)- S, S,S',S' -tetraphe\xad\nnyldisulfonium bishexafluorop\xad\nhosphate; diphenyl(4-phenylt\xad\nhiophenyl)sulfonium hexafluo\xad\nrophosphate  404-986-7  —  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 566}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 568\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-166-00-X  3,9-bis(2,6-di- tert-butyl-4- \nmethylphenoxy)-2,4,8,10- \ntetraoxa-3,9-diphosphas\xad\npiro[5.5]undecane  410-290-4  80693-00-1  Aquatic Chronic 4  H413  —  H413  \n015-167-00-5  3-(hydroxyphenylphosphinyl)pro\xad\npanoic acid  411-200-6  14657-64-8  Eye Dam. 1  H318  GHS05 \nDgr H318  \n015-168-00-0  fosthiazate (ISO); \n(RS)-S-sec-butyl-O-ethyl-2-oxo- \n1,3-thiazolidin-3-ylphosphono\xad\nthioate  — 98886-44-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH312 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH312 \nH317 \nH410  EUH070  \n015-169-00-6  tributyltetradecylphosphonium \ntetrafluoroborate  413-520-1  —  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** \nH314 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H302 \nH373 ** \nH314 \nH317 \nH410  \n015-170-00-1  reaction mass of: di-(1-octane- N, \nN,N-trimethylammonium) octylp\xad\nhosphate; 1-octane- N, N,N - \ntrimethylammonium di-octylp\xad\nhosphate; 1-octane- N, N,N - \ntrimethylammonium octylphos\xad\nphate  407-490-9  —  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  \n015-171-00-7  O, O,O -tris(2(or 4)-C  9-10-isoal\xad\nkylphenyl) phosphorothioate  406-940-1  —  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 567}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 569\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-172-00-2  reaction mass of: bis(isotridecy\xad\nlammonium)mono(di-(4- \nmethylpent-2-yloxy)thiophospho\xad\nrothionylisopropyl)phosphate; \nisotridecylammonium bis(di-(4- \nmethylpent-2-yloxy)thiophospho\xad\nrothionylisopropyl)phosphate  406-240-6  —  Flam. Liq. 3 \nSkin Corr. 1B \nAquatic Chronic 2  H226 \nH314 \nH411  GHS02 \nGHS05 \nGHS09 \nDgr H226 \nH314 \nH411  \n015-173-00-8  methyl [2-(1,1-dimethylethyl)-6- \nmethoxypyrimidin-4-yl]ethylp\xad\nhosphonothioate  414-080-3  117291-73-3  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n015-174-00-3  1-chloro- N,N-diethyl-1,1- \ndiphenyl-1-(phenylmethyl)phos\xad\nphoramine  411-370-1  82857-68-9  Acute Tox. 3 * \nEye Dam. 1 \nAquatic Chronic 2  H301 \nH318 \nH411  GHS06 \nGHS05 \nGHS09 \nDgr H301 \nH318 \nH411  \n015-175-00-9  tert -butyl (triphenylphosphor\xad\nanylidene) acetate  412-880-7  35000-38-5  Acute Tox. 3 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H301 \nH373 ** \nH319 \nH317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH373 ** \nH319 \nH317 \nH411  \n015-176-00-4  P, P,P',P' -tetrakis-(o-methoxyp\xad\nhenyl)propane-1,3-diphosphine  413-430-2  116163-96-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n015-177-00-X  ((4-phenylbutyl)hydroxyphospho\xad\nryl)acetic acid  412-170-7  83623-61-4  STOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H373 ** \nH318 \nH317  GHS08 \nGHS05 \nDgr H373 ** \nH318 \nH317  \n015-178-00-5  (R)-α-phenylethylammonium(- \n)-(1R, 2 S)-(1,2-epoxypro\xad\npyl)phosphonate monohydrate  418-570-8  25383-07-7  Repr. 2 \nAquatic Chronic 2  H361f *** \nH411  GHS08 \nGHS09 \nWng  H361f *** \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 568}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 570\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-179-00-0  UVCB condensation product of: \ntetrakis-hydroxymethylphos\xad\nphonium chloride, urea and \ndistilled hydrogenated C  16-18 \ntallow alkylamine  422-720-8  166242-53-1  Carc. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH373 ** \nH314 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H351 \nH302 \nH373 ** \nH314 \nH317 \nH410  \n015-180-00-6  [R-(R*,S*)]-[[2-methyl-1-(1- \noxopropoxy)propoxy]-(4- \nphenylbutyl)phosphinyl] acetic \nacid, (-)-cinchonidine (1:1) salt  415-820-8  137590-32-0  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n▼M23  \n015-181-00-1  phosphine  232-260-8  7803-51-2  Flam. Gas 1 \nPress. Gas \nAcute Tox. 1 \nSkin Corr. 1B \nAquatic Acute 1  H220 \nH330 \nH314 \nH400  GHS02 \nGHS04 \nGHS06 \nGHS05 \nGHS09 \nDgr H220 \nH330 \nH314 \nH400  inhalation: \nATE = 10 ppmV \n(gases)  U \n▼M16  \n015-182-00-7  tetrapropan-2-yl (dichlorome\xad\nthanediyl)bis(phosphonate)  430-630-5  10596-22-2  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1  H302 \nH319 \nH317  GHS07 \nWng  H302 \nH319 \nH317  \n015-183-00-2  (1-hydroxydodecylidene)diphos\xad\nphonic acid  425-230-2  16610-63-2  Skin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 569}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 571\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-184-00-8  salts of glyphosate, with the \nexception of those specified \nelsewhere in this Annex  — —  Aquatic Chronic 2  H411  GHS09  H411  A  \n015-186-00-9  chlorpyrifos-methyl (ISO)  O, O - \ndimethyl  O -3,5,6-trichloro-2- \npyridyl phosphorothioate  227-011-5  5598-13-0  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M = 10000  \n015-187-00-4  reaction mass of: tetraso\xad\ndium(((2-hydroxye\xad\nthyl)imino)bis(methylene))bisp\xad\nhosphonate,  N-oxide; \ntrisodium ((tetrahydro-2- \nhydroxy-4 H-1,4,2-oxazaphos\xad\nphorin-4-yl)-methyl)phosphonate,  \nN-oxide,  P-oxide  417-540-1  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n▼M8 __________  \n▼M22  \n015-189-00-5  phenyl bis(2,4,6-trimethylben\xad\nzoyl)-phosphine oxide  423-340-5  162881-26-7  Skin Sens. 1A \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n▼M16  \n015-190-00-0  bis(2,4-dicumylphenyl)neopentyl \ndiphosphite; \n3,9-bis[2,4-bis(1-methyl-1- \nphenylethyl)phenoxy]-2,4,8,10- \ntetraoxa-3,9-diphosphas\xad\npiro[5.5]undecane  421-920-2  154862-43-8  Aquatic Chronic 4  H413  —  H413  \n015-191-00-6  dodecyldiphenyl phosphate  431-760-5  27460-02-2  Skin Irrit. 2 \nAquatic Chronic 3  H315 \nH412  GHS07 \nWng  H315 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 570}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 572\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-192-00-1  tetrakis(2,6-dimethylphenyl)- m- \nphenylene biphosphate  432-770-2  139189-30-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n015-193-00-7  triphenyl(phenylmethyl)phos\xad\nphonium 1,1,2,2,3,3,4,4,4- \nnonafluoro- N-methyl-1- \nbutanesulfonamide (1:1)  442-960-7  332350-93-3  Acute Tox. 3 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH318 \nH400 \nH410  GHS05 \nGHS06 \nGHS09 \nDgr H301 \nH318 \nH410  \n015-194-00-2  tetrabutyl-phosphonium \nnonafluoro-butane-1-sulfonate  444-440-5  220689-12-3  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n015-195-00-8  reaction mass of: potassium  o- \ntoluenephosphonate; \npotassium  m-toluenephosphonate; \npotassium  p-toluenephosphonate  433-860-4  —  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H319 \nH317 \nH412  GHS07 \nWng  H319 \nH317 \nH412  \n015-196-00-3  reaction mass of: dimethyl (2- \n(hydroxymethylcarba\xad\nmoyl)ethyl)phosphonate; \ndiethyl (2-(hydroxymethylcarba\xad\nmoyl)ethyl)phosphonate; \nmethyl ethyl (2-(hydroxymethyl\xad\ncarbamoyl)ethyl)phosphonate  435-960-3  —  Carc. 1B \nMuta. 1B \nSkin Sens. 1  H350 \nH340 \nH317  GHS08 \nGHS07 \nDgr H350 \nH340 \nH317  \n015-197-00-9  bis(2,4,4-trimethylpentyl)dithiop\xad\nhosphonic acid  420-160-9  107667-02-7  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H226 \nH331 \nH302 \nH314 \nH411  GHS02 \nGHS06 \nGHS05 \nGHS09 \nDgr H226 \nH331 \nH302 \nH314 \nH411  \n015-198-00-4  (4-phenylbutyl)phosphinic acid  420-450-5  86552-32-1  Carc. 2 \nEye Dam. 1  H351 \nH318  GHS05 \nGHS08 \nDgr H351 \nH318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 571}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 573\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n015-199-00-X  tris[2-chloro-1-chloro\xad\nmethyl)ethyl] phosphate  237-159-2  13674-87-8  Carc. 2  H351  GSH08 \nWng  H351  \n015-200-00-3  indium phosphide  244-959-5  22398-80-7  Carc. 1B Repr. 2 \nSTOT RE 1  H350 \nH361f \nH372 (lungs)  GHS08 \nDgr H350 \nH361f \nH372 (lungs)  STOT RE 1; H372: \nC ≥0,1 % Carc 1B; \nH350: C \n≥0,01 % STOT \nRE 2; \nH373: 0,01 % ≤ \nC < 0,1 %  \n015-201-00-9  trixylyl phosphate  246-677-8  25155-23-1  Repr. 1B  H360F  GHS08 \nDgr H360F  \n015-202-00-4  tris(nonylphenyl) phosphite  247-759-6  26523-78-4  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n015-203-00-X  diphenyl(2,4,6-trimethylben\xad\nzoyl)phosphine oxide  278-355-8  75980-60-8  Repr. 2  H361f (causing \natrophy of the \ntestes)  GHS08 \nWng  H361f \n(causing \natrophy of \nthe testes)  \n016-001-00-4  hydrogen sulphide  231-977-3  7783-06-4  Flam. Gas 1 \nPress. Gas \nAcute Tox. 2 * \nAquatic Acute 1  H220 \nH330 \nH400  GHS02 \nGHS04 \nGHS06 \nGHS09 \nDgr H220 \nH330 \nH400  U \n016-002-00-X  barium sulphide  244-214-4  21109-95-5  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1  H332 \nH302 \nH400  GHS07 \nGHS09 \nWng  H332 \nH302 \nH400  EUH031  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 572}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 574\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-003-00-5  barium polysulphides  256-814-3  50864-67-0  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H319 \nH335 \nH315 \nH400  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH400  EUH031  \n016-004-00-0  calcium sulphide  243-873-5  20548-54-3  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H319 \nH335 \nH315 \nH400  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH400  EUH031  \n016-005-00-6  calcium polysulphides  215-709-2  1344-81-6  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H319 \nH335 \nH315 \nH400  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH400  EUH031  \n016-006-00-1  dipotassium sulphide; \npotassium sulphide  215-197-0  1312-73-8  Skin Corr. 1B \nAquatic Acute 1  H314 \nH400  GHS05 \nGHS09 \nDgr H314 \nH400  EUH031  \n016-007-00-7  potassium polysulphides  253-390-1  37199-66-9  Skin Corr. 1B \nAquatic Acute 1  H314 \nH400  GHS05 \nGHS09 \nDgr H314 \nH400  EUH031  \n016-008-00-2  ammonium polysulphides  232-989-1  9080-17-5  Skin Corr. 1B \nAquatic Acute 1  H314 \nH400  GHS05 \nGHS09 \nDgr H314 \nH400  EUH031  EUH031: C ≥1 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 573}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 575\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-009-00-8  disodium sulfide; \nsodium sulfide  215-211-5  1313-82-2  Acute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1  H311 \nH302 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H311 \nH302 \nH314 \nH400  \n016-010-00-3  sodium polysulphides  215-686-9  1344-08-7  Acute Tox. 3 * \nSkin Corr. 1B \nAquatic Acute 1  H301 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H301 \nH314 \nH400  EUH031  \n016-011-00-9  sulphur dioxide  231-195-2  7446-09-5  Press. Gas \nAcute Tox. 3 * \nSkin Corr. 1B  H331 \nH314  GHS04 \nGHS06 \nGHS05 \nDgr H331 \nH314  * U 5  \n016-012-00-4  disulphur dichloride; \nsulfur monochloride  233-036-2  10025-67-9  Acute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1A \nAquatic Acute 1  H301 \nH332 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H301 \nH332 \nH314 \nH400  EUH014 \nEUH029  STOT SE 3; H335: \nC ≥ 1 %  \n016-013-00-X  sulphur dichloride  234-129-0  10545-99-0  Skin Corr. 1B \nSTOT SE 3 \nAquatic Acute 1  H314 \nH335 \nH400  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH335 \nH400  EUH014  STOT SE 3; H335: \nC ≥ 5 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 574}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 576\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-014-00-5  sulphur tetrachloride  —  13451-08-6  Skin Corr. 1B \nAquatic Acute 1  H314 \nH400  GHS05 \nGHS09 \nDgr H314 \nH400  EUH014  STOT SE 3; H335: \nC ≥ 5 %  \n016-015-00-0  thionyl dichloride; \nthionyl chloride  231-748-8  7719-09-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H332 \nH302 \nH314  GHS05 \nGHS07 \nDgr H332 \nH302 \nH314  EUH014 \nEUH029  STOT SE 3; H335: \nC ≥ 1 %  \n016-016-00-6  sulphuryl chloride  232-245-6  7791-25-5  Skin Corr. 1B \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  EUH014  \n016-017-00-1  chlorosulphonic acid  232-234-6  7790-94-5  Skin Corr. 1A \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  EUH014  \n016-018-00-7  fluorosulphonic acid  232-149-4  7789-21-1  Acute Tox. 4 * \nSkin Corr. 1A  H332 \nH314  GHS05 \nGHS07 \nDgr H332 \nH314  \n016-019-00-2  oleum … % SO3  —  —  Skin Corr. 1A \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  EUH014  B  \n016-020-00-8  sulphuric acid … %  231-639-5  7664-93-9  Skin Corr. 1A  H314  GHS05 \nDgr H314  Skin Corr. 1A; \nH314: C ≥ 15 % \nSkin Irrit. 2; H315: \n5 % ≤ C < 15 % \nEye Irrit. 2; H319: \n5 % ≤ C < 15 %  B ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 575}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 577\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-021-00-3  methanethiol; \nmethyl mercaptan  200-822-1  74-93-1  Flam. Gas. 1 \nPress. Gas \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H220 \nH331 \nH400 \nH410  GHS02 \nGHS04 \nGHS06 \nGHS09 \nDgr H220 \nH331 \nH410  U \n016-022-00-9  ethanethiol; \nethyl mercaptan  200-837-3  75-08-1  Flam. Liq. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH332 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nDgr H225 \nH332 \nH410  \n016-023-00-4  dimethyl sulphate  201-058-1  77-78-1  Carc. 1B \nMuta. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1  H350 \nH341 \nH330 \nH301 \nH314 \nH317  GHS06 \nGHS08 \nGHS05 \nDgr H350 \nH341 \nH330 \nH301 \nH314 \nH317  Carc. 1B; H350: C \n≥ 0,01 % Muta. 2 \nH341: C ≥ 0,01 % \nSTOT SE 3; H335: \nC ≥ 5 %  \n016-024-00-X  dimexano(ISO); bis(methoxythio\xad\ncarbonyl) disulphide  215-993-8  1468-37-7  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n016-025-00-5  disul (ISO); \n2-(2,4-dichlorophenoxy)ethyl \nhydrogensulphate; \n2,4-DES  205-259-5  149-26-8  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1  H302 \nH315 \nH318  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318  \n016-026-00-0  sulphamidic acid; \nsulphamic acid; \nsulfamic acid  226-218-8  5329-14-6  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 3  H319 \nH315 \nH412  GHS07 \nWng  H319 \nH315 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 576}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 578\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-027-00-6  diethyl sulphate  200-589-6  64-67-5  Carc. 1B \nMuta. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H350 \nH340 \nH332 \nH312 \nH302 \nH314  GHS05 \nGHS08 \nGHS07 \nDgr H350 \nH340 \nH332 \nH312 \nH302 \nH314  \n016-028-00-1  sodium dithionite; \nsodium hydrosulphite  231-890-0  7775-14-6  Self-heat. 1 \nAcute Tox. 4 *  H251 \nH302  GHS02 \nGHS07 \nDgr H251 \nH302  EUH031  \n016-029-00-7  p-toluenesulphonic acid, (con\xad\ntaining more than 5 % H  2SO 4) — —  Skin Corr. 1B  H314  GHS05 \nDgr H314  Skin Corr. 1B; \nH314: C ≥ 25 % \nSkin Irrit. 2; H315: \n10 % ≤ C < 25 % \nEye Irrit. 2; H319: \n10 % ≤ C < 25 %  \n016-030-00-2  p-toluenesulphonic acid (con\xad\ntaining a maximum of 5 % \nH 2SO 4) 203-180-0  104-15-4  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  STOT SE 3; H335: \nC ≥ 20 %  \n016-031-00-8  tetrahydrothiophene-1,1-dioxide; \nsulpholane  204-783-1  126-33-0  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n016-032-00-3  1,3-propanesultone; \n1,2-oxathiolane 2,2-dioxide  214-317-9  1120-71-4  Carc. 1B \nAcute Tox. 4 * \nAcute Tox. 4 *  H350 \nH312 \nH302  GHS08 \nGHS07 \nDgr H350 \nH312 \nH302  Carc. 1B; H350: C \n≥ 0,01 %  \n016-033-00-9  dimethylsulfamoylchloride  236-412-4  13360-57-1  Carc. 1B \nAcute Tox. 2 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H350 \nH330 \nH312 \nH302 \nH314  GHS06 \nGHS05 \nGHS08 \nDgr H350 \nH330 \nH312 \nH302 \nH314  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 577}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 579\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-034-00-4  tetrasodium 3,3'-(piperazine-1,4- \ndiylbis((6-chloro-1,3,5-triazine- \n2,4-diyl)imino(2-acetamido)-4,1- \nphenyleneazo))bis(naphthalene- \n1,5-disulphonate)  400-010-9  81898-60-4  Skin Sens. 1  H317  GHS07 \nWng  H317  \n016-035-00-X  pentasodium 5-anilino-3-(4-(4-(6- \nchloro-4-(3-sulphonatoanilino)- \n1,3,5-triazin-2-ylamino)-2,5- \ndimethylphenylazo)-2,5- \ndisulphonatophenylazo)-4- \nhydroxynaphthalene-2,7- \ndisulphonate  400-120-7  —  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n016-036-00-5  tetrasodium 5-(4,6-dichloro-5- \ncyanopyrimidin-2-ylamino)-4- \nhydroxy-2,3-azodinaphthalene- \n1,2,5,7-disulphonate  400-130-1  —  Resp. Sens. 1 \nAquatic Chronic 2  H334 \nH411  GHS08 \nGHS09 \nDgr H334 \nH411  \n016-037-00-0  disodium 1-amino-4-(4-benzene\xad\nsulphonamido-3-sulphonatoa\xad\nnilino)anthraquinone-2- \nsulphonate  400-350-8  85153-93-1  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n016-038-00-6  disodium 6-((4-chloro-6-( N- \nmethyl)-2-toluidino)-1,3,5- \ntriazin-2-ylamino)-1-hydroxy-2- \n(4-methoxy-2-sulphonatopheny\xad\nlazo)naphthalene-3-sulphonate  400-380-1  86393-35-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n016-039-00-1  tetrasodium 2-(6-chloro-4-(4- \n(2,5-dimethyl-4-(2,5-disulphon\xad\natophenylazo)phenylazo)-3- \nureidoanilino)-1,3,5-triazin-2- \nylamino)benzene-1,4- \ndisulphonate  400-430-2  —  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 578}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 580\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-040-00-7  reaction mass of disodium 6- \n(2,4-dihydroxyphenylazo)-3-(4- \n(4-(2,4-dihydroxypheny\xad\nlazo)anilino)-3-sulphonatopheny\xad\nlazo)-4-hydroxynaphthalene-2- \nsulphonate and disodium 6-(2,4- \ndiaminophenylazo)-3-(4-(4-(2,4- \ndiaminophenylazo)anilino)-3- \nsulphonatophenylazo)-4-hydroxy\xad\nnaphthalene-2-sulphonate and \ntrisodium 6-(2,4-dihydroxyp\xad\nhenylazo)-3-(4-(4-(7-(2,4-dihy\xad\ndroxyphenylazo)-1-hydroxy-3- \nsulphonato-2-naphthy\xad\nlazo)anilino)-3-sulphonatopheny\xad\nlazo)-4-hydroxynaphthalene-2- \nsulphonate  400-570-4  —  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n016-041-00-2  calcium 2,5-dichloro-4-(4-((5- \nchloro-4-methyl-2-sulphonatop\xad\nhenyl)azo)-5-hydroxy-3-methyl\xad\npyrazol-1-yl)benzenesulphonate  400-710-4  —  Acute Tox. 4 *  H332  GHS07 \nWng  H332  \n016-042-00-8  tetrasodium 5-benzamido-3-(5-(4- \nfluoro-6-(1-sulphonato-2-naph\xad\nthylamino)-1,3,5-triazin-2- \nylamino)-2-sulphonatopheny\xad\nlazo)-4-hydroxynaphthalene-2,7- \ndisulphonate  400-790-0  85665-97-0  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  \n016-043-00-3  dilithium 6-acetamido-4- \nhydroxy-3-(4-((2-sulphon\xad\natooxy)ethylsulphonyl) pheny\xad\nlazo)naphthalene-2-sulphonate  401-010-1  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n016-044-00-9  disodium  S ,S-hexane-1,6- \ndiyldi(thiosulphate) dihydrate  401-320-7  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 579}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 581\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-045-00-4  lithium sodium hydrogen 4- \namino-6-(5-(5-chloro-2,6-difluor\xad\nopyrimidin-4-ylamino)-2- \nsulphonatophenylazo)-5-hydroxy- \n3-(4-(2-(sulphonatooxy)ethylsul\xad\nphonyl)phenylazo)naphthalene- \n2,7-disulphonate  401-560-2  108624-00-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n016-046-00-X  sodium hydrogensulphate  231-665-7  7681-38-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n016-047-00-5  hexasodium 7-(4-(4-(4-(2,5- \ndisulphonatoanilino)-6-fluoro- \n1,3,5-triazin-2-ylamino)-2- \nmethylphenylazo)-7-sulphonaton\xad\naphthylazo)naphthalene-1,3,5- \ntrisulphonate  401-650-1  85665-96-9  Skin Sens. 1  H317  GHS07 \nWng  H317  \n016-048-00-0  sodium 3,5-dichloro-2-(5-cyano- \n2,6-bis(3-hydroxypropylamino)- \n4-methylpyridin-3-ylazo)ben\xad\nzenesulphonate  401-870-8  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n016-049-00-6  calcium octadecylxylenesul\xad\nphonate  402-040-8  —  Skin Corr. 1B \nAquatic Chronic 2  H314 \nH411  GHS05 \nGHS09 \nDgr H314 \nH411  \n016-050-00-1  potassium sodium 5-(4-chloro-6- \n(N-(4-(4-chloro-6-(5-hydroxy- \n2,7-disulphonato-6-(2-sulphon\xad\natophenylazo)-4-naphthylamino)- \n1,3,5-triazin-2-ylamino) phenyl-  \nN-methyl)amino)-1,3,5-triazin-2- \nylamino)-4-hydroxy-3-(2- \nsulphonatophenylazo)naph\xad\nthalene-2,7-disulphonat  402-150-6  —  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 580}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 582\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-051-00-7  trisodium 7-(4-(6-fluoro-4-(2-(2- \nvinylsulphonylethoxy)ethy\xad\nlamino)-1,3,5-triazin-2-ylamino)- \n2-ureidophenylazo)naphthalene- \n1,3,6-trisulphonate  402-170-5  106359-91-5  Skin Sens. 1  H317  GHS07 \nWng  H317  \n016-052-00-2  benzyltributylammonium 4- \nhydroxynaphthalene-1-sulphonate  402-240-5  102561-46-6  Acute Tox. 4 * \nAquatic Chronic 2  H332 \nH411  GHS07 \nGHS09 \nWng  H332 \nH411  \n016-053-00-8  ( C  16 or C  18-n-alkyl)(C  16 or C  18- \nn-alkyl)ammonium 2-((C  16 or \nC 18-n-alkyl)(C  16 or C  18-n- \nalkyl)carbamoyl)benzenesul\xad\nphonate  402-460-1  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H315 \nH317 \nH413  GHS07 \nWng  H315 \nH317 \nH413  \n016-054-00-3  sodium 4-(2,4,4-trimethylpen\xad\ntylcarbonyloxy)benzenesulfonate  400-030-8  —  Acute Tox. 3 * \nSTOT RE 1 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Sens. 1  H331 \nH372 ** \nH302 \nH319 \nH335 \nH317  GHS06 \nGHS08 \nDgr H331 \nH372 ** \nH302 \nH319 \nH335 \nH317  \n016-055-00-9  tetrasodium 4-amino-3,6-bis(5- \n(6-chloro-4-(2-hydroxyethy\xad\nlamino)-1,3,5-triazin-2-ylamino)- \n2-sulfonatophenylazo)-5- \nhydroxynaphthalene-2,7- \nsulfonate (containing > 35 % \nsodium chloride and sodium \nacetate)  400-510-7  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n016-056-00-4  potassium hydrogensulphate  231-594-1  7646-93-7  Skin Corr. 1B \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  \n016-057-00-X  styrene-4-sulfonyl chloride  404-770-2  2633-67-2  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H315 \nH318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 581}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 583\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-058-00-5  thionyl chloride, reaction \nproducts with 1,3,4-thiadiazol- \n2,5-dithiol,  tert -nonanethiol \nandC  12-14-tert-alkylamine  404-820-3  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H315 \nH317 \nH412  GHS07 \nWng  H315 \nH317 \nH412  \n016-059-00-0  N, N,N',N' -tetramethyldithio\xad\nbis(ethylene)diamine dihydro\xad\nchloride  405-300-9  17339-60-5  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH317 \nH410  \n016-060-00-6  diammonium peroxodisulphate; \nammonium persulphate  231-786-5  7727-54-0  Ox. Sol. 3 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1  H272 \nH302 \nH319 \nH335 \nH315 \nH334 \nH317  GHS03 \nGHS08 \nGHS07 \nDgr H272 \nH302 \nH319 \nH335 \nH315 \nH334 \nH317  \n016-061-00-1  dipotassium peroxodisulphate; \npotassium persulphate  231-781-8  7727-21-1  Ox. Sol. 3 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1  H272 \nH302 \nH319 \nH335 \nH315 \nH334 \nH317  GHS03 \nGHS08 \nGHS07 \nDgr H272 \nH302 \nH319 \nH335 \nH315 \nH334 \nH317  \n016-062-00-7  bensultap (ISO); \n1,3-bis(phenylsulfonylthio)-2- \n(N,N-dimethylamino)propane  — 17606-31-4  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n016-063-00-2  sodium metabisulphite  231-673-0  7681-57-4  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  EUH031  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 582}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 584\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-064-00-8  sodium hydrogensulphite … %; \nsodium bisulphite . . . %  231-548-0  7631-90-5  Acute Tox. 4 *  H302  GHS07 \nWng  H302  EUH031  B  \n016-065-00-3  sodium 1-amino-4-[2-methyl-5- \n(4-methylphenylsulfony\xad\nlamino)phenylamino]anthra\xad\nquinone-2-sulfonate  400-100-8  84057-97-6  Aquatic Chronic 2  H411  GHS09  H411  \n016-066-00-9  tetrasodium [5-((4-amino-6- \nchloro-1,3,5-triazin-2-yl)amino)- \n2-((2-hydroxy-3,5-disulfonatop\xad\nhenylazo)-2-sulfonatobenzylide\xad\nnehydrazino)benzoate]copper(II)  404-070-7  116912-62-0  Aquatic Chronic 3  H412  —  H412  \n016-067-00-4  (4-methylphenyl)mesitylene \nsulfonate  407-530-5  67811-06-7  Aquatic Chronic 4  H413  —  H413  \n016-068-00-X  sodium 3,5-bis(tetradecyloxycar\xad\nbonyl)benzenesulfinate  407-720-8  155160-86-4  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n016-069-00-5  3,5-bis-(tetradecyloxycar\xad\nbonyl)benzenesulfinic acid  407-990-7  141915-64-2  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n016-070-00-0  4-benzyloxy-4'-(2,3-epoxy-2- \nmethylprop-1-yloxy)diphe\xad\nnylsulfone  408-220-2  —  Aquatic Chronic 4  H413  —  H413  \n016-071-00-6  trisodium 3-amino-6,13-dichloro- \n10-((3-((4-chloro-6-(2-sulfop\xad\nhenylamino)-1,3,5-triazin-2- \nyl)amino)propyl) amino)-4,11- \ntriphenoxydioxazinedisulfonate  410-130-3  136248-03-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n016-072-00-1  3-amino-4-hydroxy- N-(2-metho\xad\nxyethyl)-benzenesulfonamide  411-520-6  112195-27-4  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 583}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 585\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-073-00-7  tetrakis(phenylmethyl)thioper\xad\noxydi(carbothioamide)  404-310-0  10591-85-2  Aquatic Chronic 4  H413  —  H413  \n016-074-00-2  6-fluoro-2-methyl-3-(4-methyl\xad\nthiobenzyl)indene  405-410-7  —  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH411  \n016-075-00-8  2,2'-diallyl-4,4'-sulfonyldiphenol  411-570-9  41481-66-7  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n016-076-00-3  2,3-bis((2-mercaptoethyl)thio)-1- \npropanethiol  411-290-7  131538-00-6  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** H400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH410  \n016-077-00-9  2-chloro- p-toluenesulfochloride  412-890-1  42413-03-6  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H314 \nH317 \nH412  GHS05 \nGHS07 \nDgr H314 \nH317 \nH412  \n016-078-00-4  4-methyl- N, N -bis(2-(((4-methyl\xad\nphenyl)sulfonyl)amino)ethyl)ben\xad\nzenesulfonamide  413-300-5  56187-04-3  Aquatic Chronic 4  H413  —  \n016-079-00-X  N, N -bis(2-(p-toluenesulfony\xad\nloxy)ethyl)- p-toluenesulfonamide  412-920-3  16695-22-0  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n016-080-00-5  sodium 2-anilino-5-(2-nitro-4-( N- \nphenylsulfamoyl))anilinoben\xad\nzenesulfonate  412-320-1  31361-99-6  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n016-081-00-0  hexahydrocyclopenta[ c]pyrrole-1- \n(1H)-ammonium  N -ethoxycar\xad\nbonyl- N-(p-tolylsulfonyl)azanide  418-350-1  —  Muta. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H341 \nH302 \nH319 \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH302 \nH319 \nH317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 584}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 586\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-082-00-6  ethoxysulfuron (ISO); \n1-(4,6-dimethoxypyrimidin-2-yl)- \n3-(2-ethoxyphenoxysulfonyl)urea  — 126801-58-9  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n016-083-00-1  acibenzolar- S-methyl; \nbenzo[1,2,3]thiadiazole-7-carbo\xad\nthioic acid  S-methyl ester  420-050-0  135158-54-2  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH335 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH317 \nH410  \n016-084-00-7  prosulfuron (ISO); \n1-(4-methoxy-6-methyl-1,3,5- \ntriazin-2-yl)-3-[2-(3,3,3-trifluor\xad\nopropyl)phenylsulfonyl]urea  — 94125-34-5  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M=100  \n016-085-00-2  flazasulfuron (ISO); \n1-(4,6-dimethoxypyrimidin-2-yl)- \n3-(3-trifluoromethyl-2-pyridylsul\xad\nfonyl)urea  — 104040-78-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n016-086-00-8  tetrasodium 10-amino-6,13- \ndichloro-3-(3-(4-(2,5-disulfon\xad\natoanilino)-6-fluoro-1,3,5-triazin- \n2-ylamino)prop-3-ylamino)-5,12- \ndioxa-7,14-diazapentacene-4,11- \ndisulfonate  402-590-9  109125-56-6  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 585}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 587\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-087-00-3  reaction mass of: thiobis(4,1- \nphenylene)- S, S,S',S' -tetraphe\xad\nnyldisulfonium bishexafluorop\xad\nhosphate; \ndiphenyl(4-phenylthiophenyl)sul\xad\nfonium hexafluorophosphate; \npropylene carbonate  403-490-8  104558-95-4  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH317 \nH410  \n016-088-00-9  4-(bis(4-(diethylamino)phe\xad\nnyl)methyl)benzene-1,2-dime\xad\nthanesulfonic acid  407-280-7  71297-11-5  Aquatic Chronic 3  H412  —  H412  \n016-089-00-4  reaction mass of esters of \n5,5',6,6',7,7'-hexahydroxy- \n3,3,3',3'-tetramethyl-1,1'-spiro\xad\nbiindan and 2-diazo-1,2-dihydro- \n1-oxo-5-sulfonaphthalene  413-840-1  —  Self-react. C **** \nAquatic Chronic 4  H242 \nH413  GHS02 \nDgr H242 \nH413  \n016-090-00-X  4-methyl-N-(methylsulfonyl)ben\xad\nzenesulfonamide  415-040-8  14653-91-9  Acute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1  H302 \nH335 \nH318  GHS05 \nGHS07 \nDgr H302 \nH335 \nH318  \n016-091-00-5  C  12-14-tert-alkyl ammonium 1- \namino-9,10-dihydro-9,10-dioxo- \n4-(2,4,6-trimethylanilino)- \nanthracen-2-sulfonate  414-110-5  —  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n016-092-00-0  reaction mass of: 4,7-bis(mercap\xad\ntomethyl)-3,6,9-trithia-1,11- \nundecanedithiol; \n4,8-bis(mercaptomethyl)-3,6,9- \ntrithia-1,11-undecanedithiol; \n5,7-bis(mercaptomethyl)-3,6,9- \ntrithia-1,11-undecanedithiol  427-050-1  —  Repr. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361f \nH315 \nH317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 586}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 588\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-093-00-6  reaction mass of: 4-(7-hydroxy- \n2,4,4-trimethyl-2-chromanyl)re\xad\nsorcinol-4-yl-tris(6-diazo-5,6- \ndihydro-5-oxonaphthalen-1- \nsulfonate); \n4-(7-hydroxy-2,4,4-trimethyl-2- \nchromanyl)resorcinolbis(6-diazo- \n5,6-dihydro-5-oxonaphthalen-1- \nsulfonate) (2:1)  414-770-4  140698-96-0  Self-react. C **** \nCarc. 2  H242 \nH351  GHS02 \nGHS08 \nDgr H242 \nH351  \n016-094-00-1  sulfur  231-722-6  7704-34-9  Skin Irrit. 2  H315  GHS07 \nWng  H315  \n016-095-00-7  reaction mass of: reaction \nproduct of 4,4'-methylenebis[2- \n(4-hydroxybenzyl)-3,6-dimethyl\xad\nphenol] and 6-diazo-5,6-dihydro- \n5-oxo-naphthalenesulfonate (1:2); \nreaction product of 4,4'-methyl\xad\nenebis[2-(4-hydroxybenzyl)-3,6- \ndimethylphenol] and 6-diazo-5,6- \ndihydro-5-oxo-naphthalenesul\xad\nfonate (1:3)  417-980-4  —  Self-react. C **** \nCarc. 2  H242 \nH351  GHS02 \nGHS08 \nDgr H242 \nH351  \n▼M18  \n016-096-00-2  thifensulfuron-methyl (ISO); \nmethyl 3-(4-methoxy-6-methyl- \n1,3,5-triazin-2-ylcarbamoylsulfa\xad\nmoyl)thiophene-2-carboxylate  — 79277-27-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 100 \nM = 100  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 587}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 589\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n016-097-00-8  1-amino-2-methyl-2-propanethiol \nhydrochloride  434-480-1  32047-53-3  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH314 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH314 \nH317 \nH412  \n▼M23  \n016-098-00-3  dimethyl disulphide  210-871-0  624-92-0  Flam. Liq. 2 \nAcute Tox. 3 \nAcute Tox. 3 \nSTOT SE 3 \nSTOT SE 1 \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH331 \nH301 \nH336 \nH370 (upper \nrespiratory \ntract, inha\xad\nlation) \nH319 \nH317 \nH400 \nH410  GHS02 \nGHS06 \nGHS08 \nGHS09 \nDgr H225 \nH331 \nH301 \nH336 \nH370 (upper \nrespiratory \ntract, inha\xad\nlation) \nH319 \nH317 \nH410  inhalation: ATE = \n5 mg/L (vapours) \noral: ATE = \n190 mg/kg bw \nM = 1 \nM = 10  \n▼M16  \n017-001-00-7  chlorine  231-959-5  7782-50-5  Ox. Gas 1 \nPress. Gas \nAcute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H270 \nH331 \nH319 \nH335 \nH315 \nH400  GHS03 \nGHS04 \nGHS06 \nGHS09 \nDgr H270 \nH331 \nH319 \nH335 \nH315 \nH400  M = 100  U  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 588}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 590\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n017-002-00-2  hydrogen chloride  231-595-7  7647-01-0  Press. Gas \nAcute Tox. 3 * \nSkin Corr. 1A  H331 \nH314  GHS04 \nGHS06 \nGHS05 \nDgr H331 \nH314  U5 \n017-002-01-X  hydrochloric acid … %  231-595-7  —  Skin Corr. 1B \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  Skin Corr. 1B; \nH314: C ≥ 25 % \nSkin Irrit. 2; H315: \n10 % ≤ C < 25 % \nEyeIrrit. 2; H319: \n10 % ≤ C < 25 % \nSTOT SE 3; H335: \nC ≥ 10 %  B \n017-003-00-8  barium chlorate  236-760-7  13477-00-4  Ox. Sol. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H271 \nH332 \nH302 \nH411  GHS03 \nGHS07 \nGHS09 \nDgr H271 \nH332 \nH302 \nH411  \n017-004-00-3  potassium chlorate  223-289-7  3811-04-9  Ox. Sol. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H271 \nH332 \nH302 \nH411  GHS03 \nGHS07 \nGHS09 \nDgr H271 \nH332 \nH302 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 589}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 591\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n017-005-00-9  sodium chlorate  231-887-4  7775-09-9  Ox. Sol. 1 \nAcute Tox. 4 * \nAquatic Chronic 2  H271 \nH302 \nH411  GHS03 \nGHS07 \nGHS09 \nDgr H271 \nH302 \nH411  \n017-006-00-4  perchloric acid … %  231-512-4  7601-90-3  Ox. Liq. 1 \nSkin Corr. 1A  H271 \nH314  GHS03 \nGHS05 \nDgr H271 \nH314  Skin Corr. 1A; \nH314: C ≥ 50 % \nSkin Corr. 1B; \nH314: 10 % ≤ C < \n50 % \nSkin Irrit. 2; H315: \n1 % ≤ C < 10 % \nEye Irrit. 2; H319: \n1 % ≤ C < 10 % \nOx. Liq. 1; H271: \nC > 50 %: \nOx. Liq. 2; H272: \nC ≤ 50 %:  B \n017-007-00-X  barium perchlorate  236-710-4  13465-95-7  Ox. Sol. 1 \nAcute Tox. 4 * \nAcute Tox. 4 *  H271 \nH332 \nH302  GHS03 \nGHS07 \nDgr H271 \nH332 \nH302  \n017-008-00-5  potassium perchlorate  231-912-9  7778-74-7  Ox. Sol. 1 \nAcute Tox. 4 *  H271 \nH302  GHS03 \nGHS07 \nDgr H271 \nH302  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 590}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 592\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n017-009-00-0  ammonium perchlorate  232-235-1  7790-98-9  Expl. 1.1 \nOx. Sol. 1  H201 \nH271  GHS01 \nDgr H201 \nH271  T \n017-010-00-6  sodium perchlorate  231-511-9  7601-89-0  Ox. Sol. 1 \nAcute Tox. 4 *  H271 \nH302  GHS03 \nGHS07 \nDgr H271 \nH302  \n▼M18  \n017-011-00-1  sodium hypochlorite, solution … \n% Cl active  231-668-3  7681-52-9  Skin Corr. 1B \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  EUH031  M = 10 \nM = 1 \nEUH031: \nC ≥ 5 %  B \n▼M16  \n017-012-00-7  calcium hypochlorite  231-908-7  7778-54-3  Ox. Sol. 2 \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1  H272 \nH302 \nH314 \nH400  GHS03 \nGHS05 \nGHS07 \nGHS09 \nDgr H272 \nH302 \nH314 \nH400  EUH031  Skin Corr. 1B; \nH314: C ≥ 5 % \nSkin Irrit. 2; H315: \n1 % ≤ C < 5 % \nEye Dam.1; H318: \n3 % ≤ C < 5 % \nEye Irrit. 2; H319: \n0,5 % ≤ C < 3 % \nM = 10  T \n017-013-00-2  calcium chloride  233-140-8  10043-52-4  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n017-014-00-8  ammonium chloride  235-186-4  12125-02-9  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n017-015-00-3  (2-(aminomethyl)phenyl)acetyl\xad\nchloride hydrochloride  417-410-4  61807-67-8  Acute Tox. 4 * \nSkin Corr. 1A \nSkin Sens. 1  H302 \nH314 \nH317  GHS05 \nGHS07 \nDgr H302 \nH314 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 591}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 593\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n017-016-00-9  methyltriphenylphosphonium \nchloride  418-400-2  1031-15-8  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H312 \nH302 \nH315 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH315 \nH318 \nH411  \n017-017-00-4  (Z)-13-docosenyl- N,N-bis(2- \nhydroxyethyl)- N-methyl- \nammonium-chloride  426-210-6  120086-58-0  Skin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  \n017-018-00-X  N, N,N -trimethyl-2,3-bis(stearoy\xad\nloxy)propylammonium chloride  405-660-7  —  Aquatic Chronic 2  H411  GHS09  H411  \n017-019-00-5  (R)-1,2,3,4-tetrahydro-6,7-dime\xad\nthoxy-1-veratrylisoquinoline \nhydrochloride  415-110-8  54417-53-7  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n017-020-00-0  ethyl propoxy aluminium \nchloride  421-790-7  13014-29-4  Water-react. 1 \nSkin Corr. 1A  H260 \nH314  GHS02 \nGHS05 \nDgr H260 \nH314  EUH014  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 592}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 594\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n017-021-00-6  behenamidopropyl-dimethyl- \n(dihydroxypropyl) ammonium \nchloride  423-420-1  136920-10-0  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH410  \n017-023-00-7  [phosphinyldynetris(oxy)] tris[3- \naminopropyl-2-hydroxy- N, N - \ndimethyl- N-(C  6-18)-alkyl] trich\xad\nlorides  425-520-9  197179-61-6  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n017-026-00-3  chlorine dioxide  233-162-8  10049-04-4  Press. Gas \nOx. Gas 1 \nAcute Tox. 2 * \nSkin Corr. 1B \nAquatic Acute 1  H270 \nH330 \nH314 \nH400  GHS04 \nGHS03 \nGHS06 \nGHS05 \nGHS09 \nDgr H270 \nH330 \nH314 \nH400  M = 10  5  \n017-026-01-0  chlorine dioxide … %  233-162-8  10049-04-4  Acute Tox. 3 * \nSkin Corr. 1B \nAquatic Acute 1  H301 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H301 \nH314 \nH400  Skin Corr. 1B; \nH314: C ≥ 5 % \nSkin Irrit. 2; H315: \n1 % ≤ C < 5 % \nEye Dam.1; H318: \n3 % ≤ C < 5 % \nEye Irrit. 2; H319: \n0,3 % ≤ C < 3 % \nSTOT SE 3; H335: \nC ≥ 3 % M = 10  B ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 593}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 595\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n019-001-00-2  potassium  231-119-8  7440-09-7  Water-react. 1 \nSkin Corr. 1B  H260 \nH314  GHS02 \nGHS05 \nDgr H260 \nH314  EUH014  \n019-002-00-8  potassium hydroxide; \ncaustic potash  215-181-3  1310-58-3  Acute Tox. 4 * \nSkin Corr. 1A  H302 \nH314  GHS05 \nGHS07 \nDgr H302 \nH314  Skin Corr. 1A; \nH314: C ≥ 5 % \nSkin Corr. 1B; \nH314: 2 % ≤ C \n< 5 % \nSkin Irrit. 2; H315: \n0,5 % ≤ C < 2 % \nEye Irrit. 2; H319: \n0,5 % ≤ C < 2 %  \n▼M11  \n019-003-00-3  potassium (E,E)-hexa-2,4- \ndienoate  246-376-1  24634-61-5  Eye Irrit. 2  H319  GSH07 \nWng  H319  \n▼M16  \n020-001-00-X  calcium  231-179-5  7440-70-2  Water-react. 2  H261  GHS02 \nDgr H261  \n020-002-00-5  calcium cyanide  209-740-0  592-01-8  Acute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH410  EUH032  \n020-003-00-0  reaction mass of: dicalcium \n(bis(2-hydroxy-5-tetra-propenylp\xad\nhenylmethyl)methylamine)dihy\xad\ndroxide; \ntri-calcium (tris(2-hydroxy-5- \ntetra-propenylphenylme\xad\nthyl)methylamine)tri-hydroxide; \npoly[calcium ((2-hydroxy-5-tetra- \npropenyl-phenylmethyl)methyl\xad\namine)hydroxide]  420-470-4  —  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  \n022-001-00-5  titanium tetrachloride  231-441-9  7550-45-0  Skin Corr. 1B  H314  GHS05 \nDgr H314  EUH014  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 594}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 596\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n022-002-00-0  titanium(4+) oxalate  403-260-7  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n022-003-00-6  bis(η5-cyclopentadienyl)-bis(2,6- \ndifluoro-3-[pyrrol-1-yl]-phenyl)ti\xad\ntanium  412-000-1  125051-32-3  Flam. Sol. 1 \nRepr. 2 \nSTOT RE 2 * \nAquatic Chronic 2  H228 \nH361f *** \nH373 ** \nH411  GHS02 \nGHS08 \nGHS09 \nDgr H228 \nH361f *** \nH373 ** \nH411  T \n022-004-00-1  Potassium titanium \noxide(K  2Ti 6O 13) 432-240-0  12056-51-8  Carc. 2  H351  GHS08 \nWng  H351  \n022-005-00-7  [N-(1,1-dimethylethyl)-1,1- \ndimethyl-1-[(1,2,3,4,5-η)-2,3,4,5- \ntetramethyl-2,4-cyclopentadien-1- \nyl]silanaminato(2-)-κ N][(1,2,3,4- \nη)-1,3-pentadiene]-titanium  419-840-8  169104-71-6  Flam. Sol. 1**** \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 4  H228 \nH314 \nH317 \nH413  GHS02 \nGHS05 \nGHS07 \nDgr H228 \nH314 \nH317 \nH413  \n▼M22  \n►C6 022- \n006-00-2 ◄  titanium dioxide; \n[in powder form containing 1 % \nor more of particles with \naerodynamic diameter ≤ 10 μm]  236-675-5  13463-67-7  Carc. 2  H351 (inha\xad\nlation)  GHS08 \nWng  H351 (inha\xad\nlation)  V, W, 10  \n▼M16  \n023-001-00-8  divanadium pentaoxide; \nvanadium pentoxide  215-239-8  1314-62-1  Muta. 2 \nRepr. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nAquatic Chronic 2  H341 \nH361d *** \nH372 ** \nH332 \nH302 \nH335 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H341 \nH361d *** \nH372 ** \nH332 \nH302 \nH335 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 595}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 597\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n024-001-00-0  chromium (VI) trioxide  215-607-8  1333-82-0  Ox. Sol. 1 \nCarc. 1A \nMuta. 1B Repr. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nSkin Corr. 1A \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H271 \nH350 \nH340 \nH361f *** \nH330 \nH311 \nH301 \nH372 ** \nH314 \nH334 \nH317 \nH400 \nH410  GHS03 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H271 \nH350 \nH340 \nH361f *** \nH330 \nH311 \nH301 \nH372 ** \nH314 \nH334 \nH317 \nH410  STOT SE 3; H335: \nC ≥ 1 %  \n024-002-00-6  potassium dichromate  231-906-6  7778-50-9  Ox. Sol. 2 \nCarc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAcute Tox. 4 * \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH312 \nH314 \nH334 \nH317 \nH400 \nH410  GHS03 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H272 \nH350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH312 \nH314 \nH334 \nH317 \nH410  STOT SE 3; H335: \nC ≥ 5 %  3 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 596}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 598\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n024-003-00-1  ammonium dichromate  232-143-1  7789-09-5  Ox. Sol. 2 **** \nCarc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAcute Tox. 4 * \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH312 \nH314 \nH334 \nH317 \nH400 \nH410  GHS03 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H272 \nH350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH312 \nH314 \nH334 \nH317 \nH410  STOT SE 3; H335: \nC ≥ 5 % \nResp. Sens.; H334: \nC ≥0,2 % \nSkin Sens.; \nH317:C ≥0,2 %  G3 \n024-004-00-7  sodium dichromate  234-190-3  10588-01-9  Ox. Sol. 2 \nCarc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 1 \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH350 \nH340 \nH360FD \nH330 \nH301 \nH312 \nH372** \nH314 \nH334 \nH317 \nH400 \nH410  GHS03 \nGHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H272 \nH350 \nH340 \nH360FD \nH330 \nH301 \nH312 \nH372** \nH314 \nH334 \nH317 \nH410  Resp. Sens. 1; \nH334: C ≥ 0,2 % \nSkin Sens. 1; \nH317:C ≥0,2 % \nSTOT SE 3; H335: \nC ≥ 5 %  3 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 597}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 599\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M1 \n__________  \n▼M16  \n024-005-00-2  chromyl dichloride; \nchromic oxychloride  239-056-8  14977-61-8  Ox. Liq. 1 \nCarc. 1B \nMuta. 1B \nSkin Corr. 1A \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H271 \nH350i \nH340 \nH314 \nH317 \nH400 \nH410  GHS03 \nGHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H271 \nH350i \nH340 \nH314 \nH317 \nH410  Skin Corr. 1A; \nH314: C ≥ 10 % \nSkin Corr. 1B; \nH314: 5 % ≤ C \n< 10 % \nSkin Irrit. 2; H315: \n0,5 % ≤ C < 5 % \nEye Irrit. 2; H319: \n0,5 % ≤ C < 5 % \nSTOT SE 3; H335: \n0,5 % ≤ C < 5 % \nSkin Sens. 1; \nH317: C ≥ 0,5 %  T3 \n024-006-00-8  potassium chromate  232-140-5  7789-00-6  Carc. 1B \nMuta. 1B \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH340 \nH319 \nH335 \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH340 \nH319 \nH335 \nH315 \nH317 \nH410  Skin Sens. 1; \nH317:C ≥ 0,5 %  3 ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 598}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 600\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n024-007-00-3  zinc chromates including zinc \npotassium chromate  — —  Carc. 1A \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH317 \nH410  A \n024-008-00-9  calcium chromate  237-366-8  13765-19-0  Carc. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH410  \n024-009-00-4  strontium chromate  232-142-6  7789-06-2  Carc. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH400 \nH410  \n024-010-00-X  dichromium tris(chromate); \nchromium III chromate; \nchromic chromate  246-356-2  24613-89-6  Ox. Sol. 1 \nCarc. 1B \nSkin Corr. 1A \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H271 \nH350 \nH314 \nH317 \nH400 \nH410  GHS03 \nGHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H271 \nH350 \nH314 \nH317 \nH410  T \n024-011-00-5  ammonium bis(1-(3,5-dinitro-2- \noxidophenylazo)-3-( N-phenylcar\xad\nbamoyl)-2-naphtholato)chro\xad\nmate(1-)  400-110-2  109125-51-1  Self-react. C **** \nAquatic Acute 1 \nAquatic Chronic 1  H242 \nH400 \nH410  GHS02 \nGHS09 \nDgr H242 \nH410  \n024-012-00-0  trisodium bis(7-acetamido-2-(4- \nnitro-2-oxidophenylazo)-3- \nsulphonato-1-naphtholato)chro\xad\nmate(1-)  400-810-8  —  Muta. 2  H341  GHS08 \nWng  H341  \n024-013-00-6  trisodium (6-anilino-2-(5-nitro-2- \noxidophenylazo)-3-sulphonato-1- \nnaphtholato)(4-sulphonato-1,1'- \nazodi-2,2'naphtholato)chro\xad\nmate(1-)  402-500-8  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 599}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 601\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n024-014-00-1  trisodium bis(2-(5-chloro-4-nitro- \n2-oxidophenylazo)-5-sulphonato- \n1-naphtholato)chromate(1-)  402-870-0  93952-24-0  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n024-015-00-7  disodium (3-methyl-4-(5-nitro-2- \noxidophenylazo)-1-phenylpyrazo\xad\nlolato)(1-(3-nitro-2-oxido-5- \nsulfonatophenylazo)-2-naphtho\xad\nlato)chromate(1-)  404-930-1  —  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H332 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H332 \nH318 \nH411  \n024-016-00-2  tetradecylammonium bis(1-(5- \nchloro-2-oxidophenylazo)-2- \nnaphtholato)chromate(1-)  405-110-6  88377-66-6  STOT RE 2 * \nAquatic Chronic 4  H373 ** \nH413  GHS08 \nWng  H373 ** \nH413  \n024-017-00-8  chromium (VI) compounds, with \nthe exception of barium chromate \nand of compounds specified \nelsewhere in this Annex  — —  Carc. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH317 \nH410  A \n024-018-00-3  sodium chromate  231-889-5  7775-11-3  Carc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAcute Tox. 4 * \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH312 \nH314 \nH334 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH312 \nH314 \nH334 \nH317 \nH410  Resp. Sens.; \nH334: C ≥ 0,2 % \nSkin Sens.; \nH317:C ≥ 0,2 %  3 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 600}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 602\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n024-019-00-9  Main component: acetoacetic \nacid anilide/3-amino-1-hydroxy\xad\nbenzene (ATAN-MAP): \ntrisodium {6-[(2 or 3 or 4)- \namino-(4 or 5 or 6)-hydroxyp\xad\nhenylazo]-5'-(phenylsulfamoyl)- \n3-sulfonatonaphthalene-2- \nazobenzene-1,2'-diolato}-{6''-[1- \n(phenylcarbamoyl)ethylazo]-5'- \n(phenylsulfamoyl)-3-sulfonaton\xad\naphthalene-2''-azobenzene-1'',2'''- \ndiolato}chromate (III); by- \nproduct 1: acetoacetic acid \nanilide/acetoacetic acid anilide \n(ATAN-ATAN): trisodium \nbis{6-[1-(phenylcarbamoyl)ethy\xad\nlazo]-5'''-(phenylsulfonyl)-3''- \nsulfonatonaphthalene-2- \nazobenzene-1,2'-diolato}chromate \n(III); \nby-product 2: 3-amino-1- \nhydroxybenzene/3-amino-1- \nhydroxybenzene (MAP-MAP): \ntrisodium bis{6-[(2 or 3 or 4)- \namino-(4 or 5 or 6)-hydroxyp\xad\nhenylazo]-5'-(phenylsulfamoyl)- \n3-sulfonatonaphthalene-2- \nazobenzene-1,2'-diolato}chromate \n(III) 419-230-1  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n024-020-00-4  trisodium bis[(3'-nitro-5'-sulfon\xad\nato(6-amino-2-[4-(2-hydroxy-1- \nnaphtylazo)phenylsulfony\xad\nlamino]pyrimidin-5-azo)benzene- \n2',4-diolato)]chromate(III)  418-220-4  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 601}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 603\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n024-021-00-X  potassium tetrasodium bis[( N,N'- \nn)-1'-(phenylcarbamoyl)-3,5- \ndisulfonatobenzeneazo-1'-prop-1'- \nene-2,2'-diolato]chromate(III)  425-830-4  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n025-001-00-3  manganese dioxide  215-202-6  1313-13-9  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH302  GHS07 \nWng  H332 \nH302  \n▼M18  \n025-002-00-9  potassium permanganate  231-760-3  7722-64-7  Ox. Sol. 2 \nRepr. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH361d \nH302 \nH400 \nH410  GHS03 \nGHS08 \nGHS07 \nGHS09 \nDgr H272 \nH361d \nH302 \nH410  \n▼M16  \n025-003-00-4  manganese sulphate  232-089-9  7785-87-7  STOT RE 2 * \nAquatic Chronic 2  H373 ** \nH411  GHS08 \nGHS09 \nWng  H373 ** \nH411  \n025-004-00-X  bis( N, N',N'' -trimethyl-1,4,7-tria\xad\nzacyclononane)-trioxo- \ndimanganese (IV) di(hexafluo\xad\nrophosphate) monohydrate  411-760-1  116633-53-5  Aquatic Chronic 2  H411  GHS09  H411  \n025-005-00-5  reaction mass of: tri-sodium [29 H, \n31H-phthalocyanine- C, C,C - \ntrisulfonato (6-)- N29, N30, N31, \nN32] manganate (3-); tetrasodium \n[29H, 31 H-phthalocyanine- C, \nC,C, C -tetrasulfonato(6-)- N29, \nN30, N 31, \nN32], manganate (3-); \npentasodium [29 H, 31H-phthalo\xad\ncyanine- C, C,C, C,C -pentasul\xad\nfonato (6-)-  \nN29, N30, N31, N32] manganate \n(3-) 417-660-4  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 602}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 604\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n026-001-00-6  (η-cumene)-(η-cyclopentadie\xad\nnyl)iron(II) hexafluoroantimonate  407-840-0  100011-37-8  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n026-002-00-1  (η-cumene)-(η-cyclopentadie\xad\nnyl)iron(II) trifluoromethane- \nsulfonate  407-880-9  117549-13-0  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n026-003-00-7  iron (II) sulfate  231-753-5  7720-78-7  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2  H302 \nH319 \nH315  GHS07 \nWng  H302 \nH319 \nH315  \n026-003-01-4  iron (II) sulfate (1:1) heptahy\xad\ndrate; sulfuric acid, iron(II) salt \n(1:1), heptahydrate; \nferrous sulfate heptahydrate  231-753-5  7782-63-0  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2  H302 \nH319 \nH315  GHS07 \nWng  H302 \nH319 \nH315  Skin Irrit.2; H315: \nC ≥ 25 %  \n026-004-00-2  potassium ferrite  430-010-4  12160-44-0  Skin Corr. 1B \nSkin Sens. 1  H314 \nH317  GHS05 \nGHS07 \nDgr H314 \nH317  \n▼M22  \n027-001-00-9  cobalt  231-158-0  7440-48-4  Carc. 1B \nMuta. 2 \nRepr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 4  H350 \nH341 \nH360F \nH334 \nH317 \nH413  GHS08 \nDgr H350 \nH341 \nH360F \nH334 \nH317 \nH413  \n▼M16  \n027-002-00-4  cobalt oxide  215-154-6  1307-96-6  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  M=10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 603}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 605\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n027-003-00-X  cobalt sulfide  215-273-3  1317-42-6  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M=10  \n027-004-00-5  cobalt dichloride  231-589-4  7646-79-9  Carc. 1B \nMuta. 2 \nRepr. 1B \nAcute Tox. 4 * \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360F*** \nH302 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360F*** \nH302 \nH334 \nH317 \nH410  Carc. 1B; H350i: C \n≥ 0,01 % M=10  1 \n027-005-00-0  cobalt sulfate  233-334-2  10124-43-3  Carc. 1B \nMuta. 2 \nRepr. 1B \nAcute Tox. 4 * \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360F*** \nH302 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360F*** \nH302 \nH334 \nH317 \nH410  Carc. 1B; H350i: C \n≥ 0,01 % M=10  1 \n027-006-00-6  cobalt di(acetate)  200-755-8  71-48-7  Carc. 1B \nMuta. 2 \nRepr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360F*** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360F*** \nH334 \nH317 \nH410  Carc. 1B; H350i: C \n≥ 0,01 % \nM = 10  1 \n027-007-00-1  zinc hexacyanocobaltate(III), \ntertiary butyl alcohol/poly\xad\npropylene glycol complex  425-240-7  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 604}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 606\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n027-008-00-7  complex of cobalt(III)-bis( N- \nphenyl-4-(5-ethylsulfonyl-2- \nhydroxyphenylazo)-3-hydroxy\xad\nnaphthylamide), hydrated(n \nH 2O,2<n<3)  427-390-9  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n027-009-00-2  cobalt dinitrate  233-402-1  10141-05-6  Carc. 1B \nMuta. 2 \nRepr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360F*** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360F*** \nH334 \nH317 \nH410  Carc. 1B; H350i: C \n≥ 0,01 % \nM = 10  1 \n027-010-00-8  cobalt carbonate  208-169-4  513-79-1  Carc. 1B \nMuta. 2 \nRepr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360F*** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360F*** \nH334 \nH317 \nH410  Carc. 1B; H350i: C \n≥ 0,01 % M=10  1 \n028-001-00-1  tetracarbonylnickel; \nnickel tetracarbonyl  236-669-2  13463-39-3  Flam. Liq. 2 \nCarc. 2 \nRepr. 1B \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH351 \nH360D *** \nH330 \nH400 \nH410  GHS02 \nGHS06 \nGHS08 \nGHS09 \nDgr H225 \nH351 \nH360D *** \nH330 \nH410  \n028-002-00-7  nickel  231-111-4  7440-02-0  Carc. 2 \nSTOT RE 1 \nSkin Sens. 1  H351 \nH372** \nH317  GHS08 \nGHS07 \nDgr H351 \nH372** \nH317  S7 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 605}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 607\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-002-01-4  nickel powder; \n[particle diameter < 1mm]  231-111-4  7440-02-0  Carc. 2 \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Chronic 3  H351 \nH372** \nH317 \nH412  GHS08 \nGHS07 \nDgr H351 \nH372** \nH317 \nH412  \n028-003-00-2  nickel monoxide; [1] \nnickel oxide; [2] \nbunsenite [3]  215-215-7[1] \n234-323-5[2]- \n[3] 1313-99-1 [1] \n11099-02-8 [2] \n34492-97-2 [3]  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Chronic 4  H350i \nH372** \nH317 \nH413  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317 \nH413  \n028-004-00-8  nickel dioxide  234-823-3  12035-36-8  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Chronic 4  H350i \nH372** \nH317 \nH413  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317 \nH413  \n028-005-00-3  dinickel trioxide  215-217-8  1314-06-3  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Chronic 4  H350i \nH372** \nH317 \nH413  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317 \nH413  \n028-006-00-9  nickel (II) sulfide; [1] \nnickel sulfide; [2] \nmillerite [3]  240-841-2[1] \n234-349-7[2]- \n[3] 16812-54-7 [1] \n11113-75-0 [2] \n1314-04-1 [3]  Carc. 1A \nMuta. 2 \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH372** \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 606}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 608\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-007-00-4  trinickel disulfide; \nnickel subsulfide; [1] \nheazlewoodite [2]  234-829-6[1] \n-[2] 12035-72-2 [1] \n12035-71-1 [2]  Carc. 1A \nMuta. 2 \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH372** \nH317 \nH410  \n028-008-00-X  nickel dihydroxide; [1] \nnickel hydroxide [2]  235-008-5 [1] \n234-348-1 [2]  12054-48-7 [1] \n11113-74-9 [2]  Carc. 1A \nRepr. 1B \nMuta. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH360D*** \nH341 \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH360D*** \nH341 \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH410  \n028-009-00-5  nickel sulfate  232-104-9  7786-81-4  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % \nSTOT RE 2; H373: \n0,1 % ≤ C < 1 % \nSkin Irrit. 2; H315: \nC ≥ 20 % \nSkin Sens. 1; \nH317: C ≥ \n0,01 % \nM = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 607}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 609\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-010-00-0  nickel carbonate; \nbasic nickel carbonate; \ncarbonic acid, nickel (2+) salt; \n[1] \ncarbonic acid, nickel salt; [2] \n[μ-[carbonato(2-)-  \nO:O' ]]dihydroxy trinickel; [3] \n[carbonato(2-)] tetrahydroxytri\xad\nnickel [4]  222-068-2 [1] \n240-408-8 [2] \n265-748-4 [3] \n235-715-9 [4]  3333-67-3 [1] \n16337-84-1 [2] \n65405-96-1 [3] \n12607-70-4 [4]  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH410  \n028-011-00-6  nickel dichloride  231-743-0  7718-54-9  Carc. 1A Muta. 2 \nRepr. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH331 \nH301 \nH372** \nH315 \nH334 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH331 \nH301 \nH372** \nH315 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % \nSTOT RE 2; H373: \n0,1 % < C < 1 % \nSkin Irrit. 2; H315: \nC ≥ 20 % \nSkin Sens. 1; \nH317: C ≥ 0,01 % \nM = 1  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 608}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 610\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-012-00-1  nickel dinitrate; [1] \nnitric acid, nickel salt [2]  236-068-5 [1] \n238-076-4 [2]  13138-45-9 [1] \n14216-75-2 [2]  Ox. Sol. 2 \nCarc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH318 \nH334 \nH317 \nH400 \nH410  GHS03 \nGHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H272 \nH350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH318 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % \nSTOT RE 2; H373: \n0,1 % < C < 1 % \nSkin Irrit. 2; H315: \nC ≥ 20 % \nSkin Sens. 1; H317 \nC ≥0,01 % \nM = 1  \n028-013-00-7  nickel matte  273-749-6  69012-50-6  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 609}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 611\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-014-00-2  slimes and sludges, copper elec\xad\ntrolytic refining, decopperised, \nnickel sulfate  295-859-3  92129-57-2  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH315 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373:0,1 % ≤ C \n< % \nSkin Sens. 1; \nH317:C ≥ 0,01 % \nM=1  \n028-015-00-8  slimes and sludges, copper elec\xad\ntrolyte refining, decopperised  305-433-1  94551-87-8  Carc. 1A Muta. 2 \nRepr. 1A \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  \n028-016-00-3  nickel diperchlorate; \nperchloric acid, nickel(II) salt  237-124-1  13637-71-3  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH314 \nH334 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH314 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317: C ≥ 0,01 % \nM=1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 610}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 612\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-017-00-9  nickel dipotassium bis(sulfate); \n[1] \ndiammonium nickel bis(sulfate) \n[2] 237-563-9 [1] \n239-793-2 [2]  13842-46-1 [1] \n15699-18-0 [2]  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373:0,1 % ≤ C \n< 1 % \nSkin Sens. 1; \nH317:C ≥ 0,01 % \nM=1 \n▼M22  \n028-018-00-4  nickel bis(sulfamidate); \nnickel sulfamate  237-396-1  13770-89-3  Carc. 1A \nMuta. 2 \nRepr. 1B \nAcute Tox. 4 \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH302 \nH372** \nH334 \nH317 \nH400 \nH410  GHS08  \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH302 \nH372** \nH334 \nH317 \nH410  oral: ATE = 853 \nmg/kg bw \n(anhydrate) \noral: ATE = 1098 \nmg/kg bw (tetrahy\xad\ndrate) \nSTOT RE 1; \nH372: C ≥ 1 % \nSTOT RE 2; \nH373: 0,1 % ≤ C < \n1 % \nSkin Sens. 1; \nH317: C ≥ 0,01 % \nM = 1  \n▼M16  \n028-019-00-X  nickel bis(tetrafluoroborate)  238-753-4  14708-14-6  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317: C ≥0,01 % \nM=1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 611}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 613\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-021-00-0  nickel diformate; [1] \nformic acid, nickel salt; [2] \nformic acid, copper nickel salt \n[3] 222-101-0 [1] \n239-946-6 [2] \n268-755-0 [3]  3349-06-2 [1] \n15843-02-4 [2] \n68134-59-8 [3]  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317:C ≥0,01 % \nM=1  \n028-022-00-6  nickel di(acetate); [1] \nnickel acetate [2]  206-761-7 [1] \n239-086-1 [2]  373-02-4 [1] \n14998-37-9 [2]  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH332 \nH302 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317:C≥ 0,01 % \nM = 1  \n028-024-00-7  nickel dibenzoate  209-046-8  553-71-9  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317:C≥ 0,01 % \nM=1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 612}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 614\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-025-00-2  nickel bis(4-cyclohexylbutyrate)  223-463-2  3906-55-6  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317:C ≥0,01 % \nM=1  \n028-026-00-8  nickel(II) stearate; \nnickel(II) octadecanoate  218-744-1  2223-95-2  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373:0,1 % ≤ C \n< 1 % \nSkin Sens. 1; \nH317:C;≥0,01 % \nM=1  \n028-027-00-3  nickel dilactate  —  16039-61-5  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; \nH372:C ≥ 1 % \nSTOT RE 2; \nH373:0,1 % ≤ C < \n1 % \nSkin Sens. 1; \nH317: C ≥ 0,01 % \nM=1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 613}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 615\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-028-00-9  nickel(II) octanoate  225-656-7  4995-91-9  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nSkin Corr. 1A \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH314 \nH334 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH314 \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317: C ≥ 0,01 % \nM=1  \n028-029-00-4  nickel difluoride; [1] \nnickel dibromide; [2] \nnickel diiodide; [3] \nnickel potassium fluoride [4]  233-071-3 [1] \n236-665-0 [2] \n236-666-6 [3] \n-[4] 10028-18-9 [1] \n13462-88-9 [2] \n13462-90-3 [3] \n11132-10-8 [4]  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** H334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317: C ≥0,01 % \nM=1  \n028-030-00-X  nickel hexafluorosilicate  247-430-7  26043-11-8  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317:C ≥ 0,01 % \nM=1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 614}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 616\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-031-00-5  nickel selenate  239-125-2  15060-62-5  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317:C≥0,01 % \nM=1  \n028-032-00-0  nickel hydrogen phosphate; [1] \nnickel bis(dihydrogen phos\xad\nphate); [2] \ntrinickel bis(orthophosphate); [3] \ndinickel diphosphate; [4] \nnickel bis(phosphinate); [5] \nnickel phosphinate; [6] \nphosphoric acid, calcium nickel \nsalt; [7] \ndiphosphoric acid, nickel(II) \nsalt[8]  238-278-2 [1] \n242-522-3 [2] \n233-844-5 [3] \n238-426-6 [4] \n238-511-8 [5] \n252-840-4 [6] \n-[7] \n-[8] 14332-34-4 [1] \n18718-11-1 [2] \n10381-36-9 [3] \n14448-18-1 [4] \n14507-36-9 [5] \n36026-88-7 [6] \n17169-61-8 [7] \n19372-20-4 [8]  Carc. 1A \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH372** \nH334 \nH317 \nH410  \n028-033-00-6  diammonium nickel hexacyano\xad\nferrate  — 74195-78-1  Carc. 1A \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH372** \nH334 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 615}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 617\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-034-00-1  nickel dicyanide  209-160-8  557-19-7  Carc. 1A \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH372** \nH334 \nH317 \nH410  EUH032  \n028-035-00-7  nickel chromate  238-766-5  14721-18-7  Carc. 1A \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH372** \nH334 \nH317 \nH410  \n028-036-00-2  nickel(II) silicate; [1] \ndinickel orthosilicate; [2] \nnickel silicate (3:4); [3] \nsilicic acid, nickel salt; [4] \ntrihydrogen hydroxybis[orthosili\xad\ncato(4-)]trinickelate(3-) [5]  244-578-4 [1] \n237-411-1 [2] \n250-788-7 [3] \n253-461-7 [4] \n235-688-3 [5]  21784-78-1 [1] \n13775-54-7 [2] \n31748-25-1 [3] \n37321-15-6 [4] \n12519-85-6 [5]  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-037-00-8  dinickel hexacyanoferrate  238-946-3  14874-78-3  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-038-00-3  trinickel bis(arsenate); \nnickel(II) arsenate  236-771-7  13477-70-8  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH372** \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 616}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 618\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-039-00-9  nickel oxalate; [1] \noxalic acid, nickel salt [2]  208-933-7 [1] \n243-867-2 [2]  547-67-1 [1] \n20543-06-0 [2]  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-040-00-4  nickel telluride  235-260-6  12142-88-0  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-041-00-X  trinickel tetrasulfide  —  12137-12-1  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-042-00-5  trinickel bis(arsenite)  —  74646-29-0  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-043-00-0  cobalt nickel gray periclase; \nC.I. Pigment Black 25; C.I. \n77332; [1] \ncobalt nickel dioxide; [2] \ncobalt nickel oxide [3]  269-051-6 [1] \n261-346-8 [2] \n-[3] 68186-89-0 [1] \n58591-45-0 [2] \n12737-30-3 [3]  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1  H350i \nH372** \nH317  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317  \n028-044-00-6  nickel tin trioxide; \nnickel stannate  234-824-9  12035-38-0  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1  H350i \nH372** \nH317  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 617}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 619\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-045-00-1  nickel triuranium decaoxide  239-876-6  15780-33-3  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1  H350i \nH372** \nH317  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317  \n028-046-00-7  nickel dithiocyanate  237-205-1  13689-92-4  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  EUH032  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < 1 % \nSkin Sens. 1; \nH317:C≥0,01 % \nM=1  \n028-047-00-2  nickel dichromate  239-646-5  15586-38-6  Carc. 1A \nMuta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; \nH372:C ≥ 1 % \nSTOT RE 2; H373: \n0,1 % ≤ C < 1 % \nSkin Sens. 1; \nH317:C≥0,01 % \nM=1  \n028-048-00-8  nickel(II) selenite  233-263-7  10101-96-9  Carc. 1A \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH372** \nH334 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 618}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 620\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-049-00-3  nickel selenide  215-216-2  1314-05-2  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-050-00-9  silicic acid, lead nickel salt  —  68130-19-8  Carc. 1A \nRepr. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH360Df \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH360Df \nH372** \nH317 \nH410  \n028-051-00-4  nickel diarsenide; [1] \nnickel arsenide [2]  235-103-1 [1] \n248-169-1 [2]  12068-61-0 [1] \n27016-75-7 [2]  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  \n028-052-00-X  nickel barium titanium primrose \npriderite; \nC.I. Pigment Yellow 157; C.I. \n77900  271-853-6  68610-24-2  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1  H350i \nH372** \nH317  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317  \n028-053-00-5  nickel dichlorate; [1] \nnickel dibromate; [2] \nethyl hydrogen sulfate, nickel(II) \nsalt [3]  267-897-0 [1] \n238-596-1 [2] \n275-897-7 [3]  67952-43-6 [1] \n14550-87-9 [2] \n71720-48-4 [3]  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; H372: \nC ≥ 1 % STOT RE \n2; H373: 0,1 % ≤ \nC < % \nSkin Sens. 1; \nH317:C≥0,01%1 \nM=1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 619}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 621\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-054-00-0  nickel(II) trifluoroacetate; [1] \nnickel(II) propionate; [2] \nnickel bis(benzenesulfonate); [3] \nnickel(II) hydrogen citrate; [4] \ncitric acid, ammonium nickel \nsalt; [5] \ncitric acid, nickel salt; [6] \nnickel bis(2-ethylhexanoate); [7] \n2-ethylhexanoic acid, nickel salt; \n[8] \ndimethylhexanoic acid nickelsalt; \n[9] \nnickel(II) isooctanoate; [10] \nnickel isooctanoate; [11] \nnickel bis(isononanoate); [12] \nnickel(II) neononanoate; [13] \nnickel(II) isodecanoate; [14] \nnickel(II) neodecanoate; [15] \nneodecanoic acid, nickel salt;[16] \nnickel(II) neoundecanoate; [17] \nbis(d-gluconato- O1 ,O2 )nickel; \n[18] \nnickel 3,5-bis( tert-butyl)-4- \nhydroxybenzoate (1:2); [19] \nnickel(II) palmitate; [20] \n(2-ethylhexanoato- O)(isonon\xad\nanoato- O)nickel; [21] \n(isononanoato- O)(isooctanoato-  \nO)nickel; [22] \n(isooctanoato- O)(neodecanoato-  \nO)nickel; [23] \n(2-ethylhexanoato- O)(isodec\xad\nanoato- O)nickel; [24]  240-235-8 [1] \n222-102-6 [2] \n254-642-3 [3] \n242-533-3 [4] \n242-161-1 [5] \n245-119-0 [6] \n224-699-9 [7] \n231-480-1 [8] \n301-323-2 [9] \n249-555-2 [10] \n248-585-3 [11] \n284-349-6 [12] \n300-094-6 [13] \n287-468-1 [14] \n287-469-7 [15] \n257-447-1 [16] \n300-093-0 [17] \n276-205-6 [18] \n258-051-1 [19] \n294-302-1 [29] \n283-972-0 [30] \n-[31] \n237-138-8 [20] \n287-470-2 [21] \n287-471-8 [22] \n284-347-5 [23] \n284-351-7 [24] \n285-698-7 [25] \n285-909-2 [26] \n284-348-0 [27] \n287-592-6 [28]  16083-14-0 [1] \n3349-08-4 [2] \n39819-65-3 [3] \n18721-51-2 [4] \n18283-82-4 [5] \n22605-92-1 [6] \n4454-16-4 [7] \n7580-31-6 [8] \n93983-68-7 [9] \n29317-63-3 [10] \n27637-46-3 [11] \n84852-37-9 [12] \n93920-10-6 [13] \n85508-43-6 [14] \n85508-44-7 [15] \n51818-56-5 [16] \n93920-09-3 [17] \n71957-07-8 [18] \n52625-25-9 [19] \n13654-40-5 [20] \n85508-45-8 [21] \n85508-46-9 [22] \n84852-35-7 [23] \n84852-39-1 [24] \n85135-77-9 \n[25] \n85166-19-4 [26] \n84852-36-8 [27] \n85551-28-6 [28] \n91697-41-5 [29] \n84776-45-4 [30] \n72319-19-8 [31]  Carc. 1A Muta. 2 \nRepr. 1B \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH341 \nH360D*** \nH372** \nH334 \nH317 \nH410  STOT RE 1; \nH372: C ≥ 1 % \nSTOT RE 2; H373: \n0,1 % ≤ C < 1 % \nSkin Sens. 1; \nH317: C ≥ \n0,01 % M=1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 620}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 622\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n2-ethylhexanoato- O)(neodec\xad\nanoato- O)nickel; [25] \n(isodecanoato- O)(isooctanoato-  \nO)nickel; [26] \n(isodecanoato- O)(isononanoato-  \nO)nickel; [27] \n(isononanoato- O)(neodecanoato-  \nO)nickel; [28] \nfatty acids, C  6-19-branched, \nnickel salts; [29] \nfatty acids, C  8-18 and C  18- \nunsaturated, nickel salts; [30] \n2,7-naphthalenedisulfonic acid, \nnickel(II) salt; [31]  \n028-055-00-6  nickel(II) sulfite; [1] \nnickel tellurium trioxide; [2] \nnickel tellurium tetraoxide; [3] \nmolybdenum nickel hydroxide \noxide phosphate [4]  231-827-7 [1] \n239-967-0 [2] \n239-974-9 [3] \n268-585-7 [4]  7757-95-1 [1] \n15851-52-2 [2] \n15852-21-8 [3] \n68130-36-9 [4]  Carc. 1A \nSTOT RE 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350i \nH372** \nH334 \nH317 \nH410  \n028-056-00-1  nickel boride (NiB); [1] \ndinickel boride; [2] \ntrinickel boride; [3] \nnickel boride; [4] \ndinickel silicide; [5] \nnickel disilicide; [6] \ndinickel phosphide; [7] \nnickel boron phosphide [8]  234-493-0 [1] \n234-494-6 [2] \n234-495-1 [3] \n235-723-2 [4] \n235-033-1 [5] \n235-379-3 [6] \n234-828-0 [7] \n-[8] 12007-00-0 [1] \n12007-01-1 [2] \n12007-02-2 [3] \n12619-90-8 [4] \n12059-14-2 [5] \n12201-89-7 [6] \n12035-64-2 [7] \n65229-23-4 [8]  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH372** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350i \nH372** \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 621}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 623\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n028-057-00-7  dialuminium nickel tetraoxide; \n[1] \nnickel titanium trioxide; [2] \nnickel titanium oxide; [3] \nnickel divanadium hexaoxide; [4] \ncobalt dimolybdenum nickel \noctaoxide; [5] \nnickel zirkonium trioxide; [6] \nmolybdenum nickel tetraoxide; \n[7] \nnickel tungsten tetraoxide; [8] \nolivine, nickel green; [9] \nlithium nickel dioxide; [10] \nmolybdenum nickel oxide; [11]  234-454-8 [1] \n234-825-4 [2] \n235-752-0 [3] \n257-970-5 [4] \n268-169-5 [5] \n274-755-1 [6] \n238-034-5 [7] \n238-032-4 [8] \n271-112-7 [9] \n-[10] \n-[11]  12004-35-2 [1] \n12035-39-1 [2] \n12653-76-8 [3] \n52502-12-2 [4] \n68016-03-5 [5] \n70692-93-2 [6] \n14177-55-0 [7] \n14177-51-6 [8] \n68515-84-4 [9] \n12031-65-1 [10] \n12673-58-4 [11]  Carc. 1A \nSTOT RE 1 \nSkin Sens. 1  H350i \nH372** \nH317  GHS08 \nGHS07 \nDgr H350i \nH372** \nH317  \n028-058-00-2  cobalt lithium nickel oxide  442-750-5  —  Carc. 1A \nAcute Tox. 2 * \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350i \nH330 \nH372** \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350i \nH330 \nH372** \nH317 \nH410  \n029-001-00-4  copper chloride; \ncopper (I) chloride; \ncuprous chloride  231-842-9  7758-89-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH400 \nH410  \n▼M13  \n029-002-00-X  dicopper oxide; \ncopper (I) oxide  215-270-7  1317-39-1  Acute Tox. 4 \nAcute Tox. 4 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH318 \nH400 \nH410  GHS07 \nGHS05 \nGHS09 \nDgr H332 \nH302 \nH318 \nH410  M = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 622}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 624\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n029-003-00-5  naphthenic acids, copper salts; \ncopper naphthenate  215-657-0  1338-02-9  Flam. Liq. 3 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH302 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH302 \nH410  \n029-004-00-0  copper sulphate  231-847-6  7758-98-7  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH315 \nH410  \n029-005-00-6  (tris(chloromethyl)phthalocyani\xad\nnato)copper(II), reaction products \nwith N -methylpiperazine and \nmethoxyacetic acid  401-260-1  —  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n029-006-00-1  tris(octadec-9-enylammonium) \n(trisulfonatophthalocyani\xad\nnato)copper(II)  403-210-4  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n029-007-00-7  (trisodium (2-((3-(6-(2-chloro-5- \nsulfonato)anilino)-4-(3-carbo\xad\nxypyridinio)-1,3,5-triazin-2- \nylamino)-2-oxido-5-sulfonatop\xad\nhenylazo)phenylmethylazo)-4- \nsulfonatobenzoato)copper(3-)) \nhydroxide  404-670-9  89797-01-3  Skin Sens. 1  H317  GHS07 \nWng  H317  G  \n029-008-00-2  copper(II) methanesulfonate  405-400-2  54253-62-2  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH410  \n029-009-00-8  phthalocyanine- N-[3-(diethy\xad\nlamino)propyl]sulfonamide \ncopper complex  413-650-9  93971-95-0  Aquatic Chronic 3  H412  —  H412  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 623}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 625\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n029-010-00-3  reaction mass of compounds \nfrom (dodecakis( p-tolylt\xad\nhio)phthalocyaninato)copper(II)to \n(hexadecakis( p-tolylthio)phthalo\xad\ncyaninato)copper(II)  407-700-9  101408-30-4  Skin Sens. 1  H317  GHS07 \nWng  H317  \n029-011-00-9  sodium [29 H,31H-phthalo\xad\ncyaninato-(2-)-  \nN29,N30,N31,N32]-((3-( N- \nmethyl- N-(2-hydroxye\xad\nthyl)amino)propyl)amino)sul\xad\nfonyl-sulfonato, copper complex  412-730-0  150522-10-4  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n029-012-00-4  sodium (( N-(3-trimethylammon\xad\niopropyl)sulfamoyl)methylsulfon\xad\natophthalocyaninato)copper(II)  407-340-2  124719-24-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n029-013-00-X  trisodium(2-(α-(3-(4-chloro-6-(2- \n(2-(vinylsulfonyl)ethoxy)ethy\xad\nlamino)-1,3,5-triazin-2-ylamino)- \n2-oxido-5-sulfonatopheny\xad\nlazo)benzylidenehydrazino)-4- \nsulfonatobenzoato)copper(II)  407-580-8  130201-51-3  Eye Dam. 1  H318  GHS05 \nDgr H318  \n029-014-00-5  reaction mass of: 2,2'-[[ cis-1,2- \ncyclohexanediylbis(nitrilomethyl\xad\nidene)]bis[phenolate]](2-) N, N',O, \nO'-copper complex;2,2'-[[ trans - \n1,2-cyclohexanediylbis(nitrilo\xad\nmethylidyne)]bis[phenolate]](2- \n)N, N',O, O' -copper complex  419-610-7  171866-24-3  STOT RE 2 * \nAquatic Chronic 2  H373** \nH411  GHS08 \nGHS09 \nWng  H373** \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 624}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 626\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n029-015-00-0  copper thiocyanate  214-183-1  1111-67-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  EUH032  M  =  1 0  \n029-016-00-6  copper(II) oxide  215-269-1  1317-38-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 100  \n029-017-00-1  dicopper chloride trihydroxide  215-572-9  1332-65-6  Acute Tox. 4 \nAcute Tox. 3 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H332 \nH301 \nH410  M = 10  \n029-018-00-7  tetracopper hexahydroxide \nsulphate; [1] \ntetracopper hexahydroxide \nsulphate hydrate [2]  215-582-3 [1] \n215-582-3 [2]  1333-22-8 [1] \n12527-76-3 [2]  Acute Tox. 4 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M = 10  \n029-019-01-X  copper flakes (coated with \naliphatic acid)  — —  Acute Tox. 3 \nAcute Tox. 4 \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH302 \nH319 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH302 \nH319 \nH410  M = 10  \n029-020-00-8  copper(II) carbonate–copper(II) \nhydroxide (1:1)  235-113-6  12069-69-1  Acute Tox. 4 \nAcute Tox. 4 \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH302 \nH319 \nH410  M = 10  \n029-021-00-3  copper dihydroxide; \ncopper(II) hydroxide  243-815-9  20427-59-2  Acute Tox. 2 \nAcute Tox. 4 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH302 \nH318 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH302 \nH318 \nH410  M = 10  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 625}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 627\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n029-022-00-9  bordeaux mixture; \nreaction products of copper \nsulphate with calcium dihy\xad\ndroxide  — 8011-63-0  Acute Tox. 4 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH318 \nH400 \nH410  GHS07 \nGHS05 \nGHS09 \nDgr H332 \nH318 \nH410  M = 10  \n029-023-00-4  copper sulphate pentahydrate  231-847-6  7758-99-8  Acute Tox. 4 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH318 \nH400 \nH410  GHS07 \nGHS05 \nGHS09 \nDgr H302 \nH318 \nH410  M = 10  \n▼M23  \n029-024-00-X  granulated copper; \n[particle length: from 0,9 mm to \n6,0 mm; particle width: from \n0,494 to 0,949 mm]  231-159-6  7440-50-8  Aquatic Chronic 2  H411  GHS09  H411  \n029-025-00-5  bis( N-hydroxy- N-nitrosocyclo\xad\nhexylaminato- O,O’)copper; \nbis(N-cyclohexyl-diazenium- \ndioxy)-copper; \n[Cu-HDO]  239-703-4  312600-89-8 \n15627-09-5  Flam. Sol. 1 \nAcute Tox. 4 \nSTOT RE 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H228 \nH302 \nH373 (liver) \nH318 \nH400 \nH410  GHS02 \nGHS07 \nGHS08 \nGHS05 \nGHS09 \nDgr H228 \nH302 \nH373(liver) \nH318 \nH410  oral: ATE = \n360 mg/kg bw \nM = 1 \nM = 1  \n▼M16  \n030-001-00-1  zinc powder — zinc dust (pyro\xad\nphoric)  231-175-3  7440-66-6  Water-react. 1 \nPyr. Sol. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H260 \nH250 \nH400 \nH410  GHS02 \nGHS09 \nDgr H260 \nH250 \nH410  T ▼M13', metadata={'source': 'data/ycla_en.pdf', 'page': 626}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 628\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n030-001-01-9  zinc powder — zinc dust (stabi\xad\nlised)  231-175-3  7440-66-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n030-003-00-2  zinc chloride  231-592-0  7646-85-7  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH410  STOT SE 3; H335: \nC ≥ 5 %  \n030-004-00-8  dimethylzinc; [1] \ndiethylzinc [2]  208-884-1 [1] \n209-161-3 [2]  544-97-8 [1] \n557-20-0 [2]  Pyr. Liq. 1 \nWater-react. 1 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H250 \nH260 \nH314 \nH400 \nH410  GHS02 \nGHS05 \nGHS09 \nDgr H250 \nH260 \nH314 \nH410  EUH014  \n030-005-00-3  diamminediisocyanatozinc  401-610-3  —  Acute Tox. 4 * \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1  H302 \nH318 \nH334 \nH317 \nH400  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH334 \nH317 \nH400  \n030-006-00-9  zinc sulphate (hydrous) (mono-, \nhexa-and hepta hydrate); [1] \nzinc sulphate (anhydrous) [2]  231-793-3 [1] \n231-793-3 [2]  7446-19-7 [1] \n7733-02-0 [2]  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH410  \n030-007-00-4  bis(3,5-di- tert-butylsalicylato-  \nO1 ,O2 )zinc  403-360-0  42405-40-3  Flam. Sol. 1 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H228 \nH302 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nDgr H228 \nH302 \nH410  T ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 627}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 629\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n030-008-00-X  hydroxo(2-(benzenesulfon\xad\namido)benzoato)zinc(II)  403-750-0  113036-91-2  Acute Tox. 4 * \nAquatic Chronic 2  H332 \nH411  GHS07 \nGHS09 \nWng  H332 \nH411  \n030-009-00-5  zinc-bis(4-( n-octyloxycarbony\xad\nlamino)salicylate) dihydrate  417-130-2  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n030-010-00-0  2-dodec-1-enylbutanedioic \nacid,4-methyl ester zinc salt  430-740-3  —  Aquatic Chronic 2  H411  GHS09  H411  \n030-011-00-6  trizinc bis(orthophosphate)  231-944-3  7779-90-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n030-012-00-1  aluminium-magnesium-zinc- \ncarbonate-hydroxide  423-570-6  169314-88-9  Aquatic Chronic 4  H413  H413  \n030-013-00-7  zinc oxide  215-222-5  1314-13-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n030-015-00-8  tetrazinc(2+)bis(hexacyanocob\xad\nalt(3+))diacetate  440-060-9  —  Aquatic Chronic 2  H411  GHS09  H411  \n▼M11  \n031-001-00-4  gallium arsenide  215-114-8  1303-00-0  Repr. 1B \nCarc. 1B \nSTOT RE 1  H360F \nH350 \nH372 \n(respiratory \nand haemato\xad\npoietic \nsystems)  GHS08 \nDgr H360F \nH350 \nH372 \n(respiratory \nand haema\xad\ntopoietic \nsystems)  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 628}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 630\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n033-001-00-X  arsenic  231-148-6  7440-38-2  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH410  \n033-002-00-5  arsenic compounds, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH410  * A 1  \n033-003-00-0  diarsenic trioxide; \narsenic trioxide  215-481-4  1327-53-3  Carc. 1A \nAcute Tox. 2 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH300 \nH314 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H350 \nH300 \nH314 \nH410  \n033-004-00-6  diarsenic pentaoxide; \narsenic pentoxide; \narsenic oxide  215-116-9  1303-28-2  Carc. 1A \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH331 \nH301 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH301 \nH410  \n033-005-00-1  arsenic acid and it salts with the \nexception of those specified \nelsewhere in this Annex  — —  Carc. 1A \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH331 \nH301 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH301 \nH410  A \n033-006-00-7  arsine  232-066-3  7784-42-1  Flam. Gas 1 \nPress. Gas \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H220 \nH330 \nH373 ** \nH400 \nH410  GHS02 \nGHS04 \nGHS06 \nGHS08 \nGHS09 \nDgr H220 \nH330 \nH373 ** \nH410  U ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 629}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 631\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n033-007-00-2  tert -butylarsine  423-320-6  4262-43-5  Pyr. Liq. 1 \nAcute Tox. 2 *  H250 \nH330  GHS02 \nGHS06 \nDgr H250 \nH330  \n034-001-00-2  selenium  231-957-4  7782-49-2  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 4  H331 \nH301 \nH373 ** \nH413  GHS06 \nGHS08 \nDgr H331 \nH301 \nH373 ** \nH413  \n034-002-00-8  selenium compounds with the \nexception of cadmium sulpho\xad\nselenide and those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH373** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH301 \nH373** \nH410  A \n034-003-00-3  sodium selenite  233-267-9  10102-18-8  Acute Tox. 2 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Chronic 2  H300 \nH331 \nH317 \nH411  GHS06 \nGHS09 \nDgr H300 \nH331 \nH317 \nH411  EUH031  \n035-001-00-5  bromine  231-778-1  7726-95-6  Acute Tox. 2 * \nSkin Corr. 1A \nAquatic Acute 1  H330 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH314 \nH400  \n035-002-00-0  hydrogen bromide  233-113-0  10035-10-6  Press. Gas \nSkin Corr. 1A \nSTOT SE 3  H314 \nH335  GHS04 \nGHS05 \nGHS07 \nDgr H314 \nH335  U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 630}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 632\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n035-002-01-8  hydrobromic acid … %  —  —  Skin Corr. 1B \nSTOT SE 3  H314 \nH335  GHS05 \nGHS07 \nDgr H314 \nH335  Skin Corr. 1B; \nH314: C ≥ 40 % \nSkin Irrit. 2; H315: \n10 % ≤ C < 40 % \nEye Irrit. 2; H319: \n10 % ≤ C < 40 % \nSTOT SE 3; H335: \nC ≥ 10 %  B \n035-003-00-6  potassium bromate  231-829-8  7758-01-2  Ox. Sol. 1 \nCarc. 1B \nAcute Tox. 3 *  H271 \nH350 \nH301  GHS03 \nGHS06 \nGHS08 \nDgr H271 \nH350 \nH301  \n035-004-00-1  2-hydroxyethylammonium \nperbromide  407-440-6  —  Ox. Sol. 2 **** \nAcute Tox. 4 * \nSkin Corr. 1A \nSkin Sens. 1 \nAquatic Acute 1  H272 \nH302 \nH314 \nH317 \nH400  GHS03 \nGHS05 \nGHS07 \nGHS09 \nDgr H272 \nH302 \nH314 \nH317 \nH400  \n040-001-00-3  zirconium powder (pyrophoric)  231-176-9  7440-67-7  Water-react. 1 \nPyr. Sol. 1  H260 \nH250  GHS02 \nDgr H260 \nH250  T \n040-002-00-9  zirconium powder, dry (non \npyrophoric)  — —  Self-heat. 1  H251  GHS02 \nDgr H251  T  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 631}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 633\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n040-003-00-4  reaction product of 3,5-di- tert- \nbutylsalicylic acid and \nzirconium oxychloride, dehy\xad\ndrated, basic Zr: DTBS= 1.0:1.0 \nto 1.0: 1.5  430-610-6  226996-19-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n042-001-00-9  molybdenum trioxide  215-204-7  1313-27-5  Carc. 2 \nEye Irrit. 2 \nSTOT SE 3  H351 \nH319 \nH335  GHS08 \nGHS07 \nWng  H351 \nH319 \nH335  \n042-002-00-4  tetrakis(dimethylditetradecylam\xad\nmonium) hexa-μ-oxotetra-μ3- \noxodi-μ5-oxotetradecaoxoocta\xad\nmolybdate(4-)  404-760-8  117342-25-3  Acute Tox. 3 * \nEye Dam. 1  H331 \nH318  GHS06 \nGHS05 \nDgr H331 \nH318  \n042-003-00-X  tetrakis(trimethylhexadecylam\xad\nmonium) hexa-mu-oxotetra-mu3- \noxodi-mu5-oxotetradecaoxoocta\xad\nmolybdate(4-)  404-860-1  116810-46-9  Flam. Sol. 1 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H228 \nH318 \nH400 \nH410  GHS02 \nGHS05 \nGHS09 \nDgr H228 \nH318 \nH410  T \n042-004-00-5  reaction product of ammonium \nmolybdate and C  12-C 24- \ndiethoxylated alkylamine (1:5- \n1:3) 412-780-3  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H315 \nH317 \nH411  \n042-005-00-0  reaction mass of: mono-and di- \nglycerols of canola oil; \ncanola oil acid amide of \nbranched 1,3-propanediamine,  \nN-[3-(tridecyloxy)-propyl];  \nN, N -diorgano dithiocarbamate \nmolybdenum complex  434-240-6  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 632}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 634\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n046-001-00-X  tetraammine palladium (II)hy\xad\ndrogen carbonate  425-270-0  134620-00-1  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** H318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H302 \nH373** \nH318 \nH317 \nH410  \n047-001-00-2  silver nitrate  231-853-9  7761-88-8  Ox. Sol. 2 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH314 \nH400 \nH410  GHS03 \nGHS05 \nGHS09 \nDgr H272 \nH314 \nH410  \n047-002-00-8  polyphosphoric acid, copper, \nsodium, magnesium, calcium, \nsilver and zinc salt  416-850-4  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n▼M15  \n047-003-00-3  silver zinc zeolite (Zeolite, LTA \nframework type, surface- \nmodified with silver and zinc \nions) \n[This entry covers LTA (Linde \nType A) framework type zeolite \nwhich has been surface-modified \nwith both silver and zinc ions at \ncontents Ag+ 0,5 %-6 %, \nZn2 + 5 %-16 %, and potentially \nwith phosphorus, NH4+, Mg2+ \nand/or Ca2+ each at level < 3 %]  — 130328-20-0  Repr. 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH315 \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H361d \nH315 \nH318 \nH410  M = 100 \nM = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 633}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 635\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n048-001-00-5  cadmium compounds, with the \nexception of cadmium sulpho\xad\nselenide (xCdS.yCdSe), reaction \nmass of cadmium sulphide with \nzinc sulphide (xCdS.yZnS), \nreaction mass of cadmium \nsulphide with mercury sulphide \n(xCdS.yHgS), and those \nspecified elsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  * A 1  \n048-002-00-0  cadmium (non-pyrophoric); [1] \ncadmium oxide (non-pyrophoric) \n[2] 231-152-8 [1] \n215-146-2 [2]  7440-43-9 [1] \n1306-19-0 [2]  Carc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 2 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH341 \nH361fd \nH330 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH361fd \nH330 \nH372 ** \nH410  \n048-003-00-6  cadmium diformate; \ncadmiumformate  224-729-0  4464-23-7  Acute Tox. 3 * \nAcute Tox. 3 * \nCarc. 2 \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH351 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH301 \nH351 \nH373 ** \nH410  * \nSTOT RE 2; H373: \nC ≥0,25 %  \n048-004-00-1  cadmium cyanide  208-829-1  542-83-6  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nCarc. 2 \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH351 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH351 \nH373 ** \nH410  EUH032  STOT RE 2; H373: \nC ≥0,1 % \nEUH032:C≥1 %  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 634}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 636\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n048-005-00-7  cadmiumhexafluorosilicate(2-); \ncadmium fluorosilica  241-084-0  17010-21-8  Acute Tox. 3 * \nAcute Tox. 3 * \nCarc. 2 \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH351 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH301 \nH351 \nH373 ** \nH410  * \nSTOT RE 2; H373: \nC ≥0,1 %  \n048-006-00-2  cadmium fluoride  232-222-0  7790-79-6  Carc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH410  Carc. 1B; H350: C \n≥ 0,01 % \n* oral \nSTOT RE 1; H372: \nC ≥ 7 % STOT \nRE 2: \n0,1 % ≤ C <7 %  \n048-007-00-8  cadmium iodide  232-223-6  7790-80-9  Acute Tox. 3 * \nAcute Tox. 3 * \nCarc. 2 \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH351 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH301 \nH351 \nH373 ** \nH410  * \nSTOT RE 2; H373: \nC ≥ 0,1 %  \n048-008-00-3  cadmium chloride  233-296-7  10108-64-2  Carc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH410  Carc. 1B; H350: C \n≥ 0,01 % \n* oral \nSTOT RE 1; H372: \nC ≥ 7 % STOT RE \n2; H373: 0,1 % ≤ \nC < 7 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 635}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 637\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n048-009-00-9  cadmium sulphate  233-331-6  10124-36-4  Carc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH340 \nH360FD \nH330 \nH301 \nH372 ** \nH410  Carc. 1B; H350: C \n≥ 0,01 % \n* oral \nSTOT RE 1; H372: \nC ≥ 7 % STOT RE \n2; H373 0,1 % ≤ C \n< 7 %  \n048-010-00-4  cadmium sulphide  215-147-8  1306-23-6  Carc. 1B \nMuta. 2 \nRepr. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nAquatic Chronic 4  H350 \nH341 \nH361fd \nH372 ** \nH302 \nH413  GHS08 \nGHS07 \nDgr H350 \nH341 \nH361fd \nH372 ** \nH302 \nH413  * \nSTOT RE 1; H372: \nC ≥ 10 % STOT \nRE 2; H373: 0,1 % \n≤ C < 10 %  1 \n048-011-00-X  cadmium (pyrophoric)  231-152-8  7440-43-9  Pyr. Sol. 1 \nCarc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 2 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H250 \nH350 \nH341 \nH361fd \nH330 \nH372 ** \nH400 \nH410  GHS02 \nGHS06 \nGHS08 \nGHS09 \nDgr H250 \nH350 \nH341 \nH361fd \nH330 \nH372 ** \nH410  \n▼M15  \n048-012-00-5  cadmium carbonate  208-168-9  513-78-0  Carc. 1B \nMuta. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH332 \nH312 \nH302 \nH372 (kidney, \nbone) \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH340 \nH332 \nH312 \nH302 \nH372 \n(kidney, \nbone) \nH410  A1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 636}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 638\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n048-013-00-0  cadmium hydroxide; cadmium \ndihydroxide  244-168-5  21041-95-2  Carc. 1B \nMuta. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH332 \nH312 \nH302 \nH372 (kidney, \nbone) \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH340 \nH332 \nH312 \nH302 \nH372 \n(kidney, \nbone) \nH410  A1 \n048-014-00-6  cadmium nitrate; \ncadmium dinitrate  233-710-6  10325-94-7  Carc. 1B \nMuta. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH332 \nH312 \nH302 \nH372 (kidney, \nbone) \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH340 \nH332 \nH312 \nH302 \nH372 \n(kidney, \nbone) \nH410  Carc. 1B; H350: \nC ≥ 0,01 %  A1 \n▼M16  \n050-001-00-5  tin tetrachloride; \nstannic chloride  231-588-9  7646-78-8  Skin Corr. 1B \nAquatic Chronic 3  H314 \nH412  GHS05 \nDgr H314 \nH412  STOT SE 3; \nH335:C≥5 %  \n050-002-00-0  cyhexatin (ISO); hydroxytri\xad\ncyclohexylstannane; tri(cyclo\xad\nhexyl)tin hydroxide  236-049-1  13121-70-5  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  M=1000  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 637}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 639\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n050-003-00-6  fentin acetate (ISO); \ntriphenyltin acetate  212-984-0  900-95-8  Carc. 2 \nRepr. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361d*** \nH330 \nH311 \nH301 \nH372** \nH335 \nH315 \nH318 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H351 \nH361d*** \nH330 \nH311 \nH301 \nH372** \nH335 \nH315 \nH318 \nH410  M=10  \n050-004-00-1  fentin hydroxide (ISO); \ntriphenyltin hydroxide  200-990-6  76-87-9  Carc. 2 \nRepr. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361d*** \nH330 \nH311 \nH301 \nH372** \nH335 \nH315 \nH318 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H351 \nH361d*** \nH330 \nH311 \nH301 \nH372** \nH335 \nH315 \nH318 \nH410  M=10  \n050-005-00-7  trimethyltin compounds, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  * A 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 638}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 640\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n050-006-00-2  triethyltin compounds, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  * A 1  \n050-007-00-8  tripropyltin compounds, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  * A 1  \n▼M11  \n050-008-00-3  tributyltin compounds, with the \nexception of those specified \nelsewhere in this annex  — —  Repr. 1B \nAcute Tox. 3 \nAcute Tox. 4* \nSTOT RE 1 \nSkin Irrit. 2 \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H360FD \nH301 \nH312 \nH372** \nH315 \nH319 \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360FD \nH301 \nH312 \nH372** \nH315 \nH319 \nH410  * \nSTOT RE 1; H372: \nC ≥ 1 % \nSTOT RE 2; H373: \n0,25 % ≤ C < 1 % \nSkin Irrit. 2; \nH315:C ≥ 1 % \nEye Irrit. 2; \nH319:C ≥ 1 % \nM = 10  A \n1 \n▼M16  \n050-009-00-9  fluorotripentylstannane;[1] \nhexapentyldistannoxane [2]  243-546-7 [1] \n247-143-7 [2]  20153-49-5 [1] \n25637-27-8 [2]  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  * 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 639}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 641\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n050-010-00-4  fluorotrihexylstannane  243-547-2  20153-50-8  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  * 1  \n050-011-00-X  triphenyltin compounds, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  * M=100  A 1  \n050-012-00-5  tetracyclohexylstannane; [1] \nchlorotricyclohexylstannane; [2] \nbutyltricyclohexylstannane [3]  215-910-5 [1] \n221-437-5 [2] \n230-358-5 [3]  1449-55-4 [1] \n3091-32-5 [2] \n7067-44-9 [3]  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  * A 1  \n050-013-00-0  trioctyltin compounds, with the \nexception of those specified \nelsewhere in this Annex  — —  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 4  H319 \nH335 \nH315 \nH413  GHS07 \nWng  H319 \nH335 \nH315 \nH413  Skin Irrit. 2; H315: \nC ≥ 1 % Eye \nIrrit.2; H319: C ≥ \n1 % STOT SE 3; \nH335: C ≥ 1 %  A1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 640}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 642\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n050-017-00-2  fenbutatin oxide (ISO); \nbis(tris(2-methyl-2-phenylpro\xad\npyl)tin)oxide  236-407-7  13356-08-6  Acute Tox. 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH319 \nH315 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH319 \nH315 \nH410  \n050-018-00-8  tin(II) methanesulphonate  401-640-7  53408-94-9  Skin Corr. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H314 \nH302 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH302 \nH317 \nH411  \n050-019-00-3  azocyclotin (ISO); \n1-(tricyclohexylstannyl)-1 H- \n1,2,4-triazole  255-209-1  41083-11-8  Acute Tox. 2 * \nAcute Tox. 3 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH301 \nH335 \nH315 \nH318 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH301 \nH335 \nH315 \nH318 \nH410  \n050-020-00-9  trioctylstannane  413-320-4  869-59-0  STOT RE 1 \nSkin Irrit. 2 \nAquatic Chronic 4  H372 ** \nH315 \nH413  GHS08 \nGHS07 \nDgr H372 ** \nH315 \nH413  \n▼M23  \n050-021-00-4  dichlorodioctylstannane  222-583-2  3542-36-7  Repr. 1B \nAcute Tox. 2 \nSTOT RE 1 \nAquatic Chronic 3  H360D \nH330 \nH372 ** \nH412  GHS08 \nGHS06 \nDgr H360D \nH330 \nH372 ** \nH412  Repr. 1B; H360 D: \nC ≥ 0,03 % \ninhalation: ATE = \n0,098 mg/L (dusts \nor mists)  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 641}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 643\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n050-022-00-X  dibutyltin dichloride; \n(DBTC)  211-670-0  683-18-1  Muta. 2 \nRepr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 1 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH360FD \nH330 \nH301 \nH312 \nH372** \nH314 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H341 \nH360FD \nH330 \nH301 \nH312 \nH372** \nH314 \nH410  Skin Corr. 1B; \nH314: C ≥ 5 % \nSkin Irrit. 2; H315: \n0,01 % ≤ C < 5 % \nEye Dam.1; H318: \n3 % ≤ C< 5 % \nEye Irrit. 2; H319: \n0,01 % ≤ C < 3 % \nM=10  \n050-023-00-5  reaction mass of: bis[(2-ethyl-1- \noxohexyl)oxy]dioctyl stannane; \nbis[((2-ethyl-1- \noxohexyl)oxy)dioctylstan\xad\nnyl]oxide; bis(1-phenyl-1,3- \ndecanedionyl)dioctyl stannane; \n((2-ethyl-1-oxohexyl)oxy)-(1- \nphenyl-1,3-decanedionyl)dioctyl \nstannane  422-920-5  —  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373** \nH400 \nH410  GHS08 \nGHS09 \nWng  H373** \nH410  M=10  \n050-024-00-0  reaction mass of: tri- p-tolyltin \nhydroxide; hexa- p-tolyl-distann\xad\noxane  432-230-6  —  STOT RE 1 \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H372** \nH302 \nH315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H372** \nH302 \nH315 \nH318 \nH317 \nH410  \n050-025-00-6  trichloromethylstannane  213-608-8  993-16-8  Repr. 2  H361d  GHS08 \nWng  H361d  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 642}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 644\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n050-026-00-1  2-ethylhexyl 10-ethyl-4-[[2-[(2- \nethylhexyl)oxy]-2-oxoethyl]thio]- \n4-methyl-7-oxo-8-oxa-3,5-dithia- \n4-stannatetradecanoate  260-828-5  57583-34-3  Repr. 2  H361d  GHS08 \nWng  H361d  \n▼M23  \n050-027-00-7  2-ethylhexyl 10-ethyl-4,4-dioctyl- \n7-oxo-8-oxa-3,5-dithia-4-stanna\xad\ntetradecanoate; [DOTE]  239-622-4  15571-58-1  Repr. 1B \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH372 (immune \nsystem) \nH400 \nH410  GHS08 \nGHS09 \nDgr H360D \nH372 \n(immune \nsystem) \nH410  \n▼M16  \n050-028-00-2  2-ethylhexyl 10-ethyl-4,4- \ndimethyl-7-oxo-8-oxa-3,5-dithia- \n4-stannatetradecanoate  260-829-0  57583-35-4  Repr. 2 \nAcute Tox. 4 \nSTOT RE 1 \nSkin Sens. 1A  H361d \nH302 \nH372 \n(nervous \nsystem, \nimmune \nsystem) \nH317  GHS08 \nGHS07 \nDgr H361d \nH302 \nH372 \n(nervous \nsystem, \nimmune \nsystem) \nH317  \n050-029-00-8  dimethyltin dichloride  212-039-2  753-73-1  Repr. 2 \nAcute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 3 \nSTOT RE 1 \nSkin Corr. 1B  H361d \nH330 \nH301 \nH311 \nH372 \n(nervous \nsystem, \nimmune \nsystem) \nH314  GHS08 \nGHS06 \nGHS05 \nDgr H361d \nH330 \nH301 \nH311 \nH372 \n(nervous \nsystem, \nimmune \nsystem) \nH314  EUH071  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 643}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 645\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M15  \n050-030-00-3  dibutyltin dilaurate; dibu\xad\ntyl[bis(dodecanoyloxy)]stannane  201-039-8  77-58-7  Muta. 2 \nRepr. 1B \nSTOT RE 1  H341 \nH360FD \nH372 (immune \nsystem)  GHS08 \nDgr H341 \nH360FD \nH372 \n(immune \nsystem)  \n▼M23  \n050-031-00-9  dioctyltin dilaurate; [1] \nstannane, dioctyl-, bis(coco \nacyloxy) derivs. [2]  222-883-3 [1] \n293-901-5 [2]  3648-18-8 [1] \n91648-39-4 [2]  Repr. 1B \nSTOT RE 1  H360D \nH372 (immune \nsystem)  GHS08 \nDgr H360D \nH372 \n(immune \nsystem)  \n▼M16  \n051-001-00-8  antimony trichloride  233-047-2  10025-91-9  Skin Corr. 1B \nAquatic Chronic 2  H314 \nH411  GHS05 \nGHS09 \nDgr H314 \nH411  STOT SE3; H335: \nC ≥ 5 %  \n051-002-00-3  antimony pentachloride  231-601-8  7647-18-9  Skin Corr. 1B \nAquatic Chronic 2  H314 \nH411  GHS05 \nGHS09 \nDgr H314 \nH411  STOT SE 3; H335: \nC ≥ 5 %  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 644}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 646\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n051-003-00-9  antimony compounds, with the \nexception of the tetroxide \n(Sb  2O 4), pentoxide (Sb  2O 5), \ntrisulphide (Sb  2S 3), penta\xad\nsulphide (Sb  2S 5) and those \nspecified elsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H332 \nH302 \nH411  GHS07 \nGHS09 \nWng  H332 \nH302 \nH411  * A 1  \n051-004-00-4  antimony trifluoride  232-009-2  7783-56-4  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH411  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH411  \n051-005-00-X  antimony trioxide  215-175-0  1309-64-4  Carc. 2  H351  GHS08 \nWng  H351  \n051-006-00-5  diphenyl(4-phenylthiophenyl)sul\xad\nfonium hexafluoroantimonate  403-500-0  —  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n051-007-00-0  bis(4-dodecylphenyl)iodonium \nhexafluoroantimonate  404-420-9  71786-70-4  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n053-001-00-3  iodine  231-442-4  7553-56-2  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1  H332 \nH312 \nH400  GHS07 \nGHS09 \nWng  H332 \nH312 \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 645}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 647\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n053-002-00-9  hydrogen iodide  233-109-9  10034-85-2  Press. Gas \nSkin Corr. 1A  H314  GHS04 \nGHS05 \nDgr H314  Skin Corr. 1A; \nH314: C ≥ 10 % \nSkin Corr. 1B; \nH314: 0,2 % ≤ C < \n10 % \nSkin Irrit. 2; H315: \n0,02 % ≤ C < \n0,2 % \nEye Irrit. 2; H319: \n0,02 % ≤ C < \n0,2 % \nSTOT SE 3; H335: \nC ≥0,02 %  U5 \n053-002-01-6  hydriodic acid … %  —  —  Skin Corr. 1B  H314  GHS05 \nDgr Skin Corr. 1B; \nH314: C ≥ 25 % \nSkin Irrit. 2; H315: \n10 % ≤ C < 25 % \nEye Irrit. 2; H319: \n10 % ≤ C < 25 %  B \n053-003-00-4  iodoxybenzene  —  696-33-3  Expl. ****  ****  ****  ****  \n053-004-00-X  calcium iodoxybenzoate  —  —  Expl. ****  ****  ****  ****  C  \n053-005-00-5  (4-(1-methylethyl)phenyl)-(4- \nmethylphenyl)iodonium tetra\xad\nkis(pentafluorophenyl)borate(1-)  422-960-3  178233-72-2  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH373 ** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H312 \nH302 \nH373 ** \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 646}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 648\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n056-001-00-1  barium peroxide  215-128-4  1304-29-6  Ox. Sol. 2 \nAcute Tox. 4 * \nAcute Tox. 4 *  H272 \nH332 \nH302  GHS03 \nGHS07 \nDgr H272 \nH332 \nH302  \n056-002-00-7  barium salts, with the exception \nof barium sulphate, salts of 1- \nazo-2-hydroxynaphthalenyl aryl \nsulphonic acid, and of salts \nspecified elsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH302  GHS07 \nWng  H332 \nH302  * A 1  \n056-003-00-2  barium carbonate  208-167-3  513-77-9  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n056-004-00-8  barium chloride  233-788-1  10361-37-2  Acute Tox. 3 * \nAcute Tox. 4 *  H301 \nH332  GHS06 \nDgr H301 \nH332  \n064-001-00-8  gadolinium(III)sulfite trihydrate  456-900-2  51285-81-5  Aquatic Chronic 2  H411  GHS09  H411  \n072-001-00-4  hafnium tetra- n-butoxide  411-740-2  22411-22-9  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n074-001-00-X  hexasodium tungstate hydrate  412-770-9  12141-67-2  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 647}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 649\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n074-002-00-5  reaction products of tungsten \nhexachloride with 2-methyl\xad\npropan-2-ol, nonylphenol and \npentane-2,4-dione  408-250-6  —  Flam. Liq. 2 \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH332 \nH314 \nH317 \nH400 \nH410  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H225 \nH332 \nH314 \nH317 \nH410  \n076-001-00-5  osmium tetraoxide; \nosmic acid  244-058-7  20816-12-0  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSkin Corr. 1B  H330 \nH310 \nH300 \nH314  GHS06 \nGHS05 \nDgr H330 \nH310 \nH300 \nH314  \n078-001-00-0  tetrachloroplatinates with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH318 \nH334 \nH317  A \n078-002-00-6  diammonium tetrachloroplatinate  237-499-1  13820-41-2  Acute Tox. 3 * \nSkin Irrit. 2 \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH315 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH315 \nH318 \nH334 \nH317  \n078-003-00-1  disodium tetrachloroplatinate  233-051-4  10026-00-3  Acute Tox. 3 * \nSkin Irrit. 2 \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH315 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH315 \nH318 \nH334 \nH317  \n078-004-00-7  dipotassium tetrachloroplatinate  233-050-9  10025-99-7  Acute Tox. 3 * \nSkin Irrit. 2 \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH315 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH315 \nH318 \nH334 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 648}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 650\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n078-005-00-2  hexachloroplatinates with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH318 \nH334 \nH317  A \n078-006-00-8  disodium hexachloroplatinate  240-983-5  16923-58-3  Acute Tox. 3 * \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH318 \nH334 \nH317  \n078-007-00-3  dipotassium hexachloroplatinate  240-979-3  16921-30-5  Acute Tox. 3 * \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH318 \nH334 \nH317  \n078-008-00-9  diammonium hexachloroplatinate  240-973-0  16919-58-7  Acute Tox. 3 * \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH318 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH318 \nH334 \nH317  \n078-009-00-4  hexachloroplatinic acid  241-010-7  16941-12-1  Acute Tox. 3 * \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1  H301 \nH314 \nH334 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H301 \nH314 \nH334 \nH317  \n078-010-00-X  tetraammine platinum (II) \nhydrogen carbonate  426-730-3  123439-82-7  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 649}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 651\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n078-011-00-5  hydroxydisulfito platinum(II)acid  423-310-1  61420-92-6  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1A \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH373 \nH314 \nH334 \nH317 \nH412  GHS05 \nGHS08 \nGHS07 \nDgr H302 \nH373 \nH314 \nH334 \nH317 \nH412  \n078-012-00-0  platinum(IV) nitrate/nitric acid \nsolution  432-400-1  —  Skin Corr. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  \n080-001-00-0  mercury  231-106-7  7439-97-6  Repr. 1B \nAcute Tox. 2 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D*** \nH330 \nH372** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H360D*** \nH330 \nH372** \nH410  \n080-002-00-6  Inorganic compounds of mercury \nwith the exception of mercuric \nsulphide and those specified \nelsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH410  * \nSTOT RE 2; H373: \nC ≥ 0,1 %  A1 \n080-003-00-1  dimercury dichloride; \nmercurous chloride; \ncalomel  233-307-5  10112-91-1  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH335 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH335 \nH315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 650}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 652\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n080-004-00-7  organic compounds of mercury \nwith the exception of those \nspecified elsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH410  * \nSTOT RE 2; H373: \nC ≥0,1 %  A1 \n080-005-00-2  mercury difulminate; \nmercuric fulminate; \nfulminate of mercury  211-057-8  628-86-4  Unst. Expl. \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H200 \nH331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H200 \nH331 \nH311 \nH301 \nH373 ** \nH400 \nH410  \n080-005-01-X  mercury difulminate; \nmercuric fulminate; \nfulminate of mercury [≥ 20 % \nphlegmatiser]  211-057-8  628-86-4  Expl. 1.1 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH331 \nH311 \nH301 \nH373 ** \nH400 \nH410  \n080-006-00-8  dimercury dicyanide oxide; \nmercuric oxycyanide  215-629-8  1335-31-5  Expl. 1.1 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH331 \nH311 \nH301 \nH373** \nH400 \nH410  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH331 \nH311 \nH301 \nH373** \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 651}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 653\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n080-007-00-3  dimethylmercury; [1] \ndiethylmercury [2]  209-805-3 [1] \n211-000-7 [2]  593-74-8 [1] \n627-44-1 [2]  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH410  * \nSTOT RE 2; H373: \nC ≥0,05 %  1 \n080-008-00-9  phenylmercury nitrate; [1] \nphenylmercury hydroxide; [2] \nbasic phenylmercury nitrate [3]  200-242-9 [1] \n202-866-7 [2] \n-[3] 55-68-5 [1] \n100-57-2 [2] \n8003-05-2 [3]  Acute Tox. 3 * \nSTOT RE 1 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH372 ** \nH314 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H301 \nH372 ** \nH314 \nH410  \n080-009-00-4  2-methoxyethylmercury chloride  204-659-7  123-88-6  Acute Tox. 3 * \nSTOT RE 1 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH372 ** \nH314 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H301 \nH372 ** \nH314 \nH410  \n080-010-00-X  mercury dichloride; \nmercuric chloride  231-299-8  7487-94-7  Muta. 2 \nRepr. 2 \nAcute Tox. 2 * \nSTOT RE 1 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH361f*** \nH300 \nH372** \nH314 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H341 \nH361f*** \nH300 \nH372** \nH314 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 652}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 654\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n080-011-00-5  phenylmercury acetate  200-532-5  62-38-4  Acute Tox. 3 * \nSTOT RE 1 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH372 ** \nH314 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H301 \nH372 ** \nH314 \nH410  \n▼M22  \n080-012-00-0  methylmercuric chloride  204-064-2  115-09-3  Carc. 2 \nRepr. 1A \nLact. \nAcute Tox. 2 \nAcute Tox. 2 \nAcute Tox. 2 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH360Df \nH362 \nH330 \nH310 \nH300 \nH372 (nervous \nsystem, \nkidneys) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H351 \nH360Df \nH362 \nH330 \nH310 \nH300 \nH372 \n(nervous \nsystem, \nkidneys) \nH410  inhalation: ATE = \n0,05 mg/l (dusts or \nmists) \ndermal: ATE = 50 \nmg/kg bw \noral: ATE = 5 mg/ \nkg bw  1 \n▼M16  \n081-001-00-3  thallium  231-138-1  7440-28-0  Acute Tox. 2 * \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 4  H330 \nH300 \nH373 ** \nH413  GHS06 \nGHS08 \nDgr H330 \nH300 \nH373 ** \nH413  \n081-002-00-9  thallium compounds, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 2  H330 \nH300 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH300 \nH373 ** \nH411  A \n081-003-00-4  dithallium sulphate; \nthallic sulphate  231-201-3  7446-18-6  Acute Tox. 2 * \nSTOT RE 1 \nSkin Irrit. 2 \nAquatic Chronic 2  H300 \nH372 ** \nH315 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H300 \nH372 ** \nH315 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 653}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 655\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n082-001-00-6  lead compounds with the \nexception of those specified \nelsewhere in this Annex  — —  Repr. 1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH332 \nH302 \nH373 ** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360Df \nH332 \nH302 \nH373 ** \nH410  Repr.2 H361f: C ≥ \n2,5 % \n* \nSTOT RE 2; H373: \nC ≥0,5 %  A1 \n082-002-00-1  lead alkyls  —  —  Repr. 1A \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH330 \nH310 \nH300 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H360Df \nH330 \nH310 \nH300 \nH373 ** \nH410  Repr.1A; H360D: \nC≥ 0,1 % \n* \nSTOT RE 2; H373: \nC ≥0,05 %  A1 \n082-003-00-7  lead diazide; \nlead azide  236-542-1  13424-46-9  Unst. Expl. Repr. \n1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H200 \nH360Df \nH332 \nH302 \nH373 ** \nH400 \nH410  GHS01 \nGHS08 \nGHS07 \nGHS09 \nDgr H200 \nH360Df \nH332 \nH302 \nH373 ** \nH410  1 \n082-003-01-4  lead diazide; \nlead azide [≥ 20 % phlegmatiser]  236-542-1  13424-46-9  Expl. 1.1 \nRepr. 1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH360Df \nH332 \nH302 \nH373 ** \nH400 \nH410  GHS01 \nGHS08 \nGHS07 \nGHS09 \nDgr H201 \nH360Df \nH332 \nH302 \nH373 ** \nH410  1 \n082-004-00-2  lead chromate  231-846-0  7758-97-6  Carc. 1B \nRepr. 1A \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH360Df \nH373** \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH360Df \nH373** \nH410  1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 654}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 656\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n082-005-00-8  lead di(acetate)  206-104-4  301-04-2  Repr. 1A \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH373 ** \nH400 \nH410  GHS08 \nGHS09 \nDgr H360Df \nH373 ** \nH410  1 \n082-006-00-3  trilead bis(orthophosphate)  231-205-5  7446-27-7  Repr. 1A \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH373 ** \nH400 \nH410  GHS08 \nGHS09 \nDgr H360Df \nH373 ** \nH410  1 \n082-007-00-9  lead acetate, basic  215-630-3  1335-32-6  Carc. 2 \nRepr. 1A \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH360Df \nH373 ** \nH400 \nH410  GHS08 \nGHS09 \nDgr H351 \nH360Df \nH373 ** \nH410  1 \n082-008-00-4  lead(II) methanesulphonate  401-750-5  17570-76-2  Repr. 1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1  H360Df \nH332 \nH302 \nH373 ** \nH315 \nH318  GHS08 \nGHS05 \nGHS07 \nDgr H360Df \nH332 \nH302 \nH373 ** \nH315 \nH318  1 \n082-009-00-X  lead sulfochromate yellow; C.I. \nPigment Yellow 34; \n[This substance is identified in \nthe Colour Index by Colour \nIndex Constitution Number, C.I. \n77603.]  215-693-7  1344-37-2  Carc. 1B \nRepr. 1A \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH360Df \nH373** \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH360Df \nH373** \nH410  1 ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 655}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 657\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n082-010-00-5  lead chromate molybdate sulfate \nred; C.I. Pigment Red 104; \n[This substance is identified in \nthe Colour Index by Colour \nIndex Constitution Number, C.I. \n77605.]  235-759-9  12656-85-8  Carc. 1B \nRepr. 1A \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH360Df \nH373** \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH360Df \nH373** \nH410  1 \n082-011-00-0  lead hydrogen arsenate  232-064-2  7784-40-9  Carc. 1A \nRepr. 1A \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH360Df \nH331 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH360Df \nH331 \nH301 \nH373 ** \nH410  1 \n082-012-00-6  barium calcium cesium lead \nsamarium strontium bromide \nchloride fluoride iodide \neuropium doped  431-780-4  199876-46-5  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 2  H302 \nH373** \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH411  \n▼M23  \n082-013-00-1  lead powder; [particle diameter < \n1 mm]  231-100-4  7439-92-1  Repr. 1A \nLact. \nAquatic Acute 1 \nAquatic Chronic 1  H360FD \nH362 \nH400 \nH410  GHS08 \nGHS09 \nDgr H360FD \nH362 \nH410  Repr. 1A; H360D: \nC ≥ 0,03 % \nM = 1 \nM = 10  \n▼M13  \n082-014-00-7  lead massive: \n[particle diameter \n≥ 1 mm]  231-100-4  7439-92-1  Repr. 1A \nLact.  H360FD \nH362  GHS08 \nDgr H360FD \nH362  \n▼M16  \n092-001-00-8  uranium  231-170-6  7440-61-1  Acute Tox. 2 * \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 4  H330 \nH300 \nH373 ** \nH413  GHS06 \nGHS08 \nDgr H330 \nH300 \nH373 ** \nH413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 656}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 658\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n092-002-00-3  uranium compounds with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 2 * \nSTOT RE 2 \nAquatic Chronic 2  H330 \nH300 \nH373** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH300 \nH373** \nH411  A \n601-001-00-4  methane  200-812-7  74-82-8  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  \n601-002-00-X  ethane  200-814-8  74-84-0  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  \n601-003-00-5  propane  200-827-9  74-98-6  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  \n601-004-00-0  butane; [1] and isobutane [2]  203-448-7 [1] \n200-857-2 [2]  106-97-8 [1] \n75-28-5 [2]  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  C  U  \n601-004-01-8  butane (containing ≥ 0,1 % \nbutadiene (203-450-8)); [1] \nisobutane (containing ≥ 0,1 % \nbutadiene (203-450-8)) [2]  203-448-7 [1] \n200-857-2 [2]  106-97-8 [1] \n75-28-5 [2]  Flam. Gas 1 \nPress. Gas \nCarc. 1A \nMuta. 1B  H220 \nH350 \nH340  GHS02 \nGHS04 \nGHS08 \nDgr H220 \nH350 \nH340  C S U  \n601-005-00-6  2,2-dimethylpropane; \nneopentane  207-343-7  463-82-1  Flam. Gas 1 \nPress. Gas \nAquatic Chronic 2  H220 \nH411  GHS02 \nGHS04 \nGHS09 \nDgr H220 \nH411  U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 657}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 659\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-006-00-1  pentane  203-692-4  109-66-0  Flam. Liq. 2 \nAsp. Tox. 1 \nSTOT SE 3 \nAquatic Chronic 2  H225 \nH304 \nH336 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH304 \nH336 \nH411  EUH066  C  \n601-007-00-7  hexane (containing < 5 %  n- \nhexane (203-777-6)); \n2-methylpentane;[1] \n3-methylpentane; [2] \n2,2-dimethylbutane; [3] \n2,3-dimethylbutane [4]  203-523-4 [1] \n202-481-4 [2] \n200-906-8 [3] \n201-193-6 [4]  107-83-5 [1] \n96-14-0 [2] \n75-83-2 [3] \n79-29-8 [4]  Flam. Liq. 2 \nAsp. Tox. 1 \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 2  H225 \nH304 \nH315 \nH336 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH304 \nH315 \nH336 \nH411  C \n601-008-00-2  heptane;  n-heptane; [1] \n2,4-dimethylpentane; [2] \n2,2,3-trimethylbutane; [3] \n3,3-dimethylpentane; [4] \n2,3-dimethylpentane; [5] \n3-methylhexane; [6] \n2,2-dimethylpentane; [7] \n2-methylhexane; [8] \n3-ethylpentane; [9] \nisoheptane; [10]  205-563-8 [1] \n203-548-0 [2] \n207-346-3 [3] \n209-230-8 [4] \n209-280-0 [5] \n209-643-3 [6] \n209-680-5 [7] \n209-730-6 [8] \n210-529-0 [9] \n250-610-8 [10]  142-82-5 [1] \n108-08-7 [2] \n464-06-2 [3] \n562-49-2 [4] \n565-59-3 [5] \n589-34-4 [6] \n590-35-2 [7] \n591-76-4 [8] \n617-78-7 [9] \n31394-54-4 [10]  Flam. Liq. 2 \nAsp. Tox. 1 \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH304 \nH315 \nH336 \nH400 \nH410  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH304 \nH315 \nH336 \nH410  C ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 658}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 660\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-009-00-8  octane;  n-octane; [1] \n2,2,4-trimethylpentane; [2] \n2,3,3-trimethylpentane; [3] \n3,3-dimethylhexane; [4] \n2,2,3-trimethylpentane; [5] \n2,3,4-trimethylpentane; [6] \n3,4-dimethylhexane; [7] \n2,3-dimethylhexane; [8] \n2,4-dimethylhexane; [9] \n4-methylheptane; [10] \n3-methylheptane; [11] \n2,2-dimethylhexane; [12] \n2,5-dimethylhexane; [13] \n2-methylheptane; [14] \n2,2,3,3-tetramethylbutane; [15] \n3-ethyl-2-methylpentane; [16] \n3-ethylhexane; [17] \n3-ethyl-3-methylpentane; [18] \nisooctane; [19]  203-892-1 [1] \n208-759-1 [2] \n209-207-2 [3] \n209-243-9 [4] \n209-266-4 [5] \n209-292-6 [6] \n209-504-7 [7] \n209-547-1 [8] \n209-649-6 [9] \n209-650-1 [10] \n209-660-6 [11] \n209-689-4 [12] \n209-745-8 [13] \n209-747-9 [14] \n209-855-6 [15] \n210-187-2 [16] \n210-621-0 [17] \n213-923-0 [18] \n247-861-0 [19]  111-65-9 [1] \n540-84-1 [2] \n560-21-4 [3] \n563-16-6 [4] \n564-02-3 [5] \n565-75-3 [6] \n583-48-2 [7] \n584-94-1 [8] \n589-43-5 [9] \n589-53-7 [10] \n589-81-1 [11] \n590-73-8 [12] \n592-13-2 [13] \n592-27-8 [14] \n594-82-1 [15] \n609-26-7 [16] \n619-99-8 [17] \n1067-08-9 [18] \n26635-64-3 [19]  Flam. Liq. 2 \nAsp. Tox. 1 \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH304 \nH315 \nH336 \nH400 \nH410  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH304 \nH315 \nH336 \nH410  C \n601-010-00-3  ethylene  200-815-3  74-85-1  Flam. Gas 1 \nPress. Gas \nSTOT SE 3  H220 \nH336  GHS02 \nGHS04 \nGHS07 \nDgr H220 \nH336  U \n601-011-00-9  propene; \npropylene  204-062-1  115-07-1  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 659}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 661\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-012-00-4  but-1-ene; [1] \nbutene, mixed-1-and-2-isomers; \n[2] \n2-methylpropene; [3] \n(Z)-but-2-ene; [4] \n(E)-but-2-ene [5]  203-449-2 [1] \n203-452-9 [2] \n204-066-3 [3] \n209-673-7 [4] \n210-855-3 [5]  106-98-9 [1] \n107-01-7 [2] \n115-11-7 [3] \n590-18-1 [4] \n624-64-6 [5]  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  C  U  \n601-013-00-X  1,3-butadiene; \nbuta-1,3-diene  203-450-8  106-99-0  Flam. Gas 1 \nPress. Gas \nCarc. 1A \nMuta. 1B  H220 \nH350 \nH340  GHS02 \nGHS04 \nGHS08 \nDgr H220 \nH350 \nH340  D U \n601-014-00-5  isoprene (stabilised) \n2-methyl-1,3-butadiene  201-143-3  78-79-5  Flam. Liq. 1 \nCarc. 1B Muta. 2 \nAquatic Chronic 3  H224 \nH350 \nH341 \nH412  GHS02 \nGHS08 \nDgr H224 \nH350 \nH341 \nH412  D \n▼B \n601-015-00-0  acetylene; \nethyne  200-816-9  74-86-2  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  ►M4 ___ ◄ U  \n▼M16  \n601-016-00-6  cyclopropane  200-847-8  75-19-4  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  \n601-017-00-1  cyclohexane  203-806-2  110-82-7  Flam. Liq. 2 \nAsp. Tox. 1 \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH304 \nH315 \nH336 \nH400 \nH410  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH304 \nH315 \nH336 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 660}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 662\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-018-00-7  methylcyclohexane  203-624-3  108-87-2  Flam. Liq. 2 \nAsp. Tox. 1 \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 2  H225 \nH304 \nH315 \nH336 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH304 \nH315 \nH336 \nH411  \n601-019-00-2  1,4-dimethylcyclohexane  209-663-2  589-90-2  Flam. Liq. 2 \nAsp. Tox. 1 \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 2  H225 \nH304 \nH315 \nH336 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH304 \nH315 \nH336 \nH411  \n601-020-00-8  benzene  200-753-7  71-43-2  Flam. Liq. 2 \nCarc. 1a \nMuta. 1B \nSTOT RE 1 \nAsp. Tox. 1 \nEye Irrit. 2 \nSkin Irrit. 2  H225 \nH350 \nH340 \nH372 ** \nH304 \nH319 \nH315  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH350 \nH340 \nH372 ** \nH304 \nH319 \nH315  E \n601-021-00-3  toluene  203-625-9  108-88-3  Flam. Liq. 2 \nRepr. 2 \nAsp. Tox. 1 \nSTOT RE 2 * \nSkin Irrit. 2 \nSTOT SE 3  H225 \nH361d *** \nH304 \nH373 ** \nH315 \nH336  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH361d *** \nH304 \nH373 ** \nH315 \nH336  \n601-022-00-9  o-xylene; [1]  \np-xylene; [2]  \nm-xylene; [3] \nxylene [4]  202-422-2 [1] \n203-396-5 [2] \n203-576-3 [3] \n215-535-7 [4]  95-47-6 [1] \n106-42-3 [2] \n108-38-3 [3] \n1330-20-7 [4]  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2  H226 \nH332 \nH312 \nH315  GHS02 \nGHS07 \nWng  H226 \nH332 \nH312 \nH315  * C  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 661}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 663\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-023-00-4  ethylbenzene  202-849-4  100-41-4  Flam. Liq. 2 \nAcute Tox. 4* \nSTOT RE 2 \nAsp. Tox. 1  H225 \nH332 \nH373 \n(hearing \norgans) \nH304  GHS02 \nGHS07 \nGHS08 \nDgr H225 \nH332 \nH373 \n(hearing \norgans) \nH304  \n601-024-00-X  cumene; [1] \npropylbenzene [2]  202-704-5 [1] \n203-132-9 [2]  98-82-8 [1] \n103-65-1 [2]  Flam. Liq. 3 \nAsp. Tox. 1 \nSTOT SE 3 \nAquatic Chronic 2  H226 \nH304 \nH335 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H226 \nH304 \nH335 \nH411  C \n601-025-00-5  mesitylene; \n1,3,5-trimethylbenzene  203-604-4  108-67-8  Flam. Liq. 3 \nSTOT SE 3 \nAquatic Chronic 2  H226 \nH335 \nH411  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH335 \nH411  STOT SE 3; H335: \nC ≥ 25 %  \n601-026-00-0  styrene  202-851-5  100-42-5  Flam. Liq. 3 \nRepr. 2 \nAcute Tox. 4* \nSTOT RE 1 \nSkin Irrit. 2 \nEye Irrit. 2  H226 \nH361d \nH332 \nH372 \n(hearing \norgans) \nH315 \nH319  GHS02 \nGHS08 \nGHS07 \nDgr H226 \nH361d \nH332 \nH372 \n(hearing \norgans) \nH315 \nH319  * D  \n601-027-00-6  2-phenylpropene; \nα-methylstyrene  202-705-0  98-83-9  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 2  H226 \nH319 \nH335 \nH411  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH319 \nH335 \nH411  STOT SE 3; H335: \nC ≥ 25 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 662}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 664\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-028-00-1  2-methylstyrene; \n2-vinyltoluene  210-256-7  611-15-4  Acute Tox. 4 * \nAquatic Chronic 2  H332 \nH411  GHS07 \nGHS09 \nWng  H332 \nH411  \n601-029-00-7  dipentene; limonene;[1] \n(R)-p-mentha-1,8-diene; \nd-limonene; [2] \n(S)-p-mentha-1,8-diene; l- \nlimonene; [3] \ntrans-1-methyl-4-(1-methyl\xad\nvinyl)cyclohexene; [4] \n(±)-1-methyl-4-(1-methyl\xad\nvinyl)cyclohexene [5]  205-341-0 [1] \n227-813-5 [2] \n227-815-6 [3] \n229-977-3 [4] \n231-732-0 [5]  138-86-3 [1] \n5989-27-5 [2] \n5989-54-8 [3] \n6876-12-6 [4] \n7705-14-8 [5]  Flam. Liq. 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH315 \nH317 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH315 \nH317 \nH410  C \n601-030-00-2  cyclopentane  206-016-6  287-92-3  Flam. Liq. 2 \nAquatic Chronic 3  H225 \nH412  GHS02 \nDgr H225 \nH412  \n601-031-00-8  2,4,4-trimethylpent-1-ene  203-486-4  107-39-1  Flam. Liq. 2 \nAquatic Chronic 2  H225 \nH411  GHS02 \nGHS09 \nDgr H225 \nH411  \n601-032-00-3  benzo[ a]pyrene; \nbenzo[ def]chrysene  200-028-5  50-32-8  Carc. 1B \nMuta. 1B \nRepr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH340 \nH360FD \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH340 \nH360FD \nH317 \nH410  Carc. 1B; H350: C \n≥ 0,01 %  \n601-033-00-9  benz[ a]anthracene  200-280-6  56-55-3  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  M=100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 663}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 665\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-034-00-4  benz[ e]acephenanthrylene  205-911-9  205-99-2  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  \n601-035-00-X  benzo[ j]fluoranthene  205-910-3  205-82-3  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  \n601-036-00-5  benzo[ k]fluoranthene  205-916-6  207-08-9  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  \n601-037-00-0  n-hexane  203-777-6  110-54-3  Flam. Liq. 2 \nRepr. 2 \nAsp. Tox. 1 \nSTOT RE 2 * \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 2  H225 \nH361f *** \nH304 \nH373 ** \nH315 \nH336 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH361f *** \nH304 \nH373 ** \nH315 \nH336 \nH411  STOT RE 2; H373: \nC ≥ 5 %  \n601-041-00-2  dibenz[ a,h]anthracene  200-181-8  53-70-3  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  Carc. 1B; H350: C \n≥ 0,01 % M=100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 664}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 666\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-042-00-8  biphenyl; \ndiphenyl  202-163-5  92-52-4  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH335 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH410  \n601-043-00-3  1,2,4-trimethylbenzene  202-436-9  95-63-6  Flam. Liq. 3 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H226 \nH332 \nH319 \nH335 \nH315 \nH411  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH332 \nH319 \nH335 \nH315 \nH411  \n601-044-00-9  3a,4,7,7a-tetrahydro-4,7-metha\xad\nnoindene  201-052-9  77-73-6  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H225 \nH332 \nH302 \nH319 \nH335 \nH315 \nH411  GHS02 \nGHS07 \nGHS09 \nDgr H225 \nH332 \nH302 \nH319 \nH335 \nH315 \nH411  \n601-045-00-4  1,2,3,4-tetrahydronaphthalene  204-340-2  119-64-2  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H319 \nH315 \nH411  GHS07 \nGHS09 \nWng  H319 \nH315 \nH411  EUH019  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 665}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 667\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-046-00-X  7-methylocta-1,6-diene  404-210-7  42152-47-6  Flam. Liq. 3 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH400 \nH410  GHS02 \nGHS09 \nWng  H226 \nH410  \n601-047-00-5  m-mentha-1,3(8)-diene  404-150-1  17092-80-7  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n601-048-00-0  chrysene  205-923-4  218-01-9  Carc. 1B Muta. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH341 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH341 \nH410  \n601-049-00-6  benzo[ e]pyrene  205-892-7  192-97-2  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  \n601-051-00-7  4-phenylbut-1-ene  405-980-7  768-56-9  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n601-052-00-2  naphthalene  202-049-5  91-20-3  Carc. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nWng  H351 \nH302 \nH410  \n601-053-00-8  nonylphenol; [1] \n4-nonylphenol, branched [2]  246-672-0 [1] \n284-325-5 [2]  25154-52-3 [1] \n84852-15-3 [2]  Repr. 2 \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H361fd \nH302 \nH314 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H361fd \nH302 \nH314 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 666}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 668\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-054-00-3  reaction mass of isomers of: \ndibenzylbenzene; \ndibenzyl(methyl)benzene; \ndibenzyl(dimethyl)benzene; \ndibenzyl(trimethyl)benzene  405-570-8  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n601-055-00-9  reaction mass of isomers of: \nmono-(2-tetradecyl)naphthalenes; \ndi-(2-tetradecyl)naphthalenes; tri- \n(2-tetradecyl)naphthalenes  410-190-0  132983-41-6  Eye Irrit. 2 \nAquatic Chronic 4  H319 \nH413  GHS07 \nWng  H319 \nH413  \n601-056-00-4  reaction mass of isomers of: \nmethyldiphenylmethane; \ndimethyldiphenylmethane  405-470-4  73807-39-3  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n601-057-00-X  N-dodecyl-[3-(4-(dimethyl\xad\namino)benzamido)-propyl]di\xad\nmethylammonium tosylate  421-130-8  156679-41-3  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH410  \n601-058-00-5  di-L-para-menthene  417-870-6  83648-84-4  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  \n601-059-00-0  methyl 2-benzylidene-3- \noxobutyrate  420-940-9  15768-07-7  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H319 \nH315 \nH411  GHS07 \nGHS09 \nWng  H319 \nH315 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 667}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 669\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-060-00-6  1,2-bis[4-fluoro-6-{4-sulfo-5-(2- \n(4-sulfonaphtalene-3-ylazo)-1- \nhydroxy-3,6-disulfo-8-aminon\xad\naphthalene-7-ylazo)pheny\xad\nlamino}-1,3,5-triazin- \n2ylamino]ethane; \nx-sodium, y-potassium salts x = \n7,755 y =0,245  417-610-1  155522-09-1  Skin Sens. 1  H317  GHS07 \nWng  H317  \n601-061-00-1  (ethyl-1,2-ethanediyl)[-2-[[[(2- \nhydroxyethyl)methyl\xad\namino]acetyl]-propyl]ω-(nonylp\xad\nhenoxy)poly]oxy-(methyl-1,2- \nethanediyl)  418-960-8  —  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH411  \n601-062-00-7  reaction mass of: branched tria\xad\ncontane; \nbranched dotriacontane; \nbranched tetratriacontane; \nbranched hexatriacontane  417-030-9  151006-59-6  Aquatic Chronic 4  H413  —  H413  \n601-063-00-2  reaction mass of isomers of \nbranched tetracosane  417-060-2  151006-61-0  Acute Tox. 4 * \nAquatic Chronic 4  H332 \nH413  GHS07 \nWng  H332 \nH413  \n▼M23  __________  \n▼M16  \n601-065-00-3  reaction mass of: (1'α, 3'α, 6'α)- \n2,2,3' ,7', 7'-pentamethyl\xad\nspiro(1,3-dioxane-5,2'- \nnorcarane); \n(1'α, 3'β, 6'α)-2,2,3', 7', 7'-penta\xad\nmethylspiro(1,3-dioxane-5,2'- \nnorcarane)  416-930-9  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 668}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 670\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-066-00-9  1-(4-(trans-4-heptylcyclo\xad\nhexyl)phenyl) ethanone  426-820-2  78531-60-9  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n601-067-00-4  triethyl arsenate  427-700-2  15606-95-8  Carc. 1A \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH331 \nH301 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH301 \nH410  \n601-068-00-X  1,2-diacetoxybut-3-ene  421-720-5  18085-02-4  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n601-069-00-5  2-ethyl-1-(2-(1,3-dioxanyl)ethyl)- \npyridinium bromide  422-680-1  287933-44-2  Aquatic Chronic 3  H412  —  H412  \n601-070-00-0  reaction mass of: branched \nicosane; branched docosane; \nbranched tetracosane  417-050-8  151006-58-5  Acute Tox. 4 * \nAquatic Chronic 4  H332 \nH413  GHS07 \nWng  H332 \nH413  \n601-071-00-6  1-dimethoxymethyl-2-nitro- \nbenzene  423-830-9  20627-73-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n601-072-00-1  reaction mass of: 1-(4-isopro\xad\npylphenyl)-1-phenylethane; \n1-(3-isopropylphenyl)-1-phenyle\xad\nthane; \n1-(2-isopropylphenyl)-1-phenyle\xad\nthane  430-690-2  52783-21-8  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 669}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 671\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-073-00-7  1-bromo-3,5-difluorobenzene  416-710-2  461-96-1  Flam. Liq. 3 \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH302 \nH373 ** H315 \nH317 \nH400 \nH410  GHS02 \nGHS08 \nGHS07 \nGHS09 \nWng  H226 \nH302 \nH373 ** \nH315 \nH317 \nH410  \n601-074-00-2  reaction mass of: 4-(2,2,3- \ntrimethylcyclopent-3-en-1-yl)-1- \nmethyl-2-oxabi\xad\ncyclo[2.2.2]octane; \n1-(2,2,3-trimethylcyclopent-3-en- \n1-yl)-5-methyl-6-oxabi\xad\ncyclo[3.2.1]octane; \nspiro[cyclohex-3-en-1-yl- \n[(4,5,6,6a-tetrahydro-3,6',6',6'a- \ntetramethyl)-1,3'(3'a H)- \n[2H]cyclopenta[ b]furan]; \nspiro[cyclohex-3-en-1-yl- \n[4,5,6,6a-tetrahydro-4,6',6',6'a- \ntetramethyl)-1,3'(3'a H)- \n[2H]cyclopenta[ b]]furan]  422-040-1  —  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H319 \nH315 \nH411  GHS07 \nGHS09 \nWng  H319 \nH315 \nH411  \n601-075-00-8  4,4'-bis( N-carbamoyl-4-methyl\xad\nbenzenesulfonamide)diphenylme\xad\nthane  418-770-5  151882-81-4  Carc. 2  H351  GHS08 \nWng  H351  \n601-076-00-3  ethynyl cyclopropane  425-430-1  6746-94-7  Flam. Liq. 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H225 \nH315 \nH318 \nH412  GHS02 \nGHS05 \nDgr H225 \nH315 \nH318 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 670}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 672\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-077-00-9  reaction mass of: 1-heptyl-4- \nethyl-2,6,7-trioxabi\xad\ncyclo[2.2.2]octane; \n1-nonyl-4-ethyl-2,6,7-trioxabi\xad\ncyclo[2.2.2]octane  426-510-7  196965-91-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n601-078-00-4  reaction mass of: 1,7-dimethyl-2- \n[(3-methylbicyclo[2.2.1]hept-2- \nyl)methyl]bicyclo[2.2.1]heptane; \n2,3-dimethyl-2-[(3-methyl\xad\nbicyclo[2.2.1]hept-2- \nyl)methyl]bicyclo[2.2.1]heptane  427-040-5  —  Skin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  \n601-079-00-X  reaction mass of:  trans -trans - \ncyclohexadeca-1,9-diene;  \ncis-trans -cyclohexadeca-1,9- \ndiene  429-620-3  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H315 \nH317 \nH413  GHS07 \nWng  H315 \nH317 \nH413  \n601-080-00-5  reaction mass of:  sec -butylphe\xad\nnyl(phenyl)methane, mixed \nisomers; \n1-(sec-butylphenyl(phenyl)-2- \nphenylethane, mixed isomers; \n1-(sec-butylphenyl-1-phenyle\xad\nthane, mixed isomers  431-100-6  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n601-081-00-0  cyclohexadeca-1,9-diene  431-730-1  4277-06-9  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H315 \nH317 \nH413  GHS07 \nWng  H315 \nH317 \nH413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 671}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 673\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-082-00-6  reaction mass of: endo-2-methyl- \nexo-3-methyl-exo-2-[(exo-3- \nmethylbicyclo[2.2.1]hept-exo-2- \nyl)methyl]bicyclo[2.2.1]heptane; \nexo-2-methyl-exo-3-methyl-endo- \n2-[(endo-3-methyl\xad\nbicyclo[2.2.1]hept-exo-2- \nyl)methyl]bicyclo[2.2.1]heptane  434-420-4  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  \n601-083-00-1  5-endo-hexyl-bicyclo[2.2.1]hept- \n2-ene  435-000-3  22094-83-3  Asp. Tox. 1 \nSkin Irrit. 2 \nAquatic Chronic 4  H304 \nH315 \nH413  GHS08 \nGHS07 \nDgr H304 \nH315 \nH413  \n601-084-00-7  reaction mass of:5-endo-butyl- \nbicyclo[2.2.1]hept-2-ene; \n5-exo-butyl-bicyclo[2.2.1]hept-2- \nene (80:20)  435-180-3  —  Asp. Tox. 1 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H304 \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H304 \nH315 \nH410  \n601-085-00-2  isopentane; \n2-methylbutane  201-142-8  78-78-4  Flam. Liq. 1 \nAsp. Tox. 1 \nSTOT SE 3 \nAquatic Chronic 2  H224 \nH304 \nH336 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H224 \nH304 \nH336 \nH411  EUH066  \n601-087-00-3  2,4,4-trimethylpentene  246-690-9  25167-70-8  Flam. Liq. 2 \nAsp. Tox. 1 \nSTOT SE 3  H225 \nH304 \nH336  GHS02 \nGHS07 \nGHS08 \nDgr H225 \nH304 \nH336  D \n601-088-00-9  4-vinylcyclohexene  202-848-9  100-40-3  Carc. 2  H351  GHS08 \nWng  H351  \n601-089-00-4  muscalure; cis-tricos-9-ene  248-505-7  27519-02-4  Skin Sens. 1B  H317  GHS07 \nWng  H317  \n▼M22  \n601-090-00-X  benzo[ rst]pentaphene  205-877-5  189-55-9  Carc. 1B \nMuta. 2  H350 \nH341  GHS08 \nDgr H350 \nH341  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 672}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 674\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n601-091-00-5  dibenzo[ b,def ]chrysene; \ndibenzo[ a,h]pyrene  205-878-0  189-64-0  Carc. 1B \nMuta. 2  H350 \nH341  GHS08 \nDgr H350 \nH341  \n▼M23  \n601-092-00-0  dibenzo[ def,p]chrysene; \ndibenzo[ a,l]pyrene  205-886-4  191-30-0  Carc. 1B \nMuta. 2  H350 \nH341  GHS08 \nDgr H350 \nH341  Carc. 1B; H350: C \n≥ 0,001 %  \n▼M16  \n602-001-00-7  chloromethane; \nmethyl chloride  200-817-4  74-87-3  Flam. Gas 1 \nPress. Gas \nCarc. 2 \nSTOT RE 2 *  H220 \nH351 \nH373 **  GHS02 \nGHS04 \nGHS08 \nDgr H220 \nH351 \nH373 **  U \n602-002-00-2  bromomethane; \nmethylbromide  200-813-2  74-83-9  Press. Gas \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nOzone 1  H341 \nH331 \nH301 \nH373** \nH319 \nH335 \nH315 \nH400 \nH420  GHS04 \nGHS06 \nGHS08 \nGHS09 \nDgr H341 \nH331 \nH301 \nH373 ** \nH319 \nH335 \nH315 \nH400 \nH420  U \n602-003-00-8  dibromomethane  200-824-2  74-95-3  Acute Tox. 4 * \nAquatic Chronic 3  H332 \nH412  GHS07 \nWng  H332 \nH412  * \n602-004-00-3  dichloromethane; \nmethylene chloride  200-838-9  75-09-2  Carc. 2  H351  GHS08 \nWng  H351  \n602-005-00-9  methyl iodide; \niodomethane  200-819-5  74-88-4  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT SE 3 \nSkin Irrit. 2  H351 \nH312 \nH331 \nH301 \nH335 \nH315  GHS06 \nGHS08 \nDgr H351 \nH312 \nH331 \nH301 \nH335 \nH315  ▼M22', metadata={'source': 'data/ycla_en.pdf', 'page': 673}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 675\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-006-00-4  chloroform; \ntrichloromethane  200-663-8  67-66-3  Carc. 2 \nRepr. 2 \nAcute Tox. 3 \nAcute Tox. 4 \nSTOT RE 1 \nEye Irrit. 2 \nSkin Irrit. 2  H351 \nH361d \nH331 \nH302 \nH372 \nH319 \nH315  GHS06 \nGHS08 \nDgr H351 \nH361d \nH331 \nH302 \nH372 \nH319 \nH315  \n602-007-00-X  bromoform; \ntribromomethane  200-854-6  75-25-2  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H331 \nH302 \nH319 \nH315 \nH411  GHS06 \nGHS09 \nDgr H331 \nH302 \nH319 \nH315 \nH411  \n602-008-00-5  carbon tetrachloride; \ntetrachloromethane  200-262-8  56-23-5  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic \nChronic 3 \nOzone 1  H351 \nH331 \nH311 \nH301 \nH372** \nH412 \nH420  GHS06 \nGHS08 \nDgr H351 \nH331 \nH311 \nH301 \nH372 ** \nH412 \nH420  * \nSTOT RE 1; \nH372:C≥1 % \nSTOT RE 2; \nH373:0,2 % ≤C< \n1 % \n602-009-00-0  chloroethane  200-830-5  75-00-3  Flam. Gas 1 \nPress. Gas \nCarc. 2 \nAquatic Chronic 3  H220 \nH351 \nH412  GHS02 \nGHS04 \nGHS08 \nDgr H220 \nH351 \nH412  U \n602-010-00-6  1,2-dibromoethane  203-444-5  106-93-4  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H350 \nH331 \nH311 \nH301 \nH319 \nH335 \nH315 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH311 \nH301 \nH319 \nH335 \nH315 \nH411  * ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 674}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 676\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-011-00-1  1,1-dichloroethane  200-863-5  75-34-3  Flam. Liq. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 3  H225 \nH302 \nH319 \nH335 \nH412  GHS02 \nGHS07 \nDgr H225 \nH302 \nH319 \nH335 \nH412  * \n602-012-00-7  1,2-dichloroethane; \nethylene dichloride  203-458-1  107-06-2  Flam. Liq. 2 \nCarc. 1B \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H225 \nH350 \nH302 \nH319 \nH335 \nH315  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH350 \nH302 \nH319 \nH335 \nH315  \n602-013-00-2  1,1,1-trichloroethane; \nmethyl chloroform  200-756-3  71-55-6  Acute Tox. 4 * \nOzone 1  H332 \nH420  GHS07 \nWng  H332 \nH420  F \n602-014-00-8  1,1,2-trichloroethane  201-166-9  79-00-5  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H351 \nH332 \nH312 \nH302  GHS08 \nGHS07 \nWng  H351 \nH332 \nH312 \nH302  EUH066  *  \n602-015-00-3  1,1,2,2-tetrachloroethane  201-197-8  79-34-5  Acute Tox. 2 * \nAcute Tox. 1 \nAquatic Chronic 2  H330 \nH310 \nH411  GHS06 \nGHS09 \nDgr H330 \nH310 \nH411  \n602-016-00-9  1,1,2,2-tetrabromoethane  201-191-5  79-27-6  Acute Tox. 2 * \nEye Irrit. 2 \nAquatic Chronic 3  H330 \nH319 \nH412  GHS06 \nDgr H330 \nH319 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 675}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 677\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-017-00-4  pentachloroethane  200-925-1  76-01-7  Carc. 2 \nSTOT RE 1 \nAquatic Chronic 2  H351 \nH372 ** \nH411  GHS08 \nGHS09 \nDgr H351 \nH372 ** \nH411  STOT RE 1; H372: \nC≥ 1 % STOT RE \n2; H373: 0,2 % ≤ \nC < 1 %  \n602-018-00-X  1-chloropropane; [1] \n2-chloropropane [2]  208-749-7 [1] \n200-858-8 [2]  540-54-5 [1] \n75-29-6 [2]  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH332 \nH312 \nH302  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302  C \n602-019-00-5  1-bromopropane; \nn-propyl bromide  203-445-0  106-94-5  Flam. Liq. 2 \nRepr. 1B \nSTOT RE 2 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSTOT SE 3  H225 \nH360FD \nH373 ** \nH319 \nH335 \nH315 \nH336  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH360FD \nH373 ** \nH319 \nH335 \nH315 \nH336  \n▼M13  \n602-020-00-0  1,2-dichloropropane; \npropylene dichloride  201-152-2  78-87-5  Flam. Liq. 2 \nCarc. 1B \nAcute Tox. 4* \nAcute Tox. 4*  H225 \nH350 \nH332 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH350 \nH332 \nH302  \n▼M16  \n602-021-00-6  1,2-dibromo-3-chloropropane  202-479-3  96-12-8  Carc. 1B \nMuta. 1B \nRepr. 1A \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 3  H350 \nH340 \nH360F *** \nH301 \nH373 ** \nH412  GHS06 \nGHS08 \nDgr H350 \nH340 \nH360F *** \nH301 \nH373 ** \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 676}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 678\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-022-00-1  1-chloropentane; [1] \n2-chloropentane; [2] \n3-chloropentane [3]  208-846-4 [1] \n210-885-7 [2] \n210-467-4 [3]  543-59-9 [1] \n625-29-6 [2] \n616-20-6 [3]  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH332 \nH312 \nH302  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302  C \n602-023-00-7  vinyl chloride; \nchloroethylene  200-831-0  75-01-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A  H220 \nH350  GHS02 \nGHS08 \nDgr H220 \nH350  D U \n602-024-00-2  bromoethylene  209-800-6  593-60-2  Press. Gas \nFlam. Gas 1 \nCarc. 1B  H220 \nH350  GHS02 \nGHS08 \nDgr H220 \nH350  U \n602-025-00-8  1,1-dichloroethylene; \nvinylidene chloride  200-864-0  75-35-4  Flam. Liq. 1 \nCarc. 2 \nAcute Tox. 4 *  H224 \nH351 \nH332  GHS02 \nGHS08 \nGHS07 \nDgr H224 \nH351 \nH332  * D  \n602-026-00-3  1,2-dichloroethylene; [1]  \ncis-dichloroethylene; [2]  \ntrans -dichloroethylene [3]  208-750-2 [1] \n205-859-7 [2] \n205-860-2 [3]  540-59-0 [1] \n156-59-2 [2] \n156-60-5 [3]  Flam. Liq. 2 \nAcute Tox. 4 * \nAquatic Chronic 3  H225 \nH332 \nH412  GHS02 \nGHS07 \nDgr H225 \nH332 \nH412  * C  \n602-027-00-9  trichloroethylene; \ntrichloroethene  201-167-4  79-01-6  Carc. 1B \nMuta. 2 \nEye Irrit. 2 \nSkin Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 3  H350 \nH341 \nH319 \nH315 \nH336 \nH412  GHS08 \nGHS07 \nDgr H350 \nH341 \nH319 \nH315 \nH336 \nH412  \n602-028-00-4  tetrachloroethylene  204-825-9  127-18-4  Carc. 2 \nAquatic Chronic 2  H351 \nH411  GHS08 \nGHS09 \nWng  H351 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 677}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 679\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-029-00-X  3-chloropropene; \nallyl chloride  203-457-6  107-05-1  Flam. Liq. 2 \nCarc. 2 \nMuta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H225 \nH351 \nH341 \nH332 \nH312 \nH302 \nH373 ** H319 \nH335 \nH315 \nH400  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH351 \nH341 \nH332 \nH312 \nH302 \nH373 ** \nH319 \nH335 \nH315 \nH400  D \n602-030-00-5  1,3-dichloropropene; [1] \n(Z)-1,3-dichloropropene [2]  208-826-5 [1] \n233-195-8 [2]  542-75-6 [1] \n10061-01-5 [2]  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nAsp. Tox. 1 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH311 \nH301 \nH332 \nH304 \nH319 \nH335 \nH315 \nH317 \nH400 \nH410  GHS02 \nGHS06 \nGHS08 \nGHS09 \nDgr H226 \nH311 \nH301 \nH332 \nH304 \nH319 \nH335 \nH315 \nH317 \nH410  C D \n602-031-00-0  1,1-dichloropropene  209-253-3  563-58-6  Flam. Liq. 2 \nAcute Tox. 3 * \nAquatic Chronic 3  H225 \nH301 \nH412  GHS02 \nGHS06 \nDgr H225 \nH301 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 678}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 680\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-032-00-6  3-chloro-2-methylpropene  209-251-2  563-47-3  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H225 \nH332 \nH302 \nH314 \nH317 \nH411  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H225 \nH332 \nH302 \nH314 \nH317 \nH411  \n▼M13  \n602-033-00-1  chlorobenzene  203-628-5  108-90-7  Flam. Liq. 3 \nAcute Tox. 4 \nSkin Irrit. 2 \nAquatic Chronic 2  H226 \nH332 \nH315 \nH411  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH332 \nH315 \nH411  \n▼M16  \n602-034-00-7  1,2-dichlorobenzene;  \no-dichlorobenzene  202-425-9  95-50-1  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH335 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH335 \nH315 \nH410  * \n602-035-00-2  1,4-dichlorobenzene;  \np-dichlorobenzene  203-400-5  106-46-7  Carc. 2 \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH319 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH319 \nH410  \n602-036-00-8  chloroprene (stabilised); \n2-chlorobuta-1,3-diene (stabi\xad\nlised)  204-818-0  126-99-8  Flam. Liq. 2 \nCarc. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H225 \nH350 \nH332 \nH302 \nH373 ** \nH319 \nH335 \nH315  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH350 \nH332 \nH302 \nH373 ** \nH319 \nH335 \nH315  D ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 679}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 681\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-037-00-3  α-chlorotoluene; \nbenzyl chloride  202-853-6  100-44-7  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H350 \nH331 \nH302 \nH373 ** \nH335 \nH315 \nH318  GHS06 \nGHS08 \nGHS05 \nDgr H350 \nH331 \nH302 \nH373 ** \nH335 \nH315 \nH318  \n602-038-00-9  α, α, α-trichlorotoluene; \nbenzotrichloride  202-634-5  98-07-7  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H350 \nH331 \nH302 \nH335 \nH315 \nH318  GHS06 \nGHS08 \nGHS05 \nDgr H350 \nH331 \nH302 \nH335 \nH315 \nH318  \n602-039-00-4  polychlorobiphenyls; \nPCB  215-648-1  1336-36-3  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH400 \nH410  GHS08 \nGHS09 \nWng  H373 ** \nH410  STOT RE 2; H373: \nC ≥ 0,005 %  C \n602-040-00-X  2-chlorotoluene; [1] \n3-chlorotoluene; [2] \n4-chlorotoluene; [3] \nchlorotoluene [4]  202-424-3 [1] \n203-580-5 [2] \n203-397-0 [3] \n246-698-2 [4]  95-49-8 [1] \n108-41-8 [2] \n106-43-4 [3] \n25168-05-2 [4]  Acute Tox. 4 * \nAquatic Chronic 2  H332 \nH411  GHS07 \nGHS09 \nWng  H332 \nH411  C \n602-041-00-5  penthachloronaphthalene  215-320-8  1321-64-8  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH319 \nH315 \nH410  C ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 680}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 682\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-042-00-0  1,2,3,4,5,6-hexachlorcyclo\xad\nhexanes with the exception of \nthose specified elsewhere in this \nAnnex  — —  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH301 \nH312 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH301 \nH312 \nH410  A C \n602-043-00-6  lindane (ISO); \nγ-HCH or γ-BHC; \nγ-1,2,3,4,5,6-hexachlorocyclo\xad\nhexane  200-401-2  58-89-9  Acute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nLact. \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH332 \nH312 \nH373 ** \nH362 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH332 \nH312 \nH373 ** \nH362 \nH410  M=10  \n602-044-00-1  camphechlor (ISO); \ntoxaphene;  232-283-3  8001-35-2  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH301 \nH312 \nH335 \nH315 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH301 \nH312 \nH335 \nH315 \nH410  \n602-045-00-7  DDT (ISO); \nclofenotane (INN); \ndicophane;1,1,1-trichloro-2,2- \nbis(4-chlorophenyl)ethane; dich\xad\nlorodiphenyltrichloroethane  200-024-3  50-29-3  Carc. 2 \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH301 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH301 \nH372 ** \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 681}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 683\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-046-00-2  heptachlor (ISO); \n1,4,5,6,7,8,8-heptachloro- \n3a,4,7,7a-tetrahydro-4,7-metha\xad\nnoindene  200-962-3  76-44-8  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH311 \nH301 \nH373 ** \nH410  \n602-047-00-8  chlordane (ISO); \n1,2,4,5,6,7,8,8-octachloro- \n3a,4,7,7a-tetrahydro-4,7-metha\xad\nnoindan  200-349-0  57-74-9  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH312 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH312 \nH302 \nH410  \n602-048-00-3  aldrin (ISO)  206-215-8  309-00-2  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH311 \nH301 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH311 \nH301 \nH372 ** \nH410  \n602-049-00-9  dieldrin (ISO)  200-484-5  60-57-1  Carc. 2 \nAcute Tox. 1 \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH310 \nH301 \nH372 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH310 \nH301 \nH372 ** \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 682}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 684\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-050-00-4  isodrin; \n(1α,4α,4aβ, 5β,8β,8aβ)- \n1,2,3,4,10,10-hexachloro- \n1,4,4a,5,8,8a-hexahydro-1,4:5,8- \ndimethanonaphthalene  207-366-2  465-73-6  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  M=100  \n602-051-00-X  endrin (ISO); \n1,2,3,4,10,10-hexachloro-6,7- \nepoxy-1,4,4a,5,6,7,8,8a- \noctahydro-1,4:5,8-dimethanon\xad\naphthalene  200-775-7  72-20-8  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH311 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH311 \nH410  \n602-052-00-5  endosulfan (ISO); \n1,2,3,4,7,7-hexachloro-8,9,10- \ntrinorborn-2-en-5,6-ylenedi\xad\nmethylene sulfite; \n1,4,5,6,7,7-hexachloro-8,9,10- \ntrinorborn-5-en-2,3-ylenedi\xad\nmethylene sulfite  204-079-4  115-29-7  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH312 \nH410  \n602-053-00-0  isobenzan (ISO); \n1,3,4,5,6,7,8,8-octachloro- \n1,3,3a,4,7,7a-hexahydro-4,7- \nmethanoisobenzofuran  206-045-4  297-78-9  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1  H310 \nH300 \nH400  GHS06 \nGHS09 \nDgr H310 \nH300 \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 683}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 685\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-054-00-6  3-iodpropene; \nallyl iodide  209-130-4  556-56-9  Flam. Liq. 2 \nSkin Corr. 1B  H225 \nH314  GHS02 \nGHS05 \nDgr H225 \nH314  \n602-055-00-1  bromoethane; \nethyl bromide  200-825-8  74-96-4  Flam. Liq. 2 \nCarc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH351 \nH332 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH351 \nH332 \nH302  \n602-056-00-7  α, α, α-trifluorotoluene; \nbenzotrifluoride  202-635-0  98-08-8  Flam. Liq. 2 \nAquatic Chronic 2  H225 \nH411  GHS02 \nGHS09 \nDgr H225 \nH411  \n602-057-00-2  α-bromotoluene; \nbenzyl bromide  202-847-3  100-39-0  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  \n602-058-00-8  α, α-dichlorotoluene; \nbenzylidene chloride; \nbenzal chloride  202-709-2  98-87-3  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H351 \nH331 \nH302 \nH335 \nH315 \nH318  GHS06 \nGHS08 \nGHS05 \nDgr H351 \nH331 \nH302 \nH335 \nH315 \nH318  \n602-059-00-3  1-chlorobutane; \nbutyl chloride  203-696-6  109-69-3  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n602-060-00-9  bromobenzene  203-623-8  108-86-1  Flam. Liq. 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H226 \nH315 \nH411  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH315 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 684}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 686\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-061-00-4  hexafluoropropene; \nhexafluoropropylene  204-127-4  116-15-4  Press. Gas \nAcute Tox. 4 * \nSTOT SE 3  H332 \nH335  GHS07 \nWng  H332 \nH335  U \n602-062-00-X  1,2,3-trichloropropane  202-486-1  96-18-4  Carc. 1B \nRepr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H350 \nH360F *** \nH332 \nH312 \nH302  GHS08 \nGHS07 \nDgr H350 \nH360F *** \nH332 \nH312 \nH302  D \n602-063-00-5  heptachlor epoxide; \n2,3-epoxy-1,4,5,6,7,8,8- \nheptachloro-3a,4,7,7a-tetrahydro- \n4,7-methanoindane  213-831-0  1024-57-3  Carc. 2 \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH301 \nH373 ** \nH410  \n602-064-00-0  1,3-dichloro-2-propanol  202-491-9  96-23-1  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 4 *  H350 \nH301 \nH312  GHS06 \nGHS08 \nDgr H350 \nH301 \nH312  \n602-065-00-6  hexachlorobenzene  204-273-9  118-74-1  Carc. 1B \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH372 ** \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH372 ** \nH410  \n602-066-00-1  tetrachloro- p-benzoquinone  204-274-4  118-75-2  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 685}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 687\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-067-00-7  1,3-dichlorbenzene  208-792-1  541-73-1  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n602-068-00-2  ethylene bis(trichloroacetate)  219-732-9  2514-53-6  Skin Irrit. 2  H315  GHS07 \nWng  H315  \n602-069-00-8  dichloroacetylene  —  7572-29-4  Unst. Expl. \nCarc. 2 \nSTOT RE 2 *  H200 \nH351 \nH373 **  GHS01 \nGHS08 \nWng  H200 \nH351 \nH373 **  \n602-070-00-3  3-chloro-4,5,α, α, α-pentafluor\xad\notoluene  401-930-3  77227-99-7  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1  H226 \nH332 \nH302 \nH400  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH332 \nH302 \nH400  \n602-071-00-9  bromobenzylbromotoluene, \nreaction mass of isomers  402-210-1  99688-47-8  STOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 ** \nH317 \nH410  \n602-072-00-4  dichloro [(dichlorophe\xad\nnyl)methyl]methylbenzene, \nreaction mass of isomers; (dich\xad\nlorophenyl)(dichloroto\xad\nlyl)methane, reaction mass of \nisomers (IUPAC)  278-404-3  76253-60-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 686}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 688\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-073-00-X  1,4-dichlorobut-2-ene  212-121-8  764-41-0  Carc. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH330 \nH311 \nH301 \nH314 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H350 \nH330 \nH311 \nH301 \nH314 \nH410  Carc. 1B; H350: C \n≥ 0,01 % STOT SE \n3; H335:C≥5 %  \n602-074-00-5  pentachlorobenzene  210-172-0  608-93-5  Flam. Sol. 1 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H228 \nH302 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nDgr H228 \nH302 \nH410  T \n602-075-00-0  4,4,5,5-tetrachloro-1,3-dioxolan- \n2-one  404-060-2  22432-68-4  Acute Tox. 2 * \nAcute Tox. 4 * \nSkin Corr. 1B  H330 \nH302 \nH314  GHS06 \nGHS05 \nDgr H330 \nH302 \nH314  \n602-076-00-6  2,3,4-trichlorobut-1-ene  219-397-9  2431-50-7  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH331 \nH302 \nH319 \nH335 \nH315 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH331 \nH302 \nH319 \nH335 \nH315 \nH410  Carc. 2; H351: C \n≥ 0,1 %  \n602-077-00-1  dodecachloropenta\xad\ncyclo[5.2.1.02,6.03,9.05,8]decan\xad\ne; \nmirex  219-196-6  2385-85-5  Carc. 2 \nRepr. 2 \nLact. \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361fd \nH362 \nH312 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH361fd \nH362 \nH312 \nH302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 687}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 689\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-078-00-7  hexachlorocyclopentadiene  201-029-3  77-47-4  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH311 \nH302 \nH314 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH311 \nH302 \nH314 \nH410  \n602-079-00-2  2,3-dichloropropene; \n2,3-dichloropropylene  201-153-8  78-88-6  Flam. Liq. 2 \nMuta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H225 \nH341 \nH332 \nH312 \nH302 \nH335 \nH315 \nH318 \nH412  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H225 \nH341 \nH332 \nH312 \nH302 \nH335 \nH315 \nH318 \nH412  \n602-080-00-8  alkanes, C  10-13, chloro; chlor\xad\ninated paraffins, C  10-13 287-476-5  85535-84-8  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  EUH066  \n602-081-00-3  2-chloro-4,5-difluorobenzoic acid  405-380-5  —  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1  H312 \nH302 \nH318 \nH317  GHS05 \nGHS07 \nDgr H312 \nH302 \nH318 \nH317  \n602-082-00-9  2,2,6,6-tetrakis(bromomethyl)-4- \noxaheptane-1,7-diol  408-020-5  109678-33-3  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 688}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 690\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-083-00-4  diphenyl ether, pentabromo \nderivative pentabromodiphenyl \nether  251-084-2  32534-81-9  STOT RE 2 * \nLact. \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH362 \nH400 \nH410  GHS08 \nGHS09 \nWng  H373 ** \nH362 \nH410  \n602-084-00-X  1,1-dichloro-1-fluoroethane  404-080-1  1717-00-6  Aquatic \nChronic 3 \nOzone 1  H412 \nH420  GHS07 \nWng  H412 \nH420  \n602-085-00-5  2-bromopropane  200-855-1  75-26-3  Flam. Liq. 2 \nRepr. 1a \nSTOT RE 2 *  H225 \nH360F *** \nH373 **  GHS02 \nGHS08 \nDgr H225 \nH360F *** \nH373 **  EUH066  \n602-086-00-0  trifluoroiodomethane; \ntrifluoromethyl iodide  219-014-5  2314-97-8  Muta. 2  H341  GHS08 \nWng  H341  \n602-087-00-6  1,2,4-trichlorobenzene  204-428-0  120-82-1  Acute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH315 \nH410  \n602-088-00-1  2,3-dibromopropan-1-ol; \n2,3-dibromo-1-propanol  202-480-9  96-13-9  Carc. 1B Repr. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H350 \nH361f *** \nH311 \nH332 \nH302 \nH412  GHS08 \nGHS07 \nDgr H350 \nH361f *** \nH311 \nH332 \nH302 \nH412  \n602-089-00-7  4-bromo-2-chlorofluorobenzene  405-580-2  60811-21-4  Acute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 689}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 691\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-090-00-2  1-allyl-3-chloro-4-fluorobenzene  406-630-6  121626-73-1  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n602-091-00-8  1,3-dichloro-4-fluorobenzene  406-160-1  1435-48-9  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2  H302 \nH373 ** \nH315 \nH411  GHS08 \nGHS07 \nWng  H302 \nH373 ** \nH315 \nH411  \n602-092-00-3  1-bromo-3,4,5-trifluorobenzene  418-480-9  138526-69-9  Flam. Liq. 3 \nCarc. 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H226 \nH351 \nH315 \nH318 \nH411  GHS02 \nGHS08 \nGHS05 \nGHS09 \nDgr H226 \nH351 \nH315 \nH318 \nH411  \n602-093-00-9  α, α, α,4-tetrachlorotoluene;  \np-chlorobenzotrichloride  226-009-1  5216-25-1  Carc. 1B Repr. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2  H350 \nH361f *** \nH372 ** \nH312 \nH302 \nH335 \nH315  GHS08 \nGHS07 \nDgr H350 \nH361f *** \nH372 ** \nH312 \nH302 \nH335 \nH315  \n602-094-00-4  diphenylether; \noctabromo derivate  251-087-9  32536-52-0  Repr. 1B  H360Df  GHS08 \nDgr H360Df  \n602-095-00-X  alkanes, C  14-17, chloro; \nchlorinated paraffins, C  14-17 287-477-0  85535-85-9  Lact. \nAquatic Acute 1 \nAquatic Chronic 1  H362 \nH400 \nH410  GHS09 \nWng  H362 \nH410  EUH066  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 690}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 692\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-096-00-5  malachite green hydrochloride; \n[1] \nmalachite green oxalate [2]  209-322-8 [1] \n219-441-7 [2]  569-64-2 [1] \n2437-29-8 [2]  Repr. 2 \nAcute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH302 \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H361d *** \nH302 \nH318 \nH410  \n602-097-00-0  1-bromo-9-(4,4,5,5,5-pentafluor\xad\nopentylthio)nonane  422-850-5  148757-89-5  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n602-098-00-6  2-(3-bromophenoxy)tetrahydro- \n2H-pyran  429-030-6  57999-49-2  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n602-099-00-1  3-(4-fluorophenyl)-2-methylpro\xad\npionylchloride  426-370-7  —  Skin Corr. 1A \nAcute Tox. 4 * \nAquatic Chronic 3  H314 \nH302 \nH412  GHS05 \nGHS07 \nDgr H314 \nH302 \nH412  EUH014 \nEUH029  \n602-100-00-5  reaction mass of: ( R, R )- \n1,1,1,2,2,3,4,5,5,5-decafluor\xad\nopentane; \n(S, S)-1,1,1,2,2,3,4,5,5,5-decaflu\xad\noropentane  420-640-8  —  Aquatic Chronic 3  H412  —  H412  \n602-101-00-0  2-chloro-4-fluoro-5-nitrophe\xad\nnyl(isobutyl)carbonate  427-020-6  141772-37-4  STOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373** \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 691}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 693\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-102-00-6  1,1,1,3,3-pentafluorobutane  430-250-1  406-58-6  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n602-103-00-1  1-(chlorophenylmethyl)-2- \nmethylbenzene  431-450-1  41870-52-4  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n602-104-00-7  1,1,2,2,3,3,4-heptafluorocyclo\xad\npentane  430-710-1  15290-77-4  Aquatic Chronic 3  H412  —  H412  \n602-105-00-2  sodium 1,1,2,2,3,3,4,4,4- \nnonafluoro-1-butanesulfinate  422-100-7  102061-82-5  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n602-106-00-8  2-bromo-4,6-difluoroaniline  429-430-0  444-14-4  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n602-107-00-3  3,3,4,4-tetrafluoro-4-iodo-1- \nbutene  439-500-2  33831-83-3  Acute Tox. 4 * \nSkin Irrit. 2 \nAquatic Chronic 2  H302 \nH315 \nH411  GHS07 \nGHS09 \nWng  H302 \nH315 \nH411  \n602-108-00-9  (2,3,5,6-tetrafluorophenyl)me\xad\nthanol  443-840-7  4084-38-2  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1  H302 \nH319 \nH317  GHS07 \nWng  H302 \nH319 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 692}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 694\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n602-109-00-4  hexabromocyclododecane [1] \n1,2,5,6,9,10-hexabromocyclo\xad\ndodecane [2]  247-148-4 [1] \n221-695-9[2]  25637-99-4[1] \n3194-55-6[2]  Repr. 2 \nLact.  H361 \nH362  GHS08 \nWng  H361 \nH362  \n603-001-00-X  methanol  200-659-6  67-56-1  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT SE 1  H225 \nH331 \nH311 \nH301 \nH370 **  GHS02 \nGHS06 \nGHS08 \nDgr H225 \nH331 \nH311 \nH301 \nH370 **  * \nSTOT SE 1; H370: \nC≥10 % \nSTOT SE 2; H371: \n3 % ≤ C<10 %  \n603-002-00-5  ethanol; \nethyl alcohol  200-578-6  64-17-5  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n603-003-00-0  propan-1-ol;  \nn-propanol  200-746-9  71-23-8  Flam. Liq. 2 \nEye Dam. 1 \nSTOT SE 3  H225 \nH318 \nH336  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH318 \nH336  \n603-004-00-6  butan-1-ol;  \nn-butanol  200-751-6  71-36-3  Flam. Liq. 3 \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSTOT SE 3  H226 \nH302 \nH335 \nH315 \nH318 \nH336  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH302 \nH335 \nH315 \nH318 \nH336  \n603-005-00-1  2-methylpropan-2-ol;  \ntert-butyl alcohol  200-889-7  75-65-0  Flam. Liq. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3  H225 \nH332 \nH319 \nH335  GHS02 \nGHS07 \nDgr H225 \nH332 \nH319 \nH335  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 693}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 695\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-006-00-7  pentanol isomers, with the \nexception of those specified \nelsewhere in this Annex  250-378-8  Flam. Liq. 3 \nAcute Tox. 4 * \nSTOT SE 3  H226 \nH332 \nH335  GHS02 \nGHS07 \nWng  H226 \nH332 \nH335  EUH066  C  \n603-007-00-2  2-methylbutan-2-ol;  \ntert-pentanol  200-908-9  75-85-4  Flam. Liq. 2 \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2  H225 \nH332 \nH335 \nH315  GHS02 \nGHS07 \nDgr H225 \nH332 \nH335 \nH315  \n603-008-00-8  4-methylpentan-2-ol; \nmethyl isobutyl carbinol  203-551-7  108-11-2  Flam. Liq. 3 \nSTOT SE 3  H226 \nH335  GHS02 \nGHS07 \nWng  H226 \nH335  STOT SE 3; H335: \nC ≥ 25 %  \n603-009-00-3  cyclohexanol  203-630-6  108-93-0  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2  H332 \nH302 \nH335 \nH315  GHS07 \nWng  H332 \nH302 \nH335 \nH315  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 694}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 696\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-010-00-9  2-methylcyclohexanol, mixed \nisomers; [1]  \ncis-2-methylcyclohexanol; [2]  \ntrans -2-methylcyclohexanol [3]  209-512-0 [1] \n231-187-9 [2] \n231-186-3 [3]  583-59-5 [1] \n7443-70-1 [2] \n7443-52-9 [3]  Acute Tox. 4 *  H332  GHS07 \nWng  H332  C  \n603-011-00-4  2-methoxyethanol; \nethylene glycol monomethyl \nether  203-713-7  109-86-4  Flam. Liq. 3 \nRepr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH360FD \nH332 \nH312 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H226 \nH360FD \nH332 \nH312 \nH302  \n603-012-00-X  2-ethoxyethanol; \nethylene glycol monoethyl ether  203-804-1  110-80-5  Flam. Liq. 3 \nRepr. 1B \nAcute Tox. 3 \nAcute Tox. 4  H226 \nH360FD \nH331 \nH302  GHS02 \nGHS08 \nGHS06 \nDgr H226 \nH360FD \nH331 \nH302  \n603-013-00-5  2-isopropoxyethanol; \nethylene glycol monoisopropyl \nether  203-685-6  109-59-1  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2  H332 \nH312 \nH319  GHS07 \nWng  H332 \nH312 \nH319  \n▼M23  \n603-014-00-0  2-butoxyethanol; \nethylene glycol monobutyl ether  203-905-0  111-76-2  Acute Tox. 4* \nAcute Tox. 4 \nSkin Irrit. 2 \nEye Irrit. 2  H332 \nH302 \nH315 \nH319  GHS07 \nWng  H332 \nH302 \nH315 \nH319  oral: ATE = \n1200 mg/kg bw  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 695}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 697\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-015-00-6  allyl alcohol  203-470-7  107-18-6  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H225 \nH331 \nH311 \nH301 \nH319 \nH335 \nH315 \nH400  GHS02 \nGHS06 \nGHS09 \nDgr H225 \nH331 \nH311 \nH301 \nH319 \nH335 \nH315 \nH400  \n603-016-00-1  4-hydroxy-4-methylpentan-2-one; \ndiacetone alcohol  204-626-7  123-42-2  Eye Irrit. 2  H319  GHS07 \nWng  H319  Eye Irrit. 2; H319: \nC≥ 10 %  \n603-018-00-2  furfuryl alcohol  202-626-1  98-00-0  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSTOT SE 3  H351 \nH331 \nH312 \nH302 \nH373** \nH319 \nH335  GHS06 \nGHS08 \nDgr H351 \nH331 \nH312 \nH302 \nH373** \nH319 \nH335  \n603-019-00-8  dimethyl ether  204-065-8  115-10-6  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  \n603-020-00-3  ethyl methyl ether  —  540-67-0  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  U  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 696}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 698\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-021-00-9  methyl vinyl ether  203-475-4  107-25-5  Flam. Gas 1 \nPress. Gas  H220  GHS02 \nGHS04 \nDgr H220  D  U  \n603-022-00-4  diethyl ether; \nether  200-467-2  60-29-7  Flam. Liq. 1 \nAcute Tox. 4 * \nSTOT SE 3  H224 \nH302 \nH336  GHS02 \nGHS07 \nDgr H224 \nH302 \nH336  EUH019 \nEUH066  \n▼M22  \n603-023-00-X  ethylene oxide; \noxirane  200-849-9  75-21-8  Flam. Gas 1 \nPress. Gas \nCarc. 1B \nMuta. 1B \nRepr. 1B \nAcute Tox. 3 \nAcute Tox. 3 \nSTOT SE 3 \nSTOT SE 3 \nSTOT RE 1 \nSkin Corr. 1 \nEye Dam. 1  H220 \nH350 \nH340 \nH360Fd \nH331 \nH301 \nH335 \nH336 \nH372 (nervous \nsystem) \nH314 \nH318  GHS02 \nGHS08 \nGHS06 \nGHS05 \nDgr H220 \nH350 \nH340 \nH360Fd \nH331 \nH301 \nH335 \nH336 \nH372 \n(nervous \nsystem) \nH314  inhalation: ATE = \n700ppm (gases) \noral: ATE = \n100 mg/kg bw  U \n▼M16  \n603-024-00-5  1,4-dioxane  204-661-8  123-91-1  Flam. Liq. 2 \nCarc. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH351 \nH319 \nH335  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH351 \nH319 \nH335  EUH019 \nEUH066  D \n603-025-00-0  tetrahydrofuran  203-726-8  109-99-9  Flam. Liq. 2 \nCarc. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH351 \nH319 \nH335  GHS02 \nGHS07 \nGHS08 \nDgr H225 \nH351 \nH319 \nH335  EUH019  STOT SE 3; H335: \nC≥25 % Eye \nIrrit.2; \nH319: C ≥ 25 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 697}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 699\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-026-00-6  1-chloro-2,3-epoxypropane; \nepichlorhydrin  203-439-8  106-89-8  Flam. Liq. 3 \nCarc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1  H226 \nH350 \nH331 \nH311 \nH301 \nH314 \nH317  GHS02 \nGHS06 \nGHS08 \nGHS05 \nDgr H226 \nH350 \nH331 \nH311 \nH301 \nH314 \nH317  * \n603-027-00-1  ethanediol; \nethylene glycol  203-473-3  107-21-1  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n603-028-00-7  2-chloroethanol; \nethylene chlorohydrin  203-459-7  107-07-3  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 *  H330 \nH310 \nH300  GHS06 \nDgr H330 \nH310 \nH300  \n603-029-00-2  bis(2-chloroethyl) ether  203-870-1  111-44-4  Carc. 2 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 *  H351 \nH330 \nH310 \nH300  GHS06 \nGHS08 \nDgr H351 \nH330 \nH310 \nH300  \n603-030-00-8  2-aminoethanol; \nethanolamine  205-483-3  141-43-5  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H332 \nH312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H332 \nH312 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 5 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 698}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 700\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-031-00-3  1,2-dimethoxyethane; \nethylene glycol dimethyl ether; \nEGDME  203-794-9  110-71-4  Flam. Liq. 2 \nRepr. 1B \nAcute Tox. 4 *  H225 \nH360FD \nH332  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH360FD \nH332  EUH019  \n603-032-00-9  ethylene dinitrate; \nethylene glycol dinitrate  211-063-0  628-96-6  Unst. Expl. \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2  H200 \nH330 \nH310 \nH300 \nH373**  GHS01 \nGHS06 \nGHS08 \nDgr H200 \nH330 \nH310 \nH300 \nH373**  \n603-033-00-4  oxydiethylene dinitrate; \ndiethylene glycol dinitrate; \ndigol dinitrate  211-745-8  693-21-0  Unst. Expl \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 3  H200 \nH330 \nH310 \nH300 \nH373 ** \nH412  GHS01 \nGHS06 \nGHS08 \nDgr H200 \nH330 \nH310 \nH300 \nH373 ** \nH412  \n603-033-01-1  oxydiethylene dinitrate; \ndiethylene glycol dinitrate; \ndigol dinitrate; \n[>25 % phlegmatiser]  211-745-8  693-21-0  Expl. 1.1 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 3  H201 \nH330 \nH310 \nH300 \nH373 ** \nH412  GHS01 \nGHS06 \nGHS08 \nDgr H201 \nH330 \nH310 \nH300 \nH373 ** \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 699}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 701\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-034-00-X  glycerol trinitrate; nitroglycerine  200-240-8  55-63-0  Unst. Expl. \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 2  H200 \nH330 \nH310 \nH300 \nH373 ** H411  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H200 \nH330 \nH310 \nH300 \nH373 ** \nH411  \n603-034-01-7  glycerol trinitrate; nitroglycerine; \n[>40 % phlegmatiser]  200-240-8  55-63-0  Expl. 1.1 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 2  H201 \nH330 \nH310 \nH300 \nH373 ** H411  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH330 \nH310 \nH300 \nH373 ** \nH411  \n603-035-00-5  pentaerythritol tetranitrate; \npentaerythrite tetranitrate; \nP.E.T.N.  201-084-3  78-11-5  Unst. Expl.  H200  GHS01 \nDgr H200  \n603-035-01-2  pentaerythritol tetranitrate; \npentaerythrite tetranitrate; \nP.E.T.N.;[>20 % phlegmatiser]  201-084-3  78-11-5  Expl. 1.1  H201  GHS01 \nDgr H201  T  \n603-036-00-0  mannitol hexanitrate; nitro\xad\nmannite  239-924-6  15825-70-4  Unst. Expl.  H200  GHS01 \nDgr H200  \n603-036-01-8  mannitol hexanitrate; nitroman\xad\nnite;[ >40 % phlegmatiser]  239-924-6  15825-70-4  Expl. 1.1  H201  GHS01 \nDgr H201  \n603-037-00-6  cellulose nitrate; nitrocellulose  —  —  Expl. 1.1  H201  GHS01 \nDgr H201  T  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 700}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 702\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-038-00-1  allyl glycidyl ether; allyl 2,3- \nepoxypropyl ether; prop-2-en-1- \nyl 2,3-epoxypropyl ether  203-442-4  106-92-3  Flam. Liq. 3 \nCarc. 2 \nMuta. 2 \nRepr. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H226 \nH351 \nH341 \nH361f *** \nH332 \nH302 \nH335 \nH315 \nH318 \nH317 \nH412  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H226 \nH351 \nH341 \nH361f *** \nH332 \nH302 \nH335 \nH315 \nH318 \nH317 \nH412  \n603-039-00-7  butyl glycidyl ether; butyl 2,3- \nepoxypropyl ether  219-376-4  2426-08-6  Flam. Liq. 3 \nCarc. 2 \nMuta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Sens. 1 \nAquatic Chronic 3  H226 \nH351 \nH341 \nH332 \nH302 \nH335 \nH317 \nH412  GHS02 \nGHS08 \nGHS07 \nWng  H226 \nH351 \nH341 \nH332 \nH302 \nH335 \nH317 \nH412  \n603-040-00-2  sodium methanolate; sodium \nmethoxide; [1] potassium metha\xad\nnolate; potassium methoxide; [2] \nlithium methanolate; lithium \nmethoxide [3]  204-699-5 [1] \n212-736-1 [2] \n212-737-7 [3]  124-41-4 [1] \n865-33-8 [2] \n865-34-9 [3]  Self-heat 1 \nSkin Corr. 1B  H251 \nH314  GHS02 \nGHS05 \nDgr H251 \nH314  EUH014  T  \n603-041-00-8  potassium ethanolate; potassium \nethoxide; [1] sodium ethanolate; \nsodium ethoxide [2]  213-029-0 [1] \n205-487-5 [2]  917-58-8 [1] \n141-52-6 [2]  Self-heat 1 \nSkin Corr. 1B  H251 \nH314  GHS02 \nGHS05 \nDgr H251 \nH314  EUH014  T  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 701}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 703\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-042-00-3  aluminium-tri-isopropoxide  209-090-8  555-31-7  Flam. Sol. 1  H228  GHS02 \nDgr H228  T  \n603-043-00-9  triarimol (ISO); 2,4-dichloro-α- \n(pyrimidin-5-yl)benzhydryl \nalcohol  — 26766-27-8  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n603-044-00-4  dicofol (ISO); 2,2,2-trichloro-1,1- \nbis(4-chlorophenyl)ethanol  204-082-0  115-32-2  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH315 \nH317 \nH410  \n603-045-00-X  diisopropyl ether; [1] dipropyl \nether [2]  203-560-6 [1] \n203-869-6 [2]  108-20-3 [1] \n111-43-3 [2]  Flam. Liq. 2 \nSTOT SE 3  H225 \nH336  GHS02 \nGHS07 \nDgr H225 \nH336  EUH019 \nEUH066  C \n603-046-00-5  bis(chloromethyl) ether; \noxybis(chloromethane)  208-832-8  542-88-1  Flam. Liq. 2 \nCarc. 1A \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 4 *  H225 \nH350 \nH330 \nH311 \nH302  GHS02 \nGHS06 \nGHS08 \nDgr H225 \nH350 \nH330 \nH311 \nH302  Carc. 1A; H350: C \n≥ 0,001 %  \n603-047-00-0  2-dimethylaminoethanol;  N ,N- \ndimethylethanolamine  203-542-8  108-01-0  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H226 \nH332 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH332 \nH312 \nH302 \nH314  STOT SE 3; H335: \nC≥5 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 702}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 704\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-048-00-6  2-diethylaminoethanol;  N ,N- \ndiethylethanolamine  202-845-2  100-37-8  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H226 \nH332 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H226 \nH332 \nH312 \nH302 \nH314  STOT SE 3; H335: \nC≥5 %  \n603-049-00-1  chlorfenethol (ISO); 1,1-bis (4- \nchlorophenyl) ethanol  201-246-3  80-06-8  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n603-050-00-7  1-(2-butoxypropoxy)propan-2-ol  246-011-6  24083-03-2  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  \n603-051-00-2  2-ethylbutan-1-ol  202-621-4  97-95-0  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  \n603-052-00-8  3-butoxypropan-2-ol; propylene \nglycol monobutyl ether  225-878-4  5131-66-8  Eye Irrit. 2 \nSkin Irrit. 2  H319 \nH315  GHS07 \nWng  H319 \nH315  \n603-053-00-3  2-methylpentane-2,4-diol  203-489-0  107-41-5  Eye Irrit. 2 \nSkin Irrit. 2  H319 \nH315  GHS07 \nWng  H319 \nH315  \n603-054-00-9  di- n-butyl ether; dibutyl ether  205-575-3  142-96-1  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 3  H226 \nH319 \nH335 \nH315 \nH412  GHS02 \nGHS07 \nWng  H226 \nH319 \nH335 \nH315 \nH412  STOT SE 3; H335: \nC≥10 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 703}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 705\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n603-055-00-4  propylene oxide; \n1,2-epoxypropane; methyloxirane  200-879-2  75-56-9  Flam. Liq. 1 \nCarc. 1B \nMuta. 1B \nAcute Tox. 3 \nAcute Tox. 3 \nAcute Tox. 4 \nSTOT SE 3 \nEye Irrit. 2  H224 \nH350 \nH340 \nH331 \nH311 \nH302 \nH335 \nH319  GHS02 \nGHS08 \nGHS06 \nDgr H224 \nH350 \nH340 \nH331 \nH311 \nH302 \nH335 \nH319  \n▼M16  \n603-056-00-X  [ (p-tolyloxy)methyl]oxirane; [1] \n[(m-tolyloxy)methyl]oxirane; \n[2]2,3-epoxypropyl  o-tolyl ether; \n[3] [(tolyloxy)methyl]oxirane; \ncresyl glycidyl ether [4]  218-574-8 [1] \n218-575-3 [2] \n218-645-3 [3] \n247-711-4 [4]  2186-24-5 [1] \n2186-25-6 [2] \n2210-79-9 [3] \n26447-14-3 [4]  Muta. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H341 \nH315 \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH315 \nH317 \nH411  C \n603-057-00-5  benzyl alcohol  202-859-9  100-51-6  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH302  GHS07 \nWng  H332 \nH302  \n603-058-00-0  1,3-propylene oxide  207-964-3  503-30-0  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH332 \nH312 \nH302  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302  \n603-059-00-6  hexan-1-ol  203-852-3  111-27-3  Acute Tox. 4 *  H302  GHS07 \nWng  H302  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 704}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 706\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-060-00-1  2,2'-bioxirane; 1,2:3,4-diepoxy\xad\nbutane  215-979-1  1464-53-5  Carc. 1B Muta. \n1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B  H350 \nH340 \nH330 \nH311 \nH301 \nH314  GHS06 \nGHS08 \nGHS05 \nDgr H350 \nH340 \nH330 \nH311 \nH301 \nH314  \n603-061-00-7  tetrahydro-2-furyl-methanol; \ntetrahydrofurfuryl alcohol  202-625-6  97-99-4  Repr. 1B Eye Irrit. \n2 H360Df \nH319  GHS08 \nGHS07 \nDgr H360Df \nH319  \n603-062-00-2  tetrahydrofuran-2,5-diyldime\xad\nthanol  203-239-0  104-80-3  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  STOT SE 3; H335: \nC ≥10 %  \n603-063-00-8  2,3-epoxypropan-1-ol; glycidol; \noxiranemethanol  209-128-3  556-52-5  Carc. 1B Muta. 2 \nRepr. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H350 \nH341 \nH360F *** \nH331 \nH312 \nH302 \nH319 \nH335 \nH315  GHS06 \nGHS08 \nDgr H350 \nH341 \nH360F *** \nH331 \nH312 \nH302 \nH319 \nH335 \nH315  \n603-064-00-3  1-methoxy-2-propanol; mono\xad\npropylene glycol methyl ether  203-539-1  107-98-2  Flam. Liq. 3 \nSTOT SE 3  H226 \nH336  GHS02 \nGHS07 \nWng  H226 \nH336  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 705}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 707\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M23  \n603-065-00-9  m-bis(2,3-epoxypro\xad\npoxy)benzene; \nresorcinol diglycidyl ether  202-987-5  101-90-6  Carc. 1B \nMuta. 2 \nAcute Tox. 3 \nAcute Tox. 4 \nSkin Irrit. 2 \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H350 \nH341 \nH311 \nH302 \nH315 \nH319 \nH317 \nH412  GHS08 \nGHS06 \nDgr H350 \nH341 \nH311 \nH302 \nH315 \nH319 \nH317 \nH412  dermal: ATE = \n300 mg/kg bw \noral: ATE = 500 \nmg/kg bw  \n▼M16  \n603-066-00-4  1,2-epoxy-4-epoxyethylcyclo\xad\nhexane; 4-vinylcyclohexene diep\xad\noxide  203-437-7  106-87-6  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H351 \nH331 \nH311 \nH301  GHS06 \nGHS08 \nDgr H351 \nH331 \nH311 \nH301  * \n603-067-00-X  phenyl glycidyl ether; 2,3-epoxy\xad\npropyl phenyl ether;1,2-epoxy-3- \nphenoxypropane  204-557-2  122-60-1  Carc. 1B Muta. 2 \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H350 \nH341 \nH332 \nH335 \nH315 \nH317 \nH412  GHS08 \nGHS07 \nDgr H350 \nH341 \nH332 \nH335 \nH315 \nH317 \nH412  \n603-068-00-5  2,3-epoxypropyl-2-ethylcy\xad\nclohexyl ether; ethylcyclohexyl\xad\nglycidyl ether  — 130014-35-6  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  \n603-069-00-0  2,4,6-tris(dimethylamino\xad\nmethyl)phenol  202-013-9  90-72-2  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2  H302 \nH319 \nH315  GHS07 \nWng  H302 \nH319 \nH315  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 706}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 708\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-070-00-6  2-amino-2-methylpropanol  204-709-8  124-68-5  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 3  H319 \nH315 \nH412  GHS07 \nWng  H319 \nH315 \nH412  \n603-071-00-1  2,2'-iminodiethanol; diethano\xad\nlamine  203-868-0  111-42-2  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1  H302 \nH373 ** H315 \nH318  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH373 ** \nH315 \nH318  \n603-072-00-7  1,4-bis(2,3 epoxypro\xad\npoxy)butane; butanedioldig\xad\nlycidyl ether  219-371-7  2425-79-8  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H332 \nH312 \nH319 \nH315 \nH317  GHS07 \nWng  H332 \nH312 \nH319 \nH315 \nH317  \n603-073-00-2  bis-[4-(2,3-epoxipropoxi)phe\xad\nnyl]propane  216-823-5  1675-54-3  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  Eye Irrit. 2; H319: \nC≥ 5 % Skin Irrit. \n2; H315: C≥5 %  \n603-074-00-8  reaction product: bisphenol-A- \n(epichlorhydrin); epoxy resin \n(number average molecular \nweight ≤ 700)  500-033-5  25068-38-6  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H319 \nH315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H319 \nH315 \nH317 \nH411  Eye Irrit. 2; H319: \nC ≥ 5 % Skin Irrit \n2; H315: C≥ 5 %  \n603-075-00-3  chlormethyl methyl ether; \nchlorodimethyl ether  203-480-1  107-30-2  Flam. Liq. 2 \nCarc. 1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH350 \nH332 \nH312 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH350 \nH332 \nH312 \nH302  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 707}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 709\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-076-00-9  but-2-yne-1,4-diol; 2-butyne-1,4- \ndiol 203-788-6  110-65-6  Skin Corr. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1  H314 \nH331 \nH301 \nH312 \nH373 ** H317  GHS06 \nGHS05 \nGHS08 \nDgr H314 \nH331 \nH301 \nH312 \nH373 ** \nH317  Skin Corr. 1B; \nH314: C≥50 % \nSkin Irrit. 2; H315: \n25 %≤ C < 50 % \nEye Irrit. 2; H319: \n25 %≤ \nC<50 %  D \n603-077-00-4  1-dimethylaminopropan-2-ol; \ndimepranol (INN)  203-556-4  108-16-7  Flam. Liq. 3 \nAcute Tox. 4 * \nSkin Corr. 1B  H226 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH302 \nH314  \n603-078-00-X  prop-2-yn-1-ol; propargyl alcohol  203-471-2  107-19-7  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nAquatic Chronic 2  H226 \nH331 \nH311 \nH301 \nH314 \nH411  GHS02 \nGHS06 \nGHS05 \nGHS09 \nDgr H226 \nH331 \nH311 \nH301 \nH314 \nH411  \n603-079-00-5  2,2'-(methylimino)diethanol;  N- \nmethyldiethanolamine  203-312-7  105-59-9  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n603-080-00-0  2-methylaminoethanol;  N - \nmethylethanolamine;  N-methyl- \n2-ethanolamine;  N -methyl-2- \namino ethanol; 2-(methyl\xad\namino)ethanol  203-710-0  109-83-1  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  STOT SE 3; H335: \nC≥5 %  \n603-081-00-6  2,2'-thiodiethanol; thiodiglycol  203-874-3  111-48-8  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n603-082-00-1  1-aminopropan-2-ol; isopropan\xad\nolamine  201-162-7  78-96-6  Skin Corr. 1B  H314  GHS05 \nDgr H314  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 708}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 710\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-083-00-7  1,1'-iminodipropan-2-ol; di- \nisopropanolamine  203-820-9  110-97-4  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n603-084-00-2  styrene oxide;(epoxy\xad\nethyl)benzene; phenyloxirane  202-476-7  96-09-3  Carc. 1B \nAcute Tox. 4 * \nEye Irrit. 2  H350 \nH312 \nH319  GHS08 \nGHS07 \nDgr H350 \nH312 \nH319  \n603-085-00-8  bronopol (INN); 2-bromo-2- \nnitropropane-1,3-diol  200-143-0  52-51-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1  H312 \nH302 \nH335 \nH315 \nH318 \nH400  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH335 \nH315 \nH318 \nH400  M=10  \n603-086-00-3  ethirimol (ISO); 5-butyl-2-ethy\xad\nlamino-6-methylpyrimidin-4-ol  245-949-3  23947-60-6  Acute Tox. 4 *  H312  GHS07 \nWng  H312  \n603-087-00-9  2-ethylhexane-1,3-diol; octylene \nglycol; ethoexadiol  202-377-9  94-96-2  Eye Dam. 1  H318  GHS05 \nDgr H318  \n603-088-00-4  2-(octylthio)ethanol; 2-hydro\xad\nxyethyl octyl sulphide  222-598-4  3547-33-9  Eye Dam. 1  H318  GHS05 \nDgr H318  \n603-089-00-X  7,7-dimethyl-3-oxa-6-azaoctan-1- \nol 400-390-6  —  Skin Corr. 1A \nAcute Tox. 4 *  H314 \nH302  GHS05 \nGHS07 \nDgr H314 \nH302  \n603-090-00-5  2-(2-bromoethoxy)anisole  402-010-4  4463-59-6  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 709}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 711\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-091-00-0  exo -1-methyl-4-(1-methylethyl)- \n7-oxabicyclo[2.2.1]heptan-2-ol  402-470-6  87172-89-2  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n603-092-00-6  2-methyl-4-phenylpentanol  402-770-7  92585-24-5  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n603-093-00-1  cinmethylin (ISO); exo-(±)-1- \nmethyl-2-(2-methylbenzyloxy)-4- \nisopropyl-7-oxabi\xad\ncyclo(2.2.1)heptane  402-410-9  87818-31-3  Acute Tox. 4 * \nAquatic Chronic 2  H332 \nH411  GHS07 \nGHS09 \nDgr H332 \nH411  \n603-094-00-7  1,3-bis(2,3-epoxypropoxy)-2,2- \ndimethylpropane  241-536-7  17557-23-2  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n603-095-00-2  2-(propyloxy)ethanol; EGPE  220-548-6  2807-30-9  Acute Tox. 4 * \nEye Irrit. 2  H312 \nH319  GHS07 \nWng  H312 \nH319  \n603-096-00-8  2-(2-butoxyethoxy)ethanol; \ndiethylene glycol monobutyl \nether  203-961-6  112-34-5  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n603-097-00-3  1,1’,1’-nitrilotripropan-2-ol; trii\xad\nsopropanolamine  204-528-4  122-20-3  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n603-098-00-9  2-phenoxyethanol  204-589-7  122-99-6  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n603-099-00-4  3-( N-methyl- N-(4-methylamino- \n3-nitrophenyl)amino)propane- \n1,2-diol hydrochloride  403-440-5  93633-79-5  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 710}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 712\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-100-00-8  1,2-dimethoxypropane  404-630-0  7778-85-0  Flam. Liq. 2  H225  GHS02 \nDgr H225  EUH019  \n603-101-00-3  tetrahydro-2-isobutyl-4-methyl\xad\npyran-4-ol, mixed isomers ( cis \nand trans ) 405-040-6  —  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n▼M11  \n603-102-00-9  1,2-epoxybutane  203-438-2  106-88-7  Flam. Liq. 2 \nCarc. 2 \nAcute Tox. 4* \nAcute Tox. 4* \nAcute Tox. 4* \nSTOT SE 3 \nSkin Irrit. 2 \nEye Irrit. 2  H225 \nH351 \nH302 \nH312 \nH332 \nH335 \nH315 \nH319  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH351 \nH302 \nH312 \nH332 \nH335 \nH315 \nH319  \n▼M16  \n603-103-00-4  oxirane, mono[(C  12- 14-alky\xad\nloxy)methyl] derivs.  271-846-8  68609-97-2  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n603-104-00-X  fenarimol (ISO); 2,4'-dichloro-α- \n(pyrimidin-5-yl)benzhydryl \nalcohol  262-095-7  60168-88-9  Repr. 2 \nLact. \nAquatic Chronic 2  H361fd \nH362 \nH411  GHS08 \nGHS09 \nWng  H361fd \nH362 \nH411  \n603-105-00-5  furan  203-727-3  110-00-9  Flam. Liq. 1 \nCarc. 1B Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nAquatic Chronic 3  H224 \nH350 \nH341 \nH332 \nH302 \nH373 ** H315 \nH412  GHS02 \nGHS08 \nGHS07 \nDgr H224 \nH350 \nH341 \nH332 \nH302 \nH373 ** \nH315 \nH412  EUH019  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 711}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 713\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-106-00-0  2-methoxypropanol  216-455-5  1589-47-5  Flam. Liq. 3 \nRepr. 1B \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H226 \nH360D *** \nH335 \nH315 \nH318  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H226 \nH360D *** \nH335 \nH315 \nH318  \n603-107-00-6  2-(2-methoxyethoxy)ethanol; \ndiethylene glycol monomethyl \nether  203-906-6  111-77-3  Repr. 2  H361d ***  GHS08 \nWng  H361d ***  \n603-108-00-1  2-methylpropan-1-ol; iso-butanol  201-148-0  78-83-1  Flam. Liq. 3 \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSTOT SE 3  H226 \nH335 \nH315 \nH318 \nH336  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH335 \nH315 \nH318 \nH336  \n603-109-00-7  reaction mass of: 1-ethoxy- \n1,1,2,3,3,3-hexafluoro-2-(trifluor\xad\nomethyl)propane; 1-ethoxy- \n1,1,2,2,3,3,4,4,4-nonafluo\xad\nrobutane  425-340-0  —  Aquatic Chronic 4  H413  —  H413  \n603-110-00-2  reaction mass of:  cis-2-isobutyl- \n5-methyl 1,3-dioxane;  trans -2- \nisobutyl-5-methyl 1,3-dioxane  426-130-1  166301-21-9  Skin Irrit. 2 \nAquatic Chronic 3  H315 \nH412  GHS07 \nWng  H315 \nH412  \n603-111-00-8  reaction mass of: 1-(1,1- \ndimethylpropyl)-4-ethoxy- cis- \ncyclohexane; 1-(1,1-dimethyl\xad\npropyl)-4-ethoxy- trans -cyclo\xad\nhexane  426-530-6  —  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 712}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 714\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-112-00-3  cyclopentyl 2-phenylethyl ether  428-340-9  —  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n603-113-00-9  6-glycidyloxynapht-1-yl \noxymethyloxirane  429-960-2  27610-48-6  Muta. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H341 \nH312 \nH315 \nH317 \nH412  GHS08 \nGHS07 \nWng  H341 \nH312 \nH315 \nH317 \nH412  \n603-114-00-4  9-(2-propenyloxy)tri\xad\ncyclo[5.2.1.0(2,6)]dec-3(or-4- \n)-ene  430-830-2  26912-64-1  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n603-115-00-X  reaction mass of:  O, O',O'' - \n(methylsilanetriyl)tris(4-methyl- \n2-pentanone oxime) (3 stereoi\xad\nsomers)  423-580-0  —  STOT RE 2 * \nAquatic Chronic 4  H373** H413  GHS08 \nWng  H373** \nH413  \n603-116-00-5  (Z)-(2,4-difluorophenyl)piperidin- \n4-ylmethanone oxime monohy\xad\ndrochloride  424-740-2  138271-16-6  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n603-117-00-0  propan-2-ol; isopropyl alcohol; \nisopropanol  200-661-7  67-63-0  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH336  \n603-118-00-6  6-dimethylaminohexan-1-ol  404-680-3  1862-07-3  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 3  H302 \nH314 \nH412  GHS05 \nGHS07 \nDgr H302 \nH314 \nH412  \n603-119-00-1  1,1'-(1,3-phenylenedioxy)bis(3- \n(2-(prop-2-enyl)phenoxy)propan- \n2-ol)  405-840-5  —  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 713}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 715\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-120-00-7  2-methyl-5-phenylpentanol  405-890-8  25634-93-9  Eye Irrit. 2 \nSkin Irrit. 2  H319 \nH315  GHS07 \nWng  H319 \nH315  \n603-121-00-2  4-[4-(1,3-dihydroxyprop-2- \nyl)phenylamino]-1,8-dihydroxy- \n5-nitroanthraquinone  406-057-1  114565-66-1  Carc. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H351 \nH317 \nH413  GHS08 \nGHS07 \nWng  H351 \nH317 \nH413  \n603-122-00-8  sodium 2-ethylhexanolate  406-150-7  38411-13-1  Flam. Sol. 1 \nSkin Corr. 1B \nAquatic Chronic 3  H228 \nH314 \nH412  GHS02 \nGHS05 \nDgr H228 \nH314 \nH412  T \n603-123-00-3  4-methyl-8-methylenetri\xad\ncyclo[3.3.1.1  3,7 ]decan-2-ol  406-330-5  122760-84-3  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H315 \nH317 \nH411  \n603-124-00-9  1,4-bis[2-(viny\xad\nloxy)ethoxy]benzene  406-900-3  84563-49-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n603-125-00-4  2-(2,4-dichlorophenyl)-1- \n(1H—1,2,4-triazol-1-yl)pent-4- \nen-2-ol  407-850-5  89544-40-1  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n603-126-00-X  2-((4-methyl-2-nitrophe\xad\nnyl)amino)ethanol  408-090-7  100418-33-5  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH317 \nH412  GHS07 \nWng  H302 \nH317 \nH412  \n603-127-00-5  butan-2-ol; [1]( S)-butan-2-ol; [2] \n(R)-butan-2-ol; [3](±)-butan-2-ol \n[4] 201-158-5 [1] \n224-168-1 [2] \n238-967-8 [3] \n240-029-8 [4]  78-92-2 [1] \n4221-99-2 [2] \n14898-79-4 [3] \n15892-23-6 [4]  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3 \nSTOT SE 3  H226 \nH319 \nH335 \nH336  GHS02 \nGHS07 \nWng  H226 \nH319 \nH335 \nH336  C \n603-128-00-0  2-(phenylmethoxy)naphthalene  405-490-3  613-62-7  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 714}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 716\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-129-00-6  1 - tert-butoxypropan-2-ol  406-180-0  57018-52-7  Flam. Liq. 3 \nEye Dam. 1  H226 \nH318  GHS02 \nGHS05 \nDgr H226 \nH318  \n603-130-00-1  reaction mass of isomers of: α- \n((dimethyl)biphenyl)-ω- \nhydroxypoly(oxyethylene)  406-325-8  —  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n603-131-00-7  reaction mass of: 1-deoxy-1- \n[methyl-(1-oxododecyl)amino]- \nD-glucitol; 1-deoxy-1-[methyl-(1- \noxotetradecyl)amino]-D-glucitol \n(3:1)  407-290-1  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n603-132-00-2  2-hydroxymethyl-9-methyl-6-(1- \nmethylethyl)-1,4-diox\xad\naspiro[4.5]decane  408-200-3  63187-91-7  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H315 \nH318 \nH412  GHS05 \nDgr H315 \nH318 \nH412  \n603-133-00-8  reaction mass of: 3-[(4-amino-2- \nchloro-5-nitrophenyl)amino]- \npropane-1,2-diol; 3,3'-(2-chloro- \n5-nitro-1,4-phenylene\xad\ndiimino)bis(propan-1,2-diol)  408-240-1  —  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n603-134-00-3  reaction mass of substituted \ndodecyl and/or tetradecyl, \ndiphenyl ethers. The substance \nis produce by the Friedel Crafts \nreaction. The catalyst is removed \nfrom the reaction product. \nDiphenyl ether is substituted by \nC 1-C 10 alkyl groups. The alkyl \ngroups are bonded randomly \nbetween C  1 and C  6 Linear C  12 \nand C  14, 50/50 used.  410-450-3  —  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 715}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 717\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-135-00-9  bis[[2,2',2''-nitrilotris-[ethano\xad\nlato]]-1- N,O]-bis[2-(2-methoxye\xad\nthoxy)ethoxy]-titanium  410-500-4  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n603-136-00-4  3-((4-(bis(2-hydroxye\xad\nthyl)amino)-2-nitrophe\xad\nnyl)amino)-1-propanol  410-910-3  104226-19-9  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n603-137-00-X  reaction mass of:1-deoxy-1- \n[methyl-(1-oxohexadecyl)amino]- \nD-glucitol; 1-deoxy-1-[methyl-(1- \noxooctadecyl)amino]-D-glucitol  411-130-6  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n603-138-00-5  3-(2,2-dimethyl-3-hydroxypro\xad\npyl)toluene;(alt.): 2,2-dimethyl-3- \n(3-methylphenyl)propanol  403-140-4  103694-68-4  Aquatic Chronic 3  H412  —  H412  \n603-139-00-0  bis(2-methoxyethyl) ether  203-924-4  111-96-6  Flam. Liq. 3 \nRepr. 1B  H226 \nH360FD  GHS02 \nGHS08 \nDgr H226 \nH360FD  EUH019  \n603-140-00-6  2,2' -oxybisethanol; diethylene \nglycol  203-872-2  111-46-6  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n603-141-00-1  reaction mass of: dodecyloxy-1- \nmethyl-1-[oxy-poly-(2-hydroxy\xad\nmethylethanoxy)]pentadecane; \ndodecyloxy-1-methyl-1-[oxy- \npoly-(2-hydroxymethylethan\xad\noxy)]heptadecane  413-780-6  —  Aquatic Chronic 3  H412  —  H412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 716}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 718\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-142-00-7  2-(2-(2-hydroxyethoxy)ethyl)-2- \naza-bicyclo[2.2.1]heptane  407-360-1  116230-20-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1  H312 \nH302 \nH373 ** H315 \nH318  GHS06 \nGHS08 \nGHS05 \nDgr H312 \nH302 \nH373 ** \nH315 \nH318  \n603-143-00-2  R—2,3-epoxy-1-propanol  404-660-4  57044-25-4  Self-react. C **** \nCarc. 1B \nMuta. 2 \nRepr. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H242 \nH350 \nH341 \nH360F *** \nH331 \nH312 \nH302 \nH314  GHS02 \nGHS06 \nGHS08 \nGHS05 \nDgr H242 \nH350 \nH341 \nH360F *** \nH331 \nH312 \nH302 \nH314  \n603-144-00-8  Reaction mass of: 2,6,9- \ntrimethyl-2,5,9-cyclododecatrien- \n1-ol; 6,9-dimethyl-2-methylen- \n5,9-cyclododecadien-1-ol  413-530-6  111850-00-1  Aquatic Chronic 2  H411  GHS09  H411  \n603-145-00-3  2-isopropyl-2-(1-methylbutyl)- \n1,3-dimethoxypropane  406-970-5  129228-11-1  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n603-146-00-9  2-[(2-[2-(dimethyl\xad\namino)ethoxy]ethyl)methyl\xad\namino]ethanol  406-080-7  83016-70-0  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 3  H302 \nH314 \nH412  GHS05 \nGHS07 \nDgr H302 \nH314 \nH412  \n603-147-00-4  (-)- trans -4-(4'-fluorophenyl)-3- \nhydroxymethyl- N-methyl\xad\npiperidine  406-030-4  105812-81-5  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 717}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 719\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-148-00-X  1,4-bis[(vinyloxy)methyl]cyclo\xad\nhexane  413-370-7  17351-75-6  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n603-149-00-5  reaction mass of: diastereoi\xad\nsomers of 1-(1-hydroxyethyl)-4- \n(1-methylethyl)cyclohexane  407-640-3  63767-86-2  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H319 \nH315 \nH411  GHS07 \nGHS09 \nWng  H319 \nH315 \nH411  \n603-150-00-0  (±)  trans —3,3-dimethyl-5-(2,2,3- \ntrimethyl-cyclopent-3-en-1-yl)- \npent-4-en-2-ol  411-580-3  107898-54-4  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n603-151-00-6  (±)-2-(2,4-dichlorophenyl)-3-(1 H- \n1,2,4-triazol-1-yl)propan-1-ol  413-570-4  —  Aquatic Chronic 3  H412  —  H412  \n603-152-00-1  2-(4- tert-butylphenyl)ethanol  410-020-5  5406-86-0  Repr. 2 \nSTOT RE 2 * \nEye Dam. 1 \nAquatic Chronic 2  H361f *** \nH373 ** H318 \nH411  GHS08 \nGHS05 \nGHS09 \nDgr H361f *** \nH373 ** \nH318 \nH411  \n603-153-00-7  3-((2-nitro-4-(trifluor\xad\nomethyl)phenyl)amino)propane- \n1,2-diol  410-010-0  104333-00-8  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n603-154-00-2  1-[(2- tert-butyl)cyclohexyloxy]- \n2-butanol  412-300-2  139504-68-0  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 718}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 720\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M1 __________  \n▼M16  \n603-156-00-3  2-(2,4-dichlorophenyl)-2-(2- \npropenyl)oxirane  411-210-0  89544-48-9  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  \n603-157-00-9  6,9-bis(hexadecyloxymethyl)-4,7- \ndioxanonane-1,2,9-triol  411-450-6  143747-72-2  Aquatic Chronic 4  H413  —  H413  \n603-158-00-4  reaction mass of: 4 diastereoi\xad\nsomers of 2,7-dimethyl-10-(1- \nmethylethyl)-1- \noxaspiro[4.5]deca-3,6-diene  412-460-3  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n603-159-00-X  2-cyclododecylpropan-1-ol  411-410-8  118562-73-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n603-160-00-5  1,2-diethoxypropane  412-180-1  10221-57-5  Flam. Liq. 2  H225  GHS02 \nDgr H225  EUH019  \n603-161-00-0  1,3-diethoxypropane  413-140-6  3459-83-4  Flam. Liq. 3  H226  GHS02 \nWng  H226  \n603-162-00-6  α[2-[[[(2-hydroxyethyl)methyl\xad\namino]acetyl]amino]propyl]-ω \nnonylphenoxy)poly[oxo(methyl- \n1,2-ethanediyl)]  413-420-8  144736-29-8  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH411  \n603-163-00-1  2-phenyl-1,3-propanediol  411-810-2  1570-95-2  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 719}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 721\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-164-00-7  2-butyl-4-chloro-4,5-dihydro-5- \nhydroxymethyl-1-[2'-(2-triphe\xad\nnylmethyl-1,2,3,4-2 H-tetrazol-5- \nyl)-1,1'-biphenyl-4-methyl]-1 H- \nimidazole  412-420-5  133909-99-6  Aquatic Chronic 4  H413  —  H413  \n603-165-00-2  reaction mass of: 4-allyl-2,6- \nbis(2,3-epoxypropyl)phenol; 4- \nallyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6- \nbis(2,3-epoxypropyl)phenoxy)-2- \nhydroxypropyl]-4-allyl-2-(2,3- \nepoxypropyl)phenoxy]-2- \nhydroxypropyl]-4-allyl-2-(2,3- \nepoxypropyl)phenoxy]-2- \nhydroxypropyl]-2-(2,3-epoxypro\xad\npyl)phenol; 4-allyl-6-[3-(4-allyl- \n2,6-bis(2,3-epoxypro\xad\npyl)phenoxy)-2-hydroxypropyl]- \n2-(2,3-epoxypropyl)phenol; 4- \nallyl-6-[3-[6-[3-(4-allyl-2,6- \nbis(2,3-epoxypropyl)phenoxy)-2- \nhydroxypropyl]-4-allyl-2-(2,3- \nepoxypropyl)phenoxy]-2- \nhydroxypropyl]-2-(2,3-epoxypro\xad\npyl)phenol  417-470-1  —  Muta. 2 \nSkin Sens. 1  H341 \nH317  GHS08 \nGHS07 \nWng  H341 \nH317  \n603-166-00-8  R-1-chloro-2,3-epoxypropane  424-280-2  51594-55-9  Flam. Liq. 3 \nCarc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1  H226 \nH350 \nH331 \nH311 \nH301 \nH314 \nH317  GHS02 \nGHS06 \nGHS08 \nGHS05 \nDgr H226 \nH350 \nH331 \nH311 \nH301 \nH314 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 720}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 722\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-167-00-3  3,3',5,5'-tetra- tert-butylbiphenyl- \n2,2'-diol  407-920-5  6390-69-8  Aquatic Chronic 4  H413  GHS05 \nDgr H413  \n603-168-00-9  3-(2-ethylhexyloxy)propane-1,2- \ndiol 408-080-2  70445-33-9  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n603-169-00-4  (±)- trans -4-(4-fluorophenyl)-3- \nhydroxymethyl- N-methyl\xad\npiperidine  415-550-0  109887-53-8  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n603-170-00-X  reaction mass of: 2-methyl-1-(6- \nmethylbicyclo[2.2.1]hept-5-en-2- \nyl)pent-1-en-3-ol; 2-methyl-1-(1- \nmethylbicyclo[2.2.1]hept-5-en-2- \nyl)-pent-1-en-3-ol; 2-methyl-1-(5- \nmethylbicyclo[2.2.1]hept-5-en-2- \nyl)pent-1-en-3-ol  415-990-3  67739-11-1  Eye Irrit. 2 \nAquatic Chronic 2  H319 \nH411  GHS07 \nGHS09 \nWng  H319 \nH411  \n603-171-00-5  5-thiazolylmethanol  414-780-9  38585-74-9  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n603-172-00-0  mono-2-[2-(4-dibenzo[b, \nf][1,4]thiazepin-11-yl)piper\xad\nazinium-1-yl]ethoxy)ethanol \ntrans-butenedioate  415-180-1  773058-82-5  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n603-173-00-6  4,4-dimethyl-3,5,8-trioxabi\xad\ncyclo[5.1.0]octane  421-750-9  57280-22-5  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  \n603-174-00-1  4-cyclohexyl-2-methyl-2-butanol  420-630-3  83926-73-2  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 721}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 723\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-175-00-7  2-(2-hexyloxyethoxy)ethanol; \nDEGHE; diethylene glycol \nmonohexyl ether; 3,6-dioxa-1- \ndodecanol; hexyl carbitol; 3,6- \ndioxadodecan-1-ol  203-988-3  112-59-4  Acute Tox. 4 * \nEye Dam. 1  H312 \nH318  GHS05 \nGHS07 \nDgr H312 \nH318  \n603-176-00-2  1,2-bis(2-methoxyethoxy)ethane; \nTEGDME; triethylene glycol \ndimethyl ether; triglyme  203-977-3  112-49-2  Repr. 1B  H360Df  GHS08 \nDgr H360Df  EUH019  \n603-177-00-8  1-ethoxypropan-2-ol; 2PG1EE; \n1-ethoxy-2-propanol; propylene \nglycol monoethyl ether; [1] 2- \nethoxy-1-methylethyl acetate; \n2PG1EEA [2]  216-374-5 [1] \n259-370-9 [2]  1569-02-4 [1] \n54839-24-6 [2]  Flam. Liq. 3 \nSTOT SE 3  H226 \nH336  GHS02 \nGHS07 \nWng  H226 \nH336  \n603-178-00-3  2-hexyloxyethanol; ethylene \nglycol monohexyl ether; n-hexyl\xad\nglycol  203-951-1  112-25-4  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  \n603-179-00-9  ergocalciferol (ISO); Vitamin D2  200-014-9  50-14-6  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1  H330 \nH311 \nH301 \nH372 **  GHS06 \nGHS08 \nDgr H330 \nH311 \nH301 \nH372 **  \n▼M18  \n603-180-00-4  colecalciferol; \ncholecalciferol; \nvitamin D  3 200-673-2  67-97-0  Acute Tox. 2 \nAcute Tox. 2 \nAcute Tox. 2 \nSTOT RE 1  H330 \nH310 \nH300 \nH372  GHS06 \nGHS08 \nDgr H330 \nH310 \nH300 \nH372  inhalation: \nATE = 0,05 mg/L \n(dusts or mists) \ndermal: \nATE = 50 mg/kg \nbw \noral: \nATE = 35 mg/kg \nbw \nSTOT RE 1; H372: \nC ≥ 3 % \nSTOT RE 2; H373: \n0,3 % ≤ C < 3 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 722}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 724\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-181-00-X  tert -butyl methyl ether; MTBE; \n2-methoxy-2-methylpropane  216-653-1  1634-04-4  Flam. Liq. 2 \nSkin Irrit. 2  H225 \nH315  GHS02 \nGHS07 \nDgr H225 \nH315  \n603-182-00-5  reaction product of: saturated, \nmonounsaturated and multiple \nunsaturated long-chained partly \nestrified alcohols of vegetable \norigin ( Brassica napus  L.,  \nBrassica rapa  L.,  Helianthus \nannuus  L.,  Glycine hispida , \nGossypium hirsutum L., Cocos \nnucifera L., Elaeis guineensis)  \nwith O, O- diisobutyldithiop\xad\nhosphate and 2-ethylhexylamine \nand hydrogen peroxide  428-630-5  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n603-183-00-0  2-[2-(2-butoxy\xad\nethoxy)ethoxy]ethanol; TEGBE; \ntriethylene glycol monobuty\xad\nlether; butoxytriethylene glycol  205-592-6  143-22-6  Eye Dam. 1  H318  GHS05 \nDgr H318  Eye Dam.1; H318: \nC≥30 % Eye Irrit. \n2; H319: 20 % \n≤C< 30 %  \n603-184-00-6  2-(hydroxymethyl)-2-[[2- \nhydroxy-3-(isooctadecyloxy)pro\xad\npoxy]methyl]-1,3-propanediol  416-380-1  146925-83-9  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n603-185-00-1  2,4-dichloro-3-ethyl-6-nitro\xad\nphenol  420-740-1  99817-36-4  Acute Tox. 3 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H301 \nH318 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 723}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 725\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-186-00-7  trans-(5 RS,6SR)-6-amino-2,2- \ndimethyl-1,3-dioxepan-5-ol  419-050-3  79944-37-9  Skin Sens. 1  H317  GHS07 \nWng  H317  \n603-187-00-2  2-((4,6-bis(4-(2-(1-methylpyri\xad\ndinium-4-yl)vinyl)phenylamino)- \n1,3,5-triazin-2-yl)(2-hydroxye\xad\nthyl)amino)ethanol dichloride  419-360-9  163661-77-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n603-188-00-8  reaction mass of: 6,7-epoxy- \n1,2,3,4,5,6,7,8-octahydro- \n1,1,2,4,4,7-hexamethylnaph\xad\nthalene; 7,8-epoxy- \n1,2,3,4,6,7,8,8a-octahydro- \n1,1,2,4,4,7-hexamethylnaph\xad\nthalene  426-970-9  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n603-189-00-3  reaction mass of complexes of: \ntitanium, 2,2'-oxydiethanol, \nammonium lactate, nitrilotris(2- \npropanol) and ethylene glycol  405-250-8  —  Aquatic Chronic 2  H411  GHS09  H411  \n603-190-00-9  8,8-dimethyl-7-isopropyl-6,10- \ndioxaspiro[4.5]decane  424-030-2  62406-73-9  Skin Irrit. 2 \nAquatic Chronic 3  H315 \nH412  GHS07 \nWng  H315 \nH412  \n603-191-00-4  2-(4,6-bis(2,4-dimethylphenyl)- \n1,3,5-triazin-2-yl)-5-(3-((2- \nethylhexyl)oxy)-2-hydroxypro\xad\npoxy)phenol  419-740-4  137658-79-8  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 724}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 726\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-192-00-X  (E,E)-3,7,11-trimethyldodeca- \n1,4,6,10-tetraen-3-ol  423-240-1  125474-34-2  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  \n603-193-00-5  disodium 9,10-anthracenedioxide  426-030-8  46492-07-3  Skin Corr. 1A  H314  GHS05 \nDgr H314  \n603-194-00-0  2-(2-aminoethylamino)ethanol; \n(AEEA)  203-867-5  111-41-1  Repr. 1B \nSkin Corr. 1B \nSkin Sens. 1  H360Df \nH314 \nH317  GHS05 \nGHS08 \nGHS07 \nDgr H360Df \nH314 \nH317  STOT SE 3; H335: \nC≥5 %  \n603-195-00-6  2-[4-(4-methoxyphenyl)-6- \nphenyl-1,3,5-triazin-2-yl]-phenol  430-810-3  154825-62-4  Aquatic Chronic 3  H412  —  H412  \n603-196-00-1  2-(7-ethyl-1 H-indol-3-yl)ethanol  431-020-1  41340-36-7  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 2  H302 \nH373 ** H411  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH411  \n▼M11  \n603-197-00-7  tebuconazole (ISO); 1-(4-chloro\xad\nphenyl)-4,4-dimethyl-3-(1,2,4- \ntriazol-1-ylmethyl)pentan-3-ol  403-640-2  107534-96-3  Repr. 2 \nAcute Tox. 4 \nAquatic Acute 1 \nAquatic Chronic 1  H361d*** \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d*** \nH302 \nH410  M = 1 \nM = 10  \n▼M16  \n603-199-00-8  etoxazol (ISO); (RS)-5-tert-butyl- \n2-[2-(2,6-difluorophenyl)-4,5- \ndihydro-1,3-oxazol-4- \nyl]phenetole  — 153233-91-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 725}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 727\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-200-00-1  1-pentanol; [1] 3-pentanol [2]  200-752-1 [1] \n209-526-7 [2]  71-41-0 [1] \n584-02-1 [2]  Flam. Liq. 3 \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2  H226 \nH332 \nH335 \nH315  GHS02 \nGHS07 \nWng  H226 \nH332 \nH335 \nH315  \n603-201-00-7  (E)-(7R,11R)-3,7,11,15-tetra\xad\nmethylhexadec-2-ene-1-ol  416-120-5  —  Skin Irrit. 2 \nAquatic Chronic 4  H315 \nH413  GHS07 \nWng  H315 \nH413  \n603-202-00-2  4,4,5,5,5-pentafluoropentan-1-ol  421-360-9  148043-73-6  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n603-203-00-8  ( 1 R,3S,7R,8R,10R,13R)- \n5,5,7,9,9,13-hexamethyl-4,6- \ndioxatetra\xad\ncyclo[6.5.1.01,10.03,7]tetra\xad\ndecane  427-580-1  —  Skin Irrit. 2  H315  GHS07 \nWng  H315  \n603-204-00-3  reaction mass of: 2,2'-(heptane- \n1,7-diyl)bis-1,3-dioxolane; 2,2'- \n(heptane-1,6-diyl)bis-1,3- \ndioxolane  428-110-8  —  Aquatic Chronic 3  H412  —  H412  \n603-205-00-9  ( 1 S-cis)-4-(2-amino-6-chloro-9 H- \npurin-9-yl)-2-cyclopentene-1- \nmethanol hydrochloride  426-200-1  172015-79-1  STOT RE 1 \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H372** H302 \nH318 \nH317 \nH412  GHS05 \nGHS08 \nGHS07 \nDgr H372** \nH302 \nH318 \nH317 \nH412  \n603-206-00-4  2,2-dichloro-1,3-benzodioxol  426-850-6  2032-75-9  Flam. Liq. 3 \nSkin Corr. 1A \nAcute Tox. 4 * \nSkin Sens. 1  H226 \nH314 \nH302 \nH317  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH314 \nH302 \nH317  EUH014  \n603-207-00-X  2-isobutyl-2-isopropyl-1,3-dime\xad\nthoxypropane  430-800-9  129228-21-3  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 726}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 728\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-208-00-5  1,2-diethoxyethane  211-076-1  629-14-1  Flam. Liq. 2 \nRepr. 1A Eye \nIrrit. 2  H225 \nH360Df \nH319  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH360Df \nH319  EUH019  \n603-209-00-0  spinosad (ISO) (reaction mass of \nspinosyn A and spinosyn D in \nratios between 95:5 to 50:50); \nreaction mass of 50-95 % of \n(2R, 3aS, 5aR, 5bS, 9S, 13S,14R, \n16aS, 16b R)-2-(6-deoxy-2,3,4-tri-  \nO-methyl-α-l-mannopyr\xad\nanosyloxy)-13-(4-dimethylamino- \n2,3,4,6-tetradeoxy-β-d-erythro\xad\npyranosyloxy)-9-ethyl- \n2,3,3a,5a,5b,6,7,9,10,11,12,13,1\xad\n4,15,16a,16b-hexadecahydro-14- \nmethyl-1 H-8-oxacyclo\xad\ndodeca[ b]as-indacene-7,15-dione \nand 50-5 % (2 S, 3aR, 5aS,5bS, \n9S, 13S, 14R, 16a S, 16b S)-2-(6- \ndeoxy-2,3,4-tri- O-methyl-α-l- \nmannopyranosyloxy)-13-(4- \ndimethylamino-2,3,4,6-tetra\xad\ndeoxy-β-d-erythropyranosyloxy)- \n9-ethyl-2,3,3a,5a,5b,6,7,9,10, \n11,12,13,14,15,16a,16b- \nhexadecahydro-4,14-dimethyl- \n1H-8-oxacyclododeca[ b]as- \nindacene-7,15-dione; [1] \nspinosyn A; [2] spinosyn D [3]  -[1] \n-[2] \n-[3] -[1] \n131929-60-7 [2] \n131929-63-0 [3]  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M=10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 727}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 729\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-210-00-6  2,4-diethyl-1,5-pentanediol  429-310-8  57987-55-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n603-211-00-1  2,3-epoxypropyltrimethyl\xad\nammonium chloride … %; \nglycidyl trimethylammonium \nchloride … %  221-221-0  3033-77-0  Carc. 1B Muta. 2 \nRepr. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H350 \nH341 \nH361f*** \nH312 \nH302 \nH373** H318 \nH317 \nH412  GHS05 \nGHS08 \nGHS07 \nDgr H350 \nH341 \nH361f*** \nH312 \nH302 \nH373** \nH318 \nH317 \nH412  B \n603-212-00-7  1,3,4,6,7,8-hexahydro- \n4,6,6,7,8,8-hexamethyl\xad\nindeno[5,6- c]pyran; galaxo\xad\nlide;(HHCB)  214-946-9  1222-05-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n603-213-00-2  2-methoxy-2-methylbutane;  tert - \namyl methyl ether  213-611-4  994-05-8  Flam. Liq. 2 \nAcute Tox. 4 * \nSTOT SE 3  H225 \nH302 \nH336  GHS02 \nGHS07 \nDgr H225 \nH302 \nH336  \n603-214-00-8  1,1-diisopropoxycyclohexane  413-740-8  1132-95-2  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n603-215-00-3  1-hydroxy-4-fluoro-1,4-diazo\xad\nniabicyclo[2.2.2]octane bis(tetra\xad\nfluoroborate)  418-330-2  162241-33-0  Expl. 1.1**** \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH302 \nH373** H318 \nH317 \nH400 \nH410  GHS01 \nGHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H201 \nH302 \nH373** \nH318 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 728}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 730\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-216-00-9  cis -1-amino-2,3-dihydro-1 H- \ninden-2-ol  422-660-2  7480-35-5  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n603-217-00-4  2,4,6-tri- tert-butylphenyl 2-butyl- \n2-ethyl-1,3-propanediolphosphite  423-560-1  161717-32-4  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n603-220-00-0  1-{]benzyl[}2-(2-methoxyphen\xad\noxy)ethyl]amino}-3-(9 H- \ncarbazol-4-yloxy)propan-2-ol  432-890-5  72955-94-3  Aquatic Chronic 4  H413  —  H413  \n603-221-00-6  1-(2-amino-5-chlorophenyl)- \n2,2,2-trifluoro-1,1-ethanediol, \nhydrochloride; [containing < \n0,1 % 4-chloroaniline (EC \nNo 203-401-0)]  433-580-2  214353-17-0  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H302 \nH314 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH411  \n603-221-01-3  1-(2-amino-5-chlorophenyl)- \n2,2,2-trifluoro-1,1-ethanediol, \nhydrochloride; [containing ≥ \n0,1 % 4-chloroaniline (EC \nNo 203-401-0)]  433-580-2  214353-17-0  Carc. 1B \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H350 \nH302 \nH314 \nH411  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH314 \nH411  \n603-222-00-1  ( 2 R, 3S, 4R, 5R, 7R, 9R, \n10R,11S, 12 S, 13 R)-10-[(4- \ndimethylamino-3-hydroxy-6- \nmethyltetrahydropyran-2-yl)oxy]- \n2-ethyl-3,4,12-trihydroxy-9- \nmethoxy-3,5,7,9,11,13- \nhexamethyl-6,14-dioxo-1- \noxacyclotetradecane  433-820-6  118058-74-5  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n603-223-00-7  2-cyclopentylidene cyclopentanol \n1,1'-bi(cyclopentyliden)-2-ol  434-270-1  6261-30-9  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H315 \nH318 \nH412  GHS05 \nDgr H315 \nH318 \nH412  \n603-224-00-2  3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6- \ndodecafluoro-2-(trifluoromethyl)- \nhexane  435-790-1  297730-93-9  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 729}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 731\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-225-00-8  erythromycin A9-oxime (E);(3 R, \n4S, 5S, 6R, 7R, 9R, 11 R,12R, \n13S, 14 R)-4-((2,6-didesoxy-3- C- \nmethyl-3- O-methyl-α- L-ribo- \nhexopiranosyl)oxy)-14-ethyl- \n7,12,13-trihydroxy-3,5,7,9,11,13- \nhexamethyl-6-((3,4,6-tridesoxy-3- \ndimethylamino-β-d-xylohexapir\xad\nanosyl)oxy)oxacyclotetradecan-2- \nona-10-oxime (E)  437-070-0  13127-18-9  Aquatic Chronic 2  H411  GHS09  H411  \n603-226-00-3  4,4'(4-(4-methoxyphenyl)-1,3,5- \ntriazin-2,4-diyl)bisbenzene-1,3- \ndiol 444-500-0  1440-00-2  Aquatic Chronic 3  H412  —  H412  \n603-227-00-9  α-hydro-ω-[[[(1,1-dimethyl\xad\nethyl)dioxy]carbonyl]oxy]- \npoly[oxy(methyl-1,2-ethanediyl)] \nether with 2,2-bis(hydroxy\xad\nmethyl)-1,3-propanediol (4:1); \nreaction product of: α-hydro-ω- \n((chlorocarbonyl)oxy)- \npoly(oxy(methyl-1,2-ethanediyl)) \nether with 2,2-bis(hydroxy\xad\nmethyl)-1,3-propanediol with \npotassium 1,1-dimethylethylper\xad\noxalate  445-060-2  203574-04-3  **** \nAquatic Acute 1 \nAquatic Chronic 1  **** H400 \nH410  **** GHS09 \nWng  **** H410  \n603-228-00-4  (+/–)-( R*,R *)-6-fluoro-3,4- \ndihydro-2-oxiranyl-2 H-1- \nbenzopyran; 6-fluoro-2-(2- \noxiranyl)chromane  419-620-1  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 730}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 732\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-229-00-X  sodium ( Z)-3-chloro-3-(4-chloro\xad\nphenyl)-1-hydroxy-2-propene-1- \nsulfonate  420-800-7  —  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  \n603-230-00-5  2,6,6,7,8,8-hexamethyl\xad\ndecahydro-2 H-indeno[4,5-b]furan  440-030-5  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 4  H315 \nH318 \nH413  GHS05 \nDgr H315 \nH318 \nH413  \n603-231-00-0  (S)-1,1-diphenyl-1,2-propanediol  443-220-6  —  Aquatic Chronic 3  H412  —  H412  \n603-232-00-6  3,3,8,8,10,10-hexamethyl-9-[1- \n(4-oxiranylmethoxy-phenyl)- \nethoxy]-1,5-dioxa-9-aza- \nspiro[5.5]undecane  444-420-6  —  Aquatic Chronic 4  H413  —  H413  \n603-233-00-1  reaction mass of: \n4-(1,3a,4,6,7,7a-hexahydro-4,7- \nmethanoinden-5-ylidene)-3- \nmethylbutan-2-ol; \n4-(3,3a,4,6,7,7a-hexahydro-4,7- \nmethanoinden-5-ylidene)-3- \nmethylbutan-2-ol; \n1-(1,3a,4,6,7,7a-hexahydro-4,7- \nmethanoinden-5-ylidene)pentan- \n3-ol; 1-(3,3a,4,6,7,7a-hexahydro- \n4,7-methanoinden-5- \nylidene)pentan-3-ol; ( E)-4- \n(3a,4,5,6,7,7a-hexahydro-1 H-4,7- \nmethanoinden-5-yl)-3-methylbut- \n3-en-2-ol; ( E)-4-(3a,4,5,6,7,7a- \nhexahydro-3 H-4,7-metha\xad\nnoinden-5-yl)-3-methylbut-3-en- \n2-ol 444-430-0  —  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 731}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 733\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-234-00-7  ( 1 R, 4R)-4-methoxy-2,2,7,7-tetra\xad\nmethyltri\xad\ncyclo(6.2.1.0(1,6))undec-5-ene  444-480-3  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n▼M15  \n603-235-00-2  linalool; 3,7-dimethyl-1,6- \noctadien-3-ol; dl-linalool; [1] \ncoriandrol; (S)-3,7-dimethyl-1,6- \noctadien-3-ol; d-linalool; [2] \nlicareol; (R)-3,7-dimethyl-1,6- \noctadien-3-ol; l-linalool [3]  201-134-4 [1] \n204-810-7 [2] \n204-811-2 [3]  78-70-6 [1] \n126-90-9 [2] \n126-91-0 [3]  Skin Sens. 1B  H317  GHS07 \nWng  H317  \n▼M22  \n603-236-00-8  ethanol, 2,2’-iminobis-,  N-(C13- \n15-branched and linear alkyl) \nderivs.  308-208-6  97925-95-6  Repr. 1B  H360D  GHS08 \nDgr H360D  \n▼M23  \n603-237-00-3  ipconazole (ISO); \n(1RS,2SR,5RS;1RS,2SR,5SR)-2- \n(4-chlorobenzyl)-5-isopropyl-1- \n(1H-1,2,4-triazol-1-ylme\xad\nthyl)cyclopentanol  — 125225-28-7 \n115850-69-6 \n115937-89-8  Repr. 1B \nAcute Tox. 4 \nSTOT RE 2 \nAquatic Chronic 1  H360D \nH302 \nH373 (eyes, \nskin, liver) \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360D \nH302 \nH373 (eyes, \nskin, liver) \nH410  oral: ATE = \n500 mg/kg bw \nM = 100  \n603-238-00-9  bis(2-(2-methoxye\xad\nthoxy)ethyl)ether; tetraglyme  205-594-7  143-24-8  Repr. 1B  H360FD  GHS08 \nDgr H360FD  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 732}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 734\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n603-239-00-4  paclobutrazol (ISO); \n(2RS,3RS)-1-(4-chlorophenyl)- \n4,4-dimethyl-2-(1 H-1,2,4-triazol- \n1-yl)pentan-3-ol  — 76738-62-0  Repr. 2 \nAcute Tox. 4 \nAcute Tox. 4 \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH332 \nH302 \nH319 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d \nH332 \nH302 \nH319 \nH410  inhalation: ATE = \n3,13 mg/L (dusts \nor mists) \noral: ATE = \n490 mg/kg bw \nM = 10 \nM = 10  \n603-240-00-X  2,2-bis(bromomethyl)propane- \n1,3-diol  221-967-7  3296-90-0  Carc. 1B \nMuta. 1B  H350 \nH340  GHS08 \nDgr H350 \nH340  \n603-241-00-5  geraniol; \n(2E)-3,7-dimethylocta-2,6-dien-1- \nol 203-377-1  106-24-1  Skin Sens. 1  H317  GHS07 \nWng  H317  \n▼M16  \n604-001-00-2  phenol; carbolic acid; monohy\xad\ndroxybenzene; phenylalcohol  203-632-7  108-95-2  Muta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nSkin Corr. 1B  H341 \nH331 \nH311 \nH301 \nH373 ** H314  GHS06 \nGHS08 \nGHS05 \nDgr H341 \nH331 \nH311 \nH301 \nH373 ** \nH314  * \nSkin Corr. 1B; \nH314: C ≥ 3 % \nSkin Irrit. 2; H315 \n1 % ≤ C<3 % \nEye Irrit. 2; \nH319:1 % ≤C<3 %  \n604-002-00-8  pentachlorophenol  201-778-6  87-86-5  Carc. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH330 \nH311 \nH301 \nH319 \nH335 \nH315 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH330 \nH311 \nH301 \nH319 \nH335 \nH315 \nH410  ▼M23', metadata={'source': 'data/ycla_en.pdf', 'page': 733}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 735\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-003-00-3  sodiumpentachlorophenolate; [1] \npotassium pentachloropheno\xad\nlate[2]  205-025-2 [1] \n231-911-3 [2]  131-52-2 [1] \n7778-73-6 [2]  Carc. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH330 \nH311 \nH301 \nH319 \nH335 \nH315 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH330 \nH311 \nH301 \nH319 \nH335 \nH315 \nH410  \n604-004-00-9  m-cresol; [1]  o-cresol; [2]  p- \ncresol; [3] mix-cresol [4]  203-577-9 [1] \n202-423-8 [2] \n203-398-6 [3] \n215-293-2 [4]  108-39-4 [1] \n95-48-7 [2] \n106-44-5 [3] \n1319-77-3 [4]  Acute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B  H311 \nH301 \nH314  GHS06 \nGHS05 \nDgr H311 \nH301 \nH314  * C  \n604-005-00-4  1,4-dihydroxybenzene; hydro\xad\nquinone; quinol  204-617-8  123-31-9  Carc. 2 \nMuta. 2 \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H351 \nH341 \nH302 \nH318 \nH317 \nH400  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H351 \nH341 \nH302 \nH318 \nH317 \nH400  M=10  \n604-006-00-X  3,4-xylenol; [1] 2,5-xylenol; [2] \n2,4-xylenol; [3] 2,3-xylenol; [4] \n2,6-xylenol; [5] xylenol; [6] \n2,4(or 2,5)-xylenol [7]  202-439-5 [1] \n202-461-5 [2] \n203-321-6 [3] \n208-395-3 [4] \n209-400-1 [5] \n215-089-3 [6] \n276-245-4 [7]  95-65-8 [1] \n95-87-4 [2] \n105-67-9 [3] \n526-75-0 [4] \n576-26-1 [5] \n1300-71-6 [6] \n71975-58-1 [7]  Acute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nAquatic Chronic 2  H311 \nH301 \nH314 \nH411  GHS06 \nGHS05 \nGHS09 \nDgr H311 \nH301 \nH314 \nH411  C \n604-007-00-5  2-naphthol  205-182-7  135-19-3  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1  H332 \nH302 \nH400  GHS07 \nGHS09 \nWng  H332 \nH302 \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 734}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 736\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-008-00-0  2-chlorophenol; [1] 4-chloro\xad\nphenol; [2] 3-chlorophenol; [3] \nchlorophenol [4]  202-433-2 [1] \n203-402-6 [2] \n203-582-6 [3] \n246-691-4 [4]  95-57-8 [1] \n106-48-9 [2] \n108-43-0 [3] \n25167-80-0 [4]  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H332 \nH312 \nH302 \nH411  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH411  C \n604-009-00-6  pyrogallol; 1,2,3-trihydroxy\xad\nbenzene  201-762-9  87-66-1  Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H341 \nH332 \nH312 \nH302 \nH412  GHS08 \nGHS07 \nWng  H341 \nH332 \nH312 \nH302 \nH412  * \n604-010-00-1  resorcinol; 1,3-benzenediol  203-585-2  108-46-3  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1  H302 \nH319 \nH315 \nH400  GHS07 \nGHS09 \nWng  H302 \nH319 \nH315 \nH400  * \n604-011-00-7  2,4-dichlorophenol  204-429-6  120-83-2  Acute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H311 \nH302 \nH314 \nH411  GHS06 \nGHS05 \nGHS09 \nDgr H311 \nH302 \nH314 \nH411  \n604-012-00-2  4-chloro- o-cresol; 4-chloro-2- \nmethylphenol  216-381-3  1570-64-5  Acute Tox. 3 * \nSkin Corr. 1A \nAquatic Acute 1  H331 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H331 \nH314 \nH400  STOT SE 3; H335: \nC≥1 %  \n604-013-00-8  2,3,4,6-tetrachlorophenol  200-402-8  58-90-2  Acute Tox. 3 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH319 \nH315 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH319 \nH315 \nH410  * \nEye Irrit. 2; \nH319:C≥5 % Skin \nIrrit. 2; \nH315: C≥5 %  \n▼M18  \n604-014-00-3  chlorocresol; \n4-chloro-m-cresol; \n4-chloro-3-methylphenol  200-431-6  59-50-7  Acute Tox. 4 \nSkin Corr. 1C \nEye Dam. 1 \nSTOT SE 3 \nSkin Sens. 1B \nAquatic Acute 1 \nAquatic Chronic 3  H302 \nH314 \nH318 \nH335 \nH317 \nH400 \nH412  GHS07 \nGHS05 \nGHS09 \nDgr H302 \nH314 \nH335 \nH317 \nH410  M = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 735}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 737\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-015-00-9  2,2'-methylenebis-(3,4,6-trich\xad\nlorophenol); hexachlorophene  200-733-8  70-30-4  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH301 \nH410  * \n▼M18  \n604-016-00-4  1,2-dihydroxybenzene; \npyrocatechol  204-427-5  120-80-9  Carc. 1Β \nMuta. 2 \nAcute Tox. 3 \nAcute Tox. 3 \nSkin Irrit. 2 \nEye Irrit. 2  H350 \nH341 \nH311 \nH301 \nH315 \nH319  GHS08 \nGHS06 \nDgr H350 \nH341 \nH311 \nH301 \nH315 \nH319  oral: \nATE = 300 mg/kg \nbw \ndermal: \nATE = 600 mg/kg \nbw \n▼M16  \n604-017-00-X  2,4,5-trichlorophenol  202-467-8  95-95-4  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH315 \nH410  * \nEye Irrit. 2; H319: \nC≥5 % \nSkin Irrit.2; H315: \nC ≥5 %  \n604-018-00-5  2,4,6-trichlorophenol  201-795-9  88-06-2  Carc. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH319 \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH319 \nH315 \nH410  \n604-019-00-0  dichlorophen (ISO)  202-567-1  97-23-4  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH410  \n604-020-00-6  2-phenylphenol (ISO)biphenyl-2- \nol; 2-hydroxybiphenyl;  201-993-5  90-43-7  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H319 \nH335 \nH315 \nH400  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH400  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 736}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 738\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-021-00-1  sodium 2-biphenylate; 2- \nphenylphenol, sodium salt  205-055-6  132-27-4  Acute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1  H302 \nH335 \nH315 \nH318 \nH400  GHS05 \nGHS07 \nGHS09 \nWng  H302 \nH335 \nH315 \nH318 \nH400  \n604-022-00-7  2,2-dimethyl-1,3-benzodioxol-4- \nol 400-900-7  22961-82-6  Eye Dam. 1  H318  GHS05 \nDgr H318  \n604-023-00-2  2,4-dichloro-3-ethylphenol  401-060-4  —  Skin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  \n604-024-00-8  4,4-isobutylethylidenediphenol  401-720-1  6807-17-6  Repr. 1B \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H360F *** \nH319 \nH400 \nH410  GHS08 \nGHS09 \nDgr H360F *** \nH319 \nH410  \n604-025-00-3  2,5-bis(1,1-dimethylbutyl)hydro\xad\nquinone  400-220-0  —  Aquatic Chronic 2  H411  GHS09  H411  \n604-026-00-9  2,2-spirobi(6-hydroxy-4,4,7- \ntrimethylchromane)  400-270-3  —  Aquatic Chronic 2  H411  GHS09  H411  \n604-027-00-4  2-methyl-5-(1,1,3,3-tetramethyl\xad\nbutyl)hydroquinone  400-530-6  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n604-028-00-X  4-amino-3-fluorophenol  402-230-0  399-95-1  Carc. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H350 \nH302 \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 737}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 739\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-029-00-5  1-naphtol  201-969-4  90-15-3  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H312 \nH302 \nH335 \nH315 \nH318  GHS05 \nGHS07 \nDgr H312 \nH302 \nH335 \nH315 \nH318  \n▼M13  \n604-030-00-0  bisphenol A; \n4,4′-isopropylidenediphenol  201-245-8  80-05-7  Repr. 1B \nSTOT SE 3 \nEye Dam. 1 \nSkin Sens. 1  H360F \nH335 \nH318 \nH317  GHS08 \nGHS05 GHS07 \nDgr H360F \nH335 \nH318 \nH317  \n▼M16  \n604-031-00-6  guaiacol  201-964-7  90-05-1  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2  H302 \nH319 \nH315  GHS07 \nWng  H302 \nH319 \nH315  \n604-032-00-1  thymol  201-944-8  89-83-8  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H302 \nH314 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH411  \n604-033-00-7  isobutyl but-3-enoate  401-170-2  24342-03-8  Flam. Liq. 3  H226  GHS02 \nWng  H226  \n604-034-00-2  4,4'-thiodi- o-cresol  403-330-7  24197-34-0  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n604-035-00-8  4-nonylphenol, reaction products \nwith formaldehyde and \ndodecane-1-thiol  404-160-6  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 738}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 740\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-036-00-3  4,4'-oxybis(ethylenethio)diphenol  404-590-4  90884-29-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n604-037-00-9  3,5-xylenol; 3,5-dimethylphenol  203-606-5  108-68-9  Acute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B  H311 \nH301 \nH314  GHS06 \nGHS05 \nDgr H311 \nH301 \nH314  \n604-038-00-4  4-chloro-3,5-dimethylphenol; [1] \nchloroxylenol [2]  201-793-8 [1] \n215-316-6 [2]  88-04-0 [1] \n1321-23-9 [2]  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H302 \nH319 \nH315 \nH317  GHS07 \nWng  H302 \nH319 \nH315 \nH317  \n604-039-00-X  ethyl 2-[4-[(6-chlorobenzoxazol- \n2-yl)oxy]phenoxy]propionate; \nfenoxaprop-ethyl  266-362-9  66441-23-4  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n604-040-00-5  fomesafen (ISO); 5-[2-chloro-4- \n(trifluoromethyl)phenoxy]- N- \n(methylsulphonyl)-2-nitroben\xad\nzamide  276-439-9  72178-02-0  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n604-041-00-0  acifluorfen (ISO); 5-[2-chloro-4- \n(trifluoromethyl)phenoxy]-2- \nnitrobenzoic acid [1] sodium 5- \n[2-chloro-4-(trifluoromethyl) \nphenoxy]-2-nitrobenzoate; aciflu\xad\norfen-sodium [2]  256-634-5 [1] \n263-560-7 [2]  50594-66-6 [1] \n62476-59-9 [2]  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH315 \nH318 \nH410  \n604-042-00-6  4-nitrosophenol  203-251-6  104-91-6  Muta. 2 \nAcute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H341 \nH302 \nH318 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H341 \nH302 \nH318 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 739}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 741\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-043-00-1  monobenzone; 4-hydroxyphenyl \nbenzyl ether; hydroquinone \nmonobenzyl ether  203-083-3  103-16-2  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  \n604-044-00-7  mequinol; 4-methoxyphenol; \nhydroquinone monomethyl ether  205-769-8  150-76-5  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1  H302 \nH319 \nH317  GHS07 \nWng  H302 \nH319 \nH317  \n604-045-00-2  2,3,5-trimethylhydroquinone  211-838-3  700-13-0  Acute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH335 \nH315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H332 \nH335 \nH315 \nH318 \nH317 \nH410  \n604-046-00-8  4-(4-isopropoxyphenylsulfo\xad\nnyl)phenol  405-520-5  95235-30-6  Aquatic Chronic 2  H411  GHS09  H411  \n604-047-00-3  4-(4-tolyloxy)biphenyl  405-730-7  51601-57-1  STOT RE 2 * \nAquatic Chronic 4  H373 ** H413  GHS08 \nWng  H373 ** \nH413  \n604-048-00-9  4,4',4''-(ethan-1,1,1-triyl)triphenol  405-800-7  27955-94-8  Aquatic Chronic 2  H411  GHS09  H411  \n604-049-00-4  4-4'-methylenebis(oxyethylene\xad\nthio)diphenol  407-480-4  93589-69-6  Aquatic Chronic 2  H411  GHS09  H411  \n604-051-00-5  3,5-bis((3,5-di- tert-butyl-4- \nhydroxy)benzyl)-2,4,6-trimethyl\xad\nphenol  401-110-5  87113-78-8  Aquatic Chronic 3  H412  —  H412  \n604-052-00-0  2,2'-methylenebis(6-(2 H-benzo\xad\ntriazol-2-yl)-4-(1,1,3,3-tetra\xad\nmethylbutyl)phenol)  403-800-1  103597-45-1  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 740}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 742\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-053-00-6  2-methyl-4-(1,1-dimethylethyl)- \n6-(1-methyl-pentadecyl)-phenol  410-760-9  157661-93-3  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  \n604-054-00-1  reaction mass of: 2-methoxy-4- \n(tetrahydro-4-methylene-2 H- \npyran-2-yl)-phenol; 4-(3,6- \ndihydro-4-methyl-2 H-pyran-2- \nyl)-2-methoxyphenol  412-020-0  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n604-055-00-7  2,2'-((3,3', 5,5'-tetramethyl-(1,1'- \nbiphenyl)-4,4'-diyl)-bis(oxy\xad\nmethylene))-bis-oxirane  413-900-7  85954-11-6  Carc. 2 \nSkin Sens. 1  H351 \nH317  GHS08 \nGHS07 \nWng  H351 \nH317  \n604-056-00-2  2-(2-hydroxy-3,5-dinitroa\xad\nnilino)ethanol  412-520-9  99610-72-7  Flam. Sol. 2 \nRepr. 2 \nAcute Tox. 4 *  H228 \nH361f *** \nH302  GHS02 \nGHS07 \nGHS08 \nDgr H228 \nH361f *** \nH302  \n▼M15  \n604-057-00-8  reaction mass of: isomers of 2- \n(2H-benzotriazol-2-yl)-4-methyl- \n(n)-dodecylphenol; isomers of 2- \n(2H-benzotriazol-2-yl)-4-methyl- \n(n)-tetracosylphenol; isomers of \n2-(2H-benzotriazol-2-yl)-4- \nmethyl-5,6-didodecyl-phenol. n = \n5 or 6  401-680-5  —  Aquatic Chronic 4  H413  H413  \n▼M16  \n604-058-00-3  1,2-bis(3-methylphenoxy)ethane  402-730-9  54914-85-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 741}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 743\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-059-00-9  2 - n-hexadecylhydroquinone  406-400-5  —  STOT RE 2 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H373 ** H315 \nH317 \nH413  GHS08 \nGHS07 \nWng  H373 ** \nH315 \nH317 \nH413  \n604-060-00-4  9,9-bis(4-hydroxyphenyl)fluorene  406-950-6  3236-71-3  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH410  \n604-061-00-X  reaction mass of: 2-chloro-5- sec- \ntetradecylhydroquinones where  \nsec-tetradecyl = 1-methyltridecyl; \n1-ethyldodecyl; 1-propylundecyl; \n1-butyldecyl; 1-pentylnonyl; 1- \nhexyloctyl  407-740-7  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H315 \nH317 \nH412  GHS07 \nWng  H315 \nH317 \nH412  \n604-062-00-5  2,4-dimethyl-6-(1-methyl- \npentadecyl)phenol  411-220-5  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  \n604-063-00-0  5,6-dihydroxyindole  412-130-9  3131-52-0  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n604-064-00-6  2-(4,6-diphenyl-1,3,5-triazin-2- \nyl)-5-((hexyl)oxy)-phenol  411-380-6  147315-50-2  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 742}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 744\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-065-00-1  4,4',4''-(1-methylpropan-1-yl-3- \nylidene)tris(2-cyclohexyl-5- \nmethylphenol)  407-460-5  111850-25-0  Aquatic Chronic 2  H411  GHS09  H411  \n604-066-00-7  reaction mass of: phenol, 6-(1,1- \ndimethylethyl)-4-tetrapropyl-2- \n[(2-hydroxy-5-tetra-propylphe\xad\nnyl)methyl (C  41-compound) and \nmethane, 2,2'-bis[6-(1,1- \ndimethyl-ethyl)-1-hydroxy-4- \ntetrapropyl-phenyl)]-(C  45- \ncompound); 2,6-bis(1,1-dimethyl\xad\nethyl)-4-tetra-propyl-phenol and \n2-(1,1-dimethylethyl)-4-tetra\xad\npropyl-phenol; 2,6-bis[(6-(1,1- \ndimethylethyl)-1-hydroxy-4-tetra\xad\npropylphenyl)methyl]-4-(tetrapro\xad\npyl)phenol and 2-[(6-(1,1- \ndimethylethyl)-1-hydroxy-4-tetra\xad\npropylphenylmethyl]-6-[1- \nhydroxy-4-tetrapropylphe\xad\nnyl)methyl]-4-(tetrapropyl)phenol  414-550-8  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n604-067-00-2  reaction mass of: 2,2'-[[(2-hydro\xad\nxyethyl)imino]bis(methyl\xad\nene)bis[4-dodecylphenol]; \nformaldehyde, oligomer with 4- \ndodecyl phenol and 2-aminoe\xad\nthanol(n = 2); formaldehyde, \noligomer with 4-dodecyl phenol \nand 2-aminoethanol(n = 3, 4 \nand higher)  414-520-4  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 743}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 745\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-068-00-8  (±)-4-[2-[[3-(4-hydroxyphenyl)- \n1-methylpropyl]amino]-1-hydro\xad\nxyethyl]phenol hydrochloride  415-170-5  90274-24-1  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1  H332 \nH302 \nH317  GHS07 \nWng  H332 \nH302 \nH317  \n604-069-00-3  2-(1-methylpropyl)-4- tert-butylp\xad\nhenol  421-740-4  51390-14-8  Skin Corr. 1B \nAquatic Chronic 2  H314 \nH411  GHS05 \nGHS09 \nDgr H314 \nH411  \n604-070-00-9  triclosan;2,4,4'-trichloro-2'- \nhydroxy-diphenyl-ether; 5- \nchloro-2-(2,4-dichlorophen\xad\noxy)phenol  222-182-2  3380-34-5  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH410  M = 100  \n604-071-00-4  4,4'-(1-{4-[1-(4-hydroxyphenyl)- \n1-methylethyl]phenyl}ethyli\xad\ndene)diphenol  425-600-3  110726-28-8  Aquatic Chronic 4  H413  —  H413  \n604-072-00-X  1,2-bis(phenoxymethyl)benzene  428-620-0  10403-74-4  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n604-073-00-5  (E)-3-[1-[4-[2-(dimethyl\xad\namino)ethoxy]phenyl]-2- \nphenylbut-1-enyl]phenol  428-010-4  82413-20-5  Carc. 2 \nRepr. 1B Skin \nSens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH360F*** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H351 \nH360F*** \nH317 \nH410  \n604-074-00-0  tetrabromobisphenol-A; 2,2', 6,6'- \ntetrabromo-4,4'-isopropylidene\xad\ndiphenol  201-236-9  79-94-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 744}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 746\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n604-075-00-6  4-(1,1,3,3-tetramethyl\xad\nbutyl)phenol; 4- tert-octylphenol  205-426-2  140-66-9  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  M=10  \n604-076-00-1  phenolphthalein  201-004-7  77-09-8  Carc. 1B Muta. 2 \nRepr. 2  H350 \nH341 \nH361f***  GHS08 \nDgr H350 \nH341 \nH361f***  Carc. 1B; H350: C \n≥1 %  \n604-077-00-7  2-benzotriazol-2-yl-4-methyl-6- \n(2-methylallyl)phenol  419-750-9  98809-58-6  Aquatic Chronic 4  H413  —  H413  \n604-079-00-8  4,4'-(1,3-phenylene-bis(1-methyl\xad\nethylidene))bis-phenol  428-970-4  13595-25-0  Repr. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H361f*** \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H361f*** \nH317 \nH411  \n604-080-00-3  4-fluoro-3-trifluoromethylphenol  432-560-0  61721-07-1  Acute Tox. 4 * \nSkin Corr. 1A \nSkin Sens. 1 \nAquatic Chronic 2  H332 \nH314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H332 \nH314 \nH317 \nH411  \n604-081-00-9  1,1-bis(4-hydroxyphenyl)-1- \nphenylethane  433-130-5  1571-75-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n604-082-00-4  2-chloro-6-fluoro-phenol  433-890-8  2040-90-6  Muta. 1B Repr. 2 \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H340 \nH361f*** \nH302 \nH314 \nH317 \nH411  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H340 \nH361f*** \nH302 \nH314 \nH317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 745}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 747\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M22  __________  \n▼M16  \n604-084-00-5  1-ethoxy-2,3-difluorobenzene  441-000-4  121219-07-6  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n604-087-00-1  reaction mass of: 1,2-naphthoqui\xad\nnonediazide-5-sulfonylchloride \n(or sulfonic acid)monoester with \n4,4'-(1-(4-(1-(4-hydroxyphenyl)- \n1-methylethyl)phenyl)ethyli\xad\ndene)bisphenol; 1,2-naphthoqui\xad\nnonediazide-5-sulfonylchloride(or \nsulfonicacid)diester with 4,4'-(1- \n(4-(1-(4-hydroxyphenyl)-1- \nmethylethyl)phenyl)ethyli\xad\ndene)bisphenol; 1,2-naphthoqui\xad\nnonediazide-5-sulfonylchloride \n(or sulfonic acid)triester with \n4,4'-(1-(4-(1-(4-hydroxyphenyl)- \n1-methylethyl)phenyl)ethyli\xad\ndene)bisphenol  433-640-8  —  Pyr. Sol. 1 \nAquatic Chronic 4  H250 \nH413  GHS02 \nDgr H250 \nH413  EUH044  \n604-089-00-2  2-methyl-5- tert-butylthiophenol  444-970-7  —  Flam. Liq. 3 \nRepr. 2 \nSTOT RE 2 * \nAsp. Tox. 1 \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH361d*** \nH373** H304 \nH319 \nH315 \nH317 \nH336 \nH400 \nH410  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H226 \nH361d*** \nH373** \nH304 \nH319 \nH315 \nH317 \nH336 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 746}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 748\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M18  \n604-090-00-8  4 - tert-butylphenol  202-679-0  98-54-4  Repr. 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 1  H361f \nH315 \nH318 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H361f \nH315 \nH318 \nH410  M = 1  \n▼M16  \n604-091-00-3  etofenprox (ISO); 2-(4-ethoxyp\xad\nhenyl)-2-methylpropyl 3-phen\xad\noxybenzyl ether  407-980-2  80844-07-1  Lact. \nAquatic Acute 1 \nAquatic Chronic 1  H362 \nH400 \nH410  GHS09 \nWng  H362 \nH410  M = 100 \nM = 1 000  \n▼M13  \n604-092-00-9  phenol, dodecyl-, branched; [1] \nphenol, 2-dodecyl-, branched; [2] \nphenol, 3-dodecyl-, branched; [3] \nphenol, 4-dodecyl-, branched; [4] \nphenol, (tetrapropenyl) deriva\xad\ntives [5]  310-154-3 [1] \n[2] \n[3] \n[4] \n[5] 121158-58-5 \n[1] \n[2] \n[3] \n210555-94-5 \n[4] \n74499-35-7 [5]  Repr. 1B \nSkin Corr. 1C \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360F \nH314 \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H360F \nH314 \nH410  M = 10 \nM = 10  \n▼M15  \n604-093-00-4  clorofene; \nchlorophene; \n2-benzyl-4-chlorophenol  204-385-8  120-32-1  Carc. 2 \nRepr. 2 \nAcute Tox. 4 \nSkin Irrit. 2 \nSkin Sens. 1 \nEye Dam. 1 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361f \nH332 \nH315 \nH317 \nH318 \nH373 (kidney) \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H351 \nH361f \nH332 \nH315 \nH317 \nH318 \nH373 \n(kidney) \nH410  M = 1 \nM = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 747}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 749\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M18  \n604-094-00-X  isoeugenol; [1] \n(E)-2-methoxy-4-(prop-1- \nenyl)phenol; [2] \n(Z)-2-methoxy-4-(prop-1- \nenyl)phenol [3]  202-590-7 [1] \n227-678-2 [2] \n227-633-7 [3]  97-54-1 [1] \n5932-68-3 [2] \n5912-86-7 [3]  Skin Sens. 1A  H317  GHS07 \nWng  H317  Skin Sens. 1A; \nH317: C ≥ 0,01 %  \n▼M16  \n605-001-00-5  formaldehyde …%  200-001-8  50-00-0  Carc. 1B Muta. 2 \nAcute Tox. 3* \nAcute Tox. 3* \nAcute Tox. 3* \nSkin Corr. 1B \nSkin Sens. 1  H350 \nH341 \nH301 \nH311 \nH331 \nH314 \nH317  GHS08 \nGHS06 \nGHS05 \nDgr H350 \nH341 \nH301 \nH311 \nH331 \nH314 \nH317  * \nSkin Corr. 1B; \nH314: C ≥25 % \nSkin Irrit. 2; H315: \n5 % ≤C \n< 25 % \nEye Irrit. 2; H319: \n5 % ≤ C <25 % \nSTOT SE 3; H335: \nC ≥ 5 % SkinSens.; \nH317: C ≥ 0,2 %  B, D  \n605-002-00-0  1,3,5-trioxan; trioxymethylene  203-812-5  110-88-3  Flam. Sol. 1 \nRepr. 2 \nSTOT SE 3  H228 \nH361d *** \nH335  GHS02 \nGHS08 \nGHS07 \nDgr H228 \nH361d *** \nH335  T \n▼M18  \n605-003-00-6  acetaldehyde; \nethanal  200-836-8  75-07-0  Flam. Liq. 1 \nCarc. 1B \nMuta. 2 \nSTOT SE 3 \nEye Irrit. 2  H224 \nH350 \nH341 \nH335 \nH319  GHS02 \nGHS08 \nGHS07 \nDgr H224 \nH350 \nH341 \nH335 \nH319  \n▼M16  \n605-004-00-1  2,4,6-trimethyl-1,3,5-trioxane; \nparaldehyde  204-639-8  123-63-7  Flam. Liq. 3  H226  GHS02 \nWng  H226  \n▼M22  \n605-005-00-7  metaldehyde (ISO); \n2,4,6,8-tetramethyl-1,3,5,7-tetrao\xad\nxacyclooctane  203-600-2  108-62-3  Flam. Sol. 2 \nRepr. 2 \nAcute Tox. 3 \nAquatic Chronic 3  H228 \nH361f \nH301 \nH412  GHS02 \nGHS08 \nGHS06 \nDgr H228 \nH361f \nH301 \nH412  oral: ATE = \n283 mg/kg bw  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 748}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 750\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n605-006-00-2  butyraldehyde  204-646-6  123-72-8  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n605-007-00-8  1,1-dimethoxyethane; dimethyl \nacetal  208-589-8  534-15-6  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n605-008-00-3  acrolein; prop-2-enal; acrylal\xad\ndehyde  203-453-4  107-02-8  Flam. Liq. 2 \nAcute Tox. 1 \nAcute Tox. 2 \nAcute Tox. 3 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH330 \nH300 \nH311 \nH314 \nH400 \nH410  GHS02 \nGHS06 \nGHS05 \nGHS09 \nDgr H225 \nH330 \nH300 \nH311 \nH314 \nH410  EUH071  Skin Corr. 1B; \nH314:C≥ 0,1 % \nM = 100 \nM = 1  D \n605-009-00-9  crotonaldehyde; 2-butenal; [1] \n(E)-2-butenal; ( E)-crotonaldehyde \n[2] 224-030-0 [1] \n204-647-1 [2]  4170-30-3 [1] \n123-73-9 [2]  Flam. Liq. 2 \nMuta. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1  H225 \nH341 \nH330 \nH311 \nH301 \nH373 ** H335 \nH315 \nH318 \nH400  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H225 \nH341 \nH330 \nH311 \nH301 \nH373 ** \nH335 \nH315 \nH318 \nH400  \n605-010-00-4  2-furaldehyde  202-627-7  98-01-1  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H351 \nH331 \nH301 \nH312 \nH319 \nH335 \nH315  GHS06 \nGHS08 \nDgr H351 \nH331 \nH301 \nH312 \nH319 \nH335 \nH315  \n605-011-00-X  2-chlorobenzaldehyde;  o-chloro\xad\nbenzaldehyde  201-956-3  89-98-5  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n605-012-00-5  benzaldehyde  202-860-4  100-52-7  Acute Tox. 4 *  H302  GHS07 \nWng  H302  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 749}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 751\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n605-013-00-0  chloralose (INN); \n(R)-1,2-O-(2,2,2-trichloroethyli\xad\ndene)-α-D-glucofuranose; \nglucochloralose; anhydroglucoch\xad\nloral 240-016-7  15879-93-3  Acute Tox. 4* \nAcute Tox. 3 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH301 \nH336 \nH400 \nH410  GHS06 \nGHS09 \nDgr H332 \nH301 \nH336 \nH410  M = 10 \nM = 10  C \n▼M16  \n605-014-00-6  chloral hydrate; 2,2,2-trichloroe\xad\nthane-1,1-diol  206-117-5  302-17-0  Acute Tox. 3 * \nEye Irrit. 2 \nSkin Irrit. 2  H301 \nH319 \nH315  GHS06 \nDgr H301 \nH319 \nH315  \n605-015-00-1  1,1-diethoxyethane; acetal  203-310-6  105-57-7  Flam. Liq. 2 \nEye Irrit. 2 \nSkin Irrit. 2  H225 \nH319 \nH315  GHS02 \nGHS07 \nDgr H225 \nH319 \nH315  \n605-016-00-7  glyoxal…%; ethandial…%  203-474-9  107-22-2  Muta. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H341 \nH332 \nH319 \nH315 \nH317  GHS07 \nGHS08 \nWng  H341 \nH332 \nH319 \nH315 \nH317  * B  \n605-017-00-2  1,3-dioxolane  211-463-5  646-06-0  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n605-018-00-8  propanal; propionaldehyde  204-623-0  123-38-6  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H225 \nH319 \nH335 \nH315  GHS02 \nGHS07 \nDgr H225 \nH319 \nH335 \nH315  \n605-019-00-3  citral  226-394-6  5392-40-5  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n605-020-00-9  safrole; 5-allyl-1,3-benzodioxole  202-345-4  94-59-7  Carc. 1B Muta. 2 \nAcute Tox. 4 *  H350 \nH341 \nH302  GHS08 \nGHS07 \nDgr H350 \nH341 \nH302  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 750}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 752\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n605-021-00-4  formaldehyde, reaction products \nwith butylphenol  294-145-9  91673-30-2  Skin Sens. 1  H317  GHS07 \nWng  H317  \n▼M13  \n605-022-00-X  glutaral; glutaraldehyde; \n1,5-pentanedial  203-856-5  111-30-8  Acute Tox. 2 \nAcute Tox. 3 \nSTOT SE 3 \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 2  H330 \nH301 \nH335 \nH314 \nH334 \nH317 \nH400 \nH411  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H330 \nH301 \nH335 \nH314 \nH334 \nH317 \nH410  EUH071  STOT SE 3; H335: \n0,5 % ≤ C < 5 % \nM = 1  \n▼M15  \n605-023-00-5  5-chloro-2-(4-chlorophen\xad\noxy)phenol; \n[DCPP]  429-290-0  3380-30-1  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  M = 10 \nM = 10  \n▼M16  \n605-024-00-0  2-bromo-5-hydroxy-4-methoxy\xad\nbenzaldehyde  426-540-0  2973-59-3  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n605-025-00-6  chloroacetaldehyde  203-472-8  107-20-0  Carc. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nAquatic Acute 1  H351 \nH330 \nH311 \nH301 \nH314 \nH400  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H351 \nH330 \nH311 \nH301 \nH314 \nH400  STOT SE 3; H335: \nC≥ 5 %  \n605-026-00-1  2,5,7,7-tetramethyloctanal  405-690-0  114119-97-0  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H315 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 751}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 753\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n605-027-00-7  reaction mass of: 3a,4,5,6,7,7a- \nhexahydro-4,7-methano-1 H- \nindene-6-carboxaldehyde; \n3a,4,5,6,7,7a-hexahydro-4,7- \nmethano-1 H-indene-5-carbox\xad\naldehyde  410-480-7  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n605-028-00-2  β-methyl-3-(1-methylethyl)- \nbenzenepropanal  412-050-4  125109-85-5  Aquatic Chronic 2  H411  GHS09  H411  \n605-029-00-8  2-cyclohexylpropanal  412-270-0  2109-22-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n605-030-00-3  1-(p-methoxyphenyl)acet\xad\naldehyde oxime  411-510-1  3353-51-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n605-031-00-9  reaction mass of: 2,2-dimetho\xad\nxyethanal [this component is \nconsidered to be anhydrous in \nterms of identity, structure and \ncomposition. However, 2,2-dime\xad\nthoxyethanal will exist in a \nhydrated form. 60 % anhydrous \nis equivalent to 70,4 % hydrate; \nwater (Including free water and \nwater in hydrated 2,2-dimetho\xad\nxyethanal)]  421-890-0  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n605-032-00-4  3-[3-(4-fluorophenyl)-1-(1- \nmethylethyl)-1 H-indol-2-yl]-( E)- \n2-propenal  425-370-4  93957-50-7  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n605-033-00-X  Reaction mass of: 3,7,11- \ntrimethyl- cis-6,10-dodecadienal; \n3,7,11-trimethyl- trans -6,10-dode\xad\ncadienal  425-910-9  32480-08-3  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 752}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 754\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n605-034-00-5  reaction mass of: (1 RS, 2RS,3SR, \n6RS, 9 SR)-9-methoxytri\xad\ncyclo[5.2.1.0(2,6)]decane-3-carb\xad\naldehyde; (1 RS, 2RS, 3RS, 6RS, \n8SR)-8-methoxytri\xad\ncyclo[5.2.1.0(2,6)]decane-3-carb\xad\naldehyde; (1 RS, 2RS, 4SR, 6RS, \n8SR)-8-methoxytri\xad\ncyclo[5.2.1.0(2,6)]decane-4-carb\xad\naldehyde  429-860-9  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n605-035-00-0  (E)-3-(4-(4-fluorophenyl)-5- \nmethoxymethyl-2,6-bis(1- \nmethoxymethyl)pyridin-3- \nyl)prop-2-enal  426-330-9  177964-68-0  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H319 \nH317 \nH413  GHS07 \nWng  H319 \nH317 \nH413  \n605-036-00-6  2-bromomalonaldehyde  430-470-6  2065-75-0  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n605-037-00-1  trans -3-[2-(7-chloro-2-quinoli\xad\nnyl)vinyl]benzaldehyde; 3-[( E)-2- \n(7-chloro-2-quinoli\xad\nnyl)vinyl]benzaldehyde  421-800-1  120578-03-2  Aquatic Chronic 4  H413  —  H413  \n605-038-00-7  3-methyl-5-phenylpentan-1-al  433-900-0  55066-49-4  Acute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH315 \nH317 \nH411  \n605-039-00-2  3,4-dihydroxy-5-nitrobenz\xad\naldehyde  441-810-8  116313-85-0  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 753}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 755\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n605-040-00-8  hydroxyisohexyl 3-cyclohexene \ncarboxaldehyde (INCI); reaction \nmass of 4-(4-hydroxy-4-methyl\xad\npentyl)cyclohex-3-ene-1-carb\xad\naldehyde and 3-(4-hydroxy-4- \nmethylpentyl)cyclohex-3-ene-1- \ncarbaldehyde; [1] \n4-(4-hydroxy-4-methylpen\xad\ntyl)cyclohex-3-ene-1-carb\xad\naldehyde; [2] \n3-(4-hydroxy-4-methylpen\xad\ntyl)cyclohex-3-ene-1-carb\xad\naldehyde [3]  - [1] \n250-863-4 [2] \n257-187-9 [3]  130066-44-3 \n[1] \n31906-04-4 [2] \n51414-25-6 [3]  Skin Sens. 1A  H317  GHS07 \nWng  H317  \n▼M23  \n605-041-00-3  2-(4- tert-butylbenzyl)propional\xad\ndehyde  201-289-8  80-54-6  Repr. 1B  H360Fd  GHS08 \nDgr H360Fd  \n▼M16  \n606-001-00-8  acetone; propan-2-one; \npropanone  200-662-2  67-64-1  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH336  EUH066  \n606-002-00-3  butanone; ethyl methyl ketone  201-159-0  78-93-3  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH336  EUH066  \n606-003-00-9  heptan-3-one; butyl ethyl ketone  203-388-1  106-35-4  Flam. Liq. 3 \nAcute Tox. 4 * \nEye Irrit. 2  H226 \nH332 \nH319  GHS02 \nGHS07 \nWng  H226 \nH332 \nH319  \n606-004-00-4  4-methylpentan-2-one; isobutyl \nmethyl ketone  203-550-1  108-10-1  Flam. Liq. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3  H225 \nH332 \nH319 \nH335  GHS02 \nGHS07 \nDgr H225 \nH332 \nH319 \nH335  EUH066  \n606-005-00-X  2,6-dimethylheptan-4-one; di- \nisobutyl ketone  203-620-1  108-83-8  Flam. Liq. 3 \nSTOT SE 3  H226 \nH335  GHS02 \nGHS07 \nWng  H226 \nH335  STOT SE 3; H335: \nC ≥ 10 %  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 754}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 756\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-006-00-5  pentan-3-one; diethyl ketone  202-490-3  96-22-0  Flam. Liq. 2 \nSTOT SE 3 \nSTOT SE 3  H225 \nH335 \nH336  GHS02 \nGHS07 \nDgr H225 \nH335 \nH336  EUH066  \n606-007-00-0  3-methylbutan-2-one; methyl \nisopropyl ketone  209-264-3  563-80-4  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n606-009-00-1  4-methylpent-3-en-2-one; mesityl \noxide  205-502-5  141-79-7  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH332 \nH312 \nH302  GHS02 \nGHS07 \nWng  H226 \nH332 \nH312 \nH302  * \n606-010-00-7  cyclohexanone  203-631-1  108-94-1  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH332  GHS02 \nGHS07 \nWng  H226 \nH332  \n606-011-00-2  2-methylcyclohexanone  209-513-6  583-60-8  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH332  GHS02 \nGHS07 \nWng  H226 \nH332  \n606-012-00-8  3,5,5-trimethylcyclohex-2-enone; \nisophorone  201-126-0  78-59-1  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3  H351 \nH312 \nH302 \nH319 \nH335  GHS08 \nGHS07 \nWng  H351 \nH312 \nH302 \nH319 \nH335  STOT SE 3; H335: \nC ≥10 %  \n606-013-00-3  p-benzoquinone; quinone  203-405-2  106-51-4  Acute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1  H331 \nH301 \nH319 \nH335 \nH315 \nH400  GHS06 \nGHS09 \nDgr H331 \nH301 \nH319 \nH335 \nH315 \nH400  M=10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 755}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 757\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n606-014-00-9  chlorophacinone (ISO); \n2-[(4-chlorophenyl)(phe\xad\nnyl)acetyl]-1H-indene-1,3(2H)- \ndione  223-003-0  3691-35-8  Repr. 1B \nAcute Tox. 1 \nAcute Tox. 1 \nAcute Tox. 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH410  Repr. 1B; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C ≥ 0,1 % \nSTOT RE 2; H373 \n(blood): \n0,01 % ≤ C \n< 0,1 % \nM = 1 \nM = 1  \n▼M16  \n606-016-00-X  pindone (ISO); 2-pivaloylindan- \n1,3-dione  201-462-8  83-26-1  Acute Tox. 3 * \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH372 ** H400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH372 ** \nH410  \n606-017-00-5  diketene; diketen  211-617-1  674-82-8  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH332  GHS02 \nGHS07 \nWng  H226 \nH332  D \n606-018-00-0  dichlone (ISO); 2,3-dichloro-1,4- \nnaphthoquinone  204-210-5  117-80-6  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH315 \nH410  \n606-019-00-6  chlordecone (ISO); perchloropen\xad\ntacyclo[5,3,0,02,6 ,03,9 ,0 4,8 ]decan- \n5-one; decachloropenta\xad\ncyclo[5,2,1,02,6 ,03,9 ,05,8 ]decan-4- \none 205-601-3  143-50-0  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH311 \nH301 \nH410  \n606-020-00-1  5-methylheptan-3-one  208-793-7  541-85-5  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3  H226 \nH319 \nH335  GHS02 \nGHS07 \nWng  H226 \nH319 \nH335  STOT SE 3; H335: \nC≥10 %  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 756}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 758\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n606-021-00-7  N-methyl-2-pyrrolidone; 1- \nmethyl-2-pyrrolidone  212-828-1  872-50-4  Repr. 1B \nSTOT SE 3 \nSkin Irrit. 2 \nEye Irrit. 2  H360D*** \nH335 \nH315 \nH319  GHS08 \nGHS07 \nDgr H360D*** \nH335 \nH315 \nH319  STOT SE 3; H335: \nC ≥ 10 %  \n▼M16  \n606-022-00-2  1-phenyl-3-pyrazolidone  202-155-1  92-43-3  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n606-023-00-8  4-methoxy-4-methylpentan-2-one  203-512-4  107-70-0  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH332  GHS02 \nGHS07 \nWng  H226 \nH332  \n606-024-00-3  heptan-2-one; methyl amyl \nketone  203-767-1  110-43-0  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH332 \nH302  GHS02 \nGHS07 \nWng  H226 \nH332 \nH302  \n606-025-00-9  cyclopentanone  204-435-9  120-92-3  Flam. Liq. 3 \nEye Irrit. 2 \nSkin Irrit. 2  H226 \nH319 \nH315  GHS02 \nGHS07 \nWng  H226 \nH319 \nH315  \n606-026-00-4  5-methylhexan-2-one; isoamyl \nmethyl ketone  203-737-8  110-12-3  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH332  GHS02 \nGHS07 \nWng  H226 \nH332  \n606-027-00-X  heptan-4-one; di- n-propyl ketone  204-608-9  123-19-3  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH332  GHS02 \nGHS07 \nWng  H226 \nH332  \n606-028-00-5  2,4-dimethylpentan-3-one; di- \nisopropyl ketone  209-294-7  565-80-0  Flam. Liq. 2 \nAcute Tox. 4 *  H225 \nH332  GHS02 \nGHS07 \nDgr H225 \nH332  \n606-029-00-0  pentane-2,4-dione; acetylacetone  204-634-0  123-54-6  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH302  GHS02 \nGHS07 \nWng  H226 \nH302  \n606-030-00-6  hexan-2-one; methyl butyl \nketone; butyl methyl ketone; \nmethyl- n-butyl ketone  209-731-1  591-78-6  Flam. Liq. 3 \nRepr. 2 \nSTOT RE 1 \nSTOT SE 3  H226 \nH361f *** \nH372 ** H336  GHS02 \nGHS08 \nGHS07 \nDgr H226 \nH361f *** \nH372 ** \nH336  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 757}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 759\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-031-00-1  3-propanolide;1,3-propiolactone  200-340-1  57-57-8  Carc. 1B \nAcute Tox. 2 * \nEye Irrit. 2 \nSkin Irrit. 2  H350 \nH330 \nH319 \nH315  GHS06 \nGHS08 \nDgr H350 \nH330 \nH319 \nH315  \n606-032-00-7  hexachloroacetone  204-129-5  116-16-5  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n606-033-00-2  2-(3,4-dichlorophenyl)-4-methyl- \n1,2,4-oxadiazolidinedione; \nmethazole  243-761-6  20354-26-1  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H312 \nH302 \nH319 \nH315 \nH411  GHS07 \nGHS09 \nWng  H312 \nH302 \nH319 \nH315 \nH411  \n606-034-00-8  metribuzin (ISO); 4-amino-6- tert- \nbutyl-3-methylthio-1,2,4-triazin- \n5(4H)-one; 4-amino-4,5-dihydro- \n6-(1,1-dimethylethyl)-3- \nmethylthio-1,2,4-triazin-5-one  244-209-7  21087-64-9  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M=10  \n606-035-00-3  chloridazon (ISO); 5-amino-4- \nchloro-2-phenylpyridazine-3- \n(2H)-one; pyrazon  216-920-2  1698-60-8  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 758}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 760\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-036-00-9  quinomethionate; chinomethionat \n(ISO); 6-methyl-1,3-dithiolo(4,5-  \nb)quinoxalin-2-one  219-455-3  2439-01-2  Repr. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f *** \nH332 \nH312 \nH302 \nH373 ** H319 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361f *** \nH332 \nH312 \nH302 \nH373 ** \nH319 \nH317 \nH410  \n606-037-00-4  triadimefon (ISO); 1-(4-chloro\xad\nphenoxy)-3,3-dimethyl-1-(1,2,4- \ntriazol-1-yl)butanone  256-103-8  43121-43-3  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n606-038-00-X  diphacinone (ISO); 2-diphenyla\xad\ncetylindan-1,3-dione  201-434-5  82-66-6  Acute Tox. 2 * \nSTOT RE 1  H300 \nH372 **  GHS06 \nGHS08 \nDgr H300 \nH372 **  \n606-039-00-5  5(or 6)- tert-butyl-2'-chloro-6'- \nethylamino-3',7'-dimethyl\xad\nspiro(isobenzofuran-1(1 H),9'- \nxanthene)-3-one  400-680-2  —  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH410  \n606-040-00-0  (N-benzyl- N-ethyl)amino-3- \nhydroxyacetophenone hydro\xad\nchloride  401-840-4  55845-90-4  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n▼M15  \n606-041-00-6  2-methyl-1-(4-methylthiophenyl)- \n2-morpholinopropan-1-one  400-600-6  71868-10-5  Repr. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H360FD \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H360FD \nH302 \nH411  \n▼M16  \n606-042-00-1  acetophenone  202-708-7  98-86-2  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 759}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 761\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-043-00-7  2,4-di- tert-butylcyclohexanone  405-340-7  13019-04-0  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n606-044-00-2  2,4,6-trimethylbenzophenone  403-150-9  954-16-5  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH410  \n606-045-00-8  oxadiazon (ISO); 3-[2,4-dichloro- \n5-(1-methylethoxy)phenyl]-5- \n(1,1-dimethylethyl)-1,3,4- \noxadiazol-2(3 H)-one  243-215-7  19666-30-9  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-046-00-3  reaction mass of  cis-and trans - \ncyclohexadec-8-en-1-one  401-700-2  3100-36-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n▼M22  \n606-047-00-9  2-benzyl-2-dimethylamino-4'- \nmorpholinobutyrophenone  404-360-3  119313-12-1  Repr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH400 \nH410  GHS08 \nGHS09 \nDgr H360D \nH410  \n▼M16  \n606-048-00-4  2'-anilino-3'-methyl-6'-dipenty\xad\nlaminospiro(isobenzofuran- \n1(1H),9'-xanthen)-3-one  406-480-1  —  Aquatic Chronic 4  H413  —  H413  \n606-049-00-X  4-( trans -4-propylcyclohexyl)acet\xad\nophenone  406-700-6  78531-61-0  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n606-050-00-5  6-anilino-1-benzoyl-4-(4- tert- \npentylphenoxy)naphto[1,2,3- \nde]quinoline-2,7-(3H)-dione  412-480-2  72453-58-8  Aquatic Chronic 2  H411  GHS09  H411  \n606-051-00-0  4-pentylcyclohexanone  406-670-4  61203-83-6  Aquatic Chronic 2  H411  GHS09  H411  \n606-052-00-6  4-( N,N-dibutylamino)-2-hydroxy- \n2'-carboxybenzophenone  410-410-5  54574-82-2  Aquatic Chronic 3  H412  —  H412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 760}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 762\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-053-00-1  flurtamone (ISO); ( RS)-5-methyl\xad\namino-2-phenyl-4-(α, α,α- \ntrifluoro- m-tolyl)furan-3(2 H)-one  — 96525-23-4  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n▼M11  \n606-054-00-7  isoxaflutole (ISO); 5-cyclo\xad\npropyl-1,2-oxazol-4-yl α,α,α- \ntrifluoro-2-mesyl-p-tolyl ketone  — 141112-29-0  Repr. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H361d*** \nH400 \nH410  GHS08 \nGHS09 \nWng  H361d*** \nH410  M = 10 \nM = 100  \n▼M16  \n606-055-00-2  1-(2,3-dihydro-1,3,3,6-tetra\xad\nmethyl-1-(1-methylethyl)-1 H- \ninden-5-yl)ethanone  411-180-9  92836-10-7  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 2  H302 \nH373 ** H411  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH411  \n606-056-00-8  4-chloro-3',4'-dimethoxybenzop\xad\nhenone  404-610-1  116412-83-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-057-00-3  4-propylcyclohexanone  406-810-4  40649-36-3  Skin Irrit. 2 \nAquatic Chronic 3  H315 \nH412  GHS07 \nWng  H315 \nH412  \n606-058-00-9  4'-fluoro-2,2-dimethoxyacetop\xad\nhenone  407-500-1  21983-80-2  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n606-059-00-4  2,4-difluoro-α-(1 H-1,2,4-triazol- \n1-yl)acetophenone hydrochloride  412-390-3  86386-75-6  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317  \n606-060-00-X  Reaction mass of:  trans -2,4- \ndimethyl-2-(5,6,7,8-tetrahydro- \n5,5,8,8-tetramethyl-naphthalene- \n2-yl)-1,3-dioxolane;  cis -2,4- \ndimethyl-2-(5,6,7,8-tetrahydro- \n5,5,8,8-tetramethyl-naphthalene- \n2-yl)-1,3-dioxolane  412-950-7  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 761}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 763\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-061-00-5  (3-chlorophenyl)-(4-methoxy-3- \nnitrophenyl)methanone  423-290-4  66938-41-8  Muta. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH400 \nH410  GHS08 \nGHS09 \nWng  H341 \nH410  \n606-062-00-0  tetrahydrothiopyran-3-carbox\xad\naldehyde  407-330-8  61571-06-0  Repr. 1B \nEye Dam. 1 \nAquatic Chronic 3  H360D *** \nH318 \nH412  GHS08 \nGHS05 \nDgr H360D *** \nH318 \nH412  \n606-063-00-6  (E)-3-(2-chlorophenyl)-2-(4- \nfluorophenyl)propenal  410-980-5  112704-51-5  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  \n606-064-00-1  pregn-5-ene-3,20-dione \nbis(ethylene ketal)  407-450-0  7093-55-2  Aquatic Chronic 4  H413  —  H413  \n606-065-00-7  1-(4-morpholinophenyl)butan-1- \none 413-790-0  —  Aquatic Chronic 2  H411  GHS09  H411  \n606-066-00-2  (E)-5[(4-chlorophe\xad\nnyl)methylene]-2,2-dimethyl\xad\ncyclopentanone  410-440-9  164058-20-2  Aquatic Chronic 2  H411  GHS09  H411  \n606-067-00-8  reaction mass of: 1-(2,3,6,7,8,9- \nhexahydro-1,1-dimethyl-1 H- \nbenz(g)inden-4-yl)ethanone; \n1-(2,3,5,6,7,8-hexahydro-1,1- \ndimethyl-1 H-benz(f)inden-4- \nyl)ethanone; \n1-(2,3,6,7,8,9-hexahydro-1,1- \ndimethyl-1 H-benz(g)inden-5- \nyl)ethanone; 1-(2,3,6,7,8,9- \nhexahydro-3,3-dimethyl-1 H- \nbenz(g)inden-5-yl)ethanone  414-870-8  96792-67-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 762}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 764\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-068-00-3  2,7,11-trimethyl-13-(2,6,6- \ntrimethylcyclohex-1-en-1- \nyl)tridecahexaen-2,4,6,8,10,12-al  415-770-7  1638-05-7  STOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 3  H373 ** H317 \nH412  GHS08 \nGHS07 \nWng  H373 ** \nH317 \nH412  \n606-069-00-9  spiro[1,3-dioxolane-2,5'- \n(4',4',8',8'-tetramethyl-hexahydro- \n3',9'-methanonaphthalene)]  415-460-1  154171-76-3  Aquatic Chronic 2  H411  GHS09  H411  \n606-070-00-4  butroxydim (ISO); 5-(3-butyryl- \n2,4,6-trimethylphenyl)-2-[1- \n(ethoxyimino)propyl]-3-hydroxy\xad\ncyclohex-2-en-1-one  414-790-3  138164-12-2  Repr. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H361fd \nH302 \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361fd \nH302 \nH315 \nH410  \n606-071-00-X  17-spiro(5,5-dimethyl-1,3- \ndioxan-2-yl)androsta-1,4-diene-3- \none 421-050-3  13258-43-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-072-00-5  3-acetyl-1-phenyl-pyrrolidine- \n2,4-dione  421-600-2  719-86-8  STOT RE 2 * \nAquatic Chronic 2  H373 ** H411  GHS08 \nGHS09 \nWng  H373 ** \nH411  \n606-073-00-0  4,4'-bis(dimethylamino)benzop\xad\nhenone; Michler's ketone  202-027-5  90-94-8  Carc. 1B Muta. 2 \nEye Dam. 1  H350 \nH341 \nH318  GHS08 \nGHS05 \nDgr H350 \nH341 \nH318  \n606-074-00-6  reaction mass of: (1 R*, 2S*)-2- \nacetyl-1,2,3,4,5,6,7,8-octahydro- \n1,2,8,8-tetramethylnaphthalene; \n(2R*,3S*)-2-acetyl- \n1,2,3,4,5,6,7,8-octahydro-2,3,8,8- \ntetramethylnaphthalene  425-570-1  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 763}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 765\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-075-00-1  1-benzyl-5-ethoxyimidazolidine- \n2,4-dione  417-340-4  65855-02-9  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n606-076-00-7  1-((2-quinolinyl-carbonyl)oxy)- \n2,5-pyrrolidinedione  418-630-3  136465-99-1  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n606-077-00-2  ( 3 S,4S)-3-hexyl-4-[( R)-2- \nhydroxytridecyl]-2-oxetanone  418-650-2  104872-06-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-078-00-8  1-octylazepin-2-one  420-040-6  59227-88-2  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH411  \n606-079-00-3  2 - n-butyl-benzo[ d]isothiazol-3- \none 420-590-7  4299-07-4  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH410  \n▼M1 __________  \n▼M16  \n606-081-00-4  (3β, 5α, 6β)-3-(acetyloxy)-5- \nbromo-6-hydroxy-androstan-17- \none 419-790-7  4229-69-0  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n606-082-00-X  reaction mass of: butan-2-one \noxime; syn- O,O'-di(butan-2-one \noxime)diethoxysilane  406-930-7  STOT RE 1 \nSkin Sens. 1 \nAquatic Chronic 3  H372 ** H317 \nH412  GHS08 \nGHS07 \nDgr H372 ** \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 764}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 766\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-083-00-5  2-chloro-5- sec-hexadecylhydro\xad\nquinone  407-750-1  137193-60-3  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H319 \nH315 \nH317 \nH412  GHS07 \nWng  H319 \nH315 \nH317 \nH412  \n606-084-00-0  1-(4-methoxy-5-benzofuranyl)-3- \nphenyl-1,3-propanedione  414-540-3  484-33-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-085-00-6  ( 1 R,4S)-2-azabicyclo[2.2.1]hept- \n5-en-3-one  418-530-1  79200-56-9  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317  \n606-086-00-1  1-(3,3-dimethylcyclohexyl)pent- \n4-en-1-one  422-330-8  56973-87-6  Aquatic Chronic 2  H411  GHS09  H411  \n606-087-00-7  6-ethyl-5-fluoro-4(3 H)-pyri\xad\nmidone  422-460-5  137234-87-8  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n606-088-00-2  2,4,4,7-tetramethyl-6-octen-3-one  422-520-0  74338-72-0  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n606-089-00-8  reaction mass of: 1,4-diamino-2- \nchloro-3-phenoxyanthraquinone; \n1,4-diamino-2,3-bis-phenoxy\xad\nanthraquinone  423-220-2  12223-77-7  Aquatic Chronic 4  H413  —  H413  \n606-090-00-3  1-[3-[(dimethylamino)methyl]-4- \nhydroxyphenyl]ethanone  430-920-1  73096-98-7  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 765}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 767\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-091-00-9  6-chloro-5-(2-chloroethyl)-1,3- \ndihydroindol-2-one  421-320-0  118289-55-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-092-00-4  reaction mass of: ( E)-oxacyclo\xad\nhexadec-12-en-2-one; ( E)- \noxacyclohexadec-13-en-2-one; a) \n(Z)-oxacyclohexadec-(12)-en-2- \none and b) (Z)-oxacyclohexadec- \n(13)-en-2-one  422-320-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-093-00-X  5-ethyl-2,4-dihydro-4-(2-phen\xad\noxyethyl)-3 H-1,2,4-triazol-3-one  414-470-3  95885-13-5  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n606-094-00-5  N-[ethyl(3-methylbutyl)amino]-3- \nmethyl-1-phenyl-spiro[[1]benzo- \npyrano[2,3-c]pyrazole-4(1 H), \n1'(3'H)-isobenzofuran]-3'-one  417-460-7  —  Aquatic Chronic 4  H413  —  H413  \n606-095-00-0  (R, S )-2-azabicyclo[2.2.1]hept-5- \nen-3-one  421-830-3  49805-30-3  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n606-096-00-6  3-(6-O-(6-desoxy-α-l-mannopyr\xad\nanosyl-O-(α-d-glucopyranosyl)- \n(β-d-glucopyranosyl)oxy)-2-(3,4- \ndihydroxyphenyl)-5,7-dihydroxy- \n4H-1-benzopyran-4-one  424-170-4  130603-71-3  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n606-097-00-1  2,2''-dihydroxy-4,4''-(2-hydroxy- \npropane-1,3-diyldioxy)dibenzop\xad\nhenone  424-210-0  23911-85-5  Aquatic Chronic 4  H413  —  H413  \n606-098-00-7  1-benzyl-5-(hexadecyloxy)-2,4- \nimidazolidinedione  431-220-9  158574-65-3  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 766}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 768\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-099-00-2  5-methoxy-4'-(trifluor\xad\nomethyl)valerophenone  425-000-1  61718-80-7  Aquatic Chronic 2  H411  GHS09  H411  \n606-100-00-6  2-butyryl-3-hydroxy-5-thiocyclo\xad\nhexan-3-yl-cyclohex-2-en-1-one  425-150-8  94723-86-1  Repr. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H360F*** \nH302 \nH317 \nH412  GHS08 \nGHS07 \nDgr H360F*** \nH302 \nH317 \nH412  \n606-101-00-1  reaction mass of: 1,5-bis[(2- \nethylhexyl)amino]-9,10-anthra\xad\ncenedione; 1-[(2-ethylhe\xad\nxyl)amino]-5-[3-[(2-ethylhe\xad\nxyl)oxy]propyl]amino-9,10- \nanthracenedione; 1,5-bis[3-[(2- \nethylhexyl)oxy]propyl]amino- \n9,10-anthracenedione; 1-[(2- \nethylhexyl)amino]-5-[(3- \nmethoxypropyl)amino]-9,10- \nanthracenedione; 1-[3-[(2- \nethylhexyl)oxy]propyl]amino-5- \n[(3-methoxypropyl)amino]-9,10- \nanthracenedione; 1,5-bis[(3- \nmethyloxypropyl)amino]-9,10- \nanthracenedione  426-050-7  165038-51-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n606-102-00-7  4-(3-triethoxysilylpropoxy)-2- \nhydroxybenzophenone  431-490-8  79876-59-8  Aquatic Chronic 2  H411  GHS09  H411  \n606-103-00-2  1-(4-( trans -4-ethylcyclo\xad\nhexyl)phenyl)ethanone  426-460-6  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n606-104-00-8  1-(4-( trans -4-pentylcyclo\xad\nhexyl)phenyl)ethanone  426-830-7  78531-59-6  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 767}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 769\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-105-00-3  3,4,3', 4'-tetraphenyl-1,1'- \nethandiylbispyrol-2,5-dione  431-500-0  226065-73-2  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n606-106-00-9  1-(4-( trans -4-butylcyclo\xad\nhexyl)phenyl)ethanone  427-320-7  83626-30-6  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n606-107-00-4  8-azaspiro[4.5]decane-7,9-dione  427-770-4  1075-89-4  Acute Tox. 3 * \nAquatic Chronic 2  H301 \nH411  GHS06 \nGHS09 \nDgr H301 \nH411  \n606-108-00-X  1,1,1,2,2,4,5,5,5-nonafluoro-4- \n(trifluoromethyl)-3-pentanone  436-710-6  756-13-8  Aquatic Chronic 3  H412  —  H412  \n606-109-00-5  2-(4-methyl-3-pentenyl)anthra\xad\nquinone  428-320-1  71308-16-2  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 4  H302 \nH317 \nH413  GHS07 \nWng  H302 \nH317 \nH413  \n606-110-00-0  5-ethoxy-5 H-furan-2-one  428-330-4  2833-30-9  Skin Corr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1  H314 \nH312 \nH302 \nH373** H317  GHS05 \nGHS08 \nGHS07 \nDgr H314 \nH312 \nH302 \nH373** \nH317  \n606-111-00-6  5-amino-6-methyl-1,3-dihydro\xad\nbenzoimidazol-2-one  428-410-9  67014-36-2  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n606-112-00-1  (4a R*,8aR*)-4a,5,9,10,11,12- \nhexahydro-3-methoxy-11-methyl- \n6H-benzofuro[3a,3,2-ef][2]ben\xad\nzazepin-6-one  428-690-2  1668-86-6  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 3  H302 \nH319 \nH412  GHS07 \nWng  H302 \nH319 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 768}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 770\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-113-00-7  1-[4-(4-benzoylphenylsulf\xad\nanyl)phenyl]-2-methyl-2-(4- \nmethylphenylsulfonyl)propan-1- \none 429-040-0  272460-97-6  Eye Dam. 1 \nAquatic Chronic 4  H318 \nH413  GHS05 \nDgr H318 \nH413  \n606-114-00-2  4,4', 5,5', 6,6', 7,7'-octachloro- \n(2,2')biisoindolyl-1,1', 3,3'- \ntetraone  429-150-9  67887-47-2  Aquatic Chronic 4  H413  —  H413  \n606-115-00-8  profoxydim (ISO); 2-{( EZ)-1- \n[(2RS)-2-(4-chlorophenoxy)pro\xad\npoxyimino]butyl}-3-hydroxy-5- \n(thian-3-yl)cyclohex-2-en-1-one  — 139001-49-3  Carc. 2 \nRepr. 2 \nSkin Sens. 1  H351 \nH361d \nH317  GHS08 \nGHS07 \nWng  H351 \nH361d \nH317  \n606-116-00-3  tepraloxydim (ISO); ( RS)-(EZ)-2- \n{1-[(2 E)-3-chloroallyloxy\xad\nimino]propyl}-3-hydroxy-5- \nperhydropyran-4-ylcyclohex-2- \nen-1-one  — 149979-41-9  Carc. 2 \nRepr. 2  H351 \nH361fd  GHS08 \nWng  H351 \nH361fd  \n606-117-00-9  2,6-bis(1,1-dimethylethyl)-4- \n(phenylenemethylene)cyclohexa- \n2,5-dien-1-one  429-460-4  7078-98-0  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 769}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 771\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-118-00-4  N-(1,3-dimethylbutyl)- N'- \n(phenyl)-1,4-benzoquinone\xad\ndiimine  429-640-2  52870-46-9  Eye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH410  \n606-119-00-X  (E)-3-methyl-5-cyclopentadecen- \n1-one  429-900-5  —  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n606-120-00-5  2,5-dihydroxy-5-methyl-3-(mor\xad\npholin-4-yl)-2-cyclopenten-1-one  430-170-5  114625-74-0  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n606-121-00-0  (+)-(1 S, 2 S, 3 S, 5 R)-2,6,6- \ntrimethylbicyclo[3.1.1]heptane-3- \nspiro-1'-(cyclohex-2'-en-4'-one)  430-460-1  133636-82-5  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 770}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 772\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-122-00-6  3-(2-bromopropionoyl)-4,4- \ndimethyl-1,3-oxazolan-2-one  430-820-8  114341-88-7  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H302 \nH373** \nH315 \nH318 \nH317 \nH410  \n606-123-00-1  4-hexadecyl-1-phenylpyrazolidin- \n3-one  430-840-7  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n606-124-00-7  1-cyclopropyl-3-(2-methylthio-4- \ntrifluoromethylphenyl)-1,3- \npropanedione  421-080-7  161462-35-7  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373** H400 \nH410  GHS08 \nGHS09 \nWng  H373** \nH410  \n606-125-00-2  1-benzylimidazolidine-2,4-dione  421-340-1  6777-05-5  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n606-126-00-8  1,4-bis(2,3-dihydroxypropy\xad\nlamino)anthraquinone  421-470-7  99788-75-7  Aquatic Chronic 2  H411  GHS09  H411  \n606-128-00-9  2,2'-(1,3-phenylene)bis[5-chloro- \n1H-isoindole]-1,3(2 H)-dione  422-650-8  148935-94-8  Aquatic Chronic 4  H413  —  H413  \n606-129-00-4  5-amino-[2 S-di(methylphe\xad\nnyl)amino]-1,6-diphenyl-4 Z- \nhexen-3-one; (2S, 4 Z)-5-amino- \n2-(dibenzylamino)-1,6-diphe\xad\nnylhex-4-en-3-one  423-090-7  156732-13-7  Aquatic Chronic 4  H413  —  H413  \n606-130-00-X  4-(1,4-dioxa-spiro[4.5]dec-8-yl)- \ncyclohexanone  423-860-2  56309-94-5  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 771}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 773\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-131-00-5  cyclic 3-(1,2-ethanediylacetale)- \nestra-5(10),9(11)-diene-3,17- \ndione  427-230-8  5571-36-8  Repr. 1B \nSTOT RE 2 * \nAquatic Chronic 2  H360F*** \nH373** H411  GHS08 \nGHS09 \nDgr H360F*** \nH373** \nH411  \n606-132-00-0  (6β)-6,19-epoxyandrost-4-ene- \n3,17-dione  433-490-3  6563-83-3  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n606-134-00-1  androsta-1,4,9(11)-triene-3,17- \ndione  433-560-3  15375-21-0  Repr. 2  H361f***  GHS08 \nWng  H361f***  \n606-135-00-7  cyclohexadecanone  438-930-8  2550-52-9  Aquatic Chronic 4  H413  —  H413  \n606-136-00-2  ( 3 S, 6R, 9S, 12 R, 15 S, 18 R, \n21S,24R)-6,18-dibenzyl- \n3,9,15,21-tetraisobutyl- \n4,10,12,16,22,24-hexamethyl- \n1,7,13,19-tetraoxa-4,10,16,22- \ntetraazacyclo-tetracosane- \n2,5,8,11,14,17,20,23-octaone  444-350-6  133413-70-4  Eye Irrit. 2 \nAquatic Chronic 4  H319 \nH413  GHS07 \nWng  H319 \nH413  \n606-137-00-8  trans -7,7'-dimethyl-(4 H,4H')- \n(2,2')bi[benzo[1,4]thiazinyli\xad\ndene]-3,3'-dione  444-750-0  211387-26-7  Aquatic Chronic 4  H413  —  H413  \n606-138-00-3  (2-butyl-5-nitrobenzofuran-3- \nyl)[4-(3-dibutylaminopro\xad\npoxy)phenyl]methanone  444-800-1  141645-23-0  Flam. Liq. 3 \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH302 \nH373** H315 \nH318 \nH317 \nH400 \nH410  GHS02 \nGHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H226 \nH302 \nH373** \nH315 \nH318 \nH317 \nH410  M=10  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 772}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 774\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-139-00-9  (S)-4-(3,4-dichlorophenyl)-3,4- \ndihydro-2 H-naphthalen-1-one  444-830-5  124379-29-9  Aquatic Chronic 4  H413  —  H413  \n606-140-00-4  2-hydroxy-1-(4-(4-(2-hydroxy-2- \nmethylpropionyl)benzyl)phenyl)- \n2-methylpropan-1-one  444-860-9  474510-57-1  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373** H400 \nH410  GHS08 \nGHS09 \nWn H373** \nH410  \n606-141-00-X  sodium 3-(methoxycarbonyl)-4- \noxo-3,4,5,6-tetrahydro-2-pyridi\xad\nnolate  418-410-7  —  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n606-142-00-5  reaction mass of: (1 RS, 2SR,7SR, \n8SR, E ) 9 and 10-ethylidene-3- \noxatricyclo[6.2.1.0(2,7)]undecan- \n4-one; (1 RS, 2SR, 7SR, 8SR, Z )- \n10-ethylidene-3-oxatri\xad\ncyclo[6.2.1.0(2,7)]undecan-4- \none; (1 RS, 2SR, 7SR, 8SR, Z )-9- \nethylidene-3-oxatri\xad\ncyclo[6.2.1.0(2,7)]undecan-4-one  434-290-9  —  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 773}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 775\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-143-00-0  abamectin (combination of aver\xad\nmectin B1a and avermectin B1b) \n(ISO) [1] avermectin B1a (purity \n≥ 80 %); [2]  _ [1] \n265-610-3 [2]  71751-41-2 [1] \n65195-55-3 [2]  Repr. 2 \nAcute Tox. 2 \nAcute Tox. 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH300 \nH330 \nH372 (nervous \nsystem) H400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361d \nH300 \nH330 \nH372 \n(nervous \nsystem) \nH410  STOT RE 1; H372: \nC ≥ 5 % STOT RE \n2; H373: 0,5 % \n≤C< 5 % \nM = 10 000  \n606-144-00-6  acequinocyl (ISO); 3-dodecyl- \n1,4-dioxo-1,4-dihydronaphthalen- \n2-yl acetate  — 57960-19-7  Skin Sens. 1 \nSTOT SE 1 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH370 (lung) \n(inhalation) \nH373 (blood \nsystem) \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nDgr H317 \nH370 (lung) \n(inhalation) \nH373 (blood \nsystem) \nH410  M = 1 000  \n606-145-00-1  sulcotrione (ISO); 2-[2-chloro-4- \n(methylsulfonyl)benzoyl]cyclo\xad\nhexane-1,3-dione  99105-77-8  Repr. 2 \nSTOT RE 2 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H361d H373 \n(kidneys) \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d H373 \n(kidneys) \nH317 \nH410  M = 1 \nM = 10  \n606-146-00-7  tralkoxydim (ISO); 2-( N-ethoxy\xad\npropanimidoyl)-3-hydroxy-5- \nmesitylcyclohex-2-en-1-one  — 87820-88-0  Carc. 2 \nAcute Tox. 4 \nAquatic Chronic 2  H351 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 774}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 776\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n606-147-00-2  cycloxydim (ISO); 2-( N-etho\xad\nxybutanimidoyl)-3-hydroxy-5- \n(tetrahydro-2 H-thiopyran-3- \nyl)cyclohex-2-en-1-one  405-230-9  101205-02-1  Repr. 2  H361d  GHS08 \nWng  H361d  \n▼M11  \n606-148-00-8  carvone (ISO); \n2-methyl-5-(prop-1-en-2- \nyl)cyclohex-2-en-1-one; [1] \nd-carvone; (5S)-2-methyl-5- \n(prop-1-en-2-yl)cyclohex-2-en-1- \none; [2] \nl-carvone; (5R)-2-methyl-5- \n(prop-1-en-2-yl)cyclohex-2-en-1- \none [3]  202-759-5 [1] \n218-827-2 [2] \n229-352-5 [3]  99-49-0 [1] \n2244-16-8 [2] \n6485-40-1 [3]  Skin Sens. 1  H317  GHS07 \nWng  H317  \n606-149-00-3  tembotrione (ISO); 2-{2-chloro- \n4-(methylsulfonyl)-3-[(2,2,2- \ntrifluoroethoxy)methyl]ben\xad\nzoyl}cyclohexane-1,3-dione  — 335104-84-2  Repr. 2 \nSTOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH373 (eyes, \nkidneys, liver) \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d \nH373 (eyes, \nkidneys, \nliver) \nH317 \nH410  M = 100 \nM = 10  \n▼M15  \n606-150-00-9  clethodim (ISO); (5RS)-2- \n{(1EZ)-1-[(2E)-3-chloroallyloxy\xad\nimino]propyl}-5-[(2RS)-2-(ethylt\xad\nhio)propyl]-3-hydroxycyclohex- \n2-en-1-one  — 99129-21-2  Acute Tox. 4 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH317 \nH412  GHS07 \nWng  H302 \nH317 \nH412  EUH066  \n606-151-00-4  anthraquinone  201-549-0  84-65-1  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 775}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 777\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n607-001-00-0  formic acid … %  200-579-1  64-18-6  Skin Corr. 1A  H314  GHS05 \nDgr H314  Skin Corr. 1A; \nH314: C ≥ 90 % \nSkin Corr. 1B; \nH314: 10 % ≤ C < \n90 % \nSkin Irrit. 2; H315: \n2 % ≤C < 10 % \nEye Irrit. 2; H319: \n2 %≤ <10 %  B \n607-002-00-6  acetic acid … %  200-580-7  64-19-7  Flam. Liq. 3 \nSkin Corr. 1A  H226 \nH314  GHS02 \nGHS05 \nDgr H226 \nH314  Skin Corr. 1A; \nH314: C ≥90 % \nSkin Corr. 1B; \nH314: 25 %≤ C \n<90 % \nSkin Irrit. 2; H315: \n10 % ≤C <25 % \nEye Irrit. 2; H319: \n10 % ≤ C < 25 %  B \n607-003-00-1  chloroacetic acid  201-178-4  79-11-8  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nAquatic Acute 1  H331 \nH311 \nH301 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H331 \nH311 \nH301 \nH314 \nH400  STOT SE 3; H335: \nC≥ 5 %  \n607-004-00-7  TCA (ISO); trichloroacetic acid  200-927-2  76-03-9  Skin Corr. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  STOT SE 3; H335: \nC ≥ 1 %  \n607-005-00-2  TCA-sodium (ISO); sodium \ntrichloroacetate  211-479-2  650-51-1  STOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H335 \nH400 \nH410  GHS07 \nGHS09 \nWng  H335 \nH410  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 776}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 778\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-006-00-8  oxalic acid  205-634-3  144-62-7  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  * \n607-007-00-3  salts of oxalic acid (with the \nexception of those specified \nelsewhere in this Annex)  — —  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  * A  \n607-008-00-9  acetic anhydride  203-564-8  108-24-7  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H226 \nH332 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH332 \nH302 \nH314  Skin Corr. 1B; \nH314: C ≥ 2 % \nSkin Irrit. 2; H315: \n5 % ≤C < 25 % \nEye Dam. 1; H318: \n5 % ≤ C < 25 % \nEye Irrit. 2; H319: \n1 % ≤C < 5 % \nSTOT SE 3; H335: \nC ≥ 5 %  \n607-009-00-4  phthalic anhydride  201-607-5  85-44-9  Acute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H302 \nH335 \nH315 \nH318 \nH334 \nH317  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH335 \nH315 \nH318 \nH334 \nH317  \n607-010-00-X  propionic anhydride  204-638-2  123-62-6  Skin Corr. 1B  H314  GHS05 \nDgr H314  Skin Corr. 1B; \nH314: C ≥ 25 % \nSkin Irrit. 2; H315: \n10 % ≤ C < 25 % \nEye Irrit. 2; H319: \n10 % ≤ C < 25 %  \n607-011-00-5  acetyl chloride  200-865-6  75-36-5  Flam. Liq. 2 \nSkin Corr. 1B  H225 \nH314  GHS02 \nGHS05 \nDgr H225 \nH314  EUH014  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 777}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 779\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-012-00-0  benzoyl chloride  202-710-8  98-88-4  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H332 \nH312 \nH302 \nH314 \nH317  GHS05 \nGHS07 \nDgr H332 \nH312 \nH302 \nH314 \nH317  \n607-013-00-6  dimethyl carbonate  210-478-4  616-38-6  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n607-014-00-1  methyl formate  203-481-7  107-31-3  Flam. Liq. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3  H224 \nH332 \nH302 \nH319 \nH335  GHS02 \nGHS07 \nDgr H224 \nH332 \nH302 \nH319 \nH335  \n607-015-00-7  ethyl formate  203-721-0  109-94-4  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3  H225 \nH332 \nH302 \nH319 \nH335  GHS02 \nGHS07 \nDgr H225 \nH332 \nH302 \nH319 \nH335  \n607-016-00-2  propyl formate; [1] isopropyl \nformate [2]  203-798-0 [1] \n210-901-2 [2]  110-74-7 [1] \n625-55-8 [2]  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3 \nSTOT SE 3  H225 \nH319 \nH335 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH335 \nH336  C \n607-017-00-8  butyl formate; [1]  tert -butyl \nformate; [2] isobutyl formate [3]  209-772-5 [1] \n212-105-0 [2] \n208-818-1 [3]  592-84-7 [1] \n762-75-4 [2] \n542-55-2 [3]  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH335  GHS02 \nGHS07 \nDgr H225 \nH319 \nH335  C \n607-018-00-3  isopentyl formate; [1] 2- \nmethylbutyl formate [2]  203-769-2 [1] \n252-343-2 [2]  110-45-2 [1] \n35073-27-9 [2]  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH335  GHS02 \nGHS07 \nDgr H225 \nH319 \nH335  C \n607-019-00-9  methyl chloroformate  201-187-3  79-22-1  Flam. Liq. 2 \nAcute Tox. 2 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H225 \nH330 \nH312 \nH302 \nH314  GHS02 \nGHS06 \nGHS05 \nDgr H225 \nH330 \nH312 \nH302 \nH314  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 778}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 780\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-020-00-4  ethyl chloroformate  208-778-5  541-41-3  Flam. Liq. 2 \nAcute Tox. 2 * \nAcute Tox. 4 * \nSkin Corr. 1B  H225 \nH330 \nH302 \nH314  GHS02 \nGHS06 \nGHS05 \nDgr H225 \nH330 \nH302 \nH314  \n607-021-00-X  methyl acetate  201-185-2  79-20-9  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH336  EUH066  \n607-022-00-5  ethyl acetate  205-500-4  141-78-6  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH336  EUH066  \n607-023-00-0  vinyl acetate  203-545-4  108-05-4  Flam. Liq. 2 \nCarc. 2 \nAcute Tox. 4 \nSTOT SE 3  H225 \nH351 \nH332 \nH335  GHS02 \nGHS08 \nGHS07 \nDgr H225 \nH351 \nH332 \nH335  D \n607-024-00-6  propyl acetate; [1] isopropyl \nacetate [2]  203-686-1 [1] \n203-561-1 [2]  109-60-4 [1] \n108-21-4 [2]  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3  H225 \nH319 \nH336  GHS02 \nGHS07 \nDgr H225 \nH319 \nH336  EUH066  C  \n607-025-00-1  n-butyl acetate  204-658-1  123-86-4  Flam. Liq. 3 \nSTOT SE 3  H226 \nH336  GHS02 \nGHS07 \nWng  H226 \nH336  EUH066  \n607-026-00-7  sec -butyl acetate; [1] isobutyl \nacetate; [2]  tert-butyl acetate [3]  203-300-1 [1] \n203-745-1 [2] \n208-760-7 [3]  105-46-4 [1] \n110-19-0 [2] \n540-88-5 [3]  Flam. Liq. 2  H225  GHS02 \nDgr H225  EUH066  C  \n607-027-00-2  methyl propionate  209-060-4  554-12-1  Flam. Liq. 2 \nAcute Tox. 4 *  H225 \nH332  GHS02 \nGHS07 \nDgr H225 \nH332  \n607-028-00-8  ethyl propionate  203-291-4  105-37-3  Flam. Liq. 2  H225  GHS02 \nDgr H225  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 779}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 781\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-029-00-3  n-butyl propionate; [1]  sec-butyl \npropionate; [2] iso-butyl \npropionate [3]  209-669-5 [1] \n-[2] \n208-746-0 [3]  590-01-2 [1] \n591-34-4 [2] \n540-42-1 [3]  Flam. Liq. 3  H226  GHS02 \nWng  H226  C  \n607-030-00-9  propyl propionate  203-389-7  106-36-5  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH332  GHS02 \nGHS07 \nWng  H226 \nH332  \n607-031-00-4  butyl butyrate  203-656-8  109-21-7  Flam. Liq. 3  H226  GHS02 \nWng  H226  C  \n607-032-00-X  ethyl acrylate  205-438-8  140-88-5  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H225 \nH332 \nH312 \nH302 \nH319 \nH335 \nH315 \nH317  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH319 \nH335 \nH315 \nH317  Skin Irrit. 2; H315: \nC ≥ 5 % Eye Irrit. \n2; H319: C ≥ 5 % \nSTOT SE 3; H335: \nC ≥ 5 %  D \n607-033-00-5  n-butyl methacrylate  202-615-1  97-88-1  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H226 \nH319 \nH335 \nH315 \nH317  GHS02 \nGHS07 \nWng  H226 \nH319 \nH335 \nH315 \nH317  D \n607-034-00-0  methyl acrylate; methyl prope\xad\nnoate  202-500-6  96-33-3  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H225 \nH332 \nH312 \nH302 \nH319 \nH335 \nH315 \nH317  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH319 \nH335 \nH315 \nH317  D ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 780}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 782\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-035-00-6  methyl methacrylate; methyl 2- \nmethylprop-2-enoate; methyl 2- \nmethylpropenoate  201-297-1  80-62-6  Flam. Liq. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H225 \nH335 \nH315 \nH317  GHS02 \nGHS07 \nDgr H225 \nH335 \nH315 \nH317  D \n607-036-00-1  2-methoxyethyl acetate; methyl\xad\nglycol acetate  203-772-9  110-49-6  Repr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H360FD H332 \nH312 \nH302  GHS08 \nGHS07 \nDgr H360FD \nH332 \nH312 \nH302  \n607-037-00-7  2-ethoxyethyl acetate; ethylglycol \nacetate  203-839-2  111-15-9  Flam. Liq. 3 \nRepr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH360FD H332 \nH312 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H226 \nH360FD \nH332 \nH312 \nH302  \n607-038-00-2  2-butoxyethyl acetate; \nbutylglycol acetate  203-933-3  112-07-2  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH312  GHS07 \nWng  H332 \nH312  \n607-039-00-8  2,4-D (ISO); 2,4-dichlorophen\xad\noxyacetic acid  202-361-1  94-75-7  Acute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH335 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH335 \nH318 \nH317 \nH412  \n607-040-00-3  salts of 2,4-D  —  —  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  A \n607-041-00-9  2,4,5-T (ISO); 2,4,5-trichlorop\xad\nhenoxy acetic acid  202-273-3  93-76-5  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH335 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH335 \nH315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 781}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 783\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-042-00-4  salts and esters of 2,4,5-T; salts \nand esters of 2,4,5-trichlorop\xad\nhenoxy acetic acid  — —  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH335 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH335 \nH315 \nH410  A \n607-043-00-X  dicamba (ISO); 2,5-dichloro-6- \nmethoxybenzoic acid; 3,6- \ndichloro-2-methoxybenzoic acid  217-635-6  1918-00-9  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n607-044-00-5  3,6-dichloro- o-anisic acid, \ncompound with dimethylamine \n(1:1); [1] potassium 3,6- \ndichloro- o-anisate[2]  218-951-7 [1] \n233-002-7 [2]  2300-66-5 [1] \n10007-85-9 [2]  Eye Irrit. 2 \nAquatic Chronic 3  H319 \nH412  GHS07 \nWng  H319 \nH412  \n607-045-00-0  dichlorprop (ISO); 2-(2,4-dich\xad\nlorophenoxy)propionic acid  204-390-5  120-36-5  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1  H312 \nH302 \nH315 \nH318  GHS05 \nGHS07 \nDgr H312 \nH302 \nH315 \nH318  \n607-046-00-6  salts of dichlorprop  —  —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H332 \nH312 \nH302  GHS07 \nWng  H332 \nH312 \nH302  A \n607-047-00-1  fenoprop (ISO); 2-(2,4,5-trich\xad\nlorophenoxy)propionic acid  202-271-2  93-72-1  Acute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 782}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 784\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-048-00-7  salts of fenoprop; salts of 2- \n(2,4,5-trichlorophenoxy)propionic \nacid — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  A \n607-049-00-2  mecoprop (ISO); 2-(4-chloro-o- \ntolyloxy)propionic acid; ( RS)-2- \n(4-chloro-o-tolyloxy)propionic \nacid; [1] 2-(4-chloro-2-methyl\xad\nphenoxy)propionic acid [2]  230-386-8 [1] \n202-264-4 [2]  7085-19-0 [1] \n708519-0 [2]  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH315 \nH318 \nH410  M=100  \n607-050-00-8  salts of mecoprop  —  —  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH315 \nH318 \nH410  A \n607-051-00-3  MCPA (ISO); 4-chloro- o-tolylo\xad\nxyacetic acid  202-360-6  94-74-6  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH315 \nH318 \nH410  \n607-052-00-9  salts and esters of MCPA  —  —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  A ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 783}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 785\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-053-00-4  MCPB (ISO); 4-(4-chloro- o- \ntolyloxy) butyric acid  202-365-3  94-81-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-054-00-X  salts and esters of MCPB  —  —  Acute Tox. 4 *  H302  GHS07 \nWng  H302  A  \n607-055-00-5  endothal-sodium (ISO); disodium \n7-oxabicyclo(2,2,1)heptane-2,3- \ndicarboxylate  204-959-8  129-67-9  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H301 \nH312 \nH319 \nH335 \nH315  GHS06 \nDgr H301 \nH312 \nH319 \nH335 \nH315  \n▼M13  \n607-056-00-0  warfarin (ISO); \n4-hydroxy-3-(3-oxo-1- \nphenylbutyl)-2H-chromen-2-one; \n[1] \n(S)-4-hydroxy-3-(3-oxo-1- \nphenylbutyl)-2-benzopyrone; [2] \n(R)-4-hydroxy-3-(3-oxo-1- \nphenylbutyl)-2-benzopyrone [3]  201-377-6 \n[1] \n226-907-3 \n[2] \n226-908-9 \n[3] 81-81-2 [1] \n5543-57-7 \n[2] \n5543-58-8 \n[3] Repr. 1A \nAcute Tox. 1 \nAcute Tox. 1 \nAcute Tox. 2 \nSTOT RE 1 \nAquatic Chronic 2  H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH411  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH411  Repr. 1A; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C ≥ 0,5 % \nSTOT RE 2; H373 \n(blood): 0,05 % ≤ \nC < 0,5 %  \n▼M16  \n607-057-00-6  coumachlor (ISO); 3-[1-(4- \nchlorophenyl)-3-oxobutyl]-4- \nhydroxycoumarin  201-378-1  81-82-3  STOT RE 2 * \nAquatic Chronic 3  H373 ** H412  GHS08 \nWng  H373 ** \nH412  \n607-058-00-1  coumafuryl (ISO); fumarin; ( RS)- \n3-(1-(2-furyl)-3-oxobutyl)4- \nhydroxycoumarin; 4-hydroxy-3- \n[3-oxo-1-(2-furyl)butyl]coumarin  204-195-5  117-52-2  Acute Tox. 3 * \nSTOT RE 1 \nAquatic Chronic 3  H301 \nH372 ** H412  GHS06 \nGHS08 \nDgr H301 \nH372 ** \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 784}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 786\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M13  \n607-059-00-7  coumatetralyl (ISO); 4-hydroxy- \n3-(1,2,3,4-tetrahydro-1-naph\xad\nthyl)coumarin  227-424-0  5836-29-3  Repr. 1B \nAcute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 2 \nSTOT RE 1 \nAquatic Chronic 1  H360D \nH330 \nH311 \nH300 \nH372 (blood) \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH311 \nH300 \nH372 (blood) \nH410  Repr. 1B; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C ≥ 1,0 % \nSTOT RE 2; H373 \n(blood) 0,1 % ≤ C \n< 1,0 % \nM = 10  \n▼M16  \n607-060-00-2  dicoumarol; 4,4'-dihydroxy-3,3'- \nmethylenebis(2 H-chromen-2-one)  200-632-9  66-76-2  STOT RE 1 \nAcute Tox. 4 * \nAquatic Chronic 2  H372 ** H302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H372 ** \nH302 \nH411  \n607-061-00-8  acrylic acid; prop-2-enoic acid  201-177-9  79-10-7  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A \nAquatic Acute 1  H226 \nH332 \nH312 \nH302 \nH314 \nH400  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H226 \nH332 \nH312 \nH302 \nH314 \nH400  STOT SE 3; H335: \nC ≥ 1 %  D \n607-062-00-3  n-butyl acrylate  205-480-7  141-32-2  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H226 \nH319 \nH335 \nH315 \nH317  GHS02 \nGHS07 \nWng  H226 \nH319 \nH335 \nH315 \nH317  D \n607-063-00-9  isobutyric acid  201-195-7  79-31-2  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 785}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 787\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-064-00-4  benzyl chloroformate  207-925-0  501-53-1  Skin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  STOT SE 3; H335: \nC ≥ 5 %  \n607-065-00-X  bromoacetic acid  201-175-8  79-08-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1A \nSkin Sens. 1 \nAquatic Acute 1  H331 \nH311 \nH301 \nH314 \nH317 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H331 \nH311 \nH301 \nH314 \nH317 \nH400  \n607-066-00-5  dichloroacetic acid  201-207-0  79-43-6  Skin Corr. 1A \nAquatic Acute 1  H314 \nH400  GHS05 \nGHS09 \nDgr H314 \nH400  \n607-067-00-0  dichloroacetyl chloride  201-199-9  79-36-7  Skin Corr. 1A \nAquatic Acute 1  H314 \nH400  GHS05 \nGHS09 \nDgr H314 \nH400  \n607-068-00-6  iodoacetic acid  200-590-1  64-69-7  Acute Tox. 3 * \nSkin Corr. 1A  H301 \nH314  GHS06 \nGHS05 \nDgr H301 \nH314  \n607-069-00-1  ethyl bromoacetate  203-290-9  105-36-2  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 *  H330 \nH310 \nH300  GHS06 \nDgr H330 \nH310 \nH300  \n607-070-00-7  ethyl chloroacetate  203-294-0  105-39-5  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1  H331 \nH311 \nH301 \nH400  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH400  \n607-071-00-2  ethyl methacrylate  202-597-5  97-63-2  Flam. Liq. 2 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H225 \nH319 \nH335 \nH315 \nH317  GHS02 \nGHS07 \nDgr H225 \nH319 \nH335 \nH315 \nH317  D ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 786}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 788\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-072-00-8  2-hydroxyethyl acrylate  212-454-9  818-61-1  Acute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1  H311 \nH314 \nH317 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H311 \nH314 \nH317 \nH400  * \nSkin Sens. 1; \nH317: C ≥ 0,2 %  D \n607-073-00-3  4-CPA (ISO); 4-chlorophenoxy\xad\nacetic acid  204-581-3  122-88-3  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-074-00-9  chlorfenac(ISO); 2,3,6-trichlorop\xad\nhenylacetic acid  201-599-3  85-34-7  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-075-00-4  chlorfenprop-methyl; methyl 2- \nchloro-3-(4-chlorophenyl)pro\xad\npionate  238-413-5  14437-17-3  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  \n607-076-00-X  dodine(ISO); dodecylguani\xad\ndinium acetate  219-459-5  2439-10-3  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH315 \nH410  \n607-077-00-5  erbon (ISO); 2-(2,4,5-trichlorop\xad\nhenoxy)ethyl2,2-dichloropro\xad\npionate  — 136-25-4  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-078-00-0  fluenetil (ISO); 2-fluoroethyl \nbiphenyl-4-ylacetate  — 4301-50-2  Acute Tox. 1 \nAcute Tox. 2 *  H310 \nH300  GHS06 \nDgr H310 \nH300  \n607-079-00-6  kelevan (ISO); ethyl 5-(per\xad\nchloro-5-hydroxypenta\xad\ncyclo[5,3,0,02,6 ,03,9 ,04,8 ]decan-5- \nyl)-4-oxopentanoate; ethyl 5- \n(1,2,3,5,6,7,8,9,10,10-decachloro- \n4-hydroxypenta\xad\ncyclo(5,2,1,02,6 ,03,9 ,05,8 )dec-4- \nyl)-4-oxovalerate  — 4234-79-1  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Chronic 2  H311 \nH302 \nH411  GHS06 \nGHS09 \nDgr H311 \nH302 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 787}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 789\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-080-00-1  chloroacetyl chloride  201-171-6  79-04-9  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nSkin Corr. 1A \nAquatic Acute 1  H331 \nH311 \nH301 \nH372 ** H314 \nH400  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H331 \nH311 \nH301 \nH372 ** \nH314 \nH400  EUH014 \nEUH029  \n607-081-00-7  fluoroacetic acid  205-631-7  144-49-0  Acute Tox. 2 * \nAquatic Acute 1  H300 \nH400  GHS06 \nGHS09 \nDgr H300 \nH400  \n607-082-00-2  fluoroacetates, soluble  —  —  Acute Tox. 2 * \nAquatic Acute 1  H300 \nH400  GHS06 \nGHS09 \nDgr H300 \nH400  A \n607-083-00-8  2,4-DB (ISO); 4-(2,4-dichlorop\xad\nhenoxy)butyric acid  202-366-9  94-82-6  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-084-00-3  salts of 2,4-DB  —  —  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  A \n607-085-00-9  benzyl benzoate  204-402-9  120-51-4  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-086-00-4  diallyl phthalate  205-016-3  131-17-9  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 788}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 790\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-088-00-5  methacrylic acid; 2-methyl\xad\npropenoic acid  201-204-4  79-41-4  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 1 %  D \n607-089-00-0  propionic acid … %  201-176-3  79-09-4  Skin Corr. 1B  H314  GHS05 \nDgr H314  Skin Corr. 1B; \nH314: C ≥ 25 % \nSkin Irrit. 2; H319 \n10 % ≤ C < 25 % \nEye Irrit. 2; H319: \n10 % ≤ \nC < 25 % \nSTOT SE 3; H335: \nC ≥ 10 %  B \n607-090-00-6  thioglycolic acid  200-677-4  68-11-1  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B  H331 \nH311 \nH301 \nH314  GHS06 \nGHS05 \nDgr H331 \nH311 \nH301 \nH314  * \n607-091-00-1  trifluoroacetic acid . . . %  200-929-3  76-05-1  Acute Tox. 4 * \nSkin Corr. 1A \nAquatic Chronic 3  H332 \nH314 \nH412  GHS05 \nGHS07 \nDgr H332 \nH314 \nH412  * B  \n607-092-00-7  methyl lactate; [1] methyl \n(±)-lactate; [2] methyl ( R)- \nlactate; [3] methyl ( S)-(-)-lactate \n[4] 208-930-0 [1] \n218-449-8 [2] \n241-420-6 [3] \n248-704-9 [4]  547-64-8 [1] \n2155-30-8 [2] \n17392-83-5 [3] \n27871-49-4 [4]  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3  H226 \nH319 \nH335  GHS02 \nGHS07 \nWng  H226 \nH319 \nH335  C \n607-093-00-2  propionyl chloride  201-170-0  79-03-8  Flam. Liq. 2 \nSkin Corr. 1B  H225 \nH314  GHS02 \nGHS05 \nDgr H225 \nH314  EUH014  B  D  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 789}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 791\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-094-00-8  peracetic acid . . . %  201-186-8  79-21-0  Flam. Liq. 3 \nOrg. Perox. D \n**** Acute Tox. \n4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A \nAquatic Acute 1  H226 \nH242 \nH332 \nH312 \nH302 \nH314 \nH400  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H226 \nH242 \nH332 \nH312 \nH302 \nH314 \nH400  * \nSTOT SE 3; H335: \nC ≥ 1 %  B D \n607-095-00-3  maleic acid  203-742-5  110-16-7  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H302 \nH319 \nH335 \nH315 \nH317  GHS07 \nWng  H302 \nH319 \nH335 \nH315 \nH317  Skin Sens. 1; \nH317: C ≥0,1 %  \n▼M18  \n607-096-00-9  maleic anhydride  203-571-6  108-31-6  Acute Tox. 4 \nSTOT RE 1 \nSkin Corr. 1B \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1A  H302 \nH372 \n(respiratory \nsystem) (inha\xad\nlation) \nH314 \nH318 \nH334 \nH317  GHS07 \nGHS08 \nGHS05 \nDgr H302 \nH372 \n(respiratory \nsystem) \n(inhalation) \nH314 \nH334 \nH317  EUH071  Skin Sens. 1A; \nH317: C ≥ 0,001 %  \n▼M16  \n607-097-00-4  benzene-1,2,4-tricarboxylic acid \n1,2-anhydride; trimellitic \nanhydride  209-008-0  552-30-7  STOT SE 3 \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H335 \nH318 \nH334 \nH317  GHS08 \nGHS05 \nGHS07 \nDgr H335 \nH318 \nH334 \nH317  \n607-098-00-X  benzene-1,2:4,5-tetracarboxylic \ndianhydride; benzene-1,2:4,5- \ntetracarboxylic dianhydride; \npyromellitic dianhydride  201-898-9  89-32-7  Eye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H318 \nH334 \nH317  GHS08 \nGHS05 \nDgr H318 \nH334 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 790}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 792\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-099-00-5  1,2,3,6-tetrahydrophthalic \nanhydride; [1]  cis-1,2,3,6-tetrahy\xad\ndrophthalicanhydride; [2] 3,4,5,6- \ntetrahydrophthalic anhydride; [3] \ntetrahydrophthalic anhydride [4]  201-605-4 [1] \n213-308-7 [2] \n219-374-3 [3] \n247-570-9 [4]  85-43-8 [1] \n935-79-5 [2] \n2426-02-0 [3] \n26266-63-7 [4]  Eye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH334 \nH317 \nH412  GHS08 \nGHS05 \nDgr H318 \nH334 \nH317 \nH412  C \n607-100-00-9  benzophenone-3,3',4,4'-tetracar\xad\nboxylic dianhydride; 4,4'- \ncarbonyldi(phthalic anhydride)  219-348-1  2421-28-5  Eye Irrit. 2 \nSTOT SE 3  H319 \nH335  GHS07 \nWng  H319 \nH335  Eye Irrit 2; H319: \nC ≥ 1 % STOT SE \n3; H335: C ≥ 1 %  \n607-101-00-4  1,4,5,6,7,7-hexachlorobicyclo \n[2,2,1]hept-5-ene-2,3-dicarboxyli\xad\ncanhydride chlorendic anhydride  204-077-3  115-27-5  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  Skin Irrit.2; H315: \nC ≥ 1 % Eye Irrit. \n2; H319: C ≥ 1 % \nSTOT SE 3; H335: \nC ≥ 1 %  \n607-102-00-X  cyclohexane-1,2-dicarboxylic \nanhydride; [1]  cis-cyclohexane- \n1,2-dicarboxylicanhydride; [2]  \ntrans -cyclohexane-1,2-dicar\xad\nboxylic anhydride [3]  201-604-9 [1] \n236-086-3 [2] \n238-009-9 [3]  85-42-7 [1] \n13149-00-3 [2] \n14166-21-3 [3]  Eye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H318 \nH334 \nH317  GHS08 \nGHS05 \nDgr H318 \nH334 \nH317  C \n▼M18  \n607-103-00-5  succinic anhydride  203-570-0  108-30-5  Acute Tox. 4 \nSkin Corr. 1 \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H302 \nH314 \nH318 \nH334 \nH317  GHS07 \nGHS05 \nGHS08 \nDgr H302 \nH314 \nH334 \nH317  EUH071  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 791}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 793\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-104-00-0  cyclopentane-1,2,3,4-tetracar\xad\nboxylic dianhydride  227-964-7  6053-68-5  Eye Irrit. 2 \nSTOT SE 3  H319 \nH335  GHS07 \nWng  H319 \nH335  Eye Irrit. 2; H319: \nC ≥ 1 % STOT SE \n3; H335: C ≥ 1 %  \n607-105-00-6  8,9,10-trinorborn-5-ene-2,3-dicar\xad\nboxylic anhydride; [1] 1,2,3,6- \ntetrahydro-3,6-methanophthalic \nanhydride; [2] (1α,2α,3β,6β)- \n1,2,3,6-tetrahydro-3,6-metha\xad\nnophthalic anhydride [3]  204-957-7 [1] \n212-557-9 [2] \n220-384-5 [3]  129-64-6 [1] \n826-62-0 [2] \n2746-19-2 [3]  Eye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H318 \nH334 \nH317  GHS08 \nGHS05 \nDgr H318 \nH334 \nH317  C \n607-106-00-1  8,9-dinorborn-5-ene-2,3-dicar\xad\nboxylic anhydride  — 123748-85-6  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H302 \nH319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H302 \nH319 \nH335 \nH315 \nH334  STOT SE 3; H335: \nC ≥ 10 %  C \n607-107-00-7  2-ethylhexyl acrylate  203-080-7  103-11-7  STOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H335 \nH315 \nH317  GHS07 \nWng  H335 \nH315 \nH317  D \n607-108-00-2  2-hydroxy-1-methylethylacrylate; \n[1] 2-hydroxypropylacrylate; [2] \nacrylic acid, monoester with \npropane-1,2-diol [3]  220-852-9 [1] \n213-663-8 [2] \n247-118-0 [3]  2918-23-2 [1] \n999-61-1 [2] \n25584-83-2 [3]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1  H331 \nH311 \nH301 \nH314 \nH317  GHS06 \nGHS05 \nDgr H331 \nH311 \nH301 \nH314 \nH317  * \nSkin Sens. 1; \nH317:C ≥0,2 %  C D \n607-109-00-8  hexamethylene diacrylate; \nhexane-1,6-diol diacrylate  235-921-9  13048-33-4  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  D ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 792}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 794\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-110-00-3  pentaerythritol triacrylate  222-540-8  3524-68-3  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  D \n607-111-00-9  2,2-bis(acryloyloxymethyl)butyl \nacrylate; trimethylolpropane tria\xad\ncrylate  239-701-3  15625-89-5  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  D \n607-112-00-4  2,2-dimethyltrimethylene \ndiacrylate; neopentyl glycol \ndiacrylate  218-741-5  2223-82-7  Acute Tox. 3 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H311 \nH319 \nH315 \nH317  GHS06 \nDgr H311 \nH319 \nH315 \nH317  * D  \n▼M18  \n607-113-00-X  isobutyl methacrylate  202-613-0  97-86-9  Flam. Liq. 3 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1B  H226 \nH335 \nH315 \nH317  GHS02 \nGHS07 \nWng  H226 \nH335 \nH315 \nH317  D \n▼M16  \n607-114-00-5  ethylene dimethacrylate  202-617-2  97-90-5  STOT SE 3 \nSkin Sens. 1  H335 \nH317  GHS07 \nWng  H335 \nH317  STOT SE 3; H335: \nC ≥ 10 %  D \n607-115-00-0  isobutyl acrylate  203-417-8  106-63-8  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1  H226 \nH332 \nH312 \nH315 \nH317  GHS02 \nGHS07 \nWng  H226 \nH332 \nH312 \nH315 \nH317  D \n607-116-00-6  cyclohexyl acrylate  221-319-3  3066-71-5  STOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H335 \nH315 \nH411  GHS07 \nGHS09 \nWng  H335 \nH315 \nH411  STOT SE 3; H335: \nC ≥ 10 %  D ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 793}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 795\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-117-00-1  2,3-epoxypropyl acrylate; \nglycidyl acrylate  203-440-3  106-90-1  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1  H331 \nH311 \nH301 \nH314 \nH317  GHS06 \nGHS05 \nDgr H331 \nH311 \nH301 \nH314 \nH317  * \nSkin Sens. 1; \nH317:C ≥0,2 %  D \n607-118-00-7  1-methyltrimethylene diacrylate; \n1,3-butylene glycol diacrylate  243-105-9  19485-03-1  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H312 \nH314 \nH317  GHS05 \nGHS07 \nDgr H312 \nH314 \nH317  D \n607-119-00-2  tetramethylene diacrylate; 1,4- \nbutyleneglycol diacrylate  213-979-6  1070-70-8  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H312 \nH314 \nH317  GHS05 \nGHS07 \nDgr H312 \nH314 \nH317  D \n607-120-00-8  2,2'-oxydiethyl diacrylate; \ndiethylene glycol diacrylate  223-791-6  4074-88-8  Acute Tox. 3 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H311 \nH319 \nH315 \nH317  GHS06 \nDgr H311 \nH319 \nH315 \nH317  * \nSkin Sens. 1; \nH317:C≥0,2 %  D \n607-121-00-3  8,9,10-trinorborn-2-yl acrylate  —  10027-06-2  Acute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1  H312 \nH315 \nH317  GHS07 \nWng  H312 \nH315 \nH317  D \n607-122-00-9  pentaerythritol tetraacrylate  225-644-1  4986-89-4  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  D ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 794}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 796\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M15  \n607-123-00-4  2,3-epoxypropyl methacrylate; \nglycidyl methacrylate  203-441-9  106-91-2  Carc. 1B \nMuta. 2 \nRepr. 1B \nAcute Tox. 3 \nAcute Tox. 4 \nSTOT SE 3 \nSTOT RE 1 \nEye Dam. 1 \nSkin Corr. 1C \nSkin Sens. 1  H350 \nH341 \nH360F \nH311 \nH302 \nH335 \nH372 \n(respiratory \ntract) (inha\xad\nlation) \nH318 \nH314 \nH317  GHS08 \nGHS06 \nGHS05 \nDgr H350 \nH341 \nH360F \nH311 \nH302 \nH335 \nH372 \n(respiratory \ntract) (inha\xad\nlation) \nH314 \nH317  D \n▼M16  \n607-124-00-X  2-hydroxyethyl methacrylate  212-782-2  868-77-9  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  D \n607-125-00-5  2-hydroxypropyl methacrylate; \n[1] 3-hydroxypropyl methacry\xad\nlate[2]  213-090-3 [1] \n220-426-2 [2]  923-26-2 [1] \n2761-09-3 [2]  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  C D \n607-126-00-0  2,2'-(ethylenedioxy)diethyl \ndiacrylate; triethylene glycol \ndiacrylate  216-853-9  1680-21-3  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  D \n607-127-00-6  2-diethylaminoethyl methacrylate  203-275-7  105-16-8  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H332 \nH319 \nH315 \nH317  GHS07 \nWng  H332 \nH319 \nH315 \nH317  D \n607-128-00-1  2 - tert-butylaminoethyl metha\xad\ncrylate  223-228-4  3775-90-4  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  D ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 795}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 797\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-129-00-7  ethyl lactate; ethyl DL-lactate; \n[1] ethyl ( S)-2-hydroxypro\xad\npionate; ethyl L-lactate; ethyl- \n(S)-lactate [2]  202-598-0 [1] \n211-694-1 [2]  97-64-3 [1] \n687-47-8 [2]  Flam. Liq. 3 \nSTOT SE 3 \nEye Dam. 1  H226 \nH335 \nH318  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH335 \nH318  C \n607-130-00-2  pentyl acetate; [1] isopentyl \nacetate; [2] 1-methylbutyl \nacetate; [3] 2-methylbutyl acetat; \n[4] 2(or 3)-methylbutyl acetate \n[5] 211-047-3 [1] \n204-662-3 [2] \n210-946-8 [3] \n210-843-8 [4] \n282-263-3 [5]  628-63-7 [1] \n123-92-2 [2] \n626-38-0 [3] \n624-41-9 [4] \n84145-37-9 [5]  Flam. Liq. 3  H226  GHS02 \nWng  H226  EUH066  C  \n607-131-00-8  isopentyl propionate; [1] pentyl \npropionate; [2] 2-methylbutyl \npropionate [3]  203-322-1 [1] \n210-852-7 [2] \n219-449-0 [3]  105-68-0 [1] \n624-54-4 [2] \n2438-20-2 [3]  Flam. Liq. 3  H226  GHS02 \nWng  H226  C  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 796}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 798\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-132-00-3  2-dimethylaminoethyl metha\xad\ncrylate  220-688-8  2867-47-2  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H312 \nH302 \nH319 \nH315 \nH317  GHS07 \nWng  H312 \nH302 \nH319 \nH315 \nH317  D \n607-133-00-9  monoalkylor monoaryl or mono\xad\nalkylaryl esters of acrylic acid \nwith the exception of those \nspecified elsewhere in this Annex  — —  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H319 \nH335 \nH315 \nH411  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH411  STOT SE 3; H335: \nC ≥ 10 %  A \n607-134-00-4  monoalkyl or monoaryl or mono\xad\nalkyaryl esters of methacrylic \nacid with the exception of those \nspecified elsewhere in this Annex  — —  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  STOTSE 3; H335: \nC ≥ 10 %  A \n607-135-00-X  butyric acid  203-532-3  107-92-6  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n607-136-00-5  butyryl chloride  205-498-5  141-75-3  Flam. Liq. 2 \nSkin Corr. 1B  H225 \nH314  GHS02 \nGHS05 \nDgr H225 \nH314  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 797}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 799\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-137-00-0  methyl acetoacetate  203-299-8  105-45-3  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-138-00-6  butyl chloroformate; chloro\xad\nformic acid butyl ester  209-750-5  592-34-7  Flam. Liq. 3 \nAcute Tox. 3 * \nSkin Corr. 1B  H226 \nH331 \nH314  GHS02 \nGHS06 \nGHS05 \nDgr H226 \nH331 \nH314  \n607-139-00-1  2-chloropropionic acid  209-952-3  598-78-7  Acute Tox. 4 * \nSkin Corr. 1A  H302 \nH314  GHS05 \nGHS07 \nDgr H302 \nH314  \n607-140-00-7  isobutyryl chloride  201-194-1  79-30-1  Flam. Liq. 2 \nSkin Corr. 1A  H225 \nH314  GHS02 \nGHS05 \nDgr H225 \nH314  \n607-141-00-2  oxydiethylene bis(chloroformate)  203-430-9  106-75-2  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH315 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH315 \nH318 \nH411  \n607-142-00-8  propyl chloroformate; chloro\xad\nformic acid propylester;  n- \npropyl chloroformate  203-687-7  109-61-5  Flam. Liq. 2 \nAcute Tox. 3 * \nSkin Corr. 1B  H225 \nH331 \nH314  GHS02 \nGHS06 \nGHS05 \nDgr H225 \nH331 \nH314  \n607-143-00-3  valeric acid  203-677-2  109-52-4  Skin Corr. 1B \nAquatic Chronic 3  H314 \nH412  GHS05 \nDgr H314 \nH412  \n607-144-00-9  adipic acid  204-673-3  124-04-9  Eye Irrit. 2  H319  GHS07 \nWng  H319  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 798}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 800\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-145-00-4  methanesulphonic acid  200-898-6  75-75-2  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n607-146-00-X  fumaric acid  203-743-0  110-17-8  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-147-00-5  oxalic acid diethylester; diethyl \noxalate  202-464-1  95-92-1  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n607-148-00-0  guanidinium chloride; guanadine \nhydrochloride  200-002-3  50-01-1  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2  H302 \nH319 \nH315  GHS07 \nWng  H302 \nH319 \nH315  \n607-149-00-6  urethane (INN); ethyl carbamate  200-123-1  51-79-6  Carc. 1B  H350  GHS08 \nDgr H350  \n607-150-00-1  endothal (ISO); 7-oxabi\xad\ncyclo(2,2,1)heptane-2,3-dicar\xad\nboxylic acid  205-660-5  145-73-3  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H301 \nH312 \nH319 \nH335 \nH315  GHS06 \nDgr H301 \nH312 \nH319 \nH335 \nH315  \n607-151-00-7  propargite (ISO); 2-(4- tert- \nbutylphenoxy)cyclohexyl prop-2- \nynyl sulphite  219-006-1  2312-35-8  Carc. 2 \nAcute Tox. 3 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH331 \nH315 \nH318 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H351 \nH331 \nH315 \nH318 \nH410  M = 10  \n607-152-00-2  2,3,6-TBA (ISO); 2,3,6-trichloro\xad\nbenzoic acid  200-026-4  50-31-7  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-153-00-8  benazolin (ISO); 4-chloro-2,3- \ndihydro-2-oxo-1,3-benzothiazol- \n3-ylacetic acid  223-297-0  3813-05-6  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 3  H319 \nH315 \nH412  GHS07 \nWng  H319 \nH315 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 799}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 801\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-154-00-3  ethyl  N -benzoyl- N-(3,4-dich\xad\nlorophenyl)-DL-alaninate; \nbenzoylprop-ethyl (ISO)  244-845-5  22212-55-1  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n607-155-00-9  3-(3-amino-5-(1-methylgua\xad\nnidino)-1-oxopentylamino-6-(4- \namino-2-oxo-2,3-dihydro-pyri\xad\nmidin-1-yl)-2,3-dihydro-(6 H)- \npyran-2-carboxylic acid; blas\xad\nticidin-s  — 2079-00-7  Acute Tox. 2 *  H300  GHS06 \nDgr H300  \n607-156-00-4  chlorfenson (ISO); 4-chloro\xad\nphenyl 4-chlorobenzenesulfonate  201-270-4  80-33-1  Acute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH315 \nH410  \n▼M13  \n607-157-00-X  difenacoum (ISO); 3-(3-biphenyl- \n4-yl-1,2,3,4-tetrahydro-1-naph\xad\nthyl)-4-hydroxycoumarin  259-978-4  56073-07-5  Repr. 1B \nAcute Tox. 1 \nAcute Tox. 1 \nAcute Tox. 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH410  Repr. 1B; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C \n≥ 0,02 % STOT \nRE 2; H373 \n(blood): \n0,002 % ≤ C \n< 0,02 % \nM = 10 \nM = 10  \n▼M16  \n607-158-00-5  sodium salt of chloroacetic acid; \nsodium chloroacetate  223-498-3  3926-62-3  Acute Tox. 3 * \nSkin Irrit. 2 \nAquatic Acute 1  H301 \nH315 \nH400  GHS06 \nGHS09 \nDgr H301 \nH315 \nH400  \n607-159-00-0  chlorobenzilate (ISO); ethyl 2,2- \ndi(4-chlorophenyl)-2-hydro\xad\nxyacetate; ethyl 4,4'-dichloroben\xad\nzilate  208-110-2  510-15-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 800}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 802\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-160-00-6  isobutyl 2-(4-(4-chlorophen\xad\noxy)phenoxy)propionate; clofop- \nisobutyl (ISO)  — 51337-71-4  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-161-00-1  diethanolamine salt of 4-CPA  —  —  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-162-00-7  dalapon; 2,2-dichloropropionic \nacid; [1] dalapon-sodium; \nsodium 2,2-dichloropropionate[2]  200-923-0 [1] \n204-828-5 [2]  75-99-0 [1] \n127-20-8 [2]  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H315 \nH318 \nH412  GHS05 \nDgr H315 \nH318 \nH412  \n607-163-00-2  3-acetyl-6-methyl-2 H-pyran- \n2,4(3 H)-dione; dehydracetic acid  208-293-9  520-45-6  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-164-00-8  sodium 1-(3,4-dihydro-6-methyl- \n2,4-dioxo-2 H-pyran-3- \nylidene)ethonolate; sodium dehy\xad\ndracetate  224-580-1  4418-26-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-165-00-3  diclofop-methyl (ISO)methyl 2- \n(4-(2,4-dichlorophenoxy)phen\xad\noxy)propionate; methyl ( RS)-2- \n[4-(2,4-dichlorophenoxy)phen\xad\noxy]propionate;  257-141-8  51338-27-3  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n607-166-00-9  medinoterb acetate (ISO); 6- tert- \nbutyl-3-methyl-2,4-dinitrophenyl \nacetate  219-634-6  2487-01-6  Acute Tox. 3 * \nAcute Tox. 4 *  H301 \nH312  GHS06 \nDgr H301 \nH312  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 801}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 803\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-167-00-4  sodium 3-chloroacrylate  —  4312-97-4  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  \n607-168-00-X  dipropyl 6,7-methylenedioxy- \n1,2,3,4-tetrahydro-3-methylnaph\xad\nthalene-1,2-dicarboxylate; \npropylisome  — 83-59-0  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH302 \nH400 \nH410  GHS06 \nGHS09 \nDgr H311 \nH302 \nH410  \n607-169-00-5  sodium fluoroacetate  200-548-2  62-74-8  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1  H330 \nH310 \nH300 \nH400  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH400  \n607-170-00-0  bis(1,2,3-trithiacyclohexyldi\xad\nmethylammonium) oxalate; \nthiocyclam-oxalate  250-859-2  31895-22-4  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  \n▼M13  \n607-172-00-1  brodifacoum (ISO); \n4-hydroxy-3-(3-(4′-bromo-4- \nbiphenylyl)-1,2,3,4-tetrahydro-1- \nnaphthyl)coumarin  259-980-5  56073-10-0  Repr. 1A \nAcute Tox. 1 \nAcute Tox. 1 \nAcute Tox. 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH410  Repr. 1A; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C \n≥ 0,02 % STOT \nRE 2; H373 \n(blood): \n0,002 % ≤ C \n< 0,02 % \nM = 10 \nM = 10  \n▼M16  \n607-173-00-7  dimethyl (3-methyl-4-(5-nitro-3- \nethoxycarbonyl-2-thie\xad\nnyl)azo)phenylnitrilodipropionate  400-460-6  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 802}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 804\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-174-00-2  reaction mass of dodecyl 3- \n(2,2,4,4-tetramethyl-21-oxo-7- \noxa-3,20-diazadis\xad\npiro(5,1,11,2)henicosan-20- \nyl)propionate and tetradecyl 3- \n(2,2,4,4-tetramethyl-21-oxo-7- \noxa-3,20-diazadis\xad\npiro(5,1,11,2)henicosan-20- \nyl)propionate  400-580-9  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n607-175-00-8  methyl 2-(2-nitrobenzyli\xad\ndene)acetoacetate  400-650-9  39562-27-1  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-176-00-3  reaction mass of α-3-(3-(2 H- \nbenzotriazol-2-yl)-5- tert-butyl-4- \nhydroxyphenyl)propionyl-ω- \nhydroxypoly(oxyethylene) and α- \n3-(3-(2 H-benzotriazol-2-yl)-5-  \ntert-butyl-4-hydroxyphenyl)pro\xad\npionyl-ω-3-(3-(2H-benzotriazol- \n2-yl)-5- tert-butyl-4-hydroxyphe\xad\nnyl)propionyloxypoly(oxyethy\xad\nlene)  400-830-7  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n▼M23  \n607-177-00-9  tribenuron-methyl (ISO); \nmethyl 2-[ N-(4-methoxy-6- \nmethyl-1,3,5-triazin-2-yl)- N- \nmethylcarbamoylsulfamoyl]ben\xad\nzoate  401-190-1  101200-48-0  STOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 \nH317 \nH410  M = 100 \nM = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 803}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 805\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-178-00-4  methyl α-((4,6-dimethoxypyri\xad\nmidin-2-yl)ureidosulphonyl)-o- \ntoluate  401-340-6  83055-99-6  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-179-00-X  (benzothiazol-2-ylthio)succinic \nacid 401-450-4  95154-01-1  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-180-00-5  potassium 2-hydroxycarbazole-1- \ncarboxylate  401-630-2  96566-70-0  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nAquatic Chronic 3  H302 \nH319 \nH335 \nH412  GHS07 \nWng  H302 \nH319 \nH335 \nH412  \n607-181-00-0  3,5-dichloro-2,4-difluorobenzoyl \nfluoride  401-800-6  101513-70-6  Acute Tox. 3 * \nSkin Corr. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H331 \nH314 \nH302 \nH317 \nH412  GHS06 \nGHS05 \nDgr H331 \nH314 \nH302 \nH317 \nH412  EUH029  \n607-182-00-6  methyl 3-sulphamoyl-2-thenoate  402-050-2  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-183-00-1  zinc 2-hydroxy-5-C  13- 18 \nalkylbenzoate  402-280-3  —  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H319 \nH315 \nH411  GHS07 \nGHS09 \nWng  H319 \nH315 \nH411  \n607-184-00-7  S-(3-trimethoxysilyl)propyl 19- \nisocyanato-11-(6-isocyanato\xad\nhexyl)-10,12-dioxo-2,9,11,13- \ntetraazanonadecanethioate  402-290-8  85702-90-5  Flam. Liq. 3 \nResp. Sens. 1 \nSkin Sens. 1  H226 \nH334 \nH317  GHS02 \nGHS08 \nDgr H226 \nH334 \nH317  \n607-185-00-2  ethyl  trans -3-dimethylaminoa\xad\ncrylate  402-650-4  1117-37-9  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 804}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 806\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-186-00-8  quinclorac (ISO); 3,7-dichloro\xad\nquinoline-8-carboxylic acid  402-780-1  84087-01-4  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-187-00-3  bis(2,2,6,6-tetramethyl-4- \npiperidyl) succinate  402-940-0  62782-03-0  Eye Irrit. 2 \nAquatic Chronic 3  H319 \nH412  GHS07 \nWng  H319 \nH412  \n607-188-00-9  hydrogen sodium  N-carboxyla\xad\ntoethyl- N-octadec-9-enylma\xad\nleamate  402-970-4  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-189-00-4  trimethylenediaminetetraacetic \nacid 400-400-9  1939-36-2  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n607-190-00-X  methyl acrylamidometho\xad\nxyacetate (containing ≥ 0,1 % \nacrylamid)  401-890-7  77402-03-0  Carc. 1B Muta. \n1B \nAcute Tox. 4 * \nEye Irrit. 2  H350 \nH340 \nH302 \nH319  GHS08 \nGHS07 \nDgr H350 \nH340 \nH302 \nH319  \n607-191-00-5  isobutyl 3,4-epoxybutyrate  401-920-9  100181-71-3  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  \n607-192-00-0  disodium  N-carboxymethyl- N-(2- \n(2-hydroxyethoxy)ethyl)glycinate  402-360-8  92511-22-3  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 805}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 807\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-194-00-1  propylene carbonate  203-572-1  108-32-7  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-195-00-7  2-methoxy-1-methylethyl acetate  203-603-9  108-65-6  Flam. Liq. 3  H226  GHS02 \nWng  H226  \n607-196-00-2  heptanoic acid  203-838-7  111-14-8  Skin Corr. 1B  H314  GHS05 \nDgr H314  \n▼M11  \n607-197-00-8  nonanoic acid  203-931-2  112-05-0  Skin Irrit. 2 \nEye Irrit. 2 \nAquatic Chronic 3  H315 \nH319 \nH412  GHS07 \nWng  H315 \nH319 \nH412  \n▼M16  \n607-198-00-3  propyl 3,4,5-trihydroxybenzoate  204-498-2  121-79-9  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n607-199-00-9  octyl 3,4,5-trihydroxybenzoate  213-853-0  1034-01-1  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n607-200-00-2  dodecyl 3,4,5-trihydroxybenzoate  214-620-6  1166-52-5  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-201-00-8  thiocarbonyl chloride  207-341-6  463-71-8  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H331 \nH302 \nH319 \nH335 \nH315  GHS06 \nDgr H331 \nH302 \nH319 \nH335 \nH315  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 806}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 808\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-203-00-9  2-ethylhexyl[[[3,5-bis(1,1- \ndimethylethyl)-4-hydroxyphe\xad\nnyl]methyl]thio]acetate  279-452-8  80387-97-9  Repr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H360D *** \nH317 \nH412  GHS08 \nGHS07 \nDgr H360D *** \nH317 \nH412  \n607-204-00-4  (chlorophenyl)(chloroto\xad\nlyl)methane, mixed isomers  400-140-6  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-205-00-X  methyl chloroacetate  202-501-1  96-34-4  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H226 \nH331 \nH301 \nH335 \nH315 \nH318  GHS02 \nGHS06 \nGHS05 \nDgr H226 \nH331 \nH301 \nH335 \nH315 \nH318  \n607-206-00-5  isopropyl chloroacetate  203-301-7  105-48-6  Flam. Liq. 3 \nAcute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H226 \nH301 \nH319 \nH335 \nH315  GHS02 \nGHS06 \nDgr H226 \nH301 \nH319 \nH335 \nH315  \n607-207-00-0  haloxyfop-etotyl (ISO); 2-etho\xad\nxyethyl 2-(4-(3-chloro-5-trifluor\xad\nomethyl-2-pyridyloxy)phen\xad\noxy)propionate; haloxyfop-(2- \nethoxyethyl)  402-560-5  87237-48-7  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n607-208-00-6  4,8,12-trimethyltrideca-3,7,11- \ntrienoic acid, mixed isomers  403-000-2  91853-67-7  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n607-209-00-1  reaction mass of  O, O '- \ndiisopropyl (pentathio)dithio\xad\nformate and  O, O '-diisopropyl \n(trithio)dithioformate and  O, O '- \ndiisopropyl (tetrathio)dithio\xad\nformate  403-030-6  —  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 807}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 809\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-210-00-7  methyl acrylamidoglycolate (con\xad\ntaining ≥ 0,1 % acrylamide)  403-230-3  77402-05-2  Carc. 1B Muta. \n1B \nSkin Corr. 1B \nSkin Sens. 1  H350 \nH340 \nH314 \nH317  GHS08 \nGHS05 \nGHS07 \nDgr H350 \nH340 \nH314 \nH317  \n607-211-00-2  methyl 3-(3- tert-butyl-4-hydroxy- \n5-methylphenyl)propionate  403-270-1  6386-39-6  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-212-00-8  poly(oxypropylenecarbonyl-co- \noxy(ethylethylene)carbonyl), \ncontaining 27 % hydroxyvalerate  403-300-3  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-213-00-3  ethyl 3,3-bis( tert-pentylper\xad\noxy)butyrate  403-320-2  67567-23-1  Org. Perox. \nD**** Flam. \nLiq. 3 \nAquatic Chronic 2  H242 \nH226 \nH411  GHS02 \nGHS09 \nDgr H242 \nH226 \nH411  \n607-214-00-9  N, N -hydrazinodiacetic acid  403-510-5  19247-05-3  Acute Tox. 3 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 3  H301 \nH373 ** H317 \nH412  GHS06 \nGHS08 \nDgr H301 \nH373 ** \nH317 \nH412  \n607-215-00-4  3-(3- tert-butyl-4-hydroxyphe\xad\nnyl)propionic acid  403-920-4  107551-67-7  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n607-216-00-X  glutamic acid, reaction products \nwith N-(C  12- 14-alkyl)propylene\xad\ndiamine  403-950-8  —  Acute Tox. 2 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1  H330 \nH302 \nH314 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH302 \nH314 \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 808}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 810\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-217-00-5  2-ethoxyethyl 2-(4-(2,6-dihydro- \n2,6-dioxo-7-phenyl-1,5-dioxain\xad\ndacen-3-yl)phenoxy)acetate  403-960-2  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n607-218-00-0  dichlorprop-P (ISO); (+)- R-2- \n(2,4-dichlorophenoxy)propionic \nacid 403-980-1  15165-67-0  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H302 \nH315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318 \nH317  \n607-219-00-6  bis(2-ethylhexyl) dithiodiacetate  404-510-8  62268-47-7  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n607-221-00-7  6-docosyloxy-1-hydroxy-4-(1-(4- \nhydroxy-3-methylphenanthren-1- \nyl)-3-oxo-2-oxaphenalen-1- \nyl)naphthalene-2-carboxylic acid  404-550-6  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n607-222-00-2  6-(2,3-dimethylmaleimido)hexyl \nmethacrylate  404-870-6  63740-41-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-223-00-8  transfluthrin (ISO); 2,3,5,6-tetra\xad\nfluorobenzyl  trans -2-(2,2-dich\xad\nlorovinyl)-3,3-dimethylcyclopro\xad\npanecarboxylate  405-060-5  118712-89-3  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n607-224-00-3  methyl 2-(3-nitrobenzyli\xad\ndene)acetoacetate  405-270-7  39562-17-9  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n607-225-00-9  3-azidosulfonylbenzoic acid  405-310-3  15980-11-7  Self-React. C \n**** STOT RE 2 \n* \nEye Dam. 1 \nSkin Sens. 1  H241 \nH373 ** H318 \nH317  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H241 \nH373 ** \nH318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 809}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 811\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-226-00-4  reaction mass of 2-acryloylo\xad\nxyethyl hydrogen cyclohexane- \n1,2-dicarboxylate and 2-metha\xad\ncryloyloxyethyl hydrogen cyclo\xad\nhexane-1,2-dicarboxylate  405-360-6  —  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H315 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H315 \nH318 \nH317 \nH412  \n607-227-00-X  potassium 2-amino-2-methylpro\xad\npionate octahydrate  405-560-3  120447-91-8  Acute Tox. 4 * \nSkin Corr. 1A  H302 \nH314  GHS05 \nGHS07 \nDgr H302 \nH314  \n607-228-00-5  bis(2-methoxyethyl) phthalate  204-212-6  117-82-8  Repr. 1B  H360Df  GHS08 \nDgr H360Df  \n607-229-00-0  diethylcarbamoyl chloride  201-798-5  88-10-8  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H351 \nH332 \nH302 \nH319 \nH335 \nH315  GHS08 \nGHS07 \nWng  H351 \nH332 \nH302 \nH319 \nH335 \nH315  \n607-230-00-6  2-ethylhexanoic acid  205-743-6  149-57-5  Repr. 2  H361d ***  GHS08 \nWng  H361d ***  \n607-231-00-1  clopyralid (ISO); 3,6-dichloro\xad\npyridine-2-carboxylic acid  216-935-4  1702-17-6  Eye Dam. 1  H318  GHS05 \nDgr H318  \n▼M22  \n607-232-00-7  pyridate (ISO); \nO-(6-chloro-3-phenylpyridazin-4- \nyl) S-octyl thiocarbonate  259-686-7  55512-33-9  Acute Tox. 4 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH315 \nH317 \nH410  oral: ATE = \n500 mg/kg bw \nM = 1 \nM = 10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 810}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 812\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-233-00-2  hexyl acrylate  219-698-5  2499-95-8  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H319 \nH335 \nH315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH317 \nH411  \n607-234-00-8  flurenol (ISO); 9-hydroxy-9 H- \nfluorene-9-carboxylic acid  207-397-1  467-69-6  Aquatic Chronic 2  H411  GHS09  H411  \n607-235-00-3  mecrilate; methyl 2-cyanoa\xad\ncrylate  205-275-2  137-05-3  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  STOT SE 3; H335: \nC ≥ 10 %  \n607-236-00-9  ethyl 2-cyanoacrylate  230-391-5  7085-85-0  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  STOT SE 3; H335: \nC ≥ 10 %  \n607-237-00-4  benzyl 2-chloro-4-(trifluor\xad\nomethyl)thiazole-5-carboxylate; \nflurazole  276-942-3  72850-64-7  Aquatic Chronic 2  H411  GHS09  H411  \n607-238-00-X  tau-fluvalinate (ISO); cyano-(3- \nphenoxyphenyl)methyl  N -[2- \nchloro-4-(trifluor\xad\nomethyl)phenyl]-D-valinate  — 102851-06-9  Acute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH315 \nH410  \n607-239-00-5  fenpropathrin (ISO); α-cyano-3- \nphenoxybenzyl 2,2,3,3-tetra\xad\nmethylcyclopropanecarboxylate  254-485-0  39515-41-8  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH301 \nH312 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 811}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 813\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-240-00-0  cis -1,2,3,6-tetrahydro-4-methyl\xad\nphthalic anhydride; [1] 1,2,3,6- \ntetrahydro-4-methylphthalic \nanhydride; [2] 1,2,3,6-tetrahydro- \n3-methylphthalic anhydride; [3] \ntetrahydromethylphthalicanhy\xad\ndride; [4] 1,2,3,6-tetrahydro\xad\nmethylphthalic anhydride; [5] \ntetrahydro-4-methylphthalicanhy\xad\ndride; [6] 2,3,5,6-tetrahydro-2- \nmethylphthalic anhydride [7]  216-906-6 [1] \n222-323-8 [2] \n226-247-6 [3] \n234-290-7 [4] \n247-830-1 [5] \n251-823-9 [6] \n255-853-3 [7]  1694-82-2 [1] \n3425-89-6 [2] \n5333-84-6 [3] \n11070-44-3 [4] \n26590-20-5 [5] \n34090-76-1 [6] \n42498-58-8 [7]  Eye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H318 \nH334 \nH317  GHS08 \nGHS05 \nDgr H318 \nH334 \nH317  C \n607-241-00-6  hexahydro-4-methylphthalic \nanhydride; [1] hexahydromethyl\xad\nphthalic anhydride; [2] \nhexahydro-1-methylphthalic \nanhydride; [3] hexahydro-3- \nmethylphthalicanhydride [4]  243-072-0 [1] \n247-094-1 [2] \n256-356-4 [3] \n260-566-1 [4]  19438-60-9 [1] \n25550-51-0 [2] \n48122-14-1 [3] \n57110-29-9 [4]  Eye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H318 \nH334 \nH317  GHS08 \nGHS05 \nDgr H318 \nH334 \nH317  C \n607-242-00-1  tetrachlorophthalic anhydride  204-171-4  117-08-8  Eye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH334 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H318 \nH334 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 812}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 814\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-243-00-7  sodium 3,6-dichloro- o-anisate; \n[1] 3,6-dichloro- o-anisic acid, \ncompound with 2,2'-iminodie\xad\nthanol (1:1); [2] 3,6-dichloro- o- \nanisic acid, compound with 2- \naminoethanol (1:1) [3]  217-846-3 [1] \n246-590-5 [2] \n258-527-9 [3]  1982-69-0 [1] \n25059-78-3 [2] \n53404-28-7 [3]  Aquatic Chronic 3  H412  —  H412  \n607-244-00-2  isooctyl acrylate  249-707-8  29590-42-9  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH335 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH410  STOT SE 3; H335: \nC ≥ 10 %  \n607-245-00-8  tert -butyl acrylate  216-768-7  1663-39-4  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H225 \nH332 \nH312 \nH302 \nH335 \nH315 \nH317 \nH411  GHS02 \nGHS07 \nGHS09 \nDgr H225 \nH332 \nH312 \nH302 \nH335 \nH315 \nH317 \nH411  D \n607-246-00-3  allyl methacrylate; 2-methyl-2- \npropenoic acid 2-propenyl ester  202-473-0  96-05-9  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1  H226 \nH331 \nH312 \nH302 \nH400  GHS02 \nGHS06 \nGHS09 \nDgr H226 \nH331 \nH312 \nH302 \nH400  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 813}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 815\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M22  \n607-247-00-9  dodecyl methacrylate  205-570-6  142-90-5  STOT SE 3  H335  GHS07 \nWng  H335  STOT SE 3; H335: \nC ≥ 10 %  \n▼M16  \n607-248-00-4  naptalam-sodium (ISO); sodium  \nN-naphth-1-ylphthalamate  205-073-4  132-67-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-249-00-X  (1-methyl-1,2-ethane\xad\ndiyl)bis[oxy(methyl-2,1-ethane\xad\ndiyl)] diacrylate  256-032-2  42978-66-5  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H319 \nH335 \nH315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH317 \nH411  STOT SE 3; H335: \nC ≥ 10 %  \n607-250-00-5  4H-3,1-benzoxazine-2,4(1 H)- \ndione  204-255-0  118-48-9  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  \n607-251-00-0  2-methoxypropyl acetate  274-724-2  70657-70-4  Flam. Liq. 3 \nRepr. 1B \nSTOT SE 3  H226 \nH360D *** \nH335  GHS02 \nGHS08 \nGHS07 \nDgr H226 \nH360D *** \nH335  \n607-252-00-6  lambda-cyhalothrin (ISO); \nreaction mass of ( S)-α-cyano-3- \nphenoxybenzyl( Z)-(1R)-cis-3-(2- \nchloro-3,3,3-trifluoropropenyl)- \n2,2-dimethylcyclopropanecar\xad\nboxylate and ( R)-α-cyano-3- \nphenoxybenzyl ( Z)-(1S)-cis-3-(2- \nchloro-3,3,3-trifluoropropenyl)- \n2,2-dimethylcyclopropanecar\xad\nboxylate (1:1)  415-130-7  91465-08-6  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH301 \nH312 \nH410  M=10000  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 814}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 816\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-253-00-1  cyfluthrin (ISO); α-cyano-4- \nfluoro-3-phenoxybenzyl-3-(2,2- \ndichlorovinyl)-2,2-dimethylcyclo\xad\npropanecarboxylate  269-855-7  68359-37-5  Acute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H300 \nH331 \nH400 \nH410  GHS06 \nGHS09 \nDgr H300 \nH331 \nH410  M=1000  \n607-254-00-7  α-cyano-4-fluoro-3-phenoxy\xad\nbenzyl-3-(2,2-dichlorovinyl)-2,2- \ndimethylcyclopropanecar\xad\nboxylate; beta-cyfluthrin  269-855-7  68359-37-5  Acute Tox. 2 * \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH410  \n607-255-00-2  fluroxypyr (ISO);4-amino-3,5- \ndichloro-6-fluoro-2-pyridylo\xad\nxyacetic acid  — 69377-81-7  Aquatic Chronic 3  H412  —  H412  \n▼M23  \n607-256-00-8  azoxystrobin (ISO); \nmethyl ( E)-2-{2-[6-(2-cyanop\xad\nhenoxy)pyrimidin-4- \nyloxy]phenyl}-3-methoxyacrylate  — 131860-33-8  Acute Tox. 3 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH410  inhalation: \nATE = 0,7 mg/L \n(dusts or mists) \nM = 10 \nM = 10  \n▼M16  \n607-257-00-3  isopropyl propionate  211-300-8  637-78-5  Flam. Liq. 2  H225  GHS02 \nDgr H225  \n607-258-00-9  dodecyl 3-(2-(3-benzyl-4-ethoxy- \n2,5-dioxoimidazolidin-1-yl)-3-(4- \nmethoxybenzoyl)acetamido)-4- \nchlorobenzoate  403-990-6  70950-45-7  Aquatic Chronic 4  H413  —  H413  \n607-259-00-4  methyl 2 R,3S-(-)-3-(4-methoxyp\xad\nhenyl)oxiranecarboxylate  404-130-2  105560-93-8  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 815}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 817\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-260-00-X  ethyl 2-(3-nitrobenzylidene)acet\xad\noacetate  404-490-0  39562-16-8  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n607-261-00-5  iso(C  10-C 14)alkyl (3,5-di- tert- \nbutyl-4-hydroxyphenyl)methyl\xad\nthioacetate  404-800-4  118832-72-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-262-00-0  7-chloro-1-cyclopropyl-6-fluoro- \n1,4-dihydro-4-oxoquinoline-3- \ncarboxylic acid  405-050-0  86393-33-1  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n607-263-00-6  potassium iron(III) 1,3-propane\xad\ndiamine- N, N,N',N '-tetraacetate \nhemihydrate  405-680-6  —  Self-heat. 2 **** \nAquatic Chronic 2  H252 \nH411  GHS02 \nGHS09 \nWng  H252 \nH411  \n607-264-00-1  2-chloro-4-(methylsulfo\xad\nnyl)benzoic acid  406-520-8  53250-83-2  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-265-00-7  ethyl-2-chloro-2,2-dipheny\xad\nlacetate  406-580-5  52460-86-3  Skin Irrit. 2 \nAquatic Chronic 3  H315 \nH412  GHS07 \nWng  H315 \nH412  \n607-266-00-2  reaction mass of: hydroxyalu\xad\nminium bis[2-hydroxy-3,5-di-  \ntert-butylbenzoate]; 3,5-di- tert- \nbutyl-salicylic acid  406-890-0  130296-87-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n607-267-00-8  tert -butyl (5 S,6R,7R)-3-bromo\xad\nmethyl-5,8-dioxo-7-(2-(2-pheny\xad\nlacetamido)-5-thia-1-azabi\xad\ncyclo[4.2.0] oct-2-ene-2- \ncarboxylate  407-620-4  33610-13-8  Resp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H334 \nH317 \nH412  GHS08 \nDgr H334 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 816}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 818\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-268-00-3  2-methylpropyl ( R)-2-hydroxy\xad\npropanoate  407-770-0  61597-96-4  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-269-00-9  (R)-2-(4-hydroxyphenoxy)pro\xad\npanoic acid  407-960-3  94050-90-5  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-270-00-4  3,9-bis(2-(3-(3- tert-butyl-4- \nhydroxy-5-methylphenyl)pro\xad\npionyloxy-1,1-dimethylethyl)- \n2,4,8,10-tetraoxaspiro[5.5]un\xad\ndecane  410-730-5  90498-90-1  Acute Tox. 4 *  H312  GHS07 \nWng  H312  \n607-271-00-X  2-isopropyl-5-methylcyclohexy\xad\nloxycarbonyloxy-2-hydroxy\xad\npropane  417-420-9  156324-82-2  Eye Irrit. 2 \nAquatic Chronic 2  H319 \nH411  GHS07 \nGHS09 \nWng  H319 \nH411  \n607-272-00-5  fluroxypyr-meptyl (ISO); methyl\xad\nheptyl,  O-(4-amino-3,5-dichloro- \n6-fluoro-2-pyridyloxy) acetate; \n[1] fluroxypyr-butometyl (ISO); \n2-butoxy-1-methylethyl,  O -(4- \namino-3,5-dichloro-6-fluoro-2- \npyridyloxy) acetate [2]  279-752-9 [1] \n-[2] 81406-37-3 [1] \n154486-27-8 \n[2] Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-273-00-0  ammonium 7-(2,6-dimethyl-8- \n(2,2-dimethylbutyryloxy)- \n1,2,6,7,8,8a-hexahydro-1-naph\xad\nthyl)-3,5-dihydroxyheptanoate  404-520-2  —  Aquatic Chronic 3  H412  —  H412  \n607-274-00-6  2-( N-benzyl- N-methylamino)ethyl \n3-amino-2-butenoate  405-350-1  54527-73-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 817}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 819\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-275-00-1  sodium benzoyloxybenzene-4- \nsulfonate  405-450-5  66531-87-1  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-276-00-7  bis[(1-methylimidazol)-(2-ethyl- \nhexanoate)], zinc complex  405-635-0  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  \n607-277-00-2  reaction mass of: 2-(hexyl\xad\nthio)ethylamine hydrochloride; \nsodium propionate  405-720-2  —  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n607-278-00-8  reaction mass of isomers of: \nsodium phenethylnaphthalenesul\xad\nfonate; sodium naphthylethylben\xad\nzenesulfonate  405-760-0  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n607-279-00-3  reaction mass of  n-octadecylami\xad\nnodiethyl bis(hydrogen maleate);  \nn-octadecylaminodiethyl \nhydrogen maleate hydrogenph\xad\nthalate  405-960-8  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-280-00-9  sodium 4-chloro-1-hydro\xad\nxybutane-1-sulfonate  406-190-5  54322-20-2  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1  H302 \nH319 \nH317  GHS07 \nWng  H302 \nH319 \nH317  \n607-281-00-4  reaction mass of branched and \nlinear C  7-C 9 alkyl 3-[3-(2 H- \nbenzotriazol-2-yl)-5-(1,1- \ndimethylethyl)-4-hydroxyphe\xad\nnyl]propionates  407-000-3  127519-17-9  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 818}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 820\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-282-00-X  2-acetoxymethyl-4-benzyloxybut- \n1-yl acetate  407-140-5  131266-10-9  Aquatic Chronic 3  H412  —  H412  \n607-283-00-5  E-ethyl-4-oxo-4-phenylcrotonate  408-040-4  15121-89-8  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH315 \nH318 \nH317 \nH410  \n607-284-00-0  reaction mass of: sodium 3,3'- \n(1,4-phenylenebis(carbonylimino- \n3,1-propanediylimino))bis(10- \namino-6,13-dichloro-4,11-triphe\xad\nnodioxazinedisulfonate); lithium \n3,3'-(1,4-phenylenebis-(carbony\xad\nlimino-3,1-propanediyl- \nimino))bis(10-amino-6,13-dich\xad\nloro)-4,11-triphenodioxazinedis\xad\nulfonate (9:1)  410-040-4  136213-76-8  Aquatic Chronic 2  H411  GHS09  H411  \n607-285-00-6  reaction mass of: 7-(((3-aminop\xad\nhenyl)sulfonyl)amino)-naph\xad\nthalene-1,3-disulfonic acid; \nsodium 7-(((3-aminophenyl)sul\xad\nfonyl)amino)-naphthalene-1,3- \ndisulfonate; potassium 7-(((3- \naminophenyl)sulfonyl)amino)- \nnaphthalene-1,3-disulfonate  410-065-0  —  Skin Sens. 1  H317  GHS07 \nWng ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 819}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 821\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-286-00-1  reaction mass of: sodium/ \npotassium 7-[[[3-[[4-((2- \nhydroxy-naphthyl)azo)phe\xad\nnyl]azo]phenyl]sulfonyl]amino]- \nnaphthalene-1,3-disulfonate  410-070-8  141880-36-6  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-287-00-7  O' -methyl  O-(1-methyl-2-metha\xad\ncryloyloxy-ethyl)-1,2,3,6-tetrahy\xad\ndrophthalate  410-140-8  —  Aquatic Chronic 3  H412  —  H412  \n607-288-00-2  tetrasodium ( c-(3-(1-(3-( e-6- \ndichloro-5-cyanopyrimidin-f- \nyl(methyl)amino)propyl)-1,6- \ndihydro-2-hydroxy-4-methyl-6- \noxo-3-pyridylazo)-4-sulfonatop\xad\nhenylsulfamoyl)phthalocyanine-  \na, b,d -trisulfonato(6-))nickelato \nII, where  a is 1 or 2 or 3 or \n4,b is 8 or 9 or 10 or 11, c is \n15 or 16 or 17 or 18,  d is 22 \nor 23 or 24 or 25 and where  e \nand f together are 2 and 4 or 4 \nand 2 respectively  410-160-7  148732-74-5  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H319 \nH317 \nH412  GHS07 \nWng  H319 \nH317 \nH412  \n607-289-00-8  3-(3-(4-(2,4-bis(1,1-dimethylpro\xad\npyl)phenoxy)butylaminocar\xad\nbonyl-4-hydroxy-1-naphthale\xad\nnyl)thio)propanoic acid  410-370-9  105488-33-3  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 820}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 822\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-290-00-3  reaction mass (ratio not known) \nof: ammonium 1-C  14-C 18-alky\xad\nloxycarbonyl-2-(3-allyloxy-2- \nhydroxypropoxycarbonyl)ethane- \n1-sulfonate; ammonium 2-C  14- \nC 18-alkyloxycarbonyl-1-(3- \nallyloxy-2-hydroxypropoxycar\xad\nbonyl)ethane-1-sulfonate  410-540-2  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  \n607-291-00-9  dodecyl-ω-(C  5/C 6-cyclo\xad\nalkyl)alkyl carboxylate  410-630-1  104051-92-5  Aquatic Chronic 4  H413  —  H413  \n607-292-00-4  reaction mass of: [1-(methoxy\xad\nmethyl)-2-(C  12-alkoxy)- \nethoxy]acetic acid; [1-(methoxy\xad\nmethyl)-2-(C  14-alkoxy)- \nethoxy]acetic acid  410-640-6  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  \n607-293-00-X  reaction mass of:  N-aminoe\xad\nthylpiperazonium mono-2,4,6- \ntrimethylnonyldiphenyl ether di- \nsulfonate;  N -aminoethylpiper\xad\nazonium di-2,4,6-trimethyl\xad\nnonyldiphenyl ether di-sulfonate  410-650-0  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n607-294-00-5  sodium 2-benzoyloxy-1-hydro\xad\nxyethane-sulfonate  410-680-4  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-295-00-0  reaction mass of: tetrasodium \nphosphonoethane-1,2-dicar\xad\nboxylate; hexasodium phospho\xad\nnobutane-1,2,3,4-tetracarboxylate  410-800-5  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 821}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 823\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-296-00-6  reaction mass of: pentaerythriol \ntetraesters with heptanoic acid \nand 2-ethylhexanoic acid  410-830-9  —  Aquatic Chronic 4  H413  —  H413  \n607-297-00-1  (E-E)-3,3'-(1,4-phenylenedi\xad\nmethylidene)bis(2-oxobornane- \n10-sulfonic acid)  410-960-6  92761-26-7  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-298-00-7  2-(trimethylammonium)ethoxy\xad\ncarboxybenzene-4-sulfonate  411-010-3  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-299-00-2  methyl 3-(acetylthio)-2-methyl- \npropanoate  411-040-7  97101-46-7  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n607-300-00-6  trisodium [2-(5-chloro-2,6-diflu\xad\noropyrimidin-4-ylamino)-5-( b- \nsulfamoyl- c, d -sulfonatophthalo\xad\ncyanin- a-yl-K4, N29, N30, N31, \nN32-sulfonylamino)benzoato(5- \n)]cuprate(II) where  a =1,2,3,4  b \n= 8,9,10,11  c = 15,16,17,18  d =  \n22,23,24,25  411-430-7  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-301-00-1  reaction mass of: dodecanoic \nacid; poly(1-7)lactate esters of \ndodecanoic acid  411-860-5  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-302-00-7  reaction mass of: tetradecanoic \nacid; poly(1-7)lactate esters of \ntetradecanoic acid  411-910-6  —  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 822}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 824\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-303-00-2  1-cyclopropyl-6,7-difluoro-1,4- \ndihydro-4-oxoquinoline-3- \ncarboxylic acid  413-760-7  93107-30-3  Repr. 2 \nAquatic Chronic 3  H361f *** \nH412  GHS08 \nWng  H361f *** \nH412  \n607-304-00-8  fluazifop-butyl (ISO); butyl ( RS)- \n2-[4-(5-trifluoromethyl-2-pyridy\xad\nloxy)phenoxy]propionate  274-125-6  69806-50-4  Repr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360D *** \nH400 \nH410  GHS08 \nGHS09 \nDgr H360D *** \nH410  \n607-305-00-3  fluazifop-P-butyl (ISO); butyl \n(R)-2-[4-(5-trifluoromethyl-2- \npyridyloxy)phenoxy]propionate  — 79241-46-6  Repr. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH400 \nH410  GHS08 \nGHS09 \nWng  H361d *** \nH410  \n607-306-00-9  chlozolinate (ISO); ethyl ( RS)-3- \n(3,5-dichlorophenyl)-5-methyl- \n2,4-dioxo-oxazolidine-5- \ncarboxylate  282-714-4  84332-86-5  Carc. 2 \nAquatic Chronic 2  H351 \nH411  GHS08 \nGHS09 \nWng  H351 \nH411  \n607-307-00-4  vinclozolin (ISO);  N-3,5-dich\xad\nlorophenyl-5-methyl-5-vinyl-1,3- \noxazolidine-2,4-dione  256-599-6  50471-44-8  Carc. 2 \nRepr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H351 \nH360FD H317 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H351 \nH360FD \nH317 \nH411  \n607-308-00-X  esters of 2,4-D  —  —  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  A \n607-309-00-5  carfentrazone-ethyl (ISO); ethyl \n(RS)-2-chloro-3-[2-chloro-4- \nfluoro-5-[4-difluoromethyl-4,5- \ndihydro-3-methyl-5-oxo-1 H- \n1,2,4-triazol-1-yl]phenyl]pro\xad\npionate  — 128639-02-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 823}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 825\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-310-00-0  kresoxim-methyl (ISO); methyl \n(E)-2-methoxyimino-[2-( o-toly\xad\nloxymethyl)phenyl]acetate  — 143390-89-0  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n607-311-00-6  benazolin-ethyl; ethyl 4-chloro-2- \noxo-2 H-benzothiazole-3-acetate  246-591-0  25059-80-7  Aquatic Chronic 2  H411  GHS09  H411  \n607-312-00-1  methoxyacetic acid  210-894-6  625-45-6  Repr. 1B \nAcute Tox. 4 * \nSkin Corr. 1B  H360FD H302 \nH314  GHS08 \nGHS05 \nGHS07 \nDgr H360FD \nH302 \nH314  STOT SE 3; H335: \nC ≥ 5 %  \n607-313-00-7  neodecanoyl chloride  254-875-0  40292-82-8  Acute Tox. 2 * \nAcute Tox. 4 * \nSkin Corr. 1B  H330 \nH302 \nH314  GHS06 \nGHS06 \nDgr H330 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 5 %  \n▼M23  \n607-314-00-2  ethofumesate (ISO); \n(RS)-2-ethoxy-2,3-dihydro-3,3- \ndimethylbenzofuran-5-yl \nmethanesulfonate  247-525-3  26225-79-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 1  \n▼M16  \n607-315-00-8  glyphosate (ISO);  N-(phosphono\xad\nmethyl)glycine  213-997-4  1071-83-6  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n607-316-00-3  glyphosate-trimesium; glyp\xad\nhosate-trimethylsulfonium  — 81591-81-3  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-317-00-9  bis(2-ethylhexyl) phthalate; di-(2- \nethylhexyl) phthalate; DEHP  204-211-0  117-81-7  Repr. 1B  H360FD  GHS08 \nDgr H360FD  \n607-318-00-4  dibutyl phthalate; DBP  201-557-4  84-74-2  Repr. 1B \nAquatic Acute 1  H360Df \nH400  GHS08 \nGHS09 \nDgr H360Df \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 824}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 826\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-319-00-X  deltamethrin (ISO); ( S)-α-cyano- \n3-phenoxybenzyl(1 R, 3R)-3-(2,2- \ndibromovinyl)-2,2-dimethylcyclo\xad\npropanecarboxylate  258-256-6  52918-63-5  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH410  M=1000000  \n607-320-00-5  bis[4-(ethenyloxy)butyl] 1,3- \nbenzenedicarboxylate  413-930-0  130066-57-8  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n607-321-00-0  (S)-methyl-2-chloropropionate  412-470-8  73246-45-4  Flam. Liq. 3 \nSTOT RE 2 * \nEye Irrit. 2  H226 \nH373 ** H319  GHS02 \nGHS08 \nWng  H226 \nH373 ** \nH319  \n607-322-00-6  4-(4,4-dimethyl-3-oxo-pyra\xad\nzolidin-1-yl)-benzoic acid  413-120-7  107144-30-9  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-323-00-1  2-(1-(2-hydroxy-3,5-di- tert- \npentyl-phenyl)ethyl)-4,6-di- tert- \npentylphenyl acrylate  413-850-6  123968-25-2  Aquatic Chronic 4  H413  —  H413  \n607-324-00-7  reaction mass of:  N, N -di(hydro\xad\ngenated alkyl C  14-C 18)phtalamic \nacid; dihydrogenated alkyl (C  14- \nC 18)amine  413-800-3  —  Aquatic Chronic 4  H413  —  H413  \n607-325-00-2  (S)-2-chloropropionic acid  411-150-5  29617-66-1  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  \n607-326-00-8  reaction mass of: isobutyl \nhydrogen 2-(α-2,4,6- \ntrimethylnon-2-enyl)succinate; \nisobutyl hydrogen 2-(ß-2,4,6- \ntrimetyhylnon-2-enyl)succinate  410-720-0  141847-13-4  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 825}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 827\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-327-00-3  2-(2-iodoethyl)-1,3-propanediol \ndiacetate  411-780-0  127047-77-2  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-328-00-9  methyl 4-bromomethyl-3- \nmethoxybenzoate  410-310-1  70264-94-7  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  \n607-329-00-4  reaction mass of: sodium 2-(C  12- \n18-n-alkyl)amino-1,4-butandioate; \nsodium 2-octadecenyl-amino-1,4- \nbutandioate  411-250-9  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-330-00-X  (S)-2,3-dihydro-1 H-indole-2- \ncarboxylic acid  410-860-2  79815-20-6  Repr. 2 \nSTOT RE 2 * \nSkin Sens. 1  H361f *** \nH373 ** H317  GHS08 \nGHS07 \nWng  H361f *** \nH373 ** \nH317  \n607-331-00-5  reaction mass of: bis(2,2,6,6- \ntetramethyl-1-octyloxypiperidin- \n4-yl)-1,10-decanedioate; 1,8- \nbis[(2,2,6,6-tetramethyl-4- \n((2,2,6,6-tetramethyl-1-octylo\xad\nxypiperidin-4-yl)-decan-1,10- \ndioyl)piperidin-1-yl)oxy]octane  406-750-9  —  Aquatic Chronic 4  H413  —  H413  \n607-332-00-0  cyclopentyl chloroformate  411-460-0  50715-28-1  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H226 \nH331 \nH302 \nH373 ** H318 \nH317  GHS02 \nGHS06 \nGHS08 \nGHS05 \nDgr H226 \nH331 \nH302 \nH373 ** \nH318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 826}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 828\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-333-00-6  reaction mass of: dodecyl  N- \n(2,2,6,6-tetramethylpiperidin-4- \nyl)-β-alaninate; tetradecyl  N - \n(2,2,6,6-tetramethylpiperidin-4- \nyl)-β-alaninate  405-670-1  —  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** H314 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H302 \nH373 ** \nH314 \nH410  \n607-334-00-1  ethyl 1-ethyl-6,7,8-trifluoro-1,4- \ndihydro-4-oxoquinoline-3- \ncarboxylate  405-880-3  100501-62-0  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-335-00-7  methyl ( R)-2-(4-(3-chloro-5- \ntrifluoromethyl-2-pyridy\xad\nloxy)phenoxy)propionate  406-250-0  72619-32-0  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n607-336-00-2  4-methyl-8-methylenetri\xad\ncyclo[3.3.1.13,7 ]dec-2-yl acetate  406-560-6  122760-85-4  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H315 \nH317 \nH411  \n607-337-00-8  di- tert-(C  12- 14)-alkylammonium \n2-benzothiazolylthiosuccinate  406-052-4  125078-60-6  Flam. Liq. 3 \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H226 \nH302 \nH315 \nH318 \nH411  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H226 \nH302 \nH315 \nH318 \nH411  \n607-338-00-3  2-methylpropyl 2-hydroxy-2- \nmethylbut-3-enoate  406-235-9  72531-53-4  Eye Irrit. 2 \nSkin Irrit. 2  H319 \nH315  GHS07 \nWng  H319 \nH315  \n607-339-00-9  2,3,4,5-tetrachlorobenzoylch\xad\nloride  406-760-3  42221-52-3  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H302 \nH314 \nH317  GHS05 \nGHS07 \nDgr H302 \nH314 \nH317  \n607-340-00-4  1,3-bis(4-benzoyl-3-hydroxyp\xad\nhenoxy)prop-2-yl acetate  406-990-4  —  Aquatic Chronic 2  H411  GHS09  H411  \n607-341-00-X  ( 9S)-9-amino-9-deoxyery\xad\nthromycin  406-790-7  26116-56-3  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 827}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 829\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-342-00-5  4-chlorobutyl veratrate  410-950-1  69788-75-6  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-343-00-0  4,7-methanooctahydro-1 H- \nindene-diyldimethyl bis(2- \ncarboxybenzoate)  407-410-2  —  Aquatic Chronic 4  H413  —  H413  \n607-344-00-6  reaction mass of: 3-( N-(3- \ndimethylaminopropyl)-(C  4- 8)per\xad\nfluoroalkylsulfonamido)propionic \nacid; N-[dimethyl-3-(C  4- 8-perflu\xad\noroalkylsulfonamido)propylam\xad\nmonium propionate; 3-( N-(3- \ndimethyl-propylammonium)- \n(C 4- 8)perfluoroalkylsulfon\xad\namido)propionic acid propionate  407-810-7  —  STOT RE 2 *  H373 **  GHS08 \nWng  H373 **  \n607-345-00-1  potassium 2-(2,4-dichlorop\xad\nhenoxy)-( R)-propionate  413-580-9  113963-87-4  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H302 \nH315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318 \nH317  \n607-346-00-7  3-icosyl-4-henicosylidene-2- \noxetanone  401-210-9  83708-14-9  Aquatic Chronic 4  H413  —  H413  \n607-347-00-2  sodium ( R)-2-(2,4-dichlorophen\xad\noxy)propionate  413-340-3  119299-10-4  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H302 \nH315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318 \nH317  \n607-348-00-8  magnesium bis(( R)-2-(2,4-dich\xad\nlorophenoxy)propionate)  413-360-2  —  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H302 \nH315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 828}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 830\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-349-00-3  mono-(tetrapropylammonium)hy\xad\ndrogen 2,2'-dithiobisbenzoate  411-270-8  —  Aquatic Chronic 3  H412  H412  \n607-350-00-9  bis(4-(1,2-bis(ethoxycar\xad\nbonyl)ethylamino)-3-methyl\xad\ncyclohexyl)methane  412-060-9  136210-32-7  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-351-00-4  methyl  O-(4-amino-3,5-dichloro- \n6-fluoropyridin-2-yloxy)acetate  407-550-4  69184-17-4  Aquatic Chronic 2  H411  GHS09  H411  \n607-352-00-X  4,4'-oxydiphthalic anhydride  412-830-4  1823-59-2  Aquatic Chronic 3  H412  —  H412  \n607-353-00-5  reaction mass of: ethyl  exo - \ntricyclo[5.2.1.02,6]decane- endo - \n2-carboxylate; ethyl  endo - \ntricyclo[5.2.1.02,6 ]decane- exo-2- \ncarboxylate  407-520-0  80657-64-3  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n607-354-00-0  ethyl 2-cyclohexylpropionate  412-280-5  2511-00-4  Aquatic Chronic 2  H411  GHS09  H411  \n607-355-00-6  p-tolyl 4-chlorobenzoate  411-530-0  15024-10-9  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n607-356-00-1  ethyl  trans -2,2,6-trimethylcyclo\xad\nhexanecarboxylate  412-540-8  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n607-357-00-7  reaction mass of:  trans -4- \nacetoxy-4-methyl-2-propyl- \ntetrahydro-2 H-pyran;  cis -4- \nacetoxy-4-methyl-2-propyl- \ntetrahydro-2 H-pyran  412-450-9  131766-73-9  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 829}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 831\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-358-00-2  ( 1 S,3S,5R,6R)-(4-nitrophenylme\xad\nthyl)-1-dioxo-6-phenylacetamido- \npenam-3-carboxylate  412-670-5  54275-93-3  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n607-359-00-8  ( 1 S,4R,6R,7R)-(4-nitrophenylme\xad\nthyl)3-methylene-1-oxo-7-pheny\xad\nlacetamido-cepham-4-carboxyla\xad\nteido-penam-3-carboxylate  412-800-0  76109-32-5  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n607-360-00-3  sodium 3-acetoacetylamino-4- \nmethoxytolyl-6-sulfonate  411-680-7  133167-77-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-361-00-9  methyl ( R)-2-(4-hydroxyphen\xad\noxy)propionate  411-950-4  96562-58-2  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-362-00-4  reaction mass of: \n(3-methoxy)propylammonium/ \n[tris-(2-hydroxyethyl)]ammonium \n2-(2-(bis(2-hydroxye\xad\nthyl)amino)ethoxycarbonyl\xad\nmethyl)hexadec-4-enoate; \n(3-methoxy)propylammonium/ \n[tris-(2-hydroxyethyl)]ammonium \n2-(2-(bis(2-hydroxye\xad\nthyl)amino)ethoxycarbonyl\xad\nmethyl)tetradec-4-enoate; \n(3-methoxy)propylammonium/ \n[tris-(2-hydroxyethyl)]ammonium \n2-(3-methoxypropylcarba\xad\nmoylmethyl)hexadec-4-enoate; \n(3-methoxy)propylammonium/ \n[tris-(2-hydroxyethyl)]ammonium \n2-(3-methoxypropylcarba\xad\nmoylmethyl)tetradec-4-enoate  413-500-2  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H315 \nH318 \nH411  GHS05 \nGHS09 \nDgr H315 \nH318 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 830}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 832\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-363-00-X  methyl-3-methoxyacrylate  412-900-4  5788-17-0  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-364-00-5  3-phenyl-7-[4-(tetrahydrofurfury\xad\nloxy)phenyl]-1,5-dioxa-s- \nindacen-2,6-dione  413-330-9  134724-55-3  Aquatic Chronic 4  H413  H413  \n607-365-00-0  2-(2-amino-1,3-thiazol-4-yl)-( Z)- \n2-methoxyiminoacetyl chloride \nhydrochloride  410-620-7  119154-86-8  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H302 \nH314 \nH317  GHS05 \nGHS07 \nDgr H302 \nH314 \nH317  \n607-366-00-6  3,5-dimethylbenzoyl chloride  413-010-9  6613-44-1  Skin Corr. 1B \nSkin Sens. 1  H314 \nH317  GHS05 \nGHS07 \nDgr H314 \nH317  \n607-367-00-1  potassium bis( N-carboxymethyl)-  \nN-methyl-glycinato-(2-) N, O,O, \nN)-ferrate-(1-)monohydrate  411-640-9  153352-59-1  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-368-00-7  1-( N,N-dimethylcarbamoyl)-3-  \ntert-butyl-5-carbethoxy\xad\nmethylthio-1 H-1,2,4-triazole  411-650-3  110895-43-7  Acute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH410  \n607-369-00-2  reaction mass of:  trans -(2R)-5- \nacetoxy-1,3-oxathiolane-2- \ncarboxylic acid;  cis -(2R)-5- \nacetoxy-1,3-oxathiolane-2- \ncarboxylic acid  411-660-8  147027-04-1  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H302 \nH315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318 \nH317  \n607-370-00-8  2-[[2-(acetyloxy)-3-(1,1- \ndimethyl-ethyl)-5-methylphe\xad\nnyl]methyl]-6-(1,1-dimethyl\xad\nethyl)-4-methylphenol  412-210-3  41620-33-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-371-00-3  3-ethyl 5-methyl 4-(2-chloro\xad\nphenyl)-1,4-dihydro-2-[2-(1,3- \ndihydro-1,3-dioxo-(2)isoindol-2- \nyl)-ethoxymethyl]-6-methyl-3,5- \npyridinedicarboxylate  413-410-3  88150-62-3  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 831}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 833\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-372-00-9  ethoxylated bisphenol A di-(nor\xad\nbornene carboxylate)  412-410-0  —  Aquatic Chronic 3  H412  —  H412  \n▼M18  \n607-373-00-4  quizalofop-P-tefuryl (ISO); (+/–) \ntetrahydrofurfuryl (R)-2-[4-(6- \nchloroquinoxalin-2-yloxy)pheny\xad\nloxy]propionate  414-200-4  200509-41-7  Carc. 2 \nRepr. 2 \nAcute Tox. 4 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361fd \nH302 \nH373 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH361fd \nH302 \nH373 \nH410  M = 1 \nM = 1  \n▼M16  \n607-374-00-X  5-amino-2,4,6-triiodo-1,3-benze\xad\nnedicarbonyldichloride  417-220-1  37441-29-5  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n▼M13  \n607-375-00-5  flocoumafen (ISO); reaction mass \nof: cis-4-hydroxy-3-(1,2,3,4- \ntetrahydro-3-(4-(4-trifluor\xad\nomethylbenzyloxy)phenyl)-1- \nnaphthyl)coumarin and trans-4- \nhydroxy-3-(1,2,3,4-tetrahydro-3- \n(4-(4-trifluoromethylbenzy\xad\nloxy)phenyl)-1-naphthyl)cou\xad\nmarin  421-960-0  90035-08-8  Repr. 1B \nAcute Tox. 1 \nAcute Tox. 1 \nAcute Tox. 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH410  Repr. 1B; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C \n≥ 0,05 % \nSTOT RE 2; H373 \n(blood): \n0,005 % ≤ C \n< 0,05 % \nM = 10 \nM = 10  \n▼M16  \n607-376-00-0  benzyl 2,4-dibromobutanoate  420-710-8  23085-60-1  Repr. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f *** \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361f *** \nH315 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 832}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 834\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-377-00-6  trans -4-cyclohexyl-L-proline \nmonohydrochloride  419-160-1  90657-55-9  Repr. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H361f *** \nH302 \nH315 \nH318 \nH317  GHS08 \nGHS05 \nGHS07 \nDgr H361f *** \nH302 \nH315 \nH318 \nH317  \n607-378-00-1  ammonium (Z)-α-methoxyimino- \n2-furylacetate  405-990-1  97148-39-5  Flam. Sol. 2  H228  GHS02 \nDgr H228  T  \n607-379-00-7  reaction mass of: 2-[ N-(2-hydro\xad\nxyethyl)stearamido]ethyl stearate; \nsodium [bis[2-(stearoy\xad\nloxy)ethyl]amino]methylsul\xad\nfonate; sodium [bis(2-hydroxye\xad\nthyl)amino]methylsulfonate;  N, \nN-bis(2-hydroxyethyl)stearamide  401-230-8  Aquatic Chronic 3  H412  —  H412  \n607-380-00-2  reaction mass of: ammonium-1,2- \nbis(hexyloxycarbonyl)ethanesul\xad\nfonate; ammonium-1-hexyloxy\xad\ncarbonyl-2-octyloxycarbonyle\xad\nthanesulfonate; ammonium-2- \nhexyloxycarbonyl-1-octyloxycar\xad\nbonylethanesulfonate  407-320-3  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H315 \nH318 \nH412  GHS05 \nDgr H315 \nH318 \nH412  \n607-381-00-8  reaction mass of triesters of 2,2- \nbis(hydroxymethyl)butanol with \nC 7-alkanoic acids and 2- \nethylhexanoic acid  413-710-4  —  Aquatic Chronic 4  H413  —  H413  \n607-382-00-3  2-((4-amino-2-nitrophe\xad\nnyl)amino)benzoic acid  411-260-3  117907-43-4  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 833}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 835\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-383-00-9  reaction mass of: 2,2,6,6-tetra\xad\nmethylpiperidin-4-yl-hexadec\xad\nanoate; 2,2,6,6-tetramethyl\xad\npiperidin-4-yl-octadecanoate  415-430-8  86403-32-9  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH410  \n607-384-00-4  reaction mass of: esters of C  14- \nC 15 branched alcohols with 3,5- \ndi-t-butyl-4-hydroxyphenyl \npropionic acid; C  15 branched and \nlinear alkyl 3,5-bis(1,1-dimethyl\xad\nethyl)-4-hydroxybenzenepro\xad\npanoate; C  13 branched and linear \nalkyl 3,5-bis(1,1-dimethylethyl)- \n4-hydroxybenzenepropanoate  413-750-2  171090-93-0  Aquatic Chronic 4  H413  —  H413  \n607-385-00-X  copolymer of vinyl-alcohol and \nvinyl acetate partially acetilized \nwith 4-(2-(4-formylphe\xad\nnyl)ethenyl)-1-methylpyridinium \nmethylsulfate  414-590-6  125229-74-5  Aquatic Chronic 2  H411  GHS09  H411  \n607-386-00-5  reaction mass of: tetradecanoic \nacid (42,5-47,5 %); poly(1- \n7)lactate esters of tetradecanoic \nacid (52,5-57,5 %)  412-580-6  174591-51-6  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  \n607-387-00-0  reaction mass of: dodecanoic \nacid (35-40 %); poly(1-7)lactate \nesters of dodecanoic acid (60- \n65 %)  412-590-0  58856-63-6  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 834}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 836\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-388-00-6  4-ethylamino-3-nitrobenzoic acid  412-090-2  2788-74-1  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH317 \nH412  GHS07 \nWng  H302 \nH317 \nH412  \n607-389-00-1  trisodium  N, N -bis(carboxy\xad\nmethyl)-3-amino-2-hydroxypro\xad\npionate  414-130-4  119710-96-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-390-00-7  1,2,3,4-tetrahydro-6-nitro-quin\xad\noxaline  414-270-6  41959-35-7  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-391-00-2  dimethylcyclopropane-1,1-dicar\xad\nboxylate  414-240-2  6914-71-2  Aquatic Chronic 3  H412  —  H412  \n607-392-00-8  2-phenoxyethyl 4-((5-cyano-1,6- \ndihydro-2-hydroxy-1,4-dimethyl- \n6-oxo-3-pyridinyl)azo)benzoate  414-260-1  88938-37-8  Aquatic Chronic 4  H413  —  H413  \n607-393-00-3  3-( cis-1-propenyl)-7-amino-8- \noxo-5-thia-1-azabi\xad\ncyclo[4.2.0]oct-2-ene-2- \ncarboxylic acid  415-750-8  106447-44-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-394-00-9  5-methylpyrazine-2-carboxylic \nacid 413-260-9  5521-55-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-395-00-4  reaction mass of: sodium 1- \ntridecyl-4-allyl-(2 or 3)-sulfobu\xad\ntanedioate; sodium 1-dodecyl-4- \nallyl-(2 or 3)-sulfobutanedioate  410-230-7  —  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH411  \n607-396-00-X  bis(1,2,2,6,6-pentamethyl-4- \npiperidinyl) 2-(4-methoxy\xad\nbenzylidene)malonate  414-840-4  147783-69-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 835}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 837\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-397-00-5  reaction mass of: Ca salicylates \n(branched C  10-14 and C  18-30 alky\xad\nlated); Ca phenates (branched \nC 10-14 and C  18-30 alkylated); Ca \nsulfurised phenates(branched \nC 10-14 and C  18-30 alkylated)  415-930-6  —  Repr. 2 \nSkin Sens. 1  H361f*** \nH317  GHS08 \nGHS07 \nWng  H361f*** \nH317  \n607-398-00-0  ethyl  N -(5-chloro-3-(4-(diethy\xad\nlamino)-2-methylphenylimino)-4- \nmethyl-6-oxo-1,4-cyclohexadie\xad\nnyl)carbamate  414-820-5  125630-94-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-399-00-6  2,2-dimethyl 3-methyl-3-butenyl \npropanoate  415-610-6  104468-21-5  Skin Irrit. 2 \nAquatic Chronic 3  H315 \nH412  GHS07 \nWng  H315 \nH412  \n607-400-00-X  methyl 3-[[(dibutylamino)thioxo\xad\nmethyl]thio]propanoate  414-400-1  32750-89-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-401-00-5  ethyl 3-hydroxy-5-oxo-3-cyclo\xad\nhexene-1-carboxylate  414-450-4  88805-65-6  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H315 \nH318 \nH317  \n607-402-00-0  methyl  N-(phenoxycarbonyl)-L- \nvalinate  414-500-5  153441-77-1  Aquatic Chronic 3  H412  —  H412  \n607-403-00-6  reaction mass of: bis(1 S,2S,4S)- \n(1-benzyl-4- tert-butoxycarbo\xad\nxamido-2-hydroxy-5-phenyl)pen\xad\ntylammonium succinate; \nisopropyl alcohol  414-810-0  —  STOT RE 2 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** H318 \nH400 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H373 ** \nH318 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 836}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 838\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-404-00-1  reaction mass of: (( Z)-3,7- \ndimethyl-2,6-octadienyl)oxycar\xad\nbonylpropanoic acid; di-(( E)-3,7- \ndimethyl-2,6-octadienyl) \nbutandioate; di-(( Z)-3,7-dimethyl- \n2,6-octadienyl) butandioate; ( Z)- \n3,7-dimethyl-2,6-octadienyl \nbutandioate; (( E)-3,7-dimethyl- \n2,6-octadienyl)oxycarbonylpro\xad\npanoic acid  415-190-4  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-405-00-7  2-hexyldecyl-p-hydroxybenzoate  415-380-7  148348-12-3  Aquatic Chronic 2  H411  GHS09  H411  \n607-406-00-2  potassium 2,5-dichlorobenzoate  415-700-5  184637-62-5  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n607-407-00-8  ethyl 2-carboxy-3-(2-thienyl)pro\xad\npionate  415-680-8  143468-96-6  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H315 \nH318 \nH317  \n607-408-00-3  potassium  N -(4-fluorophe\xad\nnyl)glycinate  415-710-1  184637-63-6  STOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H373 ** H318 \nH317 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H373 ** \nH318 \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 837}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 839\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-409-00-9  reaction mass of: (3 R)-[1S- \n(1α,2α, 6β-((2 S)-2-methyl-1-oxo- \nbutoxy)-8aγ)hexahydro-2,6- \ndimethyl-1-naphthalene]-3,5- \ndihydroxyheptanoic acid; inert \nbiomass from  Aspergillus terreus  415-840-7  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-410-00-4  mono[2-(dimethyl\xad\namino)ethyl]monohydrogen-2- \n(hexadec-2-enyl)butanedioate \nand/or mono[2-(dimethyl\xad\namino)ethyl]monohydrogen-3- \n(hexadec-2-enyl)butanedioate  415-880-5  779343-34-9  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  \n607-411-00-X  oxiranemethanol, 4-methyl\xad\nbenzene-sulfonate, ( S)- 417-210-7  70987-78-9  Carc. 1B Muta. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H350 \nH341 \nH318 \nH317 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H350 \nH341 \nH318 \nH317 \nH411  \n607-412-00-5  ethyl 2-(1-cyanocyclo\xad\nhexyl)acetate  415-970-4  133481-10-4  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 3  H302 \nH373 ** H412  GHS08 \nGHS07 \nWng  H302 \nH373 ** \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 838}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 840\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-413-00-0  trans-4-phenyl-L-proline  416-020-1  96314-26-0  Repr. 2 \nSkin Sens. 1  H361f *** \nH317  GHS08 \nGHS07 \nWng  H361f *** \nH317  \n▼M18  \n__________  \n▼M16  \n607-415-00-1  poly-(methyl methacrylate)-co- \n(butylmethacrylate)-co-(4- \nacryloxybutyl-isopropenyl-α, α- \ndimethylbenzyl carbamate)-co- \n(maleicanhydride)  419-590-1  —  Flam. Sol. 1 \nSkin Sens. 1  H228 \nH317  GHS02 \nGHS07 \nDgr H228 \nH317  T \n607-416-00-7  4-(2-carboxymethylthio)ethoxy- \n1-hydroxy-5-isobutyloxycarbony\xad\nlamino- N-(3-dodecyloxypropyl)- \n2-naphthamide  420-730-7  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-417-00-2  3-chloropropyl chloroformiate  425-770-9  628-11-5  Acute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H331 \nH302 \nH373** H315 \nH318 \nH317  GHS06 \nGHS05 \nGHS08 \nDgr H331 \nH302 \nH373** \nH315 \nH318 \nH317  \n607-418-00-8  2-ethylhexyl 4-aminobenzoate  420-170-3  26218-04-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 839}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 841\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-419-00-3  (3'-carboxymethyl-5-(2-(3-ethyl- \n3H-benzothiazol-2-ylidene)-1- \nmethyl-ethylidene)-4,4'-dioxo-2'- \nthioxo-(2,5')bithiazolidinyliden-3- \nyl)-acetic acid  422-240-9  166596-68-5  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-420-00-9  2,2-bis(hydroxymethyl)butanoic \nacid 424-090-1  10097-02-6  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-421-00-4  cypermethrin  cis/trans  +/-40/60; \n(RS)-α-cyano-3-phenoxybenzyl \n(1RS,3RS;1RS,3SR)-3-(2,2-dich\xad\nlorovinyl)-2,2-dimethylcyclopro\xad\npanecarboxylate  257-842-9  52315-07-8  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH335 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH302 \nH335 \nH410  \n607-422-00-X  α-cypermethrin (ISO); racemate \ncomprising ( R)-α-cyano-3-phen\xad\noxybenzyl (1 S,3S)-3-(2,2-dich\xad\nlorovinyl)-2,2-dimethylcyclopro\xad\npanecarboxylate; ( S)-α-cyano-3- \nphenoxybenzyl(1 R, 3 R)-3-(2,2- \ndichlorovinyl)-2,2-dimethylcyclo\xad\npropanecarboxylate  257-842-9  67375-30-8  Acute Tox. 3 * \nSTOT RE 2 * \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH373** H335 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH373** \nH335 \nH410  M=1000  \n607-423-00-5  esters of mecoprop and of \nmecoprop-P  — —  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  A ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 840}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 842\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-424-00-0  trifloxystrobin (ISO); ( E, E )-α- \nmethoxyimino-{2-[[[[1-[3-(triflu\xad\noromethyl)phenyl]ethyli\xad\ndene]amino]oxy]methyl]benze\xad\nneacetic acid methyl ester  — 141517-21-7  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n607-425-00-6  metalaxyl (ISO); methyl- N-(2,6- \ndimethylphenyl)- N-(metho\xad\nxyacetyl)-DL-alaninate  260-979-7  57837-19-1  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH317 \nH412  GHS07 \nWng  H302 \nH317 \nH412  \n607-426-00-1  1,2-benzenedicarboxylic acid, \ndipentylester, branched and \nlinear; [1] n-pentyl-isopentylph\xad\nthalate; [2] di-n-pentyl phthalate; \n[3] diisopentylphthalate [4]  284-032-2 [1] \n-[2] \n205-017-9 [3] \n210-088-4 [4]  84777-06-0 [1] \n-[2] \n131-18-0 [3] \n605-50-5 [4]  Repr. 1B \nAquatic Acute 1  H360FD H400  GHS08 \nGHS09 \nDgr H360FD \nH400  \n607-427-00-7  bromoxynil heptanoate (ISO); \n2,6-dibromo-4-cyanophenyl hept\xad\nanoate  260-300-4  56634-95-8  Repr. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH332 \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d *** \nH332 \nH302 \nH317 \nH410  \n607-428-00-2  tetrasodium ethylene diamine \ntetraacetate  200-573-9  64-02-8  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n607-429-00-8  edetic acid; (EDTA)  200-449-4  60-00-4  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-430-00-3  BBP; benzyl butyl phthalate e  201-622-7  85-68-7  Repr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH400 \nH410  GHS08 \nGHS09 \nDgr H360Df \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 841}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 843\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-431-00-9  prallethrin (ISO); ETOC; 2- \nmethyl-4-oxo-3-(prop-2- \nynyl)cyclopent-2-en-1-yl 2,2- \ndimethyl-3-(2-methylprop-1- \nenyl)cyclopropanecarboxylate  245-387-9  23031-36-9  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH302 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH302 \nH410  \n607-432-00-4  S-metolachlor; reaction mass of \n(S)-2-chloro- N-(2-ethyl-6-methyl- \nphenyl)- N-(2-methoxy-1-methyl- \nethyl)-acetamide (80-100 %); [1] \n(R)-2-chloro- N-(2-ethyl-6- \nmethyl-phenyl)- N-(2-methoxy-1- \nmethyl-ethyl)-acetamide (0-20 %) \n[2] -[1] \n-[2] 87392-12-9 [1] \n178961-20-1 \n[2] Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n607-433-00-X  cypermethrin  cis/trans  +/-80/20; \n(RS)-α-cyano-3-phenoxybenzyl \n(1RS;3RS; 1RS, 3SR)-3-(2,2-dich\xad\nlorovinyl)-2,2-dimethylcyclopro\xad\npanecarboxylate  257-842-9  52315-07-8  Acute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH335 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH335 \nH315 \nH317 \nH410  \n607-434-00-5  mecoprop-P [1] and its salts; ( R)- \n2-(4-chloro-2-methylphen\xad\noxy)propionic acid  240-539-0  16484-77-8  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n607-435-00-0  2S-isopropyl-5 R-methyl-1 R- \ncyclohexyl 2,2-dihydroxyacetate  416-810-6  111969-64-3  STOT RE 2 * \nEye Dam. 1 \nAquatic Chronic 2  H373 ** H318 \nH411  GHS08 \nGHS05 \nGHS09 \nDgr H373 ** \nH318 \nH411  \n607-436-00-6  2-hydroxy-3-(2-ethyl-4-methyl\xad\nimidazoyl)propyl neodecanoate  417-350-9  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 842}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 844\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-437-00-1  3-(4-aminophenyl)-2-cyano-2- \npropenoic acid  417-480-6  252977-62-1  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-438-00-7  methyl-2-[(aminosulfo\xad\nnyl)methyl]benzoate  419-010-5  112941-26-1  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n607-439-00-2  methyl tetrahydro-2-furancar\xad\nboxylate  420-670-1  37443-42-8  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-440-00-8  methyl 2-aminosulfonyl-6-(triflu\xad\noromethyl)pyridine-3-c \narboxylate  421-220-7  144740-59-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-441-00-3  3-[3-(2-dodecyloxy-5-methylphe\xad\nnylcarbamoyl)-4-hydroxy-1- \nnaphthylthio]propionic acid  421-490-6  167684-63-1  Aquatic Chronic 4  H413  —  H413  \n607-442-00-9  benzyl [hydroxy-(4-phenylbu\xad\ntyl)phosphinyl] acetate  416-050-5  87460-09-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n▼M1 __________  \n▼M16  \n607-444-00-X  reaction mass of:  cis -1,4- \ndimethylcyclohexyl dibenzoate;  \ntrans -1,4-dimethylcyclohexyl \ndibenzoate  416-230-3  35541-81-2  Aquatic Chronic 4  H413  —  H413  \n607-445-00-5  Iron (III) tris(4-methylbenzene\xad\nsulfonate)  420-960-8  77214-82-5  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-446-00-0  methyl 2-[4-(2-chloro-4-nitro\xad\nphenylazo)-3-(1-oxopro\xad\npyl)amino]phenylaminopro\xad\npionate  416-240-8  155522-12-6  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 843}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 845\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-447-00-6  sodium 4-[4-(4-hydroxypheny\xad\nlazo)phenylamino]-3-nitroben\xad\nzenesulfonate  416-370-5  156738-27-1  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-448-00-1  2,3,5,6-tetrafluorobenzoic acid  416-800-1  652-18-6  Skin Irrit. 2 \nEye Dam. 1  H315 \nH318  GHS05 \nDgr H315 \nH318  \n607-449-00-7  reaction mass of: 4,4',4''-[(2,4,6- \ntrioxo-1,3,5(2 H,4H,6H)-triazine- \n1,3,5-triyl)tris[methylene(3,5,5- \ntrimethyl-3,1-cyclohex\xad\nanediyl)iminocarbonyloxy-2,1- \nethanediyl(ethyl)amino]]trisben\xad\nzenediazoniumtri[bis(2-methyl\xad\npropyl)naphthalenesulfon\xad\nate];4,4',4'',4'''-[[5,5'-[carbonyl\xad\nbis[imino(1,5,5-trimethyl-3,1- \ncyclohexanediyl)methylene]]- \n2,4,6-trioxo-1,3,5(2 H,4H,6H)- \ntriazine-1,1',3,3'-tetrayl]tetra\xad\nkis[methylene(3,5,5-trimethyl- \n3,1-cyclohexanediyl)iminocar\xad\nbonyloxy-2,1-ethane\xad\ndiyl(ethyl)amino]]tetrakisben\xad\nzenediazoniumtetra[bis(2-methyl\xad\npropyl)naphthalenesulfonate]  417-080-1  —  Self-react. D **** \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H242 \nH317 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nDgr H242 \nH317 \nH410  \n607-450-00-2  2-mercaptobenzothiazolyl-( Z)-(2- \naminothiazol-4-yl)-2-( tert- \nbutoxycarbonyl) isopropoxyimi\xad\nnoacetate  419-040-9  89604-92-2  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 844}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 846\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-451-00-8  4-[4-amino-5-hydroxy-3-(4-(2- \nsulfoxyethylsulfonyl)phenylazo)- \n2,7-disulfonapht-6-ylazo]-6-[3- \n(4-amino-5-hydroxy-3-(4-(2-sulf\xad\noxyethylsulfonyl)phenylazo)-2,7- \ndisulfonapht-6-ylazo]phenylcar\xad\nbonylamino]benzenesulfonic \nacid, sodium salt  417-640-5  161935-19-9  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-453-00-9  4-benzyl-2,6-dihydroxy-4-aza- \nheptylene bis (2,2-dimethyloct\xad\nanoate)  418-100-1  172964-15-7  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n607-454-00-4  reaction mass of:  trans -2-(1- \nmethylethyl)-1,3-dioxane-5- \ncarboxylic acid;  cis-2-(1-methyl\xad\nethyl)-1,3-dioxane-5-carboxylic \nacid 418-170-3  116193-72-7  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-455-00-X  1-amino-4-(3-[4-chloro-6-(2,5-di- \nsulfophenylamino)-1,3,5-triazin- \n2-ylamino]-2,2-dimethyl-propy\xad\nlamino)-anthraquinone-2-sulfonic \nacid, sodium/lithium salt  419-520-8  172890-93-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-456-00-5  3-amino-4-chlorobenzoic acid, \nhexadecyl ester  419-700-6  143269-74-3  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 845}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 847\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-457-00-0  tetrasodium dihydrogen 1,1''- \ndihydroxy-8,8''-[p- \nphenylbis(imino-{6-[4-(2- \naminoethyl)piperazin-1-yl]}- \n1,3,5-triazine-4,2-diyl- \nimino)]bis(2,2'-azonaphthalene- \n1',3,6-trisulfonate)  420-350-1  172277-97-3  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n607-458-00-6  reaction mass of: 2-ethyl-[2,6- \ndibromo-4-[1-[3,5-dibromo-4-(2- \nhydroxyethoxy)phenyl]-1-methyl\xad\nethyl]phenoxy]propenoate; 2,2'- \ndiethyl-[4,4'-bis(2,6-dibromop\xad\nhenoxy)-1-methylethylidene] \ndipropenoate;2,2'-[(1-methyl\xad\nethylidene)bis[[2,6-dibromo-4,1- \nphenylene)oxy]ethanol]]  420-850-1  —  Aquatic Chronic 2  H411  GHS09  H411  \n607-459-00-1  isopentyl 4-{2-[5-cyano-1,2,3,6- \ntetrahydro-1-(2-isopropoxye\xad\nthoxy-carbonylmethyl)-4-methyl- \n2,6-dioxo-3-pyridylidene]hy\xad\ndrazino}benzoate  418-930-4  —  Aquatic Chronic 4  H413  —  H413  \n607-460-00-7  3-tridecyloxy-propyl-ammonium \n9-octadecenoate  418-990-1  778577-53-0  STOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** H319 \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 ** \nH319 \nH315 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 846}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 848\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-461-00-2  reaction mass of: pentasodium 2- \n{4-{3-methyl-4-[6-sulfonato-4- \n(2-sulfonato-phenylazo)-naph\xad\nthalen-1-ylazo]-phenylamino}-6- \n[3-(2-sulfato-ethanesulfonyl)- \nphenylamino]-1,3,5-triazin-2- \nylamino}-benzene-1,4- \ndisulfonate; pentasodium 2-{4- \n{3-methyl-4-[7-sulfonato-4-(2- \nsulfonato-phenylazo)-naphthalen- \n1-ylazo]-phenylamino}-6-[3-(2- \nsulfato-ethanesulfonyl)-pheny\xad\nlamino]-1,3,5-triazin-2-ylamino}- \nbenzene-1,4-disulfonate  421-160-1  —  Aquatic Chronic 3  H412  —  H412  \n607-462-00-8  reaction mass of: 1-hexyl acetate; \n2-methyl-1-pentyl acetate; 3- \nmethyl-1-pentyl acetate; 4- \nmethyl-1-pentyl acetate; other \nmixed linear and branched C  6- \nalkyl acetates  421-230-1  88230-35-7  Aquatic Chronic 2  H411  GHS09  H411  \n607-463-00-3  3-(phenothiazin-10-yl)propionic \nacid 421-260-5  362-03-8  Aquatic Chronic 2  H411  GHS09  H411  \n607-464-00-9  reaction mass of: 7-chloro-1- \nethyl-6-fluoro-1,4-dihydro-4-oxo- \nquinoline-3-carboxylic acid; 5- \nchloro-1-ethyl-6-fluoro-1,4- \ndihydro-4-oxo-quinoline-3- \ncarboxylic acid  421-280-4  Aquatic Chronic 3  H412  —  H412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 847}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 849\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-465-00-4  tris(2-hydroxyethyl)ammonium \n7-{4-[4-(2-cyanoamino-4- \nhydroxy-6-oxidopyrimidin-5- \nylazo)benzamido]-2-ethoxy- \nphenylazo}naphthalene-1,3- \ndisulfonate  421-440-3  778583-04-3  Aquatic Chronic 3  H412  —  H412  \n607-466-00-X  reaction mass of: phenyl 1-(1-[2- \nchloro-5-(hexadecyloxycar\xad\nbonyl)phenylcarbamoyl]-3,3- \ndimethyl-2-oxobutyl)-1 H- \n2,3,3a,7a-tetrahydrobenzo\xad\ntriazole-5-carboxylate; phenyl 2- \n(1-(2-chloro-5-(hexadecyloxycar\xad\nbonyl)phenylcarbamoyl)-3,3- \ndimethyl-2-oxobutyl)-1 H- \n2,3,3a,7a-tetrahydrobenzo\xad\ntriazole-5-carboxylate; phenyl 3- \n(1-(2-chloro-5-(hexadecyloxycar\xad\nbonyl)phenylcarbamoyl)-3,3- \ndimethyl-2-oxobutyl)-1 H- \n2,3,3a,7a-tetrahydrobenzo\xad\ntriazole-5-carboxylate  421-480-1  —  Aquatic Chronic 2  H411  GHS09  H411  \n607-467-00-5  1,1,3,3-tetrabutyl-1,3-ditinoxydi\xad\ncaprylate  419-430-9  56533-00-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH373 ** H314 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH373 ** \nH314 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 848}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 850\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-468-00-0  reaction mass of: monosodium 4- \n((4-(5-sulfonato-2-methoxyp\xad\nhenylamino)-6-chloro-1,3,5- \ntriazine-2-yl)amino)-2-((1,4- \ndimethyl-6-oxido-2-oxo-5-sulfon\xad\natomethyl-1,2-dihydropyridine-3- \nyl)azo)benzenesulfonate; \ndisodium 4-((4-(5-sulfonato-2- \nmethoxyphenylamino)-6-chloro- \n1,3,5-triazine-2-yl)amino)-2- \n((1,4-dimethyl-6-oxido-2-oxo-5- \nsulfonatomethyl-1,2-dihydro\xad\npyridine-3-yl)azo)benzenesul\xad\nfonate; trisodium 4-((4-(5- \nsulfonato-2-methoxypheny\xad\nlamino)-6-chloro-1,3,5-triazine-2- \nyl)amino)-2-((1,4-dimethyl-6- \noxido-2-oxo-5-sulfonatomethyl- \n1,2-dihydropyridine-3- \nyl)azo)benzenesulfonate; tetra\xad\nsodium 4-((4-(5-sulfonato-2- \nmethoxyphenylamino)-6-chloro- \n1,3,5-triazine-2-yl)amino)-2- \n((1,4-dimethyl-6-oxido-2-oxo-5- \nsulfonatomethyl-1,2-dihydro\xad\npyridine-3-yl)azo)benzenesul\xad\nfonate  419-450-8  —  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 849}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 851\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-469-00-6  disodium 7-((4,6-bis(3-diethy\xad\nlaminopropylamino)-1,3,5- \ntriazine-2-yl)amino)-4-hydroxy- \n3-(4-(4-sulfonatopheny\xad\nlazo)phenylazo)-2-naphthalene \nsulfonate  419-460-2  120029-06-3  Aquatic Chronic 3  H412  —  H412  \n607-470-00-1  potassium sodium 6,13-dichloro- \n3,10-bis{2-[4-[3-(2-hydroxysul\xad\nphonyloxyethanesulfonyl)pheny\xad\nlamino]-6-(2,5-disulfonatopheny\xad\nlamino)-1,3,5-triazin-2- \nylamino]ethy\xad\nlamino}benzo[5,6][1,4]ox\xad\nazino[2,3-b]phenoxazine-4,11- \ndisulfonate  414-100-0  154336-20-6  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-471-00-7  1,6-bis((dibenzylthiocarba\xad\nmoyl)disulfanyl)hexane  429-280-6  151900-44-6  Aquatic Chronic 4  H413  —  H413  \n▼M1 __________  \n▼M16  \n607-473-00-8  pentaerythritol, dipentaerythritol, \nfatty acids, C  6-10, mixed esters \nwith adipic acid, heptanoic acid \nand isostearic acid  426-590-3  187412-41-5  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-474-00-3  (4-(4-(4-dimethylaminobenzy\xad\nliden-1-yl)-3-methyl-5-oxo-2- \npyrazolin-1-yl)benzoic acid  410-430-4  117573-89-4  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 850}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 852\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-475-00-9  reaction mass of: tetrasodium 7- \n(4-[4-chloro-6-[methyl-(3-sulfon\xad\natophenyl)amino]-1,3,5-triazin-2- \nylamino]-2-ureidopheny\xad\nlazo)naphthalene-1,3,6-trisul\xad\nfonate; tetrasodium 7-(4-[4- \nchloro-6-[methyl-(4-sulfonatop\xad\nhenyl)amino]-1,3,5-triazin-2- \nylamino]-2-ureidopheny\xad\nlazo)naphthalene-1,3,6-trisul\xad\nfonate (1:1)  412-940-2  148878-18-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-476-00-4  trisodium  N, N -bis(carboxy\xad\nmethyl)-β-alanine  414-070-9  129050-62-0  Skin Corr. 1B \nAquatic Chronic 3  H314 \nH412  GHS05 \nDgr H314 \nH412  \n607-477-00-X  (1α5α6α)-6-nitro-3-benzyl-3- \nazabicyclo[3.1.0]hexane \nmethanesulfonate salt  426-740-8  —  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n607-478-00-5  tetramethylammonium hydrogen \nphthalate  416-900-5  79723-02-7  Acute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1  H301 \nH373 ** H400  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH373 ** \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 851}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 853\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-479-00-0  hexadecyl 4-chloro-3-[2-(5,5- \ndimethyl-2,4-dioxo-1,3- \noxazolidin-3-yl)-4,4-dimethyl-3- \noxopentamido]benzoate  418-550-9  168689-49-4  Aquatic Chronic 4  H413  —  H413  \n607-480-00-6  1,2-benzenedicarboxylic acid; di- \nC 7-11-branched and linear alky\xad\nlesters  271-084-6  68515-42-4  Repr. 1B  H360Df  GHS08 \nDgr H360Df  \n607-481-00-1  reaction mass of: trihexyl citrate; \ndihexyloctyl citrate; dioctylhexyl \ncitrate; dihexyldecyl citrate  430-290-8  —  Aquatic Chronic 4  H413  —  H413  \n607-482-00-7  N-[1-(S)-ethoxycarbonyl-3- \nphenylpropyl]-L-alanyl- N-carbo\xad\nxyanhydride  430-360-8  84793-24-8  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-483-00-2  1,2-benzenedicarboxylic acid; di- \nC 6-8-branched alkylesters, C  7- \nrich 276-158-1  71888-89-6  Repr. 1B  H360D***  GHS08 \nDgr H360D***  \n607-484-00-8  ethyl 2-{[3-acetylamino-4-(6- \nbromo-2-methyl-1,3-dioxo-2,3- \ndihydro-1 H-isoindol-5-ylazo)phe\xad\nnyl{]ethylamino[}propionate  430-480-0  221452-67-1  Aquatic Chronic 4  H413  —  H413  \n607-485-00-3  ( 3 S-trans )-phenyl-3-[(1,3-benzo\xad\ndioxol-5-yloxy)methyl]-4-(4- \nfluorophenyl)-1-piperidinecar\xad\nboxylate  430-510-2  —  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 852}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 854\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-486-00-9  potassium sodium 5'-(6-chloro-4- \n(2-(2-vinylsulfonylethoxy)ethy\xad\nlamino)-1,3,5-triazin-2-ylamino)- \n4'-hydroxy-2,3'-azodinaph\xad\nthalene-1,2', 5,7'-disulfonate  402-110-8  110081-40-8  Aquatic Chronic 3  H412  —  H412  \n607-487-00-4  reaction mass of: disodium 4-(3- \nethoxycarbonyl-4-(5-(3-ethoxy\xad\ncarbonyl-5-hydroxy-1-(4-sulfon\xad\natophenyl)pyrazol-4-yl)penta-2,4- \ndienylidene)-4,5-dihydro-5- \noxopyrazol-1-yl)benzenesul\xad\nfonate; trisodium 4-(3-ethoxycar\xad\nbonyl-4-(5-(3-ethoxycarbonyl-5- \noxido-1-(4-sulfonatophenyl)py\xad\nrazol-4-yl)penta-2,4-dienylidene)- \n4,5-dihydro-5-oxopyrazol-1- \nyl)benzenesulfonate  402-660-9  —  Repr. 1B \nAquatic Chronic 3  H360D *** \nH412  GHS08 \nDgr H360D *** \nH412  \n607-488-00-X  ethyl (2-acetylamino-5-fluoro-4- \nisothiocyanatophenoxy)acetate  414-210-9  147379-38-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-489-00-5  reaction mass of: 2-ethylhexyl \nlinolenate, linoleate and oleate; \n2-ethylhexyl epoxyoleate; 2- \nethylhexyl diepoxylinoleate; 2- \nethylhexyl triepoxylinolenate  414-890-7  71302-79-9  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-490-00-0  N-[2-hydroxy-3-(C  12-16-alky\xad\nloxy)propyl]- N-methyl glycinate  415-060-7  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 853}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 855\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-491-00-6  reaction mass of: diester of 4,4'- \nmethylenebis[2-(2-hydroxy-5- \nmethylbenzyl)-3,6-dimethyl\xad\nphenol] and 6-diazo-5,6-dihydro- \n5-oxonaphthalene-1-sulfonic acid \n(1:2); triester of 4,4'-methylene\xad\nbis[2-(2-hydroxy-5-methyl\xad\nbenzyl)-3,6-dimethylphenol] and \n6-diazo-5,6-dihydro-5-oxonaph\xad\nthalene-1-sulfonic acid (1:3)  427-140-9  —  Carc. 2  H351  GHS08 \nWng  H351  \n607-492-00-1  2-(1-(3',3'-dimethyl-1'-cyclo\xad\nhexyl)ethoxy)-2-methyl propyl \npropanoate  415-490-5  141773-73-1  Aquatic Chronic 2  H411  GHS09  H411  \n607-493-00-7  methyl (3a R,4R,7aR)-2-methyl-4- \n(1S,2R,3-triacetoxypropyl)-3a,7a- \ndihydro-4 H-pyrano[3,4-d]ox\xad\nazole-6-carboxylate  415-670-3  78850-37-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-494-00-2  bis(2-ethylhexyl)octylphos\xad\nphonate  417-170-0  52894-02-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-495-00-8  sodium 4-sulfophenyl-6-((1- \noxononyl)amino)hexanoate  417-550-6  168151-92-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-496-00-3  2,2'-methylenebis(4,6-di- tert- \nbutyl-phenyl)-2-ethylhexyl \nphosphite  418-310-3  126050-54-2  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 854}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 856\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-497-00-9  cerium oxide isostearate  419-760-3  —  Aquatic Chronic 4  H413  —  H413  \n607-498-00-4  (E)-3,7-dimethyl-2,6-octadie\xad\nnylhexadecanoate  421-370-3  3681-73-0  Skin Irrit. 2 \nAquatic Chronic 4  H315 \nH413  GHS07 \nWng  H315 \nH413  \n607-499-00-X  bis(dimethyl-(2-hydroxye\xad\nthyl)ammonium) 1,2-ethanediyl- \nbis(2-hexadecenylsuccinate)  421-660-1  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n607-500-00-3  calcium 2,2,bis[(5-tetrapropylene- \n2-hydroxy)phenyl]ethanoate  421-670-4  —  Skin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH410  \n607-501-00-9  reaction mass of: triphenylthiop\xad\nhosphate and tertiary butylated \nphenyl derivatives  421-820-9  192268-65-8  Aquatic Chronic 4  H413  —  H413  \n607-502-00-4  (N-benzyl- N, N,N -tributyl)am\xad\nmonium 4-dodecylbenzenesul\xad\nfonate  422-200-0  178277-55-9  Skin Corr. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H314 \nH302 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH302 \nH411  \n607-503-00-X  2,4,6-tri- n-propyl-2,4,6-trioxo- \n1,3,5,2,4,6-trioxatriphospho\xad\nrinane  422-210-5  68957-94-8  Skin Corr. 1B  H314  GHS05 \nDgr H314  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 855}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 857\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-504-00-5  diammonium 1-hydroxy-2-(4-(4- \ncarboxyphenylazo)-2,5-dimetho\xad\nxyphenylazo)-7-amino-3-naph\xad\nthalenesulfonate  422-670-7  —  Repr. 2 \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H361f \nH301 \nH373** H400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361f \nH301 \nH373** \nH410  \n607-505-00-0  pentasodium 7-(4-(4-(5-amino-4- \nsulfonato-2-(4-((2-(sulfonato- \nethoxy)sulfonyl)pheny\xad\nlazo)phenylamino)-6-chloro- \n1,3,5-triazin-2-yl)amino-2- \nureidophenylazo)naphtalene- \n1,3,6-trisulfonate  422-930-1  Aquatic Chronic 3  H412  —  H412  \n607-506-00-6  reaction mass of: strontium (4- \nchloro-2-((4,5-dihydro-3-methyl- \n5-oxo-1-(3-sulfonatophenyl)-1 H- \npyrazol-4-yl)azo)-5-methyl)ben\xad\nzenesulfonate; disodium (4- \nchloro-2-((4,5-dihydro-3-methyl- \n5-oxo-1-(3-sulfonatophenyl)-1 H- \npyrazol-4-yl)azo)-5-methyl)ben\xad\nzenesulfonate  422-970-8  Aquatic Chronic 2  H411  GHS09  H411  \n607-507-00-1  potassium, sodium 2,4-diamino- \n3-[4-(2-sulfonatoethoxysulfo\xad\nnyl)phenylazo]-5-[4-(2-sulfon\xad\natoethoxysulfonyl)-2-sulfonatop\xad\nhenylazo]-benzenesulfonate  422-980-2  187026-95-5  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 856}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 858\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-508-00-7  disodium 3,3'-[iminobis[sulfonyl- \n4,1-phenylene-(5-hydroxy-3- \nmethylpyrazole-1,4-diyl)azo-4,1- \nphenylenesulfonylimino-(4- \namino-6-hydroxypyrimidine-2,5- \ndiyl)azo-4,1-phenylenesulfony\xad\nlimino(4-amino-6-hydroxypyri\xad\nmidine-2,5-diyl)azo]bis(benzene\xad\nsulfonate)]  423-110-4  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-509-00-2  2-phenoxyethyl 4-aminobenzoate  430-880-5  88938-23-2  Aquatic Chronic 2  H411  GHS09  H411  \n607-510-00-8  (2S, 5R )-6,6-dibromo-3,3- \ndimethyl-7-oxo-4-thia-1-azabi\xad\ncyclo[3.2.0]heptane-2-carboxylic \nacid 4,4-dioxide  427-200-4  76646-91-8  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H302 \nH315 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318 \nH317  \n607-511-00-3  reaction mass of: 4-[(3-decyloxy\xad\npropyl)(3-isobutoxy-1-isobutoxy\xad\ncarbonyl-3-oxopropyl)amino]-4- \noxobutyric acid; 4-[(3-isobutoxy- \n1-isobutoxycarbonyl-3-oxopro\xad\npyl)(3-octyloxypropyl)amino]-4- \noxobutyric acid  423-750-4  —  Eye Irrit. 2 \nAquatic Chronic 2  H319 \nH411  GHS07 \nGHS09 \nWng  H319 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 857}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 859\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-512-00-9  trisodium 2,4-diamino-3,5-bis-[4- \n(2-sulfonatoethoxy)sulfo\xad\nnyl)phenylazo]benzenesulfonate  423-970-0  182926-43-8  Aquatic Chronic 3  H412  —  H412  \n607-513-00-4  reaction mass of: trisodium 4- \nbenzoylamino-6-(6-ethenesul\xad\nfonyl-1-sulfato-naphthalen-2- \nylazo)-5-hydroxynaphthalene- \n2,7-disulfonate; 5-(benzoy\xad\nlamino)-4-hydroxy-3-((1-sulfo-6- \n((2-(sulfooxy)ethyl)sulfonyl)-2- \nnaphthyl)azo)naphthalene-2,7- \ndisulfonic acid sodium salt; 5- \n(benzoylamino)-4-hydroxy-3-((1- \nsulfo-6-((2-(sulfooxy)ethyl)sul\xad\nfonyl)-2-naphthyl)azo)naph\xad\nthalene-2,7-disulfonic acid  423-200-3  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n607-514-00-X  potassium  N -(1-methoxy-1- \noxobut-2-en-3-yl)valinate  427-240-2  134841-35-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-515-00-5  reaction mass of: disodium \nhexyldiphenyl ether \ndisulphonate; disodium dihexyl\xad\ndiphenyl ether disulphonate  429-650-7  147732-60-3  Eye Irrit. 2 \nAquatic Chronic 2  H319 \nH411  GHS07 \nGHS09 \nWng  H319 \nH411  \n607-516-00-0  N, N '-bis(trifluoroacetyl)- S, S '- \nbis-L-homocysteine  429-670-6  105996-54-1  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 858}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 860\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-517-00-6  (S)-α-(acetylthio)benzenepro\xad\npanoic acid  430-300-0  76932-17-7  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317  \n607-518-00-1  3-oxoandrost-4-ene-17-β- \ncarboxylic acid  414-990-0  302-97-6  Repr. 2 \nAquatic Chronic 4  H361f \nH413  GHS08 \nWng  H361f \nH413  \n607-519-00-7  poly-[((4-((4-ethyl-ethy\xad\nlene)amino)phenyl)-((4-(ethyl-(2- \noxyethylene)amino)phenyl)methi\xad\nnyl)cyclohexa-2,5-dienylidene)-  \nN-ethyl- N-(2-hydroxyethyl)am\xad\nmonium acetate]  427-280-0  176429-27-9  STOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H335 \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H335 \nH315 \nH318 \nH410  \n607-520-00-2  reaction mass of: sodium 4,5- \ndihydro-2-[(propionato)(C  6-18) \nalkyl]-3 H-imidazolium- N-ethylp\xad\nhosphate; disodium 4,5-dihydro- \n2-[(dipropionato)(C  6-18)alkyl]- \n3H-imidazolium- N-ethylphos\xad\nphate  427-740-0  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-521-00-8  tetraethyl  N, N '-(methylenedi\xad\ncyclohexane-4,1-diyl)bis-DL- \naspartate  429-270-1  136210-30-5  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-522-00-3  sodium salt of the polymer \nof:sodium 2-methyl-buta-1,3- \ndiene-1-sulfonate with acrylic \nacid and 2-hydroxyethyl-2- \nmethylacrylate  429-720-7  184246-86-4  Aquatic Chronic 3  H412  —  H412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 859}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 861\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-523-00-9  reaction mass of mono to \ntetra(lithium and/or sodium)3- \namino-10-[4-(4-amino-3-sulfon\xad\natoanilino)-6-[methyl-(2-sulfon\xad\natoethyl)amino]-1,3,5-triazin-2- \nylamino]-6-13-dichloro\xad\nbenzo[1,2-B:4,5-B']di[1,4]benz\xad\noxazine-4,11-disulfonate; mono \nto tetra(lithium and/or sodium)3- \namino-10-[4,6-bis(4-amino-3- \nsulfonatoanilino)-1,3,5-triazin-2- \nylamino]-6-13-dichloro\xad\nbenzo[1,2-B:4,5-B']di[1,4]benz\xad\noxazine-4,11-disulfonate; mono \nto penta(lithium and/or \nsodium)10,10'-diamino- \n6,6',13,13'-tetrachloro-3,3'-[6- \n[methyl-(2-sulfonatoe\xad\nthyl)amino]-1,3,5-triazin-2,4- \ndiyldiimino]bis[benzo[1,2-B:4,5- \nB']di[1,4]benzoxazine-4,11- \ndisulfonate; mono to \nhepta(lithium and/or sodium)10- \namino-6,6', 13,13'-tetrachloro- \n10'[4-(4-amino-3-sulfonatoa\xad\nnilino)-[6-methyl-(2-sulfonatoe\xad\nthyl)amino]-1,3,5-triazin-2,4- \ndiimino]bis[benzo[1,2-B:4,5- \nB']di[1,4]benzoxazine-4,11- \ndisulfonate; mono to hepta \n(lithium and/or sodium)10,10'- \ndiamino-6,6',3,3'[(2-sulfonato)- \n1,4-phenylenediiminobis[6- \nmethyl-(2-sulfonatoethyl)amino]-  430-200-7  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 860}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 862\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n1,3,5-triazin-2,4- \ndiyldiimino]bis[benzo[1,2-B:4,5- \nB']di[1,4]benzoxazine-4,11- \ndisulfonate  \n607-524-00-4  tall oil 2-[(tetrahydro-2 H-pyran- \n2-yl) thio]ethyl esters  430-310-5  —  Aquatic Chronic 4  H413  H413  \n607-525-00-X  (Z)-2-methoxymino-2-[2-(trity\xad\nlamino)thiazol-4-yl]acetic acid  431-520-1  64485-90-1  Flam. Sol. 1**** \nCarc. 2 \nAquatic Chronic 3  H228 \nH351 \nH412  GHS02 \nGHS08 \nDgr H228 \nH351 \nH412  \n607-526-00-5  cartap (ISO); 1,3-bis(carba\xad\nmoylthio)-2-(dimethyl\xad\namino)propane  — 15263-53-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-527-00-0  Reaction mass of: 1- \n(1'H,1'H,2'H,2'H-tridecafluoro\xad\noctyl)-12-(1'' H,1''H,2''H,2''H- \ntridecafluorooctyl)dodecan\xad\nedioate; 1-(1' H,1'H,2'H,2'H-tride\xad\ncafluorooctyl)-12- \n(1''H,1''H,2''H,2''H-heptdecafluor\xad\nodecyl)dodecanedioate;  423-180-6  —  STOT RE 2 *  H373 **  GHS08 \nWng  H373 **  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 861}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 863\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n1-(1'H,1'H,2'H,2'H-tridecafluoro\xad\noctyl)-12-(1'' H,1''H,2''H,2''H- \nheneicosafluorododecyl)dodecan\xad\nedioate; 1-(1' H,1'H,2'H,2'H-tride\xad\ncafluorooctyl)-12- \n(1''H,1''H,2''H,2''H-pentacosaflu\xad\norotetradecyl)dodecanedioate; 1- \n(1'H,1'H,2'H,2'H-heptadecafluor\xad\nodecyl)-12-(1'' H,1''H,2''H,2''H- \nheptadecafluorodecyl)dodecan\xad\nedioate; 1-(1' H,1'H,2'H,2'H- \nheptadecafluorodecyl)-12- \n(1''H,1''H,2''H,2''H-heneicosaflu\xad\norododecyl)dodecanedioate  \n607-528-00-6  (S)-3-methyl-2-(2-oxotetrahydro\xad\npyrimidine-1-yl)butyric acid  430-900-2  192725-50-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-529-00-1  benzyl  cis -4-ammonium-4'- \ntoluenesulfonato-1-cyclohex\xad\nanecarboxylate  426-070-6  67299-45-0  Aquatic Chronic 3  H412  —  H412  \n607-530-00-7  reaction mass of isomers of: C  7- \n9-alkyl 3-(3,5-di- tert-butyl-4- \nhydroxyphenyl)propionate  406-040-9  125643-61-0  Aquatic Chronic 4  H413  —  H413  \n607-531-00-2  methyl 3-amino-4,6-dibromo-2- \nmethyl-benzoate  425-190-6  119916-05-1  STOT RE 2 * \nAquatic Chronic 2  H373** H411  GHS08 \nGHS09 \nWng  H373** \nH411  \n607-532-00-8  (S)-1-[2- tert-butoxycarbonyl-3- \n(2-methoxyethoxy)propyl]-1- \ncyclopentanecarboxylic acid, \ncyclohexylamine salt  425-510-4  167944-94-7  Aquatic Chronic 3  H412  —  H412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 862}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 864\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-533-00-3  pentasodium monohydrogen 6- \nchloro-3,10-bis[2-[4-chloro-6- \n(2,4-disulfophenylamino)-1,3,5- \ntriazin-2-yl-amino]ethylamino]- \n13-ethylbenzo[5.6][1.4]ox\xad\nazino[2,3-b]phenoxazine-4,11- \ndisulfonate  414-910-4  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-534-00-9  ethyl 2-(3-benzoylphenyl)pro\xad\npanoate  414-920-9  60658-04-0  Acute Tox. 3 * \nSTOT RE 1 \nSkin Sens. 1 \nAquatic Chronic 2  H301 \nH372** H317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH372** \nH317 \nH411  \n607-535-00-4  potassium 4-iodo-2-sulfonato- \nbenzoic acid  426-620-5  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-536-00-X  (2,6-xylyloxy) acetic acid  430-910-7  13335-71-2  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n607-537-00-5  isopropylammonium 2-(3- \nbenzoylphenyl)propionate  417-970-1  —  Acute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 1 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH312 \nH372** H318 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H301 \nH312 \nH372** \nH318 \nH410  \n607-539-00-6  propyl((4-(5-oxo-3-propylis\xad\noxazolidin-4-ylidenmethin)phe\xad\nnyl)propoxycarbonylmethyl\xad\neneamino)acetate  431-000-2  198705-81-6  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 863}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 865\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-540-00-1  1-(mercaptomethyl)cyclopropy\xad\nlacetic acid  420-240-3  162515-68-6  Skin Corr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H314 \nH312 \nH302 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH312 \nH302 \nH317 \nH411  \n607-541-00-7  [(1-methyl-1,2-ethanediyl)bis[ni\xad\ntrilobis(methylene)]]tetra\xad\nkis(phosphonic acid)  421-940-1  28698-31-9  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n607-542-00-2  methyl 2-(4-butanesulfonamid\xad\nophenoxy)tetradecanoate  422-110-1  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-543-00-8  poly-[((4-((4-(ethyl-ethy\xad\nlene)amino)phenyl)-(4-(ethyl-(2- \noxyethylene)amino)phe\xad\nnyl)methinyl)-3-methyl\xad\ncyclohexa-2,5-dienylidene)- N- \nethyl- N-(2-hydroxyethyl)am\xad\nmonium acetate]  427-480-8  176429-22-4  STOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H335 \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H335 \nH315 \nH318 \nH410  \n607-544-00-3  ethyl 6,8-difluoro-1-(formylme\xad\nthylamino)-1,4-dihydro-7-(4- \nmethyl)piperazin-1-yl)-4-oxo- \nquinoline-3-carboxylate  427-490-2  158585-86-5  Aquatic Chronic 3  H412  —  H412  \n607-545-00-9  1,2-dimethyl-3-(1-methylethe\xad\nnyl)cyclopentyl acetate  424-070-0  94346-09-5  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 864}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 866\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-546-00-4  reaction mass of: methyl {[5- \nacetylamino-4-(2-chloro-4-nitro\xad\nphenylazo)phenyl]methoxycar\xad\nbonylmethylamino}acetate; \nmethyl {[5-acetylamino-4-(2- \nchloro-4-nitrophenylazo)phe\xad\nnyl]ethoxycarbonylmethyl\xad\namino}acetate  424-290-7  188070-47-5  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-547-00-X  18-methylnonadecyl 2,2- \ndimethylpropanoate  424-370-1  125496-22-2  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H315 \nH317 \nH413  GHS07 \nWng  H315 \nH317 \nH413  \n607-548-00-5  1-(2,4-dichlorophenyl)-2-(1 H- \nimidazol-1-yl)ethanone methane\xad\nsulfonate  431-010-7  154486-26-7  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n607-549-00-0  methyl ( E)-2((3-(1,3-benzo\xad\ndioxol-5-yl)-2-methyl-1-prope\xad\nnyl)amino)benzoate  424-430-7  125778-19-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 865}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 867\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-550-00-6  2-amino-4-bromo-5-chloro\xad\nbenzoic acid  424-700-4  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-551-00-1  tetrabutylammonium 2-amino-6- \niodopurinate  424-710-9  156126-48-6  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H312 \nH302 \nH373** H315 \nH318 \nH317 \nH411  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH373** \nH315 \nH318 \nH317 \nH411  \n607-552-00-7  hexadecyl -amino-4-isopropoxy\xad\nbenzoate  424-830-1  —  Aquatic Chronic 4  H413  —  H413  \n607-553-00-2  7-amino-4-hydroxy-2-naphtha\xad\nlenesulfonic acid, coupled with 5 \n(or 8) -amino-8 (or 5)-[[4-[[4-[[4- \namino-6(or 7)-sulfo-1-naph\xad\nthyl]azo]phenyl]amino]-3-sulfop\xad\nhenyl]azo]-2-naphthalenesulfonic \nacid and 4-hydroxy-7-(pheny\xad\nlamino)-2-naphthalenesulfonic \nacid, sodium salt  424-850-0  —  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 866}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 868\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-554-00-8  2,4-diamino-5-[4-[(2-sulfoxyl \nethyl)sulfonyl]phenylazo]ben\xad\nzenesulfonic acid  424-870-1  27624-67-5  Expl. 1.1 \nEye Dam. 1 \nAquatic Chronic 3  H201 \nH318 \nH412  GHS01 \nGHS05 \nDgr H201 \nH318 \nH412  \n607-555-00-3  1,1,3,3-tetramethylbutylperoxypi\xad\nvalate  424-980-8  22288-41-1  Flam. Liq. 2 \nOrg. Perox. D \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H225 \nH242 \nH315 \nH317 \nH411  GHS02 \nGHS07 \nGHS09 \nDgr H225 \nH242 \nH315 \nH317 \nH411  \n607-556-00-9  2-acetoxymethylene-4-acetyl\xad\nphenylacetate  425-160-2  24085-06-1  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** H318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 Dgr  H302 \nH373** \nH318 \nH317 \nH410  \n607-557-00-4  salt of: (1 S-cis)-1-amino-2,3- \ndihydro-1 H-inden-2-ol and [ R- \n[R*R*]]-2,3-dihydroxybu\xad\ntanedioic acid  425-210-3  169939-84-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-558-00-X  2S-isopropyl-5 R-methyl-1 R- \ncyclohexyl (2 R, 5S)-5-(4-amino- \n2-oxo-2 H-pyrimidin-1-yl)-[1.3]- \noxathiolane-2-carboxylate  425-250-1  147027-10-9  Aquatic Chronic 2  H411  GHS09  H411  \n607-559-00-5  coconut oil, reaction products \nwith glycerol esters of 3,5- \nbis(1,1-dimethylethyl)-4- \nhydroxybenzenepropanoic acid  425-400-6  179986-09-5  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 867}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 869\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-560-00-0  (R, S)-2-butyloctanedioic acid  431-210-4  50905-10-7  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-561-00-6  sodium 4-hydroxy-3-( N'-(2-(2- \nhydroxyethylenesulfonyl)ethy\xad\nlene)ureido)-5-nitrobenzenesul\xad\nfonate  425-460-3  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-562-00-1  reaction mass of: ( 2R, 3R )-3-(2- \nethoxyphenoxy)-2-hydroxy-3- \nphenylpropylammonium \nmethanesulfonate; ( 2S, 3S )-3-(2- \nethoxyphenoxy)-2-hydroxy-3- \nphenylpropylammonium \nmethanesulfonate  425-530-3  98769-75-6  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n607-563-00-7  5,7-dichloro-4-hydroxyquinoline- \n3-carboxylic acid  431-250-2  171850-30-9  Aquatic Chronic 2  H411  GHS09  H411  \n607-564-00-2  1,6-hexanediammonium, sodium \n5-sulfato-1,3-benzenedicar\xad\nboxylate  425-730-0  51178-75-7  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 868}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 870\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-565-00-8  3-ethyl 5 methyl 2-(2-aminoe\xad\nthoxymethyl)-4-(2-chlorophenyl)- \n1,4-dihydro-6-methyl-3,5-pyridi\xad\nnedicarboxylate  425-820-1  88150-42-9  Acute Tox. 3 * \nSTOT RE 2 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH373** H318 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H301 \nH373** \nH318 \nH410  \n607-566-00-3  reaction mass of: dodecylphenyl \ndodecylhydroxybenzenecar\xad\nboxylate; bis(dodecylphe\xad\nnyl)dodecyl hydroxybenzenedi\xad\ncarboxylate  426-140-6  —  Aquatic Chronic 4  H413  —  H413  \n607-567-00-9  potassium 3-iodo-6-methylben\xad\nzenesulfonate  426-300-5  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-568-00-4  potassium 2-chloro-3-(benzy\xad\nloxy)propionate  426-350-8  138666-92-9  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH373** H318 \nH317  GHS05 \nGHS08 \nGHS07 \nDgr H302 \nH373** \nH318 \nH317  \n607-569-00-X  reaction mass of: sodium 2- \namino-4-(2,6-difluoropyrimidin- \n4-ylamino)benzenesulfonate; \nsodium 2-amino-4-(4,6-difluor\xad\nopyrimidin-4-ylamino)benzene\xad\nsulfonate  426-470-0  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-570-00-5  sodium (6 R-trans )-7-amino-8- \noxo-3-[[[1-(sulfomethyl)-1 H- \ntetrazol-5-yl]thio]methyl]-5-thia- \n1-azabicyclo[4.2.0]oct-2-ene-2- \ncarboxylate monohydrate  426-520-1  71420-85-4  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-571-00-0  2-cyclopentene-1-acetic acid, 3- \nhydroxy-2-pentyl-, methyl ester \nacetate  431-400-7  57374-49-9  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 869}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 871\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-572-00-6  diethyl thiophosphoryl ( Z)-(2- \naminothiazol-4-yl)methoxyimino \nacetate  426-790-0  162208-27-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH373** H317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H312 \nH302 \nH373** \nH317 \nH410  \n607-573-00-1  reaction mass of: disodium 7- \n(2,4-difluoropyrimidin-6- \nylamino)-4-hydroxy-3-(4- \nmethoxy-2-sulfonatopheny\xad\nlazo)naphthalene-2-sulfonate; \ndisodium; 7-(4,6-difluoropyri\xad\nmidin-2-ylamino)-4-hydroxy-3- \n(4-methoxy-2-sulfonatopheny\xad\nlazo)naphthalene-2-sulfonate  426-840-1  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-574-00-7  [ 1 R-(1-α, 2β,5α)]-mono[5- \nmethyl-2-(1-methylethyl)cyclo\xad\nhexyl]butanedioate  426-890-4  77341-67-4  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-575-00-2  4-(5-(5-[1-(4-carboxyphenyl)hex\xad\nahydro-2,4,6-trioxopyrimidin-5- \nylidene]penta-1,3-dienyl)-1,2,3,4- \ntetrahydro-6-hydroxy-2,4-dioxo\xad\npyrimidin-1-yl)benzoic acid-trie\xad\nthylamine salt  426-900-7  —  STOT SE 3 \nAquatic Chronic 3  H335 \nH412  GHS07 \nWng  H335 \nH412  \n607-576-00-8  branched, octyl 3-[3,5-di( tert- \nbutyl)-4-hydroxyphenyl]pro\xad\npanoate  427-030-0  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 870}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 872\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-577-00-3  ( 2 R*, 3 S*)-2-(2,4-difluor\xad\nophenyl)-3-(5-fluoro-4-pyrimid\xad\ninyl)-1-(1 H-1,2,4-triazol-1- \nyl)butan-2-ol (1 R)-10-camphor\xad\nsulfonate  427-100-0  —  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317 \nH412  \n607-578-00-9  ethyl 4-((4-diethylamino-2- \nmethylphenyl)imino)-4,5- \ndihydro-1-isopropyl-5-oxo-1 H- \npyrazole-3-carboxylate  427-110-5  —  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 4  H302 \nH373** H413  GHS08 \nGHS07 \nWng  H302 \nH373** \nH413  \n607-579-00-4  diethyl[(p-ethoxyanilino)methyl\xad\nene]malonate  431-430-0  103976-28-9  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n607-580-00-X  ethyl 7-chloro-1-(2,4-difluor\xad\nophenyl)-6-fluoro-1,4-dihydro-4- \noxo-1,8-naphthyridine-3- \ncarboxylate  422-360-1  100491-29-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-581-00-5  ethyl 2-ethoxy-4-carboxymethyl\xad\nbenzoate  427-630-2  99469-99-5  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-582-00-0  reaction mass of: tetrasodium 7- \n(4-(4-fluoro-6-(4-(2-sulfonatoe\xad\nthylsulfonyl)phenylamino)-1,3,5- \ntriazin-2-ylamino)-2-ureidop\xad\nhenylazo)naphthalene-1,3,6- \ntrisulfonate; tetrasodium 7-(4-(4- \nhydroxy-6-(4-(2-sulfonatoe\xad\nthylsulfonyl)phenylamino)-1,3,5- \ntriazin-2-ylamino)-2-ureidop\xad\nhenylazo)naphthalene-1,3,6- \ntrisulfonate  427-650-1  —  Aquatic Chronic 3  H412  —  H412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 871}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 873\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-583-00-6  4-amino-3-[[4-[[2-(sul\xad\nfooxy)ethyl]sulfonyl]phenyl]azo]- \n1-naphthalene sulfonic acid  427-680-5  188907-52-0  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n607-584-00-1  trisodium 3-[2-acetylamino-4-[4- \nchloro-6-[4-(2-sulfonatoxy\xad\nethylsulfonyl)phenylamino]- \n1,3,5-triazine-2-ylamino]pheny\xad\nlazo]naphthalene-1,5-disulfonate  427-710-7  215612-56-9  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n607-585-00-7  strontium 2-[(2-hydroxy-6- \nsulfonato-1-naphthyl)azo]naph\xad\nthalene-1-sulfonate  427-930-3  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-586-00-2  dodecyl 3-amino-4-chloroben\xad\nzoate  428-020-9  6195-20-6  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n607-587-00-8  ethyl  cis-4-[4-[[2-(2,4-dichlorop\xad\nhenyl)-2-(1 H-imidazol-1-ylme\xad\nthyl)-1,3-dioxolan-4-yl]me\xad\nthoxy]phenyl]piperazine-1- \ncarboxylate  428-030-3  67914-69-6  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** H400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH410  \n607-588-00-3  reaction mass of: 2-ethylhexyl \n2,3,4,5-tetrabromobenzoate; \nbis(2-ethylhexyl) 3,4,5,6-tetrabro\xad\nmophthalate  428-050-2  —  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n607-589-00-9  tetrakis(1,2,2,6,6-pentamethyl-4- \npiperidyl)-1,2,3,4-butanetetracar\xad\nboxylate  428-070-1  91788-83-9  STOT RE 1 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H372** H302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H372** \nH302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 872}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 874\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-590-00-4  hexadecyl 3-[2-(5,5-dimethyl- \n2,4-dioxo-1,3-oxazolidin-3-yl)- \n4,4-dimethyl-3-oxovaleramido]- \n4-isopropoxybenzoate  428-140-1  210706-50-6  Aquatic Chronic 4  H413  —  H413  \n607-591-00-X  reaction mass of: trisodium 5-(4- \nfluoro-6-morpholin-4-yl-1,3,5- \ntriazin-2-ylamino)-4-hydroxy-3- \n(4-(2-sulfooxyethanesulfo\xad\nnyl)phenylazo)naphthalene-2,7- \ndisulfonate; disodium 3-(4- \nethenesulfonylphenylazo)-5-(4- \nfluoro-6-morpholin-4-yl-1,3,5- \ntriazin-2-ylamino)-4-hydroxy\xad\nnaphthalene-2,7-disulfonate  428-400-4  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-592-00-5  di(C  9-11-alkyl) cyclohexane-1,4- \ndicarboxylate  428-870-0  —  Aquatic Chronic 4  H413  —  H413  \n607-593-00-0  4-(2-methylacryloyloxy)phenyl4- \nallyloxybenzoate  429-000-2  159235-16-2  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n607-594-00-6  ethyl (1 S, 5R, 6S)-5-(1-ethylp\xad\nropoxy)-7-oxabicyclo[4.1.0]hept- \n3-ene-3-carboxylate  429-020-1  204254-96-6  STOT RE 2 * \nSkin Sens. 1  H373** H317  GHS08 \nGHS07 \nWng  H373** \nH317  \n607-595-00-1  N-amidino- N-methylglycine-2- \noxopropionate  429-120-5  208535-04-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-596-00-7  ethyl 2-(4-phenoxyphenyl)lactate  429-220-9  132584-17-9  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 873}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 875\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-597-00-2  tetrasodium 4,4'-bis{4-[4-(2- \nhydroxyethylamino)-6-(4-sulfon\xad\natoanilino)-1,3,5-triazin-2- \nylamino]phenylazo}stilbene-2,2'- \ndisulfonate  429-230-3  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-598-00-8  trisodium 3-amino-4-[4-[4-(2-(2- \nethenylsulfonylethoxy)ethy\xad\nlamino)-6-fluoro-1,3,5-triazine-2- \nylamino]-2-sulfophenylazo]-5- \nhydroxynaphthalene-2,7- \ndisulfonate  429-240-8  212652-59-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-599-00-3  1,1-dimethylpropyl 3,5,5- \ntrimethylperoxyhexanoate  431-610-9  68860-54-8  Org. Perox. D \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H242 \nH317 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nDgr H242 \nH317 \nH410  \n607-600-00-7  ( 1 S, 1'R)-[1-(3', 3'-dimethyl-1'- \ncyclohexyl)ethoxycar\xad\nbonyl]methyl propanoate  431-700-8  —  Aquatic Chronic 2  H411  GHS09  H411  \n607-601-00-2  1,4-dihydroxy-2,2,6,6-tetramethyl \npiperidinium-2-hydroxy-1,2,3- \npropanetricarboxylate  429-370-5  220410-74-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-602-00-8  ethyl (3-cyanomethyl-3,4- \ndihydro-4-oxophthalazin-1- \nyl)acetate  429-680-0  122665-86-5  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 874}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 876\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-603-00-3  lithium sodium 4,4', 4''-(nitrilo\xad\ntris(ethane-2,1-diylimino(6- \nchloro-1,3,5-triazine-4,2- \ndiyl)imino))tris(5-hydroxy-6-(1- \nsulfonaphthalene-2-ylazo)-2,7- \nnaphthalene)disulfonate  429-730-1  193562-37-7  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-604-00-9  guanidinium benzoate  429-820-0  26739-54-8  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-605-00-4  methyl 4-iodo-2-(3-(4-methoxy- \n6-methyl-1,3,5-triazine-2-yl)ure\xad\nidosulfonyl)benzoate  429-890-2  144550-06-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-606-00-X  (Z)-2-(2-t-butoxycarbonylamino- \n4-thiazolyl)pent-2-enoic acid  430-100-3  86978-24-7  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-607-00-5  reaction mass of: calcium \nbis(C  10-14 branched alkyl salicy\xad\nlate); calcium bis(C  18-30-alkyl \nsalicylate); calcium C  10-14 \nbranched alkylsalicylato-C  18-30- \nalkyl salicylate; calcium bis \n(C 10-14 branched alkyl phen\xad\nolate); calcium bis (C  18-30-alkyl \nphenolate); calcium C  10-14 \nbranched alkylphenolato-C  18-30- \nalkyl phenolate; C  10-14 branched \nalkyl phenol; C  18-30-alkyl phenol  430-180-1  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 875}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 877\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-608-00-0  pentapotassium 2-(4-{5-[1-(2,5- \ndisulfophenyl)-4,5-dihydro-3- \nmethylcarbamoyl-5-oxopyrazol- \n4-ylidene]-3-(2-pyrrolidinone-1- \nyl)-1,3-pentadienyl}-3-methylcar\xad\nbamoyl-5-oxopyrazol-1- \nyl)benzene-1,4-disulfonate  430-210-1  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-609-00-6  ethyl (3 R)-4-cyano-3-hydroxybu\xad\ntanoate  430-220-6  141942-85-0  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-610-00-1  trisodium 4-hydroxy-6-(sulfon\xad\natomethylamino)-5-(2-(2-sulfa\xad\ntoethylsulfonyl)phenylazo)naph\xad\nthalene-2-sulfonate  430-280-3  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-611-00-7  methyl 3-amino-2,2,3-trimethyl\xad\nbutyrate  431-720-7  90886-53-6  Skin Corr. 1B \nAcute Tox. 4 * \nAquatic Chronic 3  H314 \nH302 \nH412  GHS05 \nGHS07 \nDgr H314 \nH302 \nH412  \n607-612-00-2  Reaction mass of: \n3,3,4,4,5,5,6,6,7,7,8,8,8-trideca\xad\nfluoro-1-octanesulfonic acid; \nammonium \n3,3,4,4,5,5,6,6,7,7,8,8,8-trideca\xad\nfluoro-1-octanesulfonate  432-190-1  182176-52-9  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1  H302 \nH373** H318  GHS05 \nGHS08 \nGHS07 \nDgr H302 \nH373** \nH318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 876}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 878\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-613-00-8  reaction mass of: succinic acid; \nmonopersuccinic acid; diper\xad\nsuccinic acid monomethyl ester \nof succinic acid monomethyl \nester of persuccinic acid \ndimethyl succinate glutaric acid \nmonoperglutaric acid diper\xad\nglutaric acid monomethyl ester \nof glutaric acid monomethyl \nester of perglutaric acid \ndimethyl glutarate adipic acid \nmonoperadipic acid diperadipic \nacid monomethyl ester of adipic \nacid monomethyl ester of \nperadipic aciddimethyl adipate \nhydrogen peroxide methanol\xad\nwater  432-790-1  Acute Tox. 4* \nAcute Tox. 4* \nAcute Tox. 4* \nSkin Corr. 1B \nSTOT SE 2  H332 \nH312 \nH302 \nH314 \nH371 (eyes)  GHS07 \nGHS05 \nGHS08 \nDgr H332 \nH312 \nH302 \nH314 \nH371 (eyes)  \n607-614-00-3  2-(10-oxo-10 H-9-oxa-10-phos\xad\nphaphenanthren-10-ylme\xad\nthyl)succinic acid  426-480-5  63562-33-4  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 877}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 879\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-615-00-9  reaction product of thioglycerol \nand mercaptoacetic acid \nconsisting mainly of 3- \nmercapto-1,2-bismercaptoacet\xad\noxypropane and oligomers of this \nsubstance  431-120-5  —  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1  H331 \nH302 \nH319 \nH317  GHS06 \nDgr H331 \nH302 \nH319 \nH317  \n607-616-00-4  2,4-dichloro-5-fluorobenzoylch\xad\nloride  428-390-1  86393-34-2  STOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H335 \nH315 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H335 \nH315 \nH318 \nH317 \nH412  \n607-617-00-X  bis(2-ethylhexyl)-4,5-epoxycyclo\xad\nhexane-1,2-dicarboxylate  430-700-5  10138-36-0  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-618-00-5  menadione sodium bisulfite; 2- \nnaphthalenesulfonic acid,1,2,3,4- \ntetrahydro-2-methyl-1,4-dioxo-, \nsodium salt  204-987-0  130-37-0  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH410  \n607-619-00-0  menadione nicotinamide \nbisulfite; 1,2,3,4-tetrahydro-2- \nmethyl-1,4-dioxonaphthalene-2- \nsulfonicacid, compound with \nnicotin-3-amide (1:1)  277-543-7  73581-79-0  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH410  \n607-620-00-6  trisodium nitrilotriacetate  225-768-6  5064-31-3  Carc. 2 \nAcute Tox. 4 * \nEye Irrit. 2  H351 \nH302 \nH319  GHS08 \nGHS07 \nWng  H351 \nH302 \nH319  Carc. 2; H351: C \n≥ 5 %  \n607-621-00-1  milbemectin (ISO); [reaction \nmass of milbemycin A3 (CAS \nNo 51596-10-2) and milbemycin \nA4 (CAS No 51596-11-3) \n(30:70)]  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH302 \nH410  M=100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 878}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 880\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-622-00-7  2-ethylhexyl-2-ethylhexanoate  231-057-1  7425-14-1  Repr. 2  H361d***  GHS08 \nWng  H361d***  \n▼M13  \n607-623-00-2  diisobutyl phthalate  201-553-2  84-69-5  Repr. 1B  H360Df  GHS08 \nDgr H360Df  \n▼M16  \n607-624-00-8  perfluorooctane sulfonic acid; \nheptadecafluorooctane-1-sulfonic \nacid; [1] potassium perfluorooct\xad\nanesulfonate; potassium heptade\xad\ncafluorooctane-1-sulfonate; [2] \ndiethanolamine perfluorooctane \nsulfonate; [3] ammonium perflu\xad\norooctanesulfonate; ammonium \nheptadecafluorooctanesulfonate; \n[4] lithium perfluorooctane \nsulfonate; lithium heptadecaflu\xad\norooctanesulfonate [5]  217-179-8 [1] \n220-527-1 [2] \n274-460-8 [3] \n249-415-0 [4] \n249-644-6 [5]  1763-23-1 [1] \n2795-39-3 [2] \n70225-14-8 [3] \n29081-56-9 [4] \n29457-72-5 [5]  Carc. 2 \nRepr. 1B \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nLact. \nAquatic Chronic 2  H351 \nH360D*** \nH372** \nH332 \nH302 \nH362 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H351 \nH360D*** \nH372** \nH332 \nH302 \nH362 \nH411  \n607-625-00-3  clodinafop-propargyl (ISO)  —  105512-06-9  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** H317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH317 \nH410  Skin Sens. 1; \nH317: C ≥ 0,001 % \nM=1  \n607-626-00-9  ethyl 1-(2,4-dichlorophenyl)-5- \n(trichloromethyl)-1 H-1,2,4- \ntriazole-3-carboxylate  401-290-5  103112-35-2  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 879}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 881\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-627-00-4  [(4 S, 5 S)-4-benzyl-2-oxo-5- \noxazolidinyl]methyl 4-nitroben\xad\nzenesulfonate  416-360-0  162221-28-5  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-628-00-X  4-oxo-4-( p-tolyl)butyric acid \nadduct with 4-ethylmorpholine  419-240-6  171054-89-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-629-00-5  [[2-methyl-1-(1-oxopropoxy)pro\xad\npoxy](4-phenylbutyl)phosphinyl] \nacetic acid  419-270-1  123599-82-6  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-630-00-0  acrylic acid, 3-(trimethoxys\xad\nilyl)propyl ester  419-560-6  4369-14-6  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H332 \nH314 \nH317 \nH412  GHS05 \nGHS07 \nDgr H332 \nH314 \nH317 \nH412  \n607-631-00-6  reaction mass of: 2-(2-((oxo(phe\xad\nnyl)acetyl)oxy)ethoxy)ethyl \noxo(phenyl)acetate; (2-(2-hydro\xad\nxyethoxy)ethyl)oxo(phe\xad\nnyl)acetate  442-300-8  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-632-00-1  N-[3-(2,4-di-(1,1-dimethyl- \npropyl)phenoxy)-propyl]-1- \nhydroxy-5-(2-methylpropyl- \noxycarbonylamino)-naphthamide  420-210-1  111244-14-5  Aquatic Chronic 4  H413  —  H413  \n607-633-00-7  trisodium 5-{[4-chloro-6-(1- \nnaphthylamino)-1,3,5-triazin-2- \nyl]amino}-4-hydroxy-3-[( E)-(4- \nmethoxy-2-sulfonatophe\xad\nnyl)diazenyl]-2,7-naphthalenedis\xad\nulfonate  440-480-2  341026-59-3  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 880}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 882\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-634-00-2  (S)-(–)-2-acetoxypropionylch\xad\nloride; (1 S)-2-chloro-1-methyl-2- \noxoethyl acetate  420-610-4  36394-75-9  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H302 \nH314 \nH317  GHS05 \nGHS07 \nDgr H302 \nH314 \nH317  \n607-635-00-8  trisodium  N -(3-propionato)-l- \naspartate  422-090-4  172737-80-3  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-636-00-3  1-bromo-2-methylpropyl \npropionate  422-900-6  158894-67-8  Flam. Liq. 3 \nCarc. 2 \nSkin Corr. 1B \nSkin Sens. 1  H226 \nH351 \nH314 \nH317  GHS02 \nGHS05 \nGHS08 \nGHS07 \nDgr H226 \nH351 \nH314 \nH317  \n607-637-00-9  disodium 8-amino-5-{4-[2-(sul\xad\nfonatoethoxy)sulfonyl]pheny\xad\nlazo}naphthalene-2-sulfonate  423-730-5  250688-43-8  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-638-00-4  2-hydroxybenzoic acid 2-buty\xad\nloctyl ester  431-090-3  190085-41-7  Aquatic Chronic 4  H413  —  H413  \n607-639-00-X  2-(2-oxo-5-(1,1,3,3-tetramethyl\xad\nbutyl)-2,3-dihydro-1-benzofuran- \n3-yl)-4-(1,1,3,3-tetramethyl\xad\nbutyl)phenyl acetate  431-770-1  216698-07-6  Aquatic Chronic 4  H413  —  H413  \n607-641-00-0  2-(formylamino)-3-thiophenecar\xad\nboxylic acid; 2-formamido-3- \nthiophenecarboxylic acid  431-930-9  43028-69-9  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 881}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 883\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-642-00-6  3,6,9-trithiaundecamethylene- \n1,11-dimethacrylate  432-210-7  141631-22-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n607-643-00-1  dimethyl (2 S)-2-hydroxysuc\xad\ncinate  432-310-0  617-55-0  Flam. Liq. 3 \nEye Dam. 1 \nSkin Sens. 1  H226 \nH318 \nH317  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH318 \nH317  \n607-644-00-7  methyl 2,2-dimethyl-6-methyl\xad\nenecyclohexanecarboxylate  432-350-9  81752-87-6  Skin Irrit. 2  H315  GHS07 \nWng  H315  \n607-645-00-2  tetrasodium 2-(4-fluoro-6- \n(methyl-(2-(sulfatoethylsulfo\xad\nnyl)ethyl)amino)-1,3,5-triazin-2- \nylamino)-5-hydroxy-6-(4-methyl- \n2-sulfonatophenylazo)naph\xad\nthalene-1,7-disulfonate  432-550-6  243858-01-7  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-646-00-8  D-erythro-hexanoic acid 2,4- \ndideoxy-3,5- O-(1-methylethyli\xad\ndene)-1,1-dimethylethylester;  \ntert-butyl 2-[(4 R, 6 S)-6- \n(hydroxymethyl)-2,2-dimethyl- \n1,3-dioxan-4-yl]acetate  432-960-5  124655-09-0  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-647-00-3  5-acetoxy-2-( R, S )butyryloxy\xad\nmethyl-1,3-oxathiolane  433-530-1  143446-73-5  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1  H302 \nH317 \nH400  GHS07 \nGHS09 \nWng  H302 \nH317 \nH400  \n607-649-00-4  [3-(chlorocarbonyl)-2-methylphe\xad\nnyl]acetate  433-690-0  167678-46-8  Skin Corr. 1A \nSkin Sens. 1  H314 \nH317  GHS05 \nGHS07 \nDgr H314 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 882}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 884\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-650-00-X  2-methyl-1,5-pentanediamine- \n1,3-benzenedicarboxylate  433-910-5  145153-52-2  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-651-00-5  sodium 2-(nonanoyloxy)benzene\xad\nsulfonate  434-360-9  91125-43-8  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-652-00-0  ethyl N2 -dodecanoyl-l-argininate \nhydrochloride  434-630-6  60372-77-2  Eye Dam. 1 \nAquatic Acute 1  H318 \nH400  GHS05 \nGHS09 \nDgr H318 \nH400  \n607-653-00-6  tetrakis(bis(2-hydroxye\xad\nthyl)methylammonium) 3-(4-(7- \nacetylamino-1-hydroxy-3-sulfon\xad\natonaphthalen-2-ylazo)-5- \nmethoxy-2-sulfonatophenylazo)- \n7-(4-amino-3-sulfonatopheny\xad\nlamino)-4-hydroxynaphthalene-2- \nsulfonate  434-840-8  225786-91-4  Aquatic Chronic 2  H411  GHS09  H411  \n607-654-00-1  (S)-3-hydroxy-γ-butyrolactone  434-990-4  7331-52-4  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-655-00-7  ethyl 6,8-dichlorooctanoate  435-080-1  1070-64-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-656-00-2  sodium salt of 4-amino-3,6- \nbis[[5-[[4-chloro-6-[(2-methyl-4- \nsulfophenyl)amino]-1,3,5-triazin- \n2-yl]amino]-2-sulfophenyl]azo]- \n5-hydroxy-2,7-naphthalenedis\xad\nulfonic acid  435-350-7  141250-43-3  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 883}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 885\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-657-00-8  pentasodium 7-(4-(4-(3-(2-sulfa\xad\ntoethanesulfonyl)phenylamino)- \n6-(4-(2-sulfatoethanesulfo\xad\nnyl)phenylamino)-1,3,5-triazin-2- \nylamino)-2-ureidopheny\xad\nlazo)naphthalene-1,3,6-trisul\xad\nfonate  436-920-8  172399-10-9  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-658-00-3  3,10-diamino-6,13-dichloro-2- \n((6-(((4-(1,1-dimethylethyl)phe\xad\nnyl)sulfonyl)amino)-2-naphthale\xad\nnyl)sulfonyl)-4,11-triphenodioxa\xad\nzinedisulfonic acid, lithium \npotassium sodium salt  440-770-9  371921-63-0  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-659-00-9  pentasodium  N-[5-[[4-[[3-[(ami\xad\nnocarbonyl)amino]-4-[(3,6,8- \ntrisulfonatonaphthalen-2- \nyl)azo]phenyl]amino]-6-chloro- \n1,3,5-triazin-2-yl]amino]-2- \nsulfonato-4-[[4-[[-2-(oxysulfon\xad\nato)ethyl] sulfonyl]phe\xad\nnyl]azo]phenyl]-3-aminopro\xad\npanoic acid  442-030-0  321912-47-4  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-660-00-4  2-{4-[4-[4-fluoro-6-(2-(2- \nvinylsulfonylethoxy)ethylamino)- \n1,3,5-triazin-2-ylamino]phenyla\xad\nzophenylazo}naphthalene-4,6,8- \ntrisulfonate, trisodium salt  442-230-8  321679-52-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n607-661-00-X  1,1-dimethylethyl 4'-(bromo\xad\nmethyl)biphenyl-2-carboxylate  442-850-9  114772-40-6  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 884}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 886\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-662-00-5  methyl 2-(acetylamino)-3-chloro\xad\npropionate  442-860-3  87333-22-0  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n607-663-00-0  bis(2-ethylhexyl) naphthalene- \n2,6-dicarboxylate  442-980-6  127474-91-3  Aquatic Chronic 4  H413  —  H413  \n607-664-00-6  methyl 2-chlorosulfonyl-4- \n(methanesulfonylaminomethyl) \nbenzoate  443-120-2  393509-79-0  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n607-665-00-1  trans -methyl-2-ethyl-but-2-enoate  443-150-6  101226-85-1  Flam. Liq. 3  H226  GHS02 \nWng  H226  \n607-666-00-7  ( 2 S)-5-(benzyloxy)-2-(1,3-dioxo- \n1,3-dihydro-2 H-isoindol-2-yl)-5- \noxopentanoic acid  443-560-5  88784-33-2  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n607-667-00-2  chloro-1-ethylcyclohexyl \ncarbonate  444-950-8  99464-83-2  Muta. 2 \nSkin Sens. 1  H341 \nH317  GHS08 \nGHS07 \nWng  H341 \nH317  \n607-668-00-8  trans -2-isopropyl-5-carboxy-1,3- \ndioxane  445-770-2  42031-28-7  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n607-669-00-3  methyl (9-acetoxy-3,8,10- \ntriethyl-7,8,10-trimethyl-1,5- \ndioxa-9-aza-spiro[5.5]undec-3- \nyl)octadecanoate  445-990-9  376588-17-9  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 885}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 887\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-670-00-9  dibutyl-3-(4-(5-ammonio-2- \nbutyl)benzofuran-3-yl)car\xad\nbonyl)phenoxy)propyl \nammonium oxalate; (5-amino-2- \nbutylbenzofuran-3-yl) [4-(3- \ndibutylaminopropoxy)phenyl]me\xad\nthanone, dioxalate  448-700-9  500791-70-8  STOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373** H318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H373** \nH318 \nH317 \nH410  M=10  \n607-671-00-4  diethyl 1,4-cyclohexanedicar\xad\nboxylate  417-310-0  72903-27-6  Aquatic Chronic 2  H411  GHS09  H411  \n607-672-00-X  reaction mass of: 2-hydroxy-3- \n(methacryloyloxy)propyl (2- \nbenzoyl)benzoate; 1-hydroxy\xad\nmethyl-2-(methacryloyloxy)ethyl \n(2-benzoyl)benzoate; x-hydroxy- \ny-(methacryloyloxy)propyl(or \n-ethyl) (2-benzoyl)benzoate  419-000-0  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-673-00-5  1-ethyl-5,6,7,8-tetrahydroquino\xad\nlinium tosylate  419-570-0  —  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n607-675-00-6  reaction mass of:  cis-9-octade\xad\ncenedioic acid;  cis -9-cis-12- \noctadecadienedioic acid; \nhexadecanedioic acid; octadec\xad\nanedioic acid  422-260-8  —  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 886}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 888\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-676-00-1  reaction mass of: 2-methylnon\xad\nanedioic acid; 2,4-dimethyl-4- \nmethoxycarbonylundecanedioic \nacid; 2,4,6-trimethyl-4,6-dime\xad\nthoxycarbonyltridecanedioic \nacid; 8,9-dimethyl-8,9-dime\xad\nthoxycarbonylhexadecanedioic \nacid 423-670-1  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n607-677-00-7  2,5-dioxopyrrolidin-1-yl  N - \n{[methyl[[2-(1-methylethyl)-4- \nthiazoly]methyl]amino]car\xad\nbonyl}-L-Valinate  424-660-8  —  STOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H373** H318 \nH317  GHS05 \nGHS08 \nGHS07 \nDgr H373** \nH318 \nH317  \n607-678-00-2  reaction mass of: ethyl (2 R, 3R)- \n3-isopropylbicyclo[2.2.1]hept-5- \nene-2-carboxylate; ethyl (2 S, 3S)- \n3-isopropylbicyclo[2.2.1]hept-5- \nene-2-carboxylate  427-090-8  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-679-00-8  reaction mass of: 3-{5-[3-(4- \n{1,6-dihydro-2-hydroxy-4- \nmethyl-1-[3-(methyl\xad\nammonio)propyl]-6-oxo-3- \npyridylazo[}benzamido)pheny\xad\nlazo]-1,2-dihydro-6-hydroxy-4- \nmethyl-2-oxo-1-pyridyl}pro\xad\npyl(methyl)ammonium \ndi(acetate); 3-{5-[4-(3-{1,6- \ndihydro-2-hydroxy-4-methyl-1- \n[3-(methylammonio)propyl]-6-  431-440-5  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 887}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 889\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \noxo-3-pyridylazo}benza\xad\nmido]phenylazo-1,2-dihydro-6- \nhydroxy-4-methyl-2-oxo-1-pyri\xad\ndyl}propyl(dimethyl)ammonium \ndi(acetate); 3-{5-[3-(4-{1-[3- \n(dimethylammonio)propyl]-1,6- \ndihydro-2-hydroxy-4-methyl-6- \noxo-3-pyridylazo}benza\xad\nmido)phenylazo]-1,2-dihydro-6- \nhydroxy-4-methyl-2-oxo-1-pyri\xad\ndyl}propyl(dimethyl)ammoni\xad\numdi(acetate)  \n607-680-00-3  tert -butyl(6-{2-[4-(4-fluor\xad\nophenyl)-6-isopropyl-2- \n[methyl(methylsulfo\xad\nnyl)amino]pyrimidin-5-ylvi\xad\nnyl}(4 S, 6 S)-2,2- \ndimethyl[1,3]dioxan-4-yl)acetate  432-810-9  —  Aquatic Chronic 4  H413  —  H413  \n607-681-00-9  reaction mass of: 9-nonyl-10- \noctyl-19-carbonyloxyhexade\xad\ncylnonadecanoic acid; 9-nonyl- \n10-octyl-19-carbonyloxyoctade\xad\ncylnonadecanoic acid; dihex\xad\nadecyl 9-nonyl-10-octylnonadec\xad\nandioate; 1-octadecyl, 19- \nhexadecyl 9-nonyl-10-octylnon\xad\nadecandioate; dioctadecyl 9- \nnonyl-10-octylnonadecandioate  432-910-2  —  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 888}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 890\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-682-00-4  complex reaction mass of \nChinese gum rosin post reacted \nwith acrylic acid  434-230-1  144413-22-9  Aquatic Chronic 4  H413  —  H413  \n607-683-00-X  reaction mass of: methyl 3-((1 E)- \n2-methylprop-1-enyl)-2,2- \ndimethylcyclopropanecar\xad\nboxylate; methyl 3-((1 Z)-2- \nmethylprop-1-enyl)-2,2-dimethyl\xad\ncyclopropanecarboxylate (20:80)  435-450-0  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n607-684-00-5  alkenes, C  12-14, hydroformylation \nproducts, distn. residues, C- \n(hydrogen sulfobutanedioates), \ndisodium salts  435-660-2  243662-67-1  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n607-685-00-0  ammonium 2-cocoyloxyethane\xad\nsulfonate  441-050-7  —  Skin Irrit. 2 \nEye Dam. 1  H315 \nH318  GHS05 \nDgr H315 \nH318  \n607-686-00-6  6,6'-bis(diazo-5,5', 6,6'- \ntetrahydro-5,5'-dioxo)[methylene- \nbis(5-(6-diazo-5,6-dihydro-5-oxo- \n1-naphthylsulphonyloxy)-6- \nmethyl-2-phenylene]di(naph\xad\nthalene-1-sulfonate)  441-550-5  —  Self-react. C **** \nCarc. 2  H242 \nH351  GHS02 \nGHS08 \nDgr H242 \nH351  \n607-687-00-1  reaction mass of: 2-{3,6-bis-[(2- \nethylphenyl)-methylamino]- \nxanthylium-9-yl[}- \nbenzenesulfonate (2-10 %); 2- \n{3,6-bis-[(2,3-dimethylphenyl)- \nmethylamino]-xanthylium-9-yl}- \nbenzenesulfonate (2-10 %);  442-800-6  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 889}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 891\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n2-{3,6-bis-[(2,4-dimethylphenyl)- \nmethylamino]-xanthylium-9-yl}- \nbenzenesulfonate (2-10 %); 2- \n{3,6-bis-[(2,5-dimethylphenyl)- \nmethylamino]-xanthylium-9-yl}- \nbenzenesulfonate (2-10 %); 2-{3- \n[(2,3-dimethylphenyl)- \nmethylamino]-6-[(2-ethylphenyl)- \nmethylamino]-xanthylium-9-yl}- \nbenzenesulfonate (7-20 %); 2-{3- \n[(2,4-dimethylphenyl)- \nmethylamino]-6-[(2-ethylphenyl)- \nmethylamino]-xanthylium-9-yl}- \nbenzenesulfonate (7-20 %); 2-{3- \n[(2,5-dimethylphenyl)- \nmethylamino]-6-[(2-ethylphenyl)- \nmethylamino]-xanthylium-9-yl}- \nbenzenesulfonate (7-20 %); 2-{3- \n[(2,3-dimethylphenyl)- \nmethylamino]-6-[(2,4- \ndimethylphenyl)-methylamino]- \nxanthylium-9-yl}- \nbenzenesulfonate (7-20 %); 2-{3- \n[(2,3-dimethylphenyl)- \nmethylamino]-6-[(2,5- \ndimethylphenyl)-methylamino]- \nxanthylium-9-yl}- \nbenzenesulfonate (7-20 %);  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 890}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 892\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n2-{3-[(2,4-dimethylphenyl)- \nmethylamino]-6-[(2,5- \ndimethylphenyl)-methylamino]- \nxanthylium-9-yl}- \nbenzenesulfonate (7-20 %)  \n607-688-00-7  (R)-1-cyclohexa-1,4-dienyl-1- \nmethoxycarbonyl-methylammoni\xad\numchloride  444-320-2  —  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n607-689-00-2  reaction mass of: methyl 1,4- \ndimethylcyclohexanecarboxylate \n(‘para-isomer’ including  cis-and \ntrans -isomers); methyl 1,3- \ndimethylcyclohexanecarboxylate \n(‘meta-isomer’including  cis -and \ntrans -isomers)  444-920-4  —  Aquatic Chronic 3  H412  —  H412  \n607-690-00-8  dimethyl[2 S, 2 S']-6,6,6'6'- \ntetramethoxy-2,2'-[ N, N '-bis(tri\xad\nfluoracetyl)- S, S '-bi(L-homocys\xad\nteinyl) diimino]dihexanoate  432-860-1  255387-46-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n607-691-00-3  magnesium salts, fatty acids, C  16- \n18 and C  18 unsaturated, branched \nand linear  448-690-6  —  Aquatic Chronic 4  H413  —  H413  \n607-692-00-9  zinc salts, fatty acids, C  16-18 and \nC 18 unsaturated, branched and \nlinear  446-470-4  —  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 891}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 893\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M23  __________  \n▼M16  \n607-694-00-X  ethyl 5,5-diphenyl-2-isoxazoline- \n3-carboxylate  443-870-0  163520-33-0  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n607-696-00-0  pentyl formate  211-340-6  638-49-3  Flam. Liq. 3 \nEye Irrit. 2 \nSTOT SE 3  H226 \nH319 \nH335  GHS02 \nGHS07 \nDgr H226 \nH319 \nH335  C \n607-697-00-6  tert -butyl propionate  —  20487-40-5  Flam. Liq. 2  H225  GHS02 \nDgr H225  C  \n607-698-00-1  4 - tert-butylbenzoic acid  202-696-3  98-73-7  Repr. 1B \nSTOT RE 1 \nAcute Tox. 4  H360F H372 \nH302  GHS07 \nGHS08 \nDgr H360F H372 \nH302  \n607-699-00-7  bifenthrin (ISO); (2-methylbip\xad\nhenyl-3-yl)methylrel-(1 R,3R)-3- \n[(1Z)-2-chloro-3,3,3-trifluor\xad\noprop-1-en-1-yl]-2,2-dimethyl\xad\ncyclopropanecarboxylate  82657-04-3  Carc. 2 \nAcute Tox. 3 \nAcute Tox. 2 \nSTOT RE 1 \nSkin Sens. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH331 \nH300 \nH372 (nervous \nsystem) H317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH331 \nH300 \nH372 \n(nervous \nsystem) \nH317 \nH410  M = 10 000 \nM = 100 000  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 892}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 894\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-700-00-0  indoxacarb (ISO); methyl (4a S)- \n7-chloro-2-{(methoxycar\xad\nbonyl)[4-(trifluoromethoxy)phe\xad\nnyl]carbamoyl}-2,5-dihydro\xad\nindeno[1,2- e][1,3,4]oxadiazine- \n4a(3H)-carboxylate [1] reaction \nmass of ( S)-Indoxacarb and ( R)- \nIndoxacarb 75:25; methyl 7- \nchloro-2-{(methoxycarbonyl)[4- \n(trifluoromethoxy)phenyl]carba\xad\nmoyl}-2,5-dihydroindeno[1,2-  \ne][1,3,4]oxadiazine-4a(3 H)- \ncarboxylate [2]  173584-44-6 \n[1] \n144171-61-9 \n[2] Acute Tox. 3 \nAcute Tox. 4 \nSTOT RE 1 \nSkin Sens. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH332 \nH372 (blood, \nnervous \nsystem, heart) \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH332 \nH372 (blood, \nnervous \nsystem, \nheart) \nH317 \nH410  M = 1 \nM = 1  \n607-702-00-1  dihexyl phthalate  201-559-5  84-75-3  Repr. 1B  H360FD  GHS08 \nDgr H360FD  \n607-703-00-7  ammoniumpentadeca-fluorooct\xad\nanoate  223-320-4  3825-26-1  Carc. 2 \nRepr. 1B Lact. \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT RE 1 \nEye Dam.1  H351 \nH360D H362 \nH332 \nH302 \nH372 (liver) \nH318  GHS08 \nGHS07 \nGHS05 \nDgr H351 \nH360D \nH362 \nH332 \nH302 \nH372 (liver) \nH318  \n607-704-00-2  perfluorooctanoic acid  206-397-9  335-67-1  Carc. 2 \nRepr. 1B Lact. \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT RE 1 \nEye Dam. 1  H351 \nH360D H362 \nH332 \nH302 \nH372 (liver) \nH318  GHS08 \nGHS07 \nGHS05 \nDgr H351 \nH360D \nH362 \nH332 \nH302 \nH372 (liver) \nH318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 893}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 895\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-705-00-8  benzoic acid  200-618-2  65-85-0  STOT RE 1 \nSkin Irrit. 2 \nEye Dam. 1  H372 (lungs) \n(inhalation) \nH315 \nH318  GHS08 \nGHS05 \nDgr H372 (lungs) \n(inhalation) \nH315 \nH318  \n607-706-00-3  methyl 2,5-dichlorobenzoate  220-815-7  2905-69-3  Acute Tox. 4 \nSTOT SE 3 \nAquatic Chronic 2  H302 \nH336 \nH411  GHS07 \nGHS09 \nWng  H302 \nH336 \nH411  \n▼M11  \n607-707-00-9  fenoxaprop-P-ethyl (ISO); ethyl \n(2R)-2-{4-[(6-chloro-1,3-benz\xad\noxazol-2-yl)oxy]phenoxy}pro\xad\npanoate  — 71283-80-2  STOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 \n(kidneys) \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 \n(kidneys) \nH317 \nH410  M = 1 \nM = 1  \n607-708-00-4  octanoic acid  204-677-5  124-07-2  Skin Corr. 1C \nAquatic Chronic 3  H314 \nH412  GHS05 \nDgr H314 \nH412  \n607-709-00-X  decanoic acid  206-376-4  334-48-5  Skin Irrit. 2 \nEye Irrit. 2 \nAquatic Chronic 3  H315 \nH319 \nH412  GHS07 \nWng  H315 \nH319 \nH412  \n607-710-00-5  1,2-benzenedicarboxylic acid, \ndihexyl ester, branched and \nlinear  271-093-5  68515-50-4  Repr. 1B  H360FD  GHS08 \nDgr H360FD  \n607-711-00-0  spirotetramat (ISO); (5s,8s)-3- \n(2,5-dimethylphenyl)-8-methoxy- \n2-oxo-1-azaspiro[4,5]dec-3-en-4- \nyl ethyl carbonate  — 203313-25-1  Repr. 2 \nSTOT SE 3 \nEye Irrit. 2 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H361fd \nH335 \nH319 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361fd \nH335 \nH319 \nH317 \nH410  M = 1 \nM = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 894}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 896\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-712-00-6  dodemorph acetate; 4-cyclo\xad\ndodecyl-2,6-dimethylmorpholin- \n4-ium acetate  250-778-2  31717-87-0  Repr. 2 \nSTOT RE 2 \nSkin Corr. 1C \nSkin Sens. 1A \nAquatic Chronic 1  H361d \nH373 (liver) \nH314 \nH317 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H361d \nH373 (liver) \nH314 \nH317 \nH410  EUH071  M  =  1  \n607-713-00-1  fenpyroximate (ISO); tert-butyl \n4-[({(E)-[(1,3-dimethyl-5- \nphenoxy-1H-pyrazol-4-yl)methyl\xad\nene]amino}oxy)methyl]benzoate  — 134098-61-6  Acute Tox. 3 \nAcute Tox. 2 \nSkin Sens. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH330 \nH317 \nH400 \nH410  GHS06 GHS09 \nDgr H301 \nH330 \nH317 \nH410  M = 100 \nM = 1 000  \n607-714-00-7  triflusulfuron-methyl; methyl 2- \n({[4-(dimethylamino)-6-(2,2,2- \ntrifluoroethoxy)-1,3,5-triazin-2- \nyl]carbamoyl}sulfamoyl)-3- \nmethylbenzoate  — 126535-15-7  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  M = 100 \nM = 10  \n607-715-00-2  bifenazate (ISO); isopropyl 2-(4- \nmethoxybiphenyl-3-yl)hydrazine\xad\ncarboxylate  442-820-5  149877-41-8  STOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 \nH317 \nH410  M = 1 \nM = 1  \n▼M13  \n607-716-00-8  bromadiolone (ISO); 3-[3-(4′- \nbromobiphenyl-4-yl)-3-hydroxy- \n1-phenylpropyl]-4-hydroxy-2 H- \nchromen-2-one  249-205-9  28772-56-7  Repr. 1B \nAcute Tox. 1 \nAcute Tox. 1 \nAcute Tox. 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH410  Repr. 1B; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C \n≥ 0,005 % STOT \nRE 2; H373 \n(blood): \n0,0005 % ≤ C \n< 0,005 % \nM = 1 \nM = 1  ▼M11', metadata={'source': 'data/ycla_en.pdf', 'page': 895}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 897\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-717-00-3  difethialone (ISO); \n3-[3-(4′-bromobiphenyl-4-yl)- \n1,2,3,4-tetrahydronaphthalen-1- \nyl]-4-hydroxy-2 H-1-benzo\xad\nthiopyran-2-one  — 104653-34-1  Repr. 1B \nAcute Tox. 1 \nAcute Tox. 1 \nAcute Tox. 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH330 \nH310 \nH300 \nH372 (blood) \nH410  EUH070  Repr. 1B; H360D: \nC ≥ 0,003 % \nSTOT RE 1; H372 \n(blood): C \n≥ 0,02 % STOT \nRE 2; H373 \n(blood): \n0,002 % ≤ C \n< 0,02 % \nM = 100 \nM = 100  \n607-718-00-9  perfluorononan-1-oic acid [1] \nand its sodium [2] and \nammonium [3] salts  206-801-3 [1] \n[2] \n[3] 375-95-1 [1] \n21049-39-8 [2] \n4149-60-4 [3]  Carc. 2 \nRepr. 1B \nLact. \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT RE 1 \nEye Dam. 1  H351 \nH360Df \nH362 \nH332 \nH302 \nH372 (liver, \nthymus, \nspleen) \nH318  GSH08 \nGSH07 \nGHS05 \nDgr H351 \nH360Df \nH362 \nH332 \nH302 \nH372 (liver, \nthymus, \nspleen) \nH318  \n607-719-00-4  dicyclohexyl phthalate  201-545-9  84-61-7  Repr. 1B \nSkin Sens. 1  H360D \nH317  GHS08 \nGHS07 \nDgr H360D \nH317  \n▼M15  \n607-720-00-X  nonadecafluorodecanoic acid; [1] \nammonium nonadecafluorodec\xad\nanoate; [2] \nsodium nonadecafluorodecanoate \n[3] 206-400-3 [1] \n221-470-5 [2] \n[3] 335-76-2 [1] \n3108-42-7 [2] \n3830-45-3 [3]  Carc. 2 \nRepr. 1B \nLact.  H351 \nH360Df \nH362  GHS08 \nDgr H351 \nH360Df \nH362  ▼M13', metadata={'source': 'data/ycla_en.pdf', 'page': 896}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 898\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-721-00-5  N,N′-methylenedimorpholine; \nN,N′-methylenebismorpholine; \n[formaldehyde released from \nN,N′-methylenebismorpholine]; \n[MBM]  227-062-3  5625-90-1  Carc. 1B \nMuta. 2 \nAcute Tox. 4 \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT RE 2 \nSkin Corr. 1B \nSkin Sens. 1 \nEye Dam. 1  H350 \nH341 \nH332 \nH312 \nH302 \nH373 (gas\xad\ntrointestinal \ntract, \nrespiratory \ntract) \nH314 \nH317 \nH318  GHS08 \nGHS07 \nGHS05 \nDgr H350 \nH341 \nH332 \nH312 \nH302 \nH373 (gas\xad\ntrointestinal \ntract, \nrespiratory \ntract) \nH314 \nH317  EUH071  8  \n9 \n607-722-00-0  2,3,5,6-tetrafluoro-4-(methoxy\xad\nmethyl)benzyl (Z)-(1R,3R)-3-(2- \ncyanoprop-1-enyl)-2,2-dimethyl\xad\ncyclopropanecarboxylate; \nepsilon-momfluorothrin  — 1065124-65-3  Acute Tox. 4 \nSTOT SE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH371 (nervous \nsystem) \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nWng  H302 \nH371 \n(nervous \nsystem) \nH410  M = 100 \nM = 100  \n607-723-00-6  tefluthrin (ISO); \n2,3,5,6-tetrafluoro-4-methyl\xad\nbenzyl (1RS,3RS)-3-[(Z)-2- \nchloro-3,3,3-trifluoroprop-1- \nenyl]-2,2-dimethylcyclopropane\xad\ncarboxylate  — 79538-32-2  Acute Tox. 1 \nAcute Tox. 2 \nAcute Tox. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  M = 10 000 \nM = 10 000  \n▼M18  \n607-724-00-1  2,3,5,6-tetrafluoro-4-(methoxy\xad\nmethyl)benzyl (1 R,3R)-2,2- \ndimethyl-3-[(1 Z)-prop-1-en-1- \nyl]cyclopropanecarboxylate; \nepsilon-metofluthrin  — 240494-71-7  Acute Tox. 4 \nAcute Tox. 3 \nSTOT SE 1 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH301 \nH370 (nervous \nsystem) \nH373 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H332 \nH301 \nH370 \n(nervous \nsystem) \nH373 \nH410  M = 100 \nM = 100  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 897}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 899\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-725-00-7  isopropyl (2 E,4E,7S)-11- \nmethoxy-3,7,11-trimethyldodeca- \n2,4-dienoate;  S-methoprene  — 65733-16-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 1  \n607-726-00-2  pinoxaden (ISO); \n8-(2,6-diethyl-4-methylphenyl)-7- \noxo-1,2,4,5-tetrahydro-7 H-pyra\xad\nzolo[1,2-d][1,4,5]oxadiazepin-9- \nyl 2,2-dimethylpropanoate  — 243973-20-8  Repr. 2 \nAcute Tox. 4 \nAcute Tox. 4 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 3  H361d \nH332 \nH302 \nH319 \nH335 \nH317 \nH400 \nH412  GHS08 \nGHS07 \nGHS09 \nWng  H361d \nH332 \nH302 \nH319 \nH335 \nH317 \nH410  inhalation: \nATE = 4,63 mg/L \n(dusts or mists) \noral: \nATE = 500 mg/kg \nbw \nM = 1  \n607-727-00-8  tetramethrin (ISO); \n(1,3-dioxo-1,3,4,5,6,7- \nhexahydro-2 H-isoindol-2- \nyl)methyl 2,2-dimethyl-3-(2- \nmethylprop-1-en-1-yl)cyclopro\xad\npanecarboxylate  231-711-6  7696-12-0  Carc. 2 \nAcute Tox. 4 \nSTOT SE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH371 (nervous \nsystem) (inha\xad\nlation) \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH371 \n(nervous \nsystem) \n(inhalation) \nH410  M = 100 \nM = 100  \n607-728-00-3  (1,3,4,5,6,7-hexahydro-1,3- \ndioxo- 2H-isoindol-2-yl)methyl \n(1R-trans )-2,2-dimethyl-3-(2- \nmethylprop-1-enyl)cyclopropane\xad\ncarboxylate  214-619-0  1166-46-7  Carc. 2 \nAcute Tox. 4 \nSTOT SE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH371 (nervous \nsystem) (inha\xad\nlation) \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH371 \n(nervous \nsystem) \n(inhalation) \nH410  M = 100 \nM = 100  ▼M18', metadata={'source': 'data/ycla_en.pdf', 'page': 898}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 900\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-729-00-9  mesosulfuron-methyl (ISO); \nmethyl 2-[(4,6-dimethoxypyri\xad\nmidin-2-ylcarbamoyl)sulfamoyl]- \nα-(methanesulfonamido)- p- \ntoluate;  — 208465-21-8  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 100 \nM = 100  \n607-730-00-4  spirodiclofen (ISO); \n3-(2,4-dichlorophenyl)-2-oxo-1- \noxaspiro[4.5]dec-3-en-4-yl 2,2- \ndimethylbutyrate  — 148477-71-8  Carc. 1B \nRepr. 2 \nSTOT RE 2 \nSkin Sens. 1B \nAquatic Chronic 1  H350 \nH361f \nH373 \nH317 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH361f \nH373 \nH317 \nH410  M = 10  \n607-731-00-X  sodium methyl [(4-aminophe\xad\nnyl)sulphonyl]carbamate; sodium \nmethyl ( EZ)-sulfanilylcarboni\xad\nmidate; asulam-sodium  218-953-8  2302-17-2  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M = 1 \nM = 1  \n607-732-00-5  salicylic acid  200-712-3  69-72-7  Repr. 2 \nAcute Tox. 4 \nEye Dam. 1  H361d \nH302 \nH318  GHS08 \nGHS07 \nGHS05 \nDgr H361d \nH302 \nH318  ▼M18', metadata={'source': 'data/ycla_en.pdf', 'page': 899}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 901\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M22  \n607-733-00-0  cyflumetofen (ISO); \n2-methoxyethyl ( RS)-2-(4- tert- \nbutylphenyl)-2-cyano-3-oxo-3- \n(α,α,α-trifluoro- o-tolyl)propionate  — 400882-07-7  Carc. 2 \nSkin Sens. 1A  H351 \nH317  GHS08 \nGHS07 \nWng  H351 \nH317  \n607-734-00-6  pentapotassium 2,2’,2’’,2’’’,2’’’’- \n(ethane-1,2-diylnitrilo)pen\xad\ntaacetate  404-290-3  7216-95-7  Acute Tox. 4 \nSTOT RE 2 \nEye Irrit. 2  H332 \nH373 (inha\xad\nlation) \nH319  GHS08 \nGHS07  \n►M29  Wng ◄  H332 \nH373 (inha\xad\nlation) \nH319  inhalation: \nATE = 1,5 mg/l \n(dusts or mists)  \n607-735-00-1  N-carboxymethyliminobis(ethyle\xad\nnenitrilo)tetra(acetic acid)  200-652-8  67-43-6  Acute Tox. 4 \nSTOT RE 2 \nEye Irrit. 2  H332 \nH373 (inha\xad\nlation) \nH319  GHS08 \nGHS07  \n►M29  Wng ◄  H332 \nH373 (inha\xad\nlation) \nH319  inhalation: \nATE = 1,5 mg/l \n(dusts or mists)  \n607-736-00-7  pentasodium (carboxylato\xad\nmethyl)iminobis(ethyleneni\xad\ntrilo)tetraacetate  205-391-3  140-01-2  Acute Tox. 4 \nSTOT RE 2  H332 \nH373 (inha\xad\nlation)  GHS08 \nGHS07  \n►M29  Wng ◄  H332 \nH373 (inha\xad\nlation)  inhalation: \nATE = 1,5 mg/l \n(dusts or mists)  \n607-737-00-2  diisohexyl phthalate  276-090-2  71850-09-4  Repr. 1B  H360FD  GHS08 \nDgr H360FD  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 900}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 902\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M23  \n607-738-00-8  MCPA-thioethyl (ISO);  \nS-ethyl (4-chloro-2-methylphen\xad\noxy)ethanethioate;  S-ethyl 4- \nchloro- o-tolyloxythioacetate  246-831-4  25319-90-8  Acute Tox. 4 \nSTOT RE. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 (liver) \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nWng  H302 \nH373 (liver) \nH410  oral: ATE = \n450 mg/kg bw \nM = 10 \nM = 10  \n607-740-00-9  diisooctyl phthalate  248-523-5  27554-26-3  Repr. 1B  H360FD  GHS08 \nDgr H360FD  \n607-741-00-4  4-{[(6-chloropyridin-3- \nyl)methyl](2,2-difluoro\xad\nethyl)amino}furan-2(5 H)-one; \nflupyradifurone  — 951659-40-8  Acute Tox. 4 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 (muscle) \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nWng  H302 \nH373 \n(muscle) \nH410  oral: ATE = \n500 mg/kg bw \nM = 10 \nM = 10  \n607-742-00-X  thiencarbazone-methyl (ISO); \nmethyl 4-[(4,5-dihydro-3- \nmethoxy-4-methyl-5-oxo-1 H- \n1,2,4-triazol-1-yl)carbonylsulfa\xad\nmoyl]-5- methylthiophene-3- \ncarboxylate  — 317815-83-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 1000 \nM = 1000  \n607-743-00-5  L-(+)-lactic acid; \n(2S)-2-hydroxypropanoic acid  201-196-2  79-33-4  Skin Corr. 1C \nEye Dam. 1  H314 \nH318  GHS05 \nDgr H314  EUH071  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 901}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 903\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n607-744-00-0  2-methoxyethyl acrylate  221-499-3  3121-61-7  Flam. Liq. 3 \nMuta. 2 \nRepr. 1B \nAcute Tox. 3 \nAcute Tox. 4 \nSkin Corr. 1C \nEye Dam. 1 \nSkin Sens. 1  H226 \nH341 \nH360FD \nH331 \nH302 \nH314 \nH318 \nH317  GHS02 \nGHS05 \nGHS06 \nGHS08 \nDgr H226 \nH341 \nH360FD \nH331 \nH302 \nH314 \nH317  EUH071  inhalation: ATE = \n2,7 mg/L (vapours) \noral: ATE = \n404 mg/kg bw  \n607-745-00-6  glyoxylic acid …%  206-058-5  298-12-4  Eye Dam. 1 \nSkin Sens. 1B  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  B \n607-746-00-1  sodium  N -(hydroxy\xad\nmethyl)glycinate; \n[formaldehyde released from \nsodium  N-(hydroxymethyl)glyci\xad\nnate]  274-357-8  70161-44-3  Carc. 1B \nMuta. 2 \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT SE 3 \nSkin Irrit. 2 \nEye Irrit. 2 \nSkin Sens. 1  H350 \nH341 \nH332 \nH302 \nH335 \nH315 \nH319 \nH317  GHS08 \nGHS07 \nDgr H350 \nH341 \nH332 \nH302 \nH335 \nH315 \nH319 \nH317  inhalation: ATE = \n3 mg/L (dusts or \nmists) \noral: ATE = \n1100 mg/kg bw  8 \n9 \n▼M16  \n608-001-00-3  acetonitrile; cyanomethane  200-835-2  75-05-8  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2  H225 \nH332 \nH312 \nH302 \nH319  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH319  ▼M23', metadata={'source': 'data/ycla_en.pdf', 'page': 902}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 904\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-002-00-9  trichloroacetonitrile  208-885-7  545-06-2  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH411  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH411  \n608-003-00-4  acrylonitrile  203-466-5  107-13-1  Flam. Liq. 2 \nCarc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H225 \nH350 \nH331 \nH311 \nH301 \nH335 \nH315 \nH318 \nH317 \nH411  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H225 \nH350 \nH331 \nH311 \nH301 \nH335 \nH315 \nH318 \nH317 \nH411  * D  \n608-004-00-X  2-hydroxy-2-methylpropionitrile; \n2-cyanopropan-2-ol; acetone \ncyanohydrin  200-909-4  75-86-5  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH410  \n608-005-00-5  n-butyronitrile  203-700-6  109-74-0  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H225 \nH331 \nH311 \nH301  GHS02 \nGHS06 \nDgr H225 \nH331 \nH311 \nH301  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 903}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 905\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-006-00-0  bromoxynil (ISO) 3,5-dibromo-4- \nhydroxybenzonitrile; bromoxynil \nphenol  216-882-7  1689-84-5  Repr. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH330 \nH301 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361d *** \nH330 \nH301 \nH317 \nH410  M = 10  \n608-007-00-6  ioxynil (ISO) 4-hydroxy-3,5-diio\xad\ndobenzonitrile  216-881-1  1689-83-4  Repr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH331 \nH301 \nH312 \nH373 ** H319 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361d *** \nH331 \nH301 \nH312 \nH373 ** \nH319 \nH410  M = 10  \n608-008-00-1  chloroacetonitrile  203-467-0  107-14-2  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH411  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH411  \n608-009-00-7  malononitrile  203-703-2  109-77-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 904}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 906\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-010-00-2  methacrylonitrile; 2-methyl-2- \npropene nitrile  204-817-5  126-98-7  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Sens. 1  H225 \nH331 \nH311 \nH301 \nH317  GHS02 \nGHS06 \nDgr H225 \nH331 \nH311 \nH301 \nH317  * \nSkin Sens. 1; \nH317: C ≥0,2 %  D \n608-011-00-8  oxalonitrile; cyanogen  207-306-5  460-19-5  Press. Gas \nFlam. Gas 1 \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H220 \nH331 \nH400 \nH410  GHS02 \nGHS04 \nGHS06 \nGHS09 \nDgr H220 \nH331 \nH410  U \n608-012-00-3  benzonitrile  202-855-7  100-47-0  Acute Tox. 4 * \nAcute Tox. 4 *  H312 \nH302  GHS07 \nWng  H312 \nH302  \n608-013-00-9  2-chlorobenzonitrile  212-836-5  873-32-5  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2  H312 \nH302 \nH319  GHS07 \nWng  H312 \nH302 \nH319  \n608-014-00-4  chlorothalonil (ISO); tetrachloroi\xad\nsophthalonitrile  217-588-1  1897-45-6  Carc. 2 \nAcute Tox. 2 * \nSTOT SE 3 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH330 \nH335 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H351 \nH330 \nH335 \nH318 \nH317 \nH410  M=10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 905}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 907\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-015-00-X  dichlobenil (ISO); 2,6-dichloro\xad\nbenzonitrile  214-787-5  1194-65-6  Acute Tox. 4 * \nAquatic Chronic 2  H312 \nH411  GHS07 \nGHS09 \nWng  H312 \nH411  \n608-016-00-5  1,4-Dicyano-2,3,5,6-tetra-chloro- \nbenzene  401-550-8  1897-41-2  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n608-017-00-0  bromoxynil octanoate (ISO); 2,6- \ndibromo-4-cyanophenyl \noctanoate  216-885-3  1689-99-2  Repr. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH331 \nH302 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361d *** \nH331 \nH302 \nH317 \nH410  M = 10  \n608-018-00-6  ioxynil octanoate (ISO); 4-cyano- \n2,6-diiodophenyl octanoate  223-375-4  3861-47-0  Repr. 2 \nAcute Tox. 3 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH301 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361d *** \nH301 \nH319 \nH317 \nH410  M = 10  \n608-019-00-1  2,2'-dimethyl-2,2'-azodipropio\xad\nnonitrile; ADZN  201-132-3  78-67-1  Self-react. C \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H242 \nH332 \nH302 \nH412  GHS02 \nGHS07 \nDgr H242 \nH332 \nH302 \nH412  T \n608-020-00-7  diphenoxymethylenecyanamide  427-300-8  79463-77-7  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n608-021-00-2  3-(2-(diaminomethyl\xad\neneamino)thiazol-4-ylmethylt\xad\nhio)propionitrile  403-710-2  76823-93-3  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 906}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 908\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-022-00-8  3,7-dimethyloctanenitrile  403-620-3  40188-41-8  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H315 \nH317 \nH411  \n608-023-00-3  fenbuconazole (ISO); 4-(4- \nchlorophenyl)-2-phenyl-2-[(1 H- \n1,2,4-triazol-1-yl)methyl]but\xad\nanenitrile  406-140-2  114369-43-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n608-024-00-9  2-(4-( N-butyl- N-phenethy\xad\nlamino)phenyl)ethylene-1,1,2- \ntricarbonitrile  407-650-8  97460-76-9  Aquatic Chronic 4  H413  —  H413  \n608-025-00-4  2-nitro-4,5-bis(benzyloxy)pheny\xad\nlacetonitrile  410-970-0  117568-27-1  Aquatic Chronic 4  H413  —  H413  \n608-026-00-X  3-cyano-3,5,5-trimethylcyclohex\xad\nanone  411-490-4  7027-11-4  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH373 ** H317 \nH412  GHS08 \nGHS07 \nWng  H302 \nH373 ** \nH317 \nH412  \n608-027-00-5  reaction mass of: 3-(4-ethylp\xad\nhenyl)-2,2-dimethylpropaneni\xad\ntrile; 3-(2-ethylphenyl)-2,2- \ndimethylpropanenitrile; 3-(3- \nethylphenyl)-2,2-dimethylpro\xad\npanenitrile  412-660-0  —  Aquatic Chronic 2  H411  GHS09  H411  \n608-028-00-0  4-(2-cyano-3-phenylamino \nacryloyloxymethyl)-cyclohexyl- \nmethyl 2-cyano-3-phenylamino)- \nacrylate  413-510-7  147374-67-2  STOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H373 ** H317 \nH411  GHS08 \nGHS09 \nWng  H373 ** \nH317 \nH411  \n608-029-00-6  1,2-dihydro-6-hydroxy-4-methyl- \n1-[3-(1-methylethoxy)propyl]-2- \noxo-3-pyridinecarbonitrile  411-990-2  68612-94-2  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 907}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 909\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-030-00-1  N-acetyl- N-[5-cyano-3-(2-dibuty\xad\nlamino-4-phenylthyazol-5-yl- \nmethylene)-4-methyl-2,6-dioxo- \n1,2,3,6-tetrahydropyridin-1- \nyl]benzamide  412-340-0  147741-93-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n608-031-00-7  2-benzyl-2-methyl-3-butenitrile  407-870-4  97384-48-0  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n608-032-00-2  acetamiprid (ISO); \n(E)-N1 -[(6-chloro-3-pyri\xad\ndyl)methyl]-N2 -cyano-N1 -methyl\xad\nacetamidine  — 135410-20-7  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n608-033-00-8  N-butyl-3-(2-chloro-4-nitrophe\xad\nnylhydrazono)-1-cyano-2- \nmethylprop-1-ene-1,3-dicar\xad\nboximide  407-970-8  75511-91-0  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n608-034-00-3  chlorfenapyr (ISO); 4-bromo-2- \n(4-chlorophenyl)-1-ethoxy\xad\nmethyl-5-trifluoromethylpyrrole- \n3-carbonitrile  — 122453-73-0  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH302 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH302 \nH410  M=100  \n608-035-00-9  (±)-α-[(2-acetyl-5-methylphenyl)- \namino]-2,6-dichlorobenzene- \naceto-nitrile  419-290-9  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n608-036-00-4  3-(2-{4-[2-(4-cyanophe\xad\nnyl)vinyl]phenyl}vinyl)benzoni\xad\ntrile 419-060-8  79026-02-1  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 908}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 910\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-037-00-X  reaction mass of: ( E)-2,12-tride\xad\ncadiennitrile; ( E)-3,12-trideca\xad\ndiennitrile; ( Z)-3,12-tridecadien\xad\nnitrile  422-190-8  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n608-038-00-5  2,2,4-trimethyl-4-phenyl-butane- \nnitrile  422-580-8  75490-39-0  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n▼M22  \n608-039-00-0  2-phenylhexanenitrile  423-460-8  3508-98-3  Acute Tox. 4 \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  oral: \nATE = 500 mg/kg \nbw \n▼M16  \n608-040-00-6  4,4'-dithiobis(5-amino-1-(2,6- \ndichloro-4-(trifluor\xad\nomethyl)phenyl)-1 H-pyrazole-3- \ncarbonitrile)  423-490-1  130755-46-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n608-041-00-1  4'-((2-butyl-4-oxo-1,3-diaz\xad\naspiro[4.4]non-1-ene-3- \nyl)methyl)(1,1'-biphenyl)-2- \ncarbonitrile  423-500-4  138401-24-8  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n608-042-00-7  (S)-2,2-diphenyl-2-(3-pyrrolidi\xad\nnyl)acetonitrile hydrobromide  421-810-4  194602-27-2  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n608-043-00-2  3-( cis-3-hexenyloxy)propanenitril  415-220-6  142653-61-0  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH302 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH302 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 909}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 911\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-044-00-8  2-cyclohexylidene-2-phenylace\xad\ntonitrile  423-740-1  10461-98-0  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n608-046-00-9  5-(4-chloro-2-nitro-phenylazo)- \n1,2-dihydro-6-hydroxy-1,4- \ndimethyl-2-oxo-pyridine-3- \ncarbonitrile  425-310-7  77889-90-8  Aquatic Chronic 4  H413  —  H413  \n608-047-00-4  2-piperidin-1-yl-benzonitrile  427-330-1  72752-52-4  Aquatic Chronic 2  H411  GHS09  H411  \n608-048-00-X  1-(3-cyclopentyloxy-4-methoxyp\xad\nhenyl)-4-oxo-cyclohexanecarbon\xad\nitrile  427-450-4  152630-47-2  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH373** \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH317 \nH411  \n608-049-00-5  2-(4-(4-(butyl-(1-methyl\xad\nhexyl)amino)phenyl)-3-cyano-5- \noxo-1,5-dihydropyrrol-2- \nylidene)propandinitrile  429-180-2  157362-53-3  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n608-050-00-0  reaction mass of: 5-(2-cyano-4- \nnitrophenylazo)-2-(2-(2-hydro\xad\nxyethoxy)ethylamino)-4-methyl- \n6-phenylaminonicotinonitrile; \n5-(2-cyano-4-nitrophenylazo)-6- \n(2-(2-hydroxyethoxy)ethy\xad\nlamino)-4-methyl-2-phenylami\xad\nnonicotinonitrile  429-760-5  —  Aquatic Chronic 4  H413  —  H413  \n608-051-00-6  (R)-4-(4-dimethylamino-1-(4- \nfluorophenyl)-1-hydroxybutyl)-3- \n(hydroxymethyl)benzonitrile  430-760-2  219861-18-4  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n608-052-00-1  (S)-4-(4-dimethylamino-1-(4- \nfluorophenyl)-1-hydroxybutyl)-3- \n(hydroxymethyl)benzonitrile  430-770-7  128173-52-4  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 910}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 912\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-053-00-7  (R,S)-4-(4-dimethylamino-1-(4- \nfluorophenyl)-1-hydroxybutyl)-3- \n(hydroxymethyl)benzonitrile  430-780-1  103146-25-4  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n608-054-00-2  (R,S)-4-(4-dimethylamino-1-(4- \nfluorophenyl)-1-hydroxybutyl)3- \n(hydroxymethyl)benzonitrile \nhemisulfate  430-790-6  —  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n▼M15  \n608-055-00-8  fipronil (ISO); \n(±)-5-amino-1-(2,6-dichloro- \nα,α,α-trifluoro-para-tolyl)-4-triflu\xad\noromethylsulfinyl-pyrazole-3- \ncarbonitrile  424-610-5  120068-37-3  Acute Tox. 3* \nAcute Tox. 3* \nAcute Tox. 3* \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH311 \nH331 \nH372* \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH311 \nH331 \nH372* \nH410  M = 1 000 \nM = 10 000  \n▼M16  \n608-056-00-3  N-methyl- N-cyanomethylmorpho\xad\nliniummethylsulfate  429-340-1  —  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n608-057-00-9  4-(cyanomethyl)-4-methylmor\xad\npholin-4-ium hydrogen sulfate  431-200-1  208538-34-5  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH318 \nH317  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 911}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 913\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-058-00-4  esfenvalerate (ISO); \n(S)-α-cyano-3-phenoxybenzyl- \n(S)-2-(4-chlorophenyl)-3-methyl\xad\nbutyrate  — 66230-04-4  Acute Tox. 3 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH317 \nH410  M = 10000  \n608-059-00-X  5-amino-1-(2,6-dichloro-4-(triflu\xad\noromethyl)phenyl)-1 H-pyrazole- \n3-carbonitrile  421-240-6  120068-79-3  Aquatic Chronic 2  H411  GHS09  H411  \n608-060-00-5  5-methyl-2-[(2-nitrophe\xad\nnyl)amino]-3-thiophenecarbon\xad\nitrile  421-300-1  138564-59-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n608-062-00-6  2-fluoro-4-hydroxybenzonitrile  422-810-7  82380-18-5  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 912}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 914\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n608-063-00-1  (S)-α-hydroxy-3-phenoxy-benze\xad\nneacetonitrile  441-070-6  61826-76-4  Acute Tox. 3 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H301 \nH318 \nH317 \nH410  \n608-064-00-7  cyanomethyltrimethylammonium\xad\nmethylsulfate  433-720-2  —  Aquatic Chronic 3  H412  —  H412  \n608-065-00-2  salts of bromoxynil with the \nexception of those specified \nelsewhere in this Annex  — —  Repr. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH330 \nH301 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361d *** \nH330 \nH301 \nH317 \nH410  M = 10  A  \n608-066-00-8  salts of ioxynil with the \nexception of those specified \nelsewhere in this Annex  — —  Repr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H361d *** \nH331 \nH301 \nH312 \nH373 ** \nH319 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H361d *** \nH331 \nH301 \nH312 \nH373 ** \nH319 \nH410  M = 10  A  \n▼M13  \n608-067-00-3  3,7-dimethylocta-2,6-dienenitrile  225-918-0  5146-66-7  Muta. 1B  H340  GHS08 \nDgr H340  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 913}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 915\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M18  \n608-068-00-9  flutianil (ISO); \n(2Z)-{[2-fluoro-5-(trifluor\xad\nomethyl)phenyl]thio}[3-(2- \nmethoxyphenyl)-1,3-thiazolidin- \n2-ylidene]acetonitrile  — 958647-10-4  Aquatic Chronic 1  H410  GHS09 \nWng  H410  M = 100  \n▼M22  \n608-069-00-4  fludioxonil (ISO); 4-(2,2- \ndifluoro-1,3-benzodioxol-4-yl)- \n1H-pyrrole-3-carbonitrile  — 131341-86-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 10  \n▼M16  \n609-001-00-6  1-nitropropane  203-544-9  108-03-2  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH332 \nH312 \nH302  GHS02 \nGHS07 \nWng  H \n226 \nH332 \nH312 \nH302  * \n609-002-00-1  2-nitropropane  201-209-1  79-46-9  Flam. Liq. 3 \nCarc. 1B \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH350 \nH332 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H226 \nH350 \nH332 \nH302  \n609-003-00-7  nitrobenzene  202-716-0  98-95-3  Carc. 2. Repr. 1B \nAcute Tox. 3 \nAcute Tox. 3 \nAcute Tox. 3 \nSTOT RE 1 \nAquatic Chronic 3  H351 \nH360F \nH301 \nH331 \nH311 \nH372 (blood) \nH412  GHS06 \nGHS08 \nDgr H351 \nH360F \nH301 \nH331 \nH311 \nH372 (blood) \nH412  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 914}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 916\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-004-00-2  dinitrobenzene; [1] \n1,4-dinitrobenzene; [2] \n1,3-dinitrobenzene; [3] \n1,2-dinitrobenzene [4]  246-673-6 [1] \n202-833-7 [2] \n202-776-8 [3] \n208-431-8 [4]  25154-54-5 [1] \n100-25-4 [2] \n99-65-0 [3] \n528-29-0 [4]  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH410  \n609-005-00-8  1,3,5-trinitrobenzene  202-752-7  99-35-4  Expl. 1.1 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH330 \nH310 \nH300 \nH373** \nH400 \nH410  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH330 \nH310 \nH300 \nH373** \nH410  \n609-006-00-3  4-nitrotoluene  202-808-0  99-99-0  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH411  \n609-007-00-9  2,4-dinitrotoluene; [1] \ndinitrotoluene [2]  204-450-0 [1] \n246-836-1 [2]  121-14-2 [1] \n25321-14-6 [2]  Carc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH341 \nH361f*** \nH331 \nH311 \nH301 \nH373** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH361f*** \nH331 \nH311 \nH301 \nH373** \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 915}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 917\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-008-00-4  2,4,6-trinitrotoluene; TNT  204-289-6  118-96-7  Expl. 1.1 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H201 \nH331 \nH311 \nH301 \nH373 ** \nH411  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH331 \nH311 \nH301 \nH373 ** \nH411  \n609-009-00-X  2,4,6-trinitrophenol; \npicric acid  201-865-9  88-89-1  Expl. 1.1 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H201 \nH331 \nH311 \nH301  GHS01 \nGHS06 \nDgr H201 \nH331 \nH311 \nH301  \n609-010-00-5  salts of picric acid  —  —  Unst. Expl \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H201 \nH331 \nH311 \nH301  GHS01 \nGHS06 \nDgr H201 \nH331 \nH311 \nH301  T \n609-011-00-0  2,4,6-trinitroanisole  —  606-35-9  Expl. 1.1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H201 \nH332 \nH312 \nH302 \nH411  GHS01 \nGHS07 \nGHS09 \nWng  H201 \nH332 \nH312 \nH302 \nH411  \n609-012-00-6  2,4,6-trinitro- m-cresol  210-027-1  602-99-3  Expl. 1.1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H201 \nH332 \nH312 \nH302  GHS01 \nGHS07 \nWng  H201 \nH332 \nH312 \nH302  \n609-013-00-1  2,4,6-trinitro- m-xylene  211-187-5  632-92-8  Expl. 1.1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 *  H201 \nH332 \nH312 \nH302 \nH373 **  GHS01 \nGHS08 \nGHS07 \nWng  H201 \nH332 \nH312 \nH302 \nH373 **  \n609-015-00-2  4-nitrophenol;  \np-nitrophenol  202-811-7  100-02-7  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 *  H332 \nH312 \nH302 \nH373 **  GHS08 \nGHS07 \nWng  H332 \nH312 \nH302 \nH373 **  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 916}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 918\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-016-00-8  dinitrophenol (reaction mass of \nisomers); [1] \n2,4(or 2,6)-dinitrophenol [2]  247-096-2 [1] \n275-732-9 [2]  25550-58-7 [1] \n71629-74-8 [2]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH410  \n609-018-00-9  2,4,6-trinitroresorcinol; \nstyphnic acid  201-436-6  82-71-3  Expl. 1.1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H201 \nH332 \nH312 \nH302  GHS01 \nGHS07 \nDgr H201 \nH332 \nH312 \nH302  \n609-019-00-4  lead 2,4,6-trinitro- m-phenylene \ndioxide; lead 2,4,6-trinitroresor\xad\ncinoxide; \nlead styphnate  239-290-0  15245-44-0  Unst. Expl \nRepr. 1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H200 \nH360Df \nH332 \nH302 \nH373 ** \nH400 \nH410  GHS01 \nGHS08 \nGHS07 \nGHS09 \nDgr H200 \nH360Df \nH332 \nH302 \nH373 ** \nH410  1 \n609-019-01-1  lead 2,4,6-trinitro- m-phenylene \ndioxide; \nlead 2,4,6-trinitroresorcinoxide; \nlead styphnate (≥ 20 % phlegma\xad\ntiser)  239-290-0  15245-44-0  Expl. 1.1 \nRepr. 1A \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH360Df \nH332 \nH302 \nH373 ** \nH400 \nH410  GHS01 \nGHS08 \nGHS07 \nGHS09 \nDgr H201 \nH360Df \nH332 \nH302 \nH373 ** \nH410  1 \n609-020-00-X  DNOC (ISO); \n4,6-dinitro- o-cresol  208-601-1  534-52-1  Muta. 2 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH330 \nH310 \nH300 \nH315 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H341 \nH330 \nH310 \nH300 \nH315 \nH318 \nH317 \nH410  EUH044  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 917}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 919\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-021-00-5  sodium salt of DNOC; \nsodium 4,6-dinitro- o-cresolate; \n[1] \npotassium salt of DNOC; \npotassium 4,6-dinitro- o-cresolate \n[2] 219-007-7 [1] \n-[2] 2312-76-7 [1] \n5787-96-2 [2]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH410  \n609-022-00-0  ammonium salt of DNOC; \nammonium 4,6-dinitro- o-tolyl \noxide  221-037-0  2980-64-5  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH300 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH410  \n609-023-00-6  dinocap (ISO); \n(RS)-2,6-dinitro-4-octylphenyl \ncrotonates and ( RS)-2,4-dinitro-6- \noctylphenyl crotonates in which \n"octyl" is a reaction mass of 1- \nmethylheptyl, 1-ethylhexyl and \n1-propylpentyl groups  254-408-0  39300-45-3  Repr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D*** \nH332 \nH302 \nH373** \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360D*** \nH332 \nH302 \nH373** \nH315 \nH317 \nH410  M=100  \n609-024-00-1  binapacryl (ISO); \n2-sec-butyl-4,6-dinitrophenyl-3- \nmethylcrotonate  207-612-9  485-31-4  Repr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H360D *** \nH312 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360D *** \nH312 \nH302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 918}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 920\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-025-00-7  dinoseb (ISO); \n6-sec-butyl-2,4-dinitrophenol  201-861-7  88-85-7  Repr. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH311 \nH301 \nH319 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H360Df \nH311 \nH301 \nH319 \nH410  EUH044  \n609-026-00-2  salts and esters of dinoseb, with \nthe exception of those specified \nelsewhere in this Annex  — —  Repr. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH311 \nH301 \nH319 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H360Df \nH311 \nH301 \nH319 \nH410  EUH044  A  \n609-027-00-8  dinocton; \nreaction mass of isomers: \nmethyl 2-octyl-4,6-dinitrophenyl \ncarbonate, methyl 4-octyl-2,6- \ndinitrophenyl carbonate  — 63919-26-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n609-028-00-3  dinex (ISO); \n2-cyclohexyl-4,6-dinitrophenol  205-042-5  131-89-5  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  \n609-029-00-9  salts and esters of dinex  —  —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  A ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 919}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 921\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-030-00-4  dinoterb (ISO); \n2-tert-butyl-4,6-dinitrophenol  215-813-8  1420-07-1  Repr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H360D *** \nH300 \nH311 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H360D *** \nH300 \nH311 \nH410  EUH044  \n609-031-00-X  salts and esters of dinoterb  —  —  Repr. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H360D *** \nH300 \nH311 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H360D *** \nH300 \nH311 \nH410  A \n609-032-00-5  bromofenoxim (ISO); \n3,5-dibromo-4-hydroxybenz\xad\naldehyde- O-(2,4-dinitrophenyl)- \noxime  236-129-6  13181-17-4  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n609-033-00-0  dinosam (ISO); \n2-(1-methylbutyl)-4,6-dinitro\xad\nphenol  — 4097-36-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  \n609-034-00-6  salts and esters of dinosam  —  —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH410  A \n609-035-00-1  nitroethane  201-188-9  79-24-3  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH332 \nH302  GHS02 \nGHS07 \nWng  H226 \nH332 \nH302  * ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 920}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 922\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-036-00-7  nitromethane  200-876-6  75-52-5  Flam. Liq. 3 \nAcute Tox. 4 *  H226 \nH302  GHS02 \nGHS07 \nWng  H226 \nH302  * \n609-037-00-2  5-nitroacenaphthene  210-025-0  602-87-9  Carc. 1B  H350  GHS08 \nDgr H350  \n609-038-00-8  2-nitronaphthalene  209-474-5  581-89-5  Carc. 1B \nAquatic Chronic 2  H350 \nH411  GHS08 \nGHS09 \nDgr H350 \nH411  \n609-039-00-3  4-nitrobiphenyl  202-204-7  92-93-3  Carc. 1B \nAquatic Chronic 2  H350 \nH411  GHS08 \nGHS09 \nDgr H350 \nH411  \n609-040-00-9  nitrofen (ISO); \n2,4-dichlorophenyl 4-nitrophenyl \nether  217-406-0  1836-75-5  Carc. 1B \nRepr. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH360D *** \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH360D *** \nH302 \nH410  \n▼M23  \n609-041-00-4  2,4-dinitrophenol  200-087-7  51-28-5  Acute Tox. 3 * \nAcute Tox. 3 \nAcute Tox. 2 \nSTOT RE 1 \nAquatic Acute 1  H331 \nH311 \nH300 \nH372 \nH400  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH300 \nH372 \nH400  dermal: ATE = \n300 mg/kg bw \noral: ATE = 30 \nmg/kg bw  \n▼M16  \n609-042-00-X  pendimethalin (ISO);  \nN-(1-ethylpropyl)-2,6-dinitro-3,4- \nxylidine  254-938-2  40487-42-1  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n609-043-00-5  quintozene (ISO); \npentachloronitrobenzene  201-435-0  82-68-8  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 921}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 923\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-044-00-0  tecnazene (ISO); \n1,2,4,5-tetrachloro-3-nitro\xad\nbenzene  204-178-2  117-18-0  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n609-045-00-6  reaction mass of: 4,6-dinitro-2- \n(3-octyl)phenyl methyl carbonate \nand 4,6-dinitro-2-(4-octyl)phenyl \nmethyl carbonate; dinocton-6  — 8069-76-9  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n609-046-00-1  trifluralin (ISO) (containing \n<0.5 ppm NPDA); \nα, α, α-trifluoro-2,6-dinitro- N, N - \ndipropyl- p-toluidine (containing \n< 0,5 ppm NPDA); \n2,6-dinitro- N, N -dipropyl-4-triflu\xad\noromethylaniline (containing < \n0,5 ppm NPDA);  \nN, N -dipropyl-2,6-dinitro-4-triflu\xad\noromethylaniline (containing < \n0.5 ppm NPDA)  216-428-8  1582-09-8  Carc. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH317 \nH410  M=10  \n609-047-00-7  2-nitroanisole  202-052-1  91-23-6  Carc. 1B \nAcute Tox. 4 *  H350 \nH302  GHS08 \nGHS07 \nDgr H350 \nH302  \n609-048-00-2  sodium 3-nitrobenzenesulphonate  204-857-3  127-68-4  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 922}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 924\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-049-00-8  2,6-dinitrotoluene  210-106-0  606-20-2  Carc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 3  H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH412  GHS06 \nGHS08 \nDgr H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH412  \n609-050-00-3  2,3-dinitrotoluene  210-013-5  602-01-7  Carc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH410  \n609-051-00-9  3,4-dinitrotoluene  210-222-1  610-39-9  Carc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 923}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 925\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-052-00-4  3,5-dinitrotoluene  210-566-2  618-85-9  Carc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 3  H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH412  GHS06 \nGHS08 \nDgr H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH412  \n609-053-00-X  hydrazine-trinitromethane  414-850-9  —  Expl. 1.1 **** \nSelf-react. A \nCarc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Sens. 1  H201 \nH240 \nH350 \nH331 \nH301 \nH317  GHS01 \nGHS06 \nGHS08 \nDgr H201 \nH240 \nH350 \nH331 \nH301 \nH317  \n609-054-00-5  2,3-dinitrophenol; [1] \n2,5-dinitrophenol; [2] \n2,6-dinitrophenol; [3] \n3,4-dinitrophenol; [4] \nsalts of dinitrophenol [5]  200-628-7 [1] \n206-348-1 [2] \n209-357-9 [3] \n209-415-3 [4]- \n[5] 66-56-8 [1] \n329-71-5 [2] \n573-56-8 [3] \n577-71-9 [4]- \n[5] Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH411  \n609-055-00-0  2,5-dinitrotoluene  210-581-4  619-15-8  Carc. 1B Muta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH361f *** \nH331 \nH311 \nH301 \nH373 ** \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 924}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 926\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-056-00-6  2,2-dibromo-2-nitroethanol  412-380-9  69094-18-4  Expl. 1.1 \nCarc. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1A \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH351 \nH302 \nH373 ** \nH314 \nH317 \nH400 \nH410  GHS01 \nGHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H201 \nH351 \nH302 \nH373 ** \nH314 \nH317 \nH410  * \nSTOT SE 3; H335: \nC ≥ 1 %  T \n609-057-00-1  3-chloro-2,4-difluoronitrobenzene  411-980-8  3847-58-3  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH317 \nH410  \n609-058-00-7  2-nitro-2-phenyl-1,3-propanediol  410-360-4  5428-02-4  STOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H372 ** H312 \nH302 \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H372 ** \nH312 \nH302 \nH317 \nH411  EUH070  \n609-059-00-2  2-chloro-6-(ethylamino)-4-nitro\xad\nphenol  411-440-1  131657-78-8  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n609-060-00-8  4-[(3-hydroxypropyl)amino]-3- \nnitrophenol  406-305-9  92952-81-3  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 925}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 927\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-061-00-3  (E, Z )-4-chlorophenyl(cyclopro\xad\npyl)ketone  O-(4-nitrophenylme\xad\nthyl)oxime  406-100-4  94097-88-8  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n609-062-00-9  2-bromo-2-nitropropanol  407-030-7  24403-04-1  Acute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H311 \nH302 \nH373 ** \nH314 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H311 \nH302 \nH373 ** \nH314 \nH317 \nH410  \n609-063-00-4  2-[(4-chloro-2-nitrophe\xad\nnyl)amino]ethanol  413-280-8  59320-13-7  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n▼M23  \n609-064-00-X  mesotrione (ISO); \n2-[4-(methylsulfonyl)-2-nitroben\xad\nzoyl]-1,3-cyclohexanedione  — 104206-82-8  Repr. 2 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH373 (eyes, \nnervous \nsystem) \nH400 \nH410  GHS08 \nGHS09 \nWng  H361d \nH373 (eyes, \nnervous \nsystem) \nH410  M = 10 \nM = 10  \n▼M16  \n609-065-00-5  2-nitrotoluene  201-853-3  88-72-2  Carc. 1B \nMuta. 1B \nRepr. 2 \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH340 \nH361f *** \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH340 \nH361f *** \nH302 \nH411  \n609-066-00-0  lithium sodium 3-amino-10-{4- \n(10-amino-6,13-dichloro-4,11- \ndisulfonatobenzo[5,6][1,4]ox\xad\nazino[2,3-b]phenoxazine-3- \nylamino)-6-[methyl(2-sulfonato- \nethyl)amino]-1,3,5-triazin-2- \nylamino}-6,13-dichloro\xad\nbenzo[5,6][1,4]oxazino[2,3- \nb]phenoxazine-4,11-disulfonate  418-870-9  154212-58-5  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 2 **  H332 \nH312 \nH302 \nH371 **  GHS08 \nGHS07 \nDgr H332 \nH312 \nH302 \nH371 **  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 926}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 928\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-067-00-6  sodium and potassium 4-(3-amin\xad\nopropylamino)-2,6-bis[3(4- \nmethoxy-2-sulfophenylazo)4- \nhydroxy-2-sulfo-7-naphthy\xad\nlamino]-1,3,5-triazine  416-280-6  156769-97-0  Skin Sens. 1  H317  GHS07 \nWng  H317  \n609-068-00-1  musk xylene; \n5-tert-butyl-2,4,6-trinitro- m- \nxylene  201-329-4  81-15-2  Expl. 1.1 \nCarc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH351 \nH400 \nH410  GHS01 \nGHS08 \nGHS09 \nWng  H201 \nH351 \nH410  T \n609-069-00-7  musk ketone; \n3,5-dinitro-2,6-dimethyl-4- tert- \nbutylacetophenone; \n4'-tert-butyl-2', 6'-dimethyl-3', \n5'-dinitroacetophenone  201-328-9  81-14-1  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n609-070-00-2  1,4-dichloro-2-(1,1,2,3,3,3- \nhexafluoropropoxy)-5-nitro\xad\nbenzene  415-580-4  130841-23-5  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n609-071-00-8  reaction mass of: 2-methyl\xad\nsulfanyl-4,6-bis-(2-hydroxy-4- \nmethoxy-phenyl)-1,3,5-triazine; \n2-(4,6-bis-methylsulfanyl-1,3,5- \ntriazin-2-yl)-5-methoxy-phenol  423-520-3  156137-33-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n609-072-00-3  4-mesyl-2-nitrotoluene  430-550-0  1671-49-4  Repr. 2 \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H361f*** \nH302 \nH317 \nH412  GHS08 \nGHS07 \nWng  H361f*** \nH302 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 927}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 929\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n609-073-00-9  lithium potassium sodium  N,N''- \nbis{6-[7-[4-(4-chloro-1,3,5- \ntriazin-2-yl)amino-4-(2-ureidop\xad\nhenylazo)]naphthalene-1,3,6- \ntrisulfonato}- N'-(2-aminoe\xad\nthyl)piperazine  427-850-9  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n610-001-00-3  trichloronitromethane; \nchloropicrin  200-930-9  76-06-2  Acute Tox. 2 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H330 \nH302 \nH319 \nH335 \nH315  GHS06 \nDgr H330 \nH302 \nH319 \nH335 \nH315  \n610-002-00-9  1,1-dichloro-1-nitroethane  209-854-0  594-72-9  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  \n610-003-00-4  chlorodinitrobenzene  —  —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH410  C \n610-004-00-X  2-chloro-1,3,5-trinitrobenzene  201-864-3  88-88-0  Expl. 1.1 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH330 \nH310 \nH300 \nH400 \nH410  GHS01 \nGHS06 \nGHS09 \nDgr H201 \nH330 \nH310 \nH300 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 928}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 930\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n610-005-00-5  1-chloro-4-nitrobenzene  202-809-6  100-00-5  Carc. 2 \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H351 \nH341 \nH331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH341 \nH331 \nH311 \nH301 \nH373 ** \nH411  \n610-006-00-0  chloronitroanilines with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 2  H330 \nH310 \nH300 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH411  A C \n610-007-00-6  1-chloro-1-nitropropane  209-990-0  600-25-9  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH302  GHS07 \nWng  H332 \nH302  * \n610-008-00-1  2,6-dichloro-4-nitroanisole  403-350-6  17742-69-7  Acute Tox. 3 * \nAquatic Chronic 2  H301 \nH411  GHS06 \nGHS09 \nDgr H301 \nH411  \n610-009-00-7  2-chloro-4-nitroaniline  204-502-2  121-87-9  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n610-010-00-2  2-bromo-1-(2-furyl)-2-nitroe\xad\nthylene  406-110-9  35950-52-8  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** \nH314 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H302 \nH373 ** \nH314 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 929}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 931\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-001-00-6  azobenzene  203-102-5  103-33-3  Carc. 1B Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH341 \nH332 \nH302 \nH373 ** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH341 \nH332 \nH302 \nH373 ** \nH410  \n611-002-00-1  azoxybenzene  207-802-1  495-48-7  Acute Tox. 4 * \nAcute Tox. 4 *  H332 \nH302  GHS07 \nWng  H332 \nH302  \n611-003-00-7  fenaminosulf (ISO); \nsodium 4-dimethylaminoben\xad\nzenediazosulphonate  205-419-4  140-56-7  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Chronic 3  H301 \nH312 \nH412  GHS06 \nDgr H301 \nH312 \nH412  \n611-004-00-2  methyl- ONN-azoxymethyl \nacetate; \nmethyl azoxy methyl acetate  209-765-7  592-62-1  Carc. 1B Repr. 1B  H350 \nH360D ***  GHS08 \nDgr H350 \nH360D ***  \n611-005-00-8  disodium {5-[(4'-((2,6-hydroxy3- \n((2-hydroxy-5-sulphophe\xad\nnyl)azo)phenyl)azo)(1,1'- \nbiphenyl)-4-yl)azo]salicylato (4- \n)}cuprate(2-); \nCI Direct Brown 95  240-221-1  16071-86-6  Carc. 1B  H350  GHS08 \nDgr H350  \n611-006-00-3  4 - o-tolylazo- o-toluidine; \n4-amino-2',3-dimethylazo\xad\nbenzene; \nfast garnet GBC base; AAT;  \no-aminoazotoluene  202-591-2  97-56-3  Carc. 1B \nSkin Sens. 1  H350 \nH317  GHS08 \nDgr H350 \nH317  \n611-007-00-9  tricyclazole (ISO); \n5-methyl-1,2,4-triazolo(3,4- \nb)benzo-1,3-thiazole;  255-559-5  41814-78-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 930}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 932\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-008-00-4  4-aminoazobenzene; \n4-phenylazoaniline  200-453-6  60-09-3  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  \n611-009-00-X  sodium (1-(5-(4-(4-anilino-3- \nsulphophenylazo)-2-methyl-5- \nmethylsulphonamidopheny\xad\nlazo)4-hydroxy-2-oxido-3- \n(phenylazo)phenylazo)-5-nitro-4- \nsulphonato-2-naphtholato)iron(II)  401-220-3  —  Acute Tox. 4 * \nAquatic Chronic 3  H332 \nH412  GHS07 \nWng  H332 \nH412  \n611-010-00-5  2'-(2-cyano-4,6-dinitropheny\xad\nlazo)-5'-( N, N -dipropy\xad\nlamino)propionanilide  403-010-7  106359-94-8  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n611-011-00-0  N, N,N',N' -tetramethyl-3,3'- \n(propylenebis(iminocarbonyl-4,1- \nphenylenazo(1,6-dihydro-2- \nhydroxy-4-methyl-6-oxopyridine- \n3,1-diyl)))di(propylammonium) \ndilactate  403-340-1  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDg H318 \nH411  \n611-012-00-6  reaction mass of 2,2-iminodie\xad\nthanol 6-methyl-2-(4-(2,4,6- \ntriaminopyrimidin-5-ylazo)phe\xad\nnyl)benzothiazole-7-sulfonate \nand 2-methylaminoethanol 6- \nmethyl-2-(4-(2,4,6-triaminopyri\xad\nmidin-5-ylazo)phenyl)benzo\xad\nthiazole-7-sulfonate and  N, N - \ndiethylpropane-1,3-diamine 6- \nmethyl-2-(4-(2,4,6-triaminopyri\xad\nmidin-5-ylazo)phenyl)benzo\xad\nthiazole-7-sulfonate  403-410-1  114565-65-0  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 931}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 933\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-013-00-1  trilithium-1-hydroxy-7-(3-sulfon\xad\natoanilino)-2-(3-methyl-4-(2- \nmethoxy-4-(3-sulfonatopheny\xad\nlazo)phenylazo)phenylazo)naph\xad\nthalene-3-sulfonate  403-650-7  117409-78-6  Expl. 1.3 **** \nAquatic Chronic 2  H203 \nH411  GHS01 \nGHS09 \nDgr H203 \nH411  \n611-014-00-7  (tetrasodium 1-(4-(3-acetamido- \n4-(4'-nitro-2,2'-disulfonatostilben- \n4-ylazo)anilino)-6-(2,5-disulfon\xad\natoanilino)-1,3,5-triazin-2-yl)-3- \ncarboxypyridinium) hydroxide  404-250-5  115099-55-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-015-00-2  tetrasodium 4-amino-5-hydroxy- \n6-(4-(2-(2-(sulfonatooxy)ethylsul\xad\nfonyl)ethylcarbamoyl)pheny\xad\nlazo)-3-(4-(2-(sulfon\xad\natooxy)ethylsulfonyl)pheny\xad\nlazo)naphthalene-2,7-disulfonate  404-320-5  116889-78-2  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-016-00-8  reaction mass of 1,1'-((dihydro\xad\nxyphenylene)bis(azo-3,1-phenyl\xad\nenazo(1-(3-dimethylamin\xad\nopropyl)-1,2-dihydro-6-hydroxy- \n4-methyl-2-oxopyridine-5,3- \ndiyl)))dipyridinium dichloride \ndihydrochloride, mixed isomers \nand 1-(1-(3-dimethylamin\xad\nopropyl)-5-(3-((4-(1-(3-dimethyl\xad\naminopropyl)-1,6-dihydro-2- \nhydroxy-4-methyl-6-oxo-5- \npyridinio-3-pyridylazo)pheny\xad\nlazo)-2,4(or 2,6 or 3,5)-dihydro\xad\nxyphenylazo)phenylazo)-1,2- \ndihydro-6-hydroxy-4-methyl-2- \noxo-3-pyridyl)pyridinium dich\xad\nloride  404-540-1  —  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 932}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 934\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-017-00-3  2-(4-(diethylaminopropylcarba\xad\nmoyl)phenylazo)-3-oxo- N-(2,3- \ndihydro-2-oxobenzimidazol-5- \nyl)butyramide  404-910-2  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n611-018-00-9  tetraammonium 5-(4-(7-amino-1- \nhydroxy-3-sulfonato-2-naphthy\xad\nlazo)-6-sulfonato-1-naphthy\xad\nlazo)isophthalate  405-130-5  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-019-00-4  tetralithium 6-amino-4-hydroxy- \n3-(7-sulfonato-4-(4-sulfonatop\xad\nhenylazo)-1-naphthylazo)naph\xad\nthalene-2,7-disulfonate  405-150-4  106028-58-4  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-020-00-X  tetrakis(tetramethylammonium) \n6-amino-4-hydroxy-3-(7- \nsulfonato-4-(4-sulfonatopheny\xad\nlazo)-1-naphthylazo)naphthalene- \n2,7-disulfonate  405-170-3  116340-05-7  Acute Tox. 3 * \nSkin Sens. 1 \nAquatic Chronic 3  H301 \nH317 \nH412  GHS06 \nDgr H301 \nH317 \nH412  \n611-021-00-5  2-(4-(4-cyano-3-methylisothiazol- \n5-ylazo)- N-ethyl-3-methyl\xad\nanilino)ethyl acetate  405-480-9  —  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nAquatic Chronic 4  H302 \nH373 ** H315 \nH413  GHS08 \nGHS07 \nWng  H302 \nH373 ** \nH315 \nH413  \n611-022-00-0  4-dimethylaminobenzenedia\xad\nzonium 3-carboxy-4-hydroxyben\xad\nzenesulfonate  404-980-4  —  Self-react. C \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H242 \nH331 \nH301 \nH312 \nH373 ** \nH318 \nH317 \nH400 \nH410  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H242 \nH331 \nH301 \nH312 \nH373 ** \nH318 \nH317 \nH410  T ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 933}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 935\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-023-00-6  disodium 7-(4,6-dichloro-1,3,5- \ntriazin-2-ylamino)-4-hydroxy-3- \n(4-(2-(sulfonatooxy)ethylsulfo\xad\nnyl)phenylazo) naphthalene-2- \nsulfonate  404-600-7  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-024-00-1  benzidine based azo dyes; \n4,4'-diarylazobiphenyl dyes, with \nthe exception of those specified \nelsewhere in this Annex  — —  Carc. 1B  H350  GHS08 \nDgr H350  A  \n611-025-00-7  disodium 4-amino-3-[[4'-[(2,4- \ndiaminophenyl)azo][1,1'- \nbiphenyl]-4-yl]azo]-5-hydroxy-6- \n(phenylazo)naphtalene-2,7- \ndisulphonate; \nC.I. Direct Black 38  217-710-3  1937-37-7  Carc. 1B Repr. 2  H350 \nH361d ***  GHS08 \nDgr H350 \nH361d ***  \n611-026-00-2  tetrasodium 3,3'-[[1,1'-biphenyl]- \n4,4'diylbis(azo)]bis[5-amino-4- \nhydroxynaphthalene-2,7- \ndisulphonate]; \nC.I. Direct Blue 6  220-012-1  2602-46-2  Carc. 1B Repr. 2  H350 \nH361d ***  GHS08 \nDgr H350 \nH361d ***  \n611-027-00-8  disodium 3,3'-[[1,1'-biphenyl]- \n4,4'-diylbis(azo)]bis(4-aminon\xad\naphthalene-1-sulphonate); C.I. \nDirect Red 28  209-358-4  573-58-0  Carc. 1B Repr. 2  H350 \nH361d ***  GHS08 \nDgr H350 \nH361d ***  \n611-028-00-3  C,C'-azodi(formamide)  204-650-8  123-77-3  Resp. Sens. 1  H334  GHS08 \nDgr H334  G  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 934}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 936\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-029-00-9  o-dianisidine based azo dyes; \n4,4'-diarylazo-3,3'-dimethoxy\xad\nbiphenyl dyes with the exception \nof those mentioned elsewhere in \nthis Annex  — —  Carc. 1B  H350  GHS08 \nDgr H350  A  \n611-030-00-4  o-tolidine based dyes; \n4,4'-diarylazo-3,3'-dimethyl\xad\nbiphenyl dyes, with the exception \nof those mentioned elsewhere in \nthis Annex  — —  Carc. 1B  H350  GHS08 \nDgr H350  A  \n611-031-00-X  4,4'-(4-iminocyclohexa-2,5- \ndienylidenemethylene)dianiline \nhydrochloride; \nC.I. Basic Red 9  209-321-2  569-61-9  Carc. 1B  H350  GHS08 \nDgr H350  \n611-032-00-5  1,4,5,8-tetraaminoanthra \nquinone; \nC.I. Disperse Blue 1  219-603-7  2475-45-8  Carc. 1B \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H350 \nH315 \nH318 \nH317  GHS08 \nGHS05 \nGHS07 \nDgr H350 \nH315 \nH318 \nH317  \n611-033-00-0  hexasodium [4,4''-azoxybis(2,2'- \ndisulfonatostilbene-4,4'diylazo)]- \nbis[5'-sulfonatobenzene-2,2'- \ndiolato- O(2), O (2), N (1)]- \ncopper(II)  400-020-3  82027-60-9  Aquatic Chronic 2  H411  GHS09  H411  \n611-034-00-6  N-(5-(bis(2-methoxye\xad\nthyl)amino)-2-((5-nitro-2,1-benzi\xad\nsothiazol-3-yl)azo)phenylace\xad\ntamide  402-430-8  105076-77-5  Aquatic Chronic 4  H413  —  H413  \n611-035-00-1  tetralithium 6-amino-4-hydroxy- \n3-[7-sulfonato-4-(5-sulfonato-2- \nnaphthylazo)-1-naphthy\xad\nlazo]naphthalene-2,7-disulfonate  403-660-1  107246-80-0  Aquatic Chronic 2  H411  GHS09  H411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 935}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 937\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-036-00-7  2-(4-(5,6(or 6,7)-dichloro-1,3- \nbenzothiazol-2-ylazo)- N-methyl-  \nm-toluidino)ethyl acetate  405-440-0  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-037-00-2  3(or 5)-(4-( N-benzyl- N-ethy\xad\nlamino)-2-methylphenylazo)1,4- \ndimethyl-1,2,4-triazolium \nmethylsulphate  406-055-0  124584-00-5  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n611-038-00-8  trisodium 1-hydroxynaphthalene- \n2-azo-4'(5',5''-dimethylbiphenyl)- \n4''-azo(4''-phenylsulfonyloxyben\xad\nzene)-2',2'',4-trisulfonate  406-820-9  —  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n611-039-00-3  7-[((4,6-dichloro-1,3,5-triazin-2- \nyl)amino)-4-hydroxy-3-(4-((2- \nsulfoxy)ethyl)sulfonyl)pheny\xad\nlazo]naphthalene-2-sulfonic acid  407-050-6  117715-57-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-040-00-9  3-(5-acetylamino-4-(4-[4,6-bis(3- \ndiethylaminopropylamino)-1,3,5- \ntriazin-2-ylamino]phenylazo)-2- \n(2-methoxyethoxy)phenylazo)-6- \namino-4-hydroxy-2-naphthalene\xad\nsulfonic acid  407-670-7  115099-58-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n611-041-00-4  2-[[4[[4,6-bis[[3-(diethy\xad\nlamino)propyl]amino]-1,3,5- \ntriazine-2-yl]amino]phenyl]azo]-  \nN-(2,3-dihydro-2-oxo-1 H-benzi\xad\nmidazol-5-yl)-3-oxobutanamide  407-680-1  98809-11-1  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 936}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 938\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-042-00-X  trisodium 5-amino-3-[5-(2- \nbromoacryloylamino)-2-sulfon\xad\natophenylazo]-4-hydroxy-6-(4- \nvinylsulfonylphenylazo)naph\xad\nthalene-2,7-disulfonate  411-770-6  136213-71-3  Aquatic Chronic 3  H412  —  H412  \n611-043-00-5  reaction mass of: trisodium  N(1')- \nN(2):N(1''')- N(2'')-η-6-[2-amino- \n4-(or 6)-hydroxy-(or 4-amino-2- \nhydroxy)phenylazo]-6''-(1-carb\xad\naniloyl-2-hydroxyprop-1- \nenylazo)-5',5'''-disulfamoyl-3,3''- \ndisulfonatobis(naphthalene-2,1'- \nazobenzene-1,2'-diolato- O(1), \nO(2'))-chromate; \ntrisodium  N(1')-N(2):N(1''')N(2'')- \nη-6,6''-bis(1-carbaniloyl-2- \nhydroxyprop-1-enylazo)-5',5'''dis\xad\nulfamoyl-3,3''-disulfonato \nbis(naphthalene-2,1'azobenzene- \n1,2'-diolato- O(1),O(2'))-chromate; \ntrisodium  N(1')-N(2):N(1''')N(2'')- \nη-6,6''-bis[2-amino-4-(or 6)- \nhydroxy-(or 4-amino-2- \nhydroxy)phenylazo]5',5'''disul\xad\nfamoyl-3,3''-disulfonatobis(naph\xad\nthalene-2,1'azobenzene-1,2'- \ndiolato- O(1),O(2'))-chromate \n(2:1:1)  402-850-1  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 937}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 939\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-044-00-0  reaction mass of:  tert -alkyl(C  12- \nC 14)ammonium bis[1-[(2- \nhydroxy-5-nitrophenyl)azo]-2- \nnaphthalenolato(2-)]-chromate(1- \n); tert -alkyl(C  12-C 14)ammonium \nbis[1-[(2-hydroxy-4-nitrophe\xad\nnyl)azo]-2-naphthalenolato(2)]- \nchromate(1-);  tert -alkyl(C  12- \nC 14)ammonium bis[1-[[5-(1,1- \ndimethylpropyl)-2-hydroxy-3- \nnitrophenyl]azo]-2-naphthaleno\xad\nlato(2-)]-chromate(1-);  tert - \nalkyl(C  12-C 14)ammonium [[1- \n[(2-hydroxy-5-nitrophenyl)azo]- \n2-naphthalenolato(2)]-[1-[(2- \nhydroxy-5-nitrophenyl)azo]-2- \nnaphthalenolato(2-)]]-chro\xad\nmate(1-);  \ntert-alkyl(C  12-C 14)ammonium \n[[1-[[5-(1,1-dimethylpropyl)-2- \nhydroxy-3-nitrophenyl]azo]-2- \nnaphthalenolato(2-)]-[1-[(2- \nhydroxy-5-nitrophenyl)azo]-2- \nnaphthalenolato(2-)]]-chro\xad\nmate(1-);  tert -alkyl(C  12-C 14)am\xad\nmonium \n((1-(4(or 5)-nitro-2-oxidopheny\xad\nlazo)-2-naphtholato)(1-(3-nitro-2- \noxido-5-pentylphenylazo)-2- \nnaphtholato))chromate(1-)  403-720-7  117527-94-3  Aquatic Chronic 2  H411  GHS09  H411  \n611-045-00-6  2-[4-[ N-(4-acetoxybutyl)- N- \nethyl]amino-2-methylphenylazo]- \n3-acetyl-5-nitrothiophene  404-830-8  —  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 938}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 940\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-046-00-1  4,4'-diamino-2-methylazobenzene  407-590-2  43151-99-1  Acute Tox. 3 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH373 ** \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH373 ** \nH317 \nH410  \n611-047-00-7  reaction mass of: 2-[[4-[ N-ethyl-  \nN-(2-acetoxyethyl)amino]phe\xad\nnyl]azo]-5,6-dichlorobenzo\xad\nthiazole; 2-[[4-[ N-ethyl- N-(2- \nacetoxyethyl)amino]phenyl]azo]- \n6,7-dichlorobenzothiazole (1:1)  407-890-3  111381-11-4  Aquatic Chronic 4  H413  —  H413  \n611-048-00-2  reaction mass of: 2-[[4-[bis(2- \nacetoxyethyl)amino]phenyl]azo]- \n5,6-dichlorobenzothiazole; 2-[[4- \n[bis(2-acetoxyethyl)amino]phe\xad\nnyl]azo]-6,7-dichlorobenzo\xad\nthiazole (1:1)  407-900-6  111381-12-5  Aquatic Chronic 4  H413  —  H413  \n611-049-00-8  reaction mass of 7-[4-(3-diethy\xad\nlaminopropylamino)-6-(3-diethy\xad\nlammoniopropylamino)-1,3,5- \ntriazin-2-ylamino]-4-hydroxy-3- \n(4-phenylazophenylazo)-naph\xad\nthalene-2-sulfonate, acetic acid, \nlactic acid (2:1:1)  408-000-6  118658-98-3  STOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 3  H373 ** \nH317 \nH412  GHS08 \nWng  H373 ** \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 939}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 941\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-050-00-3  reaction mass of: pentasodium \n7-amino-3-[[4-[[4-[[4-[[4-[(6- \namino-1-hydroxy-3-sulfonato-2- \nnaphthyl]azo]-7-sulfonato-1naph\xad\nthyl]azo]phenyl]amino]-3-sulfon\xad\natophenyl]azo]-6-sulfonato-1- \nnaphthyl]azo]-4-hydroxynaph\xad\nthalen-2-sulfonate; \npentasodium 7-amino-8-[4-[4-[4- \n[4-(2-amino-5-hydroxy-7- \nsulfonato-naphthalen-1-ylazo)-7- \nsulfonatonaphthalen-1-ylazo]- \nphenylamino]-3-sulfonato-pheny\xad\nlazo]-6-sulfonato-naphthalen-1- \nylazo]-4-hydroxy-naphthalene-2- \nsulfonate; \npentasodium 7-amino-8-[4-[4-[4- \n[4-(6-amino-1-hydroxy-3- \nsulfonato-naphthalen-1-ylazo)-7- \nsulfonatonaphthalen-1-ylazo]- \nphenylamino]-3-sulfonato-pheny\xad\nlazo]-6-sulfonato-naphthalen-1- \nylazo]-4-hydroxy-naphthalene-2- \nsulfonate;  415-350-3  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 940}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 942\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \ntetrasodium 7-amino-4-hydroxy- \n3-[4-[4-[4-(4-hydroxy-7- \nsulfonato-naphthalen-1-ylazo)-2- \nsulfonato-phenylamino]pheny\xad\nlazo]-6-sulfonato-naphthalen-1- \nylazo]naphthalene-2-sulfonate; \ntetrasodium 7-amino-4-hydroxy- \n3-[4-[4-[4-(4-amino-7-sulfonato- \nnaphthalen-1-ylazo)-2-sulfon\xad\natophenylamino]phenylazo]-6- \nsulfonato-naphthalen-1- \nylazo]naphthalene-2-sulfonate  \n611-051-00-9  2-(4-( N-ethyl- N-(2- \nhydroxy)ethyl)amino-2-methyl\xad\nphenyl)azo-6-methoxy-3-methyl- \nbenzothiazolium chloride  411-110-7  136213-74-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n611-052-00-4  monosodium aqua-[5-[[2,4-dihy\xad\ndroxy-5-[(2-hydroxy-3,5-dinitro\xad\nphenyl)azo]phenyl]azo]-2-naph\xad\nthalensulfonate], iron complex  400-720-9  —  Aquatic Chronic 3  H412  —  H412  \n611-053-00-X  2,2'-azobis[2-methylpropion\xad\namidine] dihydrochloride  221-070-0  2997-92-4  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n611-055-00-0  C.I. Disperse Yellow 3;  \nN-[4-[(2-hydroxy-5-methylphe\xad\nnyl)azo]phenyl]acetamide  220-600-8  2832-40-8  Carc. 2 \nSkin Sens. 1  H351 \nH317  GHS08 \nGHS07 \nWng  H351 \nH317  \n611-056-00-6  C.I. Solvent Yellow 14; \n1-phenylazo-2-naphthol  212-668-2  842-07-9  Carc. 2 \nMuta. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H351 \nH341 \nH317 \nH413  GHS08 \nGHS07 \nWng  H351 \nH341 \nH317 \nH413  \n611-057-00-1  6-hydroxy-1-(3-isopropoxy\xad\npropyl)-4-methyl-2-oxo-5-[4- \n(phenylazo)phenylazo]-1,2- \ndihydro-3-pyridinecarbonitrile  400-340-3  85136-74-9  Carc. 1B \nAquatic Chronic 4  H350 \nH413  GHS08 \nWng  H350 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 941}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 943\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-058-00-7  (6-(4-hydroxy-3-(2-methoxyp\xad\nhenylazo)-2-sulfonato-7-naphthy\xad\nlamino)-1,3,5-triazin-2,4- \ndiyl)bis[(amino-1-methyl\xad\nethyl)ammonium] formate  402-060-7  108225-03-2  Carc. 1B \nEye Dam. 1 \nAquatic Chronic 2  H350 \nH318 \nH411  GHS08 \nGHS05 \nGHS09 \nDgr H350 \nH318 \nH411  \n611-059-00-2  octasodium 2-(6-(4-chloro-6-(3- \n(N-methyl- N-(4-chloro-6-(3,5- \ndisulfonato-2-naphthylazo)-1- \nhydroxy-6-naphthylamino)-1,3,5- \ntriazin-2-yl)aminomethyl)pheny\xad\nlamino)-1,3,5-triazin-2-ylamino)- \n3,5-disulfonato-1-hydroxy-2- \nnaphthylazo)naphthalene-1,5- \ndisulfonate  412-960-1  148878-21-1  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n611-060-00-8  reaction mass of: sodium 5-[8-[4- \n[4-[4-[7-(3,5-dicarboxylatopheny\xad\nlazo)-8-hydroxy-3,6-disulfonaton\xad\naphthalen-1-ylamino]-6-hydroxy- \n1,3,5-triazin-2-yl]-2,5-dimethyl\xad\npiperazin-1-yl]-6-hydroxy-1,3,5- \ntriazin-2-ylamino]-1-hydroxy- \n3,6-disulfonatonaphthalen-2- \nylazo]-isophthalate; \nammonium 5-[8-[4-[4-[4-[7-(3,5- \ndicarboxylatophenylazo)-8- \nhydroxy-3,6-disulfonatonaph\xad\nthalen-1-ylamino]-6-hydroxy- \n1,3,5-triazin-2-yl]-2,5-dimethyl\xad\npiperazin-1-yl]-6-hydroxy-1,3,5- \ntriazin-2-ylamino]-1-hydroxy 3,6- \ndisulfonatonaphthalen-2-ylazo]- \nisophthalate;  413-180-4  187285-15-0  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 942}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 944\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n5-[8-[4-[4-[4-[7-(3,5-dicarboxyla\xad\ntophenylazo)-8-hydroxy-3,6- \ndisulfonatonaphthalen-1- \nylamino]-6-hydroxy-1,3,5-triazin- \n2-yl]-2,5-dimethylpiperazin-1-yl]- \n6-hydroxy-1,3,5-triazin-2- \nylamino]-1-hydroxy-3,6-disulfon\xad\naphthalen-2-ylazo]-isophthalic \nacid \n611-061-00-3  disodium 5-[5-[4-(5-chloro-2,6- \ndifluoropyrimidin-4-ylamino)ben\xad\nzamido]-2-sulfonatophenylazo]- \n1-ethyl-6-hydroxy-4-methyl-2- \noxo-3-pyridylmethylsulfonate  412-530-3  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n611-062-00-9  octasodium 2-(8-(4-chloro-6-(3- \n((4-chloro-6-(3,6-disulfonato-2- \n(1,5-disulfonatonaphthalen-2- \nylazo)-1-hydroxynaphthalen-8- \nylamino)-1,3,5-triazin-2-yl)ami\xad\nnomethyl)phenylamino)-1,3,5- \ntriazin-2-ylamino)-3,6- \ndisulfonato-1-hydroxynaph\xad\nthalen-2-ylazo)naphthalene-1,5- \ndisulfonate  413-550-5  —  Skin Irrit. 2 \nEye Dam. 1  H315 \nH318  GHS05 \nDgr H315 \nH318  \n611-063-00-4  trisodium [4'-(8-acetylamino-3,6- \ndisulfonato-2-naphthylazo)-4''-(6- \nbenzoylamino-3-sulfonato2-naph\xad\nthylazo)-biphenyl 1,3',3'',1'''- \ntetraolato- O,O',O'',O''']copper(II)  413-590-3  164058-22-4  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 943}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 945\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-064-00-X  4-(3,4-dichlorophenylazo)-2,6-di-  \nsec-butyl-phenol  410-600-8  124719-26-2  STOT RE 2 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 ** \nH315 \nH410  \n611-065-00-5  4-(4-nitrophenylazo)-2,6-di- sec- \nbutyl-phenol  410-610-2  111850-24-9  STOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH319 \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 ** \nH319 \nH315 \nH317 \nH410  \n611-066-00-0  tetrasodium 5-[4-chloro-6-( N- \nethyl-anilino)-1,3,5-triazin-2- \nylamino]-4-hydroxy-3-(1,5- \ndisulfonatonaphthalen-2-ylazo)- \nnaphthalene-2,7-disulfonate  411-540-5  130201-57-9  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n611-067-00-6  reaction mass of: bis(tris(2-(2- \nhydroxy(1- \nmethyl)ethoxy)ethyl)ammonium) \n7-anilino-4-hydroxy-3-(2- \nmethoxy-5-methyl-4-(4-sulfon\xad\natophenylazo)phenylazo)naph\xad\nthalene-2-sulfonate; bis(tris(2-(2- \nhydroxy(2- \nmethyl)ethoxy)ethyl)ammonium) \n7-anilino-4-hydroxy-3-(2- \nmethoxy-5-methyl-4-(4-sulfon\xad\natophenylazo)phenylazo)naph\xad\nthalene-2-sulfonate  406-910-8  —  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 944}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 946\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-068-00-1  tetrasodium 4-amino-3,6-bis(5- \n[4-chloro-6-(2-hydroxyethy\xad\nlamino)-1,3,5-triazin-2-ylamino]- \n2-sulfonatophenylazo)-5- \nhydroxynaphthalene-2,7- \ndisulfonate  400-690-7  85665-98-1  Aquatic Chronic 2  H411  GHS09  H411  \n611-069-00-7  N,N-di-[poly(oxyethylene)-co- \npoly(oxypropylene)]-4-[(3,5- \ndicyano-4-methyl-2-thie\xad\nnyl)azo)]-3-methylaniline  413-380-1  —  Aquatic Chronic 2  H411  GHS09  H411  \n611-070-00-2  reaction mass of: disodium (6-(4- \nanisidino)-3-sulfonato-2-(3,5- \ndinitro-2-oxidophenylazo)-1- \nnaphtholato)(1-(5-chloro-2- \noxidophenylazo)-2-naphtho\xad\nlato)chromate(1-); \ntrisodium bis(5-(4-anisidino)-3- \nsulfonato-2-(3,5-dinitro-2-oxidop\xad\nhenylazo)-1-naphtholato)chro\xad\nmate(1-)  405-665-4  —  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n611-071-00-8  tris(tetramethylammonium) 5- \nhydroxy-1-(4-sulphonatophenyl)- \n4-(4-sulphonatophenylazo)py\xad\nrazole-3-carboxylate  406-073-9  131013-81-5  Acute Tox. 3 * \nAquatic Chronic 3  H301 \nH412  GHS06 \nDgr H301 \nH412  \n611-072-00-3  2,4-bis[2,2'-[2-( N, N -dimethyl\xad\namino)ethyloxycarbonyl]pheny\xad\nlazo]-1,3-dihydroxybenzene, \ndihydrochloride  407-010-8  118208-02-9  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 945}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 947\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-073-00-9  dimethyl 3,3'-( N-(4-(4-bromo- \n2,6-dicyanophenylazo)-3-hydro\xad\nxyphenyl)imino)dipropionate  407-310-9  122630-55-1  Aquatic Chronic 4  H413  —  H413  \n611-074-00-4  reaction mass of: sodium/ \npotassium (3-(4-(5-(5-chloro-2,6- \ndifluoropyrimidin-4-ylamino)-2- \nmethoxy-3-sulfonatophenylazo)- \n2-oxidophenylazo)-2,5,7-trisul\xad\nfonato-4-naphtholato)copper(II); \nsodium/potassium (3-(4-(5-(5- \nchloro-4,6-difluoropyrimidin-2- \nylamino)-2-methoxy-3-sulfon\xad\natophenylazo)-2-oxidopheny\xad\nlazo)-2,5,7-trisulfonato-4-naph\xad\ntholato)copper(II)  407-100-7  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-075-00-X  reaction mass of: tris(3,5,5- \ntrimethylhexylammonium) 4- \namino-3-(4-(4-(2-amino-4-hydro\xad\nxyphenylazo)anilino)-3-sulfon\xad\natophenylazo)-5,6-dihydro-5-oxo- \n6-phenylhydrazononaphthalene- \n2,7-disulfonate; \ntris(3,5,5-trimethylhexylam\xad\nmonium) 4-amino-3-(4-(4-(4- \namino-2-hydroxypheny\xad\nlazo)anilino)-3-sulfonatopheny\xad\nlazo)-5,6-dihydro-5-oxo-6- \nphenylhydrazononaphthalene- \n2,7-disulfonate (2:1)  406-000-0  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 946}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 948\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-076-00-5  3-(2,6-dichloro-4-nitropheny\xad\nlazo)-1-methyl-2-phenylindole  406-280-4  117584-16-4  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n611-077-00-0  dilithium disodium (5,5'-diamino- \n(μ-4,4'-dihydroxy-1:2κ- \n2,O4,O4',-3,3'-[3,3'-dihydroxy- \n1:2-κ-2- O3,O3'-biphenyl-4,4'- \nylenebisazo-1:2-( N3, N 4-η:N3', \nN4'-η)]-dinaphthalene-2,7- \ndisulfonato(8)))dicuprate(2-)  407-230-4  126637-70-5  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n611-078-00-6  (2,2'-(3,3'-dioxidobiphenyl-4,4'- \ndiyldiazo)bis(6-(4-(3-(diethy\xad\nlamino)propylamino)-6-(-3-(die\xad\nthylammonio)propylamino)1,3,5- \ntriazin-2-ylamino)-3-sulfonato-1- \nnaphtholato))dicopper(II) acetate \nlactate  407-240-9  159604-94-1  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n611-079-00-1  disodium 7-[4-chloro-6-( N-ethyl-  \no-toluidino)-1,3,5-triazin2- \nylamino]-4-hydroxy-3-(4- \nmethoxy-2-sulfonatophenylazo)2- \nnaphthalenesulfonate  410-390-8  147703-64-8  Eye Dam. 1  H318  GHS05 \nDgr H318  \n611-080-00-7  sodium 3-(2-acetamido-4-(4-(2- \nhydroxybutoxy)phenylazo)pheny\xad\nlazo)benzenesulfonate  410-150-2  147703-65-9  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 947}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 949\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-081-00-2  tetrasodium [7-(2,5-dihydroxy- \nKO2-7-sulfonato-6-[4-(2,5,6- \ntrichloro-pyrimidin-4- \nylamino)phenylazo]-( N1,N7-N)1- \nnaphthylazo)-8-hydroxy-K O8- \nnaphthalene-1,3,5-trisulfon\xad\nato(6)]cuprate(II)  411-470-5  141048-13-7  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n611-082-00-8  reaction mass of: pentasodium \nbis(1-(3(or 5)-(4-anilino-3-sulfon\xad\natophenylazo)-4-hydroxy-2- \noxidophenylazo)-6-nitro-4- \nsulfonato-2-naphtholato)ferrate(1- \n); pentasodium [(1-(3-(4-anilino- \n3-sulfonatophenylazo)-4- \nhydroxy-2-oxidophenylazo)-6- \nnitro-4-sulfonato-2-naphtholato)- \n(5-(4anilino-3-sulfonatopheny\xad\nlazo)-4-hydroxy-2-oxidopheny\xad\nlazo)-6-nitro-4-sulfonato-2-naph\xad\ntholato]ferrate(1-)  407-570-3  —  Aquatic Chronic 2  H411  GHS09  H411  \n611-083-00-3  reaction mass of: 2-[ N-ethyl-4- \n[(5,6-dichlorobenzothiazol-2- \nyl)azo]- m-toludino]ethyl acetate; \n2-[N-ethyl-4-[(6,7-dichlorobenzo\xad\nthiazol-2-yl)azo]- m-toludino]ethyl \nacetate (1:1)  411-560-4  —  STOT RE 1 \nSkin Sens. 1 \nAquatic Chronic 2  H372 ** H317 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H372 ** \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 948}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 950\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M1 __________  \n▼M16  \n611-085-00-4  reaction mass of: 3-cyano-5-(2- \ncyano-4-nitro-phenylazo)-2-(2- \nhydroxy-ethylamino)-4-methyl-6- \n[3-(2-phenoxyethoxy)propy\xad\nlamino]pyridine; 3-cyano-5-(2- \ncyano-4-nitro-phenylazo)-6-(2- \nhydroxy-ethylamino)-4-methyl-2- \n[3-(2-phenoxyethoxy)propy\xad\nlamino]pyridine; \n3-cyano-5-(2-cyano-4-nitro- \nphenylazo)-2-amino-4-methyl-6- \n[3-(3-hydroxypropoxy)propy\xad\nlamino]pyridine; \n3-cyano-5-(2-cyano-4-nitro- \nphenylazo)-6-amino-4-methyl-2- \n[3-(3-methoxypropoxy)propy\xad\nlamino]pyridine  411-880-4  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n611-086-00-X  monolithium 5-[[2,4-dihydroxy- \n5-[(2-hydroxy-3,5-dinitrophe\xad\nnyl)azo]phenyl]azo]-2-naphtha\xad\nlenesulfonate], iron complex, \nmonohydrate  411-360-7  —  Aquatic Chronic 3  H412  —  H412  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 949}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 951\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-087-00-5  reaction mass of: 3-((5-cyano- \n1,6-dihydro-1,4-dimethyl-2- \nhydroxyl-6-oxo-3-pyridinyl)azo)- \nbenzoyloxy-2-phenoxyethane; \n3-((5-cyano-1,6-dihydro-1,4- \ndimethyl-2-hydroxy-6-oxo-3- \npyridinyl)azo)-benzoyloxy-2- \nethyloxy-2-(ethylphenol)  411-710-9  —  Aquatic Chronic 4  H413  —  H413  \n611-088-00-0  reaction mass of: trilithium 4- \namino-3-((4-((4-((2-amino-4- \nhydroxyphenyl)azo)phe\xad\nnyl)amino)-3-sulfophenyl)azo)5- \nhydroxy-6-(phenylazo)naph\xad\nthalene-2,7-disulfonate; \ntrilithium 4-amino-3-((4-((4-((4- \namino-2-hydroxyphenyl)azo)phe\xad\nnyl)amino)-3-sulfophenyl)azo)-5- \nhydroxy-6-(phenylazo)naph\xad\nthalene-2,7-disulfonate  411-890-9  —  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n611-089-00-6  2-((4-(ethyl-(2-hydroxye\xad\nthyl)amino)-2-methylphe\xad\nnyl)azo)-6-methoxy-3-methyl- \nbenzothiazolium methylsulfate  411-100-2  136213-73-5  STOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** H317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 ** \nH317 \nH410  \n611-090-00-1  2,5-dibutoxy-4-(morpholin-4- \nyl)benzenediazonium 4-methyl\xad\nbenzenesulfonate  413-290-2  93672-52-7  Self-react. C \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H242 \nH302 \nH318 \nH317 \nH412  GHS02 \nGHS05 \nGHS07 \nDgr H242 \nH302 \nH318 \nH317 \nH412  T ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 950}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 952\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-091-00-7  sodium (1,0-1,95)/lithium (0,051) \n5-((5-((5-chloro-6-fluoro-pyri\xad\nmidin-4-yl)amino)-2-sulfonatop\xad\nhenyl)azo)-1,2-dihydro-6- \nhydroxy-1,4-dimethyl-2-oxo-3- \npyridinemethylsulfonate  413-470-0  134595-59-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-092-00-2  tert -(dodecyl/tetradecyl)- \nammonium bis(3-(4-((5-(1,1- \ndimethyl-propyl)-2-hydroxy-3- \nnitrophenyl)azo)-3-methyl-5- \nhydroxy-(1 H)-pyrazol-1-yl)ben\xad\nzenesulfonamidato)chromate  413-210-6  —  Aquatic Chronic 2  H411  GHS09  H411  \n611-093-00-8  sodium 2-(4-(4-fluoro-6-(2-sulfo- \nethylamino)-[1,3,5]triazin-2- \nylamino)-2-ureido-phenylazo)-5- \n(4-sulfophenylazo)benzene-1- \nsulfonate  410-770-3  146177-84-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-094-00-3  reaction mass of: 2-[2-acety\xad\nlamino-4-[ N, N -bis[2-ethoxy- \ncarbonyloxy)ethyl]amino]pheny\xad\nlazo]-5,6-dichloro-1,3-benzo\xad\nthiazole; \n2-[2-acetylamino-4-[ N, N -bis[2- \nethoxy-carbony\xad\nloxy)ethyl]amino]phenylazo]-6,7- \ndichloro-1,3-benzotriazole (1:1)  411-600-0  143145-93-1  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 951}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 953\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-095-00-9  hexasodium 1,1'-[(1-amino-8- \nhydroxy-3,6-disulfonate-2,7- \nnaphthalenediyl)bis(azo(4- \nsulfonate-1,3-phenyl)imino[6[(4- \nchloro-3-sulfonatophenyl)amino]- \n1,3,5-triazin-2,4-diyl]]]bis[3- \ncarboxypyridinium] dihydroxide  412-240-7  89797-03-5  Aquatic Chronic 2  H411  GHS09  H411  \n611-096-00-4  methyl  N -[3-acetylamino)-4-(2- \ncyano-4-nitrophenylazo)phenyl]-  \nN-[(1-methoxy)acetyl]glycinate  413-040-2  149850-30-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-097-00-X  reaction mass of iron complexes \nof: 1,3-dihydroxy-4-[(5-pheny\xad\nlaminosulfonyl)-2-hydroxypheny\xad\nlazo]- n-(5-amino-sulfonyl-2- \nhydroxyphenylazo)benzene \nand: 1,3-dihydroxy-4-[(5-pheny\xad\nlaminosulfonyl)-2-hydroxypheny\xad\nlazo]- n-[4-(4-nitro-2-sulfopheny\xad\nlamino)phenylazo]benzene \n(n=2,5,6)  414-150-3  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n611-098-00-5  tetrakis(tetramethylam\xad\nmonium)3,3'-(6-(2-hydroxyethy\xad\nlamino)1,3,5-triazine-2,4-diylbi\xad\nsimino(2-methyl-4,1-phenyle\xad\nneazo))bisnaphthalene-1,5- \ndisulfonate  405-950-3  131013-83-7  Acute Tox. 3 * \nAquatic Chronic 3  H301 \nH412  GHS06 \nDgr H301 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 952}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 954\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-099-00-0  (methylenebis(4,1-phenyl\xad\nenazo(1-(3-(dimethyl\xad\namino)propyl)-1,2-dihydro-6- \nhydroxy-4-methyl-2-oxopyridine- \n5,3-diyl)))-1,1'dipyridinium dich\xad\nloride dihydrochloride  401-500-5  118658-99-4  Carc. 1B \nAquatic Chronic 2  H350 \nH411  GHS08 \nGHS09 \nDgr H350 \nH411  \n611-100-00-4  potassium sodium 3,3'-(3(or 4)- \nmethyl-1,2-phenylene\xad\nbis(imino(6-chloro)-1,3,5- \ntriazine-4,2-diylimino(2-acet\xad\namido-5-methoxy)-4,1-phenyl\xad\nenazo)dinaphthalene-1,5- \ndisulfonate  403-810-6  140876-13-7  Eye Dam. 1  H318  GHS05 \nDgr H318  \n611-101-00-X  2'-(4-chloro-3-cyano-5-formyl-2- \nthienyl)azo-5'-diethylaminoacet\xad\nanilide  405-200-5  104366-25-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-102-00-5  reaction product of: C.I. Leuco \nSulfur Black 1 and reaction \nmass of: disodium-4-{4-[8- \namino-1-hydroxy-7-(4-sulfa\xad\nmoylphenylazo)-3,6-disulfonato- \n2-naphthylazo]phenylsulfony\xad\nlamino}benzendiazoniumchlorid; \ndisodium-4-{4-[2,6-dihydroxy-3- \n(8-hydroxy-3,6-disulfonato-1- \nnaphthylazo)phenylazo]phe\xad\nnylsulfonylamino}benzen-diazo\xad\nniumchlorid  424-500-7  —  Aquatic Chronic 3  H412  —  H412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 953}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 955\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-103-00-0  trisodium (1-(3-carboxylato-2- \noxido-5-sulfonatophenylazo)-5- \nhydroxy-7-sulfonatonaphthalen- \n2-amido)nickel(II)  407-110-1  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n611-104-00-6  reaction mass of: trisodium \n(2,4(or 2,6 or 4,6)-bis(3,5- \ndinitro-2-oxidophenylazo)-5- \nhydroxyphenolato)(2(or 4 or 6)- \n(3,5-dinitro-2-oxidophenylazo)5- \nhydroxy-4(or 2 or 6)-(4-(4-nitro- \n2-sulfonatoanilino)pheny\xad\nlazo)phenolato)ferrate(1-); \ntrisodium bis(2,4(or 2,6 or 4,6)- \nbis(3,5-dinitro-2-oxidopheny\xad\nlazo)-5-hydroxyphenolato)fer\xad\nrate(1-); \ntrisodium (2,4(or 2,6 or 4,6)- \nbis(3,5-dinitro-2-oxidopheny\xad\nlazo)-5-hydroxyphenolato)(2(or 4 \nor 6)-(3,5-dinitro-2-oxidopheny\xad\nlazo)-5-hydroxy-4(or 2 or 6)-(4- \nnitro-2-sulfonatophenylazo)phen\xad\nolato)ferrate(1-); trisodium \n(2,4(or 2,6 or 4,6)-bis(3,5- \ndinitro-2-oxidophenylazo)-5- \nhydroxyphenolato)(2(or 4 or 6)- \n(3,5-dinitro-2-oxidophenylazo)-5- \nhydroxy-4(or 2 or 6)-(3-sulfon\xad\natophenylazo)phenolato)ferrate(1- \n); \ndisodium 3,3'-(2,4-dihy\xad\ndroxy1,3(or 1,5 or 3,5)-pheny\xad\nlenediazo)dibenzenesulfonate  406-870-1  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 954}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 956\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-105-00-1  sodium 4-(4-chloro-6-( N-ethyla\xad\nnilino)-1,3,5-triazin-2-ylamino)- \n2-(1-(2-chlorophenyl)-5-hydroxy- \n3-methyl-1 H-pyrazol-4- \nylazo)benzenesulfonate  407-800-2  136213-75-7  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n611-106-00-7  hexasodium 4,4'-dihydroxy-3,3'- \nbis[2-sulfonato-4-(4-sulfonatop\xad\nhenylazo)phenylazo]-7,7'[p- \nphenylenebis[imino(6-chloro- \n1,3,5-triazine-4,2-diyl)imino]]di\xad\nnaphthalene-2-sulfonate  410-180-6  157627-99-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n611-107-00-2  potassium sodium 4-(4-chloro-6- \n(3,6-disulfonato-7-(5,8- \ndisulfonato-naphthalen-2-ylazo)- \n8-hydroxy-naphthalen-1- \nylamino)-1,3,5-triazin-2- \nylamino)-5-hydroxy-6-(4-(2- \nsulfatoethanesulfonyl)-pheny\xad\nlazo)-naphthalene-1,7-disulfonate  412-490-7  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-108-00-8  disodium 5-((4-((4-chloro-3- \nsulfonatophenyl)azo)-1-naph\xad\nthyl)azo)-8-(phenylamino)-1- \nnaphthalenesulfonate  413-600-6  6527-62-4  Aquatic Chronic 3  H412  —  H412  \n611-109-00-3  reaction products of: copper(II) \nsulfate and tetrasodium 2,4- \nbis[6-(2-methoxy-5-sulfonatop\xad\nhenylazo)-5-hydroxy-7-sulfonato- \n2-naphthylamino]-6-(2-hydroxye\xad\nthylamino)-1,3,5-triazine (2:1)  407-710-3  —  Aquatic Chronic 2  H411  GHS09  H411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 955}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 957\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-110-00-9  tetra -sodium/lithium 4,4'-bis-(8- \namino-3,6-disulfonato-1- \nnaphthol-2-ylazo)-3-methylazo\xad\nbenzene  408-210-8  124605-82-9  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n611-111-00-4  disodium 2-[[4-(2-chloroethylsul\xad\nfonyl)phenyl]-[(2-hydroxy-5- \nsulfo-3-[3-[2-(2-(sul\xad\nfooxy)ethylsulfonyl)ethylazo]-4- \nsulfobenzoato(3-)cuprate(1-)  414-230-8  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-112-00-X  tetrasodium 4-hydroxy-5-[4-[3- \n(2-sulfatoethanesulfonyl)pheny\xad\nlamino]-6-morpholin-4-yl-1,3,5- \ntriazin-2-ylamino]-3-(1-sulfon\xad\natonaphthalen-2-ylazo)naph\xad\nthalene-2,7-disulfonate  413-070-6  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-113-00-5  lithium sodium (2-(((5-((2,5-dich\xad\nlorophenyl)azo)-2-hydroxyphe\xad\nnyl)methylene)amino)benzoato(2- \n))(2-((4,5-dihydro-3-methyl-5- \noxo-1-phenyl-1 H-pyrazol-4- \nyl)azo)-5-sulfobenzoato(3-)) \nchromate(2-)  414-280-0  149626-00-6  Aquatic Chronic 2  H411  GHS09  H411  \n611-114-00-0  lithium sodium (4-((5-chloro-2- \nhydroxyphenyl)azo)-2,4-dihydro- \n5-methyl-3 H-pyrazol-3-onato(2- \n))(3-((4,5-dihydro-3-methyl-1-(4- \nmethylphenyl)-5-oxo-1 H- \npyrazol-4-yl)azo)-4-hydroxy-5- \nnitrobenzenesulfonato(3-)) chro\xad\nmate(2-)  414-250-7  149564-66-9  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 956}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 958\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-115-00-6  trilithium bis(4-((4-(diethy\xad\nlamino)-2-hydroxyphenyl)azo)-3- \nhydroxy-1-naphthalenesulfon\xad\nato(3-))chromate(3-)  414-290-5  149564-65-8  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n611-116-00-1  reaction mass of: trisodium 5{4- \nchloro-6-[2-(2,6-dichloro-5- \ncyanopyrimidin-4-ylamino)- \npropylamino]-1,3,5-triazin-2- \nylamino}-4-hydroxy-3-(1-sulfon\xad\natonaphthalene-2-ylazo)-naph\xad\nthalene-2,7-disulfonate; \ntrisodium 5-{4-chloro-6-[2-(2,6- \ndichloro-5-cyanopyrimidin-4- \nylamino)-1-methyl-ethylamino]- \n1,3,5-triazin-2-ylamino}-4- \nhydroxy-3-(1-sulfonatonaph\xad\nthalene-2-ylazo)-naphthalene-2,7- \ndisulfonate; \ntrisodium 5-{4-chloro-6-[2-(4,6- \ndichloro-5-cyanopyrimidin-2- \nylamino)-propylamino]-1,3,5- \ntriazin-2-ylamino}-4-hydroxy-3- \n(1-sulfonatonaphthalen-2-ylazo)- \nnaphthalene-2,7-disulfonate; \ntrisodium 5-{4-chloro-6-[2-(4,6- \ndichloro-5-cyanopyrimidin-2- \nylamino)-1-methyl-ethylamino]- \n1,3,5-triazin-2-ylamino}-4- \nhydroxy-3-(1-sulfonatonaph\xad\nthalen-2-ylazo)-naphthalene-2,7- \ndisulfonate  414-620-8  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 957}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 959\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-117-00-7  1,3-bis{6-fluoro-4-[1,5-disulfo-4- \n(3-aminocarbonyl-1-ethyl-6- \nhydroxy-4-methyl-pyrid-2-on-5- \nylazo)-phenyl-2-ylamino]-1,3,5- \ntriazin-2-ylamino}propane \nlithium-, sodium salt  415-100-3  149850-29-3  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-118-00-2  sodium 1,2-bis[4-[4-{4-(4-sulfop\xad\nhenylazo)-2-sulfophenylazo}-2- \nureido-phenyl-amino]-6-fluoro- \n1,3,5-triazin-2-ylamino]-propane, \nsodium salt  413-990-8  Skin Sens. 1  H317  GHS07 \nWng  H317  \n611-119-00-8  tetrasodium 4-[4-chloro-6-(4- \nmethyl-2-sulfophenylamino)- \n1,3,5-triazin-2-ylamino]-6-(4,5- \ndimethyl-2-sulfophenylazo)-5- \nhydroxynaphthalene-2,7- \ndisulfonate  415-400-4  148878-22-2  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n611-120-00-3  5-{4-[5-amino-2-[4-(2-sulfoxy\xad\nethylsulfonyl)phenylazo]-4-sulfo- \nphenylamino]-6-chloro-1,3,5- \ntriazin-2-ylamino}-4-hydroxy-3- \n(1-sulfo-naphthalen-2-ylazo)- \nnaphthalene-2,7-disulfonicacid \nsodium salt  418-340-7  157707-94-3  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 958}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 960\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-121-00-9  main component 6 (isomer): \nasym. 1:2 Cr(III)-complex of: \nA: 3-hydroxy-4-(2-hydroxy- \nnaphthalene-1-ylazo)naphthalene- \n1-sulfonic acid, Na-salt and B: 1- \n[2-hydroxy-5-(4-methoxy-pheny\xad\nlazo)phenylazo]naphthalene-2-ol; \nmain component 8 (isomer): \nasym. 1:2 Cr-complex of: A: \n3-hydroxy-4-(2-hydroxy-naph\xad\nthalene-1-ylazo)-naphthalene-1- \nsulfonic acid, Na-salt and B: 1- \n[2-hydroxy-5-(4-methoxy-pheny\xad\nlazo)-phenylazo]-naphthalene-2- \nol 417-280-9  30785-74-1  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n611-122-00-4  hexasodium (di[ N-(3-(4-[5-(5- \namino-3-methyl-1-phenylpyrazol- \n4-yl-azo)-2,4-disulfo-anilino]-6- \nchloro-1,3,5-triazin-2- \nylamino)phenyl)-sulfamoyl](di- \nsulfo)-phthalocyaninato)nickel  417-250-5  151436-99-6  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n611-123-00-X  3-(2,4-bis(4-((5-(4,6-bis(2-amin\xad\nopropylamino)-1,3,5-triazin-2- \nylamino)-4-hydroxy-2,7-disulfon\xad\naphthalen-3-yl)azo)pheny\xad\nlamino)-1,3,5-triazin-6- \nylamino)propyldiethylammonium \nlactate  424-310-4  178452-66-9  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 959}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 961\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-124-00-5  reaction mass of: pentasodium \n5-amino-3-(5-{4-chloro-6-[4-(2- \nsulfoxyethoxysulfonato)pheny\xad\nlamino]-1,3,5-triazin-2-ylamino}- \n2-sulfonatophenylazo)-6-[5-(2,3- \ndibromopropionylamino)-2- \nsulfonatophenylazo]-4-hydroxy\xad\nnaphthalene-2,7-disulfonate; \npentasodium 5-amino-6-[5-(2- \nbromoacryloylamino)-2-sulfon\xad\natophenylazo]-3-(5-{4-chloro-6- \n[4-(2-sulfoxyethoxysulfon\xad\nato)phenylamino]-1,3,5-triazin-2- \nylamino}-2-sulfonatophenylazo)- \n4-hydroxynaphthalene-2,7- \ndisulfonate; \ntetrasodium 5-amino-3-[5-{4- \nchloro-6-[4-(vinylsulfonyl)pheny\xad\nlamino]-1,3,5-triazin-2-ylamino}- \n2-sulfonatophenylazo]-6-[5-(2,3- \ndibromopropionylamino)-2- \nsulfonatophenylazo]-4-hydroxy\xad\nnaphthalene-2,7-disulfonate  424-320-9  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n611-125-00-0  reaction mass of: disodium 6-[3- \ncarboxy-4,5-dihydro-5-oxo-4- \nsulfonatophenyl)pyrazolin-4-yl- \nazo]-3-[2-oxido-4-(ethensul\xad\nfonyl)-5-methoxyphenylazo]-4- \noxidonaphthalene-2-sulfonate \ncopper (II) complex;  423-940-7  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 960}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 962\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \ndisodium 6-[3-carboxy-4,5- \ndihydro-5-oxo-4-sulfonatophe\xad\nnyl)pyrazolin-4-yl-azo]-3-[2- \noxido-4-(2-hydroxyethylsul\xad\nfonyl)-5-methoxyphenylazo]-4- \noxidonaphthalene-2-sulfonate \ncopper (II) complex  \n611-126-00-6  2,6-bis-(2-(4-(4-amino-pheny\xad\nlamino)-phenylazo)-1,3-dimethyl- \n3H-imidazolium)-4-dimethyl\xad\namino-1,3,5-triazine, dichloride  424-120-1  174514-06-8  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n611-127-00-1  pentasodium 4-amino-6-(5-(4-(2- \nethyl-phenylamino)-6-(2-sulfatoe\xad\nthanesulfonyl)-1,3,5-triazin-2- \nylamino)-2-sulfonatophenylazo)- \n5-hydroxy-3-(4-(2-sulfatoethane\xad\nsulfonyl)phenylazo)naphthalene- \n2,7-disulfonate  423-790-2  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  G \n611-128-00-7  N,N'-bis{6-chloro-4-[6-(4- \nvinylsulfonylphenylazo)-2,7- \ndisulfonicacid-5-hydroxynapht-4- \nylamino]-1,3,5-triazin-2-yl}- N- \n(2-hydroxyethyl)ethane-1,2- \ndiamine, sodium salt  419-500-9  171599-85-2  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 961}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 963\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-129-00-2  reaction mass of: 5-[(4-[(7- \namino-1-hydroxy-3-sulfo-2-naph\xad\nthyl)azo]-2,5-diethoxyphe\xad\nnyl)azo]-2-[(3-phosphonophe\xad\nnyl)azo]benzoic acid; \n5-[(4-[(7-amino-1-hydroxy-3- \nsulfo-2-naphthyl)azo]-2,5-dietho\xad\nxyphenyl)azo]-3-[(3-phosphonop\xad\nhenyl)azo]benzoic acid  418-230-9  163879-69-4  Expl. 1.3 **** \nRepr. 2 \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H203 \nH361f *** \nH373 ** \nH317 \nH411  GHS01 \nGHS08 \nGHS07 \nGHS09 \nDgr H203 \nH361f *** \nH373 ** \nH317 \nH411  \n611-130-00-8  tetra-ammonium 2-[6-[7-(2- \ncarboxylato-phenylazo)-8- \nhydroxy-3,6-disulfonato-1-naph\xad\nthylamino]-4-hydroxy-1,3,5- \ntriazin-2-ylamino]benzoate  418-520-5  183130-96-3  Eye Irrit. 2 \nAquatic Chronic 3  H319 \nH412  GHS07 \nWng  H319 \nH412  \n611-131-00-3  2-[2-hydroxy-3-(2-chlorophe\xad\nnyl)carbamoyl-1-naphthylazo]-7- \n[2-hydroxy-3-(3-methylphe\xad\nnyl)carbamoyl-1-naphthy\xad\nlazo]fluoren-9-one  420-580-2  151798-26-4  Repr. 1B \nAquatic Chronic 4  H360D *** \nH413  GHS08 \nDgr H360D *** \nH413  \n611-132-00-9  pentasodium bis{7-[4-(1-butyl-5- \ncyano-1,2-dihydro-2-hydroxy-4- \nmethyl-6-oxo-3-pyridylazo)phe\xad\nnylsulfonylamino]-5'-nitro-3,3'- \ndisulfonatonaphthalene-2- \nazobenzene-1,2'-diolato} \nchromate (III)  419-210-2  178452-71-6  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 962}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 964\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-133-00-4  product by process iron complex \nof azo dyestuffs obtained by \ncoupling a mixture of diazotized \n2-amino-1-hydroxybenzene-4- \nsulfanilide and 2-amino-1- \nhydroxybenzene-4-sulfonamide \nwith resorcin, the obtained \nmixture being subsequently \nsubmitted to a second coupling \nreaction with a mixture of \ndiazotized 3-aminobenzene-1- \nsulfonic acid (metanilic acid) \nand 4'-amino-4-nitro-1,1'- \ndiphenylamine-2-sulfonic acid \nand metallization with ferric \nchloride, sodium salt  419-260-5  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n611-134-00-X  trisodium 2-{α[2-hydroxy-3-[4- \nchloro-6-[4-(2,3-dibromopro\xad\npionylamino)-2-sulfonatopheny\xad\nlamino]-1,3,5-triazin-2-ylamino]- \n5-sulfonatophenylazo]-benzylide\xad\nnehydrazino}-4-sulfonatoben\xad\nzoate, copper complex  423-770-3  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n611-135-00-5  reaction product of: 2-[[4-amino- \n2-ureidophenylazo]-5-[(2-(sul\xad\nfooxy)ethyl)sulfonyl]]benzene\xad\nsulfonic acid with 2,4,6-trifluor\xad\nopyrimidine and partial \nhydrolysis to the corresponding \nvinylsulfonyl derivative, mixed \npotassium/sodium salt  424-250-9  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 963}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 965\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-136-00-0  2-{4-(2-ammoniopropylamino)-6- \n[4-hydroxy-3-(5-methyl-2- \nmethoxy-4-sulfamoylphenylazo)- \n2-sulfonatonaphth-7-ylamino]- \n1,3,5-triazin-2-ylamino}-2-amin\xad\nopropyl formate  424-260-3  —  Repr. 2 \nEye Dam. 1 \nAquatic Chronic 2  H361f *** \nH318 \nH411  GHS05 \nGHS08 \nGHS09 \nDgr H361f *** \nH318 \nH411  \n611-137-00-6  6 - tert-butyl-7-chloro-3-tridecyl- \n7,7a-dihydro-1 H-pyrazolo[5,1-c]- \n1,2,4-triazole  419-870-1  159038-16-1  Aquatic Chronic 4  H413  —  H413  \n611-138-00-1  2-(4-aminophenyl)-6- tert-butyl- \n1H-pyrazolo[1,5-b][1,2,4]triazole  415-910-7  152828-25-6  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n611-139-00-7  reaction product of: C.I. Leuco \nSulfur Black 1 with (3-chloro-2- \nhydroxypropyl)trimethylam\xad\nmonium chloride  424-510-1  —  Eye Dam. 1 \nAquatic Chronic 2  H318 \nH411  GHS05 \nGHS09 \nDgr H318 \nH411  \n611-140-00-2  azafenidin (ISO); \n2-(2,4-dichloro-5-prop-2-ynylo\xad\nxyphenyl)-5,6,7,8-tetrahydro- \n1,2,4-triazolo[4,3-a]pyridine- \n3(2H)-one  — 68049-83-2  Repr. 1B \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360Df \nH373 ** H400 \nH410  GHS08 \nGHS09 \nDgr H360Df \nH373 ** \nH410  M = 1 000  \n611-141-00-8  5-(4-[4-[4-(3,5-dicarboxy-phenyl- \nazo)phenylamino]-6-morpholin- \n4-yl-1,3,5-triazin-2- \nylamino]phenylazo)isophthalic \nacid, mixed monosodium and \ndiammonium salt  414-410-6  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 964}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 966\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-142-00-3  product-by-process definition \npolyazodyestuff obtained by \ncoupling 4-[4-(1-amino-8- \nhydroxy-3,6-disulfo-2-naphthy\xad\nlazo)phenylsulfonylamino] \nbenzenediazonium with reaction \nmass of 4-carboxybenzenedia\xad\nzonium and diphenylamine-3- \nsulfo-4,4'-bisdiazonium, and \nfurther coupling of the obtained \ncompounds with reaction mass of \nnaphth-2-ol and 3-aminophenol, \nsodium salts; \nsodium chloride  425-740-5  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n611-143-00-9  reaction mass of: trisodium 2-(2- \n[α-(2-carboxylato-κ- O-4-sulfon\xad\natophenylazo)benzylidene]hy\xad\ndrazino-κ- N')-6-(2,6-difluoropyri\xad\nmidin-4-ylamino)-4-sulfonatop\xad\nhenolatocuprate (II); trisodium 2- \n(2-[α-(2-carboxylato-κ- O-4- \nsulfonatophenylazo)benzyli\xad\ndene]hydrazino-κ- N')-6-(4,6- \ndifluoropyrimidin-2-ylamino)-4- \nsulfonatophenolatocuprate (II)  428-260-4  —  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 965}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 967\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-144-00-4  reaction mas of: 7-amino-3,8-bis- \n[4-(2-sulfoxyethylsulfonyl)pheny\xad\nlazo]-4-hydroxynaphthalene-2- \nsulfonic acid, Na/K salt; \n7-amino-3-[4-(2-sulfoxyethylsul\xad\nfonyl)phenylazo]-4-hydroxy-8- \n[4-(2-sulfoxyethylsulfonyl)-2- \nsulfophenylazo]naphthalene-2- \nsulfonic acid, Na/K salt; 7- \namino-8-[4-(2-sulfoxyethylsul\xad\nfonyl)-phenylazo]-4-hydroxy-3- \n[4-(2-sulfoxyethylsulfonyl)-2- \nsulfophenylazo]naphthalene-2- \nsulfonic acid, Na/K salt; 7- \namino-3,8-bis-[4-(2-sulfoxy\xad\nethylsulfonyl)-2-sulfophenylazo]- \n4-hydroxynaphthalene-2-sulfonic \nacid, Na/K salt  429-070-4  214362-06-8  Eye Dam. 1  H318  GHS05 \nDgr H318  \n611-145-00-X  reaction mass of: tetrasodium 3- \n(1,5-disulfonatonaphthalene-2- \nylazo)-4-hydroxy-7-{4-chloro-6- \n[4-(2-sulfoxyethylsulfonyl)pheny\xad\nlamino]-1,3,5-triazine-2- \nylamino}naphthalene-2-sulfonate; \n3-(2,5-disulfophenylazo)-4- \nhydroxy-7-{4-chloro-6-[4-(2-sulf\xad\noxyethylsulfonyl)phenylamino{- \n1,3,5-triazine-2-ylamino}naph\xad\nthalene-2-sulfonic acid, sodium \nsalt 429-440-5  —  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 966}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 968\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-146-00-5  reaction mass of: pentasodium \n3-(4-(4-(7-(2,4-diamino-5- \nsulfonato-3-(4-sulfonatopheny\xad\nlazo)phenylazo)-1-hydroxy-3- \nsulfonatonaphthalen-2-ylazo)-2- \nsulfonatophenylamino)pheny\xad\nlazo)-4-hydroxy-6-(2-oxo-1- \nphenylcarbamoylpropylazo)naph\xad\nthalene-2-sulfonate; pentasodium \n6-((2,4-diamino-5-sulfonatophe\xad\nnyl)azo)-3-((4-((4-((7-((2,4- \ndiamino-5-sulfonatophenyl)azo)- \n1-hydroxy-3-sulfonatonaph\xad\nthalen-2-yl)azo)phenyl)amino)-2- \nsulfonatophenyl)azo)-4-hydroxy\xad\nnaphthalene2-sulfonate; \npentasodium 6-((2,4-diamino-5- \nsulfonato-3-((4-sulfonatophe\xad\nnyl)azo)phenyl)azo)-3-((4-((4- \n((1,7-dihydroxy-3-sulfonatonaph\xad\nthalen-2-yl)azo)-2-sulfonatophe\xad\nnyl)amino)phenyl)azo)-4- \nhydroxynaphthalene-2-sulfonate; \nhexasodium 6-((2,4-diamino-5- \nsulfonatophenyl)azo)-3-((4-((4- \n((7-((2,4-diamino-5-sulfonato-3- \n((4-sulfonatophenyl)azo)phe\xad\nnyl)azo)-1-hydroxy-3-sulfonaton\xad\naphthalen-2-yl)azo)-2-sulfonatop\xad\nhenyl)amino)phenyl)azo)-4- \nhydroxynaphthalene-2-sulfonate  430-070-1  —  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 967}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 969\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-147-00-0  sodium, potassium, lithium 5- \namino-3,6-bis(5-(4-chloro-6- \n(methyl-(2-methylaminoace\xad\ntyl)amino)-1,3,5-triazin-2- \nylamino)-2-sulfonatophenylazo)- \n4-hydroxynaphthalene-2,7- \ndisulfonate  430-090-0  205764-96-1  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n611-148-00-6  reaction mass of: 2-(3-(2,6- \ndichloro-4-nitrophenylazo)car\xad\nbazol-9-yl)ethanol; \n2-(2-(3-(2,6-dichloro-4-nitro- \nphenylazo)-carbazol-9- \nyl)ethoxy)ethanol; \n3-(2,6-dichloro-4-nitropheny\xad\nlazo)carbazol  429-590-1  —  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n611-149-00-1  2-(2-chloroacetoxy)ethyl 3-((4- \n(2,5-dichloro-4-fluorosulfonylp\xad\nhenylazo)-3-methylphenyl)ethy\xad\nlamino)propionate  427-570-7  193486-83-8  Aquatic Chronic 2  H411  GHS09  H411  \n611-150-00-7  tetralithium 2-[6-[7-[2-(carboxy\xad\nlato)phenylazo]-8-hydroxy-3,6- \ndisulfonato-1-naphthylamino]-4- \nhydroxy-1,3,5-triazine-2- \nylamino]benzoate  440-460-3  —  Eye Irrit. 2 \nAquatic Chronic 3  H319 \nH412  GHS07 \nWng  H319 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 968}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 970\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-151-00-2  chrysoidine; \n4-(phenylazo)benzene-1,3- \ndiamine  207-803-7  495-54-5  Muta. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH302 \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH302 \nH315 \nH410  \n611-152-00-8  chrysoidine monohydrochloride; \n4-phenylazophenylene-1,3- \ndiamine monohydrochloride; [1] \nchrysoidine monoacetate; \n4-(phenylazo)benzene-1,3- \ndiamine monoacetate; [2] \nchrysoidine acetate; \n4-(phenylazo)benzene-1,3- \ndiamine acetate; [3] \nchrysoidine- p-dodecylbenzene\xad\nsulfonate; dodecylbenzene\xad\nsulfonic acid, compound with 4- \n(phenylazo)benzene-1,3-diamine \n(1:1); [4] \nchrysoidine dihydrochloride; \n4-(phenylazo)benzene-1,3- \ndiamine dihydrochloride; [5] \nchrysoidine sulfate; \nbis[4-(phenylazo)benzene-1,3- \ndiamine] sulfate [6]  208-545-8 [1] \n278-290-5 [2] \n279-116-0 [3] \n264-409-8 [4] \n281-549-5 [5] \n282-432-1 [6]  532-82-1 [1] \n75660-25-2 [2] \n79234-33-6 [3] \n63681-54-9 [4] \n83968-67-6 [5] \n84196-22-5 [6]  Muta. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH302 \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H341 \nH302 \nH315 \nH318 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 969}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 971\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-153-00-3  chrysoidine C  10-14-alkyl deriva\xad\ntives; \nbenzenesulfonic acid, mono- \nC 10-14-alkyl derivatives, \ncompounds \nwith 4-(phenylazo)-1,3-benzene\xad\ndiamine; [1] \nchrysoidine compound with \ndibutylnaphthalene sulfonic acid; \ndibutylnaphthalenesulfonic acid, \ncompound with 4-(pheny\xad\nlazo)benzene-1,3-diamine (1:1) \n[2] 286-946-7 [1] \n304-236-8 [2]  85407-90-5 [1] \n94247-67-3 [2]  Muta. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1  H341 \nH302 \nH315 \nH318  GHS05 \nGHS08 \nGHS07 \nDgr H341 \nH302 \nH315 \nH318  \n611-154-00-9  trisodium 5-benzamido-4- \nhydroxy-3-(4-methyl-2-sulfon\xad\natophenylazo)naphthalene-2,7- \ndisulfonate  403-670-6  92408-46-3  Aquatic Chronic 3  H412  —  H412  \n611-155-00-4  4,4'-oxybis(benzenesulfonyla\xad\nzide)  431-850-4  7456-68-0  Expl. 1.1**** \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H201 \nH373** \nH400 \nH410  GHS01 \nGHS08 \nGHS09 \nDgr H201 \nH373** \nH410  \n611-156-00-X  triammonium 4-[4-[7-(4-carboxy\xad\nlatoanilino)-1-hydroxy3- \nsulfonato-2-naphthylazo]-2,5- \ndimethoxyphenylazo]benzoate  432-270-4  221354-37-6  Repr. 2 \nSTOT RE 2 * \nAquatic Chronic 2  H361f*** \nH373** \nH411  GHS08 \nGHS09 \nWng  H361f*** \nH373** \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 970}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 972\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-157-00-5  benzenesulfonic acid, 3,3'- \n(methylenebis((dihydroxypheny\xad\nlene)azo)) bis-, potassium sodium \nsalt; \npotassium sodium 3-[( E)-(6{3,4- \ndihydroxy-2-}( Z)-(3-sulfonatop\xad\nhenyl)diazenyl]benzyl}-2,3-dihy\xad\ndroxyphenyl)diazenyl]benzene\xad\nsulfonate  432-590-4  243869-48-9  Eye Irrit. 2 \nAquatic Chronic 3  H319 \nH412  GHS07 \nWng  H319 \nH412  \n611-158-00-0  reaction product of: 2,3,4,2', 3', \n4'-hexahydroxy-5,5'-diacethyl- \ndiphenylmethane and 6-diazo- \n5,6-dihydro-5-oxo-1-naphthalene\xad\nsulfonylchloride and 3-diazo-3,4- \ndihydro-6-methoxy-4-oxo-1- \nnaphthalenesulfonylchloride  421-520-8  —  **** \nAquatic Chronic 4  **** H413  ****  **** H413  \n▼M22  __________  \n▼M16  \n611-160-00-1  reaction mass of: 1,1,1- \ntris(phenyl-4'-(3''-diazo-3'', 4''- \ndihydro-4''-oxo-naphthalene-1''- \nsulfonato)ethane; 1,1,1- \ntris(phenyl-4'-(6''-diazo-5'',  422-760-6  —  **** \nAquatic Chronic 4  **** H413  ****  **** H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 971}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 973\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n6''-dihydro-5''-oxo-naphthalene1''- \nsulfonato)ethane; \nreaction product of 1,1,1-tris( p- \nhydroxyphenyl)ethane with 6-dia- \nzo-5,6-dihydro-5-oxo-1-naphthyl- \nsulfonylchloride and 3-diazo-3,4- \ndihydro-4-oxo-1-naphthylsulfo- \nnylchloride (2:1); \nreaction product of 1,1,1-tris( p- \nhydroxyphenyl)ethane with 6-dia- \nzo-5,6-dihydro-5-oxo-1-naphthyl- \nsulfonylchloride and 3-diazo-3,4- \ndihydro-4-oxo-1-naphthylsulfo- \nnylchloride (1:2)  \n611-161-00-7  trisodium [1,2'-(2-(8-amino-3,5- \ndisulfonatonaphthalene)azo)-(4'- \nnitrobenzene)diolato- O, O,N ][(Z)- \n2,2-((phenylcarbamoylprop-1'- \nenyl)azo)-5-sulfamoylben\xad\nzene)diolato- O, O,N ]chro\xad\nmate(III)  423-100-1  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n611-162-00-2  2,4-bis(((2-(dimethyl\xad\nammonio)ethyloxy)car\xad\nbonyl)phen-2-ylazo)benzene-1,3- \ndiolbis(methanesulfonate)  429-600-4  —  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 972}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 974\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-163-00-8  2,4-bis(((2-(dimethyl\xad\nammonio)ethyloxy)car\xad\nbonyl)phen-2-ylazo)benzene-1,3- \ndiol sulfate  429-610-9  —  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 2  H302 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH411  \n611-164-00-3  reaction mass of: 2,2’-dimethyl- \n2,2’-azobutanenitrile; \n2-methylpentanenitrile-2-azo-2’- \n(2’-methylpropanenitrile); \n2,2’-dimethyl-2,2’-azoheptaneni\xad\ntrile; \n2-methylheptanenitrile-2-azo-2’- \n(2’-methylpropanenitrile); \n2-methylheptanenitrile-2-azo-2’- \n(2’-methylbutanenitrile)  429-710-2  —  Self-react. D \nAcute Tox. 4 * \nAquatic Chronic 2  H242 \nH302 \nH411  GHS02 \nGHS07 \nGHS09 \nDgr H242 \nH302 \nH411  \n611-165-00-9  reaction mass of: tetrasodium \n- 4-amino-6-(5-(2,6-difluoropyri\xad\nmidin-4-ylamino)-2-sulfonatop\xad\nhenylazo)-5-hydroxy-3-(4-(sulfa\xad\ntoethylsulfonyl)phenylazo)naph\xad\nthalene-2,7-disulfonate; tetra\xad\nsodium 4-amino-6-(5-(4,6-diflu\xad\noropyrimidin-2-ylamino)-2- \nsulfonatophenylazo)-5-hydroxy- \n3-(4-(2-sulfatoethylsulfo\xad\nnyl)phenylazo)naphthalene-2,7- \ndisulfonate  431-830-5  —  Aquatic Chronic 3  H412  —  H412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 973}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 975\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-166-00-4  reaction mass of: pentasodium \n4-amino-5-hydroxy-3-{( E)-4-[2- \n(sulfonatooxy)ethylsulfo\xad\nnyl]phenylazo}-6-{( E)-2- \nsulfonato-4-[2-(sulfon\xad\natooxy)ethylsulfonyl]pheny\xad\nlazo}naphthalene-2,7-disulfonate; \ntetrasodium 4-amino-5-hydroxy- \n3-{(E)-4-[2-(sulfon\xad\natooxy)ethylsulfonyl]phenylazo}- \n6-[(E)-2-sulfonato-4-(vinylsulfo\xad\nnyl)phenylazo]naphthalene-2,7- \ndisulfonate; tetrasodium - 4- \namino-5-hydroxy-6-( E)-2- \nsulfonato-4-}2-(sulfon\xad\natooxy)ethylsulfonyl{pheny\xad\nlazo}-3-[( E)-4-(vinylsulfo\xad\nnyl)phenylazo]naphthalene-2,7- \ndisulfonate  432-100-9  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n611-167-00-X  sodium bis[tris(2-hydroxye\xad\nthyl)ammonium][6-anilino-4'- \n(4,8-disulfonato-2-naphthylazo)- \n5'-methyl-3-sulfonatonaph\xad\nthalene-2-azobenzene-1,2'- \ndiolato]cuprate(II)  435-240-9  —  Aquatic Chronic 3  H412  —  H412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 974}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 976\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-168-00-5  reaction mass of: 3-[[4-chloro-6- \n[[7-[(1,5-disulfo-2-naphthale\xad\nnyl)azo]-8-hydroxy-3,6-disulfo1- \nnaphthalenyl]amino]-1,3,5- \ntriazin-2-yl]amino]-5-[[4-chloro- \n6-[[8-hydroxy-3,6-disulfo-7-[(2- \nsulfophenyl)azo]-1-naphthale\xad\nnyl]amino]-1,3,5-triazin- \n2yl]amino]benzoic acid; \n3,5-bis[[4-chloro-6-[[7-[(1,5- \ndisulfo-2-naphthalenyl)azo]-8- \nhydroxy-3,6-disulfo-1-naphthale\xad\nnyl]amino]-1,3,5-triazin-2- \nyl]amino]benzoic acid  435-440-6  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n611-169-00-0  sodium 5-(2-carboxyphenylazo)- \n6-hydroxynaphthalene-2- \nsulfonate  435-800-2  —  Aquatic Chronic 3  H412  —  H412  \n611-170-00-6  reaction mas of: trisodium 2-((1- \n(2-hydroxy-κ- O-5-(2-sulfonatoe\xad\nthansulfonyl)phenylazo-κ-N2 )-1- \nphenylmethyl)azo-κ-N1 )4-sulfon\xad\natobenzoate(5-)-κ- O)cuprate(II); \ndisodium 2-((1-(5-ethenesul\xad\nfonyl-2-hydroxy-κ- O-phenylazo- \nκ-N2 )-1-phenylmethyl)azo-κ-N1 )- \n4-sulfonatobenzoate-κ- O-(5))cu\xad\nprate(II)  435-880-9  —  Aquatic Chronic 3  H412  —  H412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 975}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 977\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-171-00-1  reaction mass of trisodium 3-(5- \n(2,6-difluoropyrimidin-4- \nylamino)-2-sulfonatopheny\xad\nlazo)5-(4-fluoro-6-morpholin-4- \nyl-1,3,5-triazin-2-ylamino)-4- \nhydroxy-2,7-naphthalenedis\xad\nulfonate; \ntrisodium 3-(5-(4,6-difluoropyri\xad\nmidin-2-ylamino)-2-sulfonatop\xad\nhenylazo)-5-(4-fluoro-6- \nmorpholin-4-yl-1,3,5-triazin-2- \nylamino)-4-hydroxy-2,7-naphtha\xad\nlenedisulfonate  436-890-6  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n611-172-00-7  reaction mass of: triammonium \n6-amino-3-((2,5-diethoxy-4-(3- \nphosphonophenyl)azo)phe\xad\nnyl)azo-4-hydroxy-2-naphtha\xad\nlenesulfonate; \ndiammonium 3-((4-((7-amino-1- \nhydroxy-3-sulfo-naphthalen-2- \nyl)azo)-2,5-diethoxyphe\xad\nnyl)azo)benzoate  438-310-7  —  Self-react. C**** \nRepr. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 3  H242 \nH361f*** \nH302 \nH373** \nH412  GHS02 \nGHS08 \nGHS07 \nDgr H242 \nH361f*** \nH302 \nH373** \nH412  \n611-173-00-2  reaction mass of: 3-[3-carbamoyl- \n5-(5-{4-chloro-6[4-(2-sulfonatoo\xad\nxyethylsulfonyl)anilino]-1,3,5- \ntriazin-2-ylamino}-2-sulfonatop\xad\nhenylazo)-1,2-dihydro-6- \nhydroxy-4-methyl-2-oxo-1-pyri\xad\ndyl]propanoic acid, trisodium salt; \n3-[3-carbamoyl-5-(5-{4-chloro-6- \n[4-(vinylsulfonyl)anilino]-1,3,5- \ntriazin-2-ylamino}-2-sulfonatop\xad\nhenylazo)-1,2-dihydro-6- \nhydroxy-4-methyl-2oxo-1-pyri\xad\ndyl]propanoicacid, disodium salt  440-510-4  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 976}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 978\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-174-00-8  reaction mass of: 3-[5-(4-ethene\xad\nsulfonylbutyrylamino)-2-sulfop\xad\nhenylazo]-5-4-chloro-[6-(4-(3- \namino-5-hydroxy-2,7-disulfon\xad\naphthalene-4-ylazo)-3-sulfop\xad\nhenylamino]-1,3,5-triazin-2- \nylamino[-4-hydroxynaphthalene- \n2,7-disulfonic acid, sodium salt; \n3-[5-(4-(2-chloroethanesulfo\xad\nnyl)butyrylamino)-2-sulfopheny\xad\nlazo]-5-4-chloro-[6-(4-(3-amino- \n5-hydroxy-2,7-disulfonaph\xad\nthalene-4-ylazo)-3-sulfopheny\xad\nlamino]-1,3,5-triazin-2-ylamino}- \n4-hydroxynaphthalene-2,7- \ndisulfonic acid, sodium salt  442-290-5  457624-86-1  Eye Dam. 1  H318  GHS05 \nDgr H318  \n611-175-00-3  reaction mass of: trisodium 5-{4- \nchloro-6-[ N-ethyl-(3-(2-sulfon\xad\natooxy)ethylsulfonyl)aniline]- \n1,3,5-triazin-2-ylamino}-4- \nhydroxy-3-[4-(vinylsulfo\xad\nnyl)phenylazo{naphthalene-2,7- \ndisulfonate; trisodium 5-4-chloro- \n6-[N-ethyl-3-(vinylsulfo\xad\nnyl)anilino]-1,3,5-triazin-2- \nylamino}-4-hydroxy-3-[4-(2-(sul\xad\nfonatooxy)ethylsulfonyl)pheny\xad\nlazo]naphthalene-2,7-disulfonate;  444-050-5  —  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 977}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 979\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \ndisodium 5-4-chloro-6-[ N-ethyl- \n3-(vinylsulfonyl)anilino]-1,3,5- \ntriazin-2-ylamino}-4-hydroxy-3- \n[(4-vinylsulfonyl)pheny\xad\nlazo]naphthalene-2,7-disulfonate; \ntetrasodium 5-4-chloro-6-[ N- \nethyl-3-(2-(sulfonatooxy)ethylsul\xad\nfonyl)anilino]-1,3,5-triazin-2- \nylamino}-3-[4(2-(sulfon\xad\natooxy)ethylsulfonyl)phenylazo]- \n4-hydroxynaphthalene-2,7- \ndisulfonate  \n611-176-00-9  2,6-bis(2,3,4-trihydroxybenzyl)-  \np-cresol ester with 6-diazo-5,6- \ndihydro-5-oxo-1-naphthalenesul\xad\nfonate  444-250-2  —  Self-react. C**** \nAquatic Chronic 2  H242 \nH411  GHS02 \nGHS09 \nDgr H242 \nH411  \n611-177-00-4  reaction mass of: pentasodium \nbis[6-anilino-3,5'-disulfonaton\xad\naphthalene-2-azobenzene-1,2'- \ndiolato]cobaltate(III); tetrasodium  444-290-0  508202-43-5  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 978}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 980\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[6-anilino-3,5'-disulfonatonaph\xad\nthalene-2-azobenzene-1,2'- \ndiolato][6-anilino-5'-sulfamoyl-3- \nsulfonatonaphthalene-2- \nazobenzene-1,2'-diolato]co\xad\nbaltate(III); trisodium bis[6- \nanilino-5'-sulfamoyl-3-sulfon\xad\natonaphthalene-2-azobenzene- \n1,2'-diolato]cobaltate(III)  \n611-178-00-X  reaction mass of: pentasodium \n4-amino-5-hydroxy-3-{( E)-4-[2- \n(sulfonatooxy)ethylsulfo\xad\nnyl]phenylazo}-6-{( E)-2- \nsulfonato-4-[2-(sulfon\xad\natooxy)ethylsulfonyl]pheny\xad\nlazo}naphthalene-2,7-disulfonate; \ntetrasodium 4-amino-5-hydroxy- \n3-{(E)-4-[2-(sulfon\xad\natooxy)ethylsulfonyl]phenylazo}- \n6-[(E)-2-sulfonato-4-(vinylsulfo\xad\nnyl)phenylazo]naphthalene-2,7- \ndisulfonate; tetrasodium 4-amino- \n5-hydroxy-6-{( E)-2-sulfonato-4- \n[2-(sulfonatooxy)ethylsulfo\xad\nnyl]phenylazo}-3-[( E)-4- \n(vinylsulfonyl)phenylazo]naph\xad\nthalene-2,7-disulfonate; trisodium \n4-amino-5-hydroxy-3-[( E)-4- \n(vinylsulfonyl)phenylazo]-6-[( E)- \n2-sulfonato-4-(vinylsulfo\xad\nnyl)phenylazo]naphthalene-2,7- \ndisulfonate;  445-280-9  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 979}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 981\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \ntrisodium 4-amino-5-hydroxy-3- \n[(2-hydroxyethylsulfonyl)-pheny\xad\nlazo]-6-[( E)-2-sulfonato-4- \n(vinylsulfonyl)phenylazo]naph\xad\nthalene-2,7-disulfonate; \ntrisodium 4-amino-5-hydroxy-3- \n[(E)-4-(vinylsulfonyl)phenylazo]- \n6-[-2-sulfonato-4-(2-hydroxye\xad\nthylsulfonyl)phenylazo]naph\xad\nthalene-2,7-disulfonate  \n611-179-00-5  reaction mass of: pentasodium \n2-[[8-[[4-chloro-6-[[4-(2-sulfon\xad\natethylsulfonyl)]phenyl]amino]- \n1,3,5-triazin-2-yl]amino-1- \nhydroxy-3,6-disulfonato-2-naph\xad\nthalenyl]azo]naphthalene-1,5- \ndisulfonate; \n2-[[8-[[4-chloro-6-[[4-[[2-ethe\xad\nnyl]sulfonyl]phenyl]amino]1,3,5- \ntriazin-2-yl]amino]-1-hydroxy- \n3,6-disulfonato-2-naphthale\xad\nnyl]azo]naphthalene-1,5- \ndisulfonate  450-010-8  —  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 980}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 982\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n611-180-00-0  iron, complexes with diazotised \n4-aminobenzenesulfonamide, \ndiazotized 3-aminobenzene\xad\nsulfonic acid, diazotised 3- \namino-4-hydroxybenzenesulfon\xad\namide, diazotised 3-amino-4- \nhydroxy- N-phenylbenzenesulfon\xad\namide, diazotised 5-amino-2- \n(phenylamino)benzenesulfonic \nacid and resorcinol, sodium salts  417-850-7  —  Aquatic Chronic 2  H411  GHS09  H411  \n▼M23  \n611-181-00-6  potassium (oxido- NNO - \nazoxy)cyclohexane; \ncyclohexylhydroxydiazene 1- \noxide, potassium salt; \n[K-HDO]  — 66603-10-9  Flam. Sol. 1 \nAcute Tox. 3 \nSTOT RE 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H228 \nH301 \nH373 (liver) \nH315 \nH318 \nH411  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H228 \nH301 \nH373 (liver) \nH315 \nH318 \nH411  oral: ATE = \n136 mg/kg bw  \n▼M16  \n612-001-00-9  mono-methylamine; [1] \ndi-methylamine; [2] \ntri-methylamine [3]  200-820-0 [1] \n204-697-4 [2] \n200-875-0 [3]  74-89-5 [1] \n124-40-3 [2] \n75-50-3 [3]  Flam. Gas 1 \nPress. Gas \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H220 \nH332 \nH335 \nH315 \nH318  GHS02 \nGHS04 \nGHS05 \nGHS07 \nDgr H220 \nH332 \nH335 \nH315 \nH318  * \nSkin Irrit. 2; \nH315: C ≥ 5 % \nEye Dam. 1; H318: \nC ≥ 5 % Eye \nIrrit. 2; \nH319: 0,5 % ≤ \nC < 5 % \nSTOT SE 3; H335: \nC ≥ 5 %  U5 \n612-001-01-6  mono-methylamine … %; [1] \ndi-methylamine … %; [2] \ntri-methylamine … % [3]  200-820-0 [1] \n204-697-4 [2] \n200-875-0 [3]  74-89-5 [1] \n124-40-3 [2] \n75-50-3 [3]  Flam. Liq. 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H224 \nH332 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H224 \nH332 \nH302 \nH314  * \nSTOT SE 3; H335: \nC ≥ 5 %  B ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 981}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 983\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-002-00-4  ethylamine  200-834-7  75-04-7  Flam. Gas 1 \nPress. Gas \nEye Irrit. 2 \nSTOT SE 3  H220 \nH319 \nH335  GHS02 \nGHS04 \nGHS07 \nDgr H220 \nH319 \nH335  U \n612-003-00-X  diethylamine  203-716-3  109-89-7  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H225 \nH332 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 1 %  \n612-004-00-5  triethylamine  204-469-4  121-44-8  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H225 \nH332 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 1 %  \n612-005-00-0  butylamine  203-699-2  109-73-9  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H225 \nH332 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 1 %  \n612-006-00-6  ethylenediamine; \n1,2-diaminoethane  203-468-6  107-15-3  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1  H226 \nH312 \nH302 \nH314 \nH334 \nH317  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H226 \nH312 \nH302 \nH314 \nH334 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 982}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 984\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-007-00-1  2-aminopropane; \nisopropylamine  200-860-9  75-31-0  Flam. Liq. 1 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H224 \nH319 \nH335 \nH315  GHS02 \nGHS07 \nDgr H224 \nH319 \nH335 \nH315  \n612-008-00-7  niline  200-539-3  62-53-3  Carc. 2 \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H351 \nH341 \nH331 \nH311 \nH301 \nH372 ** \nH318 \nH317 \nH400  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H351 \nH341 \nH331 \nH311 \nH301 \nH372 ** \nH318 \nH317 \nH400  * \nSTOT RE 1; H372: \nC ≥ 1 % \nSTOT RE 2; H373: \n0,2 % ≤ C < 1 %  \n612-009-00-2  salts of aniline  —  —  Carc. 2 \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H351 \nH341 \nH331 \nH311 \nH301 \nH372 ** \nH318 \nH317 \nH400  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H351 \nH341 \nH331 \nH311 \nH301 \nH372 ** \nH318 \nH317 \nH400  * \nSTOT RE 1; H372: \nC ≥ 1 % STOT \nRE 2; \nH373: 0,2 % ≤ \nC < 1 %  A \n612-010-00-8  chloroanilines (with exception of \nthose specified elsewhere in this \nAnnex)  — —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH410  C ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 983}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 985\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-011-00-3  4-nitrosoaniline  211-535-6  659-49-4  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H332 \nH312 \nH302  GHS07 \nWng  H332 \nH312 \nH302  \n612-012-00-9  o-nitroaniline; [1] m-nitroaniline; \n[2] p-nitroaniline [3]  201-855-4 [1] \n202-729-1 [2] \n202-810-1 [3]  88-74-4 [1] \n99-09-2 [2] \n100-01-6 [3]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 3  H331 \nH311 \nH301 \nH373 ** \nH412  GHS06 \nGHS08 \nDgr H331 \nH311 \nH301 \nH373 ** \nH412  C \n612-013-00-4  3-aminobenzene sulphonic acid; \nmetanilic acid  204-473-6  121-47-1  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H332 \nH312 \nH302  GHS07 \nWng  H332 \nH312 \nH302  \n612-014-00-X  sulphanilic acid; \n4-aminobenzenesulphonic acid  204-482-5  121-57-3  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH315 \nH317  GHS07 \nWng  H319 \nH315 \nH317  \n612-015-00-5  N-methylaniline  202-870-9  100-61-8  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH410  \n612-016-00-0  N,N-dimethylaniline  204-493-5  121-69-7  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H351 \nH331 \nH311 \nH301 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH331 \nH311 \nH301 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 984}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 986\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-017-00-6  N-methyl- N-2,4,6-tetrani\xad\ntroaniline; tetryl  207-531-9  479-45-8  Expl. 1.1 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2  H201 \nH331 \nH311 \nH301 \nH373**  GHS01 \nGHS06 \nGHS08 \nDgr H201 \nH331 \nH311 \nH301 \nH373**  \n612-018-00-1  bis(2,4,6-trinitrophenyl)amine; \nhexyl  205-037-8  131-73-7  Expl. 1.1 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 \nAquatic Chronic 2  H201 \nH330 \nH310 \nH300 \nH373** \nH411  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH330 \nH310 \nH300 \nH373** \nH411  \n612-019-00-7  dipicrylamine, ammonium salt  220-639-0  2844-92-0  Expl. 1.1 \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 \nAquatic Chronic 2  H201 \nH330 \nH310 \nH300 \nH373** \nH411  GHS01 \nGHS06 \nGHS08 \nGHS09 \nDgr H201 \nH330 \nH310 \nH300 \nH373** \nH411  \n612-020-00-2  1-naphthylamine  205-138-7  134-32-7  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n612-022-00-3  2-naphthylamine  202-080-4  91-59-8  Carc. 1A \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH411  Carc. 1A; H350: C \n≥ 0,01 %  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 985}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 987\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-023-00-9  phenylhydrazine; [1] phenylhy\xad\ndrazinium chloride; [2] \nphenylhydrazine hydrochloride; \n[3] \nphenylhydrazinium sulphate \n(2:1) [4]  202-873-5 [1] \n200-444-7 [2] \n248-259-0 [3] \n257-622-2 [4]  100-63-0 [1] \n59-88-1 [2] \n27140-08-5 [3] \n52033-74-6 [4]  Carc. 1B \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H350 \nH341 \nH331 \nH311 \nH301 \nH372 ** \nH319 \nH315 \nH317 \nH400  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH331 \nH311 \nH301 \nH372 ** \nH319 \nH315 \nH317 \nH400  \n612-024-00-4  m-toluidine; \n3-aminotoluene  203-583-1  108-44-1  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1  H331 \nH311 \nH301 \nH373 ** \nH400  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH400  \n612-025-00-X  nitrotoluidines, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH411  C \n612-026-00-5  diphenylamine  204-539-4  122-39-4  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH373 ** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 986}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 988\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-027-00-0  xylidines with the exception of \nthose specified elsewhere in this \nAnnex; \ndimethyl anilines with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH411  C \n612-028-00-6  p-phenylenediamine  203-404-7  106-50-3  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH319 \nH317 \nH410  \n612-029-00-1  benzene-1,4-diamine dihydro\xad\nchloride;  \np-phenylenediamine dihydro\xad\nchloride  210-834-9  624-18-0  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH311 \nH301 \nH319 \nH317 \nH410  \n612-030-00-7  2-methyl- p-phenylenediamine \nsulphate [1]  210-431-8 [1] \n228-871-4 [2]  615-50-9 [1] \n6369-59-1 [2]  Acute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H301 \nH332 \nH312 \nH317 \nH411  GHS06 \nGHS09 \nDgr H301 \nH332 \nH312 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 987}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 989\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-031-00-2  N,N-dimethylbenzene-1,3- \ndiamine; [1] \n4-amino- N,N-dimethylaniline; \n3-amino- N,N'-dimethylaniline [2]  220-623-3 [1] \n202-807-5 [2]  2836-04-6 [1] \n99-98-9 [2]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H331 \nH311 \nH301  GHS06 \nDgr H331 \nH311 \nH301  C \n612-032-00-8  N, N,N',N' -tetramethyl- p-pheny\xad\nlenediamine  202-831-6  100-22-1  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H332 \nH312 \nH302  GHS07 \nWng  H332 \nH312 \nH302  \n612-033-00-3  2-aminophenol  202-431-1  95-55-6  Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 *  H341 \nH332 \nH302  GHS08 \nGHS07 \nWng  H341 \nH332 \nH302  \n612-034-00-9  2-amino-4,6-dinitrophenol; \npicramic acid  202-544-6  96-91-3  Expl. 1.1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H201 \nH332 \nH312 \nH302 \nH412  GHS01 \nGHS07 \nDgr H201 \nH332 \nH312 \nH302 \nH412  \n612-034-01-6  2-amino-4,6-dinitrophenol; \npicramic acid; [≥ 20 % water]  202-544-6  96-91-3  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H332 \nH312 \nH302 \nH412  GHS07 \nWng  H332 \nH312 \nH302 \nH412  G \n612-035-00-4  2-methoxyaniline;  \no-anisidine  201-963-1  90-04-0  Carc. 1B Muta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 *  H350 \nH341 \nH331 \nH311 \nH301  GHS06 \nGHS08 \nDgr H350 \nH341 \nH331 \nH311 \nH301  \n612-036-00-X  3,3'-dimethoxybenzidine;  \no-dianisidine  204-355-4  119-90-4  Carc. 1B \nAcute Tox. 4 *  H350 \nH302  GHS08 \nGHS07 \nDgr H350 \nH302  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 988}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 990\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-037-00-5  salts of 3,3'-dimethoxybenzidine; \nsalts of  o-dianisidine  — —  Carc. 1B \nAcute Tox. 4 *  H350 \nH302  GHS08 \nGHS07 \nDgr H350 \nH302  A \n612-038-00-0  2-nitro- p-anisidine; \n4-methoxy-2-nitroaniline  202-547-2  96-96-8  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 3  H330 \nH310 \nH300 \nH373 ** \nH412  GHS06 \nGHS08 \nDgr H330 \nH310 \nH300 \nH373 ** \nH412  \n612-039-00-6  2-ethoxyaniline;  \no-phenetidine  202-356-4  94-70-2  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 *  H331 \nH311 \nH301 \nH373 **  GHS06 \nGHS08 \nDgr H331 \nH311 \nH301 \nH373 **  \n612-040-00-1  2,4-dinitroaniline  202-553-5  97-02-9  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Chronic 2  H330 \nH310 \nH300 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH411  \n612-041-00-7  4,4'-bi- o-toluidine  204-358-0  119-93-7  Carc. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH411  \n612-042-00-2  benzidine; \n1,1'-biphenyl-4,4'-diamine; \n4,4'-diaminobiphenyl; \nbiphenyl-4,4'-ylenediamine  202-199-1  92-87-5  Carc. 1A \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH410  Carc. 1A; H350: C \n≥ 0,01 %  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 989}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 991\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-043-00-8  N,N'-dimethylbenzidine  —  2810-74-4  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H332 \nH312 \nH302  GHS07 \nWng  H332 \nH312 \nH302  \n612-044-00-3  N,N'-diacetylbenzidine  210-338-2  613-35-4  Carc. 1B Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H350 \nH341 \nH332 \nH312 \nH302  GHS08 \nGHS07 \nDgr H350 \nH341 \nH332 \nH312 \nH302  \n612-046-00-4  allylamine  203-463-9  107-11-9  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H225 \nH331 \nH311 \nH301 \nH411  GHS02 \nGHS06 \nGHS09 \nDgr H225 \nH331 \nH311 \nH301 \nH411  \n612-047-00-X  benzylamine  202-854-1  100-46-9  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  \n612-048-00-5  dipropylamine  205-565-9  142-84-7  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H225 \nH332 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 1 %  \n612-049-00-0  di- n-butylamine; [1] \ndi-sec-butylamine [2]  203-921-8 [1] \n210-937-9 [2]  111-92-2 [1] \n626-23-3 [2]  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H226 \nH332 \nH312 \nH302  GHS02 \nGHS07 \nWng  H226 \nH332 \nH312 \nH302  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 990}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 992\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-050-00-6  cyclohexylamine  203-629-0  108-91-8  Flam. Liq. 3 \nRepr. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H226 \nH361f*** \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS08 \nGHS07 \nDgr H226 \nH361f*** \nH312 \nH302 \nH314  \n612-051-00-1  4,4'-diaminodiphenylmethane; \n4,4'-methylenedianiline  202-974-4  101-77-9  Carc. 1B \nMuta. 2 \nSTOT SE 1 \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H350 \nH341 \nH370 ** \nH373 ** \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH341 \nH370 ** \nH373 ** \nH317 \nH411  \n612-052-00-7  (S)-sec-butylamine; \n(S)-2-aminobutane; [1] ( R)-sec- \nbutylamine; \n(R)-2-aminobutane; [2]  \nsec-butylamine; \n2-aminobutane [3]  208-164-7 [1] \n236-232-6 [2] \n237-732-7 [3]  513-49-5 [1] \n13250-12-9 [2] \n13952-84-6 [3]  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A \nAquatic Acute 1  H225 \nH332 \nH302 \nH314 \nH400  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H225 \nH332 \nH302 \nH314 \nH400  C \n612-053-00-2  N-ethylaniline  203-135-5  103-69-5  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 *  H331 \nH311 \nH301 \nH373 **  GHS06 \nGHS08 \nDgr H331 \nH311 \nH301 \nH373 **  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 991}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 993\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-054-00-8  N,N-diethylaniline  202-088-8  91-66-7  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH411  * \n612-055-00-3  N-methyl- o-toluidine; [1]  N - \nmethyl- m-toluidine; [2]  N - \nmethyl- p-toluidine [3]  210-260-9 [1] \n211-795-0 [2] \n210-769-6 [3]  611-21-2 [1] \n696-44-6 [2] \n623-08-5 [3]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 3  H331 \nH311 \nH301 \nH373 ** \nH412  GHS06 \nGHS08 \nDgr H331 \nH311 \nH301 \nH373 ** \nH412  C \n612-056-00-9  N,N-dimethyl- p-toluidine; [1]  \nN,N-dimethyl- m-toluidine; [2]  \nN,N-dimethyl- o-toluidine [3]  202-805-4 [1] \n204-495-6 [2] \n210-199-8 [3]  99-97-8 [1] \n121-72-2 [2] \n609-72-3 [3]  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 3  H331 \nH311 \nH301 \nH373 ** \nH412  GHS06 \nGHS08 \nDgr H331 \nH311 \nH301 \nH373 ** \nH412  * C  \n612-057-00-4  piperazine; [solid]  203-808-3  110-85-0  Repr. 2 \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1  H361fd \nH314 \nH334 \nH317  GHS05 \nGHS08 \nDgr H361fd \nH314 \nH334 \nH317  \n612-057-01-1  piperazine; [liquid]  203-808-3  110-85-0  Repr. 2 \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1  H361fd \nH314 \nH334 \nH317  GHS05 \nGHS08 \nDgr H361fd \nH314 \nH334 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 992}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 994\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-058-00-X  2,2'-iminodiethylamine; \ndiethylenetriamine  203-865-4  111-40-0  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H312 \nH302 \nH314 \nH317  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314 \nH317  \n612-059-00-5  3,6-diazaoctanethylenediamin; \ntriethylenetetramine  203-950-6  112-24-3  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H312 \nH314 \nH317 \nH412  GHS05 \nGHS07 \nDgr H312 \nH314 \nH317 \nH412  \n612-060-00-0  3,6,9-triazaundecamethylene\xad\ndiamine; tetraethylenepentamine  203-986-2  112-57-2  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H312 \nH302 \nH314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH314 \nH317 \nH411  \n612-061-00-6  3-aminopropyldimethylamine;  \nN,N-dimethyl-1,3-diamin\xad\nopropane  203-680-9  109-55-7  Flam. Liq. 3 \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H226 \nH302 \nH314 \nH317  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH302 \nH314 \nH317  \n612-062-00-1  3-aminopropyldiethylamine;  \nN,N-diethyl-1,3-diaminopropane  203-236-4  104-78-9  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H226 \nH312 \nH302 \nH314 \nH317  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH312 \nH302 \nH314 \nH317  \n612-063-00-7  3,3'-iminodi(propylamine); \ndipropylenetriamine  200-261-2  56-18-8  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1A \nSkin Sens. 1  H330 \nH311 \nH302 \nH314 \nH317  GHS06 \nGHS05 \nDgr H330 \nH311 \nH302 \nH314 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 993}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 995\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-064-00-2  3,6,9,12-tetra-azatetradecamethyl\xad\nenediamine; pentacthylenehex\xad\namine  223-775-9  4067-16-7  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH410  \n612-065-00-8  polyethlyenepolyamines with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH314 \nH317 \nH410  \n612-066-00-3  dicyclohexylamine  202-980-7  101-83-7  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH410  \n612-067-00-9  3-aminomethyl-3,5,5-trimethyl\xad\ncyclohexylamine  220-666-8  2855-13-2  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H312 \nH302 \nH314 \nH317 \nH412  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314 \nH317 \nH412  \n612-068-00-4  3,3'-dichlorobenzidine; \n3,3'-dichlorobiphenyl-4,4'-ylene\xad\ndiamine  202-109-0  91-94-1  Carc. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH312 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH312 \nH317 \nH410  \n612-069-00-X  salts of 3,3'-dichlorobenzidine; \nsalts of 3,3'-dichlorobiphenyl- \n4,4'-ylenediamine  — —  Carc. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH312 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH312 \nH317 \nH410  A ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 994}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 996\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-070-00-5  salts of benzidine  208-519-6 \n208-520-1 \n244-236-4 \n252-984-8  531-85-1 \n531-86-2 \n21136-70-9 \n36341-27-2  Carc. 1A \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH410  A \n612-071-00-0  salts of 2-naphthylamine  209-030-0 \n210-313-6  553-00-4 \n612-52-2  Carc. 1A \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH411  A \n612-072-00-6  biphenyl-4-ylamine; \nxenylamine; \n4-aminobiphenyl  202-177-1  92-67-1  Carc. 1A \nAcute Tox. 4 *  H350 \nH302  GHS08 \nGHS07 \nDgr H350 \nH302  \n612-073-00-1  salts of biphenyl-4-ylamine; \nsalts of xenylamine; \nsalts of 4-aminobiphenyl  — —  Carc. 1A \nAcute Tox. 4 *  H350 \nH302  GHS08 \nGHS07 \nDgr H350 \nH302  A \n612-074-00-7  benzyldimethylamine  203-149-1  103-83-3  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 3  H226 \nH332 \nH312 \nH302 \nH314 \nH412  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH332 \nH312 \nH302 \nH314 \nH412  \n612-075-00-2  2-aminoethyldimethylamine; \n2-dimethylaminoethylamine  203-541-2  108-00-9  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H225 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH312 \nH302 \nH314  \n612-076-00-8  ethyldimethylamine  209-940-8  598-56-1  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H225 \nH332 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH332 \nH302 \nH314  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 995}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 997\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-077-00-3  dimethylnitrosoamine;  \nN-nitrosodimethylamine  200-549-8  62-75-9  Carc. 1B \nAcute Tox. 2 * \nAcute Tox. 3 * \nSTOT RE 1 \nAquatic Chronic 2  H350 \nH330 \nH301 \nH372 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH330 \nH301 \nH372 ** \nH411  Carc. 1B; H350: C \n≥ 0,001 %  \n612-078-00-9  2,2'-dichloro-4,4'-methylene\xad\ndianiline; \n4,4'-methylene bis(2-chloroani\xad\nline) 202-918-9  101-14-4  Carc. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH410  \n612-079-00-4  salts of 2,2'-dichloro-4,4'-methyl\xad\nenedianiline; \nsalts of 4,4'-methylenebis(2- \nchloroaniline)  — —  Carc. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH410  A \n612-080-00-X  4-amino- N,N-diethylaniline;  \nN,N-diethyl-p-phenylendiamine  202-214-1  93-05-0  Acute Tox. 3 * \nSkin Corr. 1B  H301 \nH314  GHS06 \nGHS05 \nDgr H301 \nH314  \n612-081-00-5  salts of 4,4'-bi- o-toluidine; \nsalts of 3,3'-dimethylbenzidine; \nsalts of  o-tolidine  210-322-5 \n265-294-7 \n277-985-0  612-82-8 \n64969-36-4 \n74753-18-7  Carc. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH411  A \n612-082-00-0  thiourea; \nthiocarbamide  200-543-5  62-56-6  Carc. 2 \nRepr. 2 \nAcute Tox. 4 * \nAquatic Chronic 2  H351 \nH361d *** \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH361d *** \nH302 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 996}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 998\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-083-00-6  1-methyl-3-nitro-1-nitrosogua\xad\nnidine  200-730-1  70-25-7  Carc. 1B \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H350 \nH332 \nH319 \nH315 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH332 \nH319 \nH315 \nH411  Carc. 1B; H350: C \n≥ 0,01 %  \n612-084-00-1  dapsone; \n4,4'-diamino diphenyl sulfone  201-248-4  80-08-0  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n612-085-00-7  4,4'-methylenedi- o-toluidine  212-658-8  838-88-0  Carc. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH317 \nH410  \n612-086-00-2  amitraz (ISO);  \nN,N-bis(2,4-xylyliminomethyl) \nmethylamine  251-375-4  33089-61-1  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH317 \nH410  M = 10  \n612-087-00-8  guazatine (ISO)  108173-90-6  Acute Tox. 2 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH312 \nH302 \nH335 \nH315 \nH318 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH312 \nH302 \nH335 \nH315 \nH318 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 997}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 999\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-088-00-3  simazine (ISO); \n6-chloro- N,N'-diethyl-1,3,5- \ntriazine-2,4-diamine  204-535-2  122-34-9  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n612-089-00-9  1,5-naphthylenediamine  218-817-8  2243-62-1  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n612-090-00-4  2,2'-(nitrosoimino)bisethanol  214-237-4  1116-54-7  Carc. 1B  H350  GHS08 \nDgr H350  \n612-091-00-X  o-toluidine; \n2-aminotoluene  202-429-0  95-53-4  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nAquatic Acute 1  H350 \nH331 \nH301 \nH319 \nH400  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH301 \nH319 \nH400  \n612-092-00-5  N, N' -(2,2-dimethylpropyli\xad\ndene)hexamethylenediamine  401-660-6  1000-78-8  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n612-093-00-0  3,5-dichloro-4-(1,1,2,2-tetraflu\xad\noroethoxy)aniline  401-790-3  104147-32-2  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n612-094-00-6  4-(2-chloro-4-trifluor\xad\nomethyl)phenoxy-2-fluoroaniline \nhydrochloride  402-190-4  113674-95-6  STOT RE 1 \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H372** \nH302 \nH373** \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H372** \nH302 \nH373** \nH318 \nH317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 998}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1000\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-095-00-1  benzyl-2-hydroxydodecyldi \nmethylammonium benzoate  402-610-6  113694-52-3  Skin Corr. 1B \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH302 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH302 \nH410  \n612-096-00-7  4,4'-carbonimidoylbis[ N, N - \ndimethylaniline]  207-762-5  492-80-8  Carc. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 2  H351 \nH302 \nH319 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH319 \nH411  \n612-097-00-2  salts of 4,4'-carbonimidoylbis[ N, \nN-dimethylaniline]  — —  Carc. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 2  H351 \nH302 \nH319 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH319 \nH411  A \n612-098-00-8  nitrosodipropylamine  210-698-0  621-64-7  Carc. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH411  Carc. 1B; H350: C \n≥ 0,001 %  \n612-099-00-3  4-methyl- m-phenylenediamine; \n2,4-toluenediamine  202-453-1  95-80-7  Carc. 1B \nMuta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H350 \nH341 \nH361f*** \nH301 \nH312 \nH373** \nH317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH361f*** \nH301 \nH312 \nH373** \nH317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 999}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1001\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-100-00-7  propylenediamine  201-155-9  78-90-0  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A  H226 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H226 \nH312 \nH302 \nH314  \n612-101-00-2  methenamine; \nhexamethylenetetramine  202-905-8  100-97-0  Flam. Sol. 2 \nSkin Sens. 1  H228 \nH317  GHS02 \nGHS07 \nWng  H228 \nH317  \n612-102-00-8  N, N -bis(3-aminopropyl)methyl\xad\namine  203-336-8  105-83-9  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1B  H331 \nH311 \nH302 \nH314  GHS06 \nGHS05 \nDgr H331 \nH311 \nH302 \nH314  \n612-103-00-3  N, N,N',N' -tetramethylethylene\xad\ndiamine  203-744-6  110-18-9  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H225 \nH332 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH332 \nH302 \nH314  \n612-104-00-9  hexamethylenediamine  204-679-6  124-09-4  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Corr. 1B  H312 \nH302 \nH335 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH335 \nH314  \n612-105-00-4  2-piperazin-1-ylethylamine  205-411-0  140-31-8  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H312 \nH302 \nH314 \nH317 \nH412  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1000}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1002\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-106-00-X  2,6-diethylaniline  209-445-7  579-66-8  Acute Tox. 4 *  H302  —  H302  \n612-107-00-5  1-phenylethylamine; [1] \nDL-α-methylbenzylamine [2]  202-706-6 [1] \n210-545-8 [2]  98-84-0 [1] \n618-36-0 [2]  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  \n612-108-00-0  3-aminopropyltriethoxysilane  213-048-4  919-30-2  Acute Tox. 4 * \nSkin Corr. 1B  H302 \nH314  GHS05 \nGHS07 \nDgr H302 \nH314  \n612-109-00-6  bis(2-dimethylaminoe\xad\nthyl)(methyl)amine  221-201-1  3030-47-5  Acute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1B  H311 \nH302 \nH314  GHS06 \nGHS05 \nDgr H311 \nH302 \nH314  \n612-110-00-1  2,2'-dimethyl-4,4'-methylene\xad\nbis(cyclohexylamine)  229-962-1  6864-37-5  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1A \nAquatic Chronic 2  H331 \nH311 \nH302 \nH314 \nH411  GHS06 \nGHS05 \nGHS09 \nDgr H331 \nH311 \nH302 \nH314 \nH411  \n612-111-00-7  2-methyl- m-phenylenediamine; \n2,6-toluenediamine  212-513-9  823-40-5  Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H341 \nH312 \nH302 \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH312 \nH302 \nH317 \nH411  \n612-112-00-2  p-anisidine; \n4-methoxyaniline  203-254-2  104-94-9  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSTOT RE 2 * \nAquatic Acute 1  H330 \nH310 \nH300 \nH373 ** \nH400  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH310 \nH300 \nH373 ** \nH400  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1001}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1003\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-113-00-8  6-methyl-2,4-bis(methyl\xad\nthio)phenylene-1,3-diamine  403-240-8  106264-79-3  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n612-114-00-3  R, R -2-hydroxy-5-(1-hydroxy-2- \n(4-phenylbut-2- \nylamino)ethyl)benzamide \nhydrogen 2,3-bis(benzoy\xad\nloxy)succinate  404-390-7  —  Flam. Sol. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H228 \nH317 \nH412  GHS02 \nGHS07 \nWng  H228 \nH317 \nH412  \n612-115-00-9  dimethyldioctadecylammonium \nhydrogen sulfate  404-050-8  123312-54-9  Eye Irrit. 2 \nAquatic Chronic 4  H319 \nH413  GHS07 \nWng  H319 \nH413  \n612-116-00-4  C  8-18 alkylbis(2-hydroxye\xad\nthyl)ammonium bis(2-ethylhe\xad\nxyl)phosphate  404-690-8  68132-19-4  Acute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH314 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H331 \nH314 \nH317 \nH410  \n612-117-00-X  C  12-14-tert-alkylamine, methyl\xad\nphosphonic acid salt  404-750-3  119415-07-5  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H302 \nH314 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH411  \n612-118-00-5  A reaction mass of: (1,3-dioxo- \n2H-benz(de)isoquinolin-2-ylpro\xad\npyl)hexadecyldimethylam\xad\nmonium 4-toluenesulfonate; (1,3- \ndioxo-2 H-benz(de)isoquinolin-2- \nylpropyl)hexadecyldimethylam\xad\nmonium bromide  405-080-4  —  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1002}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1004\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-119-00-0  benzyldimethyloctadecylam\xad\nmonium 3-nitrobenzenesulfonate  405-330-2  —  Skin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H315 \nH318 \nH410  \n612-120-00-6  aclonifen (ISO); \n2-chloro-6-nitro-3-phenoxy\xad\naniline  277-704-1  74070-46-5  Carc. 2 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGH09 \nWng  H351 \nH317 \nH410  M = 100 \nM = 10  \n612-121-00-1  amines, polyethylenepoly-; \nHEPA  268-626-9  68131-73-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH314 \nH317 \nH410  \n612-122-00-7  hydroxylamine … % \n[> 55 % in aqueous solution]  232-259-2  7803-49-8  Unst. Expl. Met. \nCorr. 1 \nCarc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H200 \nH290 \nH351 \nH312 \nH302 \nH373** \nH335 \nH315 \nH318 \nH317 \nH400  GHS01 \nGHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H200 \nH290 \nH351 \nH312 \nH302 \nH373** \nH335 \nH315 \nH318 \nH317 \nH400  B ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1003}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1005\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-122-01-4  hydroxylamine …% [≤ 55 % in \naqueous solution]  232-259-2  7803-49-8  Met. Corr. 1 \nCarc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H290 \nH351 \nH312 \nH302 \nH373** \nH335 \nH315 \nH318 \nH317 \nH400  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H290 \nH351 \nH312 \nH302 \nH373** \nH335 \nH315 \nH318 \nH317 \nH400  B \n612-123-00-2  hydroxylammonium chloride; \nhydroxylamine hydrochloride; \n[1] bis(hydroxylammonium) \nsulfate; \nhydroxylamine sulfate (2:1) [2]  226-798-2 [1] \n233-118-8 [2]  5470-11-1 [1] \n10039-54-0 [2]  Met. Corr. 1 \nCarc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H290 \nH351 \nH312 \nH302 \nH373** \nH319 \nH315 \nH317 \nH400  GHS05 \nGHS08 \nGHS07 \nGHS09 \nWng  H290 \nH351 \nH312 \nH302 \nH373** \nH319 \nH315 \nH317 \nH400  \n612-124-00-8  N,N,N-trimethylanilinium \nchloride  205-319-0  138-24-9  Acute Tox. 3 * \nAcute Tox. 3 *  H311 \nH301  GHS06 \nDgr H311 \nH301  \n612-125-00-3  2-methyl- p-phenylenediamine; \n2,5-toluenediamine  202-442-1  95-70-5  Acute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H301 \nH332 \nH312 \nH317 \nH411  GHS06 \nGHS09 \nDgr H301 \nH332 \nH312 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1004}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1006\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-126-00-9  toluene-2,4-diammonium \nsulphate; \n4-methyl-m-phenylenediamine \nsulfate  265-697-8  65321-67-7  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H350 \nH301 \nH312 \nH319 \nH317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH301 \nH312 \nH319 \nH317 \nH411  \n612-127-00-4  3-aminophenol  209-711-2  591-27-5  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H332 \nH302 \nH411  GHS07 \nGHS09 \nWng  H332 \nH302 \nH411  \n612-128-00-X  4-aminophenol  204-616-2  123-30-8  Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH332 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH332 \nH302 \nH410  \n612-129-00-5  diisopropylamine  203-558-5  108-18-9  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H225 \nH332 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH332 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 5 %  \n612-130-00-0  2,6-diamino-3,5-diethyltoluene; \n4,6-diethyl-2-methyl-1,3- \nbenzenediamine; [1] \n2,4-diamino-3,5-diethyltoluene; \n2,4-diethyl-6-methyl-1,3- \nbenzenediamine; [2] diethylme\xad\nthylbenzenediamine [3]  218-255-3 [1] \n218-256-9 [2] \n270-877-4 [3]  2095-01-4 [1] \n2095-02-5 [2] \n68479-98-1 [3]  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH373 ** \nH319 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H312 \nH302 \nH373 ** \nH319 \nH410  C ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1005}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1007\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-131-00-6  didecyldimethylammonium \nchloride  230-525-2  7173-51-5  Acute Tox. 4 * \nSkin Corr. 1B  H302 \nH314  GHS05 \nGHS07 \nDgr H302 \nH314  \n612-132-00-1  N, N' -diphenyl- p-phenylene\xad\ndiamine;  \nN, N' -diphenyl-1,4-benzene\xad\ndiamine  200-806-4  74-31-7  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n612-133-00-7  (4-ammonio- m-tolyl)ethyl(2- \nhydroxyethyl)ammonium \nsulphate; \n4-(N-ethyl- N-2-hydroxyethyl)-2- \nmethylphenylenediamine \nsulphate  247-162-0  25646-77-9  Acute Tox. 3 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH373 ** \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH373 ** \nH317 \nH410  \n612-134-00-2  N-(2-(4-amino- N-ethyl- m- \ntoluidino)ethyl)methanesul\xad\nphonamide sesquisulphate; \n4-(N-ethyl- N-2-methanesulphony\xad\nlaminoethyl)-2-methylphenylene\xad\ndiamine sesquisulphate monohy\xad\ndrate  247-161-5  25646-71-3  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n612-135-00-8  N-2-naphthylaniline;  \nN-phenyl-2-naphthylamine  205-223-9  135-88-6  Carc. 2 \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H351 \nH319 \nH315 \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH319 \nH315 \nH317 \nH411  \n612-136-00-3  N-isopropyl- N'-phenyl- p-pheny\xad\nlenediamine  202-969-7  101-72-4  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  Skin Sens. 1; \nH317:C ≥0,1 %  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1006}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1008\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-137-00-9  4-chloroaniline  203-401-0  106-47-8  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH331 \nH311 \nH301 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH311 \nH301 \nH317 \nH410  \n612-138-00-4  furalaxyl (ISO); \nmethyl  N-(2,6-dimethylphenyl)-  \nN-(2-furylcarbonyl)-DL-alaninate  260-875-1  57646-30-7  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n612-139-00-X  mefenacet (ISO); \n2-(benzothiazol-2-yloxy)- N- \nmethyl- N-phenylacetamide  277-328-8  73250-68-7  Aquatic Chronic 2  H411  GHS09  H411  \n612-140-00-5  quaternary ammonium \ncompounds, benzyl-C  8-18-alkyldi\xad\nmethyl, chlorides  264-151-6  63449-41-2  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1  H312 \nH302 \nH314 \nH400  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH314 \nH400  \n612-141-00-0  4,4'-methylenebis(2-ethylaniline); \n4,4'-methylenebis(2-ethylbenze\xad\nneamine)  243-420-1  19900-65-3  Carc. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH410  \n612-142-00-6  biphenyl-2-ylamine  201-990-9  90-41-5  Carc. 2 \nAcute Tox. 4 * \nAquatic Chronic 3  H351 \nH302 \nH412  GHS08 \nGHS07 \nWng  H351 \nH302 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1007}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1009\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-143-00-1  N5 ,N5 -diethyltoluene-2,5-diamine \nmonohydrochloride; \n4-diethylamino-2-methylaniline \nmonohydrochloride  218-130-3  2051-79-8  Acute Tox. 3 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH319 \nH317 \nH410  \n612-144-00-7  flumetralin (ISO);  \nN-(2-chloro-6-fluorobenzyl)- N- \nethyl-α, α,α-trifluoro-2,6-dinitro-  \np-toluidine  — 62924-70-3  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH317 \nH410  \n612-145-00-2  o-phenylenediamine  202-430-6  95-54-5  Carc. 2 \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH341 \nH301 \nH332 \nH312 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH341 \nH301 \nH332 \nH312 \nH319 \nH317 \nH410  \n612-146-00-8  o-phenylenediamine dihydro\xad\nchloride  210-418-7  615-28-1  Carc. 2 \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH341 \nH301 \nH332 \nH312 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH341 \nH301 \nH332 \nH312 \nH319 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1008}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1010\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-147-00-3  m-phenylenediamine  203-584-7  108-45-2  Muta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH331 \nH311 \nH301 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H341 \nH331 \nH311 \nH301 \nH319 \nH317 \nH410  \n612-148-00-9  m-phenylenediamine dihydro\xad\nchloride  208-790-0  541-69-5  Muta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH331 \nH311 \nH301 \nH319 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H341 \nH331 \nH311 \nH301 \nH319 \nH317 \nH410  \n612-149-00-4  1,3-diphenylguanidine  203-002-1  102-06-7  Repr. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H361f *** \nH302 \nH319 \nH335 \nH315 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H361f *** \nH302 \nH319 \nH335 \nH315 \nH411  \n▼M15  \n612-150-00-X  spiroxamine (ISO); \n8-tert-butyl-1,4-diox\xad\naspiro[4.5]decan-2-ylme\xad\nthyl(ethyl)(propyl)amine  — 118134-30-8  Repr. 2 \nAcute Tox. 4 \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT RE 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH332 \nH312 \nH302 \nH373 (eye) \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d \nH332 \nH312 \nH302 \nH373 (eye) \nH315 \nH317 \nH410  M = 100 \nM = 100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1009}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1011\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n612-151-00-5  methyl-phenylene diamine; \ndiaminotoluene; \n[technical product — reaction \nmass of 4-methyl- m-phenylene \ndiamine (EC No 202-453-1) and \n2-methyl- m-phenylene diamine \n(EC No 212-513-9)]  — —  Carc. 1B Muta. 2 \nRepr. 2 \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H350 \nH341 \nH361f*** \nH301 \nH312 \nH373** \nH319 \nH317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH361f*** \nH301 \nH312 \nH373** \nH319 \nH317 \nH411  \n612-152-00-0  N, N -diethyl- N',N' -dimethyl\xad\npropan-1,3-diyl-diamine  406-610-7  62478-82-4  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1A \nAquatic Chronic 3  H226 \nH332 \nH302 \nH373 ** \nH314 \nH412  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H226 \nH332 \nH302 \nH373 ** \nH314 \nH412  \n612-153-00-6  4-[ N-ethyl- N-(2-hydroxye\xad\nthyl)amino]-1-(2-hydroxye\xad\nthyl)amino-2-nitrobenzene, \nmonohydrochloride  407-020-2  132885-85-9  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH317 \nH412  GHS07 \nWng  H302 \nH317 \nH412  \n612-154-00-1  6'-(isobutylethylamino)-3'- \nmethyl-2'-phenylamino-spiro[iso\xad\nbenzo-2-oxofuran-7,9'-[9 H]- \nxanthene]  410-890-6  95235-29-3  Aquatic Chronic 4  H413  —  H413  \n612-155-00-7  2'-anilino-6'-((3-ethoxypro\xad\npyl)ethylamino)-3'-methyl\xad\nspiro(isobenzo-3-oxofuran)-1- \n(1H)-9'-xanthene  411-730-8  93071-94-4  Aquatic Chronic 4  H413  —  H413  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 1010}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1012\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-156-00-2  reaction mass of: trihexadecylme\xad\nthylammonium chloride; dihex\xad\nadecyldimethylammonium \nchloride  405-620-9  —  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n612-157-00-8  (Z)-1-benzo[ b]thien-2-ylethanone \noxime hydrochloride  410-780-8  —  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH373 ** \nH318 \nH317 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H302 \nH373 ** \nH318 \nH317 \nH411  \n612-158-00-3  reaction mass of: bis(5-dodecyl- \n2-hydroxybenzald-oximate) \ncopper (II) C  12-alkyl group is \nbranched; \n4-dodecylsalicylaldoxime  410-820-4  —  Aquatic Chronic 4  H413  —  H413  \n612-159-00-9  reaction products of: trimethyl\xad\nhexamethylene diamine (a \nmixture of 2,2,4-trimethyl-1,6- \nhexanediamine and 2,4,4- \ntrimethyl-1,6-hexanediamine, \nEINECS listed), Epoxide 8 \n(mono[(C  10-C 16-alky\xad\nloxy)methyl]oxirane derivatives) \nand p-toluene-sulfonic acid  410-880-1  —  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH410  \n612-160-00-4  p-toluidine; \n4-aminotoluene; [1] \ntoluidinium chloride; [2] \ntoluidine sulphate (1:1) [3]  203-403-1 [1] \n208-740-8 [2] \n208-741-3 [3]  106-49-0 [1] \n540-23-8 [2] \n540-25-0 [3]  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H351 \nH331 \nH311 \nH301 \nH319 \nH317 \nH400  GHS06 \nGHS08 \nGHS09 \nDgr H351 \nH331 \nH311 \nH301 \nH319 \nH317 \nH400  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1011}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1013\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-161-00-X  2,6-xylidine; \n2,6-dimethylaniline  201-758-7  87-62-7  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 2  H351 \nH332 \nH312 \nH302 \nH335 \nH315 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH332 \nH312 \nH302 \nH335 \nH315 \nH411  \n612-162-00-5  dimethyldioctadecylammonium \nchloride; \nDODMAC  203-508-2  107-64-2  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n612-163-00-0  metalaxyl- M (ISO); \nmefenoxam; \n(R)-2-[(2,6-dimethylphenyl)- \nmethoxyacetylamino]propionic \nacid methyl ester  — 70630-17-0  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n612-164-00-6  2-butyl-2-ethyl-1,5-diamin\xad\nopentane  412-700-7  137605-95-9  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H312 \nH302 \nH373 ** \nH314 \nH317 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H312 \nH302 \nH373 ** \nH314 \nH317 \nH412  \n612-165-00-1  N,N'-diphenyl- N,N'-bis(3-methyl\xad\nphenyl)-(1,1'-diphenyl)-4,4'- \ndiamine  413-810-8  65181-78-4  Aquatic Chronic 2  H411  GHS09  H411  \n612-166-00-7  reaction mass of: cis-(5- \nammonium-1,3,3-trimethyl)- \ncyclohexanemethylammonium \nphosphate (1:1); \ntrans-(5-ammonium-1,3,3- \ntrimethyl)-cyclohexanemethyl\xad\nammonium phosphate (1:1)  411-830-1  114765-88-7  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1012}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1014\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-167-00-2  5-acetyl-3-amino-10,11-dihydro- \n5H-dibenz[ b, f ]azepine-hydro\xad\nchloride  410-490-1  —  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH373 ** \nH318 \nH317 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H302 \nH373 ** \nH318 \nH317 \nH411  \n612-168-00-8  3,5-dichloro-2,6-difluoropyrdine- \n4-amine  220-630-1  2840-00-8  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H312 \nH302 \nH411  GHS07 \nGHS09 \nWng  H312 \nH302 \nH411  \n612-169-00-3  bis( N-methyl- N-phenylhydra\xad\nzine)sulfate  423-170-1  618-26-8  Flam. Liq. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H225 \nH372** \nH302 \nH318 \nH317 \nH400 \nH410  GHS02 \nGHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H225 \nH372** \nH302 \nH318 \nH317 \nH410  \n612-170-00-9  4-chlorophenyl cyclopropyl \nketone  O-(4-aminobenzyl)oxime  405-260-2  —  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n612-171-00-4  N,N,N',N'-tetraglycidyl-4,4'- \ndiamino-3,3'-diethyldiphenylme\xad\nthane  410-060-3  130728-76-6  Muta. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H341 \nH317 \nH411  GHS08 \nGHS09 \nWng  H341 \nH317 \nH411  \n612-172-00-X  4,4'-methylenebis( N,N'-dimethyl\xad\ncyclohexanamine  412-840-9  13474-64-1  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1A \nAquatic Chronic 3  H302 \nH373 ** \nH314 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH373 ** \nH314 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1013}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1015\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-173-00-5  lithium 1-amino-4-(4-tert-butyla\xad\nnilino)anthraquinone-2-sulfonate  411-140-0  125328-86-1  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n612-174-00-0  4,4-dimethoxybutylamine  407-690-6  19060-15-2  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH314 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH314 \nH317 \nH412  \n612-175-00-6  2-( O-aminooxy)ethylamine dihy\xad\ndrochloride  412-310-7  37866-45-8  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n612-176-00-1  polymer of 1,3-dibromopropane \nand N,N-diethyl- N',N'-dimethyl- \n1,3-propanediamine  410-570-6  143747-73-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n612-177-00-7  2-naphthylamino-6-sulfomethyl\xad\namide  412-120-4  104295-55-8  STOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H373 ** \nH317 \nH411  GHS08 \nGHS09 \nWng  H373 ** \nH317 \nH411  \n612-178-00-2  1,4,7,10-tetraazacyclododecane \ndisulfate  412-080-8  112193-77-8  Acute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH335 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH335 \nH318 \nH412  \n612-179-00-8  1-(2-propenyl)pyridinium \nchloride  412-740-5  25965-81-5  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n612-180-00-3  3-aminobenzylamine  412-230-2  4403-70-7  Acute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 2  H302 \nH314 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1014}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1016\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-181-00-9  2-phenylthioaniline  413-030-8  1134-94-7  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n612-182-00-4  1-ethyl-1-methylmorpholinium \nbromide  418-210-1  65756-41-4  Muta. 2  H341  GHS08 \nWng  H341  \n612-183-00-X  1-ethyl-1-methylpyrrolidinium \nbromide  418-200-5  69227-51-6  Muta. 2  H341  GHS08 \nWng  H341  \n612-184-00-5  6'-(dibutylamino)-3'-methyl-2'- \n(phenylamino)spiro[isobenzo\xad\nfuran-1(3 H),9-(9 H)-xanthen]-3- \none 403-830-5  89331-94-2  Aquatic Chronic 3  H412  —  H412  \n612-185-00-0  1-[3-[4-((heptadecafluorono\xad\nnyl)oxy)-benzamido]propyl]- N, \nN,N-trimethylammonium iodide  407-400-8  59493-72-0  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n612-186-00-6  bis( N-(7-hydroxy-8-methyl-5- \nphenylphenazin-3-ylidene)di\xad\nmethylammonium) sulfate  406-770-8  149057-64-7  STOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH318 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H373 ** \nH318 \nH317 \nH410  \n612-187-00-1  2,3,4-trifluoroaniline  407-170-9  3862-73-5  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H312 \nH302 \nH373 ** \nH315 \nH318 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH373 ** \nH315 \nH318 \nH411  \n612-188-00-7  4,4'-(9 H-fluoren-9-ylidene)bis(2- \nchloroaniline)  407-560-9  107934-68-9  Aquatic Chronic 2  H411  GHS09  H411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1015}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1017\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-189-00-2  4-amino-2-(aminomethyl)phenol \ndihydrochloride  412-510-4  135043-64-0  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n612-190-00-8  4,4'-methylenebis(2-isopropyl-6- \nmethylaniline)  415-150-6  16298-38-7  STOT RE 2 * \nAquatic Chronic 2  H373 ** \nH411  GHS08 \nGHS09 \nWng  H373 ** \nH411  \n612-191-00-3  polymer of allylamine hydro\xad\nchloride  415-050-2  71550-12-4  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n612-192-00-9  2-isopropyl-4-( N-methyl)amino\xad\nmethylthiazole  414-800-6  154212-60-9  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H312 \nH302 \nH315 \nH318 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH315 \nH318 \nH411  \n612-193-00-4  3-methylaminomethylpheny\xad\nlamine  414-570-7  18759-96-1  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH314 \nH317 \nH410  \n612-194-00-X  2-hydroxy-3-[(2-hydroxyethyl)- \n[2-(1-oxotetrade\xad\ncyl)amino]ethyl]amino]- N,N,N- \ntrimethyl-1-propanammonium \nchloride  414-670-0  141890-30-4  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH410  \n612-195-00-5  bis[tributyl 4-(methylbenzyl)am\xad\nmonium] 1,5-naphthalenedis\xad\nulfonate  415-210-1  160236-81-7  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H332 \nH302 \nH318 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1016}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1018\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-196-00-0  4-chloro-o-toluidine; [1] \n4-chloro-o-toluidine hydro\xad\nchloride [2]  202-441-6[1] \n221-627-8[2]  95-69-2[1] \n3165-93-3[2]  Carc. 1B \nMuta. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH341 \nH331 \nH311 \nH301 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH341 \nH331 \nH311 \nH301 \nH410  \n612-197-00-6  2,4,5-trimethylaniline; [1] \n2,4,5-trimethylaniline hydro\xad\nchloride [2]  205-282-0[1]- \n[2] 137-17-7 [1] \n21436-97-5[2]  Carc. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H350 \nH331 \nH311 \nH301 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH331 \nH311 \nH301 \nH411  \n612-198-00-1  4,4'-thiodianiline and its salts  205-370-9  139-65-1  Carc. 1B \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH411  \n612-199-00-7  4,4'-oxydianiline and its salts;  \np-aminophenyl ether  202-977-0  101-80-4  Carc. 1B Muta. \n1B Repr. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 2  H350 \nH340 \nH361f *** \nH331 \nH311 \nH301 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H350 \nH340 \nH361f *** \nH331 \nH311 \nH301 \nH411  \n612-200-00-0  2,4-diaminoanisole; \n4-methoxy- m-phenylenediamine; \n[1] \n2,4-diaminoanisole sulphate [2]  210-406-1 [1] \n254-323-9 [2]  615-05-4 [1] \n39156-41-7 [2]  Carc. 1B Muta. 2 \nAcute Tox. 4 * \nAquatic Chronic 2  H350 \nH341 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH341 \nH302 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1017}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1019\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-201-00-6  N,N,N',N'-tetramethyl-4,4'- \nmethylendianiline  202-959-2  101-61-1  Carc. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH410  \n612-202-00-1  3,4-dichloroaniline  202-448-4  95-76-1  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH311 \nH301 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H331 \nH311 \nH301 \nH318 \nH317 \nH410  \n612-203-00-7  C  8-10 alkyl dimethyl hydro\xad\nxyethyl ammoniumchloride \n(chain < C  8: <3 %, chain = C  8: \n15 %-70 %, chain = C  10: 30 %- \n85 %, chain > C  10: <3 %)  417-360-3  —  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2  H312 \nH302 \nH315  GHS07 \nWng  H312 \nH302 \nH315  \n612-204-00-2  C.I. Basic Violet 3; \n4-[4,4'-bis(dimethylamino) benz\xad\nhydrylidene]cyclohexa-2,5-dien- \n1-ylidene]dimethylammonium \nchloride  208-953-6  548-62-9  Carc. 2 \nAcute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H351 \nH302 \nH318 \nH410  \n612-205-00-8  C.I. Basic Violet 3 with ≥ 0,1 % \nof Michler's ketone (EC no.202- \n027-5)  208-953-6  548-62-9  Carc. 1B \nAcute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH302 \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H350 \nH302 \nH318 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1018}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1020\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-206-00-3  famoxadone (ISO); \n3-anilino-5-methyl-5-(4-phenoxy\xad\nphenyl)-1,3-oxazolidine-2,4- \ndione  — 131807-57-3  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH400 \nH410  GHS08 \nGHS09 \nWng  H373 ** \nH410  \n612-207-00-9  4-ethoxyaniline;  \np-phenetidine  205-855-5  156-43-4  Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1  H341 \nH332 \nH312 \nH302 \nH319 \nH317  GHS08 \nGHS07 \nWng  H341 \nH332 \nH312 \nH302 \nH319 \nH317  \n612-208-00-4  N-methylbenzene-1,2-diam\xad\nmonium hydrogen phosphate  424-460-0  —  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n612-209-00-X  6-methoxy- m-toluidine;  \np-cresidine  204-419-1  120-71-8  Carc. 1B \nAcute Tox. 4 *  H350 \nH302  GHS08 \nGHS07 \nDgr H350 \nH302  \n612-210-00-5  5-nitro- o-toluidine; [1] \n5-nitro- o-toluidine hydrochloride \n[2] 202-765-8 [1] \n256-960-8 [2]  99-55-8 [1] \n51085-52-0 [2]  Carc. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nAquatic Chronic 3  H351 \nH331 \nH311 \nH301 \nH412  GHS06 \nGHS08 \nDgr H351 \nH331 \nH311 \nH301 \nH412  \n612-211-00-0  N-[(benzotriazole-1-yl)methyl)]4- \ncarboxy-benzenesulfonamide  416-470-9  170292-97-4  Eye Irrit. 2 \nAquatic Chronic 2  H319 \nH411  GHS07 \nGHS09 \nWng  H319 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1019}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1021\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-212-00-6  2,6-dichloro-4-trifluoromethyl\xad\naniline  416-430-0  24279-39-8  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH302 \nH315 \nH317 \nH410  \n612-213-00-1  isobutylidene-(2-(2-isopropyl- \n4,4-dimethyloxazolidine-3-yl)- \n1,1-dimethylethyl)amine  419-850-2  148348-13-4  Skin Corr. 1B \nAquatic Chronic 3  H314 \nH412  GHS05 \nDgr H314 \nH412  \n612-214-00-7  4-(2,2-diphenylethenyl)- N,N-di- \nphenylbenzenamine  421-390-2  89114-90-9  Aquatic Chronic 4  H413  —  H413  \n612-215-00-2  3-chloro-2-(isopropylthio)aniline  421-700-6  179104-32-6  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n612-216-00-8  1-amino-1-cyanamino-2,2-dicya\xad\nnoethylene, sodium salt  425-870-2  19450-38-5  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n612-217-00-3  1-methoxy-2-propylamine  422-550-4  37143-54-7  Flam. Liq. 2 \nSkin Corr. 1B \nAcute Tox. 4 * \nAquatic Chronic 3  H225 \nH314 \nH302 \nH412  GHS02 \nGHS05 \nGHS07 \nDgr H225 \nH314 \nH302 \nH412  \n612-219-00-4  (2-hydroxy-3-(3,4-dimethyl-9- \noxo-10-thiaanthracen-2- \nyloxy)propyl)trimethylam\xad\nmonium chloride  402-200-7  —  Aquatic Chronic 3  H412  —  H412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1020}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1022\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-220-00-X  N-nitro- N-(3-methyl-3,6-dihydro- \n2H-1,3,5-oxadiazin-4-yl)amine  431-060-1  153719-38-1  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH317 \nH412  GHS07 \nWng  H302 \nH317 \nH412  \n612-221-00-5  2-amino-4-(trifluoromethyl)ben\xad\nzenethiol hydrochloride  429-560-8  4274-38-8  Skin Corr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1  H314 \nH332 \nH312 \nH302 \nH373** \nH317 \nH400  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H314 \nH332 \nH312 \nH302 \nH373** \nH317 \nH400  \n612-222-00-0  cis -1-(3-(4-fluorophen\xad\noxy)propyl)-3-methoxy-4- \npiperidinamine  425-080-8  104860-26-6  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH373** \nH318 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH373** \nH318 \nH410  \n612-223-00-6  N-benzyl- N-ethyl-(4-(5-nitro- \nbenzo[ c]isothiazol-3-ylazo)phe\xad\nnyl)amine  425-300-2  186450-73-7  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n612-224-00-1  N2,N4,N6-tris{4-[(1,4-dimethyl\xad\npentyl)amino]phenyl}-1,3,5- \ntriazine-2,4,6-triamine  426-150-0  121246-28-4  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n612-225-00-7  1,4,7,10-tetraazacyclododecane  425-450-9  294-90-6  Skin Corr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH312 \nH302 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH312 \nH302 \nH410  \n612-226-00-2  3-(2'-phenoxyethoxy)propy\xad\nlamine  427-870-8  6903-18-0  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH315 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1021}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1023\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-227-00-8  benzyl- N-(2-(2-methoxyphen\xad\noxy)ethyl)amine hydrochloride  428-290-8  120606-08-8  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH410  \n612-228-00-3  reaction mass of:  N-(3-(trimetho\xad\nxysilyl)propyl)ethylenediamine;  \nN-benzyl- N-(3-(trimethoxys\xad\nilyl)propyl)ethylenediamine;  N - \nbenzyl- N'-[3-(trimethoxys\xad\nilyl)propyl]ethylenediamine;  \nN, N' -bis-benzyl- N'-[3-(trimetho\xad\nxysilyl)propyl]ethylenediamine;  \nN, N,N' -tris-benzyl- N'-[3-(trime\xad\nthoxysilyl)propyl]ethylene\xad\ndiamine;  \nN, N -bis-benzyl- N'-[3-(trimetho\xad\nxysilyl)propyl]ethylenediamine  414-340-6  —  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT SE 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H226 \nH332 \nH312 \nH302 \nH371 \nH318 \nH317 \nH412  GHS02 \nGHS05 \nGHS08 \nGHS07 \nDgr H226 \nH332 \nH312 \nH302 \nH371 \nH318 \nH317 \nH412  \n612-229-00-9  mepanipyrim; \n4-methyl- N-phenyl-6-(1- \npropynyl)-2-pyrimidinamine  — 110235-47-7  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n612-230-00-4  N,N-bis(cocoyl-2-oxypropyl)-  \nN,N-dibutylammonium bromide  431-530-4  —  Skin Corr. 1A \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH410  \n612-231-00-X  3-((C  12-18)-acylamino)- N-(2-((2- \nhydroxyethyl)amino)-2- \noxoethyl)- N,N-dimethyl-1- \npropanaminium chloride  427-370-1  164288-56-6  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1022}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1024\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-232-00-5  reaction mass of: triisopropan\xad\nolamine salt of 1-amino-4-(3- \npropionamidoanilino)anthra\xad\nquinone-2-sulfonic acid; trii\xad\nsopropanolamine salt of 1- \namino-4-[3,4-dimethyl-5-(2- \nhydroxyethylaminosulfo\xad\nnyl)anilino]anthraquinone-2- \nsulfonic acid  430-410-9  186148-38-9  Aquatic Chronic 3  H412  —  H412  \n612-237-00-2  hydroxylammonium hydrogen\xad\nsulfate; \nhydroxylamine sulfate(1:1); [1] \nhydroxylamine phosphate; [2] \nhydroxylamine dihydrogenphos \nphate; [3] hydroxylamine 4- \nmethylben \nzenesulfonate [4]  233-154-4 [1] \n244-077-0 [2] \n242-818-2 [3] \n258-872-5 [4]  10046-00-1 [1] \n20845-01-6 [2] \n19098-16-9 [3] \n53933-48-5 [4]  Expl. 1.1 \nCarc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H201 \nH351 \nH312 \nH302 \nH373** \nH319 \nH315 \nH317 \nH400  GHS01 \nGHS08 \nGHS07 \nGHS09 \nDgr H201 \nH351 \nH312 \nH302 \nH373** \nH319 \nH315 \nH317 \nH400  T \n612-238-00-8  (3-chloro-2-hydroxypropyl) \ntrimethylammonium chloride \n…% 222-048-3  3327-22-8  Carc. 2 \nAquatic Chronic 3  H351 \nH412  GHS08 \nWng  H351 \nH412  B \n612-239-00-3  biphenyl-3,3', 4,4'-tetrayltet\xad\nraamine; \ndiaminobenzidine  202-110-6  91-95-2  Carc. 1B Muta. 2  H350 \nH341  GHS08 \nDgr H350 \nH341  \n612-240-00-9  pyrimethanil (ISO);  \nN-(4,6-dimethylpyrimidin-2- \nyl)aniline  — 53112-28-0  Aquatic Chronic 2  H411  GHS09  H411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1023}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1025\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-241-00-4  piperazine hydrochloride; [1] \npiperazine dihydrochloride; [2] \npiperazine phosphate [3]  228-042-7 [1] \n205-551-2 [2] \n217-775-8 [3]  6094-40-2 [1] \n142-64-3 [2] \n1951-97-9 [3]  Repr. 2 \nEye Irrit. 2 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H361fd \nH319 \nH315 \nH334 \nH317 \nH412  GHS08 \nDgr H361fd \nH319 \nH315 \nH334 \nH317 \nH412  \n612-242-00-X  cyprodinil (ISO); \n4-cyclopropyl-6-methyl- N- \nphenylpyrimidin-2-amine  — 121552-61-2  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M=10  \n612-243-00-5  ( 1 S-cis )-4-(3,4-dichlorophenyl)- \n1,2,3,4-tetrahydro- N-methyl-1- \nnaphthalenamine 2-hydroxy-2- \nphenylacetate  420-560-3  79617-97-3  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  M=10  \n612-244-00-0  3-(piperazin-1-yl)-benzo[d]iso\xad\nthiazole hydrochloride  421-310-6  87691-88-1  Repr. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f*** \nH302 \nH319 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361f*** \nH302 \nH319 \nH317 \nH410  \n612-245-00-6  2-ethylphenylhydrazine hydro\xad\nchloride  421-460-2  19398-06-2  Carc. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH372** \nH302 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H351 \nH372** \nH302 \nH318 \nH317 \nH410  M=10  \n612-246-00-1  (2-chloroethyl)(3-hydroxypro\xad\npyl)ammonium chloride  429-740-6  40722-80-3  Carc. 1B \nMuta. 1B \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 3  H350 \nH340 \nH373** \nH317 \nH412  GHS08 \nGHS07 \nDgr H350 \nH340 \nH373** \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1024}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1026\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-247-00-7  N-[3-(1,1-dimethylethyl)-1 H- \npyrazol-5-yl]- N'-hydroxy-4-nitro\xad\nbenzenecarboximidamide  423-530-8  152828-23-4  STOT RE 1 \nAcute Tox. 4 * \nAquatic Chronic 3  H372** H302 \nH412  GHS08 \nGHS07 \nDgr H372** \nH302 \nH412  \n612-248-00-2  reaction product of dipheny\xad\nlamine, phenothiazine, and \nalkenes, branched (C  8-10, C  9- \nrich)  439-540-0  —  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H315 \nH317 \nH413  GHS07 \nWng  H315 \nH317 \nH413  \n612-249-00-8  4-[(3-chlorophenyl)(1 H-imidazol- \n1-yl)methyl]-1,2-benzenediamine \ndihydrochloride  425-030-5  159939-85-2  Repr. 2 \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H361f*** \nH302 \nH314 \nH317 \nH411  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H361f*** \nH302 \nH314 \nH317 \nH411  \n612-250-00-3  chloro- N, N -dimethylform\xad\niminium chloride  425-970-6  3724-43-4  Repr. 1B \nAcute Tox. 4 * \nSkin Corr. 1A  H360D*** \nH302 \nH314  GHS05 \nGHS08 \nGHS07 \nDgr H360D*** \nH302 \nH314  EUH014  \n612-251-00-9  cis -1-(3-chloroallyl)-3,5,7-triaza- \n1-azoniaadamantane chloride  426-020-3  51229-78-8  Flam. Sol. 2 \nRepr. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H228 \nH361d*** \nH302 \nH315 \nH317 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nWng  H228 \nH361d*** \nH302 \nH315 \nH317 \nH411  \n612-252-00-4  imidacloprid (ISO); \n1-(6-chloropyridin-3-ylmethyl)-  \nN-nitroimidazolidin-2-ylide\xad\nnamine  428-040-8  138261-41-3  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n612-253-00-X  7-methoxy-6-(3-morpholin-4-yl- \npropoxy)-3 H-quinazolin-4-one; \n[containing < 0,5 % formamide \n(EC No 200-842-0)]  429-400-7  199327-61-2  Aquatic Chronic 3  H412  —  H412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1025}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1027\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-253-01-7  7-methoxy-6-(3-morpholin-4-yl- \npropoxy)-3 H-quinazolin-4-one; \n[containing ≥ 0,5 % formamide \n(EC No 200-842-0)]  429-400-7  199327-61-2  Repr. 1B \nAquatic Chronic 3  H360D*** \nH412  GHS08 \nDgr H360D*** \nH412  \n612-254-00-5  reaction products of diisopropan\xad\nolamine with formaldehyde (1:4)  432-440-8  220444-73-5  Carc. 2 \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H351 \nH302 \nH314 \nH317 \nH411  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H351 \nH302 \nH314 \nH317 \nH411  \n612-255-00-0  1-(3-methoxypropyl)-4-piperidi\xad\nnamine  431-950-8  179474-79-4  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Chronic 3  H312 \nH302 \nH314 \nH412  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314 \nH412  \n612-256-00-6  benzyl( S)-2-[(2'-cyanobiphenyl- \n4-ylmethyl)pentanoylamino]-3- \nmethylbutyrate  427-470-3  137864-22-3  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n612-257-00-1  tripropylammonium dihydro\xad\ngenphosphate  433-700-3  35687-90-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n612-259-00-2  N-ethyl-3-trimethoxysilyl-2- \nmethyl-propanamine  437-720-3  227085-51-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n612-261-00-3  3,5-dichloro-2-fluoro-4- \n(1,1,2,3,3,3-hexafluoropro\xad\npoxy)aniline  441-190-9  121451-05-6  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  M=10  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1026}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1028\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-265-00-5  bis(2-hydroxyethyl)-(2-hydroxy\xad\npropyl)ammonium acetate  444-360-0  191617-13-7  Aquatic Chronic 3  H412  —  H412  \n612-266-00-0  3-chloro-4-(3-fluorobenzy\xad\nloxy)aniline  445-590-4  202197-26-0  Muta. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH302 \nH373** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH302 \nH373** \nH410  \n612-267-00-6  bis(hydrogenated tallow C  16-18- \nalkyl)hydroxylamine  418-370-0  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n612-269-00-7  reaction mass of: 1-[di(4-octylp\xad\nhenyl)aminomethyl]-5-methyl- \n1H-benzotriazole; \n1-[di(4-octylphenyl)amino\xad\nmethyl]-4-methyl-1 H-benzo\xad\ntriazole; \nreaction mass of:  N-[(5-methyl- \n1H-benzotriazol-1-yl)methyl]-4- \noctyl- N-(4-octylphenyl)aniline;  \nN-[(4-methyl-1 H-benzotriazol- \n1yl)methyl]-4-octyl- N-(4-octylp\xad\nhenyl)aniline  420-720-2  —  Aquatic Chronic 4  H413  —  H413  \n612-270-00-2  (S)-azetidine-2-carboxylic acid \n4-cyanobenzylamide hydro\xad\nchloride  433-010-2  —  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH317 \nH412  GHS07 \nWng  H302 \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1027}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1029\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-271-00-8  reaction mass of: ethyl 2-((4- \n(5,6-dichlorobenzothiazol-2- \nylazo)phenyl)ethylamino)ben\xad\nzoate; \nethyl 2-((4-(6,7-dichlorobenzo\xad\nthiazol-2-ylazo)phenyl)ethy\xad\nlamino)benzoate  434-970-5  160987-57-5  Aquatic Chronic 4  H413  —  H413  \n612-272-00-3  ammonium (η-6-2-(2-(1,2-dicar\xad\nboxylatoethylamino)ethy\xad\nlamino)butane-1,4- \ndioato(4))iron(3+) monohydrate  435-210-5  —  Aquatic Chronic 2  H411  GHS09  H411  \n612-273-00-9  alkyl(rapeseed oil), bis(2-hydro\xad\nxyethyl)ammonium fluoride  435-650-8  —  Acute Tox. 4 * \nSkin Corr. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH410  \n612-274-00-4  (R, S )-1-[2-amino-1(4-methoxyp\xad\nhenyl)ethyl]cyclohexanol acetate  445-750-3  —  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317 \nH412  \n612-275-00-X  fatty acids, C  18-unsatd., dimers, \nreaction products with 1-piperazi\xad\nneethanamine and tall oil  447-880-6  206565-89-1  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  M=10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1028}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1030\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-276-00-5  1-amino-4-[(4-amino-2-sulfofe\xad\nnyl)amino]-9,10-dihydro-9,10- \ndioxo-2-anthracenesulfonic acid, \ndisodium salt, reaction products \nwith 2-[[3-[(4,6-dichloro-1,3,5- \ntriazin-2-yl)ethylamino]phe\xad\nnyl]sulfonyl]ethyl hydrogen \nsulfate, sodium salts  451-430-4  500717-36-2  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  \n612-277-00-0  reaction mass of: 4-amino-3-(4- \nethenesulfonyl-2-sulfonatopheny\xad\nlazo)-5-hydroxy-6-(5-{4-chloro- \n6-[4-(2-sulfonatooxyethanesulfo\xad\nnyl)phenylamino]-1,3,5-triazin-2- \nylamino}-2-sulfonatopheny\xad\nlazo)naphthalene-2,7-disulfonate \npotassium/sodium; \n4-amino-5-hydroxy-6-(5-{4- \nchloro-6-[4-(2-sulfonatooxye\xad\nthanesulfonyl)phenylamino]1,3,5- \ntriazin-2-ylamino}-2-sulfonatop\xad\nhenylazo)-3-(2-sulfonato-4-(2- \nsulfonatooxyethanesulfo\xad\nnyl)phenylazo)naphthalene-2,7- \ndisulfonate potassium/sodium  451-440-9  586372-44-3  Eye Dam. 1  H318  GHS05 \nDgr H318  \n612-278-00-6  ethidium bromide; \n3,8-diamino-1-ethyl-6-phenylp\xad\nhenantridinium bromide  214-984-6  1239-45-8  Muta. 2 \nAcute Tox. 2 * \nAcute Tox. 4 *  H341 \nH330 \nH302  GHS06 \nGHS08 \nDgr H341 \nH330 \nH302  \n612-279-00-1  (R, S )-2-amino-3,3-dimethyl\xad\nbutane amide  447-860-7  144177-62-8  Repr. 2 \nSTOT RE 2 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H361f*** \nH373** H319 \nH315 \nH317  GHS08 \nGHS07 \nWng  H361f*** \nH373** \nH319 \nH315 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1029}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1031\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-280-00-7  3-amino-9-ethyl carbazole; \n9-ethylcarbazol-3-ylamine  205-057-7  132-32-1  Carc. 1B  H350  GHS08 \nDgr H350  \n612-281-00-2  leucomalachite green;  N, N,N',N' - \ntetramethyl-4,4'-benzylidenedia\xad\nniline  204-961-9  129-73-7  Carc. 2 \nMuta. 2  H351 \nH341  GHS08 \nWng  H351 \nH341  \n612-282-00-8  octadecylamine  204-695-3  124-30-1  Asp. Tox. 1 \nSTOT RE 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H304 \nH373 (gas\xad\ntrointestinal \ntract, liver, \nimmune \nsystem) \nH315 \nH318 \nH400 \nH410  GHS05 \nGHS08 \nGHS09 \nDgr H304 \nH373 (gas\xad\ntrointestinal \ntract, liver, \nimmune \nsystem) \nH315 \nH318 \nH410  M = 10 \nM = 10  \n612-283-00-3  (Z )-octadec-9-enylamine  204-015-5  112-90-3  Acute Tox. 4 \nAsp Tox. 1 \nSTOT SE 3 \nSTOT RE 2 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH304 \nH335 \nH373 (gastro- \nintestinal tract, \nliver, immune \nsystem) \nH314 \nH400 \nH410  GHS05 \nGHS07 \nGHS08 \nGHS09 \nDgr H302 \nH304 \nH335 \nH373 \n(gastro- \nintestinal \ntract, liver, \nimmune \nsystem) \nH314 \nH410  M = 10 \nM = 10  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1030}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1032\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-284-00-9  amines, hydrogenated tallow \nalkyl  262-976-6  61788-45-2  Asp Tox. 1 \nSTOT RE 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H304 \nH373 (gastro- \nintestinal tract, \nliver, immune \nsystem) \nH315 \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H304 \nH373 \n(gastro- \nintestinal \ntract, liver, \nimmune \nsystem) \nH315 \nH318 \nH410  M = 10 \nM = 10  \n612-285-00-4  amines, coco alkyl  262-977-1  61788-46-3  Acute Tox. 4 \nAsp. Tox. 1 \nSTOT SE 3 \nSTOT RE 2 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH304 \nH335 \nH373 (gastro- \nintestinal tract, \nliver, immune \nsystem) \nH314 \nH400 \nH410  GHS05 \nGHS07 \nGHS08 \nGHS09 \nDgr H302 \nH304 \nH335 \nH373 \n(gastro- \nintestinal \ntract, liver, \nimmune \nsystem) \nH314 \nH410  M = 10 \nM = 10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1031}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1033\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n612-286-00-X  amines, tallow alkyl  263-125-1  61790-33-8  Acute Tox. 4 \nAsp. Tox. 1 \nSTOT RE 2 \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH304 \nH373 (gastro- \nintestinal tract, \nliver, immune \nsystem) \nH314 \nH400 \nH410  GHS05 \nGHS07 \nGHS08 \nGHS09 \nDgr H302 \nH304 \nH373 \n(gastro- \nintestinal \ntract, liver, \nimmune \nsystem) \nH314 \nH410  M = 10 \nM = 10  \n612-287-00-5  fluazinam (ISO); 3-chloro- N-[3- \nchloro-2,6-dinitro-4-(trifluor \nomethyl)phenyl]-5-(trifluor\xad\nomethyl)pyridin-2-amine  — 79622-59-6  Repr. 2 \nAcute Tox. 4 \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH332 \nH318 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS05 \nGHS09 \nDgr H361d \nH332 \nH318 \nH317 \nH410  M = 10 \nM = 10  \n▼M13  \n612-288-00-0  bupirimate (ISO); \n5-butyl-2-ethylamino-6-methyl\xad\npyrimidin-4-yl dimethylsul\xad\nphamate  255-391-2  41483-43-6  Carc. 2 \nSkin Sens. 1B \nAquatic Chronic 1  H351 \nH317 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH317 \nH410  M = 1  \n612-289-00-6  triflumizole (ISO); \n(1E)-N-[4-chloro-2-(trifluor\xad\nomethyl)phenyl]-1-(1 H-imidazol- \n1-yl)-2-propoxyethanimine  — 68694-11-1  Repr. 1B \nAcute Tox. 4 \nSTOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH302 \nH373 (liver) \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360D \nH302 \nH373 (liver) \nH317 \nH410  M = 1 \nM = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1032}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1034\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M15  \n612-290-00-1  reaction products of paraformal\xad\ndehyde and 2-hydroxypropy\xad\nlamine (ratio 3:2); \n[formaldehyde released from \n3,3′-methylenebis[5-methyl\xad\noxazolidine]; \nformaldehyde released from \noxazolidin]; \n[MBO]  — —  Carc. 1B \nMuta. 2 \nAcute Tox. 4 \nAcute Tox. 3 \nAcute Tox. 4 \nSTOT RE 2 \nSkin Corr. 1B \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Chronic 2  H350 \nH341 \nH332 \nH311 \nH302 \nH373 (gas\xad\ntrointestinal \ntract, \nrespiratory \ntract) \nH314 \nH318 \nH317 \nH411  GHS08 \nGHS06 \nGHS05 \nGHS09 \nDgr H350 \nH341 \nH332 \nH311 \nH302 \nH373 (gas\xad\ntrointestinal \ntract, \nrespiratory \ntract) \nH314 \nH317 \nH411  EUH071  8  \n9 \n612-291-00-7  reaction products of paraformal\xad\ndehyde with 2-hydroxypropy\xad\nlamine (ratio 1:1); \n[formaldehyde released from \nα,α,α-trimethyl-1,3,5-triazine- \n1,3,5(2H,4H,6H)-triethanol]; \n[HPT]  — —  Carc. 1B \nMuta. 2 \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT RE 2 \nSkin Corr. 1C \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Chronic 2  H350 \nH341 \nH332 \nH302 \nH373 (gas\xad\ntrointestinal \ntract, \nrespiratory \ntract) \nH314 \nH318 \nH317 \nH411  GHS08 \nGHS07 \nGHS05 \nGHS09 \nDgr H350 \nH341 \nH332 \nH302 \nH373 (gas\xad\ntrointestinal \ntract, \nrespiratory \ntract) \nH314 \nH317 \nH411  EUH071  8  \n9 \n612-292-00-2  methylhydrazine  200-471-4  60-34-4  Carc. 1B  H350  GHS08 \nDgr H350  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1033}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1035\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M18  \n612-293-00-8  reaction mass of 1-[2-(2-amino\xad\nbutoxy)ethoxy]but-2-ylamine and \n1-({[2-(2-aminobut\xad\noxy)ethoxy]methyl}propoxy)but- \n2-ylamine  447-920-2  -  Repr. 2 \nAcute Tox. 4 \nSkin Corr. 1B \nEye Dam. 1  H361f \nH302 \nH314 \nH318  GHS08 \nGHS07 \nGHS05 \nDgr H361f \nH302 \nH314  EUH071  \n▼M23  \n612-294-00-3  mecetronium etilsulfate;  \nN-ethyl- N,N-dimethylhexadecan- \n1-aminium ethyl sulfate; \nmecetronium ethyl sulphate; \n[MES]  221-106-5  3006-10-8  Skin Corr. 1 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H314 \nH410  EUH071  M = 100 \nM = 1000  \n▼M16  \n613-001-00-1  ethyleneimine; aziridine  205-793-9  151-56-4  Flam. Liq. 2 \nCarc. 1B \nMuta. 1B \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nSkin Corr. 1B \nAquatic Chronic 2  H225 \nH350 \nH340 \nH330 \nH310 \nH300 \nH314 \nH411  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H225 \nH350 \nH340 \nH330 \nH310 \nH300 \nH314 \nH411  D \n613-002-00-7  pyridine  203-809-9  110-86-1  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H225 \nH332 \nH312 \nH302  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302  * \n613-003-00-2  1,2,3,4-tetranitrocarbazole  —  6202-15-9  Expl. 1.1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 *  H201 \nH332 \nH312 \nH302  GHS01 \nGHS07 \nDgr H201 \nH332 \nH312 \nH302  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1034}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1036\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-004-00-8  crimidine (ISO);2-chloro-6- \nmethylpyrimidin-4- yldimethyl\xad\namine  208-622-6  535-89-7  Acute Tox. 2 *  H300  GHS06 \nDgr H300  \n613-007-00-4  desmetryne (ISO);6-isopropy\xad\nlamino-2-methylamino-4- \nmethylthio-1,3,5- triazine  213-800-1  1014-69-3  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  \n613-008-00-X  dazomet (ISO);tetrahydro-3,5- \ndimethyl-1,3,5- thiadiazine-2- \nthione  208-576-7  533-74-4  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH410  \n613-009-00-5  2,4,6-trichloro-1,3,5-triazine; \ncyanuric chloride  203-614-9  108-77-0  Acute Tox. 2 * \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1  H330 \nH302 \nH314 \nH317  GHS06 \nGHS05 \nDgr H330 \nH302 \nH314 \nH317  EUH014  STOT SE 3; H335: \nC ≥ 5 %  \n613-010-00-0  ametryn (ISO); N-ethyl- N'- \nisopropyl-6-(methyl-thio)-1,3,5- \ntriazine-2,4-diamine  212-634-7  834-12-8  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M = 100  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1035}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1037\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-011-00-6  amitrole (ISO);1,2,4-triazol-3- \nylamine  200-521-5  61-82-5  Repr. 2 \nSTOT RE 2 * \nAquatic Chronic 2  H361d *** \nH373 ** \nH411  GHS08 \nGHS09 \nWng  H361d *** \nH373 ** \nH411  \n613-012-00-1  bentazone (ISO);3-isopropyl- \n2,1,3-benzothiadiazine-4-one-2,2- \ndioxide  246-585-8  25057-89-0  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH319 \nH317 \nH412  GHS07 \nWng  H302 \nH319 \nH317 \nH412  \n613-013-00-7  cyanazine (ISO);2-(4-chloro-6- \nethylamino-1,3,5- triazine-2- \nylamino)-2-methylpropionitrile  244-544-9  21725-46-2  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-014-00-2  ethoxyquin (ISO); 6-ethoxy-1,2- \ndihydro-2,2,4-trimethylquinoline  202-075-7  91-53-2  Acute Tox. 4*  H302  GHS07 \nWng  H302  \n613-015-00-8  fenazaflor (ISO); phenyl 5,6- \ndichloro-2-trifluor-omethylbenzi\xad\nmidazole-1-carboxylate  238-134-9  14255-88-0  Acute Tox. 4* \nAcute Tox. 4* \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  \n613-016-00-3  fuberidazole (ISO);2-(2-furyl- \n)-1H-benzimidazole  223-404-0  3878-19-1  Carc. 2 \nAcute Tox. 4 \nSTOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH373 (heart) \nH317 \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nWng  H351 \nH302 \nH373 (heart) \nH317 \nH410  M = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1036}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1038\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-017-00-9  bis(8-hydroxyquinolinium) \nsulphate  205-137-1  134-31-6  Acute Tox. 4*  H302  GHS07 \nWng  H302  \n613-018-00-4  morfamquat (ISO); 1,1'-bis(3,5- \ndimethylmorpholinocarbonyl\xad\nmethyl)-4,4'-bipyridilium ion  7411-47-4  Acute Tox. 4* \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 3  H302 \nH319 \nH335 \nH315 \nH412  GHS07 \nWng  H302 \nH319 \nH335 \nH315 \nH412  \n613-019-00-X  thioquinox(ISO); 2-thio-1,3-dithi\xad\nolo(4,5,b)quinoxaline  202-272-8  93-75-4  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n613-020-00-5  tridemorph (ISO); 2,6-dimethyl- \n4-tridecylmorpholine  246-347-3  24602-86-6  Repr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H360D *** \nH332 \nH302 \nH315 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360D *** \nH332 \nH302 \nH315 \nH410  \n613-021-00-0  dithianon (ISO); 5,10-dihydro- \n5,10-dioxonaphtho(2,3-b)(1,4)di\xad\nthiazine-2,3- dicarbonitrile  222-098-6  3347-22-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-022-00-6  pyrethrins including cinerins, \nwith the exception of those \nspecified elsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  A ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1037}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1039\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-023-00-1  2-methyl-4-oxo-3-(penta-2,4- \ndienyl)cyclopent-2-enyl [1 R- \n[1α[S*(Z)],3β]]-chrysanthemate; \npyrethrin I  204-455-8  121-21-1  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  \n613-024-00-7  2-methyl-4-oxo-3-(penta-2,4- \ndienyl)cyclopent-2-enyl[1 R- \n[1α[S*(Z)](3β)]]-3-(3-methoxy-2- \nmethyl-3-oxoprop-1-enyl)-2,2- \ndimethylcyclopropanecar \nboxylate; pyrethrin II  204-462-6  121-29-9  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  \n613-025-00-2  cinerin I; 3-(but-2-enyl)-2- \nmethyl-4- oxocyclopent-2-enyl \n2,2-dimethyl-3-(2-methylprop-1- \nenyl)cyclopropanecarboxylate  246-948-0  25402-06-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-026-00-8  cinerin II; 3-(but-2-enyl)-2- \nmethyl-4- oxocyclopent-2-enyl \n2,2-dimethyl-3-(3-methoxy-2- \nmethyl-3-oxoprop-1-enyl)cyclo\xad\npropanecarboxylate  204-454-2  121-20-0  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-027-00-3  piperidine  203-813-0  110-89-4  Flam. Liq. 2 \nAcute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B  H225 \nH331 \nH311 \nH314  GHS02 \nGHS06 \nGHS05 \nDgr H225 \nH331 \nH311 \nH314  * ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1038}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1040\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-028-00-9  morpholine  203-815-1  110-91-8  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H226 \nH332 \nH312 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDg H226 \nH332 \nH312 \nH302 \nH314  \n613-029-00-4  dichloro-1,3,5-triazinetrione; \ndichloroisocyanuric acid  220-487-5  2782-57-2  Ox. Sol. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH302 \nH319 \nH335 \nH400 \nH410  GHS03 \nGHS07 \nGHS09 \nDgr H272 \nH302 \nH319 \nH335 \nH410  EUH031  T  \n613-030-00-X  troclosene potassium; [1] \ntroclosene sodium [2]  218-828-8 [1] \n220-767-7 [2]  2244-21-5 [1] \n2893-78-9 [2]  Ox. Sol. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH302 \nH319 \nH335 \nH400 \nH410  GHS03 \nGHS07 \nGHS09 \nDgr H272 \nH302 \nH319 \nH335 \nH410  EUH031  *  \nSTOT SE 3; \nH335: C ≥ 10 % \nEUH031: C ≥10 %  G \n613-030-01-7  troclosene sodium, dihydrate  220-767-7  51580-86-0  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH335 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH335 \nH410  EUH031  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1039}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1041\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-031-00-5  symclosene; trichloroisocyanuric \nacid; trichloro-1,3,5-triazinetrion  201-782-8  87-90-1  Ox. Sol. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H272 \nH302 \nH319 \nH335 \nH400 \nH410  GHS03 \nGHS07 \nGHS09 \nDgr H272 \nH302 \nH319 \nH335 \nH410  EUH031  \n613-032-00-0  methyl-2,3,5,6-tetrachloro-4- \npyridylsulphone;2,3,5,6- \ntetrachloro-4-(methylsulpho\xad\nnyl)pyridine  236-035-5  13108-52-6  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1  H312 \nH302 \nH319 \nH317  GHS07 \nWng  H312 \nH302 \nH319 \nH317  \n613-033-00-6  2-methylaziridine; propyle\xad\nneimine  200-878-7  75-55-8  Flam. Liq. 2 \nCarc. 1B \nAcute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nEye Dam. 1 \nAquatic Chronic 2  H225 \nH350 \nH330 \nH310 \nH300 \nH318 \nH411  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H225 \nH350 \nH330 \nH310 \nH300 \nH318 \nH411  Carc. 1B; \nH350: C ≥ 0,01 %  \n613-034-00-1  1,2-dimethylimidazole  217-101-2  1739-84-0  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1  H302 \nH315 \nH318  GHS05 \nGHS07 \nDgr H302 \nH315 \nH318  \n613-035-00-7  1-methylimidazole  210-484-7  616-47-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1B  H312 \nH302 \nH314  GHS05 \nGHS07 \nDgr H312 \nH302 \nH314  \n613-036-00-2  2-methylpyridine; 2-picoline  203-643-7  109-06-8  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3  H226 \nH332 \nH312 \nH302 \nH319 \nH335  GHS02 \nGHS07 \nWng  H226 \nH332 \nH312 \nH302 \nH319 \nH335  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1040}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1042\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-037-00-8  4-methylpyridine; 4-picoline  203-626-4  108-89-4  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H226 \nH311 \nH332 \nH302 \nH319 \nH335 \nH315  GHS02 \nGHS06 \nDgr H226 \nH311 \nH332 \nH302 \nH319 \nH335 \nH315  \n613-038-00-3  6-phenyl-1,3,5-triazine-2,4- \ndiyldiamine; 6-phenyl-1,3,5- \ntriazine-2,4-diamine; benzogua\xad\nnamine  202-095-6  91-76-9  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n613-039-00-9  ethylene thiourea; imidazolidine- \n2-thione; 2-imidazoline-2-thiol  202-506-9  96-45-7  Repr. 1B \nAcute Tox. 4 *  H360D *** \nH302  GHS08 \nGHS07 \nDgr H360D *** \nH302  \n613-040-00-4  azaconazole (ISO);1-{[2-(2,4- \ndichlorophenyl)-1,3- dioxolan-2- \nyl]methyl}-1 H-1,2.4- triazole  262-102-3  60207-31-0  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n613-041-00-X  morpholine-4-carbonyl chloride  239-213-0  15159-40-7  Carc. 2 \nEye Irrit. 2 \nSkin Irrit. 2  H351 \nH319 \nH315  GHS08 \nWng  H351 \nH319 \nH315  EUH014  \n▼M11  \n613-042-00-5  imazalil (ISO); 1-[2-(allyloxy)-2- \n(2,4-dichlorophenyl)ethyl]-1 H- \nimidazole  252-615-0  35554-44-0  Carc. 2 \nAcute Tox. 3 \nAcute Tox. 4 \nEye Dam. 1 \nAquatic Chronic 1  H351 \nH301 \nH332 \nH318 \nH410  GHS08 \nGHS06 \nGHS05 \nGHS09 \nDgr H351 \nH301 \nH332 \nH318 \nH410  M = 10  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1041}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1043\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n613-043-00-0  imazalil sulphate (ISO) powder; \n1-[2-(allyloxy)ethyl-2-(2,4- dich\xad\nlorophenyl)]-1 H-imid azolium \nhydrogen sulphate; [1](±)-1-[2- \n(allyloxy)ethyl-2-(2,4- dichlorop\xad\nhenyl)]-1 H-imid azolium \nhydrogen sulphate [2]  261-351-5 [1] \n281-291-3 [2]  58594-72-2 [1] \n83918-57-4 [2]  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n613-043-01-8  imazalil sulphate (ISO), aqueous \nsolution; 1-[2-(allyloxy)ethyl-2- \n(2,4- dichlorophenyl)]-1 H-imid\xad\nazolium hydrogen sulphate; [1] \n(±)-1-[2-(allyloxy)ethyl-2-(2,4- \ndichlorophenyl)]-1 H-imid \nazolium hydrogen sulphate [2]  261-351-5 [1] \n281-291-3 [2]  58594-72-2 [1] \n83918-57-4 [2]  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nWng  H302 \nH314 \nH317 \nH410  Skin Corr. 1B; \nH314: C ≥ 50 % \nSkin Irrit. 2; H315: \n30 % ≤ C < 50 % \nEye Dam. 1; H318: \n15 % ≤ C < 50 % \nEye Irrit. 2; H319: \n5 % ≤ C < 15 %  \n613-044-00-6  captan (ISO);1,2,3,6-tetrahydro-  \nN-(trichloromethyl\xad\nthio)phthalimide  205-087-0  133-06-2  Carc. 2 \nAcute Tox. 3 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H351 \nH331 \nH318 \nH317 \nH400  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H351 \nH331 \nH318 \nH317 \nH400  M=10  \n613-045-00-1  folpet (ISO); N-(trichloromethyl\xad\nthio)phthalimide  205-088-6  133-07-3  Carc. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H351 \nH332 \nH319 \nH317 \nH400  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH332 \nH319 \nH317 \nH400  M=10  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1042}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1044\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-046-00-7  captafol (ISO);1,2,3,6-tetrahydro-  \nN-(1,1,2,2- tetrachloroethylt\xad\nhio)phthalimide  219-363-3  2425-06-1  Carc. 1B Skin \nSens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H350 \nH317 \nH400 \nH410  GHS08 \nGHS09 \nDgr H350 \nH317 \nH410  \n613-047-00-2  1-dimethylcarbamoyl-5-methyl \npyrazol-3-yl dimethylcarbamate; \ndimetilan (ISO)  211-420-0  644-64-4  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH312 \nH410  \n613-048-00-8  carbendazim (ISO);methyl benzi\xad\nmidazol-2-ylcarbamate  234-232-0  10605-21-7  Muta. 1B Repr. \n1B \nAquatic Acute 1 \nAquatic Chronic 1  H340 \nH360FD H400 \nH410  GHS08 \nGHS09 \nDgr H340 \nH360FD \nH410  \n613-049-00-3  benomyl (ISO);methyl 1- \n(butylcarbamoyl)benzimidazol-2- \nylcarbamate  241-775-7  17804-35-2  Muta. 1B Repr. \n1B STOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H340 \nH360FD H335 \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H340 \nH360FD \nH335 \nH315 \nH317 \nH410  M = 10  \n613-050-00-9  carbadox (INN);methyl 3-(quin\xad\noxalin-2-ylmethylene)carbazate \n1,4-dioxide; 2-(methoxycarbonyl\xad\nhydrazonomethyl) quinoxaline \n1,4-dioxide  229-879-0  6804-07-5  Flam. Sol. 1 \nCarc. 1B \nAcute Tox. 4 *  H228 \nH350 \nH302  GHS02 \nGHS08 \nGHS07 \nDgr H228 \nH350 \nH302  T ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1043}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1045\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-051-00-4  molinate (ISO);S-ethyl 1- \nperhydroazepinecarbothioate; S- \nethyl perhydroazepine-1-carbo\xad\nthioate  218-661-0  2212-67-1  Carc. 2 \nRepr. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361f *** \nH332 \nH302 \nH373 ** H317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH361f *** \nH332 \nH302 \nH373 ** \nH317 \nH410  M = 100  \n613-052-00-X  trifenmorph (ISO);4-tritylmorp\xad\nholine  215-812-2  1420-06-0  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-053-00-5  anilazine (ISO);2-chloro- N-(4,6- \ndichloro-1,3,5- triazin-2-yl)aniline  202-910-5  101-05-3  Eye Irrit. 2 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH315 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH315 \nH410  \n▼M22  \n613-054-00-0  thiabendazole (ISO); \n2-(thiazol-4-yl)benzimidazole  205-725-8  148-79-8  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 1  \n▼M16  \n613-056-00-1  1,2-dimethyl-3,5-diphenylpyra \nzolium methylsulphate; difen\xad\nzoquat methyl sulfate  256-152-5  43222-48-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS09 \nWng  H302 \nH410  \n▼M11  \n613-057-00-7  dodemorph (ISO); 4-cyclo\xad\ndodecyl-2,6-dimethylmorpholine  216-474-9  1593-77-7  Repr. 2 \nSTOT RE 2 \nSkin Corr. 1C \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH373 (liver) \nH314 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H361d \nH373 (liver) \nH314 \nH317 \nH410  EUH071  M  =  1  \nM = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1044}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1046\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n613-058-00-2  permethrin (ISO); m-phenoxy\xad\nbenzyl 3-(2,2-dichorovinyl)-2,2- \ndimethylcyclopro panecar\xad\nboxylate  258-067-9  52645-53-1  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH302 \nH317 \nH410  M = 1 000  \n613-059-00-8  profluralin (ISO); N-(cyclopro\xad\npylmethyl)-α, α,α- trifluoro-2,6- \ndinitro- N-propyl- p-toluidine  247-656-6  26399-36-0  Eye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH410  \n613-060-00-3  resmethrin (ISO);5-benzyl-3- \nfurylmethyl (±)-cis-trans-chrysan\xad\nthemate  233-940-7  10453-86-8  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M=1000  \n613-061-00-9  6-(1α,5aβ,8aβ,9-pentahydroxy- \n7β-isopropyl-2β,5β,8β-trimethyl\xad\nperhydro-8bα,9-epoxy-5,8-etha\xad\nnocyclopenta[1,2-b]indenyl) \npyrrole-2-carboxylate; ryania  239-732-2  15662-33-6  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  \n613-062-00-4  sabadilla (ISO);veratrine  —  8051-02-3  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H319 \nH335 \nH315  GHS07 \nWng  H319 \nH335 \nH315  \n613-063-00-X  secbumeton (ISO);2-sec-buty\xad\nlamino-4-ethylamino-6-methoxy- \n1,3,5-triazine  247-554-1  26259-45-0  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH410  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1045}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1047\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-064-00-5  5-(3,6,9-trioxa-2-undecy \nloxy)benzo(d)-1,3-dioxolane; \nsesamex  — 51-14-9  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n613-065-00-0  simetryn (ISO);2,4-bis(ethy\xad\nlamino)-6- methylthio-1,3,5- \ntriazine  213-801-7  1014-70-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-066-00-6  terbumeton (ISO);2- tert-buty\xad\nlamino-4-ethylamino-6-methoxy- \n1,3,5-triazine  251-637-8  33693-04-8  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-067-00-1  propazine (ISO);2-chloro-4,6- \nbis(isopropylamino)-1,3,5- \ntriazine  205-359-9  139-40-2  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n613-068-00-7  atrazine (ISO);2-chloro-4-ethy\xad\nlamine-6- isopropylamine-1,3,5- \ntriazine  217-617-8  1912-24-9  STOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** H317 \nH400 \nH410  GHS08 \nGHS09 \nWng  H373 ** \nH317 \nH410  \n613-069-00-2  ε-caprolactam  203-313-2  105-60-2  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2  H332 \nH302 \nH319 \nH335 \nH315  GHS07 \nWng  H332 \nH302 \nH319 \nH335 \nH315  \n613-070-00-8  propylenethiourea  —  2122-19-2  Repr. 2 \nAcute Tox. 4 * \nAquatic Chronic 3  H361d *** \nH302 \nH412  GHS08 \nGHS07 \nWng  H361d *** \nH302 \nH412  \n613-071-00-3  2-fluoro-5-trifluoromethyl\xad\npyridine  400-290-2  69045-82-5  Flam. Liq. 3 \nSkin Sens. 1 \nAquatic Chronic 3  H226 \nH317 \nH412  GHS02 \nGHS07 \nWng  H226 \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1046}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1048\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-072-00-9  N, N -bis(2-ethylhexyl)-((1,2,4- \ntriazol-1-yl)methyl)amine  401-280-0  91273-04-0  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH411  \n613-073-00-4  N, N -dimethyl-2-(3-(4-chloro \nphenyl)-4,5-dihydropyrazol-1- \nylphenylsulphonyl)ethylamine  401-410-6  10357-99-0  STOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H373 ** H317 \nH411  GHS08 \nGHS09 \nWng  H373 ** \nH317 \nH411  \n613-074-00-X  3-(3-methylpent-3-yl)isoxazol-5- \nylamine  401-460-9  82560-06-3  Acute Tox. 3 * \nAcute Tox. 3 * \nEye Dam. 1 \nAquatic Chronic 3  H331 \nH301 \nH318 \nH412  GHS06 \nGHS05 \nDgr H331 \nH301 \nH318 \nH412  \n613-075-00-5  1,3-dichloro-5-ethyl-5-methyl\xad\nimidazolidine-2,4-dione  401-570-7  89415-87-2  Ox. Sol. 1 **** \nAcute Tox. 3 * \nSkin Corr. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1  H271 \nH331 \nH314 \nH302 \nH317 \nH400  GHS03 \nGHS06 \nGHS05 \nGHS09 \nDgr H271 \nH331 \nH314 \nH302 \nH317 \nH400  \n613-076-00-0  3-chloro-5-trifluoromethyl-2- \npyridylamine  401-670-0  79456-26-1  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n613-077-00-6  reaction mass of 5-heptyl-1,2,4- \ntriazol-3-ylamine and 5-nonyl- \n1,2,4-triazol-3-ylamine  401-940-8  —  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 2  H302 \nH319 \nH411  GHS07 \nGHS09 \nWng  H302 \nH319 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1047}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1049\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-078-00-1  N,N,N,N-tetrakis(4,6-bis(butyl- \n(N-methyl-2,2,6,6-tetramethyl \npiperidin-4-yl)amino)triazin-2- \nyl)-4,7-diazadecane-1,10- \ndiamine  401-990-0  106990-43-6  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n613-079-00-7  4-(1(or 4 or 5 or 6)-methyl- \n8,9,10-trinorborn-5-en-2- \nyl)pyridine, reaction mass of \nisomers  402-520-7  —  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH315 \nH317 \nH410  \n613-080-00-2  3-(bis(2-ethylhexyl)amino \nmethyl)benzothiazole-2(3 H)- \nthione  402-540-6  105254-85-1  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH410  \n613-081-00-8  1-butyl-2-methylpyridinium \nbromide  402-680-8  26576-84-1  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n613-082-00-3  2-methyl-1-pentylpyridinium \nbromide  402-690-2  —  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H312 \nH302 \nH412  GHS07 \nWng  H312 \nH302 \nH412  \n613-083-00-9  2-(4-(3-(4-chlorophenyl)-2-pyra \nzolin-1-yl)phenylsulfonyl)ethyldi\xad\nmethylammonium formate  402-120-2  —  Skin Corr. 1B \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH373 ** H317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H314 \nH373 ** \nH317 \nH410  \n613-084-00-4  2-(4-(3-(4-chlorophenyl)-4,5- \ndihydropyrazolyl)phenylsul\xad\nphonyl) ethyldimethylammonium \nhydrogen phosphonate  402-490-5  106359-93-7  Eye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1048}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1050\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-085-00-X  reaction mass of 1,1'-(methylene\xad\nbis(4,1-phenylene))dipyrrole-2,5- \ndione and N-(4-(4-(2,5-dioxo\xad\npyrrol-1-yl)benzyl)phe\xad\nnyl)acetamide and 1-(4-(4-(5- \noxo-2 H-2-furylide \nnamino)benzyl)phenyl)pyrrole- \n2,5-dione  401-970-1  —  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n613-086-00-5  caffeine  200-362-1  58-08-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n613-087-00-0  tetrahydrothiophene  203-728-9  110-01-0  Flam. Liq. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 3  H225 \nH332 \nH312 \nH302 \nH319 \nH315 \nH412  GHS02 \nGHS07 \nDgr H225 \nH332 \nH312 \nH302 \nH319 \nH315 \nH412  \n613-088-00-6  1,2-benzisothiazol-3(2 H)- \none;1,2-benzisothiazolin-3-one  220-120-9  2634-33-5  Acute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H302 \nH315 \nH318 \nH317 \nH400  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH315 \nH318 \nH317 \nH400  Skin Sens. 1; \nH317: C≥0,05 %  \n613-089-00-1  diquat dibromide; [1]diquat dich\xad\nloride; [2]6,7-dihydrodi\xad\npyrido[1,2-α:2',1'- c]pyrazine\xad\ndiylium dihydroxide [3]  201-579-4 [1] \n223-714-6 [2] \n301-467-6 [3]  85-00-7 [1] \n4032-26-2 [2] \n94021-76-8 [3]  Acute Tox. 2 * \nSTOT RE 1 \nAcute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH372 ** H302 \nH319 \nH335 \nH315 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH372 ** \nH302 \nH319 \nH335 \nH315 \nH317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1049}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1051\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-090-00-7  paraquat dichloride;1,1-dimethyl- \n4,4'-bipyridinium dichloride; \n[1]paraquat dimethylsulfate;1,1- \ndimethyl-4,4'-bipyridinium \ndimethyl sulphate [2]  217-615-7 [1] \n218-196-3 [2]  1910-42-5 [1] \n2074-50-2 [2]  Acute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH311 \nH301 \nH372 ** H319 \nH335 \nH315 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH311 \nH301 \nH372 ** \nH319 \nH335 \nH315 \nH410  \n613-091-00-2  morfamquat dichloride; [1]morf\xad\namquat sulfate [2]  225-062-8 [1] \n[2] 4636-83-3 [1] \n29873-36-7 [2]  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Chronic 3  H302 \nH319 \nH335 \nH315 \nH412  GHS07 \nWng  H302 \nH319 \nH335 \nH315 \nH412  \n613-092-00-8  1,10-phenanthroline  200-629-2  66-71-7  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  \n613-093-00-3  hexasodium 6,13-dichloro-3,10- \nbis((4-(2,5-disulfonatoanilino)-6- \nfluoro-1,3,5-triazin-2- \nylamino)prop-3-ylamino)-5,12- \ndioxa-7,14-diazapentacene-4,11- \ndisulfonate  400-050-7  85153-92-0  Resp. Sens. 1 \nSkin Sens. 1  H334 \nH317  GHS08 \nDgr H334 \nH317  \n613-094-00-9  4-methoxy- N,6-dimethyl-1,3,5- \ntriazin-2-ylamine  401-360-5  5248-39-5  Acute Tox. 4 * \nSTOT RE 2 *  H302 \nH373 **  GHS08 \nGHS07 \nWng  H302 \nH373 **  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1050}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1052\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-095-00-4  sodium 3-(2 H-benzotriazol-2- \nyl)-5- sec-butyl-4-hydroxyben \nzenesulfonate  403-080-9  92484-48-5  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-096-00-X  2-amino-6-ethoxy-4-methyl\xad\namino-1,3,5-triazine  403-580-7  62096-63-3  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n613-097-00-5  7-amino-3-((5-carboxymethyl-4- \nmethyl-1,3-thiazol-2- \nylthio)methyl)-8-oxo-5-thia-1- \nazabicyclo(4.2.0)oct-2-ene-2- \ncarboxylic acid  403-690-5  111298-82-9  Resp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H334 \nH317 \nH412  GHS08 \nDgr H334 \nH317 \nH412  \n613-098-00-0  N-(n-octyl)-2-pyrrolidone  403-700-8  2687-94-7  Skin Corr. 1B \nAquatic Chronic 2  H314 \nH411  GHS05 \nGHS09 \nDgr H314 \nH411  \n613-099-00-6  1-dodecyl-2-pyrrolidone  403-730-1  2687-96-9  Skin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH317 \nH410  \n613-100-00-X  2,9-bis(3-(diethylamino)pro\xad\npylsulfamoyl)quino(2,3-b)ac\xad\nridine-7,14-dione  404-230-6  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n613-101-00-5  N—tert-pentyl-2-benzothiazole\xad\nsulfenamide  404-380-2  110799-28-5  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n613-102-00-0  dimethomorph (ISO);4-(3-(4- \nchlorophenyl)-3-(3,4- dimetho\xad\nxyphenyl)acryloyl)morpholine  404-200-2  110488-70-5  Aquatic Chronic 2  H411  GHS09  H411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1051}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1053\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-103-00-6  sodium 5- n-butylbenzotriazole  404-450-2  118685-34-0  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH314 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH317 \nH411  \n613-104-00-1  5 - tert-butyl-3-isoxazolylamine \nhydrochloride  404-840-2  —  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH373 ** H318 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH373 ** \nH318 \nH412  \n613-105-00-7  hexakis(tetramethylammonium) \n4,4'-vinylenebis((3-sulfonato-4,1- \nphenylene)imino(6- morpholino- \n1,3,5-triazine-4,2- \ndiyl)imino)bis(5-hydroxy-6- \nphenylazonaphthalene-2,7- \ndisulfonate)  405-160-9  124537-30-0  Acute Tox. 3 * \nSkin Sens. 1 \nAquatic Chronic 3  H301 \nH317 \nH412  GHS06 \nDgr H301 \nH317 \nH412  \n613-106-00-2  tetrapotassium 2-(4-(5-(1-(2,5- \ndisulfonatophenyl)-3-ethoxycar \nbonyl-5-hydroxypyrazol-4- \nyl)penta-2,4-dienylidene)-3- \nethoxycarbonyl-5-oxo-2-pyra \nzolin-1-yl)benzene-1,4- \ndisulfonate  405-240-3  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n613-107-00-8  hexasodium 2,2'-vinylenebis((3- \nsulfonato-4,1-pheny \nlene)imino(6-( N-cyanoethyl- N-(2- \nhydroxypropyl)amino)-1,3,5- \ntriazine-4,2-diyl)imino)di\xad\nbenzene-1,4-disulfonate  405-280-1  76508-02-6  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n613-108-00-3  benzothiazole-2-thiol  205-736-8  149-30-4  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1052}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1054\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-109-00-9  bis(piperidinothiocarbonyl) \ndisulphide  202-328-1  94-37-1  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1  H319 \nH335 \nH315 \nH317  GHS07 \nWng  H319 \nH335 \nH315 \nH317  \n613-110-00-4  dimepiperate (ISO); S-(1-methyl- \n1-phenylethyl) piperidine-1- \ncarbothioate  262-784-2  61432-55-1  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n613-111-00-X  1,2,4-triazole  206-022-9  288-88-0  Repr. 2 \nAcute Tox. 4 * \nEye Irrit. 2  H361d *** \nH302 \nH319  GHS08 \nGHS07 \nWng  H361d *** \nH302 \nH319  \n▼M23  \n613-112-00-5  octhilinone (ISO); \n2-octyl-2 H-isothiazol-3-one; \n[OIT]  247-761-7  26530-20-1  Acute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 3 \nSkin Corr. 1 \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH311 \nH301 \nH314 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH311 \nH301 \nH314 \nH317 \nH410  EUH071  inhalation: ATE = \n0,27 mg/L (dusts \nor mists) \ndermal: ATE = \n311 mg/kg bw \noral: ATE = 125 \nmg/kg bw \nSkin Sens. 1A; \nH317: C ≥ \n0,0015 % \nM = 100 \nM = 100  \n▼M16  \n613-113-00-0  2-(morpholinothio)benzothiazole  203-052-4  102-77-2  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H319 \nH315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H319 \nH315 \nH317 \nH411  \n613-114-00-6  2,2',2''-(hexahydro-1,3,5- \ntriazine-1,3,5-triyl)trietha\xad\nnol;1,3,5-tris(2-hydroxye\xad\nthyl)hexahydro-1,3,5-triazine  225-208-0  4719-04-4  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  Skin Sens. 1; \nH317: C ≥ \n0,1 %  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1053}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1055\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M23  \n613-115-00-1  hymexazol (ISO); \n3-hydroxy-5-methylisoxazole  233-000-6  10004-44-1  Repr. 2 \nAcute Tox. 4 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H361d \nH302 \nH318 \nH317 \nH411  GHS08 \nGHS07 \nGHS05 \nGHS09 \nDgr H361d \nH302 \nH318 \nH317 \nH411  oral: ATE = \n1600 mg/kg bw  \n▼M16  \n613-116-00-7  tolylfluanid (ISO);dichloro- N- \n[(dimethylamino)sulpho\xad\nnyl]fluoro- N-(p-tolyl)methanesul\xad\nphenamide;[containing ≥0.1 % \n(w/w) of particles with an \naerodynamic diameter of below \n50 μm]  211-986-9  731-27-1  Acute Tox. 2 * \nSTOT RE 1 \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H330 \nH372** H319 \nH335 \nH315 \nH317 \nH400  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH372** \nH319 \nH335 \nH315 \nH317 \nH400  M=10  \n613-116-01-4  tolylfluanid (ISO);dichloro- N- \n[(dimethylamino)sulpho\xad\nnyl]fluoro- N-(p-tolyl)methanesul\xad\nphenamide;[containing < 0,1 % \n(w/w) of particles with an \naerodynamic diameter of below \n50 μm]  211-986-9  731-27-1  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H319 \nH335 \nH315 \nH317 \nH400  GHS07 \nGHS09 \nWng  H319 \nH335 \nH315 \nH317 \nH400  M=10  \n613-117-00-2  diniconazole (ISO);(E)-β-[(2,4- \ndichlorophenyl)methylene]-α- \n(1,1-dimethylethyl)-1 H—1,2,4- \ntriazol-1- ethanol;( E)-(RS)-1-(2,4- \ndichlorophenyl)-4,4-dimethyl-2- \n(1H—1,2,4- triazol-1-yl)pent-1- \nen-3-ol  — 76714-88-0  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1054}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1056\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-118-00-8  flubenzimine (ISO); N-[3-phenyl- \n4,5-bis[(trifluor\xad\nomethyl)imino]thiazolidin-2- \nylidene]aniline  253-703-1  37893-02-0  Eye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H319 \nH410  \n613-119-00-3  (benzothiazol-2-ylthio)methyl \nthiocyanate; TCMTB  244-445-0  21564-17-0  Acute Tox. 2 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH302 \nH319 \nH315 \nH317 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH302 \nH319 \nH315 \nH317 \nH410  \n613-120-00-9  bioresmethrin (ISO);(5-benzyl-3- \nfuryl)methyl (1 R)-2,2-dimethyl- \n3-(2-methylprop-1- en-1- \nyl)cyclopropanecarboxylate  249-014-0  28434-01-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 1000  \n▼M13  \n613-121-00-4  chlorsulfuron (ISO); 2-chloro-N- \n[[(4-methoxy-6-methyl-1,3,5- \ntriazin-2- yl)amino]carbonyl]ben\xad\nzenesulphonamide  265-268-5  64902-72-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 1 000 \nM = 100  \n▼M16  \n613-122-00-X  diclobutrazole (ISO);( R*, R*)- \n(±)-β-[(2,4-dichlorop \nhenyl)methyl]-α-(1,1-dimethyl\xad\nethyl)-1 H-1,2,4-triazole-1- \nethanol; (2 RS, 3RS)-1-(2,4-dich\xad\nlorophenyl)-4,4-dimethyl-2- \n(1H—1,2,4-triazol-1yl)pentan-3- \nol — 75736-33-3  Eye Irrit. 2 \nAquatic Chronic 2  H319 \nH411  GHS07 \nGHS09 \nWng  H319 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1055}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1057\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-123-00-5  5,6-dihydro-3 H-imidazo[2,1- c]- \n1,2,4-dithiazole-3-thione; etem  251-684-4  33813-20-6  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-124-00-0  fenpropimorph (ISO); cis-4-[3-( p- \ntert-butylphenyl)-2- methyl\xad\npropyl]-2,6-dimethylmorpholine  266-719-9  67564-91-4  Repr. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nAquatic Chronic 2  H361d *** \nH302 \nH315 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H361d *** \nH302 \nH315 \nH411  \n▼M23  \n613-125-00-6  hexythiazox (ISO);  \ntrans -5-(4-chlorophenyl)- N- \ncyclohexyl-4-methyl-2-oxo-3- \nthiazolidine-carboxamide  — 78587-05-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 1  \n▼M16  \n613-126-00-1  imazapyr (ISO);2-[4,5-dihydro-4- \nmethyl-4-(1- methylethyl)-5-oxo- \n1H- imidazol-2-yl]-3-pyridine \ncarboxylate  — 81334-34-1  Eye Irrit. 2 \nAquatic Chronic 3  H319 \nH412  GHS07 \nWng  H319 \nH412  \n613-127-00-7  1,1-dimethylpiperidinium \nchloride; mepiquat chloride  246-147-6  24307-26-4  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n613-128-00-2  prochloraz (ISO); N-propyl- N-[2- \n(2,4,6-trichlorop henoxy)ethyl]- \n1H-imidazole-1- carboxamide  266-994-5  67747-09-5  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-129-00-8  metamitron (ISO);4-amino-3- \nmethyl-6-phenyl-1,2,4-triazin-5- \none 255-349-3  41394-05-2  Acute Tox. 4 * \nAquatic Acute 1  H302 \nH400  GHS07 \nGHS09 \nWng  H302 \nH400  \n613-131-00-9  pyroquilon (ISO);1,2,5,6-tetrahy\xad\ndropyrrolo[3,2,1- ij]quinolin-4- \none — 57369-32-1  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1056}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1058\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-132-00-4  hexazinone (ISO);3-cyclohexyl- \n6-dimethylamino-1-methyl- \n1,2,3,4-tetrahydro-1,3,5-triazine- \n2,4-dione  257-074-4  51235-04-2  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH410  \n▼M11  \n613-133-00-X  etridiazole (ISO); 5-ethoxy-3- \ntrichloromethyl- 1,2,4-thiadiazole  219-991-8  2593-15-9  Carc. 2 \nAcute Tox. 4 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH317 \nH410  M = 1 \nM = 1  \n▼M16  \n613-134-00-5  myclobutanil(ISO);2-(4-chloro\xad\nphenyl)-2-(1 H-1,2,4- triazol-1- \nylmethyl)hexanenitrile  — 88671-89-0  Repr. 2 \nAcute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 2  H361d *** \nH302 \nH319 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H361d *** \nH302 \nH319 \nH411  \n613-135-00-0  di(benzothiazol-2-yl) disulphide  204-424-9  120-78-5  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  EUH031  \n613-136-00-6  N-cyclohexylbenzothiazole-2- \nsulphenamide  202-411-2  95-33-0  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n613-137-00-1  methabenzthiazuron (ISO);1-(1,3- \nbenzothiazol-2-yl)1,3- \ndimethylurea  242-505-0  18691-97-9  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1057}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1059\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-138-00-7  quinoxyfen (ISO);5,7-dichloro-4- \n(4-fluorophenoxy)quinoline  — 124495-18-7  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n613-139-00-2  metsulfuron-methyl (ISO); \nmethyl-2-{[(4-methoxy-6- \nmethyl-1,3,5-triazin-2-yl)carba\xad\nmoyl]sulfamoyl}benzoate  — 74223-64-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 1000  \n613-140-00-8  cycloheximide (ISO);4-{(2 R)-2- \n[(1S,3S,5S)-3,5- dimethyl-2- \noxocyclohexyl]-2- hydroxye\xad\nthyl}piperidine-2,6- dione  200-636-0  66-81-9  Muta. 2 \nRepr. 1B \nAcute Tox. 2 * \nAquatic Chronic 2  H341 \nH360D *** \nH300 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H341 \nH360D *** \nH300 \nH411  \n613-141-00-3  1,4-diamino-2-(2-butyltetrazol-5- \nyl)-3-cyanoanthraquinone  401-470-3  93686-63-6  Aquatic Chronic 4  H413  —  H413  \n613-142-00-9  trans —N-methyl-2-styryl-[4'- \naminomethine-(1-acetyl-1-(2- \nmethoxyphenyl)acetamido)]py \nridinium acetate  405-860-4  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n613-143-00-4  1-(3-phenylpropyl)-2-methylpyri\xad\ndinium bromide  405-930-4  10551-42-5  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 3  H302 \nH319 \nH412  GHS07 \nWng  H302 \nH319 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1058}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1060\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-144-00-X  reaction products of: poly(vinyl \nacetate), partially hydrolyzed, \nwith ( E)-2-(4-formylstyryl)-3,4- \ndimethylthiazoliummethylsulfate  406-460-2  125139-08-4  Aquatic Chronic 3  H412  —  H412  \n613-145-00-5  (S)-3-benzyloxycarbonyl-1,2,3,4- \ntetrahydro-isoquinolinium 4- \nmethylbenzenesulfonate  406-960-0  77497-97-3  Aquatic Chronic 2  H411  GHS09  H411  \n613-146-00-0  N-ethyl- N-methylpiperidinium \niodide  407-780-5  4186-71-4  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n613-147-00-6  4-[2-(1-methyl-2-(4-morpholi\xad\nnyl)ethoxy)ethyl]morpholine  407-940-4  111681-72-2  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-148-00-1  tetrasodium 1,2-bis(4-fluoro-6- \n[5-(1-amino-2-sulfonatoanthra \nchinon-4-ylamino)-2,4,6- \ntrimethyl-3-sulfonatopheny \nlamino]-1,3,5-triazin-2- \nylamino)ethane  411-240-4  143683-23-2  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n▼M11  \n613-149-00-7  pyridaben (ISO); 2-tert-butyl-5- \n(4-tert-butylbenzylthio)-4-chloro\xad\npyridazin-3(2H)-one  405-700-3  96489-71-3  Acute Tox. 3 \nAcute Tox. 3 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH410  M = 1 000 \nM = 1 000  \n▼M16  \n613-150-00-2  2,2'-[3,3'-(piperazine-1,4-diyl)di \npropyl]bis(1 H-benzimidazo[2,1—  \nb]benzo[ l, m,n ][3,8]phenan\xad\nthroline-1,3,6-trione  406-295-6  —  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1059}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1061\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-151-00-8  1-(3-mesyloxy-5-trityloxymethyl- \n2-D-threofuryl)thymine  406-360-9  104218-44-2  Aquatic Chronic 4  H413  —  H413  \n613-152-00-3  phenyl  N -(4,6-dimethoxypyri\xad\nmidin-2-yl)carbamate  406-600-2  89392-03-0  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n613-153-00-9  2,3,5-trichloropyridine  407-270-2  16063-70-0  Aquatic Chronic 3  H412  —  H412  \n613-154-00-4  2-amino-4-chloro-6-methoxypyri\xad\nmidine  410-050-9  5734-64-5  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n613-155-00-X  5-chloro-2,3-difluoropyridine  410-090-7  89402-43-7  Flam. Liq. 3 \nAcute Tox. 4 * \nAquatic Chronic 3  H226 \nH302 \nH412  GHS02 \nGHS07 \nWng  H226 \nH302 \nH412  \n613-156-00-5  2-butyl-4-chloro-5-formylimid\xad\nazole  410-260-0  83857-96-9  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n613-157-00-0  2,4-diamino-5-methoxymethyl\xad\npyrimidine  410-330-0  54236-98-5  Acute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2  H302 \nH373 ** H319  GHS08 \nGHS07 \nWng  H302 \nH373 ** \nH319  \n613-158-00-6  2,3-dichloro-5-trifluoromethyl- \npyridine  410-340-5  69045-84-7  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H332 \nH302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H332 \nH302 \nH318 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1060}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1062\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-159-00-1  fenazaquin (ISO);4-[2-[4-(1,1- \ndimethylethyl)phenyl]- \nethoxy]quinazoline  410-580-0  120928-09-8  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH332 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH332 \nH410  \n613-160-00-7  ( 1 S)-2-methyl-2,5-diazobi\xad\ncyclo[2.2.1]heptanes dihydro\xad\nbromide  411-000-9  125224-62-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n613-161-00-2  (2,4-diaminopteridin-6-yl)me\xad\nthanol hydrobromide  430-620-0  76145-91-0  STOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 3  H373** H317 \nH412  GHS08 \nGHS07 \nWng  H373** \nH317 \nH412  \n613-162-00-8  ( 6 R-trans )-1-((7-ammonio-2- \ncarboxylato-8-oxo-5-thia-1- \nazabicyclo-[4.2.0]oct-2-en-3- \nyl)methyl)pyridinium iodide  423-260-0  100988-63-4  Muta. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H341 \nH317 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH317 \nH411  \n613-163-00-3  azimsulfuron (ISO);1-(4,6-dime\xad\nthoxypyrimidin-2-yl)-3-[1- \nmethyl-4-(2-methyl-2 H- tetrazol- \n5-yl)pyrazol-5-ylsulfonyl]urea  — 120162-55-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M=1000  \n613-164-00-9  flufenacet (ISO); N-(4-fluor\xad\nophenyl)- N-isopropyl-2-(5-triflu\xad\noromethyl-[1,3,4]thiadiazol-2- \nyloxy)acetamide  — 142459-58-3  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** H317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH317 \nH410  M=100  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1061}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1063\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-165-00-4  flupyrsulfuron-methyl- \nsodium(ISO);methyl 2-[[(4,6- \ndimethoxypyrimidin-2-ylcarba\xad\nmoyl)sulfamoyl]-6-trifluor\xad\nomethyl]nicotinate, monosodium \nsalt — 144740-54-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M=100  \n▼M13  \n613-166-00-X  flumioxazin (ISO); \n2-[7-fluoro-3-oxo-4-(prop-2-yn- \n1-yl)-3,4-dihydro-2H-1,4-benz\xad\noxazin-6-yl]-4,5,6,7-tetrahydro- \n1H-isoindole-1,3(2H)-dione  — 103361-09-7  Repr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH400 \nH410  GHS08 \nGHS09 \nDgr H360D \nH410  M = 1 000 \nM = 1 000  \n▼M18  \n613-167-00-5  reaction mass of 5-chloro-2- \nmethyl-2 H-isothiazol-3-one and \n2-methyl-2 H-isothiazol-3-one \n(3:1)  — 55965-84-9  Acute Tox. 2 \nAcute Tox. 2 \nAcute Tox. 3 \nSkin Corr. 1C \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH310 \nH301 \nH314 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH310 \nH301 \nH314 \nH317 \nH410  EUH071  Skin Corr. 1C; \nH314: C ≥ 0,6 % \nSkin Irrit. 2; H315: \n0,06 % ≤ C < \n0,6 % \nEye Dam. 1; H318: \nC ≥ 0,6 % \nEye Irrit. 2; H319: \n0,06 % ≤ C < \n0,6 % \nSkin Sens. 1A; \nH317: C ≥ \n0,0015 % \nM = 100 \nM = 100  B \n▼M16  \n613-168-00-0  1-vinyl-2-pyrrolidone  201-800-4  88-12-0  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSTOT SE 3 \nEye Dam. 1  H351 \nH332 \nH312 \nH302 \nH373 ** H335 \nH318  GHS06 \nGHS05 \nGHS09 \nDgr H351 \nH332 \nH312 \nH302 \nH373 ** \nH335 \nH318  D ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1062}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1064\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-169-00-6  9-vinylcarbazole  216-055-0  1484-13-5  Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H341 \nH312 \nH302 \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H341 \nH312 \nH302 \nH315 \nH317 \nH410  M=100  \n613-170-00-1  2,2-ethylmethylthiazolidine  404-500-3  694-64-4  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n613-171-00-7  hexaconazole (ISO);( RS)-2-(2,4- \ndichlorophenyl)-1-(1 H-1,2,4- \ntriazol-1-yl)hexan-2- ol  413-050-7  79983-71-4  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n613-172-00-2  5-chloro-1,3-dihydro-2 H-indol-2- \none 412-200-9  17630-75-0  Repr. 2 \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 3  H361f *** \nH302 \nH317 \nH412  GHS08 \nGHS07 \nWng  H361f *** \nH302 \nH317 \nH412  \n613-173-00-8  fluquinconazole (ISO);3-(2,4- \ndichlorophenyl)-6-fluoro-2-(1 H- \n1,2,4-triazol-1-yl)quinazolin-4- \n(3H)-one  411-960-9  136426-54-5  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nAcute Tox. 4 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH372 ** H312 \nH315 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH301 \nH372 ** \nH312 \nH315 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1063}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1065\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-174-00-3  tetraconazole (ISO); \n(±) 2-(2,4-dichlorophenyl)-3-(1 H- \n1,2,4-triazol-1-yl)propyl-1,1,2,2- \ntetrafluoroethylether  407-760-6  112281-77-3  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 2  H332 \nH302 \nH411  GHS07 \nGHS09 \nWng  H332 \nH302 \nH411  \n613-175-00-9  epoxiconazole (ISO); (2 RS,3SR)- \n3-(2-chlorophenyl)-2-(4-fluor\xad\nophenyl)-[(1 H-1,2,4-triazol-1- \nyl)methyl]oxirane  406-850-2  133855-98-8  Carc. 2 \nRepr. 1B \nAquatic Chronic 2  H351 \nH360Df \nH411  GHS08 \nGHS09 \nDgr H351 \nH360Df \nH411  \n613-176-00-4  2-methyl-2-azabi\xad\ncyclo[2.2.1]heptane  404-810-9  4524-95-2  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B  H226 \nH312 \nH302 \nH373 ** \nH314  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H226 \nH312 \nH302 \nH373 ** \nH314  \n613-177-00-X  8-amino-7-methylquinoline  412-760-4  5470-82-6  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H312 \nH302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H312 \nH302 \nH317 \nH411  \n613-178-00-5  4-ethyl-2-methyl-2-isopentyl-1,3- \noxazolidine  410-470-2  137796-06-6  Skin Corr. 1B \nSkin Sens. 1  H314 \nH317  GHS05 \nGHS07 \nDgr H314 \nH317  STOT SE 3; H335: \nC ≥ 5 %  \n613-179-00-0  lithium 3-oxo-1,2(2 H)-benziso\xad\nthiazol-2-ide  411-690-1  111337-53-2  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH314 \nH317 \nH411  GHS05 \nGHS07 \nDgr H302 \nH314 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1064}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1066\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-180-00-6  N-(1,1-dimethylethyl)bis(2- \nbenzothiazolesulfen)amide  407-430-1  3741-80-8  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-181-00-1  5,5-dimethyl-perhydro-pyrimidin- \n2-one α-(4-trifluoromethylstyryl)- \nα-(4-trifluoromethyl)cinnamylide\xad\nnehydrazone  405-090-9  67485-29-4  STOT RE 1 \nAcute Tox. 4 * \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H372 ** \nH302 \nH319 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H372 ** \nH302 \nH319 \nH410  \n613-182-00-7  1-(1-naphthylmethyl)quinolinium \nchloride  406-220-7  65322-65-8  Carc. 2 \nMuta. 2 \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H351 \nH341 \nH302 \nH315 \nH318 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H351 \nH341 \nH302 \nH315 \nH318 \nH412  \n613-183-00-2  reaction mass of: 5-( N-methyl\xad\nperfluorooctylsulfon\xad\namido)methyl-3-octadecyl-1,3- \noxazolidin-2-one; 5-( N-methyl\xad\nperfluoroheptylsulfon\xad\namido)methyl-3-octadecyl-1,3- \noxazolidin-2-one  413-640-4  —  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH400 \nH410  GHS08 \nGHS09 \nWng  H373 ** \nH410  \n613-184-00-8  nitrilotriethyleneammonio\xad\npropane-2-ol 2-ethylhexanoate  413-670-8  —  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  \n613-185-00-3  2,3,5,6-tetrahydro-2-methyl-2 H- \ncyclopenta[ d]-1,2-thiazol-3-one  407-630-9  82633-79-2  Acute Tox. 3 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H301 \nH318 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1065}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1067\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-186-00-9  ( 2 R,3R)-3-(( R)-1-(tert-butyldi\xad\nmethylsiloxy)ethyl)-4- \noxoazetidin-2-yl acetate  408-050-9  76855-69-1  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H319 \nH317 \nH411  GHS07 \nGHS09 \nWng  H319 \nH317 \nH411  \n613-187-00-4  5-(2-amino-5-cyano-6-[2-(2- \nhydroxyethoxy)ethylamino]-4- \nmethylpyridin-3-ylazo)-3-methyl- \n2,4-dicarbonitrilethiophene  410-530-8  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n613-188-00-X  1-(3-(4-fluorophenoxy)propyl)3- \nmethoxy-4-piperidinone  411-500-7  116256-11-2  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n613-189-00-5  1,4,7,10-tetrakis( p-toluensul\xad\nfonyl)-1,4,7,10-tetraazacyclo\xad\ndodecane  414-030-0  52667-88-6  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n613-190-00-0  disodium 1-amino-4-(2-(5- \nchloro-6-fluoro-pyrimidin-4- \nylamino-methyl)-4-methyl-6- \nsulfo-phenylamino)-9,10-dioxo- \n9,10-dihydro-anthracene-2- \nsulfonate  414-040-5  149530-93-8  Acute Tox. 4 * \nSkin Sens. 1  H302 \nH317  GHS07 \nWng  H302 \nH317  \n613-191-00-6  3-ethyl-2-methyl-2-(3-methyl\xad\nbutyl)-1,3-oxazolidine  421-150-7  143860-04-2  Repr. 1B \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360F *** \nH314 \nH400 \nH410  GHS08 \nGHS05 \nGHS09 \nDgr H360F *** \nH314 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1066}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1068\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-192-00-1  3-benzyl-exo-6-nitro-2,4-dioxo-3- \naza-cis-bicyclo[3.1.0]hexane  426-750-2  151860-15-0  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n613-193-00-7  pentakis[3-(dimethyl\xad\nammonio)propylsulfamoyl]-[(6- \nhydroxy-4,4,8,8-tetramethyl-4,8- \ndiazoniaundecane-1,11-diyldisul\xad\nfamoyl)di[phthalocyanine\xad\ncopper(II)]] heptalactate  414-930-3  —  Aquatic Chronic 2  H411  GHS09  H411  \n613-194-00-2  6,13-dichloro-3,10-bis{2-[4- \nfluoro-6-(2-sulfophenylamino)- \n1,3,5-triazin-2-ylamino]propy\xad\nlamino}benzo[5,6][1,4]ox\xad\nazino[2,3-.b.]phenoxazine-4,11- \ndisulphonic acid, lithium-, \nsodium salt  418-000-8  163062-28-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-195-00-8  2,2-(1,4-phenylene)bis((4 H—3,1- \nbenzoxazine-4-one)  418-280-1  18600-59-4  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n613-196-00-3  5-[[4-chloro-6-[[2-[[4-fluoro-6- \n[[5-hydroxy-6-[(4-methoxy-2- \nsulfophenyl)azo]-7-sulfo-2-naph\xad\nthalenyl]amino]-1,3,5-triazin-2- \nyl]amino]-1-methylethyl]amino]- \n1,3,5-triazin-2-yl]amino]-3-[[4- \n(ethenylsulfonyl)phenyl]azo]-4- \nhydroxy-naphtalene-2,7- \ndisulfonic acid, sodium salt  418-380-5  168113-78-8  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1067}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1069\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-197-00-9  reaction mass of: 2,4,6-tri(bu\xad\ntylcarbamoyl)-1,3,5-triazine; \n2,4,6-tri(methylcarbamoyl)-1,3,5- \ntriazine; \n[(2-butyl-4,6-dimethyl)tricarba\xad\nmoyl]-1,3,5-triazine; \n[(2,4-dibutyl-6-methyl)tricarba\xad\nmoyl]-1,3,5-triazine  420-390-1  187547-46-2  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n613-198-00-4  2-amino-4-dimethylamino-6- \ntrifluoroethoxy-1,3,5-triazine  415-500-8  145963-84-4  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 3  H302 \nH373** \nH412  GHS08 \nGHS07 \nWng  H302 \nH373** \nH412  \n613-199-00-X  reaction mass of: 1,3,5-tris(3- \naminomethylphenyl)-1,3,5- \n(1H,3H,5H)-triazine-2,4,6 trione; \nreaction mass of oligomers of \n3,5-bis(3-aminomethylphenyl)1- \npoly[3,5-bis(3-aminomethyl\xad\nphenyl)-2,4,6-trioxo-1,3,5- \n(1H,3H,5H)-triazin-1-yl]- \n1,3,5(1 H,3H,5H)-triazine-2,4,6- \ntrione  421-550-1  —  Carc. 1B \nRepr. 1B \nSkin Sens. 1 \nAquatic Chronic 3  H350 \nH360D *** \nH317 \nH412  GHS08 \nDgr H350 \nH360D *** \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1068}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1070\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-200-00-3  reaction product of: copper, \n(29H,31H-phthalocyaninato(2-)-  \nN29,N30,N31,N32)-, chloro\xad\nsulfuric acid and 3-(2-sulfooxye\xad\nthylsulfonyl)aniline, sodium salts  420-980-7  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-201-00-9  (R)-5-bromo-3-(1-methyl-2- \npyrrolidinyl methyl)-1 H-indole  422-390-5  143322-57-0  Repr. 2 \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f *** \nH372 ** \nH332 \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H361f *** \nH372 ** \nH332 \nH302 \nH317 \nH410  EUH070  \n▼M23  \n613-202-00-4  pymetrozine (ISO); \n(E)-4,5-dihydro-6-methyl-4-(3- \npyridylmethyleneamino)-1,2,4- \ntriazin-3(2 H)-one  — 123312-89-0  Carc. 2 \nRepr. 2 \nAquatic Chronic 1  H351 \nH361fd \nH410  GHS08 \nGHS09 \nWng  H351 \nH361fd \nH410  M = 1  \n▼M16  \n613-203-00-X  pyraflufen-ethyl (ISO); \n2-chloro-5-(4-chloro-5-difluor\xad\nomethoxy-1-methylpyrazol-3-yl)- \n4-fluorophenoxyacetic acid ethyl \nester; [1] pyraflufen (ISO); \n2-chloro-5-(4-chloro-5-difluor\xad\nomethoxy-1-methylpyrazol-3-yl)- \n4-fluorophenoxyacetic acid [2]  -[1] \n-[2] 129630-19-9 \n[1] \n129630-17-7 \n[2] Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M=1000  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1069}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1071\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-204-00-5  oxadiargyl (ISO); \n3-[2,4-dichloro-5-(2-propyny\xad\nloxy)phenyl]-5-(1,1-dimethyl\xad\nethyl)-1,3,4-oxadiazol-2(3 H)-one  254-637-6  39807-15-3  Repr. 2 \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H361d*** \nH373** \nH400 \nH410  GHS08 \nGHS09 \nWng  H361d*** \nH373** \nH410  M = 1000  \n▼M18  \n613-205-00-0  propiconazole (ISO); \n(2RS,4RS;2RS,4SR)-1-{[2-(2,4- \ndichlorophenyl)-4-propyl-1,3- \ndioxolan-2-yl]methyl}-1 H-1,2,4- \ntriazole  262-104-4  60207-90-1  Repr. 1B \nAcute Tox. 4 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360D \nH302 \nH317 \nH410  M = 1 \nM = 1  \n▼M16  \n613-206-00-6  fenamidone (ISO); \n(S)-5-methyl-2-methylthio-5- \nphenyl-3-phenylamino-3,5-dihy\xad\ndroimidazol-4-one  — 161326-34-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-208-00-7  imazamox (ISO); \n(RS)-2-(4-isopropyl-4-methyl-5- \noxo-2-imidazolin-2-yl)-5- \nmethoxymethylnicotinic acid  — 114311-32-9  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-209-00-2  cis -1-(3-chloropropyl)-2,6- \ndimethyl-piperidin hydrochloride  417-430-3  63645-17-0  Acute Tox. 3 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Chronic 2  H301 \nH373 ** \nH317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH373 ** \nH317 \nH411  \n613-210-00-8  2-(3-chloropropyl)-2,5,5- \ntrimethyl-1,3-dioxane  417-650-1  88128-57-8  STOT RE 2 * \nAquatic Chronic 3  H373 ** \nH412  GHS08 \nWng  H373 ** \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1070}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1072\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-211-00-3  N-methyl-4-( p-formylstyryl)pyri\xad\ndinium methylsulfate  418-240-3  74401-04-0  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n613-212-00-9  4-[4-(2-ethylhexyloxy)phe\xad\nnyl](1,4-thiazinane-1,1-dioxide)  418-320-8  133467-41-1  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n613-213-00-4  cis -1-benzoyl-4-[(4-methylsulfo\xad\nnyl)oxy]-L-proline  416-040-0  120807-02-5  Aquatic Chronic 3  H412  —  H412  \n613-214-00-X  N, N -di-n-butyl-2-(1,2-dihydro-3- \nhydroxy-6-isopropyl-2-quinolyli\xad\ndene)-1,3-dioxoindan-5-carbo\xad\nxamide  416-260-7  147613-95-4  Aquatic Chronic 4  H413  —  H413  \n613-215-00-5  2-chloromethyl-3,4-dimethoxy\xad\npyridinium chloride  416-440-5  72830-09-2  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H312 \nH302 \nH373 ** \nH315 \nH318 \nH317 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H312 \nH302 \nH373 ** \nH315 \nH318 \nH317 \nH411  \n613-216-00-0  6 - tert-butyl-7-(6-diethylamino-2- \nmethyl-3-pyridylimino)-3-(3- \nmethylphenyl)pyrazolo[3,2- \nc][1,2,4]triazole  416-490-8  162208-01-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-217-00-6  4-[3-(3,5-di- tert-butyl-4-hydro\xad\nxyphenyl)propionyloxy]-1-[2-[3- \n(3,5-di- tert-butyl-4-hydrophe\xad\nnyl)propionyloxy]ethyl]-2,2,6,6- \ntetramethylpiperidine  416-770-1  73754-27-5  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1071}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1073\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-218-00-1  6-hydroxyindole  417-020-4  2380-86-1  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH317 \nH411  \n613-219-00-7  7a-ethyl-3,5-bis(1-methylethyl)- \n2,3,4,5-tetrahydrooxazolo[3,4-c]- \n2,3,4,5-tetrahydrooxazole  417-140-7  79185-77-6  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n613-220-00-2  trans-(4 S,6S)-5,6-dihydro-6- \nmethyl-4 H-thieno[2,3- \nb]thiopyran-4-ol, 7,7-dioxide  417-290-3  147086-81-5  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n613-221-00-8  2-chloro-5-methyl-pyridine  418-050-0  18368-64-4  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nAquatic Chronic 3  H312 \nH302 \nH315 \nH412  GHS07 \nWng  H312 \nH302 \nH315 \nH412  \n613-222-00-3  4-(1-oxo-2-propenyl)-morpholine  418-140-1  5117-12-4  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH373 ** \nH318 \nH317  GHS08 \nGHS05 \nGHS07 \nDgr H302 \nH373 ** \nH318 \nH317  \n613-223-00-9  N-isopropyl-3-(4-fluorophenyl)- \n1H-indole  418-790-4  93957-49-4  Aquatic Chronic 4  H413  —  H413  \n613-224-00-4  2,5-dimercaptomethyl-1,4- \ndithiane  419-770-8  136122-15-1  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1072}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1074\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-225-00-X  reaction mass of:[2-(anthra\xad\nquinon-1-ylamino)-6-[(5-benzoy\xad\nlamino)-anthraquinone-1- \nylamino]-4-phenyl]-1,3,5- \ntriazine; \n2,6-bis-[(5-benzoylamino)-anthra\xad\nquinon-1-ylamino]-4-phenyl- \n1,3,5-triazine.  421-290-9  —  STOT RE 2 * \nAquatic Chronic 4  H373 ** \nH413  GHS08 \nWng  H373 ** \nH413  \n613-226-00-5  1-(2-(ethyl(4-(4-(4-(4-(ethyl(2- \npyridinoethyl)amino)-2-methyl\xad\nphenylazo)benzoylamino)-pheny\xad\nlazo)-3-methylphe\xad\nnyl)amino)ethyl)-pyridinium \ndichloride  420-950-3  163831-67-2  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n613-227-00-0  (±)-[( R*,R*) and ( R*,S*)]-6- \nfluoro-3,4-dihydro-2-oxiranyl- \n2H-1-benzopyran  419-600-2  99199-90-3  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n613-228-00-6  (±)-( R*,S*)-6-fluoro-3,4-dihydro- \n2-oxiranyl-2 H-1-benzopyran  419-630-6  793669-26-8  Aquatic Chronic 2  H411  GHS09  H411  \n613-229-00-1  1-acetyl-4-(3-dodecyl-2,5-dioxo- \n1-pyrrolidinyl)-2,2,6,6-tetra\xad\nmethylpiperidine  411-930-5  106917-31-1  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1073}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1075\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-230-00-7  florasulam (ISO); \n2',6',8-trifluoro-5-methoxy-5-tria\xad\nzolo[1,5-c]; \npyrimidine-2-sulfonanilide  — 145701-23-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-231-00-2  2,6-diamino-3-((pyridine-3- \nyl)azo)pyridine  421-430-9  28365-08-4  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 2  H302 \nH373** \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH411  \n613-232-00-8  3-(benzo[ b]thien-2-yl)-5,6- \ndihydro-1,4,2-oxathiazine-4- \noxide  431-030-6  163269-30-5  Acute Tox. 3 * \nSTOT RE 2 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH373** \nH318 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H331 \nH373** \nH318 \nH410  \n613-233-00-3  4,4'-(oxy-(bismethylene))-bis-1,3- \ndioxolane  423-230-7  56552-15-9  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-234-00-9  imidazo[1,2-b]pyridazin hydro\xad\nchloride  431-510-5  18087-70-2  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n613-235-00-4  2,3-dihydro-2,2-dimethyl-1 H- \nperimidine  424-060-6  6364-17-6  Acute Tox. 4* \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH317 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1074}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1076\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-236-00-X  2-chloro-3-trifluoromethyl\xad\npyridine  424-520-6  65753-47-1  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 1 \nSkin Corr. 1B \nAquatic Chronic 3  H311 \nH301 \nH372** \nH314 \nH412  GHS06 \nGHS05 \nGHS08 \nDgr H311 \nH301 \nH372** \nH314 \nH412  \n613-237-00-5  6 - tert-butyl-3-(3-dodecylsulfo\xad\nnyl)propyl-7 H-1,2,4-tria\xad\nzolo[3.4b][1,3,4]thiadiazine  424-950-4  133949-92-5  Aquatic Chronic 4  H413  —  H413  \n613-238-00-0  sodium 2-[[4-[(4,6-dichloro- \n1,3,5-triazin-2-yl)amino]phe\xad\nnyl]sulfonyl]ethyl sulfate  430-890-1  81992-66-7  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n613-239-00-6  2-[3-(methylamino)propyl]-1 H- \nbenzimidazole  425-760-4  64137-52-6  Eye Dam. 1 \nAquatic Chronic 3  H318 \nH412  GHS05 \nDgr H318 \nH412  \n613-241-00-7  3-(2 H-tetrazol-5-yl)pyridine  426-810-8  3250-74-6  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-242-00-2  reaction products of 3,10-bis((2- \naminopropyl)amino)-6,13- \ndichloro-4,11-triphenodioxazine\xad\ndisulfonic acid with 2-amino-1,4- \nbenzenedisulfonic acid, 2-((4- \naminophenyl)sulfonyl)ethyl \nhydrogen sulfate and 2,4,6- \ntrifluoro-1,3,5-triazine, sodium \nsalts 426-860-0  191877-09-5  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1075}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1077\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-243-00-8  4,4'-(1,6-hexamethylenebis(for\xad\nmylimino))bis(2,2,6,6-tetra\xad\nmethyl-1-oxylpiperidine)  427-350-0  182235-14-9  Aquatic Chronic 2  H411  GHS09  H411  \n613-244-00-3  5,7-dichloro-4-hydroxyquinoline  427-420-0  21873-52-9  Aquatic Chronic 2  H411  GHS09  H411  \n613-245-00-9  2-fluoro-6-trifluoromethyl\xad\npyridine  428-100-3  94239-04-0  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H226 \nH332 \nH302 \nH412  GHS02 \nGHS07 \nWng  H226 \nH332 \nH302 \nH412  \n613-246-00-4  2-hydroxymethyl-3-methyl-4- \n(2,2,2-trifluoroethoxy)pyridine  428-200-7  103577-66-8  Aquatic Chronic 3  H412  —  H412  \n613-247-00-X  3-(2-methoxy-4-methoxycarboxy\xad\nbenzyl)-5-nitroindole  428-910-7  107786-36-7  Aquatic Chronic 4  H413  —  H413  \n613-248-00-5  3,4-dimethyl-1 H-pyrazole  429-130-1  2820-37-3  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n613-249-00-0  1-(2-hydroxyethyl)-1 H-pyrazol- \n4,5-diyldiammoniumsulfate  429-300-3  155601-30-2  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n613-250-00-6  reaction mass of: carbonato-bis-  \nN-ethyl-2-isopropyl-1,3- \noxazolidine; \nmethyl carbonato- N-ethyl-2- \nisopropyl-1,3-oxazolidine; \n2-isopropyl- N-hydroxyethyl 1,3- \noxazolidine  429-990-6  —  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H318 \nH317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1076}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1078\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-251-00-1  (R)-3-[(1-methylpyrrolidin-2- \nyl)methyl]-5-[2-(phenylsulfo\xad\nnyl)ethenyl]-1 H-indole  430-560-5  180637-89-2  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H302 \nH373** \nH318 \nH317  GHS05 \nGHS08 \nGHS07 \nDgr H302 \nH373** \nH318 \nH317  \n613-253-00-2  2,2-dialkyl-4-hydroxymethyl1,3- \ndioxolane; \nreaction products with ethylene \noxide (alkyl is C  1-12 and the \nsum to C  13, average degree of \nethoxylation is 3,5)  430-580-4  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  EUH019  \n613-254-00-8  forchlorfenuron (ISO); \n1-(2-chloro-4-pyridyl)-3-pheny\xad\nlurea  — 68157-60-8  Carc. 2 \nAquatic Chronic 2  H351 \nH411  GHS08 \nGHS09 \nWng  H351 \nH411  \n613-255-00-3  reaction mass of isomers of: \nsodium [(2-hydroxyethylsulfa\xad\nmoyl){][}2-(2-piperazin-1-ylethy\xad\nlamino)ethylsulfamoyl][2-(4- \naminoethylpiperazine-1- \nyl)ethylsulfamoyl{](sulfa\xad\nmoyl)[}(sulfonatophthalocyani\xad\nnato)]copper(II)  424-270-8  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-256-00-9  3'5'-anhydro thymidine  425-810-5  38313-48-3  Aquatic Chronic 3  H412  —  H412  \n613-257-00-4  2-phthalimidoethyl  N -[4-(2- \ncyano-4-nitrophenylazo)phenyl]-  \nN-methyl-β-alaninate  426-400-9  170222-39-6  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1077}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1079\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-258-00-X  reaction mass of: 4-chloro-7- \nmethylbenzotriazole sodium salt; \n4-chloro-5-methylbenzotriazole \nsodium salt; \n5-chloro-4-methylbenzotriazole \nsodium salt  427-730-6  202420-04-0  Skin Corr. 1B \nAquatic Chronic 3  H314 \nH412  GHS05 \nDgr H314 \nH412  \n▼M23  \n613-259-00-5  imiprothrin (ISO); \nreaction mass of: [2,4-dioxo-(2- \npropyn-1-yl)imidazolidin-3- \nyl]methyl(1 R)-cis-chrysan\xad\nthemate; [2,4-dioxo-(2-propyn-1- \nyl)imidazolidin-3-yl]methyl(1 R)- \ntrans -chrysanthemate  428-790-6  72963-72-5  Carc. 2 \nAcute Tox. 4 \nAcute Tox. 4 \nSTOT SE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH332 \nH302 \nH371 (nervous \nsystem; oral, \ninhalation) \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH332 \nH302 \nH371 \n(nervous \nsystem; oral, \ninhalation) \nH410  inhalation: ATE = \n1,4 mg/L (dusts or \nmists) \noral: ATE = \n550 mg/kg bw \nM = 10 \nM = 10  \n▼M16  \n613-260-00-0  (±)-4-(3-chlorophenyl)-6-[(4- \nchlorophenyl)hydroxy(1-methyl- \n1H-imidazol-5-yl)methyl]-1- \nmethyl-2(1 H)-quinolin  430-730-9  —  Eye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH400 \nH410  GHS05 \nGHS09 \nDgr H318 \nH410  \n613-261-00-6  pyrazole-1-carboxamidine \nmonohydrochloride  429-520-1  4023-02-3  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH373** H318 \nH317 \nH412  GHS05 \nGHS08 \nGHS07 \nDgr H302 \nH373** \nH318 \nH317 \nH412  \n613-262-00-1  disodium ( E)-1,2-bis-(4-(4- \nmethylamino-6-(4-methylcarba\xad\nmoylphenylamino)-1,3,5-triazin- \n2-ylamino)phenyl-2-sulfon\xad\nato)ethene  427-310-2  180850-95-7  Eye Dam. 1  H318  GHS05 \nDgr H318  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1078}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1080\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-263-00-7  monosodium 3-cyano-5-fluoro-6- \nhydroxypyridine-2-olate  429-570-2  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n613-266-00-3  2-chloro-5-chloromethylthiazole  429-830-5  105827-91-6  Acute Tox. 3 * \nSkin Corr. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H311 \nH314 \nH302 \nH317 \nH411  GHS06 \nGHS05 \nGHS09 \nDgr H311 \nH314 \nH302 \nH317 \nH411  \n613-267-00-9  thiamethoxam (ISO); \n3-(2-chloro-thiazol-5-ylmethyl)- \n5-methyl[1,3,5]oxadiazinan-4- \nylidene- N-nitroamine  428-650-4  153719-23-4  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M=10  \n613-268-00-4  (4a S-cis -)-6-benzyl-octahydropyr\xad\nrolo[3.4-b]pyridine  425-930-8  151213-39-7  Skin Corr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 2  H314 \nH332 \nH302 \nH373** \nH411  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H314 \nH332 \nH302 \nH373** \nH411  \n613-269-00-X  2-thiazolidinylidenecyanamide  427-720-1  26364-65-8  Acute Tox. 4* \nSTOT RE 2 * \nAquatic Chronic 3  H302 \nH373** \nH412  GHS08 \nGHS07 \nWng  H302 \nH373** \nH412  \n613-270-00-5  5-amino- N-(2,6-dichloro-3- \nmethylphenyl)-1 H-1,2,4-triazole- \n3-sulfonamide  428-150-6  113171-13-4  Aquatic Chronic 3  H412  —  H412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1079}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1081\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-271-00-0  tritosulfuron (ISO) (containing \n≤0,02 % AMTT); \n1-[4-methoxy-6-(trifluor\xad\nomethyl)-1,3,5-triazin-2-yl]-3-[2- \n(trifluoromethyl)benzenesulfo\xad\nnyl]urea (containing ≤ 0,02 % \nAMTT)  — 142469-14-5  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M=10  \n613-272-00-6  pyraclostrobin (ISO); \nmethyl  N-{2-[1-(4-chlorophenyl)- \n1H-pyrazol-3-yloxymethyl]phe\xad\nnyl}( N-methoxy)carbamate  — —  Acute Tox. 3 * \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH315 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH315 \nH410  M=100  \n613-273-00-1  tetrahydro-3-methyl-5-((2- \nphenylthio)thiazol-5-ylmethyl)- \n[4H]-1,3,5-oxadiazinan-4- \nylidene- N-nitroamine  427-600-9  192439-46-6  Aquatic Chronic 2  H411  GHS09  H411  \n613-274-00-7  2,6-dichloro-1-fluoropyridinium\xad\ntetrafluoroborate  427-400-1  140623-89-8  Skin Corr. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H314 \nH302 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H314 \nH302 \nH317 \nH410  \n613-275-00-2  3-(2-chloroethyl)-6,7,8,9-tetra- \nhydro-2-methyl-4 H-pyrido[1,2-a] \npyrimidin-4-one monohydro\xad\nchloride  424-530-0  93076-03-0  Acute Tox. 3 * \nSTOT SE 2 \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H301 \nH371** \nH373** \nH318 \nH317 \nH411  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H301 \nH371** \nH373** \nH318 \nH317 \nH411  \n613-276-00-8  1-(2-chlorophenyl)-1,2-dihydro- \n5H-tetrazol-5-one  426-110-2  98377-35-6  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1080}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1082\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-277-00-3  (4-(6-diethylamino-2-methyl\xad\npyridin-3-yl)imino-4,5-dihydro-3- \nmethyl-1-(4-methylphenyl)-1 H- \npyrazol-5-one  427-070-9  —  Aquatic Chronic 4  H413  —  H413  \n613-278-00-9  (3-aminophenyl)pyridin-3-ylme\xad\nthanone  428-230-0  79568-06-2  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373** \nH400 \nH410  GHS08 \nGHS09 \nWng  H373** \nH410  \n613-279-00-4  2-ethyl-2,3-dihydro-2-methyl-1 H- \nperimidine  424-380-6  43057-68-7  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH410  \n613-280-00-X  tetrahydro-1,3-dimethyl-1 H-pyri\xad\nmidin-2-one; \ndimethyl propyleneurea  230-625-6  7226-23-5  Repr. 2 \nAcute Tox. 4 * \nEye Dam. 1  H361f*** \nH302 \nH318  GHS05 \nGHS08 \nGHS07 \nDgr H361f*** \nH302 \nH318  \n613-281-00-5  quinoline  202-051-6  91-22-5  Carc. 1B Muta. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H350 \nH341 \nH312 \nH302 \nH319 \nH315 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H350 \nH341 \nH312 \nH302 \nH319 \nH315 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1081}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1083\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-282-00-0  triticonazole (ISO); \n(RS)-(E)-5-(4-chlorobenzyli\xad\ndene)-2,2-dimethyl-1-(1 H-1,2,4- \ntriazol-1-methyl)cyclopentanol  — 131983-72-7  Aquatic Chronic 2  H411  GHS09  H411  \n613-283-00-6  ketoconazole; \n1-[4-[4-[[(2 SR, 4RS)-2-(2,4-dich\xad\nlorophenyl)-2-(imidazol-1-ylme\xad\nthyl)-1,3-dioxolan-4-yl]me\xad\nthoxy]phenyl]piperazin-1- \nyl]ethanone  265-667-4  65277-42-1  Repr. 1B \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H360F*** \nH301 \nH373** \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H360F*** \nH301 \nH373** \nH410  \n613-284-00-1  metconazole (ISO); \n(1RS, 5RS;1RS, 5SR)-5-(4-chloro\xad\nbenzyl)-2,2-dimethyl-1-(1 H- \n1,2,4-triazol-1-ylmethyl)cyclo\xad\npentanol  — 125116-23-6  Repr. 2 \nAcute Tox. 4 * \nAquatic Chronic 2  H361d*** \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nWng  H361d*** \nH302 \nH411  \n613-285-00-7  1-hydroxybenzotriazole, \nanhydrous; [1] \n1-hydroxybenzotriazole, \nmonohydrated [2]  219-989-7 [1] \n219-989-7 [2]  2592-95-2 [1] \n123333-53-9 \n[2] Expl. 1.3  H203  GHS01 \nDgr H203  \n613-286-00-2  potassium 1-methyl-3-morpholi\xad\nnocarbonyl-4-[3-(1-methyl-3- \nmorpholinocarbonyl-5-oxo-2- \npyrazolin-4-ylidene)-1-prope\xad\nnyl]pyrazole-5-olate; \n[containing < 0,5 %  N, N - \ndimethylformamide (EC no \n200-679-5)]  418-260-2  183196-57-8  Skin Sens. 1  H317  GHS07 \nWng  H317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1082}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1084\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-286-01-X  potassium 1-methyl-3-morpholi\xad\nnocarbonyl-4-[3-(1-methyl-3- \nmorpholinocarbonyl-5-oxo-2- \npyrazolin-4-ylidene)-1-prope\xad\nnyl]pyrazole-5-olate; \n[containing ≥ 0,5 %  N, N - \ndimethylformamide (EC \nNo 200-679-5)]  418-260-2  183196-57-8  Repr. 1B \nSkin Sens. 1  H360D*** \nH317  GHS08 \nGHS07 \nDgr H360D*** \nH317  \n613-287-00-8  1-(3-iodo-4-aminobenzyl)-1 H- \n1,2,4-triazole  419-540-7  160194-26-3  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  \n613-288-00-3  1,3-bis(dimethylcarbamoyl)-imid\xad\nazolium chloride  420-930-4  135756-61-5  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n613-289-00-9  3-(4-chloro-2-fluoro-5-methyl\xad\nphenyl)-1-methyl-5-(trifluor\xad\nomethyl)-1 H-pyrazole  432-020-4  142623-48-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-290-00-4  4-hydroxy-7-(2-aminoethyl)-1,3- \nbenzothiazol-2(3 H)-one hydro\xad\nchloride  432-470-1  189012-93-9  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH410  \n613-291-00-X  2,4-dihydro-4-(4-(4-(4-hydroxyp\xad\nhenyl)-1-piperazinyl)phenyl)-2- \n(1-methylpropyl)-3 H-1,2,4- \ntriazol-3-one  434-820-9  106461-41-0  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373** \nH400 \nH410  GHS08 \nGHS09 \nWng  H373** \nH410  \n613-292-00-5  N, N',N'' -tris(2-methyl-2,3-epoxy\xad\npropyl)-perhydro-2,4,6-oxo- \n1,3,5-triazine  435-010-8  26157-73-3  Muta. 2 \nAquatic Chronic 3  H341 \nH412  GHS08 \nWng  H341 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1083}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1085\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-293-00-0  2-(4- tert-butylphenyl)-6-cyano-5- \n[bis(ethoxycarbonyl \nmethyl)carbamoyloxy]-1 H- \npyrrolo[1,2-b][1,2,4] triazole-7- \ncarboxylic acid 2,6-di- tert-butyl- \n4-methylcyclohexylester  448-050-6  444065-11-6  Aquatic Chronic 4  H413  —  H413  \n613-294-00-6  2-hexyldecanoic acid [4-(6- tert- \nbutyl-7-chloro-1 H-pyrazolo[1,5- \nb][1,2,4]triazol-2-yl)phenylcarba\xad\nmoyl]methylester  448-260-8  379268-96-9  Aquatic Chronic 4  H413  —  H413  \n613-295-00-1  11-amino-3-chloro-6,11-dihydro- \n5,5-dioxo-6-methyl-dibenzo[c, \nf][1,2]thiazepine hydrochloride  448-720-8  363138-44-7  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n613-296-00-7  pentapotassium 2-(4-(5-[1-(2,5- \ndisulfonatophenyl)-4,5-dihydro- \n3-methylcarbamoyl-5-oxopy\xad\nrazol-4-ylidene]-3-methyl-1,3- \npentadienyl)-3-methylcarbamoyl- \n5-oxidopyrazol-1yl)benzene-1,4- \ndisulfonate  418-270-7  —  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n613-297-00-2  5-(2-bromophenyl)-2- tert-butyl- \n2H-tetrazole  420-820-6  —  Flam. Liq. 3 \nAcute Tox. 4 * \nAquatic Chronic 2  H226 \nH302 \nH411  GHS02 \nGHS07 \nGHS09 \nWng  H226 \nH302 \nH411  \n613-298-00-8  bis-(6-hydroxy-4-methyl-5-(3- \nmethylimidazolium-1-yl)-3-(4- \nphenylazo)-1 H-pyridin-2- \none)ethylene dilactate  421-560-6  —  STOT RE 2 * \nEye Dam. 1 \nAquatic Chronic 2  H373** \nH318 \nH411  GHS05 \nGHS08 \nGHS09 \nDgr H373** \nH318 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1084}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1086\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-299-00-3  main component 1 (isomer 1): \n2-{6-fluoro-4-[3-(2,5-disulfo- \nphenylazo)-4-hydroxy-2- \nsulfonapht-7-ylamino]-1,3,5- \ntriazin-2-ylamino}-3-{6-fluoro-4- \n[3-(1,5-disulfonaphth-2-ylazo)-4- \nhydroxy-2-sulfonaphth-7- \nylamino]-1,3,5-triazin-2- \nylamino}-propane sodium salt; \nmain component 1 (isomer 2): \n2-{6-fluoro-4-[3-(2,5-disulfop\xad\nhenylazo)-4-hydroxy-2-sulfon\xad\naphth-7-ylamino]-1,3,5-triazin-2- \nylamino}-3-{6-fluoro-4-[3(2,5- \ndisulfo-phenylazo)-4-hydroxy-2- \nsulfonaphth-7-ylamino]-1,3,5- \ntriazin-2-ylamino}-propane \nsodium salt; \nmain component 2: 2,3-bis-{6- \nfluoro-4-[3-(2,5-disulfo-pheny\xad\nlazo)-4-hydroxy-2-sulfonaphth-7- \nylamino]-1,3,5-triazin-2- \nylamino}-propane sodium salt; \nmain component 3: 2,3-bis-{6- \nfluoro-4-[3-(1,5-disulfonaphth-2- \nylazo)-4-hydroxy-2-sulfonaphth- \n7-ylamino]-1,3,5-triazin-2- \nylamino}-propane sodium salt  422-610-1  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-300-00-7  1-imidazol-1-yl-octadecan-2-ol  434-120-3  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1085}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1087\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-301-00-2  dimethyl-1-{[2-methoxy-5-(2- \nmethyl-butoxycarbonyl)phe\xad\nnylcarbamoyl]-[2-octadecyl-1,1- \ndioxo-1,2,4-benzothiadiazin-3- \nyl]methyl} imidazole-4,5-dicar\xad\nboxylate  443-910-7  —  Aquatic Chronic 4  H413  —  H413  \n613-302-00-8  disodium 2-(5-carbamoyl-1- \nethyl-2-hydroxy-4-methyl-6-oxo- \n1,6-dihydro-pyridine-3-ylazo)-4- \n(4-fluoro-6-(4-(2-sulfonyloxy- \nethylsulfonyl)-phenylamino)- \n1,3,5-triazine-2-ylamino)benzene \nsulfonate  432-980-4  243858-60-8  Eye Dam. 1  H318  GHS05 \nDgr H318  \n613-303-00-3  2-(1-methyl-2-(4-phenoxyphen\xad\noxy)ethoxy)pyridine  429-800-1  95737-68-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-304-00-9  5,6-dihydroxy-2,3-dihydro-1 H- \nindolium bromide  421-170-6  138937-28-7  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n613-305-00-4  2-(2-hydroxy-4-octyloxyphenyl)- \n2H-benzotriazole  448-630-9  3147-77-1  Aquatic Chronic 4  H413  —  H413  \n613-306-00-X  (2,5-dioxopyrrolidin-1-yl)-9 H- \nfluoren-9-ylmethyl carbonate  433-520-5  82911-69-1  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1086}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1088\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-307-00-5  clothianidin (ISO); \n3-[(2-chloro-1,3-thiazol-5- \nyl)methyl]-2-methyl-1-nitrogua\xad\nnidine  — 210880-92-5  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M=10  \n613-308-00-0  2-amino-5-methylthiazole  423-800-5  7305-71-7  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373** \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373** \nH410  \n613-309-00-6  1-methyl-3-phenyl-1-piperazine  431-180-2  5271-27-2  Acute Tox. 4 * \nAcute Tox. 4 * \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 3  H312 \nH302 \nH315 \nH318 \nH412  GHS05 \nGHS07 \nDgr H312 \nH302 \nH315 \nH318 \nH412  \n613-310-00-1  (-)(3 S, 4R)-4-(4-fluorophenyl)-3- \n(3,4-methylenedioxy-phenoxy\xad\nmethyl)- N-benzylpiperidine \nhydrochloride  432-360-3  105813-13-6  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n613-311-00-7  methyl-5-nitrophenyl-guanidine  435-500-1  152460-07-6  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH319 \nH317 \nH412  GHS07 \nWng  H302 \nH319 \nH317 \nH412  \n613-312-00-2  2-(4-methyl-2-phenyl-1-piperazi\xad\nnyl)benzenemethanol monohy\xad\ndrochloride  420-200-5  —  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317 \nH412  \n613-313-00-8  2-(4-(4-(3-pyridinyl)-1 H- \nimidazol-1-yl)butyl)-1 H- \nisoindole-1,3(2 H)-dione  442-780-9  173838-67-0  Aquatic Chronic 3  H412  —  H412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1087}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1089\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-314-00-3  4-decyloxazolidin-2-one; \n4-decyl-1,3-oxazolidin-2-one  443-770-7  7693-82-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n613-315-00-9  tetrapotassium 4-[5-[3- \ncarboxylato-4,5-dihydro-5-oxo1- \n(4-sulfonatophenyl)pyrazol-4- \nylidene]-3-(piperidinocar\xad\nbonyl)penta-1,3-dienylidene]-5- \nhydroxy-1-(4-sulfonatophe\xad\nnyl)pyrazole-3-carboxylate  430-390-1  —  Acute Tox. 4 * \nAquatic Chronic 3  H332 \nH412  GHS07 \nWng  H332 \nH412  \n613-316-00-4  trimethylopropane tri(3-aziridi\xad\nnylpropanoate); \n(TAZ)  257-765-0  52234-82-9  Muta. 2 \nEye Dam. 1 \nSkin Sens. 1  H341 \nH318 \nH317  GHS05 \nGHS08 \nGHS07 \nDgr H341 \nH318 \nH317  \n613-317-00-X  penconazole (ISO); 1-[2-(2,4- \ndichlorophenyl)pentyl]-1 H-1,2,4- \ntriazole  266-275-6  66246-88-6  Repr. 2 \nAcute Tox. 4 \nAquatic Acute 1 \nAquatic Chronic 1  H361d \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361d \nH302 \nH410  M = 1 \nM = 1  \n▼M15  \n613-318-00-5  fenpyrazamine (ISO); \nS-allyl 5-amino-2,3-dihydro-2- \nisopropyl-3-oxo-4-(o-tolyl)py\xad\nrazole-1-carbothioate; \nS-allyl 5-amino-2-isopropyl-4-(2- \nmethylphenyl)-3-oxo-2,3-dihy\xad\ndropyrazole-1-carbothioate  — 473798-59-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 10 \nM = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1088}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1090\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M11  \n613-319-00-0  imidazole  206-019-2  288-32-4  Repr. 1B \nAcute Tox. 4 \nSkin Corr. 1C  H360D \nH302 \nH314  GHS08 \nGHS07 \nGHS05 \nDgr H360D \nH302 \nH314  \n613-320-00-6  lenacil (ISO); 3-cyclohexyl-6,7- \ndihydro-1H-cyclopenta[d]pyri\xad\nmidine-2,4(3H,5H)-dione  218-499-0  2164-08-1  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  M = 10 \nM = 10  \n▼M15  \n613-321-00-1  (RS)-4-[1-(2,3-dimethylphe\xad\nnyl)ethyl]-1H-imidazole; \nmedetomidine  — 86347-14-0  Acute Tox. 2 \nAcute Tox. 2 \nSTOT SE 3 \nSTOT SE 1 \nSTOT RE 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH336 \nH370 (eye) \nH372 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH300 \nH336 \nH370 (eye) \nH372 \nH410  M = 1 \nM = 100  \n613-322-00-7  triadimenol (ISO); \n(1RS,2RS;1RS,2SR)-1-(4-chloro\xad\nphenoxy)-3,3-dimethyl-1-(1H- \n1,2,4-triazol-1-yl)butan-2-ol; \nα-tert-butyl-β-(4-chlorophenoxy)- \n1H-1,2,4-triazole-1-ethanol  259-537-6  55219-65-3  Repr. 1B \nLact. \nAcute Tox. 4 \nAquatic Chronic 2  H360 \nH362 \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H360 \nH362 \nH302 \nH411  \n613-323-00-2  terbuthylazine (ISO); \nN-tert-butyl-6-chloro-N′-ethyl- \n1,3,5-triazine-2,4-diamine  227-637-9  5915-41-3  Acute Tox. 4 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nWng  H302 \nH373 \nH410  M = 10 \nM = 10  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1089}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1091\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-324-00-8  quinolin-8-ol; \n8-hydroxyquinoline  205-711-1  148-24-3  Repr. 1B \nAcute Tox. 3 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH301 \nH318 \nH317 \nH400 \nH410  GHS08 \nGHS06 \nGHS05 \nGHS09 \nDgr H360D \nH301 \nH318 \nH317 \nH410  M = 1 \nM = 1  \n613-325-00-3  thiacloprid (ISO); \n(Z)-3-(6-chloro-3-pyridylmethyl)- \n1,3-thiazolidin-2-ylidenecya\xad\nnamide; \n{(2Z)-3-[(6-chloropyridin-3- \nyl)methyl]-1,3-thiazolidin-2- \nylidene}cyanamide  — 111988-49-9  Carc. 2 \nRepr. 1B \nAcute Tox. 4 \nAcute Tox. 3 \nSTOT SE 3 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH360FD \nH332 \nH301 \nH336 \nH400 \nH410  GHS08 GHS06 \nGHS09 \nDgr H351 \nH360FD \nH332 \nH301 \nH336 \nH410  M = 100 \nM = 100  \n▼M18  \n613-326-00-9  2-methylisothiazol-3(2 H)-one  220-239-6  2682-20-4  Acute Tox. 2 \nAcute Tox. 3 \nAcute Tox. 3 \nSkin Corr. 1B \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH311 \nH301 \nH314 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS06 \nGHS09 \nDgr H330 \nH311 \nH301 \nH314 \nH317 \nH410  EUH071  Skin Sens. 1A; \nH317: C ≥ \n0,0015 % \nM = 10 \nM = 1  \n613-327-00-4  pyroxsulam (ISO);  \nN-(5,7-dimethoxy[1,2,4]tria\xad\nzolo[1,5-a]pyrimidin-2-yl)-2- \nmethoxy-4-(trifluor\xad\nomethyl)pyridine-3-sulfonamide  — 422556-08-9  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M = 100 \nM = 100  \n613-328-00-X  1-vinylimidazole  214-012-0  1072-63-5  Repr. 1B  H360D  GHS08 \nDgr H360D  Repr. 1B; H360D: \nC ≥ 0,03 %  ▼M15', metadata={'source': 'data/ycla_en.pdf', 'page': 1090}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1092\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M22  \n613-329-00-5  halosulfuron-methyl (ISO); \nmethyl 3-chloro-5-{[(4,6-dime\xad\nthoxypyrimidin-2-yl)carba\xad\nmoyl]sulfamoyl}-1-methyl-1H- \npyrazole-4-carboxylate  — 100784-20-1  Repr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH400 \nH410  GHS08 \nGHS09 \nDgr H360D \nH410  M = 1000 \nM = 1000  \n613-330-00-0  2-methylimidazole  211-765-7  693-98-1  Repr. 1B  H360Df  GHS08 \nDgr H360Df  \n▼M23  \n613-331-00-6  ( 2 RS)-2-[4-(4-chlorophenoxy)-2- \n(trifluoromethyl)phenyl]-1-(1 H- \n1,2,4-triazol-1-yl)propan-2-ol; \nmefentrifluconazole  — 1417782-03-6  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M = 1 \nM = 1  \n613-332-00-1  oxathiapiprolin (ISO); \n1-(4-{4-[5-(2,6-difluorophenyl)- \n4,5-dihydro-1,2-oxazol-3-yl]-1,3- \nthiazol-2-yl}piperidin-1-yl)-2-[5- \nmethyl-3-(trifluoromethyl)-1 H- \npyrazol-1-yl]ethanone  — 1003318-67-9  Aquatic Chronic 1  H410  GHS09 \nWng  H410  M  =  1  \n613-333-00-7  pyrithione zinc; ( T-4)-bis[1- \n(hydroxy-.kappa. O)pyridine- \n2(1H)-thionato-.kappa. S]zinc  236-671-3  13463-41-7  Repr. 1B \nAcute Tox. 2 \nAcute Tox. 3 \nSTOT RE 1 \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH330 \nH301 \nH372 \nH318 \nH400 \nH410  GHS08 \nGHS06 \nGHS05 \nGHS09 \nDgr H360D \nH330 \nH301 \nH372 \nH318 \nH410  inhalation: ATE = \n0,14 mg/L (dusts \nor mists) \noral: ATE = 221 \nmg/kg bw \nM = 1000 \nM = 10  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1091}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1093\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n613-334-00-2  flurochloridone (ISO); \n3-chloro-4-(chloromethyl)-1-[3- \n(trifluoromethyl)phenyl]pyr\xad\nrolidin-2-one  262-661-3  61213-25-0  Repr. 1B \nAcute Tox. 4 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H360FD \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nDgr H360FD \nH302 \nH317 \nH410  oral: ATE = \n500 mg/kg bw \nM = 100 \nM = 100  \n613-335-00-8  4,5-dichloro-2-octyl-2 H- \nisothiazol-3-one; [DCOIT]  264-843-8  64359-81-5  Acute Tox. 2 \nAcute Tox. 4 \nSkin Corr. 1 \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH302 \nH314 \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH302 \nH314 \nH317 \nH410  EUH071  inhalation: ATE = \n0,16 mg/L (dusts \nor mists) \noral: ATE = \n567 mg/kg bw \nSkin Irrit. 2; H315: \n0,025 % ≤ C < 5 % \nEye Irrit. 2; H319: \n0,025 % ≤ C < 3 % \nSkin Sens. 1A; \nH317: C ≥ \n0,0015 % \nM = 100 \nM = 100  \n613-336-00-3  2-methyl-1,2-benzothiazol-3(2 H)- \none; \n[MBIT]  — 2527-66-4  Acute Tox. 4 \nAcute Tox. 3 \nSkin Corr. 1C \nEye Dam. 1 \nSkin Sens. 1A \nAquatic Acute 1 \nAquatic Chronic 2  H312 \nH301 \nH314 \nH318 \nH317 \nH400 \nH411  GHS06 \nGHS05 \nGHS09 \nDgr H312 \nH301 \nH314 \nH317 \nH410  EUH071  dermal: ATE = \n1100 mg/kg bw \noral: ATE = \n175 mg/kg bw \nSkin Sens. 1A; \nH317: C ≥ \n0,0015 % \nM = 1  ▼M23', metadata={'source': 'data/ycla_en.pdf', 'page': 1092}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1094\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M18  \n614-001-00-4  nicotine (ISO); \n3-[(2S)-1-methylpyrrolidin-2- \nyl]pyridine  200-193-3  54-11-5  Acute Tox. 2 \nAcute Tox. 2 \nAcute Tox. 2 \nAquatic Chronic 2  H330 \nH310 \nH300 \nH411  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH411  inhalation: \nATE = 0,19 mg/L \n(dusts or mists) \ndermal: \nATE = 70 mg/kg \nbw \noral: \nATE = 5 mg/kg \nbw \n▼M16  \n614-002-00-X  salts of nicotine  —  —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 * \nAquatic Chronic 2  H330 \nH310 \nH300 \nH411  GHS06 \nGHS09 \nDgr H330 \nH310 \nH300 \nH411  A \n614-003-00-5  strychnine  200-319-7  57-24-9  Acute Tox. 1 \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H310 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H310 \nH300 \nH410  \n614-004-00-0  salts of strychnine  —  —  Acute Tox. 2 * \nAcute Tox. 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH300 \nH400 \nH410  GHS06 \nGHS09 \nDgr H330 \nH300 \nH410  A \n614-005-00-6  colchicine  200-598-5  64-86-8  Muta. 1B \nAcute Tox. 2 *  H340 \nH300  GHS06 \nGHS08 \nDgr H340 \nH300  \n614-006-00-1  brucine; \n2,3-dimethoxystrychnine  206-614-7  357-57-3  Acute Tox. 2 * \nAcute Tox. 2 * \nAquatic Chronic 3  H330 \nH300 \nH412  GHS06 \nDgr H330 \nH300 \nH412  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1093}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1095\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n614-007-00-7  brucine sulphate; [1] \nbrucine nitrate; [2] \nstrychnidin-10-one, 2,3-dime\xad\nthoxy-, mono[( R)-1-methylheptyl \n1,2-benzenedicarboxylate]; [3] \nstrychnidin-10-one, 2,3-dime\xad\nthoxy-, compd.with ( S) mono(1- \nmethylheptyl)-1,2-benzenedicar\xad\nboxylate (1:1) [4]  225-432-9 [1] \n227-317-9 [2] \n269-439-5 [3] \n269-710-8 [4]  4845-99-2 [1] \n5786-97-0 [2] \n68239-26-9 [3] \n68310-42-9 [4]  Acute Tox. 2 * \nAcute Tox. 2 * \nAquatic Chronic 3  H330 \nH300 \nH412  GHS06 \nDgr H330 \nH300 \nH412  A \n614-008-00-2  aconitine  206-121-7  302-27-2  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  \n614-009-00-8  salts of aconitine  —  —  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  A \n614-010-00-3  atropine  200-104-8  51-55-8  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  \n614-011-00-9  salts of atropine  —  —  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  A \n614-012-00-4  hyoscyamine  202-933-0  101-31-5  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  \n614-013-00-X  salts of hyoscyamine  —  —  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  A \n614-014-00-5  hyoscine  200-090-3  51-34-3  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 *  H330 \nH310 \nH300  GHS06 \nDgr H330 \nH310 \nH300  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1094}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1096\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n614-015-00-0  salts of hyoscine  —  —  Acute Tox. 2 * \nAcute Tox. 1 \nAcute Tox. 2 *  H330 \nH310 \nH300  GHS06 \nDgr H330 \nH310 \nH300  A \n614-016-00-6  pilocarpine  202-128-4  92-13-7  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  \n614-017-00-1  salts of pilocarpine  —  —  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  A \n614-018-00-7  papaverine  200-397-2  58-74-2  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n614-019-00-2  salts of papaverine  —  —  Acute Tox. 4 *  H302  GHS07 \nWng  H302  A  \n614-020-00-8  physostigmine  200-332-8  57-47-6  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  \n614-021-00-3  salts of physostigmine  —  —  Acute Tox. 2 * \nAcute Tox. 2 *  H330 \nH300  GHS06 \nDgr H330 \nH300  A \n614-022-00-9  digitoxin  200-760-5  71-63-6  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 *  H331 \nH301 \nH373 **  GHS06 \nGHS08 \nDgr H331 \nH301 \nH373 **  \n614-023-00-4  ephedrine  206-080-5  299-42-3  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n614-024-00-X  salts of ephedrine  —  —  Acute Tox. 4 *  H302  GHS07 \nWng  H302  A  \n614-025-00-5  ouabain  211-139-3  630-60-4  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 *  H331 \nH301 \nH373 **  GHS06 \nGHS08 \nDgr H331 \nH301 \nH373 **  \n614-026-00-0  strophantin-K  234-239-9  11005-63-3  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 *  H331 \nH301 \nH373 **  GHS06 \nGHS08 \nDgr H331 \nH301 \nH373 **  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1095}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1097\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n614-027-00-6  bufa-4,20,22-trienolide, 6-(acety\xad\nloxy)-3-(β-D-glucopyrano\xad\nsyloxy)-8,14-dihydroxy-, (3β, \n6β)-; \nred squill; \nscilliroside  208-077-4  507-60-8  Acute Tox. 2 *  H300  GHS06 \nDgr H300  \n614-028-00-1  reaction mass of: 2-ethylhexyl \nmono-D-glucopyranoside; \n2-ethylhexyl di-D-glucopy\xad\nranoside  414-420-0  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n614-029-00-7  constitutional isomers of penta-  \nO-allyl-β-D-fructofuranosyl-α-D- \nglucopyranoside; \nconstitutional isomers of hexa- O- \nallyl-β-D-fructofuranosyl-α-D- \nglucopyranoside; \nconstitutional isomers of hepta-  \nO-allyl-β-D-fructofuransoyl-α-D- \nglucopyranoside  419-640-0  68784-14-5  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n615-001-00-7  methyl isocyanate  210-866-3  624-83-9  Flam. Liq. 2 \nRepr. 2 \nAcute Tox. 2 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nResp. Sens. 1 \nSkin Sens. 1 \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1  H225 \nH361d*** \nH330 \nH311 \nH301 \nH334 \nH317 \nH335 \nH315 \nH318  GHS02 \nGHS06 \nGHS05 \nGHS08 \nDgr H225 \nH361d*** \nH330 \nH311 \nH301 \nH334 \nH317 \nH335 \nH315 \nH318  \n615-002-00-2  methyl isothiocyanate  209-132-5  556-61-6  Acute Tox. 3 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH314 \nH317 \nH400 \nH410  GHS06 \nGHS05 \nGHS09 \nDgr H331 \nH301 \nH314 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1096}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1098\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-003-00-8  thiocyanic acid  207-337-4  463-56-9  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H332 \nH312 \nH302 \nH412  GHS07 \nWng  H332 \nH312 \nH302 \nH412  EUH032  \n615-004-00-3  salts of thiocyanic acid, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H332 \nH312 \nH302 \nH412  GHS07 \nWng  H332 \nH312 \nH302 \nH412  EUH032  A  \n615-005-00-9  4,4'-methylenediphenyl \ndiisocyanate; diphenylmethane- \n4,4'-diisocyanate; [1] \n2,2'-methylenediphenyl \ndiisocyanate; diphenylmethane- \n2,2'-diisocyanate; [2]  \no-(p-isocyanatobenzyl)phenyl \nisocyanate; \ndiphenylmethane-2,4'- \ndiisocyanate; [3] \nmethylenediphenyl diisocyanate \n[4] 202-966-0 [1] \n219-799-4 [2] \n227-534-9 [3] \n247-714-0 [4]  101-68-8 [1] \n2536-05-2 [2] \n5873-54-1 [3] \n26447-40-5 [4]  Carc. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1  H351 \nH332 \nH373** \nH319 \nH335 \nH315 \nH334 \nH317  GHS08 \nGHS07 \nDgr H351 \nH332 \nH373** \nH319 \nH335 \nH315 \nH334 \nH317  Eye Irrit. 2; H319: \nC ≥ 5 % Skin Irrit. \n2; H315: C ≥ 5 % \nResp. Sens. 1; \nH334: C ≥ 0,1 % \nSTOT SE 3; H335: \nC ≥ 5 %  C 2 \n615-006-00-4  2-methyl- m-phenylene \ndiisocyanate; \ntoluene-2,4-di-isocyanate; [1] \n4-methyl- m-phenylene \ndiisocyanate; \ntoluene-2,6-di-isocyanate; [2]  \nm-tolylidene diisocyanate; \ntoluene-diisocyanate [3]  202-039-0 [1] \n209-544-5 [2] \n247-722-4 [3]  91-08-7 [1] \n584-84-9 [2] \n26471-62-5 [3]  Carc. 2 \nAcute Tox. 2 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H351 \nH330 \nH319 \nH335 \nH315 \nH334 \nH317 \nH412  GHS06 \nGHS08 \nDgr H351 \nH330 \nH319 \nH335 \nH315 \nH334 \nH317 \nH412  Resp. Sens. 1; \nH334: C ≥ \n0,1 %  C ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1097}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1099\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-007-00-X  1,5-naphthylene diisocyanate  221-641-4  3173-72-6  Acute Tox. 4 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nAquatic Chronic 3  H332 \nH319 \nH335 \nH315 \nH334 \nH412  GHS08 \nGHS07 \nDgr H332 \nH319 \nH335 \nH315 \nH334 \nH412  \n615-008-00-5  3-isocyanatomethyl-3,5,5- \ntrimethylcyclohexyl isocyanate; \nisophorone di-isocyanate  223-861-6  4098-71-9  Acute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H331 \nH319 \nH335 \nH315 \nH334 \nH317 \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH319 \nH335 \nH315 \nH334 \nH317 \nH411  * \nResp. Sens. 1; \nH334: C ≥0,5 % \nSkin Sens.1; H317: \nC ≥0,5 %  2 \n615-009-00-0  4,4'-methylenedi(cyclohexyl \nisocyanate); dicyclohexylme\xad\nthane-4,4'-di-isocyanate  225-863-2  5124-30-1  Acute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1  H331 \nH319 \nH335 \nH315 \nH334 \nH317  GHS06 \nGHS08 \nDgr H331 \nH319 \nH335 \nH315 \nH334 \nH317  * \nResp. Sens. 1; \nH334: C ≥0,5 % \nSkin Sens. 1; \nH317: C ≥0,5 %  2 \n615-010-00-6  2,2,4-trimethylhexamethylene- \n1,6-di-isocyanate; [1] \n2,4,4-trimethylhexamethylene- \n1,6-di-isocyanate [2]  241-001-8 [1] \n239-714-4 [2]  16938-22-0 [1] \n15646-96-5 [2]  Acute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H331 \nH319 \nH335 \nH315 \nH334  GHS06 \nGHS08 \nDgr H331 \nH319 \nH335 \nH315 \nH334  * \nResp. Sens. 1; \nH334: C ≥0,5 % \nSkin Sens. 1; \nH317: C ≥0,5 %  C 2 ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1098}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1100\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-011-00-1  hexamethylene-di-isocyanate  212-485-8  822-06-0  Acute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1 \nSkin Sens. 1  H331 \nH319 \nH335 \nH315 \nH334 \nH317  GHS06 \nGHS08 \nDgr H331 \nH319 \nH335 \nH315 \nH334 \nH317  * \nResp. Sens. 1; \nH334: C ≥ \n0,5 % \nSkin Sens. 1; \nH317: C ≥0,5 %  2 \n615-012-00-7  4-isocyanatosulphonyltoluene; \ntosyl isocyanate  223-810-8  4083-64-1  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  EUH014  Eye Irrit.; \nH319: C ≥ 5 % \nSTOT SE 3; H335: \nC ≥ 5 % Skin Irrit. \n2; H315: C ≥ 5 %  \n▼M15  \n615-013-00-2  cyanamide; \ncarbamonitril  206-992-3  420-04-2  Carc. 2 \nRepr. 2 \nAcute Tox. 3 \nAcute Tox. 3 \nSTOT RE 2 \nSkin Corr. 1 \nSkin Sens. 1 \nEye Dam. 1 \nAquatic Chronic 3  H351 \nH361fd \nH311 \nH301 \nH373 (thyroid) \nH314 \nH317 \nH318 \nH412  GHS08 \nGHS06 \nGHS05 \nDgr H351 \nH361fd \nH311 \nH301 \nH373 \n(thyroid) \nH314 \nH317 \nH412  \n▼M16  \n615-014-00-8  tris (1-dodecyl-3-methyl-2- \nphenylbenzimidazolium)hexacya\xad\nnoferrate  — 7276-58-6  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n615-015-00-3  1,7,7-trimethylbicyclo(2,2,1)hept- \n2-yl thiocyanatoacetate; \nisobornyl thiocyanoacetate  204-081-5  115-31-1  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1099}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1101\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-016-00-9  potassium cyanate  209-676-3  590-28-3  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n615-017-00-4  calcium cyanamide  205-861-8  156-62-7  Acute Tox. 4 * \nSTOT SE 3 \nEye Dam. 1  H302 \nH335 \nH318  GHS05 \nGHS07 \nDgr H302 \nH335 \nH318  \n615-018-00-X  2-(2-butoxyethoxy)ethyl thio\xad\ncyanate  203-985-7  112-56-1  Flam. Liq. 3 \nAcute Tox. 3 * \nAcute Tox. 3 *  H226 \nH311 \nH301  GHS02 \nGHS06 \nDgr H226 \nH311 \nH301  \n615-019-00-5  dicyclohexylcarbodiimide  208-704-1  538-75-0  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1  H311 \nH302 \nH318 \nH317  GHS06 \nGHS05 \nDgr H311 \nH302 \nH38 \nH317  \n615-020-00-0  methylene dithiocyanate  228-652-3  6317-18-6  Acute Tox. 2 * \nAcute Tox. 3 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1  H330 \nH301 \nH314 \nH317 \nH400  GHS06 \nGHS05 \nGHS09 \nDgr H330 \nH301 \nH314 \nH317 \nH400  \n615-021-00-6  1,3,5-tris(oxiranylmethyl)-1,3,5- \ntriazine-2,4,6(1 H,3H,5H)-trione; \nTGIC  219-514-3  2451-62-9  Muta. 1B \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H340 \nH331 \nH301 \nH373 ** \nH318 \nH317 \nH412  GHS06 \nGHS08 \nGHS05 \nDgr H340 \nH331 \nH301 \nH373 ** \nH318 \nH317 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1100}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1102\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-022-00-1  methyl 3-isocyanatosulfonyl-2- \nthiophene-carboxylate  410-550-7  79277-18-2  STOT RE 2 * \nResp. Sens. 1 \nSkin Sens. 1  H373** \nH334 \nH317  GHS08 \nDgr H373** \nH334 \nH317  EUH014  \n615-023-00-7  2-(isocyanatosulfonylme\xad\nthyl)benzoic acid methyl ester; \n(alt.):methyl 2-(isocyanatosulfo\xad\nnylmethyl)benzoate  410-900-9  83056-32-0  Flam. Liq. 3 \nMuta. 2 \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nResp. Sens. 1  H226 \nH341 \nH332 \nH373 ** \nH318 \nH334  GHS02 \nGHS08 \nGHS05 \nGHS07 \nDgr H226 \nH341 \nH332 \nH373 ** \nH318 \nH334  EUH014  \n615-024-00-2  2-phenylethylisocyanate  413-080-0  1943-82-4  Acute Tox. 3 * \nAcute Tox. 4 * \nSkin Corr. 1A \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H331 \nH302 \nH314 \nH334 \nH317 \nH411  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H331 \nH302 \nH314 \nH334 \nH317 \nH411  \n615-025-00-8  4,4'-ethylidenediphenyl dicyanate  405-740-1  47073-92-7  Acute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH302 \nH373 ** \nH318 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H332 \nH302 \nH373 ** \nH318 \nH410  \n615-026-00-3  4,4'-methylenebis(2,6-dimethyl\xad\nphenyl cyanate)  405-790-4  101657-77-6  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1101}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1103\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-028-00-4  ethyl 2-(isocyanatosulfonyl)ben\xad\nzoate  410-220-2  77375-79-2  Acute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nResp. Sens. 1 \nSkin Sens. 1  H302 \nH373** \nH318 \nH334 \nH317  GHS05 \nGHS08 \nGHS07 \nDgr H302 \nH373** \nH318 \nH334 \nH317  EUH014  \n615-029-00-X  2,5-bis-isocyanatomethyl- \nbicyclo[2.2.1]heptane  411-280-2  —  Acute Tox. 2 * \nAcute Tox. 4 * \nSkin Corr. 1B \nResp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H330 \nH302 \nH314 \nH334 \nH317 \nH412  GHS06 \nGHS08 \nGHS05 \nDgr H330 \nH302 \nH314 \nH334 \nH317 \nH412  \n615-030-00-5  alkali salts and alkali earth salts \nof thiocyanic acid, with the \nexception of those specified \nelsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Chronic 3  H332 \nH312 \nH302 \nH412  GHS07 \nWng  H332 \nH312 \nH302 \nH412  A \n615-031-00-0  thallium thiocyanate  222-571-7  3535-84-0  Acute Tox. 2 * \nAcute Tox. 2 * \nAcute Tox. 4 * \nSTOT RE 2 \nAquatic Chronic 2  H330 \nH300 \nH312 \nH373** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H330 \nH300 \nH312 \nH373** \nH411  \n615-032-00-6  metal salts of thiocyanic acid, \nwith the exception of those \nspecified elsewhere in this Annex  — —  Acute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H332 \nH312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H332 \nH312 \nH302 \nH410  A ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1102}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1104\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-033-00-1  reaction product of diphenylme\xad\nthanediisocyanate, octylamine, \noleylamine and cyclohexylamine \n(1:1.58:0.32:0097)  430-980-9  —  Aquatic Chronic 4  H413  —  H413  \n615-034-00-7  reaction product of diphenylme\xad\nthanediisocyanate, octylamine, \n4-ethoxyaniline and ethylene\xad\ndiamine (1:0,37:1,53:0,05)  430-750-8  —  Aquatic Chronic 4  H413  —  H413  \n615-035-00-2  reaction product of diphenylme\xad\nthanediisocyanate, octylamine \nand oleylamine (molar ratio \n1:1.86:0.14)  430-930-6  122886-55-9  Aquatic Chronic 4  H413  —  H413  \n615-036-00-8  reaction product of diphenylme\xad\nthanediisocyanate, toluenedii\xad\nsocyanate (reaction of isomers: \n65 % 2,4-and 35 % 2,6-diisocya\xad\nnate), octylamine, oleylamine \nand 4-ethoxyaniline (molar ratio \n4:1:7:1:2)  430-940-0  —  Aquatic Chronic 4  H413  —  H413  \n615-037-00-3  reaction product of diphenylme\xad\nthanediisocyanate, toluenedii\xad\nsocyanate (reaction mass of \nisomers: 65 % 2,4-and 35 % \n2,6-diisocyanate), octylamine \nand oleylamine (molar ratio \n4:1:9:1)  430-950-5  —  Aquatic Chronic 4  H413  —  H413  \n615-038-00-9  reaction product of toluenedii\xad\nsocyanate (reaction mass of \nisomers: 65 % 2,4- and 35 % \n2,6-diisocyanate) and aniline \n(molarratio 1:2)  430-960-1  —  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1103}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1105\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n615-039-00-4  reaction product of diphenylme\xad\nthanediisocyanate, toluenedii\xad\nsocyanate (reaction mass of \nisomers: 65 % 2,4-and 35 % \n2,6-diisocyanate), octylamine, \noleylamine and 4-ethoxyaniline \n(molar ratio \n3.88:1:6.38:0.47:2.91)  430-970-4  —  Aquatic Chronic 4  H413  —  H413  \n615-044-00-1  4-chlorophenylisocyanate  203-176-9  104-12-1  Acute Tox. 2 * \nAcute Tox. 4 * \nSTOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nResp. Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H330 \nH302 \nH335 \nH315 \nH318 \nH334 \nH400 \nH410  GHS06 \nGHS05 \nGHS08 \nGHS09 \nDgr H330 \nH302 \nH335 \nH315 \nH318 \nH334 \nH410  \n615-045-00-7  4,4'-methylene bis(3-chloro-2,6- \ndi-ethylphenylisocyanate)  420-530-1  —  Resp. Sens. 1 \nSkin Sens. 1 \nAquatic Chronic 4  H334 \nH317 \nH413  GHS08 \nDgr H334 \nH317 \nH413  \n616-001-00-X  N, N -dimethylformamide; \ndimethyl formamide  200-679-5  68-12-2  Repr. 1B \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2  H360D *** \nH332 \nH312 \nH319  GHS08 \nGHS07 \nDgr H360D *** \nH332 \nH312 \nH319  \n616-002-00-5  2-fluoroacetamide  211-363-1  640-19-7  Acute Tox. 2 * \nAcute Tox. 3 *  H300 \nH311  GHS06 \nDgr H300 \nH311  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1104}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1106\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-003-00-0  acrylamide; \nprop-2-enamide  201-173-7  79-06-1  Carc. 1B \nMuta. 1B Repr. 2 \nAcute Tox. 3 * \nSTOT RE 1 \nAcute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1  H350 \nH340 \nH361f *** \nH301 \nH372 ** \nH332 \nH312 \nH319 \nH315 \nH317  GHS06 \nGHS08 \nDgr H350 \nH340 \nH361f *** \nH301 \nH372 ** \nH332 \nH312 \nH319 \nH315 \nH317  D \n616-004-00-6  allidochlor (ISO);  \nN,N-diallylchloroacetamide  202-270-7  93-71-0  Acute Tox. 4 * \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 2  H312 \nH302 \nH319 \nH315 \nH411  GHS07 \nGHS09 \nWng  H312 \nH302 \nH319 \nH315 \nH411  \n616-005-00-1  chlorthiamid (ISO); \n2,6-dichloro (thiobenzamide)  217-637-7  1918-13-4  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n▼M15  \n616-006-00-7  dichlofluanid (ISO); \nN-[(dichlorofluoromethyl)thio]- \nN′,N′-dimethyl-N-phenylsul\xad\nfamide  214-118-7  1085-98-9  Acute Tox. 4 \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1  H332 \nH319 \nH317 \nH400  GHS07 \nGHS09 \nWng  H332 \nH319 \nH317 \nH400  M = 10  \n▼M16  \n616-007-00-2  diphenamid (ISO);  \nN, N -dimethyl-2,2-diphenylace\xad\ntamide  213-482-4  957-51-7  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1105}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1107\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-008-00-8  propachlor (ISO); \n2-chloro- N-isopropylacetanilide; \nα-chloro- N-isopropylacetanilide  217-638-2  1918-16-7  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH319 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH319 \nH317 \nH410  \n616-009-00-3  propanil (ISO); \n3',4'-dichloropropionanilide  211-914-6  709-98-8  Acute Tox. 4 * \nAquatic Acute 1  H302 \nH400  GHS07 \nGHS09 \nWng  H302 \nH400  M=10  \n616-010-00-9  tosylchloramide sodium  204-854-7  127-65-1  Acute Tox. 4 * \nSkin Corr. 1B \nResp. Sens. 1  H302 \nH314 \nH334  GHS08 \nGHS05 \nGHS07 \nDg H302 \nH314 \nH334  EUH031  \n▼M13  \n616-011-00-4  N,N-dimethylacetamide  204-826-4  127-19-5  Repr. 1B \nAcute Tox. 4* \nAcute Tox. 4*  H360D*** \nH332 \nH312  GHS08 \nGHS07 \nDgr H360D*** \nH332 \nH312  \n▼M16  \n616-012-00-X  N-(dichlorofluoromethyl\xad\nthio)phthalimide;  \nN-(fluorodichloromethyl\xad\nthio)phthalimide  211-952-3  719-96-0  Skin Irrit. 2  H315  GHS07 \nWng  H315  \n616-013-00-5  butyraldehyde oxime  203-792-8  110-69-0  Acute Tox. 3 * \nAcute Tox. 4 * \nEye Irrit. 2  H311 \nH302 \nH319  GHS06 \nDgr H311 \nH302 \nH319  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1106}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1108\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M23  \n616-014-00-0  butanone oxime; ethyl methyl \nketoxime; ethyl methyl ketone \noxime  202-496-6  96-29-7  Carc. 1B \nAcute Tox. 4 \nAcute Tox. 3 \nSTOT SE 3 \nSTOT SE 1 \nSTOT RE 2 \nSkin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1  H350 \nH312 \nH301 \nH336 \nH370 (upper \nrespiratory \ntract) \nH373 (blood \nsystem) \nH315 \nH318 \nH317  GHS08 \nGHS06 \nGHS05 \nDgr H350 \nH312 \nH301 \nH336 \nH370 (upper \nrespiratory \ntract) \nH373 (blood \nsystem) \nH315 \nH318 \nH317  dermal: ATE = \n1100 mg/kg bw \noral: ATE = \n100 mg/kg bw  \n▼M16  \n616-015-00-6  alachlor (ISO); \n2-chloro-2',6'-diethyl- N- \n(methoxymethyl)acetanilide  240-110-8  15972-60-8  Carc. 2 \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH317 \nH410  M=10  \n616-016-00-1  1-(3,4-dichlorophenylimino) \nthiosemicarbazide  — 5836-73-7  Acute Tox. 2 *  H300  GHS06 \nDgr H300  \n616-017-00-7  cartap hydrochloride  239-309-2  15263-52-2  Acute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H312 \nH302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H312 \nH302 \nH410  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1107}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1109\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M22  \n616-018-00-2  diethyltoluamide (ISO): N,N- \ndiethyl-m-toluamide; [deet]  205-149-7  134-62-3  Acute Tox. 4 \nSkin Irrit. 2 \nEye Irrit. 2  H302 \nH315 \nH319  GHS07 \nWng  H302 \nH315 \nH319  oral: \nATE = 1892 mg/kg \nbw \n▼M16  \n616-019-00-8  perfluidone (ISO); \n1,1,1-trifluoro- N-(4-phenylsul\xad\nphonyl- o-tolyl)methanesulphon\xad\namide;  253-718-3  37924-13-3  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n616-020-00-3  tebuthiuron (ISO); \n1-(5- tert-butyl-1,3,4-thiadiazol-2- \nyl)-1,3-dimethylurea  251-793-7  34014-18-1  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n616-021-00-9  thiazafluron (ISO); \n1,3-dimethyl-1-(5-trifluor\xad\nomethyl-1,3,4-thiadiazol-2- \nyl)urea  246-901-4  25366-23-8  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n616-022-00-4  acetamide  200-473-5  60-35-5  Carc. 2  H351  GHS08 \nWng  H351  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1108}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1110\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-023-00-X  N-hexadecyl(or octadecyl)- N- \nhexadecyl (or octadecyl)ben\xad\nzamide  401-980-6  —  Skin Irrit. 2 \nSkin Sens. 1  H315 \nH317  GHS07 \nWng  H315 \nH317  \n616-024-00-5  2-(4,4-dimethyl-2,5-dioxoo\xad\nxazolidin-1-yl)-2-chloro-5-(2- \n(2,4-di- tert-pentylphenoxy)buty\xad\nramido)-4,4-dimethyl-3-oxoval\xad\neranilide  402-260-4  54942-74-4  Aquatic Chronic 4  H413  —  H413  \n616-025-00-0  valinamide  402-840-7  20108-78-5  Repr. 2 \nEye Irrit. 2 \nSkin Sens. 1  H361f *** \nH319 \nH317  GHS08 \nWng  H361f *** \nH319 \nH317  \n616-026-00-6  thioacetamide  200-541-4  62-55-5  Carc. 1B \nAcute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nAquatic Chronic 3  H350 \nH302 \nH319 \nH315 \nH412  GHS08 \nGHS07 \nDgr H350 \nH302 \nH319 \nH315 \nH412  \n616-027-00-1  tris(2-(2-hydroxye\xad\nthoxy)ethyl)ammonium 3-acet\xad\noacetamido-4-methoxybenzene\xad\nsulfonate  403-760-5  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n616-028-00-7  N-(4-(3-(4-cyanophenyl)ureido)- \n3-hydroxyphenyl)-2-(2,4-di- tert- \npentylphenoxy)octanamide  403-790-9  108673-51-4  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1109}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1111\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-029-00-2  N, N' -ethylenebis(vinylsulfony\xad\nlacetamide)  404-790-1  66710-66-5  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n616-030-00-8  ethidimuron (ISO); \n1-(5-ethylsulphonyl-1,3,4-thia\xad\ndiazol-2-yl)-1,3-dimethylurea  250-010-6  30043-49-3  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n616-031-00-3  dimethachlor (ISO); \n2-chloro- N-(2,6-dimethylphenyl)-  \nN-(2-methoxyethyl)acetamide;  256-625-6  50563-36-5  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n616-032-00-9  diflufenican (ISO);  \nN-(2,4-difluorophenyl)-2-[3-(tri\xad\nfluoromethyl)phenoxy]-3-pyri\xad\ndinecarboxamide  — 83164-33-4  Aquatic Chronic 3  H412  —  H412  \n616-033-00-4  cyprofuram (ISO);  \nN-(3-chlorophenyl)- N-(tet\xad\nrahydro-2-oxo-3-furyl)cyclopro\xad\npanecarboxamide  274-050-9  69581-33-5  Acute Tox. 3 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH312 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH312 \nH410  \n616-034-00-X  pyracarbolid; (ISO); \n3,4-dihydro-6-methyl-2 H-pyran- \n5-carboxanilide  246-419-4  24691-76-7  Aquatic Chronic 3  H412  —  H412  \n616-035-00-5  cymoxanil (ISO); \n2-cyano- N-[(ethylamino)car\xad\nbonyl]-2-(methoxyimino)acet\xad\namide  261-043-0  57966-95-7  Repr. 2 \nAcute Tox. 4 \nSTOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361fd \nH302 \nH373 (blood, \nthymus) \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H361fd \nH302 \nH373 (blood, \nthymus) \nH317 \nH410  M = 1 \nM = 1  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1110}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1112\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-036-00-0  2-chloracetamide  201-174-2  79-07-2  Repr. 2 \nAcute Tox. 3 * \nSkin Sens. 1  H361f *** \nH301 \nH317  GHS06 \nGHS08 \nDgr H361f *** \nH301 \nH317  Skin Sens. 1; \nH317: C ≥ 0,1 %  \n▼M13  \n616-037-00-6  acetochlor (ISO); 2-chloro-N- \n(ethoxymethyl)-N-(2-ethyl-6- \nmethylphenyl)acetamide  251-899-3  34256-82-1  Carc. 2 \nRepr. 2 \nAcute Tox. 4 \nSTOT SE 3 \nSTOT RE 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361f \nH332 \nH335 \nH373 (kidney) \nH315 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH361f \nH332 \nH335 \nH373 \n(kidney) \nH315 \nH317 \nH410  M = 1 000 \nM = 100  \n▼M16  \n616-038-00-1  (4-aminophenyl)- N-methyl\xad\nmethylensulfonamide hydro\xad\nchloride  406-010-5  88918-84-7  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H318 \nH317 \nH411  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH411  \n616-039-00-7  3',5'-dichloro-4'-ethyl-2'-hydro\xad\nxypalmitanilide  406-200-8  117827-06-2  Skin Sens. 1  H317  GHS07 \nWng  H317  \n616-040-00-2  potassium  N-(4-toluenesulfonyl)- \n4-toluenesulfonamide  406-650-5  97888-41-0  Eye Dam. 1  H318  GHS05 \nDgr H318  \n616-041-00-8  3',5'-dichloro-2-(2,4-di- tert- \npentylphenoxy)-4'-ethyl-2'- \nhydroxyhexananilide  406-840-8  101664-25-9  Aquatic Chronic 4  H413  —  H413  \n616-042-00-3  N-(2-(6-ethyl-7-(4-methyl\xad\nphenoxy)-1 H-pyrazolo[1,5- \nb][1,2,4]triazol-2-yl)propyl)-2- \noctadecyloxybenzamide  407-070-5  142859-67-4  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1111}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1113\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-043-00-9  isoxaben (ISO);  \nN-[3-(1-ethyl-1-methylpropyl)- \n1,2-oxazol-5-yl]-2,6-dimethoxy\xad\nbenzamide  407-190-8  82558-50-7  Aquatic Chronic 4  H413  —  H413  \n616-044-00-4  N-(3,5-dichloro-4-ethyl-2-hydro\xad\nxyphenyl)-2-(3-pentadecylp\xad\nhenoxy)-butanamide  402-510-2  —  Aquatic Chronic 2  H411  GHS09  H411  \n616-045-00-X  2'-(4-chloro-3-cyano-5-formyl-2- \nthienylazo)-5'-diethylamino-2- \nmethoxyacetanilide  405-190-2  122371-93-1  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n616-046-00-5  N-(2-(6-chloro-7-methylpyra\xad\nzolo(1,5-b)-1,2,4-triazol-4- \nyl)propyl)-2-(2,4-di- tert-pentylp\xad\nhenoxy)octanamide  406-390-2  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-047-00-0  reaction mass of: 2,2',2'',2'''- \n(ethylenedinitrilotetrakis- N, N - \ndi(C  16)alkylacetamide; \n2,2',2'',2'''-(ethylenedinitrilotet\xad\nrakis- N, N -di(C  18)alkylacetamide  406-640-0  —  Skin Sens. 1  H317  GHS07 \nWng  H317  \n616-048-00-6  3'-trifluoromethylisobutyranilide  406-740-4  1939-27-1  STOT RE 2 * \nAquatic Chronic 2  H373 ** \nH411  GHS08 \nGHS09 \nWng  H373 ** \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1112}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1114\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-049-00-1  2-(2,4-bis(1,1-dimethyl\xad\nethyl)phenoxy)- N-(3,5-dichloro- \n4-ethyl-2-hydroxyphenyl)- \nhexanamide  408-150-2  99141-89-6  Aquatic Chronic 4  H413  —  H413  \n616-050-00-7  lufenuron (ISO);  \nN-[2,5-dichloro-4-(1,1,2,3,3,3- \nhexafluoropropoxy)-phenyl- \naminocarbonyl]-2,6-difluoroben\xad\nzamide  410-690-9  103055-07-8  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  \n616-051-00-2  reaction mass of: 2,4 -bis( N'-(4- \nmethylphenyl)-ureido)-toluene; \n2,6 -bis( N'-(4-methylphenyl)- \nureido)-toluene  411-070-0  —  Aquatic Chronic 4  H413  —  H413  \n616-052-00-8  formamide  200-842-0  75-12-7  Repr. 1B  H360D ***  GHS08 \nDgr H360D ***  \n616-053-00-3  N-methylacetamide  201-182-6  79-16-3  Repr. 1B  H360D ***  GHS08 \nDgr H360D ***  \n616-054-00-9  iprodione (ISO); \n3-(3,5-dichlorophenyl)-2,4-dioxo-  \nN-isopropylimidazolidine-1- \ncarboxamide  253-178-9  36734-19-7  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n616-055-00-4  propyzamide (ISO); \n3,5-dichloro- N-(1,1- \ndimethylprop-2-ynyl)benzamide  245-951-4  23950-58-5  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  \n616-056-00-X  N-methylformamide  204-624-6  123-39-7  Repr. 1B \nAcute Tox. 4 *  H360D *** \nH312  GHS08 \nGHS07 \nDg H360D *** \nH312  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1113}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1115\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-057-00-5  reaction mass of:  N-[3-hydroxy- \n2-(2-methylacryloylaminome\xad\nthoxy)propoxymethyl]-2-methyl\xad\nacrylamide;  \nN-[2,3-bis-(2-methylacryloylami\xad\nnomethoxy)propoxymethyl]-2- \nmethylacrylamide; methacry\xad\nlamide; \n2-methyl- N-(2-methylacryloy\xad\nlaminomethoxymethyl)- \nacrylamide;  \nN-(2,3-dihydroxypropoxy\xad\nmethyl)-2-methylacrylamide  412-790-8  —  Carc. 1B \nMuta. 2 \nSTOT RE 2 *  H350 \nH341 \nH373 **  GHS08 \nDgr H350 \nH341 \nH373 **  \n616-058-00-0  1,3-bis(3-methyl-2,5-dioxo-1 H- \npyrrolinylmethyl)benzene  412-570-1  119462-56-5  STOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH318 \nH317 \nH400 \nH410  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H373 ** \nH318 \nH317 \nH410  \n616-059-00-6  4-((4-(diethylamino)-2-ethoxyp\xad\nhenyl)imino)-1,4-dihydro-1-oxo-  \nN-propyl-2-naphthalenecarbo\xad\nxamide  412-650-6  121487-83-0  Aquatic Chronic 4  H413  —  H413  \n616-060-00-1  condensation product of: 3-(7- \ncarboxyhept-1-yl)-6-hexyl-4- \ncyclohexene-1,2-dicarboxylic \nacid with polyamines (primarily \namino-ethyl-piperazine and trie\xad\nthylenetetramine)  413-770-1  —  Acute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH314 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH314 \nH317 \nH410  \n616-061-00-7  N,N'—1,6-hexanediylbis( N- \n(2,2,6,6-tetramethyl-piperidin-4- \nyl)-formamide  413-610-0  124172-53-8  Eye Irrit. 2 \nAquatic Chronic 3  H319 \nH412  GHS07 \nWng  H319 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1114}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1116\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-062-00-2  N-[3-[(2-acetyloxy)ethyl](phenyl- \nmethyl)amino]-4-methoxypheny\xad\nlacetamide  411-590-8  70693-57-1  Skin Corr. 1B \nAquatic Chronic 3  H314 \nH412  GHS05 \nDgr H314 \nH412  \n616-063-00-8  3-dodecyl-(1-(1,2,2,6,6-penta\xad\nmethyl-4-piperidin)-yl)-2,5- \npyrrolidindione  411-920-0  106917-30-0  Acute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1A \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH302 \nH373 ** \nH314 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H331 \nH302 \nH373 ** \nH314 \nH410  \n616-064-00-3  N—tert-butyl-3-methylpicoli\xad\nnamide  406-720-5  32998-95-1  Aquatic Chronic 3  H412  —  H412  \n616-065-00-9  3'-(3-acetyl-4-hydroxyphenyl)- \n1,1-diethylurea  411-970-3  79881-89-3  Acute Tox. 4 * \nSTOT RE 2 *  H302 \nH373 **  GHS08 \nGHS07 \nWng  H302 \nH373 **  \n616-066-00-4  5,6,12,13-tetrachloroanthra(2,1,9- \ndef:6,5,10- d'e'f')diisoquinoline- \n1,3,8,10(2 H,9H)-tetrone  405-100-1  115662-06-1  Repr. 2  H361f ***  GHS08 \nWng  H361f ***  \n616-067-00-X  dodecyl 3-(2-(3-benzyl-4-ethoxy- \n2,5-dioxoimidazolidin-1-yl)-4,4- \ndimethyl-3-oxovaleramido)-4- \nchlorobenzoate  407-300-4  92683-20-0  Aquatic Chronic 4  H413  —  H413  \n616-068-00-5  potassium 4-(11-methacrylamid\xad\noundecanamido)benzenesulfonate  406-500-9  174393-75-0  Skin Sens. 1  H317  GHS07 \nWng  H317  \n616-069-00-0  1-hydroxy-5-(2-methylpropyloxy\xad\ncarbonylamino)- N-(3-dodecy\xad\nloxypropyl)-2-naphthoamide  406-210-2  110560-22-0  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1115}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1117\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-070-00-6  reaction mass of: 3,3'-dicyclo\xad\nhexyl-1,1'-methylenebis(4,1- \nphenylene)diurea; \n3-cyclohexyl-1-(4-(4-(3-octadecy\xad\nlureido)benzyl)phenyl)urea; \n3,3'-dioctadecyl-1,1'-methylene\xad\nbis(4,1-phenylene)diurea  406-530-2  —  Aquatic Chronic 4  H413  —  H413  \n616-071-00-1  reaction mass of: bis( N-cyclo\xad\nhexyl- N'-phenyleneur\xad\neido)methylene; \nbis(N-octadecyl- N'-phenyleneur\xad\neido)methylene; \nbis(N-dicyclohexyl- N'-phenyle\xad\nneureido)methylene (1:2:1)  406-550-1  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n616-072-00-7  1-(2-deoxy-5-O-trityl-β-D-threo\xad\npentofuranosyl)thymine  407-120-6  55612-11-8  Aquatic Chronic 4  H413  —  H413  \n616-073-00-2  4'-ethoxy-2-benzimidazoleanilide  407-600-5  120187-29-3  Muta. 2 \nAquatic Chronic 4  H341 \nH413  GHS08 \nWng  H341 \nH413  \n616-074-00-8  N-butyl-2-(4-morpholinylcarbo\xad\nnyl)benzamide  407-730-2  104958-67-0  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H319 \nH317 \nH412  GHS07 \nWng  H319 \nH317 \nH412  \n616-075-00-3  D, L-( N,N-diethyl-2-hydroxy-2- \nphenylacetamide)  408-120-9  65197-96-8  Acute Tox. 4 * \nEye Dam. 1  H302 \nH318  GHS05 \nGHS07 \nDgr H302 \nH318  \n616-076-00-9  tebufenozide (ISO);  \nN-tert-butyl- N'-(4-ethylbenzoyl)- \n3,5-dimethylbenzohydrazide  412-850-3  112410-23-8  Aquatic Chronic 2  H411  GHS09  H411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1116}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1118\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-077-00-4  reaction mass of: 2-(9-methyl- \n1,3,8,10-tetraoxo-2,3,9,10- \ntetrahydro-(1 H,8H)-anthra[2,1,9-  \ndef: 6,5,10- d'e'f']diisoquinolin-2- \nylethansulfonic acid; \npotassium 2-(9-methyl-1,3,8,10- \ntetraoxo-2,3,9,10-tetrahydro- \n(1H,8H)-anthra[2,1,9- def: 6,5,10-  \nd'e'f']diisoquinolin-2-ylethan\xad\nsulfate  411-310-4  —  Eye Dam. 1  H318  GHS05 \nDgr H318  \n616-078-00-X  2-[2,4-bis(1,1-dimethyl- \nethyl)phenoxy]- N-(2-hydroxy-5- \nmethyl-phenyl)hexanamide  411-330-3  104541-33-5  Aquatic Chronic 4  H413  —  H413  \n616-079-00-5  1,6-hexanediyl-bis(2-(2-(1- \nethylpentyl)-3-oxazolidi\xad\nnyl)ethyl)carbamate  411-700-4  140921-24-0  Skin Sens. 1  H317  GHS07 \nWng  H317  \n616-080-00-0  4-(2-((3-ethyl-4-methyl-2-oxo- \npyrrolin-1-yl)carboxa\xad\nmido)ethyl)benzenesulfonamide)  411-850-0  119018-29-0  Aquatic Chronic 3  H412  —  H412  \n616-081-00-6  5-bromo-8-naphtholactam  413-480-5  24856-00-6  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  \n616-082-00-1  N-(5-chloro-3-((4-(diethylamino)- \n2-methylphenyl)imino-4-methyl- \n6-oxo-1,4-cyclohexadien-1- \nyl)benzamide  413-200-1  129604-78-0  Skin Sens. 1  H317  GHS07 \nWng  H317  \n616-083-00-7  [2-[(4-nitrophe\xad\nnyl)amino]ethyl]urea  410-700-1  27080-42-8  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1117}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1119\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-084-00-2  2,4-bis[ N'-(4-methylphenyl)ure\xad\nido]toluene  411-790-5  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-085-00-8  3-(2,4-dichlorophenyl)-6-fluoro- \nquinazoline-2,4(1 H,3H)-dione  412-190-6  168900-02-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-086-00-3  2-acetylamino-6-chloro-4-[(4- \ndiethylamino)2-methylphenyl- \nimino]-5-methyl-1-oxo-2,5-cyclo\xad\nhexadiene  412-250-1  102387-48-4  Aquatic Chronic 4  H413  —  H413  \n616-087-00-9  reaction mass of: 7,9,9-trimethyl- \n3,14-dioxa-4,13-dioxo-5,12- \ndiazahexadecane-1,16-diyl-prop- \n2-enoate; \n7,7,9-trimethyl-3,14-dioxa-4,13- \ndioxo-5,12-diazahexadecane- \n1,16-diyl-prop-2-enoate  412-260-6  52658-19-2  Eye Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H319 \nH317 \nH411  GHS07 \nGHS09 \nWng  H319 \nH317 \nH411  \n616-088-00-4  2-aminosulfonyl- N, N -dimethyl\xad\nnicotinamide  413-440-7  112006-75-4  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n616-089-00-X  5-(2,4-dioxo-1,2,3,4-tetrahydro\xad\npyrimidine)-3-fluoro-2-hydroxy\xad\nmethyltetrahydrofuran  415-360-8  41107-56-6  Muta. 2  H341  GHS08 \nWng  H341  \n616-090-00-5  1-(1,4-benzodioxan-2-ylcarbo\xad\nnyl)piperazine hydrochloride  415-660-9  70918-74-0  Acute Tox. 3 * \nAcute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nAquatic Chronic 2  H331 \nH311 \nH301 \nH373 ** \nH411  GHS06 \nGHS08 \nGHS09 \nDgr H331 \nH311 \nH301 \nH373 ** \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1118}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1120\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-091-00-0  1,3,5-tris-[(2 S and 2 R)-2,3- \nepoxypropyl]-1,3,5-triazine- \n2,4,6-(1 H,3H,5H)-trione  423-400-0  59653-74-6  Muta. 1B \nAcute Tox. 3 * \nAcute Tox. 4 * \nSTOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1  H340 \nH331 \nH302 \nH373 ** \nH318 \nH317  GHS06 \nGHS08 \nGHS05 \nDgr H340 \nH331 \nH302 \nH373 ** \nH318 \nH317  \n616-092-00-6  polymeric reaction product of \nbicyclo[2.2.1]hepta-2,5-diene, \nethene, 1,4-hexadiene, 1-propene \nwith N, N -di-2-propenylfor\xad\nmamide  404-035-6  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n616-093-00-1  reaction products of: aniline- \nterephthalaldehyde- o-toluidine \ncondensate with maleic \nanhydride  406-620-1  129217-90-9  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n▼M15  \n616-094-00-7  3,3′-dicyclohexyl-1,1′-methylene\xad\nbis(4,1-phenylene)diurea  406-370-3  58890-25-8  Aquatic Chronic 4  H413  H413  \n▼M16  \n616-095-00-2  3,3'-dioctadecyl-1,1'-methylene \nbis(4,1-phenylene)diurea  406-690-3  43136-14-7  Aquatic Chronic 4  H413  —  H413  \n616-096-00-8  N-(3-hexadecyloxy-2- \nhydroxyprop-1-yl)- N-(2-hydro\xad\nxyethyl)palmitamide  408-110-4  110483-07-3  Aquatic Chronic 4  H413  —  H413  \n616-097-00-3  N,N'-1,4-phenylenebis(2-((2- \nmethoxy-4-nitrophenyl)azo)-3- \noxobutanamide  411-840-6  83372-55-8  Aquatic Chronic 4  H413  —  H413  \n616-098-00-9  1-[4-chloro-3-((2,2,3,3,3-penta\xad\nfluoropropoxy)methyl)phenyl]-5- \nphenyl-1 H-1,2,4-triazole-3-carbo\xad\nxamide  411-750-7  119126-15-7  Aquatic Chronic 2  H411  GHS09  H411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1119}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1121\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-099-00-4  2-[4-[(4-hydroxyphenyl)sulfo\xad\nnyl]phenoxy]-4,4-dimethyl- N-[5- \n[(methylsulfonyl)amino]-2-[4- \n(1,1,3,3-tetramethylbutyl)phen\xad\noxy]phenyl]-3-oxopentanamide  414-170-2  135937-20-1  Aquatic Chronic 4  H413  —  H413  \n616-100-00-8  1,3-dimethyl-1,3-bis(trimethyl\xad\nsilyl)urea  414-180-7  10218-17-4  Acute Tox. 4 * \nSkin Irrit. 2  H302 \nH315  GHS07 \nWng  H302 \nH315  \n616-101-00-3  (S)-N-tert-butyl-1,2,3,4- \ntetrahydro-3-isoquinolinecarbo\xad\nxamide  414-600-9  149182-72-9  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n616-102-00-9  reaction mass of: α-[3-(3-mercap\xad\ntopropanoxycarbony\xad\nlamino)methylphenylaminocar\xad\nbonyl]-ω-[3-(3-mercaptopropan\xad\noxycarbonylamino)methylpheny\xad\nlaminocarbonyloxy]-poly-(oxy\xad\nethylene-co-oxypropylene); \n1,2-(or 1,3-)bis[α-(3-mercapto\xad\npropanoxycarbonylamino)methyl\xad\nphenylaminocarbonyl)-ω-oxy- \npoly(oxyethylene-co-oxypropy\xad\nlene)]-3-(or 2-)propanol; \n1,2,3-tris[α-(3-mercaptopropan\xad\noxycarbonyl-amino)methylpheny\xad\nlaminocarbonyl)-ω-oxy-poly- \n(oxyethylene-co-oxypropy\xad\nlene)]propane]  415-870-0  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n616-103-00-4  (S,S)-trans -4-(acetylamino)-5,6- \ndihydro-6-methyl-7,7-dioxo-4 H- \nthieno[2,3-b]thiopyran-2- \nsulfonamide  415-030-3  120298-38-6  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1120}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1122\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-104-00-X  benalaxyl (ISO); \nmethyl  N-(2,6-dimethylphenyl)-  \nN-(phenylacetyl)-DL-alaninate  275-728-7  71626-11-4  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-105-00-5  chlorotoluron (ISO); \n3-(3-chloro- p-tolyl)-1,1- \ndimethylurea  239-592-2  15545-48-9  Carc. 2 \nRepr. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361d *** \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH361d *** \nH410  \n616-106-00-0  phenmedipham (ISO); \nmethyl 3-(3-methylcarbaniloy\xad\nloxy)carbanilate  237-199-0  13684-63-4  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-107-00-6  cinidon ethyl (ISO); \nethyl ( Z)-2-chloro-3-[2-chloro-5- \n(cyclohex-1-ene-1,2-dicarboxi\xad\nmido)phenyl]acrylate  — 142891-20-1  Carc. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH317 \nH410  \n616-108-00-1  iodosulfuron-methyl-sodium; \nsodium ({[5-iodo-2-(methoxycar\xad\nbonyl)phenyl]sulfonyl}carba\xad\nmoyl)(4-methoxy-6-methyl-1,3,5- \ntriazin-2-yl)azanide  — 144550-36-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1121}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1123\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-109-00-7  sulfosulfuron (ISO); \n1-(4,6-dimethoxypyrimidin-2-yl)- \n3-(2-ethylsulfonylimidazo[1,2- \na]pyridin-3-yl)sulfonylurea  — 141776-32-1  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-110-00-2  cyclanilide (ISO); \n1-(2,4-dichloroanilinocar\xad\nbonyl)cyclopropanecarboxylic \nacid 419-150-7  113136-77-9  Acute Tox. 4 * \nAquatic Chronic 2  H302 \nH411  GHS07 \nGHS09 \nWng  H302 \nH411  \n616-111-00-8  fenhexamid (ISO);  \nN-(2,3-dichlor-4-hydroxyphenyl)- \n1-methylcyclohexancarboxamid  422-530-5  126833-17-8  Aquatic Chronic 2  H411  GHS09  H411  \n616-112-00-3  oxasulfuron (ISO); \noxetan-3-yl 2-[(4,6-dimethylpyri\xad\nmidin-2-yl)-carbamoylsulfa\xad\nmoyl]benzoate  — 144651-06-9  STOT RE 2 * \nAquatic Acute 1 \nAquatic Chronic 1  H373 ** \nH400 \nH410  GHS08 \nGHS09 \nWng  H373 ** \nH410  \n616-113-00-9  desmedipham (ISO); \nethyl 3-phenylcarbamoyloxyphe\xad\nnylcarbamate  237-198-5  13684-56-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M=10  \n616-114-00-4  dodecanamide,  N,N'-(9,9',10,10'- \ntetrahydro-9,9',10,10'- \ntetraoxo(1,1'-bianthracene)-4,4'- \ndiyl)bis-  418-010-2  136897-58-0  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1122}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1124\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-115-00-X  N-(3-acetyl-2-hydroxyphenyl)-4- \n(4-phenylbutoxy)benzamide  416-150-9  136450-06-1  Aquatic Chronic 4  H413  —  H413  \n616-116-00-5  N-(4-dimethylaminopyridinium)- \n3-methoxy-4-(1-methyl-5- \nnitroindol-3-ylmethyl)- N-(o- \ntolylsulfonyl)benzamidate  416-790-9  143052-96-4  Aquatic Chronic 4  H413  —  H413  \n616-117-00-0  N-[2-(3-acetyl-5-nitrothiophen-2- \nylazo)-5-diethylaminophe\xad\nnyl]acetamide  416-860-9  777891-21-1  Repr. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H361f *** \nH317 \nH400 \nH410  GHS08 \nGHS09 \nWng  H361f *** \nH317 \nH410  \n616-118-00-6  N-(2',6'-dimethylphenyl)-2-piperi\xad\ndinecarboxamide hydrochloride  417-950-0  65797-42-4  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n616-119-00-1  2-(1-butyl-3,5-dioxo-2-phenyl- \n(1,2,4)-triazolidin-4-yl)-4,4- \ndimethyl-3-oxo- N-(2-methoxy-5- \n(2-(dodecyl-1-sulfonyl))propiony\xad\nlamino)-phenyl)-pentanamide  418-060-5  118020-93-2  Aquatic Chronic 4  H413  —  H413  \n616-120-00-7  reaction mass of:  N-(3-dimethyl\xad\namino-4-methyl-phenyl)- \nbenzamide;  \nN-(3-dimethylamino-2-methyl- \nphenyl)-benzamide;  \nN-(3-dimethylamino-3-methyl- \nphenyl)-benzamide  420-600-1  —  STOT RE 2 * \nAquatic Chronic 2  H373 ** \nH411  GHS08 \nGHS09 \nWng  H373 ** \nH411  \n616-121-00-2  2,4-dihydroxy- N-(2-methoxyphe\xad\nnyl)benzamide  419-090-1  129205-19-2  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1123}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1125\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-122-00-8  methyl neodecanamide  414-460-9  105726-67-8  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n616-123-00-3  N-[3-[[4-(diethylamino)-2- \nmethylphenyl]imino]-6-oxo-1,4- \ncyclohexadienyl]acetamide  414-740-0  96141-86-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-124-00-9  lithium bis(trifluoromethylsulfo\xad\nnyl)imide  415-300-0  90076-65-6  Acute Tox. 3 * \nAcute Tox. 3 * \nSTOT RE 2 * \nSkin Corr. 1B \nAquatic Chronic 3  H311 \nH301 \nH373** \nH314 \nH412  GHS06 \nGHS05 \nGHS08 \nDgr H311 \nH301 \nH373** \nH314 \nH412  \n616-125-00-4  3-cyano- N-(1,1-dimethylethyl)an\xad\ndrosta-3,5-diene-17-β-carbo\xad\nxamide  415-730-9  151338-11-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  410 \n616-126-00-X  1-methyl-4-nitro-3-propyl-1 H- \npyrazole-5-carboxamide  423-960-6  139756-01-7  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 3  H302 \nH373** \nH412  GHS08 \nGHS07 \nWng  H302 \nH373** \nH412  \n616-127-00-5  reaction mass of:  N, N' -Ethane- \n1,2-diylbis(decanamide); \n12-Hydroxy- N-[2-[1-oxyde\xad\ncyl)amino]ethyl]octadecanamide;  \nN, N' -Ethane-1,2-diylbis(12hy\xad\ndroxyoctadecanamide)  430-050-2  —  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n616-128-00-0  N-(2-(1-allyl-4,5-dicyanoi\xad\nmidazol-2-ylazo)-5-(dipropy\xad\nlamino)phenyl)-acetamide  417-530-7  123590-00-1  Aquatic Chronic 4  H413  —  H413  \n616-129-00-6  N,N'-bis(2,2,6,6-tetramethyl-4- \npiperidyl)isophthalamide  419-710-0  42774-15-2  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1124}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1126\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-130-00-1  N-(3-(2-(4,4-dimethyl-2,5-dioxo- \nimidazolin-1-yl)-4,4-dimethyl-3- \noxo-pentanoylamino)-4-methoxy- \nphenyl)-octadecanamide  421-780-2  150919-56-5  Aquatic Chronic 4  H413  —  H413  \n616-131-00-7  1-aminocyclopentanecarbo\xad\nxamide  422-950-9  17193-28-1  STOT RE 1 \nAcute Tox. 4 * \nEye Dam. 1  H372** \nH302 \nH318  GHS05 \nGHS08 \nGHS07 \nDgr H372** \nH302 \nH318  \n616-132-00-2  N-[4-(4-cyano-2-furfurylidene- \n2,5-dihydro-5-oxo-3-furyl)phe\xad\nnyl]butane-1-sulfonamide  423-250-6  130016-98-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-133-00-8  N-cyclohexyl- S, S-dioxo \nbenzo[ b]tiophene-2-carboxamide  423-990-1  149118-66-1  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH410  \n616-134-00-3  3,3'-bis(dioctyloxyphosphino\xad\nthioylthio)- N, N' -oxybis(methyl\xad\nene)dipropionamide  401-820-5  793710-14-2  Aquatic Chronic 3  H412  —  H412  \n616-135-00-9  ( 3 S,4aS,8aS)-2-[(2 R,3S)-3-amino- \n2-hydroxy-4-phenylbutyl]- N-tert - \nbutyldecahydroisoquinoline-3- \ncarboxamide  430-230-0  136522-17-3  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n616-136-00-4  reaction product of cocoalkyldie\xad\nthanolamides and cocoalkyl\xad\nmonoglycerides and molybde\xad\nnumtrioxide (1.75-2.2: 0.75- \n1.0:0.1-1.1)  430-380-7  —  Aquatic Chronic 2  H411  GHS09  H411  \n616-137-00-X  4-dichloroacetyl-1-oxa-4- \nazaspiro[4.5]decane  401-130-4  71526-07-3  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1125}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1127\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-138-00-5  benzoic acid,  N-tert-butyl- N'-(4- \nchlorobenzoyl)hydrazide  431-600-4  112226-61-6  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n616-139-00-0  ( 3 S, 4a S, 8a S)-N-tert-butylde\xad\ncahydro-3-isoquinolinecarbo\xad\nxamide  420-380-5  136465-81-1  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Chronic 3  H302 \nH318 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH412  \n616-140-00-6  N, N'' -(methylenedi-4,1-pheny\xad\nlene)bis[ N'-(4-methylphe\xad\nnyl)urea]  429-380-1  133336-92-2  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n616-141-00-1  zoxamide (ISO); \n(RS)-3,5-dichloro- N-(3-chloro-1- \nethyl-1-methyl-2-oxopropyl)- p- \ntoluamide  — 156052-68-5  Skin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H317 \nH410  M=10  \n616-142-00-7  1,3-bis(vinylsulfonylaceta\xad\nmido)propane  428-350-3  93629-90-4  Muta. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H341 \nH318 \nH317 \nH412  GHS08 \nGHS05 \nGHS07 \nDgr H341 \nH318 \nH317 \nH412  \n616-143-00-2  N,N'-dihexadecyl- N,N'-bis(2- \nhydroxyethyl)propanediamide  422-560-9  149591-38-8  Repr. 2 \nEye Irrit. 2 \nAquatic Chronic 4  H361f *** \nH319 \nH413  GHS08 \nWng  H361f *** \nH319 \nH413  \n616-144-00-8  3,4-dichloro- N-[5-chloro-4-[2-[4- \ndodecyloxyphenylsulfonyl]buty\xad\nramido]-2-hydroxyphenyl]ben\xad\nzamide  431-130-1  —  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1126}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1128\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-145-00-3  pethoxamide (ISO); \n2-chloro- N-(2-ethoxyethyl)- N-(2- \nmethyl-1-phenylprop-1enyl)acet\xad\namide  — 106700-29-2  Acute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  M=100  \n616-146-00-9  N-(2-methoxy-5-octadecanoylam\xad\ninophenyl)-2-(3-benzyl-2,5- \ndioxoimidazolidin-1-yl)-4,4- \ndimethyl-3-oxopentanoic \nacidamide  431-330-7  142776-95-2  Aquatic Chronic 4  H413  —  H413  \n616-147-00-4  1-methyl-4-(2-methyl-2 H- \ntetrazol-5-yl)-1 H-pyrazole-5- \nsulfonamide  424-160-1  139481-22-4  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n616-148-00-X  N-[6,9-dihydro-9-[[2-hydroxy-1- \n(hydroxymethyl)ethoxy]methyl]- \n6-oxo-1 H-purin-2-yl]acetamide  424-550-1  84245-12-5  Carc. 1B \nMuta. 1B \nRepr. 1B  H350 \nH340 \nH360FD  GHS08 \nDgr H350 \nH340 \nH360FD  \n616-150-00-0  ( 2 R,3S)-N-(3-amino-2-hydroxy-4- \nphenylbutyl)- N-isobutyl-4-nitro\xad\nbenzenesulfonamide hydro\xad\nchloride  425-260-6  —  STOT RE 2 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H373** \nH318 \nH317 \nH411  GHS05 \nGHS08 \nGHS07 \nGHS09 \nDgr H373** \nH318 \nH317 \nH411  \n616-151-00-6  N-(2-amino-4,6-dichloropyri\xad\nmidin-5-yl)formamide  425-650-6  171887-03-9  Acute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 3  H302 \nH318 \nH317 \nH412  GHS05 \nGHS07 \nDgr H302 \nH318 \nH317 \nH412  \n616-152-00-1  4-(4-fluorophenyl)-2-(2-methyl- \n1-oxopropyl)-4-oxo-3, N-diphe\xad\nnylbutanamide  425-850-3  125971-96-2  Aquatic Chronic 4  H413  —  H413  \n616-153-00-7  4-methyl-3-oxo- N-phenyl-2-(phe\xad\nnylmethylene)pentanamide  425-860-8  125971-57-5  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1127}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1129\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-154-00-2  3,4-dichloro- N-[5-chloro-4-[2-[4- \n(hexadecyloxy)phenylsulfo\xad\nnyl]butyramido]-2-hydroxyphe\xad\nnyl]benzamide  431-110-0  —  Aquatic Chronic 4  H413  —  H413  \n616-155-00-8  N,N,N',N'-tetracyclohexyl-1,3- \nbenzenedicarboxamide  431-040-0  104560-40-9  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-156-00-3  6-(2-chloro-6-cyano-4-nitro\xad\nphenylazo)-4-methoxy-3-[ N- \n(methoxycarbonylmethyl)- N-(1- \nmethoxycarbonyle\xad\nthyl)amino]acetanilide  430-500-8  204277-61-2  Aquatic Chronic 4  H413  —  H413  \n616-157-00-9  3-amino-4-hydroxy- N-(3-isopro\xad\npoxypropyl)benzenesulfonamide \nhydrochloride  427-780-9  114565-70-7  Acute Tox. 4 * \nEye Dam. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH318 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H302 \nH318 \nH410  \n616-158-00-4  N-[4-cyano-3-trifluoromethylphe\xad\nnyl]methacrylamide  427-880-2  90357-53-2  STOT RE 2 * \nAquatic Chronic 2  H373** \nH411  GHS08 \nGHS09 \nWng  H373** \nH411  \n616-160-00-5  2,2'-azobis[ N-(2-hydroxyethyl)2- \nmethylpropionamide]  429-090-3  61551-69-7  Skin Sens. 1 \nAquatic Chronic 3  H317 \nH412  GHS07 \nWng  H317 \nH412  \n616-161-00-0  2,4-dichloro-5-hydroxyacet\xad\nanilide  429-110-0  67669-19-6  Aquatic Chronic 3  H412  —  H412  \n616-162-00-6  isostearic acid monoisopropan\xad\nolamide  431-540-9  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1128}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1130\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-163-00-1  4,4'-methylenebis[ N-(4-chloro\xad\nphenyl)-3-hydroxynaphthalene-2- \ncarboxamide]  430-350-3  192463-88-0  Aquatic Chronic 4  H413  —  H413  \n616-164-00-7  dimoxystrobin (ISO); \n(E)-2-(methoxyimino)- N-methyl- \n2-[α-(2,5-xylyloxy)- o-tolyl]acet\xad\namide  — 149961-52-4  Carc. 2 \nRepr. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH361d*** \nH332 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH361d*** \nH332 \nH410  M=10  \n616-165-00-2  beflubutamid (ISO); \n(RS)-N-benzyl-2-(α, α, α, 4-tetra\xad\nfluoro- m-tolyoxy)butyramide  — 113614-08-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M=100  \n616-166-00-8  cyazofamid (ISO); \n4-chloro-2-cyano- N, N -dimethyl- \n5-p-tolylimidazole-1-sulfonamide  — 120116-88-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M=10  \n616-167-00-3  N, N -dibutyl-(2,5-dihydro-5- \nthioxo-1 H-tetrazol-1-yl)acet\xad\namide  418-290-6  168612-06-4  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  \n616-168-00-9  1-dimethylcarbamoyl-4-(2-sulfon\xad\natoethyl)pyridinium  418-440-0  136997-71-2  Skin Sens. 1  H317  GHS07 \nWng  H317  \n616-169-00-4  4-[4-(2,2-dimethyl-propana\xad\nmido)]phenylazo-3-(2-chloro-5- \n(2-(3-pentadecylphenoxy)butyla\xad\nmido)anilino)-1-(2,4,6-trichlorop\xad\nhenyl)-2-pyrazoline-5-one  420-220-4  92771-56-7  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n616-170-00-X  ( 2R)-2-amino-2-phenylacetamide  420-370-0  6485-67-2  Eye Irrit. 2 \nSkin Sens. 1  H319 \nH317  GHS07 \nWng  H319 \nH317  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1129}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1131\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-171-00-5  2-(para-chlorophenyl)glyci\xad\nneamide  420-830-0  102333-75-5  Eye Dam. 1 \nSkin Sens. 1  H318 \nH317  GHS05 \nGHS07 \nDgr H318 \nH317  \n616-172-00-0  N-(2,2,6,6-tetramethyl-1-oxylpi\xad\nperidin-4-yl)acetamide; \n(4-acetamido-2,2,6,6-tetra \nmethyl-1-piperidinyl)oxidanyl  423-840-3  14691-89-5  Acute Tox. 4 *  H302  GHS07 \nWng  H302  \n616-174-00-1  2-butyl-1,3-diazaspiro[4.4]non-1- \nen-4-one hydrochloride  424-560-4  151257-01-1  Acute Tox. 4 * \nEye Irrit. 2  H302 \nH319  GHS07 \nWng  H302 \nH319  \n616-175-00-7  2-(2-hexyldecyloxy)benzamide  431-230-3  202483-62-3  Aquatic Chronic 4  H413  —  H413  \n616-176-00-2  3 - N, N -bis(methoxyethyl)aminoa\xad\ncetanilide  432-530-7  24294-01-7  Acute Tox. 4 * \nAquatic Chronic 3  H302 \nH412  GHS07 \nWng  H302 \nH412  \n616-177-00-8  (3-(4-(2-(butyl-(4-methylphe\xad\nnylsulfonyl)amino)phenylthio)5- \noxo-1-(2,4,6-trichlorophenyl)- \n4,5-dihydro-1 H-pyrazole-3- \nylamino)-4-chlorophenyl)tetra\xad\ndecanamide;  \nN-[3-({4-[(2-{]butyl[}(4methyl\xad\nphenyl)sulfonyl{]amino[}phe\xad\nnyl)thio{]-5-oxo-1-(2,4,6-trich\xad\nlorophenyl)-4,5-dihydro-1 H- \npyrazol-3yl[}amino)-4-chlorophe\xad\nnyl]tetradecanamide  432-970-1  217324-98-6  Aquatic Chronic 4  H413  —  H413  \n616-178-00-3  N-(5-(bis(2-methoxye\xad\nthyl)amino)-2-((2-cyano-4,6-dini\xad\ntrophenyl)-azo)phenyl)acetamide  434-500-9  52583-35-4  Aquatic Chronic 4  H413  —  H413  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1130}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1132\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-179-00-9  2-chloro- N-(4-methylphenyl)acet\xad\namide  435-170-9  16634-82-5  Eye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H318 \nH317 \nH410  \n616-180-00-4  N, N -(dimethylamino)thioace\xad\ntamide hydrochloride  435-470-1  27366-72-9  Repr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H360D*** \nH400 \nH410  GHS08 \nGHS09 \nDgr H360D*** \nH410  \n616-181-00-X  4'-methyldodecane-1-sulfon\xad\nanilide  435-490-9  17417-32-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-182-00-5  N'-(1,3-dimethylbutylidene)-3- \nhydroxy-2-naphthohydrazide  435-860-1  214417-91-1  Skin Sens. 1 \nAquatic Chronic 2  H317 \nH411  GHS07 \nGHS09 \nWng  H317 \nH411  \n616-183-00-0  N-dodecyl-4-methoxybenzamide  442-340-6  1854-15-5  Aquatic Chronic 4  H413  —  H413  \n616-184-00-6  3-methyl- N-(5,8,13,14- \ntetrahydro-5,8,14-trioxon\xad\naphth[2,3-c]acridin-6-yl)ben\xad\nzamide  442-560-2  105043-55-8  Aquatic Chronic 4  H413  —  H413  \n616-186-00-7  N, N' -(2-chloro-1,4-pheny\xad\nlene)bis(3-oxobutaneamide)  443-010-4  53641-10-4  Aquatic Chronic 3  H412  —  H412  \n616-188-00-8  2-(5,5-dimethyl-2,4-dioxoo\xad\nxazolidin-3-yl)-4,4-dimethyl-3- \noxo-N-(2-methoxy-5-octadec\xad\nanoylaminophenyl)pentanoic acid \namide  443-980-9  221215-20-9  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n616-189-00-3  N-[5-(bis-(2-methoxy-ethyl)- \namino]-2-(6-bromo-2-methyl-1,3- \ndioxo-2,3-dihydro-1 H-isoindol-5- \nylazo)-phenyl]acetamide  444-780-4  452962-97-9  Aquatic Chronic 4  H413  —  H413  \n616-190-00-9  N-decyl-4-nitrobenzamide  445-880-0  64026-19-3  Aquatic Chronic 4  H413  —  H413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1131}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1133\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-191-00-4  2-ethyl- N-methyl- N-(3-methyl\xad\nphenyl)butanamide  446-190-2  406488-30-0  Acute Tox. 4 * \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H302 \nH319 \nH315 \nH317 \nH411  GHS07 \nGHS09 \nWng  H302 \nH319 \nH315 \nH317 \nH411  \n616-192-00-X  2-[2-(3-butoxypropyl)-1,1-dioxo- \n1,2,4-benzothiadiazin-3-yl]-5'-  \ntert-butyl-2-(5,5-dimethyl-2,4- \ndioxo-1,3-oxazolidin-3-yl)-2'-[(2- \nethylhexyl)thio]acetanilide  448-060-0  727678-39-9  Aquatic Chronic 4  H413  —  H413  \n616-193-00-5  N-[2-(2-butyl-4,6-dicyano-1,3- \ndioxo-2,3-dihydro-1 H-isoindol-5- \nylazo)-5-diethylamino- \nphenyl]acetamide  449-940-7  368450-39-9  Aquatic Chronic 4  H413  —  H413  \n616-194-00-0  2,2-diethoxy- N, N -dimethylacet\xad\namide  449-950-1  34640-92-1  Eye Irrit. 2  H319  GHS07 \nWng  H319  \n616-196-00-1  disodium salt of 1-hydroxy-4-(β- \n(4-(1-hydroxy-3,6-disulfo-8- \nacetylamino-2-naphthylazo)phen\xad\noxy)ethoxy)- N-dodecyl-2-naph\xad\nthamide  419-990-4  —  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n616-197-00-7  reaction mass of: potassium  N- \n[3-(dimethyloxidoamino)propyl]- \n1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8- \nheptadecafluorooctane sulfon\xad\namidate;  N -[3-(dimethyl\xad\noxidoamino)propyl]- \n1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8- \nheptadecafluorooctane \nsulfonamide  422-500-1  —  STOT RE 2 *  H373**  GHS08 \nWng  H373**  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1132}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1134\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-198-00-2  1,3-bis[12-hydroxy-octade\xad\ncamide- N-methylene]-benzene  423-300-7  —  Skin Sens. 1 \nAquatic Chronic 4  H317 \nH413  GHS07 \nWng  H317 \nH413  \n616-200-00-1  reaction mass of  N, N ’-ethane1,2- \ndiylbis(hexanamide) and 12- \nhydroxy- N-[2-[(1- \noxyhexyl)amino]ethyl]octadec\xad\nanamide and  N, N’ -ethane-1,2- \ndiylbis(12-hydroxyoctadecan \namide)  432-430-3  Aquatic Chronic 4  H413  H413  \n616-201-00-7  12-hydroxyoctadecanoic acid, \nreaction products with 1,3- \nbenzenedimethanamine and \nhexamethylenediamine  432-840-2  220926-97-6  Acute Tox. 4 * \nAquatic Chronic 4  H332 \nH413  GHS07 \nWng  H332 \nH413  \n616-202-00-2  reaction mass of: 2,2'-[(3,3'-dich\xad\nloro[1,1'-biphenyl]-4,4'- \ndiyl)bis(azo)]bis[ N-(2,4-dimethyl\xad\nphenyl)]-3-oxo-butanamide; \n2-[[3,3'-dichloro-4'-[[1[[(2,4- \ndimethylphenyl)amino]carbonyl]- \n2-oxopropyl]azo][1,1'biphenyl]- \n4-yl]azo]- N-(2-methylphenyl)-3- \noxo-butanamide; \n2-[[3,3'-dichloro-4'-[[1[[(2,4- \ndimethylphenyl)amino]carbonyl]- \n2-oxopropyl]azo][1,1'-biphenyl]- \n4-yl]azo]- N-(2-carboxylphenyl)- \n3-oxo-butanamide  434-330-5  —  Carc. 2 \nSkin Sens. 1 \nAquatic Chronic 4  H351 \nH317 \nH413  GHS08 \nGHS07 \nWng  H351 \nH317 \nH413  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1133}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1135\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-203-00-8  reaction mass of:  N-[5-[bis-(2- \nmethoxyethyl)amino]-2-(2butyl- \n4,6-dicyano-1,3-dioxo-2,3- \ndihydro-1 H-isoindol-5-yl- \nazo)phenyl]acetamide;  \nN-[2-(2-butyl-4,6-dicyano-1,3- \ndioxo-2,3-dihydro-1 H-isoindol5- \nylazo)5-diethylaminophenyl]acet\xad\namide  442-280-0  —  Aquatic Chronic 4  H413  —  H413  \n616-204-00-3  N, N'' -(methylenedi-4,1-pheny\xad\nlene)bis[ N'-octylurea]  451-060-3  122886-55-9  Aquatic Chronic 4  H413  —  H413  \n616-205-00-9  metazachlor (ISO); \n2-chloro- N-(2,6-dimethylphenyl)-  \nN-(1H-pyrazol-1-ylmethyl)-acet\xad\namide  266-583-0  67129-08-2  Skin Sens. 1B \nCarc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H317 \nH351 \nH400 \nH410  GHS07 \nGHS08 \nGHS09 \nWng  H317 \nH351 \nH410  M = 100 \nM = 100  \n616-206-00-4  flufenoxuron (ISO); \n1-(4-(2-cloro-α, α,α-p-trifluor\xad\notolyloxy)-2-fluorophenyl)-3- \n(2,6-difluorobenzolyl)urea  417-680-3  101463-69-8  Lact. \nAquatic Acute 1 \nAquatic Chronic 1  H362 \nH400 \nH410  GHS09 \nWng  H362 \nH410  M = 10 000 \nM = 10 000  \n▼M13  \n616-207-00-X  polyhexamethylene biguanide \nhydrochloride; \nPHMB  — 32289-58-0 \n27083-27-8  Carc. 2 \nAcute Tox. 2 \nAcute Tox. 4 \nSTOT RE 1 \nEye Dam. 1 \nSkin Sens. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH330 \nH302 \nH372 \n(respiratory \ntract) (inha\xad\nlation) \nH318 \nH317 \nH400 \nH410  GHS08 \nGHS06 \nGHS05 \nGHS09 \nDgr H351 \nH330 \nH302 \nH372 \n(respiratory \ntract) (inha\xad\nlation) \nH318 \nH317 \nH410  M = 10 \nM = 10  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1134}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1136\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M16  \n616-208-00-5  N-ethyl-2-pyrrolidone; \n1-ethylpyrrolidin-2-one  220-250-6  2687-91-4  Repr. 1B  H360D  GHS08 \nDgr H360D  \n616-209-00-0  amidosulfuron (ISO); \n3-(4,6-dimethoxypyrimidin-2-yl)- \n1-((N-methyl- N-methylsulfony\xad\nlamino)sulfonyl)urea  407-380-0  120923-37-7  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 100 \nM = 100  \n616-210-00-6  tebufenpyrad (ISO);  \nN-(4-tertbutylbenzyl)-4-chloro-3- \nethyl-1-methyl-1 H-pyrazole-5- \ncarboxamide  119168-77-3  Acute Tox. 3 \nAcute Tox. 4 \nSTOT RE 2 \nSkin Sens. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH332 \nH373 (gastro- \nintestinal tract) \n(Oral) \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS09 \nDgr H301 \nH332 \nH373 \n(gastro- \nintestinal \ntract) (Oral) \nH317 \nH410  M = 10 \nM = 10  \n616-211-00-1  proquinazid (ISO); \n6-iodo-2-propoxy-3-propylquina\xad\nzolin-4(3 H)-one  189278-12-4  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  M = 1 \nM = 10  \n616-212-00-7  3-iodo-2-propynyl butylcar\xad\nbamate; 3-iodoprop-2-yn-1-yl \nbutylcarbamate  259-627-5  55406-53-6  Acute Tox. 3 \nAcute Tox. 4 \nSTOT RE 1 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH302 \nH372 (larynx) \nH318 \nH317 \nH400 \nH410  GHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H331 \nH302 \nH372 \n(larynx) \nH318 \nH317 \nH410  M = 10 \nM = 1  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1135}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1137\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M11  \n616-213-00-2  mandipropamid (ISO); 2-(4- \nchlorophenyl)- N-{2-[3-methoxy- \n4-(prop-2-yn-1-yloxy)phe\xad\nnyl]ethyl}-2-(prop-2-yn-1- \nyloxy)acetamide  — 374726-62-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 1  \n616-214-00-8  metosulam (ISO); N-(2,6- \ndichloro-3-methylphenyl)-5,7- \ndimethoxy[1,2,4]triazolo[1,5- \na]pyrimidine-2-sulfonamide  — 139528-85-1  Carc. 2 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH373 (eyes, \nkidneys) \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH373 (eyes, \nkidneys) \nH410  M = 1 000 \nM = 100  \n616-215-00-3  dimethenamid-P (ISO); 2-chloro- \nN-(2,4-dimethyl-3-thienyl)-N- \n[(2S)-1-methoxypropan-2-yl]acet\xad\namide  — 163515-14-8  Acute Tox. 4 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH317 \nH410  M = 10 \nM = 10  \n616-216-00-9  flonicamid (ISO);  N -(cyano\xad\nmethyl)-4-(trifluor\xad\nomethyl)pyridine-3-carboxamide  — 158062-67-0  Acute Tox. 4  H302  GHS07 \nWng  H302  \n616-217-00-4  sulfoxaflor (ISO); \n[methyl(oxo){1-[6-(trifluor\xad\nomethyl)-3-pyridyl]ethyl}-λ6- \nsulfanylidene]cyanamide  — 946578-00-3  Acute Tox. 4 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  M = 1 \nM = 1  \n▼M13  \n616-218-00-X  benzovindiflupyr (ISO);  N-[9- \n(dichloromethylene)-1,2,3,4- \ntetrahydro-1,4-methanonaph\xad\nthalen-5-yl]-3-(difluoromethyl)-1- \nmethyl-1 H-pyrazole-4-carbo\xad\nxamide  — 1072957-71-1  Acute Tox. 3 \nAcute Tox. 3 \nAquatic Acute 1 \nAquatic Chronic 1  H331 \nH301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H331 \nH301 \nH410  M = 100 \nM = 100  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1136}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1138\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-219-00-5  fluopyram (ISO);  N-{2-[3-chloro- \n5-(trifluoromethyl)pyridin-2- \nyl]ethyl}-2-(trifluoromethyl)ben\xad\nzamide  — 658066-35-4  Aquatic Chronic 2  H411  GHS09  H411  \n616-220-00-0  pencycuron (ISO); 1-[(4-chloro\xad\nphenyl)methyl]-1-cyclopentyl-3- \nphenylurea  266-096-3  66063-05-6  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 1  \n▼M15  \n616-221-00-6  hexaflumuron (ISO); \n1-(3,5-dichloro-4-(1,1,2,2-tetra\xad\nfluoroethoxy)phenyl)-3-(2,6- \ndifluorobenzoyl)urea  401-400-1  86479-06-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M = 1 000 \nM = 10 000  \n616-222-00-1  penthiopyrad (ISO); \n(RS)-N-[2-(1,3-dimethylbutyl)-3- \nthienyl]-1-methyl-3-(trifluor\xad\nomethyl)pyrazole-4-carboxamide  — 183675-82-3  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 1  \n616-223-00-7  carbetamide (ISO); \n(R)-1-(ethylcarbamoyl)ethyl carb\xad\nanilate; (2R)-1-(ethylamino)-1- \noxopropan-2-yl phenylcarbamate  240-286-6  16118-49-3  Carc. 2 \nRepr. 1B \nAcute Tox. 4 \nAquatic Chronic 2  H351 \nH360D \nH302 \nH411  GHS08 \nGHS07 \nGHS09 \nDgr H351 \nH360D \nH302 \nH411  \n▼M18  \n616-224-00-2  amisulbrom (ISO); \n3-(3-bromo-6-fluoro-2-methyl\xad\nindol-1-ylsulfonyl)- N,N- \ndimethyl-1 H-1,2,4-triazole-1- \nsulfonamide  — 348635-87-0  Carc. 2 \nEye Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH319 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH319 \nH410  M = 10 \nM = 10  ▼M13', metadata={'source': 'data/ycla_en.pdf', 'page': 1137}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1139\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M22  \n616-225-00-8  (RS)-2-methoxy-N-methyl-2-[α- \n(2,5-xylyloxy)-o-tolyl]acetamide; \nmandestrobin  — 173662-97-0  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  M  =  1  \nM = 10  \n616-226-00-3  carboxin (ISO); \n2-methyl-N-phenyl-5,6-dihydro- \n1,4-oxathiine-3-carboxamide; \n5,6-dihydro-2-methyl-1,4- \noxathiine-3-carboxanilide  226-031-1  5234-68-4  STOT RE 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H373 \n(kidneys) \nH317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H373 \n(kidneys) \nH317 \nH410  M = 1 \nM = 1  \n616-227-00-9  metaflumizone (ISO); ( EZ)-2’-[2- \n(4-cyanophenyl)-1-(α,α,α -tri\xad\nfluoro-m-tolyl)ethylidene]-[4-(tri\xad\nfluoromethoxy)phenyl]carbani\xad\nlohydrazide [ E-isomer ≥ 90 %,  Z- \nisomer ≤ 10 % relative content]; \n[1] \n(E)-2’-[2-(4-cyanophenyl)-1- \n(α,α,α -trifluoro-m-tolyl)ethyli\xad\ndene]-[4-(trifluoromethoxy)phe\xad\nnyl]carbanilohydrazide [2]  — 139968-49-3 \n[1] \n852403-68-0 \n[2] Repr. 2 \nLact. \nSTOT RE 2  H361fd \nH362 \nH373  GHS08 \nWng  H361fd \nH362 \nH373  \n▼M23  \n616-228-00-4  3-(difluoromethyl)-1-methyl- N- \n(3',4',5'-trifluorobiphenyl-2-yl)py\xad\nrazole-4-carboxamide; \nfluxapyroxad  — 907204-31-3  Lact. \nAquatic Acute 1 \nAquatic Chronic 1  H362 \nH400 \nH410  GHS09 \nWng  H362 \nH410  M = 1 \nM = 1  ▼B", metadata={'source': 'data/ycla_en.pdf', 'page': 1138}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1140\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n616-230-00-5  N-(hydroxymethyl)acrylamide; \nmethylolacrylamide; [NMA]  213-103-2  924-42-5  Carc. 1B \nMuta. 1B \nSTOT RE 1  H350 \nH340 \nH372 \n(peripheral \nnervous \nsystem)  GHS08 \nDgr H350 \nH340 \nH372 \n(peripheral \nnervous \nsystem)  \n616-231-00-0  5-fluoro-1,3-dimethyl- N-[2-(4- \nmethylpentan-2-yl)phenyl]-1 H- \npyrazole-4-carboxamide; 2'- \n[(RS)-1,3-dimethylbutyl]-5- \nfluoro-1,3-dimethylpyrazole-4- \ncarboxanilide; \npenflufen  — 494793-67-8  Carc. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH400 \nH410  GHS08 \nGHS09 \nWng  H351 \nH410  M = 1 \nM = 1  \n616-232-00-6  iprovalicarb (ISO); \nisopropyl [(2 S)-3-methyl-1-{[1- \n(4-methylphenyl)ethyl]amino}-1- \noxobutan-2-yl]carbamate  — 140923-17-7  Carc. 2  H351  GHS08 \nWng  H351  \n616-233-00-1  silthiofam (ISO);  \nN-allyl-4,5-dimethyl-2-(trimethyl\xad\nsilyl)thiophene-3-carboxamide  — 175217-20-6  STOT RE 2 \nAquatic Chronic 2  H373 \nH411  GHS08 \nGHS09 \nWng  H373 \nH411  \n▼M16  \n617-001-00-2  di- tert-butyl peroxide  203-733-6  110-05-4  Org. Perox. E \nFlam. Liq. 2 \nMuta. 2  H242 \nH225 \nH341  GHS02 \nGHS08 \nDgr H242 \nH225 \nH341  ▼M23", metadata={'source': 'data/ycla_en.pdf', 'page': 1139}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1141\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n617-002-00-8  α, α-dimethylbenzyl hydroper\xad\noxide; \ncumene hydroperoxide  201-254-7  80-15-9  Org. Perox. E \nAcute Tox. 3 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSTOT RE 2 * \nSkin Corr. 1B \nAquatic Chronic 2  H242 \nH331 \nH312 \nH302 \nH373 ** \nH314 \nH411  GHS02 \nGHS06 \nGHS08 \nGHS05 \nGHS09 \nDgr H242 \nH331 \nH312 \nH302 \nH373 ** \nH314 \nH411  Skin Corr. 1B; \nH314: C ≥ 10 % \nSkin Irrit. 2; H315: \n3 % ≤ C \n< 10 % \nEye Dam. 1; H318: \n3 % ≤ C \n< 10 % \nEye Irrit. 2; H319: \n1 % ≤ C \n< 3 % \nSTOT SE 3; H335: \nC < 10 %  \n617-003-00-3  dilauroyl peroxide  203-326-3  105-74-8  Org. Perox. D  H242  GHS02 \nDgr H242  \n617-004-00-9  1,2,3,4-tetrahydro-1-naphthyl \nhydroperoxide  212-230-0  771-29-9  Org. Perox. D \nAcute Tox. 4 * \nSkin Corr. 1B \nAquatic Acute 1 \nAquatic Chronic 1  H242 \nH302 \nH314 \nH400 \nH410  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H242 \nH302 \nH314 \nH410  STOT SE 3; H335: \nC ≥ 5 %  \n▼M23  \n617-006-00-X  bis(α,α-dimethylbenzyl) peroxide  201-279-3  80-43-3  Org. Perox. F \nRepr. 1B \nSkin Irrit. 2 \nEye Irrit. 2 \nAquatic Chronic 2  H242 \nH360D \nH315 \nH319 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H242 \nH360D \nH315 \nH319 \nH411  \n▼M16  \n617-007-00-5  tert -butyl α, α-dimethylbenzyl \nperoxide  222-389-8  3457-61-2  Org. Perox. E \nSkin Irrit. 2 \nAquatic Chronic 2  H242 \nH315 \nH411  GHS02 \nGHS07 \nGHS09 \nWng  H242 \nH315 \nH411  \n617-008-00-0  dibenzoyl peroxide; \nbenzoyl peroxide  202-327-6  94-36-0  Org. Perox. B \nEye Irrit. 2 \nSkin Sens. 1  H241 \nH319 \nH317  GHS01 \nGHS02 \nGHS07 \nDgr H241 \nH319 \nH317  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1140}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1142\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n617-010-00-1  1-hydroperoxycyclohexyl 1- \nhydroxycyclohexyl peroxide; [1] \n1,1’-dioxybiscyclohexan-1-ol; [2] \ncyclohexylidene hydroperoxide; \n[3] \ncyclohexanone, peroxide [4]  201-091-1 [1] \n219-306-2 [2] \n220-279-4 [3] \n235-527-7 [4]  78-18-2 [1] \n2407-94-5 [2] \n2699-11-8 [3] \n12262-58-7 [4]  Org. Perox. A \nSkin Corr. 1B \nAcute Tox. 4 *  H240 \nH314 \nH302  GHS01 \nGHS05 \nGHS07 \nDgr H240 \nH314 \nH302  STOT SE 3; H335: \nC ≥ 5 %  C \n617-010-01-9  1-hydroperoxycyclohexyl 1- \nhydroxycyclohexyl peroxide; [1] \n1,1'-dioxybiscyclohexan-1-ol; [2] \ncyclohexylidene hydroperoxide; \n[3] cyclohexanone, peroxide [4] \n[≤ 91 % solution]  201-091-1 [1] \n219-306-2 [2] \n220-279-4 [3] \n235-527-7 [4]  78-18-2 [1] \n2407-94-5 [2] \n2699-11-8 [3] \n12262-58-7 [4]  Org. Perox. C \nAcute Tox. 4 * \nSkin Corr. 1B  H242 \nH302 \nH314  GHS02 \nGHS05 \nGHS07 \nDgr H242 \nH302 \nH314  STOT SE 3; H335: \nC ≥ 5 %  C T \n617-012-00-2  8 - p-menthyl hydroperoxide;  \np-menthane hydroperoxide  201-281-4  80-47-7  Org. Perox. D \nSkin Corr. 1B \nAcute Tox. 4 *  H242 \nH314 \nH332  GHS02 \nGHS05 \nGHS07 \nDgr H242 \nH314 \nH332  STOT SE 3; H335: \nC ≥ 5 %  \n617-013-00-8  O, O -tert-butyl  O-docosyl mono\xad\nperoxyoxalate  404-300-6  116753-76-5  Org. Perox. C \n**** Aquatic \nAcute 1 \nAquatic Chronic 1  H242 \nH400 \nH410  GHS02 \nGHS09 \nDgr H242 \nH410  \n617-014-00-3  6-(nonylamino)-6-oxo-peroxy\xad\nhexanoic acid  406-680-9  104788-63-8  Org. Perox. C \n**** Eye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1  H242 \nH318 \nH317 \nH400  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H242 \nH318 \nH317 \nH400  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1141}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1143\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n617-015-00-9  bis(4-methylbenzoyl)peroxide  407-950-9  895-85-2  Org. Perox. B \n**** Aquatic \nAcute 1 \nAquatic Chronic 1  H241 \nH400 \nH410  GHS01 \nGHS02 \nGHS09 \nDgr H241 \nH410  \n617-016-00-4  3-hydroxy-1,1-dimethylbutyl 2- \nethyl-2-methylheptaneperoxoate  413-910-1  —  Org. Perox. C \n**** Flam. Liq. 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H242 \nH226 \nH315 \nH400 \nH410  GHS02 \nGHS07 \nGHS09 \nDgr H242 \nH226 \nH315 \nH410  \n617-017-00-X  reaction mass of: 2,2'-bis( tert- \npentylperoxy)- p-diisopro\xad\npylbenzene; \n2,2'-bis( tert-pentylperoxy)- m- \ndiisopropylbenzene  412-140-3  32144-25-5  Org. Perox. D \nAquatic Chronic 4  H242 \nH413  GHS02 \nDgr H242 \nH413  T \n617-018-00-5  reaction mass of: 1-methyl-1-(3- \n(1-methylethyl)phenyl)ethyl-1- \nmethyl-1-phenylethylperoxide, \n63 % by weight; \n1-methyl-1-(4-(1-methyl\xad\nethyl)phenyl)ethyl-1-methyl-1- \nphenylethylperoxide, 31 % by \nweight  410-840-3  71566-50-2  Org. Perox. C \n**** Aquatic \nChronic 2  H242 \nH411  GHS02 \nGHS09 \nDgr H242 \nH411  T \n617-019-00-0  6-(phthalimido)peroxyhexanoic \nacid 410-850-8  128275-31-0  Org. Perox. D \nEye Dam. 1 \nAquatic Acute 1  H242 \nH318 \nH400  GHS02 \nGHS05 \nGHS09 \nDgDgr  H242 \nH318 \nH400  T \n617-020-00-6  1,3-di(prop-2,2-diyl)benzene \nbis(neodecanoylperoxide)  420-060-5  117663-11-3  Flam. Liq. 3 \nOrg. Perox. D \n**** Aquatic \nChronic 2  H226 \nH242 \nH411  GHS02 \nGHS09 \nDgr H226 \nH242 \nH411  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1142}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1144\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n617-021-00-1  methylethylketone peroxide \ntrimer  429-320-2  —  Org. Perox. \nB**** \nAsp. Tox. 1 \nSkin Irrit. 2 \nSkin Sens. 1  H241 \nH304 \nH315 \nH317  GHS01 \nGHS02 \nGHS08 \nGHS07 \nDgr H241 \nH304 \nH315 \nH317  \n617-022-00-7  reaction mass of: 1,2-dimethyl\xad\npropylidene dihydroperoxide; \ndimethyl 1,2-benzenedicar\xad\nboxylate  442-480-8  —  Org. Perox. C \nAcute Tox. 4 * \nSkin Corr. 1B \nSkin Sens. 1 \nAquatic Chronic 2  H242 \nH302 \nH314 \nH317 \nH411  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H242 \nH302 \nH314 \nH317 \nH411  \n▼M13  \n617-023-00-2  tert -butyl hydroperoxide  200-915-7  75-91-2  Muta. 2  H341  GHS08 \nWng  H341  \n▼M16  \n647-001-00-8  glucosidase, β-  232-589-7  9001-22-3  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n647-002-00-3  cellulase  232-734-4  9012-54-8  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n647-003-00-9  cellobiohydrolase, exo-  253-465-9  37329-65-0  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n647-004-00-4  cellulases with the exception of \nthose specified elsewhere in this \nAnnex  — —  Resp. Sens. 1  H334  GHS08 \nDgr H334  A  \n647-005-00-X  bromelain, juice  232-572-4  9001-00-7  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  \n647-006-00-5  ficin  232-599-1  9001-33-6  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1143}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1145\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n647-007-00-0  papain  232-627-2  9001-73-4  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  \n647-008-00-6  pepsin A  232-629-3  9001-75-6  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  \n647-009-00-1  rennin  232-645-0  9001-98-3  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  \n647-010-00-7  trypsin  232-650-8  9002-07-7  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  \n647-011-00-2  chymotrypsin  232-671-2  9004-07-3  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  \n647-012-00-8  subtilisin  232-752-2  9014-01-1  STOT SE 3 \nSkin Irrit. 2 \nEye Dam. 1 \nResp. Sens. 1  H335 \nH315 \nH318 \nH334  GHS08 \nGHS05 \nGHS07 \nDgr H335 \nH315 \nH318 \nH334  \n647-013-00-3  proteinase, microbial neutral  232-966-6  9068-59-1  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  \n647-014-00-9  proteases with the exception of \nthose specified elsewhere in this \nAnnex  — —  Eye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nResp. Sens. 1  H319 \nH335 \nH315 \nH334  GHS08 \nGHS07 \nDgr H319 \nH335 \nH315 \nH334  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1144}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1146\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n647-015-00-4  amylase, α-  232-565-6  9000-90-2  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n647-016-00-X  amylases with the exception of \nthose specified elsewhere in this \nAnnex  — —  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n647-017-00-5  laccase  420-150-4  80498-15-3  Resp. Sens. 1  H334  GHS08 \nDgr H334  \n648-001-00-0  Distillates (coal tar), benzole \nfraction; \nLight Oil; [A complex \ncombination of hydrocarbons \nobtained by the distillation of \ncoal tar. It consists of hydro\xad\ncarbons having carbon numbers \nprimarily in the range of C  4 to \nC 10 and distilling in the \napproximate range of 80o C to \n160  o C (175o F to 320o F).] 283-482-7  84650-02-2  Carc. 1B  H350  GHS08 \nDgr H350  \n648-002-00-6  Tar oils, brown-coal; Light Oil; \n[The distillate from lignite tar \nboiling in the range of approxi\xad\nmately 80  o C to 250  o C (176o F \nto 482  o F). Composed primarily \nof aliphatic and aromatic hydro\xad\ncarbons and monobasic phenols.]  302-674-4  94114-40-6  Carc. 1B \nMuta. 1B  H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1145}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1147\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-003-00-1  Benzol forerunnings (coal); Light \nOil Redistillate, low boiling; \n[The distillate from coke oven \nlight oil having an approximate \ndistillation range below 100  o C \n(212  o F). Composed primarily of \nC 4 to C  6 aliphatic hydrocarbons.]  266-023-5  65996-88-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-004-00-7  Distillates (coal tar), benzole \nfraction, BTX-rich; \nLight Oil Redistillate, low \nboiling; \n[A residue from the distillation of \ncrude benzole to remove benzole \nfronts. Composed primarily of \nbenzene, toluene and xylenes \nboiling in the range of approxi\xad\nmately 75  o C to 200  o C (167  o F \nto 392  o F).] 309-984-9  101896-26-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-005-00-2  Aromatic hydrocarbons, C  6-10, \nC 8-rich; Light Oil Redistillate, \nlow boiling  292-697-5  90989-41-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-006-00-8  Solvent naphtha (coal), light; \nLight Oil Redistillate, low \nboiling  287-498-5  85536-17-0  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1146}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1148\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-007-00-3  Solvent naphtha (coal), xylene- \nstyrene cut; Light Oil Redis\xad\ntillate, intermediate boiling  287-502-5  85536-20-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-008-00-9  Solvent naphtha (coal), \ncoumarone-styrene contg.; Light \nOil Redistillate, intermediate \nboiling  287-500-4  85536-19-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-009-00-4  Naphtha (coal), distn. residues; \nLight Oil Redistillate, high \nboiling; \n[The residue remaining from the \ndistillation of recovered naphtha. \nComposed primarily of naph\xad\nthalene and condensation \nproducts of indene and styrene.]  292-636-2  90641-12-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-010-00-X  Aromatic hydrocarbons, C  8; \nLight Oil Redistillate, high \nboiling  292-694-9  90989-38-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-012-00-0  Aromatic hydrocarbons, C  8-9, \nhydrocarbon resin polymn. by- \nproduct; \nLight Oil Redistillate, high \nboiling;  295-281-1  91995-20-9  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1147}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1149\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from the \nevaporation of solven under \nvacuum from polymerized hydro\xad\ncarbon resin. It consists predomi\xad\nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  8 through \nC 9 and boiling in the range of \napproximately 120  o C to 215  o \nC (248  o F to 419  o F).] \n648-013-00-6  Aromatic hydrocarbons, C  9-12, \nbenzene distn.; \nLight Oil Redistillate, high \nboiling  295-551-9  92062-36-7  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-014-00-1  Extract residues (coal), benzole \nfraction alk., acid ext.; \nLight Oil Extract Residues, low \nboiling; \n[The redistillate from the \ndistillate, freed of tar acids and \ntar bases, from bituminous coal \nhigh temperature tar boiling in \nthe approximate range of 90o C \nto 160  o C (194o F to 320  o F). It \nconsists predomi nantly of \nbenzene, toluene and xylenes.]  295-323-9  91995-61-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1148}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1150\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-015-00-7  Extract residues (coal tar), \nbenzole fraction alk., acid ext.; \nLight Oil Extract Residues, low \nboiling; \n[A complex combination of \nhydrocarbons obtained by the \nredistillation of the distillate of \nhigh temperature coal tar (tar \nacid and tar base free). It \nconsists predominantly of unsub\xad\nstituted and substituted mono\xad\nnuclear aromatic hydrocarbons \nboiling in the range of 85  o C to \n195o C (185o F to 383o F).] 309-868-8  101316-63-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-016-00-2  Extract residues (coal), benzole \nfraction acid; \nLight Oil Extract Residues, low \nboiling; \n[An acid sludge by-product of \nthe sulfuric acid refining of \ncrude high temperature coal. \nComposed primarily of sulfuric \nacid and organic compounds.]  298-725-2  93821-38-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1149}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1151\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-017-00-8  Extract residues (coal), light oil \nalk., distn. overheads; \nLight Oil Extract Residues, low \nboiling; \n[The first fraction from the distil\xad\nlation of aromatic hydrocarbons, \ncoumarone, naphthalene and \nindene rich prefractionator \nbottoms or washed carbolic oil \nboiling substantially below 145o \nC (293  o F). \nComposed primarily of C  7 and \nC 8 aliphatic and aromatic hydro\xad\ncarbons.]  292-625-2  90641-02-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-018-00-3  Extract residues (coal), light oil \nalk., acid ext., indene fraction; \nLight Oil Extract Residues, inter\xad\nmediate boiling  309-867-2  101316-62-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1150}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1152\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-019-00-9  Extract residues (coal), light oil \nalk., indene naphtha fraction; \nLight Oil Extract Residues, high \nboiling; \n[The distillate from aromatic \nhydrocarbons, coumarone, naph\xad\nthalene and indene rich prefrac\xad\ntionator bottoms or washed \nCarbolic oils, having an \napproximate boiling range of \n155o C to 180o C (311  o F to \n356  o F). Composed primarily of \nindene, indan and trimethylben\xad\nzenes.]  292-626-8  90641-03-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-020-00-4  Solvent naphtha (coal); \nLight Oil Extract Residues, high \nboiling; \n[The distillate from either high \ntemperature coal tar, coke oven \nlight oil, or coal tar oil alkaline \nextract residue having an \napproximate distillation range of \n130o C to 210o C (266o F to \n410o F). Composed primarily of \nindene and other polycyclic ring  266-013-0  65996-79-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1151}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1153\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nsystems containing a single \naromatic ring. May contain \nphenolic compounds and \naromatic nitrogen bases.]  \n648-021-00-X  Distillates (coal tar), light oils, \nneutral fraction; Light Oil \nExtract Residues, high boiling; \n[A distillate from the fractional \ndistillation of high temperature \ncoal tar. Composed primarily of \nalkyl-substituted one ring \naromatic hydrocarbons boiling \nin the range of approximately \n135o C to 210o C (275o F to \n410o F). May also include \nunsaturated hydrocarbons such \nas indene and coumarone.]  309-971-8  101794-90-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-022-00-5  Distillates (coal tar), light oils, \nacid exts.; Light Oil Extract \nResidues, high boiling; \n[This oil is a complex reaction \nmass of aromatic hydrocarbons, \nprimarily indene, naphthalene, \ncoumarone, phenol, and  o-, m- \nand p-cresol and boiling in the \nrange of 140o C to 215o C (284  \no F to 419  o F).] 292-609-5  90640-87-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1152}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1154\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-023-00-0  Distillates (coal tar), light oils; \nCarbolic Oil; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of coal tar. It consists of \naromatic and other hydrocarbons, \nphenolic compounds and \naromatic nitrogen compounds \nand distills at the approximate \nrange of 150  o C to 210  o C \n(302  o F to 410  o F).] 283-483-2  84650-03-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-024-00-6  Tar oils, coal; Carbolic Oil; \n[The distillate from high \ntemperature coal tar having an \napproximate distillation range of \n130  o C to 250  o C (266  o F to \n410  o F). Composed primarily of \nnaphthalene, alkylnaphthalenes, \nphenolic compounds, and \naromatic nitrogen bases.]  266-016-7  65996-82-9  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-026-00-7  Extract residues (coal), light oil \nalk., acid ext.;  292-624-7  90641-01-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1153}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1155\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nCarbolic Oil Extract Residue; \n[The oil resulting from the acid \nwashing of alkali-washed \ncarbolic oil to remove the minor \namounts of basic compounds (tar \nbases). \nComposed primarily of indene, \nindan and alkylbenzenes.]  \n648-027-00-2  Extract residues (coal), tar oil \nalk.; \nCarbolic Oil Extract Residue; \n[The residue obtained from coal \ntar oil by an alkaline wash such \nas aqueous sodium hydroxide \nafter the removal of crude coal \ntar acids. Composed primarily \nof naphthalenes and aromatic \nnitrogen bases.]  266-021-4  65996-87-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-028-00-8  Extract oils (coal), light oil; Acid \nExtract; \n[The aqueous extract produced \nby an acidic wash of alkali- \nwashed carbolic oil. Composed  292-622-6  90640-99-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1154}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1156\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nprimarily of acid salts of various \naromatic nitrogen bases including \npyridine, quinoline and their \nalkyl derivatives.]  \n648-029-00-3  Pyridine, alkyl derivs.; Crude Tar \nBases; \n[The complex combination of \npolyalkylated pyridines derived \nfrom coal tar distillation or as \nhigh-boiling distillates approxi \nmately above 150o C (302o F) \nfrom the reaction of ammonia \nwith acetaldehyde, formaldehyde \nor paraformaldehyde.]  269-929-9  68391-11-7  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-030-00-9  Tar bases, coal, picoline fraction; \nDistillate Bases; \n[Pyridine bases boiling in the \nrange of approximately 125o C \nto 160o C (257o F 320o F) \nobtained by distillation of \nneutralized acid extract of the \nbase-containing tar fraction \nobtained by the distillation of \nbituminous coal tars. Composed \nchiefly of lutidines and pico\xad\nlines.]  295-548-2  92062-33-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1155}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1157\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-031-00-4  Tar bases, coal, lutidine fraction; \nDistillate Bases  293-766-2  91082-52-9  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-032-00-X  Extract oils (coal), tar base, \ncollidine fraction; \nDistillate Bases; \n[The extract produced by the \nacidic extraction of bases from \ncrude coal tar aromatic oils, \nneutralization, and distillation of \nthe bases. Composed primarily of \ncollidines, aniline, toluidines, \nlutidines, xylidines.]  273-077-3  68937-63-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-033-00-5  Tar bases, coal, collidine \nfraction; \nDistillate Bases; \n[The distillation fraction boiling \nin the range of approximately \n181  o C to 186  o C (356  o F to \n367  o F) from the crude bases \nobtained from the neutralized, \nacid-extracted base-containing \ntar fractions obtained by the \ndistillation of bituminous coal \ntar. It contains chiefly aniline \nand collidines.]  295-543-5  92062-28-7  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1156}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1158\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-034-00-0  Tar bases, coal, aniline fraction; \nDistillate Bases; \n[The distillation fraction boiling \nin the range of approximately \n180o C to 200o C (356  o F to \n392  o F) from the crude bases \nobtained by dephenolating and \ndebasing the carbolated oil from \nthe distillation of coal tar. \nIt contains chiefly aniline, colli\xad\ndines, lutidines and toluidines.]  295-541-4  92062-27-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-035-00-6  Tar bases, coal, toluidine \nfraction; \nDistillate Bases  293-767-8  91082-53-0  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-036-00-1  Distillates (petroleum), alkene- \nalkyne manuf. pyrolysis oil, \nmixed with high-temp. coal tar, \nindene fraction; \nRedistillates; \n[A complex combination of \nhydrocarbons obtained as a redis\xad\ntillate from the fractional distil\xad\nlation of bituminous coal high \ntemperature tar and residual oils \nthat are obtained by the \npyrolytic production of alkenes  295-292-1  91995-31-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1157}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1159\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nand alkynes from petroleum \nproducts or natural gas. It \nconsists predominantly of indene \nand boils in a range of approxi\xad\nmately160  o C to 190  o C (320  o F \nto 374  o F).] \n648-037-00-7  Distillates (coal), coal tar-residual \npyrolysis oils, naphthalene oils; \nRedistillates; \n[The redistillate obtained from \nthe fractional distillation of \nbituminous coal high temperature \ntar and pyrolysis residual oils \nand boiling in the range of \napproximately 190o C to 270o C \n(374o F to 518o F). Composed \nprimarily of substituted \ndinuclear aromatics.]  295-295-8  91995-35-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-038-00-2  Extract oils (coal), coal tar- \nresidual pyrolysis oils, naph \nthalene oil, redistillate; Redistil\xad\nlates;  295-329-1  91995-66-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1158}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1160\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[The redistillate from the frac\xad\ntional distillation of dephe \nnolated and debased methylnaph\xad\nthalene oil obtained from \nbituminous coal high temperature \ntar and pyrolysis residual oils \nboiling in the approximate range \nof 220o C to 230o C (428o F to \n446o F). It consists predominantly \nof unsubstituted and substituted \ndinuclear aromatic hydrocar\xad\nbons.]  \n648-039-00-8  Extract oils (coal), coal tar- \nresidual pyrolysis oils, naph\xad\nthalene oils; \nRedistillates; \n[A neutral oil obtained by \ndebasing and dephenolating the \noil obtained from the distillation \nof high temperature tar and \npyrolysis residual oils which has \na boiliing range of 225o C to \n255o C (437o F to 491o F). \nComposed primarily of \nsubstituted dinuclear aromatic \nhydrocarbons.]  310-170-0  122070-79-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1159}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1161\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-040-00-3  Extract oils (coal), coal tar \nresidual pyrolysis oils, naph \nthalene oil, distn. residues; \nRedistillates; \n[Residue from the distillation of \ndephenolated and debased \nmethylnaphthalene oil (from \nbituminous coal tar and \npyrolysis residual oils) with a \nboiling range of 240  o C to \n260o C (464o F to 500o F). \nComposed primarily of \nsubstituted dinuclear aromatic \nand heterocyclic hydrocarbons.]  310-171-6  122070-80-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-041-00-9  Absorption oils, bicyclo arom. \nand heterocyclic hydrocarbon \nfraction; \nWash Oil Redistillate; \n[A complex combination of \nhydrocarbons obtained as a redis\xad\ntillate from the distillation of \nwash oil. It consists predomi\xad\nnantly of 2-ringed aromatic and \nheterocyclic hydrocarbons \nboiling in the range of approxi\xad\nmately 260  o C to 290  o C (500o F \nto 554o F).] 309-851-5  101316-45-4  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1160}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1162\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-042-00-4  Distillates (coal tar), upper, \nfluorene-rich; \nWash Oil Redistillate; \n[A complex combination of \nhydrocarbons obtained by the \ncrystallization of tar oil. It \nconsists af aromatic and poly\xad\ncyclic hydrocarbons primarily \nfluorene and some acenaph\xad\nthene.]  284-900-0  84989-11-7  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-043-00-X  Creosote oil, acenaphthene \nfraction, acenaphthene-free; \nWash Oil Redistillate; \n[The oil remaining after removal \nby a crystallization process of \nacenaphthene from acenaphthene \noil from coal tar. Composed \nprimarily of naphthalene and \nalkylnaphthalenes.]  292-606-9  90640-85-0  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1161}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1163\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-044-00-5  Distillates (coal tar), heavy oils; \nHeavy Anthracene Oil; [Distillate \nfrom the fractional distillation of \ncoal tar of bituminous coal, with \nboiling range of 240o C to 400o C \n(464o F to 752  o F). Composed \nprimarily of tri-and polynuclear \nhydrocarbons and heterocyclic \ncompounds.]  292-607-4  90640-86-1  Carc. 1B  H350  GHS08 \nDgr H350  \n648-045-00-0  Distillates (coal tar), upper; \nHeavy Anthracene Oil; \n[The distillate from coal tar \nhaving an approximate distil\xad\nlation range of 220o C to 450o C \n(428o F to 842o F). Composed \nprimarily of three to four \nmembered condensed ring \naromatic hydrocarbons and other \nhydrocarbons.]  266-026-1  65996-91-0  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-046-00-6  Anthracene oil, acid ext.; \nAnthracene Oil Extract Residue; \n[A complex combination of \nhydrocarbons from the base- \nfreed fraction obtained from the \ndistillation of coal tar and boiling \nin the range of approxi mately \n325  o C to 365  o C (617  o F to \n689  o F). It contains predomi\xad\nnantly anthracene and phenan\xad\nthrene and their alkyl deriva\xad\ntives.]  295-274-3  91995-14-1  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1162}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1164\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-047-00-1  Distillates (coal tar); Heavy \nAnthracene Oil; \n[The distillate from coal tar \nhaving an approximate distil \nlationrange of 100o C to 450o C \n(212o F to 842o F). Composed \nprimarily of two to four \nmembered condensed ring \naromatic hydrocarbons, phenolic \ncompounds, and aromatic \nnitrogen bases.]  266-027-7  65996-92-1  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-048-00-7  Distillates (coal tar), pitch, heavy \noils; \nHeavy Anthracene Oil; \n[The distillate from the distil\xad\nlation of the pitch obtained \nfrom bituminous high \ntemperature tar. Composed \nprimarily of tri-and polynuclear \naromatic hydrocarbons and \nboiling in the range of approxi\xad\nmately 300  o C to 470  o C (572  o F \nto 878  o F). The product may also \ncontain heteroatoms.]  295-312-9  91995-51-6  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-049-00-2  Distillates (coal tar), pitch; \nHeavy Anthracene Oil; \n[The oil obtained from conden\xad\nsation of the vapors from the \nheat treatment of pitch.  309-855-7  101316-49-8  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1163}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1165\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nComposed primarily of two-to \nfour-ring aromatic compounds \nboiling in the range of 200  o C \nto greater than 400  o C (392  o F \nto greater than 752  o F).] \n648-050-00-8  Distillates (coal tar), heavy oils, \npyrene fraction; \nHeavy Anthracene Oil Redis\xad\ntillate; \n[The redistillate obtained from \nthe fractional distillation of \npitch distillate boiling in the \nrange of approximately 350  o C \nto 400  o C (662  o F to 752  o F). \nConsists predominantly of tri- \nand polynuclear aromatics and \nheterocyclic hydrocarbons.]  295-304-5  91995-42-5  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-051-00-3  Distillates (coal tar), pitch, \npyrene fraction; \nHeavy Anthracene Oil Redistil\xad\nlate; 295-313-4  91995-52-7  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1164}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1166\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[The redistillate obtained from \nthe fractional distillation of \npitch distillate and boiling in \nthe range of approximately 380  \no C to 410  o C (7160 to 770  o F). \nComposed primarily of tri-and \npolynuclear aromatic hydro\xad\ncarbons and heterocyclic \ncompounds.]  \n648-052-00-9  Paraffin waxes (coal), brown- \ncoal high-temp. tar, carbon- \ntreated; \nCoal Tar Extract; [A complet \ncombination of hydrocarbons \nobtained by the treatment of \nlignite carbon ization tar with \nactivated carbon for removal of \ntrace constituents and impurities. \nIt consists predominantly of \nsaturated straight and branched \nchain hydrocarbons having \ncarbon numbers predominantly \ngreater than C  12.] 308-296-6  97926-76-6  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-053-00-4  Paraffin waxes (coal), brown- \ncoal high-temp tar, clay-treated; \nCoal Tar Extract;  308-297-1  97926-77-7  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1165}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1167\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of lignite carbonization \ntar with bentonite for removal of \ntrace constituents and impurities. \nIt consists predominantly of \nsaturated straight and branched \nchain hydrocarbons having \ncarbon numbers predominantly \ngreater than C  12.] \n648-054-00-X  Pitch; Pitch  263-072-4  61789-60-4  Carc. 1B  H350  GHS08 \nDgr H350  M  \n▼M22  \n648-055-00-5  Pitch, coal tar, high-temp.; [The \nresidue from the distillation of \nhigh temperature coal tar. A \nblack solid with an approximate \nsoftening point from 30 °C to \n180 °C (86 °F to 356 °F). \nComposed primarily of a \ncomplex mixture of three or \nmore membered condensed ring \naromatic hydrocarbons.]  266-028-2  65996-93-2  Carc. 1A \nMuta. 1B \nRepr. 1B  H350 \nH340 \nH360FD  GHS08 \nDgr H350 \nH340 \nH360FD  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1166}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1168\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-056-00-0  Pitch, coal tar, high-temp., heat- \ntreated; Pitch; [The heat treated \nresidue from the distillation of \nhigh temperature coal tar. A \nblack solid with an approximate \nsoftening point from 80o C to180  \no C (176  o F to 356  o F). \nComposed primarily of a \ncomplex mixture of three or \nmore membered condensed ring \naromatic hydrocarbons.]  310-162-7  121575-60-8  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-057-00-6  Pitch, coal tar, high-temp., \nsecondary; \nPitch Redistillate; [The residue \nobtained during the distillation \nof high boiling fractions from \nbituminous coal high temperature \ntar and/or pitch coke oil, with a \nsoftening point of 140  o C to 170  \no C (284  o F to 392  o F) according \nto DIN 52025. Composed \nprimarily of tri-and polynuclear \naromatic compounds which also \ncontain heteroatoms.]  302-650-3  94114-13-3  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1167}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1169\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-058-00-1  Residues (coal tar), pitch distn.; \nPitch Redistillate; \n[Residue from the fractional \ndistillation of pitch distillate \nboiling in the range of approxi\xad\nmately 400o C to 470o C (752  o F \nto 846  o F). Composed primarily \nof polynuclear aromatic hydro\xad\ncarbons, and heterocyclic \ncompounds.]  295-507-9  92061-94-4  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-059-00-7  Tar, coal, high-temp., distn. and \nstorage residues; \nCoal Tar Solids Residue; \n[Coke-and ash-containing solid \nresidues that separate on distil\xad\nlation and thermal treatment of \nbituminous coal high temperature \ntar in distillation installations and \nstorage vessels. Consists \npredominantly of carbon and \ncontains a small quantity of \nhetero compounds as well as \nash components.]  295-535-1  92062-20-9  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1168}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1170\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-060-00-2  Tar, coal, storage residues; Coal \nTar Solids Residue; \n[The deposit removed from crude \ncoal tar storages. Composed \nprimarily of coal tar and carbon\xad\naceous particulate matter.]  293-764-1  91082-50-7  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-061-00-8  Tar, coal, high-temp., residues; \nCoal Tar Solids Residue; \n[Solids formed during the coking \nof bituminous coal to produce \ncrude bituminous coal high \ntemperature tar. Composed \nprimarily of coke and coal \nparticles, highly aromatized \ncompounds and mineral \nsubstances.]  309-726-5  100684-51-3  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-062-00-3  Tar, coal, high-temp., high- \nsolids; \nCoal Tar Solids Residue;  273-615-7  68990-61-4  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1169}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1171\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[The condensation product \nobtained by cooling, to approxi\xad\nmately ambient temperature, the \ngas evolved in the high \ntemperature (greater than 700  \no C (1292  o F)) destructive distil\xad\nlation of coal. Composed \nprimarily of a complex mixture \nof condensed ring aromatic \nhydrocarbons with a high solid \ncontent of coal-type materials.]  \n648-063-00-9  Waste solids, coal-tar pitch \ncoking; \nCoal Tar Solids Residue; \n[The combination of wastes \nformed by the coking of \nbituminous coal tar pitch. It \nconsists predominantly of \ncarbon.]  295-549-8  92062-34-5  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-064-00-4  Extract residues (coal), brown; \nCoal Tar Extract; \n[The residue from extraction of \ndried coal.]  294-285-0  91697-23-3  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1170}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1172\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-065-00-X  Paraffin waxes (coal), brown- \ncoal-high-temp. tar; \nCoal Tar Extract; [A complex \ncombination of hydrocarbons \nobtained from lignite carbon\xad\nization tar by solvent crystalli\xad\nsation (solvent deoiling), by \nsweating or an adducting \nprocess. It consists predomi\xad\nnantly of straight and branched \nchain saturated hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  12.] 295-454-1  92045-71-1  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-066-00-5  Paraffin waxes (coal), brown- \ncoal-high-temp. tar, hydrotreated; \nCoal Tar Extract; [A complex \ncombination of hydrocarbons \nobtained from lignite carbon\xad\nization tar by solvent crystalli\xad\nsation (solvent deoiling), by \nsweating or an adducting \nprocess treated with hydrogen in \nthe presence of a catalyst. It \nconsists predomi nantly of \nstraight and branched chain \nsaturated hydrocarbons having \ncarbon numbers predominantly \ngreater than C  12.] 295-455-7  92045-72-2  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1171}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1173\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-067-00-0  Paraffin waxes (coal), brown- \ncoal high-temp tar, silicic acid- \ntreated; \nCoal Tar Extract; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of lignite carbonization \ntar with silicic acid for removal \nof trace constituents and impur\xad\nities. It consists predominantly of \nsaturated straight and branched \nchain hydrocarbons having \ncarbon numbers predominantly \ngreater than C  12.] 308-298-7  97926-78-8  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-068-00-6  Tar, coal, low-temp, distn. \nresidues; \nTar Oil, intermediate boiling; \n[Residues from fractional distil\xad\nlation of low temperature coal \ntar to remove oils that boil in a \nrange up to approximately \n300  o C (572  o F). Composed \nprimarily of aromatic \ncompounds.]  309-887-1  101316-85-2  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1172}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1174\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-069-00-1  Pitch, coal tar, low-temp; Pitch \nResidue; \n[A complex black solid or semi- \nsolid obtained from the distillation \nof a low temperature coal tar. It has \na softening point within the \napproximate range of 40  o C to \n180  o C (104o F to 356  o F). \nComposed primarily of a \ncomplex mixture of hydrocar\xad\nbons.]  292-651-4  90669-57-1  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-070-00-7  Pitch, coal tar, low-temp., \noxidized; \nPitch Residue, oxidised; \n[The product obtained by air- \nblowing, at elevated temperature, \nlow-temperature coal tar pitch. It \nhas a softening-point within the \napproximate range of 70  o C to \n180  o C (158  o F to 356  o F). \nComposed primarily of a \ncomplex mixture of hydrocar\xad\nbons.]  292-654-0  90669-59-3  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1173}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1175\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-071-00-2  Pitch, coal tar, low-temp., heat- \ntreated; \nPitch Residue, oxidised; Pitch \nResidue, heat-treated; \n[A complex black solid obtained \nby the heat treatment of low \ntemperature coal tar pitch. It has a \nsoftening point within the \napproximate range of 50  o C to \n140  o C (122o F to 284o F). \nComposed primarily of a \ncomplex mixture of aromatic \ncompounds.]  292-653-5  90669-58-2  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-072-00-8  Distillates (coal-petroleum), \ncondensed-ring arom; \nDistillates; \n[The distillate from a mixture of \ncoal and tar and aromatic \npetroleum streams having an \napproximate distillation range of \n220  o C to 450  o C (428o F to \n842o F). Composed primarily of 3- \nto 4-membered condensed ring \naromatic hydrocarbons.]  269-159-3  68188-48-7  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-073-00-3  Aromatic hydrocarbons, C  20-28, \npolycyclic, mixed coal-tar pitch- \npolyethylene-polypropylene \npyrolysis-derived; Pyrolysis Prod\xad\nucts;  309-956-6  101794-74-5  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1174}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1176\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination hydro\xad\ncarbons obtained from mixed coal \ntar pitch-polyethylene-poly\xad\npropylene pyrolysis. Composed \nprimarily of polycyclic aromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  20 through C  28 and \nhaving a softening point of \n100  o C to 220  o C (212o F to \n428o F) according to DIN 52025.];  \n648-074-00-9  Aromatic hydrocarbons, C  20-28, \npolycyclic, mixed coal-tar pitch- \npolyethylene pyrolysis-derived; \nPyrolysis Products; \n[A complex combination of \nhydrocarbonsobtained from \nmixed coal tar pitch-polyethylene \npyrolysis. Composed primarily of \npolycyclic aromatic hydrocarbons \nhaving carbon numberspredomi\xad\nnantly in the range of C  20 \nthrough C  28 and having a \nsoftening pointof 100o C to \n220o C (212o F to 428o F) \naccording to DIN 52025.]  309-957-1  101794-75-6  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1175}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1177\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-075-00-4  Aromatic hydrocarbons, C  20-28, \npolycyclic, mixed coal-tar pitch- \npolystyrene pyrolysis-derived; \nPyrolysis Products; \n[A complex combination of \nhydrocarbons obtained from \nmixed coal tar pitch-polystyrene \npyrolysis. Composed primarily of \npolycyclic aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  20 \nthrough C  28 and having a \nsoftening point of 100o C to \n220o C (212o F to 428o F) \naccording to DIN 52025.]  309-958-7  101794-76-7  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-076-00-X  Pitch, coal tar-petroleum; Pitch \nResidues; \n[The residue from the distillation \nof a mixture of coal tar and \naromatic petroleum streams. A \nsolid with a softening point \nfrom 40o C to 180o C (140o F to \n356o F). Composed; primarily of \na complex combination of three \nor more membered condensed \nring aromatic hydrocarbons.]  269-109-0  68187-57-5  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1176}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1178\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-077-00-5  Phenanthrene, distn. residues; \nHeavy Anthracene Oi Redis\xad\ntillate; \n[Residue from the distillation of \ncrude phenanthrene boiling in the \napproximate range of 340  o C to \n420  o C (644o F to 788o F). It \nconsists predominantly of phen\xad\nanthrene, anthracene and carba\xad\nzole.]  310-169-5  122070-78-4  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-078-00-0  Distillates (coal tar), upper, \nfluorene-free; Wash Oil Redis\xad\ntillate; \n[A complex combination of \nhydrocarbons obtained by the \ncrystallization of tar oil. It \nconsists of aromatic polycyclic \nhydrocarbons, primarily \ndiphenyl, dibenzofuran and \nacenaphthene.]  284-899-7  84989-10-6  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-079-00-6  Anthracene oil; Anthracene oil; \n[A complex combination of poly\xad\ncyclic aromatic hydrocarbons \nobtained from coal tar having \nan approximate distillation range \nof 300  o C to 400  o C (572o F to \n752o F). Composed primarily of \nphenanthrene, anthracene and \ncarbazole.]  292-602-7  90640-80-5  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1177}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1179\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-080-00-1  Residues (coal tar), creosote oil \ndistn.; Wash Oil Redistillate; \n[The residue from the fractional \ndistillation of wash oil boiling in \nthe approximate range of 270  o C \nto 330  o C (518  o F to 626  o F). It \nconsists predomi nantly of \ndinuclear aromatic and hetero\xad\ncyclic hydrocarbons.]  295-506-3  92061-93-3  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-081-00-7  Tar, coal; Coal tar; \n[The by-product from the \ndestructive distillation of coal. \nAlmost black semisolid. A \ncomplex combination of \naromatic hydrocarbons, phenolic \ncompounds, nitrogen bases and \nthiophene.]  232-361-7  8007-45-2  Carc. 1A  H350  GHS08 \nDgr H350  \n648-082-00-2  Tar, coal, high-temp.; Coal tar; \n[The condensation product \nobtained by cooling, to approxi \nmately ambient temperature, the \ngas evolved in the high \ntemperature (greater than \n700  o C (1292o F)) destructive \ndistillation of coal. A black \nviscous liquid denser than \nwater. Composed primarily of a \ncomplex mixture of condensed  266-024-0  65996-89-6  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1178}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1180\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nring aromatic hydrocarbons. May \ncontain minor amounts of \nphenolic compounds and \naromatic nitrogen bases.]  \n648-083-00-8  Tar, coal, low-temp.; Coal oil; \n[The condensation product \nobtained by cooling, to approxi\xad\nmately ambient temperature, the \ngas evolved in low temperature \n(less than 700  o C (1292o F)) \ndestructive distillation of coal. \nA black viscous liquid denser \nthan water. Composed primarily \nof condensed ring aromatic \nhydrocarbons, phenolic \ncompounds, aromatic nitrogen \nbases, and their alkyl deriva\xad\ntives.]  266-025-6  65996-90-9  Carc. 1A  H350  GHS08 \nDgr H350  \n648-084-00-3  Distillates (coal), coke-oven light \noil, naphthalene cut; Naphthalene \nOil; 285-076-5  85029-51-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1179}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1181\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[The complex combination of \nhydrocarbons obtained from \nprefractionation (continuous \ndistillation) of coke oven light \noil. It consists predominantly of \nnaphthalene, coumarone and \nindene and boils above 148  o C \n(298o F).] \n648-085-00-9  Distillates (coal tar), naphthalene \noils; Naphthalene Oil; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of coal tar. It \nconsists primarily of aromatic \nand other hydrocarbons, \nphenolic compound and \naromatic nitrogen compounds \nand distills in the approximate \nrange of 200  o C to 250  o C \n(392o F to 482o F).]- 283-484-8  84650-04-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-086-00-4  Distillates (coal tar), naph thalene \noils, naphthalene-low; Naph\xad\nthalene Oil Redistillate; [A \ncomplex combination of hydro\xad\ncarbons obtained by crys \ntallization of naphthalene oil. \nComposed primarily of naph\xad\nthalene, alkyl naphthalenes and \nphenolic compounds.]  284-898-1  84989-09-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1180}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1182\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-087-00-X  Distillates (coal tar), naphthalene \noil crystn. mother liquor; Naph\xad\nthalene Oil Redistillate; \n[A complex combination of \norganic compounds obtained as \na filtrate from the crystallization \nof the naphthalene fraction from \ncoal tar and boiling in the range \nof approximately 200  o C to \n230  o C (392o F to 446o F). \nContains chiefly naphthalene, \nthionaphthene and alkylnaphtha\xad\nlenes.]  295-310-8  91995-49-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-088-00-5  Extract residues (coal), naph\xad\nthalene oil, alk.; Naphthalene \nOil Extract Residue; \n[A complex combination of \nhydrocarbons obtained from the \nalkali washing of naphthalene \noil to remove phenolic \ncompounds (tar acids). It is \ncomposed of naphthalene and \nalkyl naphthalenes.]  310-166-9  121620-47-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1181}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1183\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-089-00-0  Extract residues (coal), naph\xad\nthalene oil, alk., naphthalene- \nlow; \nNaphthalene Oil Extract Residue; \n[A complex combination of \nhydrocarbons remaining after \nthe removal of naphthalene from \nalkali-washed naphthalene oil by \na crystallization process. It is \ncomposed primarily of naph\xad\nthalene and alkyl naphthalenes.]  310-167-4  121620-48-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-090-00-6  Distillates (coal tar), naphthalene \noils, naphthalene-free, alk. exts.; \nNaphthalene Oil Extract Residue; \n[The oil remaining after the \nremoval of phenolic compounds \n(tar acids) from drained naph\xad\nthalene oil by an alkali wash. \nComposed primarily of naph\xad\nthalene and alkyl naphthalenes.]  292-612-1  90640-90-7  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1182}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1184\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-091-00-1  Extract residues (coal), naph\xad\nthalene oil alk., distn. overheads; \nNaphthalene Oil Extract Residue; \n[The distillate from alkali-washed \nnaphthalene oil having an \napproximate distillation range of \n180  o C to 220  o C (356o F to 428  \no F). Composed primarily of \nnaphthalene, alkylbenzenes, \nindene and indan.]  292-627-3  90641-04-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-092-00-7  Distillates (coal tar), naphthalene \noils, methylnaphthalene fraction; \nMethylnaphthalene Oil; \n[A distillate from the fractional \ndistillation of high temperature \ncoal tar. Composed primarily of \nsubstituted two ring aromatic \nhydrocarbons and aromatic \nnitrogen bases boiling in the \nrange of approximately 225  o C \nto 255  o C (437o F to 491  o F).] 309-985-4  101896-27-9  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1183}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1185\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-093-00-2  Distillates (coal tar), naphthalene \noils, indole-methylnaphthalene \nfraction; Methylnaphthalene Oil; \n[A distillate from the fractional \ndistillation of high temperature \ncoal tar. Composed primarily of \nindole and methylnaphthalene \nboiling in the range of approxi\xad\nmately 235  o C to 255  o C (455  o F \nto 491  o F).] 309-972-3  101794-91-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-094-00-8  Distillates (coal tar), naphthalene \noils, acid exts.; Methylnaph\xad\nthalene Oil Extract Residue; \n[A complex combination of \nhydrocarbons obtained by \ndebasing the methylnaphthalene \nfraction obtained by the distil\xad\nlation of coal tar and boiling in \nthe range of approximately \n230  o C to 255  o C (446o F to \n491o F). Contains chiefly 1(2)- \nmethylnaphthalene, naphthalene, \ndimethylnaphthalene and biphe\xad\nnyl.] 295-309-2  91995-48-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1184}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1186\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-095-00-3  Extract residues (coal), naph\xad\nthalene oil alk., distn. residues; \nMethylnaphthalene Oil Extract \nResidue; [The residue from the \ndistillation of alkali-washed \nnaphthalene oil having an \napproximate distillation range of \n220  o C to 300  o C (428o F to \n572o F). Composed primarily of \nnaphthalene, alkylnaphthalenes \nand aromatic nitrogen bases.]  292-628-9  90641-05-7  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-096-00-9  Extract oils (coal), acidic, tar- \nbase free; \nMethylnaphthalene Oil Extract \nResidue; [The extract oil boiling \nin the range of approximately \n220  o C to 265  o C (428o F to \n509o F) from coal tar alkaline \nextract residue produced by an \nacidic wash such as aqueous \nsulfuric acid after distillation to \nremove tar bases. Composed \nprimarily of alkylnaphthalenes.]  284-901-6  84989-12-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1185}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1187\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-097-00-4  Distillates (coal tar), benzole \nfraction, distn. residues; \nWash Oil; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of crude benzole \n(high temperature coal tar). It \nmay be a liquid with the \napproximate distillation range of \n150o C to 300  o C (302o F to \n572o F) or a semi-solid or solid \nwith a melting point up to \n70 o C (158o F). It is composed \nprimarily of naphthalene and \nalkyl naphthalenes.]  310-165-3  121620-46-0  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-098-00-X  Creosote oil, acenaphthene \nfraction; \nWash Oil; [A complex \ncombination of hydrocarbons \nproduced by the distillation of \ncoal tar and boiling in the range \nof approximately 240  o C to 280  \no C (464o F to 536  o F). \nComposed primarily of acenaph\xad\nthene, naphthalene and alkyl \nnaphthalene.]  292-605-3  90640-84-9  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1186}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1188\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-099-00-5  Creosote oil; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of coal tar. It \nconsists primarily of aromatic \nhydrocarbons and may contain \nappreciable quantities of tar \nacids and tar bases. It distills at \nthe approximate range of 200  o C \nto 325  o C (392o F to 617o F).] 263-047-8  61789-28-4  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-100-00-9  Creosote oil, high-boiling \ndistillate; \nWash Oil; \n[The high-boiling distillation \nfraction obtained from the high \ntemperature carbonization of \nbituminous coal which is further \nrefined to remove excess \ncrystalline salts. It consists \nprimarily of creosote oil with \nsome of the normal polynuclear \naromatic salts, which are \ncomponents of coal tar distillates, \nremoved. It is crystal free at \napproximately 5  o C (41o F).] 274-565-9  70321-79-8  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1187}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1189\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-101-00-4  Creosote; \n[The distillate of coal tar \nproduced by the high \ntemperature carbonization of \nbituminous coal. It consists \nprimarily of aromatic hydro\xad\ncarbons, tar acids and tar bases.]  232-287-5  8001-58-9  Carc. 1B  H350  GHS08 \nDgr H350  \n648-102-00-X  Extract residues (coal), creosote \noil acid; \nWash Oil Extract Residue; \n[A complex combination of \nhydrocarbons from the base- \nfreed fraction from the distil\xad\nlation of coal tar, boiling in the \nrange of approximately 250  o C \nto 280  o C (482o F to 536o F). It \nconsists predominantly of \nbiphenyl and isomeric diphe\xad\nnylnaphthalenes.]  310-189-4  122384-77-4  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-103-00-5  Anthracene oil, anthracene paste; \nAnthracene Oil Fraction; \n[The anthracene-rich solid \nobtained by the crystallization \nand centrifuging of anthracene \noil. It is composed primarily of \nanthracene, carbazole and phen\xad\nanthrene.]  292-603-2  90640-81-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1188}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1190\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-104-00-0  Anthracene oil, anthracene-low; \nAnthracene Oil Fraction; \n[The oil remaining after the \nremoval, by a crystallization \nprocess, of an anthracene-rich \nsolid (anthracene paste) from \nanthracene oil. It is composed \nprimarily of two, three and four \nmembered aromatic compounds.]  292-604-8  90640-82-7  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-105-00-6  Residues (coal tar), anthracene \noil distn.; Anthracene Oil \nFraction; \n[The residue from the fraction \ndistillation of crude anthracene \nboiling in the approximate range \nof 340  o C to 400  o C (644o F to \n752o F). It consists predominantly \nof tri-and polynuclear aromatic \nand heterocyclic hydrocarbons.]  295-505-8  92061-92-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-106-00-1  Anthracene oil, anthracene paste, \nanthracene fraction; Anthracene \nOil Fraction;  295-275-9  91995-15-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1189}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1191\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of anthracene obtained by \nthe crystallization of anthracene \noil from bituminous high \ntemperature tar and boiling in \nthe range of 330  o C to 350  o C \n(626o F to 662o F). It contains \nchiefly anthracene, carbazole \nand phenanthrene.]  \n648-107-00-7  Anthracene oil, anthracene paste, \ncarbazole fraction; Anthracene \nOil Fraction; \n[A complex combination of \nhydrocarbons from the distil \nlation of anthracene obtained by \ncrystallization of anthracene oil \nfrom bituminous coal high \ntemperature tar and boiling in \nthe approximate range of \n350  o C to 360  o C (662o F to \n680  o F). It contains chiefly \nanthracene, carbazole and phen\xad\nanthrene.]  295-276-4  91995-16-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1190}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1192\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-108-00-2  Anthracene oil, anthracene paste, \ndistn. lights; \nAnthracene Oil Fraction; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of anthracene obtained by \ncrystallization of anthracene oil \nfrom bituminous high \ntemperature tar and boiling in \nthe range of approximately \n290  o C to 340  o C (554o F to \n644  o F). It contains chiefly \ntrinuclear aromatics and their \ndihydro derivatives.]  295-278-5  91995-17-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-109-00-8  Tar oils, coal, low-temp.; Tar \nOil, high boiling; \n[A distillate from low- \ntemperature coal tar. Composed \nprimarily of hydrocarbons, \nphenolic compounds and \naromatic nitrogen bases boiling \nin the range of approximately \n160  o C to 340  o C (320o F to \n644o F).] 309-889-2  101316-87-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1191}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1193\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-110-00-3  Extract residues (coal), low temp. \ncoal atar alk.; \n[The residue from low \ntemperature coal tar oils after an \nalkaline wash, such as aqueous \nsodium hydroxide, to remove \ncrude coal tar acids. Composed \nprimarily of hydrocarbons and \naromatic nitrogen bases.]  310-191-5  122384-78-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-111-00-9  Phenols, ammonia liquor ext.; \nAlkaline Extract; \n[The combination of phenols \nextracted, using isobutyl acetate, \nfrom the ammonia liquor \ncondensed from the gas evolved \nin low-temperature (less than \n700  o C (1292o F)) destructive \ndistillation of coal. It consists \npredominantly of a reaction \nmass of monohydric and \ndihydric phenols.]  284-881-9  84988-93-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1192}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1194\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-112-00-4  Distillates (coal tar), light oils, \nalk. exts.; \nAlkaline Extract; \n[The aqueous extract from \ncarbolic oil produced by an \nalkaline wash such as aqueous \nsodium hydroxide. Composed \nprimarily of the alkali salts of \nvarious phenolic compounds.]  292-610-0  90640-88-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-113-00-X  Extracts, coal tar oil alk.; \nAlkaline Extract; \n[The extract from coal tar oil \nproduced by an alkaline wash \nsuch as aqueous sodium \nhydroxide. Composed primarily \nof the alkali salts of various \nphenolic compounds.]  266-017-2  65996-83-0  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-114-00-5  Distillates (coal tar), naphthalene \noils, alk. exts.; Alkaline Extract; \n[The aqueous extract from naph\xad\nthalene oil produced by an \nalkaline wash such as aqueous \nsodium hydroxide. Composed \nprimarily of the alkali salts of \nvarious phenolic compounds.]  292-611-6  90640-89-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1193}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1195\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-115-00-0  Extract residues (coal), tar oil \nalk., carbonated, limed; \nCrude Phenols; [The product \nobtained by treatment of coal \ntar oil alkaline extract with CO2 \nand CaO. Composed primarily of \nCaCO3, Ca(OH)2, Na2CO3 and \nother organic and inorganic \nimpurities.]  292-629-4  90641-06-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-116-00-6  Tar acids, coal, crude; Crude \nPhenols; \n[The reaction product obtained \nby neutralizing coal tar oil \nalkaline extract with an acidic \nsolution, such as aqueous \nsulfuric acid, or gaseous carbon \ndioxide, to obtain the free acids. \nComposed primarily of tar acids \nsuch as phenol, cresols, and xyle\xad\nnols.]  266-019-3  65996-85-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-117-00-1  Tar acids, brown-coal, crude; \nCrude Phenols; \n[An acidified alkaline extract of \nbrown coal tar distillate. \nComposed primarily of phenol \nand phenol homologs.]  309-888-7  101316-86-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1194}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1196\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-118-00-7  Tar acids, browncoal gasifi\xad\ncation; \nCrude Phenols; \n[A complex combination of \norganic compounds obtained \nfrom brown coal gasification. \nComposed primarily of C  6-10 \nhydroxy aromatic phenols and \ntheir homologs.]  295-536-7  92062-22-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-119-00-2  Tar acids, distn. residues; \nDistillate Phenols; \n[A residue from the distillation of \ncrude phenol from coal. It \nconsists predominantly of \nphenols having carbon numbers \nin the range of C  8 through C  10 \nwith a softening point of 60  o C \nto 80  o C (140o F to 176o F).] 306-251-5  96690-55-0  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-120-00-8  Tar acids, methylphenol fraction; \nDistillate Phenols; \n[The fraction of tar acid rich in \n3-and 4-methylphenol, recovered \nby distillation of low-temperature \ncoal tar crude tar acids.]  284-892-9  84989-04-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1195}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1197\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-121-00-3  Tar acids, polyalkylphenol \nfraction; \nDistillate Phenols; \n[The fraction of tar acids, \nrecovered by distillation of low- \ntemperature coal tar crude tar \nacids, having an approximate \nboiling range of 225  o C to \n320  o C (437o F to 608o F). \nComposed primarily of poly\xad\nalkylphenols.]  284-893-4  84989-05-9  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-122-00-9  Tar acids, xylenol fraction; \nDistillate Phenols; \n[The fraction of tar acids, rich in \n2,4-and 2,5-dimethylphenol, \nrecovered by distillation of low- \ntemperature coal tar crude tar \nacids.]  284-895-5  84989-06-0  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-123-00-4  Tar acids, ethylphenol fraction; \nDistillate Phenols; \n[The fraction of tar acids, rich in \n3-and 4-ethylphenol, recovered \nby distillation of low-temperature \ncoal tar rude tar acids.]  284-891-3  84989-03-7  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1196}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1198\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-124-00-X  Tar acids, 3,5-xylenol fraction; \nDistillate Phenols; \n[The fraction of tar acids, rich in \n3,5-dimethylphenol, recovered by \ndistillation of low-temperature \ncoal tar acids.]  284-896-0  84989-07-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-125-00-5  Tar acids, residues, distillates, \nfirst-cut; \nDistillate Phenols; \n[The residue from the distillation \nin the range of 235  o C to 355  o C \n(481o F to 697o F) of light \ncarbolic oil.]  270-713-1  68477-23-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-126-00-0  Tar acids, cresylic, residues; \nDistillate Phenols; \n[The residue from crude coal tar \nacids after removal of phenol, \ncresols, xylenols and any higher \nboiling phenols. A black solid \nwith a melting point approxi\xad\nmately 80  o C (176o F). \nComposed primarily of poly\xad\nalkylphenols, resin gums, and \ninorganic salts.]  271-418-0  68555-24-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1197}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1199\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-127-00-6  Phenols, C  9-11; Distillate Phenols  293-435-2  91079-47-9  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-128-00-1  Tar acids, cresylic; Distillate \nPhenols; \n[A complex combination of \norganic compounds obtained \nfrom brown coal and boiling in \nthe range of approximately \n200  o C to 230  o C (392o F to \n446o F). It contains chiefly \nphenols and pyridine bases.]  295-540-9  92062-26-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-129-00-7  Tar acids, brown-coal, C  2- \nalkylphenol fraction; \nDistillate Phenols; \n[The distillate from the acidifi\xad\ncation of alkaline washed lignite \ntar distillate boiling in the range \nof approximately 200  o C to \n230  o C (392o F to 446o F). \nComposed primarily of  m-and \np-ethylphenol as well as cresols \nand xylenols.]  302-662-9  94114-29-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1198}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1200\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-130-00-2  Extract oils (coal), naphthalene \noils; \nAcid Extract; \n[The aqueous extract produced \nby an acidic wash of alkali- \nwashed naphthalene oil. \nComposed primarily of acid \nsalts of various aromatic \nnitrogen bases including \npyridine, quinoline and their \nalkyl derivatives.]  292-623-1  90641-00-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-131-00-8  Tar bases, quinoline derivs.; \nDistillate Bases  271-020-7  68513-87-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-132-00-3  Tar bases, coal, quinoline derivs. \nfraction; \nDistillate Bases  274-560-1  70321-67-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-133-00-9  Tar bases, coal, distn. residues; \nDistillate Bases; \n[The distillation residue \nremaining after the distillation \nof the neutralized, acid-extracted \nbase-containing tar fractions \nobtained by the distillation of \noal tars. I contains chiefly \naniline, collidines, quinoline and \nquinoline derivatives and tolui\xad\ndines.]  295-544-0  92062-29-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1199}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1201\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-134-00-4  Hydrocarbon oils, arom., mixed \nwith polyethylene and poly\xad\npropylene, pyrolyzed, light oil \nfraction; \nHeat Treatment Products; [The \noil obtained from the heat \ntreatment of a polyethylene/ \npolypropylene reaction mass \nwith coal tar pitch or aromatic \noils. It consists predominantly \nof benzene and its homologs \nboiling in a range of approxi\xad\nmately 70  o C to 120  o C (158  \no F to 248  o F).] 309-745-9  100801-63-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-135-00-X  Hydrocarbon oils, arom., mixed \nwith polyethylene, pyrolyzed, \nlight oil fraction; \nHeat Treatment Products; \n[The oil obtained from the heat \ntreatment of polyethylene with \ncoal tar pitch or aromatic oils. \nIt consists predominantly of \nbenzene and its homologs \nboiling in a range of 70  o C to \n120  o C (158o F to 248o F).] 309-748-5  100801-65-8  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1200}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1202\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-136-00-5  Hydrocarbon oils, arom., mixed \nwith polystyrene, pyrolyzed, \nlight oil fraction; \nHeat Treatment Products; \n[The oil obtained from the heat \ntreatment of polystyrene with \ncoal tar pitch or aromatic oils. \nIt consists predominantly of \nbenzene and its homologs \nboiling in a range of approxi\xad\nmately 70  o C to 210  o C (158  \no F to 410o F).] 309-749-0  100801-66-9  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-137-00-0  Extract residues (coal), tar oil \nalk., naphthalene distn. residues; \nNaphthalene Oil Extract Residue; \n[The residue obtained from \nchemical oil extracted after the \nremoval of naphthalene by distil\xad\nlation composed primarily of two \nto four membered condensed \nring aromatic hydrocarbons and \naromatic nitrogen bases.]  277-567-8  73665-18-6  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1201}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1203\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-138-00-6  Creosote oil, low-boiling \ndistillate; \nWash Oil; \n[The low-boiling distillation \nfraction obtained from the high \ntemperature carbonization of \nbituminous coal, which is \nfurther refined to remove excess \ncrystalline salts. It consists \nprimarily of creosote oil with \nsome of the normal polynuclear \naromatic salts, which are \ncomponents of coal tar distillate, \nremoved. It is crystal free at \napproximately 38  o C (100  o F).] 274-566-4  70321-80-1  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-139-00-1  Tar acids, cresylic, sodium salts, \ncaustic solns.; Alkaline Extract  272-361-4  68815-21-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1202}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1204\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-140-00-7  Extract oils (coal), tar base; Acid \nExtract; \n[The extract from coal tar oil \nalkaline extract residue produced \nby an acidic wash such as \naqueous sulfuric acid after distil\xad\nlation to remove naphthalene. \nComposed primarily of the acid \nsalts of various aromatic nitrogen \nbases including pyridine, \nquinoline, and their alkyl deriva\xad\ntives.]  266-020-9  65996-86-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM \n648-141-00-2  Tar bases, coal, crude; Crude Tar \nBases; \n[The reaction product obtained \nby neutralizing coal tar base \nextract oil with an alkaline \nsolution, such as aqueous \nsodium hydroxide, to obtain the \nfree bases. Composed primarily \nof such organic bases as \nacridine, phenanthridine, \npyridine, quinoline and their \nalkyl derivatives.]  266-018-8  65996-84-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  JM ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1203}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1205\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-142-00-8  Residues (coal), liq. solvent \nextn.; \n[A cohesive powder composed of \ncoal mineral matter and undis\xad\nsolved coal remaining after \nextraction of coal by a liquid \nsolvent.]  302-681-2  94114-46-2  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-143-00-3  Coal liquids, liq. solvent extn. \nsoln.; \n[The product obtained by \nfiltration of coal mineral matter \nand undissolved coal from coal \nextract solution produced by \ndigesting coal in a liquid \nsolvent. A black, viscous, \nhighly complex liquid \ncombination composed primarily \nof aromatic and partly hydro- \ngenated aromatic hydrocarbons, \naromatic nitrogen compounds, \naromatic sulfur compounds, \nphenolic and other aromatic \noxygen compounds and their \nalkyl derivatives.]  302-682-8  94114-47-3  Carc. 1B  H350  GHS08 \nDgr H350  M  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1204}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1206\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-144-00-9  Coal liquids, liq. solvent extn.; \n[The substantially solvent-free \nproduct obtained by the distil\xad\nlation of the solvent from \nfiltered coal extract solution \nproduced by digesting coal in a \nliquid solvent. A black semi- \nsolid, composed primarily of a \ncomplex combination of \ncondensed-ring aromatic hydro\xad\ncarbons, aromatic nitrogen \ncompounds, aromatic sulfur \ncompounds, phenolic \ncompounds and other aromatic \noxygen compounds, and their \nalkyl derivatives.]  302-683-3  94114-48-4  Carc. 1B  H350  GHS08 \nDgr H350  M  \n648-145-00-4  Tar brown-coal; \n[An oil distilled from brown-coal \ntar. Composed primarily of alip\xad\nhatic, naphthenic and one-to \nthree-ring aromatic hydro\xad\ncarbons, their alkyl derivates, \nheteroaromatics and one-and \ntwo-ring phenols boiling in the \nrange of approximately 150o C \nto 360  o C (302o F to 680o F).] 309-885-0  101316-83-0  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1205}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1207\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-146-00-X  Tar, brown-coal, low-temp.; \n[A tar obtained from low \ntemperature carbonization and \nlow temperature gasification of \nbrown coal. Composed primarily \nof aliphatic, naphthenic and \ncyclic aromatic hydrocarbons, \nheteroaromatic hydrocarbons and \ncyclic phenols.]  309-886-6  101316-84-1  Carc. 1A  H350  GHS08 \nDgr H350  \n648-147-00-5  Light oil (coal), coke-oven; \nCrude benzole; \n[The volatile organic liquid \nextracted from the gas evolved \nin the high temperature (greater \nthan 700  o C (1 292  o F)) \ndestructive distillation of coal. \nComposed primarily of benzene, \ntoluene, and xylenes. May \ncontain other minor hydrocarbon \nconstituents.]  266-012-5  65996-78-3  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1206}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1208\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-148-00-0  Distillates (coal), liq. solvent \nextn., primary; \n[The liquid product of conden\xad\nsation of vapors emitted during \nthe digestion of coal in a liquid \nsolvent and boiling in the range \nof approximately 30  o C to \n300  o C 86  o F to 572  o F). \nComposed primarily of partly \nhydrogenated condensed-ring \naromatic hydrocarbons, aromatic \ncompounds containing nitrogen, \noxygen and sulfur, and their \nalkyl derivatives having carbon \nnumbers predominantly in the \nrange of C  4 through C  14.] 302-688-0  94114-52-0  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n648-149-00-6  Distillates (coal), solvent extn., \nhydrocracked; \n[Distillate obtained by hydro\xad\ncracking of coal extract or \nsolution produced by the liquid \nsolvent extraction or supercritical \ngas extraction processes and \nboiling in the range of approxi\xad\nmately 30  o C to 300o C (86  o F to \n572  o F). Composed primarily of  302-689-6  94114-53-1  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1207}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1209\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \naromatic, hydrogenated aromatic \nand naphthenic compounds, \ntheir alkyl derivatives and \nalkanes with carbon numbers \npredominantly in the range of \nC 4 through C  14. Nitrogen, sulfur \nand oxygen-containing aromatic \nand hydrogenated aromatic \ncompounds are also present.]  \n648-150-00-1  Naphtha (coal), solvent extn., \nhydrocracked; \n[Fraction of the distillate \nobtained by hydrocracking of \ncoal extract or solution \nproduced by the liquid solvent \nextraction or supercritical gas \nextraction processes and boiling \nin the range of approximately \n30 o C to 180  o C (86o F to \n356o F). Composed primarily of \naromatic, hydrogenated aromatic \nand naphthenic compounds, \ntheir alkyl derivatives and \nalkanes with carbon numbers \npredominantly in the range of \nC 4 to C  9. Nitrogen, sulfur and \noxygen-containing aromatic and \nhydrogenated aromatic \ncompounds are also present.]  302-690-1  94114-54-2  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1208}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1210\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-151-00-7  Gasoline, coal solvent extn., \nhydrocracked naphtha; \n[Motor fuel produced by the \nreforming of the refined naphtha \nfraction of the products of hydro\xad\ncracking of coal extract or \nsolution produced by the liquid \nsolvent extraction or supercritical \ngas extraction processes and \nboiling in the range of approxi\xad\nmately 30  o C to 180  o C (86  o F to \n356o F). Composed primarily of \naromatic and naphthenic hydro\xad\ncarbons, their alkyl derivatives \nand alkyl hydrocarbons having \ncarbon numbers in the range of \nC 4 through C  9.] 302-691-7  94114-55-3  Carc. 1B  H350  GHS08 \nDgr H350  \n648-152-00-2  Distillates (coal), solvent extn., \nhydrocracked middle; \n[Distillate obtained from the \nhydrocracking of coal extract or \nsolution produced by the liquid \nsolvent extraction or supercritical \ngas extraction processes and \nboiling in the range of approxi\xad\nmately 180  o C to 300  o C (356o F \nto 572o F. Composed primarily of  302-692-2  94114-56-4  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1209}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1211\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \ntwo-ring aromatic, hydrogenated \naromatic and naphthenic \ncompounds, their alkyl deriva\xad\ntives and alkanes having carbon \nnumbers predominantly in the \nrange of C  9 through C  14. \nNitrogen, sulfur and oxygen- \ncontaining compounds are also \npresent.]  \n648-153-00-8  Distillates (coal), solvent extn., \nhydrocracked hydrogenated \nmiddle; \n[Distillate from the hydroge \nnation of hydrocracked middle \ndistillate from coal extract or \nsolution produced by the liquid \nsolvent extraction or supercritical \ngas extraction processes and \nboiling in the range of approxi\xad\nmately 180  o C to 280  o C (356 F \nto 536o F). Composed primarily \nof hydrogenated two-ring carbon \ncompounds and their alkyl deri\xad\nvatives having carbon numbers \npredominantly in the range of \nC 9 through C  14.] 302-693-8  94114-57-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1210}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1212\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n648-154-00-3  Fuels, jet aircraft, coal solvent \nextn.,hydrocracked hydro \ngenated; \n[Jet engine fuel produced by \nhydrogenation of the middle \ndistillate fraction of the products \nof hydrocracking of coal extract \nor solution produced by the \nliquid solvent extraction or \nsupercritical gas extraction \nprocesses and boiling in the \nrange of approximately 180o C \nto 225o C (356o F to 473o F). \nComposed primarily of hydro\xad\ngenated two-ring hydrocarbons \nand their alkyl derivatives \nhaving carbon numbers predomi\xad\nnantly in the range of C  10 \nthrough C  12.] 302-694-3  94114-58-6  Carc. 2  H351  GHS08 \nWng  H350  \n648-155-00-9  Fuels, diesel, coal solvent extn., \nhydrocracked hydrogenated; \n[Diesel engine fuel produced by \nthe hydrogenation of the middle \ndistillate fraction of the products \nof hydrocracking of coal extract \nor solution produced by the \nliquid solvent extraction or \nsupercritical gas extraction \nprocesses and boiling in the  302-695-9  94114-59-7  Carc. 2  H351  GHS08 \nWng  H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1211}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1213\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nrange of approximately 200o C to \n280o C (392o F to 536o F). \nComposed primarily of hydro\xad\ngenated two-ring hydrocarbons \nandtheir alkylderivatives having \ncarbon numbers predominantly \nin the range of C  11 through C  14.] \n648-156-00-4  Light oil (coal), semi-coking \nprocess; Fresh oil; [The volatile \norganic liquid condensed from \nthe gasevolved in the low- \ntemperature (less than 700  o C \n(1 292o F)) destructive distillation \nof coal. Composed primarily of \nC 6-10 hydrocarbons.]  292-635-7  90641-11-5  Carc. 1B Muta. \n1B H350 \nH340  GHS08 \nDgr H350 \nH340  J \n649-001-00-3  Extracts (petroleum), light naph\xad\nthenic distillate solvent  265-102-1  64742-03-6  Carc. 1B  H350  GHS08 \nDgr H350  \n649-002-00-9  Extracts (petroleum), heavy \nparaffinic distillate solvent  265-103-7  64742-04-7  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1212}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1214\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-003-00-4  Extracts (petroleum), light \nparaffinic distillate solvent  265-104-2  64742-05-8  Carc. 1B  H350  GHS08 \nDgr H350  \n649-004-00-X  Extracts (petroleum), heavy \nnaphthenic distillate solvent  265-111-0  64742-11-6  Carc. 1B  H350  GHS08 \nDgr H350  \n649-005-00-5  Extracts (petroleum), light \nvacuum gas oil solvent  295-341-7  91995-78-7  Carc. 1B  H350  GHS08 \nDgr H350  \n649-006-00-0  hydrocarbons C  26-55, arom-rich  307-753-7  97722-04-8  Carc. 1B  H350  GHS08 \nDgr H350  \n649-007-00-6  fatty acids, tall-oil, reaction \nproducts with iminodiethanol \nand boric acid  400-160-5  —  Skin Irrit. 2 \nAquatic Chronic 2  H315 \nH411  GHS07 \nGHS09 \nWng  H315 \nH411  \n649-008-00-1  Residues (petroleum), atm. \ntower; \nHeavy Fuel oil; \n[A complex residuum from the \natmospheric distillation of crude \noil. It consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  20 and \nboiling above approxi mately \n350  o C (662  o F). This stream is \nlikely to contain 5 wt. % or more \nof 4-to 6-membered condensed \nring aromatic hydrocarbons.]  265-045-2  64741-45-3  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1213}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1215\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-009-00-7  Gas oils (petroleum), heavy \nvacuum; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced by the \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50 \nand boiling in the range of \napproximately 350  o C to 600  o C \n(662  o F to 1112  o F). This stream \nis likely to contain 5 wt. % or \nmore of 4-to 6-membered \ncondensed ring aromatic hydro\xad\ncarbons.]  265-058-3  64741-57-7  Carc. 1B  H350  GHS08 \nDgr H350  \n649-010-00-2  Distillates (petroleum), heavy \ncatalytic cracked; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  35 \nand boiling in the range of  265-063-0  64741-61-3  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1214}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1216\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \napproximately 260o C to 500o C \n(500o F to 932o F). This stream is \nlikely to contain 5 wt. % or more \nof 4-to 6-membered condensed \nring aromatic hydrocarbons.]  \n649-011-00-8  Clarified oils (petroleum), \ncatalytic cracked; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced as the \nresidual fraction from distillation \nof the products from a catalytic \ncracking process. It consists of \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  20 and boiling above \napproximately 350o C (662o F). \nThis stream is likely to contain \n5 wt. % or more of 4-to 6- \nmembered condensed ring \naromatic hydrocarbons.]  265-064-6  64741-62-4  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1215}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1217\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-012-00-3  Residues (petroleum), hydro\xad\ncracked; Heavy Fuel oil; \n[A complex combination of \nhydrocarbons produced as the \nresidual fraction from distillation \nof the products of a hydro\xad\ncracking process. It consists of \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  20 and boiling above \napproxi mately 350o C (662  o F).] 265-076-1  64741-75-9  Carc. 1B  H350  GHS08 \nDgr H350  \n649-013-00-9  Residues (petroleum), thermal \ncracked; Heavy Fuel oil; \n[A complex combination of \nhydrocarbons produced as the \nresidual fraction from distillation \nof the product from a thermal \ncracking process. It consists \npredominantly of unsaturated \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  20 and boiling above \napproximately 350o C (662  o F). \nThis stream is likely to contain \n5 wt. % or more of 4-to 6- \nmembered condensed ring \naromatic hydrocarbons.]  265-081-9  64741-80-6  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1216}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1218\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-014-00-4  Distillates (petroleum), heavy \nthermal cracked; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of the products from a \nthermal cracking process. It \nconsists predominantly of \nunsaturated hydrocarbons having \ncarbon numbers predominantly in \nthe range of C  15 through C  36 and \nboiling in the range of approxi\xad\nmately 260o C to 480  o C (500  o F \nto 896  o F). This stream is likely \nto contain 5 wt. % or more of 4- \nto 6-membered condensed ring \naromatic hydrocarbons.]  265-082-4  64741-81-7  Carc. 1B  H350  GHS08 \nDgr H350  \n649-015-00-X  Gas oils (petroleum), hydro- \ntreated vacuum; Heavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 13 through C  50 and boiling in  265-162-9  64742-59-2  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1217}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1219\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nthe range of approximately \n230o C to 600o C (446  o F to \n1112  o F). This stream is likely \nto contain 5 wt.% or more of 4- \nto 6-membered condensed ring \naromatic hydrocarbons.]  \n649-016-00-5  Residues (petroleum), hydrode\xad\nsulfurized atmospheric tower; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by \ntreating an atmospheric tower \nresiduum with hydrogen in the \npresence of a catalyst under \nconditions primarily to remove \norganic sulfur compounds. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \ngreater than C  20 and boiling \nabove approximately 350  o C \n(662  o F). This stream is likely \nto contain 5 wt. % or more of \n4-to 6-membered condensed \nring aromatic hydrocarbons.]  265-181-2  64742-78-5  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1218}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1220\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-017-00-0  Gas oils (petroleum), hydrodesul\xad\nfurized heavy vacuum; Heavy \nFuel oil; [A complex \ncombination of hydrocarbons \nobtained from a catalytic \nhydrodesulfurization process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50 \nand boiling in the range of \napproximately 350  o C to 600  o C \n(662  o F to 1112  o C). This stream \nis likely to contain 5 wt. % or \nmore of 4-to 6-membered \ncondensed ring aromatic hydro\xad\ncarbons.]  265-189-6  64742-86-5  Carc. 1B  H350  GHS08 \nDgr H350  \n649-018-00-6  Residues (petroleum), steam- \ncracked; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained as the \nresidual fraction from the distil\xad\nlation of the products of a steam \ncracking process (including \nsteam cracking to produce ethy\xad\nlene). It consists predominantly \nof unsaturated hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  14 and 265-193-8  64742-90-1  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1219}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1221\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nboiling above approximately 260  \no C (500  o F). This stream is likely \nto contain 5 wt. % or more of 4- \nto 6-memberedcondensed ring \naromatic hydrocarbons.]  \n649-019-00-1  Residues (petroleum), atmos\xad\npheric; \nHeavy Fuel oil; \n[A complex residuum from \natmospheric distillation of crude \noil. \nIt consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  11 and \nboiling above approxi mately \n200o C (392  o F). This stream is \nlikely to contain 5 wt. % or \nmore of 4-to 6-membered \ncondensed ring aromatic hydro\xad\ncarbons.]  269-777-3  68333-22-2  Carc. 1B  H350  GHS08 \nDgr H350  \n649-020-00-7  Clarified oils (petroleum), \nhydrodesulfurized catalytic \ncracked; \nHeavy Fuel oil;  269-782-0  68333-26-6  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1220}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1222\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreating catalytic cracked \nclarified oil with hydrogen to \nconvert organic sulfur to \nhydrogen sulfide which is \nremoved. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly greater than C  20 \nand boiling above approximately \n350  o C (662  o F). This stream is \nlikely to contain 5 wt. % or more \nof 4-to 6-membered condensed \nring aromatic hydrocarbons.]  \n649-021-00-2  Distillates (petroleum), hydrode\xad\nsulfurized intermediate catalytic \ncracked; \nHeavy Fuel oil; \n[A complex combination of hydro\xad\ncarbons obtained by treating inter\xad\nmediate catalytic cracked \ndistillates with hydrogen to \nconvert organic sulfur to \nhydrogen sulfide which is \nremoved. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of C  11 \nthrough C  30 and boiling in  269-783-6  68333-27-7  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1221}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1223\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nthe range of approximately 205  o C \nto 450  o C (401  o F to 842  o F). It \ncontains a relatively large \nproportion of tricyclic aromatic \nhydrocarbons.]  \n649-022-00-8  Distillates (petroleum), hydrode\xad\nsulfurized heavy catalytic \ncracked; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by \ntreatment of heavy catalytic \ncracked distillates with hydrogen \nto convert organic sulfur to \nhydrogen sulfide which is \nremoved. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  35 and boiling in \nthe range of approximately \n260o C to 500  o C (500o F to \n932o F). This stream is likely to \ncontain 5 wt. % or more of 4-to \n6-membered condensed ring \naromatic hydrocarbons.]  269-784-1  68333-28-8  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1222}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1224\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-023-00-3  Fuel oil, residues-straight-run gas \noils, high-sulfur; \nHeavy Fuel oil  270-674-0  68476-32-4  Carc. 1B  H350  HS08 \nDgr H350  \n649-024-00-9  Fuel oil, residual; Heavy Fuel \noil; \n[The liquid product from various \nrefinery streams, usually \nresidues. The composition is \ncomplex and varies with the \nsource of the crude oil.]  270-675-6  68476-33-5  Carc. 1B  H350  GHS08 \nDgr H350  \n649-025-00-4  Residues (petroleum), catalytic \nreformer fractionator residue \ndistn.; \nHeavy Fuel oil; \n[A complex residuum from the \ndistillation of catalytic reformer \nfractionator residue. It boils \napproximately above 399o C \n(750o F).] 270-792-2  68478-13-7  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1223}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1225\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-026-00-X  Residues,(petroleum), heavy \ncoker gas oil and vacuum gas oil; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced as the \nresidual fraction from the distil\xad\nlation of heavy coker gas oil and \nvacuum gas oil. It predomi \nnantly consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  13 and \nboiling above approximately \n230  o C (446  o F).] 270-796-4  68478-17-1  Carc. 1B  H350  GHS08 \nDgr H350  \n649-027-00-5  Residues (petroleum), heavy \ncoker and light vacuum; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced as the \nresidual fraction from the distil\xad\nlation of heavy coker gas oil and \nlight vacuum gas oil. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  13 and \nboiling above approximately \n230  o C (446  o F).] 270-983-0  68512-61-8  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1224}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1226\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-028-00-0  Residues(petroleum), light \nvacuum; \nHeavy Fuel oil; [A complex \nresiduum from the vacuum distil\xad\nlation of the residuum from the \natmospheric distillation of crude \noil. It consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  13 and \nboiling above approximately \n230  o C (446  o F).] 270-984-6  68512-62-9  Carc. 1B  H350  GHS08 \nDgr H350  \n649-029-00-6  Residues (petroleum), steam- \ncracked light; \nHeavy Fuel oil; \n[A complex residuum from the \ndistillation of the products from \na steam-cracking process. It \nconsists predominantly of \naromatic and unsaturated hydro\xad\ncarbons having carbon numbers \ngreater than C  7 and boiling in \nthe range of approximately \n101o C to 555  o C (214  o F to \n1030o F).] 271-013-9  68513-69-9  Carc. 1B  H350  GHS08 \nDgr H350  \n649-030-00-1  Fuel oil, No 6; Heavy Fuel oil; \n[A distillate oil having a \nminimum viscosity of 900 SUS \nat 37.7  o C (100  o F) to a \nmaximum of 9000 SUS at 37.7  \no C (100  o F).] 271-384-7  68553-00-4  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1225}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1227\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-031-00-7  Residues (petroleum), topping \nplant, low-sulfur; \nHeavy Fuel oil; \n[A low-sulfur complex \ncombination of hydrocarbons \nproduced as the residual fraction \nfrom the topping plant distillation \nof crude oil. It is the residuum \nafter the straight-run gasoline \ncut, kerosene cut and gas oil \ncut have been removed.]  271-763-7  68607-30-7  Carc. 1B  H350  GHS08 \nDgr H350  \n649-032-00-2  Gas oils (petroleum), heavy \natmospheric; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  7 through C  35 \nand boiling in the range of \napproximately 121o C to 510  o C \n(250  o F to 950o F).] 272-184-2  68783-08-4  Carc. 1B  H350  GHS08 \nDgr H350  \n649-033-00-8  Residues(petroleum), coker \nscrubber, Condensed-ring-arom.- \ncontg.; Heavy Fuel oil; [A very \ncomplex combination of hydro\xad\ncarbons produced as the residual  272-187-9  68783-13-1  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1226}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1228\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nfraction from the distillation of \nvaccum residuum and the \nproducts from a thermal \ncracking process. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  20 and \nboiling above approximately \n350  o C (662  o F). This stream is \nlikely to contain 5 wt.% or more \nof 4-to 6-membered condensed \nrind aromatic hydrocarbons.]  \n649-034-00-3  Distillates (petroleum), petroleum \nresidues vacuum; Heavy Fuel oil; \n[A complex combination of \nhydrocarbons produced by the \nvacuum distillation of the \nresiduum from the atmospheric \ndistillation of crude oil.]  273-263-4  68955-27-1  Carc. 1B  H350  GHS08 \nDgr H350  \n649-035-00-9  Residues (petroleum), steam- \ncracked, resinous; \nHeavy Fuel oil; \n[A complex residuum from the \ndistillation of steam-cracked \npetroleum residues.]  273-272-3  68955-36-2  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1227}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1229\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-036-00-4  Distillates (petroleum), inter\xad\nmediate vacuum; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced by the \nvacuum, distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  14 through C  42 \nand boiling in the range of \napproximately 250o C to 545o C \n(482o F to 1013o F). This stream \nis likely to contain 5 wt. % or \nmore of 4-to 6-membered \ncondensed ring aromatic hydro\xad\ncarbons.]  274-683-0  70592-76-6  Carc. 1B  H350  GHS08 \nDgr H350  \n649-037-00-X  Distillates (petroleum), light \nvacuum; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced by the \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  11 through C  35 \nand boiling in the range of \napproximately 250  o C to 545o C \n(482o F to 1013  o F).] 274-684-6  70592-77-7  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1228}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1230\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-038-00-5  Distillates (petroleum), vacuum; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced by the \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \nnumbers predominantly in the \nrange of C  15 through C  50 and \nboiling in the range of approxi\xad\nmately 270  o C to 600  o C (518o F \nto 1112  o F). This stream is likely \nto contain 5 wt.% or more of 4- \nto 6-membered condensed ring \naromatic hydrocarbons.]  274-685-1  70592-78-8  Carc. 1B  H350  GHS08 \nDgr H350  \n649-039-00-0  Gas oils (petroleum), hydrodesul\xad\nfurized coker heavy vacuum; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by \nhydrodesulfurization of heavy \ncoker distillate stocks, It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range C  18 \nto C  44 and boiling in the range  285-555-9  85117-03-9  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1229}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1231\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nof approximately 304o C to \n548o C (579o F to 1018o F). \nLikely to contain 5 % or more \nof 4-to 6-membered condensed \nring aromatic hydrocarbons.]  \n649-040-00-6  Residues (petroleum), steam- \ncracked, distillates; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained during \nthe production of refined \npetroleum tar by the distillation \nof steam cracked tar. It consists \npredominantly of aromatic and \nother hydrocarbons and organic \nsulfur compounds.]  292-657-7  90669-75-3  Carc. 1B  H350  GHS08 \nDgr H350  \n649-041-00-1  Residues (petroleum), vacuum, \nlight; \nHeavy Fuel oil; \n[A complex residuum from the \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly greater than C  24 \nand boiling above approximately \n390  o C (734  o F).] 292-658-2  90669-76-4  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1230}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1232\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-042-00-7  Fuel oil, heavy, high-sulfur; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of crude petroleum. \nIt consists predominantly of alip\xad\nhatic, aromatic and cycloaliphatic \nhydrocarbons having carbon \nnumbers predominantly higher \nthan C  25 and boiling above \napproximately 400  o C (752  o F).] 295-396-7  92045-14-2  Carc. 1B  H350  GHS08 \nDgr H350  \n649-043-00-2  Residues (petroleum), catalytic \ncracking; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced as the \nresidual fraction from the distil\xad\nlation of the products from a \ncatalytic cracking process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly greater than C  11 \nand boiling above approximately \n200o C (392o F).] 295-511-0  92061-97-7  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1231}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1233\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-044-00-8  Distillates (petroleum), inter\xad\nmediate catalytic cracked, \nthermally degraded; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process which \nhas been used as a heat transfer \nfluid. It consists predominantly \nof hydrocarbons boiling in the \nrange of approximately 220  o C \nto 450 C (428  o F to 842  o F). \nThis stream is likely to contain \norganic sulfur compounds.]  295-990-6  92201-59-7  Carc. 1B  H350  GHS08 \nDgr H350  \n649-045-00-3  Residual oils (petroleum); Heavy \nFuel oil; \n[A complex combination of \nhydrocarbons, sulfur compounds \nand metal-containing organic \ncompounds obtained as the \nresidue from refinery frac\xad\ntionation cracking processes. It \nproduces a finished oil with a \nviscosity above 2cSt. at 100  o C.] 298-754-0  93821-66-0  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1232}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1234\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-046-00-9  Residues, steam cracked, \nthermally treated; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment and distillation of raw \nsteam-cracked naphtha. It \nconsists predominantly of \nunsaturated hydrocarbons boiling \nin the range above approximately \n180o C (356o F).] 308-733-0  98219-64-8  Carc. 1B  H350  GHS08 \nDgr H350  \n649-047-00-4  Distillates (petroleum), hydrode\xad\nsulfurized full-range middle; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum stock with \nhydrogen. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  9 through C  25 \nand boiling in the range of \napproximately 150o C to 400o C \n(302  o F to 752  o F).] 309-863-0  101316-57-8  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1233}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1235\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-048-00-X  Residues (petroleum), catalytic \nreformer fractionator; \nHeavy Fuel oil; \n[A complex combination of \nhydrocarbons produced as the \nresidual fraction from distillation \nof the product from a catalytic \nreforming process. It consists of \npredominantly aromatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 10 through C  25 and boiling in \nthe range of approximately 160  \no C to 400o C (320  o F to 725  \no F). This stream is likely to \ncontain 5 wt. % or more of 4- \nor 6-membered condensed ring \naromatic hydrocarbons.]  265-069-3  64741-67-9  Carc. 1B  H350  GHS08 \nDgr H350  \n649-049-00-5  Petroleum; Crude oil; \n[A complex combination of \nhydrocarbons, It consists \npredominantly of aliphatic, \nalicyclic and aromatic hydro\xad\ncarbons. It may also contain \nsmall amounts of nitrogen, \noxygen and sulfur compounds. \nThis category encompasses \nlight, medium, and heavy petro\xad\nleums, as well as the oils  232-298-5  8002-05-9  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1234}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1236\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nextended from tar sands. Hydro\xad\ncarbonaceous materials requiring \nmajor chemical changes for their \nrecovery or conversion to \npetroleum refinery feedstocks \nsuch as crude shale oils; \nupgraded shale oils and liquid \ncoal fuels are not included in \nthis definition.]  \n649-050-00-0  Distillates (petroleum), light \nparaffinic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons produced by \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  30 \nand produces a finished oil with \na viscosity of less than 100 SUS \nat 100  o F (19cSt at 40  o C). It \ncontains a relatively large \nproportion of saturated aliphatic \nhydrocarbons normally present \nin this distillation range of \ncrude oil.]  265-051-5  64741-50-0  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1235}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1237\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-051-00-6  Distillates(petroleum), heavy \nparaffinic; \nUnrefined ormildly refined \nbaseoil; [A complex combination \nof hydrocarbons produced by \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50 \nand produces a finished oil with \na viscosity of at least 100 SUS at \n100  o F (19cSt at 40  o C). It \ncontains a relatively large \nproportion of saturated aliphatic \nhydrocarbons.]  265-052-0  64741-51-1  Carc. 1A  H350  GHS08 \nDgr H350  \n649-052-00-1  Distillates (petroleum), light \nnaphthenic; \nUnrefined or mildly refined \nbaseoil;  265-053-6  64741-52-2  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1236}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1238\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons produced by \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  30 \nand produces a finished oil with \na viscosity of less than 100 SUS \nat 100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  \n649-053-00-7  Distillates (petroleum), heavy \nnaphthenic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons produced by \nvacuum distillation of the \nresiduum from atmospheric \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50 \nand produces a finished oil with \na viscosity of at least 100 SUS at \n100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-054-1  64741-53-3  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1237}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1239\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-054-00-2  Distillates (petroleum), acid- \ntreated heavy naphthenic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons obtained as a \nraffinate from a sulfuric acid \ntreating process. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  20 through C  50 and \nproduces a finished oil with a \nviscosity of at least 100 SUS at \n100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-117-3  64742-18-3  Carc. 1A  H350  GHS08 \nDgr H350  \n649-055-00-8  Distillates (petroleum), acid- \ntreated light naphthenic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons obtained as a \nraffinate from a sulfuric acid \ntreating process. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30 and \nproduces a finished oil with a \nviscosity of less than 100 SUS \nat 100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-118-9  64742-19-4  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1238}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1240\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-056-00-3  Distillates (petroleum), acid- \ntreated heavy paraffinic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons btained as a \nraffinate from a sulfuric acid \nprocess. It consists predomi \nnantly of saturated hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  20 \nthrough C  50 and produces a \nfinished oil having a viscosity \nof a least 100 SUS at 100o F \n(19cSt at 40  o C).] 265-119-4  64742-20-7  Carc. 1A  H350  GHS08 \nDgr H350  \n649-057-00-9  Distillates (petroleum), acid- \ntreated light paraffinic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons obtained as a \nraffinate from a sulfuric acid \ntreating process. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30 and \nproduces a finished oi having \naviscosity of less than 100 SUS \nat 100  o F (19cSt at 40o C).] 265-121-5  64742-21-8  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1239}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1241\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-058-00-4  Distillates (petroleum), \nchemically neutralized heavy \nparaffinic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons obtained from a \ntreating proces to remove acidic \nmaterials. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50 \nand produces a finished oil with \na viscosity of at least 100 SUS at \n100  o F (19cSt at 40  o C). It \ncontains a relatively large \nproportion of aliphatic hydrocar\xad\nbons.]  265-127-8  64742-27-4  Carc. 1A  H350  GHS08 \nDgr H350  \n649-059-00-X  Distillates (petroleum), \nchemically neutralized light \nparaffinic; \nUnrefined or mildly refined \nbaseoil;  265-128-3  64742-28-5  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1240}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1242\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons produced by a \ntreating process to remove \nacidic materials. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30 and \nproduces a finished oil with a \nviscosity less than 100 SUS at \n100  o F (19cSt at 40  o C).] \n649-060-00-5  Distillates (petroleum), \nchemically neutralized heavy \nnaphthenic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons produced by a \ntreating process to remove \nacidic materials. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  20 through C  50 and \nproduces a finished oil with a \nviscosity of at least 100 SUS at \n100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-135-1  64742-34-3  Carc. 1A  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1241}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1243\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-061-00-0  Distillates (petroleum), \nchemically neutralized light \nnaphthenic; \nUnrefined or mildly refined \nbaseoil; \n[A complex combination of \nhydrocarbons produced by a \ntreating process to remove \nacidic materials. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30 and \nproduces a finished oil with a \nviscosity of less than 100 SUS \na 100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-136-7  64742-35-4  Carc. 1A  H350  GHS08 \nDgr H350  \n649-062-00-6  Gases (petroleum), catalytic \ncracked naphtha depropanizer \noverhead, C  3-rich acid-free; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation of catalytic cracked \nhydrocarbons and treated to \nremove acidic impurities. It \nconsists of hydrocarbons having \ncarbon numbers in the range of \nC 2 through C  4, predominantly \nC 3.] 270-755-0  68477-73-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1242}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1244\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-063-00-1  Gases (petroleum), catalytic \ncracker; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of the products from \na catalytic cracking process. It \nconsists predominantly of \naliphatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  6.] 270-756-6  68477-74-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-064-00-7  Gases (petroleum), catalytic \ncracker, C  1-5-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process. It \nconsists of aliphatic hydro \ncarbons having carbon numbers \nin the range of C  1 through C  6, \npredominantly C  1 through C  5.] 270-757-1  68477-75-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-065-00-2  Gases (petroleum), catalytic \npolymd. naphtha stabilizer \noverhead, C  2-4-rich; \nPetroleum gas;  270-758-7  68477-76-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1243}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1245\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from the \nfractionation stabilization of \ncatalytic polymerized naphtha. It \nconsists of aliphatic hydro\xad\ncarbons having carbon numbers \nin the range of C  2 through C  6, \npredominantly C  2 through C  4.] \n649-066-00-8  Gases (petroleum), catalytic \nreformer, C  1-4-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from a \ncatalytic reforming process. It \nconsists of hydrocarbons having \ncarbon numbers in the range of \nC 1 through C  6, predominantly C  1 \nthrough C  4.] 270-760-8  68477-79-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-067-00-3  Gases (petroleum), C  3-5 olefinic- \nparaffinic alkylation feed; \nPetroleum gas;  270-765-5  68477-83-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1244}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1246\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nolefinic and paraffinic hydro\xad\ncarbons having carbon numbers \nin the range of C  3 through C  5 \nwhich are used as alkylation \nfeed. Ambient temperatures \nnormally exceed the critical \ntemperature of these \ncombinations.]  \n649-068-00-9  Gases (petroleum), C  4-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from a \ncatalytic fractionation process. It \nconsists of aliphatic hydro\xad\ncarbons having carbon numbers \nin the range of C  3 through C  5, \npredominantly C  4.] 270-767-6  68477-85-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-069-00-4  Gases (petroleum), deethanizer \noverheads; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced from \ndistillation of the gas and \ngasoline fractions from the \ncatalytic cracking process. It \ncontains predominantly ethane \nand ethylene.]  270-768-1  68477-86-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1245}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1247\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-070-00-X  Gasespetroleum),deisobutanizer \ntower overheads; Petroleum gas; \n[A complex combination of \nhydrocarbons produced by the \natmospheric distillation of a \nbutane-butylene stream. It \nconsists of aliphatic hydro \ncarbons having carbon numbers \npredominantly in the range of \nC 3 through C  4.] 270-769-7  68477-87-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-071-00-5  Gases (petroleum), depropanizer \ndry, propene-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from the \ngas and gasoline fractions of a \ncatalytic cracking process. It \nconsists predominantly of \npropylene withsome ethane and \npropane.]  270-772-3  68477-90-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1246}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1248\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-072-00-0  Gases (petroleum), depropanizer \noverheads; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from the gas \nand gasoline fractions of a \ncatalytic cracking process. It \nconsists of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 2 through C  4.] 270-773-9  68477-91-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-073-00-6  Gases (petroleum), gas recovery \nplant depropanizer overheads; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by frac\xad\ntionation of miscellaneous hydro\xad\ncarbon streams. It consists \npredominantly of hydrocarbons \nhaving carbon numbers in the \nrange of C  1 through C  4, predomi\xad\nnantly propane.]  270-777-0  68477-94-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-074-00-1  Gases (petroleum), Girbotol unit \nfeed; \nPetroleum gas;  270-778-6  68477-95-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1247}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1249\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons that is used as the \nfeed into the Girbatol unit to \nremove hydrogen sulfide. It \nconsists of aliphatic hydro \ncarbons having carbon numbers \npredominantly in the range of \nC 2 through C  4.] \n649-075-00-7  Gases (petroleum), isomerized \nnaphtha fractionator, C  4-rich, \nhydrogen sulfide-free; \nPetroleum gas  270-782-8  68477-99-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-076-00-2  Tail gas (petroleum), catalytic \ncracked clarified oil and thermal \ncracked vacuum residue frac\xad\ntionation reflux drum; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation of catalytic cracked \nclarified oil and thermal cracked \nvacuum residue. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6.] 270-802-5  68478-21-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1248}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1250\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-077-00-8  Tail gas (petroleum), catalytic \ncracked naphtha stabilization \nabsorber; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nstabilization of catalytic cracked \nnaphtha. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  6.] 270-803-0  68478-22-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-078-00-3  Tail gas (petroleum), catalytic \ncracker, catalytic reformer and \nhydrodesulfurizer combined frac\xad\ntionater; Petroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation of products from \ncatalytic cracking, catalytic \nreforming and hydrodesulfurizing \nprocesses treated to remove \nacidic impurities. It consists \npredominantly of hydrocarbons \nhaving cabon numbers predomi\xad\nnantly in the range of C  1 through \nC 5.] 270-804-6  68478-24-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1249}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1251\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-079-00-9  Tail gas (petroleum), catalytic \nreformed naphtha fractionation \nstabilizer; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation stabilization of \ncatalytic reformed naphtha. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4.] 270-806-7  68478-26-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-080-00-4  Tail gas (petroleum), saturate gas \nplant mixed stream, C  4-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation stabilization of \nstraight-run naphtha, distillation \ntail gas and catalytic reformed \nnaphtha stabilizer tail gas. It \nconsists of hydrocarbons having \ncarbon numbers in the range of \nC 3 through C  6, predominantly \nbutane and isobutane.]  270-813-5  68478-32-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1250}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1252\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-081-00-X  Tail gas (petroleum), saturate gas \nrecovery plant, C  1-2-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation of distillate tail gas, \nstraight-run naphtha, catalytic \nreformed naphtha stabilizer tail \ngas. It consists predominantly of \nhydrocarbons having carbon \nnumbers in the range of \nC 1through C  5, Predominantly \nmethane and ethane.]  270-814-0  68478-33-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-082-00-5  Tail gas (petroleum), vacuum \nresidues thermal cracker; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nthermal cracking of vacuum \nresidues. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] 270-815-6  68478-34-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1251}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1253\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-083-00-0  Hydrocarbons, C  3-4-rich, \npetroleum distillate; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation and condensation of crude \noil. It consists of hydrocarbons \nhaving carbon numbers in the \nrange of C  3 through C  5, predomi\xad\nnantly C  3 through C  4.] 270-990-9  68512-91-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-084-00-6  Gases (petroleum), full-range \nstraight-run naphtha dehexanizer \noff; petroleum gas; [A complex \ncombination of hydrocarbons \nobtained by the fractionation of \nthe full-range straight-run \nnaphtha. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 2 through C  6.] 271-000-8  68513-15-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1252}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1254\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-085-00-1  Gases (petroleum), hydro\xad\ncracking depropanizer off, hydro\xad\ncarbon-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbon produced by the \ndistillation of products from a \nhydrocracking process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4. It may also \ncontain small amounts of \nhydrogen and hydrogen sulfide.]  271-001-3  68513-16-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-086-00-7  Gases (petroleum), light straight- \nrun naphtha stabilizer off; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by the \nstabilization of light straight-run \nnaphtha. It consists of saturated \naliphatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  2 through C  6.] 271-002-9  68513-17-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1253}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1255\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-087-00-2  Residues (petroleum), alkylation \nsplitter, C  4-rich; \nPetroleum gas; \n[A complex residuum from the \ndistillation of streams various \nrefinery operations. It consists \nof hydrocarbons having carbon \nnumbers in the range of C  4 \nthrough C  5, predominantly \nbutane and boiling in the range \nof approximately - 11.7  o C to \n27.8  o C (11  o F to 82  o F).] 271-010-2  68513-66-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-088-00-8  Hydrocarbons, C  1-4; Petroleum \ngas; \n[A complex combination of \nhydrocarbons provided by \nthermal cracking and absorber \noperations and by distillation of \ncrude oil. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4 and boiling in \nthe range of approximately \nminus164  o C to minus 0.5  o C \n(– 263  o F to 31  o F).] 271-032-2  68514-31-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1254}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1256\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-089-00-3  Hydrocarbons, C  1-4, sweetened; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtaine by \nsubjectin hydrocarbon gases to a \nsweetening process to convert \nmercaptans o to remove acidc \nimpurities. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4 and boiling in \nthe range of approximately – \n164o C to - 0.5  o C (– 263  o F to \n31 o F).] 271-038-5  68514-36-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-090-00-9  Hydrocarbons, C  1-3; Petroleum \ngas; \n[A complex combination of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  3 and \nboiling in the range of approxi \nmately minus 164  o C to minus \n42 o C (– 263  o F to - 44  o F).] 271-259-7  68527-16-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-091-00-4  Hydrocarbons, C  1-4, debutanizer \nfraction; \nPetroleum gas  271-261-8  68527-19-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1255}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1257\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-092-00-X  Gases (petroleum), C  1-5, wet; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of crude oil and/or \nthe cracking of tower gas oil. \nIt consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 5.] 271-624-0  68602-83-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-093-00-5  Hydrocarbons, C  2-4; Petroleum \ngas 271-734-9  68606-25-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-094-00-0  Hydrocarbons, C  3; Petroleum gas  271-735-4  68606-26-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-095-00-6  Gases (petroleum), alkylation \nfeed; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ncatalytic cracking of gas oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  3 through C  4.] 271-737-5  68606-27-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1256}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1258\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-096-00-1  Gases (petroleum), depropanizer \nbottoms fractionation off; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation of depropanizer \nbottoms. It consists predomi\xad\nnantly of butane, isobutane and \nbutadiene.]  271-742-2  68606-34-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-097-00-7  Gases (petroleum), refinery \nblend; \nPetroleum gas; \n[A complex combination \nobtained from various processes. \nIt consists of hydrogen, hydrogen \nsulfide and hydrocarbons having \ncarbon numbers predominantly in \nthe range of C  1 through C  5.] 272-183-7  68783-07-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-098-00-2  Gases (petroleum), catalytic \ncracking; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of the products from \na catalytic cracking process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 3 through C  5.] 272-203-4  68783-64-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1257}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1259\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-099-00-8  Gases (petroleum), C  2-4, swee\xad\ntened; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a petroleum distillate \nto a sweetening process to \nconvert mercaptans or to \nremove acidic impurities. It \nconsists predominantly of \nsaturated and unsaturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 2 through C  4 and boiling in \nthe range of approximately - \n51 o C to - 34  o C (– 60o F to - \n30o F).] 272-205-5  68783-65-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-100-00-1  Gases (petroleum), crude oil frac\xad\ntionation off; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \nfractionation of crude oil. It \nconsists of saturated aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  5.] 272-871-7  68918-99-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1258}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1260\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-101-00-7  Gases (petroleum), dehexanizer \noff; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by the \nFractionation of combined \nnaphtha streams. It consists of \nsaturated aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 5.] 272-872-2  68919-00-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-102-00-2  Gases (petroleum), light straight \nrun gasoline fractionation \nstabilizer off; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by the \nfractionation of light straight-run \ngasoline. It consists of saturated \naliphatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  5.] 272-878-5  68919-05-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1259}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1261\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-103-00-8  Gases (petroleum), naphtha \nunifiner desulfurization stripper \noff; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by a \nnaphtha unifiner desulfurization \nprocess and stripped from the \nnaphtha product. It consists of \nsaturated aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 4.] 272-879-0  68919-06-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-104-00-3  Gases (petroleum), straight-run \nnaphtha catalytic reforming off; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by the \ncatalytic reforming of straight- \nrun naphtha and fractionation of \nthe total effluent. It consists of \nmethane, ethane, and propane.]  272-882-7  68919-09-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1260}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1262\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-105-00-9  Gases(petroleum), fluidized \ncatalytic cracker splitter over\xad\nheads; Petroleum gas; \n[A complex combination of \nhydrocarbons produced by the \nfractionation of the charge to \nthe C  3-C 4 splitter. It consists \npredominantly of C  3 hydrocar\xad\nbons.]  272-893-7  68919-20-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-106-00-4  Gases (petroleum), straight-run \nstabilizer off; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation of the liquid from \nthe first tower used in the distil\xad\nlation of crude oil. It consists of \nsaturated aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 4.] 272-883-2  68919-10-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1261}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1263\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-107-00-X  Gases (petroleum), catalytic \ncracked naphtha debutanizer; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation of catalytic cracked \nnaphtha. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4.] 273-169-3  68952-76-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-108-00-5  Tail gas (petroleum), catalytic \ncracked distillate and naphtha \nstabilizer; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by the \nfractionation of catalytic cracked \nnaphtha and distillate. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 4.] 273-170-9  68952-77-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1262}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1264\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-109-00-0  Tail gas (petroleum), thermal- \ncracked distillate, gas oil and \nnaphtha absorber; \npetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nseparation of thermal-cracked \ndistillates, naphtha and gas oil. \nIt consists pedrominantly of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  6.] 273-175-6  68952-81-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-110-00-6  Tail gas (petroleum), thermal \ncracked hydrocarbon frac\xad\ntionation stabilizer, petroleum \ncoking; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation stabilization of \nthermal cracked hydrocarbons \nfrom petroleum coking process. \nIt consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6.] 273-176-1  68952-82-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1263}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1265\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-111-00-1  Gases (petroleum, light steam- \ncracked, butadiene conc.; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \nthermal cracking process. It \nconsists of hydrocarbons having \na carbon number predominantly \nof C  4.] 273-265-5  68955-28-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-112-00-7  Gases (petroleum), straight-run \nnaphtha catalytic reformer \nstabilizer overhead; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by the \ncatalytic reforming of straight- \nrun naphtha and the frac \ntionation of the total effluent. \nIt consists of saturated aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  2 through C  4.] 273-270-2  68955-34-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1264}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1266\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-113-00-2  Hydrocarbons, C  4; Petroleum gas  289-339-5  87741-01-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-114-00-8  Alkanes, C  1-4, C 3-rich; Petroleum \ngas 292-456-4  90622-55-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-115-00-3  Gases (petroleum), steam-cracker \nC 3-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \nsteam cracking process. It \nconsists predominantly of \npropylene with some propane \nand boils in the range of approxi\xad\nmately - 70  o C to 0  o C (– 94o F \nto 32o F).] 295-404-9  92045-22-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1265}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1267\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-116-00-9  Hydrocarbons, C  4, steam-cracker \ndistillate; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of the products of a \nsteam cracking process. It \nconsists predominantly of hydro\xad\ncarbons having a carbon number \nof C  4, predominantly 1-butene \nand 2-butene, containing also \nbutane and isobutene and \nboiling in the range of approxi\xad\nmately minus 12  o C to 5  o C \n(10.4  o F to 41o F).] 295-405-4  92045-23-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-117-00-4  Petroleum gases, liquefied, swee\xad\ntened, C  4 fraction; Petroleum \ngas; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a liquified petroleum \ngas mix to a sweetening process \nto oxidize mercaptans or to \nremove acidic impurities. It \nconsists predominantly of C  4 \nsaturated and unsaturated hydro\xad\ncarbons.]  295-463-0  92045-80-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K S U  \n649-118-00-X  Hydrocarbons, C  4, 1,3-butadiene- \nand isobutene-free; Petroleum \ngas 306-004-1  95465-89-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1266}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1268\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-119-00-5  Raffinates (petroleum), steam- \ncracked C  4 fraction cuprous \nammonium acetate extn., C  3-5 \nand C  3-5 unsatd., butadiene-free; \nPetroleum gas  307-769-4  97722-19-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-120-00-0  Gases (petroleum), amine system \nfeed; \nRefinery gas; \n[The feed gas to the amine \nsystem for removal of hydrogen \nsulfide. It consists of hydrogen. \nCarbon monoxide, carbon \ndioxide, hydrogen sulfide and \naliphatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  5 \nmay also be present.]  270-746-1  68477-65-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-121-00-6  Gases (petroleum), benzene unit \nhydrodesulfurizer off; \nRefinery gas; \n[Off gases produced by the \nbenzene unit. It consists \nprimarily of hydrogen. Carbon \nmonoxide and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6, including benzene, may also \nbe present.]  270-747-7  68477-66-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1267}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1269\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-122-00-1  Gases (petroleum), benzene unit \nrecycle, hydrogen-rich; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained by \nrecycling the gases of the \nbenzene unit. It consists \nprimarily of hydrogen with \nvarious small amounts of carbon \nmonoxide and hydro carbons \nhaving carbon numbers in the \nrange of C  1 through C  6.] 270-748-2  68477-67-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-123-00-7  Gases (petroleum), blend oil, \nhydrogen-nitrogen-rich; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of a blend oil. It consists \nprimarily of hydrogen and \nnitrogen with various small \namounts of carbon monoxide, \ncarbon dioxide, and aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  5.] 270-749-8  68477-68-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1268}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1270\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-124-00-2  Gases (petroleum), catalytic \nreformed naphtha stripper over\xad\nheads; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained from \nstabilization of catalytic \nreformed naphtha. Its consists of \nhydrogen and saturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4.] 270-759-2  68477-77-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-125-00-8  Gases (petroleum), C  6-8 catalytic \nreformer recycle; \nRefinery gas; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from catalytic \nreforming of C  6-C 8 feed and \nrecycled to conserve hydrogen. \nIt consists primarily of \nhydrogen. It may also contain \nvarious small amounts of carbon \nmonoxide, carbon dioxide, \nnitrogen, and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6.] 270-761-3  68477-80-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1269}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1271\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-126-00-3  Gases (petroleum), C  6-8 catalytic \nreformer; \nRefinery gas; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from catalytic \nreforming of C  6-C 8feed. It \nconsists of hydrocarbons having \ncarbon numbers in the range of \nC 1 through C  5 and hydrogen.]  270-762-9  68477-81-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-127-00-9  Gases (petroleum), C  6-8 catalytic \nreformer recycle, hydrogen-rich; \nRefinery gas  270-763-4  68477-82-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1270}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1272\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-128-00-4  Gases (petroleum), C  2-return \nstream; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained by the \nextraction of hydrogen from a \ngas stream which consists \nprimarily of hydroge with small \namounts of nitrogen, carbon \nmonoxide, methane, ethane, and \nethylene. It contain predomi\xad\nnantly hydrocarbons such as \nmethane, ethane, and ethylene \nwith small amounts of \nhydrogen, nitrogen and carbon \nmonoxide.]  270-766-0  68477-84-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-129-00-X  Gases (petroleum), dry sour, gas- \nconcn.-unit-off; \nRefinery gas; \n[The complex combination of \ndry gase from a gas concen\xad\ntration unit. It consists of \nhydrogen, hydrogen sulfide and \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  3.] 270-774-4  68477-92-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-130-00-5  Gases (petroleum), gas concn. \nreabsorber distn.; \nRefinery gas;  270-776-5  68477-93-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1271}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1273\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from combined \ngas streams in a gas concen\xad\ntration reabsorber. It consists \npredominantly of hydrogen, \ncarbon monoxide, carbon \ndioxide, nitrogen, hydrogen \nsulfide and hydrocarbons having \ncarbon numbers in the range of \nC 1 through C  3.] \n649-131-00-0  Gases (petroleum), hydrogen \nabsorber off; \nRefinery gas; \n[A complex combination \nobtained by absorbing hydrogen \nfrom a hydrogen rich stream. It \nconsists of hydrogen, carbon \nmonoxide, nitrogen, and \nmethane with small amounts of \nC 2 hydrocarbons.]  270-779-1  68477-96-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-132-00-6  Gases (petroleum), hydrogen- \nrich; \nRefinery gas; \n[A complex combination \nseparated as a gas from hydro\xad\ncarbon gases by chilling. It \nconsists primarily of hydrogen \nwith various small amounts of \ncarbon monoxide, nitrogen, \nmethane, and C  2 hydrocarbons.]  270-780-7  68477-97-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1272}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1274\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-133-00-1  Gases (petroleum), hydrotreater \nblend oil recycle, hydrogen- \nnitrogen-rich; \nRefinery gas; \n[A complex combination \nobtained from recycled hydro\xad\ntreated blend oil. It consists \nprimarily of hydrogen and \nnitrogen with various small \namounts of carbon monoxide, \ncarbon dioxide and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 5.] 270-781-2  68477-98-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-134-00-7  Gases (petroleum), recycle, \nhydrogen-rich; \nRefinery gas; \n[A complex combination \nobtained from recycled reactor \ngases. It consists primarily of \nhydrogen with various small \namounts of carbon monoxide, \ncarbon dioxide, nitrogen, \nhydrogen sulfide, and saturated \naliphatic hydrocarbons having \ncarbon numbers in the range of \nC 1 through C  5.] 270-783-3  68478-00-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-135-00-2  Gases (petroleum), reformer \nmake-up, hydrogen-rich; \nRefinery gas;  270-784-9  68478-01-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1273}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1275\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[Acomplex combination obtained \nfrom the reformers. It consists \nprimarily of hydrogen with \nvariou smal amount of carbon \nmonoxide and aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] \n649-136-00-8  Gases (petroleum), reforming \nhydrotreater; \nRefinery gas; \n[A complex combination \nobtained from the reforming \nhydrotreating process. It consists \nprimarily of hydrogen, methane, \nand ethane with various small \namounts of hydrogen sulfide \nand aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  3 through \nC 5.] 270-785-4  68478-02-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-137-00-3  Gases (petroleum), reforming \nhydrotreater, hydrogen-methane- \nrich; \nRefinery gas;  270-787-5  68478-03-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1274}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1276\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination \nobtained fromthe reforming \nhydrotreating process. It consists \nprimarily of hydrogen and \nmethane with various small \namounts of carbon monoxide, \ncarbon dioxide, nitrogen and \nsaturated aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  2 through \nC 5.] \n649-138-00-9  Gases (petroleum), reforming \nhydrotreater make-up, hydrogen- \nrich; \nRefinery gas; \n[A complex combination \nobtained from the reforming \nhydrotreating process. It consists \nprimarily of hydrogen with \nvarious small amounts of carbon \nmonoxide and aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] 270-788-0  68478-04-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-139-00-4  Gases (petroleum), thermal \ncracking distn.; \nRefinery gas;  270-789-6  68478-05-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1275}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1277\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination \nproduced by distillation of \nproducts from a thermal \ncracking process. It consists of \nhydrogen, hydrogen sulfide, \ncarbon monoxide, carbon \ndioxide and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6.] \n649-140-00-X  Tail gas (petroleum), catalytic \ncracker refractionation absorber; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained from \nrefractionation of products from \na catalytic cracking process. It \nconsists of hydrogen and hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  3.] 270-805-1  68478-25-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-141-00-5  Tail gas (petroleum), catalytic \nreformed naphtha separator; \nRefinery gas;  270-807-2  68478-27-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1276}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1278\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from the \ncatalytic reforming of straight \nrun naphtha. It consists of \nhydrogen and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6.] \n649-142-00-0  Tail gas (petroleum), catalytic \nreformed naphtha stabilizer; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained from the \nstabilization of catalytic \nreformed naphtha. It consists of \nhydrogen and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6.] 270-808-8  68478-28-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-143-00-6  Tail gas (petroleum), cracked \ndistillate hydrotreater separator; \nRefinery gas; [A complex \ncombination of hydrocarbons \nobtained by treating cracked \ndistillates with hydrogen in the  270-809-3  68478-29-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1277}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1279\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \npresence of a catalyst. It consists \nof hydrogen and saturated \naliphatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  5.] \n649-144-00-1  Tail gas (petroleum), hydrodesul\xad\nfurized straight-run naphtha \nseparator; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained from \nhydrodesulfurization of straight- \nrun naphtha. It consists of \nhydrogen and saturated aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  6.] 270-810-9  68478-30-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-145-00-7  Gases (petroleum), catalytic \nreformed straight-run naphtha \nstabilizer overheads; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained from the \ncatalytic reforming of straight- \nrun naphtha followed by frac\xad\ntionation of the total effluent. It \nconsists of hydrogen, methane, \nethane and propane.]  270-999-8  68513-14-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1278}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1280\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-146-00-2  Gases (petroleum), reformer \neffluent high-pressure flash \ndrum off; \nRefinery gas; \n[A complex combination \nproduced by the high-pressure \nflashing of the effluent from the \nreforming reactor. It consists \nprimarily of hydrogen with \nvarious small amounts of \nmethane, ethane, and propane.]  271-003-4  68513-18-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-147-00-8  Gases (petroleum), reformer \neffluent low-pressure flash drum \noff; \nRefinery gas; \n[A complex combination \nproduced by low-pressure \nflashing of the effluent from the \nreforming reactor. It consists \nprimarily of hydrogen with \nvarious small amounts of \nmethane, ethane, and propane.]  271-005-5  68513-19-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1279}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1281\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-148-00-3  Gases (petroleum), oil refinery \ngas distn. off; \nRefinery gas; \n[A complex combination separ\xad\natedby distillation of a gas \nstream containing hydrogen, \ncarbon monoxide, carbon \ndioxide and hydrocarbons \nhaving carbon numbers in the \nrange of C  1 through C  6 or \nobtained by cracking ethane and \npropane. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  2, hydrogen, \nnitrogen, and carbon monoxide.]  271-258-1  68527-15-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-149-00-9  Gases (petroleum), benzene unit \nhydrotreater depentanizer over\xad\nheads; Refinery gas;  271-623-5  68602-82-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1280}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1282\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination \nproduced by treating the feed \nfrom the benzene unit with \nhydrogen in the presence of a \ncatalyst followed by depent\xad\nanizing. It consists primarily of \nhydrogen, ethane and propane \nwith various small amounts of \nnitrogen, carbon monoxide, \ncarbon dioxide and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 6. It may contain trace amounts \nof benzene.]  \n649-150-00-4  Gases (petroleum), secondary \nabsorber off, fluidized catalytic \ncracker overheads fractionator; \nRefinery gas; \n[A complex combination \nproduced by the fractionation of \nthe overhead products from the \ncatalyticcracking process in the \nfluidized catalytic cracker. It \nconsists of hydrogen, nitrogen, \nand hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  3.] 271-625-6  68602-84-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1281}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1283\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-151-00-X  Petroleum products, refinery \ngases; \nRefinery gas; [A complex \ncombination which consists \nprimarily of hydrogen with \nvarious small amounts of \nmethane, ethane, and propane.]  271-750-6  68607-11-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-152-00-5  Gases (petroleum), hydro\xad\ncracking low-pressure separator; \nRefinery gas; \n[A complex combination \nobtained by the liquid-vapor \nseparation of the hydrocracking \nprocess reactor effluent. It \nconsists predominantly of \nhydrogen and saturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  3.] 272-182-1  68783-06-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-153-00-0  Gases (petroleum), refinery; \nRefinery gas; \n[A complex combination \nobtained from various petroleum \nrefining operations. It consists of \nhydrogen and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 3.] 272-338-9  68814-67-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1282}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1284\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-154-00-6  Gases (petroleum), platformer \nproducts separator off; \nRefinery gas; \n[A complex combination \nobtained from the chemical \nreforming of naphthenes to \naromatics. It consists of \nhydrogen and saturated aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  2 through C  4.] 272-343-6  68814-90-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-155-00-1  Gases (petroleum), hydrotreated \nsour kerosine depentanizer \nstabilizer off; \nRefinery gas; \n[The complex combination \nobtained from the depentanizer \nstabilization of hydrotreated \nkerosine. It consists primarily of \nhydrogen, methane, ethane, and \npropane with various small \namounts of nitrogen, hydrogen \nsulfide, carbon monoxide and \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  4 through C  5.] 272-775-5  68911-58-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1283}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1285\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-156-00-7  Gases (petroleum), hydrotreated \nsour kerosine flash drum; \nRefinery gas; \n[A complex combination \nobtained from the flash drum of \nthe unit treating sour kerosine \nwith hydrogen in the presence \nof a catalyst. It consists \nprimarily of hydrogen and \nmethane with various small \namounts of nitrogen, carbon \nmonoxide, and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  2 through \nC 5.] 272-776-0  68911-59-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-157-00-2  Gases (petroleum), distillate \nunifiner desulfurization stripper \noff; \nRefinery gas; \n[A complex combination stripped \nfrom the liquid product of the \nunifiner desulfurization process. \nIt consists of hydrogen sulfide, \nmethane, ethane, and propane.]  272-873-8  68919-01-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1284}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1286\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-158-00-8  Gases (petroleum), fluidized \ncatalytic cracker fractionation \noff; \nRefinery gas; \n[A complex combination \nproduced by the fractionation of \nthe overhead product of the \nfluidized catalytic cracking \nprocess. It consists of hydrogen, \nhydrogen sulfide, nitrogen, and \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  5.] 272-874-3  68919-02-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-159-00-3  Gases (petroleum), fluidized \ncatalytic cracker scrubbing \nsecondary absorber off; \nRefinery gas; \n[A complex combination \nproduced by scrubbing the \noverhead gas from the fluidized \ncatalytic cracker. It consists of \nhydrogen, nitrogen, methane, \nethane and propane.]  272-875-9  68919-03-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1285}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1287\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-160-00-9  Gases (petroleum), heavy \ndistillate hydrotreater desulfur\xad\nization stripper off; \nRefinery gas; \n[A complex combination stripped \nfrom the liquid product of the \nheavy distillate hydrotreater \ndesulfurization process. It \nconsists of hydrogen, hydrogen \nsulfide, and saturated aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  5.] 272-876-4  68919-04-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-161-00-4  Gases (petroleum), platformer \nstabilizer off, light ends fraction\xad\nation; \nRefinery gas; \n[A complex combination \nobtained by the fractionation of \nthe light ends of the platinum \nreactors of the platformer unit. \nIt consists of hydrogen, \nmethane, ethane and propane.]  272-880-6  68919-07-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1286}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1288\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-162-00-X  Gases (petroleum), preflash \ntower off, crude distn.; \nRefinery gas; \n[A complex combination \nproduced from the first tower \nused in the distillation of crude \noil. It consists of nitrogen and \nsaturated aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 5.] 272-881-1  68919-08-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-163-00-5  Gases (petroleum), tar stripper \noff; \nRefinery gas; \n[A complex combination \nobtained by the fractionation of \nreduced crude oil. It consists of \nhydrogen and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 4.] 272-884-8  68919-11-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-164-00-0  Gases (petroleum), unifiner \nstripper off; \nRefinery gas; \n[A combination of hydrogen and \nmethane obtained by frac\xad\ntionation of the products from \nthe unifiner unit.]  272-885-3  68919-12-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1287}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1289\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-165-00-6  Tail gas (petroleum), catalytic \nhydrodesulfurized naphtha \nseparator; \nRefinery gas; \n[A complex combination of \nhydrocarbons obtained from the \nhydrodesulfurization of naphtha. \nIt consists of hydrogen, \nmethane, ethane, and propane.]  273-173-5  68952-79-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-166-00-1  Tail gas (petroleum), straight-run \nnaphtha hydrodesulfurizer; \nRefinery gas; \n[A complex combination \nobtained from the hydrodesulfur\xad\nization of straight-run naphtha. It \nconsists of hydrogen and hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] 273-174-0  68952-80-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-167-00-7  Gases (petroleum), sponge \nabsorber off, fluidized catalytic \ncracker and gas oil desulfurizer \noverhead fractionation; \nRefinery gas;  273-269-7  68955-33-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1288}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1290\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination \nobtained by the fractionation of \nproducts from the fluidized \ncatalytic cracker and gas oil \ndesulfurizer. It consists of \nhydrogen and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 4.] \n649-168-00-2  Gases (petroleum), crude distn. \nand catalytic cracking; \nRefinery gas; \n[A complex combination \nproduced by crude distillation \nand catalytic cracking processes. \nIt consists of hydrogen, hydrogen \nsulfide, nitrogen, carbon \nmonoxide and paraffinic and \nolefinic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  6.] 273-563-5  68989-88-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-169-00-8  Gases (petroleum), gas oil dietha\xad\nnolamine scrubber off; Refinery \ngas; 295-397-2  92045-15-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1289}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1291\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination \nproduced by desulfurization of \ngas oils with diethanolamine. It \nconsists predominantly of \nhydrogen sulfide, hydrogen and \naliphatic hydrocarbons having \ncarbon numbers in the range of \nC 1 through C  5.] \n649-170-00-3  Gases (petroleum), gas oil \nhydrodesulfurization effluent; \nRefinery gas; \n[A complex combination \nobtained by separation of the \nliquid phase from the effluent \nfrom the hydrogenation reaction. \nIt consists predominantly of \nhydrogen, hydrogen sulfide and \naliphatic hydro carbons having \ncarbon numbers predominantly \nin the range of C  1 through C  3.] 295-398-8  92045-16-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-171-00-9  Gases (petroleum), gas oil \nhydrodesulfurization purge; \nRefinery gas; \n[A complex combination of \ngases obtained from the \nreformer and from the purges \nfrom the hydrogenation reactor. \nIt consists predominantly of \nhydrogen and aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4.] 295-399-3  92045-17-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1290}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1292\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-172-00-4  Gases (petroleum), hydrogenator \neffluent flash drum off; \nRefinery gas; \n[A complex combination of \ngases obtained from flash of the \neffluents after the hydroge nation \nreaction. It consists predomi\xad\nnantly of hydrogen and aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  1 through C  6.] 295-400-7  92045-18-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-173-00-X  Gases (petroleum), naphtha \nsteam cracking high-pressure \nresidual; \nRefinery gas; \n[A complex combination \nobtained as a reaction mass of \nthe non-condensable portions \nfrom the product of a naphtha \nsteam cracking process as well \nas residual gases obtained \nduring the preparation of \nsubsequent products. It consists \npredominantly of hydrogen and \nparaffinic and olefinic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5 with which \nnatural gas may also be mixed.]  295-401-2  92045-19-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1291}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1293\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-174-00-5  Gases (petroleum), residue \nvisbaking off; \nRefinery gas; \n[A complex combination \nobtained from viscosity \nreduction of residues in a \nfurnace. It consists predomi\xad\nnantly of hydrogen sulfide and \nparaffinic and olefinic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] 295-402-8  92045-20-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-175-00-0  Foots oil (petroleum), acid- \ntreated; \nFoots oil; \n[A complex combination of \nhydrocarbons obtained by \ntreatment of Foot's oil with \nsulfuric acid. It consists predomi\xad\nnantly of branched-chain hydro\xad\ncarbons with carbon numbers \npredominantly in the range of \nC 20 through C  50.] 300-225-7  93924-31-3  Flam. Gas 1 \nPress. Gas \nCarc. 1B  H220 \nH350 \nH340  GHS02 \nGHS04 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1292}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1294\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-176-00-6  Foots oil (petroleum), clay- \ntreated; \nFoots oil; \n[A complex combination of \nhydrocarbons obtained by \ntreatment of Foot's oil with \nnatural or modified clay in \neither a contacting or percolation \nprocess to remove the trace \namounts of polar compounds \nand impurities present. It \nconsists predomi nantly of \nbranched chain hydro carbons \nwith carbon numbers predomi\xad\nnantly in the range of C  20 \nthrough C  50.] 300-226-2  93924-32-4  Flam. Gas 1 \nPress. Gas \nCarc. 1B  H220 \nH350 \nH340  GHS02 \nGHS04 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-177-00-1  Gases (petroleum), C  3-4; \nPetroleum gas; [A complex \ncombination of hydrocarbons \nproduced by distillation of \nproducts from the cracking of \ncrude oil. It consists of hydro\xad\ncarbons having carbon numbers \nin the range of C  3 through C  4, \npredominantly of propane and \npropylene, and boiling in the \nrange of approximately - 51  o C \nto - 1  o C (– 60  o F to 30  o F.)] 268-629-5  68131-75-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1293}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1295\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-178-00-7  Tail gas (petroleum), catalytic \ncracked distillate and catalytic \ncracked naphtha fractionation \nabsorber; Petroleum gas; \n[The complex combination of \nhydrocarbons from the distil\xad\nlation of the products from \ncatalytic cracked distillates and \ncatalytic cracked naphtha. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \nin the range of C  1 through C  4.] 269-617-2  68307-98-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-179-00-2  Tail gas (petroleum), catalytic \npolymn. naphtha fractionation \nstabilizer; Petroleum gas; \n[A complex combination of \nhydrocarbons from the frac\xad\ntionation stabilization products \nfrom polymerization of naphtha. \nIt consists predominantly of \nhydrocarbons having carbon \nnumbers in the range of C  1 \nthrough C  4.] 269-618-8  68307-99-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1294}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1296\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-180-00-8  Tail gas (petroleum), catalytic \nreformed naphtha fractionation \nstabilizer, hydrogen sulfide-free; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation stabilization of catalytic \nreformed naphtha and from \nwhich hydrogen sulfide has \nbeen removed by amine \ntreatment. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  4.] 269-619-3  68308-00-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-181-00-3  Tail gas (petroleum), cracked \ndistillate hydrotreater stripper; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained by \ntreating thermal cracked \ndistillates with hydrogen in the \npresence of a catalyst. It \nconsists predominantly of \nsaturated hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  6.] 269-620-9  68308-01-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1295}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1297\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-182-00-9  Tail gas (petroleum), straight-run \ndistillate hydrodesulfurizer, \nhydrogen sulfide-free; Petroleum \ngas; \n[A complex combination of \nhydrocarbons obtained from \ncatalytic hydrodesulfurization of \nstraight run distillates and from \nwhich hydrogen sulfide has \nbeen removed by amine \ntreatment. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  4.] 269-630-3  68308-10-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-183-00-4  Tail gas (petroleum), gas oil \ncatalytic cracking absorber; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of products from the \ncatalytic cracking of gas oil. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] 269-623-5  68308-03-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1296}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1298\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-184-00-X  Tail gas (petroleum), gas \nrecovery plant; \nPetroleum gas; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of products from miscel\xad\nlaneous hydrocarbon streams. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] 269-624-0  68308-04-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-185-00-5  Tail gas (petroleum), gas \nrecovery plant deethanizer; \nPetroleum gas; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of products from miscel\xad\nlaneous hydrocarbon streams. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  4.] 269-625-6  68308-05-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-186-00-0  Tail gas (petroleum), hydrodesul\xad\nfurized distillate and hydrodesul\xad\nfurized naphtha fractionator, \nacid-free; \nPetroleum gas;  269-626-1  68308-06-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1297}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1299\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation of hydrodesul furized \nnaphtha and distillate \nhydrocarbon streams and treated \nto remove acidic impurities. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  5.] \n649-187-00-6  Tail gas (petroleum), hydrodesul\xad\nfurized vacuum gas oil stripper, \nhydrogen sulfide-free; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from \nstripping stabilization of \ncatalytic hydrodesulfurized \nvacuum gas oil and from which \nhydrogen sulfide has been \nremoved by amine treatment. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  6.] 269-627-7  68308-07-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1298}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1300\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-188-00-1  Tail gas (petroleum), light \nstraight-run naphtha stabilizer, \nhydrogen sulfide-free; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation stabilization of light \nstraight run naphtha and from \nwhich hydrogen sulfide has \nbeen removed by amine \ntreatment. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  5.] 269-629-8  68308-09-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-189-00-7  Tail gas (petroleum), propane- \npropylene alkylation feed prep \ndeethanizer; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of the reaction \nproducts of propane with \npropylene. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  4.] 269-631-9  68308-11-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1299}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1301\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-190-00-2  Tail gas (petroleum), vacuum gas \noil hydrodesulfurizer, hydrogen \nsulfide-free; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from \ncatalytic hydrodesulfurization of \nvacuum gas oil and from which \nhydrogen sulfide has been \nremoved by amine treatment. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 1 through C  6.] 269-632-4  68308-12-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-191-00-8  Gases (petroleum), catalytic \ncracked overheads; Petroleum \ngas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from the \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  3 through C  5 \nand boiling in the range of \napproximately –48  o C to 32  o C \n(– 54  o F to 90o F).] 270-071-2  68409-99-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1300}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1302\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-193-00-9  Alkanes, C  1-2; Petroleum gas  270-651-5  68475-57-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-194-00-4  Alkanes, C  2-3; Petroleum gas  270-652-0  68475-58-1  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-195-00-X  Alkanes, C  3-4; \npetroleum gas  270-653-6  68475-59-2  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1301}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1303\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-196-00-5  Alkanes, C  4-5; Petroleum gas  270-654-1  68475-60-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-197-00-0  Fuel gases; Petroleum gas; \n[A combination of light gases. It \nconsists predominantly of \nhydrogen and/or low molecular \nweight hydrocarbons.]  270-667-2  68476-26-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-198-00-6  Fuel gases, crude oil of distil\xad\nlates; \nPetroleum gas; \n[A complex combination of light \ngases produced by distil lation of \ncrude oil and by catalytic \nreforming of naphtha. It consists \nof hydrogen and hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  1 through \nC 4 and boiling in the range of \napproximately - 217o C to - \n12 o C (– 423  o F to 10  o F).] 270-670-9  68476-29-9  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-199-00-1  Hydrocarbons, C  3-4; Petroleum \ngas 270-681-9  68476-40-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1302}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1304\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-200-00-5  Hydrocarbons, C  4-5; Petroleum \ngas 270-682-4  68476-42-6  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-201-00-0  Hydrocarbons, C  2-4, C  3-rich; \nPetroleum gas  270-689-2  68476-49-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-202-00-6  Petroleum gases, liquefied; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  3 through C  7 \nand boiling in the range of \napproximately – \n40 o C to 80  o C (– 40o F to \n176o F).] 270-704-2  68476-85-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K S U  \n649-203-00-1  Petroleum gases, liquefied, swee\xad\ntened; \nPetroleum gas;  270-705-8  68476-86-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K S U  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1303}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1305\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \nsubjecting liquefied petroleum \ngas mix to a sweetening process \nto convert mercaptans or to \nremove acidic impurities. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  3 through C  7 \nand boiling in the range of \napproximately–40  o C to 80  o C \n(– 40  o F to176  o F).] \n649-204-00-7  Gases (petroleum), C  3-4, \nisobutane-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of saturated and \nunsaturated hydrocarbons \nusually ranging in carbon \nnumbers from C  3 through C  6, \npredominantly butane and \nisobutane. It consists of \nsaturated and unsaturated hydro\xad\ncarbons having carbon numbers \nin the range of C  3 through C  4, \npredominantly isobutane.]  270-724-1  68477-33-8  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-205-00-2  Distillates (petroleum), C  3-6, \npiperylene-rich; \nPetroleum gas;  270-726-2  68477-35-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1304}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1306\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of saturated and \nunsaturated aliphatic hydro\xad\ncarbons usually ranging in the \ncarbon numbers C  3 through C  6. \nIt consists of saturated and \nunsaturated hydrocarbons having \ncarbon numbers in the range of \nC 3 through C  6, predominantly \npiperylenes.]  \n649-206-00-8  Gases (petroleum), butane splitter \noverheads; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of the butane stream. \nIt consists of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 3 through C  4.] 270-750-3  68477-69-0  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-207-00-3  Gases (petroleum), C  2-3-; \nPetroleum gas; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic fractionation process. It \ncontains predominantly ethane, \nethylene, propane, and propy\xad\nlene.]  270-751-9  68477-70-3  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1305}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1307\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-208-00-9  Gases (petroleum), catalytic- \ncracked gas oil depropanizer \nbottoms, C  4-rich acid-free; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from frac\xad\ntionation of catalytic cracked gas \noil hydrocarbon \nstream and treated to remove \nhydrogen sulfide and other \nacidic components. It consists of \nhydrocarbons having carbon \nnumbers in the range of C  3 \nthrough C  5, predominantly C  4.] 270-752-4  68477-71-4  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-209-00-4  Gases (petroleum), catalytic- \ncracked naphtha debutanizer \nbottoms, C  3-5-rich; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nstabilization of catalytic cracked \nnaphtha. It consists of aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  3 through C  5.] 270-754-5  68477-72-5  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1306}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1308\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-210-00-X  Tail gas (petroleum), isomerized \nnaphtha fractionation stabilizer; \nPetroleum gas; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation stabilization \nproducts from isomerized \nnaphtha. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  4.] 269-628-2  68308-08-7  Press. Gas \nFlam. Gas 1 \nCarc. 1A Muta. \n1B H220 \nH350 \nH340  GHS04 \nGHS02 \nGHS08 \nDgr H220 \nH350 \nH340  K U \n649-211-00-5  Foots oil (petroleum), carbon- \ntreated; \nFoots oil; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of Foots oil with \nactivated carbon for the removal \nof trace constituents and impur\xad\nities. It consists predominantly of \nsaturated straight chain hydro\xad\ncarbons having carbon numbers \npredominantly greater than C  12.] 308-126-0  97862-76-5  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1307}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1309\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-212-00-0  Distillates (petroleum), \nsweetened middle; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a petroleum distillate \nto a sweetening process to \nconvert mercaptans or to \nremove acidic impurities. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  9 through C  20 \nand boiling in the range of \napproximately 150o C to 345o C \n(302 o F to 653o F).] 265-088-7  64741-86-2  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-213-00-6  Gas oils (petroleum), solvent- \nrefined; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists \npredominantly of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 11 through C  25 and boiling in \nthe range of approximately \n205o C to 400o C (401o F to \n752o F).] 265-092-9  64741-90-8  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1308}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1310\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-214-00-1  Distillates (petroleum), solvent- \nrefined middle; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists \npredominantly of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 9 through C  20 and boiling in \nthe range of approximately \n150o C to 345o C (302o F to 653  \no F).] 265-093-4  64741-91-9  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-215-00-7  Gas oils (petroleum), acid- \ntreated; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as a \nraffinate from a sulfuric acid \ntreating process. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  13 through C  25 and \nboiling in the range of approxi\xad\nmately 230o C to 400o C (446o F to \n752  o F).] 265-112-6  64742-12-7  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1309}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1311\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-216-00-2  Distillates (petroleum), acid- \ntreated middle; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as a \nraffinate from a sulfuric acid \ntreating process. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  11 through C  20 and \nboiling in the range of approxi\xad\nmately 205  o C to 345  o C (401  o F \nto 653  o F).] 265-113-1  64742-13-8  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-217-00-8  Distillates (petroleum), acid- \ntreated light; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as a \nraffinate from a sulfuric acid \ntreating process. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  9 through C  16 and \nboiling in the range of approxi\xad\nmately 150o C to 290o C (302o F to \n554o F).] 265-114-7  64742-14-9  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1310}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1312\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-218-00-3  Gas oils (petroleum), chemically \nneutralized; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons produced by a \ntreating process to remove \nacidic materials. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  13 through C  25 and \nboiling in the range of approxi\xad\nmately 230  o C to 400  o C (446o F \nto 752  o F).] 265-129-9  64742-29-6  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-219-00-9  Distillates (petroleum), \nchemically neutralized middle; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons produced by a \ntreating process to remove \nacidic materials. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  11 through C  20 and \nboiling in the range of approxi\xad\nmately 205o C to 345o C (401o F to \n653o F).] 265-130-4  64742-30-9  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1311}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1313\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-220-00-4  Distillates (petroleum), clay- \ntreated middle; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons resulting from \ntreatment of a petroleum \nfraction with natural or modified \nclay, usually in a percolation \nprocess to remove the trace \namounts of polar compounds \nand impurities present. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  9 through C  20 \nand boiling in the range of \napproximately 150o C to 345o C \n(302o F to 653o F).] 265-139-3  64742-38-7  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-221-00-X  Distillates (petroleum), hydro\xad\ntreated middle; \nGasoil — unspecified;  265-148-2  64742-46-7  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1312}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1314\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 11 through C  25 and boiling in \nthe range of approximately \n205o C to 400o C (401  o F to 752  \no F).] \n649-222-00-5  Gas oils (petroleum), hydrodesul\xad\nfurized; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \npetroleum stock by treating with \nhydrogen to convert organic \nsulfur to hydrogen sulfide which \nis removed. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  13 through C  25 \nand boiling in the range of \napproximately 230o C to 400o C \n(446o F to 752  o F).] 265-182-8  64742-79-6  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1313}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1315\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-223-00-0  Distillates (petroleum), hydrode\xad\nsulfurized middle; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \npetroleum stock by treating with \nhydrogen to convert organic \nsulfur to hydrogen sulfide which \nis removed. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 11 through C  25 and boiling in \nthe range of approximately \n205o C to 400o C (401o F to \n752o F).] 265-183-3  64742-80-9  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-224-00-6  Fuels, diesel; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  9 through C  20 \nand boiling in the range of \napproximately 163o C to 357o C \n(325o F to 675o F).] 269-822-7  68334-30-5  Carc. 2  H351  GHS08 \nWng  H351  N  \n649-225-00-1  Fuel oil, No 2; \nGasoil — unspecified; \n[A distillate oil having a \nminimum viscosity of 32,6 SUS \nat 37,7o C (100o F) to a maximum \nof 37,9 SUS at 37,7o C (100  o F).] 270-671-4  68476-30-2  Carc. 2  H351  GHS08 \nWng  H351  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1314}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1316\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-226-00-7  Fuel oil, No 4; \nGasoil — unspecified; \n[A distillate oil having a \nminimum viscosity of 45 SUS \nat 37,7o C (100o F) to a \nmaximum of 125 SUS at 37,7  \no C (100  o F).] 270-673-5  68476-31-3  Carc. 2  H351  GHS08 \nWng  H351  \n649-227-00-2  Fuels, diesel, No 2; Gasoil — \nunspecified; \n[A distillate oil having a \nminimum viscosity of 32,6 SUS \nat 37,7  o C (100  o F).] 270-676-1  68476-34-6  Carc. 2  H351  GHS08 \nWng  H351  \n649-228-00-8  Distillates (petroleum), catalytic \nreformer fractionator residue, \nhigh-boiling; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of catalytic reformer \nfracftionator residue. It boils in \nthe range of approximately 343  \no C to 99o C (650o F to 750  o F).] 270-719-4  68477-29-2  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-229-00-3  Distillates (petroleum), catalytic \nreformer fractionator residue, \nintermediate-boiling; \nGasoil — unspecified;  270-721-5  68477-30-5  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1315}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1317\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of catalytic reformer frac\xad\ntionator residue. It boils in the \nrange of approximately 288o C \nto 371o C (550o F to 700o F).] \n649-230-00-9  Distillates (petroleum), catalytic \nreformer fractionator residue, \nlow-boiling; \nGasoil — unspecified; \n[The complex combination of \nhydrocarbons from the distil\xad\nlation of catalytic reformer frac\xad\ntionator residue. It boils approxi\xad\nmately below 288  o C (550o F).] 270-722-0  68477-31-6  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-231-00-4  Distillates (petroleum), highly \nrefined middle; \nGasoil — unspecified;  292-615-8  90640-93-0  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1316}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1318\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by the \nsubjection of a petroleum \nfraction to several of the \nfollowing steps: filtration, \ncentrifugation, atmospheric distil\xad\nlation, vacuum distillation, \nacidification, neutralization and \nclay treatment. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  10 \nthrough C  20.] \n649-232-00-X  Distillates (petroleum) catalytic \nreformer, heavy arom. conc.; \nGasoil — unspecified; [A \ncomplex combination of hydro\xad\ncarbons obtained from the distil\xad\nlation of a catalytically reformed \npetroleum cut. It consists \npredominantly of aromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  10 through C  16 and \nboiling in the range of approxi\xad\nmately 200o C to 300o C (392  o F \nto 572  o F).] 295-294-2  91995-34-5  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-233-00-5  Gas oils, paraffinic; Gasoil — \nunspecified;  300-227-8  93924-33-5  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1317}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1319\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A distillate obtained from the \nredistillation of a complex \ncombination of hydrocarbons \nobtained by the distillation of \nthe effluents from a severe \ncatalytic hydrotreatment of \nparaffins. It boils in the range \nof approximately 190o C to \n330o C (374o F to 594o F).] \n649-234-00-0  Naphtha (petroleum), solvent- \nrefined hydrodesulfurized heavy; \nGasoil — unspecified  307-035-3  97488-96-5  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-235-00-6  Hydrocarbons, C  16-20, hydro\xad\ntreated middle distillate, distn. \nlights; \nGasoil — unspecified; [A \ncomplex combination of hydro\xad\ncarbons obtained as first \nrunnings from the vacuum distil\xad\nlation of effluents from the \ntreatment of a middle distillate \nwith hydrogen. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  16 \nthrough C  20 and boiling in the  307-659-6  97675-85-9  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1318}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1320\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nrange of approximately 290  o C to \n350  o C (554  o F to 662  o F). It \nproduces a finished oil having a \nviscosity of 2cSt at 100  o C (212  \no F).] \n649-236-00-1  Hydrocarbons, C  12-20, hydro\xad\ntreated paraffinic, distn. lights; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as first \nrunnings from the vacuum distil\xad\nlation of effluent from the \ntreatment of heavy paraffins \nwith hydrogen in the presence \nof a catalyst. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  12 through C  20 \nand boiling in the range of \napproximately 230  o C to 350  o C \n(446  o F to 662  o F). It produces a \nfinished oil having viscosity of \n2cSt at 100o C (212o F).] 307-660-1  97675-86-0  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1319}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1321\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-237-00-7  Hydrocarbons, C  11-17, solvent- \nextd. light naphthenic; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nextraction of the aromatics from \na light naphthenic distillate \nhaving a visciosity of 2.2 cSt at \n40 o C (104  o F). It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  11 \nthrough C  17 and boiling in the \nrange of approximately 200o C \nto 300o C (392o F to 572  o F).] 307-757-9  97722-08-2  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-238-00-2  Gas oils, hydrotreated; Gasoil — \nunspecified; \n[A complex combination of \nhydrocarbons obtained from the \nredistillation of the effluents \nfrom the treatment of paraffins \nwith hydrogen in the presence \nof a catalyst. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  17 through C  27 \nand boiling in the range of \napproximately 330o C to 340o C \n(626o F to 644o F).] 308-128-1  97862-78-7  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1320}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1322\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-239-00-8  Distillates (petroleum), carbon- \ntreated light paraffinic; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of a petroleum oil \nfraction with activated charcoal \nfor the removal of traces of \npolar constituents and impur \nities. It consists predominantly \nof hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  12 through C  28.] 309-667-5  100683-97-4  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-240-00-3  Distillates (petroleum), inter\xad\nmediate paraffinic, carbon- \ntreated; \nGasoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of petroleum with \nactivated charcoal for the \nremoval of trace polar consti \ntuents and impurities. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  16 \nthrough C  36.] 309-668-0  100683-98-5  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1321}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1323\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-241-00-9  Distillates (petroleum), inter\xad\nmediate paraffinic, clay-treated; \nGasoil — unspecified; [A \ncomplex combination of hydro\xad\ncarbons obtained by the \ntreatment of petroleum with \nbleaching earth for the removal \nof trace polar constituents and \nimpurities. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  16 through C  36.] 309-669-6  100683-99-6  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-242-00-4  Alkanes, C  12-26-branched and \nlinear  292-454-3  90622-53-0  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-243-00-X  Lubricating greases; Grease; \n[A complex combination of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  12 through C  50. May \ncontain organic salts of alkali \nmetals, alkaline earth metals, \nand/or aluminium compounds.]  278-011-7  74869-21-9  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1322}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1324\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-244-00-5  Slack wax (petroleum); Slack \nwax; \n[A complex combination of \nhydrocarbons obtained from a \npetroleum fraction by solvent \ncrystallization (solvent \ndewaxing) or as a distillation \nfraction from a very waxy \ncrude. It consists predominantly \nof saturated straight and \nbranched chain hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  20.] 265-165-5  64742-61-6  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-245-00-0  Slack wax (petroleum), acid- \ntreated; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained as a \nraffinate by treatment of a \npetroleum slack wax fraction \nwith sulfuric acid treating \nprocess. It consists predomi\xad\nnantly of saturated straight and \nbranched chain hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  20.] 292-659-8  90669-77-5  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1323}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1325\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-246-00-6  Slack wax (petroleum), clay- \ntreated; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained by \ntreatment of a petroleum slack \nwax fraction with natural or \nmodified clay in either a \ncontacting or percolation \nprocess. It consists predomi \nnantly of saturated straight and \nbranched hydrocarbons having \ncarbon numbers predominantly \ngreater than C  20.] 292-660-3  90669-78-6  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-247-00-1  Slack wax (petroleum), hydro\xad\ntreated; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained by \ntreating slack wax with \nhydrogen in the presence of a \ncatalyst. It consists predomi\xad\nnantly of saturated straight and \nbranched chain hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  20.] 295-523-6  92062-09-4  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1324}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1326\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-248-00-7  Slack wax (petroleum), low- \nmelting; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained from a \npetroleum fraction by solvent \ndeparaffination. It consists \npredominantly of saturated \nstraight and branched chain \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  12.] 295-524-1  92062-10-7  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-249-00-2  Slack wax (petroleum), low- \nmelting, hydrotreated; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained by \ntreatment of low-melting \npetroleum slack wax with \nhydrogen in the presence of a \ncatalyst. It consists predomi \nnantly of saturated straight and \nbranched chain hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  12.] 295-525-7  92062-11-8  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1325}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1327\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-250-00-8  Slack wax (petroleum), low- \nmelting, carbon-treated; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of low-melting slack \nwax with activated carbon for \nthe removal of trace polar consti\xad\ntuents and impurities. It consists \npredominantly of saturated \nstraight and branched chain \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  12.] 308-155-9  97863-04-2  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-251-00-3  Slack wax (petroleum), low- \nmelting, clay-treated; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of low-melting \npetroleum slack wax with \nbentonite for removal of trace \npolar constituents and impur \nities. It consists predominantly \nof saturated straight and \nbranched chain hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  12.] 308-156-4  97863-05-3  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1326}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1328\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-252-00-9  Slack wax (petroleum), low- \nmelting, silicic acid-treated; \nSlack wax; [A complex \ncombination of hydrocarbons \nobtained by the treatment of \nlow-melting petroleum slack \nwax with silicic acid for the \nremoval of trace polar consti\xad\ntuents and impurities. It consists \npredominantly of saturated \nstraight and branched chain \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  12.] 308-158-5  97863-06-4  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-253-00-4  Slack wax (petroleum), carbon- \ntreated; \nSlack wax; \n[A complex combination of \nhydrocarbons obtained by \ntreatment of petroleum slack \nwax with activated charcoal for \nthe removal of trace polar consti\xad\ntuents and impurities.]  309-723-9  100684-49-9  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1327}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1329\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-254-00-X  Petrolatum; Petrolatum; \n[A complex combination of \nhydrocarbons obtained as a \nsemi-solid from dewaxing \nparaffinic residual oil. It consists \npredominantly of saturated \ncrystalline and liquid hydro\xad\ncarbons having carbon numbers \npredominantly greater than C  25.] 232-373-2  8009-03-8  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-255-00-5  Petrolatum (petroleum), oxidized; \nPetrolatum; \n[A complex combination of \norganic compounds, predomi\xad\nnantly high molecular weight \ncarboxylic acids, obtained by \nthe air oxidation of petrolatum.]  265-206-7  64743-01-7  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-256-00-0  Petrolatum (petroleum), alumina- \ntreated; \nPetrolatum;  285-098-5  85029-74-9  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1328}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1330\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained when \npetrolatum is treated with \nAl2O3 to remove polar \ncomponents and impurities. It \nconsists predominantly of satu\xad\nrated, crystalline, and liquid \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  25.] \n649-257-00-6  Petrolatum (petroleum), hydro\xad\ntreated; \nPetrolatum; \n[A complex combination of \nhydrocarbons obtained as a \nsemi-solid from dewaxed \nparaffinic residual oil treated \nwith hydrogen in the presence \nof a catalyst. It consists predomi\xad\nnantly of saturated microcryst\xad\nalline and liquid hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  20.] 295-459-9  92045-77-7  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1329}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1331\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-258-00-1  Petrolatum (petroleum), carbon- \ntreated; \nPetrolatum; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of petroleum \npetrolatum with activated carbon \nfor the removal of trace polar \nconstituents and impur ities. It \nconsists predominantly of \nsaturated hydrocarbons having \ncarbon numbers predominantly \ngreater than C  20.] 308-149-6  97862-97-0  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-259-00-7  Petrolatum (petroleum), silicic \nacid-treated; \nPetrolatum; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of petroleum \npetrolatum with silicic acid for \nthe removal of trace polar consti\xad\ntuents and impurities. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  20.] 308-150-1  97862-98-1  Carc. 1B  H350  GHS08 \nDgr H350  N  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1330}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1332\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-260-00-2  Petrolatum (petroleum), clay- \ntreated; \nPetrolatum; [A complex \ncombination of hydrocarbons \nobtained by treatment of \npetrolatum with bleaching earth \nfor the removal of traces of \npolar constituents and impurities. \nIt consists predominantly of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of greater than C  25.] 309-706-6  100684-33-1  Carc. 1B  H350  GHS08 \nDgr H350  N  \n649-261-00-8  Gasoline, natural; \nLow boiling point naphtha; \n[A complex combination of \nhydrocarbons separated from \nnatural gas by processes such as \nrefrigeration or absorption. It \nconsists predominantly of \nsaturated aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  4 through \nC 8 and boiling in the range of \napproximately minus 20  o C to \n120  o C (– 4o F to 248o F).] 232-349-1  8006-61-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1331}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1333\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-262-00-3  Naphtha; \nLow boiling point naphtha; \n[Refined, partly refined, or \nunrefined petroleum products \nproduced by the distillation of \nnatural gas. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 5 through C  6 and boiling in \nthe range of approximately 100o \nC to 200o C (212o F to 392o F).] 232-443-2  8030-30-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-263-00-9  Ligroine; \nLow boiling point naphtha; \n[A complex combination of \nhydrocarbons obtained by the \nfractional distillation of \npetroleum. This fraction boils in \na range of approximately 20  o C \nto 135  o C (58o F to 275o F).] 232-453-7  8032-32-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-264-00-4  Naphtha (petroleum), heavy \nstraight-run; Low boiling point \nnaphtha; [A complex \ncombination of hydrocarbons \nproduced by distillation of crude \noil. It consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  6 through \nC 12 and boiling in the range of \napproximately 65  o C to 230  o C \n(149o F to 446o F).] 265-041-0  64741-41-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1332}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1334\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-265-00-X  Naphtha (petroleum), full-range \nstraight-run; \nLow boiling point naphtha; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of crude oil. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  4 through C  11 and \nboiling in the range of approxi\xad\nmately - 20  o C to 220  o C (– 4  o F \nto 428o F).] 265-042-6  64741-42-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-266-00-5  Naphtha (petroleum), light \nstraight-run; \nLow boiling point naphtha; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of crude oil. It consists \npredominantly of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  10 and boiling in \nthe range of approximately - \n20 o C to 180  o C (– 4o F to \n356o F).] 265-046-8  64741-46-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1333}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1335\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-267-00-0  Solvent naphtha (petroleum), \nlight aliph.; \nLow boiling point naphtha; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of crude oil or \nnatural gasoline. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  5 through C  10 and \nboiling in the range of approxi\xad\nmately 35o C to 160o C (95o F to \n320o F).] 265-192-2  64742-89-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-268-00-6  Distillates (petroleum), straight- \nrun light; \nLow boiling point naphtha; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  2 through C  7 \nand boiling in the range of \napproximately– 88  o C to 99o C \n(– 127o F to 210o F).] 270-077-5  68410-05-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1334}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1336\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-269-00-1  Gasoline, vapor-recovery; Low \nboiling point naphtha; \n[A complex combination of \nhydrocarbons separated from the \ngases from vapor recovery \nsystems by cooling. It consists \nof hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  4 through C  11 and \nboiling in the range of approxi\xad\nmately - 20  o C to 196  o C (– 4o F \nto 384o F).] 271-025-4  68514-15-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-270-00-7  Gasoline, straight-run, topping- \nplant; Low boiling point naphtha; \n[A complex combination of \nhydrocarbons produced from the \ntopping plant by the distillation \nof crude oil. It boils in the \nrange of approximately 36,1  o C \nto 193,3  o C (97o F to 380o F).] 271-727-0  68606-11-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1335}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1337\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-271-00-2  Naphtha (petroleum), unswee\xad\ntened; Low boiling point \nnaphtha; [A complex \ncombination of hydrocarbons \nproduced from the distillation of \nnaphtha streams from various \nrefinery processes. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  5 through C  12 and \nboiling in the range of approxi\xad\nmately 0  o C to 230  o C (25o F to \n446o F).] 272-186-3  68783-12-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-272-00-8  Distillates (petroleum), light \nstraight-run gasoline frac \ntionation stabilizer overheads; \nLow boiling point naphtha; \n[A complex combination of \nhydrocarbons obtained by the \nfractionation of light straight-run \ngasoline. It consists of saturated \naliphatic hydrocarbons having \ncarbon numbers predominantly \nin he range of C  3 through C  6.] 272-931-2  68921-08-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-273-00-3  Naphtha (petroleum), heavy \nstraight run, arom.-contg.; \nLow boiling point naphtha;  309-945-6  101631-20-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1336}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1338\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from a \ndistillation process of crude \npetroleum. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers in the range of \nC 8 through C  12 and boiling in \nthe range of approximately \n130  o C to 210  o C (266o F to \n410o F).] \n649-274-00-9  Naphtha (petroleum), full-range \nalkylate; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of the reaction products of \nisobutane with monoolefinic \nhydrocarbons usually ranging in \ncarbon numbers from C  3 \nthrough C  5 It consists of \npredominantly branched chain \nsaturated hydrocarbons having \ncarbon numbers predominantly \nin the range of C  7 through C  12 \nand boiling in the range of \napproximately 90  o C to 220  o C \n(194o F to 428o F).] 265-066-7  64741-64-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1337}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1339\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-275-00-4  Naphtha (petroleum), heavy \nalkylate; \nLow boiling point modified \nnaphtha; [A complex \ncombination of hydrocarbons \nproduced by distillation of the \nreaction products of isobutane \nwith monoolefinic hydrocarbons \nusually ranging in carbon \nnumbers from C  3 to C  5. It \nconsists of predominantly \nbranched chain saturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 9 through C  12 and boiling in \nthe range of approximately \n150  o C to 220  o C (302o F to \n428o F).] 265-067-2  64741-65-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-276-00-X  Naphtha (petroleum), light \nalkylate; \nLow boiling point modified \nnaphtha;  265-068-8  64741-66-8  Carc. 1B Muta. \n1B Asp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1338}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1340\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of the reaction products of \nisobutane with monoolefinic \nhydrocarbons usually ranging in \ncarbon numbers from C  3 \nthrough C  5. It consists of \npredominantly branched chain \nsaturated hydrocarbons having \ncarbon numbers predominantly \nin the range of C  7 through C  10 \nand boiling in the range of \napproximately 90  o C to 160  o C \n(194o F to 320  o F).] \n649-277-00-5  Naphtha (petroleum), isomeriz\xad\nation; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons obtained from \ncatalytic isomerization of \nstraight chain paraffinic C  4 \nthrough C  6 hydrocarbons. It \nconsists predominantly of \nsaturated hydrocarbons such as \nisobutane, isopentane, 2,2- \ndimethylbutane, 2-methyl\xad\npentane, and 3-methylpentane.]  265-073-5  64741-70-4  Carc. 1B Muta. \n1B Asp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1339}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1341\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-278-00-0  Naphtha (petroleum), solvent- \nrefined light; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists \npredominantly of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 5 through C  11 and boiling in \nthe range of approxi mately \n35 o C to 190  o C (95o F to \n374o F).] 265-086-6  64741-84-0  Carc. 1B Muta. \n1B Asp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-279-00-6  Naphtha (petroleum), solvent- \nrefined heavy; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists \npredominantly of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 7 through C  12 and boiling in \nthe range of approximately \n90 o C to 230  o C (194o F to \n446o F).] 265-095-5  64741-92-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1340}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1342\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-280-00-1  Raffinates (petroleum), catalytic \nreformer ethylene glycol-water \ncountercurrent exts.; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from the UDEX \nextraction process on the \ncatalytic reformer stream. It \nconsists of saturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 6 through C  9.] 270-088-5  68410-71-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-281-00-7  Raffinates (petroleum), reformer, \nLurgi unit-sepd.; \nLow boiling point modified \nnaphtha; \n[The complex combination of \nhydrocarbons obtained as a \nraffinate from a Lurgi separation \nunit. It consists predominantly of \nnon-aromatic hydrocarbons with \nvarious small amounts of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  6 through C  8.] 270-349-3  68425-35-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1341}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1343\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-28-00-2  Naphtha (petroleum), full-range \nalkylate, butane-contg.; \nLow boiling point modified \nnaphta; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of the reaction \nproducts of isobutane with \nmonoolefinic hydrocarbons \nusually ranging in carbon \nnumbers from C  3 through C  5. It \nconsists of predominantly \nbranched chain saturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 7 through C  12 with some \nbutanes and boiling in the range \nof approximately 35  o C to \n200  o C (95  o F to 428  o F).] 271-267-0  68527-27-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-283-00-8  Distillates (petroleum), naphtha \nsteam cracking-derived, solvent- \nrefined light hydrotreated; \nLow boiling point modified \nnaphtha;  295-315-5  91995-53-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1342}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1344\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained as the \nraffinates from a solvent \nextraction process of hydro\xad\ntreated light distillate from \nsteam-cracked naphtha.]  \n649-284-00-3  Naphtha (petroleum),C  4-12, \nbutane-alkylate, isooctane-rich; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by alky\xad\nlation of butanes. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  4 through \nC 12, rich in isooctane, and \nboiling in the range of approxi\xad\nmately 35  o C to 210  o C (95o F to \n410o F).] 295-430-0  92045-49-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-285-00-9  Hydrocarbons, hydrotreated light \nnaphtha distillates, solvent- \nrefined;  295-436-3  92045-55-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1343}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1345\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nLow boiling point modified \nnaphtha; [A combination of \nhydrocarbons obtained from the \ndistillation of hydrotreated \nnaphtha followed by a solvent \nextraction and distillation \nprocess. It consists predomi\xad\nnantly of saturated hydrocarbons \nboiling in the range of approxi\xad\nmately 94  o C to 99  o C (201  o F \nto 210  o F).] \n649-286-00-4  Naphtha (petroleum), isomeri\xad\nsation, C  6-fraction; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of a gasoline which has \nbeen catalyticall isomerized. It \nconsists predominantly of \nhexane isomers boiling in the \nrange of approximately 60  o C \nto 66  o C (140o F to 151o F).] 295-440-5  92045-58-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-287-00-X  Hydrocarbons, C  6-7, naphtha- \ncracking, solvent-refined; \nLow boiling point modified \nnaphtha;  295-446-8  92045-64-2  Carc. 1B \nmuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1344}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1346\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by the \nsorption of benzene from a cata\xad\nlytically fully hydrogenated \nbenzene-rich hydrocarbon cut \nthat was distillatively obtained \nfrom prehydrogenated cracked \nnaphtha. It consists predomi \nnantly of paraffinic and naph\xad\nthenic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  6 through C  7 \nand boiling in the range of \napproximately 70  o C to 100  o C \n(158o F to 212o F).] \n649-288-00-5  Hydrocarbons, C  6-rich, hydro\xad\ntreated light naphtha distillates, \nsolvent-refined; \nLow boiling point modified \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of hydrotreated naphtha \nfollowed by solvent extraction. \nIt consists predominantly of \nsaturated hydrocarbons and \nboiling in the range of approxi\xad\nmately 65o C to 70o C (149o F to \n158o F).] 309-871-4  101316-67-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1345}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1347\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-289-00-0  Naphtha (petroleum), heavy \ncatalytic cracked; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons produced by a \ndistillation of products from a \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  6 through C  12 \nand boiling in the range of \napproximately 65  o C to 230  o C \n(148o F to 446  o F). It contains a \nrelatively large proportion of \nunsaturated hydrocarbons.]  265-055-7  64741-54-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-290-00-6  Naphtha (petroleum), light \ncatalytic cracked; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  4 through C  11 \nand boiling in the range of \napproximately - 20  o C to \n190  o C (– 4  o F to 374  o F). It \ncontains a relatively large \nproportion of unsaturated hydro\xad\ncarbons.]  265-056-2  64741-55-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1346}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1348\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-291-00-1  Hydrocarbons, C  3-11, catalytic \ncracker distillates; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons produced by the \ndistillations of products from a \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  3 through C  11 \nand boiling in a range approxi\xad\nmately up to 204  o C (400o F).] 270-686-6  68476-46-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-292-00-7  Naphtha (petroleum), catalytic \ncracked light distd.; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  1 through C  5.] 272-185-8  68783-09-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1347}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1349\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-293-00-2  Distillates (petroleum), naphtha \nsteam cracking-derived, hydro- \ntreated light arom.; \nLow boiling point cat-cracked \nnaphtha.; \n[A complex combination of \nhydrocarbons obtained by \ntreating a light distillate from \nsteam-cracked naphtha. It \nconsists predominantly of \naromatic hydrocarbons.]  295-311-3  91995-50-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-294-00-8  Naphtha (petroleum), heavy \ncatalytic cracked, sweetened; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a catalytic cracked \npetroleum distillate to a \nsweetening process to convert \nmercaptans or to remove acidic \nimpurities. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  6 through C  12 \nand boiling in the range of \napproximately 60  o C to200  o C \n(140o F to 392o F).] 295-431-6  92045-50-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1348}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1350\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-295-00-3  Naphtha (petroleum), light \ncatalytic cracked sweetened; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting naphtha from a \ncatalytic cracking process to a \nsweetening process to convert \nmercaptans or to remove acidic \nimpurities. It consists predomi \nnantly of hydrocarbons boiling \nin a range of approximately \n35 o C to 210  o C (95o F to \n410o F).] 295-441-0  92045-59-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-296-00-9  Hydrocarbons, C  8-12, catalytic- \ncracking, chem. neutralized; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of a cut from the \ncatalytic cracking process, \nhaving undergone an alkaline \nwashing. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers in the range of \nC 8 through C  12 and boiling in \nthe range of approximately \n130  o C to 210  o C (266o F to \n410o F).] 295-794-0  92128-94-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1349}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1351\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-297-00-4  Hydrocarbons, C  8-12, catalytic \ncracker distillates; \nLow boiling point cat-cracked \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of products from a \ncatalytic cracking process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 8 through C  12 and boiling in \nthe range of approxi mately \n140  o C to 210  o C (284o F to \n410o F).] 309-974-4  101794-97-2  Carc. 1B \nMuta. 1B A \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-298-00-X  Hydrocarbons, C  8-12, catalytic \ncracking, chem. neutralized, \nsweetened; Low boiling point \ncat-cracked naphtha  309-987-5  101896-28-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1350}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1352\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-299-00-5  Naphtha (petroleum), light \ncatalytic reformed; \nLow boiling point cat-reformed \nnaphtha; \n[A complex combination of \nhydrocarbons produced from the \ndistillation of products from a \ncatalytic reforming process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  5 through C  11 \nand boiling in the range of \napproximately 35  o C to 190o C \n(95o F to 374o F). It contains a \nrelatively large proportion of \naromatic and branched chain \nhydrocarbons. This stream may \ncontain 10 vol.% or more \nbenzene.]  265-065-1  64741-63-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-300-00-9  Naphtha (petroleum), heavy \ncatalytic reformed;  265-070-9  64741-68-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1351}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1353\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nLow boiling point cat-reformed \nnaphtha; [A complex \ncombination of hydrocarbons \nproduced from the distillation of \nproducts from a catalytic \nreforming process. It consists of \npredominantly aromatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 7 through C  12 and boiling in \nthe range of approximately \n90 o C to 230  o C (194o F to \n446o F).] \n649-301-00-4  Distillates (petroleum), catalytic \nreformed depentanizer; \nLow boiling point cat-reformed \nnaphtha; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of products from a \ncatalytic reforming process. It \nconsists predominantly of \naliphatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  3 through C  6 \nand boiling in the range of \napproximately - 49  o C to 63  o C \n(–57o F to 145o F).] 270-660-4  68475-79-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1352}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1354\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-302-00-X  Hydrocarbons, C  2-6, C  6-8 \ncatalytic reformer; \nLow boiling point cat-reformed \nnaphtha  270-687-1  68476-47-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-303-00-5  Residues (petroleum), C  6-8 \ncatalytic reformer; \nLow boiling point cat-reformed \nnaphtha; \n[A complex residuum from the \ncatalytic reforming of C  6-8 feed. \nIt consists of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  2 through \nC 6.] 270-794-3  68478-15-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-304-00-0  Naphtha (petroleum), light \ncatalytic reformed, arom.-free; \nLow boiling point cat-reformed \nnaphtha;  270-993-5  68513-03-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1353}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1355\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from \ndistillation of products from a \ncatalytic reforming process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 5 through C  8 and boiling in \nthe range of approxi mately 35o \nC to 120o C (95  o F to 248  o F). It \ncontains a relatively large \nproportion of branched chain \nhydrocarbons with the aromatic \ncomponents removed.]  \n649-305-00-6  Distillates (petroleum), catalytic \nreformed straight-run naphtha \noverheads; \nLow boiling point cat-reformed \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by the \ncatalytic reforming of straight- \nrun naphtha followed by the frac\xad\ntionation of the total effluent. It \nconsists of saturated aliphatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  2 through C  6.] 271-008-1  68513-63-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1354}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1356\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-306-00-1  Petroleum products, hydrofiner- \npowerformer reformates; \nLow boiling point cat-reformed \nnaphtha; \n[The complex combination of \nhydrocarbons obtained in a \nhydrofiner-powerformer process \nand boiling in a range of \napproximately 27  o C to 210  o C \n(80o F to 410o F).] 271-058-4  68514-79-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-307-00-7  Naphtha (petroleum), full-range \nreformed; \nLow boiling point cat-reformed \nnaphtha; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of the products from \na catalytic reforming process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  5 through C  12 \nand boiling in the range of \napproximately 35o C to 230  o C \n(95o F to 446o F).] 272-895-8  68919-37-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1355}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1357\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-308-00-2  Naphtha (petroleum), catalytic \nreformed; \nLow boiling point cat-reformed \nnaphtha; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic reforming process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  4 through C  12 \nand boiling in the range of \napproximately 30  o C to 220  o C \n(90o F to 430o F). It contains a \nrelatively large proportion of \naromatic and branched chain \nhydrocarbons. This stream may \ncontain 10 vol. % or more \nbenzene.]  273-271-8  68955-35-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-309-00-8  Distillates (petroleum), catalytic \nreformed hydrotreated light, C  8- \n12 arom. fraction;-Low boiling \npoint cat-reformed naphtha;  285-509-8  85116-58-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1356}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1358\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nalkylbenzenes obtained by the \ncatalytic reforming of petroleum \nnaphtha. It consists predomi\xad\nnantly of alkylbenzenes having \ncarbon numbers predominantly \nin the range of C  8 through C  10 \nand boiling in the range of \napproximately 160  o C to \n180  o C (320o F to 356o F).] \n649-310-00-3  Aromatic hydrocarbons, C  8, \ncatalytic reforming-derived; \nLow boiling point cat-reformed \nnaphtha  295-279-0  91995-18-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-311-00-9  Aromatic hydrocarbons, C  7-12, \nC 8-rich; \nLow boiling point cat-reformed \nnaphtha;  297-401-8  93571-75-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1357}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1359\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \nseparation from the platformate- \ncontaining fraction. It consists \npredominantly of aromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  7 through C  12 (pri\xad\nmarily C  8) and can contain \nnonaromatic hydrocarbons, both \nboiling in the range of approxi\xad\nmately 130  o C to 200  o C (266o F \nto 392o F).] \n649-312-00-4  Gasoline, C  5-11, high-octane \nstabilised reformed; \nLow boiling point cat-reformed \nnaphtha; - \n[A complex high octane \ncombination of hydrocarbons \nobtained by the catalytic dehy\xad\ndrogenation of a predominantly \nnaphthenic naphtha. It consists \npredominantly of aromatics and \nnon-aromatics having carbon \nnumbers predominantly in the \nrange of C  5 through C  11 and \nboiling in the range of approxi \nmately 45  o C to 185  o C (113o F \nto 365  o F).] 297-458-9  93572-29-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1358}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1360\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-313-00-X  Hydrocarbons, C  7-12, C≥9-arom.- \nrich, reforming heavy fraction; \nLow boiling point cat-reformed \nnaphtha; \n[A complex combination of \nhydrocarbons obtained by \nseparation from the platformate- \ncontaining fraction. It consists \npredominantly of nonaromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  7 through C  12 and \nboiling in the range of approxi\xad\nmately 120  o C to 210  o C (248o F \nto380o F) and C  9 and higher \naromatic hydrocarbons.]  297-465-7  93572-35-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-314-00-5  Hydrocarbons, C  5-11, nonaroms.- \nrich, reforming light fraction; \nLow boiling point cat-reformed \nnaphtha;  297-466-2  93572-36-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1359}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1361\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \nseparation from the platformate- \ncontaining fraction. It consists \npredominantly of nonaromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  5 through C  11 and \nboiling in the range of approxi\xad\nmately 35  o C to 125  o C (94o F to \n257o F), benzene and toluene.]  \n649-315-00-0  Foots oil (petroleum), silicic \nacid-treated; \nFoots oil; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of Foots oil with \nsilicic acid for removal of trace \nconstituents and impurities. It \nconsists predominantly of \nstraight chain hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  12.] 308-127-6  97862-77-6  Carc. 1B  H350 \nH304  GHS08 \nDgr H350 \nH304  L ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1360}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1362\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-316-00-6  Naphtha (petroleum), light \nthermal cracked; \nLow boiling point thermally \ncracked naphtha; \n[A complexcombination of \nhydrocarbons from distillation of \nproducts from a thermal cracking \nprocess. It consists predomi\xad\nnantly of unsaturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  8 and boiling in \nthe range of approximately - \n10 o C to 130  o C (14o F to \n266o F).] 265-075-6  64741-74-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-317-00-1  Naphtha (petroleum), heavy \nthermal cracked; \nLow boiling point thermally \ncracked naphtha; \n[A complex combination of \nhydrocarbons from distillation of \nthe products from a thermal \ncracking process. It consists \npredominantly of unsaturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  6 through C  12 and \nboiling in the range of approxi\xad\nmately 65o C to 220  o C (148o F \nto 428o F).] 265-085-0  64741-83-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1361}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1363\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-318-00-7  Distillates (petroleum), heavy \narom.; \nLow boiling point thermally \ncracked naphtha; \n[The complex combination of \nhydrocarbons from the distil\xad\nlation of the products from the \nthermal cracking of ethane and \npropane. This higher boiling \nfraction consists predominantly \nof C  5-7 aromatic hydrocarbons \nwith some unsaturated aliphatic \nhydrocarbons having carbon \nnumber predominantly of C  5. \nThis stream may contain \nbenzene.]  267-563-4  67891-79-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-319-00-2  Distillates (petroleum), light \narom.;  267-565-5  67891-80-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  HS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1362}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1364\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nLow boiling point thermally \ncracked naphtha; [The complex \ncombination of hydrocarbons \nfrom the distillation of the \nproducts from the thermal \ncracking of ethane and propane. \nThis lower boiling fraction \nconsists predominantly of C  5-7 \naromatic hydrocarbons with \nsome unsaturated aliphatic \nhydrocarbons having a carbon \nnumber predominantly of C  5. \nThis stream may contain \nbenzene.]  \n649-320-00-8  Distillates (petroleum), naphtha- \nraffinate pyrolyzate-derived, \ngasoline-blending; \nLow boiling point thermally \ncracked naphtha; [The complex \ncombination of hydrocarbons \nobtained by the pyrolysis frac\xad\ntionation at 816o C (1 500o F) of \nnaphtha and raffinate. It consists \npredominantly of hydrocarbons \nhaving a carbon number of C  9 \nand boiling at approximately \n204  o C (400o F).] 270-344-6  68425-29-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1363}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1365\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-321-00-3  Aromatic hydrocarbons, C  6-8, \nnaphtha-raffinate pyrolyzate- \nderived; Low boiling point \nthermally cracked naphtha; [A \ncomplex combination of hydro\xad\ncarbons obtained by the frac\xad\ntionation pyrolysis at 816  o C \n(1 500  o F) of naphtha and \nraffinate. It consists predomi\xad\nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  6 through \nC 8, including benzene.]  270-658-3  68475-70-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-322-00-9  Distillates (petroleum), thermal \ncracked naphtha and gas oil; \nLow boiling point thermally \ncracked naphtha; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of thermally cracked \nnaphtha and/or gas oil. It \nconsists predominantly of \nolefinic hydrocarbons having a \ncarbon number of C  5 and \nboiling in the range of approxi \nmately 33  o C to 60  o C (91  o F \nto 140  o F).] 271-631-9  68603-00-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1364}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1366\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-323-00-4  Distillates (petroleum), thermal \ncracked naphtha and gas oil, \nC 5-dimer-contg.; \nLow boiling point thermally \ncracked naphtha; [A complex \ncombination of hydrocarbons \nproduced by the extractive distil\xad\nlation of thermal cracked naphtha \nand/or gas oil. It consists \npredominantly of hydrocarbons \nhaving a carbon number of C  5 \nwith some dimerized C  5 olefins \nand boiling in the range of \napproximately 33o C to 184  o C \n(91o F to 363  o F).] 271-632-4  68603-01-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-324-00-X  Distillates (petroleum), thermal \ncracked naphtha and gas oil, \nextractive; \nLow boiling point thermally \ncracked naphtha; \n[A complex combination of \nhydrocarbons produced by the \nextractive distillation of thermal \ncracked naphtha and/or gas oil. \nIt consists of paraffinic and \nolefinic hydrocarbons, predomi \nnantly isoamylenes such as 2- \nmethyl-1-buteneand 2-methyl-2- \nbutene and boiling in the \nrangeof approximately 31o C to \n40o C (88o F to 104o F).] 271-634-5  68603-03-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1365}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1367\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-325-00-5  Distillates (petroleum), light \nthermal cracked, debutanized \narom.; \nLow boiling point thermally \ncracked naphtha; [A complex \ncombination of hydrocarbons \nproduced by the distillation of \nproducts from a thermal \ncracking process. It consists \npredominantly of aromatic \nhydrocarbons, primarily \nbenzene.]  273-266-0  68955-29-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-326-00-0  Naphtha (petroleum), light \nthermal cracked, sweetened; \nLow boiling point thermally \ncracked naphtha; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a petroleum distillate \nFrom the high temperature \nthermal cracking of heavy oil \nfractions to a sweetening \nprocess to convert mercaptans. \nIt consists predominantly of \naromatics, olefins and saturated \nhydrocarbons boiling in the \nrange of approximately 20  o C \nto 100  o C (68  o F to 212  o F).] 295-447-3  92045-65-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1366}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1368\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-327-00-6  Naphtha (petroleum), hydro\xad\ntreated heavy; \nLow boiling point ydrogen \ntreated naphtha; [A complex \ncombination of hydrocarbons \nobtained by treating a petroleum \nfraction with hydrogen in the \npresence of a catalyst. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  6 through C  13 \nand boiling in the range of \napproximately 65o C to 230o C \n(149o F to 446o F).] 265-150-3  64742-48-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-328-00-1  Naphtha (petroleum), hydro\xad\ntreated light; \nLow boiling point hydrogen \ntreated naphtha; [A complex \ncombination of hydrocarbons \nobtained by treating a petroleum \nfraction With hydrogen in the \npresence of a catalyst. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  4 through C  11 \nand boiling in the range of \napproximately minus 20o C to \n190o C (– 4o F to 374o F).] 265-151-9  64742-49-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1367}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1369\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-329-00-7  Naphtha (petroleum), hydrode\xad\nsulfurized light; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic hydrodesulfurization \nprocess. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  11 and boiling in \nThe range of approximately - \n20o C to 190o C (– 4o F to \n374o F).] 265-178-6  64742-73-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-330-00-2  naphtha (petroleum), hydrodesul\xad\nphurized heavy; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic hydrodesulfurization \nprocess. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 7 through C  12 and boiling in \nthe range of approximately 90o \nC to 230o C (194o F to 446  o F).] 265-185-4  64742-82-1  Carc. 1B \nMuta. 1B \nSTOT RE 1 \nAsp. Tox. 1  H350 \nH340 \nH372 (central \nnervous \nsystem) \nH304  GHS08 \nDgr H350 \nH340 \nH372 \n(central \nnervous \nsystem) \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1368}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1370\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-331-00-8  Distillates (petroleum), hydro\xad\ntreated middle, intermediate \nboiling; \nLow boiling point hydrogen \ntreated naphtha; [A complex \ncombination of hydrocarbons \nobtained by the distillation of \nproducts from a middle distillate \nhydrotreating process. It consists \nof hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  5 through C  10 and \nboiling in the range of approxi\xad\nmately 127o C to 188o C (262o F \nto 370o F).] 270-092-7  68410-96-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-332-00-3  Distillates (petroleum), light \ndistillate hydrotreating process, \nlow-boiling; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of products from the \nlight distillate hydrotreating \nprocess. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 6 through C  9 and boiling in \nthe range of approximately 3  o \nC to 194  o C (37  o F to 382  o F).] 270-093-2  68410-97-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1369}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1371\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-333-00-9  Distillates (petroleum), hydro\xad\ntreated heavy naphtha, deisohex\xad\nanizer overheads; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of the products from a \nheavy naphtha hydrotreating \nprocess. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 3 through C  6 and boiling in \nthe range of approximately - \n49 o C to 68  o C (– 57o F to \n155o F).] 270-094-8  68410-98-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-334-00-4  Solvent naphtha (petroleum), \nlight arom., hydrotreated; \nLow boiling point hydrogen \ntreated naphtha;  270-988-8  68512-78-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1370}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1372\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists predomi\xad\nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  8 through \nC 10 and boiling in the range of \napproxi mately 135  o C to 210  o C \n(275o F to 410o F).] \n649-335-00-X  Naphtha (petroleum), hydrode\xad\nsulfurized thermal cracked light; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained by frac\xad\ntionation of hydrodesulfurized \nthermal cracker distillate. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 5 to C  11 and boiling in the \nrange of approximately 23  o C \nto 195  o C (73o F to 383o F).] 285-511-9  85116-60-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1371}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1373\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-336-00-5  Naphtha (petroleum), hydro\xad\ntreated light, cycloalkane-contg.; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of a petroleum \nfraction. It consists predomi\xad\nnantly of alkanes and cyclo\xad\nalkanes boiling in the range of \napproximately - 20o C to \n190  o C (– 4o F to 374o F).] 285-512-4  85116-61-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-337-00-0  Naphtha (petroleum),heavy \nsteam-cracked, hydrogenated; \nLow boiling point hydrogen \ntreated naphtha  295-432-1  92045-51-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-338-00-6  Naphtha (petroleum), hydrode\xad\nsulfurized full-range; \nLow boiling point hydrogen \ntreated naphtha;  295-433-7  92045-52-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1372}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1374\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic hydrodesulfurization \nprocess. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  4 through C  11 \nand boiling in the range of \napproximately 30  o C to 250  o C \n(86o F to 482o F).] \n649-339-00-1  Naphtha (petroleum), hydro\xad\ntreated light steam-cracked; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction, \nderived from a pyrolysis \nprocess, with hydrogen in the \npresence of a catalyst. It \nconsists predominantly of \nunsaturated hydrocarbons having \ncarbon numbers predominantly in \nthe range of C  5 through C  11 and \nboiling in the range of approxi\xad\nmately 35o C to 190  o C (95o F to \n374o F).] 295-438-4  92045-57-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-340-00-7  Hydrocarbons, C  4-12, naphtha- \ncracking, hydrotreated;  295-443-1  92045-61-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1373}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1375\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained by distal\xad\nlation from the product of a \nnaphtha steam cracking process \nand subsequent catalytic \nselective hydrogenation of gum \nformers. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  12 and boiling in \nthe range of approximately \n30 o C to 230o C (86o F to \n446o F).] \n649-341-00-2  Solvent naphtha (petroleum), \nhydrotreated light naphthenic; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists predomi\xad\nnantly of cycloparaffinic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 6 through C  7 and boiling in \nthe range of approxi mately 73o \nC to 85o C (163  o F to 185  o F).] 295-529-9  92062-15-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1374}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1376\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-342-00-8  Naphtha (petroleum), light \nsteam-cracked, hydrogenated; \nLow boiling point hydrogen \ntreated naphtha; \n[A complex combination of \nhydrocarbons produced from the \nseparation and subsequent \nHydrogenation of the products \nof a steam-cracking process to \nproduce ethylene. It consists \npredominantly of saturated and \nunsaturated paraffins, cyclic \nparaffins and cyclic aromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  4 through C  10 and \nboiling in the range of approxi\xad\nmately 50o C to 200o C (122  o F \nto 392  o F). The proportion of \nbenzene hydrocarbons may vary \nup to 30 wt. % and the stream \nmay also contain small amounts \nofsulfur and oxygenated \ncompounds.]  296-942-7  93165-55-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-343-00-3  Hydrocarbons, C  6-11, hydro\xad\ntreated, dearomatized; \nLow boiling point hydrogen \ntreated naphtha;  297-852-0  93763-33-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1375}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1377\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained as \nsolvents which have been \nsubjected to hydrotreatment in \norder to convert aromatics to \nnaphthenes by catalytic hydroge\xad\nnation.]  \n649-344-00-9  Hydrocarbons, C  9-12, hydro\xad\ntreated, dearomatized; \nLow boiling point hydrogen \ntreated naphtha; [A complex \ncombination of hydrocarbons \nobtained as solvents which have \nbeen subjected to hydrotreatment \nin order to convert aromatics to \nnaphthenes by catalytic hydroge\xad\nnation.]  297-853-6  93763-34-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-345-00-4  stoddard solvent; \nLow boiling point naphtha — \nunspecified; \n[A colourless, refined petroleum \ndistillate that is free from rancid \nor objectionable odours and that \nboils in a range of approximately \n148,8  o C to 204,4  o C (300o F to \n400o F).] 232-489-3  8052-41-3  Carc. 1B \nMuta. 1B \nSTOT RE 1 \nAsp. Tox. 1  H350 \nH340 \nH372 (central \nnervous \nsystem) \nH304  GHS08 \nDgr H350 \nH340 \nH372 \n(central \nnervous \nsystem) \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1376}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1378\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-346-00-X  Natural gas condensates (petro\xad\nleum); \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons separated as a \nliquid from natural gas in a \nsurface separator by retrograde \ncondensation. It consists mainly \nof hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  2 to C  20. It is a \nliquid at atmospheric temperature \nand pressure.]  265-047-3  64741-47-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-347-00-5  Natural gas (petroleum), raw liq. \nmix; Low boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons separated as a \nliquid from natural gas in a gas \nrecycling plant by processes such \nas refrigeration or absorption. It \nconsists mainly of saturated \naliphatic hydrocarbons having \ncarbon numbers in the range of \nC 2 through C  8.] 265-048-9  64741-48-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1377}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1379\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-348-00-0  Naphtha (petroleum), light \nhydrocracked; \nLow boiling naphtha — \nunspecified; \n[A complex combination of \nhydrocarbons from distillation of \nthe products from a hydro\xad\ncracking process. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  4 through C  10, and \nboiling in the range of approxi \nmately - 20  o C to 180  o C \n(– 4  o F to 356  o F).] 265-071-4  64741-69-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-349-00-6  Naphtha (petroleum), heavy \nhydrocracked; \nLow boiling point naphtha \n-unspecified; [A complex \ncombination of hydrocarbons \nfrom distillation of the products \nfrom a hydrocracking process. It \nconsists predominantly of \nsaturated hydrocarbons having \ncarbon numbers predominantly \nin the range of C  6 through C  12, \nand boiling in the range of \napproximately 65  o C to 230  o C \n(148o F to 446o F).] 265-079-8  64741-78-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1378}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1380\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-350-00-1  Naphtha (petroleum) sweetened; \nLow boiling point naphtha \n-unspecified; [A complex \ncombination of hydrocarbons \nobtained by subjecting a \npetroleum naphtha to a \nsweetening process to convert \nmercaptans or to remove acidic \nimpurities. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  12 and boiling in \nthe range of approximately - \n10o C to 230o C (14o F to \n446o F).] 265-089-2  64741-87-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-351-00-7  Naphtha(petroleum), acid-treated; \nLow boilingpoint naphtha \n-unspecified; [A complex \ncombination of hydrocarbons \nobtained as a raffinate from a \nsulfuric acid treating process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  7 through C  12 \nand boiling in the range of \napproximately 90  o C to 230  o \nC (194  o F to 446  o F).] 265-115-2  64742-15-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1379}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1381\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-352-00-2  Naphtha (petroleum), chemically \nneutralized heavy; \nLow boilingpoint naphtha — \nunspecified; \n[A complex combination of \nhydrocarbons produced by a \ntreating process to remove \nacidic materials. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  6 through C  12 and \nboiling in the range of approxi\xad\nmately 65o C to 230o C (149o F \nto 446o F).] 265-122-0  64742-22-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-353-00-8  Naphtha (petroleum), chemically \nneutralized light; \nLow boilingpoint naphtha \n-unspecified; [A complex \ncombination of hydrocarbons \nproduced by a treating process \nto remove acidic materials. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  4 through C  11 \nand boiling in the range of \napproximately - 20  o C to 190o \nC (–4  o F to 374  o F).] 265-123-6  64742-23-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1380}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1382\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-354-00-3  Naphtha (petroleum), catalytic \ndewaxed; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained from the \ncatalytic dewaxing of a \npetroleum fraction. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  5 through \nC 12 and boiling in the range of \napproximately 35o C to 230  o C \n(95o F to 446o F).] 265-170-2  64742-66-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-355-00-9  Naphtha (petroleum), light \nsteam-cracked; \nLow boiling point naphtha \n-unspecified; [A complex \ncombination of hydrocarbons \nobtained by the distillation of \nthe products from a steam \ncracking process. It consists \npredominantly of unsaturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  4 through C  11 and \nboiling in the range of approxi\xad\nmately minus 20  o C to 190  o C (– \n4o F to 374o F). This stream is \nlikely to contain 10 vol.% or \nmore benzene.]  265-187-5  64742-83-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1381}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1383\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-356-00-4  Solvent naphtha (petroleum), \nlight arom.; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained from \ndistillation of aromatic streams. \nIt consists predominantly of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  8 through C  10 \nand boiling in the range of \napproximately 135  o C to \n210  o C (275o F to 410o F).] 265-199-0  64742-95-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-357-00-X  Aromatic hydrocarbons, C  6-10, \nacid-treated, neutralized; \nLow boiling point naphtha — \nunspecified  268-618-5  68131-49-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1382}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1384\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-358-00-5  Distillates (petroleum), C  3-5, 2- \nmethyl-2-butene-rich; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons from the distil \nlation of hydrocarbons usually \nranging in carbon numbers from \nC 3 through C  5, predominantly \nisopentane and 3-methyl-1- \nbutene. It consists of saturated \nand unsaturated hydrocarbons \nhaving carbon numbers in the \nrange of C  3 through C  5, predomi\xad\nnantly 2-methyl-2-butene.]  270-725-7  68477-34-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-359-00-0  Distillates (petroleum), polymd. \nsteam-cracked petroleum distil\xad\nlates, C  5-12 fraction; \nLow boiling point naphtha- \nunspecified; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of polymerized \nsteam-cracked petroleum \ndistillate. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  5 through C  12.] 270-735-1  68477-50-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1383}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1385\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-360-00-6  Distillates (petroleum), steam- \ncracked, C  5-12 fraction; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \norganic compounds obtained by \nthe distillation of products from \na steam cracking process. It \nconsists of unsaturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 5 through C  12.] 270-736-7  68477-53-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-361-00-1  Distillates (petroleum), steam- \ncracked, C  5-10 fraction, mixed \nwith light steam-cracked \npetroleum naphtha C  5 fraction; \nLow boiling point naphtha \n-unspecified  270-738-8  68477-55-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-362-00-7  Extracts (petroleum), cold-acid, \nC 4-6; Low boiling point \nnaphtha — unspecified; [A \ncomplex combination of organic \ncompounds produced by cold \nacid unit extraction of saturated \nand unsaturated aliphatic hydro\xad\ncarbons usually ranging in \ncarbon numbers from C  3 through \nC 6, predominantly pentanes and \namylenes. It consists predomi\xad\nnantly of saturated and \nunsaturated hydrocarbons having  270-741-4  68477-61-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1384}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1386\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \ncarbon numbers in the range of \nC 4 through C  6, predominantly \nC 5.] \n649-363-00-2  Distillates (petroleum), depent\xad\nanizer overheads; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic cracked gas stream. It \nconsists of aliphatic hydro \ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  6.] 270-771-8  68477-89-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-364-00-8  Residues (petroleum), butane \nsplitter bottoms; \nLow boiling point naphtha \n-unspecified; \n[A complex residuum from the \ndistillation of butane stream. It \nconsists of aliphatic hydro \ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  6.] 270-791-7  68478-12-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1385}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1387\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-365-00-3  Residual oils (petroleum), \ndeisobutanizer tower; \nLow boiling point naphtha \n-unspecified; \n[A complex residuum from the \natmospheric distillation of the \nbutane-butylene stream. It \nconsists of aliphatic hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  6.] 270-795-9  68478-16-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-366-00-9  Naphtha (petroleum), full-range \ncoker; \nLow boiling point naphtha — \nunspecified; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \nfluid coker. It consists predomi\xad\nnantly of unsaturated hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  15 and boiling in \nthe range of approximately 43o \nC to 250o C (110o F-500o F).] 270-991-4  68513-02-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1386}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1388\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-367-00-4  Naphtha (petroleum), steam- \ncracked middle arom.; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \nsteam-cracking process. It \nconsists predominantly of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  7 through C  12 \nand boiling in the range of \napproximately 130o C to 220o C \n(266o F to 428o F).] 271-138-9  68516-20-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-368-00-X  Naphtha (petroleum), clay-treated \nfull-range straight-run; Low \nboiling point naphtha -unspeci\xad\nfied; 271-262-3  68527-21-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1387}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1389\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons resulting from \ntreatment of full-range straight- \nrun naphtha with natural or \nmodified clay, usually in a \npercolation process to remove \nthe trace amounts of polar \ncompounds and impurities \npresent. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 4 through C  11 and boiling in \nthe range of approximately - \n20o C to 220o C (– 4o F to \n429o F).] \n649-369-00-5  Naphtha (petroleum), clay-treated \nlight straight-run; \nLow boiling point naphtha — \nunspecified; \n[A complex combination of \nhydrocarbons resulting from \ntreatment of light straight-run \nnaphtha with a natural or \nmodified clay, usually in a \npercolation process to remove \nthe trace amounts of polar \ncompounds and impurities \npresent. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of  271-263-9  68527-22-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1388}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1390\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nC 7 through C  10 and boiling in \nthe range of approximately \n93 o C to 180  o C (200o F to \n356o F).] \n649-370-00-0  Naphtha (petroleum), light \nsteam-cracked arom.; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from a steam- \ncracking process. It consists \npredominantly of aromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  7 through C  9 and \nboiling in the range of approxi\xad\nmately 110o C to 165  o C (230  \no F to 329  o F).] 271-264-4  68527-23-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-371-00-6  Naphtha (petroleum),light steam- \ncracked, debenzenized; Low \nboiling point naphtha -unspeci\xad\nfied; 271-266-5  68527-26-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1389}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1391\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of products from a steam- \ncracking process. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  4 through \nC 12 and boiling in the range of \napproximately 80o C to 218o C \n(176o F to 424o F).] \n649-372-00-1  Naphtha (petroleum), arom.- \ncontg.; \nLow boilingpoint naphtha — \nunspecified  271-635-0  68603-08-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-373-00-7  Gasoline, pyrolysis, debutanizer \nbottoms; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained from the \nfractionation of depropanizer \nbottoms. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly greater than C  5.] 271-726-5  68606-10-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1390}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1392\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-374-00-2  Naphtha (petroleum), light, swee\xad\ntened; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a petroleum distillate \nto a sweetening process to \nconvert mercaptans or to \nremove acidic impurities. It \nconsists predominantly of \nsaturated and unsaturated hydro \ncarbons having carbon numbers \npredominantly in the range of \nC 3 through C  6 and boiling in \nthe range of approximately - \n20o C to 100o C (– 4o F to 212  \no F).] 272-206-0  68783-66-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-375-00-8  Natural gas condensates; \nLow boiling point naphtha \n-unspecified;  272-896-3  68919-39-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1391}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1393\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons separated and/or \ncondensed from natural gas \nduring transportation and \ncollected at the wellhead and/or \nfrom the production, gathering, \ntransmission, and distribution \npipelines in deeps, scrubbers, \netc. It consists predominantly of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  2 through C  8.] \n649-376-00-3  Distillates (petroleum), naphtha \nunifiner stripper; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons produced by \nstripping the products from the \nnaphtha unifiner. It consists of \nsaturated aliphatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  2 through \nC 6.] 272-932-8  68921-09-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-377-00-9  Naphtha (petroleum), catalytic \nreformed light, arom.-free \nfraction; \nLow boiling point naphtha \n-unspecified;  285-510-3  85116-59-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1392}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1394\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons remaining after \nremoval of aromatic compounds \nfrom catalytic reformed light \nnaphtha in a selective absorption \nprocess. It consists predomi\xad\nnantly of paraffinic and cyclic \ncompounds having carbon \nnumbers predominantly in the \nrange of C  5 to C  8 and boiling \nin the range of approximately \n66o C to 121o C (151o F \nto250o F).] \n649-378-00-4  Gasoline; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons consisting \nprimarily of paraffins, cyclo\xad\nparaffins, aromatic and olefinic \nhydrocarbons having carbon \nnumbers predominantly greater \nthan C  3 and boiling in the range \nof 30  o C to 260o C (86o F to \n500o F).] 289-220-8  86290-81-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-379-00-X  Aromatic hydrocarbons, C  7-8, \ndealkylation products, distn. \nresidues; \nLow boiling point naphtha — \nunspecified  292-698-0  90989-42-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1393}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1395\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-380-00-5  Hydrocarbons, C  4-6, depentanizer \nlights, arom. hydrotreater; Low \nboiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained as first \nrunnings from the depentanizer \ncolumn before hydrotreatment of \nthe aromatic charges. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  4 through \nC 6, predominantly pentanes and \npentenes and boiling in the \nrange of approximately 25  o C \nto 40  o C (77o F to 104o F).] 295-298-4  91995-38-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-381-00-0  Distillates (petroleum), heat- \nsoaked steam-cracked naphtha, \nC 5-rich; \nLow boiling point naphtha — \nunspecified;  295-302-4  91995-41-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1394}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1396\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of heat-soaked steam- \ncracked naphtha. It consists \npredominantly of hydrocarbons \nhaving carbon numbers in the \nrange of C  4 through C  6, predomi\xad\nnantly C  5.] \n649-382-00-6  Extracts (petroleum), catalytic \nreformed light naphtha solvent; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nextract from the solvent \nextraction of a catalytically \nreformed petroleum cut. It \nconsists predominantly of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  7 through C  8 \nand boiling in the range of \napproximately 100  o C to \n200  o C (212o F to 392o F).] 295-331-2  91995-68-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-383-00-1  Naphtha (petroleum), hydrode\xad\nsulfurized light, dearomatized; \nLow boiling point naphtha \n-unspecified;  295-434-2  92045-53-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1395}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1397\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of hydrodesulfurized and \ndearomatized light petroleum \nfractions. It consists predomi\xad\nnantly of C  7 paraffins and cyclo\xad\nparaffins boiling in a range of \napproximately 90o C to 100o C \n(194o F to 212o F).] \n649-384-00-7  Naphtha (petroleum), light, C  5- \nrich, sweetened; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a petroleum naphtha \nto a sweetening process to \nconvert mercaptans or to \nremove acidic impurities. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  4 through C  5, \npredominantly C  5, and boiling \nin the range of approximately \nminus 10  o C to 35o C (14o F to \n95o F).] 295-442-6  92045-60-8  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1396}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1398\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-385-00-2  Hydrocarbons, C  8-11, naphtha- \ncracking, toluene cut; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation from prehydrogenated \ncracked naphtha. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  8 through \nC 11 and boiling in the range of \napproximately 130o C to 205o C \n(266o F to 401o F).] 295-444-7  92045-62-0  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-386-00-8  Hydrocarbons, C  4-11, naphtha- \ncracking, arom.-free; \nLow boiling point naphtha \n-unspecified;  295-445-2  92045-63-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1397}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1399\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from \nprehydrogenated cracked \nnaphtha after distillative \nseparation of benzene-and \ntoluene-containing hydrocarbon \ncuts and a higher boiling \nfraction. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  4 through C  11 \nand boiling in the range of \napproximately 30  o C to 205  o \nC (86  o F to 401  o F).] \n649-387-00-3  Naphtha (petroleum), light heat- \nsoaked, steam-cracked; \nLow boiling point naphtha — \nunspecified; \n[A complex combination of \nhydrocarbons obtained by the \nfractionation of steam cracked \nnaphtha after recovery from a \nheat soaking process. It consists \npredominantly of hydrocarbons \nhaving a carbon number \npredominantly in the range of \nC 4 through C  6 and boiling in \nthe range of approxi mately 0o \nC to 80o C (32o F to 176o F).] 296-028-8  92201-97-3  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1398}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1400\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-388-00-9  Distillates (petroleum), C  6-rich; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of a petroleum feed\xad\nstock. It consists predominantly \nof hydrocarbons having carbon \nnumbers of C  5 through C  7, rich \nin C  6, and boiling in the range of \napproximately 60o C to70o C \n(140  o F to 158  o F).] 296-903-4  93165-19-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-389-00-4  Gasoline, pyrolysis, hydro\xad\ngenated; \nLow boiling point naphtha- \nunspecified; \n[A distillation fraction from the \nhydrogenation of pyrolysis \ngasoline boiling in the range of \napproximately 20o C to 200o C \n(68o F to 392o F).] 302-639-3  94114-03-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-390-00-X  Distillates (petroleum), steam- \ncracked, C  8-12 fraction, polymd., \ndistn. lights; \nLow boiling point naphtha \n-unspecified;  305-750-5  95009-23-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1399}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1401\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of the polymerized C  8 \nthrough C  12 fraction from \nsteam-cracked petroleum distil\xad\nlates. It consists predominantly \nof aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  8 through \nC 12.] \n649-391-00-5  Extracts (petroleum) heavy \nnaphtha solvent, clay-treated; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of heavy naphthic \nsolvent petroleum extract with \nbleaching earth. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  6 through \nC 10 and boiling in the range of \napproximately 80  o C to 180  o C \n(175  o F to 356  o F).] 308-261-5  97926-43-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1400}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1402\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-392-00-0  Naphtha (petroleum), light \nsteam-cracked, debenzenized, \nthermally treated; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment and distillation of \ndebenzenized light steam- \ncracked petroleum naphtha. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 7 through C  12 and boiling in \nthe range of approximately \n95 o C to 200o C (203o F to \n392o F).] 308-713-1  98219-46-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-393-00-6  Naphtha (petroleum), light \nsteam-cracked, thermally treated; \nLow boiling point naphtha \n-unspecified;  308-714-7  98219-47-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1401}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1403\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by the \ntreatment and distillation of \nlight steam-cracked petroleum \nnaphtha. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  5 through C  6 \nand boiling in the range of \napproximately 35  o C to 80  o C \n(95  o F to 176  o F).] \n649-394-00-1  Distillates (petroleum), C  7-9, C  8- \nrich, hydrodesulfurized dear\xad\nomatized; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of petroleum light \nfraction, hydrodesulfurized and \ndearomatized. It consists \npredominantly of hydrocarbons \nhaving carbon numbers in the \nrange of C  7 through C  9, predomi\xad\nnantly C  8 paraffins and cyclo\xad\nparaffins, boiling in the range of \napproximately 120  o C to 130  o \nC (248  o F to 266  o F).] 309-862-5  101316-56-7  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1402}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1404\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-395-00-7  Hydrocarbons, C  6-8, hydro\xad\ngenated sorption-dearomatized, \ntoluene raffination; \nLow boiling point naphtha — \nunspecified; \n[A complex combination of \nhydrocarbons obtained during \nthe sorptions of toluene from a \nhydrocarbon fraction from \ncracked gasoline treated with \nhydrogen in the presence of a \ncatalyst. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  6 through C  8 \nand boiling in the range of \napproximately 80o C to 135o C \n(176o F to 275o F).] 309-870-9  101316-66-9  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-396-00-2  Naphtha (petroleum), hydrode\xad\nsulfurised full-range coker; \nLow boiling point naphtha \n-unspecified;  309-879-8  101316-76-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1403}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1405\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex ombination of \nhydrocarbons obtained by frac\xad\ntionation from hydrodesulfurised \ncoker distillate. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  5 to C  11 \nand boiling in the range of \napproximately 23  o C to 196  o C \n(73  o F to 385  o F).] \n649-397-00-8  Naphtha (petroleum), sweetened \nlight; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a petroleum naphtha \nto a sweetening process to \nconvert mercaptans or to \nremove acidic impurities. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 5 through C  8 and boiling in \nthe range of approximately 20  o \nC to 130  o C (68  o F to 266  o F).] 309-976-5  101795-01-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1404}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1406\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-398-00-3  Hydrocarbons, C  3-6, C  5-rich, \nsteam-cracked naphtha; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of steam-cracked naphtha. \nIt consists predominantly of \nhydrocarbons having carbon \nnumbers in the range of C  3 \nthrough C  6, predominantly C  5.] 310-012-0  102110-14-5  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-399-00-9  Hydrocarbons, C  5-rich, dicyclo\xad\npentadiene-contg.; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of the products from a \nsteam-cracking process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \nof C  5 and dicyclopentadiene and \nboiling in the range of approxi\xad\nmately 30o C to 170o C (86o F to \n338o F).] 310-013-6  102110-15-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1405}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1407\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-400-00-2  Residues (petroleum), steam- \ncracked light, arom.; \nLow boiling point naphtha \n-unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of the products of \nsteamcracking or similar \nprocesses after taking off the \nvery light products resulting in \na residue starting with hydro\xad\ncarbons having carbon numbers \ngreater than C  5. It consists \npredominantly of aromatic \nhydrocarbons having carbon \nnumbers greater than C  5 and \nboiling above approximately 40o \nC (104o F).] 310-057-6  102110-55-4  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-401-00-8  Hydrocarbons, C≥5, C  5-6-rich; \nLow boiling point naphtha \n-unspecified  270-690-8  68476-50-6  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1406}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1408\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-402-00-3  Hydrocarbons, C  5-rich; \nLow boiling point naphtha — \nunspecified  270-695-5  68476-55-1  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-403-00-9  Aromatic hydrocarbons, C  8-10; \nLow boiling point naphtha \n-unspecified  292-695-4  90989-39-2  Carc. 1B \nMuta. 1B \nAsp. Tox. 1  H350 \nH340 \nH304  GHS08 \nDgr H350 \nH340 \nH304  P \n649-404-00-4  Kerosine (petroleum); Straight \nrun kerosine; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of crude oil. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  9 through C  16 \nand boiling in the range of \napproximately 150o C to 290o C \n(320o F to 554o F).] 232-366-4  8008-20-6  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-405-00-X  solvent naphtha (petroleum), \nmedium aliph.; \nStraight run kerosine; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of crude oil or \nnatural gasoline. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  9 through C  12 and \nboiling in the range of approxi\xad\nmately 140o C to 220o C (284o F \nto 428o F).] 265-191-7  64742-88-7  STOT RE 1 \nAsp. Tox. 1  H372 (central \nnervous \nsystem) \nH304  GHS08 \nDgr H372 \n(central \nnervous \nsystem) \nH304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1407}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1409\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-406-00-5  Solvent naphtha (petroleum) \nheavy aliph.; \nStraight run kerosine; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of crude oil or \nnatural gasoline. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  11 through C  16 and \nboiling in the range of approxi\xad\nmately 190  o C to 290  o C (374  o F \nto 554  o F).] 265-200-4  64742-96-7  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-407-00-0  Kerosine (petroleum), straight- \nrun wide-cut; \nStraight run kerosine; \n[A complex combination of \nhydrocarbons obtained as a \nwide cut hydrocarbon fuel cut \nfrom atmospheric distillation \nand boiling in the range of \napproximately 70  o C to 220  o C \n(158  o F to 428  o F).] 295-418-5  92045-37-9  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1408}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1410\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-408-00-6  Distillates (petroleum), steam- \ncracked; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of the products from \na steam cracking process. It \nconsists predominantly of \nunsaturated hydrocarbons having \ncarbon numbers predominantly in \nthe range of C  7 through C  16 and \nboiling in the range of approxi\xad\nmately 90  o C to 290  o C (190  o F \nto 554  o F).] 265-194-3  64742-91-2  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-409-00-1  Distillates (petroleum), cracked \nstripped steam-cracked \npetroleum distillates, C  8-10 \nfraction; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by \ndistilling cracked stripped \nsteam-cracked distillates. It \nconsists of hydrocarbons having \ncarbon numbers in the range of \nC 8 through C  10 and boiling in \nthe range of approximately \n129o C to 194o C (264  o F to 382  \no F).] 270-728-3  68477-39-4  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1409}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1411\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-410-00-7  Distillates (petroleum), cracked \nstripped steam-cracked \npetroleum distillates, C  10-12 \nfraction; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by \ndistilling cracked stripped \nsteam-cracked distillates. It \nconsists predominantly of \naromatic hydrocarbons having \ncarbon numbers in the range of \nC 10 through C  12.] 270-729-9  68477-40-7  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-411-00-2  Distillates (petroleum), steam- \ncracked, C  8-12 fraction; \nCracked kerosine; \n[A complex combination of \norganic compounds obtained by \nthe distillation of products from \na steam cracking process. It \nconsists predominantly of \nunsaturated hydrocarbons having \ncarbon numbers predominantly in \nthe range of C  8 through C  12.] 270-737-2  68477-54-3  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1410}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1412\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-412-00-8  Kerosine (petroleum), hydrode\xad\nsulfurized thermal cracked; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by frac\xad\ntionation from hydrodesulfurized \nthermal cracker distillate. It \nconsists predomi nantly of \nhydrocarbons predominantly in \nthe range of C  8 to C  16 and \nboiling in the range of approxi\xad\nmately 120o C to 283o C (284o F to \n541o F).] 285-507-7  85116-55-8  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-413-00-3  Aromtic hydrocarbons, C≥10, \nsteam-cracking, hydrotreated; \nCracked kerosine; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of the products from \na steam cracking process treated \nwith hydrogen in the presence of \na catalyst. It consists predomi\xad\nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly greater than C  10 and \nboiling in the range of approxi\xad\nmately 150  o C to 320  o C (302  o F \nto 608  o F).] 292-621-0  90640-98-5  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1411}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1413\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-414-00-9  Naphtha (petroleum), steam- \ncracked, hydrotreated, C  9-10- \narom.-rich; Cracked kerosine; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of the products from \na steam cracking process \nthereafter treated with hydrogen \nin the presence of a catalyst. It \nconsists predominantly of \naromatic hydrocarbons having \ncarbon numbers in the range of \nC 9 through C  10 and boiling in \nthe range of approximately \n140o C to 200o C (284o F to \n392o F).] 292-637-8  90641-13-7  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-415-00-4  Distillates (petroleum), thermal- \ncracked, alkylarom. hydro\xad\ncarbon-rich; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of thermal-cracking heavy \ntars. It consists predominantly of \nhighly alkylated aromatic hydro\xad\ncarbons boiling in the range of \napproximately 100  o C to 250o C \n(212o F to 482o F.] 309-866-7  101316-61-4  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1412}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1414\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-416-00-X  Distillates (petroleum), catalytic \ncracked heavy tar light; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of catalytic cracking heavy \ntars. It consists predomi nantly of \nhighly alkylated aromatic hydro\xad\ncarbons boiling in the range of \napproximately 100  o C to 250  o C \n(212  o F to 482  o F).] 309-938-8  101631-13-4  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-417-00-5  Solvent naphtha (petroleum), \nhydrocracked heavy arom.; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by the \ndistillation of hydrocracked \npetroleum distillate. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  9 through \nC 16 and boiling in the range of \napproximately 235  o C to 290  o C \n(455  o F to 554  o F).] 309-881-9  101316-80-7  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1413}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1415\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-418-00-0  Distillates (petroleum), steam- \ncracked heavy tar light; \nCracked kerosine; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of steam cracking heavy \ntars. It consists predominantly \nof highly alkylated aromatic \nhydrocarbons boiling in the \nrange of approximately 100  o C \nto 250  o C (212  o F to 482  o F).] 309-940-9  101631-15-6  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-419-00-6  Distillates (petroleum), alkylate; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of the reaction products of \nisobutane with monoolefinic \nhydrocarbons usually ranging in \ncarbon numbers from C  3 \nthrough C  5. It consists of \npredominantly branched chain \nsaturated hydrocarbons having \ncarbon numbers predominantly \nin the range of C  11 through C  17 \nand boiling in the range of \napproximately 205o C to 320o C \n(401o F to 608o F).] 265-074-0  64741-73-7  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1414}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1416\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-420-00-1  Extracts (petroleum), heavy \nnaphtha solvent; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nextract from a solvent extraction \nprocess. It consists predomi \nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  7 through \nC 12 and boiling in the range of \napproximately 90o C to 220o C \n(194  o F to 428  o F).] 265-099-7  64741-98-6  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-421-00-7  Distillates (petroleum), \nchemically neutralized light; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons produced by a \ntreating process to remove \nacidic materials. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  9 through C  16 and \nboiling in the range of approxi\xad\nmately 150  o C to 290  o C (302  o F \nto 554  o F).] 265-132-5  64742-31-0  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1415}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1417\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-422-00-2  Distillates (petroleum), hydro- \ntreated light; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 9 through C  16 and boiling in \nthe range of approxi mately 150  \no C to 290  o C (302  o F to 554  \no F).] 265-149-8  64742-47-8  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-423-00-8  Kerosine (petroleum), hydrode\xad\nsulfurized; Kerosine — \nunspecified; \n[A complex combination of \nhydrocarbons obtained from a \npetroleum stock by treating with \nhydrogen to convert organic \nsulfur to hydrogen sulfide which \nis removed. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 9 through C  16 and boiling in \nthe range of approximately 150  \no C to 290  o C (302  o F to 554  \no F).] 265-184-9  64742-81-0  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1416}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1418\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-424-00-3  Solvent naphtha (petroleum), \nheavy arom.; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained from \ndistillation of aromatic streams. \nIt consists predominantly of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  9 through C  16 \nand boiling in the range of \napproximately 165  o C to 290  o C \n(330  o F to 554  o F).] 265-198-5  64742-94-5  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-425-00-9  Naphtha (petroleum), heavy \ncoker; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of products from a fluid \ncoker. It consists predominantly \nof unsaturated hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  6 through \nC 15 and boiling in the range of \napproximately 157  o C to 288  o C \n(315  o F to 550  o F).] 269-778-9  68333-23-3  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1417}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1419\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-426-00-4  Naphtha (petroleum), catalytic \nreformed hydrodesulfurized \nheavy, arom. fraction; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons produced by frac\xad\ntionation from catalytically \nreformed hydrodesulfurized \nnaphtha. It consists predomi\xad\nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnently in the range of C  7 to C 13 \nand boiling in the range of \napproximately 98o C to 218o C \n(208o F to 424o F).] 285-508-2  85116-57-0  Asp. Tox. 1  H304  GHS08-Dgr  H304  \n649-427-00-X  Kerosine (petroleum), sweetened; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsubjecting a petroleum distillate \nto a sweetening process to \nconvert mercaptans or to \nremove acidic impurities. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 9 through C  16 and boiling in \nthe range of 130  o C to 290  o C \n(266  o F to 554  o F).] 294-799-5  91770-15-9  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1418}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1420\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-428-00-5  Kerosine (petroleum), solvent- \nrefined sweetened; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \npetroleum stock by solvent \nrefining and sweetening and \nboiling in the range of approxi\xad\nmately 150  o C to 260  o C (302  o F \nto 500  o F).] 295-416-4  92045-36-8  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-429-00-0  Hydrocarbons, C  9-16, hydro\xad\ntreated, dearomatized; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained as \nsolvents which have been \nsubjected to hydrotreatment in \norder to convert aromatics to \nnaphthenes by catalytic hydroge\xad\nnation.]  297-854-1  93763-35-0  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-430-00-6  Kerosine (petroleum), solvent- \nrefined hydrodesulfurized; \nKerosine — unspecified  307-033-2  97488-94-3  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1419}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1421\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-431-00-1  Distillates (petroleum), hydrode\xad\nsulfurized full-range middle \ncoker; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained by frac\xad\ntionation from hydrodesulfurized \ncoker distillate. It consists \npredominantly of hydrocarbons \nhaving carbon \nnumbers predominantly in the \nrange of C  8 through C  16 and \nboiling in the range of approxi\xad\nmately 120  o C to 283  o C (248  o F \nto 541  o F).] 309-864-6  101316-58-9  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-432-00-7  Solvent naphtha (petroleum), \nhydrodesulfurized heavy arom.; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ncatalytic hydrodesulfurization of \na petroleum fraction. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  10 \nthrough C  13 and boiling in the \nrange of approximately 180  o C \nto 240  o C (356  o F to 464  o F).] 309-882-4  101316-81-8  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1420}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1422\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-433-00-2  Solvent naphtha (petroleum), \nhydrodesulfurized medium; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ncatalytic hydrodesulfurization of \na petroleum fraction. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  10 \nthrough C  13 and boiling in the \nrange of approximately 175  o C \nto 220  o C (347  o F to 428  o F).] 309-884-5  101316-82-9  Asp. Tox. 1  H304  GHS08 \nDgr H304  \n649-434-00-8  Kerosine (petroleum), hydro\xad\ntreated; \nKerosine — unspecified; \n[A complex combination of \nhydrocarbons obtained from the \ndistillation of petroleum and \nsubsequent hydrotreatment. It \nconsists predominantly of \nalkanes, cycloalkanes and \nalkylbenzenes having carbon \nnumbers predominantly in the \nrange of C  12 through C  16 and \nboiling in the range of approxi\xad\nmately 230  o C to 270  o C (446  o F \nto 518  o F).] 309-944-0  101631-19-0  Asp. Tox. 1  H304  GHS08 \nDgr H304  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1421}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1423\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-435-00-3  Distillates (petroleum), light \ncatalytic cracked; \nCracked gasoil; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  9 through C  25 \nand boiling in the range of \napproximately 150  o C to 400  o C \n(302  o F to 752  o F). It contains a \nrelatively large proportion of \nbicyclic aromatic hydrocarbons.]  265-060-4  64741-59-9  Carc. 1B  H350  GHS08 \nDgr H350  \n649-436-00-9  Distillates (petroleum), inter\xad\nmediate catalytic cracked; \nCracked gasoil; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  11 through C  30 \nand boiling in the range of \napproximately 205  o C to 450  o C \n(401  o F to 842  o F). It contains a \nrelatively large proportion of \ntricyclic aromatic hydrocarbons.]  265-062-5  64741-60-2  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1422}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1424\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-437-00-4  Distillates (petroleum), light \nhydrocracked; \nCracked gasoil; \n[A complex combination of \nhydrocarbons from distillation of \nthe products from a hydro\xad\ncracking process. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  10 through C  18 and \nboiling in the range of approxi \nmately 160o C to 320o C (320  o F \nto 608  o F).] 265-078-2  64741-77-1  Carc. 2  H351  GHS08 \nWng  H351  \n649-438-00-X  Distillates (petroleum), light \nthermal cracked; \nCracked gasoil; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of the products from a \nthermal cracking process. It \nconsists predominantly of \nunsaturated hydrocarbons having \ncarbon numbers predominantly in \nthe range of C  10 through C  22 and \nboiling in the range of approxi\xad\nmately 160o C to 370  o C (320o F \nto 698o F).] 265-084-5  64741-82-8  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1423}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1425\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-439-00-5  Distillates (petroleum), hydrode\xad\nsulfurized light catalytic cracked; \nCracked gasoil; \n[A complex combination of \nhydrocarbons obtained by \ntreating light catalytic cracked \ndistillates with hydrogen to \nconvert organic sulfur to \nhydrogen sulfide which is \nremoved. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 9 through C  25 and boiling in \nthe range of approximately 150  \no C to 400  o C (302  o F to 752  \no F). It contains a relatively large \nproportion of bicyclic aromatic \nhydrocarbons.]  269-781-5  68333-25-5  Carc. 1B  H350  GHS08 \nDgr H350  \n649-440-00-0  Distillates (petroleum),light \nsteam-cracked naphtha; \nCracked gasoil; \n[A complex combination of \nhydrocarbons from the multiple \ndistillation of products from a \nsteam cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  10 through C  18.] 270-662-5  68475-80-9  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1424}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1426\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-441-00-6  Distillates (petroleum), cracked \nsteam-cracked petroleum distil\xad\nlates; \nCracked gasoil; \n[A complex combination of \nhydrocarbons produced by \ndistilling cracked steam cracked \ndistillate and/or its fractionation \nproducts. It consists of hydro\xad\ncarbons having carbon numbers \npredominently in the range of \nC 10 to low molecular weight \npolymers.]  270-727-8  68477-38-3  Carc. 1B  H350  GHS08 \nDgr H350  \n649-442-00-1  Gas oils (petroleum), steam- \ncracked; \nCracked gasoil; \n[A complex combination of \nhydrocarbons produced by distil\xad\nlation of the products from a \nsteam cracking process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \ngreater than C  9 and boiling in \nthe range of from approximately \n205  o C to 400  o C (400  o F to 752  \no F).] 271-260-2  68527-18-4  Carc. 1B  H350  GHS08 \nDgr H350  \n649-443-00-7  Distillates (petroleum), hydrode\xad\nsulfurized thermal cracked \nmiddle; \nCracked gasoil;  285-505-6  85116-53-6  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1425}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1427\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by frac\xad\ntionation from hydrodesulfurized \nthemal cracker distillate stocks. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 11 to C  25 and boiling in the \nrange of approximately 205  o C \nto 400o oC (401o F to 752o F).] \n649-444-00-2  Gas oils (petroleum), thermal- \ncracked, hydrodesulfurized; \nCracked gasoil  295-411-7  92045-29-9  Carc. 1B  H350  GHS08 \nDgr H350  \n649-445-00-8  Residues (petroleum), hydro\xad\ngenated steam-cracked naphtha; \nCracked gasoil; \n[A complex combination of \nhydrocarbons obtained as a \nresidual fraction from the distil\xad\nlation of hydrotreated steam- \ncracked naphtha. It consists \npredominantly of hydrocarbons \nboiling in the range of approxi\xad\nmately 200o C to 350o C (32  o F to \n662  o F).] 295-514-7  92062-00-5  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1426}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1428\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-446-00-3  Residues (petroleum), steam- \ncracked naphtha distn.; \nCracked gasoil; \n[A complex combination of \nhydrocarbons obtained as a \ncolumn bottom from the \nseparation of effluents from \nsteam cracking naphtha at a \nhigh temperature. It boils in the \nrange of approximately 147  o C to \n300  o C (297  o F to 572  o F) and \nproduces a finished oil having a \nviscosity of 18cSt at 50  o C.] 295-517-3  92062-04-9  Carc. 1B  H350  GHS08 \nDgr H350  \n649-447-00-9  Distillates (petroleum), light \ncatalytic cracked, thermally \ndegraded; \nCracked gasoil; \n[A complex combination of \nhydrocarbons produced by the \ndistillation of products from a \ncatalytic cracking process which \nhas been used as a heat transfer \nfluid. It consists predominantly \nof hydrocarbons boiling in the \nrange of approximately 190o C \nto 340o C (374o F to 644o F). \nThis stream is likely to contain \norganic sulfur compounds.]  295-991-1  92201-60-0  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1427}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1429\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-448-00-4  Residues (petroleum), steam- \ncracked heat-soaked naphtha; \nCracked gasoil; \n[A complex combination of \nhydrocarbons obtained as \nresidue from the distillation of \nsteam cracked heat soaked \nnaphtha and boiling in the range \nof approximately 150  o C to 350  \no C (302  o F to 662  o F).] 297-905-8  93763-85-0  Carc. 1B  H350  GHS08 \nDgr H350  \n649-449-00-X  Hydrocarbons, C  16-20, solvent- \ndewaxed hydrocracked paraffinic \ndistn. residue; \nCracked gasoil; \n[A complex combination of \nhydrocarbons obtained by \nsolvent dewaxing of a distillation \nresidue from a hydrocracked \nparaffinic distillate. It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  16 \nthrough C  20 and boiling in the \nrange of approximately 360  o C \nto 500  o C (680  o F to 932  o F). \nIt produces a finished oil having \na viscosity of 4,5 cSt at approxi\xad\nmately 100  o C (212  o F).] 307-662-2  97675-88-2  Carc. 2  H351  GHS08 \nWng  H351  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1428}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1430\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-450-00-5  Gas oils (petroleum), light \nvacuum, thermal-cracked \nhydrodesulfurized; \nCracked gasoil; \n[A complex combination of \nhydrocarbons obtained by \ncatalytic dehydrosulfurization of \nthermal-cracked light vacuum \npetroleum. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  14 through C  20 \nand boiling in the range of \napproximately 270  o C to 370  o C \n(518  o F to 698  o F).] 308-278-8  97926-59-5  Carc. 1B  H350  GHS08 \nDgr H350  \n649-451-00-0  Distillates (petroleum), hydrode\xad\nsulfurized middle coker; \nCracked gasoil; \n[A complex combination of \nhydrocarbons by fractionation \nfrom hydrodesulfurised coker \ndistillate stocks. Is consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  12 through C  21 and \nboiling in the range of approxi\xad\nmately 200  o C to 360  o C (392  o F \nto 680  o F).] 309-865-1  101316-59-0  Carc. 1B  H350  GHS08 \nDgr H350  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1429}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1431\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-452-00-6  Distillates (petroleum), heavy \nsteam-cracked; \nCracked gasoil; \n[A complex combination of \nhydrocarbons obtained by distil\xad\nlation of steam cracking heavy \nresidues. It consists predomi\xad\nnantly of highly alkylated heavy \naromatic hydrocarbons boiling in \nthe range of approximately 250  \no C to 400  o C (482  o F to 752  \no F).] 309-939-3  101631-14-5  Carc. 1B  H350  GHS08 \nDgr H350  \n649-453-00-1  Distillates (petroleum), heavy \nhydrocracked; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons from the distil\xad\nlation of the products from a \nhydrocracking process. It \nconsists predominantly of \nsaturated hydrocarbons having \ncarbon numbers in the range of \nC 15-C 39 and boiling in the range \nof approximately 260  o C to 600  \no C (500  o F to 1112  o F).] 265-077-7  64741-76-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1430}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1432\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-454-00-7  Distillates (petroleum), solvent- \nrefined heavy paraffinic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  20 through C  50 and \nproduces a finished oil with a \nviscosity of at least 100 SUS at \n100  o F (19cSt at 40  o C).] 265-090-8  64741-88-4  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-455-00-2  Distillates (petroleum), solvent- \nrefined light paraffinic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists \npredominantly of saturated \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30 and \nproduces a finished oil with a \nviscosity of less than 100 SUS \nat 100  o F (19cSt at 40  o C).] 265-091-3  64741-89-5  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1431}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1433\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-456-00-8  Residual oils (petroleum), solvent \ndeasphalted; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nsolvent soluble fraction from \nC 3-C 4 solvent deasphalting of a \nresiduum. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly higher than C  25 \nand boiling above approximately \n400  o C (752  o F).] 265-096-0  64741-95-3  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-457-00-3  Distillates (petroleum), solvent- \nrefined heavy naphthenic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  20 through C  50 and \nproduces a finished oil with a \nviscosity of at least 100 SUS at \n100  o F (19cSt a 40  o C). It \ncontains relatively few normal \nparaffins.]  265-097-6  64741-96-4  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1432}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1434\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-458-00-9  Distillates (petroleum), solvent- \nrefined light naphthenic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as the \nraffinate from a solvent \nextraction process. It consists of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30 and \nproduces a finished oil with a \nviscosity of less than 100 SUS \nat 100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-098-1  64741-97-5  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-459-00-4  Residual oils (petroleum,) \nsolvent-refined; \nBaseoil — unspecified; \n[A complex combination by \nhydrocarbons obtained as the \nsolvent insoluble fraction from \nsolvent refining of a residuum \nusing a polar organic solvent \nsuch as phenol or furfural. It \nconsists of hydrocarbons having  265-101-6  64742-01-4  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1433}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1435\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \ncarbon numbers predominantly \nhigher than C  25 and boiling \nabove approximately 400o C \n(752o F).] \n649-460-00-X  Distillates (petroleum), clay- \ntreated paraffinic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons resulting from \ntreatment of a petroleum \nfraction with natural or modified \nclay in either a contacting or \npercolation process to remove \nthe trace amounts of polar \ncompounds and impurities \npresent. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 20 through C  50 and produces a \nfinished oil with a viscosity of at \nleast 100 SUS at 100  o F (19cSt \nat 40  o C). It contains a relatively \nlarge proportion of saturated \nhydrocarbons.]  265-137-2  64742-36-5  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1434}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1436\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-461-00-5  Distillates (petroleum), clay- \ntreated light paraffinic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons resulting from \ntreatment of a petroleum \nfraction with natural or modified \nclay in either a contacting or \npercolation process to remove \nthe trace amounts of polar \ncompounds and impurities \npresent. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  30 and produces a \nfinished oil with a viscosity of \nless than 100 SUS at 100  o F \n(19cSt at 40  o C). It contains a \nrelatively large proportion of \nsaturated hydrocarbons.]  265-138-8  64742-37-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-462-00-0  Residual oils (petroleum), clay- \ntreated; \nBaseoil — unspecified;  265-143-5  64742-41-2  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1435}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1437\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreatment of a residual oil with \na natural or modified clay in \neither a contacting or percolation \nprocess to remove the trace \namounts of polar compounds \nand impurities present. It \nconsists of hydro-carbons \nhaving carbon numbers predomi\xad\nnantly higher than C  25 and \nboiling above approximately \n400o C (752  o F).] \n649-463-00-6  Distillates (petroleum), clay- \ntreated heavy naphthenic; \nBaseoil — unspecified; [A \ncomplex combination of hydro\xad\ncarbons resulting from treatment \nof a petroleum fraction with \nnatural or modified clay in \neither a contacting or percolation \nprocess to remove the trace \namounts of polar compounds \nand impurities present. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50 \nand produces a finished oil with \na viscosity of at least 100 SUS at \n100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-146-1  64742-44-5  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1436}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1438\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-464-00-1  Distillates (petroleum), clay- \ntreated light naphthenic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons resulting from \ntreatment of a petroleum \nfraction with natural or modified \nclay in either a contacting or \npercolation process to remove \nthe trace amounts of polar \ncompounds and impurities \npresent. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  30 and produces a \nfinished oil with a viscosity of \nless than 100 SUS at 100  o F \n(19cSt at 40  o C). It contains \nrelatively few normal paraffins.]  265-147-7  64742-45-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-465-00-7  Distillates (petroleum), hydro\xad\ntreated heavy naphthenic; \nBaseoil — unspecified;  265-155-0  64742-52-5  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1437}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1439\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 20 through C  50 and produces a \nfinished oil of at least 100 SUS \nat 100o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  \n649-466-00-2  Distillates (petroleum), hydro\xad\ntreated light naphthenic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  30 and produces a \nfinished oil with a viscosity of \nless than 100 SUS at 100  o F \n(19cSt at 40  o C). It contains \nrelatively few normal paraffins.]  265-156-6  64742-53-6  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1438}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1440\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-467-00-8  Distillates (petroleum), hydro\xad\ntreated heavy paraffinic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 20 through C  50 and produces a \nfinished oil of at least 100 SUS \nat 100o F (19cSt at 40  o C). It \ncontains a relatively large \nproportion of saturated hydrocar\xad\nbons.]  265-157-1  64742-54-7  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-468-00-3  Distillates (petroleum), hydro\xad\ntreated light paraffinic; \nBaseoil — unspecified;  265-158-7  64742-55-8  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1439}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1441\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  30 and produces a \nfinished oil with a viscosity of \nless than 100 SUS at 100  o F \n(19cSt at 40  o C). It contains a \nrelatively large proportion of \nsaturated hydrocarbons.]  \n649-469-00-9  Distillates (petroleum), solvent- \ndewaxed light paraffinic; \nBaseoil — unspecified; \n[A complex comination of \nhydrocarbons obtained by \nremoval of normal paraffins \nfrom a petroleum fraction by \nsolvent crystallization. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  30 and produces a \nfinished oil with a viscosity of \nless than 100 SUS at 100  o F \n(19cSt at 40  o C).] 265-159-2  64742-56-9  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1440}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1442\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-470-00-4  Residual oils (petroleum), hydro\xad\ntreated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly greater than C  25 \nand boiling above approximately \n400  o C (752  o F).] 265-160-8  64742-57-0  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-471-00-X  Residual oils (petroleum), \nsolvent-dewaxed; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nremoval of ong, branched chain \nhydrocarbons from a residual oil \nby solvent crystalli zation. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \ngreater than C  25 and boiling \nabove approxi mately 400  o C \n(752  o F).] 265-166-0  64742-62-7  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1441}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1443\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-472-00-5  Distillates (petroleum), solvent- \ndewaxed heavy naphthenic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nremoval of normal paraffins \nfrom a petroleum fraction by \nsolvent crystallization. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 . through \nC 50 and produces a finished oil \nof not less than 100 SUS at 100  \no F (19cSt at 40  o C). It contains \nrelatively few normal paraffins.]  265-167-6  64742-63-8  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-473-00-0  Distillates (petroleum), solvent- \ndewaxed light naphthenic; \nBaseoil — unspecified;  265-168-1  64742-64-9  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1442}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1444\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \nremoval of normal paraffins \nfrom a petroleum fraction by \nsolvent crystallization. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range C  15 through C  30 \nand produces a finished oil with \na viscosity of less than 100 SUS \nat 100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  \n649-474-00-6  Distillates (petroleum), solvent- \ndewaxed heavy paraffinic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nremoval of normal paraffins \nfrom a petroleum fraction by \nsolvent crystallization. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 20 through C  50 and produces a \nfinished oil with a viscosity not \nless than 100 SUS at 100  o F \n(19cSt at 40  o C).] 265-169-7  64742-65-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1443}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1445\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-475-00-1  Naphthenic oils (petroleum), \ncatalytic dewaxed heavy; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic dewaxing process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 20 through C  50 and produces a \nfinished oil with a viscosity of at \nleast 100 SUS at 100  o F (19cSt \nat 40  o C). It contains relatively \nfew normal paraffins.]  265-172-3  64742-68-3  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-476-00-7  Naphthenic oils (petroleum), \ncatalytic dewaxed light; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic dewaxing process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  30 \nand produces a finished oil with \na viscosity less than 100 SUS at \n100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  265-173-9  64742-69-4  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1444}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1446\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-477-00-2  Paraffin oils (petroleum), \ncatalytic dewaxed heavy; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic dewaxing process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 20 through C  50 and produces a \nfinished oil with a viscosity of at \nleast 100 SUS at 100  o F (19cSt \nat 40  o C).] 265-174-4  64742-70-7  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-478-00-8  Paraffin oils (petroleum), \ncatalytic dewaxed light; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic dewxing process. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  30 and produces a \nfinished oil with a viscosity of \nless than 100 SUS at 100  o F \n(19cSt at 40  o C).] 265-176-5  64742-71-8  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1445}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1447\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-479-00-3  Naphthenic oils (petroleum), \ncomplex dewaxed heavy; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nremoving straight chain \nparaffin hydrocarbons as a solid \nby treatment with an agent such \nas urea. It consists of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 20 through C  50 and produces a \nfinished oil having a viscosity of \nat least 100 SUS at 100  o F \n(19cSt at 40  o C). It contains \nrelatively few normal paraffins.]  265-179-1  64742-75-2  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-480-00-9  Naphthenic oils (petroleum), \ncomplex dewaxed light; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from a \ncatalytic dewaxing process. It \nconsists of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  30 \nand produces a finished oil \nhaving a viscosity less than 100  265-180-7  64742-76-3  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1446}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1448\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nSUS at 100  o F (19cSt at 40  o C). \nIt contains relatively few normal \nparaffins.]  \n649-481-00-4  Lubricating oils (petroleum), \nC 20-50, hydrotreated neutral oil- \nbased, high-viscosity; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating light vacuum gas oil, \nheavy vacuum gas oil, and \nsolvent deasphalted residual oil \nwith hydrogen in the presence \nof a catalyst in a two stage \nprocess with dewaxing being \ncarried out between the two \nstages. It consists predominantly \nof hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  20 through C  50 and \nproduces a finished oil having a \nviscosity of approximately \n112cSt at 40  o C. It contains a \nrelatively large proportion of \nsaturated hydrocarbons.]  276-736-3  72623-85-9  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-482-00-X  Lubricating oils (petroleum), \nC 15-30, hydrotreated neutral oil- \nbased; \nBaseoil — unspecified;  276-737-9  72623-86-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1447}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1449\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreating light vacuum gas oil \nand heavy vacuum gas oil with \nhydrogen in the presence of a \ncatalyst in a two stage process \nwith dewaxing being carried out \nbetween the two stages. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  30 and produces a \nfinished oil having a viscosity of \napproximately 15cSt at 40  o C. It \ncontains a relatively large \nproportion of saturated hydro\xad\ncabons.]  \n649-483-00-5  Lubricating oils (petroleum), \nC 20-50, hydrotreated neutral oil- \nbased; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating light vacuum gas oil, \nheavy vacuum gas oil and \nsolvent deasphalted residual oil \nwith hydrogen in the presence \nof a catalyst in a two stage  276-738-4  72623-87-1  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1448}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1450\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nprocess with dewaxing being \ncarried out between the two \nstages. It consists predominantly \nof hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  20 through C  50 and \nproduces a finished oil with a \nviscosity of approximately 32cSt \nat 40  o C. It contains a relatively \nlarge proportion of saturated \nhydrocarbons.]  \n649-484-00-0  Lubricating oils; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from \nsolvent extraction and dewaxing \nprocesses. It consists predomi\xad\nnantly of saturated hydrocarbons \nhaving carbon numbers in the \nrange C  15 through C  50.] 278-012-2  74869-22-0  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-485-00-6  Distillates (petroleum), complex \ndewaxed heavy paraffinci; \nBaseoil — unspecified;  292-613-7  90640-91-8  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1449}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1451\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ndewaxing heavy paraffinic \ndistillate. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50 \nand produces a finished oil with \na viscosity of equal to or greater \nthan 100 SUS at 100  o F (19cSt at \n40 o C). It contains relatively few \nnormal paraffins.]  \n649-486-00-1  Distillates (petroleum), complex \ndewaxed light paraffinic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ndewaxing light paraffinic \ndistillate. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  12 through C  30 \nand produces a finished oil with \na viscosity of less than 100 SUS \nat 100  o F (19cSt at 40  o C). It \ncontains relatively few normal \nparaffins.]  292-614-2  90640-92-9  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1450}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1452\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-487-00-7  Distillates (petroleum), solvent \ndewaxed heavy paraffinic, clay- \ntreated; Baseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating dewaxed heavy \nparaffinic distillate with neutral \nor modified clay in either a \ncontacting or percolation \nprocess. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50.] 292-616-3  90640-94-1  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-488-00-2  Hydrocarbons, C  20-50, solvent \ndewaxed heavy paraffinic, hydro\xad\ntreated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons produced by \ntreating dewaxed heavy \nparaffinic distillate with \nhydrogen in the presence of a \ncatalyst. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50.] 292-617-9  90640-95-2  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1451}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1453\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-489-00-8  Distillates (petroleum), solvent \ndewaxed light paraffinic, clay- \ntreated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons resulting from \ntreatment of dewaxed light \nparaffinic distillate with natural \nor modified clay in either a \ncontacting or percolation \nprocess. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  30.] 292-618-4  90640-96-3  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-490-00-3  Distillates (petroleum), solvent \ndewaxed light paraffinic, hydro\xad\ntreated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons produced by \nTreating a dewaxed light \nparaffinic distillate with \nhydrogen in the presence of a \ncatalyst. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  30.] 292-620-5  90640-97-4  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1452}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1454\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-491-00-9  Residual oils (petroleum), hydro\xad\ntreated solvent dewaxed; \nBaseoil — unspecified  292-656-1  90669-74-2  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-492-00-4  Residual oils (petroleum), \ncatalytic dewaxed; \nBaseoil — unspecified  294-843-3  91770-57-9  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-493-00-X  Distillates (petroleum), dewaxed \nheavy paraffinic, hydrotreated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from an \nintensive treatment of dewaxed \ndistillate by hydrogenation in \nthe presence of a catalyst. It \nconsists predominantly of \nsaturated hydrocarbons having \ncarbon numbers predominantly \nin the range of C  25 through C  39 \nand produces a finished oil with \na viscosity of approximately 44 \ncSt at 50  o C.] 295-300-3  91995-39-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1453}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1455\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-494-00-5  Distillates (petroleum), dewaxed \nlight paraffinic, hydrotreated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from an \nintensive treatment of dewaxed \ndistillate by hydrogenation in \nthe presence of a catalyst. It \nconsists predominantly of \nsaturated hydrocarbons having \ncarbon numbers predominantly \nin the range of C  21 through C  29 \nand produces a finished oil with \na viscosity of approximately 13 \ncSt at 50  o C.] 295-301-9  91995-40-3  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-495-00-0  Distillates (petroleum), hydro\xad\ncracked solvent-refined, \ndewaxed; \nBaseoil — unspecified; [A \ncomplex combination of liquid \nhydrocarbons obtained by \nrecrystallization of dewaxed \nhydrocracked solvent-refined \npetroleum distillates.]  295-306-6  91995-45-8  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1454}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1456\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-496-00-6  Distillates (petroleum), solvent- \nrefined light naphthenic, hydro\xad\ntreated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreating a petroleum fraction \nwith hydrogen in the presence \nof a catalyst and removing the \naromatic hydrocarbons by \nsolvent extraction. It consists \npredominantly of naphthenic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30 and \nproduces a finished oil with a \nviscosity of between 13-15cSt at \n40 o C.] 295-316-0  91995-54-9  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-497-00-1  Lubricating oils (petroleum), \nC 17-35, solvent-extd., dewaxed, \nhydrotreated; \nBaseoil — unspecified  295-423-2  92045-42-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-498-00-7  Lubricating oils (petroleum), \nhydrocracked nonarom. solvent- \ndeparaffined; \nBaseoil — unspecified  295-424-8  92045-43-7  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1455}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1457\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-499-00-2  Residual oils (petroleum), hydro\xad\ncracked acid-treated solvent- \ndewaxed; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons produced by \nsolvent removal of paraffins \nfrom the residue of the distil \nlation of acid-treated, hydro\xad\ncracked heavy paraffins and \nboiling approximately above \n380  o C (716  o F).] 295-499-7  92061-86-4  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-500-00-6  Paraffin oils (petroleum), \nsolvent-refined dewaxed heavy; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained from \nsulfur-containing paraffinic \ncrude oil. It consists predomi\xad\nnantly of a solvent refined \ndeparaffinated lubricating oil \nwith a viscosity of 65cSt at \n50 o C.] 295-810-6  92129-09-4  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-501-00-1  Lubricating oils (petroleum), \nbase oils, paraffinic; \nBaseoil — unspecified;  297-474-6  93572-43-1  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1456}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1458\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \nrefining of crude oil. It consists \npredominantly of aromatics, \nnaphthenics and paraffinics and \nproduces a finished oil with a \nviscosity of 120 SUS at 100  o F \n(23cSt at 40  o C).] \n649-502-00-7  Hydrocarbons, hydrocracked \nparaffinic distn. residues, \nsolvent-dewaxed; \nBaseoil — unspecified  297-857-8  93763-38-3  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-503-00-2  Hydrocarbons, C  20-50, residual \noil hydrogenation vacuum \ndistillate; \nBaseoil — unspecified  300-257-1  93924-61-9  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-504-00-8  Distillates (petroleum), solvent- \nrefined hydrotreated heavy; \nhydrogenated; \nBaseoil — unspecified  305-588-5  94733-08-1  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1457}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1459\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-505-00-3  Distillates (petroleum), solvent- \nrefined hydrocracked light; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsolvent dearomatization of the \nresidue of hydrocracked \npetroleum. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  18 through C  27 \nand boiling in the range of \napproximately 370o C to 450o C \n(698o F to 842o F).] 305-589-0  94733-09-2  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-506-00-9  Lubricating oils (petroleum), C  18- \n40, solvent-dewaxed hydro\xad\ncracked distillate-based; \nBaseoil — unspecified; [A \ncomplex combination of hydro\xad\ncarbons obtained by solvent \ndeparaffination of the distillation \nresidue from hydrocracked \npetroleum. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  18 through C  40 \nand boiling in the range of \napproximately 370o C to 550  o C \n(698  o F to 1022o F).] 305-594-8  94733-15-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1458}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1460\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-507-00-4  Lubricating oils (petroleum), C  18- \n40, solvent-dewaxed hydro\xad\ngenated raffinate-based; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsolvent deparaffination of the \nhydrogenated raffinate obtained \nby solvent extraction of a hydro\xad\ntreated petroleum distillate. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 18 through C  40 and boiling in \nthe range of approximately \n370  o C to 550  o C (698  o F to \n1022  o F).] 305-595-3  94733-16-1  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-508-00-X  Hydrocarbons, C  13-30, arom.-rich, \nsolvent-extd. naphthenic \ndistillate; \nBaseoil — unspecified  305-971-7  95371-04-3  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1459}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1461\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-509-00-5  Hydrocarbons, C  16-32, arom. rich, \nsolvent-extd. naphthenic \ndistillate; \nBaseoil — unspecified  305-972-2  95371-05-4  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-510-00-0  Hydrocarbons, C  37-68, dewaxed \ndeasphalted hydrotreated \nvacuum distn. residues; \nBaseoil — unspecified  305-974-3  95371-07-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-511-00-6  Hydrocarbons, C  37-65, hydro\xad\ntreated deasphalted vacuum \ndistn. residues; \nBaseoil — unspecified  305-975-9  95371-08-7  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-512-00-1  Distillates (petroleum), hydro\xad\ncracked solvent-refined light; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by the \nsolvent treatment of a distillate \nfrom hydrocracked petroleum \ndistillates. It consists \npredomiantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  18 \nthrough C  27 and boiling in the \nrange of approximately 370  o C \nto 450o C (698  o F to 842  o F.] 307-010-7  97488-73-8  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1460}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1462\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-513-00-7  Distillates (petroleum), solvent- \nrefined hydrogenated heavy; \nBaseoil — unspecified; [A \ncomplex combination of hydro\xad\ncarbons, obtained by the \ntreatment of a hydrogenated \npetroleum distillate with a \nsolvent. It consists predominantly \nof hydrocarbons having carbon \nnumbers predominantly in the \nrange of C  19 through C  40 and \nboiling in the range of approxi\xad\nmately 390  o C to 550  o C (734  o F \nto 1022  o F).] 307-011-2  97488-74-9  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-514-00-2  Lubricating oils (petroleum), \nC 18-27, hydrocracked solvent- \ndewaxed; \nBaseoil — unspecified  307-034-8  97488-95-4  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1461}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1463\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-515-00-8  Hydrocarbons, C  17-30, hydro\xad\ntreated solvent-deasphalted atm. \ndistn. residue, distn. lights; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained as first \nrunnings from the vacuum distil\xad\nlation of effluents from the \ntreatment of a solvent deas\xad\nphalted short residue with \nhydrogen in the presence of a \ncatalyst. It consists predomi \nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  17 through C  30 \nand boiling in the range of \napproximately 300  o C to 400  o C \n(572  o F to 752  o F). It produces a \nfinished oil having a viscosity of \n4cSt at approximately 100  o C \n(212  o F).] 307-661-7  97675-87-1  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-516-00-3  Hydrocarbons, C  17-40, hydro\xad\ntreated solvent-deasphalted distn. \nresidue, vacuum distn. lights; \nBaseoil — unspecified;  307-755-8  97722-06-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1462}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1464\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained as first \nrunnings from the vacuum distil\xad\nlation of effluents from the \ncatalytic hydrotreatment of a \nsolvent deasphalted short residue \nhaving a viscosity of 8cSt at \napproximately 100  o C (212  o F). \nIt consists predominantly of \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  17 through C  40 and \nboiling in the range of approxi\xad\nmately 300  o C to 500  o C (592  o F \nto 932  o F).] \n649-517-00-9  Hydrocarbons, C  13-27, solvent- \nextd. light naphthenic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nextraction of the aromatics from \na light naphthenic distillate \nhaving a viscosity of 9.5cSt at \n40 o C (104  o F). It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  13 \nthrough C  27 and boiling in the \nrange of approximately 240  o C \nto 400  o C (464  o F to 752  o F).] 307-758-4  97722-09-3  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1463}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1465\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-518-00-4  Hydrocarbons, C  14-29, solvent- \nextd. light naphthenic; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nextraction of the aromatics from \na light naphthenic distillate \nhaving a viscosity of 16cSt at \n40o C (104o F). It consists \npredominantly of hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  14 \nthrough C  29 and boiling in the \nrange of approximately 250  o C \nto 425  o C (482  o F to 797  o F).] 307-760-5  97722-10-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-519-00-X  Hydrocarbons, C  27-42, dear\xad\nomatized; \nBaseoil — unspecified  308-131-8  97862-81-2  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-520-00-5  Hydrocarbons, C  17-30, hydro\xad\ntreated distillates, distn. lights; \nBaseoil — unspecified  308-132-3  97862-82-3  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1464}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1466\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-521-00-0  Hydrocarbons, C  27-45, naphthenic \nvacuum distn.; \nBaseoil — unspecified  308-133-9  97862-83-4  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-522-00-6  Hydrocarbons, C  27-45, dear\xad\nomatized; \nBaseoil — unspecified  308-287-7  97926-68-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-523-00-1  Hydrocarbons, C  20-58, hydro\xad\ntreated; \nBaseoil — unspecified  308-289-8  97926-70-0  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-524-00-7  Hydrocarbons, C  27-42, naph\xad\nthenic; \nBaseoil — unspecified  308-290-3  97926-71-1  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1465}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1467\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-525-00-2  Residual oils (petroleum), \ncarbon-treated solvent-dewaxed; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by the \ntreatment of solvent-dewaxed \npetroleum residual oils with \nactivated charcoal for the \nremoval of trace polar consti\xad\ntuents and impurities.]  309-710-8  100684-37-5  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-526-00-8  Residual oils (petroleum), clay- \ntreated solvent-dewaxed; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \ntreatment of solvent-dewaxed \npetroleum residual oils with \nbleaching earth for the removal \nof trace polar constituents and \nimpurities.]  309-711-3  100684-38-6  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1466}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1468\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-527-00-3  Lubricating oils (petroleum), \nC>25, solvent-extd., deasphalted, \ndewaxed, hydrogenated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsolvent extraction and hydroge\xad\nnation of vacuum distillation \nresidues. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \ngreater than C  25 and produces a \nfinished oil with a viscosity in \nthe order of 32cSt to 37cSt at \n100  o C (212  o F).] 309-874-0  101316-69-2  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-528-00-9  Lubricating oils (petroleum), C  17- \n32, solvent-extd., dewaxed, \nhydrogenated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsolvent extraction and hydroge\xad\nnation of atmospheric distillation \nresidues. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  17 through C  32 \nand produced a finished oil with \na viscosity in the order of 17cSt \nto 23cSt at 40  o C (104  o F.] 309-875-6  101316-70-5  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1467}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1469\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-529-00-4  Lubricating oils (petroleum), C  20- \n35, solvent-extd., dewaxed, \nhydrogenated; \nBaseoil — unspecified; \n[A complex combination of \nhydrocarbons obtained by \nsolvent extraction and hydroge\xad\nnation of atmospheric distillation \nresidues. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  35 \nand produces a finished oil with \na viscosity in the order of 37cSt \nto 44cSt at 40  o C (104  o F).] 309-876-1  101316-71-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-530-00-X  Lubricating oils (petroleum), C  24- \n50, solvent-extd., dewaxed, \nhydrogenated; \nBaseoil — unspecified;  309-877-7  101316-72-7  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1468}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1470\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \nsolvent extraction and hydroge\xad\nnation of atmospheric distillation \nresidues. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  24 through C  50 \nand produces a finished oil with \na viscosity in the order of 16cSt \nto 75cSt at 40  o C (104  o F).] \n649-531-00-5  Extracts (petroleum), heavy \nnaphthenic distillate solvent, \narom. conc.; \nDistillate aromatic extract \n(treated); \n[An aromatic concentrate \nproduced by adding water to \nheavy naphthenic distillate \nsolvent extract and extraction \nsolvent.]  272-175-3  68783-00-6  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-532-00-0  Extracts (petroleum), solvent- \nrefined heavy paraffinic distillate \nsolvent;  272-180-0  68783-04-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1469}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1471\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \nDistillate aromaticextract \n(treated); [A complex \ncombination of hydrocarbons \nobtained as the extractfrom the \nre-extraction of solvent-refined \nheavy paraffinic distillate. It \nconsists of saturated and \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  20 through C  50.] \n649-533-00-6  Extracts (petroleum), heavy \nparaffinic distillates, solvent- \ndeasphalted; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons obtained as the \nextract from a solvent extraction \nof heavy paraffinic distillate.]  272-342-0  68814-89-1  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-534-00-1  Extracts (petroleum), heavy \nnaphthenic distillate solvent, \nhydrotreated; \nDistillate aromatic extract \n(treated);  292-631-5  90641-07-9  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1470}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1472\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \ntreating a heavy naphthenic \ndistillate solvent extract with \nhydrogen in the presence of a \ncatalyst. It consists predomi \nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  20 \nthrough C  50 and produces a \nfinished oil of at least 19cSt at \n40 o C (100 SUS at 100  o F).] \n649-535-00-7  Extracts (petroleum), heavy \nparaffinic distillate solvent, \nhydrotreated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons produced by \ntreating a heavy paraffinic \ndistillate solvent extract with \nhydrogen in the presence of a \ncatalyst. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  21 through C  33 \nand boiling in the range of \napproximately 350o C to 480o C \n(662o F to 896o F). 292-632-0  90641-08-0  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1471}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1473\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-536-00-2  Extracts (petroleum), light \nparaffinic distillate solvent, \nhydrotreated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons produced by \ntreating a lightparaffinic distillate \nsolvent extract with hydrogen in \nthe presence of acatalyst. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 17 through C  26 and boiling in \nthe range of approximately \n280o C to 400o C (536  o F to \n752  o F).] 292-633-6  90641-09-1  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-537-00-8  Extracts (petroleum), hydro\xad\ntreated light paraffinic distillate \nsolvent; \nDistillate aromatic extract \n(treated);  295-335-4  91995-73-2  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1472}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1474\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained as the \nextract from solvent extraction \nof intermediate paraffinic top \nsolvent distillate that is treated \nwith hydrogen in the presence \nof a catalyst. It consists predomi\xad\nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  16 \nthrough C  36.] \n649-538-00-3  Extracts (petroleum), light naph\xad\nthenic distillate solvent, hydrode\xad\nsulfurized; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons obtained by \ntreating the extract, obtained \nfrom a solvent extraction \nprocess, with hydrogen in the \npresence of a catalyst under \nconditions primarily to remove \nsulfur compounds. It consists \npredominantly of aromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  15 through C  30. This \nstream is likely to contain 5 \nwt.% or more of 4-to 6- \nmembered condensed ring \naromatic hydrocarbons.]  295-338-0  91995-75-4  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1473}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1475\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-539-00-9  Extracts(petroleum), light \nparaffinic distillate solvent, acid- \ntreated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons obtained as a \nfraction of the distillation of an \nextract from the solvent \nextraction of light paraffinic top \npetroleum distillates that is \nsubjected to a sulfuric acid \nrefining. It consists predomi \nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  16 \nthrough C  32.] 295-339-6  91995-76-5  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-540-00-4  Extracts (petroleum), light \nparaffinic distillate solvent, \nhydrodesulfurized; \nDistillate aromatic extract \n(treated);  295-340-1  91995-77-6  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1474}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1476\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained by \nsolvent extraction of a light \nparaffin distillate and treated \nwith hydrogen to convert the \norganic sulfur to hydrogen \nsulfide which is eliminated. It \nconsists predominantly of hydro\xad\ncarbons having carbon numbers \npredominantly in the range of \nC 15 through C  40 and produces a \nfinished oil with a viscosity of \ngreater than 10cSt at 40  o C.] \n649-541-00-X  Extracts (petroleum), light \nvacuum gas oil solvent, hydro\xad\ntreated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons, obtained by \nsolvent extraction from light \nvacuum petroleum gas oils and \ntreated with hydrogen in the \npresence of a catalyst. It \nconsists predominantly of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  13 through C  30.] 295-342-2  91995-79-8  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1475}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1477\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-542-00-5  Extracts (petroleum), heavy \nparaffinic distillate solvent, clay- \ntreated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons resulting from \ntreatment of a petroleum \nfraction with natural or modified \nclay in either a contact or \npercolation process to remove \nthe trace amounts of polar \ncompounds and impurities \npresent. It consists predominantly \nof aromatic hydrocarbons having \ncarbon numbers predominantly in \nthe range of C  20 through C  50. \nThis stream is likely to contain \n5 wt.% or more 4-6 membered \nring aromatic hydrocarbons.]  296-437-1  92704-08-0  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-543-00-0  Extracts (petroleum), heavy \nnaphthenic distillate solvent, \nhydrodesulfurized; \nDistillate aromatic extract \n(treated);  297-827-4  93763-10-1  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1476}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1478\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained from a \npetroleum stock by treating with \nhydrogen to convert organic \nsulfur to hydrogen sulfide which \nis removed. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  50 \nand produces a finished oil with \na viscosity of greater than 19cSt \nat 40  o C.] \n649-544-00-6  Extracts (petroleum), solvent- \ndewaxed heavy paraffinic \ndistillate solvent, hydrodesul\xad\nfurized; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons obtained from a \nsolvent dewaxed petroleum \nstock by treating with hydrogen \nto convert organic sulfur to \nhydrogen sulfide which is \nremoved. It consists predomi\xad\nnantly of hydrocarbons having \ncarbon numbers predominantly \nin the range of C  15 through C  50 \nand produces a finished oil with \na viscosity of greater than 19cSt \nat 40  o C.] 297-829-5  93763-11-2  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1477}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1479\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-545-00-1  Extracts (petroleum), light \nparaffinic distillate solvent, \ncarbon-treated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons obtained as a \nfraction from distillation of an \nextract recovered by solvent \nextraction of light paraffinic top \npetroleum distillate treated with \nactivated charcoal to remove \ntraces of polar constituents and \nimpurities. It consists predomi\xad\nnantly of aromatic hydrocarbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  16 \nthrough C  32.] 309-672-2  100684-02-4  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-546-00-7  Extracts (petroleum), light \nparaffinic distillate solvent, clay- \ntreated; \nDistillate aromatic extract \n(treated);  309-673-8  100684-03-5  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1478}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1480\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n[A complex combination of \nhydrocarbons obtained as a \nfraction from distillation of an \nextract recovered by solvent \nextraction of light paraffinic top \npetroleum distillates treated with \nbleaching earth to remove traces \nof polar constituents and impur\xad\nities. It consists predominantly of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  16 through C  32.] \n649-547-00-2  Extracts (petroleum), light \nvacuum, gas oil solvent, carbon- \ntreated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons obtained by \nsolvent extraction of light \nvacuum petroleum gas oil \ntreated with activated charcoal \nfor the removal of trace polar \nconstituents and impurities. It \nconsists predominantly of \naromatic hydrocarbons having \ncarbon numbers predominantly \nin the range of C  13 through C  30.] 309-674-3  100684-04-6  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1479}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1481\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-548-00-8  Extracts (petroleum), light \nvacuum gas oil solvent, clay- \ntreated; \nDistillate aromatic extract \n(treated); \n[A complex combination of \nhydrocarbons obtained by \nsolvent extraction of light \nvacuum petroleum gas oils \ntreated with bleaching earth for \nremoval of trace polar consti\xad\ntuents and impurities. It consists \npredominantly of aromatic \nhydrocarbons having carbon \nnumbers predominantly in the \nrange of C  13 through C  30.] 309-675-9  100684-05-7  Carc. 1B  H350  GHS08 \nDgr H350  L  \n649-549-00-3  Foots oil (petroleum); Foots oil; \n[A complex combination of \nhydrocarbons obtained as the oil \nfraction from a solvent deoiling \nor a wax sweating process. It \nconsists predomi nantly of \nbranched chain hydro carbons \nhaving carbon numbers predomi\xad\nnantly in the range of C  20 \nthrough C  50.] 265-171-8  64742-67-2  Carc. 1B  H350  GHS08 \nDgr H350  L  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1480}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1482\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n649-550-00-9  Foots oil (petroleum), hydro\xad\ntreated; Foots oil  295-394-6  92045-12-0  Carc. 1B  H350  GHS08 \nDgr H350  L  \n650-002-00-6  turpentine, oil  232-350-7  8006-64-2  Flam. Liq. 3 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nAsp. Tox. 1 \nEye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 2  H226 \nH332 \nH312 \nH302 \nH304 \nH319 \nH315 \nH317 \nH411  GHS02 \nGHS08 \nGHS07 \nGHS09 \nDgr H226 \nH332 \nH312 \nH302 \nH304 \nH319 \nH315 \nH317 \nH411  \n650-003-00-1  fenson (ISO); \n4-chlorophenyl benzenesul\xad\nphonate;  201-274-6  80-38-6  Acute Tox. 4 * \nEye Irrit. 2 \nAquatic Chronic 2  H302 \nH319 \nH411  GHS07 \nGHS09 \nWng  H302 \nH319 \nH411  \n650-004-00-7  norbormide (ISO); \n5-(α-hydroxy-α-2-pyridylbenzyl)- \n7-(α-2-pyridylbenzyli\xad\ndene)bicycle [2.2.1] hept-5-ene- \n2,3-dicarboximide  213-589-6  991-42-4  Acute Tox. 4 *  H302  GHS07 \nWng  H302  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1481}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1483\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n650-005-00-2  ( 2 R,6aS,12aS)-1,2,6,6a,12,12a- \nhexahydro-2-isopropenyl-8,9- \ndimethoxychromeno[3,4- \nb]furo[2,3-h]chromen-6-one, \nrotenone  201-501-9  83-79-4  Acute Tox. 3 * \nEye Irrit. 2 \nSTOT SE 3 \nSkin Irrit. 2 \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH319 \nH335 \nH315 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH319 \nH335 \nH315 \nH410  \n650-006-00-8  benquinox (ISO);  \np-benzoquinone 1-benzoylhy\xad\ndrazone 4-oxime  207-807-9  495-73-8  Acute Tox. 3 * \nAcute Tox. 4 *  H301 \nH312  GHS06 \nDgr H301 \nH312  \n650-007-00-3  chlordimeform (ISO);  \nN2-(4-chloro- o-tolyl)- N1,N1- \ndimethylformamidine  228-200-5  6164-98-3  Carc. 2 \nAcute Tox. 4 * \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH312 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH312 \nH302 \nH410  \n650-008-00-9  drazoxolon (ISO); \n4-(2-chlorophenylhydrazone)-3- \nmethyl-5-isoxazolone  227-197-8  5707-69-7  Acute Tox. 3 * \nAquatic Acute 1 \nAquatic Chronic 1  H301 \nH400 \nH410  GHS06 \nGHS09 \nDgr H301 \nH410  \n650-009-00-4  chlordimeform hydrochloride;  N'- \n(4-chloro- o-tolyl)- N,N-dimethyl\xad\nformamidine monohydrochloride;  \nN2-(4-chloro- o-tolyl)- N1,N1- \ndimethylformamidine hydorch\xad\nloride  243-269-1  19750-95-9  Carc. 2 \nAcute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H351 \nH302 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H351 \nH302 \nH410  \n650-010-00-X  benzyl violet 4B; \nα-[4-(4-dimethylamino-α-{4- \n[ethyl(3-sodiosulphonato \nbenzyl)amino] phenyl}benzyli\xad\ndene)cyclohexa-2,5-dienyli\xad\ndene(ethyl)ammonio]toluene-3- \nsulphonate  216-901-9  1694-09-3  Carc. 2  H351  GHS08 \nWng  H351  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1482}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1484\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n650-012-00-0  erionite  —  12510-42-8  Carc. 1A  H350  GHS08 \nDgr H350  \n650-013-00-6  asbestos  —  \n— \n— \n— \n— \n— \n— 12001-28-4 \n132207-32-0 \n12172-73-5 \n77536-66-4 \n77536-68-6 \n77536-67-5 \n12001-29-5  Carc. 1A \nSTOT RE 1  H350 \nH372 **  GHS08 \nDgr H350 \nH372 **  \n650-014-00-1  diethyl 2,4-dihydroxycyclodis\xad\niloxane-2,4-diylbis(trimethyl\xad\nene)diphosphonate, tetrasodium \nsalt, reaction products with \ndisodium metasilicate  401-770-4  —  Skin Corr. 1B \nAcute Tox. 4 *  H314 \nH302  GHS05 \nGHS07 \nDgr H314 \nH302  \n650-015-00-7  rosin; \ncolophony  232-475-7 \n232-484-6 \n277-299-1  8050-09-7 \n8052-10-6 \n73138-82-6  Skin Sens. 1  H317  GHS07 \nWng  H317  \n650-016-00-2  Mineral wool, with the exception \nof those specified elsewhere in \nthis Annex; \n[Man-made vitreous (silicate) \nfibres with random orientation \nwith alkaline oxide and alkali \nearth oxide \n(Na2O+K2O+CaO+MgO+BaO) \ncontent greater than 18 % by \nweight]  — —  Carc. 2  H351  GHS08 \nWng  H351  AQR  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1483}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1485\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n650-017-00-8  Refractory Ceramic Fibres, \nSpecial Purpose Fibres, with the \nexception of those specified \nelsewhere in this Annex; \n[Man-made vitreous (silicate) \nfibres with random orientation \nwith alkaline oxide and alkali \nearth oxide (Na2O+K2O+CaO+ \nMgO+BaO) content less or \nequal to 18 % by weight]  — —  Carc. 1B  H350i  GHS08 \nDgr H350i  A R  \n650-018-00-3  Reaction product of: acet\xad\nophenone, formaldehyde, cyclo\xad\nhexylamine, methanol and acetic \nacid 406-230-1  —  Flam. Liq. 3 \nCarc. 2 \nSkin Corr. 1B \nAcute Tox. 4 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H226 \nH351 \nH314 \nH332 \nH317 \nH400 \nH410  GHS02 \nGHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H226 \nH351 \nH314 \nH332 \nH317 \nH410  \n650-031-00-4  bis(4-hydroxy-N-methylani\xad\nlinium) sulphate  200-237-1  55-55-0  Acute Tox. 4 * \nSTOT RE 2 * \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH373 ** H317 \nH400 \nH410  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH317 \nH410  \n▼M15  \n650-032-00-X  cyproconazole (ISO); (2RS, \n3RS;2RS,3SR)-2-(4-chloro\xad\nphenyl)-3-cyclopropyl-1-(1H- \n1,2,4-triazol-1-yl)butan-2-ol  — 94361-06-5  Repr. 1B \nAcute Tox. 3 \nSTOT RE 2 \nAquatic Acute 1 \nAquatic Chronic 1  H360D \nH301 \nH373 (liver) \nH400 \nH410  GHS08 \nGHS06 \nGHS09 \nDgr H360D \nH301 \nH373 (liver) \nH410  M = 10 \nM = 1  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1484}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1486\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n▼M1 __________  \n▼M16  \n650-041-00-9  triasulfuron (ISO); \n1-[2-(2-chloroethoxy)phenylsul\xad\nfonyl]-3-(4-methoxy-6-methyl- \n1,3,5-triazin-2-yl)urea  — 82097-50-5  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n650-042-00-4  Reaction product of: poly\xad\nethylene-polyamine-(C  16-C 18)- \nalkylamides with monothio-(C  2)- \nalkyl phosphonates  417-450-2  —  Eye Irrit. 2 \nSkin Irrit. 2 \nSkin Sens. 1 \nAquatic Chronic 3  H319 \nH315 \nH317 \nH412  GHS07 \nWng  H319 \nH315 \nH317 \nH412  \n650-043-00-X  reaction product of: 3,5-bis-tert- \nbutylsalicylic acid and alumin\xad\niumsulfate  420-310-3  —  Acute Tox. 4 * \nAquatic Acute 1 \nAquatic Chronic 1  H302 \nH400 \nH410  GHS07 \nGHS09 \nWng  H302 \nH410  \n650-044-00-5  mixed linear and branched C  14-15 \nalcohols ethoxylated, reaction \nproduct with epichlorohydrin  420-480-9  158570-99-1  Skin Irrit. 2 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH317 \nH400 \nH410  GHS07 \nGHS09 \nWng  H315 \nH317 \nH410  \n650-045-00-0  Reaction product of: 1,2,3- \npropanetricarboxylic acid, 2- \nhydroxy, diethyl ester, 1- \npropanol and zirconium tetra-n- \npropanolate  417-110-3  —  Flam. Liq. 2 \nSkin Irrit. 2 \nEye Dam. 1 \nAquatic Chronic 2  H225 \nH315 \nH318 \nH411  GHS02 \nGHS05 \nGHS09 \nDgr H225 \nH315 \nH318 \nH411  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1485}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1487\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n650-046-00-6  di(tetramethylam\xad\nmonium)(29H,31H-phthalo\xad\ncyanin-N29,N30,N31,N32)dis\xad\nulfonamide disulfonate, \ncuprate(2-)complex, derivates  416-180-2  12222-04-7  Acute Tox. 4 * \nSTOT RE 2 * \nAquatic Chronic 2  H302 \nH373 ** H411  GHS08 \nGHS07 \nGHS09 \nWng  H302 \nH373 ** \nH411  \n650-047-00-1  dibenzylphenylsulfonium \nhexafluoroantimonate  417-760-8  134164-24-2  STOT RE 1 \nAcute Tox. 4 * \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Chronic 2  H372 ** H302 \nH318 \nH317 \nH411  GHS08 \nGHS05 \nGHS07 \nGHS09 \nDgr H372 ** \nH302 \nH318 \nH317 \nH411  \n650-048-00-7  reaction product of: borax, \nhydrogen peroxide, acetic acid \nanhydride and acetic acid  420-070-1  —  Org. Perox. D \n**** Acute Tox. \n4 * \nAcute Tox. 4 * \nAcute Tox. 4 * \nSkin Corr. 1A \nAquatic Acute 1  H242 \nH332 \nH312 \nH302 \nH314 \nH400  GHS02 \nGHS05 \nGHS07 \nGHS09 \nDgr H242 \nH332 \nH312 \nH302 \nH314 \nH400  \n650-049-00-2  2-alkoyloxyethyl hydrogen \nmaleate, where alkoyl represents \n(by weight 70 to 85 % \nunsaturated octadecoyl, 0.5 to \n10 % saturated octadecoyl, and \n2 to 18 % saturated hexadecoyl  417-960-5  —  Skin Irrit. 2 \nEye Dam. 1 \nSkin Sens. 1 \nAquatic Acute 1 \nAquatic Chronic 1  H315 \nH318 \nH317 \nH400 \nH410  GHS05 \nGHS07 \nGHS09 \nDgr H315 \nH318 \nH317 \nH410  ▼M16', metadata={'source': 'data/ycla_en.pdf', 'page': 1486}), Document(page_content="02008R1272 — EN — 01.03.2022 — 021.001 — 1488\n Index No  ►M18  Chemical name ◄  EC No  CAS No  Classification  Labelling  ►M18  Specific \nConc. Limits, \nM-factors and \nATEs (*) ◄  Notes  Hazard Class and \nCategory Code(s)  Hazard statement \nCode(s)  Pictogram, Signal \nWord Code(s)  Hazard \nstatement \nCode(s)  Suppl. Hazard \nstatement \nCode(s)  \n650-050-00-8  reaction mass of: 1-methyl-3- \nhydroxypropyl 3,5-[1,1-dimethyl\xad\nethyl]-4-hydroxydihydro- \ncinnamate and/or 3-hydroxybutyl \n3,5-[1,1-dimethylethyl]-4- \nhydroxydihydrocinnamate; \n1,3-butanediol bis[3-(3'-(1,1- \ndimethylethyl)4'-hydroxy- \nphenyl)propionate] isomers; \n1,3-butanediol bis[3-(3',5'-(1,1- \ndimethylethyl)-4'-hydroxyphe\xad\nnyl)propionate] isomers  423-600-8  —  Aquatic Chronic 2  H411  GHS09  H411  \n650-055-00-5  silver sodium zirconium hydro\xad\ngenphosphate  422-570-3  155925-27-2  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  GHS09 \nWng  H410  \n▼M22  \n650-056-00-0  dibutylbis(pentane-2,4-dionato- \nO,O’)tin  245-152-0  22673-19-4  Repr. 1B \nSTOT RE 1  H360FD \nH372 (immune \nsystem)  GHS08 \nDgr H360FD \nH372 \n(immune \nsystem)  \n▼M23  \n650-057-00-6  Margosa, ext. [cold-pressed oil of  \nAzadirachta indica  seeds without \nshells extracted with super- \ncritical carbon dioxide]  283-644-7  84696-25-3  Aquatic Chronic 3  H412  H412  \n▼M18  \n(*) ATEs for oral and dermal exposure routes are expressed in m g/kg bw, which stands for milligram per kilogram bodyweight.  \n▼M13  __________  ▼M16", metadata={'source': 'data/ycla_en.pdf', 'page': 1487}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1489  \nANNEX VII  \nTranslation table from classification under Directive 67/548/EEC to \nclassification under this Regulation  \nThis Annex includes a table to assist translation of a classifi cation made for a \nsubstance or a mixture under Directive 67/548/EEC or Directive 1999/45/EC, \nrespectively, into the corresponding classification under this Regulation. \nWhenever data for the substance or mixture are available, an ev aluation and \nclassification shall be done in accordance with Articles 9 to13  of this Regulation.  \n1. Translation table  \nThe codes used are introduced in Table 1.1 and section 1.1.2.2 of Annex VI.  \nTable 1.1  \nTranslation between classification in accordance with Directive 67/548/EEC \nand this Regulation  \nClassification under \nDirective 67/548/EEC  Physical state \nof the \nsubstance \nwhen relevant  Classification under this Regulation  \nNote  Hazard Class-and- \nCategory  Hazard \nstatement  \nE; R2  No direct translation possible.  \nE; R3  No direct translation possible.  \nO; R7  Org. Perox. CD  H242  \nOrg. Perox. EF  H242  \nO; R8  gas  Ox. Gas 1  H270  \nO; R8  liquid, \nsolid  No direct translation possible.  \nO; R9  liquid  Ox. Liq. 1  H271  \nO; R9  solid  Ox. Sol. 1  H271  \nR10 liquid  No direct translation possible. \nCorrect translation of R10, liquid is: \n— Flam. Liq. 1, H224 if flashpoint < 23  o C \nand initial boiling point ≤ 35  o C \n— Flam. Liq. 2, H225 if flashpoint < 23  o C \nand initial boiling point > 35  o C \n— Flam. Liq. 3, H226 if flashpoint ≥ 23  o C \nF; R11  liquid  No direct translation possible. \nCorrect translation of F; R11, liquid is: \n— Flam. Liq. 1, H224 if initial boiling \npoint ≤ 35  o C \n— Flam. Liq. 2, H225 if initial boiling \npoint > 35  o C \nF; R11  solid  No direct translation possible.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1488}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1490  \nClassification under \nDirective 67/548/EEC  Physical state \nof the \nsubstance \nwhen relevant  Classification under this Regulation  \nNote  Hazard Class-and- \nCategory  Hazard \nstatement  \nF+; R12  gas  No direct translation possible. \nCorrect translation of F+; R12, gaseous \nresults either in Flam. Gas 1, H220 or \nFlam. Gas 2, H221.  \nF+; R12  liquid  Flam. Liq. 1  H224  \nF+; R12  liquid  Self-react. CD  H242  \nSelf-react. EF  H242  \nSelf-react. G  none  \nF; R15  No translation possible.  \nF; R17  liquid  Pyr. Liq. 1  H250  \nF; R17  solid  Pyr. Sol. 1  H250  \nXn; R20  gas  Acute Tox. 4  H332  (1)  \nXn; R20  vapours  Acute Tox. 4  H332  (1)  \nXn; R20  dust/mist  Acute Tox. 4  H332  \nXn; R21  Acute Tox. 4  H312  (1)  \nXn; R22  Acute Tox. 4  H302  (1)  \nT; R23  gas  Acute Tox. 3  H331  (1)  \nT; R23  vapour  Acute Tox. 2  H330  \nT; R23  dust/mist  Acute Tox. 3  H331  (1)  \nT; R24  Acute Tox. 3  H311  (1)  \nT; R25  Acute Tox. 3  H301  (1)  \nT+; R26  gas  Acute Tox. 2  H330  (1)  \nT+; R26  vapour  Acute Tox. 1  H330  \nT+; R26  dust/mist  Acute Tox. 2  H330  (1)  \nT+; R27  Acute Tox. 1  H310  \nT+; R28  Acute Tox. 2  H300  (1)  \nR33 STOT RE 2  H373  (3)  \n▼M12  \nC; R34  Skin Corr. 1  H314  (2)  \nC; R35  Skin Corr. 1A  H314  \n▼B \nXi; R36  Eye Irrit. 2  H319  \nXi; R37  STOT SE 3  H335  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1489}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1491  \nClassification under \nDirective 67/548/EEC  Physical state \nof the \nsubstance \nwhen relevant  Classification under this Regulation  \nNote  Hazard Class-and- \nCategory  Hazard \nstatement  \nXi; R38  Skin Irrit. 2  H315  \nT; R39/23  STOT SE 1  H370  (3)  \nT; R39/24  STOT SE 1  H370  (3)  \nT; R39/25  STOT SE 1  H370  (3)  \nT+; R39/26  STOT SE 1  H370  (3)  \nT+; R39/27  STOT SE 1  H370  (3)  \nT+; R39/28  STOT SE 1  H370  (3)  \nXi; R41  Eye Dam. 1  H318  \nR42 Resp. Sens. 1  H334  \nR43 Skin Sens. 1  H317  \nXn; R48/20  STOT RE 2  H373  (3)  \nXn; R48/21  STOT RE 2  H373  (3)  \nXn; R48/22  STOT RE 2  H373  (3)  \nT; R48/23  STOT RE 1  H372  (3)  \nT; R48/24  STOT RE 1  H372  (3)  \nT; R48/25  STOT RE 1  H372  (3)  \nR64 Lact.  H362  \nXn; R65  Asp. Tox. 1  H304  \nR67 STOT SE 3  H336  \nXn; R68/20  STOT SE 2  H371  (3)  \nXn; R68/21  STOT SE 2  H371  (3)  \nXn; R68/22  STOT SE 2  H371  (3)  \nCarc. Cat. 1; R45  Carc. 1A  H350  \nCarc. Cat. 2; R45  Carc. 1B  H350  \nCarc. Cat. 1; R49  Carc. 1A  H350i  \nCarc. Cat. 2; R49  Carc. 1B  H350i  \nCarc. Cat. 3; R40  Carc. 2  H351  \nMuta. Cat. 2; R46  Muta. 1B  H340  \nMuta. Cat. 3; R68  Muta. 2  H341  \nRepr. Cat. 1; R60  Repr. 1A  H360F  (4)  \nRepr. Cat. 2; R60  Repr. 1B  H360F  (4)  \nRepr. Cat. 1; R61  Repr. 1A  H360D  (4)  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1490}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1492  \nClassification under \nDirective 67/548/EEC  Physical state \nof the \nsubstance \nwhen relevant  Classification under this Regulation  \nNote  Hazard Class-and- \nCategory  Hazard \nstatement  \nRepr. Cat. 2; R61  Repr. 1B  H360D  (4)  \nRepr. Cat. 3; R62  Repr. 2  H361f  (4)  \nRepr. Cat. 3; R63  Repr. 2  H361d  (4)  \nRepr. Cat. 1; R60-61  Repr. 1A  H360FD  \nRepr. Cat. 1; R60 \nRepr. Cat. 2; R61  Repr. 1A  H360FD  \nRepr. Cat. 2; R60 \nRepr. Cat. 1; R61  Repr. 1A  H360FD  \nRepr. Cat. 2; R60-61  Repr. 1B  H360FD  \nRepr. Cat. 3; R62-63  Repr. 2  H361fd  \nRepr. Cat. 1; R60 \nRepr. Cat. 3; R63  Repr. 1A  H360Fd  \nRepr. Cat. 2; R60 \nRepr. Cat. 3; R63  Repr. 1B  H360Fd  \nRepr. Cat. 1; R61 \nRepr. Cat. 3; R62  Repr. 1A  H360Df  \nRepr. Cat. 2; R61 \nRepr. Cat. 3; R62  Repr. 1B  H360Df  \n▼C1 \nN; R50  Aquatic Acute 1  H400  \n▼B \nN; R50-53  Aquatic Acute 1 \nAquatic Chronic 1  H400 \nH410  \nN; R51-53  Aquatic Chronic 2  H411  \nR52-53  Aquatic Chronic 3  H412  \nR53 Aquatic Chronic 4  H413  \nN; R59  Ozone  ►M2 H420 ◄  \nNote 1  \nFor these classes it is possible to use the recommended minimum  classification as defined in \nsection 1.2.1.1 in Annex VI. Data or other information may be a vailable to indicate that re- \nclassification in a more severe category is appropriate.  \n▼M12  \nNote 2  \nGoing back to original data may not result in a possibility to distinguish between Category 1B \nor 1C, since the exposure period has normally been up to 4 hour s according to Regulation (EC) \nNo 440/2008. In these cases, Category 1 shall be assigned. Howe ver, when data are derived \nfrom tests following a sequential approach as foreseen in the R egulation (EC) No 440/2008, \nfurther sub-categorisation into Category 1B or Category 1C shal l be considered.  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1491}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1493  \nNote 3  \nThe route of exposure could be added to the hazard statement if  it is conclusively proven that no \nother routes of exposure cause the hazard.  \n▼M4 \nNote 4  \nHazard statements H360 and H361 indicate a general concern for effects on fertility and/or \ndevelopment: ‘May damage/Suspected of damaging fertility or the  unborn child’ñ. According \nto the criteria, the general hazard statement can be replaced b y the hazard statement indicating \nthe specific effect of concern in accordance with section 1.1.2 .1.2 of Annex VI. When the other \ndifferentiation is not mentioned, this is due to evidence provi ng no such effect, inconclusive \ndata or no data and the obligations in Article 4(3) shall apply  for that differentiation.  \n▼B \nTable 1.2  \nTranslation between risk phrases assigned under Directive 67/548/EEC and \nsupplementary labelling requirements under this Regulation  \nDirective 67/548/EEC  This Regulation  \nR1 EUH001  \n▼M4 \n_______  \n▼B \nR14 EUH014  \nR18 EUH018  \nR19 EUH019  \nR44 EUH044  \nR29 EUH029  \nR31 EUH031  \nR32 EUH032  \nR66 EUH066  \nR39-41  EUH070  ▼B', metadata={'source': 'data/ycla_en.pdf', 'page': 1492}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1494  \nANNEX VIII  \nHARMONISED INFORMATION RELATING TO EMERGENCY \nHEALTH RESPONSE AND PREVENTATIVE MEASURES  \nPART A  \nGENERAL REQUIREMENTS  \n1. APPLICATION  \n1.1. Importers and downstream users placing on the market mixtu res for \nconsumer use, within the meaning of Section 2.4 of Part A of th is \nAnnex, shall comply with this Annex from 1 January 2021.  \n1.2. Importers and downstream users placing on the market mixtu res for \nprofessional use, within the meaning of Section 2.4 of Part A o f this \nAnnex, shall comply with this Annex from 1 January 2021.  \n1.3. Importers and downstream users placing on the market mixtu res for \nindustrial use or mixtures with an end use not subject to notif ication \nwithin the meaning of Section 2.4 of Part A of this Annex, shal l \ncomply with this Annex from 1 January 2024.  \n1.4. Importers and downstream users having submitted informatio n relating to \nhazardous mixtures to a body appointed in accordance with Artic le 45(1) \nbefore the dates of applicability mentioned in Sections 1.1, 1. 2 and 1.3 \nand which are not in accordance with this Annex, shall for thos e mixtures \nnot be required to comply with this Annex until 1 January 2025.  \n1.5. By way of derogation from Section 1.4, if one of the chang es described in \nSection 4.1 of Part B of this Annex occurs before 1 January 202 5, \nimporters and downstream users shall comply with this Annex bef ore \nplacing that mixture, as changed, on the market.  \n2. PURPOSE, SCOPE AND DEFINITIONS  \n2.1. This Annex sets out the requirements that importers and do wnstream users \nplacing mixtures on the market, hereinafter ‘submitters’ shall fulfil in \nrespect of the submission of information so that appointed bodi es shall \nhave at their disposal the information to carry out the tasks f or which they \nare responsible under Article 45.  \n2.2. This Annex shall not apply to mixtures for scientific rese arch and devel\xad\nopment and to mixtures for product and process oriented researc h and \ndevelopment as defined in Article 3(22) of Regulation (EC) No \n1907/2006.  \nThis Annex shall not apply to mixtures classified only for one or more of \nthe following hazards:  \n(1) Gases under pressure;  \n(2) Explosives (Unstable explosives and Divisions 1.1 to 1.6).  \n2.2a. In the case of bespoke paints, submitters may, without pr ejudice to \nArticle 25(8), opt not to submit information and not to create a Unique \nFormula Identifier in accordance with this Annex.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1493}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1495  \n2.3. In the case of mixtures with an end use not subject to not ification or \nmixtures placed on the market for industrial use only, submitte rs may \nopt for a limited submission, as an alternative to general subm ission \nrequirements, in accordance with the second subparagraph of Sec tion \n3.1 of Part B, provided that a rapid access to additional detai led product \ninformation is available in accordance with Section 1.3 of that  Part.  \n2.4. For the purposes of this Annex, the following definitions shall apply:  \n(1) ‘mixture for consumer use’ means a mixture intended to be u sed by \nconsumers, either on its own or incorporated in another mixture  that is \nintended to be used by consumers and is subject to the informat ion \nrequirements in Article 45;  \n(2) ‘mixture for professional use’ means a mixture intended to be used by \nprofessional users but not at industrial sites, either on its o wn or \nincorporated in another mixture that is intended to be used by profes\xad\nsional users but not at industrial sites and is subject to the information \nrequirements in Article 45;  \n(3) ‘mixture for industrial use’ means a mixture intended to be  used at \nindustrial sites only;  \n(4) ‘mixture with an end use not subject to notification’ means  a mixture, \nincorporated in another mixture where the latter is intended to  be used \nby consumers or professional users, but which is not subject to  the \ninformation requirements in Article 45;  \n(5) ‘bespoke paint’ means a paint that is formulated in limited  amounts on \na tailor-made basis for an individual consumer or professional user at \nthe point of sale by tinting or colour mixing.  \nWhere mixtures have more than one use, the requirements for all  \nrelevant categories of use shall be met.  \n3. SUBMISSION REQUIREMENTS  \n3.1. Before placing mixtures on the market, submitters shall pr ovide \ninformation relating to mixtures classified as hazardous on the  basis of \ntheir health or physical effects to the bodies appointed under Article 45(1) \n(‘appointed bodies’), in the Member State or Member States wher e the \nmixture is placed on the market.  \nThe submission shall contain the information laid down in Part B. It shall \nbe submitted by electronic means in an XML format provided by t he \nAgency and made available free of charge.  \n3.2. Where following receipt of a submission under Section 3.1 an appointed \nbody makes a reasoned request to the submitter that additional information \nor clarification is necessary for that appointed body to carry out the tasks \nfor which it is responsible under Article 45, the submitter sha ll provide the \nnecessary information or clarification requested without undue delay.  \n3.3. The submission shall be in the official language(s) of the  Member State(s) \nwhere the mixture is placed on the market, unless the Member St ate(s) \nconcerned provide(s) otherwise.  \n3.4. The intended use of the mixture shall be described in acco rdance with a \nharmonised product categorisation system provided by the Agency . ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1494}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1496  \n3.5. A submission update shall be made without undue delay when  the \nconditions laid down in Section 4.1 of Part B are met.  \n4. GROUP SUBMISSION  \n4.1. A single submission may be provided for more than one mixt ure where all \nthe mixtures in a group have the same classification for health  and \nphysical hazards. Such a submission shall be referred to as a ‘ group \nsubmission’.  \n4.2. A group submission shall only be permitted when all mixtur es in the \ngroup contain the same components (as identified in Section 3.2  of Part \nB), and for each of the components, the reported concentration range is \nthe same for all mixtures (as provided in Section 3.4 of Part B ). \n4.3. By way of derogation from Section 4.2, a group submission shall also be \nallowed where the difference in the composition between differe nt \nmixtures in the group only concerns perfumes, provided that the  total \nconcentration of the differing perfumes contained in each mixtu re does \nnot exceed 5 %.  \n4.4. In the case of a group submission, the information require d in Part B shall \nbe provided for each of the mixtures contained in the group whe re appli\xad\ncable.  \n5. UNIQUE FORMULA IDENTIFIER (UFI)  \n5.1. The submitter shall create a Unique Formula Identifier (‘U FI’) by elec\xad\ntronic means made available by the Agency. The UFI is a unique alpha\xad\nnumeric code that unambiguously links the submitted information  on the \ncomposition of a mixture or a group of mixtures to a specific m ixture or \ngroup of mixtures. The assignment of a UFI is free of charge.  \nA new UFI shall be created when a change in the composition of the \nmixture or group of mixtures fulfils one or more of the conditi ons laid \ndown in points (a), (b) and (c) of the fourth indent of the fir st subpara\xad\ngraph of Section 4.1 of Part B or, as the case may be, one or o ther of the \nconditions laid down in the second subparagraph of that Section . \nBy way of derogation from the second subparagraph of this Secti on, a \nnew UFI shall not be required for mixtures in a group submissio n \ncontaining perfumes provided that the change in the composition  only \nconcerns those perfumes or the addition of new perfumes.  \nBy way of derogation from the second subparagraph of this Secti on, a \nnew UFI shall not be required where a change fulfilling the con dition \nforeseen in point (a) of the fourth indent of the first subpara graph of \nSection 4.1 of Part B solely concerns one or more components gr ouped \nin an interchangeable component group already included in the s ubmission \nin accordance with Section 3.5 of Part B.  \n5.2. The UFI shall be preceded by the acronym ‘UFI’ in capital letters \nfollowed by a colon (‘UFI:’) and it shall be clearly visible, l egible and \nindelibly marked.  \n5.3. Instead of including the UFI in the supplemental informati on on the label, \nthe submitter may opt to print or affix it on the inner packagi ng located \nwith the other label elements.  \nWhere the inner packaging is either in such a shape or so small  that it is \nimpossible to affix the UFI on it, the submitter may print or a ffix the UFI \nlocated with the other label elements on an outer packaging.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1495}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1497  \nIn the case of mixtures which are not packaged, the UFI shall b e indicated \nin the Safety Data Sheet or be included in the copy of the labe l elements \nreferred to in Article 29(3), as applicable.  \nIn the case of packaged mixtures supplied for use at an industr ial site, \ninstead of including the UFI on the label or packaging, the sub mitter may \nopt to indicate it in the Safety Data Sheet.  \n6. FORMATS AND TECHNICAL SUPPORT FOR SUBMISSION OF \nINFORMATION  \n6.1. The Agency shall specify, maintain and update the UFI gene rator, the \nXML formats for submissions and a harmonised product categorisa tion \nsystem and make them available free of charge on its website.  \n6.2. The Agency shall provide technical and scientific guidance , technical \nsupport and tools facilitating the submission of information.  \nPART B  \nINFORMATION CONTAINED IN A SUBMISSION  \n1. IDENTIFICATION OF THE MIXTURE AND OF THE SUBMITTER  \n1.1. Product identifier of the mixture  \nThe product identifier shall be provided in accordance with \nArticle 18(3)(a).  \nThe complete trade name(s) of the mixture shall be provided, in cluding, \nwhere relevant, brand name(s), name of the product and variant names as \nthey appear on the label, without abbreviations and enabling it s specific \nidentification.  \nIn addition, the UFI(s) shall be included in the submission.  \n1.2. Details of the submitter and contact point  \nThe name, full address, telephone number and email address of t he \nsubmitter shall be provided, and, if different, the name, full address, \ntelephone number and email address of the point of contact to b e used \nfor obtaining further information relevant for emergency health  response \npurposes.  \n1.3. Name, telephone number and email address for rapid access to ad \xad\nditional product information  \nIn the case of a limited submission as laid down in Section 2.3  of Part A, \na name, a telephone number and an email address shall be provid ed at \nwhich rapid access to detailed additional product information r elevant for \nemergency health response purposes is available in the language  provided \nin Section 3.3 of Part A. The telephone number shall be accessi ble 24 \nhours per day, 7 days per week.  \n2. HAZARDS IDENTIFICATION AND ADDITIONAL INFORMATION  \nThis Section sets out the information requirements related to t he health \nand physical hazards of the mixture and the appropriate warning  \ninformation associated with those hazards, as well as the addit ional \ninformation to be included in a submission.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1496}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1498  \n2.1. Classification of the mixture  \nThe classification of the mixture for health and physical hazar ds (hazard \nclass, category and statement) shall be provided in accordance with the \nclassification rules in Annex I.  \n2.2. Label elements  \nThe following label elements required in accordance with Articl e 17 shall \nbe provided, if applicable:  \n— hazard pictogram codes (Annex V),  \n— signal word,  \n— hazard statement codes (Annex III, including supplemental haz ard \ninformation),  \n— precautionary statement codes (Annex IV).  \n2.3. Toxicological information  \nThe submission shall include the information on the toxicologic al effects \nof the mixture or its components that is required in Section 11  of the \nSafety Data Sheet of the mixture, in accordance with Annex II t o Regu\xad\nlation (EC) No 1907/2006.  \n2.4. Additional information  \nThe following additional information shall be provided:  \n— the type(s) and size(s) of the packaging used to place the mi xture on \nthe market for consumer or professional use,  \n— the colour(s) and the physical state(s) of the mixture, as su pplied,  \n— the pH, if available, of the mixture as supplied, or where th e product is \na solid, the pH of an aqueous liquid or solution at a given con cen\xad\ntration. The concentration of the test mixture in water shall b e indi\xad\ncated. If the pH is not available, the reasons shall be given,  \n— product category (see Section 3.4 of Part A),  \n— use (consumer, professional, industrial, or a combination of any of the \nthree).  \n3. INFORMATION ON MIXTURE COMPONENTS  \n3.1. General requirements  \nThe chemical identity and the concentrations of the components contained \nin the mixture shall be indicated in the submission in accordan ce with \nSections 3.2, 3.3 and 3.4.  \nBy way of derogation from the first subparagraph, in the case o f a limited \nsubmission as laid down in Section 2.3 of Part A, the informati on to be \nsubmitted on the composition of a mixture for industrial use or  a mixture \nwith an end use not subject to notification may be limited to t he \ninformation contained in the Safety Data Sheet in accordance wi th \nAnnex II to Regulation (EC) No 1907/2006, provided that additio nal \ninformation on the composition is rapidly available on request in emerg\xad\nencies in accordance with Section 1.3.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1497}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1499  \nComponents which are not present in a mixture shall not be noti fied. \nHowever, if they are notified as part of an interchangeable com ponent \ngroup in accordance with Section 3.5 or their concentration has  been \nsubmitted as a range of percentages in accordance with Sections  3.6 or \n3.7, they may be notified if they will certainly be present in the mixture at \nsome point in time.  \nBy way of derogation from the third subparagraph, in a group su bmission, \nperfume components in mixtures shall be present in at least one  of the \nmixtures  \nFor group submissions where the perfumes vary between the mixtu res \ncontained in the group, a list shall be provided of the mixture s and the \nperfumes they contain, including their classification.  \n3.2. Identification of mixture components  \nA mixture component is either a substance or a mixture in mixtu re. \n3.2.1.  Substances  \nThe product identifier for the substances identified according to Section \n3.3 shall be provided in accordance with Article 18(2). However , an INCI \nname, a colour index name or another international chemical nam e may be \nused, provided the chemical name is well known and unambiguousl y \ndefines the substance identity. The chemical name of substances  for \nwhich an alternative chemical name has been allowed in accordan ce \nwith Article 24 shall be provided as well.  \n3.2.2.  Mixture in mixture  \nWhen a mixture is used in the composition of a second mixture p laced on \nthe market, the first mixture is referred to as a mixture in mi xture \n(‘MIM’).  \nInformation on the substances contained in a MIM shall be provi ded in \naccordance with the criteria of Section 3.2.1, unless the submi tter does not \nhave access to information on the full composition of the MIM. In the \nlatter case,  \n(a) if a UFI has been created for the MIM and the appointed bod y has \nreceived the information on the MIM in a prior submission, the MIM \nshall be identified by means of its product identifier in accor dance \nwith Article 18(3)(a), together with its concentration and UFI;  \n(b) if a UFI has been created for the MIM, but the appointed bo dy has \nnot received the information on the MIM in a prior submission, the \nMIM shall be identified by means of its product identifier in \naccordance with Article 18(3)(a), together with its concentrati on \nand UFI and the compositional information contained in the Safe ty \nData Sheet in accordance with Annex II to Regulation (EC) No \n1907/2006 of the MIM and any other known components, as well \nas the name, email address and telephone number of the MIM \nsupplier;  \n(c) in absence of a UFI, the MIM shall be identified by means o f its \nproduct identifier in accordance with Article 18(3)(a), togethe r with \nits concentration and the compositional information contained i n the \nSafety Data Sheet in accordance with Annex II to Regulation (EC ) \nNo 1907/2006 of the MIM and any other known components, as well  \nas the name, email address and telephone number of the MIM \nsupplier.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1498}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1500  \n3.2.3.  Identification by generic component identifiers  \nBy way of derogation from Sections 3.2.1 and 3.2.2, the generic  \ncomponent identifiers ‘perfumes’, or ‘colouring agents’ may be used for \nmixture components used exclusively to add perfume or colour, w here the \nfollowing conditions are met:  \n— the mixture components are not classified for any health haza rd, \n— the concentration of mixture components identified with a giv en \ngeneric component identifier does not exceed in total:  \n(a) 5 % for the sum of perfumes; and  \n(b) 25 % for the sum of colouring agents.  \n3.3. Mixture components subject to submission requirements  \nThe following mixture components shall be indicated:  \n(1) mixture components classified as hazardous on the basis of their \nhealth or physical effects which:  \n— are present in concentrations equal to or greater than 0,1 %,  \n— are identified, even if in concentrations lower than 0,1 %, u nless \nthe submitter can demonstrate that those components are \nirrelevant for the purposes of emergency health response and \npreventative measures;  \n(2) mixture components not classified as hazardous on the basis  of their \nhealth or physical effects which are identified and present in concen\xad\ntrations equal to or greater than 1 %.  \n3.4. Concentration and concentration ranges of the mixture components  \nSubmitters shall provide the information laid down in Sections 3.4.1 and \n3.4.2 with regard to the concentration of the mixture component s, \nidentified in accordance with Section 3.3.  \n3.4.1.  Hazardous components of major concern for emergency health response \nand preventative measures  \nWhen mixture components are classified in accordance with this Regu\xad\nlation for at least one of the hazard categories listed below, their concen\xad\ntration in the mixture shall be expressed as exact percentages,  in \ndescending order by mass or volume.  \n— Acute toxicity, Category 1, 2 or 3,  \n— Specific target organ toxicity – Single exposure, Category 1 or 2,  \n— Specific target organ toxicity – Repeated exposure, Category 1 or 2,  \n— Skin corrosion, category 1, 1A, 1B or 1C,  \n— Serious eye damage, Category 1.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1499}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1501  \nAs an alternative to providing concentrations as exact percenta ges, a range \nof percentages may be submitted in accordance with Table 1.  \nTable 1  \nConcentration ranges applicable to hazardous components of major \nconcern for emergency health response  \nConcentration range of the hazardous \ncomponent contained in the mixture (%)  Maximum width of the concentration \nrange to be used in the submission  \n≥ 25 – < 100  5 % units  \n≥ 10 – < 25  3 % units  \n≥ 1 – < 10  1 % units  \n≥ 0,1 – < 1  0,3 % units  \n> 0 – < 0,1  0,1 % units  \n3.4.2.  Other hazardous components and components not classified as hazardous  \nThe concentration of the hazardous components in the mixture th at are not \nclassified for any of the hazard categories listed in Section 3 .4.1 and of the \nidentified components not classified as hazardous shall be expr essed, in \naccordance with Table 2, as ranges of percentages in descending  order by \nmass or volume. As an alternative, exact percentages may be pro vided.  \nTable 2  \nConcentration ranges applicable to other hazardous components and \ncomponents not classified as hazardous  \nConcentration range of the component \ncontained in the mixture (%)  Maximum width of the concentration \nrange to be used in the submission  \n≥ 25 – < 100  20 % units  \n≥ 10 – < 25  10 % units  \n≥ 1 – < 10  3 % units  \n> 0 – < 1  1 % units  \nBy way of derogation from the first subparagraph, for perfume \ncomponents in a group submission that are not classified or onl y classified \nfor skin sensitisation Category 1, 1A or 1B or aspiration toxic ity, \nsubmitters shall not be required to provide information on thei r concen\xad\ntration.  \n3.5. Grouping of components in an interchangeable component group  \nComponents may be grouped in a submission in an interchangeable  \ncomponent group provided that:  \n(a) for all components in the interchangeable component group:  \n— the technical function(s) for which the components are used i n the \nmixture for which the submission is made is (are) identical, an d ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1500}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1502  \n— the classification for health and physical hazards is identic al \n(hazard class and category), and  \n— the toxicological properties, including at least the type of toxico\xad\nlogical effect(s) and the target organ(s), are the same; and  \n(b) for all possible combinations of the resulting final mixtur e based on \nthe components in the interchangeable component group, the haza rds \nidentification and additional information referred to in Sectio n 2 of \nPart B are identical.  \nAlternatively, components that are classified only for skin cor rosion, skin \nirritation, eye damage, eye irritation, aspiration toxicity, or  respiratory or \nskin sensitisation, or a combination thereof, may be grouped in  an inter\xad\nchangeable component group provided that:  \n(a) the classification for health and physical hazards (hazard class and \ncategory) is identical for all components; and  \n(b) the pH, where applicable, of all components classified for skin \ncorrosion, skin irritation, eye damage, or eye irritation is ei ther \nacidic, neutral or alkaline; and  \n(c) the interchangeable component group does not contain more t han five \ncomponents; and  \n(d) for all possible combinations of the resulting final mixtur e based on \nthe components grouped in the interchangeable component group, the \nhazards identification and additional information referred to i n \nSection 2 of Part B are identical.  \n3.5.1.  Name of interchangeable component group and identification of grouped \ncomponents  \nAn interchangeable component group shall be given a name which \ncorresponds to the technical function(s) of the grouped compone nts for \nwhich they were incorporated in the mixture.  \nEach component in an interchangeable component group shall be \nidentified in accordance with Section 3.2.1 or 3.2.2, as applic able.  \n3.5.2.  Concentration and concentration ranges of grouped components  \nBy way of derogation from the first subparagraph of Section 3.4 , for \ncomponents grouped in an interchangeable component group, submi tters \nshall provide the information laid down in Sections 3.4.1 and 3 .4.2 with \nregard to the total concentration of all components present in the mixture \nand grouped in the interchangeable component group.  \nWhen mixture components grouped in an interchangeable component  \ngroup are classified in accordance with this Regulation for at least one \nof the hazard categories listed in Section 3.4.1, the total con centration of \nthe components present in the mixture and grouped in the interc hangeable \ncomponent group shall be expressed as exact percentages, in des cending \norder by mass or volume. As an alternative, a range of percenta ges may be \nsubmitted in accordance with Table 1 of that Section.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1501}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1503  \nThe total concentration of the hazardous components present in the \nmixture and grouped in an interchangeable component group that are \nnot classified for any of the hazard categories listed in Secti on 3.4.1, \nand the total concentration of the identified components presen t in the \nmixture and grouped in an interchangeable component group not c lassified \nas hazardous, shall be expressed, in accordance with Table 2 of  Section \n3.4.2, as ranges of percentages in descending order by mass or volume. As \nan alternative, exact percentages may be provided.  \n3.6. Mixtures complying with standard formulas  \nBy way of derogation from Sections 3.2, 3.3 and 3.4, for a mixt ure with a \ncomposition conforming with a standard formula specified in Par t D, \nwhere the mixture classification does not change depending on t he \ncomponents’ concentration within the ranges of percentages spec ified in \nthe corresponding standard formula:  \n— if the information on composition in the standard formula, to gether \nwith information as specified in Sections 3.2 to 3.4 on the ide ntity and \nconcentration of the components not specified in the standard f ormula, \nis not less detailed than that contained in the Safety Data She et in \naccordance with Annex II to Regulation (EC) No 1907/2006, the \nidentity and concentration of one or more of the mixture’s comp onents \nmay be submitted as specified in the standard formula for the \ncomponents mentioned in that formula and as specified in Sectio ns \n3.2 to 3.4 for the other components,  \n— if the information referred to in the previous indent is less  detailed \nthan that contained in the Safety Data Sheet in accordance with  Annex \nII to Regulation (EC) No 1907/2006, the information on the iden tity \nand concentration of all the mixture’s components contained in the \nSafety Data Sheet in accordance with Annex II to Regulation (EC ) No \n1907/2006 shall be given.  \n3.7. Fuels  \nBy way of derogation from Sections 3.2, 3.3 and 3.4, for those fuels listed \nin Table 3, the identity and concentration of the mixture’s com ponents \nlisted in the Safety Data Sheet in accordance with Annex II to Regulation \n(EC) No 1907/2006 may be submitted. The identity and concentrat ion of \nany other  known component shall also be submitted.  \nTable 3  \nList of fuels  \nFuel Product description  \nGasoline EN228  Automotive fuels – Unleaded \npetrol  \nGasoline E85  Automotive fuels – Ethanol (E85) \nautomotive fuel  \nGasoline alkylate  Motor fuels – special petrol for \npowered implements  \nLPG  Liquefied Petroleum Gas used as \nfuel \nLNG  Liquefied Natural Gas used as fuel  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1502}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1504  \nFuel Product description  \nDiesel fuel  Automotive fuels – diesel engine \nfuels with/without biofuel  \nParaffinic diesel fuels (e.g GTL, \nBTL or HVO)  Automotive fuels – Paraffinic \ndiesel fuel from synthesis or hydro\xad\ntreatment  \nHeating oil  Liquid mineral fuels with the \ncharacteristics of domestic fuel oil  \nMK 1 diesel  Automotive fuels – Diesel fuel oil \nof environmental class 1 and 2 for \nhigh-speed diesel engines  \nAviation fuels  Aviation turbine engine and piston \nengine fuels  \nKerosene – Illuminating paraffin  Illuminating paraffin lampoil Type \nB and C  \nHeavy fuel oil  All grades of heavy fuel oil  \nMarine fuel  Marine fuels, containing or not \nbiodiesel  \nFatty acid methyl esters (FAME) – \nDiesel B100  Fatty acid methyl esters (FAME) \nfor use in diesel engines and \nheating applications  \n3.8. Classification of mixture components  \nThe classification for health and physical effects (hazard clas ses, hazard \ncategories and hazard statements) of substances identified in a ccordance \nwith Section 3.3 and contained in the mixture shall be provided . This \nincludes the classification for at least all substances, indica ted pursuant \nto Point 3.2.1 of Annex II to Regulation (EC) No 1907/2006 in t he Safety \nData Sheet of the mixture and in the Safety Data Sheet of any M IM \ncontained in the mixture. For MIMs identified in accordance wit h \nSection 3.3 where the submitter does not have access to the ful l \ncomposition of the MIM, the classification for health and physi cal \neffects of the MIM shall be provided in addition.  \n4. SUBMISSION UPDATE  \n4.1. Conditions for submission update  \nWhere one of the following changes applies to a mixture in an i ndividual \nor group submission, submitters shall provide a submission upda te before \nplacing that mixture, as changed, on the market:  \n— when the mixture product identifier or the UFI has changed,  \n— when the mixture classification for health or physical hazard s has \nchanged,  \n— when relevant new toxicological information that is required in Section \n11 of the Safety Data Sheet becomes available on the hazardous \nproperties of the mixture or its components,  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1503}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1505  \n— if a change in the composition of the mixture fulfils one of the \nfollowing conditions:  \n(a) addition, substitution, or deletion of one or more componen ts in \nthe mixture that shall be indicated in accordance with Section 3.3; \n(b) change in the concentration of a component in the mixture b eyond \nthe concentration range provided in the original submission;  \n(c) the exact concentration of a component was provided in \naccordance with Sections 3.4.1 or 3.4.2, and a change occurs to  \nthat concentration beyond the limits identified in Table 4.  \nBy way of derogation from the fourth indent of the first subpar agraph, the \nfollowing shall apply:  \n(a) a submission update for mixtures with a composition conform ing with \nany of the standard formulas specified in Part D is required on ly when \nthe composition of the mixture changes in such a manner that th e \nmixture’s composition no longer conforms with the standard form ula; \n(b) for mixtures where the information on composition is provid ed based \non the Safety Data sheet in accordance with Section 3.6 or 3.7 a \nsubmission update is required when Section 3 of the Safety Data  \nSheet is updated.  \nTable 4  \nVariations of the concentration of components requiring a submission \nupdate  \nExact concentration of the component \ncontained in the mixture (%)  Variations (±) of the initial component \nconcentration requiring a submission \nupdate  \n> 25 – ≤ 100  5  %  \n> 10 – ≤ 25  10 %  \n> 2,5 – ≤ 10  20 %  \n≤ 2,5  30 %  \nWhen perfumes in a group submission change, the list of mixture s and the \nperfumes they contain as required in Section 3.1 shall be updat ed. \n4.2. Content of the submission update  \nThe submission update shall comprise a revised version of the p revious \nsubmission containing the new information available as describe d in \nSection 4.1.  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1504}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1506  \nPART C  \nSUBMISSION FORMAT  \n1. SUBMISSION FORMAT  \n1.1. Submission Format  \nThe submission of information to appointed bodies in accordance  with \nArticle 45 shall be in a format to be provided by the Agency. T he \nsubmission format shall address the following elements:  \n1.2. Identification of the mixture, submitter and contact point  \nProduct identifier  \n— Complete trade name(s) of the product (in case of group submi ssion, \nall product identifiers shall be listed)  \n— Other names, synonyms  \n— Unique Formula Identifier(s) (UFI)  \n— Other identifiers (authorisation number, company product code s) \nContact details of the submitter and contact point  \n— Name  \n— Full address  \n— Telephone number  \n— Email address  \nContact details for rapid access to additional product information (24 \nhours/7 days). Only for limited submission.  \n— Name  \n— Telephone number (accessible 24 hours per day, 7 days per wee k) \n— Email address  \n1.3. Classification of the mixture, label elements and toxicology  \nClassification of the mixture and label elements  \n— Hazard class and category  \n— Hazard pictogram codes (Annex V)  \n— Signal word  \n— Hazard statement codes, including supplemental hazard informa tion \ncodes (Annex III)  \n— Precautionary statement codes (Annex IV)  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1505}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1507  \nToxicological information  \n— Description of the toxicity of the mixture or its components (as \nrequired in Section 11 of the Safety Data Sheet in accordance w ith \nAnnex II to Regulation No 1907/2006)  \nAdditional information on the mixture  \n— Colour(s)  \n— The pH, if available, of the mixture as supplied, or where th e mixture \nis a solid, the pH of an aqueous liquid or solution at a given concen\xad\ntration. The concentration of the test mixture in water shall b e indi\xad\ncated. If the pH is not available, the reasons shall be given.  \n— Physical state(s)  \n— Packaging (type(s) and size(s))  \n— Intended use (product category)  \n— Uses (consumer, professional, industrial)  \n1.4. Information on the mixture components and interchangeable \ncomponent groups  \nIdentification of the mixture components  \n— Chemical/trade name of the components  \n— CAS number (where applicable)  \n— EC number (where applicable)  \n— UFI (where applicable)  \nName of interchangeable component groups (where applicable)  \nConcentration and concentration ranges of the mixture components  \n— Exact concentration or concentration range  \nClassification of mixture components  \n— Hazard classification (where applicable)  \n— Additional identifiers (where applicable and relevant for hea lth \nresponse)  \nList according to Part B, Section 3.1, fifth subparagraph (where appli \xad\ncable)  \nPART D  \nSTANDARD FORMULAS  \nFor standard formulas 1-17 the following conditions apply:  \n— Heavy metal, trace elements: As, Ba, Cd, Cr, Co, Cu, Hg, Mo, Ni, Pb, Sb, \nSn, Te, Tl, V are below 0,1 w/w % and Mn, Sr, Zn are below 1 w/ w %  \n— PAHs are not present  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1506}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1508  \nNote applying to standard formulas 1-17:  \n— (1) UVCB substance consists of variable amounts of calcite, tricalc ium \nsilicate, dicalcium silicate, calcium oxide, quartz, potassium chloride, \npotassium sulfate, calcium sulfate, sodium aluminium silicate, magnesium \naluminium silicate, muscovite, …  \n1. CEMENT  \nCement Standard Formula – 1  \nProduct description  Portland cement  \nwith one main constituent: clinker  \nComponent name  EC No  Concentration (w/w%)  \nPortland cement clinker  266-043-4  86,5 – 100  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 2  \nProduct description  Portland-slag cement and Blast furnace cement  \nwith two main constituents: clinker and slag  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  4,6 – 94  \nGranulated blast furnace slag  266-002-0  5,5 – 95  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 3  \nProduct description  Portland-silica fume cement  \nPortland cements with two main constituents: clinker and silica fume  \nComponent name  EC No  Concentration (w/w%)  \nPortland cement clinker  266-043-4  82 – 94  \nSilica fume  273-761-1  5,5 – 10  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1507}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1509  \nCement Standard Formula – 4  \nProduct description  Portland-pozzolana cement, Pozzolanic cement  \nPortland cements with two main constituents: clinker and pozzolan (natural or natural \ncalcined pozzolan)  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  41 – 94  \nNatural (calcined) pozzolana  310-127-6  5,5 – 55  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-303-2  0 – 0,1  \nCement Standard Formula – 5  \nProduct description  Portland-fly ash cement, Pozzolanic cement  \nPortland cements with two main constituents: clinker and fly ash (siliceous and \ncalcareous fly ash)  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  41 – 94  \nFly ash  931-322-8  5,5 – 55  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 6  \nProduct description  Portland-burnt shale cement  \nPortland cements with two main constituents: clinker and burnt shale  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  59 – 94  \nBurnt shale  297-648-1  5,5 – 35  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1508}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1510  \nCement Standard Formula – 7  \nProduct description  Portland-limestone cement  \nPortland cements with two main constituents: clinker and limestone  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  59 – 94  \nLimestone  215-279-6  5,5 – 35  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 8  \nProduct description  Portland-composite cement, Composite cement (slag – limestone)  \nPortland cements with three main constituents: clinker, slag and limestone  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  31,9 – 88  \nGranulated blast furnace slag  266-002-0  5,5 – 59  \nLimestone  215-279-6  5,5 – 29  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 9  \nProduct description  Portland-composite cement, Composite Cement (slag – fly ash)  \nPortland cements with three main constituents: clinker, blast-furnace slag, siliceous and \ncalcareous fly ash  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  18,2 – 88  \nGranulated blast furnace slag  266-002-0  5,5 – 59  \nFly ash  931-322-8  5,5 – 49  \nCalcium sulfate  231-900-3  0  –  8  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1509}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1511  \nCement Standard Formula – 9  \nProduct description  Portland-composite cement, Composite Cement (slag – fly ash)  \nPortland cements with three main constituents: clinker, blast-furnace slag, siliceous and \ncalcareous fly ash  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 10  \nProduct description  Portland-composite cement, Composite cement (slag – pozzolana)  \nPortland cements with three main constituents: clinker, blast-furnace slag, natural or \nnatural calcined pozzolan  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  18,2 – 88  \nGranulated blast furnace slag  266-002-0  5,5 – 49  \nNatural (calcined) pozzolana  310-127-6  5,5 – 49  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 11  \nProduct description  Portland-composite cement (slag – burnt shale)  \nPortland cements with three main constituents: clinker, blast-furnace slag, burnt shale  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  59 – 94  \nGranulated blast furnace slag  266-002-0  5,5 – 29  \nBurnt shale  297-648-1  5,5 – 29  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1510}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1512  \nCement Standard Formula – 12  \nProduct description  Portland-composite cement (limestone – fly ash)  \nPortland cements with three main constituents: clinker, limestone, siliceous and \ncalcareous fly ash  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  46 – 94  \nLimestone  215-279-6  5,5 – 29  \nFly ash  931-322-8  5,5 – 44  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 13  \nProduct description  Portland-composite cement (limestone – pozzolana)  \nPortland cements with three main constituents: clinker, limestone, natural or natural \ncalcined pozzolan  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  46 – 94  \nLimestone  215-279-6  5,5 – 29  \nNatural (calcined) pozzolana  310-127-6  5,5 – 44  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 14  \nProduct description  Portland-composite cement (limestone – burnt shale)  \nPortland cements with three main constituents: clinker, limestone and burnt shale  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  59 – 94  \nLimestone  215-279-6  5,5 – 29  \nBurnt shale  297-648-1  5,5 – 29  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1511}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1513  \nCement Standard Formula – 15  \nProduct description  Portland-composite cement, Pozzolanic cement (fly ash – pozzola na) \nPortland cements with three main constituents: clinker, siliceous and calcareous fly ash, \nnatural or natural calcined pozzolan  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  41 – 94  \nNatural (calcined) pozzolana  310-127-6  5,5 – 55  \nFly ash  931-322-8  5,5 – 55  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 16  \nProduct description  Portland-composite  \nPortland cements with four main constituents: clinker and three of these constituents: \nblast-furnace slag, silica fume, fly ash, pozzolan, burnt shale, limestone  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  59 – 94  \nGranulated blast furnace slag \nNatural (calcined) pozzolana \nFly ashes \nBurnt shale \nLimestone \nSilica fume  266-002-0 \n310-127-6 \n931-322-8 \n297-648-1 \n215-279-6 \n273-761-1  5,5 – 23  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  \nCement Standard Formula – 17  \nProduct description  Composite cement  \nPortland cements with four main constituents: clinker, slag, siliceous fly ash and natural \nor natural calcined pozzolan  \nConstituent  EC No  Concentration (w/w%)  \nPortland cement clinker  266-043-4  18,3 – 64  \nGranulated blast furnace slag  266-002-0  16,5 – 49  \nNatural (calcined) pozzolana  310-127-6  5,5 – 43  \nFly ash  931-322-8  5,5 – 43  \nCalcium sulfate  231-900-3  0  –  8  \nFlue dust  (1) 270-659-9  \n0 – 5  \nInorganic natural mineral materials  310-127-6  \nIron(II) sulfate  231-753-5  0  –  1  \nTin(II) sulfate  231-302-2  0 – 0,1  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1512}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1514  \nCement Standard Formula – 18  \nProduct description  Calcium aluminate cement  \nConstituent  EC No  Concentration (w/w %)  \nCalcium aluminate cement clinker  266-045-5  86,5 – 100  \nGrinding aid  -  0 – 0,2  \nCement Standard Formula – 19  \nProduct description  Masonry cements – with clinker and lime – MC 5, MC 12,5, MC 22 ,5 \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  25 – 60  \nBuilding lime acc. to EN 459  215-138-9,  \n1 – 75  \nHydrated lime acc. to EN 459  215-137-3  \nOther, non-hazardous inorganic \nconstituent  310-127-6  0  –  7 4  \nInorganic pigments acc. to EN \n12878  - 0  –  1  \nCement Standard Formula – 20  \nProduct description  Masonry cements – with clinker and without lime – MC 5, MC 12, 5, MC 22,5  \nComponent name  EC No  Concentration (w/w %)  \nPortland cement clinker  266-043-4  25 – 60  \nOther, non-hazardous inorganic \nconstituent  310-127-6  40 – 75  \nInorganic pigments acc. to EN \n12878  0 – 1  \n2. GYPSUM BINDER  \nGypsum binder Standard Formula  \nComponent name  EC No  Concentration \n(w/w %)  \nCalcium sulphate  231-900-3  ≥ 50 and < 100  \nCalcium dihydroxide  215-137-3  > 0 and ≤ 5  \n3. READY MIXED CONCRETE  \nReady mixed concrete Standard Formula 1 \nConcrete strength classes C8/10, C12/15, C16/20, C20/25, C25/30, C28/35, C32/40, C35/45, C40/50, C45/55, C50/60 \nLC8/9, LC12/13, LC16/18, LC20/22, LC25/28, LC30/33, LC35/38, LC40/44, LC45/50, LC50/55, LC55/60  \nComponent name  EC No  Concentration (w/w %)  \nCement  270-659-9  3  –  1 8  \nWater  231-791-2  5  –  8  \nAggregates  273-727-6  70 – 80  \nAir entrainers (admixture)  -  0 – 0,08  \nPlasticisers/superplasticisers \n(admixture)  - 0 – 0,15  \nRetarders (admixture)  -  0 – 0,4  \nAccelerators (admixture)  -  0 – 0,2  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1513}), Document(page_content='02008R1272 — EN — 01.03.2022 — 021.001 — 1515  \nReady mixed concrete Standard Formula 1 \nConcrete strength classes C8/10, C12/15, C16/20, C20/25, C25/30, C28/35, C32/40, C35/45, C40/50, C45/55, C50/60 \nLC8/9, LC12/13, LC16/18, LC20/22, LC25/28, LC30/33, LC35/38, LC40/44, LC45/50, LC50/55, LC55/60  \nComponent name  EC No  Concentration (w/w %)  \nWater resisting (admixture)  -  0 – 0,25  \nFly ash  931-322-8  0  –  8  \nSilica fume  273-761-1  0  –  3  \nGGBS  266-002-0  0  –  6  \nReady mixed concrete Standard Formula 2 \nConcrete strength classes C55/67, C60/75, C70/85, C80/95, C90/105, C100/105, \nLC 60/66, LC70/77, LC80/88  \nComponent name  EC No  Concentration (w/w %)  \nCement  270-659-9  12 – 25  \nWater  231-791-2  5  –  8  \nAggregates  273-727-6  70 – 80  \nAir entrainers (admixture)  -  0,04 – 0,08  \nPlasticisers/superplasticisers \n(admixture)  - 0 – 0,15  \nRetarders (admixture)  -  0 – 0,4  \nAccelerators (admixture)  -  0 – 0,2  \nWater resisting (admixture)  -  0 – 0,25  \nFly ash  931-322-8  0  –  8  \nSilica fume  273-761-1  0  –  3  \nGGBS  266-002-0-  0  –  6  ▼M26', metadata={'source': 'data/ycla_en.pdf', 'page': 1514})]
